,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
8596,GO:0034097,2.38084693710924e-30,1,115,813,response to cytokine,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;CXCL1;IL1A;BIRC3;CCL20;FOSL1;ZC3H12A;CXCL5;IL16;LIF;SOD2;IL36G;IL1RN;NFKB1;EDN1;ZFP36;SERPINB2;JUN;IFNAR2;ETS1;TRAF1;SQSTM1;CSF1;IRF6;EREG;IL23A;REL;PELI1;BIRC2;IFNGR2;IL6;NFKB2;TNFRSF10B;ZFP36L1;TNFSF15;CYP27B1;RIPK2;IRAK2;JUNB;CYLD;TJP2;RELB;CDKN1A;CLDN1;GBP2;IL7R;NOD2;IL6ST;RELT;ICAM1;GCH1;SMAD3;VEGFA;IL1R2;MAP3K8;PIGA;CEBPB;CEBPD;CDC42EP4;IFNAR1;CREB1;RUNX1;SAA1;TRIM25;IFNGR1;WNT5A;VEGFC;SOCS2;PDGFB;IL20;IFIH1;MMP9;OTUD4;IL32;MT2A;MAOA;SPRY2;CXCL16;IL4R;IL24;TNFRSF6B;NFE2L2;PTPN1;TAB3;STAT5A;CAV1;HLA-A;TNIP2;TP53;HLA-B;IKBKE;STX1A;PML;PIM1;ADAM9;RELA;MUC1;AXL;HLA-F;HLA-E;GSK3B;OSMR;OCLN;VIM;XBP1;IL36RN;JUND
3273,GO:0006952,9.87284216290664e-29,1,121,918,defense response,BP,NFKBIZ;CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;TNF;IRF1;CXCL3;CXCL1;IL1A;INHBA;BIRC3;CCL20;FOSL1;ZC3H12A;CXCL5;ELF3;BMP2;CD83;PRDM1;IL36G;PMAIP1;PTX3;IL1RN;NFKB1;TNIP1;EDN1;MAP2K3;TICAM1;KDM6B;IFNAR2;ETS1;CSF1;IRF6;EREG;IL23A;REL;BCL3;PELI1;BIRC2;IFNGR2;IL6;NFKB2;ADAM8;TNFRSF10B;BDKRB1;CYP27B1;RIPK2;IRAK2;CYLD;RELB;CLDN1;GBP2;NOD2;IL6ST;RELT;ICAM1;GCH1;SMAD3;B4GALT1;NFKBID;IL1R2;ABL2;CEBPB;CD55;TAP1;CDC42EP4;IFNAR1;SLC7A2;CD47;SAA1;TRIM25;IFNGR1;WNT5A;ABCF1;DUSP10;IL20;PGLYRP4;IFIH1;LDLR;OTUD4;IL32;MT2A;CXCL16;IL4R;TNFRSF6B;RAET1L;NFE2L2;PTPN1;SMAD1;TAB3;TPST1;CAV1;VEZF1;HLA-A;TNIP2;TLR2;HLA-B;IKBKE;UBE2D3;MAPKBP1;ADGRE2;ZNF148;PML;POLR3A;RELA;CHST2;MUC1;AXL;FRK;HLA-F;HLA-E;OSMR;PPARD;HCP5;COTL1;VIM;ELF4;IL36RN;CFB
6076,GO:0019221,3.17681348937503e-28,1,87,531,cytokine-mediated signaling pathway,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;CXCL1;IL1A;BIRC3;CCL20;CXCL5;IL16;LIF;SOD2;IL36G;IL1RN;NFKB1;EDN1;SERPINB2;IFNAR2;TRAF1;SQSTM1;CSF1;IRF6;EREG;IL23A;PELI1;BIRC2;IFNGR2;IL6;TNFRSF10B;TNFSF15;RIPK2;IRAK2;JUNB;CYLD;TJP2;CDKN1A;GBP2;IL7R;NOD2;IL6ST;RELT;ICAM1;VEGFA;IL1R2;MAP3K8;CEBPD;IFNAR1;RUNX1;SAA1;TRIM25;IFNGR1;WNT5A;SOCS2;PDGFB;IL20;MMP9;OTUD4;IL32;MT2A;MAOA;IL4R;IL24;TNFRSF6B;PTPN1;TAB3;STAT5A;CAV1;HLA-A;TNIP2;TP53;HLA-B;STX1A;PML;PIM1;RELA;MUC1;AXL;HLA-F;HLA-E;OSMR;VIM;IL36RN
15210,GO:0071345,8.65276255199353e-26,1,102,746,cellular response to cytokine stimulus,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;CXCL1;IL1A;BIRC3;CCL20;ZC3H12A;CXCL5;IL16;LIF;SOD2;IL36G;IL1RN;NFKB1;EDN1;ZFP36;SERPINB2;IFNAR2;TRAF1;SQSTM1;CSF1;IRF6;EREG;IL23A;PELI1;BIRC2;IFNGR2;IL6;TNFRSF10B;ZFP36L1;TNFSF15;RIPK2;IRAK2;JUNB;CYLD;TJP2;CDKN1A;CLDN1;GBP2;IL7R;NOD2;IL6ST;RELT;ICAM1;SMAD3;VEGFA;IL1R2;MAP3K8;PIGA;CEBPB;CEBPD;CDC42EP4;IFNAR1;CREB1;RUNX1;SAA1;TRIM25;IFNGR1;WNT5A;VEGFC;SOCS2;PDGFB;IL20;MMP9;OTUD4;IL32;MT2A;MAOA;SPRY2;IL4R;IL24;TNFRSF6B;NFE2L2;PTPN1;TAB3;STAT5A;CAV1;HLA-A;TNIP2;TP53;HLA-B;STX1A;PML;PIM1;RELA;MUC1;AXL;HLA-F;HLA-E;GSK3B;OSMR;OCLN;VIM;XBP1;IL36RN
3272,GO:0006950,1.09664358604213e-25,1,227,2667,response to stress,BP,NFKBIZ;CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;PPP1R15A;ELF3;BMP2;PLAUR;CD83;SOD2;PRDM1;IL36G;TBX3;PMAIP1;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;EPHA2;EHD1;ETS1;SQSTM1;CSF1;BBC3;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;BIRC2;IFNGR2;IL6;NFKB2;ADAM8;TNFRSF10B;BDKRB1;PANX1;ZFP36L1;CYP27B1;RIPK2;IRAK2;JUNB;PHLDB2;CYLD;FZD8;RELB;C1QTNF1;CDKN1A;CLDN1;ITGA5;GBP2;RAP2B;CPEB2;GPX3;NOD2;IL6ST;RELT;TFPI2;SGK1;ICAM1;GCH1;SMAD3;B4GALT1;NFKBID;NINJ1;TRAF4;TRIB1;VEGFA;IL1R2;DKK1;PLK2;MAP3K8;ABL2;CFLAR;TXNRD1;BTG1;ANXA8;UPP1;IER5;CEBPB;CD55;TAP1;ADM;CDC42EP4;IFNAR1;ERRFI1;CREB1;USP43;NR4A2;SLC7A2;CD47;VHL;BACH1;ABTB2;TGFBR2;SFR1;SAA1;TRIM25;IFNGR1;MASTL;WNT5A;VEGFC;ABCF1;DUSP10;SLC52A3;SOX4;PDGFB;IL20;PGLYRP4;IFIH1;NRG1;TNC;SLC38A2;MMP9;LDLR;DCBLD2;ATF3;OTUD4;CAB39;IL32;PLK3;CHD2;TRPV3;MT2A;SLC9A1;RCHY1;TNKS1BP1;CXCL16;NUP153;BCL2L2;RNF152;IL4R;NEDD4;IL24;TNFRSF6B;RAET1L;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;SUSD6;TPST1;CAV1;VEZF1;HLA-A;INO80D;TNIP2;TP53;TLR2;HLA-B;IKBKE;UBE2D3;MAPKBP1;ELK3;RAD9B;ADGRE2;ZNF148;PML;POLR3A;ADAM9;RELA;ESCO2;PLAT;CHST2;MUC1;AXL;ANXA5;FRK;HLA-F;NR4A3;HLA-E;GSK3B;OSMR;PPARD;PARP1;HCP5;COTL1;JMY;VIM;EGLN1;NABP1;RPS6KA6;DDR1;XBP1;HSPA4L;ELF4;IL36RN;EID3;LMAN1;CFB;JUND
3275,GO:0006954,1.25044022788563e-25,1,70,367,inflammatory response,BP,NFKBIZ;CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;TNF;CXCL3;CXCL1;IL1A;BIRC3;CCL20;ZC3H12A;CXCL5;ELF3;BMP2;IL36G;PTX3;IL1RN;NFKB1;TNIP1;MAP2K3;TICAM1;KDM6B;ETS1;CSF1;IL23A;REL;BIRC2;IL6;NFKB2;ADAM8;TNFRSF10B;BDKRB1;RIPK2;IRAK2;RELB;NOD2;IL6ST;RELT;ICAM1;SMAD3;B4GALT1;NFKBID;IL1R2;CEBPB;CD55;SLC7A2;CD47;SAA1;WNT5A;ABCF1;DUSP10;IL20;LDLR;IL4R;TNFRSF6B;NFE2L2;SMAD1;TPST1;TNIP2;TLR2;ADGRE2;RELA;CHST2;AXL;OSMR;PPARD;IL36RN;CFB
7926,GO:0032496,1.1166931263934e-24,1,51,204,response to lipopolysaccharide,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;CXCL3;CXCL1;NOCT;CCL20;ZC3H12A;CXCL5;PRDM1;NFKB1;TNIP1;EDN1;ZFP36;JUN;TICAM1;PELI1;IL6;NFKB2;TNFRSF10B;BDKRB1;CYP27B1;RIPK2;IRAK2;JUNB;CLDN1;RELT;ICAM1;GCH1;NFKBIB;TRIB1;CEBPB;CD55;ADM;IFNAR1;WNT5A;DUSP10;IL24;TNFRSF6B;TNIP2;TLR2;ADAM9;RELA;AXL;PPARD;XBP1;JUND
881,GO:0002237,1.75962482725395e-24,1,52,214,response to molecule of bacterial origin,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;CXCL3;CXCL1;NOCT;CCL20;ZC3H12A;CXCL5;PRDM1;NFKB1;TNIP1;EDN1;ZFP36;JUN;TICAM1;PELI1;IL6;NFKB2;TNFRSF10B;BDKRB1;CYP27B1;RIPK2;IRAK2;JUNB;CLDN1;NOD2;RELT;ICAM1;GCH1;NFKBIB;TRIB1;CEBPB;CD55;ADM;IFNAR1;WNT5A;DUSP10;IL24;TNFRSF6B;TNIP2;TLR2;ADAM9;RELA;AXL;PPARD;XBP1;JUND
958,GO:0002376,2.92642546910842e-24,1,176,1863,immune system process,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;PLAU;CXCL1;IL1A;SDC4;INHBA;BIRC3;CCL20;ZC3H12A;CXCL5;IL16;RNF19B;LIF;PLAUR;CD83;PRDM1;IL36G;PMAIP1;PTX3;IL1RN;NFKB1;TNIP1;EDN1;ZFP36;JUN;TICAM1;KDM6B;IFNAR2;EPHA2;ETS1;HCAR2;SQSTM1;CSF1;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;AMPD3;EFNB1;BIRC2;IFNGR2;IL6;NFKB2;ADAM8;TNFRSF10B;BDKRB1;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;JUNB;CYLD;FZD8;TJP2;RELB;CDKN1A;CLDN1;ITGA5;GBP2;RAP2B;IL7R;CTSC;NOD2;IL6ST;RELT;ICAM1;GCH1;SMAD3;B4GALT1;NFKBID;TRIB1;VEGFA;RAB24;NRARP;IL1R2;CDKN2B;MAP3K8;ABL2;CEBPB;CD55;TAP1;CDC42EP4;IFNAR1;CREB1;SLC7A2;CD47;CANT1;RUNX1;TGFBR2;SAA1;TINAGL1;TRIM25;IFNGR1;KIF3C;WNT5A;VEGFC;SLC11A2;DUSP10;SOX4;SERPINB1;PDGFB;IL20;ANLN;PGLYRP4;IFIH1;MMP9;LDLR;OTUD4;CAB39;IL32;CHD2;MT2A;GRB7;CXCL16;IL4R;NEDD4;POU2F2;GCSAM;TNFRSF6B;RAET1L;BTN2A2;NFE2L2;PTPN1;TAB3;CAV1;HLA-A;TNIP2;TP53;TLR2;ABI1;TAPBP;EFNB2;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;CD276;ADGRE2;PML;POLR3A;ADAM9;RELA;ESCO2;EVI2B;MUC1;AXL;FRK;HLA-F;NR4A3;HLA-E;KMT2E;SLC16A1;PARP1;COTL1;VIM;XBP1;ELF4;IL36RN;TFE3;C12ORF29;MGAM;CFB
4271,GO:0009617,2.16093285956868e-23,1,59,298,response to bacterium,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;CXCL3;CXCL1;NOCT;CCL20;ZC3H12A;CXCL5;PRDM1;NFKB1;TNIP1;EDN1;ZFP36;JUN;TICAM1;IL23A;BCL3;PELI1;IL6;NFKB2;TNFRSF10B;BDKRB1;CYP27B1;RIPK2;IRAK2;JUNB;CLDN1;NOD2;RELT;ICAM1;GCH1;NFKBIB;TRIB1;CEBPB;CD55;ADM;IFNAR1;CD47;WNT5A;DUSP10;PGLYRP4;IL24;TNFRSF6B;CAV1;TNIP2;TLR2;MAPKBP1;ADAM9;RELA;AXL;HLA-E;PPARD;XBP1;JUND
4265,GO:0009607,1.86452888879739e-22,1,81,551,response to biotic stimulus,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;CXCL1;BIRC3;NOCT;CCL20;FOSL1;ZC3H12A;CXCL5;PRDM1;PMAIP1;PTX3;NFKB1;TNIP1;EDN1;ZFP36;JUN;TICAM1;IFNAR2;IL23A;BCL3;PELI1;BIRC2;IFNGR2;IL6;NFKB2;TNFRSF10B;BDKRB1;CYP27B1;RIPK2;IRAK2;JUNB;CLDN1;ODC1;NOD2;RELT;ICAM1;GCH1;SMAD3;NFKBIB;TRIB1;CEBPB;CD55;ADM;IFNAR1;CD47;TMEM265;TRIM25;IFNGR1;WNT5A;DUSP10;PGLYRP4;IFIH1;IL4R;IL24;TNFRSF6B;CAV1;TNIP2;TP53;TLR2;IKBKE;MAPKBP1;PML;POLR3A;ADAM9;RELA;AXL;HLA-E;GSK3B;PPARD;COTL1;XBP1;IL36RN;JUND
12696,GO:0050896,2.64433292439673e-22,1,364,5537,response to stimulus,BP,NFKBIZ;CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;IL36G;TBX3;PMAIP1;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;HCAR3;MAP2K3;ZFP36;G0S2;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;EPHA2;GPR156;EHD1;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;NFKBIE;BBC3;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;PANX1;ZFP36L1;TNFSF15;CYP27B1;RIPK2;IRAK2;PHLDA2;DAPP1;JUNB;PHLDB2;CYLD;FZD8;BAMBI;TJP2;RELB;ZNF217;C1QTNF1;AMOTL2;CDKN1A;CLDN1;ITGA5;GBP2;RAP2B;IL7R;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;GPX3;NOD2;IL6ST;DCUN1D3;RELT;SAV1;TFPI2;SGK1;ICAM1;GCH1;RASSF9;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;RND3;NFKBID;NINJ1;TRAF4;TRIB1;VEGFA;ARHGEF3;RAB24;FGD6;NRARP;IL1R2;SLC6A14;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;MAP3K8;ABL2;CFLAR;RNF43;TXNRD1;KLF7;PIGA;BTG1;ANXA8;UPP1;IER5;CEBPB;CEBPD;CD55;NAMPT;TAP1;TP53BP2;ADM;GJB3;CDC42EP4;IFNAR1;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;USP43;GJB4;WISP1;NEDD9;MAST4;NR4A2;SLC7A2;CD47;CANT1;VHL;PHKG2;SOGA1;SEMA4B;BACH1;ABTB2;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;SAA1;TGIF2;TMEM265;AKAP2;TINAGL1;TRIM25;IFNGR1;MASTL;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;NOTCH2NL;DUSP10;SLC52A3;SOX4;SERPINB1;SOCS2;PDGFB;IL20;PGLYRP4;CD82;IFIH1;DUSP8;NRG1;TNC;SLC38A2;MMP9;LDLR;DCBLD2;RRAD;ATF3;OTUD4;FAM83B;CAB39;IL32;TLE1;MFHAS1;PLK3;CHD2;ARRDC4;RASGEF1B;TRPV3;MT2A;SLC9A1;MAOA;RCHY1;SPRY2;FEZ1;TNKS1BP1;CYTH1;GRB7;CXCL16;NUP153;BCL2L2;RNF152;IL4R;NEDD4;POU2F2;ITSN2;GCSAM;IL24;TNFRSF6B;RAET1L;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;CHD4;SUSD6;TPRA1;ZC3H7B;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;HLA-A;UACA;INO80D;TNIP2;ZFAND5;TP53;KLF3;TLR2;ABI1;STK40;TAPBP;EFNB2;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;RAD9B;ABCA7;ADGRE2;ZNF148;PML;POLR3A;PIM1;ADAM9;RELA;RAPH1;TRIM16;ESCO2;CCBE1;TSPAN13;PLAT;CHST2;MUC1;AXL;ANXA5;FRK;HLA-F;CITED4;NR4A3;HLA-E;GSK3B;OSMR;PPARD;SLC16A1;EVC;PARP1;CYP24A1;MED13;HCP5;OCLN;COTL1;JMY;VIM;EGLN1;NABP1;RPS6KA6;DDR1;XBP1;HSPA4L;KCTD11;ELF4;IL36RN;TFE3;EID3;MGAM;LMAN1;CFB;SLC41A1;JUND
3276,GO:0006955,3.33616062102185e-22,1,131,1231,immune response,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;PLAU;CXCL1;IL1A;BIRC3;CCL20;ZC3H12A;CXCL5;IL16;RNF19B;LIF;PLAUR;CD83;PRDM1;IL36G;PTX3;IL1RN;NFKB1;TNIP1;EDN1;JUN;TICAM1;KDM6B;IFNAR2;ETS1;CSF1;IRF6;EREG;IL23A;REL;BCL3;PELI1;AMPD3;BIRC2;IFNGR2;IL6;NFKB2;ADAM8;TNFRSF10B;TNFSF15;CYP27B1;RIPK2;IRAK2;CYLD;RELB;CLDN1;GBP2;RAP2B;IL7R;CTSC;NOD2;IL6ST;RELT;ICAM1;GCH1;SMAD3;B4GALT1;RAB24;IL1R2;ABL2;CEBPB;CD55;TAP1;CDC42EP4;IFNAR1;CD47;CANT1;RUNX1;SAA1;TINAGL1;TRIM25;IFNGR1;WNT5A;DUSP10;SERPINB1;IL20;PGLYRP4;IFIH1;MMP9;OTUD4;CAB39;IL32;MT2A;CXCL16;IL4R;NEDD4;POU2F2;GCSAM;TNFRSF6B;RAET1L;BTN2A2;PTPN1;TAB3;CAV1;HLA-A;TNIP2;TLR2;ABI1;TAPBP;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;CD276;ADGRE2;PML;POLR3A;RELA;MUC1;AXL;FRK;HLA-F;NR4A3;HLA-E;COTL1;VIM;XBP1;ELF4;IL36RN;TFE3;MGAM;CFB
10388,GO:0043207,4.59438768052389e-22,1,78,524,response to external biotic stimulus,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;CXCL1;BIRC3;NOCT;CCL20;FOSL1;ZC3H12A;CXCL5;PRDM1;PMAIP1;PTX3;NFKB1;TNIP1;EDN1;ZFP36;JUN;TICAM1;IFNAR2;IL23A;BCL3;PELI1;BIRC2;IFNGR2;IL6;NFKB2;TNFRSF10B;BDKRB1;CYP27B1;RIPK2;IRAK2;JUNB;CLDN1;ODC1;NOD2;RELT;ICAM1;GCH1;SMAD3;NFKBIB;TRIB1;CEBPB;CD55;ADM;IFNAR1;CD47;TRIM25;IFNGR1;WNT5A;DUSP10;PGLYRP4;IFIH1;IL4R;IL24;TNFRSF6B;CAV1;TNIP2;TLR2;IKBKE;MAPKBP1;PML;POLR3A;ADAM9;RELA;AXL;HLA-E;PPARD;COTL1;XBP1;IL36RN;JUND
13154,GO:0051707,4.59438768052389e-22,1,78,524,response to other organism,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;CXCL1;BIRC3;NOCT;CCL20;FOSL1;ZC3H12A;CXCL5;PRDM1;PMAIP1;PTX3;NFKB1;TNIP1;EDN1;ZFP36;JUN;TICAM1;IFNAR2;IL23A;BCL3;PELI1;BIRC2;IFNGR2;IL6;NFKB2;TNFRSF10B;BDKRB1;CYP27B1;RIPK2;IRAK2;JUNB;CLDN1;ODC1;NOD2;RELT;ICAM1;GCH1;SMAD3;NFKBIB;TRIB1;CEBPB;CD55;ADM;IFNAR1;CD47;TRIM25;IFNGR1;WNT5A;DUSP10;PGLYRP4;IFIH1;IL4R;IL24;TNFRSF6B;CAV1;TNIP2;TLR2;IKBKE;MAPKBP1;PML;POLR3A;ADAM9;RELA;AXL;HLA-E;PPARD;COTL1;XBP1;IL36RN;JUND
4264,GO:0009605,4.80753316441775e-22,1,140,1342,response to external stimulus,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;EFNA1;BTG2;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;ZC3H12A;CXCL5;IL16;PLAUR;PRDM1;PMAIP1;PTX3;NFKB1;TNIP1;EDN1;ZFP36;SERPINB2;JUN;TICAM1;IFNAR2;EPHA2;ETS1;CSF1;BHLHE40;IL23A;BCL3;PELI1;GADD45A;EFNB1;BIRC2;IFNGR2;IL6;NFKB2;ADAM8;TNFRSF10B;BDKRB1;PANX1;CYP27B1;RIPK2;IRAK2;JUNB;PHLDB2;C1QTNF1;CDKN1A;CLDN1;ODC1;NOD2;IL6ST;RELT;ICAM1;GCH1;SMAD3;NFKBIB;ARNTL2;TRIB1;VEGFA;IL1R2;CDKN2B;ZSWIM4;KLF7;UPP1;CEBPB;CD55;ADM;IFNAR1;CREB1;NR4A2;SLC7A2;CD47;SEMA4B;TGFBR2;SAA1;TRIM25;IFNGR1;HMGCS1;WNT5A;VEGFC;DUSP10;PDGFB;IL20;PGLYRP4;IFIH1;NRG1;TNC;SLC38A2;LDLR;ATF3;SLC9A1;FEZ1;GRB7;CXCL16;RNF152;IL4R;IL24;TNFRSF6B;NFE2L2;SPTBN5;CAV1;TNIP2;TP53;TLR2;EFNB2;ITGAV;IKBKE;DOCK4;MAPKBP1;ADGRE2;PML;POLR3A;PIM1;ADAM9;RELA;PLAT;AXL;NR4A3;HLA-E;OSMR;PPARD;SLC16A1;CYP24A1;COTL1;XBP1;IL36RN;CFB;JUND
2225,GO:0005125,6.80868420513487e-22,1,30,78,cytokine activity,MF,CXCL8;IL1B;CXCL2;CSF2;TNF;CXCL3;CXCL1;IL1A;INHBA;CCL20;CXCL5;IL16;BMP2;LIF;IL36G;IL1RN;EDN1;CSF1;IL23A;IL6;TNFSF15;VEGFA;NAMPT;WNT5A;IL20;NRG1;IL32;CXCL16;IL24;IL36RN
3387,GO:0007165,1.33241582297351e-21,1,274,3672,signal transduction,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;CCL20;ZC3H12A;CXCL5;IL16;PPP1R15A;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;IL36G;PMAIP1;IL1RN;NFKB1;IER3;PPIF;TNIP1;EDN1;HCAR3;MAP2K3;ZFP36;G0S2;SERPINB2;JUN;TICAM1;IFNAR2;EPHA2;GPR156;TRAF1;HCAR2;SQSTM1;CSF1;BBC3;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;ZFP36L1;TNFSF15;CYP27B1;RIPK2;IRAK2;PHLDA2;DAPP1;JUNB;CYLD;FZD8;BAMBI;TJP2;RELB;ZNF217;C1QTNF1;AMOTL2;CDKN1A;ITGA5;GBP2;RAP2B;IL7R;ZNF451;CTSC;NOD2;IL6ST;RELT;SAV1;SGK1;ICAM1;RASSF9;SMAD3;NFKBIB;DLX2;RND3;NFKBID;TRAF4;TRIB1;VEGFA;ARHGEF3;RAB24;FGD6;NRARP;IL1R2;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;CFLAR;RNF43;TXNRD1;CEBPB;CEBPD;CD55;NAMPT;TP53BP2;ADM;CDC42EP4;IFNAR1;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;WISP1;NEDD9;MAST4;NR4A2;CD47;CANT1;VHL;PHKG2;SOGA1;SEMA4B;RUNX1;TGFBR2;SMURF2;DUSP16;SAA1;TGIF2;AKAP2;TRIM25;IFNGR1;MASTL;ITGB8;WNT5A;CAMK1G;VEGFC;TGFA;NOTCH2NL;DUSP10;SOX4;SOCS2;PDGFB;IL20;PGLYRP4;CD82;IFIH1;DUSP8;NRG1;MMP9;DCBLD2;RRAD;ATF3;OTUD4;FAM83B;CAB39;IL32;TLE1;MFHAS1;PLK3;ARRDC4;RASGEF1B;MT2A;SLC9A1;MAOA;SPRY2;TNKS1BP1;CYTH1;GRB7;CXCL16;BCL2L2;RNF152;IL4R;NEDD4;ITSN2;GCSAM;IL24;TNFRSF6B;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;CHD4;TPRA1;NFAT5;STAT5A;CAV1;RHOV;HLA-A;UACA;TNIP2;ZFAND5;TP53;TLR2;ABI1;STK40;EFNB2;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;RAD9B;ABCA7;ADGRE2;PML;PIM1;ADAM9;RELA;RAPH1;TRIM16;CCBE1;TSPAN13;PLAT;MUC1;AXL;ANXA5;FRK;HLA-F;NR4A3;HLA-E;GSK3B;OSMR;PPARD;EVC;PARP1;CYP24A1;MED13;JMY;VIM;RPS6KA6;DDR1;XBP1;KCTD11;IL36RN
3388,GO:0007166,4.73348166904424e-21,1,172,1873,cell surface receptor signaling pathway,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;CXCL1;IL1A;EFNA1;INHBA;BIRC3;CCL20;ZC3H12A;CXCL5;IL16;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;IL36G;PMAIP1;IL1RN;NFKB1;EDN1;G0S2;SERPINB2;JUN;TICAM1;IFNAR2;EPHA2;TRAF1;SQSTM1;CSF1;IRF6;EREG;IL23A;PELI1;EFNB1;BIRC2;IFNGR2;IL6;CSRNP1;TNFRSF10B;TNFSF15;RIPK2;IRAK2;JUNB;CYLD;FZD8;BAMBI;TJP2;RELB;AMOTL2;CDKN1A;ITGA5;GBP2;IL7R;ZNF451;NOD2;IL6ST;RELT;ICAM1;SMAD3;DLX2;TRIB1;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;FGF5;MAP3K8;ABL2;CFLAR;RNF43;CEBPD;CD55;IFNAR1;ERRFI1;ADAMTS1;CREB1;GORAB;WISP1;NEDD9;NR4A2;CD47;SOGA1;SEMA4B;RUNX1;TGFBR2;SMURF2;SAA1;TGIF2;AKAP2;TRIM25;IFNGR1;ITGB8;WNT5A;VEGFC;TGFA;NOTCH2NL;SOX4;SOCS2;PDGFB;IL20;CD82;NRG1;MMP9;ATF3;OTUD4;FAM83B;IL32;TLE1;MT2A;MAOA;SPRY2;GRB7;BCL2L2;IL4R;NEDD4;GCSAM;IL24;TNFRSF6B;BTN2A2;PTPN1;WNT7B;SMAD1;TAB3;STAT5A;CAV1;HLA-A;TNIP2;ZFAND5;TP53;TLR2;ABI1;EFNB2;HLA-B;ITGAV;GEM;UBE2D3;STX1A;CD276;ABCA7;ADGRE2;PML;PIM1;ADAM9;RELA;CCBE1;TSPAN13;PLAT;MUC1;AXL;FRK;HLA-F;NR4A3;HLA-E;GSK3B;OSMR;EVC;PARP1;VIM;DDR1;KCTD11;IL36RN
3376,GO:0007154,6.92835502435422e-21,1,287,3959,cell communication,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;CCL20;FOSL1;ZC3H12A;CXCL5;IL16;PPP1R15A;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;IL36G;TBX3;PMAIP1;IL1RN;NFKB1;IER3;PPIF;TNIP1;EDN1;HCAR3;MAP2K3;ZFP36;G0S2;SERPINB2;JUN;TICAM1;IFNAR2;EPHA2;GPR156;TRAF1;HCAR2;SQSTM1;CSF1;BBC3;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;PIM3;PANX1;ZFP36L1;TNFSF15;CYP27B1;RIPK2;IRAK2;PHLDA2;DAPP1;JUNB;CYLD;FZD8;BAMBI;TJP2;RELB;ZNF217;C1QTNF1;AMOTL2;CDKN1A;FJX1;ITGA5;GBP2;RAP2B;IL7R;ZNF451;CTSC;NOD2;IL6ST;RELT;SAV1;SGK1;ICAM1;RASSF9;SMAD3;NFKBIB;DLX2;RND3;NFKBID;TRAF4;TRIB1;VEGFA;ARHGEF3;RAB24;FGD6;NRARP;IL1R2;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;CFLAR;RNF43;TXNRD1;UPP1;CEBPB;CEBPD;CD55;NAMPT;TP53BP2;ADM;GJB3;CDC42EP4;IFNAR1;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;GJB4;WISP1;NEDD9;MAST4;NR4A2;CD47;CANT1;VHL;PHKG2;SOGA1;SEMA4B;RUNX1;TGFBR2;SMURF2;DUSP16;SAA1;TGIF2;AKAP2;TRIM25;IFNGR1;MASTL;ITGB8;WNT5A;CAMK1G;VEGFC;TGFA;NOTCH2NL;DUSP10;SOX4;SOCS2;PDGFB;IL20;PGLYRP4;CD82;IFIH1;DUSP8;NRG1;TNC;SLC38A2;MMP9;DCBLD2;RRAD;ATF3;OTUD4;FAM83B;CAB39;IL32;TLE1;MFHAS1;PLK3;ARRDC4;RASGEF1B;MT2A;SLC9A1;MAOA;SPRY2;TNKS1BP1;CYTH1;GRB7;CXCL16;BCL2L2;RNF152;IL4R;NEDD4;ITSN2;GCSAM;IL24;TNFRSF6B;MARCKS;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;CHD4;TPRA1;NFAT5;STAT5A;CAV1;RHOV;HLA-A;UACA;TNIP2;ZFAND5;TP53;TLR2;ABI1;STK40;EFNB2;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;RAD9B;ABCA7;ADGRE2;PML;PIM1;ADAM9;RELA;RAPH1;TRIM16;CCBE1;TSPAN13;PLAT;MUC1;AXL;ANXA5;FRK;HLA-F;NR4A3;HLA-E;GSK3B;OSMR;PPARD;SLC16A1;EVC;PARP1;CYP24A1;MED13;JMY;VIM;RPS6KA6;DDR1;XBP1;KCTD11;IL36RN;GJC1
12079,GO:0048018,1.43626877648606e-20,1,41,166,receptor ligand activity,MF,CXCL8;IL1B;CXCL2;CSF2;TNF;CXCL3;HBEGF;CXCL1;IL1A;INHBA;CCL20;CXCL5;IL16;BMP2;LIF;IL36G;IL1RN;EDN1;CSF1;EREG;IL23A;IL6;TNFSF15;VEGFA;DKK1;FGF5;NAMPT;ADM;SEMA4B;SAA1;WNT5A;VEGFC;TGFA;PDGFB;IL20;NRG1;IL32;CXCL16;IL24;WNT7B;IL36RN
12257,GO:0048522,2.96052974532557e-20,1,261,3485,positive regulation of cellular process,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;CD83;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;G0S2;JUN;TICAM1;KDM6B;EPHA2;EHD1;ETS1;HCAR2;SQSTM1;CSF1;SERTAD2;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;EFNB1;BIRC2;IL6;ETS2;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;RFX5;PANX1;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;RELB;C1QTNF1;CDKN1A;CLDN1;ITGA5;RAP2B;IL7R;NAV3;ODC1;NEDD4L;CTSC;NOD2;IL6ST;DCUN1D3;SAV1;ICAM1;SMAD3;B4GALT1;DLX2;ARNTL2;RNF144B;MARCKSL1;NFKBID;TRAF4;TRIB1;VEGFA;ARHGEF3;NRARP;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;CD55;NAMPT;TP53BP2;ANKLE2;ADM;CDC42EP4;CREB1;TAF4B;GORAB;CCNL1;NR4A2;CD47;CANT1;VHL;PHKG2;SEMA4B;BACH1;MYBL1;RUNX1;TGFBR2;SMURF2;SFR1;SAA1;TGIF2;GPBP1;NFE2L3;TRIM25;WNT5A;VEGFC;TGFA;DUSP10;SOX4;SOCS2;PDGFB;IL20;ANLN;PGLYRP4;IFIH1;NRG1;TNC;MMP9;LDLR;ATF3;OTUD4;IKZF2;CAB39;PLK3;ARRDC4;SUCO;SLC9A1;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;GRB7;CXCL16;RNF152;IL4R;NEDD4;MMD;POU2F2;ITSN2;IL24;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;PAOX;NFAT5;STAT5A;CAV1;VEZF1;TNIP2;UGCG;TP53;TLR2;ABI1;EFNB2;RAB9A;ITGAV;IKBKE;UBE2D3;STX1A;CD276;DOCK4;ELK3;JPH2;ABCA7;SDR16C5;ZNF148;UBE2Z;PML;PIM1;ESPL1;ADAM9;RELA;TRIM16;FOXN2;CCBE1;EVI2B;MUC1;AXL;CITED4;NR4A3;HLA-E;GSK3B;KMT2E;OSMR;PPARD;EVC;PARP1;KDM7A;MED13;JMY;VIM;CREB5;EGLN1;ZXDA;DDR1;CEP135;XBP1;QKI;KCTD11;ELF4;TFE3;EID3;ZMIZ2;LMAN1;JUND
13161,GO:0051716,5.16336263866334e-20,1,318,4670,cellular response to stimulus,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;IL36G;TBX3;PMAIP1;IL1RN;NFKB1;IER3;PPIF;TNIP1;EDN1;HCAR3;MAP2K3;ZFP36;G0S2;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;EPHA2;GPR156;EHD1;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BBC3;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;ZFP36L1;TNFSF15;CYP27B1;RIPK2;IRAK2;PHLDA2;DAPP1;JUNB;CYLD;FZD8;BAMBI;TJP2;RELB;ZNF217;C1QTNF1;AMOTL2;CDKN1A;CLDN1;ITGA5;GBP2;RAP2B;IL7R;CPEB2;ZNF451;CTSC;GPX3;NOD2;IL6ST;RELT;SAV1;TFPI2;SGK1;ICAM1;GCH1;RASSF9;SMAD3;NFKBIB;DLX2;RND3;NFKBID;TRAF4;TRIB1;VEGFA;ARHGEF3;RAB24;FGD6;NRARP;IL1R2;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;CFLAR;RNF43;TXNRD1;PIGA;UPP1;IER5;CEBPB;CEBPD;CD55;NAMPT;TP53BP2;ADM;GJB3;CDC42EP4;IFNAR1;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;USP43;WISP1;NEDD9;MAST4;NR4A2;CD47;CANT1;VHL;PHKG2;SOGA1;SEMA4B;BACH1;ABTB2;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;SAA1;TGIF2;AKAP2;TRIM25;IFNGR1;MASTL;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;TGFA;NOTCH2NL;DUSP10;SLC52A3;SOX4;SOCS2;PDGFB;IL20;PGLYRP4;CD82;IFIH1;DUSP8;NRG1;TNC;SLC38A2;MMP9;LDLR;DCBLD2;RRAD;ATF3;OTUD4;FAM83B;CAB39;IL32;TLE1;MFHAS1;PLK3;CHD2;ARRDC4;RASGEF1B;MT2A;SLC9A1;MAOA;RCHY1;SPRY2;FEZ1;TNKS1BP1;CYTH1;GRB7;CXCL16;NUP153;BCL2L2;RNF152;IL4R;NEDD4;ITSN2;GCSAM;IL24;TNFRSF6B;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;CHD4;SUSD6;TPRA1;ZC3H7B;CLIC4;NFAT5;STAT5A;CAV1;RHOV;HLA-A;UACA;INO80D;TNIP2;ZFAND5;TP53;KLF3;TLR2;ABI1;STK40;EFNB2;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;RAD9B;ABCA7;ADGRE2;PML;PIM1;ADAM9;RELA;RAPH1;TRIM16;ESCO2;CCBE1;TSPAN13;PLAT;MUC1;AXL;ANXA5;FRK;HLA-F;NR4A3;HLA-E;GSK3B;OSMR;PPARD;SLC16A1;EVC;PARP1;CYP24A1;MED13;OCLN;JMY;VIM;EGLN1;NABP1;RPS6KA6;DDR1;XBP1;HSPA4L;KCTD11;IL36RN;EID3;SLC41A1;JUND
8562,GO:0033993,6.65205149809062e-20,1,82,593,response to lipid,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;CXCL3;CXCL1;INHBA;NOCT;CCL20;FOSL1;ZC3H12A;CXCL5;PRDM1;IL1RN;NFKB1;TNIP1;EDN1;ZFP36;JUN;TICAM1;ETS1;DUSP1;PELI1;IL6;NFKB2;TNFRSF10B;BDKRB1;ZFP36L1;CYP27B1;RIPK2;IRAK2;JUNB;CDKN1A;CLDN1;RELT;ICAM1;GCH1;NFKBIB;TRIB1;DKK1;ABL2;CFLAR;CEBPB;CD55;ADM;GJB3;IFNAR1;ERRFI1;CREB1;NR4A2;RUNX1;TGFBR2;TRIM25;HMGCS1;WNT5A;DUSP10;SOCS2;TNC;LDLR;NEDD4;IL24;TNFRSF6B;WNT7B;CAV1;TNIP2;TP53;TLR2;PIM1;ADAM9;RELA;TRIM16;AXL;NR4A3;PPARD;PARP1;CYP24A1;MED13;XBP1;JUND
6651,GO:0023052,1.64323810325446e-19,1,282,3934,signaling,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;CCL20;ZC3H12A;CXCL5;IL16;PPP1R15A;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;IL36G;TBX3;PMAIP1;IL1RN;NFKB1;IER3;PPIF;TNIP1;EDN1;HCAR3;MAP2K3;ZFP36;G0S2;SERPINB2;JUN;TICAM1;IFNAR2;EPHA2;GPR156;TRAF1;HCAR2;SQSTM1;CSF1;BBC3;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;PIM3;PANX1;ZFP36L1;TNFSF15;CYP27B1;RIPK2;IRAK2;PHLDA2;DAPP1;JUNB;CYLD;FZD8;BAMBI;TJP2;RELB;ZNF217;C1QTNF1;AMOTL2;CDKN1A;FJX1;ITGA5;GBP2;RAP2B;IL7R;ZNF451;CTSC;NOD2;IL6ST;RELT;SAV1;SGK1;ICAM1;RASSF9;SMAD3;NFKBIB;DLX2;RND3;NFKBID;TRAF4;TRIB1;VEGFA;ARHGEF3;RAB24;FGD6;NRARP;IL1R2;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;CFLAR;RNF43;TXNRD1;CEBPB;CEBPD;CD55;NAMPT;TP53BP2;ADM;CDC42EP4;IFNAR1;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;WISP1;NEDD9;MAST4;NR4A2;CD47;CANT1;VHL;PHKG2;SOGA1;SEMA4B;RUNX1;TGFBR2;SMURF2;DUSP16;SAA1;TGIF2;AKAP2;TRIM25;IFNGR1;MASTL;ITGB8;WNT5A;CAMK1G;VEGFC;TGFA;NOTCH2NL;DUSP10;SOX4;SOCS2;PDGFB;IL20;PGLYRP4;CD82;IFIH1;DUSP8;NRG1;TNC;MMP9;DCBLD2;RRAD;ATF3;OTUD4;FAM83B;CAB39;IL32;TLE1;MFHAS1;PLK3;ARRDC4;RASGEF1B;MT2A;SLC9A1;MAOA;SPRY2;TNKS1BP1;CYTH1;GRB7;CXCL16;BCL2L2;RNF152;IL4R;NEDD4;ITSN2;GCSAM;IL24;TNFRSF6B;MARCKS;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;CHD4;TPRA1;NFAT5;STAT5A;CAV1;RHOV;HLA-A;UACA;TNIP2;ZFAND5;TP53;TLR2;ABI1;STK40;EFNB2;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;RAD9B;ABCA7;ADGRE2;PML;PIM1;ADAM9;RELA;RAPH1;TRIM16;CCBE1;TSPAN13;PLAT;MUC1;AXL;ANXA5;FRK;HLA-F;NR4A3;HLA-E;GSK3B;OSMR;PPARD;SLC16A1;EVC;PARP1;CYP24A1;MED13;JMY;VIM;RPS6KA6;DDR1;XBP1;KCTD11;IL36RN;GJC1
12286,GO:0048584,1.83101479100714e-19,1,141,1444,positive regulation of response to stimulus,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;CXCL1;IL1A;EFNA1;INHBA;BIRC3;PLEKHF1;CCL20;ZC3H12A;CXCL5;IL16;PPP1R15A;ELF3;BMP2;LIF;PLAUR;PMAIP1;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;G0S2;JUN;TICAM1;EPHA2;ETS1;CSF1;BBC3;EREG;IL23A;REL;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ADAM8;TNFRSF10B;TNFSF15;CYP27B1;RIPK2;IRAK2;CYLD;FZD8;BAMBI;RELB;C1QTNF1;ITGA5;IL7R;CTSC;NOD2;IL6ST;ICAM1;SMAD3;TRAF4;VEGFA;NRARP;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;CFLAR;IER5;CD55;TP53BP2;GORAB;CD47;CANT1;RUNX1;TGFBR2;SMURF2;SAA1;TRIM25;WNT5A;VEGFC;TGFA;SOX4;SOCS2;PDGFB;IL20;PGLYRP4;IFIH1;NRG1;MMP9;LDLR;ATF3;OTUD4;SLC9A1;SPRY2;GRB7;IL4R;NEDD4;ITSN2;GCSAM;IL24;BTN2A2;NFE2L2;PTPN1;WNT7B;TAB3;CAV1;TNIP2;TP53;TLR2;ABI1;ITGAV;IKBKE;UBE2D3;STX1A;CD276;JPH2;ABCA7;PML;ADAM9;RELA;TRIM16;CCBE1;MUC1;AXL;NR4A3;HLA-E;GSK3B;OSMR;PPARD;EVC;PARP1;DDR1;XBP1;EID3;CFB
9871,GO:0042127,3.79391663285086e-19,1,113,1035,regulation of cell proliferation,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;PLAU;CXCL1;IL1A;SDC4;BTG2;INHBA;FOSL1;CXCL5;BMP2;LIF;SOD2;PRDM1;TBX3;EDN1;ZFP36;JUN;TICAM1;ETS1;CSF1;IRF6;EREG;IL23A;PELI1;EFNB1;BIRC2;IL6;TNFRSF10B;ZFP36L1;CYP27B1;SIX4;RIPK2;PHLDA2;JUNB;BAMBI;CDKN1A;IL7R;ODC1;NOD2;IL6ST;RELT;SAV1;SGK1;SMAD3;B4GALT1;MARCKSL1;TRIB1;VEGFA;NRARP;CDKN2B;FGF5;ABL2;CFLAR;BTG1;IER5;CEBPB;CD55;NAMPT;ADM;ERRFI1;ADAMTS1;CREB1;CD47;VHL;TGFBR2;WNT5A;VEGFC;TGFA;DUSP10;SOX4;PDGFB;NRG1;TNC;MMP9;ATF3;BTG3;SPRY2;IL4R;IL24;TNFRSF6B;BTN2A2;SMAD1;STAT5A;CAV1;TP53;TLR2;ABI1;EFNB2;ITGAV;CD276;PML;PIM1;RELA;EMP3;SAT1;FRK;NR4A3;HLA-E;OSMR;PPARD;DDR1;XBP1;KCTD11;JUND
12253,GO:0048518,4.04520883207581e-19,1,278,3902,positive regulation of biological process,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;CD83;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;G0S2;JUN;TICAM1;KDM6B;EPHA2;EHD1;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;SERTAD2;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;EFNB1;BIRC2;IL6;ETS2;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;RFX5;PANX1;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;RELB;C1QTNF1;CDKN1A;CLDN1;ITGA5;RAP2B;IL7R;NAV3;ODC1;NEDD4L;CTSC;NOD2;IL6ST;DCUN1D3;SAV1;SGK1;ICAM1;GCH1;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;RNF144B;MARCKSL1;NFKBID;NINJ1;TRAF4;TRIB1;VEGFA;ARHGEF3;NRARP;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;CFLAR;KLF7;PIGA;BTG1;IER5;CEBPB;CEBPD;CD55;NAMPT;TP53BP2;ANKLE2;ADM;CDC42EP4;CREB1;TAF4B;GORAB;CCNL1;NR4A2;CD47;CANT1;VHL;PHKG2;SEMA4B;BACH1;MYBL1;RUNX1;TGFBR2;SMURF2;SFR1;SAA1;TGIF2;GPBP1;NFE2L3;TRIM25;ITGB8;WNT5A;VEGFC;TGFA;DUSP10;SOX4;SOCS2;PDGFB;IL20;ANLN;PGLYRP4;IFIH1;NRG1;TNC;MMP9;LDLR;ATF3;OTUD4;IKZF2;CAB39;TLE1;PLK3;ARRDC4;TRPV3;SUCO;SLC9A1;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;GRB7;CXCL16;RNF152;IL4R;NEDD4;MMD;POU2F2;ITSN2;GCSAM;IL24;BTN2A2;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;PAOX;NFAT5;STAT5A;CAV1;VEZF1;TNIP2;UGCG;TP53;TLR2;ABI1;EFNB2;RAB9A;ITGAV;IKBKE;UBE2D3;STX1A;CD276;DOCK4;ELK3;JPH2;ABCA7;ADGRE2;SDR16C5;ZNF148;UBE2Z;PML;POLR3A;PIM1;ESPL1;ADAM9;RELA;TRIM16;FOXN2;CCBE1;EVI2B;MUC1;AXL;CITED4;NR4A3;HLA-E;GSK3B;KMT2E;OSMR;PPARD;EVC;PARP1;KDM7A;MED13;JMY;COL8A1;VIM;CREB5;EGLN1;RIPK4;ZXDA;DDR1;CEP135;XBP1;QKI;KCTD11;ELF4;TFE3;EID3;ZMIZ2;LMAN1;CFB;JUND
6941,GO:0030545,6.09011093681526e-19,1,41,182,receptor regulator activity,MF,CXCL8;IL1B;CXCL2;CSF2;TNF;CXCL3;HBEGF;CXCL1;IL1A;INHBA;CCL20;CXCL5;IL16;BMP2;LIF;IL36G;IL1RN;EDN1;CSF1;EREG;IL23A;IL6;TNFSF15;VEGFA;DKK1;FGF5;NAMPT;ADM;SEMA4B;SAA1;WNT5A;VEGFC;TGFA;PDGFB;IL20;NRG1;IL32;CXCL16;IL24;WNT7B;IL36RN
12868,GO:0051173,6.7339343689197e-19,1,181,2095,positive regulation of nitrogen compound metabolic process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;CCL20;FOSL1;NCOA7;ZC3H12A;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;JUN;TICAM1;KDM6B;EPHA2;ETS1;SQSTM1;CSF1;SERTAD2;BBC3;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ETS2;CSRNP1;NFKB2;ADAM8;TNFRSF10B;RFX5;ZFP36L1;TNFSF15;SIX4;RIPK2;IRAK2;JUNB;FZD8;BAMBI;RELB;C1QTNF1;CDKN1A;ITGA5;RAP2B;NEDD4L;CTSC;NOD2;IL6ST;DCUN1D3;ICAM1;SMAD3;DLX2;ARNTL2;RNF144B;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;PLK2;MAP3K8;CFLAR;KLF7;IER5;CEBPB;CEBPD;NAMPT;ANKLE2;ADM;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;TGFBR2;SMURF2;SFR1;SAA1;GPBP1;NFE2L3;WNT5A;VEGFC;TGFA;SOX4;PDGFB;IL20;NRG1;MMP9;LDLR;ATF3;OTUD4;IKZF2;CAB39;PLK3;ARRDC4;SLC9A1;RCHY1;YAF2;SPRY2;TNKS1BP1;NEDD4;MMD;POU2F2;IL24;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;PAOX;NFAT5;CAV1;VEZF1;TNIP2;TP53;TLR2;ABI1;ITGAV;CD276;ELK3;ABCA7;SDR16C5;ZNF148;PML;ADAM9;RELA;TRIM16;FOXN2;CCBE1;MUC1;AXL;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;VIM;CREB5;EGLN1;ZXDA;DDR1;XBP1;QKI;ELF4;TFE3;ZMIZ2;JUND
4344,GO:0009893,8.91681385757325e-19,1,195,2362,positive regulation of metabolic process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;PRDM1;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;JUN;TICAM1;KDM6B;EPHA2;ETS1;SQSTM1;CSF1;SERTAD2;BBC3;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ETS2;CSRNP1;NFKB2;ADAM8;TNFRSF10B;RFX5;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;JUNB;FZD8;BAMBI;RELB;C1QTNF1;CDKN1A;ITGA5;RAP2B;IL7R;NEDD4L;CTSC;NOD2;IL6ST;DCUN1D3;ICAM1;GCH1;SMAD3;DLX2;ARNTL2;RNF144B;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;PLK2;MAP3K8;ABL2;CFLAR;KLF7;PIGA;IER5;CEBPB;CEBPD;NAMPT;ANKLE2;ADM;CREB1;TAF4B;CCNL1;NR4A2;VHL;PHKG2;BACH1;MYBL1;RUNX1;TGFBR2;SMURF2;SFR1;SAA1;GPBP1;NFE2L3;ITGB8;WNT5A;VEGFC;TGFA;SOX4;PDGFB;IL20;NRG1;TNC;MMP9;LDLR;ATF3;OTUD4;IKZF2;CAB39;TLE1;PLK3;ARRDC4;SUCO;SLC9A1;RCHY1;YAF2;SPRY2;TNKS1BP1;RNF152;NEDD4;MMD;POU2F2;IL24;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;PAOX;NFAT5;CAV1;VEZF1;TNIP2;TP53;TLR2;ABI1;ITGAV;CD276;ELK3;ABCA7;SDR16C5;ZNF148;PML;ADAM9;RELA;TRIM16;FOXN2;CCBE1;MUC1;AXL;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;VIM;CREB5;EGLN1;ZXDA;DDR1;XBP1;QKI;ELF4;TFE3;ZMIZ2;JUND
14989,GO:0070887,1.25780944867191e-18,1,179,2123,cellular response to chemical stimulus,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;CXCL1;IL1A;INHBA;BIRC3;CCL20;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;BMP2;LIF;SOD2;PRDM1;IL36G;PMAIP1;IL1RN;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;EPHA2;EHD1;ETS1;TRAF1;SQSTM1;CSF1;IRF6;EREG;IL23A;DUSP1;PELI1;BIRC2;IFNGR2;IL6;ADAM8;TNFRSF10B;PIM3;ZFP36L1;TNFSF15;CYP27B1;RIPK2;IRAK2;JUNB;CYLD;BAMBI;TJP2;CDKN1A;CLDN1;ITGA5;GBP2;IL7R;CPEB2;ZNF451;GPX3;NOD2;IL6ST;RELT;ICAM1;GCH1;SMAD3;NFKBIB;TRIB1;VEGFA;IL1R2;DKK1;CDKN2B;FGF5;MAP3K8;ABL2;CFLAR;TXNRD1;PIGA;CEBPB;CEBPD;CD55;GJB3;CDC42EP4;IFNAR1;ERRFI1;CREB1;NR4A2;VHL;SOGA1;BACH1;ABTB2;RUNX1;TGFBR2;SMURF2;SFR1;SAA1;TRIM25;IFNGR1;HMGCS1;WNT5A;VEGFC;SOX4;SOCS2;PDGFB;IL20;IFIH1;TNC;MMP9;LDLR;ATF3;OTUD4;IL32;PLK3;MT2A;SLC9A1;MAOA;SPRY2;FEZ1;CXCL16;IL4R;NEDD4;IL24;TNFRSF6B;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;ZC3H7B;CLIC4;STAT5A;CAV1;HLA-A;TNIP2;TP53;KLF3;TLR2;HLA-B;UBE2D3;STX1A;DOCK4;ADGRE2;PML;PIM1;ADAM9;RELA;CCBE1;MUC1;AXL;HLA-F;NR4A3;HLA-E;GSK3B;OSMR;PPARD;SLC16A1;PARP1;CYP24A1;MED13;OCLN;VIM;EGLN1;XBP1;HSPA4L;IL36RN;SLC41A1;JUND
1098,GO:0002684,1.82178682253197e-18,1,81,621,positive regulation of immune system process,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;TNF;IRF1;CXCL3;CXCL1;IL1A;INHBA;BIRC3;CCL20;ZC3H12A;CXCL5;LIF;CD83;PRDM1;NFKB1;TNIP1;EDN1;JUN;TICAM1;ETS1;HCAR2;CSF1;EREG;IL23A;PELI1;EFNB1;BIRC2;IL6;ADAM8;BDKRB1;ZFP36L1;RIPK2;IRAK2;CYLD;RELB;CDKN1A;IL7R;NOD2;IL6ST;ICAM1;TRIB1;VEGFA;MAP3K8;CD55;CREB1;CD47;RUNX1;TGFBR2;WNT5A;VEGFC;DUSP10;IL20;PGLYRP4;IFIH1;OTUD4;IL4R;GCSAM;BTN2A2;TAB3;CAV1;TNIP2;TP53;TLR2;ABI1;EFNB2;IKBKE;UBE2D3;CD276;ADGRE2;RELA;EVI2B;MUC1;AXL;NR4A3;HLA-E;XBP1;CFB
9906,GO:0042221,3.02969035789762e-18,1,215,2784,response to chemical,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;BTG2;INHBA;BIRC3;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;BMP2;LIF;PLAUR;CD83;SOD2;PRDM1;IL36G;PMAIP1;IL1RN;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;EPHA2;EHD1;ETS1;TRAF1;SQSTM1;CSF1;NFKBIE;IRF6;EREG;IL23A;REL;DUSP1;PELI1;EFNB1;BIRC2;IFNGR2;IL6;NFKB2;ADAM8;TNFRSF10B;BDKRB1;PIM3;PANX1;ZFP36L1;TNFSF15;CYP27B1;RIPK2;IRAK2;JUNB;CYLD;BAMBI;TJP2;RELB;CDKN1A;CLDN1;ITGA5;GBP2;IL7R;CPEB2;ZNF451;NEDD4L;CTSC;GPX3;NOD2;IL6ST;RELT;ICAM1;GCH1;SMAD3;NFKBIB;TRIB1;VEGFA;IL1R2;SLC6A14;DKK1;CDKN2B;ZSWIM4;FGF5;MAP3K8;ABL2;CFLAR;TXNRD1;KLF7;PIGA;BTG1;CEBPB;CEBPD;CD55;NAMPT;ADM;GJB3;CDC42EP4;IFNAR1;ERRFI1;CREB1;GJB4;NR4A2;SLC7A2;VHL;SOGA1;SEMA4B;BACH1;ABTB2;RUNX1;TGFBR2;SMURF2;SFR1;SAA1;TRIM25;IFNGR1;HMGCS1;WNT5A;VEGFC;SLC11A2;DUSP10;SLC52A3;SOX4;SOCS2;PDGFB;IL20;IFIH1;NRG1;TNC;MMP9;LDLR;ATF3;OTUD4;IL32;PLK3;MT2A;SLC9A1;MAOA;SPRY2;FEZ1;GRB7;CXCL16;IL4R;NEDD4;IL24;TNFRSF6B;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;ZC3H7B;CLIC4;STAT5A;CAV1;HLA-A;TNIP2;TP53;KLF3;TLR2;EFNB2;HLA-B;ITGAV;IKBKE;UBE2D3;STX1A;DOCK4;ADGRE2;PML;PIM1;ADAM9;RELA;TRIM16;CCBE1;MUC1;AXL;ANXA5;HLA-F;NR4A3;HLA-E;GSK3B;OSMR;PPARD;SLC16A1;PARP1;CYP24A1;MED13;OCLN;VIM;EGLN1;XBP1;HSPA4L;IL36RN;SLC41A1;JUND
4536,GO:0010604,3.87860558123318e-18,1,185,2217,positive regulation of macromolecule metabolic process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;PRDM1;TBX3;PMAIP1;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;JUN;TICAM1;KDM6B;EPHA2;ETS1;SQSTM1;CSF1;SERTAD2;BBC3;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ETS2;CSRNP1;NFKB2;ADAM8;TNFRSF10B;RFX5;ZFP36L1;TNFSF15;SIX4;RIPK2;IRAK2;JUNB;FZD8;BAMBI;RELB;C1QTNF1;CDKN1A;ITGA5;RAP2B;IL7R;NEDD4L;CTSC;NOD2;IL6ST;DCUN1D3;ICAM1;SMAD3;DLX2;ARNTL2;RNF144B;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;PLK2;MAP3K8;CFLAR;KLF7;IER5;CEBPB;CEBPD;NAMPT;ANKLE2;CREB1;TAF4B;CCNL1;NR4A2;VHL;PHKG2;BACH1;MYBL1;RUNX1;TGFBR2;SMURF2;SFR1;SAA1;GPBP1;NFE2L3;ITGB8;WNT5A;VEGFC;TGFA;SOX4;PDGFB;IL20;NRG1;TNC;MMP9;LDLR;ATF3;OTUD4;IKZF2;CAB39;TLE1;PLK3;ARRDC4;SLC9A1;RCHY1;YAF2;SPRY2;TNKS1BP1;NEDD4;MMD;POU2F2;IL24;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;NFAT5;CAV1;VEZF1;TNIP2;TP53;TLR2;ABI1;ITGAV;CD276;ELK3;ABCA7;SDR16C5;ZNF148;PML;ADAM9;RELA;TRIM16;FOXN2;CCBE1;MUC1;AXL;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;VIM;CREB5;EGLN1;ZXDA;DDR1;XBP1;QKI;ELF4;TFE3;ZMIZ2;JUND
1096,GO:0002682,4.34867647407684e-18,1,102,932,regulation of immune system process,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;CXCL1;IL1A;SDC4;INHBA;BIRC3;CCL20;ZC3H12A;CXCL5;LIF;CD83;PRDM1;NFKB1;TNIP1;EDN1;ZFP36;JUN;TICAM1;IFNAR2;ETS1;HCAR2;CSF1;EREG;IL23A;PELI1;EFNB1;BIRC2;IFNGR2;IL6;ADAM8;BDKRB1;ZFP36L1;RIPK2;IRAK2;CYLD;TJP2;RELB;CDKN1A;IL7R;NOD2;IL6ST;ICAM1;SMAD3;NFKBID;TRIB1;VEGFA;NRARP;MAP3K8;CEBPB;CD55;IFNAR1;CREB1;SLC7A2;CD47;RUNX1;TGFBR2;IFNGR1;WNT5A;VEGFC;DUSP10;IL20;PGLYRP4;IFIH1;LDLR;OTUD4;IL4R;GCSAM;BTN2A2;NFE2L2;PTPN1;TAB3;CAV1;HLA-A;TNIP2;TP53;TLR2;ABI1;EFNB2;HLA-B;IKBKE;UBE2D3;CD276;ADGRE2;RELA;EVI2B;MUC1;AXL;HLA-F;NR4A3;HLA-E;KMT2E;XBP1;TFE3;CFB
4385,GO:0010033,8.41464079342695e-18,1,180,2173,response to organic substance,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;CXCL1;IL1A;BTG2;INHBA;BIRC3;NOCT;CCL20;FOSL1;ZC3H12A;CXCL5;IL16;PPP1R15A;BMP2;LIF;CD83;SOD2;PRDM1;IL36G;PMAIP1;IL1RN;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;SERPINB2;JUN;TICAM1;IFNAR2;EPHA2;EHD1;ETS1;TRAF1;SQSTM1;CSF1;IRF6;EREG;IL23A;REL;DUSP1;PELI1;BIRC2;IFNGR2;IL6;NFKB2;TNFRSF10B;BDKRB1;PIM3;PANX1;ZFP36L1;TNFSF15;CYP27B1;RIPK2;IRAK2;JUNB;CYLD;BAMBI;TJP2;RELB;CDKN1A;CLDN1;ITGA5;GBP2;IL7R;CPEB2;ZNF451;CTSC;GPX3;NOD2;IL6ST;RELT;ICAM1;GCH1;SMAD3;NFKBIB;TRIB1;VEGFA;IL1R2;DKK1;CDKN2B;FGF5;MAP3K8;ABL2;CFLAR;PIGA;BTG1;CEBPB;CEBPD;CD55;NAMPT;ADM;GJB3;CDC42EP4;IFNAR1;ERRFI1;CREB1;NR4A2;SOGA1;RUNX1;TGFBR2;SMURF2;SAA1;TRIM25;IFNGR1;HMGCS1;WNT5A;VEGFC;DUSP10;SOX4;SOCS2;PDGFB;IL20;IFIH1;TNC;MMP9;LDLR;ATF3;OTUD4;IL32;MT2A;SLC9A1;MAOA;SPRY2;FEZ1;CXCL16;IL4R;NEDD4;IL24;TNFRSF6B;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;ZC3H7B;STAT5A;CAV1;HLA-A;TNIP2;TP53;KLF3;TLR2;HLA-B;IKBKE;UBE2D3;STX1A;PML;PIM1;ADAM9;RELA;TRIM16;CCBE1;MUC1;AXL;ANXA5;HLA-F;NR4A3;HLA-E;GSK3B;OSMR;PPARD;SLC16A1;PARP1;CYP24A1;MED13;OCLN;VIM;XBP1;HSPA4L;IL36RN;JUND
4476,GO:0010469,1.46877263448191e-17,1,43,215,regulation of signaling receptor activity,BP,CXCL8;IL1B;CXCL2;CSF2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;INHBA;CCL20;CXCL5;IL16;BMP2;LIF;IL36G;IL1RN;EDN1;CSF1;EREG;IL23A;IL6;TNFSF15;PHLDA2;VEGFA;DKK1;FGF5;NAMPT;ADM;ERRFI1;WNT5A;VEGFC;TGFA;PDGFB;IL20;NRG1;IL32;CXCL16;IL24;WNT7B;MED13;IL36RN
12911,GO:0051240,2.49821409858174e-17,1,107,982,positive regulation of multicellular organismal process,BP,CXCL8;IL1B;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;INHBA;BIRC3;CCL20;ZC3H12A;BMP2;LIF;CD83;PRDM1;NFKB1;EDN1;MAP2K3;JUN;TICAM1;ETS1;HCAR2;CSF1;EREG;IL23A;BCL3;PELI1;BIRC2;IL6;NFKB2;ADAM8;PANX1;ZFP36L1;CYP27B1;SIX4;RIPK2;PHLDB2;CYLD;BAMBI;C1QTNF1;ITGA5;IL7R;NEDD4L;NOD2;IL6ST;ICAM1;GCH1;SMAD3;B4GALT1;DLX2;TRIB1;VEGFA;DKK1;PLK2;ABL2;CFLAR;BTG1;CEBPB;ADM;CREB1;GORAB;RUNX1;TGFBR2;SMURF2;SAA1;TGIF2;ITGB8;WNT5A;VEGFC;DUSP10;SOCS2;PDGFB;IL20;IFIH1;NRG1;MMP9;LDLR;SUCO;SLC9A1;FEZ1;IL4R;MMD;ITSN2;NFE2L2;WNT7B;SMAD1;STAT5A;CAV1;TLR2;EFNB2;CD276;ABCA7;POLR3A;PIM1;ADAM9;RELA;TRIM16;CCBE1;EVI2B;AXL;NR4A3;HLA-E;PARP1;XBP1;KCTD11;JUND
2226,GO:0005126,4.10426819335645e-17,1,34,137,cytokine receptor binding,MF,CXCL8;IL1B;CXCL2;CSF2;TNF;CXCL3;CXCL1;IL1A;INHBA;CCL20;CXCL5;BMP2;LIF;IL36G;IL1RN;TRAF1;CSF1;IL23A;IL6;TNFSF15;BAMBI;ITGA5;IL6ST;SMAD3;TRAF4;VEGFA;CFLAR;TGFBR2;SMURF2;VEGFC;SOCS2;IL20;CXCL16;IL36RN
7320,GO:0031325,4.27698871895378e-17,1,181,2178,positive regulation of cellular metabolic process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;CCL20;FOSL1;NCOA7;ZC3H12A;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;JUN;TICAM1;KDM6B;EPHA2;ETS1;SQSTM1;CSF1;SERTAD2;BBC3;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ETS2;CSRNP1;NFKB2;ADAM8;TNFRSF10B;RFX5;ZFP36L1;TNFSF15;SIX4;RIPK2;IRAK2;JUNB;FZD8;BAMBI;RELB;C1QTNF1;CDKN1A;ITGA5;RAP2B;CTSC;NOD2;IL6ST;DCUN1D3;ICAM1;SMAD3;DLX2;ARNTL2;RNF144B;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;PLK2;MAP3K8;CFLAR;KLF7;IER5;CEBPB;CEBPD;NAMPT;ANKLE2;ADM;CREB1;TAF4B;CCNL1;NR4A2;VHL;PHKG2;BACH1;MYBL1;RUNX1;TGFBR2;SFR1;SAA1;GPBP1;NFE2L3;WNT5A;VEGFC;TGFA;SOX4;PDGFB;IL20;NRG1;MMP9;LDLR;ATF3;OTUD4;IKZF2;CAB39;PLK3;ARRDC4;SLC9A1;RCHY1;YAF2;SPRY2;TNKS1BP1;RNF152;MMD;POU2F2;IL24;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;PAOX;NFAT5;CAV1;VEZF1;TNIP2;TP53;TLR2;ABI1;ITGAV;CD276;ELK3;ABCA7;SDR16C5;ZNF148;PML;ADAM9;RELA;TRIM16;FOXN2;CCBE1;MUC1;AXL;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;VIM;CREB5;EGLN1;ZXDA;DDR1;XBP1;QKI;ELF4;TFE3;ZMIZ2;JUND
15187,GO:0071310,5.20069012328528e-17,1,157,1808,cellular response to organic substance,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;CXCL1;IL1A;INHBA;BIRC3;CCL20;ZC3H12A;CXCL5;IL16;PPP1R15A;BMP2;LIF;SOD2;PRDM1;IL36G;IL1RN;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;SERPINB2;JUN;TICAM1;IFNAR2;EHD1;TRAF1;SQSTM1;CSF1;IRF6;EREG;IL23A;DUSP1;PELI1;BIRC2;IFNGR2;IL6;TNFRSF10B;PIM3;ZFP36L1;TNFSF15;CYP27B1;RIPK2;IRAK2;JUNB;CYLD;BAMBI;TJP2;CDKN1A;CLDN1;ITGA5;GBP2;IL7R;CPEB2;ZNF451;NOD2;IL6ST;RELT;ICAM1;SMAD3;NFKBIB;TRIB1;VEGFA;IL1R2;DKK1;CDKN2B;FGF5;MAP3K8;ABL2;CFLAR;PIGA;CEBPB;CEBPD;CD55;GJB3;CDC42EP4;IFNAR1;ERRFI1;CREB1;NR4A2;SOGA1;RUNX1;TGFBR2;SMURF2;SAA1;TRIM25;IFNGR1;HMGCS1;WNT5A;VEGFC;SOX4;SOCS2;PDGFB;IL20;IFIH1;TNC;MMP9;LDLR;ATF3;OTUD4;IL32;MT2A;SLC9A1;MAOA;SPRY2;FEZ1;IL4R;NEDD4;IL24;TNFRSF6B;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;ZC3H7B;STAT5A;CAV1;HLA-A;TNIP2;TP53;KLF3;TLR2;HLA-B;UBE2D3;STX1A;PML;PIM1;ADAM9;RELA;CCBE1;MUC1;AXL;HLA-F;NR4A3;HLA-E;GSK3B;OSMR;PPARD;SLC16A1;PARP1;CYP24A1;MED13;OCLN;VIM;XBP1;HSPA4L;IL36RN;JUND
4765,GO:0010941,6.90757737689832e-17,1,118,1191,regulation of cell death,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;NUAK2;IL1A;EFNA1;BTG2;INHBA;BIRC3;PLEKHF1;FOSL1;NCOA7;ZC3H12A;BMP2;PLAUR;SOD2;TBX3;PMAIP1;NFKB1;IER3;PPIF;EDN1;MAP2K3;ZFP36;G0S2;SERPINB2;JUN;EPHA2;TRAF1;HCAR2;SQSTM1;BBC3;REL;DUSP1;BCL3;GADD45A;PLAGL2;BIRC2;IL6;ADAM8;TNFRSF10B;PIM3;ZFP36L1;TNFSF15;SIX4;RIPK2;JUNB;CYLD;TNFAIP8;CDKN1A;ITGA5;CTSC;NOD2;IL6ST;DCUN1D3;RELT;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;RNF144B;NFKBID;TRAF4;VEGFA;ARHGEF3;DKK1;PLK2;MAP3K8;ABL2;CFLAR;BTG1;CEBPB;TP53BP2;ANKLE2;ADM;CREB1;WISP1;NR4A2;VHL;WNT5A;SOX4;SOCS2;MMP9;ATF3;TLE1;PLK3;SLC9A1;SPRY2;BCL2L2;TNFRSF6B;NFE2L2;PTPN1;CAV1;TNIP2;TP53;STK40;EFNB2;ITGAV;UBE2Z;PML;PIM1;RELA;EVI2B;MUC1;AXL;ANXA5;NR4A3;GSK3B;PPARD;PARP1;JMY;EGLN1;DDR1;XBP1;JUND
15139,GO:0071219,7.67382290051108e-17,1,31,111,cellular response to molecule of bacterial origin,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;CCL20;ZC3H12A;PRDM1;NFKB1;TNIP1;ZFP36;TICAM1;IL6;RIPK2;IRAK2;NOD2;ICAM1;NFKBIB;TRIB1;CEBPB;CD55;WNT5A;IL24;TNIP2;TLR2;ADAM9;RELA;AXL;PPARD;XBP1
4365,GO:0009966,1.29826470229299e-16,1,177,2144,regulation of signal transduction,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;INHBA;BIRC3;PLEKHF1;CCL20;ZC3H12A;CXCL5;IL16;PPP1R15A;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;IL36G;PMAIP1;IL1RN;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;G0S2;JUN;TICAM1;IFNAR2;EPHA2;TRAF1;SQSTM1;CSF1;BBC3;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IFNGR2;IL6;ADAM8;TNFRSF10B;TNFSF15;CYP27B1;RIPK2;IRAK2;PHLDA2;CYLD;FZD8;BAMBI;C1QTNF1;ITGA5;IL7R;ZNF451;CTSC;NOD2;IL6ST;ICAM1;SMAD3;DLX2;NFKBID;TRAF4;TRIB1;VEGFA;ARHGEF3;FGD6;NRARP;IL1R2;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;CFLAR;RNF43;CD55;NAMPT;TP53BP2;ADM;IFNAR1;ERRFI1;TAF4B;GORAB;NR4A2;CANT1;VHL;RUNX1;TGFBR2;SMURF2;DUSP16;SAA1;TRIM25;IFNGR1;WNT5A;VEGFC;TGFA;DUSP10;SOX4;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;ATF3;OTUD4;IL32;TLE1;PLK3;SLC9A1;SPRY2;CYTH1;GRB7;CXCL16;BCL2L2;RNF152;NEDD4;ITSN2;GCSAM;IL24;NFE2L2;PTPN1;WNT7B;TAB3;CHD4;NFAT5;CAV1;RHOV;UACA;TNIP2;TP53;TLR2;STK40;ITGAV;IKBKE;PJA2;STX1A;TRIP10;MAPKBP1;JPH2;RAD9B;ABCA7;PML;ADAM9;RELA;TRIM16;CCBE1;MUC1;AXL;GSK3B;PPARD;EVC;PARP1;MED13;JMY;RPS6KA6;DDR1;XBP1;KCTD11;IL36RN
15142,GO:0071222,1.46597832346062e-16,1,30,106,cellular response to lipopolysaccharide,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;CCL20;ZC3H12A;PRDM1;NFKB1;TNIP1;ZFP36;TICAM1;IL6;RIPK2;IRAK2;ICAM1;NFKBIB;TRIB1;CEBPB;CD55;WNT5A;IL24;TNIP2;TLR2;ADAM9;RELA;AXL;PPARD;XBP1
12285,GO:0048583,1.57356477555716e-16,1,209,2719,regulation of response to stimulus,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;INHBA;BIRC3;PLEKHF1;CCL20;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;IL36G;PMAIP1;IL1RN;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;G0S2;SERPINB2;JUN;TICAM1;IFNAR2;EPHA2;ETS1;TRAF1;SQSTM1;CSF1;BBC3;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IFNGR2;IL6;ADAM8;TNFRSF10B;PIM3;TNFSF15;CYP27B1;RIPK2;IRAK2;PHLDA2;PHLDB2;CYLD;FZD8;BAMBI;RELB;C1QTNF1;ITGA5;IL7R;ZNF451;CTSC;NOD2;IL6ST;ICAM1;GCH1;SMAD3;DLX2;NFKBID;TRAF4;TRIB1;VEGFA;ARHGEF3;FGD6;NRARP;IL1R2;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;MAP3K8;CFLAR;RNF43;IER5;CD55;NAMPT;TP53BP2;ADM;IFNAR1;ERRFI1;TAF4B;GORAB;NR4A2;SLC7A2;CD47;CANT1;VHL;SEMA4B;RUNX1;TGFBR2;SMURF2;DUSP16;SAA1;TRIM25;IFNGR1;WNT5A;VEGFC;TGFA;DUSP10;SOX4;SOCS2;PDGFB;IL20;PGLYRP4;IFIH1;DUSP8;NRG1;MMP9;LDLR;ATF3;OTUD4;IL32;TLE1;PLK3;SLC9A1;SPRY2;CYTH1;GRB7;CXCL16;NUP153;BCL2L2;RNF152;IL4R;NEDD4;ITSN2;GCSAM;IL24;BTN2A2;NFE2L2;PTPN1;WNT7B;TAB3;CHD4;NFAT5;CAV1;RHOV;HLA-A;UACA;TNIP2;TP53;TLR2;ABI1;STK40;EFNB2;HLA-B;ITGAV;IKBKE;UBE2D3;PJA2;STX1A;CD276;TRIP10;MAPKBP1;JPH2;RAD9B;ABCA7;ADGRE2;PML;ADAM9;RELA;TRIM16;CCBE1;PLAT;MUC1;AXL;HLA-F;NR4A3;HLA-E;GSK3B;OSMR;PPARD;EVC;PARP1;MED13;JMY;RPS6KA6;DDR1;XBP1;KCTD11;IL36RN;EID3;CFB
15137,GO:0071216,1.77836109895237e-16,1,33,129,cellular response to biotic stimulus,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;CCL20;ZC3H12A;PRDM1;NFKB1;TNIP1;ZFP36;TICAM1;IL6;RIPK2;IRAK2;NOD2;ICAM1;NFKBIB;TRIB1;CEBPB;CD55;WNT5A;IL24;TNIP2;TP53;TLR2;ADAM9;RELA;AXL;GSK3B;PPARD;XBP1
10250,GO:0042981,1.87680304865415e-16,1,111,1100,regulation of apoptotic process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;NUAK2;IL1A;EFNA1;BTG2;INHBA;BIRC3;PLEKHF1;FOSL1;ZC3H12A;BMP2;PLAUR;SOD2;TBX3;PMAIP1;NFKB1;IER3;PPIF;EDN1;MAP2K3;ZFP36;G0S2;SERPINB2;JUN;EPHA2;TRAF1;HCAR2;SQSTM1;BBC3;DUSP1;BCL3;GADD45A;PLAGL2;BIRC2;IL6;ADAM8;TNFRSF10B;PIM3;ZFP36L1;TNFSF15;SIX4;RIPK2;CYLD;TNFAIP8;CDKN1A;ITGA5;CTSC;NOD2;IL6ST;DCUN1D3;RELT;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;RNF144B;NFKBID;TRAF4;VEGFA;ARHGEF3;DKK1;PLK2;MAP3K8;ABL2;CFLAR;BTG1;CEBPB;TP53BP2;ANKLE2;ADM;CREB1;NR4A2;VHL;WNT5A;SOX4;SOCS2;MMP9;ATF3;TLE1;PLK3;SLC9A1;SPRY2;BCL2L2;TNFRSF6B;NFE2L2;PTPN1;CAV1;TNIP2;TP53;STK40;ITGAV;UBE2Z;PML;PIM1;RELA;EVI2B;MUC1;AXL;ANXA5;NR4A3;GSK3B;PPARD;PARP1;JMY;DDR1;XBP1
3745,GO:0008283,3.70305966480444e-16,1,126,1333,cell proliferation,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;PLAU;CXCL1;IL1A;SDC4;BTG2;INHBA;FOSL1;CXCL5;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;EDN1;ZFP36;JUN;TICAM1;EPHA2;ETS1;CSF1;IRF6;EREG;IL23A;PELI1;EFNB1;BIRC2;IL6;TNFRSF10B;ZFP36L1;CYP27B1;SIX4;RIPK2;PHLDA2;JUNB;BAMBI;CDKN1A;IL7R;ODC1;NOD2;IL6ST;RELT;SAV1;SGK1;SMAD3;B4GALT1;MARCKSL1;TRIB1;VEGFA;NRARP;CDKN2B;FGF5;ABL2;CDV3;CFLAR;RNF43;TXNRD1;BTG1;IER5;CEBPB;CD55;NAMPT;ADM;ERRFI1;ADAMTS1;CREB1;CD47;VHL;RUNX1;TGFBR2;WNT5A;VEGFC;TGFA;DUSP10;SOX4;PDGFB;NRG1;TNC;MMP9;ATF3;BTG3;FAM83B;SPRY2;BCL2L2;IL4R;IL24;TNFRSF6B;BTN2A2;WNT7B;SMAD1;MXD1;STAT5A;CAV1;TP53;TLR2;ABI1;EFNB2;ITGAV;CD276;SDR16C5;PML;PIM1;RELA;EMP3;SAT1;FRK;NR4A3;HLA-E;OSMR;PPARD;COL8A1;DDR1;XBP1;KCTD11;ELF4;JUND
10307,GO:0043067,4.01585430979299e-16,1,111,1112,regulation of programmed cell death,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;NUAK2;IL1A;EFNA1;BTG2;INHBA;BIRC3;PLEKHF1;FOSL1;ZC3H12A;BMP2;PLAUR;SOD2;TBX3;PMAIP1;NFKB1;IER3;PPIF;EDN1;MAP2K3;ZFP36;G0S2;SERPINB2;JUN;EPHA2;TRAF1;HCAR2;SQSTM1;BBC3;DUSP1;BCL3;GADD45A;PLAGL2;BIRC2;IL6;ADAM8;TNFRSF10B;PIM3;ZFP36L1;TNFSF15;SIX4;RIPK2;CYLD;TNFAIP8;CDKN1A;ITGA5;CTSC;NOD2;IL6ST;DCUN1D3;RELT;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;RNF144B;NFKBID;TRAF4;VEGFA;ARHGEF3;DKK1;PLK2;MAP3K8;ABL2;CFLAR;BTG1;CEBPB;TP53BP2;ANKLE2;ADM;CREB1;NR4A2;VHL;WNT5A;SOX4;SOCS2;MMP9;ATF3;TLE1;PLK3;SLC9A1;SPRY2;BCL2L2;TNFRSF6B;NFE2L2;PTPN1;CAV1;TNIP2;TP53;STK40;ITGAV;UBE2Z;PML;PIM1;RELA;EVI2B;MUC1;AXL;ANXA5;NR4A3;GSK3B;PPARD;PARP1;JMY;DDR1;XBP1
3711,GO:0008219,7.25877573669459e-16,1,139,1571,cell death,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;NUAK2;IL1A;EFNA1;BTG2;INHBA;BIRC3;PLEKHF1;FOSL1;NCOA7;ZC3H12A;PPP1R15A;BMP2;PLAUR;SOD2;TBX3;PMAIP1;NFKB1;IER3;PPIF;EDN1;MAP2K3;ZFP36;G0S2;SERPINB2;JUN;TICAM1;EPHA2;TRAF1;HCAR2;SQSTM1;SPRR2D;BBC3;REL;DUSP1;BCL3;GADD45A;PLAGL2;BIRC2;IL6;CSRNP1;ADAM8;TNFRSF10B;PIM3;ZFP36L1;TNFSF15;SIX4;RIPK2;PHLDA2;JUNB;CYLD;TNFAIP8;CDKN1A;ITGA5;CTSC;NOD2;IL6ST;DCUN1D3;RELT;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;PHLDA1;RNF144B;NFKBID;TRAF4;KRT34;VEGFA;ARHGEF3;DKK1;PLK2;MAP3K8;ABL2;CFLAR;BTG1;CEBPB;TP53BP2;ANKLE2;ADM;CREB1;WISP1;NR4A2;VHL;TGFBR2;WNT5A;SOX4;SOCS2;MMP9;ATF3;TLE1;PLK3;SLC9A1;SPRY2;BCL2L2;RNF152;IL24;TNFRSF6B;NFE2L2;PTPN1;SUSD6;CAV1;UACA;DRAM1;TNIP2;TP53;TLR2;STK40;EFNB2;ITGAV;IKBKE;UBE2D3;SPRR2A;UBE2Z;PML;PIM1;ESPL1;RELA;EMP3;EVI2B;MUC1;AXL;ANXA5;NR4A3;GSK3B;PPARD;PARP1;JMY;EGLN1;DDR1;XBP1;EPB41L3;JUND
6741,GO:0030155,7.46332101308681e-16,1,62,424,regulation of cell adhesion,BP,CXCL8;IL1B;TNF;IRF1;PLAU;EFNA1;SDC4;BMP2;CD83;IL1RN;EPHA2;ETS1;CSF1;IL23A;PELI1;EFNB1;IL6;ADAM8;RIPK2;PHLDB2;CYLD;C1QTNF1;ITGA5;IL7R;NOD2;IL6ST;ICAM1;SMAD3;NFKBID;NINJ1;VEGFA;NRARP;MAP3K8;ABL2;CEBPB;CD55;CD47;TGFBR2;SAA1;WNT5A;VEGFC;DUSP10;TNC;SLC9A1;CYTH1;IL4R;BTN2A2;CAV1;EFNB2;ITGAV;CD276;PML;ADAM9;MUC1;NR4A3;HLA-E;GSK3B;LAMA3;COL8A1;DDR1;XBP1;TFE3
2214,GO:0005102,8.53860817469262e-16,1,95,883,signaling receptor binding,MF,CXCL8;IL1B;CXCL2;CSF2;TNF;CXCL3;HBEGF;CXCL1;IL1A;EFNA1;INHBA;CCL20;NCOA7;CXCL5;IL16;BMP2;LIF;PLAUR;IL36G;IL1RN;EDN1;TRAF1;SQSTM1;CSF1;EREG;IL23A;EFNB1;IL6;ETS2;PANX1;TNFSF15;RIPK2;FZD8;BAMBI;ITGA5;IL6ST;ICAM1;SMAD3;TRAF4;VEGFA;DKK1;FGF5;ABL2;CFLAR;RNF43;CEBPB;NAMPT;TAP1;ADM;WISP1;NR4A2;SEMA4B;TGFBR2;SMURF2;SAA1;ITGB8;WNT5A;VEGFC;TGFA;SOCS2;PDGFB;IL20;NRG1;FAM83B;IL32;RCHY1;CXCL16;NEDD4;IL24;RAET1L;BTN2A2;PTPN1;WNT7B;PAOX;CAV1;HLA-A;TP53;TLR2;TAPBP;EFNB2;HLA-B;ITGAV;CD276;DOCK4;ADAM9;PLAT;FRK;HLA-F;NR4A3;HLA-E;PARP1;LAMA3;MED13;IL36RN;JUND
12910,GO:0051239,2.49794181159893e-15,1,155,1833,regulation of multicellular organismal process,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;PLAU;IL1A;EFNA1;INHBA;BIRC3;NOCT;CCL20;ZC3H12A;BMP2;LIF;PLAUR;CD83;PRDM1;TBX3;IL1RN;MAFF;NFKB1;EDN1;MAP2K3;ZFP36;SERPINB2;JUN;TICAM1;EPHA2;ETS1;HCAR2;CSF1;EREG;IL23A;REL;BCL3;PELI1;BIRC2;IL6;NFKB2;ADAM8;PANX1;ZFP36L1;CYP27B1;SIX4;RIPK2;PHLDA2;PHLDB2;CYLD;BAMBI;TJP2;RELB;C1QTNF1;ITGA5;IL7R;NAV3;NEDD4L;NOD2;IL6ST;SAV1;SGK1;ICAM1;GCH1;SMAD3;B4GALT1;DLX2;NFKBID;TRIB1;VEGFA;NRARP;IL1R2;DKK1;ZSWIM4;PLK2;ABL2;CFLAR;BTG1;CEBPB;ADM;ERRFI1;CREB1;GORAB;NR4A2;SEMA4B;RUNX1;TGFBR2;SMURF2;SAA1;TGIF2;TRIM25;ITGB8;WNT5A;VEGFC;DUSP10;SOCS2;PDGFB;IL20;IFIH1;NRG1;MMP9;LDLR;TRPV3;SUCO;SLC9A1;SPRY2;FEZ1;IL4R;NEDD4;MMD;ITSN2;BTN2A2;NFE2L2;WNT7B;SMAD1;STAT5A;CAV1;VEZF1;TLR2;EFNB2;IKBKE;CD276;DOCK4;MAPKBP1;JPH2;ABCA7;PML;POLR3A;PIM1;ADAM9;RELA;TRIM16;CCBE1;EVI2B;PLAT;AXL;ANXA5;NR4A3;HLA-E;GSK3B;KMT2E;PPARD;PARP1;LAMA3;VIM;EGLN1;RPS6KA6;XBP1;KCTD11;IL36RN;TFE3;JUND;GJC1
3254,GO:0006915,2.73534586480064e-15,1,127,1396,apoptotic process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;NUAK2;IL1A;EFNA1;BTG2;INHBA;BIRC3;PLEKHF1;FOSL1;ZC3H12A;PPP1R15A;BMP2;PLAUR;SOD2;TBX3;PMAIP1;NFKB1;IER3;PPIF;EDN1;MAP2K3;ZFP36;G0S2;SERPINB2;JUN;TICAM1;EPHA2;TRAF1;HCAR2;SQSTM1;BBC3;DUSP1;BCL3;GADD45A;PLAGL2;BIRC2;IL6;CSRNP1;ADAM8;TNFRSF10B;PIM3;ZFP36L1;TNFSF15;SIX4;RIPK2;PHLDA2;CYLD;TNFAIP8;CDKN1A;ITGA5;CTSC;NOD2;IL6ST;DCUN1D3;RELT;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;PHLDA1;RNF144B;NFKBID;TRAF4;VEGFA;ARHGEF3;DKK1;PLK2;MAP3K8;ABL2;CFLAR;BTG1;CEBPB;TP53BP2;ANKLE2;ADM;CREB1;NR4A2;VHL;TGFBR2;WNT5A;SOX4;SOCS2;MMP9;ATF3;TLE1;PLK3;SLC9A1;SPRY2;BCL2L2;RNF152;IL24;TNFRSF6B;NFE2L2;PTPN1;CAV1;UACA;DRAM1;TNIP2;TP53;TLR2;STK40;ITGAV;IKBKE;UBE2D3;UBE2Z;PML;PIM1;ESPL1;RELA;EVI2B;MUC1;AXL;ANXA5;NR4A3;GSK3B;PPARD;PARP1;JMY;DDR1;XBP1;EPB41L3
11095,GO:0045087,4.47453116296774e-15,1,69,561,innate immune response,BP,NFKBIA;TNFAIP3;IRF1;BIRC3;CCL20;PRDM1;IL36G;PTX3;NFKB1;TNIP1;EDN1;TICAM1;IFNAR2;CSF1;IRF6;EREG;IL23A;REL;PELI1;BIRC2;IFNGR2;NFKB2;ADAM8;CYP27B1;RIPK2;IRAK2;CYLD;RELB;CLDN1;GBP2;NOD2;ICAM1;GCH1;ABL2;CD55;CDC42EP4;IFNAR1;SAA1;TRIM25;IFNGR1;WNT5A;DUSP10;PGLYRP4;IFIH1;OTUD4;MT2A;CXCL16;RAET1L;PTPN1;TAB3;CAV1;HLA-A;TNIP2;TLR2;HLA-B;IKBKE;UBE2D3;PML;POLR3A;RELA;MUC1;AXL;FRK;HLA-F;HLA-E;VIM;ELF4;IL36RN;CFB
9185,GO:0035556,4.63079745452855e-15,1,164,1986,intracellular signal transduction,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;HBEGF;NUAK2;CXCL1;IL1A;EFNA1;BTG2;INHBA;BIRC3;PLEKHF1;CCL20;ZC3H12A;PPP1R15A;BMP2;LIF;PLAUR;TIFA;SOD2;PMAIP1;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;JUN;TICAM1;IFNAR2;EPHA2;SQSTM1;CSF1;BBC3;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IL6;NFKB2;ADAM8;TNFRSF10B;ZFP36L1;TNFSF15;RIPK2;IRAK2;CYLD;FZD8;TJP2;RELB;C1QTNF1;AMOTL2;CDKN1A;RAP2B;IL7R;NOD2;IL6ST;SAV1;SGK1;ICAM1;RND3;NFKBID;TRAF4;TRIB1;VEGFA;ARHGEF3;RAB24;FGD6;DKK1;FGF5;PLK2;MAP3K8;CFLAR;CEBPB;TP53BP2;ADM;CDC42EP4;IFNAR1;ERRFI1;CREB1;TAF4B;MAST4;CANT1;VHL;PHKG2;DUSP16;SAA1;TRIM25;MASTL;WNT5A;CAMK1G;TGFA;DUSP10;SOX4;SOCS2;PDGFB;IL20;IFIH1;DUSP8;NRG1;MMP9;RRAD;ATF3;CAB39;TLE1;PLK3;RASGEF1B;SLC9A1;SPRY2;TNKS1BP1;CYTH1;BCL2L2;RNF152;NEDD4;ITSN2;IL24;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;CHD4;NFAT5;STAT5A;CAV1;RHOV;UACA;TNIP2;TP53;TLR2;STK40;RAB9A;ITGAV;IKBKE;PJA2;DOCK4;TRIP10;MAPKBP1;JPH2;RAD9B;ABCA7;PML;ADAM9;RELA;MUC1;AXL;GSK3B;PPARD;PARP1;JMY;RPS6KA6;DDR1;XBP1
4568,GO:0010646,6.28537804739324e-15,1,182,2315,regulation of cell communication,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;INHBA;BIRC3;PLEKHF1;CCL20;ZC3H12A;CXCL5;IL16;PPP1R15A;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;IL36G;PMAIP1;IL1RN;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;G0S2;JUN;TICAM1;IFNAR2;EPHA2;TRAF1;HCAR2;SQSTM1;CSF1;BBC3;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IFNGR2;IL6;ADAM8;TNFRSF10B;PIM3;TNFSF15;CYP27B1;RIPK2;IRAK2;PHLDA2;CYLD;FZD8;BAMBI;C1QTNF1;ITGA5;IL7R;ZNF451;CTSC;NOD2;IL6ST;ICAM1;SMAD3;DLX2;NFKBID;TRAF4;TRIB1;VEGFA;ARHGEF3;FGD6;NRARP;IL1R2;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;CFLAR;RNF43;CD55;NAMPT;TP53BP2;ADM;IFNAR1;ERRFI1;CREB1;TAF4B;GORAB;NR4A2;CANT1;VHL;RUNX1;TGFBR2;SMURF2;DUSP16;SAA1;TRIM25;IFNGR1;WNT5A;VEGFC;TGFA;DUSP10;SOX4;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;ATF3;OTUD4;IL32;TLE1;PLK3;SLC9A1;SPRY2;CYTH1;GRB7;CXCL16;BCL2L2;RNF152;NEDD4;ITSN2;GCSAM;IL24;MARCKS;NFE2L2;PTPN1;WNT7B;TAB3;CHD4;NFAT5;CAV1;RHOV;UACA;TNIP2;TP53;TLR2;STK40;ITGAV;IKBKE;PJA2;STX1A;TRIP10;MAPKBP1;JPH2;RAD9B;ABCA7;PML;ADAM9;RELA;TRIM16;CCBE1;MUC1;AXL;GSK3B;PPARD;SLC16A1;EVC;PARP1;MED13;JMY;RPS6KA6;DDR1;XBP1;KCTD11;IL36RN
17766,GO:1901700,6.82504124944562e-15,1,103,1025,response to oxygen-containing compound,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;CXCL3;CXCL1;BTG2;INHBA;NOCT;CCL20;FOSL1;ZC3H12A;CXCL5;SOD2;PRDM1;NFKB1;PPIF;TNIP1;EDN1;ZFP36;JUN;TICAM1;KDM6B;ETS1;EREG;DUSP1;PELI1;BIRC2;IL6;NFKB2;TNFRSF10B;BDKRB1;PIM3;PANX1;ZFP36L1;CYP27B1;RIPK2;IRAK2;JUNB;CDKN1A;CLDN1;CPEB2;GPX3;NOD2;RELT;ICAM1;GCH1;NFKBIB;TRIB1;DKK1;ABL2;CFLAR;TXNRD1;BTG1;CEBPB;CD55;ADM;GJB3;IFNAR1;ERRFI1;CREB1;NR4A2;SOGA1;TGFBR2;TRIM25;HMGCS1;WNT5A;DUSP10;SOX4;SOCS2;PDGFB;TNC;MMP9;LDLR;PLK3;SLC9A1;IL24;TNFRSF6B;NFE2L2;PTPN1;WNT7B;STAT5A;CAV1;TNIP2;TP53;KLF3;TLR2;PIM1;ADAM9;RELA;TRIM16;AXL;NR4A3;GSK3B;PPARD;PARP1;CYP24A1;EGLN1;XBP1;JUND
10306,GO:0043066,8.37696390238326e-15,1,74,619,negative regulation of apoptotic process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;NUAK2;IL1A;EFNA1;BTG2;BIRC3;ZC3H12A;PLAUR;SOD2;TBX3;NFKB1;IER3;PPIF;EDN1;SERPINB2;JUN;EPHA2;SQSTM1;DUSP1;BCL3;BIRC2;IL6;ADAM8;TNFRSF10B;PIM3;SIX4;RIPK2;TNFAIP8;CDKN1A;ITGA5;NOD2;IL6ST;ICAM1;SMAD3;RNF144B;VEGFA;DKK1;PLK2;CFLAR;CEBPB;ANKLE2;NR4A2;VHL;WNT5A;SOCS2;MMP9;TLE1;PLK3;SLC9A1;SPRY2;BCL2L2;TNFRSF6B;NFE2L2;PTPN1;CAV1;TNIP2;TP53;STK40;ITGAV;PIM1;RELA;EVI2B;MUC1;AXL;ANXA5;NR4A3;GSK3B;PPARD;DDR1;XBP1
13918,GO:0060548,9.91823060039478e-15,1,79,690,negative regulation of cell death,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;NUAK2;IL1A;EFNA1;BTG2;BIRC3;NCOA7;ZC3H12A;PLAUR;SOD2;TBX3;NFKB1;IER3;PPIF;EDN1;SERPINB2;JUN;EPHA2;SQSTM1;REL;DUSP1;BCL3;BIRC2;IL6;ADAM8;TNFRSF10B;PIM3;SIX4;RIPK2;TNFAIP8;CDKN1A;ITGA5;NOD2;IL6ST;ICAM1;SMAD3;RNF144B;VEGFA;DKK1;PLK2;CFLAR;CEBPB;ANKLE2;CREB1;WISP1;NR4A2;VHL;WNT5A;SOX4;SOCS2;MMP9;TLE1;PLK3;SLC9A1;SPRY2;BCL2L2;TNFRSF6B;NFE2L2;PTPN1;CAV1;TNIP2;TP53;STK40;ITGAV;PIM1;RELA;EVI2B;MUC1;AXL;ANXA5;NR4A3;GSK3B;PPARD;DDR1;XBP1
4366,GO:0009967,1.26373471981937e-14,1,105,1065,positive regulation of signal transduction,BP,IL1B;CSF2;TNF;HBEGF;IL1A;EFNA1;INHBA;BIRC3;PLEKHF1;CCL20;ZC3H12A;ELF3;BMP2;LIF;PLAUR;PMAIP1;NFKB1;PPIF;EDN1;MAP2K3;G0S2;JUN;TICAM1;EPHA2;CSF1;BBC3;EREG;IL23A;REL;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ADAM8;TNFRSF10B;TNFSF15;CYP27B1;RIPK2;IRAK2;CYLD;FZD8;BAMBI;C1QTNF1;ITGA5;IL7R;CTSC;NOD2;IL6ST;ICAM1;SMAD3;TRAF4;VEGFA;NRARP;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;CFLAR;TP53BP2;GORAB;CANT1;SMURF2;SAA1;TRIM25;WNT5A;TGFA;SOX4;SOCS2;PDGFB;IL20;NRG1;MMP9;ATF3;SLC9A1;SPRY2;GRB7;NEDD4;ITSN2;IL24;PTPN1;WNT7B;TAB3;CAV1;TNIP2;TP53;TLR2;ITGAV;IKBKE;STX1A;JPH2;ABCA7;PML;ADAM9;RELA;TRIM16;CCBE1;AXL;GSK3B;PPARD;EVC;PARP1;DDR1;XBP1
4809,GO:0012501,1.71001525406573e-14,1,130,1485,programmed cell death,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;NUAK2;IL1A;EFNA1;BTG2;INHBA;BIRC3;PLEKHF1;FOSL1;ZC3H12A;PPP1R15A;BMP2;PLAUR;SOD2;TBX3;PMAIP1;NFKB1;IER3;PPIF;EDN1;MAP2K3;ZFP36;G0S2;SERPINB2;JUN;TICAM1;EPHA2;TRAF1;HCAR2;SQSTM1;SPRR2D;BBC3;DUSP1;BCL3;GADD45A;PLAGL2;BIRC2;IL6;CSRNP1;ADAM8;TNFRSF10B;PIM3;ZFP36L1;TNFSF15;SIX4;RIPK2;PHLDA2;CYLD;TNFAIP8;CDKN1A;ITGA5;CTSC;NOD2;IL6ST;DCUN1D3;RELT;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;PHLDA1;RNF144B;NFKBID;TRAF4;KRT34;VEGFA;ARHGEF3;DKK1;PLK2;MAP3K8;ABL2;CFLAR;BTG1;CEBPB;TP53BP2;ANKLE2;ADM;CREB1;NR4A2;VHL;TGFBR2;WNT5A;SOX4;SOCS2;MMP9;ATF3;TLE1;PLK3;SLC9A1;SPRY2;BCL2L2;RNF152;IL24;TNFRSF6B;NFE2L2;PTPN1;CAV1;UACA;DRAM1;TNIP2;TP53;TLR2;STK40;ITGAV;IKBKE;UBE2D3;SPRR2A;UBE2Z;PML;PIM1;ESPL1;RELA;EVI2B;MUC1;AXL;ANXA5;NR4A3;GSK3B;PPARD;PARP1;JMY;DDR1;XBP1;EPB41L3
10309,GO:0043069,2.40140930927394e-14,1,74,632,negative regulation of programmed cell death,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;NUAK2;IL1A;EFNA1;BTG2;BIRC3;ZC3H12A;PLAUR;SOD2;TBX3;NFKB1;IER3;PPIF;EDN1;SERPINB2;JUN;EPHA2;SQSTM1;DUSP1;BCL3;BIRC2;IL6;ADAM8;TNFRSF10B;PIM3;SIX4;RIPK2;TNFAIP8;CDKN1A;ITGA5;NOD2;IL6ST;ICAM1;SMAD3;RNF144B;VEGFA;DKK1;PLK2;CFLAR;CEBPB;ANKLE2;NR4A2;VHL;WNT5A;SOCS2;MMP9;TLE1;PLK3;SLC9A1;SPRY2;BCL2L2;TNFRSF6B;NFE2L2;PTPN1;CAV1;TNIP2;TP53;STK40;ITGAV;PIM1;RELA;EVI2B;MUC1;AXL;ANXA5;NR4A3;GSK3B;PPARD;DDR1;XBP1
6650,GO:0023051,2.50726661388425e-14,1,182,2348,regulation of signaling,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;INHBA;BIRC3;PLEKHF1;CCL20;ZC3H12A;CXCL5;IL16;PPP1R15A;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;IL36G;PMAIP1;IL1RN;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;G0S2;JUN;TICAM1;IFNAR2;EPHA2;TRAF1;HCAR2;SQSTM1;CSF1;BBC3;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IFNGR2;IL6;ADAM8;TNFRSF10B;PIM3;TNFSF15;CYP27B1;RIPK2;IRAK2;PHLDA2;CYLD;FZD8;BAMBI;C1QTNF1;ITGA5;IL7R;ZNF451;CTSC;NOD2;IL6ST;ICAM1;SMAD3;DLX2;NFKBID;TRAF4;TRIB1;VEGFA;ARHGEF3;FGD6;NRARP;IL1R2;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;CFLAR;RNF43;CD55;NAMPT;TP53BP2;ADM;IFNAR1;ERRFI1;CREB1;TAF4B;GORAB;NR4A2;CANT1;VHL;RUNX1;TGFBR2;SMURF2;DUSP16;SAA1;TRIM25;IFNGR1;WNT5A;VEGFC;TGFA;DUSP10;SOX4;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;ATF3;OTUD4;IL32;TLE1;PLK3;SLC9A1;SPRY2;CYTH1;GRB7;CXCL16;BCL2L2;RNF152;NEDD4;ITSN2;GCSAM;IL24;MARCKS;NFE2L2;PTPN1;WNT7B;TAB3;CHD4;NFAT5;CAV1;RHOV;UACA;TNIP2;TP53;TLR2;STK40;ITGAV;IKBKE;PJA2;STX1A;TRIP10;MAPKBP1;JPH2;RAD9B;ABCA7;PML;ADAM9;RELA;TRIM16;CCBE1;MUC1;AXL;GSK3B;PPARD;SLC16A1;EVC;PARP1;MED13;JMY;RPS6KA6;DDR1;XBP1;KCTD11;IL36RN
630,GO:0001817,3.48576113101471e-14,1,57,415,regulation of cytokine production,BP,IL1B;TNFAIP3;CSF2;TNF;IRF1;IL1A;INHBA;BIRC3;CCL20;ZC3H12A;CD83;NFKB1;MAP2K3;ZFP36;TICAM1;EREG;IL23A;REL;BCL3;PELI1;BIRC2;IL6;NFKB2;ADAM8;PANX1;RIPK2;CYLD;RELB;NAV3;NOD2;IL6ST;SMAD3;IL1R2;CEBPB;ERRFI1;CREB1;RUNX1;SAA1;TRIM25;WNT5A;IFIH1;IL4R;BTN2A2;TLR2;IKBKE;CD276;MAPKBP1;PML;POLR3A;RELA;TRIM16;CCBE1;AXL;NR4A3;HLA-E;XBP1;IL36RN
7676,GO:0032101,4.16748501555915e-14,1,59,439,regulation of response to external stimulus,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;TNF;CXCL3;PLAU;CXCL1;BIRC3;ZC3H12A;CXCL5;IL16;PLAUR;PRDM1;NFKB1;TNIP1;EDN1;SERPINB2;TICAM1;ETS1;CSF1;IL23A;BIRC2;IL6;ADAM8;CYP27B1;RIPK2;PHLDB2;C1QTNF1;NOD2;IL6ST;SMAD3;TRIB1;VEGFA;IL1R2;ZSWIM4;CD55;SLC7A2;CD47;SEMA4B;TGFBR2;SAA1;WNT5A;VEGFC;DUSP10;PDGFB;IL20;LDLR;NFE2L2;CAV1;TLR2;EFNB2;MAPKBP1;RELA;PLAT;OSMR;PPARD;CFB
629,GO:0001816,4.43833133081846e-14,1,60,455,cytokine production,BP,IL1B;TNFAIP3;CSF2;TNF;IRF1;IL1A;INHBA;BIRC3;CCL20;ZC3H12A;CD83;NFKB1;MAP2K3;ZFP36;TICAM1;EREG;IL23A;REL;BCL3;PELI1;BIRC2;IL6;NFKB2;ADAM8;PANX1;RIPK2;CYLD;RELB;NAV3;NOD2;IL6ST;SMAD3;IL1R2;CEBPB;CD55;ERRFI1;CREB1;RUNX1;SAA1;TRIM25;WNT5A;IFIH1;IL4R;BTN2A2;NFAT5;TLR2;ITGAV;IKBKE;CD276;MAPKBP1;PML;POLR3A;RELA;TRIM16;CCBE1;AXL;NR4A3;HLA-E;XBP1;IL36RN
12622,GO:0050789,4.81027402093702e-14,1,425,7514,regulation of biological process,BP,NFKBIZ;CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;IL36G;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;HCAR3;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;EPHA2;GPR156;EHD1;ZNF697;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;ZNF267;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;PANX1;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;KLHL21;PHLDA2;DAPP1;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;C1QTNF1;AMOTL2;CDKN1A;CLDN1;CCDC85B;ITGA5;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;ODC1;NEDD4L;CTSC;NOD2;ELMSAN1;IL6ST;DCUN1D3;RELT;SAV1;TFPI2;SGK1;ICAM1;GCH1;RASSF9;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;RNF144B;RND3;MARCKSL1;NFKBID;NINJ1;TRAF4;TRIB1;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;NRARP;IL1R2;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;MAP3K8;ZBED2;ABL2;CFLAR;RNF43;TXNRD1;KLF7;PIGA;BTG1;ANXA8;IER5;PPP4R4;CEBPB;CEBPD;CD55;KCNJ15;NAMPT;TP53BP2;ANKLE2;ADM;CDC42EP4;IFNAR1;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;CCNL1;WISP1;NEDD9;MAST4;NR4A2;PATL1;SLC7A2;CD47;CANT1;VHL;PHKG2;SOGA1;SEMA4B;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;AKAP2;PNRC2;NFE2L3;TRIM25;IFNGR1;MASTL;NAB1;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;TGFA;NOTCH2NL;DUSP10;ROBO4;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;ANLN;PGLYRP4;CD82;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;DCBLD2;RRAD;ATF3;OTUD4;BTG3;IKZF2;FAM83B;CAB39;IL32;TLE1;MFHAS1;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;TRPV3;MT2A;SUCO;SLC9A1;ZBTB10;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;CYTH1;GRB7;CXCL16;NUP153;BCL2L2;RNF152;IL4R;NEDD4;MMD;POU2F2;ITSN2;GCSAM;IL24;TNFRSF6B;MARCKS;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;TAB3;PAOX;SPTBN5;MXD1;CHD4;TPRA1;ZC3H7B;CLIC4;NFAT5;STAT5A;CAV1;VEZF1;RHOV;SH3RF2;HLA-A;UACA;DRAM1;INO80D;TNIP2;ZNFX1;UGCG;ZFAND5;TP53;KLF3;TLR2;ABI1;STK40;TAPBP;EFNB2;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;RAD9B;SNAPC4;ABCA7;CLK4;ADGRE2;SDR16C5;ZNF148;UBE2Z;PML;POLR3A;PIM1;ESPL1;ADAM9;RELA;RAPH1;TRIM16;ESCO2;EMP3;FOXN2;CCBE1;PPP6R3;EVI2B;TSPAN13;PLAT;MUC1;AXL;ANXA5;ELL2;SAT1;FRK;HLA-F;CITED4;NR4A3;HLA-E;GSK3B;KMT2E;OSMR;PPARD;SLC16A1;EVC;PARP1;CYP24A1;MMP10;LAMA3;KDM7A;MED13;MXD3;CRAMP1;TBC1D22B;OCLN;JMY;COL8A1;VIM;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;RPS6KA6;DDR1;CEP135;XBP1;QKI;EPB41L3;KCTD11;ZBTB5;ELF4;IL36RN;TFE3;EID3;ZMIZ2;LMAN1;CFB;JUND;GJC1;DENND4A
12626,GO:0050794,4.99768055131766e-14,1,410,7120,regulation of cellular process,BP,NFKBIZ;CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;IL36G;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;HCAR3;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;EPHA2;GPR156;EHD1;ZNF697;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;ZNF267;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;PANX1;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;KLHL21;PHLDA2;DAPP1;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;C1QTNF1;AMOTL2;CDKN1A;CLDN1;CCDC85B;ITGA5;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;ODC1;NEDD4L;CTSC;NOD2;ELMSAN1;IL6ST;DCUN1D3;RELT;SAV1;TFPI2;SGK1;ICAM1;GCH1;RASSF9;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;RNF144B;RND3;MARCKSL1;NFKBID;TRAF4;TRIB1;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;NRARP;IL1R2;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;MAP3K8;ZBED2;ABL2;CFLAR;RNF43;TXNRD1;KLF7;BTG1;ANXA8;IER5;PPP4R4;CEBPB;CEBPD;CD55;NAMPT;TP53BP2;ANKLE2;ADM;CDC42EP4;IFNAR1;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;CCNL1;WISP1;NEDD9;MAST4;NR4A2;SLC7A2;CD47;CANT1;VHL;PHKG2;SOGA1;SEMA4B;BACH1;PDE4DIP;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;SAA1;TGIF2;GPBP1;AKAP2;PNRC2;NFE2L3;TRIM25;IFNGR1;MASTL;NAB1;ITGB8;WNT5A;CAMK1G;VEGFC;TGFA;NOTCH2NL;DUSP10;ROBO4;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;ANLN;PGLYRP4;CD82;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;DCBLD2;RRAD;ATF3;OTUD4;BTG3;IKZF2;FAM83B;CAB39;IL32;TLE1;MFHAS1;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;MT2A;SUCO;SLC9A1;ZBTB10;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;CYTH1;GRB7;CXCL16;NUP153;BCL2L2;RNF152;IL4R;NEDD4;MMD;POU2F2;ITSN2;GCSAM;IL24;TNFRSF6B;MARCKS;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;PAOX;SPTBN5;MXD1;CHD4;TPRA1;ZC3H7B;CLIC4;NFAT5;STAT5A;CAV1;VEZF1;RHOV;SH3RF2;HLA-A;UACA;DRAM1;INO80D;TNIP2;ZNFX1;UGCG;ZFAND5;TP53;KLF3;TLR2;ABI1;STK40;EFNB2;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;RAD9B;SNAPC4;ABCA7;CLK4;ADGRE2;SDR16C5;ZNF148;UBE2Z;PML;PIM1;ESPL1;ADAM9;RELA;RAPH1;TRIM16;ESCO2;EMP3;FOXN2;CCBE1;PPP6R3;EVI2B;TSPAN13;PLAT;MUC1;AXL;ANXA5;ELL2;SAT1;FRK;HLA-F;CITED4;NR4A3;HLA-E;GSK3B;KMT2E;OSMR;PPARD;SLC16A1;EVC;PARP1;CYP24A1;MMP10;LAMA3;KDM7A;MED13;MXD3;CRAMP1;TBC1D22B;OCLN;JMY;VIM;CREB5;EGLN1;NABP1;RIPK4;ZXDA;RPS6KA6;DDR1;CEP135;XBP1;QKI;EPB41L3;KCTD11;ZBTB5;ELF4;IL36RN;TFE3;EID3;ZMIZ2;LMAN1;JUND;DENND4A
9796,GO:0040012,5.44256360005541e-14,1,74,621,regulation of locomotion,BP,CXCL8;IL1B;CXCL2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;CCL20;ZC3H12A;CXCL5;IL16;BMP2;SOD2;EDN1;MAP2K3;JUN;EPHA2;ETS1;CSF1;EREG;IL23A;IL6;ADAM8;BDKRB1;PHLDA2;PHLDB2;AMOTL2;ITGA5;RAP2B;NAV3;SGK1;ICAM1;SMAD3;RND3;TRIB1;VEGFA;ZSWIM4;PLK2;ABL2;SEMA4B;TGFBR2;SMURF2;TRIM25;WNT5A;VEGFC;DUSP10;ROBO4;PDGFB;NRG1;MMP9;PARD6B;SPRY2;GRB7;CXCL16;GCSAM;IL24;NFE2L2;CLIC4;STAT5A;TP53;EFNB2;ITGAV;DOCK4;PML;ADAM9;CCBE1;PPARD;MMP10;LAMA3;XBP1
12254,GO:0048519,7.6806846060868e-14,1,245,3637,negative regulation of biological process,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;FOSL1;NCOA7;ZC3H12A;PPP1R15A;ELF3;BMP2;LIF;PLAUR;CD83;SOD2;PRDM1;TBX3;PTX3;IL1RN;NFKB1;IER3;PPIF;TNIP1;EDN1;ZFP36;PNRC1;SERPINB2;JUN;TICAM1;EPHA2;ETS1;HCAR2;SQSTM1;BHLHE40;SERTAD2;NFKBIE;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;BIRC2;IL6;ETS2;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;TJP2;RELB;ZNF217;C1QTNF1;CDKN1A;CCDC85B;ITGA5;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;NEDD4L;NOD2;IL6ST;DCUN1D3;SAV1;TFPI2;ICAM1;SMAD3;B4GALT1;DLX2;RNF144B;NFKBID;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;PLK2;CFLAR;RNF43;BTG1;ANXA8;PPP4R4;CEBPB;CD55;TP53BP2;ANKLE2;ADM;ERRFI1;ADAMTS1;CREB1;WISP1;NR4A2;PATL1;VHL;SOGA1;SEMA4B;BACH1;MYBL1;TGFBR2;SMURF2;DUSP16;SAA1;TGIF2;PNRC2;NFE2L3;TRIM25;MASTL;NAB1;ITGB8;WNT5A;VEGFC;DUSP10;SOX4;SERPINB1;SOCS2;PDGFB;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;DCBLD2;RRAD;ATF3;OTUD4;BTG3;IKZF2;CAB39;TLE1;PLK3;TRPV3;MT2A;SLC9A1;YAF2;SPRY2;FEZ1;TNKS1BP1;GRB7;NUP153;BCL2L2;RNF152;IL4R;NEDD4;GCSAM;IL24;TNFRSF6B;BTN2A2;NFE2L2;PTPN1;SMAD1;TAB3;SPTBN5;MXD1;CHD4;TPRA1;ZC3H7B;CLIC4;CAV1;SH3RF2;TNIP2;TP53;KLF3;TLR2;ABI1;STK40;EFNB2;ITGAV;IKBKE;GEM;UBE2D3;DOCK4;MAPKBP1;ELK3;JPH2;RAD9B;ABCA7;SDR16C5;ZNF148;PML;PIM1;ESPL1;RELA;EMP3;EVI2B;PLAT;MUC1;AXL;ANXA5;FRK;NR4A3;HLA-E;GSK3B;KMT2E;PPARD;PARP1;MED13;MXD3;JMY;VIM;EGLN1;NABP1;RPS6KA6;DDR1;XBP1;QKI;KCTD11;ZBTB5;IL36RN;JUND
12933,GO:0051270,9.61210970413226e-14,1,73,615,regulation of cellular component movement,BP,CXCL8;IL1B;CXCL2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;CCL20;ZC3H12A;CXCL5;BMP2;SOD2;EDN1;MAP2K3;JUN;EPHA2;ETS1;CSF1;EREG;IL23A;IL6;ADAM8;BDKRB1;PHLDA2;PHLDB2;AMOTL2;ITGA5;RAP2B;NAV3;SGK1;ICAM1;SMAD3;B4GALT1;RND3;TRIB1;VEGFA;ZSWIM4;PLK2;ABL2;SEMA4B;TGFBR2;SMURF2;WNT5A;VEGFC;DUSP10;ROBO4;PDGFB;NRG1;MMP9;PARD6B;SPRY2;FEZ1;GRB7;CXCL16;GCSAM;IL24;NFE2L2;CLIC4;STAT5A;CAV1;TP53;ITGAV;DOCK4;ADAM9;CCBE1;PPARD;MMP10;LAMA3;XBP1
11493,GO:0045944,9.73791993334792e-14,1,86,792,positive regulation of transcription by RNA polymerase II,BP,IL1B;NFKBIA;TNF;IRF1;IL1A;INHBA;FOSL1;NCOA7;ZC3H12A;ELF3;BMP2;LIF;EHF;MAFF;NFKB1;TNIP1;EDN1;JUN;KDM6B;ETS1;SQSTM1;KLF6;IRF6;IL23A;REL;BCL3;PLAGL2;IL6;ETS2;CSRNP1;NFKB2;RFX5;SIX4;RIPK2;JUNB;FZD8;RELB;NOD2;SMAD3;DLX2;ARNTL2;VEGFA;CDKN2B;KLF7;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;BACH1;MYBL1;RUNX1;WNT5A;SOX4;PDGFB;NRG1;ATF3;IKZF2;SLC9A1;POU2F2;NFE2L2;SMAD1;NFAT5;VEZF1;TNIP2;TP53;TLR2;ELK3;ZNF148;PML;RELA;MUC1;CITED4;NR4A3;PPARD;PARP1;MED13;EGLN1;XBP1;ELF4;TFE3;ZMIZ2;JUND
4551,GO:0010628,9.80019920492057e-14,1,122,1365,positive regulation of gene expression,BP,IL1B;NFKBIA;CSF2;TNF;IRF1;IL1A;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;PPP1R15A;ELF3;BMP2;LIF;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;JUN;TICAM1;KDM6B;ETS1;SQSTM1;CSF1;SERTAD2;KLF6;IRF6;IL23A;REL;BCL3;PLAGL2;IL6;ETS2;CSRNP1;NFKB2;ADAM8;RFX5;SIX4;RIPK2;JUNB;FZD8;BAMBI;RELB;C1QTNF1;IL7R;NOD2;SMAD3;DLX2;ARNTL2;VEGFA;DKK1;CDKN2B;KLF7;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SFR1;GPBP1;NFE2L3;ITGB8;WNT5A;SOX4;PDGFB;NRG1;TNC;LDLR;ATF3;IKZF2;TLE1;SLC9A1;YAF2;SPRY2;POU2F2;NFE2L2;SMAD1;NFAT5;CAV1;VEZF1;TNIP2;TP53;TLR2;ELK3;ZNF148;PML;RELA;TRIM16;FOXN2;CCBE1;MUC1;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;VIM;CREB5;EGLN1;ZXDA;XBP1;QKI;ELF4;TFE3;ZMIZ2;JUND
4569,GO:0010647,1.32624836732634e-13,1,108,1150,positive regulation of cell communication,BP,IL1B;CSF2;TNF;HBEGF;IL1A;EFNA1;INHBA;BIRC3;PLEKHF1;CCL20;ZC3H12A;ELF3;BMP2;LIF;PLAUR;PMAIP1;NFKB1;PPIF;EDN1;MAP2K3;G0S2;JUN;TICAM1;EPHA2;HCAR2;SQSTM1;CSF1;BBC3;EREG;IL23A;REL;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ADAM8;TNFRSF10B;TNFSF15;CYP27B1;RIPK2;IRAK2;CYLD;FZD8;BAMBI;C1QTNF1;ITGA5;IL7R;CTSC;NOD2;IL6ST;ICAM1;SMAD3;TRAF4;VEGFA;NRARP;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;CFLAR;TP53BP2;CREB1;GORAB;CANT1;SMURF2;SAA1;TRIM25;WNT5A;TGFA;SOX4;SOCS2;PDGFB;IL20;NRG1;MMP9;ATF3;SLC9A1;SPRY2;GRB7;NEDD4;ITSN2;IL24;PTPN1;WNT7B;TAB3;CAV1;TNIP2;TP53;TLR2;ITGAV;IKBKE;STX1A;JPH2;ABCA7;PML;ADAM9;RELA;TRIM16;CCBE1;AXL;GSK3B;PPARD;EVC;PARP1;DDR1;XBP1
6868,GO:0030334,1.70356803893045e-13,1,67,541,regulation of cell migration,BP,CXCL8;IL1B;CXCL2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;CCL20;ZC3H12A;CXCL5;BMP2;SOD2;EDN1;MAP2K3;JUN;EPHA2;ETS1;CSF1;IL23A;IL6;ADAM8;BDKRB1;PHLDA2;PHLDB2;AMOTL2;ITGA5;RAP2B;NAV3;SGK1;ICAM1;SMAD3;RND3;TRIB1;VEGFA;PLK2;SEMA4B;TGFBR2;SMURF2;WNT5A;VEGFC;DUSP10;ROBO4;PDGFB;NRG1;MMP9;PARD6B;SPRY2;GRB7;CXCL16;GCSAM;IL24;NFE2L2;CLIC4;STAT5A;TP53;ITGAV;DOCK4;ADAM9;CCBE1;PPARD;MMP10;LAMA3;XBP1
6652,GO:0023056,1.89074019637111e-13,1,108,1156,positive regulation of signaling,BP,IL1B;CSF2;TNF;HBEGF;IL1A;EFNA1;INHBA;BIRC3;PLEKHF1;CCL20;ZC3H12A;ELF3;BMP2;LIF;PLAUR;PMAIP1;NFKB1;PPIF;EDN1;MAP2K3;G0S2;JUN;TICAM1;EPHA2;HCAR2;SQSTM1;CSF1;BBC3;EREG;IL23A;REL;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ADAM8;TNFRSF10B;TNFSF15;CYP27B1;RIPK2;IRAK2;CYLD;FZD8;BAMBI;C1QTNF1;ITGA5;IL7R;CTSC;NOD2;IL6ST;ICAM1;SMAD3;TRAF4;VEGFA;NRARP;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;CFLAR;TP53BP2;CREB1;GORAB;CANT1;SMURF2;SAA1;TRIM25;WNT5A;TGFA;SOX4;SOCS2;PDGFB;IL20;NRG1;MMP9;ATF3;SLC9A1;SPRY2;GRB7;NEDD4;ITSN2;IL24;PTPN1;WNT7B;TAB3;CAV1;TNIP2;TP53;TLR2;ITGAV;IKBKE;STX1A;JPH2;ABCA7;PML;ADAM9;RELA;TRIM16;CCBE1;AXL;GSK3B;PPARD;EVC;PARP1;DDR1;XBP1
18042,GO:1902531,2.00494108439434e-13,1,119,1313,regulation of intracellular signal transduction,BP,IL1B;TNFAIP3;CSF2;TNF;HBEGF;IL1A;EFNA1;INHBA;BIRC3;PLEKHF1;CCL20;ZC3H12A;BMP2;LIF;PLAUR;SOD2;PMAIP1;IER3;PPIF;TNIP1;EDN1;MAP2K3;JUN;TICAM1;EPHA2;SQSTM1;CSF1;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;CYLD;FZD8;C1QTNF1;IL7R;NOD2;IL6ST;ICAM1;NFKBID;TRAF4;TRIB1;VEGFA;ARHGEF3;FGD6;DKK1;FGF5;PLK2;MAP3K8;CFLAR;TP53BP2;ERRFI1;TAF4B;CANT1;VHL;DUSP16;SAA1;TRIM25;WNT5A;TGFA;DUSP10;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;ATF3;TLE1;PLK3;SLC9A1;SPRY2;CYTH1;BCL2L2;RNF152;NEDD4;ITSN2;IL24;NFE2L2;PTPN1;WNT7B;TAB3;CHD4;NFAT5;CAV1;RHOV;UACA;TNIP2;TP53;STK40;ITGAV;IKBKE;PJA2;TRIP10;MAPKBP1;JPH2;RAD9B;ABCA7;PML;ADAM9;RELA;MUC1;AXL;PPARD;PARP1;JMY;RPS6KA6;DDR1;XBP1
19779,GO:2000145,2.48538526583488e-13,1,69,573,regulation of cell motility,BP,CXCL8;IL1B;CXCL2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;CCL20;ZC3H12A;CXCL5;BMP2;SOD2;EDN1;MAP2K3;JUN;EPHA2;ETS1;CSF1;EREG;IL23A;IL6;ADAM8;BDKRB1;PHLDA2;PHLDB2;AMOTL2;ITGA5;RAP2B;NAV3;SGK1;ICAM1;SMAD3;RND3;TRIB1;VEGFA;PLK2;ABL2;SEMA4B;TGFBR2;SMURF2;WNT5A;VEGFC;DUSP10;ROBO4;PDGFB;NRG1;MMP9;PARD6B;SPRY2;GRB7;CXCL16;GCSAM;IL24;NFE2L2;CLIC4;STAT5A;TP53;ITGAV;DOCK4;ADAM9;CCBE1;PPARD;MMP10;LAMA3;XBP1
11295,GO:0045597,3.13231834573926e-13,1,71,600,positive regulation of cell differentiation,BP,IL1B;CSF2;TNF;INHBA;NOCT;ZC3H12A;BMP2;LIF;CD83;PRDM1;NFKB1;EDN1;ZFP36;JUN;EHD1;ETS1;CSF1;IL23A;IL6;ADAM8;ZFP36L1;CYP27B1;RIPK2;JUNB;CYLD;BAMBI;IL7R;NEDD4L;IL6ST;SAV1;SMAD3;DLX2;TRIB1;VEGFA;DKK1;ABL2;CFLAR;BTG1;CEBPB;ADM;CREB1;VHL;RUNX1;TGFBR2;TGIF2;WNT5A;VEGFC;DUSP10;SOCS2;IL20;NRG1;SUCO;FEZ1;IL4R;MMD;ITSN2;NFE2L2;WNT7B;SMAD1;VEZF1;TLR2;EFNB2;RELA;TRIM16;EVI2B;AXL;PPARD;PARP1;XBP1;KCTD11;JUND
8156,GO:0032879,4.10133504364938e-13,1,141,1692,regulation of localization,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;INHBA;CCL20;ZC3H12A;CXCL5;IL16;BMP2;LIF;SOD2;PMAIP1;PTX3;NFKB1;PPIF;EDN1;MAP2K3;ZFP36;JUN;EPHA2;EHD1;ETS1;HCAR2;SQSTM1;CSF1;BBC3;EREG;IL23A;PLAGL2;IL6;ADAM8;BDKRB1;PIM3;PANX1;ZFP36L1;SIX4;RIPK2;PHLDA2;PHLDB2;CYLD;C1QTNF1;AMOTL2;CDKN1A;ITGA5;RAP2B;NAV3;NEDD4L;NOD2;SGK1;ICAM1;SMAD3;B4GALT1;RND3;TRIB1;VEGFA;IL1R2;DKK1;ZSWIM4;PLK2;ABL2;KCNJ15;TP53BP2;CREB1;CD47;SEMA4B;TGFBR2;SMURF2;SAA1;WNT5A;VEGFC;DUSP10;ROBO4;SOX4;PDGFB;IFIH1;NRG1;MMP9;LDLR;RRAD;CAB39;PLK3;PARD6B;TRPV3;SLC9A1;SPRY2;FEZ1;GRB7;CXCL16;NUP153;IL4R;NEDD4;MMD;GCSAM;IL24;MARCKS;BTN2A2;NFE2L2;PTPN1;CLIC4;STAT5A;CAV1;UGCG;TP53;TLR2;RAB9A;ITGAV;IKBKE;GEM;UBE2D3;STX1A;DOCK4;MAPKBP1;JPH2;ABCA7;ADGRE2;PML;ADAM9;TRIM16;CCBE1;TSPAN13;AXL;NR4A3;HLA-E;GSK3B;PPARD;SLC16A1;PARP1;MMP10;LAMA3;TBC1D22B;XBP1;IL36RN
5519,GO:0016477,4.57411720723161e-13,1,91,887,cell migration,BP,CXCL8;IL1B;CXCL2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;CCL20;ZC3H12A;CXCL5;IL16;BMP2;SOD2;EDN1;MAP2K3;JUN;EPHA2;ETS1;CSF1;IL23A;EFNB1;IL6;ADAM8;TNFRSF10B;BDKRB1;SIX4;PHLDA2;PHLDB2;BAMBI;AMOTL2;ITGA5;RAP2B;NAV3;SGK1;ICAM1;SMAD3;B4GALT1;RND3;TRIB1;VEGFA;PLK2;BTG1;NEDD9;NR4A2;CD47;SEMA4B;TGFBR2;SMURF2;SAA1;WNT5A;VEGFC;DUSP10;ROBO4;PDGFB;ANLN;NRG1;MMP9;PARD6B;SLC9A1;SPRY2;GRB7;CXCL16;GCSAM;IL24;NFE2L2;CLIC4;STAT5A;CAV1;RHOV;ZFAND5;TP53;EFNB2;ITGAV;DOCK4;ADGRE2;PML;ADAM9;CCBE1;PLAT;AXL;FRK;PPARD;SLC16A1;MMP10;LAMA3;DDR1;XBP1
12914,GO:0051247,7.9846653696277e-13,1,106,1150,positive regulation of protein metabolic process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;SDC4;INHBA;BIRC3;CCL20;ZC3H12A;PPP1R15A;RNF19B;BMP2;LIF;PLAUR;PMAIP1;TNIP1;EDN1;MAP2K3;JUN;TICAM1;EPHA2;SQSTM1;CSF1;BBC3;EREG;IL23A;BCL3;PELI1;GADD45A;BIRC2;IL6;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;NEDD4L;CTSC;NOD2;IL6ST;DCUN1D3;ICAM1;SMAD3;RNF144B;TRAF4;TRIB1;VEGFA;DKK1;PLK2;MAP3K8;CFLAR;ANKLE2;CCNL1;TGFBR2;SMURF2;SAA1;WNT5A;VEGFC;TGFA;SOX4;PDGFB;IL20;NRG1;MMP9;LDLR;CAB39;PLK3;ARRDC4;RCHY1;SPRY2;TNKS1BP1;NEDD4;MMD;IL24;NFE2L2;PTPN1;WNT7B;TAB3;CAV1;TP53;ABI1;ITGAV;CD276;ABCA7;SDR16C5;PML;ADAM9;RELA;CCBE1;MUC1;AXL;GSK3B;KMT2E;VIM;DDR1;XBP1
11205,GO:0045321,8.1707270857675e-13,1,80,768,leukocyte activation,BP,CXCL8;IL1B;TNFAIP3;CSF2;IRF1;PLAU;CXCL1;SDC4;INHBA;ZC3H12A;PLAUR;CD83;PRDM1;PTX3;NFKB1;EDN1;JUN;TICAM1;CSF1;KLF6;IL23A;BCL3;PELI1;AMPD3;EFNB1;IL6;ADAM8;ZFP36L1;RIPK2;CYLD;FZD8;RELB;CDKN1A;RAP2B;IL7R;CTSC;NOD2;IL6ST;ICAM1;SMAD3;B4GALT1;NFKBID;RAB24;NRARP;MAP3K8;CEBPB;CD55;SLC7A2;CD47;CANT1;RUNX1;TGFBR2;WNT5A;DUSP10;SOX4;SERPINB1;MMP9;LDLR;CAB39;IL4R;NEDD4;POU2F2;BTN2A2;CAV1;TNIP2;TLR2;EFNB2;ITGAV;CD276;ADGRE2;ADAM9;AXL;FRK;NR4A3;HLA-E;KMT2E;COTL1;XBP1;ELF4;MGAM
1108,GO:0002694,8.81341303309472e-13,1,44,285,regulation of leukocyte activation,BP,IL1B;TNFAIP3;IRF1;SDC4;INHBA;ZC3H12A;CD83;PRDM1;TICAM1;IL23A;PELI1;EFNB1;IL6;ADAM8;ZFP36L1;RIPK2;CYLD;CDKN1A;IL7R;NOD2;IL6ST;NFKBID;NRARP;MAP3K8;CEBPB;CD55;SLC7A2;CD47;RUNX1;TGFBR2;WNT5A;DUSP10;LDLR;IL4R;BTN2A2;CAV1;TNIP2;EFNB2;CD276;ADGRE2;AXL;NR4A3;HLA-E;XBP1
12674,GO:0050865,1.13485049565687e-12,1,46,310,regulation of cell activation,BP,IL1B;TNFAIP3;IRF1;SDC4;INHBA;ZC3H12A;CD83;PRDM1;TICAM1;IL23A;PELI1;EFNB1;IL6;ADAM8;ZFP36L1;RIPK2;CYLD;C1QTNF1;CDKN1A;IL7R;NOD2;IL6ST;NFKBID;NRARP;MAP3K8;CEBPB;CD55;SLC7A2;CD47;RUNX1;TGFBR2;WNT5A;DUSP10;PDGFB;LDLR;IL4R;BTN2A2;CAV1;TNIP2;EFNB2;CD276;ADGRE2;AXL;NR4A3;HLA-E;XBP1
3381,GO:0007159,1.29714370823058e-12,1,35,192,leukocyte cell-cell adhesion,BP,IL1B;TNF;IRF1;SDC4;CD83;TNIP1;ETS1;IL23A;PELI1;EFNB1;IL6;ADAM8;RIPK2;CYLD;ITGA5;IL7R;NOD2;IL6ST;ICAM1;NFKBID;NRARP;MAP3K8;CEBPB;CD55;CD47;TGFBR2;DUSP10;IL4R;BTN2A2;CAV1;EFNB2;CD276;NR4A3;HLA-E;XBP1
12813,GO:0051094,1.30587160904492e-12,1,86,831,positive regulation of developmental process,BP,CXCL8;IL1B;TNFAIP3;CSF2;TNF;IL1A;INHBA;NOCT;ZC3H12A;BMP2;LIF;CD83;PRDM1;NFKB1;EDN1;ZFP36;JUN;EHD1;ETS1;CSF1;IL23A;IL6;ADAM8;ZFP36L1;CYP27B1;SIX4;RIPK2;JUNB;PHLDB2;CYLD;BAMBI;ITGA5;IL7R;NEDD4L;IL6ST;SAV1;SMAD3;B4GALT1;DLX2;TRIB1;VEGFA;DKK1;PLK2;ABL2;CFLAR;BTG1;CEBPB;ADM;CREB1;GORAB;VHL;RUNX1;TGFBR2;SMURF2;TGIF2;ITGB8;WNT5A;VEGFC;DUSP10;SOCS2;PDGFB;IL20;NRG1;SUCO;FEZ1;IL4R;MMD;ITSN2;NFE2L2;WNT7B;SMAD1;VEZF1;TLR2;EFNB2;PIM1;ADAM9;RELA;TRIM16;CCBE1;EVI2B;AXL;PPARD;PARP1;XBP1;KCTD11;JUND
11455,GO:0045893,1.42482300465501e-12,1,101,1057,positive regulation of transcription, DNA-templated,BP,IL1B;NFKBIA;TNF;IRF1;IL1A;INHBA;FOSL1;NCOA7;ZC3H12A;ELF3;BMP2;LIF;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;JUN;KDM6B;ETS1;SQSTM1;SERTAD2;KLF6;IRF6;IL23A;REL;BCL3;PLAGL2;IL6;ETS2;CSRNP1;NFKB2;RFX5;SIX4;RIPK2;JUNB;FZD8;BAMBI;RELB;NOD2;SMAD3;DLX2;ARNTL2;VEGFA;CDKN2B;KLF7;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SFR1;GPBP1;NFE2L3;WNT5A;SOX4;PDGFB;NRG1;ATF3;IKZF2;SLC9A1;YAF2;POU2F2;NFE2L2;SMAD1;NFAT5;VEZF1;TNIP2;TP53;TLR2;ELK3;ZNF148;PML;RELA;TRIM16;FOXN2;MUC1;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;CREB5;EGLN1;ZXDA;XBP1;ELF4;TFE3;ZMIZ2;JUND
18444,GO:1903508,1.42482300465501e-12,1,101,1057,positive regulation of nucleic acid-templated transcription,BP,IL1B;NFKBIA;TNF;IRF1;IL1A;INHBA;FOSL1;NCOA7;ZC3H12A;ELF3;BMP2;LIF;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;JUN;KDM6B;ETS1;SQSTM1;SERTAD2;KLF6;IRF6;IL23A;REL;BCL3;PLAGL2;IL6;ETS2;CSRNP1;NFKB2;RFX5;SIX4;RIPK2;JUNB;FZD8;BAMBI;RELB;NOD2;SMAD3;DLX2;ARNTL2;VEGFA;CDKN2B;KLF7;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SFR1;GPBP1;NFE2L3;WNT5A;SOX4;PDGFB;NRG1;ATF3;IKZF2;SLC9A1;YAF2;POU2F2;NFE2L2;SMAD1;NFAT5;VEZF1;TNIP2;TP53;TLR2;ELK3;ZNF148;PML;RELA;TRIM16;FOXN2;MUC1;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;CREB5;EGLN1;ZXDA;XBP1;ELF4;TFE3;ZMIZ2;JUND
12921,GO:0051254,1.46684778000836e-12,1,105,1119,positive regulation of RNA metabolic process,BP,IL1B;NFKBIA;TNF;IRF1;IL1A;BTG2;INHBA;FOSL1;NCOA7;ZC3H12A;ELF3;BMP2;LIF;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;JUN;KDM6B;ETS1;SQSTM1;SERTAD2;KLF6;IRF6;IL23A;REL;BCL3;PLAGL2;IL6;ETS2;CSRNP1;NFKB2;RFX5;ZFP36L1;SIX4;RIPK2;JUNB;FZD8;BAMBI;RELB;NOD2;SMAD3;DLX2;ARNTL2;VEGFA;CDKN2B;KLF7;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SFR1;GPBP1;NFE2L3;WNT5A;SOX4;PDGFB;NRG1;ATF3;IKZF2;SLC9A1;YAF2;POU2F2;NFE2L2;SMAD1;NFAT5;VEZF1;TNIP2;TP53;TLR2;ELK3;ZNF148;PML;RELA;TRIM16;FOXN2;MUC1;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;CREB5;EGLN1;ZXDA;XBP1;QKI;ELF4;TFE3;ZMIZ2;JUND
18095,GO:1902680,1.5061462350756e-12,1,101,1058,positive regulation of RNA biosynthetic process,BP,IL1B;NFKBIA;TNF;IRF1;IL1A;INHBA;FOSL1;NCOA7;ZC3H12A;ELF3;BMP2;LIF;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;JUN;KDM6B;ETS1;SQSTM1;SERTAD2;KLF6;IRF6;IL23A;REL;BCL3;PLAGL2;IL6;ETS2;CSRNP1;NFKB2;RFX5;SIX4;RIPK2;JUNB;FZD8;BAMBI;RELB;NOD2;SMAD3;DLX2;ARNTL2;VEGFA;CDKN2B;KLF7;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SFR1;GPBP1;NFE2L3;WNT5A;SOX4;PDGFB;NRG1;ATF3;IKZF2;SLC9A1;YAF2;POU2F2;NFE2L2;SMAD1;NFAT5;VEZF1;TNIP2;TP53;TLR2;ELK3;ZNF148;PML;RELA;TRIM16;FOXN2;MUC1;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;CREB5;EGLN1;ZXDA;XBP1;ELF4;TFE3;ZMIZ2;JUND
9795,GO:0040011,1.54902932151288e-12,1,104,1104,locomotion,BP,CXCL8;IL1B;CXCL2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;CCL20;FOSL1;ZC3H12A;CXCL5;IL16;BMP2;PLAUR;SOD2;EDN1;MAP2K3;JUN;EPHA2;ETS1;CSF1;EREG;IL23A;EFNB1;IL6;ADAM8;TNFRSF10B;BDKRB1;SIX4;PHLDA2;PHLDB2;BAMBI;AMOTL2;ITGA5;RAP2B;NAV3;SGK1;ICAM1;SMAD3;B4GALT1;RND3;TRIB1;VEGFA;ZSWIM4;PLK2;ABL2;KLF7;BTG1;CREB1;NEDD9;NR4A2;CD47;SEMA4B;TGFBR2;SMURF2;SAA1;TRIM25;WNT5A;VEGFC;DUSP10;ROBO4;PDGFB;ANLN;NRG1;MMP9;PARD6B;SLC9A1;SPRY2;FEZ1;GRB7;CXCL16;NEDD4;GCSAM;IL24;NFE2L2;SPTBN5;CLIC4;STAT5A;CAV1;RHOV;ZFAND5;TP53;EFNB2;ITGAV;DOCK4;ADGRE2;PML;ADAM9;CCBE1;PLAT;AXL;FRK;NR4A3;PPARD;SLC16A1;MMP10;LAMA3;JMY;DDR1;XBP1
11407,GO:0045785,1.58837716590354e-12,1,40,242,positive regulation of cell adhesion,BP,IL1B;TNF;SDC4;CD83;ETS1;CSF1;IL23A;EFNB1;IL6;ADAM8;RIPK2;CYLD;ITGA5;IL7R;NOD2;IL6ST;ICAM1;SMAD3;NINJ1;VEGFA;MAP3K8;CD55;CD47;TGFBR2;SAA1;WNT5A;VEGFC;DUSP10;IL4R;CAV1;EFNB2;ITGAV;CD276;ADAM9;NR4A3;HLA-E;GSK3B;COL8A1;XBP1;TFE3
4339,GO:0009888,1.65994392564858e-12,1,111,1231,tissue development,BP,IL1B;TNF;HBEGF;EFNA1;SDC4;BTG2;INHBA;ELF3;BMP2;LIF;PRDM1;TBX3;EHF;MAFF;EDN1;ZFP36;JUN;KDM6B;EPHA2;CSF1;SPRR2D;IRF6;EREG;DUSP1;EFNB1;ETS2;ZFP36L1;CYP27B1;SIX4;PHLDA2;JUNB;PHLDB2;BAMBI;TJP2;CDKN1A;CLDN1;ITGA5;SAV1;ICAM1;SMAD3;B4GALT1;DLX2;NINJ1;KRT34;VEGFA;NRARP;DKK1;LAMB3;CFLAR;TXNRD1;BTG1;CEBPB;ADM;ERRFI1;CREB1;GORAB;SEMA4B;RUNX1;TGFBR2;SMURF2;NAB1;ITGB8;WNT5A;VEGFC;DUSP10;SOX4;PDGFB;IL20;NRG1;TNC;MMP9;ATF3;COL12A1;SLC9A1;SPRY2;NEDD4;RHCG;WNT7B;SMAD1;CLIC4;CAV1;VEZF1;UGCG;ZFAND5;NOM1;ABI1;EFNB2;ITGAV;JPH2;SPRR2A;PML;PIM1;ADAM9;RELA;TRIM16;FOXN2;COL27A1;NR4A3;GSK3B;PPARD;EVC;LAMA3;LCE1C;COL8A1;VIM;EGLN1;RIPK4;RPS6KA6;DDR1;XBP1;GJC1
721,GO:0001944,1.86400662584602e-12,1,59,458,vasculature development,BP,CXCL8;IL1B;TNFAIP3;IL1A;EFNA1;FOSL1;ZC3H12A;LIF;PRDM1;TBX3;EDN1;JUN;EPHA2;ETS1;EREG;IL6;ADAM8;ZFP36L1;JUNB;FZD8;AMOTL2;ITGA5;TNFAIP2;B4GALT1;VEGFA;NRARP;PLK2;CFLAR;BTG1;ADM;ERRFI1;RUNX1;TGFBR2;ITGB8;WNT5A;VEGFC;ROBO4;SOX4;PDGFB;SPRY2;NEDD4;NFE2L2;WNT7B;SMAD1;CLIC4;CAV1;VEZF1;ZFAND5;EFNB2;ITGAV;ELK3;PML;CCBE1;SAT1;COL8A1;EGLN1;XBP1;QKI;GJC1
18249,GO:1903037,1.97770990043256e-12,1,33,174,regulation of leukocyte cell-cell adhesion,BP,IL1B;TNF;IRF1;SDC4;CD83;ETS1;IL23A;PELI1;EFNB1;IL6;ADAM8;RIPK2;CYLD;IL7R;NOD2;IL6ST;ICAM1;NFKBID;NRARP;MAP3K8;CEBPB;CD55;CD47;TGFBR2;DUSP10;IL4R;BTN2A2;CAV1;EFNB2;CD276;NR4A3;HLA-E;XBP1
12258,GO:0048523,2.07459366033399e-12,1,224,3288,negative regulation of cellular process,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;FOSL1;NCOA7;ZC3H12A;PPP1R15A;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;PTX3;IL1RN;NFKB1;IER3;PPIF;TNIP1;EDN1;ZFP36;SERPINB2;JUN;TICAM1;EPHA2;ETS1;SQSTM1;BHLHE40;SERTAD2;IRF6;EREG;REL;DUSP1;BCL3;PELI1;GADD45A;BIRC2;IL6;ETS2;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;ZFP36L1;CYP27B1;SIX4;RIPK2;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;TJP2;RELB;ZNF217;C1QTNF1;CDKN1A;CCDC85B;ITGA5;RAP2B;ABCA5;CPEB2;ZNF451;NAV3;NEDD4L;NOD2;IL6ST;DCUN1D3;SAV1;TFPI2;ICAM1;SMAD3;B4GALT1;DLX2;RNF144B;NFKBID;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;PLK2;CFLAR;RNF43;BTG1;ANXA8;PPP4R4;CEBPB;CD55;TP53BP2;ANKLE2;ADM;ERRFI1;ADAMTS1;CREB1;WISP1;NR4A2;VHL;SOGA1;SEMA4B;BACH1;MYBL1;TGFBR2;SMURF2;DUSP16;TGIF2;NFE2L3;MASTL;NAB1;WNT5A;VEGFC;DUSP10;SOX4;SERPINB1;SOCS2;PDGFB;DUSP8;NRG1;TNC;MMP9;LDLR;DCBLD2;ATF3;OTUD4;BTG3;IKZF2;CAB39;TLE1;PLK3;SLC9A1;YAF2;SPRY2;FEZ1;TNKS1BP1;GRB7;NUP153;BCL2L2;RNF152;IL4R;NEDD4;GCSAM;IL24;TNFRSF6B;BTN2A2;NFE2L2;PTPN1;SMAD1;TAB3;SPTBN5;MXD1;CHD4;TPRA1;ZC3H7B;CLIC4;CAV1;SH3RF2;TNIP2;TP53;KLF3;TLR2;ABI1;STK40;EFNB2;ITGAV;UBE2D3;MAPKBP1;ELK3;JPH2;RAD9B;ABCA7;SDR16C5;ZNF148;PML;PIM1;ESPL1;RELA;EMP3;EVI2B;PLAT;MUC1;AXL;ANXA5;FRK;NR4A3;GSK3B;KMT2E;PPARD;PARP1;MED13;MXD3;JMY;VIM;EGLN1;NABP1;RPS6KA6;DDR1;XBP1;QKI;KCTD11;ZBTB5;IL36RN;JUND
12431,GO:0048870,2.19992915375999e-12,1,94,959,cell motility,BP,CXCL8;IL1B;CXCL2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;CCL20;ZC3H12A;CXCL5;IL16;BMP2;SOD2;EDN1;MAP2K3;JUN;EPHA2;ETS1;CSF1;EREG;IL23A;EFNB1;IL6;ADAM8;TNFRSF10B;BDKRB1;SIX4;PHLDA2;PHLDB2;BAMBI;AMOTL2;ITGA5;RAP2B;NAV3;SGK1;ICAM1;SMAD3;B4GALT1;RND3;TRIB1;VEGFA;PLK2;ABL2;BTG1;NEDD9;NR4A2;CD47;SEMA4B;TGFBR2;SMURF2;SAA1;WNT5A;VEGFC;DUSP10;ROBO4;PDGFB;ANLN;NRG1;MMP9;PARD6B;SLC9A1;SPRY2;GRB7;CXCL16;GCSAM;IL24;NFE2L2;CLIC4;STAT5A;CAV1;RHOV;ZFAND5;TP53;EFNB2;ITGAV;DOCK4;ADGRE2;PML;ADAM9;CCBE1;PLAT;AXL;FRK;PPARD;SLC16A1;MMP10;LAMA3;JMY;DDR1;XBP1
13141,GO:0051674,2.19992915375999e-12,1,94,959,localization of cell,BP,CXCL8;IL1B;CXCL2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;CCL20;ZC3H12A;CXCL5;IL16;BMP2;SOD2;EDN1;MAP2K3;JUN;EPHA2;ETS1;CSF1;EREG;IL23A;EFNB1;IL6;ADAM8;TNFRSF10B;BDKRB1;SIX4;PHLDA2;PHLDB2;BAMBI;AMOTL2;ITGA5;RAP2B;NAV3;SGK1;ICAM1;SMAD3;B4GALT1;RND3;TRIB1;VEGFA;PLK2;ABL2;BTG1;NEDD9;NR4A2;CD47;SEMA4B;TGFBR2;SMURF2;SAA1;WNT5A;VEGFC;DUSP10;ROBO4;PDGFB;ANLN;NRG1;MMP9;PARD6B;SLC9A1;SPRY2;GRB7;CXCL16;GCSAM;IL24;NFE2L2;CLIC4;STAT5A;CAV1;RHOV;ZFAND5;TP53;EFNB2;ITGAV;DOCK4;ADGRE2;PML;ADAM9;CCBE1;PLAT;AXL;FRK;PPARD;SLC16A1;MMP10;LAMA3;JMY;DDR1;XBP1
7758,GO:0032270,3.06256519636053e-12,1,100,1080,positive regulation of cellular protein metabolic process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;HBEGF;IL1A;EFNA1;SDC4;INHBA;BIRC3;CCL20;ZC3H12A;PPP1R15A;RNF19B;BMP2;LIF;PLAUR;PMAIP1;TNIP1;EDN1;MAP2K3;JUN;TICAM1;EPHA2;SQSTM1;CSF1;BBC3;EREG;IL23A;BCL3;PELI1;GADD45A;BIRC2;IL6;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;CTSC;NOD2;IL6ST;DCUN1D3;ICAM1;SMAD3;RNF144B;TRAF4;TRIB1;VEGFA;DKK1;PLK2;MAP3K8;CFLAR;ANKLE2;CCNL1;TGFBR2;SAA1;WNT5A;VEGFC;TGFA;SOX4;PDGFB;IL20;NRG1;MMP9;LDLR;CAB39;PLK3;ARRDC4;RCHY1;SPRY2;TNKS1BP1;MMD;IL24;NFE2L2;PTPN1;WNT7B;TAB3;CAV1;TP53;ABI1;ITGAV;ABCA7;SDR16C5;PML;ADAM9;CCBE1;MUC1;AXL;GSK3B;KMT2E;VIM;DDR1;XBP1
15776,GO:0072358,3.06972631378223e-12,1,59,464,cardiovascular system development,BP,CXCL8;IL1B;TNFAIP3;IL1A;EFNA1;FOSL1;ZC3H12A;LIF;PRDM1;TBX3;EDN1;JUN;EPHA2;ETS1;EREG;IL6;ADAM8;ZFP36L1;JUNB;FZD8;AMOTL2;ITGA5;TNFAIP2;B4GALT1;VEGFA;NRARP;PLK2;CFLAR;BTG1;ADM;ERRFI1;RUNX1;TGFBR2;ITGB8;WNT5A;VEGFC;ROBO4;SOX4;PDGFB;SPRY2;NEDD4;NFE2L2;WNT7B;SMAD1;CLIC4;CAV1;VEZF1;ZFAND5;EFNB2;ITGAV;ELK3;PML;CCBE1;SAT1;COL8A1;EGLN1;XBP1;QKI;GJC1
14522,GO:0065007,3.32589392794462e-12,1,435,7909,biological regulation,BP,NFKBIZ;CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;IL36G;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;HCAR3;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;RAB3IP;EPHA2;GPR156;EHD1;ZNF697;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;ZNF267;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;PANX1;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;KLHL21;PHLDA2;DAPP1;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;STEAP4;C1QTNF1;AMOTL2;CDKN1A;CLDN1;CCDC85B;ITGA5;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;ODC1;NEDD4L;CTSC;NOD2;ELMSAN1;IL6ST;DCUN1D3;RELT;SAV1;TFPI2;SGK1;ICAM1;GCH1;RASSF9;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;RNF144B;RND3;MARCKSL1;NFKBID;NINJ1;TRAF4;TRIB1;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;NRARP;IL1R2;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;MAP3K8;ZBED2;ABL2;CFLAR;RNF43;TXNRD1;KLF7;PIGA;BTG1;ANXA8;IER5;PPP4R4;CEBPB;CEBPD;CD55;KCNJ15;DENND3;NAMPT;TP53BP2;ANKLE2;ADM;CDC42EP4;IFNAR1;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;CCNL1;WISP1;NEDD9;MAST4;NR4A2;PATL1;SLC7A2;CD47;CANT1;VHL;PHKG2;SOGA1;SEMA4B;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;AKAP2;PNRC2;NFE2L3;TRIM25;IFNGR1;MASTL;NAB1;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;TGFA;NOTCH2NL;DUSP10;ROBO4;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;ANLN;PGLYRP4;CD82;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;DCBLD2;RRAD;ATF3;OTUD4;BTG3;IKZF2;FAM83B;CAB39;IL32;TLE1;MFHAS1;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;TRPV3;MT2A;SUCO;SLC9A1;ZBTB10;SLC25A37;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;CYTH1;GRB7;CXCL16;NUP153;BCL2L2;RNF152;IL4R;NEDD4;MMD;RHCG;POU2F2;ITSN2;GCSAM;IL24;TNFRSF6B;MARCKS;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;TAB3;PAOX;SPTBN5;MXD1;CHD4;TPRA1;ZC3H7B;CLIC4;NFAT5;STAT5A;CAV1;VEZF1;RHOV;SH3RF2;HLA-A;UACA;DRAM1;INO80D;TNIP2;ZNFX1;UGCG;ZFAND5;TP53;KLF3;TLR2;ABI1;STK40;TAPBP;EFNB2;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;RAD9B;SNAPC4;ABCA7;CLK4;ADGRE2;SDR16C5;ZNF148;UBE2Z;PML;POLR3A;PIM1;ESPL1;ADAM9;RELA;RAPH1;TRIM16;ESCO2;EMP3;FOXN2;SLC9A8;CCBE1;PPP6R3;EVI2B;TSPAN13;PLAT;MUC1;AXL;ANXA5;ELL2;SAT1;FRK;HLA-F;CITED4;NR4A3;HLA-E;GSK3B;KMT2E;OSMR;PPARD;SLC16A1;EVC;PARP1;CYP24A1;MMP10;LAMA3;KDM7A;MED13;MXD3;CRAMP1;TBC1D22B;OCLN;JMY;COL8A1;VIM;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;RPS6KA6;DDR1;CEP135;XBP1;QKI;EPB41L3;KCTD11;ZBTB5;ELF4;IL36RN;SLC39A14;TFE3;EID3;ZMIZ2;LMAN1;CFB;SLC41A1;JUND;GJC1;DENND4A
3377,GO:0007155,3.46492102439887e-12,1,83,800,cell adhesion,BP,CXCL8;IL1B;TNF;IRF1;PLAU;EFNA1;SDC4;BMP2;CD83;IL1RN;TNIP1;EPHA2;ETS1;CSF1;IL23A;PELI1;EFNB1;IL6;ADAM8;ZFP36L1;RIPK2;PHLDB2;CYLD;C1QTNF1;CLDN1;ITGA5;RAP2B;IL7R;NOD2;IL6ST;ICAM1;SMAD3;B4GALT1;RND3;NFKBID;NINJ1;SERPINB8;VEGFA;NRARP;MAP3K8;ABL2;LAMB3;CEBPB;VMP1;CD55;WISP1;NEDD9;CD47;TGFBR2;SAA1;TINAGL1;ITGB8;WNT5A;VEGFC;DUSP10;TNC;COL12A1;IL32;SLC9A1;FEZ1;CYTH1;IL4R;BTN2A2;WNT7B;CAV1;EFNB2;ITGAV;CD276;ADGRE2;PML;ADAM9;MUC1;AXL;CRB3;NR4A3;HLA-E;GSK3B;PPARD;LAMA3;COL8A1;DDR1;XBP1;TFE3
12251,GO:0048514,3.77216370586843e-12,1,52,379,blood vessel morphogenesis,BP,CXCL8;IL1B;TNFAIP3;IL1A;EFNA1;ZC3H12A;PRDM1;EDN1;JUN;EPHA2;ETS1;EREG;IL6;ADAM8;ZFP36L1;JUNB;FZD8;AMOTL2;ITGA5;TNFAIP2;B4GALT1;VEGFA;NRARP;PLK2;BTG1;ADM;RUNX1;TGFBR2;ITGB8;WNT5A;VEGFC;ROBO4;SOX4;SPRY2;NEDD4;NFE2L2;WNT7B;SMAD1;CLIC4;CAV1;VEZF1;EFNB2;ITGAV;ELK3;PML;CCBE1;SAT1;COL8A1;EGLN1;XBP1;QKI;GJC1
18044,GO:1902533,4.12052654141716e-12,1,72,664,positive regulation of intracellular signal transduction,BP,IL1B;CSF2;TNF;HBEGF;IL1A;EFNA1;BIRC3;PLEKHF1;CCL20;ZC3H12A;BMP2;LIF;PMAIP1;EDN1;MAP2K3;JUN;TICAM1;EPHA2;CSF1;EREG;IL23A;REL;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;IL7R;NOD2;IL6ST;ICAM1;TRAF4;VEGFA;DKK1;FGF5;PLK2;MAP3K8;CFLAR;CANT1;SAA1;TRIM25;WNT5A;TGFA;PDGFB;IL20;NRG1;SLC9A1;SPRY2;NEDD4;IL24;PTPN1;WNT7B;TAB3;CAV1;TNIP2;TP53;ITGAV;IKBKE;JPH2;ABCA7;ADAM9;RELA;AXL;PPARD;DDR1
6598,GO:0022610,4.14026030522013e-12,1,83,803,biological adhesion,BP,CXCL8;IL1B;TNF;IRF1;PLAU;EFNA1;SDC4;BMP2;CD83;IL1RN;TNIP1;EPHA2;ETS1;CSF1;IL23A;PELI1;EFNB1;IL6;ADAM8;ZFP36L1;RIPK2;PHLDB2;CYLD;C1QTNF1;CLDN1;ITGA5;RAP2B;IL7R;NOD2;IL6ST;ICAM1;SMAD3;B4GALT1;RND3;NFKBID;NINJ1;SERPINB8;VEGFA;NRARP;MAP3K8;ABL2;LAMB3;CEBPB;VMP1;CD55;WISP1;NEDD9;CD47;TGFBR2;SAA1;TINAGL1;ITGB8;WNT5A;VEGFC;DUSP10;TNC;COL12A1;IL32;SLC9A1;FEZ1;CYTH1;IL4R;BTN2A2;WNT7B;CAV1;EFNB2;ITGAV;CD276;ADGRE2;PML;ADAM9;MUC1;AXL;CRB3;NR4A3;HLA-E;GSK3B;PPARD;LAMA3;COL8A1;DDR1;XBP1;TFE3
15250,GO:0071396,4.29773758762307e-12,1,52,390,cellular response to lipid,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;INHBA;CCL20;ZC3H12A;PRDM1;NFKB1;TNIP1;EDN1;ZFP36;TICAM1;IL6;ZFP36L1;CYP27B1;RIPK2;IRAK2;CLDN1;ICAM1;NFKBIB;TRIB1;ABL2;CFLAR;CEBPB;CD55;GJB3;ERRFI1;CREB1;NR4A2;RUNX1;HMGCS1;WNT5A;TNC;LDLR;NEDD4;IL24;WNT7B;TNIP2;TLR2;PIM1;ADAM9;RELA;AXL;NR4A3;PPARD;PARP1;CYP24A1;MED13;XBP1
12317,GO:0048646,4.44507826576978e-12,1,76,695,anatomical structure formation involved in morphogenesis,BP,CXCL8;IL1B;TNFAIP3;TNF;IL1A;EFNA1;SDC4;INHBA;ZC3H12A;TBX3;EDN1;JUN;KDM6B;EPHA2;EHD1;ETS1;EREG;DUSP1;BCL3;IL6;ETS2;NFKB2;ADAM8;SIX4;JUNB;PHLDB2;FZD8;AMOTL2;FJX1;ITGA5;TNFAIP2;SMAD3;B4GALT1;VEGFA;NRARP;DKK1;PLK2;LAMB3;CFLAR;TXNRD1;BTG1;ADM;ADAMTS1;RUNX1;TGFBR2;ITGB8;WNT5A;VEGFC;ROBO4;SOX4;MMP9;COL12A1;SPRY2;IL4R;NFE2L2;SMAD1;CLIC4;CAV1;VEZF1;TLR2;ABI1;EFNB2;ITGAV;ELK3;PML;PIM1;ADAM9;CCBE1;SAT1;NR4A3;LAMA3;COL8A1;EGLN1;XBP1;EPB41L3;ERVFRD-1
6869,GO:0030335,4.96784452275982e-12,1,46,317,positive regulation of cell migration,BP,CXCL8;IL1B;CXCL2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;CCL20;ZC3H12A;CXCL5;BMP2;SOD2;EDN1;MAP2K3;JUN;ETS1;CSF1;IL23A;IL6;ADAM8;BDKRB1;ITGA5;ICAM1;SMAD3;VEGFA;PLK2;SEMA4B;TGFBR2;SMURF2;WNT5A;VEGFC;PDGFB;MMP9;SPRY2;GRB7;CXCL16;NFE2L2;STAT5A;TP53;ITGAV;DOCK4;ADAM9;CCBE1;XBP1
7931,GO:0032501,5.07166519578443e-12,1,269,4178,multicellular organismal process,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;NOCT;CCL20;FOSL1;ZC3H12A;ELF3;BMP2;LIF;PLAUR;CD83;SOD2;PRDM1;TBX3;EHF;IL1RN;MAFF;NFKB1;EDN1;MAP2K3;ZFP36;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;EHD1;ETS1;HCAR2;CSF1;BHLHE40;N4BP3;ZNF267;SPRR2D;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;PLAGL2;EFNB1;BIRC2;IL6;ETS2;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;PANX1;ZFP36L1;CYP27B1;SIX4;RIPK2;PHLDA2;JUNB;PHLDB2;CYLD;FZD8;BAMBI;TJP2;RELB;ZNF217;C1QTNF1;AMOTL2;CDKN1A;CLDN1;FJX1;ITGA5;RAP2B;ABCA5;IL7R;NAV3;ODC1;TNFAIP2;NEDD4L;NOD2;IL6ST;RELT;SAV1;TFPI2;SGK1;ICAM1;GCH1;SMAD3;B4GALT1;DLX2;B3GNT5;NFKBID;NINJ1;TRAF4;TRIB1;KRT34;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;ABL2;LAMB3;CFLAR;TXNRD1;KLF7;BTG1;ANXA8;CEBPB;VMP1;CD55;NAMPT;ANKLE2;ADM;GJB3;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;GJB4;NR4A2;SLC7A2;SEMA4B;ABTB2;MYBL1;RUNX1;TGFBR2;SMURF2;SAA1;TGIF2;MTURN;TRIM25;MASTL;NAB1;ITGB8;HMGCS1;WNT5A;VEGFC;SLC11A2;NOTCH2NL;DUSP10;SLC52A3;ROBO4;SOX4;SOCS2;PDGFB;IL20;ANLN;IFIH1;NRG1;TNC;SLC38A2;MMP9;LDLR;ATF3;COL12A1;TLE1;CHD2;PARD6B;TRPV3;SUCO;SLC9A1;SPRY2;FEZ1;GRB7;BCL2L2;IL4R;NEDD4;MMD;POU2F2;ITSN2;TNFRSF6B;BTN2A2;NFE2L2;WNT7B;SMAD1;SPTBN5;MXD1;TPRA1;DIEXF;CLIC4;NFAT5;STAT5A;CAV1;VEZF1;RTTN;ZFAND5;TP53;NOM1;KLF3;TLR2;ABI1;STK40;EFNB2;ITGAV;IKBKE;PJA2;CD276;DOCK4;MAPKBP1;ELK3;JPH2;SPRR2A;ABCA7;ZNF148;PML;POLR3A;PIM1;ADAM9;RELA;RAPH1;TRIM16;ESCO2;SPATA2;FOXN2;CCBE1;EVI2B;COL27A1;PLAT;CHST2;AXL;ANXA5;SAT1;NR4A3;HLA-E;GSK3B;KMT2E;PPARD;EVC;PARP1;CYP24A1;LAMA3;KDM7A;LCE1C;COL8A1;VIM;EGLN1;RPS6KA6;DDR1;XBP1;QKI;EPB41L3;KCTD11;IL36RN;TFE3;C12ORF29;MGAM;LMAN1;JUND;GJC1
359,GO:0000977,5.12688284398443e-12,1,56,434,RNA polymerase II regulatory region sequence-specific DNA binding,MF,IRF1;FOSL1;ELF3;PRDM1;TBX3;EHF;NFKB1;JUN;KDM6B;ETS1;BHLHE40;KLF6;REL;GADD45A;ETS2;NFKB2;RFX5;SIX4;JUNB;RELB;ZNF217;SMAD3;DLX2;ARNTL2;KLF7;CEBPB;CEBPD;CREB1;NR4A2;BACH1;MYBL1;RUNX1;NFE2L3;ATF3;POU2F2;NFE2L2;SMAD1;MXD1;CHD4;NFAT5;VEZF1;TP53;KLF3;ELK3;ZNF148;RELA;MUC1;NR4A3;PPARD;PARP1;MXD3;XBP1;ZBTB5;ELF4;TFE3;JUND
7363,GO:0031401,5.68985178515159e-12,1,81,790,positive regulation of protein modification process,BP,IL1B;CSF2;TNF;HBEGF;IL1A;EFNA1;SDC4;INHBA;BIRC3;CCL20;ZC3H12A;PPP1R15A;BMP2;LIF;PLAUR;TNIP1;EDN1;MAP2K3;JUN;TICAM1;EPHA2;SQSTM1;CSF1;EREG;IL23A;PELI1;GADD45A;BIRC2;IL6;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;NOD2;IL6ST;DCUN1D3;ICAM1;TRAF4;VEGFA;DKK1;MAP3K8;CFLAR;ANKLE2;CCNL1;TGFBR2;SAA1;WNT5A;VEGFC;TGFA;SOX4;PDGFB;IL20;NRG1;MMP9;CAB39;ARRDC4;RCHY1;SPRY2;TNKS1BP1;MMD;IL24;PTPN1;WNT7B;TAB3;CAV1;TP53;ABI1;ITGAV;ABCA7;SDR16C5;ADAM9;MUC1;AXL;KMT2E;DDR1
12935,GO:0051272,5.99439100711665e-12,1,47,332,positive regulation of cellular component movement,BP,CXCL8;IL1B;CXCL2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;CCL20;ZC3H12A;CXCL5;BMP2;SOD2;EDN1;MAP2K3;JUN;ETS1;CSF1;IL23A;IL6;ADAM8;BDKRB1;ITGA5;ICAM1;SMAD3;VEGFA;PLK2;SEMA4B;TGFBR2;SMURF2;WNT5A;VEGFC;PDGFB;MMP9;SPRY2;FEZ1;GRB7;CXCL16;NFE2L2;STAT5A;TP53;ITGAV;DOCK4;ADAM9;CCBE1;XBP1
380,GO:0001012,6.91555392575040e-12,1,56,437,RNA polymerase II regulatory region DNA binding,MF,IRF1;FOSL1;ELF3;PRDM1;TBX3;EHF;NFKB1;JUN;KDM6B;ETS1;BHLHE40;KLF6;REL;GADD45A;ETS2;NFKB2;RFX5;SIX4;JUNB;RELB;ZNF217;SMAD3;DLX2;ARNTL2;KLF7;CEBPB;CEBPD;CREB1;NR4A2;BACH1;MYBL1;RUNX1;NFE2L3;ATF3;POU2F2;NFE2L2;SMAD1;MXD1;CHD4;NFAT5;VEZF1;TP53;KLF3;ELK3;ZNF148;RELA;MUC1;NR4A3;PPARD;PARP1;MXD3;XBP1;ZBTB5;ELF4;TFE3;JUND
19781,GO:2000147,8.47810859609959e-12,1,46,323,positive regulation of cell motility,BP,CXCL8;IL1B;CXCL2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;CCL20;ZC3H12A;CXCL5;BMP2;SOD2;EDN1;MAP2K3;JUN;ETS1;CSF1;IL23A;IL6;ADAM8;BDKRB1;ITGA5;ICAM1;SMAD3;VEGFA;PLK2;SEMA4B;TGFBR2;SMURF2;WNT5A;VEGFC;PDGFB;MMP9;SPRY2;GRB7;CXCL16;NFE2L2;STAT5A;TP53;ITGAV;DOCK4;ADAM9;CCBE1;XBP1
609,GO:0001775,8.63354224384386e-12,1,84,863,cell activation,BP,CXCL8;IL1B;TNFAIP3;CSF2;IRF1;PLAU;CXCL1;SDC4;INHBA;ZC3H12A;PLAUR;CD83;PRDM1;PTX3;NFKB1;EDN1;JUN;TICAM1;CSF1;KLF6;IL23A;BCL3;PELI1;AMPD3;EFNB1;IL6;NFKB2;ADAM8;ZFP36L1;RIPK2;CYLD;FZD8;RELB;C1QTNF1;CDKN1A;RAP2B;IL7R;CTSC;NOD2;IL6ST;ICAM1;SMAD3;B4GALT1;NFKBID;RAB24;NRARP;MAP3K8;CEBPB;CD55;SLC7A2;CD47;CANT1;RUNX1;TGFBR2;SAA1;WNT5A;DUSP10;SOX4;SERPINB1;PDGFB;MMP9;LDLR;CAB39;IL4R;NEDD4;POU2F2;BTN2A2;CAV1;TNIP2;TLR2;EFNB2;ITGAV;CD276;ADGRE2;ADAM9;AXL;FRK;NR4A3;HLA-E;KMT2E;COTL1;XBP1;ELF4;MGAM
13152,GO:0051704,9.8688043027323e-12,1,126,1584,multi-organism process,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;CXCL1;INHBA;BIRC3;NOCT;CCL20;FOSL1;ZC3H12A;CXCL5;IL16;LIF;PRDM1;PMAIP1;PTX3;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;JUN;TICAM1;IFNAR2;EPHA2;ETS1;SQSTM1;EREG;IL23A;BCL3;PELI1;BIRC2;IFNGR2;IL6;NFKB2;TNFRSF10B;BDKRB1;CYP27B1;RIPK2;IRAK2;JUNB;CLDN1;ITGA5;ODC1;NEDD4L;NOD2;IL6ST;RELT;ICAM1;GCH1;SMAD3;B4GALT1;NFKBIB;TRIB1;CFLAR;BTG1;CEBPB;VMP1;CD55;NAMPT;TAP1;ADM;GJB3;IFNAR1;ADAMTS1;CREB1;TAF4B;CD47;MYBL1;TGFBR2;SMURF2;TRIM25;IFNGR1;MASTL;WNT5A;DUSP10;PGLYRP4;IFIH1;SLC38A2;MMP9;LDLR;NUP153;BCL2L2;IL4R;NEDD4;IL24;TNFRSF6B;RAET1L;SMAD1;ZC3H7B;CLIC4;CAV1;HLA-A;TNIP2;TP53;TLR2;ABI1;EFNB2;RAB9A;HLA-B;ITGAV;IKBKE;MAPKBP1;ZNF148;PML;POLR3A;ADAM9;RELA;SPATA2;AXL;HLA-E;PPARD;COTL1;VIM;DDR1;XBP1;QKI;IL36RN;JUND
455,GO:0001228,1.00111335088738e-11,1,41,261,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,IRF1;FOSL1;ELF3;EHF;MAFF;NFKB1;JUN;ETS1;KLF6;IRF6;REL;PLAGL2;CSRNP1;NFKB2;RFX5;SIX4;JUNB;DLX2;KLF7;CEBPB;CEBPD;CREB1;NR4A2;BACH1;MYBL1;RUNX1;SOX4;ATF3;POU2F2;NFE2L2;SMAD1;NFAT5;VEZF1;TP53;ELK3;RELA;NR4A3;PARP1;ELF4;TFE3;JUND
3440,GO:0007249,1.09516843497077e-11,1,35,207,I-kappaB kinase/NF-kappaB signaling,BP,IL1B;NFKBIA;TNFAIP3;TNF;IL1A;BIRC3;ZC3H12A;TIFA;NFKB1;TNIP1;TICAM1;SQSTM1;REL;BCL3;PELI1;BIRC2;NFKB2;TNFRSF10B;RIPK2;IRAK2;RELB;NOD2;NFKBID;PLK2;CFLAR;CANT1;TRIM25;WNT5A;TLE1;TAB3;TNIP2;TLR2;IKBKE;MAPKBP1;RELA
506,GO:0001568,1.15058011039814e-11,1,56,439,blood vessel development,BP,CXCL8;IL1B;TNFAIP3;IL1A;EFNA1;FOSL1;ZC3H12A;PRDM1;TBX3;EDN1;JUN;EPHA2;ETS1;EREG;IL6;ADAM8;ZFP36L1;JUNB;FZD8;AMOTL2;ITGA5;TNFAIP2;B4GALT1;VEGFA;NRARP;PLK2;CFLAR;BTG1;ADM;RUNX1;TGFBR2;ITGB8;WNT5A;VEGFC;ROBO4;SOX4;PDGFB;SPRY2;NEDD4;NFE2L2;WNT7B;SMAD1;CLIC4;CAV1;VEZF1;EFNB2;ITGAV;ELK3;PML;CCBE1;SAT1;COL8A1;EGLN1;XBP1;QKI;GJC1
2866,GO:0006357,1.18624458531333e-11,1,131,1595,regulation of transcription by RNA polymerase II,BP,NFKBIZ;IL1B;NFKBIA;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;FOSL1;NCOA7;ZC3H12A;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;ZFP36;JUN;KDM6B;ETS1;SQSTM1;BHLHE40;ZNF267;KLF6;IRF6;IL23A;REL;BCL3;PLAGL2;IL6;ETS2;CSRNP1;NFKB2;RFX5;ZFP36L1;SIX4;RIPK2;THAP10;JUNB;FZD8;RELB;ZNF217;CDKN1A;ZNF451;NEDD4L;NOD2;ELMSAN1;SMAD3;DLX2;ARNTL2;NFKBID;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;KLF7;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;TGIF2;NFE2L3;WNT5A;TGFA;SOX4;PDGFB;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;NEDD4;POU2F2;NFE2L2;SMAD1;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;SDR16C5;ZNF148;PML;RELA;FOXN2;MUC1;FRK;CITED4;NR4A3;PPARD;PARP1;MED13;MXD3;CRAMP1;JMY;CREB5;EGLN1;XBP1;ZBTB5;ELF4;TFE3;ZMIZ2;JUND
14524,GO:0065009,1.46950090388469e-11,1,166,2244,regulation of molecular function,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;INHBA;BIRC3;PLEKHF1;CCL20;FOSL1;ZC3H12A;CXCL5;IL16;PPP1R15A;BMP2;LIF;PLAUR;IL36G;PMAIP1;PTX3;IL1RN;NFKB1;PPIF;EDN1;MAP2K3;ZFP36;SERPINB2;JUN;TICAM1;RAB3IP;EPHA2;TRAF1;CSF1;BHLHE40;NFKBIE;BBC3;EREG;IL23A;DUSP1;BCL3;PELI1;GADD45A;BIRC2;IL6;NFKB2;ADAM8;TNFRSF10B;TNFSF15;CYP27B1;RIPK2;IRAK2;PHLDA2;CYLD;FZD8;TNFAIP8;BAMBI;CDKN1A;RAP2B;CPEB2;NEDD4L;NOD2;DCUN1D3;SAV1;TFPI2;SGK1;ICAM1;GCH1;SMAD3;NFKBIB;NFKBID;TRAF4;TRIB1;SERPINB8;VEGFA;ARHGEF3;FGD6;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;CFLAR;ANXA8;PPP4R4;DENND3;NAMPT;ANKLE2;ADM;CDC42EP4;ERRFI1;CCNL1;NR4A2;TGFBR2;DUSP16;SAA1;TRIM25;MASTL;WNT5A;VEGFC;TGFA;DUSP10;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;RRAD;CAB39;IL32;ARRDC4;RASGEF1B;SLC9A1;SPRY2;CYTH1;CXCL16;NEDD4;MMD;ITSN2;IL24;TNFRSF6B;PTPN1;WNT7B;TAB3;SPTBN5;CAV1;SH3RF2;TP53;TLR2;ABI1;RAB9A;GEM;STX1A;DOCK4;TRIP10;JPH2;PML;PIM1;ADAM9;RELA;PPP6R3;TSPAN13;AXL;ANXA5;GSK3B;PARP1;MED13;TBC1D22B;JMY;EGLN1;RIPK4;DDR1;IL36RN;DENND4A
7678,GO:0032103,1.61810840052705e-11,1,30,162,positive regulation of response to external stimulus,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNF;CXCL3;CXCL1;CXCL5;IL16;TNIP1;EDN1;TICAM1;ETS1;CSF1;IL23A;IL6;ADAM8;CYP27B1;RIPK2;NOD2;IL6ST;SMAD3;VEGFA;CD47;WNT5A;VEGFC;PDGFB;LDLR;TLR2;OSMR
632,GO:0001819,1.66416725037757e-11,1,39,256,positive regulation of cytokine production,BP,IL1B;CSF2;TNF;IRF1;IL1A;BIRC3;CCL20;CD83;NFKB1;TICAM1;EREG;IL23A;BCL3;PELI1;BIRC2;IL6;NFKB2;ADAM8;PANX1;RIPK2;NOD2;IL6ST;SMAD3;CEBPB;CREB1;RUNX1;SAA1;WNT5A;IFIH1;IL4R;TLR2;CD276;POLR3A;RELA;TRIM16;CCBE1;NR4A3;HLA-E;XBP1
1024,GO:0002521,2.60119474754085e-11,1,43,298,leukocyte differentiation,BP,CSF2;TNF;IRF1;INHBA;LIF;CD83;PRDM1;JUN;EPHA2;CSF1;KLF6;IL23A;BCL3;IL6;ADAM8;ZFP36L1;RIPK2;JUNB;CYLD;FZD8;TJP2;RELB;IL7R;NFKBID;TRIB1;VEGFA;NRARP;CEBPB;CREB1;RUNX1;TGFBR2;DUSP10;SOX4;IL20;MMP9;IL4R;POU2F2;TLR2;EVI2B;AXL;PARP1;XBP1;TFE3
17887,GO:1902107,2.6446126899814e-11,1,22,86,positive regulation of leukocyte differentiation,BP,TNF;LIF;CD83;PRDM1;JUN;CSF1;IL23A;ADAM8;ZFP36L1;RIPK2;CYLD;IL7R;TRIB1;CREB1;RUNX1;TGFBR2;DUSP10;IL20;IL4R;EVI2B;AXL;XBP1
12913,GO:0051246,3.01081799816391e-11,1,151,2017,regulation of protein metabolic process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;CCL20;NCOA7;ZC3H12A;PPP1R15A;RNF19B;BMP2;LIF;PLAUR;PMAIP1;PTX3;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;SERPINB2;JUN;TICAM1;EPHA2;SQSTM1;CSF1;BBC3;EREG;IL23A;DUSP1;BCL3;PELI1;GADD45A;BIRC2;IL6;ADAM8;TNFRSF10B;BDKRB1;N4BP1;ZFP36L1;TNFSF15;RIPK2;IRAK2;FZD8;TNFAIP8;C1QTNF1;CDKN1A;ITGA5;RAP2B;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;NOD2;IL6ST;DCUN1D3;TFPI2;ICAM1;SMAD3;RNF144B;TRAF4;TRIB1;SERPINB8;VEGFA;IL1R2;DKK1;CDKN2B;PLK2;MAP3K8;CFLAR;ANXA8;PPP4R4;CEBPB;CD55;ANKLE2;ERRFI1;CCNL1;ABTB2;TGFBR2;SMURF2;DUSP16;SAA1;MASTL;WNT5A;VEGFC;TGFA;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;LDLR;ATF3;OTUD4;CAB39;PLK3;ARRDC4;RCHY1;SPRY2;TNKS1BP1;GRB7;NUP153;NEDD4;MMD;IL24;TNFRSF6B;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;ZC3H7B;CAV1;SH3RF2;TP53;ABI1;STK40;ITGAV;CD276;ABCA7;SDR16C5;PML;ADAM9;RELA;CCBE1;PPP6R3;PLAT;MUC1;AXL;GSK3B;KMT2E;VIM;RPS6KA6;DDR1;XBP1;QKI;CFB
9801,GO:0040017,3.180392507412e-11,1,47,348,positive regulation of locomotion,BP,CXCL8;IL1B;CXCL2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;CCL20;ZC3H12A;CXCL5;IL16;BMP2;SOD2;EDN1;MAP2K3;JUN;ETS1;CSF1;IL23A;IL6;ADAM8;BDKRB1;ITGA5;ICAM1;SMAD3;VEGFA;PLK2;SEMA4B;TGFBR2;SMURF2;WNT5A;VEGFC;PDGFB;MMP9;SPRY2;GRB7;CXCL16;NFE2L2;STAT5A;TP53;ITGAV;DOCK4;ADAM9;CCBE1;XBP1
6584,GO:0022407,3.43773485908878e-11,1,37,234,regulation of cell-cell adhesion,BP,IL1B;TNF;IRF1;SDC4;BMP2;CD83;IL1RN;ETS1;IL23A;PELI1;EFNB1;IL6;ADAM8;RIPK2;CYLD;C1QTNF1;IL7R;NOD2;IL6ST;ICAM1;NFKBID;NRARP;MAP3K8;CEBPB;CD55;CD47;TGFBR2;WNT5A;DUSP10;IL4R;BTN2A2;CAV1;EFNB2;CD276;NR4A3;HLA-E;XBP1
12916,GO:0051249,3.56598915526372e-11,1,38,248,regulation of lymphocyte activation,BP,IL1B;TNFAIP3;IRF1;SDC4;INHBA;CD83;PRDM1;TICAM1;IL23A;PELI1;EFNB1;IL6;ADAM8;ZFP36L1;RIPK2;CYLD;CDKN1A;IL7R;NOD2;IL6ST;NFKBID;NRARP;MAP3K8;CEBPB;CD55;CD47;RUNX1;TGFBR2;DUSP10;IL4R;BTN2A2;CAV1;TNIP2;EFNB2;CD276;AXL;HLA-E;XBP1
12698,GO:0050900,4.03172382212878e-11,1,36,228,leukocyte migration,BP,CXCL8;IL1B;CXCL2;TNF;CXCL3;CXCL1;IL1A;SDC4;CCL20;CXCL5;IL16;EDN1;CSF1;IL23A;IL6;ADAM8;TNFRSF10B;BDKRB1;ITGA5;ICAM1;B4GALT1;VEGFA;CD47;SAA1;WNT5A;VEGFC;PDGFB;MMP9;GRB7;CXCL16;GCSAM;CAV1;TP53;ITGAV;ADGRE2;SLC16A1
4342,GO:0009891,4.41500521450033e-11,1,113,1324,positive regulation of biosynthetic process,BP,IL1B;NFKBIA;CSF2;TNF;IRF1;IL1A;INHBA;CCL20;FOSL1;NCOA7;ZC3H12A;PPP1R15A;ELF3;BMP2;LIF;TBX3;EHF;PTX3;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;JUN;TICAM1;KDM6B;ETS1;SQSTM1;SERTAD2;KLF6;IRF6;EREG;IL23A;REL;BCL3;PLAGL2;IL6;ETS2;CSRNP1;NFKB2;RFX5;SIX4;RIPK2;JUNB;FZD8;BAMBI;RELB;NOD2;ICAM1;SMAD3;DLX2;ARNTL2;VEGFA;CDKN2B;KLF7;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SFR1;GPBP1;NFE2L3;WNT5A;SOX4;PDGFB;NRG1;LDLR;ATF3;IKZF2;SUCO;SLC9A1;YAF2;POU2F2;NFE2L2;SMAD1;PAOX;NFAT5;VEZF1;TNIP2;TP53;TLR2;CD276;ELK3;ZNF148;PML;RELA;TRIM16;FOXN2;MUC1;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;VIM;CREB5;EGLN1;ZXDA;XBP1;ELF4;TFE3;ZMIZ2;JUND
9861,GO:0042107,4.86684096078509e-11,1,19,65,cytokine metabolic process,BP,IL1B;TNF;IRF1;IL1A;INHBA;CCL20;NFKB1;MAP2K3;ZFP36;TICAM1;EREG;BCL3;IL6;TNFSF15;CEBPB;ERRFI1;WNT5A;CD276;RELA
9864,GO:0042110,4.8697973385386e-11,1,40,272,T cell activation,BP,IL1B;IRF1;SDC4;CD83;PRDM1;IL23A;BCL3;PELI1;EFNB1;IL6;ADAM8;ZFP36L1;RIPK2;CYLD;FZD8;RELB;IL7R;NOD2;IL6ST;ICAM1;SMAD3;NFKBID;NRARP;MAP3K8;CEBPB;CD55;CD47;RUNX1;TGFBR2;DUSP10;SOX4;IL4R;NEDD4;BTN2A2;CAV1;EFNB2;CD276;HLA-E;XBP1;ELF4
15984,GO:0080090,4.98523560068908e-11,1,280,4505,regulation of primary metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;ZNF267;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;RFX5;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;PHLDA2;JUNB;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;RELB;ZNF217;C1QTNF1;CDKN1A;CCDC85B;ITGA5;RAP2B;IL7R;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;NOD2;ELMSAN1;IL6ST;DCUN1D3;SAV1;TFPI2;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;RNF144B;NFKBID;TRAF4;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;PLK2;MAP3K8;ZBED2;CFLAR;TXNRD1;KLF7;BTG1;ANXA8;IER5;PPP4R4;CEBPB;CEBPD;CD55;NAMPT;ANKLE2;ADM;ERRFI1;CREB1;TAF4B;CCNL1;NR4A2;VHL;PHKG2;SOGA1;BACH1;ABTB2;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;SAA1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;MASTL;NAB1;HMGCS1;WNT5A;VEGFC;TGFA;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;BAZ1A;DUSP8;NRG1;MMP9;LDLR;ATF3;OTUD4;IKZF2;CAB39;TLE1;PLK3;CHD2;ARRDC4;SLC9A1;ZBTB10;RCHY1;YAF2;SPRY2;TNKS1BP1;GRB7;NUP153;NEDD4;MMD;POU2F2;IL24;TNFRSF6B;NFE2L2;PTPN1;WNT7B;SMAD1;LACTB;TAB3;PAOX;MXD1;CHD4;ZC3H7B;NFAT5;STAT5A;CAV1;VEZF1;SH3RF2;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;ABI1;STK40;PDP1;ITGAV;UBE2D3;CD276;ELK3;SNAPC4;ABCA7;CLK4;SDR16C5;ZNF148;PML;PIM1;ADAM9;RELA;TRIM16;ESCO2;FOXN2;CCBE1;PPP6R3;PLAT;MUC1;AXL;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;CREB5;EGLN1;RIPK4;ALAS1;ZXDA;RPS6KA6;DDR1;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;CFB;JUND;DENND4A
7323,GO:0031328,5.17244953167672e-11,1,112,1310,positive regulation of cellular biosynthetic process,BP,IL1B;NFKBIA;CSF2;TNF;IRF1;IL1A;INHBA;CCL20;FOSL1;NCOA7;ZC3H12A;PPP1R15A;ELF3;BMP2;LIF;TBX3;EHF;PTX3;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;JUN;TICAM1;KDM6B;ETS1;SQSTM1;SERTAD2;KLF6;IRF6;EREG;IL23A;REL;BCL3;PLAGL2;IL6;ETS2;CSRNP1;NFKB2;RFX5;SIX4;RIPK2;JUNB;FZD8;BAMBI;RELB;NOD2;ICAM1;SMAD3;DLX2;ARNTL2;VEGFA;CDKN2B;KLF7;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SFR1;GPBP1;NFE2L3;WNT5A;SOX4;PDGFB;NRG1;LDLR;ATF3;IKZF2;SLC9A1;YAF2;POU2F2;NFE2L2;SMAD1;PAOX;NFAT5;VEZF1;TNIP2;TP53;TLR2;CD276;ELK3;ZNF148;PML;RELA;TRIM16;FOXN2;MUC1;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;VIM;CREB5;EGLN1;ZXDA;XBP1;ELF4;TFE3;ZMIZ2;JUND
7341,GO:0031347,5.3250175385092e-11,1,54,459,regulation of defense response,BP,IL1B;NFKBIA;TNFAIP3;TNF;IRF1;BIRC3;ZC3H12A;NFKB1;TNIP1;TICAM1;IFNAR2;ETS1;EREG;IL23A;PELI1;BIRC2;IFNGR2;IL6;ADAM8;RIPK2;IRAK2;CYLD;RELB;NOD2;IL6ST;SMAD3;IL1R2;CD55;IFNAR1;SLC7A2;CD47;SAA1;IFNGR1;WNT5A;DUSP10;IL20;PGLYRP4;IFIH1;LDLR;OTUD4;PTPN1;TAB3;CAV1;TNIP2;TLR2;IKBKE;UBE2D3;MAPKBP1;RELA;MUC1;HLA-E;OSMR;PPARD;CFB
9826,GO:0042035,5.56282507907777e-11,1,18,58,regulation of cytokine biosynthetic process,BP,IL1B;TNF;IRF1;IL1A;INHBA;CCL20;NFKB1;MAP2K3;ZFP36;TICAM1;EREG;BCL3;IL6;CEBPB;ERRFI1;WNT5A;CD276;RELA
712,GO:0001934,5.85192607054769e-11,1,67,621,positive regulation of protein phosphorylation,BP,IL1B;CSF2;TNF;HBEGF;IL1A;EFNA1;SDC4;INHBA;CCL20;ZC3H12A;BMP2;LIF;PLAUR;EDN1;MAP2K3;JUN;EPHA2;SQSTM1;CSF1;EREG;IL23A;GADD45A;IL6;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;NOD2;IL6ST;ICAM1;TRAF4;VEGFA;DKK1;MAP3K8;CFLAR;CCNL1;TGFBR2;SAA1;WNT5A;VEGFC;TGFA;PDGFB;IL20;NRG1;MMP9;CAB39;SPRY2;TNKS1BP1;MMD;IL24;PTPN1;WNT7B;TAB3;CAV1;TP53;ABI1;ITGAV;ABCA7;ADAM9;AXL;DDR1
11487,GO:0045935,5.92298588898227e-11,1,110,1277,positive regulation of nucleobase-containing compound metabolic process,BP,IL1B;NFKBIA;CSF2;TNF;IRF1;IL1A;BTG2;INHBA;FOSL1;NCOA7;ZC3H12A;ELF3;BMP2;LIF;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;JUN;KDM6B;ETS1;SQSTM1;SERTAD2;KLF6;IRF6;EREG;IL23A;REL;BCL3;PLAGL2;IL6;ETS2;CSRNP1;NFKB2;RFX5;ZFP36L1;SIX4;RIPK2;JUNB;FZD8;BAMBI;RELB;NOD2;SMAD3;DLX2;ARNTL2;VEGFA;CDKN2B;KLF7;IER5;CEBPB;CEBPD;NAMPT;ADM;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SFR1;GPBP1;NFE2L3;WNT5A;SOX4;PDGFB;NRG1;ATF3;OTUD4;IKZF2;SLC9A1;YAF2;POU2F2;NFE2L2;PTPN1;SMAD1;NFAT5;VEZF1;TNIP2;TP53;TLR2;ELK3;ZNF148;PML;RELA;TRIM16;FOXN2;MUC1;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;CREB5;EGLN1;ZXDA;XBP1;QKI;ELF4;TFE3;ZMIZ2;JUND
18251,GO:1903039,5.99015530254627e-11,1,26,126,positive regulation of leukocyte cell-cell adhesion,BP,IL1B;TNF;CD83;ETS1;IL23A;EFNB1;IL6;ADAM8;RIPK2;CYLD;IL7R;NOD2;IL6ST;ICAM1;MAP3K8;CD55;CD47;TGFBR2;DUSP10;IL4R;CAV1;EFNB2;CD276;NR4A3;HLA-E;XBP1
4510,GO:0010557,6.96912417588108e-11,1,108,1250,positive regulation of macromolecule biosynthetic process,BP,IL1B;NFKBIA;CSF2;TNF;IRF1;IL1A;INHBA;CCL20;FOSL1;NCOA7;ZC3H12A;PPP1R15A;ELF3;BMP2;LIF;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;JUN;TICAM1;KDM6B;ETS1;SQSTM1;SERTAD2;KLF6;IRF6;EREG;IL23A;REL;BCL3;PLAGL2;IL6;ETS2;CSRNP1;NFKB2;RFX5;SIX4;RIPK2;JUNB;FZD8;BAMBI;RELB;NOD2;SMAD3;DLX2;ARNTL2;VEGFA;CDKN2B;KLF7;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SFR1;GPBP1;NFE2L3;WNT5A;SOX4;PDGFB;NRG1;ATF3;IKZF2;SLC9A1;YAF2;POU2F2;NFE2L2;SMAD1;NFAT5;VEZF1;TNIP2;TP53;TLR2;CD276;ELK3;ZNF148;PML;RELA;TRIM16;FOXN2;MUC1;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;VIM;CREB5;EGLN1;ZXDA;XBP1;ELF4;TFE3;ZMIZ2;JUND
12586,GO:0050727,7.26951846682338e-11,1,31,181,regulation of inflammatory response,BP,IL1B;NFKBIA;TNFAIP3;TNF;BIRC3;ZC3H12A;NFKB1;TNIP1;TICAM1;ETS1;IL23A;BIRC2;IL6;ADAM8;NOD2;IL6ST;SMAD3;IL1R2;CD55;SLC7A2;CD47;SAA1;WNT5A;DUSP10;IL20;LDLR;TLR2;RELA;OSMR;PPARD;CFB
15991,GO:0080134,8.60688169303558e-11,1,90,990,regulation of response to stress,BP,IL1B;NFKBIA;TNFAIP3;TNF;IRF1;HBEGF;PLAU;IL1A;BIRC3;NCOA7;ZC3H12A;PPP1R15A;BMP2;PLAUR;SOD2;PMAIP1;NFKB1;IER3;TNIP1;EDN1;SERPINB2;TICAM1;IFNAR2;ETS1;EREG;IL23A;PELI1;GADD45A;BIRC2;IFNGR2;IL6;ADAM8;RIPK2;IRAK2;PHLDB2;CYLD;FZD8;RELB;C1QTNF1;NOD2;IL6ST;GCH1;SMAD3;TRAF4;VEGFA;IL1R2;DKK1;PLK2;IER5;CD55;IFNAR1;ERRFI1;SLC7A2;CD47;TGFBR2;SAA1;IFNGR1;WNT5A;DUSP10;PDGFB;IL20;PGLYRP4;IFIH1;LDLR;OTUD4;NUP153;NFE2L2;PTPN1;WNT7B;TAB3;CAV1;TNIP2;TP53;TLR2;IKBKE;UBE2D3;MAPKBP1;PML;RELA;PLAT;MUC1;NR4A3;HLA-E;GSK3B;OSMR;PPARD;PARP1;XBP1;EID3;CFB
9028,GO:0035239,9.0915791525306e-11,1,62,542,tube morphogenesis,BP,CXCL8;IL1B;TNFAIP3;TNF;IL1A;EFNA1;SDC4;ZC3H12A;BMP2;PRDM1;TBX3;EDN1;JUN;EPHA2;ETS1;CSF1;EREG;IL6;ADAM8;ZFP36L1;SIX4;JUNB;FZD8;AMOTL2;ITGA5;TNFAIP2;SMAD3;B4GALT1;VEGFA;NRARP;PLK2;BTG1;ADM;RUNX1;TGFBR2;ITGB8;WNT5A;VEGFC;ROBO4;SOX4;TNC;SPRY2;NEDD4;NFE2L2;WNT7B;SMAD1;CLIC4;CAV1;VEZF1;EFNB2;ITGAV;ELK3;PML;CCBE1;SAT1;NR4A3;COL8A1;EGLN1;DDR1;XBP1;QKI;GJC1
3746,GO:0008284,1.00771991047564e-10,1,60,544,positive regulation of cell proliferation,BP,IL1B;TNFAIP3;CSF2;TNF;HBEGF;FOSL1;CXCL5;BMP2;LIF;TBX3;EDN1;JUN;TICAM1;ETS1;CSF1;EREG;IL23A;PELI1;EFNB1;IL6;RIPK2;BAMBI;CDKN1A;IL7R;ODC1;NOD2;IL6ST;B4GALT1;MARCKSL1;VEGFA;NRARP;FGF5;CFLAR;CD55;NAMPT;ADM;CD47;TGFBR2;WNT5A;VEGFC;TGFA;SOX4;PDGFB;NRG1;TNC;MMP9;ATF3;IL24;STAT5A;EFNB2;ITGAV;CD276;PML;PIM1;RELA;NR4A3;HLA-E;OSMR;PPARD;XBP1
364,GO:0000982,1.12984430761696e-10,1,40,269,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,IRF1;BTG2;FOSL1;ELF3;PRDM1;TBX3;EHF;JUN;ETS1;BHLHE40;KLF6;PLAGL2;ETS2;NFKB2;SIX4;JUNB;ZNF217;ARNTL2;KLF7;CEBPB;CEBPD;CREB1;NR4A2;BACH1;MYBL1;NFE2L3;SOX4;ATF3;POU2F2;SMAD1;MXD1;NFAT5;TP53;ELK3;ZNF148;RELA;NR4A3;ELF4;TFE3;JUND
9065,GO:0035295,1.13816095033239e-10,1,70,657,tube development,BP,CXCL8;IL1B;TNFAIP3;TNF;IL1A;EFNA1;SDC4;ZC3H12A;BMP2;LIF;PRDM1;TBX3;EDN1;JUN;EPHA2;ETS1;CSF1;EREG;IL6;ADAM8;ZFP36L1;SIX4;JUNB;FZD8;AMOTL2;CDKN1A;ITGA5;TNFAIP2;SAV1;SMAD3;B4GALT1;TRAF4;VEGFA;NRARP;PLK2;BTG1;ADM;ERRFI1;CREB1;GORAB;RUNX1;TGFBR2;ITGB8;WNT5A;VEGFC;ROBO4;SOX4;TNC;SPRY2;NEDD4;NFE2L2;WNT7B;SMAD1;CLIC4;CAV1;VEZF1;STK40;EFNB2;ITGAV;ELK3;PML;CCBE1;SAT1;NR4A3;COL8A1;EGLN1;DDR1;XBP1;QKI;GJC1
9838,GO:0042060,1.2089577869066e-10,1,45,345,wound healing,BP,TNFAIP3;IRF1;HBEGF;PLAU;IL1A;SDC4;CCL20;PLAUR;MAFF;EDN1;SERPINB2;EHD1;ETS1;EREG;IL6;PHLDB2;C1QTNF1;ITGA5;RAP2B;TFPI2;SMAD3;B4GALT1;NINJ1;CFLAR;ANXA8;TGFBR2;SAA1;WNT5A;DUSP10;PDGFB;NRG1;TNC;DCBLD2;IL24;NFE2L2;CAV1;TP53;ELK3;PLAT;AXL;ANXA5;PPARD;DDR1;XBP1;LMAN1
6638,GO:0023014,1.27460278273809e-10,1,66,625,signal transduction by protein phosphorylation,BP,IL1B;CSF2;TNF;HBEGF;IL1A;EFNA1;INHBA;CCL20;ZC3H12A;BMP2;LIF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;JUN;EPHA2;EREG;DUSP1;GADD45A;IL6;ADAM8;TNFRSF10B;ZFP36L1;RIPK2;IRAK2;FZD8;C1QTNF1;NOD2;ICAM1;TRAF4;TRIB1;VEGFA;DKK1;FGF5;MAP3K8;CFLAR;ERRFI1;TGFBR2;DUSP16;SAA1;WNT5A;TGFA;DUSP10;PDGFB;DUSP8;NRG1;ATF3;CAB39;SPRY2;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;CAV1;TNIP2;STK40;ITGAV;ABCA7;ADAM9;AXL;RPS6KA6;DDR1
358,GO:0000976,1.41220438045006e-10,1,58,497,transcription regulatory region sequence-specific DNA binding,MF,IRF1;FOSL1;ELF3;PRDM1;TBX3;EHF;NFKB1;JUN;KDM6B;ETS1;BHLHE40;KLF6;REL;GADD45A;ETS2;NFKB2;RFX5;SIX4;JUNB;RELB;ZNF217;SMAD3;DLX2;ARNTL2;KLF7;CEBPB;CEBPD;CREB1;NR4A2;BACH1;MYBL1;RUNX1;NFE2L3;SOX4;ATF3;CHD2;POU2F2;NFE2L2;SMAD1;MXD1;CHD4;NFAT5;VEZF1;TP53;KLF3;ELK3;ZNF148;RELA;MUC1;NR4A3;PPARD;PARP1;MXD3;XBP1;ZBTB5;ELF4;TFE3;JUND
1101,GO:0002687,1.43494973564754e-10,0.999999999984932,19,72,positive regulation of leukocyte migration,BP,CXCL8;CXCL2;TNF;CXCL3;CXCL1;IL1A;CCL20;CXCL5;EDN1;CSF1;IL23A;IL6;ADAM8;BDKRB1;ICAM1;VEGFA;WNT5A;VEGFC;TP53
2941,GO:0006468,1.55745225819795e-10,1,111,1320,protein phosphorylation,BP,IL1B;TNFAIP3;CSF2;TNF;HBEGF;NUAK2;IL1A;EFNA1;SDC4;INHBA;CCL20;ZC3H12A;BMP2;LIF;PLAUR;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;JUN;EPHA2;SQSTM1;CSF1;EREG;IL23A;DUSP1;PELI1;GADD45A;IL6;ADAM8;TNFRSF10B;BDKRB1;PIM3;ZFP36L1;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;NOD2;IL6ST;SGK1;ICAM1;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;CFLAR;ERRFI1;ANKK1;CREB1;CCNL1;MAST4;PHKG2;TGFBR2;DUSP16;SAA1;MASTL;WNT5A;CAMK1G;VEGFC;TGFA;DUSP10;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;ATF3;CAB39;PLK3;SPRY2;TNKS1BP1;MMD;IL24;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;STAT5A;CAV1;TNIP2;TP53;TLR2;ABI1;STK40;ITGAV;IKBKE;ABCA7;CLK4;PML;PIM1;ADAM9;AXL;FRK;GSK3B;RIPK4;RPS6KA6;DDR1
11293,GO:0045595,1.82161401438821e-10,1,100,1156,regulation of cell differentiation,BP,IL1B;NFKBIA;CSF2;TNF;IRF1;EFNA1;INHBA;NOCT;ZC3H12A;BMP2;LIF;CD83;PRDM1;TBX3;MAFF;NFKB1;EDN1;ZFP36;JUN;EHD1;ETS1;CSF1;EREG;IL23A;BIRC2;IL6;ADAM8;ZFP36L1;CYP27B1;SIX4;RIPK2;JUNB;PHLDB2;CYLD;BAMBI;TJP2;CCDC85B;ABCA5;IL7R;NEDD4L;IL6ST;SAV1;SMAD3;DLX2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;ZSWIM4;PLK2;ABL2;CFLAR;BTG1;CEBPB;ADM;ERRFI1;CREB1;VHL;SEMA4B;RUNX1;TGFBR2;TGIF2;WNT5A;VEGFC;DUSP10;SOCS2;PDGFB;IL20;NRG1;LDLR;SUCO;SPRY2;FEZ1;IL4R;NEDD4;MMD;ITSN2;NFE2L2;WNT7B;SMAD1;CAV1;VEZF1;TLR2;EFNB2;ITGAV;RELA;TRIM16;EVI2B;AXL;NR4A3;GSK3B;KMT2E;PPARD;PARP1;VIM;XBP1;KCTD11;TFE3;JUND
480,GO:0001525,1.98432098593227e-10,1,44,323,angiogenesis,BP,CXCL8;IL1B;TNFAIP3;IL1A;EFNA1;ZC3H12A;EDN1;JUN;EPHA2;ETS1;EREG;IL6;ADAM8;FZD8;AMOTL2;ITGA5;TNFAIP2;B4GALT1;VEGFA;NRARP;PLK2;BTG1;ADM;RUNX1;TGFBR2;ITGB8;WNT5A;VEGFC;ROBO4;SPRY2;NFE2L2;SMAD1;CLIC4;CAV1;VEZF1;EFNB2;ITGAV;ELK3;PML;CCBE1;SAT1;COL8A1;EGLN1;XBP1
15777,GO:0072359,1.99181035349532e-10,1,71,682,circulatory system development,BP,CXCL8;IL1B;TNFAIP3;IL1A;EFNA1;FOSL1;ZC3H12A;BMP2;LIF;PRDM1;TBX3;EDN1;JUN;KDM6B;EPHA2;ETS1;EREG;IL6;ADAM8;ZFP36L1;JUNB;FZD8;AMOTL2;ITGA5;TNFAIP2;SAV1;SMAD3;B4GALT1;VEGFA;NRARP;DKK1;PLK2;CFLAR;BTG1;ADM;ERRFI1;ADAMTS1;CREB1;RUNX1;TGFBR2;ITGB8;WNT5A;VEGFC;ROBO4;SOX4;PDGFB;NRG1;SLC9A1;SPRY2;NEDD4;NFE2L2;WNT7B;SMAD1;CLIC4;CAV1;VEZF1;ZFAND5;EFNB2;ITGAV;ELK3;JPH2;PML;PIM1;CCBE1;SAT1;PPARD;COL8A1;EGLN1;XBP1;QKI;GJC1
17885,GO:1902105,2.08116149200009e-10,0.999999999964814,29,159,regulation of leukocyte differentiation,BP,TNF;IRF1;INHBA;LIF;CD83;PRDM1;JUN;CSF1;IL23A;ADAM8;ZFP36L1;RIPK2;CYLD;TJP2;IL7R;NFKBID;TRIB1;NRARP;CEBPB;CREB1;RUNX1;TGFBR2;DUSP10;IL20;IL4R;EVI2B;AXL;XBP1;TFE3
82,GO:0000165,2.35107202196452e-10,1,64,607,MAPK cascade,BP,IL1B;CSF2;TNF;HBEGF;IL1A;EFNA1;INHBA;CCL20;ZC3H12A;BMP2;LIF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;JUN;EPHA2;EREG;DUSP1;GADD45A;IL6;ADAM8;TNFRSF10B;ZFP36L1;RIPK2;IRAK2;FZD8;C1QTNF1;NOD2;ICAM1;TRAF4;TRIB1;VEGFA;DKK1;FGF5;MAP3K8;CFLAR;ERRFI1;DUSP16;SAA1;WNT5A;TGFA;DUSP10;PDGFB;DUSP8;NRG1;ATF3;SPRY2;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;CAV1;TNIP2;STK40;ITGAV;ABCA7;ADAM9;AXL;RPS6KA6;DDR1
18542,GO:1903708,2.36053294990015e-10,0.999999999966445,24,112,positive regulation of hemopoiesis,BP,TNF;INHBA;LIF;CD83;PRDM1;JUN;ETS1;CSF1;IL23A;ADAM8;ZFP36L1;RIPK2;CYLD;IL7R;TRIB1;CREB1;RUNX1;TGFBR2;DUSP10;IL20;IL4R;EVI2B;AXL;XBP1
6077,GO:0019222,2.37428459148576e-10,1,295,4909,regulation of metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;ZNF267;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;RFX5;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;PHLDA2;JUNB;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;RELB;ZNF217;C1QTNF1;CDKN1A;CCDC85B;ITGA5;RAP2B;IL7R;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;NOD2;ELMSAN1;IL6ST;DCUN1D3;SAV1;TFPI2;SGK1;ICAM1;GCH1;SMAD3;NFKBIB;DLX2;ARNTL2;RNF144B;NFKBID;TRAF4;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ZBED2;ABL2;CFLAR;TXNRD1;KLF7;PIGA;BTG1;ANXA8;IER5;PPP4R4;CEBPB;CEBPD;CD55;NAMPT;ANKLE2;ADM;ERRFI1;CREB1;TAF4B;CCNL1;NR4A2;PATL1;VHL;PHKG2;SOGA1;BACH1;ABTB2;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;MASTL;NAB1;ITGB8;HMGCS1;WNT5A;VEGFC;TGFA;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;BAZ1A;DUSP8;NRG1;TNC;MMP9;LDLR;ATF3;OTUD4;IKZF2;CAB39;TLE1;PLK3;CHD2;ARRDC4;SUCO;SLC9A1;ZBTB10;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;GRB7;NUP153;RNF152;NEDD4;MMD;POU2F2;IL24;TNFRSF6B;BTN2A2;NFE2L2;PTPN1;WNT7B;SMAD1;LACTB;TAB3;PAOX;MXD1;CHD4;ZC3H7B;NFAT5;STAT5A;CAV1;VEZF1;SH3RF2;DRAM1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;ABI1;STK40;TAPBP;PDP1;ITGAV;UBE2D3;CD276;ELK3;SNAPC4;ABCA7;CLK4;SDR16C5;ZNF148;PML;PIM1;ADAM9;RELA;TRIM16;ESCO2;FOXN2;CCBE1;PPP6R3;PLAT;MUC1;AXL;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;CREB5;EGLN1;RIPK4;ALAS1;ZXDA;RPS6KA6;DDR1;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;CFB;JUND;DENND4A
4515,GO:0010562,2.51996133059203e-10,1,71,700,positive regulation of phosphorus metabolic process,BP,IL1B;CSF2;TNF;HBEGF;IL1A;EFNA1;SDC4;INHBA;CCL20;ZC3H12A;PPP1R15A;BMP2;LIF;PLAUR;EDN1;MAP2K3;JUN;EPHA2;SQSTM1;CSF1;EREG;IL23A;GADD45A;IL6;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;NOD2;IL6ST;ICAM1;SMAD3;TRAF4;VEGFA;DKK1;MAP3K8;CFLAR;ANKLE2;ADM;CCNL1;TGFBR2;SAA1;WNT5A;VEGFC;TGFA;PDGFB;IL20;NRG1;MMP9;CAB39;SPRY2;TNKS1BP1;MMD;IL24;PTPN1;WNT7B;TAB3;CAV1;TP53;ABI1;ITGAV;ABCA7;ADAM9;AXL;DDR1
11489,GO:0045937,2.51996133059203e-10,1,71,700,positive regulation of phosphate metabolic process,BP,IL1B;CSF2;TNF;HBEGF;IL1A;EFNA1;SDC4;INHBA;CCL20;ZC3H12A;PPP1R15A;BMP2;LIF;PLAUR;EDN1;MAP2K3;JUN;EPHA2;SQSTM1;CSF1;EREG;IL23A;GADD45A;IL6;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;NOD2;IL6ST;ICAM1;SMAD3;TRAF4;VEGFA;DKK1;MAP3K8;CFLAR;ANKLE2;ADM;CCNL1;TGFBR2;SAA1;WNT5A;VEGFC;TGFA;PDGFB;IL20;NRG1;MMP9;CAB39;SPRY2;TNKS1BP1;MMD;IL24;PTPN1;WNT7B;TAB3;CAV1;TP53;ABI1;ITGAV;ABCA7;ADAM9;AXL;DDR1
360,GO:0000978,2.57996635262288e-10,1,41,290,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,IRF1;FOSL1;ELF3;PRDM1;TBX3;EHF;JUN;KDM6B;ETS1;BHLHE40;KLF6;ETS2;NFKB2;RFX5;SIX4;JUNB;ZNF217;SMAD3;ARNTL2;KLF7;CEBPB;CEBPD;CREB1;NR4A2;MYBL1;NFE2L3;ATF3;POU2F2;SMAD1;MXD1;CHD4;NFAT5;TP53;ELK3;ZNF148;RELA;MUC1;NR4A3;ELF4;TFE3;JUND
7756,GO:0032268,2.68320259541636e-10,1,141,1897,regulation of cellular protein metabolic process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;HBEGF;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;CCL20;NCOA7;ZC3H12A;PPP1R15A;RNF19B;BMP2;LIF;PLAUR;PMAIP1;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;SERPINB2;JUN;TICAM1;EPHA2;SQSTM1;CSF1;BBC3;EREG;IL23A;DUSP1;BCL3;PELI1;GADD45A;BIRC2;IL6;ADAM8;TNFRSF10B;BDKRB1;N4BP1;ZFP36L1;TNFSF15;RIPK2;IRAK2;FZD8;TNFAIP8;C1QTNF1;CDKN1A;ITGA5;RAP2B;CPEB2;ZNF451;CTSC;NOD2;IL6ST;DCUN1D3;TFPI2;ICAM1;SMAD3;RNF144B;TRAF4;TRIB1;SERPINB8;VEGFA;IL1R2;DKK1;CDKN2B;PLK2;MAP3K8;CFLAR;ANXA8;PPP4R4;CD55;ANKLE2;ERRFI1;CCNL1;TGFBR2;DUSP16;SAA1;MASTL;WNT5A;VEGFC;TGFA;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;LDLR;ATF3;OTUD4;CAB39;PLK3;ARRDC4;RCHY1;SPRY2;TNKS1BP1;GRB7;NUP153;MMD;IL24;TNFRSF6B;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;ZC3H7B;CAV1;SH3RF2;TP53;ABI1;STK40;ITGAV;ABCA7;SDR16C5;PML;ADAM9;RELA;CCBE1;PPP6R3;PLAT;MUC1;AXL;GSK3B;KMT2E;VIM;RPS6KA6;DDR1;XBP1;QKI
3747,GO:0008285,3.00158074293365e-10,1,54,471,negative regulation of cell proliferation,BP,CXCL8;IL1B;TNFAIP3;TNF;IRF1;CXCL1;IL1A;SDC4;BTG2;INHBA;FOSL1;BMP2;LIF;SOD2;PRDM1;JUN;ETS1;IRF6;EREG;PELI1;IL6;CYP27B1;CDKN1A;SAV1;SMAD3;B4GALT1;TRIB1;CDKN2B;BTG1;CEBPB;ADM;ADAMTS1;VHL;TGFBR2;WNT5A;VEGFC;DUSP10;SOX4;BTG3;SPRY2;IL24;BTN2A2;SMAD1;CAV1;TP53;TLR2;ABI1;EFNB2;PML;EMP3;FRK;PPARD;DDR1;KCTD11
12672,GO:0050863,3.35378392372486e-10,0.999999999938882,31,186,regulation of T cell activation,BP,IL1B;IRF1;SDC4;CD83;PRDM1;IL23A;PELI1;EFNB1;IL6;ADAM8;RIPK2;CYLD;IL7R;NOD2;IL6ST;NFKBID;NRARP;MAP3K8;CEBPB;CD55;CD47;RUNX1;TGFBR2;DUSP10;IL4R;BTN2A2;CAV1;EFNB2;CD276;HLA-E;XBP1
1110,GO:0002696,3.36615111315775e-10,0.99999999994021,30,176,positive regulation of leukocyte activation,BP,IL1B;CD83;PRDM1;TICAM1;IL23A;PELI1;EFNB1;IL6;ADAM8;RIPK2;CYLD;CDKN1A;IL7R;NOD2;IL6ST;MAP3K8;CD55;CD47;TGFBR2;WNT5A;DUSP10;IL4R;CAV1;TNIP2;EFNB2;CD276;AXL;NR4A3;HLA-E;XBP1
7361,GO:0031399,3.50179041812021e-10,1,106,1261,regulation of protein modification process,BP,IL1B;TNFAIP3;CSF2;TNF;HBEGF;IL1A;EFNA1;SDC4;INHBA;BIRC3;CCL20;NCOA7;ZC3H12A;PPP1R15A;BMP2;LIF;PLAUR;TNIP1;EDN1;MAP2K3;JUN;TICAM1;EPHA2;SQSTM1;CSF1;EREG;IL23A;DUSP1;PELI1;GADD45A;BIRC2;IL6;ADAM8;TNFRSF10B;BDKRB1;N4BP1;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;ZNF451;NOD2;IL6ST;DCUN1D3;ICAM1;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;MAP3K8;CFLAR;PPP4R4;ANKLE2;ERRFI1;CCNL1;TGFBR2;DUSP16;SAA1;MASTL;WNT5A;VEGFC;TGFA;DUSP10;SOX4;PPP1R3B;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;ATF3;OTUD4;CAB39;ARRDC4;RCHY1;SPRY2;TNKS1BP1;MMD;IL24;PTPN1;WNT7B;TAB3;CAV1;SH3RF2;TP53;ABI1;STK40;ITGAV;ABCA7;SDR16C5;PML;ADAM9;RELA;PPP6R3;MUC1;AXL;GSK3B;KMT2E;RPS6KA6;DDR1
9847,GO:0042089,3.57437095250953e-10,0.999999999963359,18,64,cytokine biosynthetic process,BP,IL1B;TNF;IRF1;IL1A;INHBA;CCL20;NFKB1;MAP2K3;ZFP36;TICAM1;EREG;BCL3;IL6;CEBPB;ERRFI1;WNT5A;CD276;RELA
8367,GO:0033256,3.70569922891201e-10,1,7,7,I-kappaB/NF-kappaB complex,CC,NFKBIA;NFKB1;REL;BCL3;NFKB2;RELB;RELA
11796,GO:0046649,3.76073790800317e-10,1,48,392,lymphocyte activation,BP,IL1B;TNFAIP3;IRF1;SDC4;INHBA;CD83;PRDM1;TICAM1;KLF6;IL23A;BCL3;PELI1;EFNB1;IL6;ADAM8;ZFP36L1;RIPK2;CYLD;FZD8;RELB;CDKN1A;IL7R;NOD2;IL6ST;ICAM1;SMAD3;NFKBID;NRARP;MAP3K8;CEBPB;CD55;CD47;RUNX1;TGFBR2;DUSP10;SOX4;IL4R;NEDD4;POU2F2;BTN2A2;CAV1;TNIP2;EFNB2;CD276;AXL;HLA-E;XBP1;ELF4
12912,GO:0051241,3.76702157492864e-10,1,68,679,negative regulation of multicellular organismal process,BP,IL1B;NFKBIA;TNFAIP3;TNF;IRF1;PLAU;EFNA1;INHBA;NOCT;ZC3H12A;BMP2;PLAUR;CD83;NFKB1;EDN1;ZFP36;SERPINB2;IL23A;REL;BCL3;IL6;ZFP36L1;SIX4;CYLD;TJP2;RELB;C1QTNF1;NAV3;SAV1;SMAD3;DLX2;NFKBID;TRIB1;NRARP;IL1R2;DKK1;PLK2;ADM;ERRFI1;SEMA4B;TGFBR2;TRIM25;WNT5A;DUSP10;SOCS2;PDGFB;IFIH1;NRG1;LDLR;TRPV3;SPRY2;IL4R;BTN2A2;NFE2L2;TLR2;EFNB2;IKBKE;DOCK4;MAPKBP1;PML;PLAT;AXL;ANXA5;GSK3B;VIM;RPS6KA6;KCTD11;IL36RN
17767,GO:1901701,4.07652206720079e-10,1,71,717,cellular response to oxygen-containing compound,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;INHBA;CCL20;ZC3H12A;SOD2;PRDM1;NFKB1;PPIF;TNIP1;EDN1;ZFP36;JUN;TICAM1;KDM6B;ETS1;IL6;PIM3;ZFP36L1;CYP27B1;RIPK2;IRAK2;CLDN1;CPEB2;NOD2;ICAM1;GCH1;NFKBIB;TRIB1;ABL2;CFLAR;CEBPB;CD55;GJB3;ERRFI1;CREB1;NR4A2;SOGA1;HMGCS1;WNT5A;SOX4;SOCS2;PDGFB;TNC;MMP9;LDLR;SLC9A1;IL24;NFE2L2;PTPN1;WNT7B;STAT5A;CAV1;TNIP2;TP53;KLF3;TLR2;PIM1;ADAM9;RELA;AXL;NR4A3;GSK3B;PPARD;PARP1;CYP24A1;XBP1
2873,GO:0006366,4.13211357694902e-10,1,135,1761,transcription by RNA polymerase II,BP,NFKBIZ;IL1B;NFKBIA;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;ZFP36;JUN;KDM6B;ETS1;SQSTM1;BHLHE40;ZNF267;KLF6;IRF6;IL23A;REL;BCL3;PLAGL2;IL6;ETS2;CSRNP1;NFKB2;RFX5;ZFP36L1;SIX4;RIPK2;THAP10;JUNB;FZD8;RELB;ZNF217;CDKN1A;ZNF451;NEDD4L;NOD2;ELMSAN1;SMAD3;DLX2;ARNTL2;NFKBID;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;KLF7;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;TGIF2;NFE2L3;WNT5A;TGFA;SOX4;PDGFB;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;NEDD4;POU2F2;NFE2L2;SMAD1;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;SDR16C5;ZNF148;PML;RELA;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;PPARD;PARP1;MED13;MXD3;CRAMP1;JMY;SRSF11;CREB5;EGLN1;NABP1;XBP1;ZBTB5;ELF4;TFE3;ZMIZ2;JUND
6740,GO:0030154,4.62030561510699e-10,1,177,2525,cell differentiation,BP,IL1B;NFKBIA;CSF2;TNF;IRF1;IL1A;EFNA1;SDC4;BTG2;INHBA;NOCT;ZC3H12A;ELF3;BMP2;LIF;CD83;PRDM1;TBX3;EHF;MAFF;NFKB1;EDN1;ZFP36;JUN;KDM6B;EPHA2;EHD1;ETS1;SQSTM1;CSF1;SPRR2D;KLF6;IRF6;EREG;IL23A;BCL3;EFNB1;BIRC2;IL6;ETS2;NFKB2;ADAM8;ZFP36L1;CYP27B1;SIX4;RIPK2;JUNB;PHLDB2;CYLD;FZD8;BAMBI;TJP2;RELB;STEAP4;CDKN1A;CLDN1;CCDC85B;ITGA5;ABCA5;IL7R;TNFAIP2;NEDD4L;IL6ST;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;DLX2;NFKBID;TRIB1;KRT34;VEGFA;NRARP;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;ABL2;LAMB3;CFLAR;KLF7;BTG1;CEBPB;ADM;ERRFI1;CREB1;TAF4B;NR4A2;VHL;SEMA4B;ABTB2;MYBL1;RUNX1;TGFBR2;MREG;TGIF2;NAB1;WNT5A;VEGFC;SLC11A2;NOTCH2NL;DUSP10;ROBO4;SOX4;SOCS2;PDGFB;IL20;ANLN;NRG1;TNC;MMP9;LDLR;ATF3;COL12A1;CHD2;PARD6B;SUCO;SLC9A1;SPRY2;FEZ1;GRB7;IL4R;NEDD4;MMD;RHCG;POU2F2;ITSN2;NFE2L2;WNT7B;SMAD1;SPTBN5;CLIC4;CAV1;VEZF1;TP53;NOM1;TLR2;ABI1;EFNB2;ITGAV;ELK3;SPRR2A;SNAPC4;PML;ADAM9;RELA;RAPH1;TRIM16;ESCO2;SPATA2;FOXN2;EVI2B;COL27A1;AXL;FRK;NR4A3;GSK3B;KMT2E;PPARD;PARP1;CYP24A1;LAMA3;LCE1C;COL8A1;VIM;DDR1;XBP1;QKI;EPB41L3;KCTD11;ELF4;TFE3;C12ORF29;JUND;GJC1
6586,GO:0022409,4.95876185354999e-10,0.999999999918166,27,146,positive regulation of cell-cell adhesion,BP,IL1B;TNF;CD83;ETS1;IL23A;EFNB1;IL6;ADAM8;RIPK2;CYLD;IL7R;NOD2;IL6ST;ICAM1;MAP3K8;CD55;CD47;TGFBR2;WNT5A;DUSP10;IL4R;CAV1;EFNB2;CD276;NR4A3;HLA-E;XBP1
366,GO:0000987,5.57833077803452e-10,1,41,297,proximal promoter sequence-specific DNA binding,MF,IRF1;FOSL1;ELF3;PRDM1;TBX3;EHF;JUN;KDM6B;ETS1;BHLHE40;KLF6;ETS2;NFKB2;RFX5;SIX4;JUNB;ZNF217;SMAD3;ARNTL2;KLF7;CEBPB;CEBPD;CREB1;NR4A2;MYBL1;NFE2L3;ATF3;POU2F2;SMAD1;MXD1;CHD4;NFAT5;TP53;ELK3;ZNF148;RELA;MUC1;NR4A3;ELF4;TFE3;JUND
12287,GO:0048585,5.72702919012727e-10,1,95,1104,negative regulation of response to stimulus,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;HBEGF;PLAU;IL1A;EFNA1;NCOA7;ZC3H12A;PPP1R15A;BMP2;LIF;PLAUR;SOD2;PRDM1;IL1RN;NFKB1;PPIF;TNIP1;EDN1;SERPINB2;TICAM1;EPHA2;ETS1;EREG;DUSP1;BCL3;IL6;TNFRSF10B;PIM3;PHLDB2;CYLD;BAMBI;C1QTNF1;IL7R;ZNF451;NOD2;ICAM1;SMAD3;DLX2;NFKBID;TRIB1;NRARP;IL1R2;DKK1;PLK2;CFLAR;RNF43;CD55;ADM;ERRFI1;NR4A2;VHL;SEMA4B;TGFBR2;SMURF2;DUSP16;SAA1;WNT5A;DUSP10;SOCS2;PDGFB;DUSP8;NRG1;MMP9;ATF3;OTUD4;TLE1;SPRY2;BCL2L2;RNF152;IL4R;NEDD4;NFE2L2;PTPN1;CAV1;ITGAV;MAPKBP1;RELA;PLAT;MUC1;AXL;NR4A3;HLA-E;GSK3B;PPARD;MED13;RPS6KA6;DDR1;XBP1;KCTD11;IL36RN
4268,GO:0009611,6.03780196362735e-10,1,49,418,response to wounding,BP,TNFAIP3;IRF1;HBEGF;PLAU;IL1A;SDC4;CCL20;PLAUR;MAFF;EDN1;ZFP36;SERPINB2;JUN;EHD1;ETS1;EREG;IL6;ZFP36L1;PHLDB2;C1QTNF1;ITGA5;RAP2B;TFPI2;SMAD3;B4GALT1;NINJ1;CFLAR;ANXA8;ADM;TGFBR2;SAA1;WNT5A;DUSP10;PDGFB;NRG1;TNC;DCBLD2;IL24;NFE2L2;CAV1;TP53;ELK3;PLAT;AXL;ANXA5;PPARD;DDR1;XBP1;LMAN1
12918,GO:0051251,6.12671380127029e-10,0.999999999878026,28,159,positive regulation of lymphocyte activation,BP,IL1B;CD83;PRDM1;TICAM1;IL23A;PELI1;EFNB1;IL6;ADAM8;RIPK2;CYLD;CDKN1A;IL7R;NOD2;IL6ST;MAP3K8;CD55;CD47;TGFBR2;DUSP10;IL4R;CAV1;TNIP2;EFNB2;CD276;AXL;HLA-E;XBP1
9961,GO:0042327,6.15068622950254e-10,1,67,655,positive regulation of phosphorylation,BP,IL1B;CSF2;TNF;HBEGF;IL1A;EFNA1;SDC4;INHBA;CCL20;ZC3H12A;BMP2;LIF;PLAUR;EDN1;MAP2K3;JUN;EPHA2;SQSTM1;CSF1;EREG;IL23A;GADD45A;IL6;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;NOD2;IL6ST;ICAM1;TRAF4;VEGFA;DKK1;MAP3K8;CFLAR;CCNL1;TGFBR2;SAA1;WNT5A;VEGFC;TGFA;PDGFB;IL20;NRG1;MMP9;CAB39;SPRY2;TNKS1BP1;MMD;IL24;PTPN1;WNT7B;TAB3;CAV1;TP53;ABI1;ITGAV;ABCA7;ADAM9;AXL;DDR1
4288,GO:0009653,6.72621282853658e-10,1,133,1705,anatomical structure morphogenesis,BP,CXCL8;IL1B;TNFAIP3;TNF;HBEGF;IL1A;EFNA1;SDC4;INHBA;ZC3H12A;ELF3;BMP2;LIF;PRDM1;TBX3;IL1RN;IER3;EDN1;JUN;KDM6B;EPHA2;EHD1;ETS1;CSF1;EREG;DUSP1;BCL3;EFNB1;IL6;ETS2;CSRNP1;NFKB2;ADAM8;ZFP36L1;SIX4;PHLDA2;JUNB;PHLDB2;FZD8;BAMBI;AMOTL2;FJX1;ITGA5;IL7R;TNFAIP2;NEDD4L;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;DLX2;RND3;NINJ1;VEGFA;FGD6;NRARP;DKK1;ZSWIM4;PLK2;LAMB3;CFLAR;TXNRD1;KLF7;BTG1;CEBPB;ADM;CDC42EP4;ERRFI1;ADAMTS1;CREB1;GORAB;NR4A2;VHL;SEMA4B;RUNX1;TGFBR2;SMURF2;TGIF2;NAB1;ITGB8;WNT5A;VEGFC;SLC11A2;ROBO4;SOX4;NRG1;TNC;MMP9;COL12A1;TLE1;PARD6B;SPRY2;FEZ1;GRB7;IL4R;NEDD4;ITSN2;NFE2L2;WNT7B;SMAD1;SPTBN5;CLIC4;CAV1;VEZF1;RHOV;ZFAND5;TLR2;ABI1;STK40;EFNB2;ITGAV;ELK3;PML;PIM1;ADAM9;RELA;RAPH1;CCBE1;COL27A1;AXL;SAT1;NR4A3;LAMA3;COL8A1;EGLN1;RIPK4;DDR1;XBP1;QKI;EPB41L3;ERVFRD-1;GJC1
12866,GO:0051171,8.54173058154956e-10,1,269,4388,regulation of nitrogen compound metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;ZNF267;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;RFX5;ZFP36L1;TNFSF15;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;RELB;ZNF217;C1QTNF1;CDKN1A;CCDC85B;ITGA5;RAP2B;IL7R;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;NOD2;ELMSAN1;IL6ST;DCUN1D3;SAV1;TFPI2;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;RNF144B;NFKBID;TRAF4;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;PLK2;MAP3K8;ZBED2;CFLAR;KLF7;BTG1;ANXA8;IER5;PPP4R4;CEBPB;CEBPD;CD55;NAMPT;ANKLE2;ADM;ERRFI1;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;ABTB2;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;SAA1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;MASTL;NAB1;WNT5A;VEGFC;TGFA;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;BAZ1A;DUSP8;NRG1;MMP9;LDLR;ATF3;OTUD4;IKZF2;CAB39;TLE1;PLK3;CHD2;ARRDC4;SLC9A1;ZBTB10;RCHY1;YAF2;SPRY2;TNKS1BP1;GRB7;NUP153;NEDD4;MMD;POU2F2;IL24;TNFRSF6B;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;PAOX;MXD1;CHD4;ZC3H7B;NFAT5;STAT5A;CAV1;VEZF1;SH3RF2;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;ABI1;STK40;ITGAV;UBE2D3;CD276;ELK3;SNAPC4;ABCA7;CLK4;SDR16C5;ZNF148;PML;PIM1;ADAM9;RELA;TRIM16;ESCO2;FOXN2;CCBE1;PPP6R3;PLAT;MUC1;AXL;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;CREB5;EGLN1;RIPK4;ZXDA;RPS6KA6;DDR1;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;CFB;JUND;DENND4A
12676,GO:0050867,9.30970833492189e-10,0.999999999798717,30,183,positive regulation of cell activation,BP,IL1B;CD83;PRDM1;TICAM1;IL23A;PELI1;EFNB1;IL6;ADAM8;RIPK2;CYLD;CDKN1A;IL7R;NOD2;IL6ST;MAP3K8;CD55;CD47;TGFBR2;WNT5A;DUSP10;IL4R;CAV1;TNIP2;EFNB2;CD276;AXL;NR4A3;HLA-E;XBP1
19721,GO:2000026,1.12929236984723e-09,1,105,1276,regulation of multicellular organismal development,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;INHBA;NOCT;ZC3H12A;BMP2;LIF;CD83;PRDM1;TBX3;IL1RN;MAFF;EDN1;ZFP36;JUN;EPHA2;ETS1;CSF1;IL23A;IL6;ADAM8;ZFP36L1;CYP27B1;SIX4;RIPK2;PHLDA2;PHLDB2;CYLD;BAMBI;TJP2;ITGA5;IL7R;NEDD4L;IL6ST;SAV1;SMAD3;B4GALT1;DLX2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;ZSWIM4;PLK2;ABL2;CFLAR;BTG1;CEBPB;ADM;ERRFI1;CREB1;GORAB;SEMA4B;RUNX1;TGFBR2;SMURF2;TGIF2;ITGB8;WNT5A;VEGFC;DUSP10;SOCS2;PDGFB;IL20;NRG1;LDLR;SPRY2;FEZ1;IL4R;NEDD4;MMD;ITSN2;NFE2L2;SMAD1;CAV1;VEZF1;TLR2;EFNB2;JPH2;PML;PIM1;RELA;TRIM16;CCBE1;EVI2B;AXL;NR4A3;GSK3B;KMT2E;PPARD;LAMA3;VIM;EGLN1;RPS6KA6;XBP1;KCTD11;TFE3
10770,GO:0044212,1.15705017466935e-09,1,64,609,transcription regulatory region DNA binding,MF,TNF;IRF1;FOSL1;ELF3;PRDM1;TBX3;EHF;NFKB1;JUN;KDM6B;ETS1;BHLHE40;KLF6;IRF6;REL;GADD45A;ETS2;NFKB2;RFX5;SIX4;JUNB;RELB;ZNF217;ELMSAN1;SMAD3;DLX2;ARNTL2;KLF7;CEBPB;CEBPD;CREB1;NR4A2;BACH1;MYBL1;RUNX1;NFE2L3;WNT5A;SOX4;ATF3;IKZF2;CHD2;POU2F2;NFE2L2;SMAD1;MXD1;CHD4;NFAT5;VEZF1;TP53;KLF3;ELK3;SNAPC4;ZNF148;RELA;MUC1;NR4A3;PPARD;PARP1;MXD3;XBP1;ZBTB5;ELF4;TFE3;JUND
396,GO:0001067,1.24338540696256e-09,1,64,610,regulatory region nucleic acid binding,MF,TNF;IRF1;FOSL1;ELF3;PRDM1;TBX3;EHF;NFKB1;JUN;KDM6B;ETS1;BHLHE40;KLF6;IRF6;REL;GADD45A;ETS2;NFKB2;RFX5;SIX4;JUNB;RELB;ZNF217;ELMSAN1;SMAD3;DLX2;ARNTL2;KLF7;CEBPB;CEBPD;CREB1;NR4A2;BACH1;MYBL1;RUNX1;NFE2L3;WNT5A;SOX4;ATF3;IKZF2;CHD2;POU2F2;NFE2L2;SMAD1;MXD1;CHD4;NFAT5;VEZF1;TP53;KLF3;ELK3;SNAPC4;ZNF148;RELA;MUC1;NR4A3;PPARD;PARP1;MXD3;XBP1;ZBTB5;ELF4;TFE3;JUND
7318,GO:0031323,1.33038271431979e-09,1,279,4612,regulation of cellular metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;ZNF267;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;RFX5;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;PHLDA2;JUNB;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;RELB;ZNF217;C1QTNF1;CDKN1A;CCDC85B;ITGA5;RAP2B;IL7R;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;NOD2;ELMSAN1;IL6ST;DCUN1D3;SAV1;TFPI2;SGK1;ICAM1;GCH1;SMAD3;NFKBIB;DLX2;ARNTL2;RNF144B;NFKBID;TRAF4;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;PLK2;MAP3K8;ZBED2;ABL2;CFLAR;KLF7;BTG1;ANXA8;IER5;PPP4R4;CEBPB;CEBPD;CD55;NAMPT;ANKLE2;ADM;ERRFI1;CREB1;TAF4B;CCNL1;NR4A2;VHL;PHKG2;SOGA1;BACH1;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;SAA1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;MASTL;NAB1;WNT5A;VEGFC;TGFA;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;BAZ1A;DUSP8;NRG1;MMP9;LDLR;ATF3;OTUD4;IKZF2;CAB39;TLE1;PLK3;CHD2;ARRDC4;SLC9A1;ZBTB10;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;GRB7;NUP153;RNF152;NEDD4;MMD;POU2F2;IL24;TNFRSF6B;BTN2A2;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;PAOX;MXD1;CHD4;ZC3H7B;NFAT5;STAT5A;CAV1;VEZF1;SH3RF2;DRAM1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;ABI1;STK40;PDP1;ITGAV;UBE2D3;CD276;ELK3;SNAPC4;ABCA7;CLK4;SDR16C5;ZNF148;PML;PIM1;ADAM9;RELA;TRIM16;ESCO2;FOXN2;CCBE1;PPP6R3;PLAT;MUC1;AXL;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;CREB5;EGLN1;RIPK4;ZXDA;RPS6KA6;DDR1;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
12250,GO:0048513,1.52065295690293e-09,1,153,2136,animal organ development,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;EFNA1;SDC4;BTG2;INHBA;FOSL1;ELF3;BMP2;LIF;CD83;PRDM1;TBX3;MAFF;EDN1;ZFP36;JUN;KDM6B;EPHA2;ETS1;CSF1;SPRR2D;KLF6;IRF6;EREG;IL23A;BCL3;EFNB1;BIRC2;IL6;CSRNP1;NFKB2;ADAM8;ZFP36L1;CYP27B1;SIX4;RIPK2;PHLDA2;JUNB;PHLDB2;CYLD;FZD8;BAMBI;TJP2;RELB;CDKN1A;CLDN1;FJX1;IL7R;ODC1;SAV1;ICAM1;SMAD3;B4GALT1;DLX2;B3GNT5;NFKBID;NINJ1;TRAF4;TRIB1;KRT34;VEGFA;NRARP;DKK1;CDKN2B;CFLAR;CEBPB;ADM;GJB3;ERRFI1;ADAMTS1;CREB1;GORAB;NR4A2;SEMA4B;RUNX1;TGFBR2;SMURF2;TGIF2;NAB1;ITGB8;HMGCS1;WNT5A;VEGFC;SLC11A2;DUSP10;SOX4;SOCS2;PDGFB;IL20;ANLN;NRG1;TNC;SLC38A2;MMP9;ATF3;TLE1;CHD2;SLC9A1;SPRY2;FEZ1;BCL2L2;IL4R;NEDD4;POU2F2;NFE2L2;WNT7B;SMAD1;CLIC4;STAT5A;CAV1;ZFAND5;NOM1;TLR2;ABI1;STK40;EFNB2;JPH2;SPRR2A;ZNF148;PML;PIM1;ADAM9;RELA;TRIM16;ESCO2;FOXN2;CCBE1;EVI2B;COL27A1;AXL;NR4A3;GSK3B;KMT2E;PPARD;EVC;PARP1;KDM7A;LCE1C;COL8A1;VIM;EGLN1;DDR1;XBP1;TFE3;C12ORF29;GJC1
3461,GO:0007275,1.59202792442193e-09,1,216,3307,multicellular organism development,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;NOCT;FOSL1;ZC3H12A;ELF3;BMP2;LIF;CD83;PRDM1;TBX3;EHF;IL1RN;MAFF;EDN1;ZFP36;JUN;KDM6B;EPHA2;EHD1;ETS1;CSF1;N4BP3;ZNF267;SPRR2D;KLF6;IRF6;EREG;IL23A;DUSP1;BCL3;PLAGL2;EFNB1;BIRC2;IL6;ETS2;CSRNP1;NFKB2;ADAM8;TNFRSF10B;ZFP36L1;CYP27B1;SIX4;RIPK2;PHLDA2;JUNB;PHLDB2;CYLD;FZD8;BAMBI;TJP2;RELB;ZNF217;AMOTL2;CDKN1A;CLDN1;FJX1;ITGA5;IL7R;NAV3;ODC1;TNFAIP2;NEDD4L;IL6ST;RELT;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;DLX2;B3GNT5;NFKBID;NINJ1;TRAF4;TRIB1;KRT34;VEGFA;NRARP;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;ABL2;LAMB3;CFLAR;TXNRD1;KLF7;BTG1;CEBPB;VMP1;ANKLE2;ADM;GJB3;ERRFI1;ADAMTS1;CREB1;GORAB;NR4A2;SEMA4B;ABTB2;RUNX1;TGFBR2;SMURF2;TGIF2;MTURN;NAB1;ITGB8;HMGCS1;WNT5A;VEGFC;SLC11A2;NOTCH2NL;DUSP10;ROBO4;SOX4;SOCS2;PDGFB;IL20;ANLN;NRG1;TNC;SLC38A2;MMP9;LDLR;ATF3;COL12A1;TLE1;CHD2;PARD6B;SUCO;SLC9A1;SPRY2;FEZ1;GRB7;BCL2L2;IL4R;NEDD4;MMD;POU2F2;ITSN2;TNFRSF6B;NFE2L2;WNT7B;SMAD1;SPTBN5;MXD1;TPRA1;DIEXF;CLIC4;STAT5A;CAV1;VEZF1;RTTN;ZFAND5;TP53;NOM1;KLF3;TLR2;ABI1;STK40;EFNB2;ITGAV;ELK3;JPH2;SPRR2A;ZNF148;PML;PIM1;ADAM9;RELA;RAPH1;TRIM16;ESCO2;SPATA2;FOXN2;CCBE1;EVI2B;COL27A1;CHST2;AXL;SAT1;NR4A3;GSK3B;KMT2E;PPARD;EVC;PARP1;LAMA3;KDM7A;LCE1C;COL8A1;VIM;EGLN1;RPS6KA6;DDR1;XBP1;QKI;EPB41L3;KCTD11;TFE3;C12ORF29;GJC1
19664,GO:1990837,1.64325865899842e-09,1,58,530,sequence-specific double-stranded DNA binding,MF,IRF1;FOSL1;ELF3;PRDM1;TBX3;EHF;NFKB1;JUN;KDM6B;ETS1;BHLHE40;KLF6;REL;GADD45A;ETS2;NFKB2;RFX5;SIX4;JUNB;RELB;ZNF217;SMAD3;DLX2;ARNTL2;KLF7;CEBPB;CEBPD;CREB1;NR4A2;BACH1;MYBL1;RUNX1;NFE2L3;SOX4;ATF3;CHD2;POU2F2;NFE2L2;SMAD1;MXD1;CHD4;NFAT5;VEZF1;TP53;KLF3;ELK3;ZNF148;RELA;MUC1;NR4A3;PPARD;PARP1;MXD3;XBP1;ZBTB5;ELF4;TFE3;JUND
12625,GO:0050793,1.69492668825963e-09,1,127,1658,regulation of developmental process,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;INHBA;NOCT;ZC3H12A;BMP2;LIF;CD83;PRDM1;TBX3;IL1RN;MAFF;NFKB1;EDN1;ZFP36;JUN;EPHA2;EHD1;ETS1;CSF1;EREG;IL23A;BIRC2;IL6;ADAM8;ZFP36L1;CYP27B1;SIX4;RIPK2;PHLDA2;JUNB;PHLDB2;CYLD;BAMBI;TJP2;CCDC85B;ITGA5;ABCA5;IL7R;NEDD4L;IL6ST;SAV1;ICAM1;SMAD3;B4GALT1;DLX2;RND3;NFKBID;TRIB1;VEGFA;FGD6;NRARP;DKK1;ZSWIM4;PLK2;ABL2;CFLAR;BTG1;CEBPB;ADM;CDC42EP4;ERRFI1;CREB1;GORAB;VHL;SEMA4B;RUNX1;TGFBR2;SMURF2;TGIF2;NAB1;ITGB8;WNT5A;VEGFC;DUSP10;SOCS2;PDGFB;IL20;NRG1;LDLR;SUCO;SPRY2;FEZ1;IL4R;NEDD4;MMD;ITSN2;NFE2L2;WNT7B;SMAD1;STAT5A;CAV1;VEZF1;RHOV;TLR2;EFNB2;ITGAV;JPH2;PML;PIM1;ADAM9;RELA;TRIM16;CCBE1;EVI2B;AXL;NR4A3;GSK3B;KMT2E;PPARD;PARP1;LAMA3;VIM;EGLN1;RPS6KA6;XBP1;EPB41L3;KCTD11;TFE3;JUND
14044,GO:0060759,2.02203825023048e-09,0.999999999617224,25,136,regulation of response to cytokine stimulus,BP,TNFAIP3;TNF;BIRC3;IL1RN;EDN1;IFNAR2;TRAF1;CSF1;BIRC2;IFNGR2;IL6;RIPK2;IRAK2;CYLD;IL1R2;IFNAR1;RUNX1;IFNGR1;WNT5A;IFIH1;OTUD4;PTPN1;CAV1;AXL;IL36RN
10509,GO:0043408,2.30268500937791e-09,1,53,476,regulation of MAPK cascade,BP,IL1B;TNF;IL1A;EFNA1;INHBA;CCL20;ZC3H12A;BMP2;LIF;TNIP1;EDN1;MAP2K3;JUN;EPHA2;DUSP1;GADD45A;IL6;ADAM8;TNFRSF10B;RIPK2;IRAK2;FZD8;C1QTNF1;NOD2;ICAM1;TRAF4;TRIB1;VEGFA;DKK1;MAP3K8;CFLAR;ERRFI1;DUSP16;SAA1;WNT5A;TGFA;DUSP10;PDGFB;DUSP8;NRG1;ATF3;SPRY2;PTPN1;WNT7B;TAB3;CAV1;STK40;ITGAV;ABCA7;ADAM9;AXL;RPS6KA6;DDR1
1050,GO:0002573,2.31901011315637e-09,0.999999999577113,24,123,myeloid leukocyte differentiation,BP,CSF2;TNF;INHBA;LIF;JUN;EPHA2;CSF1;IL23A;ZFP36L1;JUNB;TJP2;RELB;TRIB1;VEGFA;CEBPB;CREB1;RUNX1;TGFBR2;IL20;MMP9;TLR2;EVI2B;PARP1;TFE3
13845,GO:0060429,2.40743329291244e-09,1,75,811,epithelium development,BP,IL1B;TNF;HBEGF;SDC4;INHBA;ELF3;BMP2;LIF;PRDM1;TBX3;EHF;MAFF;EDN1;ZFP36;JUN;KDM6B;EPHA2;CSF1;SPRR2D;IRF6;EREG;ZFP36L1;CYP27B1;SIX4;PHLDB2;TJP2;CDKN1A;CLDN1;ITGA5;SAV1;ICAM1;SMAD3;B4GALT1;KRT34;VEGFA;NRARP;DKK1;BTG1;CEBPB;ADM;ERRFI1;CREB1;GORAB;RUNX1;TGFBR2;SMURF2;WNT5A;VEGFC;DUSP10;SOX4;PDGFB;IL20;NRG1;TNC;SPRY2;RHCG;WNT7B;SMAD1;CLIC4;CAV1;VEZF1;NOM1;ABI1;EFNB2;SPRR2A;PML;ADAM9;RELA;TRIM16;GSK3B;LCE1C;VIM;RIPK4;DDR1;XBP1
363,GO:0000981,2.80465969718552e-09,1,70,713,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,IRF1;BTG2;FOSL1;ELF3;PRDM1;TBX3;EHF;MAFF;NFKB1;JUN;ETS1;BHLHE40;ZNF267;KLF6;IRF6;REL;PLAGL2;ETS2;CSRNP1;NFKB2;RFX5;ZFP36L1;SIX4;THAP10;JUNB;RELB;ZNF217;ZNF451;ELMSAN1;SMAD3;DLX2;ARNTL2;ZBED2;KLF7;CEBPB;CEBPD;CREB1;TAF4B;NR4A2;BACH1;MYBL1;RUNX1;NFE2L3;SOX4;ATF3;POU2F2;NFE2L2;SMAD1;MXD1;NFAT5;STAT5A;VEZF1;ZNFX1;TP53;ELK3;SNAPC4;ZNF148;RELA;FOXN2;NR4A3;PPARD;PARP1;MXD3;CRAMP1;CREB5;XBP1;ZBTB5;ELF4;TFE3;JUND
733,GO:0001959,2.81127019377842e-09,0.999999999480207,24,128,regulation of cytokine-mediated signaling pathway,BP,TNFAIP3;TNF;BIRC3;IL1RN;EDN1;IFNAR2;TRAF1;CSF1;BIRC2;IFNGR2;IL6;RIPK2;IRAK2;CYLD;IL1R2;IFNAR1;RUNX1;IFNGR1;WNT5A;OTUD4;PTPN1;CAV1;AXL;IL36RN
12613,GO:0050776,2.98883182845916e-09,1,59,584,regulation of immune response,BP,IL1B;NFKBIA;TNFAIP3;TNF;IRF1;BIRC3;ZC3H12A;NFKB1;TNIP1;JUN;TICAM1;IFNAR2;EREG;IL23A;PELI1;BIRC2;IFNGR2;IL6;ADAM8;RIPK2;IRAK2;CYLD;RELB;IL7R;NOD2;IL6ST;ICAM1;SMAD3;CD55;IFNAR1;RUNX1;IFNGR1;WNT5A;DUSP10;PGLYRP4;IFIH1;OTUD4;IL4R;GCSAM;BTN2A2;PTPN1;TAB3;CAV1;HLA-A;TNIP2;TLR2;ABI1;HLA-B;IKBKE;UBE2D3;CD276;ADGRE2;RELA;MUC1;HLA-F;NR4A3;HLA-E;XBP1;CFB
5938,GO:0018212,3.16707868722254e-09,1,34,235,peptidyl-tyrosine modification,BP,CSF2;HBEGF;EFNA1;LIF;MAP2K3;EPHA2;EREG;IL23A;IL6;RIPK2;ITGA5;RAP2B;IL6ST;ICAM1;VEGFA;FGF5;ABL2;ERRFI1;VEGFC;TGFA;PDGFB;IL20;NRG1;IL24;PTPN1;STAT5A;TPST1;CAV1;TP53;ABI1;CLK4;AXL;FRK;DDR1
13716,GO:0060255,3.19897116861156e-09,1,274,4571,regulation of macromolecule metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;ZNF267;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;RFX5;ZFP36L1;TNFSF15;SIX4;RIPK2;IRAK2;THAP10;PHLDA2;JUNB;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;RELB;ZNF217;C1QTNF1;CDKN1A;CCDC85B;ITGA5;RAP2B;IL7R;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;NOD2;ELMSAN1;IL6ST;DCUN1D3;SAV1;TFPI2;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;RNF144B;NFKBID;TRAF4;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ZBED2;CFLAR;KLF7;BTG1;ANXA8;IER5;PPP4R4;CEBPB;CEBPD;CD55;NAMPT;ANKLE2;ERRFI1;CREB1;TAF4B;CCNL1;NR4A2;PATL1;VHL;PHKG2;BACH1;ABTB2;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;MASTL;NAB1;ITGB8;WNT5A;VEGFC;TGFA;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;BAZ1A;DUSP8;NRG1;TNC;MMP9;LDLR;ATF3;OTUD4;IKZF2;CAB39;TLE1;PLK3;CHD2;ARRDC4;SLC9A1;ZBTB10;RCHY1;YAF2;SPRY2;TNKS1BP1;GRB7;NUP153;NEDD4;MMD;POU2F2;IL24;TNFRSF6B;NFE2L2;PTPN1;WNT7B;SMAD1;TAB3;MXD1;CHD4;ZC3H7B;NFAT5;STAT5A;CAV1;VEZF1;SH3RF2;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;ABI1;STK40;TAPBP;ITGAV;UBE2D3;CD276;ELK3;SNAPC4;ABCA7;CLK4;SDR16C5;ZNF148;PML;PIM1;ADAM9;RELA;TRIM16;ESCO2;FOXN2;CCBE1;PPP6R3;PLAT;MUC1;AXL;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;CREB5;EGLN1;RIPK4;ZXDA;RPS6KA6;DDR1;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;CFB;JUND;DENND4A
7072,GO:0030855,3.3706748472605e-09,1,49,436,epithelial cell differentiation,BP,IL1B;TNF;ELF3;BMP2;LIF;PRDM1;TBX3;EHF;MAFF;ZFP36;JUN;KDM6B;EPHA2;SPRR2D;IRF6;EREG;ZFP36L1;CYP27B1;TJP2;CDKN1A;CLDN1;SAV1;ICAM1;SMAD3;B4GALT1;KRT34;VEGFA;BTG1;CEBPB;ERRFI1;CREB1;RUNX1;WNT5A;SOX4;PDGFB;IL20;NRG1;RHCG;WNT7B;CLIC4;CAV1;VEZF1;SPRR2A;ADAM9;TRIM16;GSK3B;LCE1C;VIM;XBP1
12809,GO:0051090,4.11005034252596e-09,1,39,304,regulation of DNA binding transcription factor activity,BP,IL1B;NFKBIA;TNFAIP3;TNF;FOSL1;ZC3H12A;NFKB1;EDN1;JUN;TICAM1;TRAF1;BHLHE40;NFKBIE;PELI1;IL6;NFKB2;ADAM8;RIPK2;IRAK2;CYLD;NOD2;SAV1;SGK1;ICAM1;NFKBIB;NFKBID;TRIB1;VEGFA;CFLAR;TRIM25;WNT5A;TAB3;TLR2;PIM1;RELA;MED13;JMY;EGLN1;RIPK4
7319,GO:0031324,4.13120664713823e-09,1,137,1891,negative regulation of cellular metabolic process,BP,IL1B;TNFAIP3;CSF2;TNF;IRF1;HBEGF;EFNA1;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;NCOA7;ZC3H12A;PPP1R15A;ELF3;BMP2;LIF;PLAUR;PRDM1;TBX3;PTX3;NFKB1;PPIF;TNIP1;EDN1;ZFP36;SERPINB2;JUN;SQSTM1;BHLHE40;EREG;REL;DUSP1;BCL3;GADD45A;BIRC2;IL6;ETS2;NFKB2;TNFRSF10B;BDKRB1;N4BP1;RFX5;ZFP36L1;CYP27B1;SIX4;JUNB;FZD8;TNFAIP8;RELB;ZNF217;CDKN1A;CCDC85B;CPEB2;ZNF451;NEDD4L;TFPI2;SMAD3;DLX2;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;CFLAR;ANXA8;PPP4R4;CEBPB;CD55;ANKLE2;ERRFI1;CREB1;NR4A2;VHL;SOGA1;BACH1;SMURF2;DUSP16;TGIF2;NFE2L3;MASTL;NAB1;WNT5A;DUSP10;SOX4;SERPINB1;SOCS2;PDGFB;DUSP8;NRG1;MMP9;ATF3;IKZF2;TLE1;PLK3;YAF2;SPRY2;FEZ1;GRB7;NUP153;NEDD4;TNFRSF6B;BTN2A2;PTPN1;SMAD1;TAB3;MXD1;CHD4;ZC3H7B;CAV1;SH3RF2;TP53;KLF3;ITGAV;UBE2D3;ELK3;ABCA7;SDR16C5;ZNF148;PML;RELA;PLAT;MUC1;FRK;NR4A3;GSK3B;PPARD;PARP1;MXD3;EGLN1;RPS6KA6;QKI;ZBTB5;JUND
15212,GO:0071347,4.36396650513268e-09,0.999999999186827,23,129,cellular response to interleukin-1,BP,CXCL8;IL1B;NFKBIA;IL1A;CCL20;ZC3H12A;IL1RN;NFKB1;EDN1;SQSTM1;PELI1;IL6;RIPK2;IRAK2;NOD2;ICAM1;IL1R2;MAP3K8;CEBPB;OTUD4;TAB3;TNIP2;RELA
7343,GO:0031349,4.82825844468336e-09,1,38,302,positive regulation of defense response,BP,IL1B;NFKBIA;TNFAIP3;TNF;IRF1;BIRC3;NFKB1;TNIP1;TICAM1;ETS1;EREG;IL23A;PELI1;BIRC2;IL6;ADAM8;RIPK2;IRAK2;CYLD;RELB;NOD2;IL6ST;CD47;WNT5A;PGLYRP4;IFIH1;LDLR;OTUD4;TAB3;CAV1;TNIP2;TLR2;IKBKE;UBE2D3;RELA;MUC1;HLA-E;OSMR
16505,GO:0097190,4.85611361809146e-09,1,50,470,apoptotic signaling pathway,BP,IL1B;TNFAIP3;CSF2;TNF;IL1A;INHBA;PLEKHF1;PPP1R15A;PLAUR;SOD2;PMAIP1;PPIF;G0S2;JUN;TICAM1;EPHA2;TRAF1;BBC3;BCL3;PLAGL2;TNFRSF10B;CYLD;CDKN1A;CTSC;RELT;ICAM1;SMAD3;CFLAR;CEBPB;TP53BP2;NR4A2;MMP9;ATF3;BCL2L2;TNFRSF6B;NFE2L2;PTPN1;CAV1;UACA;TP53;ITGAV;IKBKE;PML;RELA;MUC1;GSK3B;PPARD;PARP1;JMY;XBP1
12430,GO:0048869,5.01230760827594e-09,1,181,2681,cellular developmental process,BP,IL1B;NFKBIA;CSF2;TNF;IRF1;IL1A;EFNA1;SDC4;BTG2;INHBA;NOCT;ZC3H12A;ELF3;BMP2;LIF;CD83;PRDM1;TBX3;EHF;MAFF;NFKB1;EDN1;ZFP36;JUN;KDM6B;EPHA2;EHD1;ETS1;SQSTM1;CSF1;SPRR2D;KLF6;IRF6;EREG;IL23A;BCL3;EFNB1;BIRC2;IL6;ETS2;NFKB2;ADAM8;ZFP36L1;CYP27B1;SIX4;RIPK2;JUNB;PHLDB2;CYLD;FZD8;BAMBI;TJP2;RELB;STEAP4;CDKN1A;CLDN1;CCDC85B;ITGA5;ABCA5;IL7R;TNFAIP2;NEDD4L;IL6ST;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;DLX2;RND3;NFKBID;TRIB1;KRT34;VEGFA;FGD6;NRARP;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;ABL2;LAMB3;CFLAR;KLF7;BTG1;CEBPB;ADM;CDC42EP4;ERRFI1;CREB1;TAF4B;NR4A2;VHL;SEMA4B;ABTB2;MYBL1;RUNX1;TGFBR2;MREG;TGIF2;NAB1;WNT5A;VEGFC;SLC11A2;NOTCH2NL;DUSP10;ROBO4;SOX4;SOCS2;PDGFB;IL20;ANLN;NRG1;TNC;MMP9;LDLR;ATF3;COL12A1;CHD2;PARD6B;SUCO;SLC9A1;SPRY2;FEZ1;GRB7;IL4R;NEDD4;MMD;RHCG;POU2F2;ITSN2;NFE2L2;WNT7B;SMAD1;SPTBN5;CLIC4;CAV1;VEZF1;RHOV;TP53;NOM1;TLR2;ABI1;EFNB2;ITGAV;ELK3;SPRR2A;SNAPC4;PML;ADAM9;RELA;RAPH1;TRIM16;ESCO2;SPATA2;FOXN2;EVI2B;COL27A1;AXL;FRK;NR4A3;GSK3B;KMT2E;PPARD;PARP1;CYP24A1;LAMA3;LCE1C;COL8A1;VIM;DDR1;XBP1;QKI;EPB41L3;KCTD11;ELF4;TFE3;C12ORF29;JUND;GJC1
12867,GO:0051172,5.06264324734453e-09,1,130,1776,negative regulation of nitrogen compound metabolic process,BP,IL1B;TNFAIP3;CSF2;TNF;IRF1;HBEGF;EFNA1;BTG2;INHBA;BIRC3;NOCT;NCOA7;ZC3H12A;PPP1R15A;ELF3;BMP2;LIF;PLAUR;PRDM1;TBX3;PTX3;NFKB1;PPIF;TNIP1;EDN1;ZFP36;SERPINB2;JUN;SQSTM1;BHLHE40;EREG;REL;DUSP1;BCL3;GADD45A;BIRC2;IL6;ETS2;NFKB2;TNFRSF10B;BDKRB1;N4BP1;RFX5;ZFP36L1;SIX4;JUNB;FZD8;TNFAIP8;RELB;ZNF217;CDKN1A;CCDC85B;CPEB2;ZNF451;NEDD4L;TFPI2;SMAD3;DLX2;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;ANXA8;PPP4R4;CEBPB;CD55;ERRFI1;CREB1;NR4A2;VHL;BACH1;SMURF2;DUSP16;TGIF2;NFE2L3;MASTL;NAB1;WNT5A;DUSP10;SOX4;SERPINB1;SOCS2;PDGFB;DUSP8;NRG1;MMP9;LDLR;ATF3;IKZF2;TLE1;PLK3;YAF2;SPRY2;GRB7;NUP153;NEDD4;TNFRSF6B;PTPN1;SMAD1;MXD1;CHD4;ZC3H7B;CAV1;SH3RF2;TP53;KLF3;ITGAV;UBE2D3;ELK3;ABCA7;SDR16C5;ZNF148;PML;RELA;PLAT;MUC1;FRK;NR4A3;GSK3B;PPARD;PARP1;MXD3;EGLN1;RPS6KA6;QKI;ZBTB5;JUND
3259,GO:0006928,5.32106450660908e-09,1,104,1272,movement of cell or subcellular component,BP,CXCL8;IL1B;CXCL2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;CCL20;ZC3H12A;CXCL5;IL16;BMP2;SOD2;EDN1;MAP2K3;JUN;EPHA2;ETS1;CSF1;EREG;IL23A;EFNB1;IL6;ADAM8;TNFRSF10B;BDKRB1;SIX4;PHLDA2;PHLDB2;BAMBI;AMOTL2;ITGA5;RAP2B;NAV3;NEDD4L;SGK1;ICAM1;SMAD3;B4GALT1;RND3;TRIB1;VEGFA;ZSWIM4;PLK2;ABL2;KLF7;BTG1;CREB1;NEDD9;NR4A2;CD47;SEMA4B;TGFBR2;SMURF2;SAA1;KIF3C;WNT5A;VEGFC;DUSP10;ROBO4;PDGFB;ANLN;NRG1;MMP9;PARD6B;SLC9A1;SPRY2;FEZ1;GRB7;CXCL16;GCSAM;IL24;NFE2L2;SPTBN5;CLIC4;STAT5A;CAV1;RHOV;ZFAND5;TP53;EFNB2;ITGAV;DOCK4;ADGRE2;PML;ADAM9;CCBE1;PLAT;AXL;FRK;NR4A3;PPARD;SLC16A1;MMP10;LAMA3;JMY;VIM;DDR1;XBP1;GJC1
2595,GO:0005887,5.32494106678861e-09,1,71,741,integral component of plasma membrane,CC,TNF;HBEGF;EFNA1;SDC4;BMP2;PLAUR;CD83;HCAR3;IFNAR2;EPHA2;EREG;EFNB1;BIRC2;IFNGR2;IL6;ADAM8;TNFRSF10B;BDKRB1;TNFSF15;STEAP4;C1QTNF1;CLDN1;ITGA5;IL6ST;RELT;ICAM1;TM4SF1;SLC6A14;RNF43;CD55;KCNJ15;SLC28A3;IFNAR1;SLC7A2;CD47;TGFBR2;IFNGR1;ITGB8;SLC11A2;TGFA;SLC52A3;CD82;NRG1;SLC38A2;LDLR;DCBLD2;RHD;TRPV3;SLC9A1;IL4R;MMD;RHCG;SLC2A6;TNFRSF6B;SGMS2;CAV1;TLR2;EFNB2;ITGAV;PRRG1;STX1A;HS3ST3B1;EVI2B;TSPAN13;MUC1;AXL;SLC16A13;OSMR;SLC16A1;DDR1;SLC39A14
4861,GO:0014070,5.55347015721413e-09,1,63,638,response to organic cyclic compound,BP,IL1B;NFKBIA;TNF;BTG2;INHBA;FOSL1;ZC3H12A;BMP2;CD83;PMAIP1;IL1RN;NFKB1;EDN1;ZFP36;JUN;TICAM1;ETS1;DUSP1;PELI1;BIRC2;IL6;PANX1;ZFP36L1;CYP27B1;RIPK2;JUNB;CDKN1A;CLDN1;NOD2;ICAM1;SMAD3;CFLAR;CEBPB;NAMPT;ADM;ERRFI1;NR4A2;RUNX1;TGFBR2;TRIM25;HMGCS1;SOCS2;PDGFB;IFIH1;TNC;SLC9A1;NEDD4;WNT7B;SMAD1;ZC3H7B;CAV1;TP53;TLR2;PIM1;ADAM9;RELA;NR4A3;PPARD;SLC16A1;PARP1;CYP24A1;MED13;JUND
6702,GO:0030097,5.9416851661993e-09,1,58,590,hemopoiesis,BP,NFKBIA;CSF2;TNF;IRF1;INHBA;LIF;CD83;PRDM1;ZFP36;JUN;EPHA2;ETS1;CSF1;KLF6;IL23A;BCL3;IL6;ADAM8;ZFP36L1;RIPK2;JUNB;CYLD;FZD8;TJP2;RELB;IL7R;NFKBID;TRIB1;VEGFA;NRARP;CDKN2B;CEBPB;CREB1;RUNX1;TGFBR2;WNT5A;SLC11A2;DUSP10;SOX4;IL20;ANLN;MMP9;CHD2;IL4R;POU2F2;NFE2L2;TLR2;ABI1;PML;ESCO2;EVI2B;AXL;NR4A3;KMT2E;PARP1;XBP1;TFE3;C12ORF29
12263,GO:0048534,6.00934032063831e-09,1,60,619,hematopoietic or lymphoid organ development,BP,NFKBIA;CSF2;TNF;IRF1;INHBA;LIF;CD83;PRDM1;ZFP36;JUN;EPHA2;ETS1;CSF1;KLF6;IL23A;BCL3;IL6;NFKB2;ADAM8;ZFP36L1;SIX4;RIPK2;JUNB;CYLD;FZD8;TJP2;RELB;IL7R;NFKBID;TRIB1;VEGFA;NRARP;CDKN2B;CEBPB;CREB1;RUNX1;TGFBR2;WNT5A;SLC11A2;DUSP10;SOX4;IL20;ANLN;MMP9;CHD2;IL4R;POU2F2;NFE2L2;TLR2;ABI1;PML;ESCO2;EVI2B;AXL;NR4A3;KMT2E;PARP1;XBP1;TFE3;C12ORF29
12869,GO:0051174,6.60237780237907e-09,1,99,1206,regulation of phosphorus metabolic process,BP,IL1B;TNFAIP3;CSF2;TNF;HBEGF;IL1A;EFNA1;SDC4;INHBA;PLEKHF1;CCL20;ZC3H12A;PPP1R15A;BMP2;LIF;PLAUR;PPIF;TNIP1;EDN1;MAP2K3;JUN;EPHA2;SQSTM1;CSF1;EREG;IL23A;DUSP1;GADD45A;IL6;ADAM8;TNFRSF10B;BDKRB1;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;NOD2;IL6ST;ICAM1;SMAD3;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;MAP3K8;CFLAR;PPP4R4;ANKLE2;ADM;ERRFI1;CCNL1;TGFBR2;DUSP16;SAA1;MASTL;WNT5A;VEGFC;TGFA;DUSP10;PPP1R3B;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;LDLR;ATF3;CAB39;SPRY2;TNKS1BP1;NUP153;MMD;IL24;PTPN1;WNT7B;TAB3;CAV1;SH3RF2;TP53;ABI1;STK40;PDP1;ITGAV;ABCA7;PML;ADAM9;PPP6R3;AXL;GSK3B;PARP1;EGLN1;RPS6KA6;DDR1
6075,GO:0019220,7.5344027384916e-09,1,98,1193,regulation of phosphate metabolic process,BP,IL1B;TNFAIP3;CSF2;TNF;HBEGF;IL1A;EFNA1;SDC4;INHBA;PLEKHF1;CCL20;ZC3H12A;PPP1R15A;BMP2;LIF;PLAUR;PPIF;TNIP1;EDN1;MAP2K3;JUN;EPHA2;SQSTM1;CSF1;EREG;IL23A;DUSP1;GADD45A;IL6;ADAM8;TNFRSF10B;BDKRB1;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;NOD2;IL6ST;ICAM1;SMAD3;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;MAP3K8;CFLAR;PPP4R4;ANKLE2;ADM;ERRFI1;CCNL1;TGFBR2;DUSP16;SAA1;MASTL;WNT5A;VEGFC;TGFA;DUSP10;PPP1R3B;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;LDLR;ATF3;CAB39;SPRY2;TNKS1BP1;NUP153;MMD;IL24;PTPN1;WNT7B;TAB3;CAV1;SH3RF2;TP53;ABI1;STK40;ITGAV;ABCA7;PML;ADAM9;PPP6R3;AXL;GSK3B;PARP1;EGLN1;RPS6KA6;DDR1
12590,GO:0050731,7.88995773676344e-09,0.999999998632239,21,104,positive regulation of peptidyl-tyrosine phosphorylation,BP,CSF2;HBEGF;EFNA1;LIF;EREG;IL23A;IL6;RIPK2;ITGA5;IL6ST;ICAM1;VEGFA;VEGFC;TGFA;PDGFB;IL20;NRG1;IL24;PTPN1;TP53;ABI1
7932,GO:0032502,8.2001324079277e-09,1,242,3899,developmental process,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;NOCT;FOSL1;ZC3H12A;ELF3;BMP2;LIF;CD83;SOD2;PRDM1;TBX3;EHF;IL1RN;MAFF;NFKB1;IER3;EDN1;ZFP36;JUN;KDM6B;EPHA2;EHD1;ETS1;SQSTM1;CSF1;N4BP3;ZNF267;SPRR2D;KLF6;IRF6;EREG;IL23A;DUSP1;BCL3;PLAGL2;EFNB1;BIRC2;IL6;ETS2;CSRNP1;NFKB2;ADAM8;TNFRSF10B;ZFP36L1;CYP27B1;SIX4;RIPK2;PHLDA2;JUNB;PHLDB2;CYLD;FZD8;BAMBI;TJP2;RELB;ZNF217;STEAP4;AMOTL2;CDKN1A;CLDN1;FJX1;CCDC85B;ITGA5;ABCA5;IL7R;NAV3;ODC1;TNFAIP2;NEDD4L;CTSC;IL6ST;RELT;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;DLX2;B3GNT5;RND3;NFKBID;NINJ1;TRAF4;TRIB1;KRT34;VEGFA;FGD6;NRARP;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;ABL2;LAMB3;CFLAR;TXNRD1;KLF7;BTG1;CEBPB;VMP1;ANKLE2;ADM;GJB3;CDC42EP4;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;NR4A2;VHL;SEMA4B;ABTB2;MYBL1;RUNX1;TGFBR2;MREG;SMURF2;TGIF2;MTURN;NAB1;ITGB8;HMGCS1;WNT5A;VEGFC;SLC11A2;NOTCH2NL;DUSP10;ROBO4;SOX4;SOCS2;PDGFB;IL20;ANLN;NRG1;TNC;SLC38A2;MMP9;LDLR;ATF3;COL12A1;TLE1;CHD2;PARD6B;SUCO;SLC9A1;SPRY2;FEZ1;GRB7;BCL2L2;IL4R;NEDD4;MMD;RHCG;POU2F2;ITSN2;TNFRSF6B;NFE2L2;WNT7B;SMAD1;SPTBN5;MXD1;TPRA1;DIEXF;CLIC4;STAT5A;CAV1;VEZF1;RHOV;RTTN;UGCG;ZFAND5;TP53;NOM1;KLF3;TLR2;ABI1;STK40;EFNB2;ITGAV;ELK3;JPH2;SPRR2A;SNAPC4;ZNF148;PML;PIM1;ADAM9;RELA;RAPH1;TRIM16;ESCO2;SPATA2;FOXN2;CCBE1;EVI2B;COL27A1;CHST2;AXL;SAT1;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;EVC;PARP1;CYP24A1;LAMA3;KDM7A;LCE1C;COL8A1;VIM;EGLN1;RIPK4;RPS6KA6;DDR1;XBP1;QKI;EPB41L3;KCTD11;ELF4;TFE3;ERVFRD-1;C12ORF29;JUND;GJC1
4766,GO:0010942,8.8031673147442e-09,1,52,498,positive regulation of cell death,BP,TNF;INHBA;PLEKHF1;FOSL1;ZC3H12A;BMP2;PLAUR;PMAIP1;PPIF;G0S2;JUN;HCAR2;SQSTM1;BBC3;DUSP1;GADD45A;PLAGL2;IL6;ADAM8;TNFRSF10B;TNFSF15;RIPK2;CYLD;TNFAIP8;CDKN1A;CTSC;DCUN1D3;SAV1;SMAD3;B4GALT1;NFKBID;ARHGEF3;DKK1;CFLAR;BTG1;TP53BP2;ADM;CREB1;WNT5A;SOX4;MMP9;ATF3;SLC9A1;CAV1;TP53;EFNB2;UBE2Z;PML;NR4A3;GSK3B;PARP1;JMY
710,GO:0001932,8.90443712306831e-09,1,82,938,regulation of protein phosphorylation,BP,IL1B;TNFAIP3;CSF2;TNF;HBEGF;IL1A;EFNA1;SDC4;INHBA;CCL20;ZC3H12A;BMP2;LIF;PLAUR;TNIP1;EDN1;MAP2K3;JUN;EPHA2;SQSTM1;CSF1;EREG;IL23A;DUSP1;GADD45A;IL6;ADAM8;TNFRSF10B;BDKRB1;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;NOD2;IL6ST;ICAM1;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;MAP3K8;CFLAR;ERRFI1;CCNL1;TGFBR2;DUSP16;SAA1;WNT5A;VEGFC;TGFA;DUSP10;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;ATF3;CAB39;SPRY2;TNKS1BP1;MMD;IL24;PTPN1;WNT7B;TAB3;CAV1;TP53;ABI1;STK40;ITGAV;ABCA7;PML;ADAM9;AXL;RPS6KA6;DDR1
12420,GO:0048856,9.27490470278043e-09,1,228,3616,anatomical structure development,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;NOCT;FOSL1;ZC3H12A;ELF3;BMP2;LIF;CD83;PRDM1;TBX3;EHF;IL1RN;MAFF;IER3;EDN1;ZFP36;JUN;KDM6B;EPHA2;EHD1;ETS1;CSF1;N4BP3;ZNF267;SPRR2D;KLF6;IRF6;EREG;IL23A;DUSP1;BCL3;PLAGL2;EFNB1;BIRC2;IL6;ETS2;CSRNP1;NFKB2;ADAM8;TNFRSF10B;ZFP36L1;CYP27B1;SIX4;RIPK2;PHLDA2;JUNB;PHLDB2;CYLD;FZD8;BAMBI;TJP2;RELB;ZNF217;AMOTL2;CDKN1A;CLDN1;FJX1;ITGA5;IL7R;NAV3;ODC1;TNFAIP2;NEDD4L;IL6ST;RELT;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;DLX2;B3GNT5;RND3;NFKBID;NINJ1;TRAF4;TRIB1;KRT34;VEGFA;FGD6;NRARP;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;ABL2;LAMB3;CFLAR;TXNRD1;KLF7;BTG1;CEBPB;VMP1;ANKLE2;ADM;GJB3;CDC42EP4;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;NR4A2;VHL;SEMA4B;ABTB2;RUNX1;TGFBR2;SMURF2;TGIF2;MTURN;NAB1;ITGB8;HMGCS1;WNT5A;VEGFC;SLC11A2;NOTCH2NL;DUSP10;ROBO4;SOX4;SOCS2;PDGFB;IL20;ANLN;NRG1;TNC;SLC38A2;MMP9;LDLR;ATF3;COL12A1;TLE1;CHD2;PARD6B;SUCO;SLC9A1;SPRY2;FEZ1;GRB7;BCL2L2;IL4R;NEDD4;MMD;RHCG;POU2F2;ITSN2;TNFRSF6B;NFE2L2;WNT7B;SMAD1;SPTBN5;MXD1;TPRA1;DIEXF;CLIC4;STAT5A;CAV1;VEZF1;RHOV;RTTN;UGCG;ZFAND5;TP53;NOM1;KLF3;TLR2;ABI1;STK40;EFNB2;ITGAV;ELK3;JPH2;SPRR2A;ZNF148;PML;PIM1;ADAM9;RELA;RAPH1;TRIM16;ESCO2;SPATA2;FOXN2;CCBE1;EVI2B;COL27A1;CHST2;AXL;SAT1;NR4A3;GSK3B;KMT2E;PPARD;EVC;PARP1;LAMA3;KDM7A;LCE1C;COL8A1;VIM;EGLN1;RIPK4;RPS6KA6;DDR1;XBP1;QKI;EPB41L3;KCTD11;TFE3;ERVFRD-1;C12ORF29;JUND;GJC1
1023,GO:0002520,9.90296056166605e-09,1,62,656,immune system development,BP,NFKBIA;TNFAIP3;CSF2;TNF;IRF1;INHBA;LIF;CD83;PRDM1;ZFP36;JUN;EPHA2;ETS1;CSF1;KLF6;IL23A;BCL3;IL6;NFKB2;ADAM8;ZFP36L1;SIX4;RIPK2;JUNB;CYLD;FZD8;TJP2;RELB;IL7R;SMAD3;NFKBID;TRIB1;VEGFA;NRARP;CDKN2B;CEBPB;CREB1;RUNX1;TGFBR2;WNT5A;SLC11A2;DUSP10;SOX4;IL20;ANLN;MMP9;CHD2;IL4R;POU2F2;NFE2L2;TLR2;ABI1;PML;ESCO2;EVI2B;AXL;NR4A3;KMT2E;PARP1;XBP1;TFE3;C12ORF29
12588,GO:0050729,1.00807543575489e-08,0.999999998745535,16,64,positive regulation of inflammatory response,BP,IL1B;NFKBIA;TNF;TNIP1;TICAM1;ETS1;IL23A;IL6;ADAM8;NOD2;IL6ST;CD47;WNT5A;LDLR;TLR2;OSMR
18689,GO:1904018,1.02472869482102e-08,0.999999998102309,22,112,positive regulation of vasculature development,BP,CXCL8;IL1B;IL1A;ZC3H12A;ETS1;ITGA5;VEGFA;PLK2;CFLAR;BTG1;ADM;RUNX1;TGFBR2;ITGB8;WNT5A;VEGFC;PDGFB;NFE2L2;SMAD1;EFNB2;CCBE1;XBP1
18080,GO:1902624,1.02984191689758e-08,0.999999999615021,9,18,positive regulation of neutrophil migration,BP,CXCL8;CXCL2;CXCL3;CXCL1;IL1A;CXCL5;EDN1;IL23A;ADAM8
5906,GO:0018108,1.05009270506357e-08,0.999999997725571,33,232,peptidyl-tyrosine phosphorylation,BP,CSF2;HBEGF;EFNA1;LIF;MAP2K3;EPHA2;EREG;IL23A;IL6;RIPK2;ITGA5;RAP2B;IL6ST;ICAM1;VEGFA;FGF5;ABL2;ERRFI1;VEGFC;TGFA;PDGFB;IL20;NRG1;IL24;PTPN1;STAT5A;CAV1;TP53;ABI1;CLK4;AXL;FRK;DDR1
1099,GO:0002685,1.05454287051359e-08,0.999999998229509,20,101,regulation of leukocyte migration,BP,CXCL8;CXCL2;TNF;CXCL3;CXCL1;IL1A;CCL20;CXCL5;EDN1;CSF1;IL23A;IL6;ADAM8;BDKRB1;ICAM1;VEGFA;WNT5A;VEGFC;GCSAM;TP53
14829,GO:0070555,1.07312690949059e-08,0.999999997797771,24,145,response to interleukin-1,BP,CXCL8;IL1B;NFKBIA;IL1A;CCL20;ZC3H12A;IL1RN;NFKB1;EDN1;ETS1;SQSTM1;PELI1;IL6;RIPK2;IRAK2;NOD2;ICAM1;IL1R2;MAP3K8;CEBPB;OTUD4;TAB3;TNIP2;RELA
6962,GO:0030595,1.09299484541653e-08,0.999999998156845,20,103,leukocyte chemotaxis,BP,CXCL8;IL1B;CXCL2;CXCL3;CXCL1;CCL20;CXCL5;IL16;EDN1;CSF1;IL23A;IL6;ADAM8;VEGFA;SAA1;WNT5A;VEGFC;PDGFB;CXCL16;ADGRE2
4371,GO:0009986,1.14440448088052e-08,1,44,374,cell surface,CC,TNF;HBEGF;PLAU;SDC4;BMP2;PLAUR;CD83;EPHA2;ADAM8;TNFRSF10B;ITGA5;IL7R;NOD2;IL6ST;ICAM1;B4GALT1;VEGFA;LAYN;CD55;TGFBR2;ITGB8;WNT5A;SLC11A2;TGFA;PDGFB;NRG1;LDLR;DCBLD2;SLC9A1;BTN2A2;CLIC4;HLA-A;TLR2;HLA-B;ITGAV;CD276;ABCA7;ADAM9;PLAT;AXL;ANXA5;HLA-F;HLA-E;CLDND1
12542,GO:0050673,1.16184846228047e-08,0.999999997383044,35,258,epithelial cell proliferation,BP,TNFAIP3;TNF;BMP2;EHF;ZFP36;JUN;EPHA2;IRF6;EREG;ZFP36L1;SIX4;NOD2;SAV1;SMAD3;B4GALT1;VEGFA;NRARP;CDKN2B;CFLAR;CEBPB;ERRFI1;WNT5A;VEGFC;TGFA;DUSP10;PDGFB;BCL2L2;STAT5A;CAV1;EFNB2;SDR16C5;NR4A3;PPARD;COL8A1;XBP1
10916,GO:0044459,1.26371161227317e-08,1,114,1456,plasma membrane part,CC,TNF;HBEGF;EFNA1;SDC4;FOSL1;BMP2;PLAUR;CD83;HCAR3;IFNAR2;EPHA2;EHD1;EREG;EFNB1;BIRC2;IFNGR2;IL6;ADAM8;TNFRSF10B;BDKRB1;TNFSF15;CYLD;FZD8;STEAP4;C1QTNF1;AMOTL2;CLDN1;ITGA5;IL7R;NOD2;IL6ST;RELT;ICAM1;B4GALT1;TM4SF1;SLC6A14;ABL2;CFLAR;RNF43;CD55;KCNJ15;GJB3;SLC28A3;IFNAR1;ERRFI1;GJB4;SLC7A2;CD47;TGFBR2;MREG;IFNGR1;MASTL;ITGB8;SLC11A2;TGFA;SLC52A3;PDGFB;CD82;NRG1;SLC38A2;LDLR;DCBLD2;RHD;PARD6B;TRPV3;SLC9A1;SPRY2;CYTH1;IL4R;NEDD4;MMD;RHCG;SLC2A6;TNFRSF6B;BTN2A2;SGMS2;SPTBN5;CAV1;HLA-A;TLR2;ABI1;EFNB2;HLA-B;ITGAV;PRRG1;GEM;PJA2;STX1A;CD276;TRIP10;ABCA7;ADGRE2;HS3ST3B1;ADAM9;EVI2B;TSPAN13;MUC1;AXL;SLC16A13;ANXA5;CRB3;FRK;HLA-F;HLA-E;OSMR;SLC16A1;EVC;OCLN;DDR1;EPB41L3;SLC39A14;MGAM;SLC41A1;GJC1
12788,GO:0051050,1.26447378950929e-08,1,60,611,positive regulation of transport,BP,IL1B;NFKBIA;TNF;IL1A;SDC4;INHBA;ZC3H12A;PMAIP1;PTX3;EDN1;EHD1;HCAR2;BBC3;PLAGL2;IL6;ADAM8;BDKRB1;PANX1;RIPK2;C1QTNF1;NEDD4L;NOD2;SGK1;VEGFA;TP53BP2;CREB1;CD47;SAA1;WNT5A;VEGFC;SOX4;PDGFB;IFIH1;NRG1;LDLR;PLK3;TRPV3;SLC9A1;FEZ1;IL4R;NEDD4;NFE2L2;CAV1;UGCG;TP53;TLR2;RAB9A;ITGAV;UBE2D3;STX1A;JPH2;ABCA7;ADAM9;TRIM16;AXL;NR4A3;HLA-E;GSK3B;PPARD;XBP1
10511,GO:0043410,1.35806729825863e-08,1,41,336,positive regulation of MAPK cascade,BP,IL1B;TNF;IL1A;EFNA1;CCL20;ZC3H12A;BMP2;LIF;EDN1;MAP2K3;JUN;EPHA2;GADD45A;IL6;ADAM8;TNFRSF10B;RIPK2;IRAK2;FZD8;C1QTNF1;NOD2;ICAM1;TRAF4;VEGFA;DKK1;MAP3K8;CFLAR;SAA1;WNT5A;TGFA;PDGFB;NRG1;SPRY2;PTPN1;WNT7B;TAB3;ITGAV;ABCA7;ADAM9;AXL;DDR1
12679,GO:0050870,1.37326670956904e-08,0.999999997399356,22,118,positive regulation of T cell activation,BP,IL1B;CD83;IL23A;EFNB1;IL6;ADAM8;RIPK2;CYLD;IL7R;NOD2;IL6ST;MAP3K8;CD55;CD47;TGFBR2;DUSP10;IL4R;CAV1;EFNB2;CD276;HLA-E;XBP1
16666,GO:0097529,1.54323334766461e-08,0.999999997657627,18,85,myeloid leukocyte migration,BP,CXCL8;IL1B;CXCL2;CXCL3;CXCL1;IL1A;CCL20;CXCL5;EDN1;CSF1;IL23A;IL6;ADAM8;VEGFA;SAA1;VEGFC;PDGFB;ADGRE2
7263,GO:0031226,1.57115536592833e-08,1,72,777,intrinsic component of plasma membrane,CC,TNF;HBEGF;EFNA1;SDC4;BMP2;PLAUR;CD83;HCAR3;IFNAR2;EPHA2;EREG;EFNB1;BIRC2;IFNGR2;IL6;ADAM8;TNFRSF10B;BDKRB1;TNFSF15;STEAP4;C1QTNF1;CLDN1;ITGA5;IL6ST;RELT;ICAM1;TM4SF1;SLC6A14;RNF43;CD55;KCNJ15;SLC28A3;IFNAR1;SLC7A2;CD47;TGFBR2;IFNGR1;ITGB8;SLC11A2;TGFA;SLC52A3;CD82;NRG1;SLC38A2;LDLR;DCBLD2;RHD;TRPV3;SLC9A1;IL4R;MMD;RHCG;SLC2A6;TNFRSF6B;SGMS2;CAV1;TLR2;EFNB2;ITGAV;PRRG1;STX1A;HS3ST3B1;ADAM9;EVI2B;TSPAN13;MUC1;AXL;SLC16A13;OSMR;SLC16A1;DDR1;SLC39A14
2594,GO:0005886,1.63155726461159e-08,1,188,2826,plasma membrane,CC,NFKBIA;TNF;HBEGF;PLAU;EFNA1;SDC4;FOSL1;IL16;BMP2;PLAUR;CD83;IL1RN;HCAR3;SERPINB2;IFNAR2;EPHA2;GPR156;EHD1;HCAR2;CSF1;SPRR2D;EREG;BCL3;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ADAM8;TNFRSF10B;BDKRB1;PANX1;TNFSF15;IRAK2;DAPP1;PHLDB2;CYLD;FZD8;BAMBI;TJP2;STEAP4;C1QTNF1;AMOTL2;CLDN1;ITGA5;RAP2B;IL7R;NEDD4L;NOD2;IL6ST;DCUN1D3;RELT;SGK1;ICAM1;SMAD3;B4GALT1;RND3;MARCKSL1;TM4SF1;TRAF4;RAB24;IL1R2;SLC6A14;DKK1;ABL2;CDV3;CFLAR;RNF43;ANXA8;VMP1;CD55;KCNJ15;GJB3;CDC42EP4;SLC28A3;IFNAR1;ERRFI1;GJB4;NEDD9;SLC7A2;CD47;CANT1;SEMA4B;TGFBR2;MREG;SMURF2;GPBP1;IFNGR1;MASTL;ITGB8;WNT5A;CAMK1G;SLC11A2;TGFA;SLC52A3;PDGFB;CD82;NRG1;SLC38A2;LDLR;DCBLD2;RRAD;RHD;ARRDC4;PARD6B;TRPV3;FAM57A;SLC9A1;SPRY2;FEZ1;CYTH1;GRB7;CXCL16;IL4R;NEDD4;MMD;RHCG;SLC2A6;GCSAM;TNFRSF6B;MARCKS;RAET1L;BTN2A2;NFE2L2;PTPN1;WNT7B;SGMS2;TAB3;SPTBN5;CLIC4;CAV1;RHOV;HLA-A;NECAP2;TLR2;ABI1;EFNB2;RAB9A;HLA-B;ITGAV;PRRG1;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;JPH2;SPRR2A;ABCA7;ADGRE2;SDR16C5;HS3ST3B1;PIM1;ADAM9;RAPH1;TRIM16;EMP3;SLC9A8;PPP6R3;EVI2B;TSPAN13;MUC1;AXL;SLC16A13;ANXA5;CRB3;FRK;HLA-F;HLA-E;GSK3B;KMT2E;OSMR;SLC16A1;EVC;CYP24A1;LCE1C;OCLN;VIM;DDR1;EPB41L3;SLC39A14;ERVFRD-1;MGAM;CFB;SLC41A1;GJC1
3626,GO:0008083,2.12972937043783e-08,0.999999997171433,16,68,growth factor activity,MF,CSF2;HBEGF;CXCL1;INHBA;BMP2;LIF;CSF1;EREG;IL6;VEGFA;DKK1;FGF5;VEGFC;TGFA;PDGFB;NRG1
8705,GO:0034341,2.30660116627942e-08,0.999999995456483,22,125,response to interferon-gamma,BP,IRF1;CCL20;EDN1;IRF6;IFNGR2;CYP27B1;CLDN1;GBP2;ICAM1;GCH1;CDC42EP4;TRIM25;IFNGR1;WNT5A;MT2A;CXCL16;HLA-A;HLA-B;PML;HLA-F;HLA-E;VIM
20290,GO:2001233,2.34868257381842e-08,0.999999994397111,37,308,regulation of apoptotic signaling pathway,BP,IL1B;TNFAIP3;CSF2;TNF;IL1A;INHBA;PLEKHF1;PLAUR;SOD2;PMAIP1;PPIF;G0S2;TRAF1;BBC3;PLAGL2;TNFRSF10B;CYLD;CTSC;ICAM1;SMAD3;CFLAR;TP53BP2;NR4A2;MMP9;ATF3;BCL2L2;NFE2L2;PTPN1;CAV1;TP53;ITGAV;PML;RELA;MUC1;GSK3B;PARP1;XBP1
10308,GO:0043068,2.68511538992649e-08,1,49,472,positive regulation of programmed cell death,BP,TNF;INHBA;PLEKHF1;FOSL1;ZC3H12A;BMP2;PLAUR;PMAIP1;PPIF;G0S2;JUN;HCAR2;SQSTM1;BBC3;DUSP1;GADD45A;PLAGL2;IL6;ADAM8;TNFRSF10B;TNFSF15;RIPK2;CYLD;TNFAIP8;CDKN1A;CTSC;DCUN1D3;SAV1;SMAD3;B4GALT1;NFKBID;ARHGEF3;CFLAR;BTG1;TP53BP2;ADM;CREB1;WNT5A;SOX4;MMP9;ATF3;SLC9A1;CAV1;TP53;UBE2Z;PML;NR4A3;GSK3B;JMY
17645,GO:1901342,2.82880683661219e-08,0.999999992746197,29,192,regulation of vasculature development,BP,CXCL8;IL1B;TNFAIP3;IL1A;EFNA1;ZC3H12A;EPHA2;ETS1;IL6;ITGA5;VEGFA;PLK2;CFLAR;BTG1;ADM;RUNX1;TGFBR2;ITGB8;WNT5A;VEGFC;PDGFB;SPRY2;NFE2L2;SMAD1;EFNB2;PML;CCBE1;EGLN1;XBP1
8036,GO:0032675,3.06319923355157e-08,0.999999995849147,16,65,regulation of interleukin-6 production,BP,IL1B;TNFAIP3;TNF;IL1A;ZC3H12A;TICAM1;EREG;IL6;RIPK2;NOD2;CEBPB;WNT5A;IFIH1;TLR2;XBP1;IL36RN
12568,GO:0050707,3.52267132034646e-08,0.999999993953726,19,94,regulation of cytokine secretion,BP,IL1B;TNF;IL1A;ZC3H12A;PANX1;RIPK2;NOD2;IL1R2;SAA1;WNT5A;IFIH1;IL4R;BTN2A2;TLR2;MAPKBP1;PML;TRIM16;XBP1;IL36RN
16798,GO:0098609,3.65950399487166e-08,1,48,445,cell-cell adhesion,BP,IL1B;TNF;IRF1;SDC4;BMP2;CD83;IL1RN;TNIP1;ETS1;IL23A;PELI1;EFNB1;IL6;ADAM8;ZFP36L1;RIPK2;CYLD;C1QTNF1;CLDN1;ITGA5;RAP2B;IL7R;NOD2;IL6ST;ICAM1;NFKBID;SERPINB8;NRARP;MAP3K8;CEBPB;VMP1;CD55;CD47;TGFBR2;WNT5A;DUSP10;IL4R;BTN2A2;WNT7B;CAV1;EFNB2;ITGAV;CD276;ADAM9;CRB3;NR4A3;HLA-E;XBP1
15554,GO:0071944,3.9481842076924e-08,1,190,2898,cell periphery,CC,NFKBIA;TNF;HBEGF;PLAU;EFNA1;SDC4;FOSL1;IL16;BMP2;PLAUR;CD83;IL1RN;HCAR3;SERPINB2;IFNAR2;EPHA2;GPR156;EHD1;HCAR2;CSF1;SPRR2D;EREG;BCL3;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ADAM8;TNFRSF10B;BDKRB1;PANX1;TNFSF15;IRAK2;DAPP1;PHLDB2;CYLD;FZD8;BAMBI;TJP2;STEAP4;C1QTNF1;AMOTL2;CLDN1;ITGA5;RAP2B;IL7R;TNFAIP2;NEDD4L;NOD2;IL6ST;DCUN1D3;RELT;SGK1;ICAM1;SMAD3;B4GALT1;RND3;MARCKSL1;TM4SF1;TRAF4;RAB24;IL1R2;SLC6A14;DKK1;ABL2;CDV3;CFLAR;RNF43;ANXA8;VMP1;CD55;KCNJ15;GJB3;CDC42EP4;SLC28A3;IFNAR1;ERRFI1;GJB4;NEDD9;SLC7A2;CD47;CANT1;SEMA4B;TGFBR2;MREG;SMURF2;GPBP1;IFNGR1;MASTL;ITGB8;WNT5A;CAMK1G;SLC11A2;TGFA;SLC52A3;PDGFB;ANLN;CD82;NRG1;SLC38A2;LDLR;DCBLD2;RRAD;RHD;ARRDC4;PARD6B;TRPV3;FAM57A;SLC9A1;SPRY2;FEZ1;CYTH1;GRB7;CXCL16;IL4R;NEDD4;MMD;RHCG;SLC2A6;GCSAM;TNFRSF6B;MARCKS;RAET1L;BTN2A2;NFE2L2;PTPN1;WNT7B;SGMS2;TAB3;SPTBN5;CLIC4;CAV1;RHOV;HLA-A;NECAP2;TLR2;ABI1;EFNB2;RAB9A;HLA-B;ITGAV;PRRG1;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;JPH2;SPRR2A;ABCA7;ADGRE2;SDR16C5;HS3ST3B1;PIM1;ADAM9;RAPH1;TRIM16;EMP3;SLC9A8;PPP6R3;EVI2B;TSPAN13;MUC1;AXL;SLC16A13;ANXA5;CRB3;FRK;HLA-F;HLA-E;GSK3B;KMT2E;OSMR;SLC16A1;EVC;CYP24A1;LCE1C;OCLN;VIM;DDR1;EPB41L3;SLC39A14;ERVFRD-1;MGAM;CFB;SLC41A1;GJC1
12365,GO:0048731,4.20699297092041e-08,1,191,2946,system development,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;FOSL1;ZC3H12A;ELF3;BMP2;LIF;CD83;PRDM1;TBX3;MAFF;EDN1;ZFP36;JUN;KDM6B;EPHA2;EHD1;ETS1;CSF1;N4BP3;SPRR2D;KLF6;IRF6;EREG;IL23A;BCL3;EFNB1;BIRC2;IL6;ETS2;CSRNP1;NFKB2;ADAM8;ZFP36L1;CYP27B1;SIX4;RIPK2;PHLDA2;JUNB;PHLDB2;CYLD;FZD8;BAMBI;TJP2;RELB;AMOTL2;CDKN1A;CLDN1;FJX1;ITGA5;IL7R;NAV3;ODC1;TNFAIP2;NEDD4L;IL6ST;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;DLX2;B3GNT5;NFKBID;NINJ1;TRAF4;TRIB1;KRT34;VEGFA;NRARP;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;ABL2;CFLAR;KLF7;BTG1;CEBPB;ANKLE2;ADM;GJB3;ERRFI1;ADAMTS1;CREB1;GORAB;NR4A2;SEMA4B;ABTB2;RUNX1;TGFBR2;SMURF2;TGIF2;NAB1;ITGB8;HMGCS1;WNT5A;VEGFC;SLC11A2;DUSP10;ROBO4;SOX4;SOCS2;PDGFB;IL20;ANLN;NRG1;TNC;SLC38A2;MMP9;LDLR;ATF3;COL12A1;TLE1;CHD2;PARD6B;SLC9A1;SPRY2;FEZ1;GRB7;BCL2L2;IL4R;NEDD4;MMD;POU2F2;ITSN2;NFE2L2;WNT7B;SMAD1;SPTBN5;CLIC4;STAT5A;CAV1;VEZF1;ZFAND5;NOM1;TLR2;ABI1;STK40;EFNB2;ITGAV;ELK3;JPH2;SPRR2A;ZNF148;PML;PIM1;ADAM9;RELA;RAPH1;TRIM16;ESCO2;FOXN2;CCBE1;EVI2B;COL27A1;AXL;SAT1;NR4A3;GSK3B;KMT2E;PPARD;EVC;PARP1;KDM7A;LCE1C;COL8A1;VIM;EGLN1;RPS6KA6;DDR1;XBP1;QKI;EPB41L3;KCTD11;TFE3;C12ORF29;GJC1
4387,GO:0010035,4.29696841340374e-08,0.999999989138161,40,348,response to inorganic substance,BP,TNFAIP3;CSF2;TNF;IL1A;FOSL1;ZC3H12A;SOD2;PPIF;EDN1;JUN;KDM6B;ETS1;DUSP1;IL6;JUNB;CLDN1;NEDD4L;ICAM1;GCH1;CFLAR;TXNRD1;CREB1;HMGCS1;WNT5A;SLC11A2;MMP9;MT2A;NEDD4;NFE2L2;CLIC4;CAV1;TP53;ADAM9;RELA;AXL;NR4A3;PARP1;EGLN1;SLC41A1;JUND
401,GO:0001077,4.33590331072456e-08,0.999999989302479,27,171,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,IRF1;FOSL1;ELF3;EHF;JUN;ETS1;KLF6;PLAGL2;NFKB2;SIX4;JUNB;KLF7;CEBPB;CEBPD;CREB1;NR4A2;MYBL1;SOX4;POU2F2;SMAD1;NFAT5;ELK3;RELA;NR4A3;ELF4;TFE3;JUND
874,GO:0002221,4.3663107170546e-08,0.999999991082916,22,123,pattern recognition receptor signaling pathway,BP,NFKBIA;TNFAIP3;IRF1;BIRC3;TNIP1;TICAM1;PELI1;BIRC2;RIPK2;IRAK2;CYLD;NOD2;PGLYRP4;IFIH1;OTUD4;TAB3;CAV1;TNIP2;TLR2;IKBKE;UBE2D3;RELA
4570,GO:0010648,4.94305050192884e-08,1,79,937,negative regulation of cell communication,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;HBEGF;IL1A;EFNA1;INHBA;ZC3H12A;PPP1R15A;BMP2;LIF;PLAUR;SOD2;PRDM1;IL1RN;PPIF;TNIP1;EDN1;TICAM1;EPHA2;EREG;DUSP1;BCL3;IL6;TNFRSF10B;PIM3;CYLD;BAMBI;ZNF451;ICAM1;SMAD3;DLX2;NFKBID;TRIB1;NRARP;IL1R2;DKK1;PLK2;CFLAR;RNF43;ADM;ERRFI1;NR4A2;VHL;TGFBR2;SMURF2;DUSP16;WNT5A;DUSP10;SOCS2;PDGFB;DUSP8;NRG1;MMP9;ATF3;OTUD4;TLE1;SPRY2;BCL2L2;RNF152;NEDD4;NFE2L2;PTPN1;CAV1;ITGAV;MAPKBP1;RELA;MUC1;AXL;GSK3B;MED13;RPS6KA6;DDR1;XBP1;KCTD11;IL36RN
4343,GO:0009892,5.211348436296e-08,1,145,2164,negative regulation of metabolic process,BP,IL1B;TNFAIP3;CSF2;TNF;IRF1;HBEGF;EFNA1;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;NCOA7;ZC3H12A;PPP1R15A;ELF3;BMP2;LIF;PLAUR;PRDM1;TBX3;PTX3;NFKB1;PPIF;TNIP1;EDN1;ZFP36;PNRC1;SERPINB2;JUN;HCAR2;SQSTM1;BHLHE40;EREG;REL;DUSP1;BCL3;GADD45A;BIRC2;IL6;ETS2;NFKB2;TNFRSF10B;BDKRB1;N4BP1;RFX5;ZFP36L1;CYP27B1;SIX4;JUNB;FZD8;TNFAIP8;RELB;ZNF217;CDKN1A;CCDC85B;CPEB2;ZNF451;NEDD4L;TFPI2;SMAD3;DLX2;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;CFLAR;ANXA8;PPP4R4;CEBPB;CD55;ANKLE2;ERRFI1;CREB1;NR4A2;PATL1;VHL;SOGA1;BACH1;SMURF2;DUSP16;TGIF2;PNRC2;NFE2L3;MASTL;NAB1;ITGB8;WNT5A;DUSP10;SOX4;SERPINB1;SOCS2;PDGFB;DUSP8;NRG1;MMP9;LDLR;ATF3;IKZF2;TLE1;PLK3;YAF2;SPRY2;FEZ1;TNKS1BP1;GRB7;NUP153;NEDD4;TNFRSF6B;BTN2A2;PTPN1;SMAD1;TAB3;MXD1;CHD4;ZC3H7B;CAV1;SH3RF2;TP53;KLF3;ITGAV;UBE2D3;ELK3;ABCA7;SDR16C5;ZNF148;PML;RELA;PLAT;MUC1;FRK;NR4A3;GSK3B;PPARD;PARP1;MXD3;VIM;EGLN1;RPS6KA6;QKI;ZBTB5;JUND
13766,GO:0060326,5.3494101699088e-08,0.999999988373936,23,143,cell chemotaxis,BP,CXCL8;IL1B;CXCL2;CXCL3;HBEGF;CXCL1;CCL20;CXCL5;IL16;EDN1;EPHA2;CSF1;IL23A;IL6;ADAM8;VEGFA;SAA1;WNT5A;VEGFC;PDGFB;CXCL16;DOCK4;ADGRE2
10305,GO:0043065,5.60446210549006e-08,1,48,469,positive regulation of apoptotic process,BP,TNF;INHBA;PLEKHF1;FOSL1;ZC3H12A;BMP2;PLAUR;PMAIP1;PPIF;G0S2;JUN;HCAR2;SQSTM1;BBC3;DUSP1;GADD45A;PLAGL2;IL6;ADAM8;TNFRSF10B;TNFSF15;RIPK2;CYLD;TNFAIP8;CTSC;DCUN1D3;SAV1;SMAD3;B4GALT1;NFKBID;ARHGEF3;CFLAR;BTG1;TP53BP2;ADM;CREB1;WNT5A;SOX4;MMP9;ATF3;SLC9A1;CAV1;TP53;UBE2Z;PML;NR4A3;GSK3B;JMY
6653,GO:0023057,5.65763124108516e-08,1,79,940,negative regulation of signaling,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;HBEGF;IL1A;EFNA1;INHBA;ZC3H12A;PPP1R15A;BMP2;LIF;PLAUR;SOD2;PRDM1;IL1RN;PPIF;TNIP1;EDN1;TICAM1;EPHA2;EREG;DUSP1;BCL3;IL6;TNFRSF10B;PIM3;CYLD;BAMBI;ZNF451;ICAM1;SMAD3;DLX2;NFKBID;TRIB1;NRARP;IL1R2;DKK1;PLK2;CFLAR;RNF43;ADM;ERRFI1;NR4A2;VHL;TGFBR2;SMURF2;DUSP16;WNT5A;DUSP10;SOCS2;PDGFB;DUSP8;NRG1;MMP9;ATF3;OTUD4;TLE1;SPRY2;BCL2L2;RNF152;NEDD4;NFE2L2;PTPN1;CAV1;ITGAV;MAPKBP1;RELA;MUC1;AXL;GSK3B;MED13;RPS6KA6;DDR1;XBP1;KCTD11;IL36RN
16667,GO:0097530,5.7408482208331e-08,0.999999993130133,14,56,granulocyte migration,BP,CXCL8;IL1B;CXCL2;CXCL3;CXCL1;IL1A;CCL20;CXCL5;EDN1;CSF1;IL23A;ADAM8;SAA1;ADGRE2
12915,GO:0051248,6.45793346880011e-08,1,74,887,negative regulation of protein metabolic process,BP,IL1B;TNFAIP3;TNF;HBEGF;EFNA1;BTG2;INHBA;BIRC3;NCOA7;ZC3H12A;PPP1R15A;LIF;PLAUR;PTX3;NFKB1;TNIP1;EDN1;ZFP36;SERPINB2;JUN;DUSP1;BCL3;GADD45A;BIRC2;IL6;TNFRSF10B;BDKRB1;N4BP1;ZFP36L1;TNFAIP8;CDKN1A;CPEB2;ZNF451;TFPI2;SMAD3;TRIB1;SERPINB8;VEGFA;IL1R2;DKK1;CDKN2B;ANXA8;PPP4R4;CD55;ERRFI1;DUSP16;MASTL;DUSP10;SOX4;SERPINB1;SOCS2;DUSP8;NRG1;MMP9;LDLR;ATF3;SPRY2;GRB7;NUP153;TNFRSF6B;PTPN1;SMAD1;ZC3H7B;CAV1;SH3RF2;ITGAV;ABCA7;SDR16C5;PML;RELA;PLAT;GSK3B;RPS6KA6;QKI
12533,GO:0050663,6.52601024689443e-08,0.99999998759981,20,107,cytokine secretion,BP,IL1B;TNF;IL1A;ZC3H12A;PANX1;RIPK2;NOD2;IL1R2;SAA1;WNT5A;IFIH1;IL4R;BTN2A2;TLR2;ITGAV;MAPKBP1;PML;TRIM16;XBP1;IL36RN
7999,GO:0032612,6.82943682822354e-08,0.999999991733207,14,55,interleukin-1 production,BP,IL1B;TNFAIP3;CCL20;ZC3H12A;PANX1;RIPK2;NOD2;SMAD3;IL1R2;ERRFI1;SAA1;WNT5A;PML;TRIM16
8012,GO:0032635,7.07342123523344e-08,0.999999989682485,16,69,interleukin-6 production,BP,IL1B;TNFAIP3;TNF;IL1A;ZC3H12A;TICAM1;EREG;IL6;RIPK2;NOD2;CEBPB;WNT5A;IFIH1;TLR2;XBP1;IL36RN
18078,GO:1902622,7.08123340152993e-08,0.999999996368303,9,21,regulation of neutrophil migration,BP,CXCL8;CXCL2;CXCL3;CXCL1;IL1A;CXCL5;EDN1;IL23A;ADAM8
12589,GO:0050730,8.09701073649658e-08,0.999999981267691,24,150,regulation of peptidyl-tyrosine phosphorylation,BP,CSF2;HBEGF;EFNA1;LIF;EREG;IL23A;IL6;RIPK2;ITGA5;RAP2B;IL6ST;ICAM1;VEGFA;ERRFI1;VEGFC;TGFA;PDGFB;IL20;NRG1;IL24;PTPN1;CAV1;TP53;ABI1
9959,GO:0042325,9.44207356983757e-08,1,85,1039,regulation of phosphorylation,BP,IL1B;TNFAIP3;CSF2;TNF;HBEGF;IL1A;EFNA1;SDC4;INHBA;CCL20;ZC3H12A;BMP2;LIF;PLAUR;PPIF;TNIP1;EDN1;MAP2K3;JUN;EPHA2;SQSTM1;CSF1;EREG;IL23A;DUSP1;GADD45A;IL6;ADAM8;TNFRSF10B;BDKRB1;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;NOD2;IL6ST;ICAM1;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;MAP3K8;CFLAR;ANKLE2;ERRFI1;CCNL1;TGFBR2;DUSP16;SAA1;WNT5A;VEGFC;TGFA;DUSP10;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;ATF3;CAB39;SPRY2;TNKS1BP1;NUP153;MMD;IL24;PTPN1;WNT7B;TAB3;CAV1;TP53;ABI1;STK40;ITGAV;ABCA7;PML;ADAM9;AXL;RPS6KA6;DDR1
8024,GO:0032652,9.69297798866496e-08,0.999999989184342,13,48,regulation of interleukin-1 production,BP,TNFAIP3;CCL20;ZC3H12A;PANX1;RIPK2;NOD2;SMAD3;IL1R2;ERRFI1;SAA1;WNT5A;PML;TRIM16
4367,GO:0009968,9.69799701898159e-08,1,75,888,negative regulation of signal transduction,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;HBEGF;IL1A;EFNA1;ZC3H12A;PPP1R15A;BMP2;LIF;PLAUR;SOD2;PRDM1;IL1RN;PPIF;TNIP1;TICAM1;EPHA2;EREG;DUSP1;BCL3;IL6;TNFRSF10B;CYLD;BAMBI;ZNF451;ICAM1;SMAD3;DLX2;NFKBID;TRIB1;NRARP;IL1R2;DKK1;CFLAR;RNF43;ADM;ERRFI1;NR4A2;VHL;TGFBR2;SMURF2;DUSP16;WNT5A;DUSP10;SOCS2;PDGFB;DUSP8;NRG1;MMP9;ATF3;OTUD4;TLE1;SPRY2;BCL2L2;RNF152;NEDD4;NFE2L2;PTPN1;CAV1;ITGAV;MAPKBP1;RELA;MUC1;AXL;GSK3B;MED13;RPS6KA6;DDR1;XBP1;KCTD11;IL36RN
11096,GO:0045088,1.06963844048094e-07,0.999999968267135,35,291,regulation of innate immune response,BP,NFKBIA;TNFAIP3;IRF1;BIRC3;NFKB1;TNIP1;TICAM1;IFNAR2;EREG;PELI1;BIRC2;IFNGR2;ADAM8;RIPK2;IRAK2;CYLD;RELB;NOD2;IFNAR1;IFNGR1;WNT5A;DUSP10;PGLYRP4;IFIH1;OTUD4;PTPN1;TAB3;CAV1;TNIP2;TLR2;IKBKE;UBE2D3;RELA;MUC1;HLA-E
19515,GO:1990266,1.07275481415313e-07,0.999999989286986,12,43,neutrophil migration,BP,CXCL8;IL1B;CXCL2;CXCL3;CXCL1;IL1A;CCL20;CXCL5;EDN1;IL23A;ADAM8;SAA1
14173,GO:0061041,1.19462890867986e-07,0.999999980344081,17,80,regulation of wound healing,BP,TNFAIP3;HBEGF;PLAU;PLAUR;EDN1;SERPINB2;PHLDB2;C1QTNF1;SMAD3;TGFBR2;DUSP10;PDGFB;NFE2L2;CAV1;PLAT;PPARD;XBP1
1457,GO:0003690,1.20942794538191e-07,1,58,602,double-stranded DNA binding,MF,IRF1;FOSL1;ELF3;PRDM1;TBX3;EHF;NFKB1;JUN;KDM6B;ETS1;BHLHE40;KLF6;REL;GADD45A;ETS2;NFKB2;RFX5;SIX4;JUNB;RELB;ZNF217;SMAD3;DLX2;ARNTL2;KLF7;CEBPB;CEBPD;CREB1;NR4A2;BACH1;MYBL1;RUNX1;NFE2L3;SOX4;ATF3;CHD2;POU2F2;NFE2L2;SMAD1;MXD1;CHD4;NFAT5;VEZF1;TP53;KLF3;ELK3;ZNF148;RELA;MUC1;NR4A3;PPARD;PARP1;MXD3;XBP1;ZBTB5;ELF4;TFE3;JUND
9862,GO:0042108,1.50593833446124e-07,0.999999986939118,11,33,positive regulation of cytokine biosynthetic process,BP,IL1B;TNF;IRF1;IL1A;CCL20;TICAM1;EREG;BCL3;WNT5A;CD276;RELA
12811,GO:0051092,1.60375843493389e-07,0.999999967486285,20,114,positive regulation of NF-kappaB transcription factor activity,BP,IL1B;NFKBIA;TNF;NFKB1;TICAM1;TRAF1;NFKB2;ADAM8;RIPK2;IRAK2;NOD2;ICAM1;NFKBIB;CFLAR;TRIM25;WNT5A;TAB3;TLR2;RELA;RIPK4
18540,GO:1903706,1.65887684654089e-07,0.999999946352289,36,329,regulation of hemopoiesis,BP,NFKBIA;CSF2;TNF;IRF1;INHBA;LIF;CD83;PRDM1;ZFP36;JUN;ETS1;CSF1;IL23A;ADAM8;ZFP36L1;RIPK2;CYLD;TJP2;IL7R;NFKBID;TRIB1;NRARP;CEBPB;CREB1;RUNX1;TGFBR2;DUSP10;IL20;IL4R;NFE2L2;EVI2B;AXL;NR4A3;KMT2E;XBP1;TFE3
11399,GO:0045766,1.78706231583111e-07,0.999999965561434,19,100,positive regulation of angiogenesis,BP,CXCL8;IL1B;IL1A;ZC3H12A;ETS1;ITGA5;VEGFA;PLK2;BTG1;ADM;RUNX1;TGFBR2;ITGB8;WNT5A;VEGFC;NFE2L2;SMAD1;CCBE1;XBP1
7089,GO:0030879,1.81388224162692e-07,0.999999965046545,19,99,mammary gland development,BP,ELF3;TBX3;EPHA2;CSF1;IRF6;B4GALT1;VEGFA;CEBPB;CREB1;TGFBR2;WNT5A;SOCS2;NRG1;WNT7B;STAT5A;CAV1;PML;DDR1;XBP1
3588,GO:0008009,1.81697548506744e-07,0.99999999429976,7,14,chemokine activity,MF,CXCL8;CXCL2;CXCL3;CXCL1;CCL20;CXCL5;CXCL16
19915,GO:2000379,1.88309065858127e-07,0.999999974918151,14,58,positive regulation of reactive oxygen species metabolic process,BP,IL1B;TNF;ZC3H12A;PTX3;EDN1;TICAM1;GADD45A;CDKN1A;ICAM1;SMAD3;TGFBR2;PDGFB;NFE2L2;TP53
10333,GO:0043122,1.95819006769661e-07,0.999999948797261,26,181,regulation of I-kappaB kinase/NF-kappaB signaling,BP,IL1B;TNFAIP3;TNF;IL1A;BIRC3;ZC3H12A;TNIP1;TICAM1;SQSTM1;REL;PELI1;BIRC2;TNFRSF10B;RIPK2;NOD2;NFKBID;PLK2;CFLAR;CANT1;TRIM25;WNT5A;TLE1;TNIP2;IKBKE;MAPKBP1;RELA
8438,GO:0033554,1.96004647542389e-07,1,115,1621,cellular response to stress,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;TNF;NUAK2;IL1A;BTG2;PLEKHF1;NCOA7;ZC3H12A;PPP1R15A;BMP2;SOD2;TBX3;PMAIP1;NFKB1;IER3;PPIF;EDN1;MAP2K3;ZFP36;JUN;KDM6B;EPHA2;ETS1;SQSTM1;BBC3;REL;BCL3;GADD45A;IL6;ADAM8;TNFRSF10B;ZFP36L1;RIPK2;IRAK2;JUNB;FZD8;RELB;CDKN1A;CPEB2;GPX3;NOD2;TFPI2;SGK1;ICAM1;GCH1;TRAF4;TRIB1;VEGFA;DKK1;PLK2;MAP3K8;CFLAR;TXNRD1;UPP1;IER5;CEBPB;ADM;ERRFI1;USP43;NR4A2;VHL;BACH1;SFR1;TRIM25;MASTL;WNT5A;DUSP10;SLC52A3;SOX4;TNC;SLC38A2;MMP9;ATF3;CAB39;PLK3;CHD2;SLC9A1;RCHY1;TNKS1BP1;NUP153;BCL2L2;RNF152;NEDD4;NFE2L2;PTPN1;WNT7B;TAB3;SUSD6;CAV1;INO80D;TNIP2;TP53;IKBKE;UBE2D3;RAD9B;PML;RELA;ESCO2;MUC1;AXL;NR4A3;GSK3B;PPARD;PARP1;JMY;EGLN1;NABP1;RPS6KA6;XBP1;HSPA4L;EID3;JUND
1158,GO:0002763,2.01217172450689e-07,0.999999981871714,11,34,positive regulation of myeloid leukocyte differentiation,BP,TNF;LIF;JUN;CSF1;IL23A;ZFP36L1;TRIB1;CREB1;RUNX1;IL20;EVI2B
14969,GO:0070851,2.02877452235566e-07,0.99999996512814,17,83,growth factor receptor binding,MF,IL1B;CSF2;HBEGF;IL1A;IL36G;IL1RN;EREG;IL6;ITGA5;IL6ST;VEGFA;FGF5;VEGFC;TGFA;PDGFB;FAM83B;IL36RN
3264,GO:0006935,2.09483821408065e-07,0.999999931444479,40,357,chemotaxis,BP,CXCL8;IL1B;CXCL2;CXCL3;HBEGF;PLAU;CXCL1;EFNA1;CCL20;FOSL1;CXCL5;IL16;PLAUR;EDN1;EPHA2;CSF1;IL23A;EFNB1;IL6;ADAM8;SMAD3;VEGFA;ZSWIM4;KLF7;CREB1;SEMA4B;SAA1;WNT5A;VEGFC;PDGFB;NRG1;FEZ1;GRB7;CXCL16;SPTBN5;EFNB2;ITGAV;DOCK4;ADGRE2;NR4A3
9963,GO:0042330,2.09483821408065e-07,0.999999931444479,40,357,taxis,BP,CXCL8;IL1B;CXCL2;CXCL3;HBEGF;PLAU;CXCL1;EFNA1;CCL20;FOSL1;CXCL5;IL16;PLAUR;EDN1;EPHA2;CSF1;IL23A;EFNB1;IL6;ADAM8;SMAD3;VEGFA;ZSWIM4;KLF7;CREB1;SEMA4B;SAA1;WNT5A;VEGFC;PDGFB;NRG1;FEZ1;GRB7;CXCL16;SPTBN5;EFNB2;ITGAV;DOCK4;ADGRE2;NR4A3
631,GO:0001818,2.15533029180513e-07,0.999999947000107,24,161,negative regulation of cytokine production,BP,TNFAIP3;TNF;INHBA;ZC3H12A;CD83;NFKB1;ZFP36;IL23A;REL;BCL3;IL6;CYLD;RELB;NAV3;IL1R2;ERRFI1;TRIM25;IFIH1;BTN2A2;IKBKE;MAPKBP1;PML;AXL;IL36RN
11398,GO:0045765,2.31112106170596e-07,0.999999939137528,26,176,regulation of angiogenesis,BP,CXCL8;IL1B;TNFAIP3;IL1A;EFNA1;ZC3H12A;EPHA2;ETS1;IL6;ITGA5;VEGFA;PLK2;BTG1;ADM;RUNX1;TGFBR2;ITGB8;WNT5A;VEGFC;SPRY2;NFE2L2;SMAD1;PML;CCBE1;EGLN1;XBP1
4537,GO:0010605,2.4618901293683e-07,1,134,2015,negative regulation of macromolecule metabolic process,BP,IL1B;TNFAIP3;CSF2;TNF;IRF1;HBEGF;EFNA1;BTG2;INHBA;BIRC3;NOCT;NCOA7;ZC3H12A;PPP1R15A;ELF3;BMP2;LIF;PLAUR;PRDM1;TBX3;PTX3;NFKB1;TNIP1;EDN1;ZFP36;PNRC1;SERPINB2;JUN;SQSTM1;BHLHE40;EREG;REL;DUSP1;BCL3;GADD45A;BIRC2;IL6;ETS2;NFKB2;TNFRSF10B;BDKRB1;N4BP1;RFX5;ZFP36L1;SIX4;JUNB;FZD8;TNFAIP8;RELB;ZNF217;CDKN1A;CCDC85B;CPEB2;ZNF451;NEDD4L;TFPI2;SMAD3;DLX2;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;ANXA8;PPP4R4;CEBPB;CD55;ERRFI1;CREB1;NR4A2;PATL1;VHL;BACH1;SMURF2;DUSP16;TGIF2;PNRC2;NFE2L3;MASTL;NAB1;ITGB8;WNT5A;DUSP10;SOX4;SERPINB1;SOCS2;PDGFB;DUSP8;NRG1;MMP9;LDLR;ATF3;IKZF2;TLE1;PLK3;YAF2;SPRY2;TNKS1BP1;GRB7;NUP153;NEDD4;TNFRSF6B;PTPN1;SMAD1;MXD1;CHD4;ZC3H7B;CAV1;SH3RF2;TP53;KLF3;ITGAV;UBE2D3;ELK3;ABCA7;SDR16C5;ZNF148;PML;RELA;PLAT;MUC1;FRK;NR4A3;GSK3B;PPARD;PARP1;MXD3;VIM;RPS6KA6;QKI;ZBTB5;JUND
14799,GO:0070498,2.50742903264406e-07,0.99999995561556,17,94,interleukin-1-mediated signaling pathway,BP,IL1B;NFKBIA;IL1A;IL1RN;NFKB1;SQSTM1;PELI1;IL6;RIPK2;IRAK2;NOD2;IL1R2;MAP3K8;OTUD4;TAB3;TNIP2;RELA
565,GO:0001704,2.60881111818554e-07,0.999999954523109,17,80,formation of primary germ layer,BP,INHBA;KDM6B;DUSP1;ETS2;ITGA5;SMAD3;DKK1;LAMB3;TXNRD1;WNT5A;MMP9;COL12A1;SMAD1;ITGAV;NR4A3;LAMA3;COL8A1
12810,GO:0051091,2.78215790732529e-07,0.999999925768373,26,184,positive regulation of DNA binding transcription factor activity,BP,IL1B;NFKBIA;TNF;FOSL1;NFKB1;EDN1;TICAM1;TRAF1;IL6;NFKB2;ADAM8;RIPK2;IRAK2;NOD2;SAV1;ICAM1;NFKBIB;VEGFA;CFLAR;TRIM25;WNT5A;TAB3;TLR2;RELA;JMY;RIPK4
1027,GO:0002526,2.84357474649783e-07,0.999999960460724,14,61,acute inflammatory response,BP,IL1B;TNF;IL1A;IL1RN;IL6;ADAM8;IL6ST;ICAM1;B4GALT1;CEBPB;CD55;SAA1;OSMR;CFB
10739,GO:0044092,3.43677024311668e-07,1,64,748,negative regulation of molecular function,BP,IL1B;NFKBIA;TNFAIP3;TNF;BIRC3;PLEKHF1;ZC3H12A;PPP1R15A;PLAUR;PTX3;NFKB1;PPIF;ZFP36;SERPINB2;JUN;BHLHE40;NFKBIE;DUSP1;PELI1;GADD45A;BIRC2;TNFRSF10B;CYP27B1;IRAK2;CYLD;TNFAIP8;CDKN1A;CPEB2;NEDD4L;NOD2;TFPI2;NFKBID;TRIB1;SERPINB8;VEGFA;DKK1;CDKN2B;ANXA8;PPP4R4;ERRFI1;DUSP16;MASTL;DUSP10;SERPINB1;SOCS2;PDGFB;DUSP8;MMP9;RRAD;CAB39;SPRY2;NEDD4;TNFRSF6B;PTPN1;CAV1;SH3RF2;TP53;RAB9A;GEM;PIM1;ANXA5;GSK3B;MED13;EGLN1
547,GO:0001666,3.49040063652296e-07,0.999999892690215,31,256,response to hypoxia,BP,PLAU;BMP2;PMAIP1;EDN1;ETS1;BIRC2;ADAM8;ZFP36L1;CPEB2;ICAM1;SMAD3;VEGFA;CFLAR;ADM;CREB1;NR4A2;VHL;BACH1;TGFBR2;VEGFC;PLK3;SLC9A1;NFE2L2;CAV1;TP53;TLR2;UBE2D3;PML;PLAT;PPARD;EGLN1
12787,GO:0051049,3.88700707598446e-07,1,87,1116,regulation of transport,BP,IL1B;NFKBIA;TNF;IL1A;SDC4;INHBA;ZC3H12A;IL16;LIF;PMAIP1;PTX3;NFKB1;PPIF;EDN1;EHD1;HCAR2;BBC3;PLAGL2;IL6;ADAM8;BDKRB1;PIM3;PANX1;RIPK2;C1QTNF1;CDKN1A;NEDD4L;NOD2;SGK1;ICAM1;VEGFA;IL1R2;DKK1;ABL2;KCNJ15;TP53BP2;CREB1;CD47;SAA1;WNT5A;VEGFC;SOX4;PDGFB;IFIH1;NRG1;MMP9;LDLR;RRAD;CAB39;PLK3;TRPV3;SLC9A1;FEZ1;NUP153;IL4R;NEDD4;MARCKS;BTN2A2;NFE2L2;PTPN1;CLIC4;CAV1;UGCG;TP53;TLR2;RAB9A;ITGAV;GEM;UBE2D3;STX1A;MAPKBP1;JPH2;ABCA7;ADGRE2;PML;ADAM9;TRIM16;TSPAN13;AXL;NR4A3;HLA-E;GSK3B;PPARD;SLC16A1;TBC1D22B;XBP1;IL36RN
18478,GO:1903555,3.99702056857319e-07,0.99999993732536,15,70,regulation of tumor necrosis factor superfamily cytokine production,BP,TNFAIP3;ZC3H12A;ZFP36;TICAM1;IL23A;BCL3;ADAM8;RIPK2;NOD2;ERRFI1;WNT5A;IFIH1;TLR2;AXL;HLA-E
7496,GO:0031663,4.03876172770679e-07,0.999999960042771,11,37,lipopolysaccharide-mediated signaling pathway,BP,IL1B;NFKBIA;TNFAIP3;TNF;PRDM1;TICAM1;RIPK2;IRAK2;TRIB1;CD55;TLR2
11310,GO:0045619,4.06111234952016e-07,0.999999921269112,18,97,regulation of lymphocyte differentiation,BP,IRF1;INHBA;CD83;PRDM1;IL23A;ADAM8;ZFP36L1;RIPK2;CYLD;IL7R;NFKBID;NRARP;RUNX1;TGFBR2;DUSP10;IL4R;AXL;XBP1
15211,GO:0071346,4.09680494717892e-07,0.999999915598228,19,111,cellular response to interferon-gamma,BP,IRF1;CCL20;EDN1;IRF6;IFNGR2;CLDN1;GBP2;ICAM1;CDC42EP4;TRIM25;IFNGR1;WNT5A;MT2A;HLA-A;HLA-B;PML;HLA-F;HLA-E;VIM
15390,GO:0071621,4.10747560015927e-07,0.999999952308441,12,48,granulocyte chemotaxis,BP,CXCL8;IL1B;CXCL2;CXCL3;CXCL1;CCL20;CXCL5;EDN1;CSF1;IL23A;SAA1;ADGRE2
5447,GO:0016310,4.15083250392951e-07,1,116,1646,phosphorylation,BP,IL1B;TNFAIP3;CSF2;TNF;HBEGF;NUAK2;IL1A;ITPKC;EFNA1;SDC4;INHBA;CCL20;ZC3H12A;BMP2;LIF;PLAUR;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;JUN;EPHA2;SQSTM1;CSF1;EREG;IL23A;DUSP1;PELI1;GADD45A;IL6;ADAM8;TNFRSF10B;BDKRB1;PIM3;ZFP36L1;TNFSF15;RIPK2;IRAK2;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;NOD2;IL6ST;SGK1;ICAM1;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;CFLAR;ANKLE2;ERRFI1;ANKK1;CREB1;CCNL1;MAST4;PHKG2;TGFBR2;DUSP16;SAA1;MASTL;WNT5A;CAMK1G;VEGFC;TGFA;DUSP10;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;ATF3;CAB39;PLK3;SPRY2;TNKS1BP1;NUP153;MMD;IL24;KBTBD7;PTPN1;WNT7B;SMAD1;SGMS2;TAB3;SPTBN5;STAT5A;CAV1;TNIP2;TP53;TLR2;ABI1;STK40;ITGAV;IKBKE;ABCA7;CLK4;PML;PIM1;ADAM9;AXL;FRK;GSK3B;RIPK4;RPS6KA6;DDR1
14885,GO:0070663,4.37725987123579e-07,0.99999990462709,20,122,regulation of leukocyte proliferation,BP,IL1B;TNFAIP3;IRF1;SDC4;PRDM1;TICAM1;CSF1;IL23A;PELI1;EFNB1;IL6;RIPK2;CDKN1A;IL6ST;CEBPB;CD55;TGFBR2;BTN2A2;CD276;HLA-E
8081,GO:0032755,4.50531631008353e-07,0.999999948055538,12,44,positive regulation of interleukin-6 production,BP,IL1B;TNF;IL1A;TICAM1;EREG;IL6;RIPK2;NOD2;WNT5A;IFIH1;TLR2;XBP1
3490,GO:0007369,4.96479887670288e-07,0.999999886485627,21,123,gastrulation,BP,INHBA;IL1RN;KDM6B;DUSP1;ETS2;PHLDB2;ITGA5;SMAD3;DKK1;LAMB3;TXNRD1;TGFBR2;TGIF2;WNT5A;MMP9;COL12A1;SMAD1;ITGAV;NR4A3;LAMA3;COL8A1
11784,GO:0046633,5.05018749911006e-07,0.999999982439121,7,13,alpha-beta T cell proliferation,BP,IRF1;IL23A;RIPK2;CD55;TGFBR2;HLA-E;ELF4
12615,GO:0050778,5.17520910514749e-07,0.999999815064492,45,453,positive regulation of immune response,BP,IL1B;NFKBIA;TNFAIP3;TNF;IRF1;BIRC3;ZC3H12A;NFKB1;TNIP1;TICAM1;EREG;IL23A;PELI1;BIRC2;IL6;ADAM8;RIPK2;IRAK2;CYLD;RELB;NOD2;IL6ST;CD55;RUNX1;WNT5A;PGLYRP4;IFIH1;OTUD4;IL4R;GCSAM;BTN2A2;TAB3;CAV1;TNIP2;TLR2;ABI1;IKBKE;UBE2D3;CD276;RELA;MUC1;NR4A3;HLA-E;XBP1;CFB
14729,GO:0070371,5.3373594852088e-07,0.999999852280655,26,186,ERK1 and ERK2 cascade,BP,IL1B;TNF;IL1A;CCL20;BMP2;LIF;TNIP1;JUN;EPHA2;DUSP1;ZFP36L1;RIPK2;NOD2;ICAM1;CFLAR;ERRFI1;DUSP10;PDGFB;ATF3;SPRY2;PTPN1;ITGAV;ABCA7;AXL;RPS6KA6;DDR1
6704,GO:0030099,5.7177321269447e-07,0.999999812257957,33,292,myeloid cell differentiation,BP,NFKBIA;CSF2;TNF;INHBA;LIF;ZFP36;JUN;EPHA2;ETS1;CSF1;IL23A;ZFP36L1;JUNB;TJP2;RELB;TRIB1;VEGFA;CDKN2B;CEBPB;CREB1;RUNX1;TGFBR2;SLC11A2;IL20;MMP9;TLR2;ABI1;PML;EVI2B;NR4A3;KMT2E;PARP1;TFE3
4274,GO:0009628,5.7628648151838e-07,1,71,869,response to abiotic stimulus,BP,IL1B;NFKBIA;TNF;IRF1;PLAU;IL1A;BTG2;FOSL1;BMP2;PMAIP1;NFKB1;EDN1;JUN;ETS1;BHLHE40;DUSP1;BCL3;GADD45A;BIRC2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;ZFP36L1;JUNB;RELB;CDKN1A;CLDN1;CPEB2;DCUN1D3;ICAM1;SMAD3;VEGFA;CFLAR;IER5;ADM;ERRFI1;CREB1;NR4A2;VHL;BACH1;TGFBR2;HMGCS1;VEGFC;SLC52A3;TNC;SLC38A2;CAB39;PLK3;TRPV3;SLC9A1;TNKS1BP1;NUP153;NEDD4;NFE2L2;CAV1;TP53;TLR2;UBE2D3;STX1A;RAD9B;PML;RELA;PLAT;GSK3B;PPARD;PARP1;EGLN1;NABP1;HSPA4L;JUND
1104,GO:0002690,5.88729391579772e-07,0.999999929200512,12,48,positive regulation of leukocyte chemotaxis,BP,CXCL8;CXCL2;CXCL3;CXCL1;CXCL5;EDN1;CSF1;IL23A;IL6;VEGFA;WNT5A;VEGFC
8831,GO:0034612,6.01602630262019e-07,0.999999826736717,27,216,response to tumor necrosis factor,BP,CXCL8;NFKBIA;TNFAIP3;TNF;BIRC3;CCL20;ZC3H12A;NFKB1;EDN1;ZFP36;TRAF1;BIRC2;TNFRSF10B;ZFP36L1;TNFSF15;CYLD;TJP2;CLDN1;RELT;ICAM1;GCH1;CXCL16;TNFRSF6B;NFE2L2;ADAM9;RELA;OCLN
12565,GO:0050704,6.20223856586575e-07,0.999999955601569,9,25,regulation of interleukin-1 secretion,BP,ZC3H12A;PANX1;RIPK2;NOD2;IL1R2;SAA1;WNT5A;PML;TRIM16
876,GO:0002224,6.57503693640367e-07,0.999999875369969,17,91,toll-like receptor signaling pathway,BP,NFKBIA;TNFAIP3;IRF1;BIRC3;TNIP1;TICAM1;PELI1;BIRC2;RIPK2;IRAK2;OTUD4;TAB3;CAV1;TNIP2;TLR2;IKBKE;UBE2D3
16079,GO:0090023,6.657081887083e-07,0.999999973444585,7,15,positive regulation of neutrophil chemotaxis,BP,CXCL8;CXCL2;CXCL3;CXCL1;CXCL5;EDN1;IL23A
59,GO:0000122,6.72803782255541e-07,0.999999791187203,56,604,negative regulation of transcription by RNA polymerase II,BP,TNF;EFNA1;BTG2;BMP2;PRDM1;TBX3;NFKB1;EDN1;ZFP36;JUN;SQSTM1;BHLHE40;REL;ETS2;NFKB2;RFX5;JUNB;FZD8;RELB;ZNF217;ZNF451;NEDD4L;SMAD3;DLX2;VEGFA;NRARP;DKK1;CEBPB;NR4A2;VHL;BACH1;SMURF2;TGIF2;NFE2L3;PDGFB;ATF3;IKZF2;TLE1;PLK3;NEDD4;MXD1;CHD4;CAV1;TP53;KLF3;UBE2D3;SDR16C5;ZNF148;RELA;FRK;NR4A3;PPARD;PARP1;MXD3;ZBTB5;JUND
9543,GO:0036293,7.46975128648653e-07,0.999999761394807,31,264,response to decreased oxygen levels,BP,PLAU;BMP2;PMAIP1;EDN1;ETS1;BIRC2;ADAM8;ZFP36L1;CPEB2;ICAM1;SMAD3;VEGFA;CFLAR;ADM;CREB1;NR4A2;VHL;BACH1;TGFBR2;VEGFC;PLK3;SLC9A1;NFE2L2;CAV1;TP53;TLR2;UBE2D3;PML;PLAT;PPARD;EGLN1
14757,GO:0070423,8.32059787180925e-07,0.999999924390794,10,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,NFKBIA;TNFAIP3;BIRC3;BIRC2;RIPK2;IRAK2;CYLD;NOD2;TAB3;RELA
15446,GO:0071706,8.58259399260502e-07,0.999999855674522,15,74,tumor necrosis factor superfamily cytokine production,BP,TNFAIP3;ZC3H12A;ZFP36;TICAM1;IL23A;BCL3;ADAM8;RIPK2;NOD2;ERRFI1;WNT5A;IFIH1;TLR2;AXL;HLA-E
16866,GO:0098772,9.5468740843236e-07,0.99999966761733,86,1128,molecular function regulator,MF,CXCL8;IL1B;CXCL2;CSF2;TNF;CXCL3;HBEGF;CXCL1;IL1A;INHBA;BIRC3;CCL20;CXCL5;IL16;PPP1R15A;BMP2;LIF;IL36G;IL1RN;EDN1;SERPINB2;JUN;RAB3IP;CSF1;EREG;IL23A;BIRC2;IL6;TNFSF15;TNFAIP8;CDKN1A;CPEB2;NEDD4L;CTSC;TFPI2;SGK1;TRIB1;SERPINB8;VEGFA;ARHGEF3;FGD6;DKK1;CDKN2B;FGF5;CFLAR;PPP4R4;DENND3;NAMPT;ANKLE2;ADM;CDC42EP4;ERRFI1;CCNL1;SEMA4B;SAA1;WNT5A;VEGFC;TGFA;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;NRG1;CAB39;IL32;RASGEF1B;SPRY2;CYTH1;CXCL16;NEDD4;ITSN2;IL24;WNT7B;SPTBN5;CAV1;SH3RF2;ABI1;STX1A;DOCK4;TRIP10;TSPAN13;ANXA5;TBC1D22B;IL36RN;DENND4A
1156,GO:0002761,9.93304881471351e-07,0.999999831491059,15,72,regulation of myeloid leukocyte differentiation,BP,TNF;INHBA;LIF;JUN;CSF1;IL23A;ZFP36L1;TJP2;TRIB1;CEBPB;CREB1;RUNX1;IL20;EVI2B;TFE3
4341,GO:0009890,1.01132765409661e-06,0.999999643545485,91,1221,negative regulation of biosynthetic process,BP,CSF2;TNF;IRF1;HBEGF;EFNA1;BTG2;INHBA;ZC3H12A;ELF3;BMP2;PRDM1;TBX3;NFKB1;EDN1;ZFP36;JUN;SQSTM1;BHLHE40;EREG;REL;DUSP1;BCL3;IL6;ETS2;NFKB2;RFX5;ZFP36L1;CYP27B1;SIX4;JUNB;FZD8;RELB;ZNF217;CCDC85B;CPEB2;ZNF451;NEDD4L;SMAD3;DLX2;VEGFA;NRARP;DKK1;CFLAR;CEBPB;ERRFI1;CREB1;NR4A2;VHL;SOGA1;BACH1;SMURF2;TGIF2;NFE2L3;NAB1;WNT5A;PDGFB;NRG1;ATF3;IKZF2;TLE1;PLK3;YAF2;GRB7;NUP153;NEDD4;SMAD1;MXD1;CHD4;ZC3H7B;CAV1;TP53;KLF3;ITGAV;UBE2D3;ELK3;ABCA7;SDR16C5;ZNF148;PML;RELA;MUC1;FRK;NR4A3;GSK3B;PPARD;PARP1;MXD3;EGLN1;QKI;ZBTB5;JUND
6960,GO:0030593,1.01150538190428e-06,0.999999902644402,10,36,neutrophil chemotaxis,BP,CXCL8;IL1B;CXCL2;CXCL3;CXCL1;CCL20;CXCL5;EDN1;IL23A;SAA1
18463,GO:1903532,1.02526824619164e-06,0.999999688722887,28,220,positive regulation of secretion by cell,BP,IL1B;TNF;IL1A;SDC4;INHBA;EDN1;HCAR2;IL6;ADAM8;PANX1;RIPK2;C1QTNF1;NOD2;CREB1;SAA1;WNT5A;VEGFC;SOX4;IFIH1;IL4R;TLR2;RAB9A;STX1A;ADAM9;TRIM16;HLA-E;PPARD;XBP1
15393,GO:0071624,1.02575874755161e-06,0.999999954756815,7,16,positive regulation of granulocyte chemotaxis,BP,CXCL8;CXCL2;CXCL3;CXCL1;CXCL5;EDN1;IL23A
15885,GO:0072593,1.08971235363342e-06,0.999999713403369,23,166,reactive oxygen species metabolic process,BP,IL1B;TNF;ZC3H12A;SOD2;PMAIP1;PTX3;EDN1;TICAM1;GADD45A;BIRC2;CDKN1A;GPX3;ICAM1;GCH1;SMAD3;CFLAR;SLC7A2;TGFBR2;PDGFB;NFE2L2;CAV1;TP53;TLR2
148,GO:0000302,1.11085887523923e-06,0.999999707385975,23,167,response to reactive oxygen species,BP,TNFAIP3;TNF;FOSL1;SOD2;PPIF;EDN1;JUN;KDM6B;ETS1;DUSP1;IL6;GCH1;CFLAR;TXNRD1;MMP9;PLK3;NFE2L2;TP53;ADAM9;RELA;AXL;NR4A3;EGLN1
9363,GO:0035872,1.1399615970015e-06,0.999999891734805,10,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,NFKBIA;TNFAIP3;BIRC3;BIRC2;RIPK2;IRAK2;CYLD;NOD2;TAB3;RELA
12569,GO:0050708,1.1642544034649e-06,0.999999618726479,31,260,regulation of protein secretion,BP,IL1B;TNF;IL1A;ZC3H12A;HCAR2;IL6;ADAM8;PIM3;PANX1;RIPK2;NOD2;IL1R2;SAA1;WNT5A;VEGFC;SOX4;IFIH1;IL4R;MARCKS;BTN2A2;TLR2;STX1A;MAPKBP1;PML;ADAM9;TRIM16;HLA-E;PPARD;SLC16A1;XBP1;IL36RN
8202,GO:0032944,1.29058269408782e-06,0.999999710312668,19,119,regulation of mononuclear cell proliferation,BP,IL1B;IRF1;SDC4;PRDM1;TICAM1;CSF1;IL23A;PELI1;EFNB1;IL6;RIPK2;CDKN1A;IL6ST;CEBPB;CD55;TGFBR2;BTN2A2;CD276;HLA-E
14788,GO:0070482,1.29272591775907e-06,0.999999565001102,32,284,response to oxygen levels,BP,PLAU;BMP2;PMAIP1;EDN1;ETS1;BIRC2;ADAM8;ZFP36L1;CDKN1A;CPEB2;ICAM1;SMAD3;VEGFA;CFLAR;ADM;CREB1;NR4A2;VHL;BACH1;TGFBR2;VEGFC;PLK3;SLC9A1;NFE2L2;CAV1;TP53;TLR2;UBE2D3;PML;PLAT;PPARD;EGLN1
12543,GO:0050678,1.29520435349897e-06,0.999999601832539,28,220,regulation of epithelial cell proliferation,BP,TNFAIP3;TNF;BMP2;ZFP36;JUN;EREG;ZFP36L1;SIX4;NOD2;SAV1;SMAD3;B4GALT1;VEGFA;NRARP;CDKN2B;CFLAR;ERRFI1;WNT5A;VEGFC;TGFA;DUSP10;PDGFB;STAT5A;CAV1;EFNB2;NR4A3;PPARD;XBP1
3907,GO:0008544,1.34536472211734e-06,0.999999555524591,31,269,epidermis development,BP,TNF;INHBA;ELF3;MAFF;ZFP36;EPHA2;SPRR2D;IRF6;EREG;ZFP36L1;CYP27B1;SAV1;KRT34;DKK1;LAMB3;ERRFI1;GORAB;RUNX1;NAB1;WNT5A;IL20;CLIC4;UGCG;NOM1;SPRR2A;ADAM9;RELA;TRIM16;PPARD;LAMA3;LCE1C
8039,GO:0032680,1.36559313413996e-06,0.999999779532864,14,67,regulation of tumor necrosis factor production,BP,TNFAIP3;ZC3H12A;ZFP36;TICAM1;IL23A;BCL3;RIPK2;NOD2;ERRFI1;WNT5A;IFIH1;TLR2;AXL;HLA-E
11296,GO:0045598,1.37405036470859e-06,0.999999741511672,16,83,regulation of fat cell differentiation,BP,TNF;NOCT;ZC3H12A;BMP2;ZFP36;IL6;ZFP36L1;CCDC85B;SAV1;SMAD3;CEBPB;CREB1;WNT5A;DUSP10;PPARD;XBP1
12716,GO:0050921,1.42672571213245e-06,0.999999748174033,15,78,positive regulation of chemotaxis,BP,CXCL8;CXCL2;CXCL3;CXCL1;CXCL5;IL16;EDN1;CSF1;IL23A;IL6;SMAD3;VEGFA;WNT5A;VEGFC;PDGFB
14730,GO:0070372,1.44863633253014e-06,0.999999599800004,24,172,regulation of ERK1 and ERK2 cascade,BP,IL1B;TNF;IL1A;CCL20;BMP2;LIF;TNIP1;JUN;EPHA2;DUSP1;RIPK2;NOD2;ICAM1;CFLAR;ERRFI1;DUSP10;PDGFB;ATF3;SPRY2;PTPN1;ABCA7;AXL;RPS6KA6;DDR1
7073,GO:0030856,1.47131757891448e-06,0.999999702564422,17,94,regulation of epithelial cell differentiation,BP,IL1B;TNF;LIF;TBX3;MAFF;ZFP36;ZFP36L1;CYP27B1;BTG1;CEBPB;ERRFI1;RUNX1;IL20;CAV1;VEZF1;TRIM16;GSK3B
11898,GO:0046903,1.54033260805642e-06,0.999999319462054,78,1001,secretion,BP,IL1B;CSF2;TNF;PLAU;CXCL1;IL1A;SDC4;INHBA;ZC3H12A;LIF;PLAUR;TBX3;PTX3;IL1RN;NFKB1;EDN1;HCAR2;AMPD3;IL6;ADAM8;PIM3;PANX1;RIPK2;C1QTNF1;RAP2B;TNFAIP2;CTSC;NOD2;SGK1;B4GALT1;VEGFA;RAB24;IL1R2;VMP1;CD55;ADM;CREB1;CD47;CANT1;SAA1;WNT5A;VEGFC;SOX4;SERPINB1;SOCS2;PDGFB;IFIH1;NRG1;SLC38A2;MMP9;CAB39;IL4R;POU2F2;MARCKS;BTN2A2;STAT5A;CAV1;TLR2;RAB9A;ITGAV;STX1A;MAPKBP1;ADGRE2;PML;ADAM9;TRIM16;AXL;ANXA5;FRK;NR4A3;HLA-E;PPARD;SLC16A1;COTL1;DDR1;XBP1;IL36RN;MGAM
6786,GO:0030217,1.57698656927455e-06,0.999999607904407,21,137,T cell differentiation,BP,IRF1;CD83;PRDM1;IL23A;BCL3;IL6;ADAM8;ZFP36L1;RIPK2;CYLD;FZD8;RELB;IL7R;NFKBID;NRARP;RUNX1;TGFBR2;DUSP10;SOX4;IL4R;XBP1
11612,GO:0046209,1.63997952852537e-06,0.99999978103092,12,49,nitric oxide metabolic process,BP,IL1B;TNF;ZC3H12A;PTX3;EDN1;TICAM1;ICAM1;GCH1;SMAD3;SLC7A2;CAV1;TLR2
3389,GO:0007167,1.68359472952518e-06,0.999999303797062,61,693,enzyme linked receptor protein signaling pathway,BP,IL1B;HBEGF;EFNA1;INHBA;BMP2;LIF;PLAUR;JUN;EPHA2;CSF1;EREG;EFNB1;CSRNP1;BAMBI;ITGA5;ZNF451;IL6ST;SMAD3;VEGFA;DKK1;CDKN2B;FGF5;ABL2;ERRFI1;CREB1;NEDD9;SOGA1;TGFBR2;SMURF2;TGIF2;AKAP2;WNT5A;VEGFC;TGFA;SOCS2;PDGFB;NRG1;MMP9;FAM83B;SPRY2;GRB7;NEDD4;PTPN1;SMAD1;STAT5A;CAV1;ZFAND5;ABI1;EFNB2;ITGAV;UBE2D3;PML;ADAM9;RELA;CCBE1;PLAT;AXL;FRK;PARP1;VIM;DDR1
2864,GO:0006355,1.7192211592125e-06,0.999999329481039,177,2829,regulation of transcription, DNA-templated,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;CCDC85B;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;YAF2;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;SDR16C5;ZNF148;PML;PIM1;RELA;TRIM16;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;CREB5;EGLN1;RIPK4;ZXDA;XBP1;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
14883,GO:0070661,1.73927082698477e-06,0.9999995454415,22,157,leukocyte proliferation,BP,IL1B;TNFAIP3;IRF1;SDC4;PRDM1;TICAM1;CSF1;IL23A;PELI1;EFNB1;IL6;RIPK2;CDKN1A;IL7R;IL6ST;CEBPB;CD55;TGFBR2;BTN2A2;CD276;HLA-E;ELF4
7998,GO:0032611,1.82026503639438e-06,0.999999783287952,11,42,interleukin-1 beta production,BP,IL1B;TNFAIP3;ZC3H12A;PANX1;RIPK2;NOD2;SMAD3;ERRFI1;WNT5A;PML;TRIM16
11097,GO:0045089,1.87253400075366e-06,0.999999397105514,29,246,positive regulation of innate immune response,BP,NFKBIA;TNFAIP3;IRF1;BIRC3;NFKB1;TNIP1;TICAM1;EREG;PELI1;BIRC2;ADAM8;RIPK2;IRAK2;CYLD;RELB;NOD2;WNT5A;PGLYRP4;IFIH1;OTUD4;TAB3;CAV1;TNIP2;TLR2;IKBKE;UBE2D3;RELA;MUC1;HLA-E
4511,GO:0010558,1.96209083488884e-06,0.999999105866572,87,1163,negative regulation of macromolecule biosynthetic process,BP,CSF2;TNF;IRF1;HBEGF;EFNA1;BTG2;INHBA;ZC3H12A;ELF3;BMP2;PRDM1;TBX3;NFKB1;EDN1;ZFP36;JUN;SQSTM1;BHLHE40;EREG;REL;DUSP1;BCL3;IL6;ETS2;NFKB2;RFX5;ZFP36L1;SIX4;JUNB;FZD8;RELB;ZNF217;CCDC85B;CPEB2;ZNF451;NEDD4L;SMAD3;DLX2;VEGFA;NRARP;DKK1;CEBPB;ERRFI1;CREB1;NR4A2;VHL;BACH1;SMURF2;TGIF2;NFE2L3;NAB1;WNT5A;PDGFB;NRG1;ATF3;IKZF2;TLE1;PLK3;YAF2;GRB7;NUP153;NEDD4;SMAD1;MXD1;CHD4;ZC3H7B;CAV1;TP53;KLF3;ITGAV;UBE2D3;ELK3;ABCA7;SDR16C5;ZNF148;PML;RELA;MUC1;FRK;NR4A3;GSK3B;PPARD;PARP1;MXD3;QKI;ZBTB5;JUND
11454,GO:0045892,2.00010066086564e-06,0.999999131837932,71,893,negative regulation of transcription, DNA-templated,BP,CSF2;TNF;IRF1;EFNA1;BTG2;ELF3;BMP2;PRDM1;TBX3;NFKB1;EDN1;ZFP36;JUN;SQSTM1;BHLHE40;EREG;REL;BCL3;ETS2;NFKB2;RFX5;SIX4;JUNB;FZD8;RELB;ZNF217;CCDC85B;ZNF451;NEDD4L;SMAD3;DLX2;VEGFA;NRARP;DKK1;CEBPB;CREB1;NR4A2;VHL;BACH1;SMURF2;TGIF2;NFE2L3;NAB1;WNT5A;PDGFB;NRG1;ATF3;IKZF2;TLE1;PLK3;YAF2;NEDD4;MXD1;CHD4;CAV1;TP53;KLF3;UBE2D3;ELK3;SDR16C5;ZNF148;PML;RELA;MUC1;FRK;NR4A3;PPARD;PARP1;MXD3;ZBTB5;JUND
11328,GO:0045639,2.13454866364878e-06,0.999999673407981,13,58,positive regulation of myeloid cell differentiation,BP,TNF;INHBA;LIF;JUN;ETS1;CSF1;IL23A;ZFP36L1;TRIB1;CREB1;RUNX1;IL20;EVI2B
11178,GO:0045236,2.23300381736666e-06,0.999999968715956,5,7,CXCR chemokine receptor binding,MF,CXCL8;CXCL2;CXCL3;CXCL1;CXCL5
11283,GO:0045580,2.28227776237952e-06,0.999999580941412,15,78,regulation of T cell differentiation,BP,IRF1;CD83;PRDM1;IL23A;ADAM8;RIPK2;CYLD;IL7R;NFKBID;NRARP;RUNX1;TGFBR2;DUSP10;IL4R;XBP1
8015,GO:0032640,2.37010055718093e-06,0.999999596055208,14,70,tumor necrosis factor production,BP,TNFAIP3;ZC3H12A;ZFP36;TICAM1;IL23A;BCL3;RIPK2;NOD2;ERRFI1;WNT5A;IFIH1;TLR2;AXL;HLA-E
1097,GO:0002683,2.39163925294222e-06,0.999999200898976,30,266,negative regulation of immune system process,BP,NFKBIA;TNFAIP3;TNF;IRF1;SDC4;INHBA;ZC3H12A;PRDM1;ZFP36;TICAM1;PELI1;ZFP36L1;CYLD;TJP2;IL7R;NOD2;NFKBID;TRIB1;NRARP;CEBPB;CD55;DUSP10;LDLR;OTUD4;IL4R;GCSAM;BTN2A2;NFE2L2;AXL;HLA-E
8236,GO:0033002,2.42648578186398e-06,0.99999943084867,19,118,muscle cell proliferation,BP,TNFAIP3;TNF;HBEGF;EDN1;JUN;EREG;IL6;SAV1;TRIB1;CFLAR;NAMPT;TGFBR2;PDGFB;MMP9;SMAD1;TP53;PIM1;NR4A3;PPARD
7322,GO:0031327,2.4847546403432e-06,0.999998856275085,89,1205,negative regulation of cellular biosynthetic process,BP,CSF2;TNF;IRF1;HBEGF;EFNA1;BTG2;INHBA;ZC3H12A;ELF3;BMP2;PRDM1;TBX3;NFKB1;EDN1;ZFP36;JUN;SQSTM1;BHLHE40;EREG;REL;DUSP1;BCL3;IL6;ETS2;NFKB2;RFX5;ZFP36L1;CYP27B1;SIX4;JUNB;FZD8;RELB;ZNF217;CCDC85B;CPEB2;ZNF451;NEDD4L;SMAD3;DLX2;VEGFA;NRARP;DKK1;CEBPB;ERRFI1;CREB1;NR4A2;VHL;SOGA1;BACH1;SMURF2;TGIF2;NFE2L3;NAB1;WNT5A;PDGFB;NRG1;ATF3;IKZF2;TLE1;PLK3;YAF2;GRB7;NUP153;NEDD4;SMAD1;MXD1;CHD4;ZC3H7B;CAV1;TP53;KLF3;UBE2D3;ELK3;ABCA7;SDR16C5;ZNF148;PML;RELA;MUC1;FRK;NR4A3;GSK3B;PPARD;PARP1;MXD3;EGLN1;QKI;ZBTB5;JUND
14383,GO:0061614,2.5513474064609e-06,0.999999732117432,10,33,pri-miRNA transcription by RNA polymerase II,BP,FOSL1;BMP2;JUN;ETS1;SMAD3;PDGFB;SMAD1;TP53;RELA;PPARD
12785,GO:0051047,2.64902877105119e-06,0.999999150480358,28,232,positive regulation of secretion,BP,IL1B;TNF;IL1A;SDC4;INHBA;EDN1;HCAR2;IL6;ADAM8;PANX1;RIPK2;C1QTNF1;NOD2;CREB1;SAA1;WNT5A;VEGFC;SOX4;IFIH1;IL4R;TLR2;RAB9A;STX1A;ADAM9;TRIM16;HLA-E;PPARD;XBP1
8204,GO:0032946,2.6744326822884e-06,0.999999537029799,14,73,positive regulation of mononuclear cell proliferation,BP,IL1B;TICAM1;CSF1;IL23A;PELI1;EFNB1;IL6;RIPK2;CDKN1A;IL6ST;CD55;TGFBR2;CD276;HLA-E
11792,GO:0046641,2.74395121334748e-06,0.999999959857149,5,7,positive regulation of alpha-beta T cell proliferation,BP,IL23A;RIPK2;CD55;TGFBR2;HLA-E
1153,GO:0002758,2.80993281115235e-06,0.999999163488168,25,199,innate immune response-activating signal transduction,BP,NFKBIA;TNFAIP3;IRF1;BIRC3;NFKB1;TNIP1;TICAM1;PELI1;BIRC2;RIPK2;IRAK2;CYLD;RELB;NOD2;PGLYRP4;IFIH1;OTUD4;TAB3;CAV1;TNIP2;TLR2;IKBKE;UBE2D3;RELA;MUC1
1171,GO:0002791,2.85101312711732e-06,0.999999019980624,31,272,regulation of peptide secretion,BP,IL1B;TNF;IL1A;ZC3H12A;HCAR2;IL6;ADAM8;PIM3;PANX1;RIPK2;NOD2;IL1R2;SAA1;WNT5A;VEGFC;SOX4;IFIH1;IL4R;MARCKS;BTN2A2;TLR2;STX1A;MAPKBP1;PML;ADAM9;TRIM16;HLA-E;PPARD;SLC16A1;XBP1;IL36RN
4278,GO:0009636,2.92585609664974e-06,0.999998936103378,34,326,response to toxic substance,BP,TNFAIP3;TNF;FOSL1;ZC3H12A;SOD2;NFKB1;PPIF;EDN1;JUN;KDM6B;ETS1;DUSP1;BIRC2;IL6;CDKN1A;CLDN1;GPX3;ICAM1;GCH1;SLC6A14;TXNRD1;CREB1;NR4A2;ABTB2;PDGFB;TNC;MT2A;NFE2L2;TP53;TLR2;ADAM9;RELA;AXL;NR4A3
8023,GO:0032651,2.94185017483858e-06,0.999999679875795,10,36,regulation of interleukin-1 beta production,BP,TNFAIP3;ZC3H12A;PANX1;RIPK2;NOD2;SMAD3;ERRFI1;WNT5A;PML;TRIM16
11312,GO:0045621,2.99731121475352e-06,0.999999570932862,12,52,positive regulation of lymphocyte differentiation,BP,CD83;PRDM1;IL23A;ADAM8;RIPK2;CYLD;IL7R;TGFBR2;DUSP10;IL4R;AXL;XBP1
11791,GO:0046640,3.09550531288822e-06,0.999999897852136,6,11,regulation of alpha-beta T cell proliferation,BP,IRF1;IL23A;RIPK2;CD55;TGFBR2;HLA-E
18442,GO:1903506,3.09597219519745e-06,0.999998409692988,177,2846,regulation of nucleic acid-templated transcription,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;CCDC85B;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;YAF2;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;SDR16C5;ZNF148;PML;PIM1;RELA;TRIM16;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;CREB5;EGLN1;RIPK4;ZXDA;XBP1;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
16770,GO:0098542,3.11124611698264e-06,0.999998967050611,29,261,defense response to other organism,BP,IL1B;TNFAIP3;TNF;IRF1;BIRC3;CCL20;ZC3H12A;PMAIP1;TICAM1;IFNAR2;IL23A;BCL3;BIRC2;IL6;RIPK2;NOD2;CEBPB;TRIM25;PGLYRP4;IFIH1;IL4R;TLR2;MAPKBP1;PML;POLR3A;RELA;HLA-E;COTL1;IL36RN
18246,GO:1903034,3.13523492482555e-06,0.999999324269002,17,100,regulation of response to wounding,BP,TNFAIP3;HBEGF;PLAU;PLAUR;EDN1;SERPINB2;PHLDB2;C1QTNF1;SMAD3;TGFBR2;DUSP10;PDGFB;NFE2L2;CAV1;PLAT;PPARD;XBP1
4315,GO:0009790,3.18970920780198e-06,0.999998670748747,59,671,embryo development,BP,CXCL8;CSF2;TNF;EFNA1;SDC4;INHBA;NOCT;FOSL1;ELF3;BMP2;LIF;PRDM1;TBX3;IL1RN;MAFF;EDN1;KDM6B;DUSP1;EFNB1;ETS2;ZFP36L1;SIX4;PHLDA2;JUNB;PHLDB2;ITGA5;SMAD3;DLX2;VEGFA;NRARP;DKK1;LAMB3;TXNRD1;CEBPB;ADM;GJB3;GORAB;TGFBR2;TGIF2;WNT5A;VEGFC;SOX4;PDGFB;NRG1;MMP9;COL12A1;SPRY2;NFE2L2;WNT7B;SMAD1;TPRA1;ZFAND5;ABI1;ITGAV;NR4A3;LAMA3;COL8A1;EGLN1;RPS6KA6
20239,GO:2001141,3.21734401671486e-06,0.999998346408859,177,2848,regulation of RNA biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;CCDC85B;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;YAF2;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;SDR16C5;ZNF148;PML;PIM1;RELA;TRIM16;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;CREB5;EGLN1;RIPK4;ZXDA;XBP1;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
20225,GO:2001057,3.21881058078623e-06,0.999999535909,12,52,reactive nitrogen species metabolic process,BP,IL1B;TNF;ZC3H12A;PTX3;EDN1;TICAM1;ICAM1;GCH1;SMAD3;SLC7A2;CAV1;TLR2
6599,GO:0022612,3.29338811279165e-06,0.999999332781041,16,86,gland morphogenesis,BP,TNFAIP3;TNF;ELF3;TBX3;EPHA2;CSF1;B4GALT1;CFLAR;CEBPB;TGFBR2;WNT5A;TNC;CAV1;PML;DDR1;XBP1
4374,GO:0009991,3.29735536075603e-06,0.99999875700671,36,343,response to extracellular stimulus,BP,IL1B;NUAK2;PLEKHF1;NOCT;FOSL1;ZC3H12A;PMAIP1;ZFP36;JUN;PANX1;CYP27B1;CDKN1A;NOD2;ICAM1;CDKN2B;UPP1;ADM;CREB1;NR4A2;TGFBR2;TRIM25;HMGCS1;TNC;SLC38A2;LDLR;ATF3;RNF152;NFE2L2;TP53;PIM1;RELA;AXL;PPARD;SLC16A1;CYP24A1;XBP1
9691,GO:0038066,3.47340519850079e-06,0.999999680986612,9,28,p38MAPK cascade,BP,IL1B;ZC3H12A;BMP2;MAP2K3;ZFP36;GADD45A;ZFP36L1;VEGFA;DUSP10
12994,GO:0051384,3.49078613024402e-06,0.999999284721466,16,92,response to glucocorticoid,BP,TNF;FOSL1;IL1RN;EDN1;ZFP36;DUSP1;IL6;ZFP36L1;CDKN1A;CLDN1;ICAM1;CFLAR;ADM;ERRFI1;WNT7B;ADAM9
13771,GO:0060333,3.56463725315832e-06,0.999999420069807,13,64,interferon-gamma-mediated signaling pathway,BP,IRF1;IRF6;IFNGR2;GBP2;ICAM1;TRIM25;IFNGR1;MT2A;HLA-A;HLA-B;PML;HLA-F;HLA-E
12562,GO:0050701,3.63291120254033e-06,0.999999658554229,9,30,interleukin-1 secretion,BP,ZC3H12A;PANX1;RIPK2;NOD2;IL1R2;SAA1;WNT5A;PML;TRIM16
19913,GO:2000377,3.6528623960144e-06,0.999999155749371,18,115,regulation of reactive oxygen species metabolic process,BP,IL1B;TNF;ZC3H12A;PTX3;EDN1;TICAM1;GADD45A;BIRC2;CDKN1A;ICAM1;GCH1;SMAD3;CFLAR;TGFBR2;PDGFB;NFE2L2;CAV1;TP53
10600,GO:0043565,3.67271473160034e-06,0.999998426706326,64,753,sequence-specific DNA binding,MF,IRF1;FOSL1;ELF3;PRDM1;TBX3;EHF;MAFF;NFKB1;JUN;KDM6B;ETS1;BHLHE40;KLF6;IRF6;REL;GADD45A;PLAGL2;ETS2;CSRNP1;NFKB2;RFX5;SIX4;JUNB;RELB;ZNF217;SMAD3;DLX2;ARNTL2;KLF7;CEBPB;CEBPD;CREB1;NR4A2;BACH1;MYBL1;RUNX1;NFE2L3;SOX4;ATF3;CHD2;POU2F2;NFE2L2;SMAD1;MXD1;CHD4;NFAT5;VEZF1;TP53;KLF3;ELK3;SNAPC4;ZNF148;RELA;FOXN2;MUC1;NR4A3;PPARD;PARP1;MXD3;XBP1;ZBTB5;ELF4;TFE3;JUND
8201,GO:0032943,3.73219212814243e-06,0.999999010365119,21,152,mononuclear cell proliferation,BP,IL1B;IRF1;SDC4;PRDM1;TICAM1;CSF1;IL23A;PELI1;EFNB1;IL6;RIPK2;CDKN1A;IL7R;IL6ST;CEBPB;CD55;TGFBR2;BTN2A2;CD276;HLA-E;ELF4
12575,GO:0050714,3.84915976744178e-06,0.999998979457658,21,147,positive regulation of protein secretion,BP,IL1B;TNF;IL1A;HCAR2;IL6;ADAM8;PANX1;RIPK2;NOD2;SAA1;WNT5A;VEGFC;SOX4;IFIH1;IL4R;TLR2;ADAM9;TRIM16;HLA-E;PPARD;XBP1
7596,GO:0031960,3.8498933674528e-06,0.999999154005653,17,104,response to corticosteroid,BP,TNF;FOSL1;IL1RN;EDN1;ZFP36;DUSP1;IL6;ZFP36L1;CDKN1A;CLDN1;ICAM1;CFLAR;ADM;ERRFI1;WNT7B;ADAM9;PARP1
16078,GO:0090022,3.88692310556779e-06,0.999999778035558,7,18,regulation of neutrophil chemotaxis,BP,CXCL8;CXCL2;CXCL3;CXCL1;CXCL5;EDN1;IL23A
14887,GO:0070665,3.91676312082371e-06,0.999999296365163,14,75,positive regulation of leukocyte proliferation,BP,IL1B;TICAM1;CSF1;IL23A;PELI1;EFNB1;IL6;RIPK2;CDKN1A;IL6ST;CD55;TGFBR2;CD276;HLA-E
16508,GO:0097193,3.9174275577033e-06,0.999998713121444,28,245,intrinsic apoptotic signaling pathway,BP,TNF;PLEKHF1;PPP1R15A;PLAUR;SOD2;PMAIP1;PPIF;EPHA2;BBC3;BCL3;PLAGL2;TNFRSF10B;CYLD;CDKN1A;CEBPB;TP53BP2;MMP9;BCL2L2;NFE2L2;PTPN1;CAV1;TP53;IKBKE;PML;MUC1;PARP1;JMY;XBP1
13005,GO:0051403,3.99047405291693e-06,0.999998755363311,26,205,stress-activated MAPK cascade,BP,IL1B;TNF;IL1A;ZC3H12A;BMP2;NFKB1;EDN1;MAP2K3;ZFP36;GADD45A;ZFP36L1;RIPK2;IRAK2;FZD8;NOD2;TRAF4;TRIB1;VEGFA;DKK1;MAP3K8;WNT5A;DUSP10;PTPN1;WNT7B;TAB3;TNIP2
13857,GO:0060443,4.16716564988986e-06,0.999999530576456,10,35,mammary gland morphogenesis,BP,ELF3;TBX3;EPHA2;CSF1;B4GALT1;TGFBR2;WNT5A;CAV1;PML;DDR1
8021,GO:0032649,4.40160405053788e-06,0.999999412688861,11,47,regulation of interferon-gamma production,BP,IL1B;TNF;INHBA;ZC3H12A;IL23A;BCL3;RIPK2;WNT5A;CD276;AXL;IL36RN
1090,GO:0002675,4.52222916765608e-06,0.999999829696712,6,12,positive regulation of acute inflammatory response,BP,IL1B;TNF;IL6;ADAM8;IL6ST;OSMR
19765,GO:2000113,4.74318617838334e-06,0.999997618733121,83,1116,negative regulation of cellular macromolecule biosynthetic process,BP,CSF2;TNF;IRF1;HBEGF;EFNA1;BTG2;ZC3H12A;ELF3;BMP2;PRDM1;TBX3;NFKB1;EDN1;ZFP36;JUN;SQSTM1;BHLHE40;EREG;REL;DUSP1;BCL3;ETS2;NFKB2;RFX5;ZFP36L1;SIX4;JUNB;FZD8;RELB;ZNF217;CCDC85B;CPEB2;ZNF451;NEDD4L;SMAD3;DLX2;VEGFA;NRARP;DKK1;CEBPB;CREB1;NR4A2;VHL;BACH1;SMURF2;TGIF2;NFE2L3;NAB1;WNT5A;PDGFB;NRG1;ATF3;IKZF2;TLE1;PLK3;YAF2;GRB7;NUP153;NEDD4;SMAD1;MXD1;CHD4;ZC3H7B;CAV1;TP53;KLF3;UBE2D3;ELK3;ABCA7;SDR16C5;ZNF148;PML;RELA;MUC1;FRK;NR4A3;GSK3B;PPARD;PARP1;MXD3;QKI;ZBTB5;JUND
12539,GO:0050670,4.77835662905763e-06,0.99999887094561,18,118,regulation of lymphocyte proliferation,BP,IL1B;IRF1;SDC4;PRDM1;TICAM1;IL23A;PELI1;EFNB1;IL6;RIPK2;CDKN1A;IL6ST;CEBPB;CD55;TGFBR2;BTN2A2;CD276;HLA-E
11443,GO:0045860,4.92298792850224e-06,0.999998055659913,38,371,positive regulation of protein kinase activity,BP,IL1B;TNF;EFNA1;SDC4;BMP2;EDN1;MAP2K3;CSF1;EREG;IL23A;GADD45A;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;CDKN1A;NOD2;TRAF4;VEGFA;DKK1;MAP3K8;CCNL1;TGFBR2;SAA1;WNT5A;TGFA;PDGFB;NRG1;CAB39;SPRY2;MMD;PTPN1;WNT7B;TAB3;ABI1;ADAM9
14189,GO:0061061,5.00915518430696e-06,0.999997994868144,39,381,muscle structure development,BP,TNF;HBEGF;BTG2;BMP2;LIF;TBX3;MAFF;EDN1;KDM6B;EHD1;EREG;ZFP36L1;SIX4;SAV1;SMAD3;VEGFA;DKK1;CFLAR;BTG1;ADM;CREB1;TGFBR2;WNT5A;PDGFB;NRG1;ATF3;CHD2;SLC9A1;IL4R;CAV1;EFNB2;JPH2;PIM1;FOXN2;PPARD;EVC;EGLN1;XBP1;QKI
12675,GO:0050866,5.20025051702694e-06,0.999998830107088,17,104,negative regulation of cell activation,BP,TNFAIP3;IRF1;SDC4;INHBA;ZC3H12A;PRDM1;PELI1;CYLD;C1QTNF1;NFKBID;NRARP;CEBPB;PDGFB;LDLR;IL4R;BTN2A2;AXL
6747,GO:0030162,5.20164564356486e-06,0.999997821834112,46,519,regulation of proteolysis,BP,IL1B;TNF;EFNA1;BIRC3;ZC3H12A;RNF19B;PLAUR;PMAIP1;TNIP1;SERPINB2;BBC3;BIRC2;ADAM8;TNFRSF10B;N4BP1;TNFSF15;RIPK2;TNFAIP8;CTSC;TFPI2;SMAD3;RNF144B;TRIB1;SERPINB8;VEGFA;IL1R2;PLK2;CFLAR;ANXA8;CD55;ABTB2;SERPINB1;MMP9;OTUD4;PLK3;RCHY1;TNFRSF6B;NFE2L2;CAV1;PML;ADAM9;CCBE1;PLAT;GSK3B;XBP1;CFB
16724,GO:0097696,5.31820681527961e-06,0.999998868872636,16,95,STAT cascade,BP,CSF2;LIF;IFNAR2;IL23A;BCL3;IL6;IL7R;IL6ST;IFNAR1;VHL;SOCS2;IL20;IL24;PTPN1;STAT5A;CAV1
10506,GO:0043405,5.42978061173674e-06,0.999998107443124,30,261,regulation of MAP kinase activity,BP,IL1B;TNF;BMP2;EDN1;MAP2K3;DUSP1;GADD45A;ADAM8;RIPK2;IRAK2;FZD8;NOD2;TRIB1;VEGFA;DKK1;MAP3K8;DUSP16;SAA1;WNT5A;TGFA;DUSP10;PDGFB;DUSP8;NRG1;SPRY2;PTPN1;WNT7B;TAB3;CAV1;ADAM9
11294,GO:0045596,5.43202599924521e-06,0.999997761829263,41,423,negative regulation of cell differentiation,BP,NFKBIA;TNF;IRF1;EFNA1;INHBA;NOCT;BMP2;TBX3;ZFP36;EREG;IL6;ZFP36L1;SIX4;CYLD;TJP2;CCDC85B;ABCA5;SMAD3;DLX2;NFKBID;TRIB1;NRARP;DKK1;PLK2;CFLAR;SEMA4B;WNT5A;DUSP10;PDGFB;NRG1;LDLR;IL4R;NFE2L2;CAV1;EFNB2;ITGAV;GSK3B;PPARD;VIM;XBP1;KCTD11
3185,GO:0006809,5.52365875007938e-06,0.999999247160583,11,46,nitric oxide biosynthetic process,BP,IL1B;TNF;ZC3H12A;PTX3;EDN1;TICAM1;ICAM1;GCH1;SMAD3;SLC7A2;CAV1
15221,GO:0071356,5.60302115768914e-06,0.99999830446646,24,202,cellular response to tumor necrosis factor,BP,CXCL8;NFKBIA;TNFAIP3;TNF;BIRC3;CCL20;ZC3H12A;NFKB1;EDN1;ZFP36;TRAF1;BIRC2;TNFRSF10B;ZFP36L1;TNFSF15;CYLD;TJP2;CLDN1;RELT;ICAM1;TNFRSF6B;NFE2L2;RELA;OCLN
8499,GO:0033674,5.88425246514434e-06,0.999997568614511,41,415,positive regulation of kinase activity,BP,IL1B;TNF;EFNA1;SDC4;BMP2;EDN1;MAP2K3;EPHA2;CSF1;EREG;IL23A;GADD45A;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;CDKN1A;NOD2;TRAF4;VEGFA;DKK1;MAP3K8;CCNL1;TGFBR2;SAA1;WNT5A;TGFA;PDGFB;NRG1;CAB39;SPRY2;MMD;PTPN1;WNT7B;TAB3;ABI1;ADAM9;AXL;DDR1
15317,GO:0071496,5.99935876643468e-06,0.999997984759637,28,238,cellular response to external stimulus,BP,IL1B;IRF1;NUAK2;PLEKHF1;FOSL1;ZC3H12A;PMAIP1;NFKB1;JUN;GADD45A;TNFRSF10B;CYP27B1;CDKN1A;ICAM1;CDKN2B;UPP1;NR4A2;TNC;SLC38A2;ATF3;SLC9A1;RNF152;NFE2L2;TP53;PIM1;AXL;CYP24A1;XBP1
12784,GO:0051046,6.18757490165711e-06,0.9999974356262,41,426,regulation of secretion,BP,IL1B;TNF;IL1A;SDC4;INHBA;ZC3H12A;LIF;EDN1;HCAR2;IL6;ADAM8;PIM3;PANX1;RIPK2;C1QTNF1;NOD2;SGK1;IL1R2;CREB1;SAA1;WNT5A;VEGFC;SOX4;IFIH1;NRG1;IL4R;MARCKS;BTN2A2;TLR2;RAB9A;STX1A;MAPKBP1;ADGRE2;PML;ADAM9;TRIM16;HLA-E;PPARD;SLC16A1;XBP1;IL36RN
4556,GO:0010634,6.24252121752806e-06,0.999998576480574,17,103,positive regulation of epithelial cell migration,BP,HBEGF;ZC3H12A;EDN1;MAP2K3;JUN;ETS1;VEGFA;PLK2;TGFBR2;WNT5A;VEGFC;PDGFB;MMP9;NFE2L2;STAT5A;ADAM9;CCBE1
3274,GO:0006953,6.26912820599837e-06,0.999999614144255,7,18,acute-phase response,BP,IL1B;TNF;IL1A;IL1RN;IL6;CEBPB;SAA1
12576,GO:0050715,6.30188779984994e-06,0.999998915503117,13,65,positive regulation of cytokine secretion,BP,IL1B;TNF;IL1A;PANX1;RIPK2;NOD2;SAA1;WNT5A;IFIH1;IL4R;TLR2;TRIM16;XBP1
10304,GO:0043062,6.76319154229645e-06,0.999997665322931,29,244,extracellular structure organization,BP,TNF;SDC4;ELF3;ETS1;BCL3;PLAGL2;NFKB2;ADAM8;PHLDB2;ITGA5;ABCA5;ICAM1;SMAD3;B4GALT1;LAMB3;CFLAR;CD47;ITGB8;PDGFB;TNC;MMP9;COL12A1;ITGAV;ABCA7;COL27A1;MMP10;LAMA3;COL8A1;DDR1
9866,GO:0042116,6.79367557872546e-06,0.999999176083801,10,38,macrophage activation,BP,CSF2;ZC3H12A;JUN;TICAM1;SLC7A2;WNT5A;LDLR;IL4R;TNIP2;TLR2
15391,GO:0071622,6.85351876427115e-06,0.999999420917083,8,26,regulation of granulocyte chemotaxis,BP,CXCL8;CXCL2;CXCL3;CXCL1;CXCL5;EDN1;CSF1;IL23A
6793,GO:0030225,6.85444021680931e-06,0.999999440365086,8,23,macrophage differentiation,BP,INHBA;LIF;CSF1;TRIB1;VEGFA;MMP9;TLR2;PARP1
9873,GO:0042129,7.32223260163624e-06,0.999998496588115,15,88,regulation of T cell proliferation,BP,IL1B;IRF1;SDC4;IL23A;PELI1;EFNB1;IL6;RIPK2;IL6ST;CEBPB;CD55;TGFBR2;BTN2A2;CD276;HLA-E
11480,GO:0045926,7.33014630786225e-06,0.999997889623884,22,166,negative regulation of growth,BP,TNF;INHBA;SQSTM1;SERTAD2;BDKRB1;CYP27B1;CDKN1A;CCDC85B;DCUN1D3;SAV1;SMAD3;BTG1;SEMA4B;TGFBR2;WNT5A;DUSP10;SOCS2;DCBLD2;MT2A;TP53;PML;PPARD
18094,GO:1902679,7.67502986477798e-06,0.999996248869645,71,926,negative regulation of RNA biosynthetic process,BP,CSF2;TNF;IRF1;EFNA1;BTG2;ELF3;BMP2;PRDM1;TBX3;NFKB1;EDN1;ZFP36;JUN;SQSTM1;BHLHE40;EREG;REL;BCL3;ETS2;NFKB2;RFX5;SIX4;JUNB;FZD8;RELB;ZNF217;CCDC85B;ZNF451;NEDD4L;SMAD3;DLX2;VEGFA;NRARP;DKK1;CEBPB;CREB1;NR4A2;VHL;BACH1;SMURF2;TGIF2;NFE2L3;NAB1;WNT5A;PDGFB;NRG1;ATF3;IKZF2;TLE1;PLK3;YAF2;NEDD4;MXD1;CHD4;CAV1;TP53;KLF3;UBE2D3;ELK3;SDR16C5;ZNF148;PML;RELA;MUC1;FRK;NR4A3;PPARD;PARP1;MXD3;ZBTB5;JUND
18443,GO:1903507,7.67502986477798e-06,0.999996248869645,71,926,negative regulation of nucleic acid-templated transcription,BP,CSF2;TNF;IRF1;EFNA1;BTG2;ELF3;BMP2;PRDM1;TBX3;NFKB1;EDN1;ZFP36;JUN;SQSTM1;BHLHE40;EREG;REL;BCL3;ETS2;NFKB2;RFX5;SIX4;JUNB;FZD8;RELB;ZNF217;CCDC85B;ZNF451;NEDD4L;SMAD3;DLX2;VEGFA;NRARP;DKK1;CEBPB;CREB1;NR4A2;VHL;BACH1;SMURF2;TGIF2;NFE2L3;NAB1;WNT5A;PDGFB;NRG1;ATF3;IKZF2;TLE1;PLK3;YAF2;NEDD4;MXD1;CHD4;CAV1;TP53;KLF3;UBE2D3;ELK3;SDR16C5;ZNF148;PML;RELA;MUC1;FRK;NR4A3;PPARD;PARP1;MXD3;ZBTB5;JUND
11298,GO:0045600,7.73783902487967e-06,0.999999047083778,10,38,positive regulation of fat cell differentiation,BP,NOCT;ZC3H12A;BMP2;ZFP36;ZFP36L1;SAV1;CEBPB;CREB1;PPARD;XBP1
6703,GO:0030098,7.77143835395351e-06,0.999997539510418,25,201,lymphocyte differentiation,BP,IRF1;INHBA;CD83;PRDM1;KLF6;IL23A;BCL3;IL6;ADAM8;ZFP36L1;RIPK2;CYLD;FZD8;RELB;IL7R;NFKBID;NRARP;RUNX1;TGFBR2;DUSP10;SOX4;IL4R;POU2F2;AXL;XBP1
20293,GO:2001236,7.9945200312119e-06,0.999998032435418,18,121,regulation of extrinsic apoptotic signaling pathway,BP,IL1B;TNFAIP3;CSF2;TNF;IL1A;INHBA;PMAIP1;G0S2;TRAF1;TNFRSF10B;CYLD;ICAM1;CFLAR;ATF3;CAV1;ITGAV;PML;RELA
1173,GO:0002793,8.10341388573623e-06,0.999997732746152,21,155,positive regulation of peptide secretion,BP,IL1B;TNF;IL1A;HCAR2;IL6;ADAM8;PANX1;RIPK2;NOD2;SAA1;WNT5A;VEGFC;SOX4;IFIH1;IL4R;TLR2;ADAM9;TRIM16;HLA-E;PPARD;XBP1
18461,GO:1903530,8.16976038186995e-06,0.999996652156849,39,400,regulation of secretion by cell,BP,IL1B;TNF;IL1A;SDC4;INHBA;ZC3H12A;LIF;EDN1;HCAR2;IL6;ADAM8;PIM3;PANX1;RIPK2;C1QTNF1;NOD2;IL1R2;CREB1;SAA1;WNT5A;VEGFC;SOX4;IFIH1;IL4R;MARCKS;BTN2A2;TLR2;RAB9A;STX1A;MAPKBP1;ADGRE2;PML;ADAM9;TRIM16;HLA-E;PPARD;SLC16A1;XBP1;IL36RN
1102,GO:0002688,8.57510591679062e-06,0.999998604964973,12,61,regulation of leukocyte chemotaxis,BP,CXCL8;CXCL2;CXCL3;CXCL1;CXCL5;EDN1;CSF1;IL23A;IL6;VEGFA;WNT5A;VEGFC
6294,GO:0019900,8.6567825960239e-06,0.999996026231381,52,586,kinase binding,MF,TNFAIP3;SDC4;PPP1R15A;TNIP1;MAP2K3;ZFP36;TICAM1;IFNAR2;EPHA2;SQSTM1;GADD45A;CYLD;RELB;CDKN1A;NOD2;GCH1;SMAD3;RND3;TRAF4;TRIB1;CDKN2B;BTG1;CEBPB;ERRFI1;TGFBR2;DUSP10;NRG1;FAM83B;CAB39;PARD6B;SPRY2;FEZ1;GRB7;GCSAM;MARCKS;PTPN1;SMAD1;CAV1;RHOV;TNIP2;TP53;ITGAV;PJA2;STX1A;DOCK4;ADAM9;RELA;AXL;NR4A3;GSK3B;PARP1;DDR1
9792,GO:0040007,8.65776933547607e-06,0.999995918187911,56,653,growth,BP,TNF;HBEGF;INHBA;EDN1;SQSTM1;CSF1;SERTAD2;EREG;BDKRB1;ZFP36L1;CYP27B1;SIX4;PHLDA2;CDKN1A;CCDC85B;NEDD4L;DCUN1D3;SAV1;SGK1;SMAD3;NINJ1;VEGFA;CFLAR;BTG1;ADM;CREB1;WISP1;NEDD9;SEMA4B;TGFBR2;WNT5A;DUSP10;SOCS2;NRG1;TNC;DCBLD2;MT2A;SLC9A1;SPRY2;CXCL16;ITSN2;WNT7B;SMAD1;CLIC4;STAT5A;TP53;STK40;PML;PIM1;RAPH1;COL27A1;PPARD;EVC;DDR1;EPB41L3;KCTD11
4475,GO:0010468,8.90049667624477e-06,0.99999437186508,207,3515,regulation of gene expression,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;BIRC3;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;PHLDA2;JUNB;CYLD;FZD8;BAMBI;WTAP;RELB;ZNF217;C1QTNF1;CDKN1A;CCDC85B;IL7R;CPEB2;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;FGF5;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;CD55;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;PATL1;VHL;BACH1;MYBL1;RUNX1;TGFBR2;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;ITGB8;WNT5A;TGFA;SOX4;PDGFB;BAZ1A;NRG1;TNC;LDLR;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;YAF2;SPRY2;TNKS1BP1;GRB7;NUP153;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;MXD1;CHD4;ZC3H7B;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;STK40;TAPBP;UBE2D3;ELK3;SNAPC4;CLK4;SDR16C5;ZNF148;PML;PIM1;RELA;TRIM16;FOXN2;CCBE1;MUC1;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;CREB5;EGLN1;RIPK4;ZXDA;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;CFB;JUND;DENND4A
598,GO:0001763,9.40047393997135e-06,0.999997451779853,20,136,morphogenesis of a branching structure,BP,TNF;BMP2;PRDM1;TBX3;EDN1;EPHA2;CSF1;SIX4;B4GALT1;DLX2;VEGFA;NRARP;ADM;TGFBR2;WNT5A;TNC;SPRY2;CLIC4;PML;DDR1
9988,GO:0042379,9.49088361024777e-06,0.999999334114867,7,22,chemokine receptor binding,MF,CXCL8;CXCL2;CXCL3;CXCL1;CCL20;CXCL5;CXCL16
12715,GO:0050920,9.51047131813496e-06,0.999997626752985,18,122,regulation of chemotaxis,BP,CXCL8;CXCL2;CXCL3;CXCL1;CXCL5;IL16;EDN1;CSF1;IL23A;IL6;SMAD3;VEGFA;ZSWIM4;SEMA4B;WNT5A;VEGFC;PDGFB;EFNB2
2939,GO:0006464,9.69615345171569e-06,0.999994081777395,187,3082,cellular protein modification process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;HBEGF;NUAK2;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;CCL20;NCOA7;ZC3H12A;PPP1R15A;RNF19B;BMP2;LIF;PLAUR;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;JUN;TICAM1;KDM6B;EPHA2;SQSTM1;CSF1;SPRR2D;EREG;IL23A;DUSP1;PELI1;GADD45A;BIRC2;IL6;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;ZFP36L1;TNFSF15;RIPK2;IRAK2;KLHL21;DAPP1;CYLD;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;ZNF451;NEDD4L;NOD2;IL6ST;DCUN1D3;SGK1;ICAM1;SMAD3;B4GALT1;B3GNT5;RNF144B;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;PPTC7;CFLAR;RNF43;PIGA;BTG1;PPP4R4;ANKLE2;ERRFI1;ANKK1;CREB1;CCNL1;USP43;MAST4;VHL;PHKG2;BACH1;TGFBR2;SMURF2;DUSP16;SAA1;KLHL5;TRIM25;MASTL;WNT5A;CAMK1G;VEGFC;TGFA;DUSP10;SOX4;PPP1R3B;SOCS2;PDGFB;IL20;IFIH1;DUSP8;NRG1;TNC;MMP9;KIAA1586;ATF3;OTUD4;CAB39;PLK3;ARRDC4;RCHY1;SPRY2;TNKS1BP1;B4GALT5;ARSJ;NUP153;RNF152;NEDD4;MMD;IL24;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;CHD4;STAT5A;TPST1;CAV1;SH3RF2;INO80D;TNIP2;TP53;TLR2;ABI1;STK40;PDP1;ITGAV;IKBKE;UBE2D3;PJA2;SPRR2A;ABCA7;CLK4;TMEM132A;SDR16C5;UBE2Z;PML;PIM1;ADAM9;RELA;TRIM16;ESCO2;PPP6R3;PLAT;MUC1;AXL;FRK;USP31;GSK3B;KMT2E;PARP8;PARP1;KDM7A;LCE1C;EGLN1;RIPK4;RNF145;RPS6KA6;DDR1;KCTD11;LMAN1
9519,GO:0036211,9.69615345171569e-06,0.999994081777395,187,3082,protein modification process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;HBEGF;NUAK2;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;CCL20;NCOA7;ZC3H12A;PPP1R15A;RNF19B;BMP2;LIF;PLAUR;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;JUN;TICAM1;KDM6B;EPHA2;SQSTM1;CSF1;SPRR2D;EREG;IL23A;DUSP1;PELI1;GADD45A;BIRC2;IL6;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;ZFP36L1;TNFSF15;RIPK2;IRAK2;KLHL21;DAPP1;CYLD;FZD8;C1QTNF1;CDKN1A;ITGA5;RAP2B;ZNF451;NEDD4L;NOD2;IL6ST;DCUN1D3;SGK1;ICAM1;SMAD3;B4GALT1;B3GNT5;RNF144B;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;PPTC7;CFLAR;RNF43;PIGA;BTG1;PPP4R4;ANKLE2;ERRFI1;ANKK1;CREB1;CCNL1;USP43;MAST4;VHL;PHKG2;BACH1;TGFBR2;SMURF2;DUSP16;SAA1;KLHL5;TRIM25;MASTL;WNT5A;CAMK1G;VEGFC;TGFA;DUSP10;SOX4;PPP1R3B;SOCS2;PDGFB;IL20;IFIH1;DUSP8;NRG1;TNC;MMP9;KIAA1586;ATF3;OTUD4;CAB39;PLK3;ARRDC4;RCHY1;SPRY2;TNKS1BP1;B4GALT5;ARSJ;NUP153;RNF152;NEDD4;MMD;IL24;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;CHD4;STAT5A;TPST1;CAV1;SH3RF2;INO80D;TNIP2;TP53;TLR2;ABI1;STK40;PDP1;ITGAV;IKBKE;UBE2D3;PJA2;SPRR2A;ABCA7;CLK4;TMEM132A;SDR16C5;UBE2Z;PML;PIM1;ADAM9;RELA;TRIM16;ESCO2;PPP6R3;PLAT;MUC1;AXL;FRK;USP31;GSK3B;KMT2E;PARP8;PARP1;KDM7A;LCE1C;EGLN1;RIPK4;RNF145;RPS6KA6;DDR1;KCTD11;LMAN1
12319,GO:0048660,1.03302603949035e-05,0.999997816934694,15,87,regulation of smooth muscle cell proliferation,BP,TNFAIP3;TNF;HBEGF;EDN1;JUN;EREG;IL6;TRIB1;NAMPT;TGFBR2;PDGFB;MMP9;TP53;NR4A3;PPARD
872,GO:0002218,1.06702896556905e-05,0.999996545036172,25,214,activation of innate immune response,BP,NFKBIA;TNFAIP3;IRF1;BIRC3;NFKB1;TNIP1;TICAM1;PELI1;BIRC2;RIPK2;IRAK2;CYLD;RELB;NOD2;PGLYRP4;IFIH1;OTUD4;TAB3;CAV1;TNIP2;TLR2;IKBKE;UBE2D3;RELA;MUC1
14764,GO:0070431,1.07294029664437e-05,0.999999742942526,5,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,NFKBIA;TNFAIP3;RIPK2;NOD2;RELA
17737,GO:1901652,1.08893770645664e-05,0.999995704187213,35,341,response to peptide,BP,IL1B;NFKBIA;TNFAIP3;BTG2;NFKB1;EDN1;EREG;ZFP36L1;RIPK2;CPEB2;NOD2;ICAM1;CFLAR;BTG1;ADM;ERRFI1;CREB1;NR4A2;SOGA1;SOCS2;SLC9A1;NFE2L2;PTPN1;STAT5A;CAV1;TP53;KLF3;TLR2;RELA;TRIM16;NR4A3;GSK3B;PARP1;XBP1;JUND
12366,GO:0048732,1.09089021843169e-05,0.999995897213024,32,296,gland development,BP,NFKBIA;TNFAIP3;TNF;ELF3;BMP2;TBX3;JUN;EPHA2;ETS1;CSF1;IRF6;SIX4;CLDN1;SMAD3;B4GALT1;VEGFA;CFLAR;CEBPB;CREB1;TGFBR2;HMGCS1;WNT5A;SOCS2;NRG1;TNC;WNT7B;STAT5A;CAV1;PML;RELA;DDR1;XBP1
11782,GO:0046631,1.14299870231825e-05,0.999997909348046,13,67,alpha-beta T cell activation,BP,IRF1;CD83;PRDM1;IL23A;BCL3;IL6;RIPK2;RELB;CD55;TGFBR2;IL4R;HLA-E;ELF4
12318,GO:0048659,1.19024401203218e-05,0.999997450695924,15,88,smooth muscle cell proliferation,BP,TNFAIP3;TNF;HBEGF;EDN1;JUN;EREG;IL6;TRIB1;NAMPT;TGFBR2;PDGFB;MMP9;TP53;NR4A3;PPARD
1170,GO:0002790,1.19338145311704e-05,0.999995267538009,35,348,peptide secretion,BP,IL1B;TNF;IL1A;ZC3H12A;IL1RN;EDN1;HCAR2;IL6;ADAM8;PIM3;PANX1;RIPK2;NOD2;IL1R2;SAA1;WNT5A;VEGFC;SOX4;IFIH1;IL4R;POU2F2;MARCKS;BTN2A2;TLR2;ITGAV;STX1A;MAPKBP1;PML;ADAM9;TRIM16;HLA-E;PPARD;SLC16A1;XBP1;IL36RN
8199,GO:0032940,1.19845182583005e-05,0.999993847999967,71,936,secretion by cell,BP,IL1B;TNF;PLAU;CXCL1;IL1A;SDC4;INHBA;ZC3H12A;LIF;PLAUR;TBX3;PTX3;IL1RN;NFKB1;EDN1;HCAR2;AMPD3;IL6;ADAM8;PIM3;PANX1;RIPK2;C1QTNF1;RAP2B;TNFAIP2;CTSC;NOD2;B4GALT1;VEGFA;RAB24;IL1R2;VMP1;CD55;ADM;CREB1;CD47;CANT1;SAA1;WNT5A;VEGFC;SOX4;SERPINB1;PDGFB;IFIH1;SLC38A2;MMP9;CAB39;IL4R;POU2F2;MARCKS;BTN2A2;TLR2;RAB9A;ITGAV;STX1A;MAPKBP1;ADGRE2;PML;ADAM9;TRIM16;AXL;ANXA5;FRK;NR4A3;HLA-E;PPARD;SLC16A1;COTL1;XBP1;IL36RN;MGAM
4201,GO:0009306,1.20502035877213e-05,0.999995287427831,34,333,protein secretion,BP,IL1B;TNF;IL1A;ZC3H12A;IL1RN;HCAR2;IL6;ADAM8;PIM3;PANX1;RIPK2;NOD2;IL1R2;SAA1;WNT5A;VEGFC;SOX4;IFIH1;IL4R;POU2F2;MARCKS;BTN2A2;TLR2;ITGAV;STX1A;MAPKBP1;PML;ADAM9;TRIM16;HLA-E;PPARD;SLC16A1;XBP1;IL36RN
11797,GO:0046651,1.20506883220359e-05,0.999996652616083,20,151,lymphocyte proliferation,BP,IL1B;IRF1;SDC4;PRDM1;TICAM1;IL23A;PELI1;EFNB1;IL6;RIPK2;CDKN1A;IL7R;IL6ST;CEBPB;CD55;TGFBR2;BTN2A2;CD276;HLA-E;ELF4
12540,GO:0050671,1.20703072066473e-05,0.999997763261952,13,72,positive regulation of lymphocyte proliferation,BP,IL1B;TICAM1;IL23A;PELI1;EFNB1;IL6;RIPK2;CDKN1A;IL6ST;CD55;TGFBR2;CD276;HLA-E
7757,GO:0032269,1.2081104642992e-05,0.999993951019847,65,847,negative regulation of cellular protein metabolic process,BP,IL1B;TNFAIP3;TNF;EFNA1;BTG2;BIRC3;NCOA7;ZC3H12A;PPP1R15A;LIF;PLAUR;NFKB1;TNIP1;EDN1;ZFP36;SERPINB2;JUN;DUSP1;GADD45A;BIRC2;TNFRSF10B;BDKRB1;N4BP1;ZFP36L1;TNFAIP8;CDKN1A;CPEB2;ZNF451;TFPI2;SMAD3;TRIB1;SERPINB8;VEGFA;IL1R2;DKK1;CDKN2B;ANXA8;PPP4R4;CD55;ERRFI1;DUSP16;MASTL;DUSP10;SOX4;SERPINB1;SOCS2;DUSP8;MMP9;ATF3;SPRY2;GRB7;NUP153;TNFRSF6B;PTPN1;SMAD1;ZC3H7B;CAV1;SH3RF2;SDR16C5;PML;RELA;PLAT;GSK3B;RPS6KA6;QKI
8062,GO:0032722,1.217868780105e-05,0.9999986275696,9,34,positive regulation of chemokine production,BP,IL1B;TNF;IL1A;TICAM1;IL6;RIPK2;WNT5A;IL4R;TLR2
4340,GO:0009889,1.23883250650679e-05,0.99999213881658,202,3401,regulation of biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;BTG2;INHBA;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;PTX3;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;CCDC85B;CPEB2;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;NAMPT;ERRFI1;CREB1;TAF4B;CCNL1;NR4A2;VHL;SOGA1;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;HMGCS1;WNT5A;TGFA;SOX4;PPP1R3B;PDGFB;BAZ1A;NRG1;LDLR;ATF3;IKZF2;TLE1;PLK3;CHD2;SUCO;SLC9A1;ZBTB10;YAF2;GRB7;NUP153;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;PAOX;MXD1;CHD4;ZC3H7B;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;PDP1;ITGAV;UBE2D3;CD276;ELK3;SNAPC4;ABCA7;SDR16C5;ZNF148;PML;PIM1;RELA;TRIM16;ESCO2;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;CREB5;EGLN1;RIPK4;ZXDA;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
9793,GO:0040008,1.24922083773869e-05,0.999994600939827,42,450,regulation of growth,BP,TNF;HBEGF;INHBA;EDN1;SQSTM1;CSF1;SERTAD2;BDKRB1;CYP27B1;SIX4;PHLDA2;CDKN1A;CCDC85B;NEDD4L;DCUN1D3;SAV1;SGK1;SMAD3;VEGFA;BTG1;CREB1;WISP1;NEDD9;SEMA4B;TGFBR2;WNT5A;DUSP10;SOCS2;NRG1;DCBLD2;MT2A;SLC9A1;CXCL16;ITSN2;STAT5A;TP53;PML;PIM1;PPARD;DDR1;EPB41L3;KCTD11
1109,GO:0002695,1.29545662363594e-05,0.999997201836156,15,89,negative regulation of leukocyte activation,BP,TNFAIP3;IRF1;SDC4;INHBA;ZC3H12A;PRDM1;PELI1;CYLD;NFKBID;NRARP;CEBPB;LDLR;IL4R;BTN2A2;AXL
12379,GO:0048754,1.35413518715455e-05,0.999996708036629,17,106,branching morphogenesis of an epithelial tube,BP,TNF;BMP2;TBX3;EDN1;EPHA2;CSF1;SIX4;B4GALT1;VEGFA;NRARP;TGFBR2;WNT5A;TNC;SPRY2;CLIC4;PML;DDR1
15533,GO:0071900,1.4210640790995e-05,0.999994080028851,38,392,regulation of protein serine/threonine kinase activity,BP,IL1B;TNFAIP3;TNF;BMP2;EDN1;MAP2K3;DUSP1;GADD45A;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;CDKN1A;NOD2;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;MAP3K8;CCNL1;DUSP16;SAA1;WNT5A;TGFA;DUSP10;PDGFB;DUSP8;NRG1;CAB39;SPRY2;PTPN1;WNT7B;TAB3;CAV1;ADAM9
13909,GO:0060537,1.43664155482818e-05,0.999995036871901,27,228,muscle tissue development,BP,BTG2;BMP2;TBX3;MAFF;EDN1;KDM6B;SIX4;SAV1;SMAD3;VEGFA;DKK1;CFLAR;CREB1;TGFBR2;WNT5A;NRG1;ATF3;SLC9A1;SMAD1;CAV1;ZFAND5;EFNB2;JPH2;PIM1;FOXN2;EGLN1;GJC1
548,GO:0001667,1.44416594432262e-05,0.999994681408826,30,272,ameboidal-type cell migration,BP,HBEGF;EFNA1;SDC4;ZC3H12A;EDN1;MAP2K3;JUN;EPHA2;ETS1;EFNB1;AMOTL2;VEGFA;PLK2;SEMA4B;TGFBR2;SMURF2;WNT5A;VEGFC;DUSP10;PDGFB;ANLN;MMP9;NFE2L2;STAT5A;ZFAND5;EFNB2;PML;ADAM9;CCBE1;PPARD
20062,GO:2000660,1.45889158469307e-05,0.999999874763007,4,5,negative regulation of interleukin-1-mediated signaling pathway,BP,IL1RN;IL6;IL1R2;OTUD4
4269,GO:0009612,1.46688883773438e-05,0.999996043128465,19,133,response to mechanical stimulus,BP,IL1B;NFKBIA;IRF1;BTG2;FOSL1;NFKB1;EDN1;JUN;ETS1;GADD45A;TNFRSF10B;BDKRB1;JUNB;TGFBR2;TNC;SLC38A2;SLC9A1;RELA;JUND
887,GO:0002250,1.46816026977194e-05,0.999995284762071,24,198,adaptive immune response,BP,IL1B;TNFAIP3;TNF;IRF1;RNF19B;PRDM1;IL23A;BCL3;IL6;NFKB2;RIPK2;RELB;IL7R;CTSC;IL6ST;ICAM1;CD55;TAP1;DUSP10;IL4R;NEDD4;POU2F2;HLA-E;TFE3
10101,GO:0042605,1.47254157833085e-05,0.999999251548832,6,14,peptide antigen binding,MF,TAP1;HLA-A;TAPBP;HLA-B;HLA-F;HLA-E
11081,GO:0045073,1.51173804428566e-05,0.999999559859906,5,9,regulation of chemokine biosynthetic process,BP,IL1B;TNF;TICAM1;IL6;WNT5A
19983,GO:2000516,1.55165532751834e-05,0.999999203813525,6,14,positive regulation of CD4-positive, alpha-beta T cell activation,BP,CD83;IL23A;RIPK2;CD55;TGFBR2;IL4R
2860,GO:0006351,1.55915042403116e-05,0.999990026217359,180,2975,transcription, DNA-templated,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;CCDC85B;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;YAF2;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ZXDA;XBP1;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
7321,GO:0031326,1.58078737947721e-05,0.99998993930826,199,3351,regulation of cellular biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;BTG2;INHBA;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;PTX3;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;CCDC85B;CPEB2;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;NAMPT;ERRFI1;CREB1;TAF4B;CCNL1;NR4A2;VHL;SOGA1;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PPP1R3B;PDGFB;BAZ1A;NRG1;LDLR;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;YAF2;GRB7;NUP153;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;PAOX;MXD1;CHD4;ZC3H7B;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;PDP1;UBE2D3;CD276;ELK3;SNAPC4;ABCA7;SDR16C5;ZNF148;PML;PIM1;RELA;TRIM16;ESCO2;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;CREB5;EGLN1;RIPK4;ZXDA;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
898,GO:0002274,1.60249456822575e-05,0.999993193361592,39,428,myeloid leukocyte activation,BP,CXCL8;CSF2;PLAU;CXCL1;ZC3H12A;PLAUR;PTX3;NFKB1;JUN;TICAM1;CSF1;AMPD3;ADAM8;RELB;RAP2B;CTSC;B4GALT1;RAB24;CD55;SLC7A2;CD47;CANT1;TGFBR2;WNT5A;SERPINB1;MMP9;LDLR;CAB39;IL4R;TNIP2;TLR2;ITGAV;ADGRE2;ADAM9;FRK;NR4A3;KMT2E;COTL1;MGAM
10961,GO:0044706,1.60253075747837e-05,0.999995644358926,19,135,multi-multicellular organism process,BP,IL1B;FOSL1;LIF;PRDM1;MAFF;EDN1;ETS1;CYP27B1;JUNB;B4GALT1;VMP1;NAMPT;ADM;TGFBR2;SMURF2;SLC38A2;MMP9;PPARD;DDR1
9429,GO:0035994,1.61293086490876e-05,0.999999197746843,6,13,response to muscle stretch,BP,NFKBIA;NFKB1;EDN1;JUN;SLC9A1;RELA
3519,GO:0007492,1.62013318076601e-05,0.999997208887657,12,57,endoderm development,BP,INHBA;DUSP1;ZFP36L1;ITGA5;SMAD3;DKK1;LAMB3;MMP9;COL12A1;ITGAV;LAMA3;COL8A1
7996,GO:0032609,1.64015861726583e-05,0.999997428988064,11,53,interferon-gamma production,BP,IL1B;TNF;INHBA;ZC3H12A;IL23A;BCL3;RIPK2;WNT5A;CD276;AXL;IL36RN
1149,GO:0002753,1.68393370970862e-05,0.999997373257281,11,50,cytoplasmic pattern recognition receptor signaling pathway,BP,NFKBIA;TNFAIP3;BIRC3;BIRC2;RIPK2;IRAK2;CYLD;NOD2;IFIH1;TAB3;RELA
7677,GO:0032102,1.70378745553058e-05,0.99999462941078,23,188,negative regulation of response to external stimulus,BP,TNFAIP3;PLAU;ZC3H12A;PLAUR;PRDM1;NFKB1;EDN1;SERPINB2;ETS1;PHLDB2;C1QTNF1;NOD2;SMAD3;TRIB1;IL1R2;SEMA4B;SAA1;WNT5A;DUSP10;PDGFB;MAPKBP1;PLAT;PPARD
12567,GO:0050706,1.72116223005183e-05,0.999998709896284,7,20,regulation of interleukin-1 beta secretion,BP,ZC3H12A;PANX1;RIPK2;NOD2;WNT5A;PML;TRIM16
11285,GO:0045582,1.7317493277908e-05,0.999997603192412,10,43,positive regulation of T cell differentiation,BP,CD83;IL23A;ADAM8;RIPK2;CYLD;IL7R;TGFBR2;DUSP10;IL4R;XBP1
4509,GO:0010556,1.82941065073108e-05,0.999988165786664,194,3256,regulation of macromolecule biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;BTG2;INHBA;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;CCDC85B;CPEB2;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;NAMPT;ERRFI1;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PPP1R3B;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;YAF2;GRB7;NUP153;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;MXD1;CHD4;ZC3H7B;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;ITGAV;UBE2D3;CD276;ELK3;SNAPC4;ABCA7;SDR16C5;ZNF148;PML;PIM1;RELA;TRIM16;ESCO2;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;CREB5;EGLN1;RIPK4;ZXDA;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
12812,GO:0051093,1.84243716701352e-05,0.999991375836991,49,566,negative regulation of developmental process,BP,NFKBIA;TNF;IRF1;EFNA1;INHBA;NOCT;BMP2;TBX3;ZFP36;EREG;IL6;ZFP36L1;SIX4;PHLDB2;CYLD;TJP2;CCDC85B;ABCA5;SAV1;SMAD3;DLX2;NFKBID;TRIB1;NRARP;DKK1;PLK2;CFLAR;SEMA4B;TGFBR2;WNT5A;DUSP10;SOCS2;PDGFB;NRG1;LDLR;SPRY2;IL4R;NFE2L2;CAV1;TLR2;EFNB2;ITGAV;PML;GSK3B;PPARD;VIM;RPS6KA6;XBP1;KCTD11
4867,GO:0014706,1.87463971080502e-05,0.999993567315379,26,219,striated muscle tissue development,BP,BTG2;BMP2;TBX3;MAFF;EDN1;KDM6B;SIX4;SAV1;SMAD3;VEGFA;DKK1;CFLAR;CREB1;TGFBR2;WNT5A;NRG1;ATF3;SLC9A1;SMAD1;CAV1;EFNB2;JPH2;PIM1;FOXN2;EGLN1;GJC1
11253,GO:0045444,1.9187771542603e-05,0.999994495546303,20,148,fat cell differentiation,BP,TNF;NOCT;ZC3H12A;BMP2;ZFP36;IL6;ZFP36L1;STEAP4;CCDC85B;SAV1;SMAD3;LAMB3;CEBPB;CREB1;NR4A2;WNT5A;DUSP10;NR4A3;PPARD;XBP1
18167,GO:1902895,1.92730198180829e-05,0.999998553981033,7,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,BMP2;JUN;SMAD3;PDGFB;SMAD1;TP53;RELA
2117,GO:0004904,1.96152221351288e-05,0.999999818069232,4,5,interferon receptor activity,MF,IFNAR2;IFNGR2;IFNAR1;IFNGR1
15535,GO:0071902,1.97046312106118e-05,0.999992751435105,29,265,positive regulation of protein serine/threonine kinase activity,BP,IL1B;TNF;BMP2;EDN1;MAP2K3;GADD45A;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;NOD2;TRAF4;VEGFA;DKK1;MAP3K8;CCNL1;SAA1;WNT5A;TGFA;PDGFB;NRG1;CAB39;SPRY2;PTPN1;WNT7B;TAB3;ADAM9
16714,GO:0097659,2.02092645655203e-05,0.99998700671089,180,2989,nucleic acid-templated transcription,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;CCDC85B;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;YAF2;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ZXDA;XBP1;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
567,GO:0001706,2.02790520593492e-05,0.999997161407716,10,41,endoderm formation,BP,INHBA;DUSP1;ITGA5;DKK1;LAMB3;MMP9;COL12A1;ITGAV;LAMA3;COL8A1
3448,GO:0007259,2.06165867607359e-05,0.999995338809535,15,94,JAK-STAT cascade,BP,CSF2;LIF;IFNAR2;IL23A;BCL3;IL6;IL6ST;IFNAR1;VHL;SOCS2;IL20;IL24;PTPN1;STAT5A;CAV1
13921,GO:0060558,2.07543754892233e-05,0.999999804636491,4,5,regulation of calcidiol 1-monooxygenase activity,BP,IL1B;TNF;NFKB1;CYP27B1
14663,GO:0070245,2.07837870233132e-05,0.999999804287038,4,5,positive regulation of thymocyte apoptotic process,BP,ADAM8;NFKBID;WNT5A;TP53
17321,GO:0140110,2.15334603346984e-05,0.999987587830078,99,1402,transcription regulator activity,MF,NFKBIZ;IRF1;BTG2;NOCT;FOSL1;NCOA7;ELF3;PRDM1;TBX3;EHF;MAFF;NFKB1;JUN;KDM6B;ETS1;BHLHE40;ZNF267;SERTAD2;KLF6;IRF6;REL;BCL3;PLAGL2;BIRC2;ETS2;ZNF436;CSRNP1;NFKB2;RFX5;ZFP36L1;SIX4;THAP10;JUNB;RELB;ZNF217;ZNF451;ELMSAN1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;ZBED2;KLF7;BTG1;CEBPB;CEBPD;CREB1;TAF4B;NR4A2;BACH1;MYBL1;RUNX1;SFR1;TGIF2;GPBP1;NFE2L3;TRIM25;NAB1;WNT5A;SOX4;NRG1;ATF3;IKZF2;TLE1;YAF2;POU2F2;NFE2L2;SMAD1;MXD1;NFAT5;STAT5A;VEZF1;ZNFX1;TP53;KLF3;ELK3;SNAPC4;SDR16C5;ZNF148;RELA;FOXN2;MUC1;CITED4;NR4A3;PPARD;PARP1;MED13;MXD3;CRAMP1;JMY;CREB5;ZXDA;XBP1;ZBTB5;ELF4;TFE3;ZMIZ2;JUND
8069,GO:0032732,2.15536324159097e-05,0.999997819235147,8,28,positive regulation of interleukin-1 production,BP,CCL20;PANX1;RIPK2;NOD2;SMAD3;SAA1;WNT5A;TRIM16
9855,GO:0042098,2.26656274913485e-05,0.999994503364921,16,108,T cell proliferation,BP,IL1B;IRF1;SDC4;IL23A;PELI1;EFNB1;IL6;RIPK2;IL6ST;CEBPB;CD55;TGFBR2;BTN2A2;CD276;HLA-E;ELF4
4338,GO:0009887,2.36949573550636e-05,0.999988399042132,54,643,animal organ morphogenesis,BP,TNFAIP3;TNF;EFNA1;INHBA;ELF3;BMP2;LIF;PRDM1;TBX3;EDN1;JUN;EPHA2;CSF1;EREG;CSRNP1;SIX4;PHLDA2;FJX1;SAV1;SMAD3;B4GALT1;DLX2;VEGFA;DKK1;CFLAR;CEBPB;ADM;ERRFI1;ADAMTS1;TGFBR2;SMURF2;NAB1;WNT5A;VEGFC;SOX4;NRG1;TNC;TLE1;SPRY2;NEDD4;WNT7B;CAV1;ZFAND5;STK40;EFNB2;PML;PIM1;RELA;COL27A1;NR4A3;COL8A1;EGLN1;DDR1;XBP1
8096,GO:0032774,2.45792591122147e-05,0.999984136190169,180,2999,RNA biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;CCDC85B;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;YAF2;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ZXDA;XBP1;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
683,GO:0001890,2.4946554001723e-05,0.999993584383927,17,116,placenta development,BP,CSF2;FOSL1;LIF;PRDM1;BIRC2;ZFP36L1;CYP27B1;PHLDA2;JUNB;CEBPB;ADM;GJB3;ITGB8;PDGFB;WNT7B;PPARD;EGLN1
12920,GO:0051253,2.54487142119365e-05,0.999986289887862,73,992,negative regulation of RNA metabolic process,BP,CSF2;TNF;IRF1;EFNA1;BTG2;NOCT;ZC3H12A;ELF3;BMP2;PRDM1;TBX3;NFKB1;EDN1;ZFP36;JUN;SQSTM1;BHLHE40;EREG;REL;BCL3;ETS2;NFKB2;RFX5;SIX4;JUNB;FZD8;RELB;ZNF217;CCDC85B;ZNF451;NEDD4L;SMAD3;DLX2;VEGFA;NRARP;DKK1;CEBPB;CREB1;NR4A2;VHL;BACH1;SMURF2;TGIF2;NFE2L3;NAB1;WNT5A;PDGFB;NRG1;ATF3;IKZF2;TLE1;PLK3;YAF2;NEDD4;MXD1;CHD4;CAV1;TP53;KLF3;UBE2D3;ELK3;SDR16C5;ZNF148;PML;RELA;MUC1;FRK;NR4A3;PPARD;PARP1;MXD3;ZBTB5;JUND
9825,GO:0042033,2.56663829988849e-05,0.999999092120769,5,10,chemokine biosynthetic process,BP,IL1B;TNF;TICAM1;IL6;WNT5A
12597,GO:0050755,2.56663829988849e-05,0.999999092120769,5,10,chemokine metabolic process,BP,IL1B;TNF;TICAM1;IL6;WNT5A
20292,GO:2001235,2.60623776944925e-05,0.999992605588277,19,150,positive regulation of apoptotic signaling pathway,BP,INHBA;PLEKHF1;PLAUR;PMAIP1;PPIF;G0S2;BBC3;PLAGL2;TNFRSF10B;CYLD;CTSC;SMAD3;TP53BP2;MMP9;ATF3;CAV1;TP53;PML;GSK3B
14577,GO:0070098,2.63032033865012e-05,0.999997830005271,7,22,chemokine-mediated signaling pathway,BP,CXCL8;CXCL2;CXCL3;CXCL1;CCL20;CXCL5;EDN1
11326,GO:0045637,2.63144503716475e-05,0.999991937330301,21,183,regulation of myeloid cell differentiation,BP,NFKBIA;CSF2;TNF;INHBA;LIF;ZFP36;JUN;ETS1;CSF1;IL23A;ZFP36L1;TJP2;TRIB1;CEBPB;CREB1;RUNX1;IL20;EVI2B;NR4A3;KMT2E;TFE3
11251,GO:0045428,2.85621235278325e-05,0.999996365651005,9,36,regulation of nitric oxide biosynthetic process,BP,IL1B;TNF;ZC3H12A;PTX3;EDN1;TICAM1;ICAM1;SMAD3;CAV1
9423,GO:0035987,2.87957071323834e-05,0.999996370167751,9,34,endodermal cell differentiation,BP,INHBA;ITGA5;DKK1;LAMB3;MMP9;COL12A1;ITGAV;LAMA3;COL8A1
7211,GO:0031098,2.90881292292877e-05,0.999989727847764,26,228,stress-activated protein kinase signaling cascade,BP,IL1B;TNF;IL1A;ZC3H12A;BMP2;NFKB1;EDN1;MAP2K3;ZFP36;GADD45A;ZFP36L1;RIPK2;IRAK2;FZD8;NOD2;TRAF4;TRIB1;VEGFA;DKK1;MAP3K8;WNT5A;DUSP10;PTPN1;WNT7B;TAB3;TNIP2
6594,GO:0022603,2.99064442348657e-05,0.999984872557289,58,713,regulation of anatomical structure morphogenesis,BP,CXCL8;IL1B;TNFAIP3;TNF;IL1A;EFNA1;ZC3H12A;BMP2;LIF;IL1RN;EDN1;EPHA2;EHD1;ETS1;CSF1;IL6;SIX4;PHLDB2;BAMBI;ITGA5;NEDD4L;ICAM1;B4GALT1;RND3;VEGFA;FGD6;NRARP;DKK1;ZSWIM4;PLK2;CFLAR;BTG1;ADM;CDC42EP4;SEMA4B;RUNX1;TGFBR2;SMURF2;TGIF2;ITGB8;WNT5A;VEGFC;NRG1;SPRY2;IL4R;NEDD4;ITSN2;NFE2L2;SMAD1;RHOV;EFNB2;PML;PIM1;ADAM9;CCBE1;EGLN1;XBP1;EPB41L3
16506,GO:0097191,3.01495455363041e-05,0.999990704866945,21,171,extrinsic apoptotic signaling pathway,BP,IL1B;TNFAIP3;CSF2;TNF;IL1A;INHBA;PMAIP1;G0S2;TRAF1;TNFRSF10B;CYLD;ICAM1;SMAD3;CFLAR;ATF3;BCL2L2;CAV1;ITGAV;PML;RELA;GSK3B
18165,GO:1902893,3.32328757952015e-05,0.999996450645111,8,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,BMP2;JUN;SMAD3;PDGFB;SMAD1;TP53;RELA;PPARD
3523,GO:0007498,3.37279950095041e-05,0.99999308510395,13,72,mesoderm development,BP,INHBA;TBX3;KDM6B;ETS2;ZFP36L1;SMAD3;VEGFA;DKK1;TXNRD1;WNT5A;SMAD1;NR4A3;RPS6KA6
7500,GO:0031667,3.37466723255993e-05,0.999986480707075,32,320,response to nutrient levels,BP,IL1B;NUAK2;PLEKHF1;ZC3H12A;PMAIP1;ZFP36;JUN;PANX1;CYP27B1;CDKN1A;NOD2;ICAM1;CDKN2B;UPP1;ADM;CREB1;TGFBR2;TRIM25;HMGCS1;TNC;SLC38A2;LDLR;ATF3;RNF152;NFE2L2;TP53;PIM1;RELA;PPARD;SLC16A1;CYP24A1;XBP1
12369,GO:0048738,3.38268468350467e-05,0.999990668143821,18,125,cardiac muscle tissue development,BP,BMP2;TBX3;EDN1;KDM6B;SAV1;VEGFA;DKK1;CREB1;TGFBR2;WNT5A;NRG1;SLC9A1;SMAD1;EFNB2;JPH2;PIM1;EGLN1;GJC1
12919,GO:0051252,3.50741900462187e-05,0.999976827077835,181,3024,regulation of RNA metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;WTAP;RELB;ZNF217;CDKN1A;CCDC85B;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;YAF2;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;CLK4;SDR16C5;ZNF148;PML;PIM1;RELA;TRIM16;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;CREB5;EGLN1;RIPK4;ZXDA;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
19764,GO:2000112,3.54287122492317e-05,0.999976461066952,190,3207,regulation of cellular macromolecule biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;CCDC85B;CPEB2;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PPP1R3B;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;YAF2;GRB7;NUP153;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;MXD1;CHD4;ZC3H7B;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;ABCA7;SDR16C5;ZNF148;PML;PIM1;RELA;TRIM16;ESCO2;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;CREB5;EGLN1;RIPK4;ZXDA;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
8613,GO:0034121,3.58712571540289e-05,0.999995296707324,9,36,regulation of toll-like receptor signaling pathway,BP,TNFAIP3;IRF1;BIRC3;TICAM1;PELI1;BIRC2;OTUD4;CAV1;TLR2
16773,GO:0098552,3.6342902978096e-05,0.999986398899296,28,262,side of membrane,CC,TNF;CD83;BIRC2;CYLD;ITGA5;IL7R;IL6ST;ICAM1;B4GALT1;ABL2;ERRFI1;TGFBR2;NRG1;LDLR;CYTH1;BTN2A2;PTPN1;HLA-A;TAPBP;HLA-B;ITGAV;GEM;CD276;ADAM9;ANXA5;FRK;HLA-F;HLA-E
13183,GO:0051767,3.71348771754588e-05,0.999998578157678,5,10,nitric-oxide synthase biosynthetic process,BP,CCL20;EDN1;NOD2;NAMPT;TLR2
13184,GO:0051769,3.71348771754588e-05,0.999998578157678,5,10,regulation of nitric-oxide synthase biosynthetic process,BP,CCL20;EDN1;NOD2;NAMPT;TLR2
6304,GO:0019915,3.73589828435832e-05,0.999994270736621,10,46,lipid storage,BP,IL1B;NFKBIA;TNF;ZC3H12A;NFKB1;EHD1;IL6;CAV1;ITGAV;IKBKE
10613,GO:0043588,3.80916725308569e-05,0.999986292078443,26,240,skin development,BP,TNF;INHBA;ZFP36;EPHA2;SPRR2D;IRF6;EREG;ZFP36L1;CYP27B1;CLDN1;SAV1;KRT34;DKK1;GJB3;ERRFI1;GORAB;RUNX1;WNT5A;IL20;CLIC4;NOM1;SPRR2A;ADAM9;RELA;TRIM16;LCE1C
12978,GO:0051347,3.84103862694675e-05,0.999982291711791,43,483,positive regulation of transferase activity,BP,IL1B;TNF;EFNA1;SDC4;BMP2;EDN1;MAP2K3;EPHA2;CSF1;EREG;IL23A;GADD45A;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;CDKN1A;NOD2;DCUN1D3;TRAF4;VEGFA;DKK1;MAP3K8;CCNL1;TGFBR2;SAA1;WNT5A;TGFA;PDGFB;NRG1;CAB39;ARRDC4;SPRY2;MMD;PTPN1;WNT7B;TAB3;ABI1;ADAM9;AXL;DDR1
889,GO:0002252,4.04353067007315e-05,0.999979150232954,58,753,immune effector process,BP,IL1B;TNFAIP3;TNF;IRF1;PLAU;CXCL1;BIRC3;ZC3H12A;CXCL5;PLAUR;PMAIP1;PTX3;NFKB1;TICAM1;IFNAR2;IL23A;BCL3;AMPD3;BIRC2;IL6;ADAM8;RIPK2;RELB;RAP2B;IL7R;CTSC;NOD2;ICAM1;B4GALT1;RAB24;CD55;CD47;CANT1;TRIM25;WNT5A;DUSP10;SERPINB1;IFIH1;MMP9;CAB39;IL4R;POU2F2;RAET1L;TLR2;ABI1;ITGAV;ADGRE2;PML;POLR3A;RELA;FRK;NR4A3;HLA-E;KMT2E;COTL1;XBP1;MGAM;CFB
14673,GO:0070266,4.04938314497485e-05,0.999995447528748,8,30,necroptotic process,BP,TNF;BIRC3;PPIF;TICAM1;BIRC2;CYLD;CFLAR;CAV1
11442,GO:0045859,4.08811070947007e-05,0.999980115947291,49,583,regulation of protein kinase activity,BP,IL1B;TNFAIP3;TNF;EFNA1;SDC4;BMP2;EDN1;MAP2K3;CSF1;EREG;IL23A;DUSP1;GADD45A;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;CDKN1A;RAP2B;NOD2;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;MAP3K8;ERRFI1;CCNL1;TGFBR2;DUSP16;SAA1;WNT5A;TGFA;DUSP10;SOCS2;PDGFB;DUSP8;NRG1;CAB39;SPRY2;MMD;PTPN1;WNT7B;TAB3;CAV1;ABI1;ADAM9
2241,GO:0005149,4.2093106883846e-05,0.999998344235879,5,10,interleukin-1 receptor binding,MF,IL1B;IL1A;IL36G;IL1RN;IL36RN
1152,GO:0002757,4.25475105534776e-05,0.999982720694253,32,330,immune response-activating signal transduction,BP,NFKBIA;TNFAIP3;IRF1;BIRC3;ZC3H12A;NFKB1;TNIP1;TICAM1;PELI1;BIRC2;RIPK2;IRAK2;CYLD;RELB;NOD2;RUNX1;PGLYRP4;IFIH1;OTUD4;GCSAM;BTN2A2;TAB3;CAV1;TNIP2;TLR2;ABI1;IKBKE;UBE2D3;CD276;RELA;MUC1;NR4A3
18408,GO:1903409,4.29863176248491e-05,0.999991641920017,12,67,reactive oxygen species biosynthetic process,BP,IL1B;TNF;ZC3H12A;PTX3;EDN1;TICAM1;ICAM1;GCH1;SMAD3;CFLAR;SLC7A2;CAV1
14177,GO:0061045,4.30281325747083e-05,0.999993286814664,10,46,negative regulation of wound healing,BP,PLAU;PLAUR;EDN1;SERPINB2;PHLDB2;C1QTNF1;SMAD3;DUSP10;PDGFB;PLAT
6295,GO:0019901,4.40613118003756e-05,0.999979014231248,46,526,protein kinase binding,MF,SDC4;PPP1R15A;TNIP1;MAP2K3;ZFP36;TICAM1;IFNAR2;EPHA2;SQSTM1;CYLD;RELB;CDKN1A;NOD2;GCH1;SMAD3;RND3;TRAF4;TRIB1;CDKN2B;ERRFI1;TGFBR2;DUSP10;NRG1;FAM83B;PARD6B;SPRY2;FEZ1;GRB7;GCSAM;MARCKS;PTPN1;SMAD1;CAV1;RHOV;TNIP2;TP53;ITGAV;PJA2;DOCK4;ADAM9;RELA;AXL;NR4A3;GSK3B;PARP1;DDR1
1461,GO:0003700,4.46471044425936e-05,0.999974707585096,80,1084,DNA binding transcription factor activity,MF,IRF1;BTG2;NOCT;FOSL1;ELF3;PRDM1;TBX3;EHF;MAFF;NFKB1;JUN;ETS1;BHLHE40;ZNF267;KLF6;IRF6;REL;BCL3;PLAGL2;ETS2;ZNF436;CSRNP1;NFKB2;RFX5;ZFP36L1;SIX4;THAP10;JUNB;RELB;ZNF217;ZNF451;ELMSAN1;SMAD3;DLX2;ARNTL2;ZBED2;KLF7;CEBPB;CEBPD;CREB1;TAF4B;NR4A2;BACH1;MYBL1;RUNX1;TGIF2;GPBP1;NFE2L3;TRIM25;WNT5A;SOX4;ATF3;IKZF2;POU2F2;NFE2L2;SMAD1;MXD1;NFAT5;STAT5A;VEZF1;ZNFX1;TP53;KLF3;ELK3;SNAPC4;ZNF148;RELA;FOXN2;NR4A3;PPARD;PARP1;MXD3;CRAMP1;CREB5;ZXDA;XBP1;ZBTB5;ELF4;TFE3;JUND
4626,GO:0010743,4.49787691074237e-05,0.999997034367914,6,16,regulation of macrophage derived foam cell differentiation,BP,NFKBIA;CSF2;NFKB1;CSF1;ABCA5;ITGAV
8151,GO:0032874,4.59023849610854e-05,0.999988182034432,16,107,positive regulation of stress-activated MAPK cascade,BP,IL1B;TNF;IL1A;ZC3H12A;BMP2;EDN1;GADD45A;RIPK2;FZD8;NOD2;TRAF4;VEGFA;DKK1;WNT5A;PTPN1;WNT7B
14741,GO:0070391,4.74536571115571e-05,0.9999991615371,4,6,response to lipoteichoic acid,BP,CCL20;RIPK2;TLR2;RELA
15143,GO:0071223,4.74536571115571e-05,0.9999991615371,4,6,cellular response to lipoteichoic acid,BP,CCL20;RIPK2;TLR2;RELA
6768,GO:0030198,4.74734043779347e-05,0.999983116207434,25,215,extracellular matrix organization,BP,TNF;ELF3;ETS1;BCL3;NFKB2;ADAM8;PHLDB2;ITGA5;ICAM1;SMAD3;B4GALT1;LAMB3;CFLAR;CD47;ITGB8;PDGFB;TNC;MMP9;COL12A1;ITGAV;COL27A1;MMP10;LAMA3;COL8A1;DDR1
9858,GO:0042102,4.76627851157794e-05,0.999992387669102,10,50,positive regulation of T cell proliferation,BP,IL1B;IL23A;EFNB1;IL6;RIPK2;IL6ST;CD55;TGFBR2;CD276;HLA-E
4724,GO:0010883,4.76863452520904e-05,0.999994510061388,8,30,regulation of lipid storage,BP,NFKBIA;TNF;ZC3H12A;NFKB1;EHD1;IL6;ITGAV;IKBKE
890,GO:0002253,4.84429297778748e-05,0.999979583490624,34,362,activation of immune response,BP,NFKBIA;TNFAIP3;IRF1;BIRC3;ZC3H12A;NFKB1;TNIP1;TICAM1;PELI1;BIRC2;RIPK2;IRAK2;CYLD;RELB;NOD2;CD55;RUNX1;PGLYRP4;IFIH1;OTUD4;GCSAM;BTN2A2;TAB3;CAV1;TNIP2;TLR2;ABI1;IKBKE;UBE2D3;CD276;RELA;MUC1;NR4A3;CFB
20291,GO:2001234,5.0098660113255e-05,0.999984474982095,20,167,negative regulation of apoptotic signaling pathway,BP,IL1B;TNFAIP3;CSF2;TNF;IL1A;PLAUR;SOD2;PPIF;TNFRSF10B;ICAM1;CFLAR;NR4A2;MMP9;BCL2L2;NFE2L2;PTPN1;ITGAV;RELA;MUC1;XBP1
8826,GO:0034599,5.10737577820439e-05,0.999982127972926,24,221,cellular response to oxidative stress,BP,TNFAIP3;TNF;NCOA7;ZC3H12A;SOD2;PPIF;JUN;KDM6B;ETS1;IL6;CPEB2;GPX3;GCH1;CFLAR;TXNRD1;NR4A2;MMP9;NFE2L2;TP53;PML;RELA;AXL;NR4A3;PARP1
14696,GO:0070304,5.1460221982362e-05,0.999986610035913,16,108,positive regulation of stress-activated protein kinase signaling cascade,BP,IL1B;TNF;IL1A;ZC3H12A;BMP2;EDN1;GADD45A;RIPK2;FZD8;NOD2;TRAF4;VEGFA;DKK1;WNT5A;PTPN1;WNT7B
14222,GO:0061138,5.27617652664543e-05,0.999984888438601,18,129,morphogenesis of a branching epithelium,BP,TNF;BMP2;TBX3;EDN1;EPHA2;CSF1;SIX4;B4GALT1;VEGFA;NRARP;ADM;TGFBR2;WNT5A;TNC;SPRY2;CLIC4;PML;DDR1
11358,GO:0045682,5.30375671409247e-05,0.999989438478578,12,68,regulation of epidermis development,BP,TNF;MAFF;ZFP36;ZFP36L1;CYP27B1;ERRFI1;RUNX1;NAB1;WNT5A;IL20;TRIM16;PPARD
11833,GO:0046718,5.33677913476482e-05,0.999988443375,13,79,viral entry into host cell,BP,PTX3;EPHA2;CLDN1;ITGA5;ICAM1;CD55;TRIM25;LDLR;NUP153;CAV1;EFNB2;ITGAV;AXL
1088,GO:0002673,5.36725466912537e-05,0.999993636664681,8,32,regulation of acute inflammatory response,BP,IL1B;TNF;IL6;ADAM8;IL6ST;CD55;OSMR;CFB
12644,GO:0050818,5.64968587367341e-05,0.999990810292943,10,49,regulation of coagulation,BP,PLAU;PLAUR;EDN1;SERPINB2;C1QTNF1;PDGFB;NFE2L2;CAV1;PLAT;ANXA5
13919,GO:0060556,5.8681109579157e-05,0.999998903463293,4,6,regulation of vitamin D biosynthetic process,BP,IL1B;TNF;NFKB1;CYP27B1
3289,GO:0006979,5.89585944872077e-05,0.999975980727721,31,326,response to oxidative stress,BP,TNFAIP3;TNF;FOSL1;NCOA7;ZC3H12A;SOD2;PPIF;EDN1;JUN;KDM6B;ETS1;DUSP1;IL6;CPEB2;GPX3;GCH1;CFLAR;TXNRD1;BTG1;NR4A2;MMP9;PLK3;NFE2L2;TP53;PML;ADAM9;RELA;AXL;NR4A3;PARP1;EGLN1
10507,GO:0043406,6.02679276157529e-05,0.999979278233108,23,197,positive regulation of MAP kinase activity,BP,IL1B;TNF;BMP2;EDN1;MAP2K3;GADD45A;ADAM8;RIPK2;IRAK2;FZD8;NOD2;VEGFA;DKK1;MAP3K8;SAA1;WNT5A;TGFA;PDGFB;NRG1;PTPN1;WNT7B;TAB3;ADAM9
18480,GO:1903557,6.08434680581641e-05,0.999991296793917,9,40,positive regulation of tumor necrosis factor superfamily cytokine production,BP,TICAM1;IL23A;ADAM8;RIPK2;NOD2;WNT5A;IFIH1;TLR2;HLA-E
19090,GO:1904951,6.10206574555104e-05,0.99997471476047,32,333,positive regulation of establishment of protein localization,BP,IL1B;TNF;IL1A;ZC3H12A;PMAIP1;HCAR2;BBC3;PLAGL2;IL6;ADAM8;PANX1;RIPK2;NOD2;TP53BP2;SAA1;WNT5A;VEGFC;SOX4;IFIH1;NRG1;PLK3;IL4R;UGCG;TP53;TLR2;UBE2D3;ADAM9;TRIM16;HLA-E;GSK3B;PPARD;XBP1
1489,GO:0003823,6.1392156625345e-05,0.999994063214234,7,24,antigen binding,MF,IL7R;TAP1;HLA-A;TAPBP;HLA-B;HLA-F;HLA-E
7924,GO:0032494,6.14951125718978e-05,0.999998836578067,4,6,response to peptidoglycan,BP,IL6;RIPK2;NOD2;RELA
12917,GO:0051250,6.19009514198971e-05,0.999986393192149,13,79,negative regulation of lymphocyte activation,BP,TNFAIP3;IRF1;SDC4;INHBA;PRDM1;PELI1;CYLD;NFKBID;NRARP;CEBPB;IL4R;BTN2A2;AXL
11135,GO:0045165,6.25258080243996e-05,0.999982600631424,17,121,cell fate commitment,BP,BMP2;PRDM1;TBX3;KDM6B;IL23A;IL6;ETS2;CYLD;DLX2;DKK1;CEBPB;WNT5A;NRG1;SPRY2;WNT7B;SMAD1;PML
7501,GO:0031668,6.39973777102197e-05,0.999978500779451,22,188,cellular response to extracellular stimulus,BP,NUAK2;PLEKHF1;FOSL1;ZC3H12A;PMAIP1;JUN;CYP27B1;CDKN1A;ICAM1;CDKN2B;UPP1;NR4A2;TNC;SLC38A2;ATF3;RNF152;NFE2L2;TP53;PIM1;AXL;CYP24A1;XBP1
12577,GO:0050716,6.42103561823588e-05,0.999995381815046,6,17,positive regulation of interleukin-1 secretion,BP,PANX1;RIPK2;NOD2;SAA1;WNT5A;TRIM16
12645,GO:0050819,6.4287827985341e-05,0.999992174623937,8,32,negative regulation of coagulation,BP,PLAU;PLAUR;EDN1;SERPINB2;C1QTNF1;PDGFB;PLAT;ANXA5
13501,GO:0055024,6.5552607855988e-05,0.999989199176974,10,47,regulation of cardiac muscle tissue development,BP,BMP2;EDN1;SAV1;DKK1;CREB1;TGFBR2;NRG1;EFNB2;JPH2;PIM1
10512,GO:0043412,6.56096641268769e-05,0.999955664387225,190,3240,macromolecule modification,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;HBEGF;NUAK2;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;CCL20;NCOA7;ZC3H12A;PPP1R15A;RNF19B;BMP2;LIF;PLAUR;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;JUN;TICAM1;KDM6B;EPHA2;SQSTM1;CSF1;SPRR2D;EREG;IL23A;DUSP1;PELI1;GADD45A;BIRC2;IL6;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;ZFP36L1;TNFSF15;RIPK2;IRAK2;KLHL21;DAPP1;CYLD;FZD8;WTAP;C1QTNF1;CDKN1A;ITGA5;RAP2B;ZNF451;NEDD4L;NOD2;IL6ST;DCUN1D3;SGK1;ICAM1;SMAD3;B4GALT1;B3GNT5;RNF144B;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;PPTC7;CFLAR;RNF43;PIGA;BTG1;PPP4R4;ANKLE2;ERRFI1;ANKK1;CREB1;CCNL1;USP43;MAST4;VHL;PHKG2;BACH1;TGFBR2;SMURF2;DUSP16;SAA1;KLHL5;TRIM25;MASTL;WNT5A;CAMK1G;VEGFC;TGFA;DUSP10;SOX4;PPP1R3B;SOCS2;PDGFB;IL20;IFIH1;DUSP8;NRG1;TNC;MMP9;KIAA1586;ATF3;OTUD4;CAB39;PLK3;ARRDC4;RCHY1;SPRY2;TNKS1BP1;B4GALT5;ARSJ;NUP153;RNF152;NEDD4;MMD;DUS4L;IL24;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;CHD4;STAT5A;TPST1;CAV1;SH3RF2;INO80D;TNIP2;TP53;TLR2;ABI1;STK40;PUS10;PDP1;ITGAV;IKBKE;UBE2D3;PJA2;SPRR2A;ABCA7;CLK4;TMEM132A;SDR16C5;UBE2Z;PML;PIM1;ADAM9;RELA;TRIM16;ESCO2;PPP6R3;PLAT;MUC1;AXL;FRK;USP31;GSK3B;KMT2E;PARP8;PARP1;KDM7A;LCE1C;EGLN1;RIPK4;RNF145;RPS6KA6;DDR1;KCTD11;LMAN1
4554,GO:0010632,6.69492229234888e-05,0.999978852400757,20,159,regulation of epithelial cell migration,BP,HBEGF;EFNA1;ZC3H12A;EDN1;MAP2K3;JUN;EPHA2;ETS1;VEGFA;PLK2;TGFBR2;WNT5A;VEGFC;DUSP10;PDGFB;MMP9;NFE2L2;STAT5A;ADAM9;CCBE1
11378,GO:0045732,6.9262790643196e-05,0.999977297013253,21,176,positive regulation of protein catabolic process,BP,IL1B;TNFAIP3;TNF;RNF19B;ADAM8;NEDD4L;CTSC;RNF144B;TRIB1;PLK2;SMURF2;WNT5A;LDLR;PLK3;RCHY1;NEDD4;NFE2L2;CAV1;ADAM9;GSK3B;XBP1
12320,GO:0048661,6.97842139764971e-05,0.999986980339225,11,58,positive regulation of smooth muscle cell proliferation,BP,TNF;HBEGF;EDN1;JUN;EREG;IL6;NAMPT;TGFBR2;PDGFB;MMP9;NR4A3
16536,GO:0097237,6.98052645067889e-05,0.999978553394728,19,162,cellular response to toxic substance,BP,TNFAIP3;TNF;ZC3H12A;SOD2;NFKB1;PPIF;KDM6B;ETS1;IL6;GPX3;GCH1;TXNRD1;ABTB2;PDGFB;NFE2L2;TP53;RELA;AXL;NR4A3
11785,GO:0046634,7.10894727113424e-05,0.999989617639795,9,40,regulation of alpha-beta T cell activation,BP,IRF1;CD83;PRDM1;IL23A;RIPK2;CD55;TGFBR2;IL4R;HLA-E
9878,GO:0042136,7.16775906712322e-05,0.999986560785612,11,59,neurotransmitter biosynthetic process,BP,IL1B;TNF;ZC3H12A;PTX3;EDN1;TICAM1;ICAM1;GCH1;SMAD3;SLC7A2;CAV1
10589,GO:0043549,7.16914265229445e-05,0.999963548616145,52,642,regulation of kinase activity,BP,IL1B;TNFAIP3;TNF;EFNA1;SDC4;BMP2;EDN1;MAP2K3;EPHA2;CSF1;EREG;IL23A;DUSP1;GADD45A;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;CDKN1A;RAP2B;NOD2;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;MAP3K8;ERRFI1;CCNL1;TGFBR2;DUSP16;SAA1;WNT5A;TGFA;DUSP10;SOCS2;PDGFB;DUSP8;NRG1;CAB39;SPRY2;MMD;PTPN1;WNT7B;TAB3;CAV1;ABI1;ADAM9;AXL;DDR1
14661,GO:0070243,7.36930229084009e-05,0.999996531156129,5,11,regulation of thymocyte apoptotic process,BP,EFNA1;ADAM8;NFKBID;WNT5A;TP53
1159,GO:0002764,7.42836828799775e-05,0.999968395271196,33,354,immune response-regulating signaling pathway,BP,NFKBIA;TNFAIP3;IRF1;BIRC3;ZC3H12A;NFKB1;TNIP1;JUN;TICAM1;PELI1;BIRC2;RIPK2;IRAK2;CYLD;RELB;NOD2;RUNX1;PGLYRP4;IFIH1;OTUD4;GCSAM;BTN2A2;TAB3;CAV1;TNIP2;TLR2;ABI1;IKBKE;UBE2D3;CD276;RELA;MUC1;NR4A3
4270,GO:0009615,7.4937182497162e-05,0.999973084825846,24,224,response to virus,BP,IL1B;TNFAIP3;TNF;IRF1;BIRC3;FOSL1;ZC3H12A;PMAIP1;TICAM1;IFNAR2;IL23A;BCL3;BIRC2;IFNGR2;IL6;ODC1;IFNAR1;TRIM25;IFNGR1;IFIH1;IKBKE;PML;POLR3A;RELA
12789,GO:0051051,7.50573619955682e-05,0.999971168269513,27,264,negative regulation of transport,BP,IL1B;TNF;INHBA;ZC3H12A;LIF;NFKB1;PPIF;EDN1;PIM3;NEDD4L;ICAM1;IL1R2;SOX4;NRG1;MMP9;RRAD;CAB39;NUP153;NEDD4;BTN2A2;CAV1;TLR2;ITGAV;GEM;MAPKBP1;PML;IL36RN
12563,GO:0050702,7.50882867106204e-05,0.999992496236117,7,24,interleukin-1 beta secretion,BP,ZC3H12A;PANX1;RIPK2;NOD2;WNT5A;PML;TRIM16
12969,GO:0051338,7.55173514335992e-05,0.99996020992432,57,732,regulation of transferase activity,BP,IL1B;TNFAIP3;TNF;EFNA1;SDC4;BMP2;EDN1;MAP2K3;ZFP36;EPHA2;CSF1;EREG;IL23A;DUSP1;GADD45A;ADAM8;TNFRSF10B;TNFSF15;RIPK2;IRAK2;FZD8;CDKN1A;RAP2B;NOD2;DCUN1D3;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;MAP3K8;ERRFI1;CCNL1;TGFBR2;DUSP16;SAA1;WNT5A;TGFA;DUSP10;SOCS2;PDGFB;DUSP8;NRG1;CAB39;ARRDC4;SPRY2;MMD;PTPN1;WNT7B;TAB3;CAV1;TP53;ABI1;ADAM9;AXL;GSK3B;DDR1
8704,GO:0034340,7.61524379484963e-05,0.999984110775652,12,74,response to type I interferon,BP,IRF1;IFNAR2;IRF6;GBP2;IFNAR1;WNT5A;PTPN1;HLA-A;HLA-B;IKBKE;HLA-F;HLA-E
11943,GO:0046979,8.08884513523297e-05,1,3,3,TAP2 binding,MF,TAP1;TAPBP;HLA-F
2382,GO:0005515,8.39971441088032e-05,0.999944286549348,418,8318,protein binding,MF,NFKBIZ;CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;ITPKC;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;IL36G;TBX3;PMAIP1;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;JUN;TICAM1;KDM6B;IFNAR2;RAB3IP;EPHA2;EHD1;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;N4BP3;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;EFNB1;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;PANX1;ZFP36L1;TNFSF15;RIPK2;IRAK2;THAP10;KLHL21;DAPP1;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;C1QTNF1;AMOTL2;CDKN1A;KIAA0040;CLDN1;CCDC85B;ITGA5;C11ORF68;GBP2;RAP2B;IL7R;ZNF451;NAV3;ODC1;TNFAIP2;NEDD4L;CTSC;GPX3;NOD2;ELMSAN1;IL6ST;DCUN1D3;SAV1;TMCC3;SGK1;ICAM1;GCH1;RASSF9;SMAD3;IRGQ;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;RNF144B;RND3;MARCKSL1;TM4SF1;NFKBID;NINJ1;TRAF4;TRIB1;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;LGALSL;IL1R2;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;C3ORF52;LAMB3;CFLAR;RNF43;TXNRD1;LACC1;PIGA;BTG1;ANXA8;IER5;PPP4R4;CEBPB;CEBPD;VMP1;CD55;KCNJ15;DENND3;NAMPT;TAP1;TP53BP2;ANKLE2;ADM;CDC42EP4;IFNAR1;ERRFI1;CREB1;TAF4B;GORAB;CCNL1;WISP1;NEDD9;NR4A2;PATL1;MSANTD3;CD47;CANT1;VHL;PHKG2;SEMA4B;BACH1;ABTB2;PDE4DIP;RUNX1;TGFBR2;SMURF2;SFR1;SAA1;GPBP1;AKAP2;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;IFNGR1;MASTL;NAB1;KIF3C;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;NOTCH2NL;DUSP10;SOX4;PPP1R3B;SOCS2;PDGFB;IL20;ANLN;PGLYRP4;CD82;BAZ1A;IFIH1;EFHD2;NRG1;TNC;SLC38A2;MMP9;LDLR;GPATCH2L;DCBLD2;RRAD;ATF3;OTUD4;BTG3;IKZF2;FAM83B;CAB39;IL32;TLE1;MFHAS1;TRAF3IP3;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;FAM57A;MT2A;SLC9A1;ZBTB10;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;CYTH1;GRB7;CXCL16;NUP153;BCL2L2;RNF152;IL4R;NEDD4;RHCG;POU2F2;ITSN2;GCSAM;IL24;TNFRSF6B;MARCKS;RAET1L;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;TAB3;PAOX;SPTBN5;MXD1;CHD4;SUSD6;TPRA1;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;RHOV;SH3RF2;CACFD1;HLA-A;UACA;DRAM1;TNIP2;ZFAND5;TP53;NOM1;KLF3;TLR2;ABI1;STK40;TAPBP;EFNB2;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;SPRR2A;RAD9B;CLK4;SDR16C5;ZNF148;UBE2Z;PML;PIM1;ESPL1;ADAM9;RELA;RAPH1;TRIM16;EMP3;SPATA2;FOXN2;CCBE1;PPP6R3;PLAT;MUC1;YARS2;AXL;ANXA5;AKIRIN1;CRB3;ELL2;SAT1;FRK;HLA-F;NR4A3;HLA-E;GSK3B;KMT2E;OSMR;PPARD;SLC16A1;PARP1;LAMA3;KDM7A;MED13;MXD3;TBC1D22B;OCLN;COTL1;JMY;COL8A1;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;DDR1;CEP135;XBP1;HSPA4L;QKI;EPB41L3;KCTD11;ZBTB5;ELF4;IL36RN;SREK1IP1;TFE3;EID3;ZMIZ2;CCSER2;LMAN1;CFB;JUND;DENND4A
12189,GO:0048305,8.48282426156374e-05,0.999995697547609,5,12,immunoglobulin secretion,BP,TNF;IL6;POU2F2;HLA-E;XBP1
8031,GO:0032663,8.50627978442489e-05,0.999989211264711,8,32,regulation of interleukin-2 production,BP,IL1B;TNFAIP3;IL1A;CD83;ZFP36;RIPK2;NAV3;RUNX1
11786,GO:0046635,9.0276474124574e-05,0.999990616127555,7,25,positive regulation of alpha-beta T cell activation,BP,CD83;IL23A;RIPK2;CD55;TGFBR2;IL4R;HLA-E
10314,GO:0043086,9.04082587150142e-05,0.999956062086477,44,536,negative regulation of catalytic activity,BP,IL1B;TNFAIP3;TNF;BIRC3;PLEKHF1;PPP1R15A;PLAUR;PTX3;NFKB1;PPIF;ZFP36;SERPINB2;DUSP1;GADD45A;BIRC2;TNFRSF10B;CYP27B1;TNFAIP8;CDKN1A;CPEB2;TFPI2;TRIB1;SERPINB8;VEGFA;CDKN2B;ANXA8;PPP4R4;ERRFI1;DUSP16;MASTL;DUSP10;SERPINB1;SOCS2;DUSP8;MMP9;SPRY2;TNFRSF6B;PTPN1;CAV1;SH3RF2;TP53;ANXA5;GSK3B;EGLN1
10740,GO:0044093,9.1093764692537e-05,0.999945658943403,87,1259,positive regulation of molecular function,BP,IL1B;NFKBIA;TNF;CXCL1;EFNA1;SDC4;CCL20;FOSL1;PPP1R15A;BMP2;PLAUR;PMAIP1;NFKB1;EDN1;MAP2K3;JUN;TICAM1;EPHA2;TRAF1;CSF1;BBC3;EREG;IL23A;GADD45A;IL6;NFKB2;ADAM8;TNFRSF10B;TNFSF15;CYP27B1;RIPK2;IRAK2;FZD8;BAMBI;CDKN1A;NOD2;DCUN1D3;SAV1;SGK1;ICAM1;GCH1;SMAD3;NFKBIB;TRAF4;VEGFA;DKK1;PLK2;MAP3K8;ABL2;CFLAR;CDC42EP4;ERRFI1;CCNL1;NR4A2;TGFBR2;SAA1;TRIM25;WNT5A;TGFA;PDGFB;NRG1;MMP9;CAB39;ARRDC4;RASGEF1B;SLC9A1;SPRY2;MMD;PTPN1;WNT7B;TAB3;CAV1;TLR2;ABI1;DOCK4;TRIP10;JPH2;PML;ADAM9;RELA;AXL;GSK3B;PARP1;TBC1D22B;JMY;RIPK4;DDR1
4553,GO:0010631,9.29919527524931e-05,0.999967012211855,23,203,epithelial cell migration,BP,HBEGF;EFNA1;ZC3H12A;EDN1;MAP2K3;JUN;EPHA2;ETS1;VEGFA;PLK2;TGFBR2;WNT5A;VEGFC;DUSP10;PDGFB;ANLN;MMP9;NFE2L2;STAT5A;EFNB2;ADAM9;CCBE1;PPARD
8833,GO:0034614,9.30149377403863e-05,0.999974289953184,16,123,cellular response to reactive oxygen species,BP,TNFAIP3;TNF;SOD2;PPIF;JUN;KDM6B;ETS1;IL6;GCH1;CFLAR;MMP9;NFE2L2;TP53;RELA;AXL;NR4A3
7911,GO:0032479,9.42143374432802e-05,0.999975320955253,15,107,regulation of type I interferon production,BP,TNFAIP3;IRF1;NFKB1;TICAM1;REL;NFKB2;RIPK2;CYLD;RELB;TRIM25;IFIH1;TLR2;IKBKE;POLR3A;RELA
4347,GO:0009896,9.43765477945591e-05,0.999959932106691,32,331,positive regulation of catabolic process,BP,IL1B;TNFAIP3;TNF;BTG2;PLEKHF1;ZC3H12A;RNF19B;ZFP36;TICAM1;ADAM8;ZFP36L1;RIPK2;NEDD4L;CTSC;RNF144B;TRIB1;PLK2;PHKG2;SMURF2;WNT5A;LDLR;PLK3;RCHY1;RNF152;NEDD4;NFE2L2;PTPN1;CAV1;ADAM9;GSK3B;XBP1;QKI
14761,GO:0070427,9.51088658665986e-05,1,3,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,NFKBIA;TNFAIP3;RIPK2
18414,GO:1903426,9.87563095670072e-05,0.999982665353304,10,52,regulation of reactive oxygen species biosynthetic process,BP,IL1B;TNF;ZC3H12A;PTX3;EDN1;TICAM1;ICAM1;SMAD3;CFLAR;CAV1
3530,GO:0007517,9.91433516624428e-05,0.999962906621666,25,229,muscle organ development,BP,HBEGF;BTG2;BMP2;LIF;MAFF;EDN1;SIX4;SAV1;SMAD3;DKK1;CFLAR;CREB1;TGFBR2;WNT5A;NRG1;ATF3;CHD2;CAV1;EFNB2;JPH2;PIM1;FOXN2;EVC;EGLN1;XBP1
20299,GO:2001242,9.93539779650879e-05,0.999972312680686,16,128,regulation of intrinsic apoptotic signaling pathway,BP,PLEKHF1;PLAUR;SOD2;PMAIP1;PPIF;PLAGL2;CYLD;MMP9;BCL2L2;NFE2L2;PTPN1;CAV1;TP53;MUC1;PARP1;XBP1
19435,GO:1905952,0.000100205563740193,0.999978487374898,12,73,regulation of lipid localization,BP,IL1B;NFKBIA;TNF;ZC3H12A;NFKB1;EDN1;EHD1;IL6;C1QTNF1;ITGAV;IKBKE;ABCA7
16145,GO:0090132,0.000101169999812686,0.999963892343669,23,204,epithelium migration,BP,HBEGF;EFNA1;ZC3H12A;EDN1;MAP2K3;JUN;EPHA2;ETS1;VEGFA;PLK2;TGFBR2;WNT5A;VEGFC;DUSP10;PDGFB;ANLN;MMP9;NFE2L2;STAT5A;EFNB2;ADAM9;CCBE1;PPARD
6813,GO:0030260,0.000101743139914066,0.999974708481894,14,95,entry into host cell,BP,CXCL8;PTX3;EPHA2;CLDN1;ITGA5;ICAM1;CD55;TRIM25;LDLR;NUP153;CAV1;EFNB2;ITGAV;AXL
10878,GO:0044409,0.000101743139914066,0.999974708481894,14,95,entry into host,BP,CXCL8;PTX3;EPHA2;CLDN1;ITGA5;ICAM1;CD55;TRIM25;LDLR;NUP153;CAV1;EFNB2;ITGAV;AXL
13209,GO:0051806,0.000101743139914066,0.999974708481894,14,95,entry into cell of other organism involved in symbiotic interaction,BP,CXCL8;PTX3;EPHA2;CLDN1;ITGA5;ICAM1;CD55;TRIM25;LDLR;NUP153;CAV1;EFNB2;ITGAV;AXL
13216,GO:0051828,0.000101743139914066,0.999974708481894,14,95,entry into other organism involved in symbiotic interaction,BP,CXCL8;PTX3;EPHA2;CLDN1;ITGA5;ICAM1;CD55;TRIM25;LDLR;NUP153;CAV1;EFNB2;ITGAV;AXL
19437,GO:1905954,0.000101755520571064,0.999984246026757,9,43,positive regulation of lipid localization,BP,IL1B;NFKBIA;ZC3H12A;NFKB1;EDN1;EHD1;C1QTNF1;IKBKE;ABCA7
7993,GO:0032606,0.000103009669070725,0.999972776028059,15,108,type I interferon production,BP,TNFAIP3;IRF1;NFKB1;TICAM1;REL;NFKB2;RIPK2;CYLD;RELB;TRIM25;IFIH1;TLR2;IKBKE;POLR3A;RELA
14640,GO:0070201,0.000105665677711743,0.999948732881986,43,516,regulation of establishment of protein localization,BP,IL1B;TNF;IL1A;ZC3H12A;PMAIP1;HCAR2;BBC3;PLAGL2;IL6;ADAM8;PIM3;PANX1;RIPK2;CDKN1A;NOD2;IL1R2;TP53BP2;SAA1;WNT5A;VEGFC;SOX4;IFIH1;NRG1;PLK3;IL4R;MARCKS;BTN2A2;PTPN1;UGCG;TP53;TLR2;UBE2D3;STX1A;MAPKBP1;PML;ADAM9;TRIM16;HLA-E;GSK3B;PPARD;SLC16A1;XBP1;IL36RN
12673,GO:0050864,0.000106114318692317,0.999977104562523,12,72,regulation of B cell activation,BP,TNFAIP3;INHBA;PRDM1;TICAM1;PELI1;IL6;ZFP36L1;CYLD;CDKN1A;NOD2;TNIP2;XBP1
16558,GO:0097300,0.000107241760678601,0.999985713325366,8,35,programmed necrotic cell death,BP,TNF;BIRC3;PPIF;TICAM1;BIRC2;CYLD;CFLAR;CAV1
16143,GO:0090130,0.000107675632951546,0.99996139486436,23,205,tissue migration,BP,HBEGF;EFNA1;ZC3H12A;EDN1;MAP2K3;JUN;EPHA2;ETS1;VEGFA;PLK2;TGFBR2;WNT5A;VEGFC;DUSP10;PDGFB;ANLN;MMP9;NFE2L2;STAT5A;EFNB2;ADAM9;CCBE1;PPARD
9875,GO:0042133,0.000109557369446954,0.999974366198918,13,83,neurotransmitter metabolic process,BP,IL1B;TNF;ZC3H12A;PTX3;EDN1;TICAM1;ICAM1;GCH1;SMAD3;SLC7A2;MAOA;CAV1;TLR2
15144,GO:0071224,0.000109694887385721,1,3,3,cellular response to peptidoglycan,BP,RIPK2;NOD2;RELA
6985,GO:0030656,0.00011212194479016,0.999996995342073,4,7,regulation of vitamin metabolic process,BP,IL1B;TNF;NFKB1;CYP27B1
3178,GO:0006796,0.000112335285243676,0.999925911264574,140,2289,phosphate-containing compound metabolic process,BP,IL1B;TNFAIP3;CSF2;TNF;HBEGF;NUAK2;IL1A;ITPKC;EFNA1;SDC4;INHBA;PLEKHF1;CCL20;ZC3H12A;PPP1R15A;BMP2;LIF;PLAUR;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;JUN;EPHA2;SQSTM1;CSF1;EREG;IL23A;DUSP1;PELI1;AMPD3;GADD45A;IL6;ADAM8;TNFRSF10B;BDKRB1;PIM3;ZFP36L1;TNFSF15;RIPK2;IRAK2;DAPP1;FZD8;TJP2;C1QTNF1;CDKN1A;NMNAT2;ITGA5;RAP2B;NOD2;IL6ST;SGK1;ICAM1;GCH1;SMAD3;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;PPTC7;CFLAR;PIGA;UPP1;PPP4R4;NAMPT;ANKLE2;ADM;ERRFI1;ANKK1;CREB1;CCNL1;MAST4;PHKG2;TGFBR2;DUSP16;SAA1;MASTL;HMGCS1;WNT5A;CAMK1G;VEGFC;TGFA;DUSP10;PPP1R3B;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;LDLR;ATF3;CAB39;PLK3;SPRY2;TNKS1BP1;NUP153;MMD;IL24;KBTBD7;PTPN1;WNT7B;SMAD1;SGMS2;TAB3;SPTBN5;STAT5A;TPST1;CAV1;SH3RF2;TNIP2;TP53;TLR2;ABI1;STK40;PDP1;ITGAV;IKBKE;ABCA7;CLK4;PML;PIM1;ADAM9;PPP6R3;AXL;FRK;GSK3B;PPARD;PARP1;EGLN1;RIPK4;RPS6KA6;DDR1
20061,GO:2000659,0.000112929166192613,0.999996967943089,4,7,regulation of interleukin-1-mediated signaling pathway,BP,IL1RN;IL6;IL1R2;OTUD4
508,GO:0001570,0.000113741233885827,0.999979824199818,10,49,vasculogenesis,BP,ZFP36L1;JUNB;VEGFA;ADM;TGFBR2;WNT7B;CAV1;ITGAV;QKI;GJC1
6785,GO:0030216,0.000113967562633298,0.999964937920929,18,151,keratinocyte differentiation,BP,ZFP36;EPHA2;SPRR2D;IRF6;EREG;ZFP36L1;CYP27B1;SAV1;KRT34;ERRFI1;RUNX1;WNT5A;IL20;CLIC4;SPRR2A;ADAM9;TRIM16;LCE1C
3543,GO:0007566,0.000116042045406653,0.99998435943307,8,35,embryo implantation,BP,IL1B;LIF;VMP1;TGFBR2;SMURF2;MMP9;PPARD;DDR1
14326,GO:0061448,0.00011626734763895,0.999964331362076,18,139,connective tissue development,BP,BMP2;EDN1;CSF1;SMAD3;DLX2;CFLAR;RUNX1;TGFBR2;ITGB8;WNT5A;PDGFB;WNT7B;SMAD1;RELA;COL27A1;PPARD;EVC;XBP1
6323,GO:0019966,0.000117740994127057,0.999996803534497,4,7,interleukin-1 binding,MF,IL1RN;IL1R2;TRIM16;IL36RN
4533,GO:0010595,0.000118266987825036,0.999974178733166,12,72,positive regulation of endothelial cell migration,BP,ZC3H12A;EDN1;MAP2K3;ETS1;VEGFA;PLK2;WNT5A;VEGFC;PDGFB;NFE2L2;STAT5A;CCBE1
17764,GO:1901698,0.000120340810380543,0.999935281958823,57,741,response to nitrogen compound,BP,IL1B;NFKBIA;TNFAIP3;TNF;BTG2;FOSL1;ZC3H12A;PMAIP1;NFKB1;EDN1;JUN;TICAM1;EREG;DUSP1;PELI1;BIRC2;IL6;PANX1;ZFP36L1;RIPK2;JUNB;CDKN1A;CPEB2;NOD2;ICAM1;SMAD3;CFLAR;BTG1;CEBPB;ADM;ERRFI1;CREB1;NR4A2;SOGA1;TRIM25;HMGCS1;SOCS2;IFIH1;LDLR;SLC9A1;NFE2L2;PTPN1;SMAD1;ZC3H7B;STAT5A;CAV1;TP53;KLF3;TLR2;RELA;TRIM16;NR4A3;GSK3B;PARP1;EGLN1;XBP1;JUND
11088,GO:0045080,0.000121109004351698,0.999996687373416,4,7,positive regulation of chemokine biosynthetic process,BP,IL1B;TNF;TICAM1;WNT5A
10472,GO:0043331,0.000122279041686056,0.999973172346525,12,73,response to dsRNA,BP,NFKBIA;ZC3H12A;PMAIP1;NFKB1;TICAM1;PELI1;RIPK2;SMAD3;IFIH1;SMAD1;ZC3H7B;CAV1
9981,GO:0042368,0.000123126022078318,0.999996617388582,4,7,vitamin D biosynthetic process,BP,IL1B;TNF;NFKB1;CYP27B1
4552,GO:0010629,0.000125080870331484,0.999923490043196,92,1431,negative regulation of gene expression,BP,CSF2;TNF;IRF1;EFNA1;BTG2;BIRC3;NOCT;ZC3H12A;ELF3;BMP2;PRDM1;TBX3;NFKB1;EDN1;ZFP36;PNRC1;JUN;SQSTM1;BHLHE40;EREG;REL;BCL3;BIRC2;ETS2;NFKB2;RFX5;ZFP36L1;SIX4;JUNB;FZD8;RELB;ZNF217;CDKN1A;CCDC85B;CPEB2;ZNF451;NEDD4L;SMAD3;DLX2;VEGFA;NRARP;IL1R2;DKK1;CEBPB;CD55;CREB1;NR4A2;PATL1;VHL;BACH1;SMURF2;TGIF2;PNRC2;NFE2L3;NAB1;ITGB8;WNT5A;PDGFB;NRG1;LDLR;ATF3;IKZF2;TLE1;PLK3;YAF2;TNKS1BP1;GRB7;NUP153;NEDD4;SMAD1;MXD1;CHD4;ZC3H7B;CAV1;TP53;KLF3;UBE2D3;ELK3;SDR16C5;ZNF148;PML;RELA;MUC1;FRK;NR4A3;PPARD;PARP1;MXD3;VIM;QKI;ZBTB5;JUND
12713,GO:0050918,0.000128372001001805,0.999982436371377,8,35,positive chemotaxis,BP,CXCL8;IL16;SMAD3;VEGFA;SAA1;WNT5A;VEGFC;PDGFB
12897,GO:0051222,0.000129481396877406,0.999946556428198,29,301,positive regulation of protein transport,BP,IL1B;TNF;IL1A;ZC3H12A;HCAR2;PLAGL2;IL6;ADAM8;PANX1;RIPK2;NOD2;SAA1;WNT5A;VEGFC;SOX4;IFIH1;NRG1;PLK3;IL4R;UGCG;TP53;TLR2;UBE2D3;ADAM9;TRIM16;HLA-E;GSK3B;PPARD;XBP1
2114,GO:0004896,0.000131246786669012,0.999978968166812,9,43,cytokine receptor activity,MF,IFNAR2;IFNGR2;IL7R;IL6ST;IL1R2;IFNAR1;IFNGR1;IL4R;OSMR
12797,GO:0051059,0.000131828770730819,0.999985183146709,7,27,NF-kappaB binding,MF,NFKBIA;NFKBID;TP53BP2;TAF4B;RELA;GSK3B;PPARD
542,GO:0001660,0.000132645565334173,0.999996282971279,4,7,fever generation,BP,IL1B;TNF;IL1A;IL1RN
13149,GO:0051701,0.000136195475191856,0.999955920743596,19,160,interaction with host,BP,CXCL8;ZC3H12A;PTX3;TNIP1;EPHA2;CLDN1;ITGA5;ICAM1;SMAD3;CD55;TRIM25;LDLR;NUP153;NEDD4;CAV1;EFNB2;ITGAV;PML;AXL
9827,GO:0042036,0.00013664732210174,0.999988302064082,6,19,negative regulation of cytokine biosynthetic process,BP,INHBA;NFKB1;ZFP36;BCL3;IL6;ERRFI1
7589,GO:0031952,0.00014069886892267,0.999980670152175,8,33,regulation of protein autophosphorylation,BP,JUN;RAP2B;VEGFA;ERRFI1;VEGFC;PDGFB;TNKS1BP1;CAV1
11486,GO:0045934,0.000141891598258493,0.999916670772519,76,1097,negative regulation of nucleobase-containing compound metabolic process,BP,CSF2;TNF;IRF1;EFNA1;BTG2;NOCT;ZC3H12A;ELF3;BMP2;PRDM1;TBX3;NFKB1;PPIF;EDN1;ZFP36;JUN;SQSTM1;BHLHE40;EREG;REL;DUSP1;BCL3;ETS2;NFKB2;RFX5;SIX4;JUNB;FZD8;RELB;ZNF217;CCDC85B;ZNF451;NEDD4L;SMAD3;DLX2;VEGFA;NRARP;DKK1;CEBPB;CREB1;NR4A2;VHL;BACH1;SMURF2;TGIF2;NFE2L3;NAB1;WNT5A;PDGFB;NRG1;ATF3;IKZF2;TLE1;PLK3;YAF2;NEDD4;MXD1;CHD4;CAV1;TP53;KLF3;UBE2D3;ELK3;SDR16C5;ZNF148;PML;RELA;MUC1;FRK;NR4A3;PPARD;PARP1;MXD3;EGLN1;ZBTB5;JUND
4348,GO:0009897,0.000143328229999782,0.999960934315362,15,108,external side of plasma membrane,CC,TNF;CD83;ITGA5;IL7R;IL6ST;ICAM1;B4GALT1;TGFBR2;NRG1;LDLR;BTN2A2;ITGAV;CD276;ADAM9;ANXA5
3542,GO:0007565,0.000150897353036505,0.999956495045123,16,121,female pregnancy,BP,IL1B;FOSL1;LIF;PRDM1;ETS1;CYP27B1;JUNB;VMP1;NAMPT;ADM;TGFBR2;SMURF2;SLC38A2;MMP9;PPARD;DDR1
13185,GO:0051770,0.000154098144332649,0.999995505865244,4,7,positive regulation of nitric-oxide synthase biosynthetic process,BP,CCL20;NOD2;NAMPT;TLR2
11252,GO:0045429,0.000154641742689391,0.999982286728533,7,26,positive regulation of nitric oxide biosynthetic process,BP,IL1B;TNF;PTX3;EDN1;TICAM1;ICAM1;SMAD3
18844,GO:1904407,0.000154641742689391,0.999982286728533,7,26,positive regulation of nitric oxide metabolic process,BP,IL1B;TNF;PTX3;EDN1;TICAM1;ICAM1;SMAD3
8017,GO:0032642,0.000156193832099904,0.999974151351015,9,46,regulation of chemokine production,BP,IL1B;TNF;IL1A;TICAM1;IL6;RIPK2;WNT5A;IL4R;TLR2
12898,GO:0051223,0.000157319171111678,0.999924294638772,40,477,regulation of protein transport,BP,IL1B;TNF;IL1A;ZC3H12A;HCAR2;PLAGL2;IL6;ADAM8;PIM3;PANX1;RIPK2;CDKN1A;NOD2;IL1R2;SAA1;WNT5A;VEGFC;SOX4;IFIH1;NRG1;PLK3;IL4R;MARCKS;BTN2A2;PTPN1;UGCG;TP53;TLR2;UBE2D3;STX1A;MAPKBP1;PML;ADAM9;TRIM16;HLA-E;GSK3B;PPARD;SLC16A1;XBP1;IL36RN
7698,GO:0032147,0.000163333814106752,0.999936727081348,25,238,activation of protein kinase activity,BP,IL1B;TNF;BMP2;MAP2K3;IL23A;GADD45A;TNFRSF10B;TNFSF15;RIPK2;IRAK2;NOD2;TRAF4;VEGFA;MAP3K8;TGFBR2;SAA1;WNT5A;TGFA;PDGFB;NRG1;CAB39;PTPN1;WNT7B;TAB3;ADAM9
9835,GO:0042056,0.000164405964074607,0.999989748978095,5,14,chemoattractant activity,MF,VEGFA;SAA1;WNT5A;VEGFC;PDGFB
12198,GO:0048332,0.000164555954639802,0.999972890870624,9,42,mesoderm morphogenesis,BP,INHBA;TBX3;KDM6B;SMAD3;DKK1;TXNRD1;WNT5A;SMAD1;NR4A3
13775,GO:0060337,0.000165574576975368,0.999965262548919,11,69,type I interferon signaling pathway,BP,IRF1;IFNAR2;IRF6;GBP2;IFNAR1;WNT5A;PTPN1;HLA-A;HLA-B;HLA-F;HLA-E
15222,GO:0071357,0.000165574576975368,0.999965262548919,11,69,cellular response to type I interferon,BP,IRF1;IFNAR2;IRF6;GBP2;IFNAR1;WNT5A;PTPN1;HLA-A;HLA-B;HLA-F;HLA-E
11445,GO:0045862,0.00016621525491623,0.999932721006444,27,281,positive regulation of proteolysis,BP,IL1B;TNF;EFNA1;ZC3H12A;RNF19B;PMAIP1;TNIP1;BBC3;ADAM8;TNFRSF10B;TNFSF15;RIPK2;CTSC;SMAD3;RNF144B;TRIB1;PLK2;CFLAR;PLK3;RCHY1;NFE2L2;CAV1;PML;ADAM9;CCBE1;GSK3B;XBP1
6177,GO:0019538,0.000167860902899808,0.999881640578009,230,4211,protein metabolic process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;CCL20;NCOA7;ZC3H12A;PPP1R15A;RNF19B;BMP2;LIF;PLAUR;PMAIP1;PTX3;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;SQSTM1;CSF1;SPRR2D;BBC3;EREG;IL23A;DUSP1;BCL3;PELI1;GADD45A;BIRC2;IL6;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;ZFP36L1;TNFSF15;RIPK2;IRAK2;KLHL21;DAPP1;CYLD;FZD8;TNFAIP8;C1QTNF1;CDKN1A;ITGA5;RAP2B;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;NOD2;IL6ST;DCUN1D3;TFPI2;SGK1;ICAM1;SMAD3;B4GALT1;PHLDA1;B3GNT5;RNF144B;TRAF4;TRIB1;SERPINB8;VEGFA;IL1R2;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;PPTC7;CFLAR;RNF43;PIGA;BTG1;ANXA8;PPP4R4;CEBPB;CD55;DENND3;ANKLE2;DSE;ERRFI1;ADAMTS1;ANKK1;CREB1;CCNL1;USP43;MAST4;CANT1;VHL;PHKG2;BACH1;ABTB2;TGFBR2;SMURF2;DUSP16;DDX3Y;SAA1;TINAGL1;KLHL5;TRIM25;MASTL;WNT5A;CAMK1G;VEGFC;ABCF1;TGFA;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;KIAA1586;ATF3;OTUD4;CAB39;PLK3;ARRDC4;RCHY1;SPRY2;TNKS1BP1;B4GALT5;GRB7;ARSJ;NUP153;RNF152;NEDD4;MMD;IL24;TNFRSF6B;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;TAB3;SPTBN5;CHD4;STAT5A;TPST1;CAV1;SH3RF2;INO80D;TNIP2;TP53;TLR2;ABI1;STK40;PDP1;ITGAV;IKBKE;UBE2D3;PJA2;CD276;SPRR2A;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;UBE2Z;HS3ST3B1;PML;PIM1;ESPL1;ADAM9;RELA;TRIM16;ESCO2;CCBE1;PPP6R3;PLAT;MUC1;YARS2;AXL;FRK;USP31;GSK3B;KMT2E;PPARD;PARP8;PARP1;MMP10;KDM7A;LCE1C;VIM;EGLN1;RIPK4;RNF145;RPS6KA6;DDR1;XBP1;QKI;KCTD11;LMAN1;CFB
12296,GO:0048608,0.000171870525484968,0.999927837449027,29,299,reproductive structure development,BP,CSF2;INHBA;FOSL1;LIF;PRDM1;TBX3;EREG;BIRC2;ZFP36L1;CYP27B1;SIX4;PHLDA2;JUNB;ICAM1;VEGFA;CEBPB;ADM;GJB3;ADAMTS1;ITGB8;HMGCS1;WNT5A;PDGFB;TNC;BCL2L2;WNT7B;AXL;PPARD;EGLN1
6074,GO:0019219,0.000173635363168502,0.999879621427074,189,3268,regulation of nucleobase-containing compound metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;WTAP;RELB;ZNF217;CDKN1A;CCDC85B;IL7R;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;NAMPT;ADM;CREB1;TAF4B;CCNL1;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;OTUD4;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;YAF2;NUP153;NEDD4;POU2F2;NFE2L2;PTPN1;SMAD1;TAB3;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;CLK4;SDR16C5;ZNF148;PML;PIM1;RELA;TRIM16;ESCO2;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;CREB5;EGLN1;RIPK4;ZXDA;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
7925,GO:0032495,0.000178507332902158,0.999989347487965,5,12,response to muramyl dipeptide,BP,NFKBIA;TNFAIP3;RIPK2;NOD2;RELA
502,GO:0001558,0.000178588787902305,0.999926090968815,28,289,regulation of cell growth,BP,HBEGF;INHBA;EDN1;SERTAD2;BDKRB1;CYP27B1;CDKN1A;CCDC85B;NEDD4L;DCUN1D3;SGK1;SMAD3;VEGFA;BTG1;WISP1;SEMA4B;WNT5A;SOCS2;NRG1;DCBLD2;SLC9A1;CXCL16;ITSN2;TP53;PML;PPARD;DDR1;EPB41L3
6933,GO:0030522,0.000180780842887372,0.999931042967496,24,225,intracellular receptor signaling pathway,BP,NFKBIA;TNFAIP3;BIRC3;BIRC2;CYP27B1;RIPK2;IRAK2;CYLD;NOD2;NR4A2;RUNX1;IFIH1;DCBLD2;NEDD4;TAB3;PML;PIM1;RELA;TRIM16;NR4A3;PPARD;PARP1;CYP24A1;MED13
524,GO:0001618,0.000183345552063732,0.999969156561314,9,44,virus receptor activity,MF,EPHA2;CLDN1;ITGA5;ICAM1;CD55;LDLR;EFNB2;ITGAV;AXL
17199,GO:0104005,0.000183345552063732,0.999969156561314,9,44,hijacked molecular function,MF,EPHA2;CLDN1;ITGA5;ICAM1;CD55;LDLR;EFNB2;ITGAV;AXL
12363,GO:0048729,0.000183770116494371,0.999911770182337,39,450,tissue morphogenesis,BP,TNF;HBEGF;SDC4;INHBA;BMP2;LIF;TBX3;EDN1;KDM6B;EPHA2;CSF1;SIX4;PHLDB2;ITGA5;SMAD3;B4GALT1;VEGFA;NRARP;DKK1;TXNRD1;ADM;GORAB;TGFBR2;SMURF2;WNT5A;VEGFC;SOX4;NRG1;TNC;SPRY2;WNT7B;SMAD1;CLIC4;EFNB2;PML;NR4A3;EGLN1;RIPK4;DDR1
7128,GO:0030947,0.000185213189678311,0.999983210349061,6,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,IL1B;ITGA5;VEGFA;VEGFC;NEDD4;PTPN1
9281,GO:0035710,0.000186128272077025,0.99996853508963,9,45,CD4-positive, alpha-beta T cell activation,BP,CD83;IL23A;BCL3;IL6;RIPK2;RELB;CD55;TGFBR2;IL4R
6764,GO:0030193,0.000190773863120634,0.999967553853956,9,46,regulation of blood coagulation,BP,PLAU;PLAUR;EDN1;SERPINB2;C1QTNF1;PDGFB;NFE2L2;CAV1;PLAT
17369,GO:1900046,0.000190773863120634,0.999967553853956,9,46,regulation of hemostasis,BP,PLAU;PLAUR;EDN1;SERPINB2;C1QTNF1;PDGFB;NFE2L2;CAV1;PLAT
7326,GO:0031331,0.000193892210227917,0.999919388312103,28,284,positive regulation of cellular catabolic process,BP,IL1B;TNFAIP3;TNF;BTG2;PLEKHF1;ZC3H12A;RNF19B;ZFP36;TICAM1;ADAM8;ZFP36L1;RIPK2;CTSC;RNF144B;TRIB1;PLK2;PHKG2;LDLR;PLK3;RCHY1;RNF152;NFE2L2;PTPN1;CAV1;ADAM9;GSK3B;XBP1;QKI
12270,GO:0048545,0.000195865225696286,0.999919957008016,27,273,response to steroid hormone,BP,TNF;FOSL1;IL1RN;EDN1;ZFP36;DUSP1;IL6;ZFP36L1;CDKN1A;CLDN1;ICAM1;CFLAR;ADM;ERRFI1;NR4A2;RUNX1;TGFBR2;NEDD4;WNT7B;CAV1;TLR2;ADAM9;RELA;NR4A3;PPARD;PARP1;MED13
14328,GO:0061458,0.000198266887168513,0.999915991644982,29,302,reproductive system development,BP,CSF2;INHBA;FOSL1;LIF;PRDM1;TBX3;EREG;BIRC2;ZFP36L1;CYP27B1;SIX4;PHLDA2;JUNB;ICAM1;VEGFA;CEBPB;ADM;GJB3;ADAMTS1;ITGB8;HMGCS1;WNT5A;PDGFB;TNC;BCL2L2;WNT7B;AXL;PPARD;EGLN1
19760,GO:2000108,0.000198868686367805,0.999981263983262,6,21,positive regulation of leukocyte apoptotic process,BP,HCAR2;ADAM8;NFKBID;WNT5A;TP53;NR4A3
12725,GO:0050930,0.000202154883611283,0.999992918817961,4,8,induction of positive chemotaxis,BP,CXCL8;IL16;VEGFA;VEGFC
4625,GO:0010742,0.000204023249731871,0.999980910733083,6,20,macrophage derived foam cell differentiation,BP,NFKBIA;CSF2;NFKB1;CSF1;ABCA5;ITGAV
16110,GO:0090077,0.000204023249731871,0.999980910733083,6,20,foam cell differentiation,BP,NFKBIA;CSF2;NFKB1;CSF1;ABCA5;ITGAV
10106,GO:0042612,0.000204276747569968,0.999992277147506,4,9,MHC class I protein complex,CC,HLA-A;HLA-B;HLA-F;HLA-E
8070,GO:0032733,0.000205895364667072,0.999986512084718,5,14,positive regulation of interleukin-10 production,BP,CD83;IL23A;BCL3;NOD2;TLR2
10334,GO:0043123,0.00020914485157522,0.999934890332275,17,141,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNF;IL1A;BIRC3;TICAM1;REL;PELI1;BIRC2;TNFRSF10B;RIPK2;NOD2;PLK2;CFLAR;CANT1;TRIM25;TNIP2;IKBKE;RELA
9974,GO:0042359,0.000215319166490514,0.999985755126901,5,14,vitamin D metabolic process,BP,IL1B;TNF;NFKB1;CYP27B1;CYP24A1
14895,GO:0070673,0.000220820088891015,0.999992080256299,4,8,response to interleukin-18,BP,RIPK2;CLDN1;PDGFB;OCLN
3287,GO:0006977,0.000221980268766089,0.999956282704692,10,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
9686,GO:0038061,0.000223460688582995,0.999939355189133,14,111,NIK/NF-kappaB signaling,BP,TNF;BIRC3;NFKB1;REL;BIRC2;NFKB2;TNFRSF10B;TNFSF15;RELB;NOD2;TRAF4;UACA;IKBKE;RELA
8066,GO:0032729,0.000223590938253848,0.99997220262098,7,29,positive regulation of interferon-gamma production,BP,IL1B;TNF;IL23A;BCL3;RIPK2;WNT5A;CD276
11783,GO:0046632,0.0002243915022013,0.999956057063739,10,55,alpha-beta T cell differentiation,BP,IRF1;CD83;PRDM1;IL23A;BCL3;IL6;RIPK2;RELB;TGFBR2;IL4R
12571,GO:0050710,0.000228585052550701,0.999971476549182,7,29,negative regulation of cytokine secretion,BP,TNF;ZC3H12A;IL1R2;BTN2A2;MAPKBP1;PML;IL36RN
8419,GO:0033483,0.000230601431034424,0.999991632967594,4,8,gas homeostasis,BP,SOD2;WNT7B;CAV1;EGLN1
14967,GO:0070848,0.000233850809588411,0.999885169384637,40,472,response to growth factor,BP,CXCL8;IL1B;BMP2;EDN1;MAP2K3;ZFP36;JUN;EPHA2;EHD1;ZFP36L1;BAMBI;CLDN1;ITGA5;ZNF451;SMAD3;VEGFA;DKK1;CDKN2B;FGF5;CFLAR;ERRFI1;CREB1;TGFBR2;SMURF2;WNT5A;VEGFC;PDGFB;TNC;SPRY2;FEZ1;NEDD4;PTPN1;SMAD1;CAV1;UBE2D3;PML;ADAM9;RELA;CCBE1;PARP1
11519,GO:0045995,0.000233995497928712,0.999940579754807,13,86,regulation of embryonic development,BP,NOCT;IL1RN;SIX4;PHLDA2;PHLDB2;NRARP;DKK1;GORAB;TGIF2;WNT5A;NFE2L2;LAMA3;RPS6KA6
10062,GO:0042542,0.000246861987697153,0.999932482956951,14,107,response to hydrogen peroxide,BP,TNFAIP3;FOSL1;PPIF;JUN;KDM6B;ETS1;DUSP1;IL6;NFE2L2;TP53;ADAM9;RELA;AXL;NR4A3
14672,GO:0070265,0.000248414049117104,0.999961769479886,8,40,necrotic cell death,BP,TNF;BIRC3;PPIF;TICAM1;BIRC2;CYLD;CFLAR;CAV1
1009,GO:0002480,0.000251300267771912,0.999989959304597,4,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,HLA-A;HLA-B;HLA-F;HLA-E
8084,GO:0032760,0.000253930987633199,0.999961055062544,8,38,positive regulation of tumor necrosis factor production,BP,TICAM1;IL23A;RIPK2;NOD2;WNT5A;IFIH1;TLR2;HLA-E
9046,GO:0035259,0.000254515264098792,0.999983003038763,5,13,glucocorticoid receptor binding,MF,ETS2;SMAD3;CEBPB;NR4A2;NR4A3
9897,GO:0042176,0.00026150827587049,0.999888995416831,28,300,regulation of protein catabolic process,BP,IL1B;TNFAIP3;TNF;EFNA1;RNF19B;ADAM8;N4BP1;ODC1;NEDD4L;CTSC;SMAD3;RNF144B;TRIB1;PLK2;SMURF2;WNT5A;NRG1;LDLR;PLK3;RCHY1;NEDD4;NFE2L2;CAV1;PML;ADAM9;RELA;GSK3B;XBP1
11404,GO:0045778,0.000262217124002498,0.999947520464968,10,56,positive regulation of ossification,BP,BMP2;IL6;IL6ST;SMAD3;CEBPB;WNT5A;SUCO;WNT7B;SMAD1;JUND
17679,GO:1901522,0.000262242200365201,0.999974266780692,6,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,BMP2;VEGFA;NFE2L2;SMAD1;RELA;XBP1
15810,GO:0072431,0.000263508567910899,0.99994687287324,10,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
17997,GO:1902400,0.000263508567910899,0.99994687287324,10,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
12722,GO:0050927,0.000274204798151486,0.999980864921183,5,14,positive regulation of positive chemotaxis,BP,CXCL8;IL16;SMAD3;VEGFA;VEGFC
18247,GO:1903035,0.000275721874674113,0.999944362633307,10,57,negative regulation of response to wounding,BP,PLAU;PLAUR;EDN1;SERPINB2;PHLDB2;C1QTNF1;SMAD3;DUSP10;PDGFB;PLAT
16119,GO:0090087,0.000276638929958113,0.999862854223505,40,491,regulation of peptide transport,BP,IL1B;TNF;IL1A;ZC3H12A;HCAR2;PLAGL2;IL6;ADAM8;PIM3;PANX1;RIPK2;CDKN1A;NOD2;IL1R2;SAA1;WNT5A;VEGFC;SOX4;IFIH1;NRG1;PLK3;IL4R;MARCKS;BTN2A2;PTPN1;UGCG;TP53;TLR2;UBE2D3;STX1A;MAPKBP1;PML;ADAM9;TRIM16;HLA-E;GSK3B;PPARD;SLC16A1;XBP1;IL36RN
19065,GO:1904892,0.000279370981917266,0.999932197445929,12,82,regulation of STAT cascade,BP,CSF2;LIF;IL23A;BCL3;IL6;IL7R;IL6ST;VHL;SOCS2;IL20;IL24;CAV1
7991,GO:0032602,0.000281145817371335,0.999948975816655,9,51,chemokine production,BP,IL1B;TNF;IL1A;TICAM1;IL6;RIPK2;WNT5A;IL4R;TLR2
8006,GO:0032623,0.000282755711496179,0.999955922522974,8,38,interleukin-2 production,BP,IL1B;TNFAIP3;IL1A;CD83;ZFP36;RIPK2;NAV3;RUNX1
11945,GO:0046982,0.00028656120072624,0.999875208674232,29,352,protein heterodimerization activity,MF,INHBA;BMP2;NFKB1;JUN;BHLHE40;GADD45A;PANX1;IRAK2;SMAD3;VEGFA;CEBPB;TAF4B;NR4A2;ABTB2;SOX4;PDGFB;PGLYRP4;ATF3;IKZF2;BCL2L2;SMAD1;CAV1;TP53;TLR2;STX1A;RELA;AXL;PPARD;XBP1
15287,GO:0071456,0.000288985295225403,0.999907129176873,17,151,cellular response to hypoxia,BP,PMAIP1;EDN1;ADAM8;ZFP36L1;CPEB2;ICAM1;VEGFA;CFLAR;VHL;BACH1;PLK3;SLC9A1;NFE2L2;TP53;UBE2D3;PPARD;EGLN1
10162,GO:0042742,0.00029030298907195,0.999928577859971,12,94,defense response to bacterium,BP,TNF;CCL20;IL23A;BCL3;IL6;RIPK2;NOD2;CEBPB;PGLYRP4;TLR2;MAPKBP1;HLA-E
3280,GO:0006959,0.0002906194587339,0.999933849291967,11,84,humoral immune response,BP,TNF;CD83;BCL3;IL6;CD55;PGLYRP4;POU2F2;HLA-E;IL36RN;TFE3;CFB
8068,GO:0032731,0.000291240179491914,0.999970502354823,6,21,positive regulation of interleukin-1 beta production,BP,PANX1;RIPK2;NOD2;SMAD3;WNT5A;TRIM16
12623,GO:0050790,0.000294380012355092,0.99981044446828,103,1615,regulation of catalytic activity,BP,IL1B;TNFAIP3;TNF;CXCL1;EFNA1;SDC4;BIRC3;PLEKHF1;CCL20;PPP1R15A;BMP2;PLAUR;PMAIP1;PTX3;NFKB1;PPIF;EDN1;MAP2K3;ZFP36;SERPINB2;JUN;EPHA2;CSF1;BBC3;EREG;IL23A;DUSP1;GADD45A;BIRC2;ADAM8;TNFRSF10B;TNFSF15;CYP27B1;RIPK2;IRAK2;FZD8;TNFAIP8;CDKN1A;RAP2B;CPEB2;NOD2;DCUN1D3;TFPI2;SGK1;ICAM1;GCH1;SMAD3;TRAF4;TRIB1;SERPINB8;VEGFA;FGD6;DKK1;CDKN2B;MAP3K8;ABL2;CFLAR;ANXA8;PPP4R4;ANKLE2;CDC42EP4;ERRFI1;CCNL1;NR4A2;TGFBR2;DUSP16;SAA1;MASTL;WNT5A;TGFA;DUSP10;PPP1R3B;SERPINB1;SOCS2;PDGFB;DUSP8;NRG1;MMP9;CAB39;ARRDC4;RASGEF1B;SPRY2;MMD;TNFRSF6B;PTPN1;WNT7B;TAB3;CAV1;SH3RF2;TP53;ABI1;DOCK4;TRIP10;PML;ADAM9;PPP6R3;AXL;ANXA5;GSK3B;PARP1;TBC1D22B;EGLN1;DDR1
13858,GO:0060444,0.000298622057031018,0.999969962186296,6,20,branching involved in mammary gland duct morphogenesis,BP,TBX3;EPHA2;CSF1;WNT5A;PML;DDR1
7201,GO:0031086,0.000298666955149945,0.999988384497264,4,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,ZFP36;PNRC1;ZFP36L1;PNRC2
6314,GO:0019955,0.000298899610673937,0.999938953695346,10,58,cytokine binding,MF,IL1RN;ZFP36;IL6ST;IL1R2;IFNAR1;TGFBR2;IFNGR1;ITGAV;TRIM16;IL36RN
11255,GO:0045446,0.000299596722613425,0.99993282588946,11,66,endothelial cell differentiation,BP,IL1B;TNF;KDM6B;TJP2;CLDN1;ICAM1;BTG1;NRG1;WNT7B;CLIC4;VEZF1
12579,GO:0050718,0.000301056352241481,0.999978551648479,5,14,positive regulation of interleukin-1 beta secretion,BP,PANX1;RIPK2;NOD2;WNT5A;TRIM16
15803,GO:0072413,0.000305371302128304,0.999937163399228,10,61,signal transduction involved in mitotic cell cycle checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
17998,GO:1902402,0.000305371302128304,0.999937163399228,10,61,signal transduction involved in mitotic DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
17999,GO:1902403,0.000305371302128304,0.999937163399228,10,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
14657,GO:0070234,0.000307494484498192,0.999987031659087,4,9,positive regulation of T cell apoptotic process,BP,ADAM8;NFKBID;WNT5A;TP53
6766,GO:0030195,0.000313479435467023,0.999958516588946,7,30,negative regulation of blood coagulation,BP,PLAU;PLAUR;EDN1;SERPINB2;C1QTNF1;PDGFB;PLAT
17370,GO:1900047,0.000313479435467023,0.999958516588946,7,30,negative regulation of hemostasis,BP,PLAU;PLAUR;EDN1;SERPINB2;C1QTNF1;PDGFB;PLAT
1175,GO:0002819,0.000313927698595683,0.99992280465035,12,82,regulation of adaptive immune response,BP,IL1B;TNFAIP3;TNF;IRF1;IL23A;IL6;RIPK2;IL7R;IL6ST;DUSP10;IL4R;HLA-E
10798,GO:0044267,0.000321039165467269,0.999771093226186,214,3918,cellular protein metabolic process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;HBEGF;NUAK2;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;CCL20;NCOA7;ZC3H12A;PPP1R15A;RNF19B;BMP2;LIF;PLAUR;PMAIP1;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;SQSTM1;CSF1;SPRR2D;BBC3;EREG;IL23A;DUSP1;BCL3;PELI1;GADD45A;BIRC2;IL6;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;ZFP36L1;TNFSF15;RIPK2;IRAK2;KLHL21;DAPP1;CYLD;FZD8;TNFAIP8;C1QTNF1;CDKN1A;ITGA5;RAP2B;CPEB2;ZNF451;NEDD4L;CTSC;NOD2;IL6ST;DCUN1D3;TFPI2;SGK1;ICAM1;SMAD3;B4GALT1;B3GNT5;RNF144B;TRAF4;TRIB1;SERPINB8;VEGFA;IL1R2;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;PPTC7;CFLAR;RNF43;PIGA;BTG1;ANXA8;PPP4R4;CD55;DENND3;ANKLE2;ERRFI1;ANKK1;CREB1;CCNL1;USP43;MAST4;VHL;PHKG2;BACH1;ABTB2;TGFBR2;SMURF2;DUSP16;DDX3Y;SAA1;TINAGL1;KLHL5;TRIM25;MASTL;WNT5A;CAMK1G;VEGFC;ABCF1;TGFA;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;KIAA1586;ATF3;OTUD4;CAB39;PLK3;ARRDC4;RCHY1;SPRY2;TNKS1BP1;B4GALT5;GRB7;ARSJ;NUP153;RNF152;NEDD4;MMD;IL24;TNFRSF6B;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;CHD4;STAT5A;TPST1;CAV1;SH3RF2;INO80D;TNIP2;TP53;TLR2;ABI1;STK40;PDP1;ITGAV;IKBKE;UBE2D3;PJA2;SPRR2A;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;UBE2Z;PML;PIM1;ADAM9;RELA;TRIM16;ESCO2;CCBE1;PPP6R3;PLAT;MUC1;YARS2;AXL;FRK;USP31;GSK3B;KMT2E;PARP8;PARP1;KDM7A;LCE1C;VIM;EGLN1;RIPK4;RNF145;RPS6KA6;DDR1;XBP1;QKI;KCTD11;LMAN1
8482,GO:0033627,0.000323406788663554,0.999948545898125,8,38,cell adhesion mediated by integrin,BP,PLAU;EFNA1;EPHA2;ITGA5;ICAM1;ITGAV;ADAM9;MUC1
7502,GO:0031669,0.000324976186372697,0.999886902468468,19,167,cellular response to nutrient levels,BP,NUAK2;PLEKHF1;ZC3H12A;PMAIP1;JUN;CYP27B1;CDKN1A;ICAM1;CDKN2B;UPP1;TNC;SLC38A2;ATF3;RNF152;NFE2L2;TP53;PIM1;CYP24A1;XBP1
3336,GO:0007050,0.000333394487593385,0.999872997898089,22,215,cell cycle arrest,BP,CXCL8;IRF1;BTG2;INHBA;PPP1R15A;IRF6;DUSP1;GADD45A;CDKN1A;SMAD3;CDKN2B;PLK2;SOX4;CAB39;PLK3;TNKS1BP1;TP53;PML;EVI2B;MUC1;KMT2E;JMY
8157,GO:0032880,0.000337965631290485,0.999815083473136,52,692,regulation of protein localization,BP,IL1B;TNF;IL1A;ZC3H12A;LIF;PMAIP1;EPHA2;HCAR2;SQSTM1;BBC3;PLAGL2;IL6;ADAM8;PIM3;PANX1;SIX4;RIPK2;CYLD;CDKN1A;NEDD4L;NOD2;IL1R2;TP53BP2;SAA1;WNT5A;VEGFC;SOX4;IFIH1;NRG1;PLK3;IL4R;MMD;MARCKS;BTN2A2;PTPN1;UGCG;TP53;TLR2;RAB9A;UBE2D3;STX1A;MAPKBP1;PML;ADAM9;TRIM16;HLA-E;GSK3B;PPARD;SLC16A1;PARP1;XBP1;IL36RN
12977,GO:0051346,0.000339233680446289,0.999858608466607,26,278,negative regulation of hydrolase activity,BP,TNF;BIRC3;PLEKHF1;PPP1R15A;PLAUR;PTX3;PPIF;SERPINB2;BIRC2;TNFRSF10B;TNFAIP8;CPEB2;TFPI2;SERPINB8;VEGFA;ANXA8;PPP4R4;MASTL;SERPINB1;MMP9;SPRY2;TNFRSF6B;SH3RF2;TP53;GSK3B;EGLN1
11488,GO:0045936,0.000341162759925242,0.999833990606602,37,439,negative regulation of phosphate metabolic process,BP,IL1B;TNFAIP3;TNF;EFNA1;INHBA;PLEKHF1;ZC3H12A;PPP1R15A;LIF;PPIF;TNIP1;JUN;DUSP1;GADD45A;BDKRB1;CDKN1A;TRIB1;DKK1;CDKN2B;PPP4R4;ANKLE2;ERRFI1;DUSP16;MASTL;DUSP10;SOCS2;PDGFB;DUSP8;ATF3;SPRY2;PTPN1;CAV1;SH3RF2;GSK3B;PARP1;EGLN1;RPS6KA6
3549,GO:0007584,0.000344326820264066,0.999887831948779,17,145,response to nutrient,BP,IL1B;PANX1;CYP27B1;NOD2;CDKN2B;CREB1;TGFBR2;TRIM25;HMGCS1;TNC;TP53;PIM1;RELA;PPARD;SLC16A1;CYP24A1;XBP1
11809,GO:0046677,0.00034578132021515,0.999867826218907,22,219,response to antibiotic,BP,TNFAIP3;FOSL1;ZC3H12A;PPIF;EDN1;JUN;KDM6B;ETS1;DUSP1;BIRC2;IL6;CLDN1;ICAM1;PDGFB;TNC;SLC9A1;NFE2L2;TP53;ADAM9;RELA;AXL;NR4A3
9667,GO:0038023,0.000345926225949709,0.999837208990982,34,386,signaling receptor activity,MF,SDC4;PLAUR;HCAR3;IFNAR2;EPHA2;GPR156;HCAR2;IFNGR2;TNFRSF10B;BDKRB1;FZD8;IL7R;IL6ST;RELT;ICAM1;IL1R2;IFNAR1;NR4A2;CD47;TGFBR2;IFNGR1;PGLYRP4;IL4R;TNFRSF6B;TPRA1;TLR2;ITGAV;ABCA7;ADGRE2;AXL;NR4A3;OSMR;PPARD;DDR1
13631,GO:0060089,0.000345926225949709,0.999837208990982,34,386,molecular transducer activity,MF,SDC4;PLAUR;HCAR3;IFNAR2;EPHA2;GPR156;HCAR2;IFNGR2;TNFRSF10B;BDKRB1;FZD8;IL7R;IL6ST;RELT;ICAM1;IL1R2;IFNAR1;NR4A2;CD47;TGFBR2;IFNGR1;PGLYRP4;IL4R;TNFRSF6B;TPRA1;TLR2;ITGAV;ABCA7;ADGRE2;AXL;NR4A3;OSMR;PPARD;DDR1
11357,GO:0045672,0.000348742104240052,0.999973743950874,5,15,positive regulation of osteoclast differentiation,BP,TNF;CSF1;IL23A;CREB1;IL20
4516,GO:0010563,0.000355847551832749,0.999826435895971,37,440,negative regulation of phosphorus metabolic process,BP,IL1B;TNFAIP3;TNF;EFNA1;INHBA;PLEKHF1;ZC3H12A;PPP1R15A;LIF;PPIF;TNIP1;JUN;DUSP1;GADD45A;BDKRB1;CDKN1A;TRIB1;DKK1;CDKN2B;PPP4R4;ANKLE2;ERRFI1;DUSP16;MASTL;DUSP10;SOCS2;PDGFB;DUSP8;ATF3;SPRY2;PTPN1;CAV1;SH3RF2;GSK3B;PARP1;EGLN1;RPS6KA6
97,GO:0000187,0.000355983501136237,0.99989915005829,14,104,activation of MAPK activity,BP,IL1B;TNF;BMP2;MAP2K3;RIPK2;IRAK2;NOD2;SAA1;WNT5A;TGFA;NRG1;PTPN1;WNT7B;TAB3
11941,GO:0046977,0.000357541108265587,0.999995830500406,3,4,TAP binding,MF,TAP1;TAPBP;HLA-F
11942,GO:0046978,0.000357541108265587,0.999995830500406,3,4,TAP1 binding,MF,TAP1;TAPBP;HLA-F
4388,GO:0010038,0.0003675120283301,0.999858897426909,22,218,response to metal ion,BP,IL1A;PPIF;EDN1;JUN;DUSP1;JUNB;CLDN1;NEDD4L;ICAM1;CREB1;WNT5A;SLC11A2;MMP9;MT2A;NEDD4;CLIC4;CAV1;TP53;ADAM9;PARP1;SLC41A1;JUND
11636,GO:0046330,0.000378381579199583,0.999898456266723,13,91,positive regulation of JNK cascade,BP,IL1B;TNF;IL1A;EDN1;GADD45A;RIPK2;FZD8;NOD2;TRAF4;DKK1;WNT5A;PTPN1;WNT7B
3163,GO:0006775,0.000381485848472269,0.999958170981544,6,24,fat-soluble vitamin metabolic process,BP,IL1B;TNF;NFKB1;CYP27B1;PPARD;CYP24A1
12684,GO:0050878,0.000383097143880365,0.999833199328818,28,308,regulation of body fluid levels,BP,IRF1;PLAU;PLAUR;MAFF;EDN1;SERPINB2;EHD1;IL6;C1QTNF1;CLDN1;RAP2B;TFPI2;VEGFA;ANXA8;ADM;CREB1;SAA1;SOCS2;PDGFB;NFE2L2;STAT5A;CAV1;PLAT;AXL;ANXA5;DDR1;XBP1;LMAN1
12984,GO:0051353,0.000386781762952265,0.999946429579107,7,32,positive regulation of oxidoreductase activity,BP,IL1B;TNF;EDN1;CYP27B1;NOD2;GCH1;ABL2
14732,GO:0070374,0.000393198651976181,0.999881336122081,15,118,positive regulation of ERK1 and ERK2 cascade,BP,TNF;IL1A;CCL20;BMP2;JUN;EPHA2;RIPK2;NOD2;ICAM1;CFLAR;PDGFB;SPRY2;ABCA7;AXL;DDR1
14731,GO:0070373,0.000399360766626343,0.999924211729888,9,49,negative regulation of ERK1 and ERK2 cascade,BP,LIF;TNIP1;DUSP1;ERRFI1;DUSP10;ATF3;SPRY2;PTPN1;RPS6KA6
12872,GO:0051179,0.00040035609965553,0.999711119029659,236,4314,localization,BP,CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;INHBA;PLEKHF1;CCL20;ZC3H12A;CXCL5;IL16;PPP1R15A;BMP2;LIF;PLAUR;SOD2;TBX3;PMAIP1;PTX3;IL1RN;NFKB1;PPIF;EDN1;MAP2K3;ZFP36;JUN;RAB3IP;EPHA2;EHD1;ETS1;HCAR2;SQSTM1;CSF1;STARD5;NFKBIE;BBC3;EREG;IL23A;BCL3;AMPD3;PLAGL2;EFNB1;IL6;ADAM8;TNFRSF10B;BDKRB1;PIM3;PANX1;ZFP36L1;CYP27B1;SIX4;RIPK2;KLHL21;PHLDA2;PHLDB2;CYLD;BAMBI;TJP2;STEAP4;C1QTNF1;AMOTL2;CDKN1A;CLDN1;ITGA5;RAP2B;ABCA5;NAV3;TNFAIP2;NEDD4L;CTSC;ARL5B;NOD2;SGK1;ICAM1;RASSF9;SMAD3;B4GALT1;RND3;TRIB1;VEGFA;RAB24;IL1R2;SLC6A14;DKK1;ZSWIM4;PLK2;ABL2;BTG1;ANXA8;VMP1;CD55;KCNJ15;DENND3;TAP1;TP53BP2;HEPHL1;ADM;GJB3;SLC28A3;CREB1;NEDD9;NR4A2;NIPAL4;SLC7A2;CD47;CANT1;SEMA4B;TGFBR2;MREG;SMURF2;DUSP16;SAA1;TINAGL1;KIF3C;WNT5A;VEGFC;SLC11A2;ABCF1;TGFA;DUSP10;SLC52A3;ROBO4;SOX4;SERPINB1;SOCS2;PDGFB;ANLN;IFIH1;NRG1;SLC38A2;MMP9;LDLR;RRAD;CAB39;RHD;PLK3;ARRDC4;PARD6B;TRPV3;SLC9A1;SLC25A37;SYS1;SPRY2;FEZ1;CYTH1;GRB7;CXCL16;NUP153;IL4R;NEDD4;MMD;RHCG;SLC2A6;POU2F2;ITSN2;GCSAM;IL24;MARCKS;BTN2A2;NFE2L2;PTPN1;SPTBN5;CLIC4;STAT5A;CAV1;RHOV;CACFD1;NECAP2;UGCG;ZFAND5;TP53;TLR2;ABI1;TAPBP;EFNB2;RAB9A;ITGAV;IKBKE;GEM;UBE2D3;STX1A;DOCK4;TRIP10;MAPKBP1;JPH2;ABCA7;SPCS2;ADGRE2;PML;ESPL1;ADAM9;SLC43A3;TRIM16;ESCO2;SLC9A8;CCBE1;PPP6R3;TSPAN13;PLAT;AXL;SLC16A13;ANXA5;CRB3;FRK;NR4A3;HLA-E;GSK3B;PPARD;SLC16A1;PARP1;MMP10;LAMA3;TBC1D22B;COTL1;JMY;SRSF11;DDR1;CEP135;XBP1;QKI;EPB41L3;IL36RN;SLC39A14;MGAM;LMAN1;SLC41A1;GJC1
685,GO:0001892,0.000400504514806407,0.999906531689076,11,70,embryonic placenta development,BP,CSF2;LIF;PRDM1;ZFP36L1;PHLDA2;JUNB;CEBPB;ADM;PDGFB;WNT7B;EGLN1
10673,GO:0043900,0.000400911651031631,0.999830882438688,26,284,regulation of multi-organism process,BP,CXCL8;IL1B;TNFAIP3;TNF;INHBA;BIRC3;ZC3H12A;PRDM1;PTX3;TNIP1;ZFP36;JUN;SQSTM1;IL23A;BIRC2;RIPK2;B4GALT1;TRIB1;CD55;SMURF2;TRIM25;PGLYRP4;CAV1;ITGAV;MAPKBP1;PML
11355,GO:0045670,0.000405842062029949,0.999932919970582,8,39,regulation of osteoclast differentiation,BP,TNF;CSF1;IL23A;TJP2;CEBPB;CREB1;IL20;TFE3
10523,GO:0043434,0.00040670717444827,0.999822388086349,28,299,response to peptide hormone,BP,IL1B;BTG2;NFKB1;EDN1;EREG;ZFP36L1;CPEB2;ICAM1;CFLAR;BTG1;ADM;ERRFI1;CREB1;NR4A2;SOGA1;SOCS2;SLC9A1;NFE2L2;PTPN1;STAT5A;CAV1;TLR2;RELA;TRIM16;NR4A3;PARP1;XBP1;JUND
17526,GO:1900745,0.000407328345720891,0.999968254320364,5,15,positive regulation of p38MAPK cascade,BP,IL1B;ZC3H12A;BMP2;GADD45A;VEGFA
18719,GO:1904063,0.000410873324202316,0.999931739245487,8,40,negative regulation of cation transmembrane transport,BP,PPIF;NEDD4L;MMP9;RRAD;CAB39;NEDD4;CAV1;GEM
12228,GO:0048468,0.00041515677053232,0.999737916567384,88,1299,cell development,BP,IL1B;TNF;IL1A;EFNA1;SDC4;BTG2;INHBA;BMP2;LIF;PRDM1;TBX3;EDN1;JUN;EPHA2;EHD1;CSF1;IRF6;EREG;EFNB1;IL6;SIX4;TJP2;CDKN1A;CLDN1;NEDD4L;IL6ST;SGK1;ICAM1;SMAD3;B4GALT1;DLX2;TRIB1;VEGFA;DKK1;ZSWIM4;PLK2;ABL2;CFLAR;KLF7;ADM;CREB1;TAF4B;NR4A2;SEMA4B;RUNX1;TGFBR2;TGIF2;WNT5A;VEGFC;SLC11A2;DUSP10;SOX4;SOCS2;PDGFB;NRG1;TNC;LDLR;PARD6B;FEZ1;GRB7;NEDD4;MMD;POU2F2;ITSN2;NFE2L2;WNT7B;SPTBN5;CLIC4;VEZF1;TLR2;ABI1;EFNB2;ITGAV;RELA;RAPH1;EVI2B;COL27A1;AXL;NR4A3;GSK3B;VIM;DDR1;XBP1;QKI;EPB41L3;KCTD11;JUND;GJC1
9977,GO:0042362,0.000416590162805048,0.999980934384038,4,9,fat-soluble vitamin biosynthetic process,BP,IL1B;TNF;NFKB1;CYP27B1
12721,GO:0050926,0.000417048970895947,0.999967325240253,5,15,regulation of positive chemotaxis,BP,CXCL8;IL16;SMAD3;VEGFA;VEGFC
19894,GO:2000347,0.000418054458984604,0.999994850880162,3,4,positive regulation of hepatocyte proliferation,BP,TNFAIP3;CFLAR;XBP1
9434,GO:0036003,0.000429459826598734,0.999952224298661,6,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,VEGFA;CEBPB;ATF3;NFE2L2;TP53;MUC1
8048,GO:0032692,0.000433358445047394,0.999965104450072,5,16,negative regulation of interleukin-1 production,BP,TNFAIP3;ZC3H12A;IL1R2;ERRFI1;PML
10886,GO:0044421,0.000435394996470245,0.999700923875385,141,2518,extracellular region part,CC,CXCL8;IL1B;CXCL2;TNFAIP3;CSF2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;CCL20;CXCL5;IL16;BMP2;LIF;PLAUR;SOD2;IL36G;PTX3;IL1RN;EDN1;SERPINB2;EHD1;SQSTM1;CSF1;IRF6;EREG;IL23A;EFNB1;IL6;TNFSF15;STEAP4;C1QTNF1;FJX1;RAP2B;TNFAIP2;NEDD4L;CTSC;GPX3;IL6ST;RELT;TFPI2;ICAM1;FRMD4B;RASSF9;B4GALT1;RND3;MARCKSL1;KRT34;SERPINB8;VEGFA;SLC6A14;DKK1;FGF5;LAMB3;TXNRD1;CD55;NAMPT;TMEM106A;ANXA8L1;ADM;ADAMTS1;WISP1;CD47;CANT1;SOGA1;SEMA4B;SAA1;TINAGL1;ITGB8;WNT5A;VEGFC;SLC11A2;TGFA;ROBO4;SERPINB1;PDGFB;IL20;CD82;NRG1;TNC;MMP9;LDLR;COL12A1;CAB39;IL32;CHD2;ARRDC4;PARD6B;SLC9A1;B4GALT5;CXCL16;BCL2L2;IL4R;NEDD4;RHCG;ITSN2;IL24;TNFRSF6B;MARCKS;BTN2A2;WNT7B;TAB3;SPTBN5;CLIC4;UACA;ABI1;RAB9A;ITGAV;UBE2D3;CD276;TRIP10;TMEM132A;ADAM9;MAMDC2;CCBE1;COL27A1;PLAT;MUC1;AXL;ANXA5;CRB3;FRK;HLA-E;SLC16A1;MMP10;LAMA3;COTL1;COL8A1;VIM;CREB5;DDR1;IL36RN;MGAM;LMAN1;CFB
17738,GO:1901653,0.000436013571254998,0.999818838548367,25,256,cellular response to peptide,BP,IL1B;NFKB1;EDN1;ZFP36L1;RIPK2;CPEB2;NOD2;CFLAR;ERRFI1;CREB1;NR4A2;SOGA1;SOCS2;SLC9A1;NFE2L2;PTPN1;STAT5A;CAV1;TP53;KLF3;RELA;NR4A3;GSK3B;PARP1;XBP1
5903,GO:0018105,0.000447348999403081,0.999825880757455,22,211,peptidyl-serine phosphorylation,BP,TNF;LIF;IL6;RIPK2;SGK1;VEGFA;DKK1;PLK2;MAST4;PHKG2;TGFBR2;MASTL;WNT5A;CAMK1G;PDGFB;CAB39;SPRY2;TNKS1BP1;IL24;CAV1;IKBKE;GSK3B
3177,GO:0006793,0.000448564609175209,0.999692172064865,140,2360,phosphorus metabolic process,BP,IL1B;TNFAIP3;CSF2;TNF;HBEGF;NUAK2;IL1A;ITPKC;EFNA1;SDC4;INHBA;PLEKHF1;CCL20;ZC3H12A;PPP1R15A;BMP2;LIF;PLAUR;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;JUN;EPHA2;SQSTM1;CSF1;EREG;IL23A;DUSP1;PELI1;AMPD3;GADD45A;IL6;ADAM8;TNFRSF10B;BDKRB1;PIM3;ZFP36L1;TNFSF15;RIPK2;IRAK2;DAPP1;FZD8;TJP2;C1QTNF1;CDKN1A;NMNAT2;ITGA5;RAP2B;NOD2;IL6ST;SGK1;ICAM1;GCH1;SMAD3;TRAF4;TRIB1;VEGFA;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;PPTC7;CFLAR;PIGA;UPP1;PPP4R4;NAMPT;ANKLE2;ADM;ERRFI1;ANKK1;CREB1;CCNL1;MAST4;PHKG2;TGFBR2;DUSP16;SAA1;MASTL;HMGCS1;WNT5A;CAMK1G;VEGFC;TGFA;DUSP10;PPP1R3B;SOCS2;PDGFB;IL20;DUSP8;NRG1;MMP9;LDLR;ATF3;CAB39;PLK3;SPRY2;TNKS1BP1;NUP153;MMD;IL24;KBTBD7;PTPN1;WNT7B;SMAD1;SGMS2;TAB3;SPTBN5;STAT5A;TPST1;CAV1;SH3RF2;TNIP2;TP53;TLR2;ABI1;STK40;PDP1;ITGAV;IKBKE;ABCA7;CLK4;PML;PIM1;ADAM9;PPP6R3;AXL;FRK;GSK3B;PPARD;PARP1;EGLN1;RIPK4;RPS6KA6;DDR1
15227,GO:0071363,0.0004507728202479,0.999775019193433,38,455,cellular response to growth factor stimulus,BP,CXCL8;IL1B;BMP2;EDN1;MAP2K3;ZFP36;JUN;EHD1;ZFP36L1;BAMBI;CLDN1;ITGA5;ZNF451;SMAD3;VEGFA;DKK1;CDKN2B;FGF5;CFLAR;ERRFI1;CREB1;TGFBR2;SMURF2;WNT5A;VEGFC;PDGFB;SPRY2;FEZ1;NEDD4;PTPN1;SMAD1;CAV1;UBE2D3;PML;ADAM9;RELA;CCBE1;PARP1
12544,GO:0050679,0.000460004137515547,0.9998588327588,15,121,positive regulation of epithelial cell proliferation,BP,TNFAIP3;BMP2;JUN;NOD2;B4GALT1;VEGFA;NRARP;CFLAR;WNT5A;VEGFC;TGFA;PDGFB;STAT5A;NR4A3;XBP1
10288,GO:0043030,0.000463621122072785,0.999947658914617,6,23,regulation of macrophage activation,BP,ZC3H12A;SLC7A2;WNT5A;LDLR;IL4R;TNIP2
3292,GO:0006984,0.000466453462977286,0.999920980440856,8,40,ER-nucleus signaling pathway,BP,CXCL8;PPP1R15A;ATF3;NFE2L2;PTPN1;TP53;GSK3B;XBP1
18541,GO:1903707,0.00047286792140298,0.999877062167769,12,94,negative regulation of hemopoiesis,BP,NFKBIA;IRF1;INHBA;ZFP36;ZFP36L1;CYLD;TJP2;NFKBID;TRIB1;NRARP;IL4R;NFE2L2
6847,GO:0030308,0.000478259855532632,0.999852603187189,15,122,negative regulation of cell growth,BP,INHBA;SERTAD2;BDKRB1;CYP27B1;CDKN1A;CCDC85B;DCUN1D3;SMAD3;BTG1;SEMA4B;WNT5A;DCBLD2;TP53;PML;PPARD
10794,GO:0044260,0.00047912886482786,0.999651594416685,322,6227,cellular macromolecule metabolic process,BP,NFKBIZ;CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;ZNF267;SPRR2D;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;ZFP36L1;TNFSF15;SIX4;RIPK2;IRAK2;THAP10;KLHL21;PHLDA2;DAPP1;JUNB;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;RELB;ZNF217;C1QTNF1;CDKN1A;CCDC85B;ITGA5;RAP2B;IL7R;CPEB2;ZNF451;NEDD4L;CTSC;NOD2;ELMSAN1;IL6ST;DCUN1D3;SAV1;TFPI2;SGK1;ICAM1;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;RNF144B;NFKBID;TRAF4;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ZBED2;ABL2;PPTC7;CFLAR;RNF43;KLF7;PIGA;BTG1;ANXA8;IER5;PPP4R4;CEBPB;CEBPD;CD55;DENND3;NAMPT;ANKLE2;ADM;DSE;ERRFI1;ANKK1;CREB1;TAF4B;CCNL1;USP43;MAST4;NR4A2;PATL1;CANT1;VHL;PHKG2;BACH1;ABTB2;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;MASTL;NAB1;WNT5A;CAMK1G;VEGFC;ABCF1;TGFA;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;KIAA1586;ATF3;OTUD4;IKZF2;CAB39;TLE1;PLK3;CHD2;ARRDC4;SLC9A1;ZBTB10;RCHY1;YAF2;SPRY2;TNKS1BP1;B4GALT5;GRB7;ARSJ;NUP153;RNF152;NEDD4;MMD;POU2F2;IL24;TNFRSF6B;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;TAB3;SPTBN5;MXD1;CHD4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;SH3RF2;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;ABI1;STK40;PDP1;ITGAV;IKBKE;UBE2D3;PJA2;ELK3;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ADAM9;RELA;TRIM16;ESCO2;FOXN2;CCBE1;PPP6R3;PLAT;MUC1;YARS2;AXL;ELL2;FRK;CITED4;NR4A3;USP31;GSK3B;KMT2E;PPARD;PARP8;PARP1;KDM7A;MED13;MXD3;CRAMP1;LCE1C;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;RNF145;ZXDA;RPS6KA6;DDR1;XBP1;QKI;KCTD11;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;MGAM;LMAN1;JUND;DENND4A
6824,GO:0030278,0.000479430755857711,0.99985247833283,15,118,regulation of ossification,BP,TNF;NOCT;BMP2;CSF1;IL6;CYP27B1;IL6ST;SMAD3;DKK1;CEBPB;WNT5A;SUCO;WNT7B;SMAD1;JUND
545,GO:0001664,0.000484333968170621,0.999850352632943,15,125,G-protein coupled receptor binding,MF,CXCL8;CXCL2;CXCL3;CXCL1;CCL20;CXCL5;EDN1;BAMBI;RNF43;ADM;SAA1;WNT5A;CXCL16;NEDD4;WNT7B
12768,GO:0051023,0.000493052114204005,0.999975120476786,4,10,regulation of immunoglobulin secretion,BP,TNF;IL6;HLA-E;XBP1
798,GO:0002064,0.000493543634715342,0.999834058089766,17,143,epithelial cell development,BP,IL1B;TNF;PRDM1;EPHA2;TJP2;CDKN1A;CLDN1;ICAM1;B4GALT1;WNT5A;PDGFB;WNT7B;CLIC4;VEZF1;GSK3B;VIM;XBP1
999,GO:0002460,0.000494582566812957,0.999839938993844,16,136,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,IL1B;TNFAIP3;TNF;IL23A;BCL3;IL6;NFKB2;RIPK2;RELB;IL7R;CTSC;ICAM1;CD55;IL4R;POU2F2;HLA-E
6852,GO:0030316,0.000497582810933855,0.999891091504691,10,60,osteoclast differentiation,BP,TNF;EPHA2;CSF1;IL23A;JUNB;TJP2;CEBPB;CREB1;IL20;TFE3
5386,GO:0016202,0.000502753808395078,0.999869686199222,12,81,regulation of striated muscle tissue development,BP,BMP2;EDN1;SIX4;SAV1;SMAD3;DKK1;CREB1;TGFBR2;NRG1;EFNB2;JPH2;PIM1
17804,GO:1901861,0.000502753808395078,0.999869686199222,12,81,regulation of muscle tissue development,BP,BMP2;EDN1;SIX4;SAV1;SMAD3;DKK1;CREB1;TGFBR2;NRG1;EFNB2;JPH2;PIM1
2407,GO:0005576,0.000513584718338571,0.99964139051858,154,2799,extracellular region,CC,CXCL8;IL1B;CXCL2;TNFAIP3;CSF2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;CCL20;CXCL5;IL16;BMP2;LIF;PLAUR;SOD2;IL36G;PTX3;IL1RN;NFKB1;EDN1;SERPINB2;IFNAR2;EHD1;SQSTM1;CSF1;IRF6;EREG;IL23A;AMPD3;EFNB1;IL6;TNFSF15;STEAP4;C1QTNF1;FJX1;RAP2B;IL7R;TNFAIP2;NEDD4L;CTSC;GPX3;IL6ST;RELT;TFPI2;ICAM1;FRMD4B;RASSF9;B4GALT1;RND3;MARCKSL1;KRT34;SERPINB8;VEGFA;IL1R2;SLC6A14;DKK1;FGF5;LAMB3;TXNRD1;CD55;NAMPT;TMEM106A;ANXA8L1;ADM;ADAMTS1;WISP1;CD47;CANT1;SOGA1;SEMA4B;SAA1;TINAGL1;C9ORF47;ITGB8;WNT5A;VEGFC;SLC11A2;TGFA;NOTCH2NL;ROBO4;SERPINB1;PDGFB;IL20;PGLYRP4;CD82;NRG1;TNC;MMP9;LDLR;COL12A1;CAB39;IL32;CHD2;ARRDC4;PARD6B;SLC9A1;B4GALT5;CXCL16;ARSJ;BCL2L2;IL4R;NEDD4;RHCG;ITSN2;IL24;TNFRSF6B;MARCKS;RAET1L;BTN2A2;WNT7B;TAB3;SPTBN5;CLIC4;UACA;ABI1;RAB9A;ITGAV;PRRG1;UBE2D3;STX1A;CD276;TRIP10;TMEM132A;ADAM9;MAMDC2;CCBE1;COL27A1;PLAT;MUC1;AXL;ANXA5;THSD1;CRB3;FRK;HLA-E;SLC16A1;MMP10;LAMA3;COTL1;COL8A1;VIM;CREB5;DDR1;IL36RN;MGAM;LMAN1;CFB
4351,GO:0009913,0.000513863538105755,0.999813476672461,19,183,epidermal cell differentiation,BP,MAFF;ZFP36;EPHA2;SPRR2D;IRF6;EREG;ZFP36L1;CYP27B1;SAV1;KRT34;ERRFI1;RUNX1;WNT5A;IL20;CLIC4;SPRR2A;ADAM9;TRIM16;LCE1C
18416,GO:1903428,0.000525770667976309,0.999923271648259,7,32,positive regulation of reactive oxygen species biosynthetic process,BP,IL1B;TNF;PTX3;EDN1;TICAM1;ICAM1;SMAD3
8020,GO:0032648,0.000528950093993524,0.999908360902392,8,41,regulation of interferon-beta production,BP,IRF1;TICAM1;REL;RIPK2;RELB;IFIH1;TLR2;POLR3A
11361,GO:0045685,0.000535241446877544,0.999907101371511,8,41,regulation of glial cell differentiation,BP,BMP2;LIF;IL6ST;DLX2;DUSP10;LDLR;TLR2;RELA
9544,GO:0036294,0.000536410050564397,0.999817435574871,17,158,cellular response to decreased oxygen levels,BP,PMAIP1;EDN1;ADAM8;ZFP36L1;CPEB2;ICAM1;VEGFA;CFLAR;VHL;BACH1;PLK3;SLC9A1;NFE2L2;TP53;UBE2D3;PPARD;EGLN1
15869,GO:0072574,0.000543566576564927,0.999973265119556,4,9,hepatocyte proliferation,BP,TNFAIP3;CFLAR;CEBPB;XBP1
15870,GO:0072575,0.000543566576564927,0.999973265119556,4,9,epithelial cell proliferation involved in liver morphogenesis,BP,TNFAIP3;CFLAR;CEBPB;XBP1
14660,GO:0070242,0.000543588210867945,0.999953952093501,5,16,thymocyte apoptotic process,BP,EFNA1;ADAM8;NFKBID;WNT5A;TP53
1255,GO:0003006,0.000550822273596191,0.999730411024051,35,414,developmental process involved in reproduction,BP,IL1B;CSF2;IL1A;INHBA;FOSL1;LIF;PRDM1;TBX3;CSF1;EREG;BIRC2;ZFP36L1;CYP27B1;SIX4;PHLDA2;JUNB;ICAM1;B4GALT1;VEGFA;CEBPB;ADM;GJB3;ADAMTS1;TAF4B;ITGB8;HMGCS1;WNT5A;PDGFB;TNC;BCL2L2;WNT7B;AXL;PPARD;EGLN1;QKI
15284,GO:0071453,0.000551131289154464,0.999805088829006,18,172,cellular response to oxygen levels,BP,PMAIP1;EDN1;ADAM8;ZFP36L1;CPEB2;ICAM1;VEGFA;CFLAR;VHL;BACH1;PLK3;SLC9A1;NFE2L2;CAV1;TP53;UBE2D3;PPARD;EGLN1
12769,GO:0051024,0.000557137868643264,0.999988885490049,3,5,positive regulation of immunoglobulin secretion,BP,IL6;HLA-E;XBP1
19067,GO:1904894,0.00056033093776149,0.999901255395794,8,44,positive regulation of STAT cascade,BP,CSF2;LIF;IL23A;IL6;IL7R;IL6ST;IL20;IL24
5935,GO:0018209,0.00056145057957462,0.999772218226912,23,229,peptidyl-serine modification,BP,TNF;LIF;IL6;RIPK2;SGK1;VEGFA;DKK1;PLK2;MAST4;PHKG2;TGFBR2;MASTL;WNT5A;CAMK1G;PDGFB;CAB39;SPRY2;TNKS1BP1;IL24;CAV1;IKBKE;GSK3B;PARP1
12306,GO:0048634,0.000564801213427158,0.99985149674748,12,82,regulation of muscle organ development,BP,BMP2;EDN1;SIX4;SAV1;SMAD3;DKK1;CREB1;TGFBR2;NRG1;EFNB2;JPH2;PIM1
10627,GO:0043620,0.000567678783581355,0.999839132085159,13,108,regulation of DNA-templated transcription in response to stress,BP,JUN;VEGFA;CEBPB;VHL;BACH1;ATF3;NEDD4;NFE2L2;TP53;UBE2D3;RELA;MUC1;EGLN1
17525,GO:1900744,0.000567972385623654,0.999933313709304,6,23,regulation of p38MAPK cascade,BP,IL1B;ZC3H12A;BMP2;GADD45A;VEGFA;DUSP10
6865,GO:0030330,0.000590805155590118,0.999832495712061,13,101,DNA damage response, signal transduction by p53 class mediator,BP,BTG2;PMAIP1;BCL3;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1;RPS6KA6
6152,GO:0019438,0.000591303901048178,0.999575676320252,192,3429,aromatic compound biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;NMNAT2;CCDC85B;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;GCH1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;UPP1;IER5;CEBPB;CEBPD;NAMPT;ADM;CREB1;TAF4B;CCNL1;USP43;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;SLC11A2;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;NUP153;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;XBP1;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
15157,GO:0071248,0.000604121107431057,0.999828405846276,13,100,cellular response to metal ion,BP,PPIF;EDN1;JUN;JUNB;CLDN1;CREB1;WNT5A;MMP9;MT2A;CLIC4;PARP1;SLC41A1;JUND
568,GO:0001707,0.000605993344350991,0.999893102592126,8,40,mesoderm formation,BP,INHBA;KDM6B;SMAD3;DKK1;TXNRD1;WNT5A;SMAD1;NR4A3
5912,GO:0018130,0.000615361955218875,0.999557964616806,192,3432,heterocycle biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;NMNAT2;CCDC85B;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;GCH1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;UPP1;IER5;CEBPB;CEBPD;NAMPT;ADM;CREB1;TAF4B;CCNL1;USP43;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;SLC11A2;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;NUP153;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;XBP1;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
2105,GO:0004871,0.000618314442142616,0.999654058555896,51,678,signal transducer activity,MF,SDC4;PLAUR;HCAR3;MAP2K3;TICAM1;IFNAR2;EPHA2;GPR156;HCAR2;IFNGR2;TNFRSF10B;BDKRB1;RIPK2;FZD8;IL7R;IL6ST;RELT;ICAM1;SMAD3;NFKBIB;RND3;IL1R2;DKK1;PLK2;MAP3K8;CFLAR;IFNAR1;NR4A2;CD47;CANT1;TGFBR2;IFNGR1;PGLYRP4;NRG1;IL4R;TNFRSF6B;SMAD1;TPRA1;STAT5A;RHOV;TLR2;ITGAV;IKBKE;JPH2;ABCA7;ADGRE2;AXL;NR4A3;OSMR;PPARD;DDR1
16193,GO:0090200,0.000623746145707626,0.999923278844007,6,27,positive regulation of release of cytochrome c from mitochondria,BP,PLAUR;PMAIP1;PPIF;BBC3;MMP9;TP53
18043,GO:1902532,0.000626813458632363,0.999697785199621,33,390,negative regulation of intracellular signal transduction,BP,IL1B;TNFAIP3;EFNA1;ZC3H12A;LIF;PLAUR;SOD2;PPIF;TNIP1;EPHA2;DUSP1;BCL3;NFKBID;ERRFI1;VHL;DUSP16;DUSP10;SOCS2;DUSP8;MMP9;ATF3;TLE1;SPRY2;BCL2L2;RNF152;NFE2L2;PTPN1;CAV1;MAPKBP1;RELA;MUC1;RPS6KA6;XBP1
9415,GO:0035976,0.000627589682452807,0.999986947147928,3,5,transcription factor AP-1 complex,CC,JUN;JUNB;JUND
10044,GO:0042493,0.000633243932410521,0.999656122182785,46,613,response to drug,BP,IL1B;NFKBIA;TNFAIP3;TNF;INHBA;FOSL1;ZC3H12A;NFKB1;PPIF;EDN1;JUN;KDM6B;ETS1;NFKBIE;DUSP1;BIRC2;IL6;PANX1;RIPK2;JUNB;CDKN1A;CLDN1;NOD2;ICAM1;CFLAR;ERRFI1;CREB1;NR4A2;SLC7A2;TGFBR2;HMGCS1;VEGFC;SLC52A3;PDGFB;TNC;MT2A;NFE2L2;CAV1;TP53;TLR2;ADAM9;RELA;AXL;NR4A3;EGLN1;JUND
3554,GO:0007595,0.000637891286753736,0.99990376935121,7,32,lactation,BP,VEGFA;CREB1;SOCS2;STAT5A;CAV1;DDR1;XBP1
12294,GO:0048598,0.00065013950187883,0.999686072970561,33,379,embryonic morphogenesis,BP,EFNA1;SDC4;INHBA;TBX3;IL1RN;EDN1;KDM6B;DUSP1;ETS2;ZFP36L1;SIX4;PHLDB2;ITGA5;SMAD3;DLX2;DKK1;LAMB3;TXNRD1;ADM;TGFBR2;TGIF2;WNT5A;VEGFC;SOX4;MMP9;COL12A1;SPRY2;WNT7B;SMAD1;ITGAV;NR4A3;LAMA3;COL8A1
10051,GO:0042509,0.000650641779699159,0.999882369745762,8,45,regulation of tyrosine phosphorylation of STAT protein,BP,CSF2;LIF;IL23A;IL6;IL6ST;IL20;IL24;CAV1
10577,GO:0043536,0.000656885952823442,0.999881973202369,8,42,positive regulation of blood vessel endothelial cell migration,BP,MAP2K3;ETS1;VEGFA;PLK2;VEGFC;PDGFB;NFE2L2;STAT5A
7854,GO:0032410,0.000660849196752532,0.999881149916239,8,42,negative regulation of transporter activity,BP,PPIF;NEDD4L;MMP9;RRAD;CAB39;NEDD4;CAV1;GEM
4822,GO:0014013,0.000663519574570773,0.99984852697881,10,63,regulation of gliogenesis,BP,BMP2;LIF;CSF1;IL6ST;DLX2;CREB1;DUSP10;LDLR;TLR2;RELA
8619,GO:0034134,0.000667863525315251,0.999963408924185,4,10,toll-like receptor 2 signaling pathway,BP,TNFAIP3;RIPK2;TNIP2;TLR2
12972,GO:0051341,0.000673453657270863,0.999860809501909,9,55,regulation of oxidoreductase activity,BP,IL1B;TNF;NFKB1;EDN1;CYP27B1;NOD2;GCH1;ABL2;CAV1
10105,GO:0042611,0.000687538898266632,0.999959302740942,4,12,MHC protein complex,CC,HLA-A;HLA-B;HLA-F;HLA-E
2434,GO:0005615,0.000696812610355456,0.999518176754138,134,2408,extracellular space,CC,CXCL8;IL1B;CXCL2;TNFAIP3;CSF2;TNF;CXCL3;HBEGF;PLAU;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;CCL20;CXCL5;IL16;BMP2;LIF;PLAUR;SOD2;IL36G;PTX3;IL1RN;EDN1;SERPINB2;EHD1;SQSTM1;CSF1;IRF6;EREG;IL23A;EFNB1;IL6;TNFSF15;STEAP4;C1QTNF1;FJX1;RAP2B;TNFAIP2;NEDD4L;CTSC;GPX3;IL6ST;RELT;ICAM1;FRMD4B;RASSF9;B4GALT1;RND3;MARCKSL1;KRT34;SERPINB8;VEGFA;SLC6A14;DKK1;FGF5;TXNRD1;CD55;NAMPT;TMEM106A;ANXA8L1;ADM;WISP1;CD47;CANT1;SOGA1;SEMA4B;SAA1;TINAGL1;ITGB8;WNT5A;VEGFC;TGFA;ROBO4;SERPINB1;PDGFB;IL20;CD82;NRG1;TNC;MMP9;LDLR;COL12A1;CAB39;IL32;CHD2;PARD6B;SLC9A1;B4GALT5;CXCL16;BCL2L2;IL4R;NEDD4;RHCG;ITSN2;IL24;TNFRSF6B;MARCKS;BTN2A2;WNT7B;TAB3;SPTBN5;CLIC4;UACA;ABI1;RAB9A;ITGAV;UBE2D3;CD276;TRIP10;TMEM132A;ADAM9;CCBE1;PLAT;MUC1;AXL;ANXA5;CRB3;FRK;HLA-E;SLC16A1;MMP10;LAMA3;COTL1;COL8A1;VIM;CREB5;DDR1;IL36RN;MGAM;LMAN1;CFB
4297,GO:0009725,0.000719566952793443,0.999599104379312,49,654,response to hormone,BP,IL1B;TNF;BTG2;INHBA;FOSL1;IL1RN;NFKB1;EDN1;ZFP36;JUN;ETS1;EREG;DUSP1;IL6;ZFP36L1;JUNB;CDKN1A;CLDN1;CPEB2;ICAM1;CFLAR;BTG1;ADM;ERRFI1;CREB1;NR4A2;SOGA1;RUNX1;TGFBR2;HMGCS1;SOCS2;TNC;SLC9A1;NEDD4;NFE2L2;PTPN1;WNT7B;STAT5A;CAV1;TLR2;ADAM9;RELA;TRIM16;NR4A3;PPARD;PARP1;MED13;XBP1;JUND
15346,GO:0071556,0.00072118431902147,0.999932940893738,5,18,integral component of lumenal side of endoplasmic reticulum membrane,CC,HLA-A;TAPBP;HLA-B;HLA-F;HLA-E
16774,GO:0098553,0.00072118431902147,0.999932940893738,5,18,lumenal side of endoplasmic reticulum membrane,CC,HLA-A;TAPBP;HLA-B;HLA-F;HLA-E
4427,GO:0010243,0.000722812790586483,0.999597186431454,49,656,response to organonitrogen compound,BP,IL1B;NFKBIA;TNFAIP3;TNF;BTG2;FOSL1;NFKB1;EDN1;JUN;TICAM1;EREG;DUSP1;BIRC2;IL6;PANX1;ZFP36L1;RIPK2;JUNB;CDKN1A;CPEB2;NOD2;ICAM1;CFLAR;BTG1;CEBPB;ADM;ERRFI1;CREB1;NR4A2;SOGA1;TRIM25;HMGCS1;SOCS2;LDLR;SLC9A1;NFE2L2;PTPN1;STAT5A;CAV1;TP53;KLF3;TLR2;RELA;TRIM16;NR4A3;GSK3B;PARP1;XBP1;JUND
7995,GO:0032608,0.000730531631754165,0.999866189874733,8,43,interferon-beta production,BP,IRF1;TICAM1;REL;RIPK2;RELB;IFIH1;TLR2;POLR3A
4532,GO:0010594,0.000730889938226248,0.999776116973015,14,111,regulation of endothelial cell migration,BP,EFNA1;ZC3H12A;EDN1;MAP2K3;EPHA2;ETS1;VEGFA;PLK2;WNT5A;VEGFC;PDGFB;NFE2L2;STAT5A;CCBE1
19981,GO:2000514,0.000735111677174141,0.999907834160392,6,25,regulation of CD4-positive, alpha-beta T cell activation,BP,CD83;IL23A;RIPK2;CD55;TGFBR2;IL4R
3391,GO:0007169,0.000736813703693069,0.999615052045531,40,498,transmembrane receptor protein tyrosine kinase signaling pathway,BP,IL1B;HBEGF;EFNA1;BMP2;PLAUR;EPHA2;CSF1;EREG;EFNB1;CSRNP1;ITGA5;VEGFA;FGF5;ABL2;ERRFI1;NEDD9;SOGA1;WNT5A;VEGFC;TGFA;SOCS2;PDGFB;NRG1;MMP9;FAM83B;SPRY2;GRB7;NEDD4;PTPN1;STAT5A;ZFAND5;ABI1;EFNB2;ITGAV;RELA;CCBE1;PLAT;AXL;FRK;DDR1
12587,GO:0050728,0.000743726016133282,0.999826767633003,10,67,negative regulation of inflammatory response,BP,TNFAIP3;ZC3H12A;NFKB1;ETS1;NOD2;SMAD3;IL1R2;SAA1;DUSP10;PPARD
15350,GO:0071560,0.000751605666767013,0.999727377077533,18,164,cellular response to transforming growth factor beta stimulus,BP,EDN1;JUN;ZFP36L1;BAMBI;CLDN1;ZNF451;SMAD3;CDKN2B;CFLAR;CREB1;TGFBR2;SMURF2;WNT5A;SMAD1;CAV1;PML;ADAM9;PARP1
5922,GO:0018193,0.000766659109593046,0.999537358292987,65,945,peptidyl-amino acid modification,BP,IL1B;CSF2;TNF;HBEGF;EFNA1;NCOA7;LIF;PPIF;MAP2K3;EPHA2;EREG;IL23A;IL6;RIPK2;ITGA5;RAP2B;ZNF451;IL6ST;SGK1;ICAM1;VEGFA;DKK1;FGF5;PLK2;ABL2;ERRFI1;MAST4;PHKG2;TGFBR2;MASTL;WNT5A;CAMK1G;VEGFC;TGFA;SOX4;PDGFB;IL20;IFIH1;NRG1;KIAA1586;CAB39;SPRY2;TNKS1BP1;NUP153;IL24;PTPN1;STAT5A;TPST1;CAV1;TP53;ABI1;IKBKE;CLK4;SDR16C5;RELA;TRIM16;MUC1;AXL;FRK;GSK3B;KMT2E;PARP1;EGLN1;DDR1;LMAN1
18690,GO:1904019,0.000770961287513885,0.999820466626257,10,63,epithelial cell apoptotic process,BP,TNFAIP3;TNF;ZFP36;IL6;ZFP36L1;ICAM1;CFLAR;TGFBR2;NFE2L2;TNIP2
7635,GO:0032036,0.000772377086967795,0.999982721435934,3,5,myosin heavy chain binding,MF,SPTBN5;STX1A;AXL
10052,GO:0042531,0.000780788170443563,0.999876076203437,7,36,positive regulation of tyrosine phosphorylation of STAT protein,BP,CSF2;LIF;IL23A;IL6;IL6ST;IL20;IL24
8860,GO:0034654,0.00078267127940816,0.999435106313233,189,3383,nucleobase-containing compound biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;NMNAT2;CCDC85B;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;UPP1;IER5;CEBPB;CEBPD;NAMPT;ADM;CREB1;TAF4B;CCNL1;USP43;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;NUP153;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ZXDA;XBP1;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
7445,GO:0031571,0.000789660497728878,0.999814388012939,10,68,mitotic G1 DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
11009,GO:0044819,0.000789660497728878,0.999814388012939,10,68,mitotic G1/S transition checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
648,GO:0001836,0.000797669821408133,0.999849578249936,8,50,release of cytochrome c from mitochondria,BP,PLAUR;SOD2;PMAIP1;PPIF;JUN;BBC3;MMP9;TP53
11311,GO:0045620,0.000801566357881064,0.99989779052364,6,25,negative regulation of lymphocyte differentiation,BP,IRF1;INHBA;CYLD;NFKBID;NRARP;IL4R
11354,GO:0045669,0.000804520822179931,0.999850397490605,8,43,positive regulation of osteoblast differentiation,BP,BMP2;IL6;IL6ST;CEBPB;SUCO;WNT7B;SMAD1;JUND
19758,GO:2000106,0.000807077766711148,0.999828541039861,9,56,regulation of leukocyte apoptotic process,BP,EFNA1;HCAR2;ADAM8;NOD2;NFKBID;WNT5A;TP53;AXL;NR4A3
10483,GO:0043372,0.000840655060892151,0.999949014223519,4,11,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,CD83;IL23A;RIPK2;IL4R
14241,GO:0061180,0.000846112195186315,0.999819940080996,9,53,mammary gland epithelium development,BP,TBX3;EPHA2;CSF1;IRF6;CEBPB;WNT5A;WNT7B;PML;DDR1
8071,GO:0032735,0.000846222902424375,0.9999184195457,5,18,positive regulation of interleukin-12 production,BP,IRF1;IL23A;RIPK2;TLR2;RELA
8623,GO:0034138,0.000847275682569204,0.999919399947986,5,17,toll-like receptor 3 signaling pathway,BP,TNFAIP3;TICAM1;PELI1;CAV1;TNIP2
414,GO:0001101,0.000848970984838449,0.999651863217149,22,227,response to acid chemical,BP,TNF;ZC3H12A;EDN1;DUSP1;CLDN1;ICAM1;VEGFA;DKK1;ABL2;CEBPB;GJB3;CREB1;WNT5A;PDGFB;TNC;LDLR;WNT7B;TP53;TLR2;RELA;TRIM16;XBP1
7071,GO:0030854,0.000857813779757939,0.999980088092911,3,5,positive regulation of granulocyte differentiation,BP,TRIB1;RUNX1;EVI2B
8047,GO:0032691,0.000868889764763754,0.999946824240429,4,11,negative regulation of interleukin-1 beta production,BP,TNFAIP3;ZC3H12A;ERRFI1;PML
8923,GO:0034763,0.000869079703506799,0.999793580888094,10,66,negative regulation of transmembrane transport,BP,IL1B;TNF;PPIF;NEDD4L;MMP9;RRAD;CAB39;NEDD4;CAV1;GEM
10674,GO:0043901,0.000871373894628378,0.999726972209872,14,120,negative regulation of multi-organism process,BP,TNFAIP3;TNF;ZC3H12A;PRDM1;PTX3;TNIP1;ZFP36;JUN;SQSTM1;TRIB1;TRIM25;ITGAV;MAPKBP1;PML
20039,GO:2000630,0.000874053610375455,0.999979576557114,3,5,positive regulation of miRNA metabolic process,BP,ZC3H12A;NFKB1;RELA
1313,GO:0003158,0.00087773990618285,0.999773210564833,11,75,endothelium development,BP,IL1B;TNF;KDM6B;TJP2;CLDN1;ICAM1;BTG1;NRG1;WNT7B;CLIC4;VEZF1
7815,GO:0032364,0.000882839586227669,0.999979298384761,3,5,oxygen homeostasis,BP,SOD2;WNT7B;EGLN1
12289,GO:0048589,0.000891569349245624,0.999556047700705,34,396,developmental growth,BP,EDN1;CSF1;EREG;ZFP36L1;SIX4;PHLDA2;NEDD4L;SAV1;SMAD3;NINJ1;VEGFA;CFLAR;ADM;CREB1;SEMA4B;TGFBR2;WNT5A;DUSP10;SOCS2;NRG1;TNC;SPRY2;ITSN2;WNT7B;SMAD1;CLIC4;STAT5A;STK40;PIM1;RAPH1;COL27A1;PPARD;EVC;DDR1
12651,GO:0050830,0.000894474147159782,0.999878269616337,6,34,defense response to Gram-positive bacterium,BP,TNF;IL6;RIPK2;PGLYRP4;TLR2;HLA-E
10990,GO:0044783,0.00089676364957775,0.999785378312797,10,69,G1 DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
10037,GO:0042482,0.000897400131099617,0.999978835202366,3,5,positive regulation of odontogenesis,BP,BMP2;EDN1;CSF1
1029,GO:0002532,0.00090207873031493,0.999853717886651,7,35,production of molecular mediator involved in inflammatory response,BP,ZC3H12A;TICAM1;NOD2;IL1R2;SLC7A2;DUSP10;IL4R
15871,GO:0072576,0.000909107780661695,0.999945815231609,4,10,liver morphogenesis,BP,TNFAIP3;CFLAR;CEBPB;XBP1
2250,GO:0005160,0.000909438084941025,0.999881132699648,6,25,transforming growth factor beta receptor binding,MF,INHBA;BMP2;BAMBI;SMAD3;TGFBR2;SMURF2
3449,GO:0007260,0.000914906167491077,0.999824767734578,8,47,tyrosine phosphorylation of STAT protein,BP,CSF2;LIF;IL23A;IL6;IL6ST;IL20;IL24;CAV1
13193,GO:0051785,0.000916153245814452,0.999825269634655,8,45,positive regulation of nuclear division,BP,IL1B;IL1A;EDN1;EREG;WNT5A;TGFA;PDGFB;ESPL1
4894,GO:0014812,0.000916814820195995,0.999802277976198,9,54,muscle cell migration,BP,PLAU;SIX4;TRIB1;PDGFB;NFE2L2;DOCK4;PLAT;PPARD;DDR1
15258,GO:0071407,0.000918495802035436,0.999536509867018,35,424,cellular response to organic cyclic compound,BP,IL1B;NFKBIA;TNF;INHBA;ZC3H12A;BMP2;NFKB1;EDN1;ZFP36;ZFP36L1;CYP27B1;NOD2;ICAM1;SMAD3;CFLAR;CEBPB;ERRFI1;NR4A2;RUNX1;HMGCS1;PDGFB;IFIH1;TNC;SLC9A1;NEDD4;SMAD1;ZC3H7B;CAV1;PIM1;NR4A3;PPARD;SLC16A1;PARP1;CYP24A1;MED13
15336,GO:0071542,0.00093651942996412,0.999908860908749,5,17,dopaminergic neuron differentiation,BP,VEGFA;DKK1;NR4A2;WNT5A;GSK3B
15349,GO:0071559,0.000937199733384596,0.999653032055629,18,167,response to transforming growth factor beta,BP,EDN1;JUN;ZFP36L1;BAMBI;CLDN1;ZNF451;SMAD3;CDKN2B;CFLAR;CREB1;TGFBR2;SMURF2;WNT5A;SMAD1;CAV1;PML;ADAM9;PARP1
10576,GO:0043535,0.000939978403146751,0.999774390826837,10,66,regulation of blood vessel endothelial cell migration,BP,EFNA1;MAP2K3;EPHA2;ETS1;VEGFA;PLK2;VEGFC;PDGFB;NFE2L2;STAT5A
11352,GO:0045667,0.000952256733515482,0.999750966578981,11,77,regulation of osteoblast differentiation,BP,TNF;NOCT;BMP2;IL6;IL6ST;SMAD3;CEBPB;SUCO;WNT7B;SMAD1;JUND
11671,GO:0046425,0.000953397557367701,0.999749760905931,11,81,regulation of JAK-STAT cascade,BP,CSF2;LIF;IL23A;BCL3;IL6;IL6ST;VHL;SOCS2;IL20;IL24;CAV1
1995,GO:0004713,0.000957427591816179,0.999698259186671,14,111,protein tyrosine kinase activity,MF,CSF2;HBEGF;MAP2K3;EPHA2;EREG;RIPK2;FGF5;ABL2;NRG1;STAT5A;CLK4;AXL;FRK;DDR1
5327,GO:0016049,0.000958055244296244,0.999543281092323,30,349,cell growth,BP,HBEGF;INHBA;EDN1;SERTAD2;BDKRB1;CYP27B1;CDKN1A;CCDC85B;NEDD4L;DCUN1D3;SGK1;SMAD3;VEGFA;BTG1;WISP1;SEMA4B;TGFBR2;WNT5A;SOCS2;NRG1;DCBLD2;SLC9A1;CXCL16;ITSN2;TP53;PML;RAPH1;PPARD;DDR1;EPB41L3
402,GO:0001078,0.000966267634616549,0.999710939069439,13,100,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,BTG2;PRDM1;TBX3;BHLHE40;ETS2;ZNF217;CEBPB;BACH1;NFE2L3;ATF3;MXD1;ZNF148;RELA
19772,GO:2000134,0.000984447713396479,0.999721532533796,12,93,negative regulation of G1/S transition of mitotic cell cycle,BP,BTG2;GADD45A;CDKN1A;DCUN1D3;CDKN2B;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
8022,GO:0032650,0.000986235717159852,0.999971492958725,3,6,regulation of interleukin-1 alpha production,BP,CCL20;PANX1;IL1R2
989,GO:0002443,0.000997204493440573,0.999478604114769,38,504,leukocyte mediated immunity,BP,IL1B;TNF;PLAU;CXCL1;CXCL5;PLAUR;PTX3;NFKB1;IL23A;BCL3;AMPD3;IL6;ADAM8;RAP2B;IL7R;CTSC;NOD2;ICAM1;B4GALT1;RAB24;CD55;CD47;CANT1;SERPINB1;MMP9;CAB39;IL4R;POU2F2;RAET1L;TLR2;ITGAV;ADGRE2;FRK;NR4A3;HLA-E;KMT2E;COTL1;MGAM
18702,GO:1904035,0.00100183047000512,0.999806681599668,8,44,regulation of epithelial cell apoptotic process,BP,TNFAIP3;ZFP36;IL6;ZFP36L1;ICAM1;CFLAR;NFE2L2;TNIP2
11307,GO:0045616,0.00101607688084084,0.99983177968628,7,35,regulation of keratinocyte differentiation,BP,ZFP36;ZFP36L1;CYP27B1;ERRFI1;RUNX1;IL20;TRIM16
9634,GO:0036499,0.00102358767274089,0.999896962942061,5,18,PERK-mediated unfolded protein response,BP,CXCL8;PPP1R15A;ATF3;NFE2L2;PTPN1
2202,GO:0005080,0.00102393042072348,0.999830251362794,7,35,protein kinase C binding,MF,SDC4;SQSTM1;PARD6B;FEZ1;MARCKS;ITGAV;ADAM9
11887,GO:0046885,0.00102622519766024,0.999898028617956,5,17,regulation of hormone biosynthetic process,BP,IL1B;TNF;BMP2;NFKB1;CYP27B1
10624,GO:0043616,0.0010300330097312,0.999829707667967,7,34,keratinocyte proliferation,BP,ZFP36;IRF6;EREG;ZFP36L1;EFNB2;SDR16C5;PPARD
14653,GO:0070230,0.00103726000056561,0.999931320925683,4,12,positive regulation of lymphocyte apoptotic process,BP,ADAM8;NFKBID;WNT5A;TP53
14206,GO:0061097,0.00104357254365124,0.999769932157065,9,56,regulation of protein tyrosine kinase activity,BP,EFNA1;EREG;RAP2B;ERRFI1;TGFA;PDGFB;PTPN1;CAV1;ABI1
4295,GO:0009719,0.00106267801314668,0.999334114585121,72,1071,response to endogenous stimulus,BP,CXCL8;IL1B;TNF;BTG2;INHBA;FOSL1;BMP2;IL1RN;NFKB1;EDN1;ZFP36;JUN;TICAM1;EHD1;ETS1;EREG;DUSP1;IL6;ZFP36L1;RIPK2;JUNB;BAMBI;CDKN1A;CLDN1;CPEB2;ZNF451;NOD2;ICAM1;SMAD3;DKK1;CDKN2B;FGF5;CFLAR;BTG1;CEBPB;ADM;ERRFI1;CREB1;NR4A2;SOGA1;RUNX1;TGFBR2;SMURF2;HMGCS1;WNT5A;SOCS2;TNC;LDLR;SLC9A1;SPRY2;NEDD4;NFE2L2;PTPN1;WNT7B;SMAD1;STAT5A;CAV1;TP53;KLF3;TLR2;UBE2D3;PML;ADAM9;RELA;TRIM16;NR4A3;GSK3B;PPARD;PARP1;MED13;XBP1;JUND
5792,GO:0017017,0.00107854543448917,0.999929967150415,4,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP1;DUSP16;DUSP10;DUSP8
9848,GO:0042090,0.00109036717365493,0.999972451582605,3,5,interleukin-12 biosynthetic process,BP,IRF1;NFKB1;RELA
11083,GO:0045075,0.00109036717365493,0.999972451582605,3,5,regulation of interleukin-12 biosynthetic process,BP,IRF1;NFKB1;RELA
678,GO:0001885,0.00109475678248436,0.999785765499513,8,44,endothelial cell development,BP,IL1B;TNF;TJP2;CLDN1;ICAM1;WNT7B;CLIC4;VEZF1
368,GO:0000989,0.00109956985804775,0.999412263391701,40,517,transcription factor activity, transcription factor binding,MF,NFKBIZ;NCOA7;ELF3;JUN;KDM6B;BHLHE40;SERTAD2;BIRC2;NFKB2;JUNB;RELB;ZNF451;SMAD3;NFKBIB;NFKBID;KLF7;BTG1;CREB1;TAF4B;MYBL1;SFR1;NFE2L3;NAB1;SOX4;NRG1;ATF3;TLE1;YAF2;MXD1;TP53;ELK3;SNAPC4;SDR16C5;MUC1;CITED4;PPARD;MED13;JMY;ZMIZ2;JUND
19112,GO:1904996,0.00110569002241977,0.99997192602101,3,5,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,TNF;ETS1;ICAM1
8065,GO:0032728,0.00113588197242282,0.99984386441362,6,26,positive regulation of interferon-beta production,BP,IRF1;TICAM1;RIPK2;IFIH1;TLR2;POLR3A
1111,GO:0002697,0.00113638952106856,0.999545379110336,20,205,regulation of immune effector process,BP,IL1B;TNFAIP3;TNF;BIRC3;ZC3H12A;IL23A;BIRC2;IL6;RIPK2;IL7R;NOD2;CD55;WNT5A;DUSP10;IL4R;ADGRE2;NR4A3;HLA-E;XBP1;CFB
10625,GO:0043618,0.00113881118831429,0.999670373807055,12,103,regulation of transcription from RNA polymerase II promoter in response to stress,BP,JUN;VEGFA;CEBPB;VHL;BACH1;ATF3;NEDD4;NFE2L2;TP53;UBE2D3;MUC1;EGLN1
1462,GO:0003705,0.00114102863547801,0.999745572732354,9,55,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,NFKB1;JUN;BHLHE40;REL;CEBPB;CREB1;BACH1;NFE2L2;RELA
17812,GO:1901888,0.00114779491533013,0.999717360826869,10,65,regulation of cell junction assembly,BP,TNF;SDC4;PHLDB2;CLDN1;SMAD3;VEGFA;RUNX1;SLC9A1;CAV1;OCLN
13925,GO:0060562,0.00116243870220572,0.999511682899539,22,222,epithelial tube morphogenesis,BP,TNF;SDC4;BMP2;TBX3;EDN1;EPHA2;CSF1;SIX4;SMAD3;B4GALT1;VEGFA;NRARP;ADM;TGFBR2;WNT5A;SOX4;TNC;SPRY2;CLIC4;EFNB2;PML;DDR1
3444,GO:0007254,0.00116788102126683,0.999573159092663,17,156,JNK cascade,BP,IL1B;TNF;IL1A;EDN1;GADD45A;RIPK2;IRAK2;FZD8;NOD2;TRAF4;TRIB1;DKK1;WNT5A;DUSP10;PTPN1;WNT7B;TAB3
10522,GO:0043433,0.00117891160355092,0.999618725082913,14,119,negative regulation of DNA binding transcription factor activity,BP,NFKBIA;TNFAIP3;ZC3H12A;BHLHE40;NFKBIE;PELI1;IRAK2;CYLD;NOD2;NFKBID;TRIB1;PIM1;MED13;EGLN1
15152,GO:0071241,0.00118351358346822,0.999616915845616,14,120,cellular response to inorganic substance,BP,PPIF;EDN1;JUN;JUNB;CLDN1;CFLAR;CREB1;WNT5A;MMP9;MT2A;CLIC4;PARP1;SLC41A1;JUND
15523,GO:0071887,0.00118464518139393,0.999705075897805,10,71,leukocyte apoptotic process,BP,EFNA1;HCAR2;IL6;ADAM8;NOD2;NFKBID;WNT5A;TP53;AXL;NR4A3
13953,GO:0060603,0.00119343045115365,0.99983542937366,6,25,mammary gland duct morphogenesis,BP,TBX3;EPHA2;CSF1;WNT5A;PML;DDR1
7857,GO:0032413,0.00119858021035672,0.999795018882866,7,36,negative regulation of ion transmembrane transporter activity,BP,NEDD4L;MMP9;RRAD;CAB39;NEDD4;CAV1;GEM
18137,GO:1902807,0.00122589204921731,0.999643447092677,12,96,negative regulation of cell cycle G1/S phase transition,BP,BTG2;GADD45A;CDKN1A;DCUN1D3;CDKN2B;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
3398,GO:0007178,0.00122791781733677,0.999493513193757,21,212,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,INHBA;BMP2;JUN;BAMBI;ZNF451;SMAD3;DKK1;CDKN2B;CREB1;TGFBR2;SMURF2;TGIF2;AKAP2;WNT5A;SMAD1;CAV1;UBE2D3;PML;ADAM9;PARP1;VIM
11881,GO:0046879,0.00123238054891429,0.999531554213236,18,174,hormone secretion,BP,IL1B;TNF;INHBA;LIF;TBX3;IL1RN;EDN1;HCAR2;IL6;PIM3;C1QTNF1;ADM;CREB1;SOX4;MARCKS;STX1A;PPARD;SLC16A1
7362,GO:0031400,0.00123665131758258,0.999357817353014,36,457,negative regulation of protein modification process,BP,IL1B;TNFAIP3;TNF;EFNA1;NCOA7;ZC3H12A;PPP1R15A;LIF;TNIP1;JUN;DUSP1;GADD45A;BDKRB1;N4BP1;CDKN1A;ZNF451;TRIB1;DKK1;CDKN2B;PPP4R4;ERRFI1;DUSP16;MASTL;DUSP10;SOX4;SOCS2;DUSP8;ATF3;SPRY2;PTPN1;CAV1;SH3RF2;SDR16C5;RELA;GSK3B;RPS6KA6
7212,GO:0031099,0.00123671061031801,0.999597807634733,14,120,regeneration,BP,NFKBIA;JUN;CDKN1A;CLDN1;NINJ1;CFLAR;CEBPB;ADM;TGFBR2;DUSP10;TNC;AXL;NR4A3;PPARD
14693,GO:0070301,0.00125467920385131,0.999684896013872,10,72,cellular response to hydrogen peroxide,BP,TNFAIP3;PPIF;KDM6B;ETS1;IL6;NFE2L2;TP53;RELA;AXL;NR4A3
9865,GO:0042113,0.00125959684036951,0.999552694166606,16,145,B cell activation,BP,TNFAIP3;INHBA;PRDM1;TICAM1;KLF6;BCL3;PELI1;IL6;ZFP36L1;CYLD;CDKN1A;IL7R;NOD2;POU2F2;TNIP2;XBP1
6858,GO:0030323,0.00127082238692431,0.999586408097667,14,115,respiratory tube development,BP,TNF;LIF;SAV1;TRAF4;VEGFA;ERRFI1;CREB1;TGFBR2;WNT5A;TNC;SPRY2;WNT7B;STK40;CCBE1
9885,GO:0042149,0.0012751239466232,0.999779542278972,7,36,cellular response to glucose starvation,BP,NUAK2;ZC3H12A;PMAIP1;UPP1;NFE2L2;TP53;XBP1
15151,GO:0071236,0.00128240133186589,0.999602270007567,13,108,cellular response to antibiotic,BP,TNFAIP3;ZC3H12A;PPIF;KDM6B;ETS1;IL6;PDGFB;SLC9A1;NFE2L2;TP53;RELA;AXL;NR4A3
17652,GO:1901362,0.0012887844184797,0.999055083736476,194,3525,organic cyclic compound biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;NMNAT2;CCDC85B;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;GCH1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;UPP1;IER5;CEBPB;CEBPD;NAMPT;ADM;CREB1;TAF4B;CCNL1;USP43;NR4A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;HMGCS1;WNT5A;SLC11A2;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;NUP153;NEDD4;POU2F2;NFE2L2;SMAD1;TAB3;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;FOXN2;MUC1;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;XBP1;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
12680,GO:0050871,0.00129356345391912,0.999737759523056,8,48,positive regulation of B cell activation,BP,PRDM1;TICAM1;PELI1;IL6;CDKN1A;NOD2;TNIP2;XBP1
15801,GO:0072401,0.00130222361519339,0.999671305568026,10,72,signal transduction involved in DNA integrity checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
15805,GO:0072422,0.00130222361519339,0.999671305568026,10,72,signal transduction involved in DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
367,GO:0000988,0.00131204516106409,0.999291594752027,40,522,transcription factor activity, protein binding,MF,NFKBIZ;NCOA7;ELF3;JUN;KDM6B;BHLHE40;SERTAD2;BIRC2;NFKB2;JUNB;RELB;ZNF451;SMAD3;NFKBIB;NFKBID;KLF7;BTG1;CREB1;TAF4B;MYBL1;SFR1;NFE2L3;NAB1;SOX4;NRG1;ATF3;TLE1;YAF2;MXD1;TP53;ELK3;SNAPC4;SDR16C5;MUC1;CITED4;PPARD;MED13;JMY;ZMIZ2;JUND
14207,GO:0061098,0.00132126604465909,0.999811739323941,6,27,positive regulation of protein tyrosine kinase activity,BP,EFNA1;EREG;TGFA;PDGFB;PTPN1;ABI1
11334,GO:0045649,0.00132219089426958,0.999909192803966,4,11,regulation of macrophage differentiation,BP,INHBA;LIF;CSF1;TRIB1
12786,GO:0051048,0.00132964929950675,0.999585725195556,13,109,negative regulation of secretion,BP,IL1B;TNF;INHBA;ZC3H12A;LIF;EDN1;PIM3;IL1R2;NRG1;BTN2A2;MAPKBP1;PML;IL36RN
7997,GO:0032610,0.00134216049791935,0.999952292351754,3,7,interleukin-1 alpha production,BP,CCL20;PANX1;IL1R2
8037,GO:0032677,0.00136155588085609,0.999759641985238,7,39,regulation of interleukin-8 production,BP,IL1B;TNF;BCL3;NOD2;WNT5A;TLR2;MAPKBP1
16250,GO:0090287,0.00136409948921935,0.999477022871235,18,171,regulation of cellular response to growth factor stimulus,BP,IL1B;BAMBI;ITGA5;ZNF451;SMAD3;VEGFA;DKK1;CDKN2B;CFLAR;TGFBR2;SMURF2;WNT5A;VEGFC;SPRY2;NEDD4;PTPN1;CAV1;CCBE1
4947,GO:0014909,0.00137341753839025,0.999720069692123,8,46,smooth muscle cell migration,BP,PLAU;TRIB1;PDGFB;NFE2L2;DOCK4;PLAT;PPARD;DDR1
9390,GO:0035925,0.00138916589951654,0.999903281133196,4,11,mRNA 3'-UTR AU-rich region binding,MF,ZC3H12A;ZFP36;ZFP36L1;CPEB2
11302,GO:0045604,0.001398693563425,0.999712892101702,8,48,regulation of epidermal cell differentiation,BP,MAFF;ZFP36;ZFP36L1;CYP27B1;ERRFI1;RUNX1;IL20;TRIM16
12154,GO:0048247,0.00140460398785524,0.999843187207665,5,21,lymphocyte chemotaxis,BP,CCL20;ADAM8;SAA1;WNT5A;CXCL16
8216,GO:0032966,0.00141554984095241,0.999953513885005,3,6,negative regulation of collagen biosynthetic process,BP,IL6;ERRFI1;PPARD
17597,GO:1901214,0.00142613248532354,0.999418231595033,20,206,regulation of neuron death,BP,BTG2;NCOA7;SOD2;JUN;REL;ADAM8;SIX4;DKK1;CEBPB;TP53BP2;CREB1;NR4A2;WNT5A;TP53;EFNB2;AXL;NR4A3;GSK3B;PARP1;EGLN1
14552,GO:0070059,0.00143343438251708,0.999704032343304,8,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,PPP1R15A;PMAIP1;BBC3;TNFRSF10B;CEBPB;PTPN1;PML;XBP1
15192,GO:0071316,0.00143427227190388,0.999952679115629,3,6,cellular response to nicotine,BP,TNF;NFKB1;RELA
6791,GO:0030223,0.00143868258833942,0.999952481900762,3,6,neutrophil differentiation,BP,CSF2;TRIB1;EVI2B
6992,GO:0030666,0.00144957084145173,0.99954328227256,13,112,endocytic vesicle membrane,CC,HBEGF;TAP1;WNT5A;LDLR;WNT7B;CAV1;HLA-A;TLR2;TAPBP;RAB9A;HLA-B;HLA-F;HLA-E
17600,GO:1901222,0.00146070876829382,0.999698075861497,8,48,regulation of NIK/NF-kappaB signaling,BP,TNF;BIRC2;TNFRSF10B;TNFSF15;NOD2;TRAF4;UACA;RELA
12603,GO:0050766,0.00146326594290623,0.999786068030842,6,28,positive regulation of phagocytosis,BP,IL1B;TNF;PTX3;CD47;ITGAV;ABCA7
14236,GO:0061158,0.00146532743523861,0.999896460145858,4,11,3'-UTR-mediated mRNA destabilization,BP,ZC3H12A;ZFP36;ZFP36L1;QKI
12894,GO:0051216,0.00147089035522428,0.999537617273566,13,104,cartilage development,BP,BMP2;EDN1;SMAD3;DLX2;RUNX1;TGFBR2;ITGB8;WNT5A;WNT7B;SMAD1;RELA;COL27A1;EVC
15799,GO:0072395,0.0014786564015279,0.999619913526219,10,73,signal transduction involved in cell cycle checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
3555,GO:0007596,0.00148372981159988,0.999391897025782,20,214,blood coagulation,BP,IRF1;PLAU;PLAUR;MAFF;EDN1;SERPINB2;EHD1;IL6;C1QTNF1;RAP2B;TFPI2;ANXA8;SAA1;PDGFB;NFE2L2;CAV1;PLAT;AXL;ANXA5;LMAN1
4863,GO:0014074,0.00150101440172662,0.999553279394591,12,94,response to purine-containing compound,BP,IL1B;FOSL1;JUN;DUSP1;BIRC2;PANX1;ZFP36L1;JUNB;HMGCS1;TP53;RELA;JUND
6731,GO:0030139,0.00151948511065393,0.999376562888612,20,208,endocytic vesicle,CC,HBEGF;ADAM8;RAB24;TAP1;CDC42EP4;SAA1;WNT5A;LDLR;WNT7B;CAV1;HLA-A;TLR2;TAPBP;RAB9A;HLA-B;ITGAV;HLA-F;HLA-E;OCLN;VIM
4352,GO:0009914,0.00152204531683056,0.999409788568543,18,177,hormone transport,BP,IL1B;TNF;INHBA;LIF;TBX3;IL1RN;EDN1;HCAR2;IL6;PIM3;C1QTNF1;ADM;CREB1;SOX4;MARCKS;STX1A;PPARD;SLC16A1
11591,GO:0046136,0.00153715065625894,1,2,2,positive regulation of vitamin metabolic process,BP,IL1B;TNF
13920,GO:0060557,0.00153715065625894,1,2,2,positive regulation of vitamin D biosynthetic process,BP,IL1B;TNF
13922,GO:0060559,0.00153715065625894,1,2,2,positive regulation of calcidiol 1-monooxygenase activity,BP,IL1B;TNF
17700,GO:1901564,0.00155619297997265,0.998834745220926,254,4910,organonitrogen compound metabolic process,BP,IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;CCL20;NCOA7;ZC3H12A;PPP1R15A;RNF19B;BMP2;LIF;PLAUR;PMAIP1;PTX3;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;SQSTM1;CSF1;SPRR2D;BBC3;EREG;IL23A;DUSP1;BCL3;PELI1;AMPD3;GADD45A;BIRC2;IL6;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;ZFP36L1;TNFSF15;RIPK2;IRAK2;KLHL21;DAPP1;CYLD;FZD8;TNFAIP8;TJP2;C1QTNF1;CDKN1A;NMNAT2;ITGA5;RAP2B;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;NOD2;IL6ST;DCUN1D3;TFPI2;SGK1;ICAM1;GCH1;SMAD3;B4GALT1;PHLDA1;B3GNT5;RNF144B;TRAF4;TRIB1;SERPINB8;VEGFA;IL1R2;SLC6A14;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ABL2;PPTC7;CFLAR;RNF43;PIGA;BTG1;ANXA8;UPP1;PPP4R4;CEBPB;CD55;DENND3;NAMPT;ANKLE2;ADM;DSE;ERRFI1;ADAMTS1;ANKK1;CREB1;CCNL1;USP43;MAST4;NR4A2;SLC7A2;CANT1;VHL;PHKG2;BACH1;ABTB2;TGFBR2;SMURF2;DUSP16;DDX3Y;SAA1;TINAGL1;KLHL5;TRIM25;MASTL;ITGB8;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;DUSP10;SLC52A3;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;PGLYRP4;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;KIAA1586;ATF3;OTUD4;CAB39;PLK3;ARRDC4;SLC9A1;MAOA;RCHY1;SPRY2;TNKS1BP1;B4GALT5;HAL;GRB7;ARSJ;NUP153;RNF152;NEDD4;MMD;IL24;TNFRSF6B;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;CHD4;STAT5A;TPST1;CAV1;SH3RF2;INO80D;TNIP2;UGCG;TP53;TLR2;ABI1;STK40;TAPBP;PDP1;ITGAV;IKBKE;UBE2D3;PJA2;CD276;SPRR2A;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;UBE2Z;HS3ST3B1;PML;PIM1;ESPL1;ADAM9;RELA;TRIM16;ESCO2;CCBE1;PPP6R3;PLAT;CHST2;MUC1;YARS2;AXL;SAT1;FRK;USP31;GSK3B;KMT2E;PPARD;PARP8;PARP1;MMP10;KDM7A;LCE1C;VIM;EGLN1;RIPK4;RNF145;ALAS1;RPS6KA6;DDR1;XBP1;QKI;KCTD11;LMAN1;CFB
10575,GO:0043534,0.00156628707215829,0.999561924949028,11,82,blood vessel endothelial cell migration,BP,EFNA1;MAP2K3;EPHA2;ETS1;VEGFA;PLK2;VEGFC;PDGFB;NFE2L2;STAT5A;EFNB2
13820,GO:0060395,0.00157013568780087,0.999718367479776,7,36,SMAD protein signal transduction,BP,INHBA;BMP2;JUN;SMAD3;SMAD1;PARP1;VIM
12782,GO:0051044,0.00158289223907649,0.999882255134772,4,12,positive regulation of membrane protein ectodomain proteolysis,BP,IL1B;TNF;ADAM8;ADAM9
12643,GO:0050817,0.00158627120096804,0.999346027388355,20,215,coagulation,BP,IRF1;PLAU;PLAUR;MAFF;EDN1;SERPINB2;EHD1;IL6;C1QTNF1;RAP2B;TFPI2;ANXA8;SAA1;PDGFB;NFE2L2;CAV1;PLAT;AXL;ANXA5;LMAN1
14012,GO:0060712,0.00158638401317364,0.999881923343769,4,12,spongiotrophoblast layer development,BP,LIF;ZFP36L1;PHLDA2;ADM
8149,GO:0032872,0.00160360003635549,0.999395374718293,17,160,regulation of stress-activated MAPK cascade,BP,IL1B;TNF;IL1A;ZC3H12A;BMP2;EDN1;GADD45A;RIPK2;FZD8;NOD2;TRAF4;VEGFA;DKK1;WNT5A;DUSP10;PTPN1;WNT7B
13654,GO:0060142,0.0016067442732801,0.99987998458554,4,12,regulation of syncytium formation by plasma membrane fusion,BP,EHD1;CFLAR;IL4R;ADAM9
18462,GO:1903531,0.00161845674288572,0.999512784195429,12,98,negative regulation of secretion by cell,BP,IL1B;TNF;INHBA;ZC3H12A;LIF;EDN1;PIM3;IL1R2;BTN2A2;MAPKBP1;PML;IL36RN
8435,GO:0033549,0.00162568251015946,0.999878174974084,4,12,MAP kinase phosphatase activity,MF,DUSP1;DUSP16;DUSP10;DUSP8
8307,GO:0033138,0.00163154896582813,0.999613298068557,9,61,positive regulation of peptidyl-serine phosphorylation,BP,TNF;LIF;IL6;RIPK2;VEGFA;WNT5A;SPRY2;TNKS1BP1;CAV1
12856,GO:0051153,0.00164677348962624,0.999610187881545,9,59,regulation of striated muscle cell differentiation,BP,BMP2;EDN1;EHD1;DKK1;CFLAR;NRG1;IL4R;EFNB2;XBP1
12677,GO:0050868,0.00165378694820715,0.999607753588988,9,60,negative regulation of T cell activation,BP,IRF1;SDC4;PELI1;CYLD;NFKBID;NRARP;CEBPB;IL4R;BTN2A2
17796,GO:1901842,0.00167263010959031,1,2,2,negative regulation of high voltage-gated calcium channel activity,BP,RRAD;GEM
10478,GO:0043367,0.00169007003030471,0.999690914388559,7,38,CD4-positive, alpha-beta T cell differentiation,BP,CD83;IL23A;BCL3;IL6;RIPK2;RELB;IL4R
3545,GO:0007568,0.00169491240822971,0.999297558804425,20,212,aging,BP,SOD2;TBX3;EDN1;JUN;NFKB2;CDKN1A;CLDN1;CTSC;ICAM1;DKK1;PLK2;ADM;CREB1;TGFBR2;NFE2L2;TPRA1;TP53;PML;RELA;JUND
1966,GO:0004672,0.00169946432102691,0.99908468545682,38,475,protein kinase activity,MF,CSF2;HBEGF;NUAK2;MAP2K3;EPHA2;SQSTM1;EREG;PELI1;PIM3;RIPK2;IRAK2;CDKN1A;SGK1;FGF5;PLK2;MAP3K8;ABL2;ANKK1;MAST4;PHKG2;TGFBR2;MASTL;CAMK1G;NRG1;CAB39;PLK3;MMD;STAT5A;STK40;IKBKE;CLK4;PIM1;AXL;FRK;GSK3B;RIPK4;RPS6KA6;DDR1
16251,GO:0090288,0.00170623148337214,0.999484299597722,12,94,negative regulation of cellular response to growth factor stimulus,BP,BAMBI;ZNF451;SMAD3;DKK1;CFLAR;TGFBR2;SMURF2;WNT5A;SPRY2;NEDD4;PTPN1;CAV1
14694,GO:0070302,0.001714655564688,0.999349175851212,17,161,regulation of stress-activated protein kinase signaling cascade,BP,IL1B;TNF;IL1A;ZC3H12A;BMP2;EDN1;GADD45A;RIPK2;FZD8;NOD2;TRAF4;VEGFA;DKK1;WNT5A;DUSP10;PTPN1;WNT7B
8158,GO:0032881,0.00172169533726394,0.999741389830418,6,27,regulation of polysaccharide metabolic process,BP,NFKB1;PHLDA2;PHKG2;PPP1R3B;PDGFB;GSK3B
11342,GO:0045657,0.00172535607903039,0.999939212569129,3,6,positive regulation of monocyte differentiation,BP,JUN;CSF1;ZFP36L1
4541,GO:0010611,0.00172903448882472,0.999683474614592,7,37,regulation of cardiac muscle hypertrophy,BP,EDN1;IL6ST;SMAD3;ERRFI1;SLC9A1;NR4A3;PARP1
4884,GO:0014743,0.00172903448882472,0.999683474614592,7,37,regulation of muscle hypertrophy,BP,EDN1;IL6ST;SMAD3;ERRFI1;SLC9A1;NR4A3;PARP1
11435,GO:0045840,0.00173067300969428,0.999681232400548,7,39,positive regulation of mitotic nuclear division,BP,IL1B;IL1A;EDN1;EREG;TGFA;PDGFB;ESPL1
3558,GO:0007599,0.00175298234417138,0.999270818401636,20,217,hemostasis,BP,IRF1;PLAU;PLAUR;MAFF;EDN1;SERPINB2;EHD1;IL6;C1QTNF1;RAP2B;TFPI2;ANXA8;SAA1;PDGFB;NFE2L2;CAV1;PLAT;AXL;ANXA5;LMAN1
12851,GO:0051148,0.00176944025283718,0.999731302618505,6,28,negative regulation of muscle cell differentiation,BP,BMP2;EREG;DKK1;CFLAR;PDGFB;XBP1
957,GO:0002374,0.00179569062311007,0.999861667472358,4,12,cytokine secretion involved in immune response,BP,TNF;NOD2;WNT5A;TLR2
454,GO:0001227,0.00180786901722222,0.9993102939895,17,161,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,BTG2;PRDM1;TBX3;NFKB1;BHLHE40;ETS2;ZNF217;CEBPB;BACH1;NFE2L3;ATF3;MXD1;ZNF148;RELA;PPARD;MXD3;ZBTB5
4725,GO:0010884,0.00182739693638383,0.999858538050505,4,12,positive regulation of lipid storage,BP,ZC3H12A;NFKB1;EHD1;IKBKE
10552,GO:0043500,0.00184450083611419,0.999555397696918,9,60,muscle adaptation,BP,IL1B;EDN1;IL6ST;SMAD3;CFLAR;ERRFI1;SLC9A1;NR4A3;PARP1
765,GO:0002009,0.0018544373668639,0.999052924360567,32,394,morphogenesis of an epithelium,BP,TNF;HBEGF;SDC4;BMP2;LIF;TBX3;EDN1;EPHA2;CSF1;SIX4;PHLDB2;ITGA5;SMAD3;B4GALT1;VEGFA;NRARP;DKK1;ADM;GORAB;TGFBR2;SMURF2;WNT5A;VEGFC;SOX4;TNC;SPRY2;WNT7B;CLIC4;EFNB2;PML;RIPK4;DDR1
7667,GO:0032092,0.00185777911646194,0.999507303816743,10,73,positive regulation of protein binding,BP,BMP2;TICAM1;RIPK2;BAMBI;TRAF4;PLK2;WNT5A;MMP9;CAV1;GSK3B
8076,GO:0032743,0.00186162029232818,0.999780232142028,5,20,positive regulation of interleukin-2 production,BP,IL1B;IL1A;CD83;RIPK2;RUNX1
728,GO:0001954,0.0018733526178114,0.99965105348866,7,38,positive regulation of cell-matrix adhesion,BP,SDC4;CSF1;SMAD3;NINJ1;VEGFA;VEGFC;GSK3B
2345,GO:0005381,0.00188375714034835,0.999931521055979,3,6,iron ion transmembrane transporter activity,MF,SLC11A2;SLC25A37;SLC39A14
12114,GO:0048144,0.00188415461961199,0.999542697769198,9,63,fibroblast proliferation,BP,JUN;EREG;CDKN1A;CREB1;WNT5A;PDGFB;WNT7B;TP53;PML
15180,GO:0071294,0.00188742377106531,0.999919292710714,3,8,cellular response to zinc ion,BP,CREB1;MT2A;PARP1
14169,GO:0061036,0.00189333743947132,0.999777889051842,5,19,positive regulation of cartilage development,BP,BMP2;SMAD3;WNT5A;SMAD1;RELA
12389,GO:0048771,0.00189395065799118,0.999419235249142,12,97,tissue remodeling,BP,TNFAIP3;IL1A;ELF3;LIF;EPHA2;IL23A;IL6;ADAM8;B4GALT1;SUCO;CAV1;AXL
8013,GO:0032637,0.00190637351743373,0.999640883209553,7,41,interleukin-8 production,BP,IL1B;TNF;BCL3;NOD2;WNT5A;TLR2;MAPKBP1
11284,GO:0045581,0.00190960933816035,0.999773233455762,5,20,negative regulation of T cell differentiation,BP,IRF1;CYLD;NFKBID;NRARP;IL4R
10547,GO:0043491,0.00194147588205777,0.999279216313,16,150,protein kinase B signaling,BP,IL1B;TNF;HBEGF;EPHA2;EREG;ADAM8;ZFP36L1;C1QTNF1;CDKN1A;FGF5;CREB1;PDGFB;NRG1;PLK3;SPRY2;AXL
18913,GO:1904580,0.00194238416930694,1,2,2,regulation of intracellular mRNA localization,BP,ZFP36;ZFP36L1
18914,GO:1904582,0.00194238416930694,1,2,2,positive regulation of intracellular mRNA localization,BP,ZFP36;ZFP36L1
11416,GO:0045807,0.00194566319116801,0.999439182038464,11,85,positive regulation of endocytosis,BP,IL1B;TNF;PTX3;NEDD4L;VEGFA;CD47;WNT5A;LDLR;ITGAV;ABCA7;AXL
726,GO:0001952,0.00195274065293043,0.999438135323014,11,82,regulation of cell-matrix adhesion,BP,PLAU;SDC4;CSF1;PHLDB2;SMAD3;NINJ1;VEGFA;VEGFC;SLC9A1;GSK3B;DDR1
13097,GO:0051592,0.00195733921302262,0.999435789910931,11,84,response to calcium ion,BP,PPIF;EDN1;JUN;DUSP1;JUNB;WNT5A;NEDD4;CLIC4;CAV1;ADAM9;JUND
4601,GO:0010713,0.00196352443541409,0.999920130410252,3,7,negative regulation of collagen metabolic process,BP,IL6;ERRFI1;PPARD
2119,GO:0004906,0.00197390825568149,1,2,2,interferon-gamma receptor activity,MF,IFNGR2;IFNGR1
8917,GO:0034755,0.00198271294055474,0.999842987726888,4,12,iron ion transmembrane transport,BP,STEAP4;SLC11A2;SLC25A37;SLC39A14
1397,GO:0003308,0.00199317701870539,1,2,2,negative regulation of Wnt signaling pathway involved in heart development,BP,BMP2;DKK1
7020,GO:0030728,0.00199655274416712,0.999841584719337,4,12,ovulation,BP,INHBA;EREG;ADAMTS1;IL4R
6585,GO:0022408,0.00199980069154194,0.99938201381612,12,99,negative regulation of cell-cell adhesion,BP,IRF1;SDC4;BMP2;IL1RN;PELI1;CYLD;C1QTNF1;NFKBID;NRARP;CEBPB;IL4R;BTN2A2
896,GO:0002266,0.00200481163961739,1,2,2,follicular dendritic cell activation,BP,BCL3;NFKB2
897,GO:0002268,0.00200481163961739,1,2,2,follicular dendritic cell differentiation,BP,BCL3;NFKB2
8368,GO:0033257,0.00200481163961739,1,2,2,Bcl3/NF-kappaB2 complex,CC,BCL3;NFKB2
11811,GO:0046683,0.0020068637180385,0.999419222177062,11,85,response to organophosphorus,BP,IL1B;FOSL1;JUN;DUSP1;BIRC2;PANX1;ZFP36L1;JUNB;RELA;TRIM16;JUND
1395,GO:0003306,0.00200866216121611,0.999925287073741,3,6,Wnt signaling pathway involved in heart development,BP,BMP2;DKK1;WNT5A
9300,GO:0035740,0.00201459681246084,1,2,2,CD8-positive, alpha-beta T cell proliferation,BP,IRF1;HLA-E
20002,GO:2000564,0.00201459681246084,1,2,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,IRF1;HLA-E
2118,GO:0004905,0.00202291546162321,1,2,2,type I interferon receptor activity,MF,IFNAR2;IFNAR1
8215,GO:0032965,0.0020276086920378,0.999753635838112,5,21,regulation of collagen biosynthetic process,BP,IL6;ERRFI1;SUCO;PPARD;VIM
11789,GO:0046638,0.00207952779236127,0.999745839861113,5,21,positive regulation of alpha-beta T cell differentiation,BP,CD83;IL23A;RIPK2;TGFBR2;IL4R
15119,GO:0071158,0.00208047766602843,0.999437595843238,10,77,positive regulation of cell cycle arrest,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1
11280,GO:0045577,0.00208620560408561,0.999747122177401,5,20,regulation of B cell differentiation,BP,INHBA;PRDM1;ZFP36L1;CYLD;XBP1
4248,GO:0009445,0.00210154166487455,0.999912422627111,3,7,putrescine metabolic process,BP,ODC1;PAOX;SAT1
15148,GO:0071229,0.00211890487487573,0.999236125386655,15,137,cellular response to acid chemical,BP,TNF;ZC3H12A;EDN1;CLDN1;VEGFA;ABL2;CEBPB;GJB3;CREB1;WNT5A;PDGFB;TNC;LDLR;WNT7B;XBP1
19988,GO:2000535,0.0021192089625656,0.999919650458588,3,6,regulation of entry of bacterium into host cell,BP,CXCL8;CAV1;ITGAV
13071,GO:0051549,0.00212355822016541,0.999919426460995,3,6,positive regulation of keratinocyte migration,BP,HBEGF;MMP9;ADAM9
7489,GO:0031649,0.00212952685243226,0.999823800409889,4,13,heat generation,BP,IL1B;TNF;IL1A;IL1RN
446,GO:0001205,0.00213117901388681,0.999740385723701,5,20,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,NFKB1;REL;BACH1;NFE2L2;RELA
18105,GO:1902714,0.00213162167359876,1,2,2,negative regulation of interferon-gamma secretion,BP,ZC3H12A;IL36RN
9270,GO:0035690,0.00214425294661553,0.99905035466063,22,245,cellular response to drug,BP,IL1B;TNFAIP3;TNF;ZC3H12A;NFKB1;PPIF;EDN1;KDM6B;ETS1;IL6;RIPK2;NOD2;ICAM1;CFLAR;ERRFI1;PDGFB;MT2A;NFE2L2;TP53;RELA;AXL;NR4A3
150,GO:0000305,0.00214673327032241,0.999731623128876,5,23,response to oxygen radical,BP,TNF;SOD2;GCH1;TXNRD1;NFE2L2
19514,GO:1990264,0.0021538379045547,1,2,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,DUSP10;PTPN1
11444,GO:0045861,0.00215421979138044,0.999109739863391,19,210,negative regulation of proteolysis,BP,EFNA1;BIRC3;PLAUR;SERPINB2;BIRC2;TNFRSF10B;N4BP1;TNFAIP8;TFPI2;SERPINB8;VEGFA;IL1R2;ANXA8;CD55;SERPINB1;MMP9;TNFRSF6B;PML;PLAT
7913,GO:0032481,0.00215549613700362,0.999466262148566,9,63,positive regulation of type I interferon production,BP,IRF1;NFKB1;TICAM1;NFKB2;RIPK2;IFIH1;TLR2;POLR3A;RELA
9982,GO:0042369,0.00215723876739657,1,2,2,vitamin D catabolic process,BP,CYP27B1;CYP24A1
12601,GO:0050764,0.00216129080328032,0.999584680777458,7,40,regulation of phagocytosis,BP,IL1B;TNF;PTX3;CD47;TLR2;ITGAV;ABCA7
14758,GO:0070424,0.0021683028366874,0.999917112323932,3,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,TNFAIP3;BIRC3;BIRC2
13842,GO:0060425,0.00223119666596589,0.999569949101392,7,39,lung morphogenesis,BP,TNF;LIF;TGFBR2;TNC;SPRY2;WNT7B;STK40
8025,GO:0032653,0.00223695373014592,0.999719681203556,5,22,regulation of interleukin-10 production,BP,CD83;IL23A;BCL3;NOD2;TLR2
20294,GO:2001237,0.0022465365362532,0.999386721822351,10,76,negative regulation of extrinsic apoptotic signaling pathway,BP,IL1B;TNFAIP3;CSF2;TNF;IL1A;TNFRSF10B;ICAM1;CFLAR;ITGAV;RELA
2457,GO:0005667,0.00226099139486919,0.998973771776564,23,261,transcription factor complex,CC,JUN;ETS1;REL;JUNB;ELMSAN1;SMAD3;ARNTL2;CEBPB;CREB1;TAF4B;NR4A2;SOX4;TLE1;SMAD1;NFAT5;TP53;SNAPC4;RELA;NR4A3;PPARD;PARP1;MXD3;JUND
8377,GO:0033273,0.00227963124329891,0.999430780103317,9,63,response to vitamin,BP,CYP27B1;TRIM25;HMGCS1;TNC;TP53;PIM1;RELA;PPARD;CYP24A1
8026,GO:0032655,0.0022836088476098,0.99962989765632,6,31,regulation of interleukin-12 production,BP,IRF1;NFKB1;IL23A;RIPK2;TLR2;RELA
11788,GO:0046637,0.00228446553752363,0.999631290042121,6,30,regulation of alpha-beta T cell differentiation,BP,CD83;PRDM1;IL23A;RIPK2;TGFBR2;IL4R
5316,GO:0016021,0.00229847479837309,0.998325697275697,153,2706,integral component of membrane,CC,TNF;HBEGF;EFNA1;SDC4;RNF19B;BMP2;PLAUR;CD83;IER3;PPIF;HCAR3;IFNAR2;EPHA2;GPR156;HCAR2;CSF1;EREG;EFNB1;BIRC2;IFNGR2;IL6;ADAM8;TNFRSF10B;BDKRB1;PANX1;TNFSF15;FZD8;BAMBI;STEAP4;C1QTNF1;CLDN1;ITGA5;ABCA5;IL7R;IL6ST;RELT;TMCC3;ICAM1;B4GALT1;B3GNT5;RNF144B;TM4SF1;NINJ1;IL1R2;SLC6A14;C3ORF52;RNF43;PIGA;TMEM217;LAYN;VMP1;CD55;KCNJ15;TAP1;TMEM106A;ANKLE2;HEPHL1;GJB3;SLC28A3;IFNAR1;DSE;GJB4;NIPAL4;SLC7A2;CD47;CANT1;SEMA4B;TGFBR2;TMEM265;IFNGR1;ITGB8;SLC11A2;TGFA;SLC52A3;ROBO4;CD82;NRG1;SLC38A2;TMEM154;LDLR;DCBLD2;TRAF3IP3;RHD;TRPV3;FAM57A;SUCO;SLC9A1;SLC25A37;SYS1;MAOA;B4GALT5;CXCL16;RNF152;IL4R;MMD;RHCG;SLC2A6;TNFRSF6B;BTN2A2;SMAD1;SGMS2;SUSD6;TPRA1;CLIC4;TPST1;CAV1;CACFD1;HLA-A;DRAM1;UGCG;TLR2;TAPBP;EFNB2;HLA-B;ITGAV;PRRG1;STX1A;CD276;JPH2;ABCA7;SPCS2;TMEM132A;ADGRE2;SDR16C5;HS3ST3B1;ADAM9;SLC43A3;EMP3;SLC9A8;EVI2B;TSPAN13;CHST2;MUC1;AXL;SLC16A13;THSD1;CRB3;HLA-F;HLA-E;OSMR;SLC16A1;EVC;OCLN;CLDND1;RNF145;DDR1;XBP1;SLC39A14;ERVFRD-1;MGAM;LMAN1;SLC41A1;GJC1
1113,GO:0002699,0.00230535400685262,0.999273587900239,12,103,positive regulation of immune effector process,BP,IL1B;TNF;IL23A;IL6;RIPK2;NOD2;WNT5A;IL4R;ADGRE2;NR4A3;HLA-E;XBP1
6259,GO:0019838,0.00230888954069598,0.999319071855548,11,86,growth factor binding,MF,IL1RN;DUSP1;IL6ST;IL1R2;WISP1;TGFBR2;PDGFB;ITGAV;TRIM16;OSMR;IL36RN
11360,GO:0045684,0.00232876035359552,0.999619598441808,6,32,positive regulation of epidermis development,BP,TNF;CYP27B1;WNT5A;IL20;TRIM16;PPARD
13938,GO:0060584,0.00233050219342603,1,2,2,regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1;NOD2
13939,GO:0060585,0.00233050219342603,1,2,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1;NOD2
7591,GO:0031954,0.00234593014779084,0.999707756456065,5,20,positive regulation of protein autophosphorylation,BP,RAP2B;VEGFA;VEGFC;PDGFB;TNKS1BP1
4774,GO:0010956,0.00234633671251982,1,2,2,negative regulation of calcidiol 1-monooxygenase activity,BP,NFKB1;CYP27B1
2604,GO:0005900,0.00235992380463538,1,2,2,oncostatin-M receptor complex,CC,IL6ST;OSMR
362,GO:0000980,0.00236199485959407,0.999469454227568,8,51,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,NFKB1;JUN;REL;CREB1;BACH1;NFE2L2;CHD4;RELA
8926,GO:0034766,0.00236349847394297,0.999469061343074,8,51,negative regulation of ion transmembrane transport,BP,PPIF;NEDD4L;MMP9;RRAD;CAB39;NEDD4;CAV1;GEM
4627,GO:0010744,0.00236560913177196,0.99989716309736,3,7,positive regulation of macrophage derived foam cell differentiation,BP,CSF2;NFKB1;CSF1
17675,GO:1901492,0.00236714919415936,1,2,2,positive regulation of lymphangiogenesis,BP,VEGFC;CCBE1
846,GO:0002158,0.00238237095250423,1,2,2,osteoclast proliferation,BP,TNFAIP3;CSF1
8697,GO:0034329,0.00239778864031639,0.99903042006391,18,175,cell junction assembly,BP,TNF;SDC4;PHLDB2;CLDN1;ITGA5;SMAD3;VEGFA;LAMB3;VMP1;RUNX1;PARD6B;SLC9A1;CAV1;CRB3;LAMA3;OCLN;EPB41L3;GJC1
11673,GO:0046427,0.00242579074439426,0.999520634848527,7,43,positive regulation of JAK-STAT cascade,BP,CSF2;LIF;IL23A;IL6;IL6ST;IL20;IL24
14549,GO:0070053,0.0024477705454731,1,2,2,thrombospondin receptor activity,MF,SDC4;CD47
20001,GO:2000563,0.0024529531128307,1,2,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,CD55;TGFBR2
10096,GO:0042594,0.00245295809157993,0.999101065981691,15,140,response to starvation,BP,NUAK2;PLEKHF1;ZC3H12A;PMAIP1;ZFP36;JUN;CDKN1A;UPP1;ADM;SLC38A2;ATF3;RNF152;NFE2L2;TP53;XBP1
9676,GO:0038034,0.00247620728713348,0.999436819387713,8,54,signal transduction in absence of ligand,BP,IL1B;CSF2;TNF;IL1A;INHBA;BCL2L2;ITGAV;GSK3B
16507,GO:0097192,0.00247620728713348,0.999436819387713,8,54,extrinsic apoptotic signaling pathway in absence of ligand,BP,IL1B;CSF2;TNF;IL1A;INHBA;BCL2L2;ITGAV;GSK3B
13832,GO:0060412,0.00248120734459043,0.999594630188576,6,29,ventricular septum morphogenesis,BP,TBX3;SAV1;TGFBR2;WNT5A;SOX4;EGLN1
18250,GO:1903038,0.00250201177859318,0.999365741866942,9,64,negative regulation of leukocyte cell-cell adhesion,BP,IRF1;SDC4;PELI1;CYLD;NFKBID;NRARP;CEBPB;IL4R;BTN2A2
13602,GO:0060055,0.00251041088436152,0.999782503410356,4,13,angiogenesis involved in wound healing,BP,TNFAIP3;ETS1;B4GALT1;XBP1
10582,GO:0043542,0.0025235281331068,0.999072135532384,15,141,endothelial cell migration,BP,EFNA1;ZC3H12A;EDN1;MAP2K3;EPHA2;ETS1;VEGFA;PLK2;WNT5A;VEGFC;PDGFB;NFE2L2;STAT5A;EFNB2;CCBE1
13109,GO:0051607,0.00252509309513832,0.999034809255274,16,160,defense response to virus,BP,IL1B;TNFAIP3;IRF1;BIRC3;ZC3H12A;PMAIP1;TICAM1;IFNAR2;IL23A;BIRC2;IL6;TRIM25;IFIH1;PML;POLR3A;RELA
10201,GO:0042802,0.00252943686850416,0.998350764895343,73,1165,identical protein binding,MF,NFKBIA;TNFAIP3;TNF;SDC4;INHBA;CXCL5;SOD2;PTX3;NFKB1;TNIP1;JUN;EHD1;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;GADD45A;RIPK2;IRAK2;RELB;AMOTL2;CLDN1;ODC1;CTSC;IL6ST;SAV1;GCH1;SMAD3;TRAF4;VEGFA;IER5;CEBPB;NAMPT;TAP1;TP53BP2;CREB1;NR4A2;MSANTD3;CANT1;SMURF2;HMGCS1;PDGFB;IFIH1;MMP9;LDLR;ATF3;IKZF2;TLE1;RCHY1;GRB7;NUP153;BCL2L2;RHCG;MARCKS;SMAD1;LACTB;TPST1;CAV1;TP53;RAB9A;TRIP10;PML;RELA;YARS2;SAT1;NR4A3;SLC16A1;PARP1;VIM;ALAS1;XBP1;KCTD11
3553,GO:0007589,0.00253381661285102,0.999423336509161,8,52,body fluid secretion,BP,EDN1;VEGFA;CREB1;SOCS2;STAT5A;CAV1;DDR1;XBP1
13603,GO:0060056,0.00254725442458823,0.999886295841803,3,7,mammary gland involution,BP,ELF3;B4GALT1;CAV1
98,GO:0000188,0.00256445836497549,0.999668235241575,5,22,inactivation of MAPK activity,BP,DUSP1;DUSP16;DUSP10;DUSP8;CAV1
18036,GO:1902523,0.00262480033772492,1,2,2,positive regulation of protein K63-linked ubiquitination,BP,BIRC2;NOD2
12282,GO:0048568,0.00262751730298293,0.998771129758343,24,271,embryonic organ development,BP,CXCL8;CSF2;TNF;EFNA1;LIF;PRDM1;TBX3;EDN1;ZFP36L1;SIX4;PHLDA2;JUNB;SMAD3;DLX2;VEGFA;CEBPB;ADM;TGFBR2;WNT5A;PDGFB;SPRY2;WNT7B;NR4A3;EGLN1
1256,GO:0003007,0.00263309300451163,0.998991782076624,16,150,heart morphogenesis,BP,EFNA1;BMP2;TBX3;JUN;SAV1;SMAD3;VEGFA;DKK1;ADAMTS1;TGFBR2;WNT5A;SOX4;NRG1;NEDD4;PIM1;EGLN1
13377,GO:0052548,0.00264976603384559,0.998802787369652,22,267,regulation of endopeptidase activity,BP,TNF;EFNA1;BIRC3;PLAUR;PMAIP1;SERPINB2;BBC3;BIRC2;TNFRSF10B;TNFSF15;RIPK2;TNFAIP8;TFPI2;SMAD3;SERPINB8;VEGFA;CFLAR;ANXA8;SERPINB1;MMP9;TNFRSF6B;PML
6859,GO:0030324,0.00265009157533171,0.9991052943535,13,111,lung development,BP,TNF;LIF;SAV1;VEGFA;ERRFI1;CREB1;TGFBR2;WNT5A;TNC;SPRY2;WNT7B;STK40;CCBE1
8092,GO:0032769,0.00266908725486019,0.999878845558536,3,7,negative regulation of monooxygenase activity,BP,NFKB1;CYP27B1;CAV1
6293,GO:0019899,0.00268371866462801,0.998117171091859,110,1826,enzyme binding,MF,NFKBIA;TNFAIP3;CSF2;TNF;HBEGF;SDC4;PPP1R15A;RNF19B;PLAUR;PRDM1;TNIP1;MAP2K3;ZFP36;JUN;TICAM1;IFNAR2;RAB3IP;EPHA2;EHD1;ETS1;TRAF1;SQSTM1;BBC3;EREG;GADD45A;PANX1;RIPK2;CYLD;FZD8;RELB;CDKN1A;CTSC;NOD2;DCUN1D3;GCH1;SMAD3;RNF144B;RND3;TRAF4;TRIB1;ARHGEF3;FGD6;CDKN2B;FGF5;CFLAR;BTG1;CEBPB;DENND3;ANKLE2;CDC42EP4;ERRFI1;CREB1;VHL;PHKG2;ABTB2;PDE4DIP;TGFBR2;MASTL;DUSP10;PPP1R3B;PDGFB;ANLN;NRG1;LDLR;FAM83B;CAB39;RASGEF1B;PARD6B;SLC9A1;SPRY2;FEZ1;TNKS1BP1;CYTH1;GRB7;RNF152;NEDD4;ITSN2;GCSAM;MARCKS;PTPN1;SMAD1;SPTBN5;CHD4;CAV1;RHOV;SH3RF2;TNIP2;TP53;ITGAV;IKBKE;PJA2;STX1A;DOCK4;UBE2Z;PML;ADAM9;RELA;CCBE1;PPP6R3;AXL;NR4A3;GSK3B;KMT2E;PARP1;TBC1D22B;COTL1;EGLN1;DDR1;JUND;DENND4A
8001,GO:0032615,0.00271590608008133,0.999542318064263,6,32,interleukin-12 production,BP,IRF1;NFKB1;IL23A;RIPK2;TLR2;RELA
4979,GO:0015093,0.00272692661244736,1,2,2,ferrous iron transmembrane transporter activity,MF,SLC11A2;SLC39A14
5153,GO:0015684,0.00272692661244736,1,2,2,ferrous iron transport,BP,SLC11A2;SLC39A14
18617,GO:1903874,0.00272692661244736,1,2,2,ferrous iron transmembrane transport,BP,SLC11A2;SLC39A14
13068,GO:0051546,0.0027302180819135,0.999757818592892,4,13,keratinocyte migration,BP,HBEGF;MMP9;ADAM9;PPARD
13376,GO:0052547,0.00273649583627172,0.998735733045527,23,284,regulation of peptidase activity,BP,TNF;EFNA1;BIRC3;PLAUR;PMAIP1;SERPINB2;BBC3;BIRC2;TNFRSF10B;TNFSF15;RIPK2;TNFAIP8;TFPI2;SMAD3;SERPINB8;VEGFA;CFLAR;ANXA8;SERPINB1;MMP9;TNFRSF6B;CAV1;PML
713,GO:0001935,0.00274787697263208,0.999169298770608,11,89,endothelial cell proliferation,BP,TNF;BMP2;JUN;VEGFA;NRARP;WNT5A;VEGFC;PDGFB;STAT5A;CAV1;XBP1
11213,GO:0045335,0.00277325318036887,0.999105166192613,12,105,phagocytic vesicle,CC,ADAM8;TAP1;CDC42EP4;HLA-A;TLR2;TAPBP;RAB9A;HLA-B;ITGAV;HLA-F;HLA-E;VIM
17886,GO:1902106,0.00278181402405357,0.999357122470483,8,52,negative regulation of leukocyte differentiation,BP,IRF1;INHBA;CYLD;TJP2;NFKBID;TRIB1;NRARP;IL4R
531,GO:0001649,0.00278375032890055,0.998965690837751,15,141,osteoblast differentiation,BP,TNF;NOCT;BMP2;EPHA2;IL6;JUNB;IL6ST;SMAD3;CEBPB;TNC;SUCO;WNT7B;SMAD1;CYP24A1;JUND
10510,GO:0043409,0.00280102532456558,0.999000426975842,14,129,negative regulation of MAPK cascade,BP,IL1B;EFNA1;LIF;TNIP1;DUSP1;ERRFI1;DUSP16;DUSP10;DUSP8;ATF3;SPRY2;PTPN1;CAV1;RPS6KA6
6590,GO:0022414,0.0028021110135087,0.998268846665322,56,827,reproductive process,BP,IL1B;CSF2;IL1A;INHBA;BIRC3;FOSL1;LIF;PRDM1;TBX3;MAFF;EDN1;ETS1;CSF1;EREG;DUSP1;BIRC2;ZFP36L1;CYP27B1;SIX4;PHLDA2;JUNB;ICAM1;B4GALT1;VEGFA;BTG1;CEBPB;VMP1;NAMPT;ADM;GJB3;ADAMTS1;TAF4B;MYBL1;TGFBR2;SMURF2;MASTL;ITGB8;HMGCS1;WNT5A;PDGFB;TNC;SLC38A2;MMP9;BCL2L2;IL4R;WNT7B;SMAD1;CLIC4;ZNF148;ESPL1;SPATA2;AXL;PPARD;EGLN1;DDR1;QKI
10217,GO:0042834,0.00280414511365656,0.999870440129073,3,7,peptidoglycan binding,MF,NOD2;PGLYRP4;TLR2
18835,GO:1904385,0.0028064650852721,0.999744178452085,4,14,cellular response to angiotensin,BP,NFKB1;NFE2L2;CAV1;RELA
9078,GO:0035326,0.00281333390035565,0.999208155825051,10,75,enhancer binding,MF,NFKB1;JUN;REL;SMAD3;CREB1;BACH1;NFE2L2;CHD4;RELA;XBP1
19110,GO:1904994,0.00281533482511002,0.99986973695871,3,7,regulation of leukocyte adhesion to vascular endothelial cell,BP,TNF;ETS1;ICAM1
997,GO:0002456,0.00282632175828038,0.999342154262229,8,55,T cell mediated immunity,BP,IL1B;IL23A;IL6;IL7R;CTSC;ICAM1;CD55;HLA-E
18384,GO:1903364,0.00282853166555952,0.999035668449246,13,116,positive regulation of cellular protein catabolic process,BP,TNFAIP3;RNF19B;CTSC;RNF144B;TRIB1;PLK2;LDLR;PLK3;RCHY1;NFE2L2;CAV1;GSK3B;XBP1
8183,GO:0032916,0.00283908793281141,1,2,2,positive regulation of transforming growth factor beta3 production,BP,SMAD3;CREB1
8881,GO:0034686,0.00283908793281141,1,2,2,integrin alphav-beta8 complex,CC,ITGB8;ITGAV
19555,GO:1990430,0.00283908793281141,1,2,2,extracellular matrix protein binding,MF,ITGB8;ITGAV
6705,GO:0030100,0.00284352815622533,0.998900338522578,16,158,regulation of endocytosis,BP,IL1B;TNF;PTX3;NEDD4L;VEGFA;DKK1;ABL2;CD47;WNT5A;LDLR;PTPN1;CAV1;TLR2;ITGAV;ABCA7;AXL
4763,GO:0010939,0.00287728308290319,0.999612360964722,5,24,regulation of necrotic cell death,BP,BIRC3;PPIF;BIRC2;CFLAR;CAV1
2,GO:0000003,0.00287894793132774,0.998218979720832,56,828,reproduction,BP,IL1B;CSF2;IL1A;INHBA;BIRC3;FOSL1;LIF;PRDM1;TBX3;MAFF;EDN1;ETS1;CSF1;EREG;DUSP1;BIRC2;ZFP36L1;CYP27B1;SIX4;PHLDA2;JUNB;ICAM1;B4GALT1;VEGFA;BTG1;CEBPB;VMP1;NAMPT;ADM;GJB3;ADAMTS1;TAF4B;MYBL1;TGFBR2;SMURF2;MASTL;ITGB8;HMGCS1;WNT5A;PDGFB;TNC;SLC38A2;MMP9;BCL2L2;IL4R;WNT7B;SMAD1;CLIC4;ZNF148;ESPL1;SPATA2;AXL;PPARD;EGLN1;DDR1;QKI
431,GO:0001158,0.00288099199694282,0.999253966911586,9,64,enhancer sequence-specific DNA binding,MF,NFKB1;JUN;REL;CREB1;BACH1;NFE2L2;CHD4;RELA;XBP1
4729,GO:0010888,0.00292390330409629,0.999730383773725,4,14,negative regulation of lipid storage,BP,NFKBIA;TNF;IL6;ITGAV
20038,GO:2000628,0.00294327237150489,0.999861625048666,3,7,regulation of miRNA metabolic process,BP,ZC3H12A;NFKB1;RELA
4192,GO:0009267,0.00295615738105372,0.998987323138724,13,115,cellular response to starvation,BP,NUAK2;PLEKHF1;ZC3H12A;PMAIP1;JUN;CDKN1A;UPP1;SLC38A2;ATF3;RNF152;NFE2L2;TP53;XBP1
4543,GO:0010613,0.00297641839484037,0.999604406710568,5,21,positive regulation of cardiac muscle hypertrophy,BP,EDN1;IL6ST;SLC9A1;NR4A3;PARP1
4883,GO:0014742,0.00297641839484037,0.999604406710568,5,21,positive regulation of muscle hypertrophy,BP,EDN1;IL6ST;SLC9A1;NR4A3;PARP1
14523,GO:0065008,0.00297648415133178,0.997843510868833,136,2391,regulation of biological quality,BP,IL1B;NFKBIA;TNFAIP3;TNF;IRF1;PLAU;IL1A;EFNA1;INHBA;NOCT;ZC3H12A;PPP1R15A;BMP2;LIF;PLAUR;SOD2;TBX3;PMAIP1;PTX3;IL1RN;MAFF;NFKB1;PPIF;EDN1;ZFP36;SERPINB2;JUN;TICAM1;EHD1;ETS1;HCAR2;SQSTM1;CSF1;NFKBIE;BBC3;BCL3;AMPD3;IL6;ADAM8;BDKRB1;PIM3;ZFP36L1;CYP27B1;SIX4;CYLD;BAMBI;TJP2;STEAP4;C1QTNF1;CDKN1A;CLDN1;RAP2B;IL7R;NEDD4L;NOD2;SAV1;TFPI2;SGK1;ICAM1;GCH1;SMAD3;RND3;VEGFA;FGD6;DKK1;PLK2;ABL2;TXNRD1;ANXA8;CD55;TP53BP2;ADM;CDC42EP4;CREB1;SLC7A2;VHL;SEMA4B;SAA1;WNT5A;VEGFC;SLC11A2;SOX4;SOCS2;PDGFB;NRG1;LDLR;MT2A;SLC9A1;SLC25A37;MAOA;TNKS1BP1;NEDD4;RHCG;MARCKS;NFE2L2;WNT7B;SMAD1;SPTBN5;CLIC4;STAT5A;CAV1;RHOV;TNIP2;TP53;TLR2;TAPBP;ITGAV;IKBKE;STX1A;DOCK4;JPH2;ABCA7;SDR16C5;PML;SLC9A8;PLAT;AXL;ANXA5;NR4A3;GSK3B;KMT2E;PPARD;SLC16A1;PARP1;MED13;JMY;VIM;EGLN1;DDR1;XBP1;QKI;EPB41L3;SLC39A14;LMAN1;SLC41A1;GJC1
465,GO:0001503,0.00298391663268825,0.998641869185534,22,243,ossification,BP,TNF;NOCT;BMP2;EPHA2;CSF1;IL6;CYP27B1;JUNB;IL6ST;SMAD3;DKK1;CEBPB;RUNX1;NAB1;WNT5A;TNC;MMP9;SUCO;WNT7B;SMAD1;CYP24A1;JUND
9846,GO:0042088,0.00301135453258019,0.999592568600904,5,23,T-helper 1 type immune response,BP,IL23A;BCL3;RIPK2;RELB;IL4R
8989,GO:0035094,0.00302598553807414,0.999593032508153,5,22,response to nicotine,BP,TNF;NFKB1;EDN1;CREB1;RELA
15061,GO:0070997,0.00305473852953082,0.998634549423595,21,235,neuron death,BP,BTG2;NCOA7;SOD2;JUN;REL;ADAM8;SIX4;DKK1;CEBPB;TP53BP2;CREB1;NR4A2;WNT5A;SLC9A1;TP53;EFNB2;AXL;NR4A3;GSK3B;PARP1;EGLN1
8627,GO:0034142,0.00307134134481196,0.999712837837572,4,14,toll-like receptor 4 signaling pathway,BP,NFKBIA;TNFAIP3;PELI1;RIPK2
18363,GO:1903317,0.00307872192272969,0.999274287772526,8,54,regulation of protein maturation,BP,BIRC3;BIRC2;ADAM8;IL1R2;CD55;SOX4;CCBE1;CFB
2287,GO:0005243,0.00309404553225478,0.999851898102386,3,7,gap junction channel activity,MF,PANX1;GJB3;GJC1
714,GO:0001936,0.00312871426400776,0.999103914546465,10,78,regulation of endothelial cell proliferation,BP,TNF;BMP2;JUN;VEGFA;NRARP;WNT5A;VEGFC;PDGFB;STAT5A;CAV1
4250,GO:0009447,0.00318403414951667,0.99996435110595,2,3,putrescine catabolic process,BP,PAOX;SAT1
5325,GO:0016045,0.00320584127946452,0.999844571961526,3,7,detection of bacterium,BP,NOD2;PGLYRP4;TLR2
16771,GO:0098543,0.00320584127946452,0.999844571961526,3,7,detection of other organism,BP,NOD2;PGLYRP4;TLR2
7202,GO:0031087,0.00321410125011737,0.999844026895923,3,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,ZFP36;PNRC1;PNRC2
7912,GO:0032480,0.00326511657297721,0.999317625279664,7,44,negative regulation of type I interferon production,BP,TNFAIP3;REL;CYLD;RELB;TRIM25;IFIH1;IKBKE
18368,GO:1903322,0.00330674079681315,0.998908415859314,12,107,positive regulation of protein modification by small protein conjugation or removal,BP,BIRC3;ZC3H12A;TNIP1;TICAM1;PELI1;BIRC2;RIPK2;NOD2;DCUN1D3;ARRDC4;RCHY1;CAV1
10182,GO:0042770,0.00333612114511276,0.998838007228447,13,121,signal transduction in response to DNA damage,BP,BTG2;PMAIP1;BCL3;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1;RPS6KA6
4029,GO:0009059,0.00336456820167251,0.997446979569434,217,4117,macromolecule biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;SDC4;BTG2;INHBA;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;CCDC85B;CPEB2;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;PIGA;BTG1;IER5;CEBPB;CEBPD;NAMPT;DSE;ERRFI1;CREB1;TAF4B;CCNL1;USP43;NR4A2;CANT1;VHL;PHKG2;BACH1;MYBL1;RUNX1;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;ABCF1;TGFA;SOX4;PPP1R3B;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;B4GALT5;GRB7;NUP153;NEDD4;POU2F2;RAET1L;NFE2L2;SMAD1;TAB3;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;ITGAV;UBE2D3;CD276;ELK3;RAD9B;SNAPC4;ABCA7;SDR16C5;ZNF148;HS3ST3B1;PML;POLR3A;PIM1;RELA;TRIM16;ESCO2;FOXN2;CHST2;MUC1;YARS2;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ZXDA;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;LMAN1;JUND;DENND4A
15117,GO:0071156,0.00336640455663739,0.998950414752768,11,96,regulation of cell cycle arrest,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;EVI2B;MUC1
12570,GO:0050709,0.0034258676840452,0.999085414575846,9,68,negative regulation of protein secretion,BP,IL1B;TNF;ZC3H12A;PIM3;IL1R2;BTN2A2;MAPKBP1;PML;IL36RN
12248,GO:0048511,0.00342627770237384,0.998563186017414,18,187,rhythmic process,BP,CSF2;INHBA;NOCT;JUN;ETS1;BHLHE40;EREG;NFKB2;RELB;ARNTL2;NAMPT;ADAMTS1;CREB1;TP53;PML;AXL;GSK3B;JUND
8000,GO:0032613,0.00342824339341524,0.999518702130058,5,24,interleukin-10 production,BP,CD83;IL23A;BCL3;NOD2;TLR2
8474,GO:0033613,0.00343968838985698,0.999174181122234,8,54,activating transcription factor binding,MF,TBX3;JUN;BHLHE40;SMAD3;CREB1;NFE2L2;SDR16C5;RELA
14655,GO:0070232,0.00344831745637988,0.999515216198193,5,24,regulation of T cell apoptotic process,BP,EFNA1;ADAM8;NFKBID;WNT5A;TP53
11634,GO:0046328,0.00346524228893584,0.998733418021288,14,129,regulation of JNK cascade,BP,IL1B;TNF;IL1A;EDN1;GADD45A;RIPK2;FZD8;NOD2;TRAF4;DKK1;WNT5A;DUSP10;PTPN1;WNT7B
7806,GO:0032351,0.00347329621245629,0.999826664904393,3,7,negative regulation of hormone metabolic process,BP,BMP2;NFKB1;CYP27B1
7808,GO:0032353,0.00347329621245629,0.999826664904393,3,7,negative regulation of hormone biosynthetic process,BP,BMP2;NFKB1;CYP27B1
19892,GO:2000345,0.00349816106873328,0.999824973511566,3,7,regulation of hepatocyte proliferation,BP,TNFAIP3;CFLAR;XBP1
17498,GO:1900407,0.00351459885380987,0.999150788032248,8,56,regulation of cellular response to oxidative stress,BP,TNF;NCOA7;SOD2;GCH1;NFE2L2;TP53;NR4A3;PARP1
2970,GO:0006508,0.00353827921430854,0.99763515330107,77,1255,proteolysis,BP,IL1B;NFKBIA;TNFAIP3;TNF;PLAU;EFNA1;BIRC3;ZC3H12A;RNF19B;PLAUR;PMAIP1;NFKB1;TNIP1;MAP2K3;SERPINB2;SQSTM1;BBC3;BIRC2;ADAM8;TNFRSF10B;N4BP1;TNFSF15;RIPK2;CYLD;TNFAIP8;NEDD4L;CTSC;NOD2;TFPI2;SMAD3;RNF144B;TRIB1;SERPINB8;VEGFA;IL1R2;PLK2;CFLAR;RNF43;ANXA8;CD55;ADAMTS1;USP43;VHL;ABTB2;SMURF2;TINAGL1;TRIM25;SERPINB1;IFIH1;MMP9;OTUD4;PLK3;RCHY1;NEDD4;TNFRSF6B;NFE2L2;SMAD1;LACTB;CAV1;INO80D;TNIP2;TP53;UBE2D3;SPCS2;PML;ESPL1;ADAM9;RELA;CCBE1;PLAT;USP31;GSK3B;PARP1;MMP10;RNF145;XBP1;CFB
4600,GO:0010712,0.00355368994067147,0.999496837141296,5,24,regulation of collagen metabolic process,BP,IL6;ERRFI1;SUCO;PPARD;VIM
7130,GO:0030949,0.00356375603899819,0.999820490244548,3,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,IL1B;ITGA5;VEGFA
8383,GO:0033280,0.00356877221651527,0.999500967660593,5,22,response to vitamin D,BP,CYP27B1;TRIM25;TNC;PIM1;CYP24A1
9261,GO:0035666,0.00359410872530522,0.999489751701013,5,24,TRIF-dependent toll-like receptor signaling pathway,BP,BIRC3;TICAM1;BIRC2;IKBKE;UBE2D3
15154,GO:0071243,0.00360011545937459,0.99963725010069,4,16,cellular response to arsenic-containing substance,BP,ZC3H12A;PPIF;CPEB2;ATF3
4524,GO:0010574,0.00364254998519424,0.999484538129799,5,23,regulation of vascular endothelial growth factor production,BP,IL1B;IL1A;IL6;IL6ST;CCBE1
7497,GO:0031664,0.00364401183804803,0.999636590804637,4,15,regulation of lipopolysaccharide-mediated signaling pathway,BP,TNFAIP3;PRDM1;TRIB1;CD55
2384,GO:0005518,0.00365146962335824,0.99922449134285,7,42,collagen binding,MF,C1QTNF1;SMAD3;PDGFB;MMP9;ADAM9;CCBE1;DDR1
1172,GO:0002792,0.00370321495353224,0.998998588213851,9,69,negative regulation of peptide secretion,BP,IL1B;TNF;ZC3H12A;PIM3;IL1R2;BTN2A2;MAPKBP1;PML;IL36RN
12069,GO:0048008,0.00375420327379998,0.999200480261862,7,41,platelet-derived growth factor receptor signaling pathway,BP,CSRNP1;VEGFA;ABL2;PDGFB;PTPN1;ZFAND5;PLAT
12572,GO:0050711,0.00376650824203612,0.999793783988394,3,8,negative regulation of interleukin-1 secretion,BP,ZC3H12A;IL1R2;PML
7805,GO:0032350,0.00377200477810866,0.999461782154742,5,23,regulation of hormone metabolic process,BP,IL1B;TNF;BMP2;NFKB1;CYP27B1
13189,GO:0051781,0.0037980188975754,0.99907166037812,8,55,positive regulation of cell division,BP,IL1B;IL1A;EREG;VEGFA;FGF5;VEGFC;TGFA;PDGFB
12836,GO:0051128,0.00381011115763481,0.997300083204873,108,1807,regulation of cellular component organization,BP,IL1B;CSF2;TNF;HBEGF;IL1A;EFNA1;SDC4;INHBA;FOSL1;PPP1R15A;LIF;PLAUR;PMAIP1;PTX3;PPIF;EDN1;JUN;EPHA2;EHD1;ETS1;SQSTM1;SERTAD2;BBC3;EREG;DUSP1;PLAGL2;BIRC2;BDKRB1;CYP27B1;SIX4;PHLDB2;CYLD;BAMBI;CDKN1A;CLDN1;CCDC85B;ZNF451;NAV3;NEDD4L;DCUN1D3;SGK1;ICAM1;SMAD3;RND3;VEGFA;FGD6;DKK1;ZSWIM4;PLK2;ABL2;CFLAR;BTG1;TP53BP2;CDC42EP4;CREB1;WISP1;CD47;SEMA4B;PDE4DIP;RUNX1;WNT5A;TGFA;SOCS2;PDGFB;ANLN;NRG1;MMP9;LDLR;DCBLD2;SLC9A1;SPRY2;FEZ1;CXCL16;IL4R;NEDD4;ITSN2;NFE2L2;PTPN1;SPTBN5;CLIC4;CAV1;RHOV;UGCG;TP53;TLR2;EFNB2;ITGAV;UBE2D3;STX1A;ABCA7;SDR16C5;PML;ESPL1;ADAM9;MUC1;AXL;GSK3B;KMT2E;PPARD;PARP1;TBC1D22B;OCLN;JMY;VIM;DDR1;CEP135;EPB41L3;LMAN1
2673,GO:0006022,0.00381575320934944,0.998651562474201,13,117,aminoglycan metabolic process,BP,IL1B;SDC4;NFKB1;B4GALT1;B3GNT5;DSE;PDGFB;PGLYRP4;SLC9A1;B4GALT5;HS3ST3B1;PIM1;CHST2
20100,GO:2000725,0.00383171050201501,0.999451221795662,5,23,regulation of cardiac muscle cell differentiation,BP,BMP2;EDN1;DKK1;NRG1;EFNB2
10155,GO:0042730,0.00383800797434688,0.999611577212093,4,15,fibrinolysis,BP,PLAU;PLAUR;SERPINB2;PLAT
15184,GO:0071305,0.00389629073236139,0.99961033470951,4,14,cellular response to vitamin D,BP,CYP27B1;TNC;PIM1;CYP24A1
13486,GO:0055007,0.0039664388510039,0.998920346944059,9,65,cardiac muscle cell differentiation,BP,BMP2;TBX3;EDN1;KDM6B;VEGFA;DKK1;NRG1;SLC9A1;EFNB2
19770,GO:2000121,0.00397782737565341,0.999777876540225,3,8,regulation of removal of superoxide radicals,BP,TNF;GCH1;NFE2L2
9440,GO:0036015,0.00399349237712441,0.999949720294723,2,3,response to interleukin-3,BP,MT2A;GSK3B
9441,GO:0036016,0.00399349237712441,0.999949720294723,2,3,cellular response to interleukin-3,BP,MT2A;GSK3B
20295,GO:2001238,0.0039963128809135,0.999129905353499,7,46,positive regulation of extrinsic apoptotic signaling pathway,BP,INHBA;PMAIP1;G0S2;CYLD;ATF3;CAV1;PML
6792,GO:0030224,0.00403766712354612,0.999410746644807,5,24,monocyte differentiation,BP,CSF2;JUN;CSF1;ZFP36L1;VEGFA
18284,GO:1903131,0.00403766712354612,0.999410746644807,5,24,mononuclear cell differentiation,BP,CSF2;JUN;CSF1;ZFP36L1;VEGFA
2260,GO:0005172,0.00405355961281982,0.999772098372368,3,8,vascular endothelial growth factor receptor binding,MF,ITGA5;VEGFA;VEGFC
14137,GO:0060986,0.0040584837804603,0.999410746566606,5,23,endocrine hormone secretion,BP,IL1B;INHBA;TBX3;HCAR2;C1QTNF1
19415,GO:1905898,0.00406795147957001,0.99925011254337,6,34,positive regulation of response to endoplasmic reticulum stress,BP,PPP1R15A;PMAIP1;NFE2L2;PTPN1;CAV1;XBP1
7498,GO:0031665,0.00407856347101633,0.999770181828973,3,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,TNFAIP3;PRDM1;TRIB1
1187,GO:0002831,0.00411573630176615,0.998682631914291,11,95,regulation of response to biotic stimulus,BP,IL1B;TNFAIP3;BIRC3;ZC3H12A;PRDM1;IL23A;BIRC2;RIPK2;TRIB1;CD55;MAPKBP1
18703,GO:1904036,0.00412257224325631,0.999399205262663,5,23,negative regulation of epithelial cell apoptotic process,BP,TNFAIP3;ICAM1;CFLAR;NFE2L2;TNIP2
1332,GO:0003181,0.00415667997408575,0.999576569597165,4,14,atrioventricular valve morphogenesis,BP,EFNA1;BMP2;TGFBR2;SOX4
10726,GO:0044057,0.00418652125851459,0.99803667035573,22,252,regulation of system process,BP,IL1B;HBEGF;INHBA;ZC3H12A;EDN1;HCAR2;C1QTNF1;IL6ST;SGK1;ICAM1;GCH1;SMAD3;ADM;ERRFI1;PDGFB;NRG1;SLC9A1;CAV1;DOCK4;NR4A3;PARP1;GJC1
6149,GO:0019430,0.00419670814092314,0.999553140620553,4,17,removal of superoxide radicals,BP,TNF;SOD2;GCH1;NFE2L2
3527,GO:0007507,0.00420592521448134,0.997804456737344,29,356,heart development,BP,EFNA1;BMP2;PRDM1;TBX3;EDN1;JUN;KDM6B;ZFP36L1;SAV1;SMAD3;VEGFA;DKK1;ADM;ADAMTS1;CREB1;TGFBR2;WNT5A;SOX4;PDGFB;NRG1;SLC9A1;NEDD4;SMAD1;EFNB2;JPH2;PIM1;PPARD;EGLN1;GJC1
3653,GO:0008134,0.00424664510000495,0.99759663453564,37,505,transcription factor binding,MF,NFKBIA;NCOA7;TBX3;NFKB1;JUN;ETS1;BHLHE40;BCL3;ETS2;JUNB;GPX3;ELMSAN1;SMAD3;NFKBID;TRIB1;CEBPB;TP53BP2;CREB1;TAF4B;NR4A2;VHL;NAB1;TLE1;NFE2L2;CHD4;NFAT5;TP53;SDR16C5;PIM1;RELA;NR4A3;GSK3B;PPARD;PARP1;MED13;XBP1;JUND
18259,GO:1903053,0.0042855693450384,0.99936965363669,5,23,regulation of extracellular matrix organization,BP,ETS1;PHLDB2;SMAD3;CFLAR;DDR1
13912,GO:0060541,0.0042876640757648,0.998393242597733,14,131,respiratory system development,BP,TNF;LIF;SIX4;SAV1;VEGFA;ERRFI1;CREB1;TGFBR2;WNT5A;TNC;SPRY2;WNT7B;STK40;CCBE1
12838,GO:0051130,0.00429310682316942,0.997248173829598,60,910,positive regulation of cellular component organization,BP,IL1B;CSF2;TNF;IL1A;SDC4;FOSL1;PPP1R15A;LIF;PLAUR;PMAIP1;PTX3;PPIF;EDN1;JUN;EHD1;BBC3;EREG;PLAGL2;PHLDB2;CLDN1;NAV3;NEDD4L;ICAM1;SMAD3;VEGFA;ABL2;CFLAR;TP53BP2;CDC42EP4;CREB1;CD47;WNT5A;TGFA;PDGFB;ANLN;NRG1;MMP9;LDLR;FEZ1;IL4R;ITSN2;NFE2L2;CAV1;UGCG;TP53;ITGAV;UBE2D3;ABCA7;SDR16C5;PML;ESPL1;ADAM9;MUC1;AXL;GSK3B;KMT2E;PARP1;JMY;CEP135;LMAN1
563,GO:0001701,0.00430021348284575,0.997978904399271,22,251,in utero embryonic development,BP,CSF2;FOSL1;ELF3;BMP2;LIF;PRDM1;TBX3;MAFF;EDN1;ZFP36L1;PHLDA2;JUNB;SMAD3;VEGFA;CEBPB;ADM;GJB3;TGFBR2;PDGFB;WNT7B;ZFAND5;EGLN1
11611,GO:0046208,0.00433695249126722,0.999943003947735,2,3,spermine catabolic process,BP,PAOX;SAT1
15171,GO:0071277,0.00433909052355373,0.999046558174473,7,43,cellular response to calcium ion,BP,PPIF;EDN1;JUN;JUNB;WNT5A;CLIC4;JUND
1150,GO:0002755,0.0043508270122249,0.999353653616939,5,24,MyD88-dependent toll-like receptor signaling pathway,BP,IRF1;TNIP1;IRAK2;TAB3;TLR2
7261,GO:0031224,0.00438638993631386,0.996737337822199,154,2771,intrinsic component of membrane,CC,TNF;HBEGF;EFNA1;SDC4;RNF19B;BMP2;PLAUR;CD83;IER3;PPIF;HCAR3;IFNAR2;EPHA2;GPR156;HCAR2;CSF1;EREG;EFNB1;BIRC2;IFNGR2;IL6;ADAM8;TNFRSF10B;BDKRB1;PANX1;TNFSF15;FZD8;BAMBI;STEAP4;C1QTNF1;CLDN1;ITGA5;ABCA5;IL7R;IL6ST;RELT;TMCC3;ICAM1;B4GALT1;B3GNT5;RNF144B;TM4SF1;NINJ1;IL1R2;SLC6A14;C3ORF52;RNF43;PIGA;TMEM217;LAYN;VMP1;CD55;KCNJ15;TAP1;TMEM106A;ANKLE2;HEPHL1;GJB3;SLC28A3;IFNAR1;DSE;GJB4;NIPAL4;SLC7A2;CD47;CANT1;SEMA4B;TGFBR2;TMEM265;IFNGR1;ITGB8;SLC11A2;TGFA;SLC52A3;ROBO4;CD82;NRG1;SLC38A2;TMEM154;LDLR;DCBLD2;TRAF3IP3;RHD;TRPV3;FAM57A;SUCO;SLC9A1;SLC25A37;SYS1;MAOA;B4GALT5;CXCL16;RNF152;IL4R;MMD;RHCG;SLC2A6;TNFRSF6B;RAET1L;BTN2A2;SMAD1;SGMS2;SUSD6;TPRA1;CLIC4;TPST1;CAV1;CACFD1;HLA-A;DRAM1;UGCG;TLR2;TAPBP;EFNB2;HLA-B;ITGAV;PRRG1;STX1A;CD276;JPH2;ABCA7;SPCS2;TMEM132A;ADGRE2;SDR16C5;HS3ST3B1;ADAM9;SLC43A3;EMP3;SLC9A8;EVI2B;TSPAN13;CHST2;MUC1;AXL;SLC16A13;THSD1;CRB3;HLA-F;HLA-E;OSMR;SLC16A1;EVC;OCLN;CLDND1;RNF145;DDR1;XBP1;SLC39A14;ERVFRD-1;MGAM;LMAN1;SLC41A1;GJC1
14924,GO:0070741,0.00440707804307889,0.999347442104095,5,23,response to interleukin-6,BP,NFKB1;IL6;IL6ST;ICAM1;RELA
15219,GO:0071354,0.00440707804307889,0.999347442104095,5,23,cellular response to interleukin-6,BP,NFKB1;IL6;IL6ST;ICAM1;RELA
908,GO:0002287,0.00440987135692313,0.999173384319681,6,34,alpha-beta T cell activation involved in immune response,BP,IL23A;BCL3;IL6;RIPK2;RELB;IL4R
911,GO:0002293,0.00440987135692313,0.999173384319681,6,34,alpha-beta T cell differentiation involved in immune response,BP,IL23A;BCL3;IL6;RIPK2;RELB;IL4R
912,GO:0002294,0.00440987135692313,0.999173384319681,6,34,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,IL23A;BCL3;IL6;RIPK2;RELB;IL4R
9851,GO:0042093,0.00440987135692313,0.999173384319681,6,34,T-helper cell differentiation,BP,IL23A;BCL3;IL6;RIPK2;RELB;IL4R
1011,GO:0002483,0.00446306166588105,0.999740171544866,3,8,antigen processing and presentation of endogenous peptide antigen,BP,TAP1;TAPBP;HLA-E
3567,GO:0007611,0.00448594370794273,0.998309119532634,14,133,learning or memory,BP,BTG2;FOSL1;JUN;ITGA5;SGK1;DKK1;PLK2;CEBPB;CREB1;SLC11A2;LDLR;TLR2;PJA2;ABCA7
7075,GO:0030858,0.00449373198250509,0.999151744265442,6,35,positive regulation of epithelial cell differentiation,BP,LIF;CYP27B1;BTG1;IL20;VEZF1;TRIM16
7940,GO:0032515,0.00454527469860276,0.999139981407277,6,35,negative regulation of phosphoprotein phosphatase activity,BP,TNF;PPP1R15A;PPP4R4;MASTL;SH3RF2;GSK3B
10800,GO:0044271,0.0045471185745919,0.996529591844351,207,3950,cellular nitrogen compound biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;PTX3;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;NMNAT2;CCDC85B;CPEB2;ZNF451;ODC1;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;GCH1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;UPP1;IER5;CEBPB;CEBPD;NAMPT;ADM;CREB1;TAF4B;CCNL1;USP43;NR4A2;SLC7A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;SLC11A2;ABCF1;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;GRB7;NUP153;NEDD4;POU2F2;NFE2L2;SMAD1;SGMS2;TAB3;PAOX;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;UGCG;TP53;KLF3;TLR2;UBE2D3;ELK3;SNAPC4;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;FOXN2;MUC1;YARS2;ELL2;SAT1;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
7213,GO:0031100,0.00457654387045842,0.998841315646103,8,58,animal organ regeneration,BP,NFKBIA;CDKN1A;CLDN1;CEBPB;ADM;TGFBR2;AXL;NR4A3
11084,GO:0045076,0.00460184410766936,0.999729097269873,3,8,regulation of interleukin-2 biosynthetic process,BP,IL1B;IL1A;ZFP36
8352,GO:0033209,0.00460902412597832,0.998322459391599,13,138,tumor necrosis factor-mediated signaling pathway,BP,NFKBIA;TNFAIP3;TNF;BIRC3;TRAF1;BIRC2;TNFRSF10B;TNFSF15;CYLD;TJP2;RELT;TNFRSF6B;RELA
2642,GO:0005976,0.00463880574222977,0.998592505441579,10,80,polysaccharide metabolic process,BP,NFKB1;PHLDA2;IL6ST;B3GNT5;PHKG2;PPP1R3B;PDGFB;STK40;GSK3B;MGAM
15921,GO:0072679,0.00466567561333593,0.999936307339897,2,3,thymocyte migration,BP,CCL20;ADAM8
6566,GO:0022008,0.00466866176128961,0.996926160267128,67,1019,neurogenesis,BP,EFNA1;SDC4;BTG2;INHBA;BMP2;LIF;PRDM1;JUN;EHD1;CSF1;EFNB1;IL6;SIX4;FZD8;NEDD4L;IL6ST;SGK1;DLX2;VEGFA;DKK1;ZSWIM4;FGF5;PLK2;ABL2;CFLAR;KLF7;CEBPB;ADM;CREB1;NR4A2;SEMA4B;ABTB2;RUNX1;TGIF2;NAB1;WNT5A;VEGFC;SLC11A2;DUSP10;SOX4;SOCS2;NRG1;TNC;LDLR;PARD6B;FEZ1;GRB7;NEDD4;MMD;ITSN2;NFE2L2;WNT7B;SPTBN5;NOM1;TLR2;ABI1;EFNB2;RELA;RAPH1;AXL;NR4A3;GSK3B;VIM;DDR1;XBP1;EPB41L3;KCTD11
12850,GO:0051147,0.00476390802357994,0.998445653188583,11,94,regulation of muscle cell differentiation,BP,BMP2;EDN1;EHD1;EREG;DKK1;CFLAR;PDGFB;NRG1;IL4R;EFNB2;XBP1
19898,GO:2000352,0.00476527756020982,0.999487079814913,4,15,negative regulation of endothelial cell apoptotic process,BP,TNFAIP3;ICAM1;NFE2L2;TNIP2
14162,GO:0061028,0.00487373133237495,0.999070306159084,6,33,establishment of endothelial barrier,BP,IL1B;TNF;TJP2;CLDN1;ICAM1;WNT7B
7943,GO:0032526,0.00489331120195259,0.998616154233994,9,71,response to retinoic acid,BP,DUSP1;DKK1;ABL2;GJB3;WNT5A;TNC;WNT7B;TP53;TRIM16
16786,GO:0098581,0.00489587154002369,0.999705225475125,3,8,detection of external biotic stimulus,BP,NOD2;PGLYRP4;TLR2
13882,GO:0060485,0.00489827948304775,0.997992780587363,16,163,mesenchyme development,BP,IL1B;EFNA1;BMP2;EDN1;EFNB1;ZFP36L1;SIX4;PHLDB2;BAMBI;SMAD3;SEMA4B;TGFBR2;WNT5A;NRG1;NEDD4;GSK3B
12348,GO:0048699,0.00492491181081309,0.99678974838123,63,947,generation of neurons,BP,EFNA1;SDC4;BTG2;INHBA;BMP2;LIF;PRDM1;JUN;EHD1;CSF1;EFNB1;IL6;SIX4;FZD8;NEDD4L;IL6ST;SGK1;DLX2;VEGFA;DKK1;ZSWIM4;PLK2;ABL2;CFLAR;KLF7;CEBPB;ADM;CREB1;NR4A2;SEMA4B;RUNX1;TGIF2;WNT5A;VEGFC;SLC11A2;DUSP10;SOX4;SOCS2;NRG1;TNC;LDLR;PARD6B;FEZ1;GRB7;NEDD4;MMD;ITSN2;NFE2L2;WNT7B;SPTBN5;TLR2;ABI1;EFNB2;RELA;RAPH1;AXL;NR4A3;GSK3B;VIM;DDR1;XBP1;EPB41L3;KCTD11
13952,GO:0060602,0.00495511973974333,0.999460649837695,4,15,branch elongation of an epithelium,BP,SIX4;WNT5A;TNC;SPRY2
7068,GO:0030851,0.00496324090432619,0.999452109217042,4,16,granulocyte differentiation,BP,CSF2;TRIB1;RUNX1;EVI2B
15233,GO:0071375,0.00501068008490341,0.997708040399135,20,225,cellular response to peptide hormone stimulus,BP,IL1B;NFKB1;EDN1;ZFP36L1;CPEB2;CFLAR;ERRFI1;CREB1;NR4A2;SOGA1;SOCS2;SLC9A1;NFE2L2;PTPN1;STAT5A;CAV1;RELA;NR4A3;PARP1;XBP1
18366,GO:1903320,0.00503414684798039,0.997862438549126,17,188,regulation of protein modification by small protein conjugation or removal,BP,TNFAIP3;BIRC3;ZC3H12A;TNIP1;TICAM1;PELI1;BIRC2;N4BP1;RIPK2;NOD2;DCUN1D3;SOX4;OTUD4;ARRDC4;RCHY1;CAV1;RELA
7879,GO:0032436,0.0050406225704072,0.998567900553148,9,71,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,RNF19B;RNF144B;TRIB1;PLK2;PLK3;RCHY1;NFE2L2;CAV1;GSK3B
14699,GO:0070307,0.00505805604377594,0.999691825493385,3,8,lens fiber cell development,BP,EPHA2;WNT7B;VIM
10985,GO:0044773,0.0050911006500693,0.998319542395929,11,99,mitotic DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;RAD9B;PML;MUC1
8624,GO:0034139,0.00510969232424435,0.999687525227696,3,8,regulation of toll-like receptor 3 signaling pathway,BP,TNFAIP3;PELI1;CAV1
1116,GO:0002702,0.00513295323331057,0.998825295736753,7,48,positive regulation of production of molecular mediator of immune response,BP,IL6;NOD2;WNT5A;IL4R;NR4A3;HLA-E;XBP1
19644,GO:1990776,0.00514057252845906,0.999426803828735,4,16,response to angiotensin,BP,NFKB1;NFE2L2;CAV1;RELA
12199,GO:0048333,0.00514425091730849,0.999434019812909,4,15,mesodermal cell differentiation,BP,INHBA;KDM6B;DKK1;SMAD1
6995,GO:0030670,0.00514519692034577,0.99866527537994,8,62,phagocytic vesicle membrane,CC,TAP1;HLA-A;TLR2;TAPBP;RAB9A;HLA-B;HLA-F;HLA-E
8061,GO:0032720,0.00515247202473123,0.999194190851522,5,26,negative regulation of tumor necrosis factor production,BP,TNFAIP3;ZC3H12A;BCL3;ERRFI1;AXL
13789,GO:0060353,0.00515304992588304,0.99992591351612,2,3,regulation of cell adhesion molecule production,BP,IL1B;CAV1
13790,GO:0060355,0.00515304992588304,0.99992591351612,2,3,positive regulation of cell adhesion molecule production,BP,IL1B;CAV1
415,GO:0001102,0.00516505777132214,0.99899634336713,6,35,RNA polymerase II activating transcription factor binding,MF,TBX3;JUN;BHLHE40;SMAD3;CREB1;NFE2L2
19436,GO:1905953,0.00526219587467769,0.999177155718788,5,25,negative regulation of lipid localization,BP,NFKBIA;TNF;NFKB1;IL6;ITGAV
1107,GO:0002693,0.00527166346184418,0.999673931322807,3,8,positive regulation of cellular extravasation,BP,IL1A;ADAM8;ICAM1
13843,GO:0060426,0.00534745060432348,0.999921617343538,2,3,lung vasculature development,BP,LIF;ERRFI1
10471,GO:0043330,0.00539485293890454,0.999146922863962,5,26,response to exogenous dsRNA,BP,NFKBIA;TICAM1;RIPK2;IFIH1;CAV1
10057,GO:0042536,0.00544693364233695,0.999919386377029,2,3,negative regulation of tumor necrosis factor biosynthetic process,BP,BCL3;ERRFI1
4523,GO:0010573,0.00544960729726569,0.999140650570347,5,25,vascular endothelial growth factor production,BP,IL1B;IL1A;IL6;IL6ST;CCBE1
6842,GO:0030301,0.00547855962819979,0.998730866025689,7,48,cholesterol transport,BP,NFKBIA;NFKB1;STARD5;ABCA5;LDLR;CAV1;ABCA7
2614,GO:0005921,0.00549836378148565,0.999374963810344,4,16,gap junction,CC,PANX1;GJB3;GJB4;GJC1
1151,GO:0002756,0.00551269649732514,0.999123748214574,5,26,MyD88-independent toll-like receptor signaling pathway,BP,BIRC3;TICAM1;BIRC2;IKBKE;UBE2D3
6781,GO:0030212,0.00553115087739859,0.999124668300725,5,25,hyaluronan metabolic process,BP,IL1B;NFKB1;PDGFB;SLC9A1;PIM1
7342,GO:0031348,0.00553495839496678,0.998043837153916,12,114,negative regulation of defense response,BP,TNFAIP3;ZC3H12A;NFKB1;ETS1;NOD2;SMAD3;IL1R2;SAA1;DUSP10;MAPKBP1;HLA-E;PPARD
1299,GO:0003129,0.00555597934181414,0.999916916011744,2,3,heart induction,BP,BMP2;DKK1
2601,GO:0005896,0.00558327443791893,0.999916293599895,2,3,interleukin-6 receptor complex,CC,IL6;IL6ST
12413,GO:0048845,0.00558604202754574,0.999647100650386,3,8,venous blood vessel morphogenesis,BP,VEGFA;EFNB2;CCBE1
12116,GO:0048146,0.00560058253929654,0.998886932689243,6,37,positive regulation of fibroblast proliferation,BP,JUN;EREG;CDKN1A;WNT5A;PDGFB;PML
4770,GO:0010951,0.00562046027080733,0.997906195736994,13,135,negative regulation of endopeptidase activity,BP,BIRC3;PLAUR;SERPINB2;BIRC2;TNFRSF10B;TNFAIP8;TFPI2;SERPINB8;VEGFA;ANXA8;SERPINB1;MMP9;TNFRSF6B
16192,GO:0090199,0.00562401599005954,0.998873233859149,6,40,regulation of release of cytochrome c from mitochondria,BP,PLAUR;PMAIP1;PPIF;BBC3;MMP9;TP53
16417,GO:0097028,0.00563475647734136,0.999347381518308,4,17,dendritic cell differentiation,BP,CSF2;RELB;TGFBR2;AXL
19557,GO:1990440,0.00574147620316692,0.999616963402653,3,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,CEBPB;ATF3;TP53
8045,GO:0032689,0.00575278043824189,0.999329733613253,4,17,negative regulation of interferon-gamma production,BP,INHBA;ZC3H12A;AXL;IL36RN
8082,GO:0032757,0.00580057990841734,0.999062177215844,5,27,positive regulation of interleukin-8 production,BP,IL1B;TNF;NOD2;WNT5A;TLR2
10431,GO:0043271,0.00580261407146515,0.998314716255914,9,71,negative regulation of ion transport,BP,PPIF;NEDD4L;ICAM1;MMP9;RRAD;CAB39;NEDD4;CAV1;GEM
8129,GO:0032814,0.00582654416342409,0.999318649093354,4,17,regulation of natural killer cell activation,BP,PRDM1;TICAM1;IL23A;AXL
986,GO:0002440,0.00582664239631965,0.997927060490839,12,114,production of molecular mediator of immune response,BP,TNF;IL6;IL7R;NOD2;CD55;WNT5A;IL4R;POU2F2;TLR2;NR4A3;HLA-E;XBP1
1396,GO:0003307,0.00584063401919546,0.999910345947326,2,3,regulation of Wnt signaling pathway involved in heart development,BP,BMP2;DKK1
13069,GO:0051547,0.00584928282024802,0.999624193734676,3,8,regulation of keratinocyte migration,BP,HBEGF;MMP9;ADAM9
10274,GO:0043011,0.00589893537167615,0.999602553060024,3,9,myeloid dendritic cell differentiation,BP,CSF2;RELB;TGFBR2
12433,GO:0048872,0.00589954824491216,0.997529900045206,16,171,homeostasis of number of cells,BP,TNFAIP3;INHBA;PMAIP1;ZFP36;ETS1;HCAR2;CSF1;AMPD3;IL6;ZFP36L1;CYLD;IL7R;VEGFA;SLC11A2;AXL;KMT2E
13502,GO:0055025,0.00590702287612696,0.999050245317844,5,25,positive regulation of cardiac muscle tissue development,BP,EDN1;CREB1;NRG1;EFNB2;PIM1
15252,GO:0071398,0.00594478268490048,0.998810268058574,6,35,cellular response to fatty acid,BP,ZC3H12A;EDN1;CLDN1;CREB1;TNC;LDLR
4824,GO:0014015,0.00594770649205756,0.998806146824554,6,36,positive regulation of gliogenesis,BP,BMP2;LIF;CSF1;IL6ST;TLR2;RELA
8305,GO:0033135,0.00595897869385804,0.998117483819856,10,86,regulation of peptidyl-serine phosphorylation,BP,TNF;LIF;IL6;RIPK2;VEGFA;DKK1;WNT5A;SPRY2;TNKS1BP1;CAV1
18479,GO:1903556,0.00597544862082988,0.99902696253133,5,27,negative regulation of tumor necrosis factor superfamily cytokine production,BP,TNFAIP3;ZC3H12A;BCL3;ERRFI1;AXL
907,GO:0002286,0.00598643803693888,0.998589986974924,7,48,T cell activation involved in immune response,BP,IL23A;BCL3;IL6;RIPK2;RELB;ICAM1;IL4R
15282,GO:0071450,0.00599701052229797,0.999279359607771,4,19,cellular response to oxygen radical,BP,TNF;SOD2;GCH1;NFE2L2
15283,GO:0071451,0.00599701052229797,0.999279359607771,4,19,cellular response to superoxide,BP,TNF;SOD2;GCH1;NFE2L2
716,GO:0001938,0.00600802890606806,0.998403323128495,8,60,positive regulation of endothelial cell proliferation,BP,BMP2;JUN;VEGFA;NRARP;WNT5A;VEGFC;PDGFB;STAT5A
18258,GO:1903052,0.00601571108953476,0.997968594571956,11,99,positive regulation of proteolysis involved in cellular protein catabolic process,BP,RNF19B;CTSC;RNF144B;TRIB1;PLK2;PLK3;RCHY1;NFE2L2;CAV1;GSK3B;XBP1
8968,GO:0035035,0.00603578023111487,0.999024473191244,5,25,histone acetyltransferase binding,MF,ETS1;CEBPB;CREB1;TP53;NR4A3
910,GO:0002292,0.00603791258190018,0.998784195940882,6,36,T cell differentiation involved in immune response,BP,IL23A;BCL3;IL6;RIPK2;RELB;IL4R
16103,GO:0090068,0.00603968879267866,0.997248297259062,19,219,positive regulation of cell cycle process,BP,IL1B;IL1A;BTG2;EDN1;EREG;GADD45A;CDKN1A;PLK2;WNT5A;TGFA;SOX4;PDGFB;PLK3;TNKS1BP1;TP53;PML;ESPL1;MUC1;KMT2E
10335,GO:0043124,0.00605742861545282,0.998782923597155,6,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNFAIP3;ZC3H12A;TNIP1;NFKBID;TLE1;MAPKBP1
11821,GO:0046697,0.00610883951701417,0.999284203920202,4,16,decidualization,BP,LIF;CYP27B1;JUNB;PPARD
10361,GO:0043170,0.00613233524389516,0.995253034110815,341,6854,macromolecule metabolic process,BP,NFKBIZ;CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;ZNF267;SPRR2D;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;ZFP36L1;TNFSF15;SIX4;RIPK2;IRAK2;THAP10;KLHL21;PHLDA2;DAPP1;JUNB;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;RELB;ZNF217;C1QTNF1;CDKN1A;CCDC85B;ITGA5;RAP2B;IL7R;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;NOD2;ELMSAN1;IL6ST;DCUN1D3;SAV1;TFPI2;SGK1;ICAM1;SMAD3;ZC3H12C;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;RNF144B;NFKBID;TRAF4;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ZBED2;ABL2;PPTC7;CFLAR;RNF43;KLF7;PIGA;BTG1;ANXA8;IER5;PPP4R4;CEBPB;CEBPD;CD55;DENND3;NAMPT;ANKLE2;ADM;DSE;ERRFI1;ADAMTS1;ANKK1;CREB1;TAF4B;CCNL1;USP43;MAST4;NR4A2;PATL1;CANT1;VHL;PHKG2;BACH1;ABTB2;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;MASTL;NAB1;ITGB8;WNT5A;CAMK1G;VEGFC;ABCF1;TGFA;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;PGLYRP4;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;KIAA1586;ATF3;OTUD4;IKZF2;CAB39;TLE1;PLK3;CHD2;ARRDC4;SLC9A1;ZBTB10;RCHY1;YAF2;SPRY2;TNKS1BP1;B4GALT5;GRB7;ARSJ;NUP153;RNF152;NEDD4;MMD;POU2F2;DUS4L;IL24;TNFRSF6B;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;TAB3;SPTBN5;MXD1;CHD4;ZC3H7B;DIEXF;NFAT5;STAT5A;TPST1;CAV1;VEZF1;SH3RF2;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;ABI1;STK40;PUS10;TAPBP;PDP1;ITGAV;IKBKE;UBE2D3;PJA2;CD276;MAPKBP1;ELK3;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;ADAM9;RELA;TRIM16;ESCO2;FOXN2;CCBE1;PPP6R3;PLAT;CHST2;MUC1;YARS2;AXL;ELL2;FRK;CITED4;NR4A3;USP31;GSK3B;KMT2E;PPARD;PARP8;PARP1;MMP10;KDM7A;MED13;MXD3;CRAMP1;LCE1C;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;RNF145;ZXDA;RPS6KA6;DDR1;XBP1;QKI;KCTD11;ZBTB5;ELF4;SREK1IP1;TFE3;EID3;ZMIZ2;MGAM;LMAN1;CFB;JUND;DENND4A
14514,GO:0062012,0.00615612184090233,0.996811777876346,26,337,regulation of small molecule metabolic process,BP,IL1B;TNF;BMP2;PMAIP1;NFKB1;PPIF;CYP27B1;PHLDA2;C1QTNF1;ODC1;VEGFA;ADM;PHKG2;SOGA1;HMGCS1;WNT5A;PPP1R3B;PDGFB;LDLR;NUP153;CAV1;PDP1;NR4A3;GSK3B;PARP1;EGLN1
12115,GO:0048145,0.00618671762247481,0.998343993462101,8,62,regulation of fibroblast proliferation,BP,JUN;EREG;CDKN1A;CREB1;WNT5A;PDGFB;TP53;PML
1178,GO:0002822,0.00622763802249644,0.998166573893616,9,74,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,IL1B;TNFAIP3;TNF;IL23A;IL6;RIPK2;IL7R;IL4R;HLA-E
15423,GO:0071674,0.00622793316297799,0.99897120192874,5,28,mononuclear cell migration,BP,TNF;CCL20;CSF1;IL6;PDGFB
17814,GO:1901890,0.0062652759428507,0.998978195278278,5,25,positive regulation of cell junction assembly,BP,SDC4;CLDN1;SMAD3;VEGFA;CAV1
4473,GO:0010466,0.00627655585951776,0.99762860536745,13,137,negative regulation of peptidase activity,BP,BIRC3;PLAUR;SERPINB2;BIRC2;TNFRSF10B;TNFAIP8;TFPI2;SERPINB8;VEGFA;ANXA8;SERPINB1;MMP9;TNFRSF6B
10313,GO:0043085,0.00628771974635224,0.995824253075444,65,1025,positive regulation of catalytic activity,BP,IL1B;TNF;CXCL1;EFNA1;SDC4;CCL20;PPP1R15A;BMP2;PMAIP1;EDN1;MAP2K3;JUN;EPHA2;CSF1;BBC3;EREG;IL23A;GADD45A;ADAM8;TNFRSF10B;TNFSF15;CYP27B1;RIPK2;IRAK2;FZD8;CDKN1A;NOD2;DCUN1D3;ICAM1;GCH1;SMAD3;TRAF4;VEGFA;DKK1;MAP3K8;ABL2;CFLAR;CDC42EP4;ERRFI1;CCNL1;NR4A2;TGFBR2;SAA1;WNT5A;TGFA;PDGFB;NRG1;CAB39;ARRDC4;RASGEF1B;SPRY2;MMD;PTPN1;WNT7B;TAB3;CAV1;ABI1;DOCK4;TRIP10;PML;ADAM9;AXL;GSK3B;TBC1D22B;DDR1
16345,GO:0090557,0.00629522358752034,0.999584503134143,3,8,establishment of endothelial intestinal barrier,BP,TJP2;CLDN1;ICAM1
6773,GO:0030203,0.00629547351653778,0.997741235611732,12,110,glycosaminoglycan metabolic process,BP,IL1B;SDC4;NFKB1;B4GALT1;DSE;PDGFB;PGLYRP4;SLC9A1;B4GALT5;HS3ST3B1;PIM1;CHST2
17777,GO:1901739,0.00631496913745007,0.999563788241308,3,9,regulation of myoblast fusion,BP,EHD1;CFLAR;IL4R
11092,GO:0045084,0.00636141192702813,0.999897881937029,2,3,positive regulation of interleukin-12 biosynthetic process,BP,IRF1;RELA
11363,GO:0045687,0.00636463130083903,0.998952629469735,5,26,positive regulation of glial cell differentiation,BP,BMP2;LIF;IL6ST;TLR2;RELA
11638,GO:0046332,0.00639106326250485,0.998289577413173,8,57,SMAD binding,MF,BMP2;JUN;SMAD3;TGFBR2;SMURF2;SMAD1;PML;PARP1
10084,GO:0042581,0.00639405347959243,0.997819615701819,11,102,specific granule,CC,PLAU;CXCL1;PLAUR;PTX3;NFKB1;ADAM8;RAP2B;CD47;CANT1;ITGAV;FRK
4775,GO:0010957,0.00641675812681534,0.999896524248785,2,3,negative regulation of vitamin D biosynthetic process,BP,NFKB1;CYP27B1
11592,GO:0046137,0.00641675812681534,0.999896524248785,2,3,negative regulation of vitamin metabolic process,BP,NFKB1;CYP27B1
2244,GO:0005152,0.00646009999785439,0.999895456664631,2,3,interleukin-1 receptor antagonist activity,MF,IL1RN;IL36RN
14175,GO:0061043,0.00648504169978292,0.999894840571995,2,3,regulation of vascular wound healing,BP,TNFAIP3;XBP1
9941,GO:0042288,0.00648894892639075,0.999547287300958,3,9,MHC class I protein binding,MF,TAP1;TAPBP;HLA-E
11409,GO:0045787,0.00652088383681838,0.996705957058272,24,302,positive regulation of cell cycle,BP,IL1B;IL1A;BTG2;FOSL1;TBX3;EDN1;EREG;GADD45A;CDKN1A;PLK2;CCNL1;WNT5A;TGFA;SOX4;PDGFB;PLK3;TNKS1BP1;TP53;PML;ESPL1;EVI2B;MUC1;NR4A3;KMT2E
2246,GO:0005154,0.0065740551523774,0.998909644444894,5,26,epidermal growth factor receptor binding,MF,HBEGF;EREG;ITGA5;TGFA;FAM83B
4063,GO:0009110,0.00658469968188725,0.999202361694551,4,17,vitamin biosynthetic process,BP,IL1B;TNF;NFKB1;CYP27B1
734,GO:0001960,0.00661194601775586,0.998632549943274,6,39,negative regulation of cytokine-mediated signaling pathway,BP,IL1RN;IL6;IL1R2;OTUD4;CAV1;IL36RN
14266,GO:0061302,0.00663264742778644,0.999891168680555,2,3,smooth muscle cell-matrix adhesion,BP,PLAU;DDR1
9960,GO:0042326,0.00665109033570885,0.996488566064538,27,349,negative regulation of phosphorylation,BP,IL1B;TNFAIP3;EFNA1;INHBA;ZC3H12A;LIF;PPIF;TNIP1;JUN;DUSP1;GADD45A;BDKRB1;CDKN1A;TRIB1;DKK1;CDKN2B;ANKLE2;ERRFI1;DUSP16;DUSP10;SOCS2;DUSP8;ATF3;SPRY2;PTPN1;CAV1;RPS6KA6
11428,GO:0045833,0.00667922402917888,0.998391433794672,7,49,negative regulation of lipid metabolic process,BP,IL1B;TNF;BMP2;NFKB1;HCAR2;CYP27B1;PDGFB
18159,GO:1902882,0.00668409511755727,0.998186999060397,8,62,regulation of response to oxidative stress,BP,TNF;NCOA7;SOD2;GCH1;NFE2L2;TP53;NR4A3;PARP1
12357,GO:0048710,0.00669617887273849,0.999184911951207,4,17,regulation of astrocyte differentiation,BP,BMP2;LIF;IL6ST;LDLR
8483,GO:0033628,0.00670256954331554,0.998877814460476,5,27,regulation of cell adhesion mediated by integrin,BP,PLAU;EFNA1;EPHA2;ADAM9;MUC1
8853,GO:0034645,0.00672951012707781,0.994798212783434,211,4046,cellular macromolecule biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;CCDC85B;CPEB2;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;PIGA;BTG1;IER5;CEBPB;CEBPD;NAMPT;DSE;CREB1;TAF4B;CCNL1;USP43;NR4A2;CANT1;VHL;PHKG2;BACH1;MYBL1;RUNX1;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;ABCF1;TGFA;SOX4;PPP1R3B;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;B4GALT5;GRB7;NUP153;NEDD4;POU2F2;RAET1L;NFE2L2;SMAD1;TAB3;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;UBE2D3;ELK3;RAD9B;SNAPC4;ABCA7;SDR16C5;ZNF148;HS3ST3B1;PML;POLR3A;PIM1;RELA;TRIM16;ESCO2;FOXN2;MUC1;YARS2;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ZXDA;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;LMAN1;JUND;DENND4A
1325,GO:0003171,0.00674007917717978,0.9991874713957,4,16,atrioventricular valve development,BP,EFNA1;BMP2;TGFBR2;SOX4
950,GO:0002366,0.00682116480953497,0.996145496221598,33,471,leukocyte activation involved in immune response,BP,PLAU;CXCL1;PLAUR;PTX3;NFKB1;TICAM1;IL23A;BCL3;AMPD3;IL6;ADAM8;RIPK2;RELB;RAP2B;CTSC;ICAM1;B4GALT1;RAB24;CD55;CD47;CANT1;SERPINB1;MMP9;CAB39;IL4R;TLR2;ITGAV;ADGRE2;FRK;NR4A3;COTL1;XBP1;MGAM
17410,GO:1900127,0.00684812470549741,0.999885729693633,2,3,positive regulation of hyaluronan biosynthetic process,BP,NFKB1;PDGFB
14045,GO:0060760,0.00685651712121896,0.998577997213677,6,37,positive regulation of response to cytokine stimulus,BP,EDN1;CSF1;RIPK2;WNT5A;IFIH1;AXL
990,GO:0002444,0.00685763752915955,0.996321355664926,28,386,myeloid leukocyte mediated immunity,BP,PLAU;CXCL1;CXCL5;PLAUR;PTX3;NFKB1;AMPD3;IL6;ADAM8;RAP2B;CTSC;B4GALT1;RAB24;CD55;CD47;CANT1;SERPINB1;MMP9;CAB39;IL4R;TLR2;ITGAV;ADGRE2;FRK;NR4A3;KMT2E;COTL1;MGAM
11343,GO:0045658,0.00687303628866184,0.999885094911908,2,3,regulation of neutrophil differentiation,BP,TRIB1;EVI2B
11885,GO:0046883,0.00694329075655272,0.997237585181833,14,144,regulation of hormone secretion,BP,IL1B;TNF;INHBA;LIF;EDN1;HCAR2;PIM3;C1QTNF1;CREB1;SOX4;MARCKS;STX1A;PPARD;SLC16A1
10213,GO:0042825,0.00694584508776414,0.999883232591528,2,3,TAP complex,CC,TAP1;TAPBP
10633,GO:0043627,0.00694988298396539,0.998313630335652,7,49,response to estrogen,BP,CYP27B1;TGFBR2;SFR1;TRIM25;IL4R;CAV1;CITED4
19924,GO:2000389,0.0069615047071517,0.999882830676415,2,3,regulation of neutrophil extravasation,BP,IL1A;ADAM8
19925,GO:2000391,0.0069615047071517,0.999882830676415,2,3,positive regulation of neutrophil extravasation,BP,IL1A;ADAM8
4372,GO:0009987,0.00696181683608916,0.995338602361466,496,10480,cellular process,BP,NFKBIZ;CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;ITPKC;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;IL36G;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;HCAR3;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;RAB3IP;EPHA2;GPR156;EHD1;ZNF697;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;ZNF267;SPRR2D;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;PANX1;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;KLHL21;PHLDA2;DAPP1;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;STEAP4;C1QTNF1;AMOTL2;CDKN1A;CLDN1;NMNAT2;FJX1;CCDC85B;ITGA5;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;ODC1;TNFAIP2;NEDD4L;CTSC;GPX3;NOD2;ELMSAN1;IL6ST;DCUN1D3;RELT;SAV1;TFPI2;SGK1;ICAM1;GCH1;FRMD4B;RASSF9;SMAD3;ZC3H12C;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;RNF144B;RND3;MARCKSL1;NFKBID;TRAF4;TRIB1;KRT34;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;NRARP;IL1R2;SLC6A14;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;MAP3K8;ZBED2;ABL2;PPTC7;LAMB3;CFLAR;RNF43;TXNRD1;KLF7;PIGA;BTG1;ANXA8;UPP1;IER5;PPP4R4;CEBPB;CEBPD;VMP1;CD55;KCNJ15;DENND3;NAMPT;TAP1;TP53BP2;ANKLE2;ADM;GJB3;CDC42EP4;IFNAR1;DSE;ERRFI1;ADAMTS1;ANKK1;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;WISP1;NEDD9;MAST4;NR4A2;PATL1;SLC7A2;CD47;CANT1;VHL;PHKG2;SOGA1;SEMA4B;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;TGFBR2;MREG;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;AKAP2;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;IFNGR1;MASTL;NAB1;KIF3C;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;NOTCH2NL;DUSP10;SLC52A3;ROBO4;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;ANLN;PGLYRP4;CD82;BAZ1A;IFIH1;DUSP8;NRG1;TNC;SLC38A2;MMP9;LDLR;KIAA1586;DCBLD2;RRAD;ATF3;OTUD4;BTG3;IKZF2;COL12A1;FAM83B;CAB39;IL32;TLE1;MFHAS1;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;MT2A;SUCO;SLC9A1;ZBTB10;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;HAL;CYTH1;GRB7;CXCL16;ARSJ;NUP153;BCL2L2;RNF152;IL4R;NEDD4;MMD;RHCG;POU2F2;ITSN2;DUS4L;GCSAM;IL24;TNFRSF6B;MARCKS;RAET1L;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;SUSD6;TPRA1;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;RTTN;HLA-A;UACA;DRAM1;INO80D;TNIP2;ZNFX1;UGCG;ZFAND5;GOLGA8B;TP53;NOM1;KLF3;TLR2;ABI1;STK40;PUS10;TAPBP;EFNB2;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;ADGRE2;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;ADAM9;RELA;RAPH1;TRIM16;ESCO2;EMP3;SPATA2;FOXN2;SLC9A8;CCBE1;PPP6R3;EVI2B;TSPAN13;COL27A1;PLAT;CHST2;MUC1;YARS2;AXL;ANXA5;CRB3;ELL2;SAT1;FRK;HLA-F;CITED4;NR4A3;HLA-E;USP31;GSK3B;KMT2E;OSMR;PPARD;PARP8;SLC16A1;EVC;PARP1;CYP24A1;MMP10;LAMA3;KDM7A;MED13;MXD3;CRAMP1;TBC1D22B;LCE1C;OCLN;COTL1;JMY;COL8A1;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;RNF145;ALAS1;ZXDA;RPS6KA6;DDR1;CEP135;XBP1;HSPA4L;QKI;EPB41L3;KCTD11;ZBTB5;ELF4;IL36RN;SREK1IP1;SLC39A14;TFE3;EID3;ZMIZ2;ERVFRD-1;C12ORF29;MGAM;CCSER2;LMAN1;SLC41A1;JUND;GJC1;DENND4A
3288,GO:0006978,0.00699041627938052,0.999129751083745,4,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,CDKN1A;TP53;MUC1;RPS6KA6
9073,GO:0035308,0.00700352079511346,0.998537301007178,6,38,negative regulation of protein dephosphorylation,BP,TNF;PPP1R15A;PPP4R4;MASTL;SH3RF2;GSK3B
5571,GO:0016579,0.00703587622031014,0.996670847875927,20,243,protein deubiquitination,BP,NFKBIA;TNFAIP3;BIRC3;ZC3H12A;TNIP1;BIRC2;RIPK2;CYLD;NOD2;SMAD3;USP43;SMURF2;TRIM25;IFIH1;OTUD4;SMAD1;INO80D;TNIP2;TP53;USP31
686,GO:0001893,0.00703820324874381,0.998813151383682,5,26,maternal placenta development,BP,LIF;PRDM1;CYP27B1;JUNB;PPARD
10524,GO:0043435,0.0070608734975927,0.999880269049248,2,3,response to corticotropin-releasing hormone,BP,NR4A2;NR4A3
15234,GO:0071376,0.0070608734975927,0.999880269049248,2,3,cellular response to corticotropin-releasing hormone stimulus,BP,NR4A2;NR4A3
4628,GO:0010745,0.00709350154036576,0.999488666130094,3,9,negative regulation of macrophage derived foam cell differentiation,BP,NFKBIA;ABCA5;ITGAV
16177,GO:0090184,0.00713729902867517,0.998786643906581,5,27,positive regulation of kidney development,BP,LIF;SIX4;VEGFA;CFLAR;PDGFB
20300,GO:2001243,0.00716079410208074,0.997837008642463,9,79,negative regulation of intrinsic apoptotic signaling pathway,BP,PLAUR;SOD2;PPIF;MMP9;BCL2L2;NFE2L2;PTPN1;MUC1;XBP1
7069,GO:0030852,0.00716204507924608,0.99948189696278,3,9,regulation of granulocyte differentiation,BP,TRIB1;RUNX1;EVI2B
11243,GO:0045408,0.00716267191680293,0.999481834944827,3,9,regulation of interleukin-6 biosynthetic process,BP,IL1B;EREG;CEBPB
11315,GO:0045624,0.00719917321331821,0.999460712790243,3,10,positive regulation of T-helper cell differentiation,BP,IL23A;RIPK2;IL4R
6640,GO:0023019,0.00721079026542156,0.999477068112912,3,9,signal transduction involved in regulation of gene expression,BP,SMAD3;FGF5;PARP1
3713,GO:0008228,0.00721552676710143,0.999876243763617,2,3,opsonization,BP,PTX3;CD47
4262,GO:0009595,0.00722363855859979,0.999475793264062,3,9,detection of biotic stimulus,BP,NOD2;PGLYRP4;TLR2
4951,GO:0014916,0.00723218220536169,0.999875807479471,2,3,regulation of lung blood pressure,BP,GCH1;SMAD3
2130,GO:0004924,0.00729336038519178,0.999874200318146,2,3,oncostatin-M receptor activity,MF,IL6ST;OSMR
9728,GO:0038165,0.00729336038519178,0.999874200318146,2,3,oncostatin-M-mediated signaling pathway,BP,IL6ST;OSMR
8174,GO:0032907,0.00735095152400624,0.999872680773728,2,3,transforming growth factor beta3 production,BP,SMAD3;CREB1
8177,GO:0032910,0.00735095152400624,0.999872680773728,2,3,regulation of transforming growth factor beta3 production,BP,SMAD3;CREB1
12071,GO:0048010,0.00738734732356566,0.997767262733162,9,73,vascular endothelial growth factor receptor signaling pathway,BP,IL1B;ITGA5;VEGFA;VEGFC;NEDD4;PTPN1;ABI1;ITGAV;AXL
13916,GO:0060546,0.00741275629174385,0.999456929773537,3,9,negative regulation of necroptotic process,BP,BIRC3;BIRC2;CAV1
1177,GO:0002821,0.00747387095664686,0.998155797469738,7,51,positive regulation of adaptive immune response,BP,IL1B;TNF;IL23A;IL6;RIPK2;IL6ST;HLA-E
770,GO:0002020,0.00749562015447203,0.997545041294723,10,90,protease binding,MF,TNFAIP3;TNF;PANX1;RIPK2;CFLAR;LDLR;TP53;ITGAV;CCBE1;GSK3B
12080,GO:0048019,0.00750670883844387,0.999428971915185,3,10,receptor antagonist activity,MF,IL1RN;DKK1;IL36RN
10508,GO:0043407,0.0075818511444395,0.997896190140037,8,63,negative regulation of MAP kinase activity,BP,IL1B;DUSP1;DUSP16;DUSP10;DUSP8;SPRY2;PTPN1;CAV1
894,GO:0002263,0.00758828504031892,0.995679142376695,33,474,cell activation involved in immune response,BP,PLAU;CXCL1;PLAUR;PTX3;NFKB1;TICAM1;IL23A;BCL3;AMPD3;IL6;ADAM8;RIPK2;RELB;RAP2B;CTSC;ICAM1;B4GALT1;RAB24;CD55;CD47;CANT1;SERPINB1;MMP9;CAB39;IL4R;TLR2;ITGAV;ADGRE2;FRK;NR4A3;COTL1;XBP1;MGAM
13247,GO:0051897,0.00760231298421083,0.997510554412114,10,86,positive regulation of protein kinase B signaling,BP,TNF;HBEGF;EREG;ADAM8;C1QTNF1;FGF5;PDGFB;NRG1;SPRY2;AXL
17602,GO:1901224,0.0076056764310352,0.998383470633963,6,38,positive regulation of NIK/NF-kappaB signaling,BP,TNF;TNFRSF10B;TNFSF15;NOD2;TRAF4;RELA
16573,GO:0097343,0.00762282590397947,0.999865421379089,2,3,ripoptosome assembly,BP,BIRC2;CYLD
17545,GO:1901026,0.00762282590397947,0.999865421379089,2,3,ripoptosome assembly involved in necroptotic process,BP,BIRC2;CYLD
6556,GO:0021983,0.00763901946690112,0.999033936997594,4,17,pituitary gland development,BP,BMP2;ETS1;CREB1;WNT5A
4469,GO:0010460,0.00764013633070039,0.999415046349964,3,10,positive regulation of heart rate,BP,EDN1;GCH1;ADM
1465,GO:0003712,0.00766773794933684,0.99563338941196,33,457,transcription cofactor activity,MF,NFKBIZ;NCOA7;ELF3;JUN;BHLHE40;SERTAD2;BIRC2;NFKB2;JUNB;RELB;ZNF451;NFKBIB;NFKBID;KLF7;BTG1;CREB1;TAF4B;SFR1;NFE2L3;SOX4;NRG1;ATF3;TLE1;YAF2;MXD1;ELK3;MUC1;CITED4;PPARD;MED13;JMY;ZMIZ2;JUND
16879,GO:0098797,0.00767315110629568,0.996133557825529,23,281,plasma membrane protein complex,CC,BMP2;BIRC2;IL6;ADAM8;FZD8;ITGA5;IL6ST;CFLAR;GJB3;GJB4;TGFBR2;ITGB8;HLA-A;TLR2;HLA-B;ITGAV;STX1A;ABCA7;HLA-F;HLA-E;OSMR;EVC;GJC1
8091,GO:0032768,0.00767624493922443,0.998361408820807,6,39,regulation of monooxygenase activity,BP,IL1B;TNF;NFKB1;CYP27B1;GCH1;CAV1
1257,GO:0003008,0.00768257381089228,0.995058838524289,53,803,system process,BP,IL1B;HBEGF;BTG2;INHBA;FOSL1;ZC3H12A;SOD2;TBX3;EDN1;MAP2K3;JUN;HCAR2;BDKRB1;TJP2;C1QTNF1;ITGA5;NEDD4L;NOD2;IL6ST;SGK1;ICAM1;GCH1;SMAD3;DKK1;PLK2;CFLAR;CEBPB;ADM;ERRFI1;CREB1;GJB4;VEGFC;SLC11A2;SLC52A3;PDGFB;NRG1;LDLR;SLC9A1;SPRY2;NFAT5;CAV1;ZFAND5;TLR2;STK40;PJA2;DOCK4;ABCA7;CCBE1;NR4A3;PPARD;PARP1;VIM;GJC1
149,GO:0000303,0.00770396350314286,0.998997083148197,4,20,response to superoxide,BP,TNF;SOD2;GCH1;NFE2L2
14832,GO:0070561,0.00771503942252429,0.999426400062912,3,9,vitamin D receptor signaling pathway,BP,CYP27B1;PIM1;CYP24A1
2397,GO:0005539,0.00775661142168453,0.997282018455101,11,103,glycosaminoglycan binding,MF,HBEGF;NOD2;VEGFA;LAYN;ADAMTS1;WISP1;TGFBR2;SAA1;PGLYRP4;TLR2;ADGRE2
12745,GO:0050995,0.00777059938869076,0.999401341104567,3,10,negative regulation of lipid catabolic process,BP,IL1B;TNF;HCAR2
8510,GO:0033687,0.00783505785914827,0.99900181173586,4,17,osteoblast proliferation,BP,BMP2;JUNB;SMAD3;ITGAV
17598,GO:1901215,0.00785455077522702,0.996953777160142,13,131,negative regulation of neuron death,BP,BTG2;NCOA7;SOD2;JUN;REL;ADAM8;SIX4;CEBPB;CREB1;NR4A2;AXL;NR4A3;GSK3B
12309,GO:0048638,0.00785617688464637,0.996416164220226,18,199,regulation of developmental growth,BP,EDN1;CSF1;SIX4;PHLDA2;NEDD4L;SAV1;VEGFA;CREB1;SEMA4B;TGFBR2;WNT5A;DUSP10;SOCS2;NRG1;ITSN2;STAT5A;PIM1;PPARD
19728,GO:2000045,0.00790643143709108,0.996927666974556,13,135,regulation of G1/S transition of mitotic cell cycle,BP,BTG2;GADD45A;CDKN1A;DCUN1D3;CDKN2B;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1;KMT2E
11336,GO:0045651,0.0079521710597449,0.999402130407754,3,9,positive regulation of macrophage differentiation,BP,LIF;CSF1;TRIB1
2432,GO:0005610,0.00802226693517197,0.999854501895656,2,3,laminin-5 complex,CC,LAMB3;LAMA3
2674,GO:0006023,0.00802501121592394,0.99735088815699,10,86,aminoglycan biosynthetic process,BP,IL1B;SDC4;NFKB1;B4GALT1;B3GNT5;DSE;PDGFB;B4GALT5;HS3ST3B1;CHST2
13096,GO:0051591,0.0080587373008261,0.997744743634185,8,61,response to cAMP,BP,FOSL1;JUN;DUSP1;BIRC2;ZFP36L1;JUNB;RELA;JUND
17540,GO:1901017,0.008061117090382,0.999390887284191,3,9,negative regulation of potassium ion transmembrane transporter activity,BP,NEDD4L;CAB39;CAV1
17659,GO:1901380,0.008061117090382,0.999390887284191,3,9,negative regulation of potassium ion transmembrane transport,BP,NEDD4L;CAB39;CAV1
10986,GO:0044774,0.00806961049046965,0.997154263538043,11,105,mitotic DNA integrity checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;RAD9B;PML;MUC1
1385,GO:0003281,0.0080882700418784,0.99798653905913,7,47,ventricular septum development,BP,PRDM1;TBX3;SAV1;TGFBR2;WNT5A;SOX4;EGLN1
4345,GO:0009894,0.00809637950950442,0.994842897534591,50,770,regulation of catabolic process,BP,IL1B;TNFAIP3;TNF;EFNA1;BTG2;PLEKHF1;NOCT;ZC3H12A;RNF19B;ZFP36;TICAM1;HCAR2;ADAM8;N4BP1;ZFP36L1;RIPK2;ODC1;NEDD4L;CTSC;SMAD3;RNF144B;TRIB1;PLK2;ABL2;PHKG2;SOGA1;SMURF2;WNT5A;PPP1R3B;NRG1;LDLR;PLK3;RCHY1;FEZ1;NUP153;RNF152;NEDD4;NFE2L2;PTPN1;TAB3;CAV1;DRAM1;PML;ADAM9;RELA;GSK3B;VIM;EGLN1;XBP1;QKI
10184,GO:0042772,0.00810632784970921,0.998937239817373,4,19,DNA damage response, signal transduction resulting in transcription,BP,CDKN1A;TP53;MUC1;RPS6KA6
7360,GO:0031398,0.00811581000329972,0.997308879738727,10,91,positive regulation of protein ubiquitination,BP,BIRC3;TICAM1;PELI1;BIRC2;RIPK2;NOD2;DCUN1D3;ARRDC4;RCHY1;CAV1
11813,GO:0046685,0.00812158925988201,0.998563264733018,5,29,response to arsenic-containing substance,BP,ZC3H12A;PPIF;CDKN1A;CPEB2;ATF3
995,GO:0002449,0.00814420221579816,0.996823505234436,13,135,lymphocyte mediated immunity,BP,IL1B;TNF;IL23A;BCL3;IL6;IL7R;CTSC;ICAM1;CD55;IL4R;POU2F2;RAET1L;HLA-E
1181,GO:0002825,0.00819023566591387,0.999356670712216,3,10,regulation of T-helper 1 type immune response,BP,IL23A;RIPK2;IL4R
17787,GO:1901800,0.00820468535299232,0.997276441127374,10,90,positive regulation of proteasomal protein catabolic process,BP,RNF19B;RNF144B;TRIB1;PLK2;PLK3;RCHY1;NFE2L2;CAV1;GSK3B;XBP1
4334,GO:0009880,0.00820885844161315,0.998235713470611,6,36,embryonic pattern specification,BP,TBX3;EFNB1;SMAD3;NRARP;WNT5A;SMAD1
7663,GO:0032088,0.00824994130080798,0.997674764620493,8,64,negative regulation of NF-kappaB transcription factor activity,BP,NFKBIA;TNFAIP3;ZC3H12A;PELI1;IRAK2;CYLD;NOD2;NFKBID
4378,GO:0010001,0.00827529332164322,0.996769533879356,13,131,glial cell differentiation,BP,BMP2;LIF;IL6ST;DLX2;FGF5;NAB1;DUSP10;SOX4;NRG1;LDLR;TLR2;RELA;VIM
13262,GO:0051924,0.00828562502530071,0.996909985270175,12,117,regulation of calcium ion transport,BP,IL16;BDKRB1;ICAM1;PDGFB;RRAD;TRPV3;SLC9A1;CAV1;GEM;JPH2;PML;TSPAN13
20149,GO:2000810,0.00831061674880018,0.998922877491306,4,17,regulation of bicellular tight junction assembly,BP,TNF;CLDN1;RUNX1;OCLN
15617,GO:0072089,0.00832547502444059,0.99743719637518,9,72,stem cell proliferation,BP,TBX3;ZFP36L1;VEGFA;RNF43;RUNX1;WNT5A;VEGFC;WNT7B;KCTD11
665,GO:0001866,0.00834057738015653,0.999783028210133,2,4,NK T cell proliferation,BP,IL23A;ELF4
3399,GO:0007179,0.00834319167399893,0.996741603412784,13,129,transforming growth factor beta receptor signaling pathway,BP,JUN;BAMBI;ZNF451;SMAD3;CDKN2B;CREB1;TGFBR2;SMURF2;SMAD1;CAV1;PML;ADAM9;PARP1
11346,GO:0045661,0.00839844148556737,0.998507954467462,5,28,regulation of myoblast differentiation,BP,TNF;TBX3;ZFP36L1;BTG1;PPARD
13361,GO:0052405,0.00848062821446715,0.999777447068528,2,4,negative regulation by host of symbiont molecular function,BP,PTX3;RAB9A
13914,GO:0060544,0.0085464393945903,0.998862151913954,4,19,regulation of necroptotic process,BP,BIRC3;BIRC2;CFLAR;CAV1
8213,GO:0032963,0.00867746135562645,0.997304755538146,9,75,collagen metabolic process,BP,IL6;ERRFI1;MMP9;COL12A1;SUCO;PPARD;MMP10;COL8A1;VIM
12566,GO:0050705,0.00870166483749036,0.999768538088114,2,4,regulation of interleukin-1 alpha secretion,BP,PANX1;IL1R2
14039,GO:0060749,0.00876899496352265,0.999293630195769,3,10,mammary gland alveolus development,BP,VEGFA;SOCS2;DDR1
14303,GO:0061377,0.00876899496352265,0.999293630195769,3,10,mammary gland lobule development,BP,VEGFA;SOCS2;DDR1
17599,GO:1901216,0.0087753773756403,0.997499925338516,8,64,positive regulation of neuron death,BP,JUN;DKK1;TP53BP2;WNT5A;TP53;EFNB2;GSK3B;PARP1
4920,GO:0014855,0.00877659067771422,0.998081397165765,6,37,striated muscle cell proliferation,BP,SAV1;CFLAR;TGFBR2;SMAD1;PIM1;PPARD
3550,GO:0007585,0.00879316876771343,0.998067710968165,6,39,respiratory gaseous exchange,BP,EDN1;TRAF4;NR4A2;ZFAND5;STK40;CCBE1
12985,GO:0051354,0.00884055062932037,0.999285723597992,3,10,negative regulation of oxidoreductase activity,BP,NFKB1;CYP27B1;CAV1
12817,GO:0051098,0.00887450955672939,0.995539430302899,22,282,regulation of binding,BP,NFKBIA;BMP2;LIF;PLAUR;JUN;TICAM1;BCL3;RIPK2;PHLDA2;CYLD;BAMBI;SMAD3;TRAF4;DKK1;PLK2;WNT5A;PDGFB;NRG1;MMP9;CAV1;GSK3B;PARP1
19767,GO:2000116,0.00894203764891626,0.99606910519858,16,191,regulation of cysteine-type endopeptidase activity,BP,TNF;BIRC3;PLAUR;PMAIP1;BBC3;BIRC2;TNFRSF10B;TNFSF15;RIPK2;TNFAIP8;SMAD3;VEGFA;CFLAR;MMP9;TNFRSF6B;PML
2615,GO:0005922,0.00895263586047944,0.999273289718062,3,10,connexin complex,CC,GJB3;GJB4;GJC1
10137,GO:0042692,0.00895500973488238,0.995856717143515,18,204,muscle cell differentiation,BP,BMP2;TBX3;EDN1;KDM6B;EHD1;EREG;SIX4;VEGFA;DKK1;CFLAR;ADM;PDGFB;NRG1;SLC9A1;IL4R;EFNB2;XBP1;QKI
4560,GO:0010638,0.00897047302926387,0.994703268718154,36,516,positive regulation of organelle organization,BP,IL1B;CSF2;TNF;IL1A;SDC4;LIF;PLAUR;PMAIP1;PPIF;EDN1;BBC3;EREG;PLAGL2;NAV3;ICAM1;SMAD3;VEGFA;TP53BP2;CDC42EP4;WNT5A;TGFA;PDGFB;NRG1;MMP9;UGCG;TP53;UBE2D3;SDR16C5;PML;ESPL1;MUC1;GSK3B;KMT2E;JMY;CEP135;LMAN1
15918,GO:0072676,0.00897874976761034,0.998009551111649,6,41,lymphocyte migration,BP,CCL20;ADAM8;SAA1;WNT5A;CXCL16;GCSAM
696,GO:0001913,0.00899122408036778,0.998775678281646,4,20,T cell mediated cytotoxicity,BP,IL23A;IL7R;CTSC;HLA-E
19722,GO:2000027,0.00906222117273614,0.996014697236529,16,184,regulation of organ morphogenesis,BP,TNFAIP3;TNF;BMP2;LIF;EDN1;CSF1;SIX4;B4GALT1;VEGFA;DKK1;CFLAR;TGFBR2;SMURF2;WNT5A;PIM1;XBP1
400,GO:0001076,0.00916722306626155,0.996227804467313,14,146,transcription factor activity, RNA polymerase II transcription factor binding,MF,JUN;KDM6B;BHLHE40;ZNF451;CREB1;MYBL1;SOX4;TLE1;TP53;SNAPC4;SDR16C5;CITED4;PPARD;MED13
10272,GO:0043009,0.00929875845167023,0.99473112583751,31,416,chordate embryonic development,BP,CSF2;SDC4;FOSL1;ELF3;BMP2;LIF;PRDM1;TBX3;MAFF;EDN1;ZFP36L1;SIX4;PHLDA2;JUNB;SMAD3;DLX2;VEGFA;NRARP;DKK1;CEBPB;ADM;GJB3;GORAB;TGFBR2;WNT5A;SOX4;PDGFB;WNT7B;ZFAND5;ABI1;EGLN1
20312,GO:2001267,0.00931000230973837,0.998719296360673,4,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,PLAUR;TNFRSF10B;SMAD3;MMP9
2112,GO:0004888,0.00932425527453081,0.995071755369541,25,321,transmembrane signaling receptor activity,MF,HCAR3;IFNAR2;EPHA2;GPR156;HCAR2;IFNGR2;TNFRSF10B;BDKRB1;FZD8;IL7R;IL6ST;RELT;ICAM1;IL1R2;IFNAR1;TGFBR2;IFNGR1;IL4R;TNFRSF6B;TPRA1;ABCA7;ADGRE2;AXL;OSMR;DDR1
10481,GO:0043370,0.00947810943457818,0.998699358856955,4,19,regulation of CD4-positive, alpha-beta T cell differentiation,BP,CD83;IL23A;RIPK2;IL4R
17765,GO:1901699,0.00951642651953651,0.994496558933655,33,454,cellular response to nitrogen compound,BP,IL1B;TNF;ZC3H12A;NFKB1;EDN1;ZFP36L1;RIPK2;CPEB2;NOD2;ICAM1;SMAD3;CFLAR;CEBPB;ERRFI1;CREB1;NR4A2;SOGA1;SOCS2;IFIH1;SLC9A1;NFE2L2;PTPN1;SMAD1;ZC3H7B;STAT5A;CAV1;TP53;KLF3;RELA;NR4A3;GSK3B;PARP1;XBP1
16484,GO:0097154,0.00951800519283895,0.999734589192158,2,4,GABAergic neuron differentiation,BP,INHBA;DLX2
13917,GO:0060547,0.00953846781746457,0.999207345480409,3,10,negative regulation of necrotic cell death,BP,BIRC3;BIRC2;CAV1
893,GO:0002262,0.0095575014415235,0.996546986930116,11,106,myeloid cell homeostasis,BP,INHBA;ZFP36;ETS1;HCAR2;AMPD3;IL6;ZFP36L1;VEGFA;SLC11A2;AXL;KMT2E
951,GO:0002367,0.00956422919229977,0.997516096401263,7,54,cytokine production involved in immune response,BP,TNF;IL6;NOD2;CD55;WNT5A;TLR2;NR4A3
8214,GO:0032964,0.00959554140481348,0.998231532130183,5,29,collagen biosynthetic process,BP,IL6;ERRFI1;SUCO;PPARD;VIM
614,GO:0001780,0.009661307823889,0.99919331771945,3,10,neutrophil homeostasis,BP,HCAR2;IL6;AXL
16260,GO:0090303,0.00967303064998977,0.998213708374183,5,29,positive regulation of wound healing,BP,HBEGF;TGFBR2;NFE2L2;PPARD;XBP1
6081,GO:0019229,0.00973880205920745,0.998205603781544,5,28,regulation of vasoconstriction,BP,EDN1;ICAM1;ADM;CAV1;DOCK4
10439,GO:0043281,0.00974206537109603,0.995807044455361,15,176,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,TNF;BIRC3;PLAUR;PMAIP1;BBC3;BIRC2;TNFRSF10B;TNFSF15;TNFAIP8;SMAD3;VEGFA;CFLAR;MMP9;TNFRSF6B;PML
3188,GO:0006812,0.00975286645662819,0.994082294516912,39,577,cation transport,BP,CSF2;IL16;PPIF;EDN1;NFKBIE;BDKRB1;PANX1;CYP27B1;STEAP4;NEDD4L;SGK1;ICAM1;KCNJ15;HEPHL1;SLC28A3;NIPAL4;SLC7A2;SLC11A2;PDGFB;SLC38A2;MMP9;RRAD;CAB39;RHD;TRPV3;SLC9A1;SLC25A37;NEDD4;RHCG;SLC2A6;CAV1;ITGAV;GEM;JPH2;PML;SLC9A8;TSPAN13;SLC39A14;SLC41A1
3498,GO:0007399,0.00977957485923594,0.993005616620038,89,1472,nervous system development,BP,CXCL1;EFNA1;SDC4;BTG2;INHBA;ZC3H12A;BMP2;LIF;PRDM1;TBX3;JUN;KDM6B;EHD1;ETS1;CSF1;N4BP3;EFNB1;IL6;ZFP36L1;SIX4;FZD8;CLDN1;NAV3;NEDD4L;IL6ST;SGK1;DLX2;B3GNT5;NINJ1;VEGFA;DKK1;ZSWIM4;FGF5;PLK2;ABL2;CFLAR;KLF7;CEBPB;ANKLE2;ADM;CREB1;GORAB;NR4A2;SEMA4B;ABTB2;RUNX1;TGFBR2;TGIF2;NAB1;HMGCS1;WNT5A;VEGFC;SLC11A2;DUSP10;SOX4;SOCS2;NRG1;TNC;SLC38A2;LDLR;PARD6B;FEZ1;GRB7;NEDD4;MMD;ITSN2;NFE2L2;WNT7B;SMAD1;SPTBN5;NOM1;TLR2;ABI1;EFNB2;ZNF148;RELA;RAPH1;AXL;NR4A3;GSK3B;PPARD;KDM7A;VIM;RPS6KA6;DDR1;XBP1;QKI;EPB41L3;KCTD11
722,GO:0001945,0.00979694269726067,0.998654233687788,4,18,lymph vessel development,BP,VEGFA;VEGFC;EFNB2;CCBE1
9325,GO:0035794,0.00981929612033524,0.99743376552591,7,55,positive regulation of mitochondrial membrane permeability,BP,PMAIP1;PPIF;BBC3;TP53BP2;SLC9A1;TP53;GSK3B
19368,GO:1905710,0.00981929612033524,0.99743376552591,7,55,positive regulation of membrane permeability,BP,PMAIP1;PPIF;BBC3;TP53BP2;SLC9A1;TP53;GSK3B
8029,GO:0032660,0.00984842691132111,0.999150538532459,3,11,regulation of interleukin-17 production,BP,IL23A;NOD2;IL36RN
9909,GO:0042226,0.00986714115453196,0.999169659683919,3,10,interleukin-6 biosynthetic process,BP,IL1B;EREG;CEBPB
1186,GO:0002830,0.00989653136444749,0.99914484657207,3,11,positive regulation of type 2 immune response,BP,IL6;NOD2;IL4R
10496,GO:0043393,0.00991283438418228,0.995730183171796,15,169,regulation of protein binding,BP,BMP2;TICAM1;RIPK2;PHLDA2;CYLD;BAMBI;TRAF4;DKK1;PLK2;WNT5A;PDGFB;NRG1;MMP9;CAV1;GSK3B
12781,GO:0051043,0.00991747746696529,0.998620852904052,4,19,regulation of membrane protein ectodomain proteolysis,BP,IL1B;TNF;ADAM8;ADAM9
3356,GO:0007093,0.00993299863608819,0.995865349392962,14,154,mitotic cell cycle checkpoint,BP,BTG2;DUSP1;GADD45A;CDKN1A;CDKN2B;PLK2;SOX4;PLK3;TNKS1BP1;TP53;RAD9B;PML;MUC1;NABP1
3569,GO:0007613,0.0100036765056148,0.997086588136893,8,63,memory,BP,ITGA5;SGK1;PLK2;CEBPB;CREB1;LDLR;PJA2;ABCA7
17549,GO:1901031,0.010057419451655,0.9981179498379,5,30,regulation of response to reactive oxygen species,BP,TNF;GCH1;NFE2L2;TP53;NR4A3
270,GO:0000768,0.0100584029108721,0.998131854205199,5,28,syncytium formation by plasma membrane fusion,BP,EHD1;CFLAR;IL4R;ADAM9;ERVFRD-1
10753,GO:0044130,0.0100590363131616,0.999711204423675,2,4,negative regulation of growth of symbiont in host,BP,TNF;SQSTM1
10756,GO:0044146,0.0100590363131616,0.999711204423675,2,4,negative regulation of growth of symbiont involved in interaction with host,BP,TNF;SQSTM1
11482,GO:0045930,0.0100988064591049,0.994949808697396,21,275,negative regulation of mitotic cell cycle,BP,TNF;BTG2;DUSP1;GADD45A;ZFP36L1;CDKN1A;DCUN1D3;SMAD3;CDKN2B;PLK2;BTG1;SOX4;BTG3;PLK3;TNKS1BP1;TPRA1;TP53;RAD9B;PML;MUC1;NABP1
15891,GO:0072604,0.0101241905035629,0.998583546447508,4,19,interleukin-6 secretion,BP,IL1B;ZC3H12A;IFIH1;XBP1
10406,GO:0043235,0.0101254636537045,0.995375774867741,17,185,receptor complex,CC,BMP2;EPHA2;BIRC2;IL6;ITGA5;IL6ST;SMAD3;TGFBR2;ITGB8;LDLR;TRPV3;IL4R;TLR2;ITGAV;AXL;OSMR;DDR1
7590,GO:0031953,0.0101411890378759,0.999137867565409,3,10,negative regulation of protein autophosphorylation,BP,JUN;ERRFI1;CAV1
20310,GO:2001258,0.0101762154699687,0.998563153306074,4,20,negative regulation of cation channel activity,BP,MMP9;RRAD;CAV1;GEM
14698,GO:0070306,0.0102076395738597,0.998580775535797,4,18,lens fiber cell differentiation,BP,EPHA2;SMAD3;WNT7B;VIM
14861,GO:0070613,0.0102110541037137,0.99731779481826,7,53,regulation of protein processing,BP,BIRC3;BIRC2;ADAM8;IL1R2;CD55;CCBE1;CFB
12691,GO:0050886,0.0102584923658738,0.997664484254159,6,40,endocrine process,BP,IL1B;INHBA;TBX3;EDN1;HCAR2;C1QTNF1
4474,GO:0010467,0.0104034464685826,0.991834359426987,219,4269,gene expression,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;PLAU;IL1A;EFNA1;BTG2;INHBA;BIRC3;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;PHLDA2;JUNB;CYLD;FZD8;BAMBI;WTAP;RELB;ZNF217;C1QTNF1;CDKN1A;CCDC85B;IL7R;CPEB2;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;IL1R2;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;CD55;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;PATL1;VHL;BACH1;MYBL1;RUNX1;TGFBR2;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;ITGB8;WNT5A;ABCF1;TGFA;SOX4;PDGFB;BAZ1A;NRG1;TNC;LDLR;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;YAF2;SPRY2;TNKS1BP1;GRB7;NUP153;NEDD4;POU2F2;DUS4L;NFE2L2;SMAD1;TAB3;MXD1;CHD4;ZC3H7B;DIEXF;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;STK40;PUS10;TAPBP;UBE2D3;MAPKBP1;ELK3;SNAPC4;CLK4;SPCS2;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;FOXN2;CCBE1;PLAT;MUC1;YARS2;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ZXDA;XBP1;QKI;ZBTB5;ELF4;SREK1IP1;TFE3;EID3;ZMIZ2;CFB;JUND;DENND4A
6939,GO:0030540,0.0104080033353776,0.999106596867519,3,10,female genitalia development,BP,TBX3;WNT5A;AXL
1001,GO:0002467,0.0105460074620185,0.999090301267572,3,10,germinal center formation,BP,TNFAIP3;BCL3;NFKB2
1393,GO:0003300,0.0105842184732746,0.997211876376445,7,50,cardiac muscle hypertrophy,BP,EDN1;IL6ST;SMAD3;ERRFI1;SLC9A1;NR4A3;PARP1
4940,GO:0014897,0.0105842184732746,0.997211876376445,7,50,striated muscle hypertrophy,BP,EDN1;IL6ST;SMAD3;ERRFI1;SLC9A1;NR4A3;PARP1
1311,GO:0003156,0.0106561257756879,0.998474861927677,4,20,regulation of animal organ formation,BP,BMP2;DKK1;WNT5A;PIM1
3281,GO:0006968,0.0106959787786298,0.998479147399921,4,19,cellular defense response,BP,FOSL1;VEZF1;ZNF148;RELA
7819,GO:0032368,0.0106970414412838,0.997161133762492,7,54,regulation of lipid transport,BP,IL1B;NFKBIA;NFKB1;EDN1;C1QTNF1;ITGAV;ABCA7
16884,GO:0098802,0.0107323604631505,0.996292329018347,10,89,plasma membrane receptor complex,CC,BMP2;BIRC2;IL6;ITGA5;IL6ST;TGFBR2;ITGB8;TLR2;ITGAV;OSMR
14821,GO:0070542,0.0107410119371414,0.997154521859333,7,52,response to fatty acid,BP,ZC3H12A;EDN1;CLDN1;CREB1;TNC;LDLR;TLR2
14046,GO:0060761,0.0107458106200716,0.997514271530438,6,43,negative regulation of response to cytokine stimulus,BP,IL1RN;IL6;IL1R2;OTUD4;CAV1;IL36RN
8059,GO:0032715,0.0107645822969531,0.99846650456163,4,19,negative regulation of interleukin-6 production,BP,TNFAIP3;TNF;ZC3H12A;IL36RN
12995,GO:0051385,0.010841919233535,0.998440349894818,4,20,response to mineralocorticoid,BP,FOSL1;EDN1;CDKN1A;PARP1
3777,GO:0008330,0.0108846688174695,0.999674200924874,2,4,protein tyrosine/threonine phosphatase activity,MF,DUSP1;DUSP10
9066,GO:0035296,0.0110250188433132,0.996724429581643,8,66,regulation of tube diameter,BP,SOD2;EDN1;ICAM1;GCH1;ADM;CAV1;DOCK4;PPARD
16745,GO:0097746,0.0110250188433132,0.996724429581643,8,66,regulation of blood vessel diameter,BP,SOD2;EDN1;ICAM1;GCH1;ADM;CAV1;DOCK4;PPARD
9999,GO:0042406,0.0110326393398586,0.999667404346149,2,4,extrinsic component of endoplasmic reticulum membrane,CC,ZC3H12A;PML
4666,GO:0010811,0.0110440128248173,0.996427779609823,9,77,positive regulation of cell-substrate adhesion,BP,SDC4;CSF1;ITGA5;SMAD3;NINJ1;VEGFA;VEGFC;GSK3B;COL8A1
1324,GO:0003170,0.01106166644761,0.997896449228049,5,28,heart valve development,BP,EFNA1;BMP2;PRDM1;TGFBR2;SOX4
4939,GO:0014896,0.0110939641194586,0.997046526932165,7,51,muscle hypertrophy,BP,EDN1;IL6ST;SMAD3;ERRFI1;SLC9A1;NR4A3;PARP1
6449,GO:0021761,0.011109257104179,0.996697899322324,8,65,limbic system development,BP,BTG2;TBX3;KDM6B;ETS1;DLX2;FEZ1;NR4A3;GSK3B
983,GO:0002437,0.0111122277337277,0.998378835894501,4,21,inflammatory response to antigenic stimulus,BP,IL1B;TNF;KDM6B;ICAM1
4672,GO:0010817,0.0112111468908339,0.994242581548806,22,282,regulation of hormone levels,BP,IL1B;TNF;INHBA;BMP2;LIF;TBX3;IL1RN;NFKB1;EDN1;HCAR2;IL6;PIM3;CYP27B1;C1QTNF1;ADM;CREB1;SOX4;MARCKS;STX1A;SDR16C5;PPARD;SLC16A1
7467,GO:0031620,0.011215503408378,0.999658936875054,2,4,regulation of fever generation,BP,IL1B;TNF
7468,GO:0031622,0.011215503408378,0.999658936875054,2,4,positive regulation of fever generation,BP,IL1B;TNF
3282,GO:0006970,0.011219549705014,0.996998519715082,7,53,response to osmotic stress,BP,TNF;ZFP36L1;RELB;CLDN1;ERRFI1;CAB39;PLK3
19187,GO:1905207,0.0113032727074259,0.997830474760703,5,29,regulation of cardiocyte differentiation,BP,BMP2;EDN1;DKK1;NRG1;EFNB2
2252,GO:0005164,0.0113071615083745,0.998341915895544,4,21,tumor necrosis factor receptor binding,MF,TNF;TRAF1;TNFSF15;TRAF4
16117,GO:0090085,0.0113301951574626,0.998970481037196,3,11,regulation of protein deubiquitination,BP,ZC3H12A;TNIP1;OTUD4
11408,GO:0045786,0.0113369162635007,0.993192697830775,36,535,negative regulation of cell cycle,BP,CXCL8;TNFAIP3;TNF;IRF1;BTG2;INHBA;PPP1R15A;BMP2;LIF;IRF6;DUSP1;GADD45A;ZFP36L1;CDKN1A;DCUN1D3;SMAD3;CDKN2B;PLK2;BTG1;TP53BP2;SOX4;BTG3;CAB39;PLK3;YAF2;TNKS1BP1;TPRA1;TP53;RAD9B;PML;ESPL1;EVI2B;MUC1;KMT2E;JMY;NABP1
12564,GO:0050703,0.0113573355449034,0.999597661582279,2,5,interleukin-1 alpha secretion,BP,PANX1;IL1R2
2251,GO:0005161,0.0113616651126836,0.998992332472877,3,10,platelet-derived growth factor receptor binding,MF,ITGA5;VEGFA;PDGFB
9852,GO:0042094,0.0113675613608986,0.998965817410108,3,11,interleukin-2 biosynthetic process,BP,IL1B;IL1A;ZFP36
3045,GO:0006598,0.0114268731842883,0.99959389255966,2,5,polyamine catabolic process,BP,PAOX;SAT1
19740,GO:2000060,0.011490056204271,0.996251960362935,9,80,positive regulation of ubiquitin-dependent protein catabolic process,BP,RNF19B;RNF144B;TRIB1;PLK2;PLK3;RCHY1;NFE2L2;CAV1;GSK3B
9914,GO:0042246,0.011545227948031,0.997764284759951,5,30,tissue regeneration,BP,NINJ1;CFLAR;TGFBR2;DUSP10;PPARD
15641,GO:0072126,0.0115646202906024,0.999642563629923,2,4,positive regulation of glomerular mesangial cell proliferation,BP,CFLAR;PDGFB
12358,GO:0048711,0.011572054746345,0.998940190748891,3,11,positive regulation of astrocyte differentiation,BP,BMP2;LIF;IL6ST
18869,GO:1904467,0.0115881336730521,0.998964638989854,3,10,regulation of tumor necrosis factor secretion,BP,ZC3H12A;WNT5A;IFIH1
8754,GO:0034405,0.0116008939519779,0.997750810939306,5,30,response to fluid shear stress,BP,CSF2;ETS1;TFPI2;NFE2L2;ADAM9
6283,GO:0019883,0.011609739951367,0.998935448998144,3,11,antigen processing and presentation of endogenous antigen,BP,TAP1;TAPBP;HLA-E
3271,GO:0006949,0.0116773711893962,0.997740405825008,5,29,syncytium formation,BP,EHD1;CFLAR;IL4R;ADAM9;ERVFRD-1
20265,GO:2001185,0.01173008593259,0.99963470913941,2,4,regulation of CD8-positive, alpha-beta T cell activation,BP,IRF1;HLA-E
14870,GO:0070633,0.0117347277639112,0.998919680021848,3,11,transepithelial transport,BP,CSF2;EDN1;RHCG
9947,GO:0042303,0.0117712607908343,0.996147431277108,9,79,molting cycle,BP,TNF;INHBA;SAV1;DKK1;GORAB;WNT5A;TRPV3;NOM1;RELA
10118,GO:0042633,0.0117712607908343,0.996147431277108,9,79,hair cycle,BP,TNF;INHBA;SAV1;DKK1;GORAB;WNT5A;TRPV3;NOM1;RELA
15316,GO:0071495,0.0118228998587104,0.992066285153812,58,912,cellular response to endogenous stimulus,BP,CXCL8;IL1B;TNF;INHBA;BMP2;NFKB1;EDN1;ZFP36;JUN;EHD1;DUSP1;ZFP36L1;RIPK2;JUNB;BAMBI;CLDN1;CPEB2;ZNF451;NOD2;ICAM1;SMAD3;DKK1;CDKN2B;FGF5;CFLAR;CEBPB;ERRFI1;CREB1;NR4A2;SOGA1;RUNX1;TGFBR2;SMURF2;HMGCS1;WNT5A;SOCS2;TNC;SLC9A1;SPRY2;NEDD4;NFE2L2;PTPN1;SMAD1;STAT5A;CAV1;TP53;KLF3;UBE2D3;PML;ADAM9;RELA;NR4A3;GSK3B;PPARD;PARP1;MED13;XBP1;JUND
541,GO:0001659,0.0118238364421747,0.998254983939404,4,20,temperature homeostasis,BP,IL1B;TNF;IL1A;IL1RN
19776,GO:2000142,0.0118434744289228,0.997691898655199,5,30,regulation of DNA-templated transcription, initiation,BP,FOSL1;JUN;ZNF451;CREB1;TP53
10289,GO:0043031,0.0118529189385373,0.999628839452847,2,4,negative regulation of macrophage activation,BP,ZC3H12A;LDLR
8292,GO:0033116,0.0118638627613273,0.996783519850662,7,55,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,CTSC;VMP1;CD55;TAP1;TGFA;TAPBP;LMAN1
8131,GO:0032816,0.0118763576063871,0.998901733142408,3,11,positive regulation of natural killer cell activation,BP,TICAM1;IL23A;AXL
18966,GO:1904707,0.0119151220206776,0.998250865235152,4,19,positive regulation of vascular smooth muscle cell proliferation,BP,TNF;JUN;PDGFB;MMP9
3043,GO:0006596,0.0119402603731291,0.998871107016453,3,12,polyamine biosynthetic process,BP,ODC1;PAOX;SAT1
7157,GO:0031012,0.0119848437174173,0.994029259676501,20,243,extracellular matrix,CC,TFPI2;ICAM1;VEGFA;LAMB3;ADAMTS1;WISP1;TINAGL1;WNT5A;SERPINB1;PDGFB;TNC;MMP9;COL12A1;WNT7B;MAMDC2;CCBE1;COL27A1;MMP10;LAMA3;COL8A1
11516,GO:0045992,0.0119894468679907,0.998236706285037,4,19,negative regulation of embryonic development,BP,NRARP;DKK1;WNT5A;RPS6KA6
11803,GO:0046660,0.0120094430785045,0.996056519800817,9,79,female sex differentiation,BP,INHBA;TBX3;EREG;ICAM1;VEGFA;CEBPB;ADAMTS1;WNT5A;AXL
1125,GO:0002711,0.0120337870222665,0.998202587297593,4,21,positive regulation of T cell mediated immunity,BP,IL1B;IL23A;IL6;HLA-E
2127,GO:0004920,0.0120370715694235,0.99961997775776,2,4,interleukin-10 receptor activity,MF,IFNGR2;IFNAR1
12849,GO:0051146,0.0120993231110725,0.994846239290268,14,149,striated muscle cell differentiation,BP,BMP2;TBX3;EDN1;KDM6B;EHD1;SIX4;VEGFA;DKK1;CFLAR;NRG1;SLC9A1;IL4R;EFNB2;XBP1
10290,GO:0043032,0.0121091235083941,0.998872058559172,3,11,positive regulation of macrophage activation,BP,WNT5A;IL4R;TNIP2
2616,GO:0005923,0.0121142780273401,0.995736764545215,10,89,bicellular tight junction,CC,TJP2;AMOTL2;CLDN1;RAP2B;FRMD4B;TRAF4;PARD6B;CYTH1;CRB3;OCLN
13655,GO:0060143,0.0121415976674806,0.998867900928645,3,11,positive regulation of syncytium formation by plasma membrane fusion,BP,EHD1;IL4R;ADAM9
10515,GO:0043415,0.0121570331167303,0.999614165351263,2,4,positive regulation of skeletal muscle tissue regeneration,BP,TGFBR2;PPARD
10516,GO:0043416,0.0121570331167303,0.999614165351263,2,4,regulation of skeletal muscle tissue regeneration,BP,TGFBR2;PPARD
720,GO:0001942,0.0121633838139424,0.996322558141212,8,66,hair follicle development,BP,TNF;INHBA;SAV1;DKK1;GORAB;WNT5A;NOM1;RELA
18446,GO:1903510,0.0121943374400664,0.99598835048295,9,78,mucopolysaccharide metabolic process,BP,IL1B;NFKB1;B4GALT1;DSE;PDGFB;SLC9A1;B4GALT5;PIM1;CHST2
4525,GO:0010575,0.0122044820496425,0.998195589584902,4,19,positive regulation of vascular endothelial growth factor production,BP,IL1B;IL1A;IL6ST;CCBE1
9934,GO:0042277,0.0122259305112664,0.994600040371279,15,172,peptide binding,MF,NFKBIA;INHBA;PPIF;BDKRB1;NOD2;TAP1;LDLR;NUP153;HLA-A;TLR2;TAPBP;HLA-B;ITGAV;HLA-F;HLA-E
10480,GO:0043369,0.012255881237763,0.998853235252416,3,11,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,IL23A;IL6;CYLD
7821,GO:0032370,0.0122763748419707,0.997570453962872,5,32,positive regulation of lipid transport,BP,IL1B;NFKBIA;EDN1;C1QTNF1;ABCA7
15872,GO:0072577,0.0122781904802164,0.997594173810076,5,29,endothelial cell apoptotic process,BP,TNFAIP3;TNF;ICAM1;NFE2L2;TNIP2
1008,GO:0002479,0.0123923638636454,0.996575428860491,7,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,TAP1;HLA-A;TAPBP;HLA-B;ITGAV;HLA-F;HLA-E
5274,GO:0015918,0.0124174618274325,0.996603272859117,7,55,sterol transport,BP,NFKBIA;NFKB1;STARD5;ABCA5;LDLR;CAV1;ABCA7
8698,GO:0034330,0.012528201088735,0.993995791905251,18,205,cell junction organization,BP,TNF;SDC4;PHLDB2;CLDN1;ITGA5;SMAD3;VEGFA;LAMB3;VMP1;RUNX1;PARD6B;SLC9A1;CAV1;CRB3;LAMA3;OCLN;EPB41L3;GJC1
16554,GO:0097286,0.0125597309155191,0.998813986724689,3,11,iron ion import,BP,STEAP4;SLC11A2;SLC25A37
19917,GO:2000381,0.0125842547254667,0.999593213348684,2,4,negative regulation of mesoderm development,BP,DKK1;RPS6KA6
17404,GO:1900119,0.0126194565699651,0.998781994363606,3,12,positive regulation of execution phase of apoptosis,BP,ZC3H12A;TP53BP2;TP53
10212,GO:0042824,0.0126572108067434,0.99958959631329,2,4,MHC class I peptide loading complex,CC,TAP1;TAPBP
6955,GO:0030578,0.0127380936381674,0.999585573039733,2,4,PML body organization,BP,ETS1;PML
2647,GO:0005981,0.01275918712907,0.999584521522252,2,4,regulation of glycogen catabolic process,BP,PHKG2;PPP1R3B
6782,GO:0030213,0.0128691362618565,0.998773641785278,3,11,hyaluronan biosynthetic process,BP,IL1B;NFKB1;PDGFB
15760,GO:0072332,0.0128924187762842,0.996039856236157,8,73,intrinsic apoptotic signaling pathway by p53 class mediator,BP,PMAIP1;BCL3;CDKN1A;TP53BP2;TP53;PML;MUC1;JMY
16347,GO:0090559,0.0128998973312162,0.996042844297319,8,71,regulation of membrane permeability,BP,PMAIP1;PPIF;BBC3;TJP2;TP53BP2;SLC9A1;TP53;GSK3B
17348,GO:1900015,0.0129037581528739,0.998045578379045,4,20,regulation of cytokine production involved in inflammatory response,BP,ZC3H12A;TICAM1;NOD2;IL1R2
11001,GO:0044798,0.0129431735552437,0.994431232559943,14,157,nuclear transcription factor complex,CC,JUN;JUNB;SMAD3;CEBPB;CREB1;TAF4B;SOX4;TLE1;NFAT5;TP53;SNAPC4;PPARD;MXD3;JUND
12424,GO:0048861,0.0129526722138449,0.999574832261426,2,4,leukemia inhibitory factor signaling pathway,BP,LIF;IL6ST
4948,GO:0014910,0.0129581689688193,0.996889440930084,6,41,regulation of smooth muscle cell migration,BP,PLAU;TRIB1;PDGFB;NFE2L2;DOCK4;PPARD
10728,GO:0044060,0.0129921184488195,0.99802819718962,4,20,regulation of endocrine process,BP,IL1B;INHBA;HCAR2;C1QTNF1
4317,GO:0009792,0.0130197327828481,0.992428310649231,31,426,embryo development ending in birth or egg hatching,BP,CSF2;SDC4;FOSL1;ELF3;BMP2;LIF;PRDM1;TBX3;MAFF;EDN1;ZFP36L1;SIX4;PHLDA2;JUNB;SMAD3;DLX2;VEGFA;NRARP;DKK1;CEBPB;ADM;GJB3;GORAB;TGFBR2;WNT5A;SOX4;PDGFB;WNT7B;ZFAND5;ABI1;EGLN1
9299,GO:0035739,0.0130295470187991,0.999570960618073,2,4,CD4-positive, alpha-beta T cell proliferation,BP,CD55;TGFBR2
19999,GO:2000561,0.0130295470187991,0.999570960618073,2,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,CD55;TGFBR2
10554,GO:0043502,0.0130301817910573,0.996410587053507,7,53,regulation of muscle adaptation,BP,EDN1;IL6ST;SMAD3;ERRFI1;SLC9A1;NR4A3;PARP1
9054,GO:0035270,0.0130627771932275,0.995996528591315,8,67,endocrine system development,BP,BMP2;ETS1;IL6;SMAD3;CREB1;WNT5A;SOX4;GSK3B
9978,GO:0042363,0.0130823334666713,0.999568294935298,2,4,fat-soluble vitamin catabolic process,BP,CYP27B1;CYP24A1
10036,GO:0042481,0.0130886311518763,0.998744791780408,3,11,regulation of odontogenesis,BP,BMP2;EDN1;CSF1
20313,GO:2001268,0.0131071935558178,0.999499134467735,2,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,PLAUR;MMP9
8606,GO:0034113,0.0131200210734297,0.997376769741661,5,30,heterotypic cell-cell adhesion,BP,IL1B;TNF;IL1RN;ITGA5;ITGAV
17570,GO:1901099,0.0131636084510981,0.997968549756233,4,22,negative regulation of signal transduction in absence of ligand,BP,IL1B;CSF2;TNF;IL1A
20297,GO:2001240,0.0131636084510981,0.997968549756233,4,22,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,IL1B;CSF2;TNF;IL1A
15241,GO:0071385,0.0131869035079622,0.996810382030155,6,43,cellular response to glucocorticoid stimulus,BP,EDN1;ZFP36;ZFP36L1;ICAM1;CFLAR;ERRFI1
10353,GO:0043154,0.0132125575991502,0.995929526824226,8,71,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,BIRC3;PLAUR;BIRC2;TNFRSF10B;TNFAIP8;VEGFA;MMP9;TNFRSF6B
14877,GO:0070646,0.0133024961056044,0.99329435302125,20,258,protein modification by small protein removal,BP,NFKBIA;TNFAIP3;BIRC3;ZC3H12A;TNIP1;BIRC2;RIPK2;CYLD;NOD2;SMAD3;USP43;SMURF2;TRIM25;IFIH1;OTUD4;SMAD1;INO80D;TNIP2;TP53;USP31
8067,GO:0032730,0.0133340305551242,0.999485812722016,2,5,positive regulation of interleukin-1 alpha production,BP,CCL20;PANX1
7786,GO:0032306,0.0133865024041574,0.999482713575588,2,5,regulation of prostaglandin secretion,BP,IL1B;EDN1
7787,GO:0032308,0.0133865024041574,0.999482713575588,2,5,positive regulation of prostaglandin secretion,BP,IL1B;EDN1
12857,GO:0051154,0.0133928391813457,0.997948914299571,4,20,negative regulation of striated muscle cell differentiation,BP,BMP2;DKK1;CFLAR;XBP1
19087,GO:1904948,0.013410881759031,0.998702095609362,3,11,midbrain dopaminergic neuron differentiation,BP,DKK1;NR4A2;WNT5A
5119,GO:0015440,0.0134645393897915,0.999548819796982,2,4,peptide-transporting ATPase activity,MF,TAP1;TAPBP
8357,GO:0033220,0.0134645393897915,0.999548819796982,2,4,amide-transporting ATPase activity,MF,TAP1;TAPBP
1442,GO:0003418,0.0135973853551416,0.999541979506115,2,4,growth plate cartilage chondrocyte differentiation,BP,TGFBR2;COL27A1
1446,GO:0003431,0.0135973853551416,0.999541979506115,2,4,growth plate cartilage chondrocyte development,BP,TGFBR2;COL27A1
1123,GO:0002709,0.0136218924979438,0.997225086721086,5,33,regulation of T cell mediated immunity,BP,IL1B;IL23A;IL6;IL7R;HLA-E
19390,GO:1905809,0.0136255098647646,0.998673436583724,3,11,negative regulation of synapse organization,BP,EFNA1;WNT5A;TLR2
11886,GO:0046884,0.0136287776531302,0.999540357770431,2,4,follicle-stimulating hormone secretion,BP,INHBA;TBX3
6989,GO:0030662,0.0136528680375179,0.994536888642511,12,127,coated vesicle membrane,CC,HBEGF;IL7R;RASSF9;WNT5A;TGFA;LDLR;HLA-A;NECAP2;HLA-B;HLA-F;HLA-E;LMAN1
14954,GO:0070830,0.0137436290028173,0.996657934665446,6,41,bicellular tight junction assembly,BP,TNF;CLDN1;RUNX1;PARD6B;CRB3;OCLN
5826,GO:0017091,0.0137624485579664,0.997860781859579,4,21,AU-rich element binding,MF,ZC3H12A;ZFP36;ZFP36L1;CPEB2
8599,GO:0034103,0.0138120354956722,0.996624996985571,6,43,regulation of tissue remodeling,BP,TNFAIP3;IL23A;IL6;ADAM8;B4GALT1;SUCO
10020,GO:0042446,0.0138359918203831,0.996606401479323,6,45,hormone biosynthetic process,BP,IL1B;TNF;BMP2;NFKB1;CYP27B1;ADM
3402,GO:0007183,0.0138366501599767,0.998645071726849,3,11,SMAD protein complex assembly,BP,SMAD3;SMAD1;PARP1
18104,GO:1902713,0.0138493703528219,0.999528904599133,2,4,regulation of interferon-gamma secretion,BP,ZC3H12A;IL36RN
15330,GO:0071532,0.0138545044597855,0.999528636845057,2,4,ankyrin repeat binding,MF,TNKS1BP1;RELA
3709,GO:0008217,0.0139181579056602,0.995308336970228,9,82,regulation of blood pressure,BP,SOD2;EDN1;BDKRB1;SGK1;GCH1;SMAD3;ADM;VEGFC;PDGFB
17673,GO:1901490,0.0139210878111909,0.999525159494002,2,4,regulation of lymphangiogenesis,BP,VEGFC;CCBE1
14370,GO:0061578,0.0139514017733331,0.99862958499909,3,11,Lys63-specific deubiquitinase activity,MF,TNFAIP3;CYLD;OTUD4
12382,GO:0048762,0.0139583807703085,0.994164087020984,13,137,mesenchymal cell differentiation,BP,IL1B;EFNA1;BMP2;EDN1;EFNB1;PHLDB2;BAMBI;SMAD3;SEMA4B;TGFBR2;WNT5A;NRG1;GSK3B
14608,GO:0070160,0.0140197906674371,0.994948447166622,10,91,occluding junction,CC,TJP2;AMOTL2;CLDN1;RAP2B;FRMD4B;TRAF4;PARD6B;CYTH1;CRB3;OCLN
7922,GO:0032490,0.014028753585798,0.999519517396076,2,4,detection of molecule of bacterial origin,BP,NOD2;TLR2
15914,GO:0072672,0.0140481683949849,0.99951849746625,2,4,neutrophil extravasation,BP,IL1A;ADAM8
15261,GO:0071417,0.0141047084467732,0.991988135575368,28,380,cellular response to organonitrogen compound,BP,IL1B;TNF;NFKB1;EDN1;ZFP36L1;RIPK2;CPEB2;NOD2;ICAM1;CFLAR;CEBPB;ERRFI1;CREB1;NR4A2;SOGA1;SOCS2;SLC9A1;NFE2L2;PTPN1;STAT5A;CAV1;TP53;KLF3;RELA;NR4A3;GSK3B;PARP1;XBP1
20296,GO:2001239,0.0141127732465107,0.99709163469836,5,34,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,IL1B;CSF2;TNF;IL1A;INHBA
8615,GO:0034123,0.0141213329177835,0.99857838237561,3,12,positive regulation of toll-like receptor signaling pathway,BP,PELI1;CAV1;TLR2
799,GO:0002065,0.0141402230851803,0.995600535729884,8,68,columnar/cuboidal epithelial cell differentiation,BP,BMP2;PRDM1;CDKN1A;SAV1;CEBPB;WNT5A;SOX4;GSK3B
17380,GO:1900084,0.0141933443179098,0.999510846514483,2,4,regulation of peptidyl-tyrosine autophosphorylation,BP,VEGFA;CAV1
15145,GO:0071225,0.0143353237854514,0.999503322615589,2,4,cellular response to muramyl dipeptide,BP,RIPK2;NOD2
3384,GO:0007162,0.0143810682525032,0.993527740204298,15,169,negative regulation of cell adhesion,BP,IRF1;SDC4;BMP2;IL1RN;PELI1;PHLDB2;CYLD;C1QTNF1;NFKBID;NRARP;CEBPB;TNC;IL4R;BTN2A2;MUC1
8128,GO:0032813,0.0143921715191368,0.997027328614025,5,33,tumor necrosis factor receptor superfamily binding,MF,TNF;TRAF1;TNFSF15;TRAF4;CFLAR
9671,GO:0038027,0.0144078644060536,0.999499462730887,2,4,apolipoprotein A-I-mediated signaling pathway,BP,ITGAV;ABCA7
16867,GO:0098773,0.0144287030146751,0.995494404419081,8,68,skin epidermis development,BP,TNF;INHBA;SAV1;DKK1;GORAB;WNT5A;NOM1;RELA
18606,GO:1903845,0.0144609103685289,0.995923854464578,7,55,negative regulation of cellular response to transforming growth factor beta stimulus,BP,BAMBI;ZNF451;SMAD3;CFLAR;TGFBR2;SMURF2;CAV1
18457,GO:1903524,0.01449141464217,0.99701018615831,5,32,positive regulation of blood circulation,BP,EDN1;ICAM1;GCH1;ADM;CAV1
11299,GO:0045601,0.0144924058787201,0.997727602986071,4,20,regulation of endothelial cell differentiation,BP,IL1B;TNF;BTG1;VEZF1
3947,GO:0008637,0.0145224803571899,0.994706644836769,10,105,apoptotic mitochondrial changes,BP,PLAUR;SOD2;PMAIP1;PPIF;JUN;BBC3;TP53BP2;MMP9;TP53;GSK3B
18136,GO:1902806,0.0145391234619335,0.99387580830057,13,146,regulation of cell cycle G1/S phase transition,BP,BTG2;GADD45A;CDKN1A;DCUN1D3;CDKN2B;PLK2;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1;KMT2E
10093,GO:0042590,0.0146109637242472,0.995823416017466,7,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,TAP1;HLA-A;TAPBP;HLA-B;ITGAV;HLA-F;HLA-E
6581,GO:0022404,0.0146669099832767,0.99540646076977,8,68,molting cycle process,BP,TNF;INHBA;SAV1;DKK1;GORAB;WNT5A;NOM1;RELA
6582,GO:0022405,0.0146669099832767,0.99540646076977,8,68,hair cycle process,BP,TNF;INHBA;SAV1;DKK1;GORAB;WNT5A;NOM1;RELA
13932,GO:0060575,0.0146749236256136,0.998501137009288,3,12,intestinal epithelial cell differentiation,BP,PRDM1;CDKN1A;SAV1
463,GO:0001501,0.0148140729661087,0.991955593776266,24,311,skeletal system development,BP,BMP2;TBX3;EDN1;ETS2;CSRNP1;SIX4;TJP2;SMAD3;DLX2;RUNX1;TGFBR2;NAB1;ITGB8;WNT5A;SOX4;MMP9;COL12A1;WNT7B;SMAD1;ZFAND5;ABI1;RELA;COL27A1;EVC
6968,GO:0030618,0.014916717823472,0.999472089258796,2,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,SMAD3;SMAD1
15181,GO:0071295,0.0149324945868495,0.997637524525467,4,20,cellular response to vitamin,BP,CYP27B1;TNC;PIM1;CYP24A1
13290,GO:0051964,0.0150448653707734,0.999465114114065,2,4,negative regulation of synapse assembly,BP,WNT5A;TLR2
12840,GO:0051132,0.0151628636392734,0.999373982376066,2,5,NK T cell activation,BP,IL23A;ELF4
16077,GO:0090009,0.015174030198319,0.999458050636611,2,4,primitive streak formation,BP,ETS2;WNT5A
12858,GO:0051155,0.0152216997960746,0.996820269159562,5,32,positive regulation of striated muscle cell differentiation,BP,EDN1;EHD1;NRG1;IL4R;EFNB2
19643,GO:1990774,0.0152289832192449,0.998453863316258,3,11,tumor necrosis factor secretion,BP,ZC3H12A;WNT5A;IFIH1
1076,GO:0002639,0.0153758080463748,0.997514598310781,4,22,positive regulation of immunoglobulin production,BP,IL6;IL4R;HLA-E;XBP1
12260,GO:0048525,0.0153795522962198,0.99512362380869,8,73,negative regulation of viral process,BP,TNF;ZC3H12A;PTX3;TNIP1;ZFP36;JUN;TRIM25;PML
664,GO:0001865,0.0153797275323811,0.999446733889608,2,4,NK T cell differentiation,BP,PRDM1;TGFBR2
12843,GO:0051136,0.0153797275323811,0.999446733889608,2,4,regulation of NK T cell differentiation,BP,PRDM1;TGFBR2
12692,GO:0050890,0.0153945222101128,0.993234327407808,14,155,cognition,BP,BTG2;FOSL1;JUN;ITGA5;SGK1;DKK1;PLK2;CEBPB;CREB1;SLC11A2;LDLR;TLR2;PJA2;ABCA7
4203,GO:0009309,0.015450460279774,0.998364560368069,3,13,amine biosynthetic process,BP,ODC1;PAOX;SAT1
9995,GO:0042401,0.015450460279774,0.998364560368069,3,13,cellular biogenic amine biosynthetic process,BP,ODC1;PAOX;SAT1
17739,GO:1901654,0.0154790766558545,0.993696205613671,12,128,response to ketone,BP,FOSL1;EDN1;DUSP1;CDKN1A;CLDN1;ICAM1;CFLAR;ERRFI1;CAV1;TLR2;RELA;PARP1
20102,GO:2000727,0.0154934943070996,0.998384831122256,3,12,positive regulation of cardiac muscle cell differentiation,BP,EDN1;NRG1;EFNB2
15849,GO:0072540,0.0154978563230185,0.999352664207547,2,5,T-helper 17 cell lineage commitment,BP,IL23A;IL6
9008,GO:0035150,0.0155005133309191,0.995088920521701,8,70,regulation of tube size,BP,SOD2;EDN1;ICAM1;GCH1;ADM;CAV1;DOCK4;PPARD
12686,GO:0050880,0.0155005133309191,0.995088920521701,8,70,regulation of blood vessel size,BP,SOD2;EDN1;ICAM1;GCH1;ADM;CAV1;DOCK4;PPARD
15534,GO:0071901,0.015589216872264,0.993937035799278,11,115,negative regulation of protein serine/threonine kinase activity,BP,IL1B;TNFAIP3;DUSP1;CDKN1A;CDKN2B;DUSP16;DUSP10;DUSP8;SPRY2;PTPN1;CAV1
14077,GO:0060841,0.0155905114387038,0.998403061988515,3,11,venous blood vessel development,BP,VEGFA;EFNB2;CCBE1
620,GO:0001787,0.01566185657096,0.999342135470561,2,5,natural killer cell proliferation,BP,IL23A;ELF4
8004,GO:0032620,0.0156703205249227,0.998332434434467,3,13,interleukin-17 production,BP,IL23A;NOD2;IL36RN
697,GO:0001914,0.0156958807177296,0.998328688125193,3,13,regulation of T cell mediated cytotoxicity,BP,IL23A;IL7R;HLA-E
2675,GO:0006024,0.015707403459458,0.994600441898607,9,81,glycosaminoglycan biosynthetic process,BP,IL1B;SDC4;NFKB1;B4GALT1;DSE;PDGFB;B4GALT5;HS3ST3B1;CHST2
19970,GO:2000482,0.0158011736191595,0.998313230477292,3,13,regulation of interleukin-8 secretion,BP,WNT5A;TLR2;MAPKBP1
13367,GO:0052428,0.0158711061795391,0.999328614358346,2,5,modulation by host of symbiont molecular function,BP,PTX3;RAB9A
11362,GO:0045686,0.015986973440332,0.998313539792644,3,12,negative regulation of glial cell differentiation,BP,DLX2;DUSP10;LDLR
18238,GO:1903019,0.0160617681139612,0.998274800914233,3,13,negative regulation of glycoprotein metabolic process,BP,HBEGF;PTX3;ABCA7
15342,GO:0071548,0.0161483941158088,0.996566050754661,5,33,response to dexamethasone,BP,EDN1;CLDN1;ICAM1;CFLAR;ERRFI1
607,GO:0001773,0.0162165920331043,0.998251853423314,3,13,myeloid dendritic cell activation,BP,CSF2;RELB;TGFBR2
15992,GO:0080135,0.0163590106994844,0.989916565375988,36,537,regulation of cellular response to stress,BP,IL1B;TNF;IL1A;NCOA7;ZC3H12A;PPP1R15A;BMP2;SOD2;PMAIP1;IER3;EDN1;GADD45A;RIPK2;FZD8;NOD2;GCH1;TRAF4;VEGFA;DKK1;PLK2;IER5;WNT5A;DUSP10;NUP153;NFE2L2;PTPN1;WNT7B;CAV1;TP53;PML;MUC1;NR4A3;GSK3B;PARP1;XBP1;EID3
11438,GO:0045843,0.016430697818693,0.99650053490097,5,32,negative regulation of striated muscle tissue development,BP,BMP2;SIX4;SAV1;DKK1;TGFBR2
17805,GO:1901862,0.016430697818693,0.99650053490097,5,32,negative regulation of muscle tissue development,BP,BMP2;SIX4;SAV1;DKK1;TGFBR2
5668,GO:0016773,0.0164612982659049,0.989591907747857,40,582,phosphotransferase activity, alcohol group as acceptor,MF,CSF2;HBEGF;NUAK2;ITPKC;MAP2K3;EPHA2;SQSTM1;EREG;PELI1;PIM3;RIPK2;IRAK2;CDKN1A;SGK1;FGF5;PLK2;MAP3K8;ABL2;ANKK1;MAST4;PHKG2;TGFBR2;MASTL;CAMK1G;PDGFB;NRG1;CAB39;PLK3;MMD;STAT5A;STK40;IKBKE;CLK4;PIM1;AXL;FRK;GSK3B;RIPK4;RPS6KA6;DDR1
13552,GO:0055123,0.0164757767349627,0.994290670523315,9,81,digestive system development,BP,CXCL8;TNF;PRDM1;CDKN1A;SAV1;SMAD3;TGFBR2;WNT5A;XBP1
14886,GO:0070664,0.0166071430933228,0.995758796242084,6,45,negative regulation of leukocyte proliferation,BP,TNFAIP3;SDC4;PRDM1;PELI1;CEBPB;BTN2A2
3042,GO:0006595,0.0166316340107085,0.998165251042848,3,14,polyamine metabolic process,BP,ODC1;PAOX;SAT1
17866,GO:1902041,0.0166623689573521,0.995741545104917,6,45,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,TNFAIP3;PMAIP1;TNFRSF10B;ICAM1;CFLAR;ATF3
3255,GO:0006919,0.0166923375764733,0.994614171831733,8,77,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,TNF;PMAIP1;BBC3;TNFRSF10B;TNFSF15;SMAD3;CFLAR;PML
12574,GO:0050713,0.0167413416954862,0.999271342220948,2,5,negative regulation of interleukin-1 beta secretion,BP,ZC3H12A;PML
8054,GO:0032703,0.0167470165916229,0.998202049777648,3,12,negative regulation of interleukin-2 production,BP,TNFAIP3;ZFP36;NAV3
4659,GO:0010800,0.0168021199916804,0.997227299009288,4,21,positive regulation of peptidyl-threonine phosphorylation,BP,RIPK2;WNT5A;CAB39;TNKS1BP1
11890,GO:0046888,0.0168262973509413,0.996384305889708,5,33,negative regulation of hormone secretion,BP,IL1B;INHBA;LIF;EDN1;PIM3
15403,GO:0071639,0.0168448391182921,0.999264420350372,2,5,positive regulation of monocyte chemotactic protein-1 production,BP,IL1B;IL1A
10372,GO:0043184,0.0168467335191872,0.999264293436398,2,5,vascular endothelial growth factor receptor 2 binding,MF,ITGA5;VEGFA
3181,GO:0006801,0.016851060821373,0.996350577340446,5,36,superoxide metabolic process,BP,TNF;SOD2;EDN1;GCH1;NFE2L2
992,GO:0002446,0.0168640884505569,0.990593823300455,25,361,neutrophil mediated immunity,BP,PLAU;CXCL1;CXCL5;PLAUR;PTX3;NFKB1;AMPD3;IL6;ADAM8;RAP2B;CTSC;B4GALT1;RAB24;CD55;CD47;CANT1;SERPINB1;MMP9;CAB39;TLR2;ITGAV;FRK;KMT2E;COTL1;MGAM
13503,GO:0055026,0.0169504570155276,0.997195396168499,4,21,negative regulation of cardiac muscle tissue development,BP,BMP2;SAV1;DKK1;TGFBR2
5337,GO:0016070,0.0169688111621554,0.986558017117637,194,3759,RNA metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;BCL3;PELI1;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;WTAP;RELB;ZNF217;CDKN1A;CCDC85B;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;NR4A2;PATL1;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;YAF2;TNKS1BP1;NEDD4;POU2F2;DUS4L;NFE2L2;SMAD1;TAB3;MXD1;CHD4;ZC3H7B;DIEXF;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;PUS10;UBE2D3;MAPKBP1;ELK3;SNAPC4;CLK4;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;FOXN2;MUC1;YARS2;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ZXDA;XBP1;QKI;ZBTB5;ELF4;SREK1IP1;TFE3;EID3;ZMIZ2;JUND;DENND4A
6604,GO:0022617,0.0169939412518068,0.995042489462399,7,57,extracellular matrix disassembly,BP,ETS1;ADAM8;LAMB3;MMP9;MMP10;LAMA3;DDR1
4665,GO:0010810,0.0170281014991092,0.992688019805465,13,139,regulation of cell-substrate adhesion,BP,PLAU;SDC4;CSF1;PHLDB2;ITGA5;SMAD3;NINJ1;VEGFA;VEGFC;SLC9A1;GSK3B;COL8A1;DDR1
9925,GO:0042268,0.0170742574383423,0.999184967988921,2,6,regulation of cytolysis,BP,CSF2;PGLYRP4
711,GO:0001933,0.0170748227823633,0.990599025689198,24,325,negative regulation of protein phosphorylation,BP,IL1B;TNFAIP3;EFNA1;ZC3H12A;LIF;TNIP1;JUN;DUSP1;GADD45A;BDKRB1;CDKN1A;TRIB1;DKK1;CDKN2B;ERRFI1;DUSP16;DUSP10;SOCS2;DUSP8;ATF3;SPRY2;PTPN1;CAV1;RPS6KA6
9839,GO:0042063,0.0170761386881795,0.992147213227522,15,174,gliogenesis,BP,BMP2;LIF;CSF1;IL6ST;DLX2;FGF5;CREB1;NAB1;DUSP10;SOX4;NRG1;LDLR;TLR2;RELA;VIM
15162,GO:0071260,0.0171401108255568,0.994986053160763,7,58,cellular response to mechanical stimulus,BP,IL1B;IRF1;NFKB1;GADD45A;TNFRSF10B;SLC38A2;SLC9A1
14654,GO:0070231,0.0172364224627783,0.99625429776416,5,35,T cell apoptotic process,BP,EFNA1;ADAM8;NFKBID;WNT5A;TP53
3332,GO:0007043,0.0172605532846268,0.993971591329326,9,81,cell-cell junction assembly,BP,TNF;CLDN1;RUNX1;PARD6B;CAV1;CRB3;OCLN;EPB41L3;GJC1
2709,GO:0006073,0.0172871440569689,0.994945116378535,7,56,cellular glucan metabolic process,BP,PHLDA2;IL6ST;PHKG2;PPP1R3B;STK40;GSK3B;MGAM
10724,GO:0044042,0.0172871440569689,0.994945116378535,7,56,glucan metabolic process,BP,PHLDA2;IL6ST;PHKG2;PPP1R3B;STK40;GSK3B;MGAM
9831,GO:0042045,0.0172987538781428,0.999233788530231,2,5,epithelial fluid transport,BP,CSF2;EDN1
14043,GO:0060754,0.0174213660140641,0.999225438030508,2,5,positive regulation of mast cell chemotaxis,BP,VEGFA;VEGFC
15240,GO:0071384,0.0174214833270113,0.995496111684999,6,46,cellular response to corticosteroid stimulus,BP,EDN1;ZFP36;ZFP36L1;ICAM1;CFLAR;ERRFI1
14235,GO:0061157,0.0174984797046138,0.997076771997588,4,21,mRNA destabilization,BP,ZC3H12A;ZFP36;ZFP36L1;QKI
11073,GO:0045063,0.017573458130641,0.99807854810553,3,12,T-helper 1 cell differentiation,BP,RIPK2;RELB;IL4R
735,GO:0001961,0.0175950510712209,0.996175821140548,5,33,positive regulation of cytokine-mediated signaling pathway,BP,EDN1;CSF1;RIPK2;WNT5A;AXL
1119,GO:0002705,0.0176817117276449,0.994785042546917,7,60,positive regulation of leukocyte mediated immunity,BP,IL1B;TNF;IL23A;IL6;NOD2;IL4R;HLA-E
9692,GO:0038083,0.0176894405253604,0.996172487851322,5,31,peptidyl-tyrosine autophosphorylation,BP,VEGFA;ABL2;CAV1;FRK;DDR1
8972,GO:0035051,0.0177125318621502,0.993782989960715,9,82,cardiocyte differentiation,BP,BMP2;TBX3;EDN1;KDM6B;VEGFA;DKK1;NRG1;SLC9A1;EFNB2
17548,GO:1901030,0.0177174589194297,0.996122664153163,5,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1;BBC3;TP53BP2;TP53;GSK3B
15223,GO:0071359,0.0179042571781079,0.994716513438857,7,58,cellular response to dsRNA,BP,ZC3H12A;NFKB1;SMAD3;IFIH1;SMAD1;ZC3H7B;CAV1
4812,GO:0012507,0.0179343631763877,0.995333347489517,6,46,ER to Golgi transport vesicle membrane,CC,TGFA;HLA-A;HLA-B;HLA-F;HLA-E;LMAN1
6615,GO:0022829,0.01794136345329,0.997990512727166,3,13,wide pore channel activity,MF,PANX1;GJB3;GJC1
10896,GO:0044433,0.0179738894089688,0.987499804854159,62,1041,cytoplasmic vesicle part,CC,HBEGF;PLAU;CXCL1;PLEKHF1;PLAUR;PTX3;NFKB1;TICAM1;EHD1;AMPD3;IFNGR2;ADAM8;IRAK2;STEAP4;RAP2B;ABCA5;IL7R;CTSC;RASSF9;B4GALT1;VEGFA;RAB24;DKK1;ANXA8;CD55;TAP1;CD47;CANT1;SAA1;WNT5A;VEGFC;SLC11A2;TGFA;SERPINB1;PDGFB;MMP9;LDLR;CAB39;MMD;WNT7B;TAB3;CLIC4;CAV1;RHOV;HLA-A;NECAP2;TLR2;TAPBP;RAB9A;HLA-B;ITGAV;IKBKE;UBE2D3;STX1A;ABCA7;PML;FRK;HLA-F;HLA-E;COTL1;MGAM;LMAN1
10751,GO:0044126,0.017977476623816,0.999187160870467,2,5,regulation of growth of symbiont in host,BP,TNF;SQSTM1
10754,GO:0044144,0.017977476623816,0.999187160870467,2,5,modulation of growth of symbiont involved in interaction with host,BP,TNF;SQSTM1
11880,GO:0046875,0.0180725006488064,0.996933067263081,4,22,ephrin receptor binding,MF,EFNA1;EFNB1;PTPN1;EFNB2
12899,GO:0051224,0.0181366735964795,0.993157892408504,10,104,negative regulation of protein transport,BP,IL1B;TNF;ZC3H12A;PIM3;IL1R2;SOX4;BTN2A2;MAPKBP1;PML;IL36RN
16552,GO:0097283,0.0181656892970317,0.999174057482406,2,5,keratinocyte apoptotic process,BP,ZFP36;ZFP36L1
17904,GO:1902172,0.0181656892970317,0.999174057482406,2,5,regulation of keratinocyte apoptotic process,BP,ZFP36;ZFP36L1
18248,GO:1903036,0.0182159423944742,0.995995116175883,5,34,positive regulation of response to wounding,BP,HBEGF;TGFBR2;NFE2L2;PPARD;XBP1
1180,GO:0002824,0.0182409419857018,0.995228524430325,6,47,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,IL1B;TNF;IL23A;IL6;RIPK2;HLA-E
14979,GO:0070873,0.018261720437412,0.996909600079468,4,21,regulation of glycogen metabolic process,BP,PHLDA2;PHKG2;PPP1R3B;GSK3B
1114,GO:0002700,0.0183206197264724,0.993998852804514,8,74,regulation of production of molecular mediator of immune response,BP,TNF;IL6;NOD2;WNT5A;IL4R;NR4A3;HLA-E;XBP1
7335,GO:0031341,0.0185054762449525,0.995895485844875,5,36,regulation of cell killing,BP,IL23A;IL7R;ICAM1;PGLYRP4;HLA-E
9107,GO:0035376,0.0185080275118311,0.999150032635505,2,5,sterol import,BP,STARD5;LDLR
14802,GO:0070508,0.0185080275118311,0.999150032635505,2,5,cholesterol import,BP,STARD5;LDLR
13788,GO:0060352,0.0185357741069214,0.999148074648923,2,5,cell adhesion molecule production,BP,IL1B;CAV1
8148,GO:0032870,0.0186037679305776,0.988679301818103,33,478,cellular response to hormone stimulus,BP,IL1B;INHBA;NFKB1;EDN1;ZFP36;JUN;DUSP1;ZFP36L1;JUNB;CPEB2;ICAM1;CFLAR;ERRFI1;CREB1;NR4A2;SOGA1;RUNX1;HMGCS1;SOCS2;TNC;SLC9A1;NEDD4;NFE2L2;PTPN1;STAT5A;CAV1;RELA;NR4A3;PPARD;PARP1;MED13;XBP1;JUND
10326,GO:0043112,0.0186591211414454,0.992195955779862,12,130,receptor metabolic process,BP,CXCL8;TNF;EDN1;VEGFA;DKK1;RNF43;ADM;NRG1;NEDD4;PTPN1;CAV1;ITGAV
10651,GO:0043666,0.0187072305945853,0.993358228433351,9,86,regulation of phosphoprotein phosphatase activity,BP,TNF;PPP1R15A;PPP4R4;ANKLE2;MASTL;PPP1R3B;SH3RF2;PPP6R3;GSK3B
12307,GO:0048635,0.018730046507416,0.995863528883147,5,33,negative regulation of muscle organ development,BP,BMP2;SIX4;SAV1;DKK1;TGFBR2
5237,GO:0015850,0.018783934563898,0.992882458345528,10,101,organic hydroxy compound transport,BP,NFKBIA;NFKB1;STARD5;C1QTNF1;ABCA5;LDLR;CAV1;STX1A;ABCA7;SLC16A1
6359,GO:0021536,0.0188003835395107,0.99584400396569,5,33,diencephalon development,BP,BMP2;ETS1;CREB1;NR4A2;WNT5A
337,GO:0000932,0.0188049002292354,0.993810637494648,8,74,P-body,CC,NOCT;ZC3H12A;ZFP36;PNRC1;SQSTM1;ZFP36L1;PATL1;PNRC2
17663,GO:1901386,0.0188660775430201,0.999124642834015,2,5,negative regulation of voltage-gated calcium channel activity,BP,RRAD;GEM
17795,GO:1901841,0.0189101418457417,0.999121499739959,2,5,regulation of high voltage-gated calcium channel activity,BP,RRAD;GEM
4249,GO:0009446,0.0189137388438595,0.999121242989252,2,5,putrescine biosynthetic process,BP,ODC1;PAOX
4717,GO:0010876,0.0190449572319941,0.990430225656426,18,223,lipid localization,BP,IL1B;NFKBIA;TNF;INHBA;ZC3H12A;NFKB1;EDN1;EHD1;STARD5;IL6;C1QTNF1;ABCA5;LDLR;CAV1;ITGAV;IKBKE;ABCA7;PPARD
899,GO:0002275,0.0191994605973294,0.989033415719082,26,382,myeloid cell activation involved in immune response,BP,PLAU;CXCL1;PLAUR;PTX3;NFKB1;TICAM1;AMPD3;ADAM8;RAP2B;CTSC;B4GALT1;RAB24;CD55;CD47;CANT1;SERPINB1;MMP9;CAB39;IL4R;TLR2;ITGAV;ADGRE2;FRK;NR4A3;COTL1;MGAM
18261,GO:1903055,0.0192702400603412,0.997817814631771,3,12,positive regulation of extracellular matrix organization,BP,PHLDB2;SMAD3;CFLAR
14411,GO:0061665,0.0192999254255065,0.99909352161621,2,5,SUMO ligase activity,MF,ZNF451;KIAA1586
16750,GO:0097755,0.0193086589788534,0.995680464978638,5,35,positive regulation of blood vessel diameter,BP,SOD2;GCH1;ADM;DOCK4;PPARD
690,GO:0001906,0.019382467315976,0.994142746734692,7,67,cell killing,BP,IL23A;IL7R;CTSC;ICAM1;PGLYRP4;RAET1L;HLA-E
818,GO:0002088,0.0193894166090573,0.994881741122393,6,44,lens development in camera-type eye,BP,EPHA2;SMAD3;TGFBR2;WNT5A;WNT7B;VIM
18982,GO:1904738,0.0194063262563946,0.997796496246932,3,12,vascular associated smooth muscle cell migration,BP,PDGFB;NFE2L2;DOCK4
18992,GO:1904752,0.0194063262563946,0.997796496246932,3,12,regulation of vascular associated smooth muscle cell migration,BP,PDGFB;NFE2L2;DOCK4
9850,GO:0042092,0.0194192414376502,0.996597490104427,4,24,type 2 immune response,BP,BCL3;IL6;NOD2;IL4R
3694,GO:0008200,0.0194560263186451,0.996589087801658,4,24,ion channel inhibitor activity,MF,NEDD4L;NEDD4;CAV1;STX1A
9550,GO:0036303,0.0194839040118547,0.997784316861765,3,12,lymph vessel morphogenesis,BP,VEGFA;VEGFC;CCBE1
1968,GO:0004674,0.019613844806122,0.988431691215616,29,397,protein serine/threonine kinase activity,MF,NUAK2;MAP2K3;EPHA2;SQSTM1;PELI1;PIM3;RIPK2;IRAK2;CDKN1A;SGK1;PLK2;MAP3K8;ANKK1;MAST4;PHKG2;TGFBR2;MASTL;CAMK1G;CAB39;PLK3;STK40;IKBKE;CLK4;PIM1;AXL;GSK3B;RIPK4;RPS6KA6;DDR1
10556,GO:0043506,0.0196774086660592,0.99348731237224,8,70,regulation of JUN kinase activity,BP,TNF;EDN1;FZD8;DKK1;WNT5A;DUSP10;PTPN1;WNT7B
19778,GO:2000144,0.0197008693662199,0.996549744191949,4,23,positive regulation of DNA-templated transcription, initiation,BP,FOSL1;JUN;CREB1;TP53
19768,GO:2000117,0.0197171636563442,0.99344116240083,8,77,negative regulation of cysteine-type endopeptidase activity,BP,BIRC3;PLAUR;BIRC2;TNFRSF10B;TNFAIP8;VEGFA;MMP9;TNFRSF6B
10039,GO:0042487,0.0197374649168926,0.999061743343543,2,5,regulation of odontogenesis of dentin-containing tooth,BP,BMP2;CSF1
15892,GO:0072606,0.019761257910878,0.997672770396122,3,14,interleukin-8 secretion,BP,WNT5A;TLR2;MAPKBP1
7503,GO:0031670,0.0197630240879385,0.994744148201255,6,46,cellular response to nutrient,BP,CYP27B1;CDKN2B;TNC;PIM1;CYP24A1;XBP1
11316,GO:0045625,0.0197751453951429,0.999058988321286,2,5,regulation of T-helper 1 cell differentiation,BP,RIPK2;IL4R
14109,GO:0060923,0.0198216863091159,0.99905558147136,2,5,cardiac muscle cell fate commitment,BP,TBX3;DKK1
18631,GO:1903898,0.0199816242933705,0.999043840230417,2,5,negative regulation of PERK-mediated unfolded protein response,BP,PPP1R15A;PTPN1
8287,GO:0033089,0.0199890851631385,0.999043291250335,2,5,positive regulation of T cell differentiation in thymus,BP,ADAM8;IL7R
10429,GO:0043269,0.020015951824916,0.989126037108993,22,296,regulation of ion transport,BP,IL1B;IL16;PPIF;EDN1;BDKRB1;NEDD4L;ICAM1;KCNJ15;PDGFB;MMP9;RRAD;CAB39;TRPV3;SLC9A1;NEDD4;CLIC4;CAV1;GEM;JPH2;ABCA7;PML;TSPAN13
9371,GO:0035886,0.020087749602084,0.997651268031591,3,13,vascular smooth muscle cell differentiation,BP,VEGFA;ADM;PDGFB
3707,GO:0008215,0.0201306230479833,0.998950705331435,2,6,spermine metabolic process,BP,PAOX;SAT1
4658,GO:0010799,0.0201440038384649,0.995467287833558,5,33,regulation of peptidyl-threonine phosphorylation,BP,RIPK2;WNT5A;CAB39;SPRY2;TNKS1BP1
8598,GO:0034101,0.0201683912340116,0.992739812266489,9,88,erythrocyte homeostasis,BP,INHBA;ZFP36;ETS1;AMPD3;ZFP36L1;VEGFA;SLC11A2;AXL;KMT2E
1466,GO:0003713,0.0203479497085681,0.989287048656463,20,261,transcription coactivator activity,MF,NCOA7;ELF3;JUN;SERTAD2;BIRC2;NFKB2;JUNB;NFKBIB;KLF7;TAF4B;SFR1;NFE2L3;SOX4;YAF2;CITED4;PPARD;MED13;JMY;ZMIZ2;JUND
13168,GO:0051726,0.0204118492728926,0.985784533265788,60,1002,regulation of cell cycle,BP,CXCL8;IL1B;TNFAIP3;TNF;IRF1;IL1A;BTG2;INHBA;FOSL1;PPP1R15A;BMP2;LIF;TBX3;EDN1;MAP2K3;JUN;IRF6;EREG;DUSP1;GADD45A;BIRC2;PIM3;ZFP36L1;KLHL21;JUNB;CYLD;CDKN1A;DCUN1D3;SMAD3;CDKN2B;PLK2;MAP3K8;BTG1;TP53BP2;CCNL1;MASTL;WNT5A;TGFA;SOX4;PDGFB;ANLN;BTG3;CAB39;PLK3;YAF2;TNKS1BP1;TPRA1;TP53;RAD9B;PML;PIM1;ESPL1;EVI2B;MUC1;NR4A3;KMT2E;JMY;NABP1;CEP135;JUND
12616,GO:0050779,0.0204225332574795,0.996403207857596,4,22,RNA destabilization,BP,ZC3H12A;ZFP36;ZFP36L1;QKI
1074,GO:0002637,0.0204439004660038,0.995358849705871,5,35,regulation of immunoglobulin production,BP,TNF;IL6;IL4R;HLA-E;XBP1
6279,GO:0019870,0.0204903077616767,0.999006152824438,2,5,potassium channel inhibitor activity,MF,NEDD4L;CAV1
11340,GO:0045655,0.0205743214349101,0.997572290826183,3,13,regulation of monocyte differentiation,BP,JUN;CSF1;ZFP36L1
16244,GO:0090280,0.0205992114237886,0.998998016607821,2,5,positive regulation of calcium ion import,BP,PDGFB;TRPV3
1105,GO:0002691,0.0206217018084892,0.997564560402166,3,13,regulation of cellular extravasation,BP,IL1A;ADAM8;ICAM1
1030,GO:0002534,0.0208677385164446,0.996280822519926,4,23,cytokine production involved in inflammatory response,BP,ZC3H12A;TICAM1;NOD2;IL1R2
13967,GO:0060638,0.0208741312303995,0.998977371605081,2,5,mesenchymal-epithelial cell signaling,BP,WNT5A;TNC
12956,GO:0051302,0.0208850445401675,0.99151152786538,11,117,regulation of cell division,BP,IL1B;IL1A;EREG;KLHL21;VEGFA;FGF5;VEGFC;TGFA;PDGFB;PLK3;EVI2B
14610,GO:0070162,0.0208979865548187,0.998975573078227,2,5,adiponectin secretion,BP,IL1B;HCAR2
14611,GO:0070163,0.0208979865548187,0.998975573078227,2,5,regulation of adiponectin secretion,BP,IL1B;HCAR2
12979,GO:0051348,0.02095428497038,0.989346325817324,18,235,negative regulation of transferase activity,BP,IL1B;TNFAIP3;ZFP36;DUSP1;GADD45A;CDKN1A;TRIB1;CDKN2B;ERRFI1;DUSP16;DUSP10;SOCS2;DUSP8;SPRY2;PTPN1;CAV1;TP53;GSK3B
10997,GO:0044793,0.0209845409797908,0.998969037948442,2,5,negative regulation by host of viral process,BP,ZC3H12A;PTX3
5914,GO:0018149,0.0210766081526979,0.996143055665759,4,29,peptide cross-linking,BP,SPRR2D;SPRR2A;ABCA7;LCE1C
9867,GO:0042117,0.021079408699935,0.9989618580093,2,5,monocyte activation,BP,CSF1;ADAM9
12284,GO:0048570,0.0211028260122863,0.998960082947406,2,5,notochord morphogenesis,BP,EFNA1;WNT5A
3258,GO:0006925,0.0211387163272273,0.997445746585371,3,14,inflammatory cell apoptotic process,BP,HCAR2;IL6;NOD2
1447,GO:0003433,0.0211485441066613,0.998956614319472,2,5,chondrocyte development involved in endochondral bone morphogenesis,BP,TGFBR2;COL27A1
8834,GO:0034616,0.0211778339479909,0.997473298722818,3,13,response to laminar fluid shear stress,BP,ETS1;NFE2L2;ADAM9
10796,GO:0044264,0.0212700047077075,0.992847737982275,8,72,cellular polysaccharide metabolic process,BP,PHLDA2;IL6ST;B3GNT5;PHKG2;PPP1R3B;STK40;GSK3B;MGAM
14450,GO:0061756,0.0213358635318734,0.997447190552827,3,13,leukocyte adhesion to vascular endothelial cell,BP,TNF;ETS1;ICAM1
16822,GO:0098657,0.0213399001978637,0.986774019509776,34,500,import into cell,BP,CXCL8;IL1B;TNF;PTX3;EHD1;STEAP4;NEDD4L;VEGFA;DKK1;ABL2;ADM;SLC7A2;CD47;TGFBR2;SAA1;TINAGL1;WNT5A;LDLR;SLC9A1;CXCL16;NEDD4;ITSN2;PTPN1;CAV1;RHOV;NECAP2;TLR2;ABI1;ITGAV;TRIP10;ABCA7;SLC9A8;AXL;SLC39A14
13923,GO:0060560,0.021348035071598,0.990216165558531,14,156,developmental growth involved in morphogenesis,BP,CSF1;SIX4;NEDD4L;VEGFA;SEMA4B;TGFBR2;WNT5A;NRG1;TNC;SPRY2;ITSN2;WNT7B;RAPH1;DDR1
682,GO:0001889,0.0213745082309445,0.991729125509263,10,102,liver development,BP,NFKBIA;TNFAIP3;JUN;CLDN1;SMAD3;CFLAR;CEBPB;HMGCS1;RELA;XBP1
3944,GO:0008630,0.0213837695516781,0.992203563820341,9,94,intrinsic apoptotic signaling pathway in response to DNA damage,BP,TNF;EPHA2;BCL3;CDKN1A;BCL2L2;TP53;IKBKE;PML;MUC1
4285,GO:0009649,0.0214448434486597,0.996146016565174,4,23,entrainment of circadian clock,BP,BHLHE40;ARNTL2;TP53;PML
14791,GO:0070487,0.0215006739642994,0.998929759506618,2,5,monocyte aggregation,BP,IL1B;NR4A3
7877,GO:0032434,0.0215252352697457,0.991652163890312,10,105,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,RNF19B;N4BP1;RNF144B;TRIB1;PLK2;PLK3;RCHY1;NFE2L2;CAV1;GSK3B
18382,GO:1903362,0.021541427266384,0.989511699065368,16,201,regulation of cellular protein catabolic process,BP,TNFAIP3;EFNA1;RNF19B;N4BP1;CTSC;RNF144B;TRIB1;PLK2;LDLR;PLK3;RCHY1;NFE2L2;CAV1;PML;GSK3B;XBP1
14313,GO:0061419,0.0216654720520015,0.998917107271978,2,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,VEGFA;NFE2L2
13844,GO:0060428,0.0216726803258033,0.996092473581291,4,23,lung epithelium development,BP,SAV1;ERRFI1;CREB1;WNT7B
10557,GO:0043507,0.0217085173691807,0.993346002230171,7,57,positive regulation of JUN kinase activity,BP,TNF;EDN1;FZD8;DKK1;WNT5A;PTPN1;WNT7B
10960,GO:0044703,0.021750783299096,0.986305128499479,36,548,multi-organism reproductive process,BP,IL1B;INHBA;BIRC3;FOSL1;LIF;PRDM1;MAFF;EDN1;ETS1;EREG;CYP27B1;JUNB;B4GALT1;BTG1;VMP1;NAMPT;ADM;GJB3;ADAMTS1;TAF4B;MYBL1;TGFBR2;SMURF2;MASTL;SLC38A2;MMP9;BCL2L2;IL4R;SMAD1;CLIC4;ZNF148;SPATA2;AXL;PPARD;DDR1;QKI
14947,GO:0070820,0.0218137331519069,0.991513365672015,10,108,tertiary granule,CC,PLAU;CXCL1;PTX3;ADAM8;RAP2B;CD55;CD47;CANT1;MMP9;MGAM
18527,GO:1903672,0.0218155264986639,0.996058811589052,4,23,positive regulation of sprouting angiogenesis,BP,ITGA5;VEGFA;PLK2;SMAD1
4677,GO:0010822,0.021903153885638,0.990606191158514,12,140,positive regulation of mitochondrion organization,BP,PLAUR;PMAIP1;PPIF;BBC3;PLAGL2;TP53BP2;NRG1;MMP9;UGCG;TP53;UBE2D3;GSK3B
4574,GO:0010656,0.0219159536015805,0.996035103326561,4,23,negative regulation of muscle cell apoptotic process,BP,ZC3H12A;EDN1;CFLAR;NFE2L2
7789,GO:0032310,0.0219981068158953,0.998797443168114,2,6,prostaglandin secretion,BP,IL1B;EDN1
19794,GO:2000178,0.0220580157509849,0.997326907156917,3,13,negative regulation of neural precursor cell proliferation,BP,BTG2;WNT5A;KCTD11
15135,GO:0071214,0.0221162391954421,0.988693455892381,18,230,cellular response to abiotic stimulus,BP,IL1B;IRF1;NFKB1;GADD45A;TNFRSF10B;N4BP1;ZFP36L1;RELB;CDKN1A;ERRFI1;SLC38A2;CAB39;SLC9A1;TNKS1BP1;NEDD4;TP53;RAD9B;PARP1
17198,GO:0104004,0.0221162391954421,0.988693455892381,18,230,cellular response to environmental stimulus,BP,IL1B;IRF1;NFKB1;GADD45A;TNFRSF10B;N4BP1;ZFP36L1;RELB;CDKN1A;ERRFI1;SLC38A2;CAB39;SLC9A1;TNKS1BP1;NEDD4;TP53;RAD9B;PARP1
18365,GO:1903319,0.0221226924617443,0.997316056895888,3,13,positive regulation of protein maturation,BP,ADAM8;SOX4;CCBE1
5591,GO:0016605,0.0221378292999643,0.991906425063741,9,87,PML body,CC,SQSTM1;N4BP1;ZNF451;PATL1;TP53;IKBKE;PML;TRIM16;ELF4
18311,GO:1903201,0.0221404164578245,0.993933420360055,6,49,regulation of oxidative stress-induced cell death,BP,NCOA7;SOD2;NFE2L2;TP53;NR4A3;PARP1
2217,GO:0005109,0.0221773587291885,0.995973228836987,4,23,frizzled binding,MF,BAMBI;RNF43;WNT5A;WNT7B
11842,GO:0046777,0.0221943536986184,0.989462356196144,15,172,protein autophosphorylation,BP,JUN;PIM3;RAP2B;VEGFA;ABL2;ERRFI1;VEGFC;PDGFB;TNKS1BP1;CAV1;CLK4;PIM1;FRK;GSK3B;DDR1
16620,GO:0097443,0.0223026196659055,0.998867689967919,2,5,sorting endosome,CC,LDLR;PTPN1
19657,GO:1990823,0.0223197879396892,0.992416982286289,8,74,response to leukemia inhibitory factor,BP,ICAM1;PIGA;CREB1;TRIM25;VEGFC;SPRY2;PML;XBP1
19660,GO:1990830,0.0223197879396892,0.992416982286289,8,74,cellular response to leukemia inhibitory factor,BP,ICAM1;PIGA;CREB1;TRIM25;VEGFC;SPRY2;PML;XBP1
16129,GO:0090101,0.0223246347984637,0.992420020962221,8,73,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,BAMBI;ZNF451;SMAD3;DKK1;TGFBR2;SMURF2;WNT5A;CAV1
11903,GO:0046914,0.0223684149785639,0.985101012321504,46,734,transition metal ion binding,MF,TNFAIP3;IL1A;SOD2;TRAF1;SQSTM1;BIRC2;ADAM8;CYP27B1;CYLD;GCH1;TRIM47;SMAD3;B4GALT1;TRAF4;ZSWIM4;ABL2;LACC1;KLF7;HEPHL1;ADAMTS1;NR4A2;TRIM25;SLC11A2;PGLYRP4;IFIH1;MMP9;MT2A;RCHY1;PTPN1;CHD4;ZNFX1;ZFAND5;TP53;PML;PIM1;TRIM16;NR4A3;PPARD;PARP1;CYP24A1;MMP10;KDM7A;EGLN1;RNF145;SREK1IP1;ZMIZ2
2409,GO:0005578,0.0224382571700768,0.98903732737945,16,190,proteinaceous extracellular matrix,CC,TFPI2;VEGFA;LAMB3;ADAMTS1;WISP1;WNT5A;TNC;MMP9;COL12A1;WNT7B;MAMDC2;CCBE1;COL27A1;MMP10;LAMA3;COL8A1
11114,GO:0045123,0.0224476132434348,0.995909012824621,4,23,cellular extravasation,BP,TNF;IL1A;ADAM8;ICAM1
6761,GO:0030182,0.0224829390889047,0.984553362040246,54,853,neuron differentiation,BP,EFNA1;SDC4;BTG2;INHBA;BMP2;LIF;PRDM1;JUN;EHD1;EFNB1;IL6;FZD8;NEDD4L;SGK1;DLX2;VEGFA;DKK1;ZSWIM4;PLK2;ABL2;CFLAR;KLF7;CEBPB;ADM;CREB1;NR4A2;SEMA4B;RUNX1;TGIF2;WNT5A;SLC11A2;SOX4;SOCS2;NRG1;TNC;PARD6B;FEZ1;GRB7;NEDD4;MMD;ITSN2;NFE2L2;WNT7B;SPTBN5;ABI1;EFNB2;RAPH1;NR4A3;GSK3B;VIM;DDR1;XBP1;EPB41L3;KCTD11
6280,GO:0019871,0.0226184333389816,0.998842902337073,2,5,sodium channel inhibitor activity,MF,NEDD4L;NEDD4
2229,GO:0005129,0.0226190011472101,1,1,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,CSF2
8565,GO:0034021,0.0226190011472101,1,1,1,response to silicon dioxide,BP,CSF2
5442,GO:0016301,0.0227860408145932,0.985097883094494,42,635,kinase activity,MF,CSF2;HBEGF;NUAK2;ITPKC;MAP2K3;EPHA2;SQSTM1;EREG;PELI1;PIM3;RIPK2;IRAK2;TJP2;CDKN1A;SGK1;FGF5;PLK2;MAP3K8;ABL2;ANKK1;MAST4;PHKG2;TGFBR2;MASTL;CAMK1G;PDGFB;NRG1;CAB39;PLK3;MMD;SGMS2;STAT5A;STK40;IKBKE;CLK4;PIM1;AXL;FRK;GSK3B;RIPK4;RPS6KA6;DDR1
11297,GO:0045599,0.0227901696768282,0.994678825755123,5,35,negative regulation of fat cell differentiation,BP,TNF;IL6;CCDC85B;SMAD3;WNT5A
5412,GO:0016248,0.0228209538738081,0.995781463135648,4,25,channel inhibitor activity,MF,NEDD4L;NEDD4;CAV1;STX1A
1091,GO:0002676,0.0228518722130792,0.998724912360432,2,6,regulation of chronic inflammatory response,BP,TNFAIP3;TNF
10117,GO:0042632,0.0229031030515267,0.994633387242363,5,36,cholesterol homeostasis,BP,EHD1;LDLR;CAV1;MED13;XBP1
13535,GO:0055092,0.0229031030515267,0.994633387242363,5,36,sterol homeostasis,BP,EHD1;LDLR;CAV1;MED13;XBP1
1310,GO:0003151,0.0229266760740394,0.993694087655955,6,46,outflow tract morphogenesis,BP,TBX3;JUN;VEGFA;TGFBR2;WNT5A;NEDD4
15502,GO:0071850,0.022943548335881,0.997139309946681,3,14,mitotic cell cycle arrest,BP,DUSP1;GADD45A;CDKN1A
19235,GO:1905331,0.0229598293307162,0.997174481852575,3,13,negative regulation of morphogenesis of an epithelium,BP,TNF;PHLDB2;WNT5A
11402,GO:0045776,0.0229602420594485,0.995766292940156,4,24,negative regulation of blood pressure,BP,SOD2;BDKRB1;GCH1;VEGFC
8034,GO:0032673,0.0230495045906293,0.997121011971071,3,14,regulation of interleukin-4 production,BP,CD83;CEBPB;HLA-E
3578,GO:0007623,0.0231263950759436,0.990020216653075,12,133,circadian rhythm,BP,CSF2;NOCT;JUN;BHLHE40;RELB;ARNTL2;NAMPT;CREB1;TP53;PML;GSK3B;JUND
10427,GO:0043267,0.0231432015104343,0.997143191136999,3,13,negative regulation of potassium ion transport,BP,NEDD4L;CAB39;CAV1
4477,GO:0010470,0.0231736412641224,0.995735269932247,4,23,regulation of gastrulation,BP,IL1RN;PHLDB2;DKK1;TGIF2
1134,GO:0002720,0.0232214336319186,0.995684498154135,4,25,positive regulation of cytokine production involved in immune response,BP,IL6;NOD2;WNT5A;NR4A3
8607,GO:0034114,0.0232431443475402,0.997087484794351,3,14,regulation of heterotypic cell-cell adhesion,BP,IL1B;TNF;IL1RN
19089,GO:1904950,0.0232571647614603,0.990858071153929,10,108,negative regulation of establishment of protein localization,BP,IL1B;TNF;ZC3H12A;PIM3;IL1R2;SOX4;BTN2A2;MAPKBP1;PML;IL36RN
4767,GO:0010944,0.0232628393595798,0.998689458196811,2,6,negative regulation of transcription by competitive promoter binding,BP,CREB1;MUC1
4546,GO:0010616,0.0233698225056753,0.998783153986616,2,5,negative regulation of cardiac muscle adaptation,BP,SMAD3;ERRFI1
18332,GO:1903243,0.0233698225056753,0.998783153986616,2,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,SMAD3;ERRFI1
608,GO:0001774,0.0234232995180352,0.997095203350126,3,13,microglial cell activation,BP,JUN;LDLR;TLR2
1440,GO:0003416,0.0234244182948386,0.997095011212661,3,13,endochondral bone growth,BP,TGFBR2;COL27A1;EVC
13523,GO:0055078,0.0235287276818143,0.997077081097968,3,13,sodium ion homeostasis,BP,EDN1;NEDD4L;SLC9A1
15920,GO:0072678,0.0235733629735139,0.995598842430344,4,25,T cell migration,BP,CCL20;ADAM8;WNT5A;CXCL16
507,GO:0001569,0.0235854620671015,0.995635932108799,4,23,branching involved in blood vessel morphogenesis,BP,EDN1;VEGFA;NRARP;TGFBR2
14958,GO:0070838,0.0236006126655556,0.987606057960602,19,245,divalent metal ion transport,BP,IL16;BDKRB1;PANX1;CYP27B1;ICAM1;NIPAL4;SLC11A2;PDGFB;RRAD;TRPV3;SLC9A1;CAV1;ITGAV;GEM;JPH2;PML;TSPAN13;SLC39A14;SLC41A1
658,GO:0001846,0.02374858932497,0.998647103761296,2,6,opsonin binding,MF,PTX3;ITGAV
19897,GO:2000351,0.0238709644273324,0.995566734138741,4,23,regulation of endothelial cell apoptotic process,BP,TNFAIP3;ICAM1;NFE2L2;TNIP2
10862,GO:0044362,0.0239385239196098,0.998630411201956,2,6,negative regulation of molecular function in other organism,BP,PTX3;RAB9A
13337,GO:0052204,0.0239385239196098,0.998630411201956,2,6,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,PTX3;RAB9A
10746,GO:0044110,0.0239510059175437,0.998629311633673,2,6,growth involved in symbiotic interaction,BP,TNF;SQSTM1
10749,GO:0044116,0.0239510059175437,0.998629311633673,2,6,growth of symbiont involved in interaction with host,BP,TNF;SQSTM1
10750,GO:0044117,0.0239510059175437,0.998629311633673,2,6,growth of symbiont in host,BP,TNF;SQSTM1
14196,GO:0061081,0.0239618246990677,0.998628358325126,2,6,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,WNT5A;NR4A3
12580,GO:0050719,0.0241757523723829,1,1,1,interleukin-1 alpha biosynthetic process,BP,CCL20
12582,GO:0050721,0.0241757523723829,1,1,1,regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
12585,GO:0050726,0.0241757523723829,1,1,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
10094,GO:0042592,0.0241931088263603,0.982800542405184,64,1102,homeostatic process,BP,IL1B;TNFAIP3;TNF;IL1A;INHBA;SOD2;PMAIP1;IL1RN;EDN1;ZFP36;EHD1;ETS1;HCAR2;CSF1;AMPD3;IL6;ADAM8;BDKRB1;PIM3;ZFP36L1;CYP27B1;CYLD;STEAP4;C1QTNF1;CLDN1;IL7R;NEDD4L;NOD2;ICAM1;SMAD3;VEGFA;ABL2;TXNRD1;CD55;ADM;SAA1;SLC11A2;SOX4;LDLR;MT2A;SLC9A1;SLC25A37;TNKS1BP1;RHCG;NFE2L2;WNT7B;SMAD1;CLIC4;CAV1;TP53;ITGAV;JPH2;PML;SLC9A8;AXL;NR4A3;KMT2E;SLC16A1;PARP1;MED13;EGLN1;XBP1;SLC39A14;SLC41A1
15347,GO:0071557,0.0242236089482434,0.998713955889418,2,5,histone H3-K27 demethylation,BP,KDM6B;KDM7A
15348,GO:0071558,0.0242236089482434,0.998713955889418,2,5,histone demethylase activity (H3-K27 specific),MF,KDM6B;KDM7A
14154,GO:0061008,0.0242609451683548,0.990411478819778,10,104,hepaticobiliary system development,BP,NFKBIA;TNFAIP3;JUN;CLDN1;SMAD3;CFLAR;CEBPB;HMGCS1;RELA;XBP1
14042,GO:0060753,0.0242813968873573,0.998600091488196,2,6,regulation of mast cell chemotaxis,BP,VEGFA;VEGFC
12545,GO:0050680,0.0243218140733816,0.990962020428168,9,87,negative regulation of epithelial cell proliferation,BP,TNF;EREG;SAV1;CDKN2B;WNT5A;DUSP10;CAV1;EFNB2;PPARD
7091,GO:0030881,0.0244210020722194,0.998587678077715,2,6,beta-2-microglobulin binding,MF,HLA-A;HLA-E
16586,GO:0097366,0.0244625216833907,0.995400611955858,4,24,response to bronchodilator,BP,ICAM1;CFLAR;NR4A2;EGLN1
13871,GO:0060462,0.0244853166585606,0.998692469184559,2,5,lung lobe development,BP,LIF;TGFBR2
13872,GO:0060463,0.0244853166585606,0.998692469184559,2,5,lung lobe morphogenesis,BP,LIF;TGFBR2
4423,GO:0010224,0.0245354444815457,0.996860893718131,3,14,response to UV-B,BP,CDKN1A;TP53;RELA
15826,GO:0072511,0.0246065463489175,0.987017800934329,19,246,divalent inorganic cation transport,BP,IL16;BDKRB1;PANX1;CYP27B1;ICAM1;NIPAL4;SLC11A2;PDGFB;RRAD;TRPV3;SLC9A1;CAV1;ITGAV;GEM;JPH2;PML;TSPAN13;SLC39A14;SLC41A1
9075,GO:0035313,0.0246109561480354,0.996889184870792,3,13,wound healing, spreading of epidermal cells,BP,HBEGF;PHLDB2;ITGA5
948,GO:0002360,0.02475594989052,0.996821743282298,3,14,T cell lineage commitment,BP,IL23A;IL6;CYLD
11897,GO:0046902,0.0247619147299483,0.992140560532968,7,66,regulation of mitochondrial membrane permeability,BP,PMAIP1;PPIF;BBC3;TP53BP2;SLC9A1;TP53;GSK3B
13733,GO:0060284,0.0247750663755094,0.984054898436885,38,570,regulation of cell development,BP,IL1B;TNF;EFNA1;BMP2;LIF;EDN1;CSF1;TJP2;NEDD4L;IL6ST;DLX2;TRIB1;VEGFA;DKK1;ZSWIM4;PLK2;ABL2;CFLAR;CREB1;SEMA4B;TGIF2;WNT5A;VEGFC;DUSP10;SOCS2;NRG1;LDLR;FEZ1;NEDD4;MMD;ITSN2;NFE2L2;TLR2;EFNB2;RELA;GSK3B;VIM;KCTD11
7457,GO:0031589,0.0248452257699009,0.987138054009522,18,225,cell-substrate adhesion,BP,PLAU;EFNA1;SDC4;CSF1;PHLDB2;ITGA5;SMAD3;NINJ1;VEGFA;VEGFC;SLC9A1;ITGAV;ADAM9;AXL;GSK3B;PPARD;COL8A1;DDR1
11076,GO:0045066,0.0249284182132788,0.996791023977974,3,14,regulatory T cell differentiation,BP,IRF1;RUNX1;DUSP10
11290,GO:0045589,0.0249284182132788,0.996791023977974,3,14,regulation of regulatory T cell differentiation,BP,IRF1;RUNX1;DUSP10
4661,GO:0010803,0.0249816459383175,0.992938439944745,6,52,regulation of tumor necrosis factor-mediated signaling pathway,BP,TNFAIP3;TNF;BIRC3;TRAF1;BIRC2;CYLD
12177,GO:0048286,0.0249886415912361,0.995293277159042,4,23,lung alveolus development,BP,LIF;ERRFI1;CREB1;STK40
2236,GO:0005138,0.0249975198415763,0.998535998713273,2,6,interleukin-6 receptor binding,MF,IL6;IL6ST
1431,GO:0003401,0.0250101638095487,0.995287971811236,4,23,axis elongation,BP,SIX4;WNT5A;TNC;SPRY2
20159,GO:2000826,0.0250480799804884,0.995256072661455,4,24,regulation of heart morphogenesis,BP,BMP2;DKK1;TGFBR2;PIM1
3708,GO:0008216,0.0251546652868334,0.998442481029528,2,7,spermidine metabolic process,BP,PAOX;SAT1
17426,GO:1900151,0.0251555565903762,0.996750436691356,3,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,BTG2;ZFP36;ZFP36L1
17428,GO:1900153,0.0251555565903762,0.996750436691356,3,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,BTG2;ZFP36;ZFP36L1
11385,GO:0045742,0.0252444680495263,0.995186534729288,4,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,PLAUR;EREG;TGFA;MMP9
15636,GO:0072111,0.025284418522983,0.996727344731853,3,14,cell proliferation involved in kidney development,BP,BMP2;CFLAR;PDGFB
6706,GO:0030101,0.0252889111673194,0.993894287135191,5,38,natural killer cell activation,BP,PRDM1;TICAM1;IL23A;AXL;ELF4
6943,GO:0030547,0.0254225742068943,0.996665277241709,3,15,receptor inhibitor activity,MF,IL1RN;DKK1;IL36RN
9869,GO:0042119,0.0256125500708535,0.985329029956898,24,357,neutrophil activation,BP,CXCL8;PLAU;CXCL1;PLAUR;PTX3;NFKB1;AMPD3;ADAM8;RAP2B;CTSC;B4GALT1;RAB24;CD55;CD47;CANT1;SERPINB1;MMP9;CAB39;TLR2;ITGAV;FRK;KMT2E;COTL1;MGAM
6258,GO:0019835,0.0256477205004911,0.996563131365679,3,17,cytolysis,BP,CSF2;PGLYRP4;MMD
19738,GO:2000058,0.0257751628657598,0.989162700535069,11,124,regulation of ubiquitin-dependent protein catabolic process,BP,RNF19B;N4BP1;RNF144B;TRIB1;PLK2;PLK3;RCHY1;NFE2L2;CAV1;PML;GSK3B
11347,GO:0045662,0.0257760216435222,0.996600863710396,3,15,negative regulation of myoblast differentiation,BP,TNF;TBX3;PPARD
692,GO:0001909,0.0257885746106587,0.99264897620721,6,53,leukocyte mediated cytotoxicity,BP,IL23A;IL7R;CTSC;ICAM1;RAET1L;HLA-E
16176,GO:0090183,0.025822617882919,0.993757101144243,5,36,regulation of kidney development,BP,LIF;SIX4;VEGFA;CFLAR;PDGFB
15018,GO:0070936,0.0258616458577152,0.99265779799677,6,49,protein K48-linked ubiquitination,BP,TNFAIP3;PELI1;BIRC2;NEDD4L;RNF152;UBE2D3
3512,GO:0007423,0.0258736309781979,0.985379044164788,23,311,sensory organ development,BP,SDC4;INHBA;BMP2;PRDM1;EDN1;JUN;EPHA2;SIX4;FJX1;SMAD3;DLX2;NINJ1;VEGFA;TGFBR2;TGIF2;WNT5A;SPRY2;WNT7B;CLIC4;NR4A3;COL8A1;VIM;DDR1
4753,GO:0010921,0.026044971890796,0.988563441261016,12,134,regulation of phosphatase activity,BP,TNF;PLEKHF1;PPP1R15A;BMP2;SMAD3;PPP4R4;ANKLE2;MASTL;PPP1R3B;SH3RF2;PPP6R3;GSK3B
12818,GO:0051099,0.0260550989005927,0.988542878105764,12,140,positive regulation of binding,BP,BMP2;PLAUR;TICAM1;RIPK2;BAMBI;TRAF4;PLK2;WNT5A;MMP9;CAV1;GSK3B;PARP1
9026,GO:0035234,0.0261771489445036,0.998428186228222,2,6,ectopic germ cell programmed cell death,BP,IL1B;IL1A
13831,GO:0060411,0.0261787677887566,0.992566745940571,6,47,cardiac septum morphogenesis,BP,TBX3;SAV1;TGFBR2;WNT5A;SOX4;EGLN1
16857,GO:0098754,0.0262652562316156,0.991512085328415,7,75,detoxification,BP,TNF;SOD2;GPX3;GCH1;TXNRD1;MT2A;NFE2L2
11915,GO:0046934,0.02639997098264,0.993610249519646,5,34,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,HBEGF;EREG;FGF5;PDGFB;NRG1
405,GO:0001085,0.0265507370504399,0.989343851239521,10,106,RNA polymerase II transcription factor binding,MF,TBX3;JUN;BHLHE40;SMAD3;CREB1;NFE2L2;CHD4;TP53;GSK3B;XBP1
19610,GO:1990668,0.0265529875202726,0.998393258481885,2,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,TAP1;TAPBP
11946,GO:0046983,0.0266359436414553,0.981816428299044,49,854,protein dimerization activity,MF,INHBA;BMP2;NFKB1;JUN;SQSTM1;CSF1;BHLHE40;GADD45A;PANX1;RIPK2;IRAK2;ODC1;IL6ST;GCH1;SMAD3;ARNTL2;VEGFA;CEBPB;NAMPT;TAP1;TAF4B;NR4A2;CANT1;ABTB2;HMGCS1;SOX4;PDGFB;PGLYRP4;ATF3;IKZF2;RCHY1;BCL2L2;SMAD1;MXD1;TPST1;CAV1;TP53;TLR2;STX1A;PML;RELA;YARS2;AXL;NR4A3;PPARD;SLC16A1;MXD3;XBP1;TFE3
20117,GO:2000756,0.0267941734175734,0.992321230791319,6,50,regulation of peptidyl-lysine acetylation,BP,IL1B;LIF;ZNF451;SOX4;SDR16C5;MUC1
19936,GO:2000406,0.0268136542746878,0.996409714007097,3,15,positive regulation of T cell migration,BP,CCL20;ADAM8;WNT5A
615,GO:0001781,0.0268187308324561,0.998368395160868,2,6,neutrophil apoptotic process,BP,HCAR2;IL6
6014,GO:0019058,0.0268370874690186,0.985693772484063,19,256,viral life cycle,BP,CXCL8;TNF;ZC3H12A;PTX3;TNIP1;EPHA2;CLDN1;ITGA5;NEDD4L;ICAM1;CD55;TRIM25;LDLR;NUP153;CAV1;EFNB2;ITGAV;PML;AXL
8280,GO:0033081,0.0268395368698067,0.996404907302274,3,15,regulation of T cell differentiation in thymus,BP,ADAM8;IL7R;NFKBID
68,GO:0000139,0.0269097244884044,0.982568993506049,38,585,Golgi membrane,CC,IFNGR2;STEAP4;NMNAT2;GBP2;ABCA5;CTSC;B4GALT1;B3GNT5;RND3;CD55;DSE;CANT1;CAMK1G;TGFA;PDGFB;SYS1;B4GALT5;CYTH1;SGMS2;TPST1;CAV1;HLA-A;UGCG;GOLGA8B;TAPBP;RAB9A;HLA-B;PJA2;ABCA7;TMEM132A;HS3ST3B1;SLC9A8;PPP6R3;CHST2;SLC16A13;HLA-F;HLA-E;LMAN1
774,GO:0002026,0.0269165390965328,0.996430811245437,3,14,regulation of the force of heart contraction,BP,ADM;SLC9A1;CAV1
14516,GO:0062014,0.0270081044800429,0.991286052800223,7,64,negative regulation of small molecule metabolic process,BP,BMP2;NFKB1;PPIF;CYP27B1;SOGA1;PARP1;EGLN1
18256,GO:1903050,0.0270362094061026,0.987181024830444,14,174,regulation of proteolysis involved in cellular protein catabolic process,BP,EFNA1;RNF19B;N4BP1;CTSC;RNF144B;TRIB1;PLK2;PLK3;RCHY1;NFE2L2;CAV1;PML;GSK3B;XBP1
20150,GO:2000811,0.0271086201124908,0.996395424360942,3,14,negative regulation of anoikis,BP,ITGA5;TLE1;CAV1
13524,GO:0055080,0.0271266507261297,0.984016144955264,26,381,cation homeostasis,BP,EDN1;BDKRB1;CYP27B1;STEAP4;C1QTNF1;NEDD4L;SMAD3;ABL2;CD55;ADM;SAA1;SLC11A2;MT2A;SLC9A1;SLC25A37;RHCG;CLIC4;CAV1;TP53;ITGAV;JPH2;PML;SLC9A8;EGLN1;SLC39A14;SLC41A1
16820,GO:0098655,0.0272266662525561,0.983619986166325,28,415,cation transmembrane transport,BP,PPIF;BDKRB1;PANX1;STEAP4;NEDD4L;KCNJ15;SLC28A3;NIPAL4;SLC7A2;SLC11A2;MMP9;RRAD;CAB39;RHD;TRPV3;SLC9A1;SLC25A37;NEDD4;RHCG;SLC2A6;CAV1;ITGAV;GEM;JPH2;SLC9A8;TSPAN13;SLC39A14;SLC41A1
10138,GO:0042693,0.0272876123517343,0.998324190253763,2,6,muscle cell fate commitment,BP,TBX3;DKK1
17772,GO:1901724,0.0274011370751635,0.998313423265265,2,6,positive regulation of cell proliferation involved in kidney development,BP,CFLAR;PDGFB
14011,GO:0060711,0.0275600087140969,0.993207887645025,5,37,labyrinthine layer development,BP,ZFP36L1;JUNB;ADM;WNT7B;EGLN1
9788,GO:0039706,0.0275766316174487,0.998296729833002,2,6,co-receptor binding,MF,BMP2;DKK1
4287,GO:0009651,0.027616176864626,0.996259810422307,3,15,response to salt stress,BP,TNF;ZFP36L1;CLDN1
4777,GO:0010959,0.0276341722570554,0.986484401115185,15,186,regulation of metal ion transport,BP,IL16;BDKRB1;NEDD4L;ICAM1;PDGFB;RRAD;CAB39;TRPV3;SLC9A1;NEDD4;CAV1;GEM;JPH2;PML;TSPAN13
4275,GO:0009629,0.0277132388462452,0.998283694290344,2,6,response to gravity,BP,FOSL1;STX1A
9199,GO:0035580,0.0277161177091204,0.993120567972067,5,40,specific granule lumen,CC,CXCL1;PTX3;NFKB1;CANT1;FRK
12280,GO:0048565,0.0277240060936952,0.990188547064854,8,74,digestive tract development,BP,CXCL8;TNF;PRDM1;CDKN1A;SAV1;SMAD3;TGFBR2;WNT5A
12907,GO:0051235,0.0277339629657598,0.985746630547797,17,221,maintenance of location,BP,IL1B;NFKBIA;TNF;ZC3H12A;NFKB1;EHD1;NFKBIE;BCL3;IL6;BDKRB1;SOX4;CAV1;ITGAV;IKBKE;JPH2;PML;EPB41L3
18098,GO:1902686,0.0277728101546889,0.991947170553505,6,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,PMAIP1;PPIF;BBC3;TP53BP2;TP53;GSK3B
4773,GO:0010955,0.027810139675525,0.994514658957105,4,26,negative regulation of protein processing,BP,BIRC3;BIRC2;IL1R2;CD55
18364,GO:1903318,0.027810139675525,0.994514658957105,4,26,negative regulation of protein maturation,BP,BIRC3;BIRC2;IL1R2;CD55
11384,GO:0045741,0.0278313858253056,0.998272391291166,2,6,positive regulation of epidermal growth factor-activated receptor activity,BP,EREG;TGFA
11246,GO:0045414,0.0278343013704423,0.998272112024315,2,6,regulation of interleukin-8 biosynthetic process,BP,TNF;BCL3
4734,GO:0010894,0.0278411892708231,0.996217461160986,3,15,negative regulation of steroid biosynthetic process,BP,BMP2;NFKB1;CYP27B1
4605,GO:0010717,0.0278649652299725,0.990965956180926,7,62,regulation of epithelial to mesenchymal transition,BP,IL1B;EFNA1;BMP2;PHLDB2;BAMBI;SMAD3;TGFBR2
9612,GO:0036473,0.0279774506201248,0.990899911921588,7,65,cell death in response to oxidative stress,BP,NCOA7;SOD2;NFE2L2;TP53;PML;NR4A3;PARP1
10569,GO:0043524,0.0280662896795869,0.98927697180248,9,93,negative regulation of neuron apoptotic process,BP,BTG2;SOD2;JUN;ADAM8;SIX4;CEBPB;NR4A2;AXL;NR4A3
16445,GO:0097084,0.0280758293671499,0.998248920430277,2,6,vascular smooth muscle cell development,BP,VEGFA;ADM
17019,GO:0099106,0.0280851859169813,0.991853676798785,6,51,ion channel regulator activity,MF,NEDD4L;SGK1;NEDD4;CAV1;STX1A;TSPAN13
6215,GO:0019730,0.0281564979822463,0.994247294555916,4,39,antimicrobial humoral response,BP,BCL3;PGLYRP4;HLA-E;IL36RN
16186,GO:0090193,0.0282030615311494,0.998236658557175,2,6,positive regulation of glomerulus development,BP,CFLAR;PDGFB
16791,GO:0098590,0.0283466234846155,0.981266991826554,41,626,plasma membrane region,CC,FOSL1;PLAUR;EPHA2;EHD1;AMOTL2;CLDN1;ITGA5;NOD2;B4GALT1;SLC6A14;TGFBR2;MREG;MASTL;SLC11A2;TGFA;SLC52A3;PDGFB;NRG1;LDLR;PARD6B;SLC9A1;SPRY2;NEDD4;RHCG;SPTBN5;CAV1;ABI1;ITGAV;PJA2;STX1A;ABCA7;ADGRE2;ADAM9;MUC1;CRB3;OSMR;EVC;OCLN;EPB41L3;MGAM;SLC41A1
11309,GO:0045618,0.0283947416015212,0.996112688918302,3,15,positive regulation of keratinocyte differentiation,BP,CYP27B1;IL20;TRIM16
14084,GO:0060850,0.0285310350510633,0.998204907687667,2,6,regulation of transcription involved in cell fate commitment,BP,DLX2;CEBPB
13613,GO:0060068,0.0285557057080559,0.998202511039239,2,6,vagina development,BP,WNT5A;AXL
4950,GO:0014912,0.028577108171981,0.996077989610574,3,15,negative regulation of smooth muscle cell migration,BP,TRIB1;NFE2L2;PPARD
1346,GO:0003206,0.02862879525006,0.989799846780685,8,75,cardiac chamber morphogenesis,BP,TBX3;SAV1;ADAMTS1;TGFBR2;WNT5A;SOX4;NRG1;EGLN1
8626,GO:0034141,0.0286303258617517,0.998195254955873,2,6,positive regulation of toll-like receptor 3 signaling pathway,BP,PELI1;CAV1
458,GO:0001306,0.0286442255025144,1,1,1,age-dependent response to oxidative stress,BP,SOD2
459,GO:0001315,0.0286442255025144,1,1,1,age-dependent response to reactive oxygen species,BP,SOD2
1277,GO:0003068,0.0286442255025144,1,1,1,regulation of systemic arterial blood pressure by acetylcholine,BP,SOD2
1278,GO:0003069,0.0286442255025144,1,1,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,SOD2
1279,GO:0003070,0.0286442255025144,1,1,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,SOD2
3547,GO:0007571,0.0286442255025144,1,1,1,age-dependent general metabolic decline,BP,SOD2
3590,GO:0008015,0.0286486414364595,0.984625092802235,19,250,blood circulation,BP,HBEGF;ZC3H12A;SOD2;EDN1;MAP2K3;BDKRB1;NEDD4L;SGK1;ICAM1;GCH1;SMAD3;ADM;VEGFC;PDGFB;SLC9A1;CAV1;DOCK4;PPARD;GJC1
14158,GO:0061014,0.028659197107278,0.992878884548452,5,36,positive regulation of mRNA catabolic process,BP,BTG2;ZC3H12A;ZFP36;ZFP36L1;QKI
10446,GO:0043299,0.0286998429086487,0.983179069011552,25,378,leukocyte degranulation,BP,PLAU;CXCL1;PLAUR;PTX3;NFKB1;AMPD3;ADAM8;RAP2B;CTSC;B4GALT1;RAB24;CD55;CD47;CANT1;SERPINB1;MMP9;CAB39;IL4R;TLR2;ITGAV;ADGRE2;FRK;NR4A3;COTL1;MGAM
9527,GO:0036230,0.0287387633481072,0.983352282583774,24,361,granulocyte activation,BP,CXCL8;PLAU;CXCL1;PLAUR;PTX3;NFKB1;AMPD3;ADAM8;RAP2B;CTSC;B4GALT1;RAB24;CD55;CD47;CANT1;SERPINB1;MMP9;CAB39;TLR2;ITGAV;FRK;KMT2E;COTL1;MGAM
571,GO:0001710,0.0287552449910178,0.998183084072794,2,6,mesodermal cell fate commitment,BP,DKK1;SMAD1
9698,GO:0038092,0.0287810643465705,0.99818056479139,2,6,nodal signaling pathway,BP,SMAD3;TGIF2
7108,GO:0030900,0.0288054261559555,0.984827588855587,18,230,forebrain development,BP,BTG2;INHBA;BMP2;TBX3;KDM6B;ETS1;DLX2;DKK1;CREB1;NR4A2;WNT5A;NRG1;SLC38A2;FEZ1;WNT7B;AXL;NR4A3;GSK3B
1363,GO:0003231,0.0288697039668945,0.989704001039775,8,74,cardiac ventricle development,BP,PRDM1;TBX3;SAV1;TGFBR2;WNT5A;SOX4;NRG1;EGLN1
15218,GO:0071353,0.0288938630496952,0.994232861452768,4,26,cellular response to interleukin-4,BP,IL4R;IL24;PML;XBP1
8511,GO:0033688,0.0289042335177199,0.996059758378389,3,14,regulation of osteoblast proliferation,BP,BMP2;SMAD3;ITGAV
16090,GO:0090037,0.0289552135321752,0.998163539418083,2,6,positive regulation of protein kinase C signaling,BP,VEGFA;WNT5A
10829,GO:0044319,0.0290158285795244,0.994223645398752,4,25,wound healing, spreading of cells,BP,HBEGF;PHLDB2;ITGA5;DDR1
16333,GO:0090505,0.0290158285795244,0.994223645398752,4,25,epiboly involved in wound healing,BP,HBEGF;PHLDB2;ITGA5;DDR1
11272,GO:0045519,0.0290372606847805,1,1,1,interleukin-23 receptor binding,MF,IL23A
14926,GO:0070743,0.0290372606847805,1,1,1,interleukin-23 complex,CC,IL23A
16918,GO:0098868,0.0290455367518003,0.996032975618164,3,14,bone growth,BP,TGFBR2;COL27A1;EVC
16124,GO:0090092,0.0290672184166506,0.987021184621569,12,137,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,INHBA;BMP2;BAMBI;ZNF451;SMAD3;DKK1;CDKN2B;TGFBR2;SMURF2;WNT5A;CAV1;PARP1
16572,GO:0097342,0.0290975529505897,0.998149581176283,2,6,ripoptosome,CC,TICAM1;CFLAR
467,GO:0001505,0.0291587542400251,0.986043624355677,14,170,regulation of neurotransmitter levels,BP,IL1B;TNF;ZC3H12A;PTX3;EDN1;TICAM1;ICAM1;GCH1;SMAD3;SLC7A2;MAOA;CAV1;TLR2;STX1A
3941,GO:0008625,0.0292334143263059,0.990396850981755,7,66,extrinsic apoptotic signaling pathway via death domain receptors,BP,TNFAIP3;TNF;PMAIP1;TNFRSF10B;ICAM1;CFLAR;ATF3
14174,GO:0061042,0.0292927589133564,0.99813037637308,2,6,vascular wound healing,BP,TNFAIP3;XBP1
14651,GO:0070228,0.029302781470445,0.992619377370793,5,40,regulation of lymphocyte apoptotic process,BP,EFNA1;ADAM8;NFKBID;WNT5A;TP53
2411,GO:0005581,0.029317585544659,0.992687819405377,5,35,collagen trimer,CC,C1QTNF1;COL12A1;CCBE1;COL27A1;COL8A1
18227,GO:1903003,0.0293222761878745,0.998127466134621,2,6,positive regulation of protein deubiquitination,BP,ZC3H12A;TNIP1
11245,GO:0045410,0.0293832937160518,0.998121444938035,2,6,positive regulation of interleukin-6 biosynthetic process,BP,IL1B;EREG
9412,GO:0035970,0.0294062842597109,0.995919091527969,3,15,peptidyl-threonine dephosphorylation,BP,DUSP1;DUSP10;PDP1
6453,GO:0021766,0.0294803297070363,0.991362609220279,6,50,hippocampus development,BP,BTG2;KDM6B;DLX2;FEZ1;NR4A3;GSK3B
2534,GO:0005788,0.0297079065699594,0.985335305753575,15,186,endoplasmic reticulum lumen,CC,PLAUR;EDN1;CSF1;IL23A;IL6;CTSC;WNT5A;PDGFB;TNC;COL12A1;ARSJ;WNT7B;TMEM132A;COL27A1;COL8A1
13836,GO:0060416,0.0297399908199334,0.994059372401304,4,24,response to growth hormone,BP,SOCS2;PTPN1;STAT5A;TRIM16
7563,GO:0031901,0.029784579596828,0.987813982992509,10,107,early endosome membrane,CC,EHD1;STEAP4;DKK1;CAV1;HLA-A;HLA-B;ABCA7;PML;HLA-F;HLA-E
12310,GO:0048639,0.0298379991169938,0.987796809871579,10,105,positive regulation of developmental growth,BP,EDN1;CSF1;NEDD4L;VEGFA;CREB1;TGFBR2;NRG1;ITSN2;PIM1;PPARD
15759,GO:0072331,0.0298637334235551,0.984180993892818,18,247,signal transduction by p53 class mediator,BP,BTG2;PMAIP1;BCL3;GADD45A;CDKN1A;PLK2;TP53BP2;TAF4B;SOX4;PLK3;TNKS1BP1;CHD4;TP53;RAD9B;PML;MUC1;JMY;RPS6KA6
14010,GO:0060710,0.0300443369100397,0.998055764689365,2,6,chorio-allantoic fusion,BP,ZFP36L1;WNT7B
11254,GO:0045445,0.0300593751633566,0.991142608546094,6,51,myoblast differentiation,BP,TNF;TBX3;ZFP36L1;BTG1;NRG1;PPARD
20301,GO:2001244,0.0300712543302953,0.992326575056621,5,44,positive regulation of intrinsic apoptotic signaling pathway,BP,PLEKHF1;PMAIP1;PLAGL2;CAV1;TP53
12606,GO:0050769,0.0301520463398752,0.982932698222174,22,297,positive regulation of neurogenesis,BP,BMP2;LIF;CSF1;NEDD4L;IL6ST;DLX2;VEGFA;DKK1;ABL2;CFLAR;TGIF2;WNT5A;VEGFC;SOCS2;NRG1;FEZ1;MMD;ITSN2;NFE2L2;TLR2;RELA;KCTD11
14986,GO:0070884,0.0303004454211472,0.995745689219644,3,15,regulation of calcineurin-NFAT signaling cascade,BP,NRG1;SLC9A1;NFAT5
17219,GO:0106056,0.0303004454211472,0.995745689219644,3,15,regulation of calcineurin-mediated signaling,BP,NRG1;SLC9A1;NFAT5
17585,GO:1901184,0.030362158016333,0.989034690001928,8,79,regulation of ERBB signaling pathway,BP,HBEGF;PLAUR;EREG;ERRFI1;TGFA;NRG1;MMP9;SPRY2
6648,GO:0023035,0.0304614999721346,0.998013895235222,2,6,CD40 signaling pathway,BP,TNFAIP3;TNIP2
959,GO:0002377,0.0305714672795129,0.989870504282254,7,65,immunoglobulin production,BP,TNF;IL6;IL7R;IL4R;POU2F2;HLA-E;XBP1
11080,GO:0045072,0.030633896433958,0.997996497709619,2,6,regulation of interferon-gamma biosynthetic process,BP,INHBA;CD276
10445,GO:0043297,0.0306429690836121,0.990951933396668,6,49,apical junction assembly,BP,TNF;CLDN1;RUNX1;PARD6B;CRB3;OCLN
17846,GO:1901991,0.0306454584620832,0.984782300829541,15,202,negative regulation of mitotic cell cycle phase transition,BP,BTG2;DUSP1;GADD45A;ZFP36L1;CDKN1A;DCUN1D3;CDKN2B;PLK2;SOX4;PLK3;TNKS1BP1;TPRA1;TP53;PML;MUC1
12321,GO:0048662,0.0306482309970836,0.993746921151962,4,27,negative regulation of smooth muscle cell proliferation,BP,TNFAIP3;TRIB1;TP53;PPARD
17867,GO:1902042,0.0307395451710918,0.99372246630729,4,27,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,TNFAIP3;TNFRSF10B;ICAM1;CFLAR
7461,GO:0031593,0.0308077886767968,0.992180754914114,5,37,polyubiquitin modification-dependent protein binding,MF,TNFAIP3;TNIP1;SQSTM1;TNIP2;IKBKE
3663,GO:0008150,0.0308110472191256,0.980261983630588,522,11228,biological_process,BP,NFKBIZ;CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;ITPKC;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;IL36G;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;HCAR3;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;RAB3IP;EPHA2;GPR156;EHD1;ZNF697;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;N4BP3;ZNF267;SPRR2D;SERTAD2;STARD5;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;PANX1;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;KLHL21;PHLDA2;DAPP1;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;STEAP4;C1QTNF1;AMOTL2;CDKN1A;CLDN1;NMNAT2;FJX1;CCDC85B;ITGA5;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;ODC1;TNFAIP2;NEDD4L;CTSC;ARL5B;GPX3;NOD2;ELMSAN1;IL6ST;DCUN1D3;RELT;SAV1;TFPI2;SGK1;ICAM1;GCH1;FRMD4B;RASSF9;SMAD3;ZC3H12C;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;RNF144B;RND3;MARCKSL1;TM4SF1;NFKBID;NINJ1;TRAF4;TRIB1;KRT34;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;NRARP;IL1R2;SLC6A14;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;MAP3K8;ZBED2;ABL2;PPTC7;CDV3;LAMB3;CFLAR;RNF43;TXNRD1;KLF7;PIGA;BTG1;ANXA8;UPP1;IER5;PPP4R4;CEBPB;CEBPD;VMP1;CD55;KCNJ15;DENND3;NAMPT;TAP1;TMEM106A;TP53BP2;ANKLE2;HEPHL1;ADM;GJB3;CDC42EP4;SLC28A3;IFNAR1;DSE;ERRFI1;ADAMTS1;ANKK1;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;WISP1;NEDD9;MAST4;NR4A2;PATL1;NIPAL4;SLC7A2;CD47;CANT1;VHL;PHKG2;SOGA1;SEMA4B;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;TGFBR2;MREG;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TMEM265;AKAP2;TINAGL1;PNRC2;KLHL5;MTURN;NFE2L3;TRIM25;IFNGR1;MASTL;NAB1;KIF3C;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;NOTCH2NL;DUSP10;SLC52A3;ROBO4;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;ANLN;PGLYRP4;CD82;BAZ1A;IFIH1;DUSP8;NRG1;TNC;SLC38A2;MMP9;LDLR;KIAA1586;DCBLD2;RRAD;ATF3;OTUD4;BTG3;IKZF2;COL12A1;FAM83B;CAB39;IL32;TLE1;MFHAS1;RHD;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;TRPV3;FAM57A;MT2A;SUCO;SLC9A1;ZBTB10;SLC25A37;SYS1;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;HAL;CYTH1;GRB7;CXCL16;ARSJ;NUP153;BCL2L2;RNF152;IL4R;NEDD4;MMD;RHCG;SLC2A6;POU2F2;ITSN2;DUS4L;GCSAM;IL24;TNFRSF6B;MARCKS;RAET1L;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;SUSD6;TPRA1;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;CACFD1;RTTN;HLA-A;UACA;DRAM1;INO80D;TNIP2;NECAP2;ZNFX1;UGCG;ZFAND5;GOLGA8B;TP53;NOM1;KLF3;TLR2;ABI1;STK40;PUS10;TAPBP;EFNB2;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;ADGRE2;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;ADAM9;SLC43A3;RELA;RAPH1;TRIM16;ESCO2;EMP3;SPATA2;FOXN2;SLC9A8;CCBE1;PPP6R3;EVI2B;TSPAN13;COL27A1;PLAT;CHST2;MUC1;YARS2;AXL;SLC16A13;ANXA5;CRB3;ELL2;SAT1;FRK;HLA-F;CITED4;NR4A3;HLA-E;USP31;GSK3B;KMT2E;OSMR;PPARD;PARP8;SLC16A1;EVC;PARP1;CYP24A1;MMP10;LAMA3;KDM7A;MED13;HCP5;MXD3;CRAMP1;TBC1D22B;LCE1C;OCLN;COTL1;JMY;COL8A1;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;RNF145;ALAS1;ZXDA;RPS6KA6;DDR1;CEP135;XBP1;HSPA4L;QKI;EPB41L3;KCTD11;ZBTB5;ELF4;IL36RN;CDRT1;SREK1IP1;SLC39A14;TFE3;EID3;ZMIZ2;ERVFRD-1;C12ORF29;MGAM;CCSER2;LMAN1;CFB;SLC41A1;JUND;GJC1;DENND4A
18814,GO:1904338,0.0308777443155036,0.99797179546574,2,6,regulation of dopaminergic neuron differentiation,BP,DKK1;GSK3B
15297,GO:0071470,0.0309589597883311,0.993686285343891,4,26,cellular response to osmotic stress,BP,ZFP36L1;RELB;ERRFI1;CAB39
11462,GO:0045906,0.0310133040510127,0.997958015414828,2,6,negative regulation of vasoconstriction,BP,ADM;DOCK4
1262,GO:0003013,0.0310185431524787,0.983202545415448,19,252,circulatory system process,BP,HBEGF;ZC3H12A;SOD2;EDN1;MAP2K3;BDKRB1;NEDD4L;SGK1;ICAM1;GCH1;SMAD3;ADM;VEGFC;PDGFB;SLC9A1;CAV1;DOCK4;PPARD;GJC1
6762,GO:0030183,0.0310639900073691,0.988738232351681,8,78,B cell differentiation,BP,INHBA;PRDM1;KLF6;BCL3;ZFP36L1;CYLD;POU2F2;XBP1
13246,GO:0051896,0.0311464607817997,0.98651889550013,11,123,regulation of protein kinase B signaling,BP,TNF;HBEGF;EPHA2;EREG;ADAM8;C1QTNF1;FGF5;PDGFB;NRG1;SPRY2;AXL
13163,GO:0051721,0.0311799608535595,0.993651909169225,4,25,protein phosphatase 2A binding,MF,ANKLE2;MASTL;PTPN1;TP53
7358,GO:0031396,0.0312089626889922,0.985376212784639,13,162,regulation of protein ubiquitination,BP,TNFAIP3;BIRC3;TICAM1;PELI1;BIRC2;N4BP1;RIPK2;NOD2;DCUN1D3;SOX4;ARRDC4;RCHY1;CAV1
3401,GO:0007182,0.0312111860726523,0.997937839196297,2,6,common-partner SMAD protein phosphorylation,BP,TGFBR2;PML
17408,GO:1900125,0.0312551729550747,0.997933344448151,2,6,regulation of hyaluronan biosynthetic process,BP,NFKB1;PDGFB
10444,GO:0043296,0.0312702280961812,0.987120412740072,10,103,apical junction complex,CC,TJP2;AMOTL2;CLDN1;RAP2B;FRMD4B;TRAF4;PARD6B;CYTH1;CRB3;OCLN
7162,GO:0031018,0.0314492703155552,0.993554707441236,4,26,endocrine pancreas development,BP,IL6;WNT5A;SOX4;GSK3B
9385,GO:0035914,0.0314613016887331,0.991954424171054,5,38,skeletal muscle cell differentiation,BP,BTG2;MAFF;SIX4;ATF3;FOXN2
8513,GO:0033690,0.0314911723019253,0.997909168328544,2,6,positive regulation of osteoblast proliferation,BP,BMP2;ITGAV
16788,GO:0098586,0.0315073792121166,0.991955367476975,5,37,cellular response to virus,BP,BIRC3;ZC3H12A;BIRC2;IFIH1;IKBKE
14168,GO:0061035,0.0315688468614123,0.991935496211048,5,37,regulation of cartilage development,BP,BMP2;SMAD3;WNT5A;SMAD1;RELA
8074,GO:0032740,0.0318489471586928,0.997758967280363,2,7,positive regulation of interleukin-17 production,BP,IL23A;NOD2
17314,GO:0140096,0.0320329857322654,0.975568635559712,96,1702,catalytic activity, acting on a protein,MF,TNFAIP3;CSF2;HBEGF;NUAK2;PLAU;BIRC3;ZC3H12A;RNF19B;PPIF;MAP2K3;KDM6B;EPHA2;SQSTM1;EREG;DUSP1;PELI1;BIRC2;ADAM8;PIM3;RIPK2;IRAK2;KLHL21;CYLD;CDKN1A;ZNF451;NEDD4L;CTSC;SGK1;RNF144B;FGF5;PLK2;MAP3K8;ABL2;PPTC7;CFLAR;RNF43;ADAMTS1;ANKK1;USP43;MAST4;VHL;PHKG2;BACH1;TGFBR2;SMURF2;DUSP16;TINAGL1;KLHL5;TRIM25;MASTL;CAMK1G;DUSP10;PPP1R3B;DUSP8;NRG1;MMP9;KIAA1586;OTUD4;CAB39;PLK3;RCHY1;RNF152;NEDD4;MMD;KBTBD7;PTPN1;LACTB;CHD4;STAT5A;TPST1;STK40;PDP1;IKBKE;UBE2D3;PJA2;CLK4;SPCS2;UBE2Z;PIM1;ESPL1;ADAM9;PLAT;AXL;FRK;USP31;GSK3B;KMT2E;PARP1;MMP10;KDM7A;EGLN1;RIPK4;RNF145;RPS6KA6;DDR1;CFB
13586,GO:0060039,0.0320332266670197,0.995454470655076,3,14,pericardium development,BP,BMP2;SMAD3;WNT5A
19931,GO:2000401,0.0321506027421181,0.993341550860506,4,27,regulation of lymphocyte migration,BP,CCL20;ADAM8;WNT5A;GCSAM
15379,GO:0071605,0.0321723995105206,0.997723706880414,2,7,monocyte chemotactic protein-1 production,BP,IL1B;IL1A
15401,GO:0071637,0.0321723995105206,0.997723706880414,2,7,regulation of monocyte chemotactic protein-1 production,BP,IL1B;IL1A
3382,GO:0007160,0.0322823204957418,0.984833159554025,13,150,cell-matrix adhesion,BP,PLAU;SDC4;CSF1;PHLDB2;SMAD3;NINJ1;VEGFA;VEGFC;SLC9A1;ITGAV;ADAM9;GSK3B;DDR1
3438,GO:0007229,0.032289738144332,0.989203402354732,7,62,integrin-mediated signaling pathway,BP,ITGA5;ADAMTS1;NEDD9;CD47;ITGB8;ITGAV;ADAM9
5905,GO:0018107,0.0323201929351974,0.98734469314675,9,92,peptidyl-threonine phosphorylation,BP,RIPK2;PHKG2;TGFBR2;WNT5A;CAMK1G;CAB39;SPRY2;TNKS1BP1;GSK3B
3394,GO:0007173,0.0324056633382653,0.986550404999544,10,108,epidermal growth factor receptor signaling pathway,BP,HBEGF;PLAUR;EREG;ABL2;ERRFI1;TGFA;MMP9;FAM83B;SPRY2;GRB7
3333,GO:0007044,0.0324830493268288,0.988142961024389,8,75,cell-substrate junction assembly,BP,SDC4;PHLDB2;ITGA5;SMAD3;VEGFA;LAMB3;SLC9A1;LAMA3
17587,GO:1901186,0.0325591600939734,0.993230213745484,4,27,positive regulation of ERBB signaling pathway,BP,PLAUR;EREG;TGFA;MMP9
20119,GO:2000758,0.0328458377467472,0.993151813229983,4,27,positive regulation of peptidyl-lysine acetylation,BP,IL1B;LIF;SOX4;MUC1
17523,GO:1900739,0.0329720423821953,0.993094567249211,4,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1;BBC3;TP53BP2;TP53
17524,GO:1900740,0.0329720423821953,0.993094567249211,4,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1;BBC3;TP53BP2;TP53
18183,GO:1902931,0.0329762207997583,0.997635216651985,2,7,negative regulation of alcohol biosynthetic process,BP,NFKB1;CYP27B1
1330,GO:0003179,0.0330211187331158,0.993155022712797,4,25,heart valve morphogenesis,BP,EFNA1;BMP2;TGFBR2;SOX4
11313,GO:0045622,0.0330307891663692,0.995157591449332,3,16,regulation of T-helper cell differentiation,BP,IL23A;RIPK2;IL4R
659,GO:0001848,0.0330801431716911,0.997623686676034,2,7,complement binding,MF,PTX3;CFB
1183,GO:0002827,0.0331325254932567,0.997617867225771,2,7,positive regulation of T-helper 1 type immune response,BP,IL23A;RIPK2
11490,GO:0045939,0.033135352872284,0.995136250796506,3,16,negative regulation of steroid metabolic process,BP,BMP2;NFKB1;CYP27B1
13433,GO:0052813,0.0331366178407108,0.991442836182067,5,36,phosphatidylinositol bisphosphate kinase activity,MF,HBEGF;EREG;FGF5;PDGFB;NRG1
11270,GO:0045517,0.0332208610757687,1,1,1,interleukin-20 receptor binding,MF,IL20
11271,GO:0045518,0.0332208610757687,1,1,1,interleukin-22 receptor binding,MF,IL20
6664,GO:0030014,0.0332362966744785,0.995161765873544,3,15,CCR4-NOT complex,CC,ZFP36;PATL1;TNKS1BP1
17458,GO:1900223,0.0333107517924022,0.997719353985807,2,6,positive regulation of amyloid-beta clearance,BP,LDLR;ABCA7
16406,GO:0097011,0.0333578112264268,0.997592779914524,2,7,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,CSF2;ZFP36
16407,GO:0097012,0.0333578112264268,0.997592779914524,2,7,response to granulocyte macrophage colony-stimulating factor,BP,CSF2;ZFP36
14892,GO:0070670,0.0333753785547867,0.993006397738192,4,27,response to interleukin-4,BP,IL4R;IL24;PML;XBP1
2020,GO:0004745,0.0334854492076773,0.997578523987358,2,7,retinol dehydrogenase activity,MF,BMP2;SDR16C5
9952,GO:0042310,0.0334926905561857,0.991291030264491,5,38,vasoconstriction,BP,EDN1;ICAM1;ADM;CAV1;DOCK4
16332,GO:0090504,0.0335282133130215,0.992989327593797,4,26,epiboly,BP,HBEGF;PHLDB2;ITGA5;DDR1
365,GO:0000983,0.0335415505300223,0.995099797772951,3,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,SMAD3;TAF4B;RELA
3483,GO:0007346,0.0335647477913184,0.978138507662728,36,577,regulation of mitotic cell cycle,BP,IL1B;TNF;IL1A;BTG2;EDN1;MAP2K3;EREG;DUSP1;GADD45A;PIM3;ZFP36L1;CYLD;CDKN1A;DCUN1D3;SMAD3;CDKN2B;PLK2;MAP3K8;BTG1;TGFA;SOX4;PDGFB;ANLN;BTG3;PLK3;TNKS1BP1;TPRA1;TP53;RAD9B;PML;PIM1;ESPL1;MUC1;KMT2E;NABP1;CEP135
9940,GO:0042287,0.0336630343441267,0.995028134756142,3,16,MHC protein binding,MF,TAP1;TAPBP;HLA-E
12671,GO:0050862,0.0338268462187399,0.997540242735664,2,7,positive regulation of T cell receptor signaling pathway,BP,CYLD;RELA
12630,GO:0050801,0.0340166083477232,0.979117179771736,28,425,ion homeostasis,BP,EDN1;BDKRB1;CYP27B1;STEAP4;C1QTNF1;NEDD4L;SMAD3;ABL2;CD55;ADM;SAA1;SLC11A2;MT2A;SLC9A1;SLC25A37;RHCG;CLIC4;CAV1;TP53;ITGAV;JPH2;PML;SLC9A8;PARP1;EGLN1;XBP1;SLC39A14;SLC41A1
6727,GO:0030134,0.0340496342779143,0.988434408539626,7,68,COPII-coated ER to Golgi transport vesicle,CC,CTSC;TGFA;HLA-A;HLA-B;HLA-F;HLA-E;LMAN1
19529,GO:1990384,0.0341372579164024,1,1,1,hyaloid vascular plexus regression,BP,NINJ1
8063,GO:0032725,0.0341929750928066,0.997498945524165,2,7,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,IL1B;IL23A
4542,GO:0010612,0.0342626493607692,0.997617673290885,2,6,regulation of cardiac muscle adaptation,BP,SMAD3;ERRFI1
18331,GO:1903242,0.0342626493607692,0.997617673290885,2,6,regulation of cardiac muscle hypertrophy in response to stress,BP,SMAD3;ERRFI1
16865,GO:0098771,0.0343472428590905,0.979305581786768,26,389,inorganic ion homeostasis,BP,EDN1;BDKRB1;CYP27B1;STEAP4;C1QTNF1;NEDD4L;SMAD3;ABL2;CD55;ADM;SAA1;SLC11A2;MT2A;SLC9A1;SLC25A37;RHCG;CLIC4;CAV1;TP53;ITGAV;JPH2;PML;SLC9A8;EGLN1;SLC39A14;SLC41A1
6656,GO:0030001,0.0343925517362837,0.978499743372371,30,452,metal ion transport,BP,IL16;BDKRB1;PANX1;CYP27B1;STEAP4;NEDD4L;SGK1;ICAM1;KCNJ15;HEPHL1;SLC28A3;NIPAL4;SLC11A2;PDGFB;SLC38A2;RRAD;CAB39;TRPV3;SLC9A1;SLC25A37;NEDD4;CAV1;ITGAV;GEM;JPH2;PML;SLC9A8;TSPAN13;SLC39A14;SLC41A1
8159,GO:0032885,0.0345009309507214,0.992748898865636,4,25,regulation of polysaccharide biosynthetic process,BP,NFKB1;PPP1R3B;PDGFB;GSK3B
11779,GO:0046627,0.0345541602206645,0.992679946961796,4,27,negative regulation of insulin receptor signaling pathway,BP,IL1B;SOCS2;PTPN1;RELA
20131,GO:2000778,0.0345763296325616,0.994839365581089,3,16,positive regulation of interleukin-6 secretion,BP,IL1B;IFIH1;XBP1
1242,GO:0002931,0.0346564524531447,0.992651441127939,4,27,response to ischemia,BP,PPIF;SQSTM1;PANX1;CAV1
649,GO:0001837,0.0346768725246787,0.986238513869295,9,94,epithelial to mesenchymal transition,BP,IL1B;EFNA1;BMP2;PHLDB2;BAMBI;SMAD3;TGFBR2;WNT5A;GSK3B
10861,GO:0044359,0.0348793154316128,0.997420856802234,2,7,modulation of molecular function in other organism,BP,PTX3;RAB9A
13338,GO:0052205,0.0348793154316128,0.997420856802234,2,7,modulation of molecular function in other organism involved in symbiotic interaction,BP,PTX3;RAB9A
10183,GO:0042771,0.0349240181824756,0.990740263391602,5,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,BCL3;CDKN1A;TP53;PML;MUC1
14398,GO:0061635,0.035064365504441,0.997399652945589,2,7,regulation of protein complex stability,BP,SQSTM1;TAPBP
3186,GO:0006810,0.0352387412473845,0.971553924100746,172,3353,transport,BP,CXCL8;IL1B;NFKBIA;CSF2;TNF;PLAU;CXCL1;IL1A;SDC4;INHBA;ZC3H12A;IL16;LIF;PLAUR;TBX3;PMAIP1;PTX3;IL1RN;NFKB1;PPIF;EDN1;ZFP36;RAB3IP;EHD1;HCAR2;SQSTM1;STARD5;NFKBIE;BBC3;BCL3;AMPD3;PLAGL2;IL6;ADAM8;BDKRB1;PIM3;PANX1;ZFP36L1;CYP27B1;RIPK2;TJP2;STEAP4;C1QTNF1;CDKN1A;CLDN1;RAP2B;ABCA5;TNFAIP2;NEDD4L;CTSC;NOD2;SGK1;ICAM1;RASSF9;B4GALT1;VEGFA;RAB24;IL1R2;SLC6A14;DKK1;ABL2;ANXA8;VMP1;CD55;KCNJ15;DENND3;TAP1;TP53BP2;HEPHL1;ADM;GJB3;SLC28A3;CREB1;NIPAL4;SLC7A2;CD47;CANT1;TGFBR2;MREG;DUSP16;SAA1;TINAGL1;KIF3C;WNT5A;VEGFC;SLC11A2;ABCF1;TGFA;SLC52A3;SOX4;SERPINB1;SOCS2;PDGFB;IFIH1;NRG1;SLC38A2;MMP9;LDLR;RRAD;CAB39;RHD;PLK3;ARRDC4;TRPV3;SLC9A1;SLC25A37;SYS1;FEZ1;CYTH1;CXCL16;NUP153;IL4R;NEDD4;RHCG;SLC2A6;POU2F2;ITSN2;MARCKS;BTN2A2;NFE2L2;PTPN1;SPTBN5;CLIC4;STAT5A;CAV1;RHOV;CACFD1;NECAP2;UGCG;TP53;TLR2;ABI1;TAPBP;RAB9A;ITGAV;GEM;UBE2D3;STX1A;TRIP10;MAPKBP1;JPH2;ABCA7;SPCS2;ADGRE2;PML;ADAM9;SLC43A3;TRIM16;SLC9A8;PPP6R3;TSPAN13;AXL;SLC16A13;ANXA5;FRK;NR4A3;HLA-E;GSK3B;PPARD;SLC16A1;TBC1D22B;COTL1;SRSF11;DDR1;XBP1;QKI;IL36RN;SLC39A14;MGAM;LMAN1;SLC41A1;GJC1
12906,GO:0051234,0.0353241122444972,0.971440992135582,176,3437,establishment of localization,BP,CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;PLAU;CXCL1;IL1A;SDC4;INHBA;ZC3H12A;IL16;LIF;PLAUR;TBX3;PMAIP1;PTX3;IL1RN;NFKB1;PPIF;EDN1;ZFP36;RAB3IP;EHD1;HCAR2;SQSTM1;STARD5;NFKBIE;BBC3;BCL3;AMPD3;PLAGL2;IL6;ADAM8;BDKRB1;PIM3;PANX1;ZFP36L1;CYP27B1;RIPK2;PHLDB2;TJP2;STEAP4;C1QTNF1;CDKN1A;CLDN1;RAP2B;ABCA5;TNFAIP2;NEDD4L;CTSC;NOD2;SGK1;ICAM1;RASSF9;B4GALT1;VEGFA;RAB24;IL1R2;SLC6A14;DKK1;ABL2;ANXA8;VMP1;CD55;KCNJ15;DENND3;TAP1;TP53BP2;HEPHL1;ADM;GJB3;SLC28A3;CREB1;NIPAL4;SLC7A2;CD47;CANT1;TGFBR2;MREG;DUSP16;SAA1;TINAGL1;KIF3C;WNT5A;VEGFC;SLC11A2;ABCF1;TGFA;SLC52A3;SOX4;SERPINB1;SOCS2;PDGFB;IFIH1;NRG1;SLC38A2;MMP9;LDLR;RRAD;CAB39;RHD;PLK3;ARRDC4;TRPV3;SLC9A1;SLC25A37;SYS1;SPRY2;FEZ1;CYTH1;CXCL16;NUP153;IL4R;NEDD4;RHCG;SLC2A6;POU2F2;ITSN2;MARCKS;BTN2A2;NFE2L2;PTPN1;SPTBN5;CLIC4;STAT5A;CAV1;RHOV;CACFD1;NECAP2;UGCG;TP53;TLR2;ABI1;TAPBP;RAB9A;ITGAV;GEM;UBE2D3;STX1A;TRIP10;MAPKBP1;JPH2;ABCA7;SPCS2;ADGRE2;PML;ESPL1;ADAM9;SLC43A3;TRIM16;SLC9A8;PPP6R3;TSPAN13;AXL;SLC16A13;ANXA5;FRK;NR4A3;HLA-E;GSK3B;PPARD;SLC16A1;TBC1D22B;COTL1;SRSF11;DDR1;XBP1;QKI;IL36RN;SLC39A14;MGAM;LMAN1;SLC41A1;GJC1
11823,GO:0046703,0.0353265567690946,0.997198711339487,2,9,natural killer cell lectin-like receptor binding,MF,RAET1L;HLA-E
3183,GO:0006807,0.0353639130864403,0.971143633315665,355,7381,nitrogen compound metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;ZNF267;SPRR2D;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;ZFP36L1;TNFSF15;SIX4;RIPK2;IRAK2;THAP10;KLHL21;DAPP1;JUNB;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;C1QTNF1;CDKN1A;NMNAT2;CCDC85B;ITGA5;RAP2B;IL7R;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;NOD2;ELMSAN1;IL6ST;DCUN1D3;SAV1;TFPI2;SGK1;ICAM1;GCH1;SMAD3;ZC3H12C;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;RNF144B;NFKBID;TRAF4;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;SLC6A14;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ZBED2;ABL2;PPTC7;CFLAR;RNF43;TXNRD1;KLF7;PIGA;BTG1;ANXA8;UPP1;IER5;PPP4R4;CEBPB;CEBPD;CD55;DENND3;NAMPT;ANKLE2;ADM;DSE;ERRFI1;ADAMTS1;ANKK1;CREB1;TAF4B;CCNL1;USP43;MAST4;NR4A2;PATL1;SLC7A2;CANT1;VHL;PHKG2;BACH1;ABTB2;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;MASTL;NAB1;ITGB8;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;DUSP10;SLC52A3;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;PGLYRP4;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;KIAA1586;ATF3;OTUD4;IKZF2;CAB39;TLE1;PLK3;CHD2;ARRDC4;SLC9A1;ZBTB10;MAOA;RCHY1;YAF2;SPRY2;TNKS1BP1;B4GALT5;HAL;GRB7;ARSJ;NUP153;RNF152;NEDD4;MMD;POU2F2;DUS4L;IL24;TNFRSF6B;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;ZC3H7B;DIEXF;NFAT5;STAT5A;TPST1;CAV1;VEZF1;SH3RF2;INO80D;TNIP2;ZNFX1;UGCG;TP53;KLF3;TLR2;ABI1;STK40;PUS10;TAPBP;PDP1;ITGAV;IKBKE;UBE2D3;PJA2;CD276;MAPKBP1;ELK3;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;ADAM9;RELA;TRIM16;ESCO2;FOXN2;CCBE1;PPP6R3;PLAT;CHST2;MUC1;YARS2;AXL;ELL2;SAT1;FRK;CITED4;NR4A3;USP31;GSK3B;KMT2E;PPARD;PARP8;PARP1;MMP10;KDM7A;MED13;MXD3;CRAMP1;LCE1C;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;RNF145;ALAS1;ZXDA;RPS6KA6;DDR1;XBP1;QKI;KCTD11;ZBTB5;ELF4;SREK1IP1;TFE3;EID3;ZMIZ2;LMAN1;CFB;JUND;DENND4A
13043,GO:0051480,0.0353877686979972,0.983710850812663,12,143,regulation of cytosolic calcium ion concentration,BP,EDN1;BDKRB1;C1QTNF1;SMAD3;ABL2;CD55;ADM;SAA1;CAV1;ITGAV;JPH2;PML
8356,GO:0033218,0.035412010541054,0.982091408115132,15,198,amide binding,MF,NFKBIA;INHBA;PPIF;BDKRB1;NOD2;TAP1;LDLR;NUP153;HLA-A;TLR2;TAPBP;HLA-B;ITGAV;HLA-F;HLA-E
12555,GO:0050691,0.0354956634921507,0.992391687411915,4,28,regulation of defense response to virus by host,BP,IL1B;TNFAIP3;ZC3H12A;IL23A
12552,GO:0050688,0.0355740653092654,0.989071870680619,6,53,regulation of defense response to virus,BP,IL1B;TNFAIP3;BIRC3;ZC3H12A;IL23A;BIRC2
9716,GO:0038127,0.0356389071269331,0.984236188155341,11,125,ERBB signaling pathway,BP,HBEGF;PLAUR;EREG;ABL2;ERRFI1;TGFA;NRG1;MMP9;FAM83B;SPRY2;GRB7
15605,GO:0072073,0.0360050903329164,0.985626328435192,9,92,kidney epithelium development,BP,SDC4;BMP2;LIF;SIX4;SMAD3;VEGFA;WNT7B;SMAD1;EFNB2
634,GO:0001821,0.0360228683178353,0.997189024447941,2,8,histamine secretion,BP,CSF2;EDN1
12614,GO:0050777,0.0361316613290013,0.986471405777237,8,84,negative regulation of immune response,BP,TNFAIP3;TNF;IL7R;NOD2;CD55;DUSP10;IL4R;HLA-E
4606,GO:0010718,0.0363518888991278,0.990337803334916,5,38,positive regulation of epithelial to mesenchymal transition,BP,IL1B;BMP2;BAMBI;SMAD3;TGFBR2
3776,GO:0008329,0.036356747587145,0.997249806824148,2,7,signaling pattern recognition receptor activity,MF,PGLYRP4;TLR2
9737,GO:0038187,0.036356747587145,0.997249806824148,2,7,pattern recognition receptor activity,MF,PGLYRP4;TLR2
12968,GO:0051336,0.0364967067792368,0.974220844563214,53,897,regulation of hydrolase activity,BP,TNF;EFNA1;BIRC3;PLEKHF1;CCL20;PPP1R15A;BMP2;PLAUR;PMAIP1;PTX3;PPIF;SERPINB2;JUN;EPHA2;BBC3;BIRC2;TNFRSF10B;TNFSF15;RIPK2;TNFAIP8;CPEB2;TFPI2;ICAM1;SMAD3;SERPINB8;VEGFA;FGD6;ABL2;CFLAR;ANXA8;PPP4R4;ANKLE2;CDC42EP4;ERRFI1;MASTL;WNT5A;PPP1R3B;SERPINB1;MMP9;RASGEF1B;SPRY2;TNFRSF6B;PTPN1;CAV1;SH3RF2;TP53;DOCK4;TRIP10;PML;PPP6R3;GSK3B;TBC1D22B;EGLN1
10383,GO:0043200,0.0365717712037289,0.986287588545589,8,82,response to amino acid,BP,TNF;EDN1;ICAM1;CEBPB;CREB1;TP53;RELA;XBP1
9394,GO:0035929,0.0367045962773602,0.997208952832207,2,7,steroid hormone secretion,BP,INHBA;C1QTNF1
2184,GO:0005031,0.0367078623340752,0.994344778830638,3,17,tumor necrosis factor-activated receptor activity,MF,TNFRSF10B;RELT;TNFRSF6B
2186,GO:0005035,0.0367078623340752,0.994344778830638,3,17,death receptor activity,MF,TNFRSF10B;RELT;TNFRSF6B
14752,GO:0070412,0.0367710568186477,0.994430173152239,3,15,R-SMAD binding,MF,JUN;SMAD3;PARP1
4548,GO:0010623,0.0369006386447201,0.997185831090733,2,7,programmed cell death involved in cell development,BP,IL1B;IL1A
2122,GO:0004910,0.0369397785997858,1,1,1,interleukin-1, Type II, blocking receptor activity,MF,IL1R2
8046,GO:0032690,0.0369397785997858,1,1,1,negative regulation of interleukin-1 alpha production,BP,IL1R2
12573,GO:0050712,0.0369397785997858,1,1,1,negative regulation of interleukin-1 alpha secretion,BP,IL1R2
19189,GO:1905209,0.0369629689145728,0.994336405080898,3,16,positive regulation of cardiocyte differentiation,BP,EDN1;NRG1;EFNB2
684,GO:0001891,0.0370065666461023,0.994327089279633,3,16,phagocytic cup,CC,TNF;TRIP10;ABCA7
6885,GO:0030377,0.0370585449365868,1,1,1,urokinase plasminogen activator receptor activity,MF,PLAUR
9744,GO:0038195,0.0370585449365868,1,1,1,urokinase plasminogen activator signaling pathway,BP,PLAUR
16919,GO:0098869,0.0371225049527299,0.988380886771798,6,63,cellular oxidant detoxification,BP,TNF;SOD2;GPX3;GCH1;TXNRD1;NFE2L2
11405,GO:0045779,0.037138443295703,0.997157690145609,2,7,negative regulation of bone resorption,BP,TNFAIP3;IL6
14515,GO:0062013,0.0371435606073688,0.985064383606118,9,96,positive regulation of small molecule metabolic process,BP,IL1B;TNF;PMAIP1;NFKB1;ADM;PHKG2;WNT5A;PDGFB;NR4A3
3454,GO:0007267,0.0371650926877109,0.973637178974762,54,908,cell-cell signaling,BP,IL1B;TNF;EFNA1;INHBA;CCL20;CXCL5;BMP2;LIF;IL36G;TBX3;IL1RN;NFKB1;EDN1;HCAR2;SQSTM1;EREG;EFNB1;IL6;PIM3;PANX1;CYLD;FZD8;BAMBI;C1QTNF1;AMOTL2;FJX1;SMAD3;NRARP;DKK1;FGF5;PLK2;RNF43;NAMPT;ADM;CREB1;WISP1;NR4A2;RUNX1;SMURF2;WNT5A;SOX4;PDGFB;TNC;TLE1;MARCKS;WNT7B;CAV1;TLR2;EFNB2;STX1A;GSK3B;PPARD;SLC16A1;GJC1
7519,GO:0031700,0.0372099844459176,1,1,1,adrenomedullin receptor binding,MF,ADM
13537,GO:0055094,0.0374018385268529,0.994242422135964,3,16,response to lipoprotein particle,BP,TICAM1;HMGCS1;LDLR
4608,GO:0010720,0.0374129399221928,0.977780669687265,24,340,positive regulation of cell development,BP,BMP2;LIF;EDN1;CSF1;NEDD4L;IL6ST;DLX2;TRIB1;VEGFA;DKK1;ABL2;CFLAR;TGIF2;WNT5A;VEGFC;SOCS2;NRG1;FEZ1;MMD;ITSN2;NFE2L2;TLR2;RELA;KCTD11
7187,GO:0031065,0.0374740552013331,0.994226913163147,3,16,positive regulation of histone deacetylation,BP,VEGFA;TP53;SDR16C5
3441,GO:0007250,0.0374952607413302,0.994222356791071,3,16,activation of NF-kappaB-inducing kinase activity,BP,TNFRSF10B;TNFSF15;TRAF4
15814,GO:0072488,0.0376037755418014,0.997102328264571,2,7,ammonium transmembrane transport,BP,RHD;RHCG
18266,GO:1903071,0.0376262046288887,0.997099649934559,2,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,NFE2L2;CAV1
12355,GO:0048708,0.0376379876329385,0.989865822821441,5,40,astrocyte differentiation,BP,BMP2;LIF;IL6ST;LDLR;VIM
7531,GO:0031731,0.037696011971442,0.99963857263307,1,2,CCR6 chemokine receptor binding,MF,CCL20
11424,GO:0045823,0.0377217619553739,0.994125871529191,3,17,positive regulation of heart contraction,BP,EDN1;GCH1;ADM
3196,GO:0006825,0.0377802015259082,0.994071007743874,3,18,copper ion transport,BP,STEAP4;HEPHL1;SLC11A2
9853,GO:0042095,0.0378262385957175,0.997075723135392,2,7,interferon-gamma biosynthetic process,BP,INHBA;CD276
15635,GO:0072110,0.0378276777940892,0.99707555072651,2,7,glomerular mesangial cell proliferation,BP,CFLAR;PDGFB
15639,GO:0072124,0.0378276777940892,0.99707555072651,2,7,regulation of glomerular mesangial cell proliferation,BP,CFLAR;PDGFB
12604,GO:0050767,0.0379493949641676,0.975533347628192,33,497,regulation of neurogenesis,BP,EFNA1;BMP2;LIF;CSF1;NEDD4L;IL6ST;DLX2;VEGFA;DKK1;ZSWIM4;PLK2;ABL2;CFLAR;CREB1;SEMA4B;TGIF2;WNT5A;VEGFC;DUSP10;SOCS2;NRG1;LDLR;FEZ1;NEDD4;MMD;ITSN2;NFE2L2;TLR2;EFNB2;RELA;GSK3B;VIM;KCTD11
17546,GO:1901028,0.0380256649875357,0.989685139341068,5,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1;BBC3;TP53BP2;TP53;GSK3B
9154,GO:0035504,0.0380568162833077,1,1,1,regulation of myosin light chain kinase activity,BP,IL1B
9155,GO:0035505,0.0380568162833077,1,1,1,positive regulation of myosin light chain kinase activity,BP,IL1B
10889,GO:0044425,0.0381403296343331,0.968937345368789,190,3704,membrane part,CC,TNF;HBEGF;EFNA1;SDC4;BIRC3;PLEKHF1;FOSL1;ZC3H12A;PPP1R15A;RNF19B;BMP2;PLAUR;CD83;IER3;PPIF;HCAR3;IFNAR2;EPHA2;GPR156;EHD1;HCAR2;CSF1;EREG;EFNB1;BIRC2;IFNGR2;IL6;ADAM8;TNFRSF10B;BDKRB1;PANX1;TNFSF15;CYLD;FZD8;BAMBI;STEAP4;C1QTNF1;AMOTL2;CLDN1;ITGA5;RAP2B;ABCA5;IL7R;NAV3;NOD2;IL6ST;RELT;TMCC3;SGK1;ICAM1;B4GALT1;B3GNT5;RNF144B;TM4SF1;NINJ1;IL1R2;SLC6A14;ABL2;C3ORF52;CFLAR;RNF43;PIGA;TMEM217;LAYN;VMP1;CD55;KCNJ15;TAP1;TMEM106A;ANKLE2;HEPHL1;GJB3;SLC28A3;IFNAR1;DSE;ERRFI1;GJB4;NIPAL4;SLC7A2;CD47;CANT1;SEMA4B;TGFBR2;MREG;SMURF2;TMEM265;IFNGR1;MASTL;ITGB8;SLC11A2;TGFA;SLC52A3;ROBO4;PDGFB;CD82;EFHD2;NRG1;SLC38A2;TMEM154;LDLR;DCBLD2;TRAF3IP3;RHD;PARD6B;TRPV3;FAM57A;SUCO;SLC9A1;SLC25A37;SYS1;MAOA;SPRY2;B4GALT5;CYTH1;CXCL16;RNF152;IL4R;NEDD4;MMD;RHCG;SLC2A6;TNFRSF6B;RAET1L;BTN2A2;PTPN1;SMAD1;SGMS2;SPTBN5;SUSD6;TPRA1;CLIC4;TPST1;CAV1;CACFD1;HLA-A;DRAM1;NECAP2;UGCG;TLR2;ABI1;TAPBP;EFNB2;RAB9A;HLA-B;ITGAV;PRRG1;GEM;PJA2;STX1A;CD276;TRIP10;JPH2;ABCA7;SPCS2;TMEM132A;ADGRE2;SDR16C5;HS3ST3B1;PML;ADAM9;SLC43A3;EMP3;SLC9A8;EVI2B;TSPAN13;CHST2;MUC1;AXL;SLC16A13;ANXA5;THSD1;CRB3;FRK;HLA-F;HLA-E;OSMR;SLC16A1;EVC;OCLN;CLDND1;RNF145;DDR1;XBP1;EPB41L3;SLC39A14;ERVFRD-1;MGAM;LMAN1;SLC41A1;GJC1
19933,GO:2000403,0.0383460480892016,0.993989864231988,3,17,positive regulation of lymphocyte migration,BP,CCL20;ADAM8;WNT5A
14272,GO:0061311,0.0383468655178158,0.994038495925474,3,16,cell surface receptor signaling pathway involved in heart development,BP,BMP2;DKK1;WNT5A
2539,GO:0005794,0.0384050857579266,0.971773622268878,67,1152,Golgi apparatus,CC,SDC4;PPP1R15A;ELF3;EHF;NFKBIE;IFNGR2;FZD8;STEAP4;NMNAT2;ITGA5;GBP2;ABCA5;NEDD4L;CTSC;NOD2;B4GALT1;B3GNT5;RND3;FGD6;CD55;DSE;GORAB;NEDD9;CANT1;PDE4DIP;PNRC2;WNT5A;CAMK1G;TGFA;DUSP10;PDGFB;LDLR;PLK3;SYS1;FEZ1;B4GALT5;CYTH1;NEDD4;MMD;NFE2L2;WNT7B;SGMS2;TPST1;CAV1;HLA-A;UGCG;GOLGA8B;TLR2;TAPBP;RAB9A;HLA-B;PJA2;DOCK4;TRIP10;ABCA7;TMEM132A;ZNF148;HS3ST3B1;ESCO2;SLC9A8;PPP6R3;CHST2;MUC1;SLC16A13;HLA-F;HLA-E;LMAN1
3030,GO:0006576,0.0384393652630424,0.991501487189146,4,30,cellular biogenic amine metabolic process,BP,ODC1;MAOA;PAOX;SAT1
6655,GO:0023061,0.0385306269425081,0.97898031262394,18,244,signal release,BP,IL1B;TNF;INHBA;LIF;TBX3;IL1RN;EDN1;HCAR2;IL6;PIM3;C1QTNF1;ADM;CREB1;SOX4;MARCKS;STX1A;PPARD;SLC16A1
1343,GO:0003199,0.0385307612516141,1,1,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,EFNA1
4828,GO:0014028,0.0385307612516141,1,1,1,notochord formation,BP,EFNA1
6924,GO:0030512,0.0385336980270538,0.98793658613782,6,53,negative regulation of transforming growth factor beta receptor signaling pathway,BP,BAMBI;ZNF451;SMAD3;TGFBR2;SMURF2;CAV1
6285,GO:0019885,0.0386157618810351,0.996980583661004,2,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,TAP1;TAPBP
9452,GO:0036037,0.0386651243747914,0.996974598290327,2,7,CD8-positive, alpha-beta T cell activation,BP,IRF1;HLA-E
10169,GO:0042752,0.0387005392619063,0.986501023103268,7,67,regulation of circadian rhythm,BP,CSF2;NOCT;BHLHE40;ARNTL2;CREB1;TP53;PML
8146,GO:0032868,0.0387887380629267,0.98015954879203,15,193,response to insulin,BP,IL1B;ZFP36L1;CPEB2;ICAM1;CFLAR;ADM;ERRFI1;SOGA1;SOCS2;SLC9A1;PTPN1;TLR2;RELA;PARP1;XBP1
14100,GO:0060911,0.0388956491922274,0.996946588801445,2,7,cardiac cell fate commitment,BP,TBX3;DKK1
10140,GO:0042698,0.038921291178686,0.989443301335992,5,39,ovulation cycle,BP,INHBA;ETS1;EREG;ADAMTS1;AXL
11888,GO:0046886,0.0389656865170306,0.996938060284475,2,7,positive regulation of hormone biosynthetic process,BP,IL1B;TNF
3187,GO:0006811,0.0391991414365948,0.972362732990336,51,862,ion transport,BP,IL1B;CSF2;IL16;PPIF;EDN1;STARD5;NFKBIE;BDKRB1;PANX1;CYP27B1;STEAP4;NEDD4L;SGK1;ICAM1;SLC6A14;KCNJ15;HEPHL1;SLC28A3;NIPAL4;SLC7A2;SLC11A2;SLC52A3;PDGFB;SLC38A2;MMP9;LDLR;RRAD;CAB39;RHD;TRPV3;SLC9A1;SLC25A37;NEDD4;RHCG;SLC2A6;CLIC4;CAV1;ITGAV;GEM;STX1A;JPH2;ABCA7;PML;SLC9A8;TSPAN13;SLC16A13;PPARD;SLC16A1;SLC39A14;SLC41A1;GJC1
9910,GO:0042228,0.0392636737504898,0.996901676506662,2,7,interleukin-8 biosynthetic process,BP,TNF;BCL3
11094,GO:0045086,0.0393295183461271,0.99689361569891,2,7,positive regulation of interleukin-2 biosynthetic process,BP,IL1B;IL1A
656,GO:0001844,0.039383426152692,0.991225514307563,4,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1;BBC3;TP53BP2;TP53
7324,GO:0031329,0.0395068488149435,0.973100322176915,42,692,regulation of cellular catabolic process,BP,IL1B;TNFAIP3;TNF;EFNA1;BTG2;PLEKHF1;NOCT;ZC3H12A;RNF19B;ZFP36;TICAM1;ADAM8;N4BP1;ZFP36L1;RIPK2;CTSC;RNF144B;TRIB1;PLK2;ABL2;PHKG2;SOGA1;PPP1R3B;LDLR;PLK3;RCHY1;FEZ1;NUP153;RNF152;NEDD4;NFE2L2;PTPN1;TAB3;CAV1;DRAM1;PML;ADAM9;GSK3B;VIM;EGLN1;XBP1;QKI
17376,GO:1900077,0.0395202464326768,0.991236061223937,4,28,negative regulation of cellular response to insulin stimulus,BP,IL1B;SOCS2;PTPN1;RELA
12313,GO:0048642,0.039727022924355,0.996844789240287,2,7,negative regulation of skeletal muscle tissue development,BP,SIX4;DKK1
6071,GO:0019216,0.0397680528986627,0.977833773386874,19,261,regulation of lipid metabolic process,BP,IL1B;TNF;BMP2;NFKB1;G0S2;HCAR2;CYP27B1;NOD2;TXNRD1;CREB1;HMGCS1;PDGFB;LDLR;LACTB;CAV1;PDP1;NR4A3;PPARD;ALAS1
3647,GO:0008120,0.0399956162495203,1,1,1,ceramide glucosyltransferase activity,MF,UGCG
17181,GO:0102769,0.0399956162495203,1,1,1,dihydroceramide glucosyltransferase activity,MF,UGCG
13264,GO:0051928,0.0399993570659253,0.987340857354248,6,55,positive regulation of calcium ion transport,BP,BDKRB1;PDGFB;TRPV3;SLC9A1;CAV1;JPH2
4687,GO:0010832,0.040071617385192,0.996802235721188,2,7,negative regulation of myotube differentiation,BP,CFLAR;XBP1
18605,GO:1903844,0.0403693989393151,0.984568153709704,8,82,regulation of cellular response to transforming growth factor beta stimulus,BP,BAMBI;ZNF451;SMAD3;CDKN2B;CFLAR;TGFBR2;SMURF2;CAV1
1213,GO:0002876,0.0404239071890716,1,1,1,positive regulation of chronic inflammatory response to antigenic stimulus,BP,TNF
1240,GO:0002925,0.0404239071890716,1,1,1,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,TNF
14180,GO:0061048,0.0404239071890716,1,1,1,negative regulation of branching involved in lung morphogenesis,BP,TNF
15863,GO:0072564,0.0404239071890716,1,1,1,blood microparticle formation,BP,TNF
19115,GO:1904999,0.0404239071890716,1,1,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,TNF
19884,GO:2000332,0.0404239071890716,1,1,1,regulation of blood microparticle formation,BP,TNF
19885,GO:2000334,0.0404239071890716,1,1,1,positive regulation of blood microparticle formation,BP,TNF
7846,GO:0032398,0.0405866705913156,1,1,1,MHC class Ib protein complex,CC,HLA-E
8014,GO:0032639,0.0405866705913156,1,1,1,TRAIL production,BP,HLA-E
8038,GO:0032679,0.0405866705913156,1,1,1,regulation of TRAIL production,BP,HLA-E
8083,GO:0032759,0.0405866705913156,1,1,1,positive regulation of TRAIL production,BP,HLA-E
20003,GO:2000566,0.0405866705913156,1,1,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,HLA-E
20267,GO:2001187,0.0405866705913156,1,1,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,HLA-E
8010,GO:0032633,0.0406769764952577,0.993473968084332,3,17,interleukin-4 production,BP,CD83;CEBPB;HLA-E
14219,GO:0061134,0.0407435160307434,0.983272559352191,9,108,peptidase regulator activity,MF,BIRC3;SERPINB2;BIRC2;TNFAIP8;CTSC;TFPI2;SERPINB8;SERPINB1;CAV1
4784,GO:0010967,0.040806410535106,1,1,1,regulation of polyamine biosynthetic process,BP,PAOX
13465,GO:0052899,0.040806410535106,1,1,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,PAOX
13467,GO:0052902,0.040806410535106,1,1,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,PAOX
13468,GO:0052903,0.040806410535106,1,1,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,PAOX
13469,GO:0052904,0.040806410535106,1,1,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,PAOX
17630,GO:1901304,0.040806410535106,1,1,1,regulation of spermidine biosynthetic process,BP,PAOX
17631,GO:1901307,0.040806410535106,1,1,1,positive regulation of spermidine biosynthetic process,BP,PAOX
14487,GO:0061880,0.0408662825261181,1,1,1,regulation of anterograde axonal transport of mitochondrion,BP,FEZ1
14488,GO:0061881,0.0408662825261181,1,1,1,positive regulation of anterograde axonal transport of mitochondrion,BP,FEZ1
12744,GO:0050994,0.0409377471428433,0.990819280179016,4,28,regulation of lipid catabolic process,BP,IL1B;TNF;HCAR2;LDLR
693,GO:0001910,0.0409515587552614,0.990762176122731,4,30,regulation of leukocyte mediated cytotoxicity,BP,IL23A;IL7R;ICAM1;HLA-E
14331,GO:0061469,0.0409638894692505,0.99669107895647,2,7,regulation of type B pancreatic cell proliferation,BP,ERRFI1;NR4A3
699,GO:0001916,0.0411055261661499,0.996551470512256,2,8,positive regulation of T cell mediated cytotoxicity,BP,IL23A;HLA-E
4742,GO:0010906,0.0411641453823431,0.985450157803692,7,67,regulation of glucose metabolic process,BP,PMAIP1;PHLDA2;C1QTNF1;PHKG2;SOGA1;PPP1R3B;GSK3B
16309,GO:0090400,0.0411718344211843,0.996664973255629,2,7,stress-induced premature senescence,BP,CDKN1A;TP53
18101,GO:1902692,0.0412225912923639,0.993405151522652,3,16,regulation of neuroblast proliferation,BP,VEGFA;VEGFC;KCTD11
5858,GO:0017151,0.0412419053575576,0.99665615943704,2,7,DEAD/H-box RNA helicase binding,MF,SMAD3;SMAD1
1132,GO:0002718,0.0412778321712557,0.988551885087985,5,43,regulation of cytokine production involved in immune response,BP,TNF;IL6;NOD2;WNT5A;NR4A3
13536,GO:0055093,0.0413078745660335,0.993332174381105,3,17,response to hyperoxia,BP,CDKN1A;CAV1;TP53
11093,GO:0045085,0.0413267842490749,1,1,1,negative regulation of interleukin-2 biosynthetic process,BP,ZFP36
16852,GO:0098745,0.0413267842490749,1,1,1,Dcp1-Dcp2 complex,CC,ZFP36
17790,GO:1901834,0.0413267842490749,1,1,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,ZFP36
17791,GO:1901835,0.0413267842490749,1,1,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,ZFP36
18779,GO:1904246,0.0413267842490749,1,1,1,negative regulation of polynucleotide adenylyltransferase activity,BP,ZFP36
10285,GO:0043027,0.0413873559676103,0.993314246568425,3,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,BIRC3;BIRC2;TNFAIP8
16751,GO:0097756,0.0414425137845141,0.988546913145636,5,40,negative regulation of blood vessel diameter,BP,EDN1;ICAM1;ADM;CAV1;DOCK4
12854,GO:0051151,0.0414684005835161,0.996627611325729,2,7,negative regulation of smooth muscle cell differentiation,BP,EREG;PDGFB
11889,GO:0046887,0.0415218345179595,0.985267280661236,7,70,positive regulation of hormone secretion,BP,INHBA;EDN1;HCAR2;C1QTNF1;CREB1;SOX4;PPARD
3833,GO:0008430,0.041523179506205,1,1,1,selenium binding,MF,GPX3
489,GO:0001541,0.0415981273034656,0.988455721939557,5,42,ovarian follicle development,BP,INHBA;EREG;ICAM1;VEGFA;CEBPB
15647,GO:0072132,0.0416044286465643,0.990651799546151,4,27,mesenchyme morphogenesis,BP,BMP2;SMAD3;TGFBR2;WNT5A
11227,GO:0045352,0.0417541417437657,1,1,1,interleukin-1 Type I receptor antagonist activity,MF,IL1RN
11228,GO:0045353,0.0417541417437657,1,1,1,interleukin-1 Type II receptor antagonist activity,MF,IL1RN
4357,GO:0009948,0.0417572715756541,0.990576067946232,4,28,anterior/posterior axis specification,BP,TBX3;ETS2;NRARP;WNT5A
7970,GO:0032570,0.0418242115979429,0.990527919074153,4,29,response to progesterone,BP,FOSL1;CAV1;TLR2;RELA
18415,GO:1903427,0.0418447608257812,0.993162465581993,3,18,negative regulation of reactive oxygen species biosynthetic process,BP,ZC3H12A;CFLAR;CAV1
996,GO:0002455,0.0418876201950478,0.993152681745174,3,18,humoral immune response mediated by circulating immunoglobulin,BP,TNF;BCL3;CD55
594,GO:0001756,0.0419267260289913,0.988396358180658,5,39,somitogenesis,BP,SMAD3;NRARP;DKK1;WNT5A;ABI1
3922,GO:0008591,0.0419655211766175,1,1,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,DKK1
10131,GO:0042662,0.0419655211766175,1,1,1,negative regulation of mesodermal cell fate specification,BP,DKK1
11417,GO:0045813,0.0419655211766175,1,1,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,DKK1
14444,GO:0061743,0.0419655211766175,1,1,1,motor learning,BP,DKK1
16113,GO:0090081,0.0419655211766175,1,1,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,DKK1
16114,GO:0090082,0.0419655211766175,1,1,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,DKK1
16299,GO:0090381,0.0419655211766175,1,1,1,regulation of heart induction,BP,DKK1
16927,GO:0098883,0.0419655211766175,1,1,1,synapse disassembly,BP,DKK1
17119,GO:0100012,0.0419655211766175,1,1,1,regulation of heart induction by canonical Wnt signaling pathway,BP,DKK1
17623,GO:1901296,0.0419655211766175,1,1,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,DKK1
17636,GO:1901321,0.0419655211766175,1,1,1,positive regulation of heart induction,BP,DKK1
18963,GO:1904701,0.0419655211766175,1,1,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,DKK1
18968,GO:1904711,0.0419655211766175,1,1,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,DKK1
18978,GO:1904723,0.0419655211766175,1,1,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,DKK1
19144,GO:1905067,0.0419655211766175,1,1,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,DKK1
19379,GO:1905771,0.0419655211766175,1,1,1,negative regulation of mesodermal cell differentiation,BP,DKK1
19417,GO:1905903,0.0419655211766175,1,1,1,negative regulation of mesoderm formation,BP,DKK1
2125,GO:0004917,0.041985198507325,1,1,1,interleukin-7 receptor activity,MF,IL7R
9140,GO:0035470,0.0419999052272502,1,1,1,positive regulation of vascular wound healing,BP,XBP1
13994,GO:0060690,0.0419999052272502,1,1,1,epithelial cell differentiation involved in salivary gland development,BP,XBP1
13995,GO:0060691,0.0419999052272502,1,1,1,epithelial cell maturation involved in salivary gland development,BP,XBP1
17386,GO:1900098,0.0419999052272502,1,1,1,regulation of plasma cell differentiation,BP,XBP1
17387,GO:1900100,0.0419999052272502,1,1,1,positive regulation of plasma cell differentiation,BP,XBP1
18439,GO:1903489,0.0419999052272502,1,1,1,positive regulation of lactation,BP,XBP1
669,GO:0001871,0.0420078658265529,0.996559256031745,2,7,pattern binding,MF,PTX3;TINAGL1
6807,GO:0030247,0.0420078658265529,0.996559256031745,2,7,polysaccharide binding,MF,PTX3;TINAGL1
15618,GO:0072091,0.0420154989412536,0.988345129440687,5,40,regulation of stem cell proliferation,BP,TBX3;ZFP36L1;VEGFA;VEGFC;KCTD11
7652,GO:0032059,0.0420280788312218,0.996556685033182,2,7,bleb,CC,PANX1;ANLN
2089,GO:0004850,0.0420437625808382,1,1,1,uridine phosphorylase activity,MF,UPP1
2786,GO:0006218,0.0420437625808382,1,1,1,uridine catabolic process,BP,UPP1
11572,GO:0046108,0.0420437625808382,1,1,1,uridine metabolic process,BP,UPP1
5421,GO:0016264,0.0421464258771854,0.99654161763884,2,7,gap junction assembly,BP,CAV1;GJC1
7160,GO:0031016,0.0421586306321263,0.988275592589621,5,41,pancreas development,BP,IL6;WNT5A;SOX4;GSK3B;XBP1
4470,GO:0010463,0.0422471216948206,0.990460744810443,4,27,mesenchymal cell proliferation,BP,BMP2;VEGFA;TGFBR2;WNT5A
8235,GO:0032996,0.0425574492341759,1,1,1,Bcl3-Bcl10 complex,CC,BCL3
11090,GO:0045082,0.0425574492341759,1,1,1,positive regulation of interleukin-10 biosynthetic process,BP,BCL3
8093,GO:0032770,0.0426483765241299,0.992978324662763,3,18,positive regulation of monooxygenase activity,BP,IL1B;TNF;GCH1
2942,GO:0006469,0.0428363302124389,0.977780971745983,15,200,negative regulation of protein kinase activity,BP,IL1B;TNFAIP3;DUSP1;GADD45A;CDKN1A;TRIB1;CDKN2B;ERRFI1;DUSP16;DUSP10;SOCS2;DUSP8;SPRY2;PTPN1;CAV1
428,GO:0001135,0.0428860341048594,0.996446905617245,2,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,MYBL1;SNAPC4
2206,GO:0005088,0.0429389067781969,0.978328480952425,14,172,Ras guanyl-nucleotide exchange factor activity,MF,CSF2;HBEGF;RAB3IP;EREG;ARHGEF3;FGD6;FGF5;DENND3;PDGFB;NRG1;RASGEF1B;ITSN2;SPTBN5;DENND4A
670,GO:0001872,0.0431058830186157,1,1,1,(1->3)-beta-D-glucan binding,MF,PTX3
11029,GO:0044866,0.0431058830186157,1,1,1,modulation by host of viral exo-alpha-sialidase activity,BP,PTX3
11030,GO:0044867,0.0431058830186157,1,1,1,modulation by host of viral catalytic activity,BP,PTX3
11032,GO:0044869,0.0431058830186157,1,1,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,PTX3
11033,GO:0044870,0.0431058830186157,1,1,1,modulation by host of viral glycoprotein metabolic process,BP,PTX3
11034,GO:0044871,0.0431058830186157,1,1,1,negative regulation by host of viral glycoprotein metabolic process,BP,PTX3
13360,GO:0052403,0.0431058830186157,1,1,1,negative regulation by host of symbiont catalytic activity,BP,PTX3
18235,GO:1903015,0.0431058830186157,1,1,1,regulation of exo-alpha-sialidase activity,BP,PTX3
18236,GO:1903016,0.0431058830186157,1,1,1,negative regulation of exo-alpha-sialidase activity,BP,PTX3
7785,GO:0032305,0.0431720755195932,0.996278802498019,2,8,positive regulation of icosanoid secretion,BP,IL1B;EDN1
19800,GO:2000193,0.0431720755195932,0.996278802498019,2,8,positive regulation of fatty acid transport,BP,IL1B;EDN1
1543,GO:0003933,0.0432417472918212,1,1,1,GTP cyclohydrolase activity,MF,GCH1
1544,GO:0003934,0.0432417472918212,1,1,1,GTP cyclohydrolase I activity,MF,GCH1
9431,GO:0035998,0.0432417472918212,1,1,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,GCH1
3222,GO:0006873,0.0432672131767791,0.974203348605832,23,344,cellular ion homeostasis,BP,EDN1;BDKRB1;C1QTNF1;NEDD4L;SMAD3;ABL2;CD55;ADM;SAA1;SLC11A2;MT2A;SLC9A1;RHCG;CLIC4;CAV1;TP53;ITGAV;JPH2;PML;SLC9A8;EGLN1;SLC39A14;SLC41A1
17778,GO:1901740,0.0432881916237665,1,1,1,negative regulation of myoblast fusion,BP,CFLAR
18656,GO:1903943,0.0432881916237665,1,1,1,regulation of hepatocyte apoptotic process,BP,CFLAR
18657,GO:1903944,0.0432881916237665,1,1,1,negative regulation of hepatocyte apoptotic process,BP,CFLAR
19916,GO:2000380,0.0432908568597922,0.996394666100146,2,7,regulation of mesoderm development,BP,DKK1;RPS6KA6
14185,GO:0061053,0.0433087846895647,0.986072412738665,6,52,somite development,BP,SIX4;SMAD3;NRARP;DKK1;WNT5A;ABI1
13514,GO:0055065,0.0433506069776223,0.974473142017012,22,325,metal ion homeostasis,BP,EDN1;BDKRB1;CYP27B1;STEAP4;C1QTNF1;NEDD4L;SMAD3;ABL2;CD55;ADM;SAA1;SLC11A2;MT2A;SLC9A1;SLC25A37;CAV1;ITGAV;JPH2;PML;EGLN1;SLC39A14;SLC41A1
1438,GO:0003413,0.043361730934948,0.996385491351662,2,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,TGFBR2;COL27A1
10979,GO:0044764,0.0433790871069108,0.990060460920767,4,29,multi-organism cellular process,BP,BIRC3;BIRC2;PGLYRP4;IFIH1
16275,GO:0090322,0.0433943467137851,0.992761044392806,3,19,regulation of superoxide metabolic process,BP,TNF;GCH1;NFE2L2
3418,GO:0007204,0.0434085547021719,0.980152026555732,11,132,positive regulation of cytosolic calcium ion concentration,BP,EDN1;BDKRB1;C1QTNF1;ABL2;CD55;ADM;SAA1;CAV1;ITGAV;JPH2;PML
7762,GO:0032274,0.0434101640581284,0.996379216661098,2,7,gonadotropin secretion,BP,INHBA;TBX3
14060,GO:0060795,0.0434307103300223,0.992848449213054,3,17,cell fate commitment involved in formation of primary germ layer,BP,ETS2;DKK1;SMAD1
9134,GO:0035456,0.0434866835998132,0.992699131744977,3,20,response to interferon-beta,BP,IRF1;IFNAR2;IKBKE
11345,GO:0045660,0.0435073395737128,1,1,1,positive regulation of neutrophil differentiation,BP,EVI2B
2102,GO:0004866,0.0435314681756961,0.984334084540935,7,77,endopeptidase inhibitor activity,MF,BIRC3;SERPINB2;BIRC2;TNFAIP8;TFPI2;SERPINB8;SERPINB1
6892,GO:0030414,0.0435314681756961,0.984334084540935,7,77,peptidase inhibitor activity,MF,BIRC3;SERPINB2;BIRC2;TNFAIP8;TFPI2;SERPINB8;SERPINB1
4910,GO:0014841,0.043574107508831,0.996357947347072,2,7,skeletal muscle satellite cell proliferation,BP,CFLAR;PPARD
4911,GO:0014842,0.043574107508831,0.996357947347072,2,7,regulation of skeletal muscle satellite cell proliferation,BP,CFLAR;PPARD
4921,GO:0014856,0.043574107508831,0.996357947347072,2,7,skeletal muscle cell proliferation,BP,CFLAR;PPARD
4922,GO:0014857,0.043574107508831,0.996357947347072,2,7,regulation of skeletal muscle cell proliferation,BP,CFLAR;PPARD
9198,GO:0035579,0.0437406987603726,0.985857340362314,6,55,specific granule membrane,CC,PLAU;PLAUR;ADAM8;RAP2B;CD47;ITGAV
8546,GO:0033872,0.0437418426355083,1,1,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,HS3ST3B1
19972,GO:2000484,0.0437440548271623,0.996201990451278,2,8,positive regulation of interleukin-8 secretion,BP,WNT5A;TLR2
8477,GO:0033619,0.0437647795761655,0.985847681957614,6,55,membrane protein proteolysis,BP,IL1B;TNF;NFKB1;ADAM8;ADAM9;RELA
2290,GO:0005246,0.0438001568293688,0.992711869158492,3,18,calcium channel regulator activity,MF,SGK1;STX1A;TSPAN13
10273,GO:0043010,0.0438545961601043,0.977204867829035,15,191,camera-type eye development,BP,INHBA;JUN;EPHA2;FJX1;SMAD3;DLX2;NINJ1;VEGFA;TGFBR2;TGIF2;WNT5A;WNT7B;CLIC4;COL8A1;VIM
4064,GO:0009111,0.0438972619945719,0.996181317887149,2,8,vitamin catabolic process,BP,CYP27B1;CYP24A1
2650,GO:0005984,0.0439349794976614,0.996310967348586,2,7,disaccharide metabolic process,BP,B4GALT1;MGAM
14754,GO:0070417,0.0439595101215937,0.996307765761054,2,7,cellular response to cold,BP,NFKBIA;SLC9A1
1267,GO:0003018,0.0440170132935252,0.982867455759467,8,84,vascular process in circulatory system,BP,SOD2;EDN1;ICAM1;GCH1;ADM;CAV1;DOCK4;PPARD
10373,GO:0043185,0.0440395024733278,1,1,1,vascular endothelial growth factor receptor 3 binding,MF,VEGFC
4902,GO:0014826,0.0441266529775363,1,1,1,vein smooth muscle contraction,BP,EDN1
6763,GO:0030185,0.0441266529775363,1,1,1,nitric oxide transport,BP,EDN1
7452,GO:0031583,0.0441266529775363,1,1,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,EDN1
7523,GO:0031705,0.0441266529775363,1,1,1,bombesin receptor binding,MF,EDN1
7524,GO:0031707,0.0441266529775363,1,1,1,endothelin A receptor binding,MF,EDN1
7525,GO:0031708,0.0441266529775363,1,1,1,endothelin B receptor binding,MF,EDN1
9338,GO:0035815,0.0441266529775363,1,1,1,positive regulation of renal sodium excretion,BP,EDN1
9954,GO:0042313,0.0441266529775363,1,1,1,protein kinase C deactivation,BP,EDN1
10369,GO:0043179,0.0441266529775363,1,1,1,rhythmic excitation,BP,EDN1
7633,GO:0032028,0.0441753151552366,1,1,1,myosin head/neck binding,MF,STX1A
1117,GO:0002703,0.0441758307209242,0.981621490539976,9,103,regulation of leukocyte mediated immunity,BP,IL1B;TNF;IL23A;IL6;IL7R;NOD2;IL4R;ADGRE2;HLA-E
5179,GO:0015732,0.0442342683987169,0.996135699419847,2,8,prostaglandin transport,BP,IL1B;EDN1
11301,GO:0045603,0.0442875420422514,0.996264854419507,2,7,positive regulation of endothelial cell differentiation,BP,BTG1;VEZF1
13821,GO:0060396,0.0444212083420992,0.992678698069443,3,16,growth hormone receptor signaling pathway,BP,SOCS2;PTPN1;STAT5A
14628,GO:0070184,0.0444230876400997,1,1,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,YARS2
15851,GO:0072545,0.0444230876400997,1,1,1,tyrosine binding,MF,YARS2
7765,GO:0032277,0.0444760349705537,1,1,1,negative regulation of gonadotropin secretion,BP,INHBA
10559,GO:0043509,0.0444760349705537,1,1,1,activin A complex,CC,INHBA
10560,GO:0043511,0.0444760349705537,1,1,1,inhibin complex,CC,INHBA
10561,GO:0043512,0.0444760349705537,1,1,1,inhibin A complex,CC,INHBA
11085,GO:0045077,0.0444760349705537,1,1,1,negative regulation of interferon-gamma biosynthetic process,BP,INHBA
11884,GO:0046882,0.0444760349705537,1,1,1,negative regulation of follicle-stimulating hormone secretion,BP,INHBA
12130,GO:0048180,0.0444760349705537,1,1,1,activin complex,CC,INHBA
13728,GO:0060278,0.0444760349705537,1,1,1,regulation of ovulation,BP,INHBA
13729,GO:0060279,0.0444760349705537,1,1,1,positive regulation of ovulation,BP,INHBA
10884,GO:0044419,0.0445413608463857,0.96951721734414,41,727,interspecies interaction between organisms,BP,CXCL8;NFKBIA;TNF;ZC3H12A;IL16;PTX3;TNIP1;ZFP36;JUN;EPHA2;SQSTM1;CLDN1;ITGA5;NEDD4L;IL6ST;ICAM1;SMAD3;CFLAR;CD55;TAP1;CREB1;TRIM25;PGLYRP4;IFIH1;LDLR;NUP153;NEDD4;RAET1L;ZC3H7B;CAV1;HLA-A;TP53;ABI1;EFNB2;RAB9A;HLA-B;ITGAV;PML;RELA;AXL;VIM
14750,GO:0070410,0.044576438127763,0.996226910895074,2,7,co-SMAD binding,MF,SMAD3;SMAD1
2505,GO:0005753,0.0445815858606619,1,1,1,mitochondrial proton-transporting ATP synthase complex,CC,PPIF
4698,GO:0010849,0.0445815858606619,1,1,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,PPIF
19842,GO:2000276,0.0445815858606619,1,1,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,PPIF
3733,GO:0008269,0.0446300571120995,1,1,1,JAK pathway signal transduction adaptor activity,MF,SOCS2
5107,GO:0015389,0.0446887324601546,1,1,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,SLC28A3
5108,GO:0015390,0.0446887324601546,1,1,1,purine-specific nucleoside:sodium symporter activity,MF,SLC28A3
5109,GO:0015391,0.0446887324601546,1,1,1,nucleobase:cation symporter activity,MF,SLC28A3
18456,GO:1903523,0.044720044557741,0.992549745564225,3,17,negative regulation of blood circulation,BP,ZC3H12A;ADM;DOCK4
19131,GO:1905042,0.0447601245098141,1,1,1,negative regulation of epithelium regeneration,BP,DUSP10
18964,GO:1904705,0.0448883295906844,0.989601224016529,4,29,regulation of vascular smooth muscle cell proliferation,BP,TNF;JUN;PDGFB;MMP9
19672,GO:1990874,0.0448883295906844,0.989601224016529,4,29,vascular smooth muscle cell proliferation,BP,TNF;JUN;PDGFB;MMP9
17360,GO:1900036,0.0450707462401316,1,1,1,positive regulation of cellular response to heat,BP,IER5
1513,GO:0003870,0.0450796320108684,1,1,1,5-aminolevulinate synthase activity,MF,ALAS1
5658,GO:0016749,0.0450796320108684,1,1,1,N-succinyltransferase activity,MF,ALAS1
13066,GO:0051543,0.045134631687163,1,1,1,regulation of elastin biosynthetic process,BP,HBEGF
13067,GO:0051545,0.045134631687163,1,1,1,negative regulation of elastin biosynthetic process,BP,HBEGF
18972,GO:1904716,0.0451599464726653,1,1,1,positive regulation of chaperone-mediated autophagy,BP,PLK3
9632,GO:0036497,0.0451957232194196,1,1,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,PPP1R15A
17972,GO:1902310,0.0451957232194196,1,1,1,positive regulation of peptidyl-serine dephosphorylation,BP,PPP1R15A
18642,GO:1903916,0.0451957232194196,1,1,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,PPP1R15A
18643,GO:1903917,0.0451957232194196,1,1,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,PPP1R15A
12202,GO:0048340,0.0451958014416697,0.996145086557887,2,7,paraxial mesoderm morphogenesis,BP,SMAD3;WNT5A
6492,GO:0021840,0.045198437974313,1,1,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,NRG1
6493,GO:0021842,0.045198437974313,1,1,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,NRG1
2123,GO:0004913,0.0452199706767171,1,1,1,interleukin-4 receptor activity,MF,IL4R
15997,GO:0080163,0.0452319411456749,1,1,1,regulation of protein serine/threonine phosphatase activity,BP,PPP4R4
11870,GO:0046850,0.0452334432745756,0.989526551182419,4,28,regulation of bone remodeling,BP,TNFAIP3;IL6;ADAM8;SUCO
9133,GO:0035455,0.0452960723218066,0.992313703224868,3,19,response to interferon-alpha,BP,IFNAR2;IFNAR1;AXL
2247,GO:0005157,0.0453230781436753,1,1,1,macrophage colony-stimulating factor receptor binding,MF,CSF1
10040,GO:0042488,0.0453230781436753,1,1,1,positive regulation of odontogenesis of dentin-containing tooth,BP,CSF1
13956,GO:0060611,0.0453230781436753,1,1,1,mammary gland fat development,BP,CSF1
17930,GO:1902228,0.0453230781436753,1,1,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,CSF1
18671,GO:1903971,0.0453230781436753,1,1,1,positive regulation of response to macrophage colony-stimulating factor,BP,CSF1
18674,GO:1903974,0.0453230781436753,1,1,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,CSF1
18731,GO:1904124,0.0453230781436753,1,1,1,microglial cell migration,BP,CSF1
18732,GO:1904139,0.0453230781436753,1,1,1,regulation of microglial cell migration,BP,CSF1
18733,GO:1904141,0.0453230781436753,1,1,1,positive regulation of microglial cell migration,BP,CSF1
19611,GO:1990682,0.0453230781436753,1,1,1,CSF1-CSF1R complex,CC,CSF1
7992,GO:0032604,0.0453469565210492,0.995983667155039,2,8,granulocyte macrophage colony-stimulating factor production,BP,IL1B;IL23A
8018,GO:0032645,0.0453469565210492,0.995983667155039,2,8,regulation of granulocyte macrophage colony-stimulating factor production,BP,IL1B;IL23A
17839,GO:1901983,0.0453988737014282,0.985162219723959,6,57,regulation of protein acetylation,BP,IL1B;LIF;ZNF451;SOX4;SDR16C5;MUC1
7492,GO:0031652,0.0454038408187375,0.995975836646385,2,8,positive regulation of heat generation,BP,IL1B;TNF
5106,GO:0015386,0.045410728058879,0.996116540796431,2,7,potassium:proton antiporter activity,MF,SLC9A1;SLC9A8
2630,GO:0005954,0.0454384481630669,1,1,1,calcium- and calmodulin-dependent protein kinase complex,CC,CAMK1G
1845,GO:0004498,0.0454707433186554,1,1,1,calcidiol 1-monooxygenase activity,MF,CYP27B1
2739,GO:0006117,0.0456641746286728,1,1,1,acetaldehyde metabolic process,BP,RELA
9173,GO:0035525,0.0456641746286728,1,1,1,NF-kappaB p50/p65 complex,CC,RELA
10240,GO:0042942,0.0456717472507209,1,1,1,D-serine transport,BP,NFKBIE
17726,GO:1901622,0.0456739102277055,1,1,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,GORAB
398,GO:0001074,0.0456868840229377,1,1,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,TP53
404,GO:0001084,0.0456868840229377,1,1,1,transcription factor activity, TFIID-class binding,MF,TP53
8436,GO:0033552,0.0456868840229377,1,1,1,response to vitamin B3,BP,TP53
8288,GO:0033091,0.0456890458738133,1,1,1,positive regulation of immature T cell proliferation,BP,RIPK2
19793,GO:2000177,0.0457630193215894,0.986984900504962,5,41,regulation of neural precursor cell proliferation,BP,BTG2;VEGFA;WNT5A;VEGFC;KCTD11
2419,GO:0005591,0.0457681096966427,1,1,1,collagen type VIII trimer,CC,COL8A1
2425,GO:0005598,0.0457681096966427,1,1,1,short-chain collagen trimer,CC,COL8A1
7124,GO:0030935,0.0457681096966427,1,1,1,sheet-forming collagen trimer,CC,COL8A1
16815,GO:0098646,0.0457681096966427,1,1,1,collagen sheet,CC,COL8A1
15113,GO:0071141,0.0458423961172595,0.996058972823608,2,7,SMAD protein complex,CC,SMAD3;SMAD1
14706,GO:0070320,0.0458672436850429,1,1,1,inward rectifier potassium channel inhibitor activity,MF,CAV1
17381,GO:1900085,0.0458672436850429,1,1,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,CAV1
18503,GO:1903596,0.0458672436850429,1,1,1,regulation of gap junction assembly,BP,CAV1
18504,GO:1903598,0.0458672436850429,1,1,1,positive regulation of gap junction assembly,BP,CAV1
18507,GO:1903609,0.0458672436850429,1,1,1,negative regulation of inward rectifier potassium channel activity,BP,CAV1
1041,GO:0002551,0.0459211936886564,0.995904361126809,2,8,mast cell chemotaxis,BP,VEGFA;VEGFC
19139,GO:1905062,0.0459504346174762,1,1,1,positive regulation of cardioblast proliferation,BP,PIM1
9396,GO:0035931,0.0459644396781974,1,1,1,mineralocorticoid secretion,BP,C1QTNF1
9397,GO:0035932,0.0459644396781974,1,1,1,aldosterone secretion,BP,C1QTNF1
20176,GO:2000855,0.0459644396781974,1,1,1,regulation of mineralocorticoid secretion,BP,C1QTNF1
20177,GO:2000857,0.0459644396781974,1,1,1,positive regulation of mineralocorticoid secretion,BP,C1QTNF1
20178,GO:2000858,0.0459644396781974,1,1,1,regulation of aldosterone secretion,BP,C1QTNF1
20179,GO:2000860,0.0459644396781974,1,1,1,positive regulation of aldosterone secretion,BP,C1QTNF1
9069,GO:0035304,0.0459835583362616,0.980740212014758,9,101,regulation of protein dephosphorylation,BP,TNF;PPP1R15A;PPP4R4;ANKLE2;MASTL;PPP1R3B;SH3RF2;PPP6R3;GSK3B
10492,GO:0043385,0.0460240106375101,1,1,1,mycotoxin metabolic process,BP,NFE2L2
10493,GO:0043387,0.0460240106375101,1,1,1,mycotoxin catabolic process,BP,NFE2L2
11615,GO:0046222,0.0460240106375101,1,1,1,aflatoxin metabolic process,BP,NFE2L2
11616,GO:0046223,0.0460240106375101,1,1,1,aflatoxin catabolic process,BP,NFE2L2
17656,GO:1901376,0.0460240106375101,1,1,1,organic heteropentacyclic compound metabolic process,BP,NFE2L2
17657,GO:1901377,0.0460240106375101,1,1,1,organic heteropentacyclic compound catabolic process,BP,NFE2L2
18579,GO:1903786,0.0460240106375101,1,1,1,regulation of glutathione biosynthetic process,BP,NFE2L2
18580,GO:1903788,0.0460240106375101,1,1,1,positive regulation of glutathione biosynthetic process,BP,NFE2L2
15848,GO:0072539,0.0461622983654936,0.99587089228809,2,8,T-helper 17 cell differentiation,BP,IL23A;IL6
15697,GO:0072209,0.0464069649207889,1,1,1,metanephric mesangial cell differentiation,BP,PDGFB
15720,GO:0072254,0.0464069649207889,1,1,1,metanephric glomerular mesangial cell differentiation,BP,PDGFB
15721,GO:0072255,0.0464069649207889,1,1,1,metanephric glomerular mesangial cell development,BP,PDGFB
17465,GO:1900241,0.0464069649207889,1,1,1,positive regulation of phenotypic switching,BP,PDGFB
19181,GO:1905176,0.0464069649207889,1,1,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,PDGFB
14613,GO:0070165,0.0464523932815173,1,1,1,positive regulation of adiponectin secretion,BP,HCAR2
14828,GO:0070553,0.0464523932815173,1,1,1,nicotinic acid receptor activity,MF,HCAR2
19278,GO:1905435,0.0464523932815173,1,1,1,regulation of histone H3-K4 trimethylation,BP,KMT2E
19279,GO:1905437,0.0464523932815173,1,1,1,positive regulation of histone H3-K4 trimethylation,BP,KMT2E
10977,GO:0044753,0.0464843129819893,1,1,1,amphisome,CC,SQSTM1
18871,GO:1904469,0.0465159008988152,0.99596852736722,2,7,positive regulation of tumor necrosis factor secretion,BP,WNT5A;IFIH1
11439,GO:0045844,0.0466254445362686,0.986671527640695,5,41,positive regulation of striated muscle tissue development,BP,EDN1;CREB1;NRG1;EFNB2;PIM1
12308,GO:0048636,0.0466254445362686,0.986671527640695,5,41,positive regulation of muscle organ development,BP,EDN1;CREB1;NRG1;EFNB2;PIM1
17806,GO:1901863,0.0466254445362686,0.986671527640695,5,41,positive regulation of muscle tissue development,BP,EDN1;CREB1;NRG1;EFNB2;PIM1
740,GO:0001968,0.0466288020997576,0.992100861274553,3,17,fibronectin binding,MF,SDC4;VEGFA;ITGAV
10004,GO:0042416,0.0466381526181835,0.995804541573674,2,8,dopamine biosynthetic process,BP,GCH1;NR4A2
13779,GO:0060341,0.0466829912593975,0.968431874233196,38,618,regulation of cellular localization,BP,IL1B;TNF;ZC3H12A;LIF;PMAIP1;ZFP36;EPHA2;EHD1;SQSTM1;BBC3;PLAGL2;BDKRB1;PIM3;ZFP36L1;CYLD;CDKN1A;NEDD4L;TP53BP2;WNT5A;SOX4;NRG1;PLK3;PARD6B;FEZ1;NUP153;IL4R;NEDD4;PTPN1;CAV1;UGCG;TP53;UBE2D3;STX1A;JPH2;ADGRE2;PML;GSK3B;PARP1
913,GO:0002295,0.046703928949068,0.995795339285804,2,8,T-helper cell lineage commitment,BP,IL23A;IL6
10484,GO:0043373,0.046703928949068,0.995795339285804,2,8,CD4-positive, alpha-beta T cell lineage commitment,BP,IL23A;IL6
12678,GO:0050869,0.0467679620083223,0.99206782681475,3,17,negative regulation of B cell activation,BP,TNFAIP3;INHBA;PRDM1
1411,GO:0003342,0.0468870731045328,1,1,1,proepicardium development,BP,ZFP36L1
1412,GO:0003343,0.0468870731045328,1,1,1,septum transversum development,BP,ZFP36L1
16603,GO:0097403,0.0468870731045328,1,1,1,cellular response to raffinose,BP,ZFP36L1
17692,GO:1901545,0.0468870731045328,1,1,1,response to raffinose,BP,ZFP36L1
15569,GO:0072001,0.0468934020352754,0.975401832028904,15,192,renal system development,BP,SDC4;BMP2;LIF;SIX4;ODC1;SMAD3;VEGFA;CFLAR;ADAMTS1;WNT5A;SOX4;PDGFB;WNT7B;SMAD1;EFNB2
2643,GO:0005977,0.0473456560382525,0.984396338705131,6,55,glycogen metabolic process,BP,PHLDA2;IL6ST;PHKG2;PPP1R3B;STK40;GSK3B
10005,GO:0042417,0.0473837474228567,0.991864107789295,3,18,dopamine metabolic process,BP,GCH1;NR4A2;MAOA
8973,GO:0035054,0.047394661173747,1,1,1,embryonic heart tube anterior/posterior pattern specification,BP,BMP2
12779,GO:0051040,0.047394661173747,1,1,1,regulation of calcium-independent cell-cell adhesion,BP,BMP2
12780,GO:0051042,0.047394661173747,1,1,1,negative regulation of calcium-independent cell-cell adhesion,BP,BMP2
13647,GO:0060128,0.047394661173747,1,1,1,corticotropin hormone secreting cell differentiation,BP,BMP2
14062,GO:0060804,0.047394661173747,1,1,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,BMP2
14915,GO:0070724,0.047394661173747,1,1,1,BMP receptor complex,CC,BMP2
7687,GO:0032127,0.0474029407841311,1,1,1,dense core granule membrane,CC,ADAM8
15096,GO:0071065,0.0474029407841311,1,1,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,ADAM8
15110,GO:0071133,0.0474029407841311,1,1,1,alpha9-beta1 integrin-ADAM8 complex,CC,ADAM8
15844,GO:0072535,0.0474029407841311,1,1,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
15922,GO:0072680,0.0474029407841311,1,1,1,extracellular matrix-dependent thymocyte migration,BP,ADAM8
15923,GO:0072681,0.0474029407841311,1,1,1,fibronectin-dependent thymocyte migration,BP,ADAM8
19862,GO:2000307,0.0474029407841311,1,1,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
19863,GO:2000309,0.0474029407841311,1,1,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
19939,GO:2000410,0.0474029407841311,1,1,1,regulation of thymocyte migration,BP,ADAM8
19940,GO:2000412,0.0474029407841311,1,1,1,positive regulation of thymocyte migration,BP,ADAM8
19941,GO:2000413,0.0474029407841311,1,1,1,regulation of fibronectin-dependent thymocyte migration,BP,ADAM8
19942,GO:2000415,0.0474029407841311,1,1,1,positive regulation of fibronectin-dependent thymocyte migration,BP,ADAM8
1786,GO:0004397,0.047423688351954,1,1,1,histidine ammonia-lyase activity,MF,HAL
6185,GO:0019556,0.047423688351954,1,1,1,histidine catabolic process to glutamate and formamide,BP,HAL
6186,GO:0019557,0.047423688351954,1,1,1,histidine catabolic process to glutamate and formate,BP,HAL
10620,GO:0043606,0.047423688351954,1,1,1,formamide metabolic process,BP,HAL
3814,GO:0008403,0.0475010428033872,1,1,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,CYP24A1
6872,GO:0030342,0.0475010428033872,1,1,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,CYP24A1
2128,GO:0004921,0.0476005791047252,1,1,1,interleukin-11 receptor activity,MF,IL6ST
6324,GO:0019970,0.0476005791047252,1,1,1,interleukin-11 binding,MF,IL6ST
9722,GO:0038154,0.0476005791047252,1,1,1,interleukin-11-mediated signaling pathway,BP,IL6ST
1003,GO:0002474,0.0476076882401723,0.98248224513129,7,83,antigen processing and presentation of peptide antigen via MHC class I,BP,TAP1;HLA-A;TAPBP;HLA-B;ITGAV;HLA-F;HLA-E
1265,GO:0003016,0.0476116906351737,0.991866650669391,3,17,respiratory system process,BP,ZFAND5;STK40;CCBE1
12362,GO:0048715,0.0477243991807592,0.995651619040822,2,8,negative regulation of oligodendrocyte differentiation,BP,DLX2;DUSP10
3385,GO:0007163,0.0478150441598626,0.976187813317781,13,159,establishment or maintenance of cell polarity,BP,AMOTL2;FRMD4B;RND3;WNT5A;PARD6B;SLC9A1;SPRY2;FEZ1;CYTH1;WNT7B;CLIC4;RHOV;CRB3
4478,GO:0010477,0.0478210409613951,1,1,1,response to sulfur dioxide,BP,ICAM1
8203,GO:0032945,0.0478542152506042,0.986181195962027,5,43,negative regulation of mononuclear cell proliferation,BP,SDC4;PRDM1;PELI1;CEBPB;BTN2A2
12541,GO:0050672,0.0478542152506042,0.986181195962027,5,43,negative regulation of lymphocyte proliferation,BP,SDC4;PRDM1;PELI1;CEBPB;BTN2A2
11608,GO:0046189,0.0478823156728328,0.991743957870196,3,18,phenol-containing compound biosynthetic process,BP,GCH1;NR4A2;WNT5A
10054,GO:0042533,0.0478987371585088,0.995626887089645,2,8,tumor necrosis factor biosynthetic process,BP,BCL3;ERRFI1
10055,GO:0042534,0.0478987371585088,0.995626887089645,2,8,regulation of tumor necrosis factor biosynthetic process,BP,BCL3;ERRFI1
17349,GO:1900016,0.0479425894806782,0.995620657924675,2,8,negative regulation of cytokine production involved in inflammatory response,BP,ZC3H12A;IL1R2
16003,GO:0085032,0.047957671710544,1,1,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,TNIP1
8609,GO:0034116,0.0479791194888201,0.995615466375198,2,8,positive regulation of heterotypic cell-cell adhesion,BP,IL1B;TNF
18558,GO:1903749,0.0480692964932435,0.980902808943781,8,91,positive regulation of establishment of protein localization to mitochondrion,BP,PMAIP1;BBC3;PLAGL2;TP53BP2;NRG1;UGCG;TP53;UBE2D3
16789,GO:0098588,0.0480821639019829,0.963136703345114,84,1520,bounding membrane of organelle,CC,HBEGF;PLAU;PLEKHF1;ZC3H12A;PPP1R15A;PLAUR;PMAIP1;TICAM1;EHD1;IFNGR2;ADAM8;CYP27B1;IRAK2;STEAP4;NMNAT2;GBP2;RAP2B;ABCA5;IL7R;NAV3;CTSC;RASSF9;B4GALT1;B3GNT5;RND3;RAB24;DKK1;ANXA8;VMP1;CD55;TAP1;DSE;CD47;CANT1;WNT5A;CAMK1G;SLC11A2;TGFA;PDGFB;LDLR;SUCO;SYS1;MAOA;B4GALT5;CYTH1;BCL2L2;RNF152;MMD;WNT7B;SGMS2;TAB3;SPTBN5;TPST1;CAV1;RHOV;HLA-A;DRAM1;NECAP2;UGCG;GOLGA8B;TLR2;TAPBP;RAB9A;HLA-B;ITGAV;IKBKE;UBE2D3;PJA2;STX1A;JPH2;ABCA7;TMEM132A;HS3ST3B1;PML;SLC9A8;PPP6R3;CHST2;SLC16A13;HLA-F;HLA-E;EVC;CYP24A1;MGAM;LMAN1
9339,GO:0035821,0.0480822147520626,0.98088938341094,8,92,modification of morphology or physiology of other organism,BP,ZC3H12A;PTX3;TNIP1;JUN;SMAD3;PGLYRP4;RAB9A;ITGAV
12986,GO:0051365,0.0481319490250805,1,1,1,cellular response to potassium ion starvation,BP,JUN
19631,GO:1990748,0.04815838097284,0.983917463509088,6,67,cellular detoxification,BP,TNF;SOD2;GPX3;GCH1;TXNRD1;NFE2L2
17779,GO:1901741,0.0482488761920358,0.995577058699125,2,8,positive regulation of myoblast fusion,BP,EHD1;IL4R
1040,GO:0002548,0.0483963588303677,0.99152087081222,3,20,monocyte chemotaxis,BP,CCL20;IL6;PDGFB
9332,GO:0035809,0.0484247462176897,0.995551951658345,2,8,regulation of urine volume,BP,EDN1;ADM
10479,GO:0043368,0.0484569693772902,0.991604814470884,3,18,positive T cell selection,BP,IL23A;IL6;CYLD
12437,GO:0048878,0.0484612852323051,0.966957722142793,39,647,chemical homeostasis,BP,SOD2;EDN1;EHD1;BDKRB1;PIM3;CYP27B1;STEAP4;C1QTNF1;CLDN1;NEDD4L;ICAM1;SMAD3;VEGFA;ABL2;CD55;ADM;SAA1;SLC11A2;SOX4;LDLR;MT2A;SLC9A1;SLC25A37;RHCG;WNT7B;CLIC4;CAV1;TP53;ITGAV;JPH2;PML;SLC9A8;SLC16A1;PARP1;MED13;EGLN1;XBP1;SLC39A14;SLC41A1
9093,GO:0035354,0.0484959007209465,1,1,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,TLR2
9714,GO:0038123,0.0484959007209465,1,1,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,TLR2
10046,GO:0042495,0.0484959007209465,1,1,1,detection of triacyl bacterial lipopeptide,BP,TLR2
10048,GO:0042497,0.0484959007209465,1,1,1,triacyl lipopeptide binding,MF,TLR2
15455,GO:0071725,0.0484959007209465,1,1,1,response to triacyl bacterial lipopeptide,BP,TLR2
15457,GO:0071727,0.0484959007209465,1,1,1,cellular response to triacyl bacterial lipopeptide,BP,TLR2
12889,GO:0051204,0.0485009500479219,0.988392328371904,4,32,protein insertion into mitochondrial membrane,BP,PMAIP1;BBC3;TP53BP2;TP53
13288,GO:0051962,0.0485186656009527,0.970743584743727,23,329,positive regulation of nervous system development,BP,BMP2;LIF;CSF1;NEDD4L;IL6ST;DLX2;VEGFA;DKK1;ABL2;CFLAR;GORAB;TGIF2;WNT5A;VEGFC;SOCS2;NRG1;FEZ1;MMD;ITSN2;NFE2L2;TLR2;RELA;KCTD11
14460,GO:0061772,0.0485878831026237,1,1,1,drug transport across blood-nerve barrier,BP,CLDN1
18472,GO:1903544,0.0485878831026237,1,1,1,response to butyrate,BP,CLDN1
18473,GO:1903545,0.0485878831026237,1,1,1,cellular response to butyrate,BP,CLDN1
14013,GO:0060713,0.0486068986045717,0.991568396074751,3,18,labyrinthine layer morphogenesis,BP,ZFP36L1;ADM;WNT7B
13110,GO:0051608,0.0486347942060472,0.995402112368908,2,9,histamine transport,BP,CSF2;EDN1
13776,GO:0060338,0.0488330260069278,0.988376058759356,4,29,regulation of type I interferon-mediated signaling pathway,BP,IFNAR2;IFNAR1;WNT5A;PTPN1
1795,GO:0004421,0.0488976538471389,1,1,1,hydroxymethylglutaryl-CoA synthase activity,MF,HMGCS1
4282,GO:0009645,0.0488976538471389,1,1,1,response to low light intensity stimulus,BP,HMGCS1
4407,GO:0010142,0.0488976538471389,1,1,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,HMGCS1
11818,GO:0046690,0.0488976538471389,1,1,1,response to tellurium ion,BP,HMGCS1
18127,GO:1902767,0.0488976538471389,1,1,1,isoprenoid biosynthetic process via mevalonate,BP,HMGCS1
11327,GO:0045638,0.0489167909332077,0.983602308073054,6,67,negative regulation of myeloid cell differentiation,BP,NFKBIA;INHBA;ZFP36;ZFP36L1;TJP2;TRIB1
9668,GO:0038024,0.0489538569143758,0.985795421647568,5,42,cargo receptor activity,MF,TINAGL1;LDLR;CXCL16;ABCA7;CRB3
11167,GO:0045216,0.048959572578182,0.974823263403071,14,174,cell-cell junction organization,BP,TNF;SDC4;PHLDB2;CLDN1;SMAD3;VEGFA;RUNX1;PARD6B;SLC9A1;CAV1;CRB3;OCLN;EPB41L3;GJC1
14498,GO:0061900,0.0489680538224743,0.991540073792505,3,17,glial cell activation,BP,JUN;LDLR;TLR2
12648,GO:0050822,0.0489857306253374,1,1,1,peptide stabilization,BP,TAPBP
12649,GO:0050823,0.0489857306253374,1,1,1,peptide antigen stabilization,BP,TAPBP
14819,GO:0070539,0.0490413632925796,1,1,1,linoleic acid binding,MF,PPARD
9695,GO:0038086,0.049062223158041,1,1,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,VEGFA
9697,GO:0038091,0.049062223158041,1,1,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,VEGFA
18488,GO:1903570,0.049062223158041,1,1,1,regulation of protein kinase D signaling,BP,VEGFA
18489,GO:1903572,0.049062223158041,1,1,1,positive regulation of protein kinase D signaling,BP,VEGFA
17843,GO:1901988,0.049091909591151,0.974026219899628,15,215,negative regulation of cell cycle phase transition,BP,BTG2;DUSP1;GADD45A;ZFP36L1;CDKN1A;DCUN1D3;CDKN2B;PLK2;SOX4;PLK3;TNKS1BP1;TPRA1;TP53;PML;MUC1
6361,GO:0021538,0.0491155190940564,1,1,1,epithalamus development,BP,NR4A2
6558,GO:0021986,0.0491155190940564,1,1,1,habenula development,BP,NR4A2
13227,GO:0051866,0.0491155190940564,1,1,1,general adaptation syndrome,BP,NR4A2
14914,GO:0070723,0.0491895742348485,0.991486369115572,3,17,response to cholesterol,BP,INHBA;TGFBR2;HMGCS1
11291,GO:0045590,0.0492405193409058,1,1,1,negative regulation of regulatory T cell differentiation,BP,IRF1
11161,GO:0045208,0.0492821257736005,1,1,1,MAPK phosphatase export from nucleus,BP,DUSP16
11162,GO:0045209,0.0492821257736005,1,1,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,DUSP16
10271,GO:0043008,0.0494290068387101,0.995407576829037,2,8,ATP-dependent protein binding,MF,PLK2;STX1A
11332,GO:0045647,0.0494880682077487,0.995399032794446,2,8,negative regulation of erythrocyte differentiation,BP,ZFP36;ZFP36L1
3551,GO:0007586,0.0494957422597243,0.985573766286382,5,43,digestion,BP,TJP2;NOD2;SGK1;LDLR;MGAM
6790,GO:0030222,0.049558215013353,1,1,1,eosinophil differentiation,BP,TRIB1
11329,GO:0045643,0.049558215013353,1,1,1,regulation of eosinophil differentiation,BP,TRIB1
11330,GO:0045645,0.049558215013353,1,1,1,positive regulation of eosinophil differentiation,BP,TRIB1
3375,GO:0007147,0.0495673680099208,1,1,1,female meiosis II,BP,MASTL
18181,GO:1902916,0.0496013103209471,0.995382634278897,2,8,positive regulation of protein polyubiquitination,BP,BIRC2;NOD2
11871,GO:0046851,0.0497579511373262,0.995359915513422,2,8,negative regulation of bone remodeling,BP,TNFAIP3;IL6
5523,GO:0016485,0.0497714908924504,0.975814963227804,12,155,protein processing,BP,PLAU;BIRC3;BIRC2;ADAM8;RIPK2;IL1R2;CD55;SPCS2;CCBE1;PLAT;PARP1;CFB
18009,GO:1902442,0.0500630682926822,1,1,1,regulation of ripoptosome assembly involved in necroptotic process,BP,BIRC2
18010,GO:1902443,0.0500630682926822,1,1,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,BIRC2
13783,GO:0060347,0.0500957377441823,0.995310782954039,2,8,heart trabecula formation,BP,ADAMTS1;EGLN1
9710,GO:0038111,0.0501955104343308,0.990865421721836,3,26,interleukin-7-mediated signaling pathway,BP,IL7R;SOCS2;STAT5A
16862,GO:0098760,0.0501955104343308,0.990865421721836,3,26,response to interleukin-7,BP,IL7R;SOCS2;STAT5A
16863,GO:0098761,0.0501955104343308,0.990865421721836,3,26,cellular response to interleukin-7,BP,IL7R;SOCS2;STAT5A
9244,GO:0035635,0.0502169184281699,0.991174329023818,3,18,entry of bacterium into host cell,BP,CXCL8;CAV1;ITGAV
10628,GO:0043621,0.0502868252514691,0.985278878599441,5,43,protein self-association,MF,TNFAIP3;ADAM8;CTSC;SPTBN5;TP53
16801,GO:0098625,0.050333380871822,1,1,1,methylselenol reductase activity,MF,TXNRD1
16802,GO:0098626,0.050333380871822,1,1,1,methylseleninic acid reductase activity,MF,TXNRD1
9687,GO:0038062,0.0504779664400683,1,1,1,protein tyrosine kinase collagen receptor activity,MF,DDR1
5460,GO:0016332,0.0507859546902438,1,1,1,establishment or maintenance of polarity of embryonic epithelium,BP,WNT7B
15600,GO:0072060,0.0507859546902438,1,1,1,outer medullary collecting duct development,BP,WNT7B
17756,GO:1901676,0.0508098705175951,1,1,1,positive regulation of histone H3-K27 acetylation,BP,LIF
11420,GO:0045819,0.0508770006701423,1,1,1,positive regulation of glycogen catabolic process,BP,PHKG2
9856,GO:0042100,0.0509457678971578,0.984992312917445,5,45,B cell proliferation,BP,PRDM1;TICAM1;PELI1;CDKN1A;IL7R
15255,GO:0071402,0.0510229968012459,0.990974997567823,3,18,cellular response to lipoprotein particle stimulus,BP,TICAM1;HMGCS1;LDLR
4685,GO:0010830,0.0510665557525203,0.987633305131088,4,30,regulation of myotube differentiation,BP,EHD1;CFLAR;IL4R;XBP1
8670,GO:0034238,0.0510836655890376,1,1,1,macrophage fusion,BP,ADAM9
8671,GO:0034239,0.0510836655890376,1,1,1,regulation of macrophage fusion,BP,ADAM9
8672,GO:0034241,0.0510836655890376,1,1,1,positive regulation of macrophage fusion,BP,ADAM9
18997,GO:1904762,0.0511355090625745,1,1,1,positive regulation of myofibroblast differentiation,BP,PARP1
11816,GO:0046688,0.0511746419880316,0.990745224163156,3,22,response to copper ion,BP,IL1A;ICAM1;MT2A
15877,GO:0072584,0.0511968021597102,0.995149296500372,2,8,caveolin-mediated endocytosis,BP,NEDD4L;CAV1
15236,GO:0071378,0.0512485656014074,0.990982302670907,3,17,cellular response to growth hormone stimulus,BP,SOCS2;PTPN1;STAT5A
10568,GO:0043523,0.0512985958257443,0.975871784611341,11,137,regulation of neuron apoptotic process,BP,BTG2;SOD2;JUN;ADAM8;SIX4;CEBPB;NR4A2;TP53;AXL;NR4A3;PARP1
11091,GO:0045083,0.0514815862388907,1,1,1,negative regulation of interleukin-12 biosynthetic process,BP,NFKB1
3850,GO:0008457,0.0515384089061724,1,1,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,B3GNT5
11985,GO:0047256,0.0515384089061724,1,1,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,B3GNT5
4997,GO:0015130,0.0516097350321493,1,1,1,mevalonate transmembrane transporter activity,MF,SLC16A1
5177,GO:0015728,0.0516097350321493,1,1,1,mevalonate transport,BP,SLC16A1
13188,GO:0051780,0.0516097350321493,1,1,1,behavioral response to nutrient,BP,SLC16A1
5463,GO:0016338,0.0516298807002825,0.994954117651757,2,9,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,BMP2;CLDN1
12714,GO:0050919,0.0516772299487206,0.987507737331552,4,28,negative chemotaxis,BP,SEMA4B;WNT5A;NRG1;ITGAV
4976,GO:0015086,0.0517063662080078,1,1,1,cadmium ion transmembrane transporter activity,MF,SLC11A2
4977,GO:0015087,0.0517063662080078,1,1,1,cobalt ion transmembrane transporter activity,MF,SLC11A2
4980,GO:0015094,0.0517063662080078,1,1,1,lead ion transmembrane transporter activity,MF,SLC11A2
5157,GO:0015692,0.0517063662080078,1,1,1,lead ion transport,BP,SLC11A2
14866,GO:0070627,0.0517063662080078,1,1,1,ferrous iron import,BP,SLC11A2
14950,GO:0070826,0.0517063662080078,1,1,1,paraferritin complex,CC,SLC11A2
4272,GO:0009620,0.0519171363501497,0.990598028550784,3,21,response to fungus,BP,PTX3;COTL1;IL36RN
15095,GO:0071062,0.0519889836536742,1,1,1,alphav-beta3 integrin-vitronectin complex,CC,ITGA5
13848,GO:0060433,0.0521115274191652,0.995013597281232,2,8,bronchus development,BP,TGFBR2;WNT7B
11472,GO:0045918,0.0522070522720522,0.999301516591612,1,2,negative regulation of cytolysis,BP,CSF2
9301,GO:0035743,0.0522376773291788,0.994861328401267,2,9,CD4-positive, alpha-beta T cell cytokine production,BP,IL6;CD55
938,GO:0002335,0.0522979928006152,0.990599208064,3,19,mature B cell differentiation,BP,BCL3;POU2F2;XBP1
1710,GO:0004252,0.052310074764386,0.980425325301433,7,75,serine-type endopeptidase activity,MF,PLAU;ADAM8;CTSC;MMP9;PLAT;MMP10;CFB
8631,GO:0034146,0.0523673579826235,1,1,1,toll-like receptor 5 signaling pathway,BP,TNFAIP3
8632,GO:0034147,0.0523673579826235,1,1,1,regulation of toll-like receptor 5 signaling pathway,BP,TNFAIP3
8633,GO:0034148,0.0523673579826235,1,1,1,negative regulation of toll-like receptor 5 signaling pathway,BP,TNFAIP3
14759,GO:0070425,0.0523673579826235,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,TNFAIP3
14762,GO:0070428,0.0523673579826235,1,1,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,TNFAIP3
14763,GO:0070429,0.0523673579826235,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,TNFAIP3
14766,GO:0070433,0.0523673579826235,1,1,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,TNFAIP3
15868,GO:0072573,0.0523673579826235,1,1,1,tolerance induction to lipopolysaccharide,BP,TNFAIP3
16252,GO:0090289,0.0523673579826235,1,1,1,regulation of osteoclast proliferation,BP,TNFAIP3
16253,GO:0090291,0.0523673579826235,1,1,1,negative regulation of osteoclast proliferation,BP,TNFAIP3
19896,GO:2000349,0.0523673579826235,1,1,1,negative regulation of CD40 signaling pathway,BP,TNFAIP3
15824,GO:0072509,0.0523881108614705,0.990634361529664,3,18,divalent inorganic cation transmembrane transporter activity,MF,SLC11A2;SLC39A14;SLC41A1
9348,GO:0035853,0.0524754696427146,1,1,1,chromosome passenger complex localization to spindle midzone,BP,KLHL21
1143,GO:0002732,0.0524891107074371,1,1,1,positive regulation of dendritic cell cytokine production,BP,NOD2
7928,GO:0032498,0.0524891107074371,1,1,1,detection of muramyl dipeptide,BP,NOD2
7929,GO:0032499,0.0524891107074371,1,1,1,detection of peptidoglycan,BP,NOD2
7930,GO:0032500,0.0524891107074371,1,1,1,muramyl dipeptide binding,MF,NOD2
19904,GO:2000361,0.0524891107074371,1,1,1,regulation of prostaglandin-E synthase activity,BP,NOD2
19905,GO:2000363,0.0524891107074371,1,1,1,positive regulation of prostaglandin-E synthase activity,BP,NOD2
961,GO:0002380,0.0525026054748462,1,1,1,immunoglobulin secretion involved in immune response,BP,POU2F2
8134,GO:0032823,0.0526324648160605,0.994935694347653,2,8,regulation of natural killer cell differentiation,BP,PRDM1;AXL
16034,GO:0086040,0.0526450046154636,1,1,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,SLC9A1
16066,GO:0086092,0.0526450046154636,1,1,1,regulation of the force of heart contraction by cardiac conduction,BP,SLC9A1
11990,GO:0047280,0.0526567666898925,1,1,1,nicotinamide phosphoribosyltransferase activity,MF,NAMPT
10142,GO:0042700,0.0527260705180702,1,1,1,luteinizing hormone signaling pathway,BP,EREG
12121,GO:0048160,0.0527260705180702,1,1,1,primary follicle stage,BP,EREG
1020,GO:0002514,0.0527831981381093,1,1,1,B cell tolerance induction,BP,TGFBR2
1079,GO:0002649,0.0527831981381093,1,1,1,regulation of tolerance induction to self antigen,BP,TGFBR2
1080,GO:0002651,0.0527831981381093,1,1,1,positive regulation of tolerance induction to self antigen,BP,TGFBR2
1082,GO:0002661,0.0527831981381093,1,1,1,regulation of B cell tolerance induction,BP,TGFBR2
1083,GO:0002663,0.0527831981381093,1,1,1,positive regulation of B cell tolerance induction,BP,TGFBR2
2182,GO:0005026,0.0527831981381093,1,1,1,transforming growth factor beta receptor activity, type II,MF,TGFBR2
19229,GO:1905317,0.0527831981381093,1,1,1,inferior endocardial cushion morphogenesis,BP,TGFBR2
14948,GO:0070821,0.0528086812656377,0.98430833581556,5,44,tertiary granule membrane,CC,PLAU;ADAM8;RAP2B;CD47;MGAM
2266,GO:0005179,0.0528347601377419,0.990411202021256,3,20,hormone activity,MF,INHBA;EDN1;ADM
10780,GO:0044228,0.0528800355808943,1,1,1,host cell surface,CC,AXL
1321,GO:0003166,0.0529032306141568,1,1,1,bundle of His development,BP,TBX3
1322,GO:0003167,0.0529032306141568,1,1,1,atrioventricular bundle cell differentiation,BP,TBX3
13947,GO:0060596,0.0529032306141568,1,1,1,mammary placode formation,BP,TBX3
14113,GO:0060932,0.0529032306141568,1,1,1,His-Purkinje system cell differentiation,BP,TBX3
18741,GO:1904170,0.0529408600841748,1,1,1,regulation of bleb assembly,BP,ANLN
18742,GO:1904172,0.0529408600841748,1,1,1,positive regulation of bleb assembly,BP,ANLN
10777,GO:0044220,0.0529990475881693,1,1,1,host cell perinuclear region of cytoplasm,CC,LMAN1
14456,GO:0061768,0.0530193926788687,1,1,1,magnesium:sodium antiporter activity,MF,SLC41A1
20120,GO:2000759,0.0530311881434403,1,1,1,regulation of N-terminal peptidyl-lysine acetylation,BP,SOX4
20121,GO:2000761,0.0530311881434403,1,1,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,SOX4
7401,GO:0031460,0.0530520268941707,1,1,1,glycine betaine transport,BP,SLC38A2
8281,GO:0033082,0.053074061679337,1,1,1,regulation of extrathymic T cell differentiation,BP,PRDM1
19607,GO:1990654,0.053074061679337,1,1,1,sebum secreting cell proliferation,BP,PRDM1
1495,GO:0003831,0.0531229130864841,0.994861939997255,2,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,B4GALT1;B4GALT5
14492,GO:0061889,0.0532759076720351,1,1,1,negative regulation of astrocyte activation,BP,LDLR
18679,GO:1903979,0.0532759076720351,1,1,1,negative regulation of microglial cell activation,BP,LDLR
4247,GO:0009444,0.0532860541711746,1,1,1,pyruvate oxidation,BP,NR4A3
9703,GO:0038097,0.0532860541711746,1,1,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,NR4A3
55,GO:0000117,0.0533273436875566,1,1,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,BACH1
1032,GO:0002537,0.0533287141831904,1,1,1,nitric oxide production involved in inflammatory response,BP,SLC7A2
1743,GO:0004339,0.0533287141831904,1,1,1,glucan 1,4-alpha-glucosidase activity,MF,MGAM
2221,GO:0005115,0.0533287141831904,1,1,1,receptor tyrosine kinase-like orphan receptor binding,MF,WNT5A
2648,GO:0005982,0.0533287141831904,1,1,1,starch metabolic process,BP,MGAM
2649,GO:0005983,0.0533287141831904,1,1,1,starch catabolic process,BP,MGAM
5577,GO:0016590,0.0533287141831904,1,1,1,ACF complex,CC,BAZ1A
6034,GO:0019089,0.0533287141831904,1,1,1,transmission of virus,BP,NEDD4
6321,GO:0019962,0.0533287141831904,1,1,1,type I interferon binding,MF,IFNAR1
7597,GO:0031962,0.0533287141831904,1,1,1,mineralocorticoid receptor binding,MF,SMAD3
7634,GO:0032029,0.0533287141831904,1,1,1,myosin tail binding,MF,SPTBN5
8871,GO:0034670,0.0533287141831904,1,1,1,chemotaxis to arachidonic acid,BP,CREB1
8878,GO:0034683,0.0533287141831904,1,1,1,integrin alphav-beta3 complex,CC,ITGAV
9650,GO:0036517,0.0533287141831904,1,1,1,chemoattraction of serotonergic neuron axon,BP,WNT5A
10715,GO:0044007,0.0533287141831904,1,1,1,dissemination or transmission of symbiont from host,BP,NEDD4
10788,GO:0044245,0.0533287141831904,1,1,1,polysaccharide digestion,BP,MGAM
11366,GO:0045715,0.0533287141831904,1,1,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
12595,GO:0050748,0.0533287141831904,1,1,1,negative regulation of lipoprotein metabolic process,BP,ITGAV
13214,GO:0051821,0.0533287141831904,1,1,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,NEDD4
13238,GO:0051885,0.0533287141831904,1,1,1,positive regulation of timing of anagen,BP,WNT5A
13321,GO:0052066,0.0533287141831904,1,1,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,ITGAV
13331,GO:0052190,0.0533287141831904,1,1,1,modulation by symbiont of host phagocytosis,BP,ITGAV
13332,GO:0052191,0.0533287141831904,1,1,1,positive regulation by symbiont of host phagocytosis,BP,ITGAV
13342,GO:0052231,0.0533287141831904,1,1,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
13358,GO:0052370,0.0533287141831904,1,1,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
13375,GO:0052522,0.0533287141831904,1,1,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
13581,GO:0060031,0.0533287141831904,1,1,1,mediolateral intercalation,BP,WNT5A
13612,GO:0060067,0.0533287141831904,1,1,1,cervix development,BP,WNT5A
13736,GO:0060290,0.0533287141831904,1,1,1,transdifferentiation,BP,SMAD3
13949,GO:0060599,0.0533287141831904,1,1,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,WNT5A
14056,GO:0060775,0.0533287141831904,1,1,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,WNT5A
14063,GO:0060809,0.0533287141831904,1,1,1,mesodermal to mesenchymal transition involved in gastrulation,BP,WNT5A
14288,GO:0061347,0.0533287141831904,1,1,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,WNT5A
14289,GO:0061348,0.0533287141831904,1,1,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,WNT5A
14290,GO:0061349,0.0533287141831904,1,1,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,WNT5A
14291,GO:0061350,0.0533287141831904,1,1,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,WNT5A
14293,GO:0061354,0.0533287141831904,1,1,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,WNT5A
14329,GO:0061459,0.0533287141831904,1,1,1,L-arginine transmembrane transporter activity,MF,SLC7A2
14401,GO:0061642,0.0533287141831904,1,1,1,chemoattraction of axon,BP,WNT5A
14455,GO:0061767,0.0533287141831904,1,1,1,negative regulation of lung blood pressure,BP,SMAD3
16693,GO:0097625,0.0533287141831904,1,1,1,low-affinity basic amino acid transmembrane transporter activity,MF,SLC7A2
16694,GO:0097626,0.0533287141831904,1,1,1,low-affinity L-arginine transmembrane transporter activity,MF,SLC7A2
16695,GO:0097627,0.0533287141831904,1,1,1,high-affinity L-ornithine transmembrane transporter activity,MF,SLC7A2
16704,GO:0097639,0.0533287141831904,1,1,1,L-lysine import across plasma membrane,BP,SLC7A2
16705,GO:0097640,0.0533287141831904,1,1,1,L-ornithine import across plasma membrane,BP,SLC7A2
17991,GO:1902379,0.0533287141831904,1,1,1,chemoattractant activity involved in axon guidance,MF,WNT5A
18110,GO:1902725,0.0533287141831904,1,1,1,negative regulation of satellite cell differentiation,BP,SIX4
18739,GO:1904167,0.0533287141831904,1,1,1,regulation of thyroid hormone receptor activity,BP,MED13
18740,GO:1904168,0.0533287141831904,1,1,1,negative regulation of thyroid hormone receptor activity,BP,MED13
19083,GO:1904933,0.0533287141831904,1,1,1,regulation of cell proliferation in midbrain,BP,WNT5A
19084,GO:1904934,0.0533287141831904,1,1,1,negative regulation of cell proliferation in midbrain,BP,WNT5A
19093,GO:1904955,0.0533287141831904,1,1,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT5A
19280,GO:1905438,0.0533287141831904,1,1,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT5A
19989,GO:2000536,0.0533287141831904,1,1,1,negative regulation of entry of bacterium into host cell,BP,ITGAV
17558,GO:1901074,0.0533287141831906,1,1,1,regulation of engulfment of apoptotic cell,BP,ABCA7
17559,GO:1901076,0.0533287141831906,1,1,1,positive regulation of engulfment of apoptotic cell,BP,ABCA7
2423,GO:0005595,0.0533287141831907,1,1,1,collagen type XII trimer,CC,COL12A1
13860,GO:0060447,0.0533287141831907,1,1,1,bud outgrowth involved in lung branching,BP,TNC
14031,GO:0060739,0.0533287141831907,1,1,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,TNC
14553,GO:0070060,0.0533287141831907,1,1,1,'de novo' actin filament nucleation,BP,JMY
18815,GO:1904339,0.0533287141831907,1,1,1,negative regulation of dopaminergic neuron differentiation,BP,GSK3B
19405,GO:1905878,0.0533287141831907,1,1,1,invadopodium disassembly,BP,NAV3
19425,GO:1905927,0.0533287141831907,1,1,1,regulation of invadopodium disassembly,BP,NAV3
19426,GO:1905929,0.0533287141831907,1,1,1,positive regulation of invadopodium disassembly,BP,NAV3
20325,GO:2001288,0.0533287141831907,1,1,1,positive regulation of caveolin-mediated endocytosis,BP,NEDD4L
1441,GO:0003417,0.0533449393341264,0.994828420661572,2,8,growth plate cartilage development,BP,TGFBR2;COL27A1
7109,GO:0030901,0.0534003909347394,0.981814496474554,6,59,midbrain development,BP,DKK1;NR4A2;WNT5A;SMAD1;ZNF148;KDM7A
19442,GO:1990001,0.0534807294502964,0.994807880334927,2,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,BIRC3;BIRC2
8601,GO:0034105,0.0535890101694132,0.990271884551497,3,19,positive regulation of tissue remodeling,BP,IL23A;ADAM8;B4GALT1
10876,GO:0044403,0.0536581535197342,0.962914528204846,40,715,symbiont process,BP,CXCL8;NFKBIA;TNF;ZC3H12A;IL16;PTX3;TNIP1;ZFP36;JUN;EPHA2;SQSTM1;CLDN1;ITGA5;NEDD4L;IL6ST;ICAM1;SMAD3;CFLAR;CD55;TAP1;CREB1;TRIM25;IFIH1;LDLR;NUP153;NEDD4;RAET1L;ZC3H7B;CAV1;HLA-A;TP53;ABI1;EFNB2;RAB9A;HLA-B;ITGAV;PML;RELA;AXL;VIM
13286,GO:0051960,0.0538440455902746,0.963776804608117,35,547,regulation of nervous system development,BP,EFNA1;BMP2;LIF;CSF1;SIX4;NEDD4L;IL6ST;DLX2;VEGFA;DKK1;ZSWIM4;PLK2;ABL2;CFLAR;CREB1;GORAB;SEMA4B;TGIF2;WNT5A;VEGFC;DUSP10;SOCS2;NRG1;LDLR;FEZ1;NEDD4;MMD;ITSN2;NFE2L2;TLR2;EFNB2;RELA;GSK3B;VIM;KCTD11
15182,GO:0071300,0.0538545673551135,0.983910123727699,5,44,cellular response to retinoic acid,BP,ABL2;GJB3;WNT5A;TNC;WNT7B
7129,GO:0030948,0.0538730770924275,0.994748361133637,2,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,NEDD4;PTPN1
16228,GO:0090257,0.0539467741553685,0.975488300209543,10,120,regulation of muscle system process,BP,ZC3H12A;EDN1;IL6ST;SMAD3;ERRFI1;SLC9A1;CAV1;DOCK4;NR4A3;PARP1
8680,GO:0034250,0.0539980579346435,0.975437849648312,10,124,positive regulation of cellular amide metabolic process,BP,TNF;EFNA1;ZC3H12A;PPP1R15A;BCL3;IL6;SOX4;PLK3;NFE2L2;VIM
18634,GO:1903901,0.0541560604421902,0.981451668998663,6,62,negative regulation of viral life cycle,BP,TNF;ZC3H12A;PTX3;TNIP1;TRIM25;PML
19823,GO:2000241,0.0542164652016223,0.979550912797846,7,75,regulation of reproductive process,BP,INHBA;LIF;DUSP1;PHLDA2;B4GALT1;SMURF2;WNT5A
15230,GO:0071372,0.0542626224171341,0.994689016697509,2,8,cellular response to follicle-stimulating hormone stimulus,BP,INHBA;HMGCS1
9717,GO:0038128,0.0543124042759019,0.986546992468813,4,31,ERBB2 signaling pathway,BP,HBEGF;EREG;NRG1;GRB7
10550,GO:0043496,0.0543847750933816,0.990014055836241,3,20,regulation of protein homodimerization activity,BP,TICAM1;TRAF4;NRG1
3762,GO:0008305,0.0544377866940965,0.990184393985464,3,17,integrin complex,CC,ITGA5;ITGB8;ITGAV
16808,GO:0098636,0.0544377866940965,0.990184393985464,3,17,protein complex involved in cell adhesion,CC,ITGA5;ITGB8;ITGAV
17539,GO:1901016,0.0544634530128327,0.986531209051166,4,30,regulation of potassium ion transmembrane transporter activity,BP,NEDD4L;CAB39;NEDD4;CAV1
505,GO:0001562,0.0545713368808024,0.994499251390593,2,9,response to protozoan,BP,BCL3;IL4R
10216,GO:0042832,0.0545713368808024,0.994499251390593,2,9,defense response to protozoan,BP,BCL3;IL4R
8954,GO:0035004,0.0548083954247886,0.983615147797561,5,41,phosphatidylinositol 3-kinase activity,MF,HBEGF;EREG;FGF5;PDGFB;NRG1
15400,GO:0071636,0.0552828116727406,0.994532420363317,2,8,positive regulation of transforming growth factor beta production,BP,SMAD3;CREB1
19934,GO:2000404,0.0553831640744296,0.989755665053519,3,20,regulation of T cell migration,BP,CCL20;ADAM8;WNT5A
1184,GO:0002828,0.0554377685488854,0.989741475056092,3,20,regulation of type 2 immune response,BP,IL6;NOD2;IL4R
14220,GO:0061135,0.055460926139988,0.978905862164186,7,82,endopeptidase regulator activity,MF,BIRC3;SERPINB2;BIRC2;TNFAIP8;TFPI2;SERPINB8;SERPINB1
16006,GO:0086003,0.0557738331325231,0.986136958056219,4,29,cardiac muscle cell contraction,BP,NEDD4L;SLC9A1;CAV1;GJC1
8117,GO:0032800,0.0557740243176427,0.989710197317053,3,19,receptor biosynthetic process,BP,TNF;EDN1;ITGAV
1333,GO:0003183,0.0560738321467471,0.994409832614849,2,8,mitral valve morphogenesis,BP,EFNA1;SOX4
13933,GO:0060576,0.0560796102851036,0.99426037760403,2,9,intestinal epithelial cell development,BP,PRDM1;CDKN1A
16566,GO:0097327,0.0563450189315517,0.978577153015737,7,74,response to antineoplastic agent,BP,ZC3H12A;EDN1;CLDN1;ICAM1;CFLAR;ERRFI1;PDGFB
3229,GO:0006883,0.0563895177900413,0.994360625799011,2,8,cellular sodium ion homeostasis,BP,NEDD4L;SLC9A1
6658,GO:0030003,0.0563947865337172,0.965812668732687,22,336,cellular cation homeostasis,BP,EDN1;BDKRB1;C1QTNF1;NEDD4L;SMAD3;ABL2;CD55;ADM;SAA1;SLC11A2;MT2A;SLC9A1;CLIC4;CAV1;TP53;ITGAV;JPH2;PML;SLC9A8;EGLN1;SLC39A14;SLC41A1
16269,GO:0090312,0.0564002184221551,0.989547461474401,3,19,positive regulation of protein deacetylation,BP,VEGFA;TP53;SDR16C5
7783,GO:0032303,0.0566053546170649,0.994176223649234,2,9,regulation of icosanoid secretion,BP,IL1B;EDN1
14148,GO:0061000,0.0566427689681904,0.994321034128752,2,8,negative regulation of dendritic spine development,BP,EFNA1;PLK2
792,GO:0002053,0.0567212674483642,0.989528075649109,3,18,positive regulation of mesenchymal cell proliferation,BP,VEGFA;TGFBR2;WNT5A
18091,GO:1902667,0.0567505634106274,0.985813672404345,4,29,regulation of axon guidance,BP,VEGFA;ZSWIM4;SEMA4B;WNT5A
7469,GO:0031623,0.0567576479744911,0.980379268970111,6,59,receptor internalization,BP,CXCL8;VEGFA;DKK1;ADM;NEDD4;CAV1
11122,GO:0045136,0.056874727395616,0.994132928913878,2,9,development of secondary sexual characteristics,BP,B4GALT1;WNT5A
6690,GO:0030054,0.057116800147901,0.958674432831836,51,872,cell junction,CC,PLAU;SDC4;PLAUR;HCAR3;EPHA2;HCAR2;IRF6;PANX1;PHLDB2;TJP2;AMOTL2;CLDN1;ITGA5;RAP2B;ICAM1;FRMD4B;B4GALT1;RND3;TRAF4;LAYN;NAMPT;TP53BP2;GJB3;CDC42EP4;GJB4;NEDD9;SLC7A2;TNC;PARD6B;SLC9A1;TNKS1BP1;CYTH1;GRB7;MARCKS;CLIC4;CAV1;ABI1;EFNB2;ITGAV;PJA2;STX1A;ABCA7;ADAM9;ESCO2;ANXA5;CRB3;SLC16A1;OCLN;VIM;EPB41L3;GJC1
2200,GO:0005072,0.057137907632286,0.994243327813937,2,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,SMAD3;SMAD1
1683,GO:0004145,0.0572159233460053,0.999158860324141,1,2,diamine N-acetyltransferase activity,MF,SAT1
6247,GO:0019809,0.0572159233460053,0.999158860324141,1,2,spermidine binding,MF,SAT1
8184,GO:0032917,0.0572159233460053,0.999158860324141,1,2,polyamine acetylation,BP,SAT1
8185,GO:0032918,0.0572159233460053,0.999158860324141,1,2,spermidine acetylation,BP,SAT1
14984,GO:0070878,0.0572647632731306,0.994223355612999,2,8,primary miRNA binding,MF,SMAD3;SMAD1
11304,GO:0045606,0.0573287806229955,0.989246382712663,3,20,positive regulation of epidermal cell differentiation,BP,CYP27B1;IL20;TRIM16
5105,GO:0015385,0.0574675053232896,0.994191381989548,2,8,sodium:proton antiporter activity,MF,SLC9A1;SLC9A8
11141,GO:0045177,0.0575825890709841,0.968218738331944,16,217,apical part of cell,CC,AMOTL2;CLDN1;MREG;SLC11A2;SLC52A3;LDLR;PARD6B;SLC9A1;RHCG;CLIC4;PLAT;MUC1;CRB3;OSMR;OCLN;MGAM
5126,GO:0015491,0.0577241222921377,0.989266715196537,3,18,cation:cation antiporter activity,MF,SLC9A1;SLC9A8;SLC41A1
5319,GO:0016032,0.0580282973248776,0.960025179388256,38,680,viral process,BP,CXCL8;NFKBIA;TNF;ZC3H12A;IL16;PTX3;TNIP1;ZFP36;JUN;EPHA2;CLDN1;ITGA5;NEDD4L;IL6ST;ICAM1;SMAD3;CFLAR;CD55;TAP1;CREB1;TRIM25;IFIH1;LDLR;NUP153;NEDD4;RAET1L;ZC3H7B;CAV1;HLA-A;TP53;ABI1;EFNB2;HLA-B;ITGAV;PML;RELA;AXL;VIM
635,GO:0001822,0.0580553530674772,0.969377573371385,14,182,kidney development,BP,SDC4;BMP2;LIF;SIX4;ODC1;SMAD3;VEGFA;CFLAR;ADAMTS1;SOX4;PDGFB;WNT7B;SMAD1;EFNB2
3224,GO:0006875,0.0580992934818007,0.966091582258615,19,282,cellular metal ion homeostasis,BP,EDN1;BDKRB1;C1QTNF1;NEDD4L;SMAD3;ABL2;CD55;ADM;SAA1;SLC11A2;MT2A;SLC9A1;CAV1;ITGAV;JPH2;PML;EGLN1;SLC39A14;SLC41A1
4591,GO:0010692,0.0581893960123239,0.994076998831984,2,8,regulation of alkaline phosphatase activity,BP,TNF;SMAD3
1261,GO:0003012,0.0582844605762419,0.967762047069515,16,223,muscle system process,BP,IL1B;ZC3H12A;EDN1;MAP2K3;NEDD4L;IL6ST;SMAD3;CFLAR;ERRFI1;SLC9A1;CAV1;DOCK4;NR4A3;PARP1;VIM;GJC1
17402,GO:1900117,0.0583524614359763,0.988975410849296,3,20,regulation of execution phase of apoptosis,BP,ZC3H12A;TP53BP2;TP53
537,GO:0001655,0.0585144843180275,0.967641135263375,16,215,urogenital system development,BP,SDC4;BMP2;LIF;SIX4;ODC1;SMAD3;VEGFA;CFLAR;ADAMTS1;WNT5A;SOX4;PDGFB;TNC;WNT7B;SMAD1;EFNB2
11481,GO:0045927,0.0586595227085801,0.969828592735972,13,171,positive regulation of growth,BP,HBEGF;EDN1;CSF1;NEDD4L;VEGFA;CREB1;TGFBR2;NRG1;SLC9A1;CXCL16;ITSN2;PIM1;PPARD
7490,GO:0031650,0.0586945893427853,0.993837302457484,2,9,regulation of heat generation,BP,IL1B;TNF
11113,GO:0045121,0.058748582964607,0.968182449322747,15,202,membrane raft,CC,TNF;SDC4;BIRC3;EFNB1;BIRC2;RAP2B;ICAM1;CFLAR;CD55;TGFBR2;SMURF2;EFHD2;SLC9A1;CAV1;TLR2
20054,GO:2000650,0.0587765308172004,0.993983351382948,2,8,negative regulation of sodium ion transmembrane transporter activity,BP,NEDD4L;NEDD4
16826,GO:0098662,0.0590182406185249,0.963217563449892,24,373,inorganic cation transmembrane transport,BP,PPIF;BDKRB1;PANX1;STEAP4;NEDD4L;KCNJ15;SLC28A3;NIPAL4;SLC11A2;RRAD;CAB39;TRPV3;SLC9A1;SLC25A37;NEDD4;SLC2A6;CAV1;ITGAV;GEM;JPH2;SLC9A8;TSPAN13;SLC39A14;SLC41A1
16849,GO:0098739,0.0590256633079797,0.981931794641552,5,43,import across plasma membrane,BP,STEAP4;SLC7A2;SLC9A1;SLC9A8;SLC39A14
3241,GO:0006897,0.0591911654017597,0.961409685005418,29,453,endocytosis,BP,CXCL8;IL1B;TNF;PTX3;EHD1;NEDD4L;VEGFA;DKK1;ABL2;ADM;CD47;TGFBR2;SAA1;TINAGL1;WNT5A;LDLR;CXCL16;NEDD4;ITSN2;PTPN1;CAV1;RHOV;NECAP2;TLR2;ABI1;ITGAV;TRIP10;ABCA7;AXL
1122,GO:0002708,0.0592964285356788,0.98173449451935,5,47,positive regulation of lymphocyte mediated immunity,BP,IL1B;TNF;IL23A;IL6;HLA-E
10535,GO:0043471,0.0593539263972923,0.993728857806242,2,9,regulation of cellular carbohydrate catabolic process,BP,PHKG2;PPP1R3B
10352,GO:0043153,0.0594724481165038,0.988737840373219,3,19,entrainment of circadian clock by photoperiod,BP,BHLHE40;TP53;PML
12846,GO:0051140,0.0595275784202078,0.999088415820049,1,2,regulation of NK T cell proliferation,BP,IL23A
12847,GO:0051142,0.0595275784202078,0.999088415820049,1,2,positive regulation of NK T cell proliferation,BP,IL23A
16668,GO:0097531,0.0596687350587498,0.993676829635206,2,9,mast cell migration,BP,VEGFA;VEGFC
18264,GO:1903069,0.0597399242262202,0.993665041907194,2,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,NFE2L2;CAV1
17367,GO:1900044,0.0597774697875979,0.993822433297679,2,8,regulation of protein K63-linked ubiquitination,BP,BIRC2;NOD2
1345,GO:0003205,0.0598108497770492,0.973682783988096,9,101,cardiac chamber development,BP,PRDM1;TBX3;SAV1;ADAMTS1;TGFBR2;WNT5A;SOX4;NRG1;EGLN1
14811,GO:0070528,0.0598917807912922,0.988625905435114,3,19,protein kinase C signaling,BP,VEGFA;WNT5A;PDGFB
13759,GO:0060317,0.0599358355818231,0.988614125890054,3,19,cardiac epithelial to mesenchymal transition,BP,EFNA1;BMP2;TGFBR2
131,GO:0000271,0.0599409474566542,0.978997163965089,6,59,polysaccharide biosynthetic process,BP,NFKB1;B3GNT5;PHKG2;PPP1R3B;PDGFB;GSK3B
13650,GO:0060135,0.059972312995262,0.981534971165175,5,44,maternal process involved in female pregnancy,BP,LIF;PRDM1;CYP27B1;JUNB;PPARD
5161,GO:0015696,0.0601228372150136,0.981407826315571,5,47,ammonium transport,BP,CSF2;EDN1;SLC38A2;RHD;RHCG
10458,GO:0043312,0.0603159281384748,0.963138586788537,22,351,neutrophil degranulation,BP,PLAU;CXCL1;PLAUR;PTX3;NFKB1;AMPD3;ADAM8;RAP2B;CTSC;B4GALT1;RAB24;CD55;CD47;CANT1;SERPINB1;MMP9;CAB39;TLR2;ITGAV;FRK;COTL1;MGAM
18313,GO:1903203,0.060351488538089,0.988502802584359,3,19,regulation of oxidative stress-induced neuron death,BP,NCOA7;NR4A3;PARP1
13962,GO:0060627,0.0604410837333767,0.962656693903983,23,346,regulation of vesicle-mediated transport,BP,IL1B;TNF;SDC4;PTX3;EHD1;NEDD4L;VEGFA;DKK1;ABL2;CD47;WNT5A;LDLR;IL4R;PTPN1;CAV1;TLR2;RAB9A;ITGAV;STX1A;ABCA7;ADGRE2;AXL;TBC1D22B
785,GO:0002040,0.0605020033765694,0.976653800117532,7,72,sprouting angiogenesis,BP,ITGA5;VEGFA;NRARP;PLK2;SMAD1;EFNB2;CCBE1
12077,GO:0048016,0.0605399124245558,0.984460990078028,4,31,inositol phosphate-mediated signaling,BP,EDN1;NRG1;SLC9A1;NFAT5
140,GO:0000290,0.060628391192739,0.993517234750585,2,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,NOCT;PATL1
11672,GO:0046426,0.0608382651529062,0.984322823053206,4,32,negative regulation of JAK-STAT cascade,BP,BCL3;VHL;SOCS2;CAV1
19066,GO:1904893,0.0608382651529062,0.984322823053206,4,32,negative regulation of STAT cascade,BP,BCL3;VHL;SOCS2;CAV1
7143,GO:0030971,0.0608562338910744,0.981185488838865,5,44,receptor tyrosine kinase binding,MF,SQSTM1;NRG1;PTPN1;TP53;DOCK4
16915,GO:0098857,0.0609592615040705,0.966811602343787,15,203,membrane microdomain,CC,TNF;SDC4;BIRC3;EFNB1;BIRC2;RAP2B;ICAM1;CFLAR;CD55;TGFBR2;SMURF2;EFHD2;SLC9A1;CAV1;TLR2
18475,GO:1903547,0.0609752384099391,0.999042811901818,1,2,regulation of growth hormone activity,BP,PHLDA2
4506,GO:0010536,0.0611372427028473,0.999037637000622,1,2,positive regulation of activation of Janus kinase activity,BP,IL23A
8977,GO:0035065,0.0611669133042995,0.981015143085516,5,46,regulation of histone acetylation,BP,IL1B;LIF;ZNF451;SDR16C5;MUC1
17594,GO:1901203,0.0612047720907277,0.993590217328768,2,8,positive regulation of extracellular matrix assembly,BP,PHLDB2;SMAD3
15634,GO:0072109,0.0612839335261074,0.993407358278254,2,9,glomerular mesangium development,BP,CFLAR;PDGFB
4673,GO:0010818,0.0613950459920816,0.99338866580476,2,9,T cell chemotaxis,BP,WNT5A;CXCL16
4755,GO:0010923,0.0615113144678319,0.97614984427688,7,74,negative regulation of phosphatase activity,BP,TNF;PLEKHF1;PPP1R15A;PPP4R4;MASTL;SH3RF2;GSK3B
2379,GO:0005507,0.0616371477159331,0.983895680805969,4,37,copper ion binding,MF,IL1A;LACC1;HEPHL1;TP53
14988,GO:0070886,0.0616993847059478,0.993337364998547,2,9,positive regulation of calcineurin-NFAT signaling cascade,BP,NRG1;SLC9A1
17221,GO:0106058,0.0616993847059478,0.993337364998547,2,9,positive regulation of calcineurin-mediated signaling,BP,NRG1;SLC9A1
16575,GO:0097345,0.061898794270552,0.980659483209405,5,49,mitochondrial outer membrane permeabilization,BP,PMAIP1;BBC3;TP53BP2;TP53;GSK3B
18614,GO:1903861,0.061914791661362,0.993473501468559,2,8,positive regulation of dendrite extension,BP,NEDD4L;ITSN2
905,GO:0002283,0.0619212986671916,0.962044867157901,22,352,neutrophil activation involved in immune response,BP,PLAU;CXCL1;PLAUR;PTX3;NFKB1;AMPD3;ADAM8;RAP2B;CTSC;B4GALT1;RAB24;CD55;CD47;CANT1;SERPINB1;MMP9;CAB39;TLR2;ITGAV;FRK;COTL1;MGAM
16185,GO:0090192,0.0621213846152102,0.993265984120494,2,9,regulation of glomerulus development,BP,CFLAR;PDGFB
17841,GO:1901985,0.0621853439603934,0.983824614513021,4,33,positive regulation of protein acetylation,BP,IL1B;LIF;SOX4;MUC1
13526,GO:0055082,0.0622918420931597,0.959825832275962,27,433,cellular chemical homeostasis,BP,EDN1;BDKRB1;PIM3;C1QTNF1;NEDD4L;ICAM1;SMAD3;ABL2;CD55;ADM;SAA1;SLC11A2;SOX4;MT2A;SLC9A1;RHCG;CLIC4;CAV1;TP53;ITGAV;JPH2;PML;SLC9A8;EGLN1;XBP1;SLC39A14;SLC41A1
7181,GO:0031058,0.0623290440473559,0.975748218595966,7,75,positive regulation of histone modification,BP,IL1B;LIF;VEGFA;TP53;SDR16C5;MUC1;KMT2E
18583,GO:1903793,0.0623672042289506,0.987834339060787,3,21,positive regulation of anion transport,BP,IL1B;EDN1;ABCA7
3566,GO:0007610,0.0624823777088159,0.962173131118237,21,312,behavior,BP,CSF2;BTG2;FOSL1;JUN;ITGA5;SGK1;DKK1;PLK2;CEBPB;CREB1;GJB4;NR4A2;SLC11A2;NRG1;LDLR;TP53;TLR2;PJA2;ABCA7;NR4A3;SLC16A1
17499,GO:1900408,0.0625304155447371,0.983672191890851,4,34,negative regulation of cellular response to oxidative stress,BP,NCOA7;SOD2;NFE2L2;NR4A3
18312,GO:1903202,0.0625304155447371,0.983672191890851,4,34,negative regulation of oxidative stress-induced cell death,BP,NCOA7;SOD2;NFE2L2;NR4A3
14812,GO:0070530,0.0626968418230151,0.987868447331217,3,19,K63-linked polyubiquitin modification-dependent protein binding,MF,TNFAIP3;SQSTM1;TNIP2
2516,GO:0005767,0.0627525653591123,0.993020074272567,2,10,secondary lysosome,CC,SQSTM1;ADAM8
18718,GO:1904062,0.0627856295244653,0.968342688334952,12,157,regulation of cation transmembrane transport,BP,PPIF;BDKRB1;NEDD4L;MMP9;RRAD;CAB39;SLC9A1;NEDD4;CAV1;GEM;JPH2;TSPAN13
3470,GO:0007292,0.0629019235452802,0.975474869167814,7,75,female gamete generation,BP,INHBA;FOSL1;EREG;ADAMTS1;TAF4B;MASTL;IL4R
3544,GO:0007567,0.0630575356861204,0.993106615323589,2,9,parturition,BP,MAFF;EDN1
11858,GO:0046827,0.063139514126411,0.987681223131132,3,20,positive regulation of protein export from nucleus,BP,IL1B;TP53;GSK3B
13853,GO:0060439,0.0631627051924253,0.99308862382178,2,9,trachea morphogenesis,BP,TGFBR2;WNT7B
10505,GO:0043403,0.0632748979413398,0.987643983600768,3,20,skeletal muscle tissue regeneration,BP,CFLAR;TGFBR2;PPARD
5936,GO:0018210,0.0633164951674832,0.971808911645377,9,104,peptidyl-threonine modification,BP,RIPK2;PHKG2;TGFBR2;WNT5A;CAMK1G;CAB39;SPRY2;TNKS1BP1;GSK3B
2609,GO:0005911,0.0635151315555798,0.961494989105414,21,302,cell-cell junction,CC,PANX1;TJP2;AMOTL2;CLDN1;ITGA5;RAP2B;FRMD4B;B4GALT1;TRAF4;GJB3;CDC42EP4;GJB4;PARD6B;SLC9A1;TNKS1BP1;CYTH1;CLIC4;CRB3;OCLN;EPB41L3;GJC1
18315,GO:1903205,0.0635826191064306,0.98749903217529,3,21,regulation of hydrogen peroxide-induced cell death,BP,NFE2L2;TP53;NR4A3
10421,GO:0043256,0.0636316909742722,0.993188000695361,2,8,laminin complex,CC,LAMB3;LAMA3
14312,GO:0061418,0.0636474119004943,0.977188509279678,6,71,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,VEGFA;VHL;BACH1;NFE2L2;UBE2D3;EGLN1
766,GO:0002011,0.0638825382090194,0.979977264151356,5,44,morphogenesis of an epithelial sheet,BP,HBEGF;PHLDB2;ITGA5;WNT5A;DDR1
4768,GO:0010948,0.0639961096319311,0.962181907875752,19,295,negative regulation of cell cycle process,BP,BTG2;LIF;DUSP1;GADD45A;ZFP36L1;CDKN1A;DCUN1D3;CDKN2B;PLK2;SOX4;PLK3;YAF2;TNKS1BP1;TPRA1;TP53;PML;ESPL1;EVI2B;MUC1
7807,GO:0032352,0.0640131839443444,0.99294248293956,2,9,positive regulation of hormone metabolic process,BP,IL1B;TNF
13243,GO:0051893,0.0640295233961149,0.97991812626325,5,44,regulation of focal adhesion assembly,BP,SDC4;PHLDB2;SMAD3;VEGFA;SLC9A1
16134,GO:0090109,0.0640295233961149,0.97991812626325,5,44,regulation of cell-substrate junction assembly,BP,SDC4;PHLDB2;SMAD3;VEGFA;SLC9A1
536,GO:0001654,0.064082017146098,0.964113458347588,16,219,eye development,BP,INHBA;PRDM1;JUN;EPHA2;FJX1;SMAD3;DLX2;NINJ1;VEGFA;TGFBR2;TGIF2;WNT5A;WNT7B;CLIC4;COL8A1;VIM
17350,GO:1900017,0.0641466697016445,0.992919441021777,2,9,positive regulation of cytokine production involved in inflammatory response,BP,TICAM1;NOD2
13585,GO:0060038,0.0642395616484012,0.983184766521645,4,31,cardiac muscle cell proliferation,BP,SAV1;TGFBR2;SMAD1;PIM1
18630,GO:1903897,0.0644273050785337,0.992870906234432,2,9,regulation of PERK-mediated unfolded protein response,BP,PPP1R15A;PTPN1
9293,GO:0035729,0.0645594858640695,0.992848002770544,2,9,cellular response to hepatocyte growth factor stimulus,BP,CREB1;RELA
4771,GO:0010952,0.0648346364203717,0.96821179995008,11,151,positive regulation of peptidase activity,BP,TNF;EFNA1;PMAIP1;BBC3;TNFRSF10B;TNFSF15;RIPK2;SMAD3;CFLAR;CAV1;PML
17968,GO:1902306,0.0649273438169865,0.992784116799753,2,9,negative regulation of sodium ion transmembrane transport,BP,NEDD4L;NEDD4
8498,GO:0033673,0.064953866389623,0.964290124242548,15,212,negative regulation of kinase activity,BP,IL1B;TNFAIP3;DUSP1;GADD45A;CDKN1A;TRIB1;CDKN2B;ERRFI1;DUSP16;DUSP10;SOCS2;DUSP8;SPRY2;PTPN1;CAV1
16823,GO:0098659,0.0649619943213031,0.982932437085957,4,31,inorganic cation import across plasma membrane,BP,STEAP4;SLC9A1;SLC9A8;SLC39A14
17089,GO:0099587,0.0649619943213031,0.982932437085957,4,31,inorganic ion import across plasma membrane,BP,STEAP4;SLC9A1;SLC9A8;SLC39A14
10894,GO:0044431,0.0651057308031559,0.953749137590527,43,723,Golgi apparatus part,CC,SDC4;IFNGR2;STEAP4;NMNAT2;GBP2;ABCA5;CTSC;B4GALT1;B3GNT5;RND3;CD55;DSE;CANT1;WNT5A;CAMK1G;TGFA;PDGFB;PLK3;SYS1;B4GALT5;CYTH1;WNT7B;SGMS2;TPST1;CAV1;HLA-A;UGCG;GOLGA8B;TAPBP;RAB9A;HLA-B;PJA2;ABCA7;TMEM132A;HS3ST3B1;SLC9A8;PPP6R3;CHST2;MUC1;SLC16A13;HLA-F;HLA-E;LMAN1
8628,GO:0034143,0.0651357003380492,0.992747836400333,2,9,regulation of toll-like receptor 4 signaling pathway,BP,TNFAIP3;PELI1
7337,GO:0031343,0.0651461030534222,0.987007411209008,3,22,positive regulation of cell killing,BP,IL23A;PGLYRP4;HLA-E
9555,GO:0036314,0.0652020257844725,0.987179364073994,3,19,response to sterol,BP,INHBA;TGFBR2;HMGCS1
6953,GO:0030575,0.0652150433754093,0.992734002613638,2,9,nuclear body organization,BP,ETS1;PML
7853,GO:0032409,0.0652872779888496,0.968016843776933,11,139,regulation of transporter activity,BP,PPIF;NEDD4L;SGK1;MMP9;RRAD;CAB39;SLC9A1;NEDD4;CAV1;GEM;JPH2
15823,GO:0072507,0.0653972263740873,0.963244971531716,16,229,divalent inorganic cation homeostasis,BP,EDN1;BDKRB1;CYP27B1;C1QTNF1;SMAD3;ABL2;CD55;ADM;SAA1;MT2A;CAV1;ITGAV;JPH2;PML;SLC39A14;SLC41A1
3734,GO:0008270,0.0656446970876666,0.955053191416275,35,574,zinc ion binding,MF,TNFAIP3;TRAF1;SQSTM1;BIRC2;ADAM8;CYLD;GCH1;TRIM47;SMAD3;TRAF4;ZSWIM4;KLF7;ADAMTS1;NR4A2;TRIM25;PGLYRP4;IFIH1;MMP9;MT2A;RCHY1;PTPN1;CHD4;ZNFX1;ZFAND5;TP53;PML;TRIM16;NR4A3;PPARD;PARP1;MMP10;KDM7A;RNF145;SREK1IP1;ZMIZ2
9614,GO:0036475,0.0657505645192036,0.986956927798453,3,20,neuron death in response to oxidative stress,BP,NCOA7;NR4A3;PARP1
8486,GO:0033631,0.0658080287800853,0.992630298197607,2,9,cell-cell adhesion mediated by integrin,BP,ITGA5;ADAM9
9996,GO:0042402,0.0658284030723854,0.992357381204249,2,11,cellular biogenic amine catabolic process,BP,PAOX;SAT1
17752,GO:1901671,0.0658571123631969,0.998880533636626,1,2,positive regulation of superoxide dismutase activity,BP,TNF
19031,GO:1904833,0.0658571123631969,0.998880533636626,1,2,positive regulation of removal of superoxide radicals,BP,TNF
18979,GO:1904724,0.0663311943315419,0.98221598191988,4,38,tertiary granule lumen,CC,CXCL1;PTX3;CANT1;MMP9
3552,GO:0007588,0.0663529469483283,0.986724335174844,3,21,excretion,BP,EDN1;NEDD4L;NFAT5
13498,GO:0055021,0.0664581061739762,0.982366265104307,4,32,regulation of cardiac muscle tissue growth,BP,EDN1;SAV1;TGFBR2;PIM1
17693,GO:1901550,0.0664776414334161,0.992512526298274,2,9,regulation of endothelial cell development,BP,IL1B;TNF
18287,GO:1903140,0.0664776414334161,0.992512526298274,2,9,regulation of establishment of endothelial barrier,BP,IL1B;TNF
3656,GO:0008138,0.0664864960517603,0.982282881597461,4,34,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP1;DUSP16;DUSP10;DUSP8
3379,GO:0007157,0.0664943127750006,0.986684418606595,3,21,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,ITGA5;ICAM1;CRB3
3290,GO:0006982,0.0665053970171355,0.998857995258237,1,2,response to lipid hydroperoxide,BP,GPX3
17456,GO:1900221,0.0665883830225163,0.992492981015648,2,9,regulation of amyloid-beta clearance,BP,LDLR;ABCA7
12272,GO:0048548,0.0666963180780314,0.9924739125287,2,9,regulation of pinocytosis,BP,CAV1;AXL
11853,GO:0046822,0.0668761461571045,0.971570353421187,8,92,regulation of nucleocytoplasmic transport,BP,IL1B;ZC3H12A;CDKN1A;SOX4;NUP153;NEDD4;TP53;GSK3B
19810,GO:2000209,0.0669062428482842,0.986632284084428,3,20,regulation of anoikis,BP,ITGA5;TLE1;CAV1
13855,GO:0060441,0.066984026845063,0.986610344857165,3,20,epithelial tube branching involved in lung morphogenesis,BP,TNF;TNC;SPRY2
9625,GO:0036488,0.0670508775611058,0.998838850808489,1,2,CHOP-C/EBP complex,CC,CEBPB
2735,GO:0006112,0.0670561999968683,0.975818031921272,6,60,energy reserve metabolic process,BP,PHLDA2;IL6ST;PHKG2;PPP1R3B;STK40;GSK3B
11457,GO:0045899,0.067194618896384,0.992231951702636,2,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,CREB1;TP53
4886,GO:0014745,0.0673175595268084,0.99236380469091,2,9,negative regulation of muscle adaptation,BP,SMAD3;ERRFI1
10050,GO:0042501,0.0673505085975122,0.99220371849392,2,10,serine phosphorylation of STAT protein,BP,LIF;IL24
12325,GO:0048666,0.0674716980356337,0.951943132838542,43,708,neuron development,BP,EFNA1;SDC4;BTG2;LIF;PRDM1;JUN;EHD1;EFNB1;IL6;NEDD4L;SGK1;VEGFA;ZSWIM4;PLK2;ABL2;CFLAR;KLF7;ADM;CREB1;NR4A2;SEMA4B;RUNX1;WNT5A;SLC11A2;NRG1;TNC;PARD6B;FEZ1;GRB7;NEDD4;ITSN2;NFE2L2;WNT7B;SPTBN5;ABI1;EFNB2;RAPH1;NR4A3;GSK3B;VIM;DDR1;XBP1;EPB41L3
20172,GO:2000848,0.0675207875799609,0.998822226477686,1,2,positive regulation of corticosteroid hormone secretion,BP,C1QTNF1
4769,GO:0010950,0.0676954640732344,0.967869872064421,10,135,positive regulation of endopeptidase activity,BP,TNF;EFNA1;PMAIP1;BBC3;TNFRSF10B;TNFSF15;RIPK2;SMAD3;CFLAR;PML
3485,GO:0007351,0.0678049647461625,0.992276994599528,2,9,tripartite regional subdivision,BP,TBX3;WNT5A
3926,GO:0008595,0.0678049647461625,0.992276994599528,2,9,anterior/posterior axis specification, embryo,BP,TBX3;WNT5A
12683,GO:0050877,0.067956973418652,0.956178500246852,26,407,nervous system process,BP,BTG2;FOSL1;SOD2;EDN1;JUN;BDKRB1;ITGA5;SGK1;ICAM1;GCH1;DKK1;PLK2;CEBPB;CREB1;GJB4;SLC11A2;SLC52A3;NRG1;LDLR;SLC9A1;SPRY2;TLR2;PJA2;ABCA7;NR4A3;GJC1
15901,GO:0072643,0.068054977180604,0.992232321646984,2,9,interferon-gamma secretion,BP,ZC3H12A;IL36RN
1031,GO:0002536,0.0680616691637613,0.998802939800792,1,2,respiratory burst involved in inflammatory response,BP,DUSP10
13721,GO:0060264,0.0680616691637613,0.998802939800792,1,2,regulation of respiratory burst involved in inflammatory response,BP,DUSP10
13723,GO:0060266,0.0680616691637613,0.998802939800792,1,2,negative regulation of respiratory burst involved in inflammatory response,BP,DUSP10
3533,GO:0007520,0.0681557792332818,0.986278500534571,3,20,myoblast fusion,BP,EHD1;CFLAR;IL4R
11049,GO:0045019,0.0683110711979531,0.992028898282601,2,10,negative regulation of nitric oxide biosynthetic process,BP,ZC3H12A;CAV1
18843,GO:1904406,0.0683110711979531,0.992028898282601,2,10,negative regulation of nitric oxide metabolic process,BP,ZC3H12A;CAV1
12349,GO:0048701,0.0684467619323637,0.981659341693114,4,32,embryonic cranial skeleton morphogenesis,BP,SIX4;SMAD3;DLX2;TGFBR2
13507,GO:0055038,0.0685018994229937,0.975111022031307,6,63,recycling endosome membrane,CC,EHD1;RAP2B;HLA-A;HLA-B;HLA-F;HLA-E
7277,GO:0031253,0.0685342868915948,0.962067555718169,15,203,cell projection membrane,CC,PLAUR;EPHA2;EHD1;ITGA5;B4GALT1;SLC6A14;SLC11A2;NRG1;SPRY2;SPTBN5;ITGAV;ABCA7;ADGRE2;EVC;EPB41L3
1384,GO:0003279,0.0685648787001586,0.972768761129877,7,73,cardiac septum development,BP,PRDM1;TBX3;SAV1;TGFBR2;WNT5A;SOX4;EGLN1
443,GO:0001191,0.0685835291332662,0.981534246926269,4,34,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,BHLHE40;ZNF451;TLE1;SDR16C5
19601,GO:1990622,0.0685946242572844,0.998783777005433,1,2,CHOP-ATF3 complex,CC,ATF3
6699,GO:0030072,0.0686219402862752,0.966072710459016,11,143,peptide hormone secretion,BP,IL1B;TNF;IL1RN;EDN1;IL6;PIM3;SOX4;MARCKS;STX1A;PPARD;SLC16A1
15120,GO:0071159,0.0687500667376638,0.998778158252289,1,2,NF-kappaB complex,CC,RELA
9323,GO:0035791,0.0687534854008838,0.992106993462085,2,9,platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB;PTPN1
3532,GO:0007519,0.0687916692292413,0.970583472174947,8,92,skeletal muscle tissue development,BP,BTG2;MAFF;SIX4;DKK1;CFLAR;ATF3;CAV1;FOXN2
4196,GO:0009299,0.0688311079722028,0.986086101589685,3,20,mRNA transcription,BP,EREG;TP53;PPARD
694,GO:0001911,0.068913946689922,0.991918428926291,2,10,negative regulation of leukocyte mediated cytotoxicity,BP,IL7R;HLA-E
12663,GO:0050854,0.0690065220472299,0.981382232545677,4,34,regulation of antigen receptor-mediated signaling pathway,BP,CYLD;RUNX1;GCSAM;RELA
13212,GO:0051817,0.0690442569755545,0.972465641578566,7,78,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,ZC3H12A;PTX3;TNIP1;JUN;SMAD3;RAB9A;ITGAV
2943,GO:0006470,0.0690674679187457,0.960158215785426,17,244,protein dephosphorylation,BP,TNF;PPP1R15A;DUSP1;DAPP1;PPTC7;PPP4R4;ANKLE2;DUSP16;MASTL;DUSP10;PPP1R3B;DUSP8;PTPN1;SH3RF2;PDP1;PPP6R3;GSK3B
8079,GO:0032753,0.0691808671528716,0.991869335515832,2,10,positive regulation of interleukin-4 production,BP,CEBPB;HLA-E
796,GO:0002062,0.0691830732458902,0.974873134990289,6,59,chondrocyte differentiation,BP,BMP2;SMAD3;RUNX1;TGFBR2;RELA;COL27A1
17586,GO:1901185,0.0692191211547995,0.97769954817367,5,48,negative regulation of ERBB signaling pathway,BP,HBEGF;EREG;ERRFI1;NRG1;SPRY2
8188,GO:0032922,0.069230469832339,0.977771169232687,5,45,circadian regulation of gene expression,BP,NOCT;BHLHE40;RELB;NAMPT;PML
1326,GO:0003174,0.0692334315283638,0.992020440108599,2,9,mitral valve development,BP,EFNA1;SOX4
12315,GO:0048644,0.069254604433287,0.977761205983513,5,45,muscle organ morphogenesis,BP,BMP2;LIF;WNT5A;NRG1;EGLN1
9135,GO:0035457,0.0693433544821502,0.99200056626856,2,9,cellular response to interferon-alpha,BP,IFNAR1;AXL
4823,GO:0014014,0.0694633351624812,0.985837550449679,3,21,negative regulation of gliogenesis,BP,DLX2;DUSP10;LDLR
12926,GO:0051259,0.0695039297818367,0.956338186564475,23,379,protein complex oligomerization,BP,TNFAIP3;BIRC3;ZC3H12A;SOD2;PMAIP1;EHD1;SQSTM1;BIRC2;PANX1;C1QTNF1;CLDN1;GPX3;NOD2;GCH1;B4GALT1;CAB39;SLC9A1;MARCKS;SPTBN5;CAV1;TP53;IKBKE;KCTD11
11074,GO:0045064,0.0695995234896131,0.991792107510714,2,10,T-helper 2 cell differentiation,BP,BCL3;IL4R
8490,GO:0033643,0.0696286085011421,0.991948905490112,2,9,host cell part,CC,AXL;LMAN1
19841,GO:2000275,0.0699047897536102,0.998735998301708,1,2,regulation of oxidative phosphorylation uncoupler activity,BP,PPIF
9803,GO:0040019,0.0700453344837165,0.985738082718366,3,20,positive regulation of embryonic development,BP,SIX4;PHLDB2;GORAB
2189,GO:0005044,0.0700460808184766,0.985669435684196,3,21,scavenger receptor activity,MF,TINAGL1;CXCL16;CRB3
9061,GO:0035282,0.070344723745776,0.974324137003879,6,60,segmentation,BP,TBX3;SMAD3;NRARP;DKK1;WNT5A;ABI1
9907,GO:0042222,0.0703664182993967,0.998718936312284,1,2,interleukin-1 biosynthetic process,BP,CCL20
11235,GO:0045360,0.0703664182993967,0.998718936312284,1,2,regulation of interleukin-1 biosynthetic process,BP,CCL20
11236,GO:0045362,0.0703664182993967,0.998718936312284,1,2,positive regulation of interleukin-1 biosynthetic process,BP,CCL20
15847,GO:0072538,0.0707488846475507,0.991578670409336,2,10,T-helper 17 type immune response,BP,IL23A;IL6
784,GO:0002039,0.0708212483074236,0.974087166212508,6,61,p53 binding,MF,TP53BP2;PLK3;RCHY1;TP53;MUC1;GSK3B
2357,GO:0005451,0.0708959985136082,0.991717852574899,2,9,monovalent cation:proton antiporter activity,MF,SLC9A1;SLC9A8
15702,GO:0072216,0.0711586730062521,0.991502070940432,2,10,positive regulation of metanephros development,BP,LIF;PDGFB
19874,GO:2000321,0.0712480140485142,0.998686022357583,1,2,positive regulation of T-helper 17 cell differentiation,BP,IL23A
19882,GO:2000330,0.0712480140485142,0.998686022357583,1,2,positive regulation of T-helper 17 cell lineage commitment,BP,IL23A
13244,GO:0051894,0.0713827246341463,0.985351675517596,3,20,positive regulation of focal adhesion assembly,BP,SDC4;SMAD3;VEGFA
11087,GO:0045079,0.071402544515071,0.998680208408832,1,2,negative regulation of chemokine biosynthetic process,BP,IL6
723,GO:0001946,0.071422995291283,0.991621048167462,2,9,lymphangiogenesis,BP,VEGFC;CCBE1
8147,GO:0032869,0.0714310591307396,0.96321975691946,12,158,cellular response to insulin stimulus,BP,IL1B;ZFP36L1;CPEB2;CFLAR;ERRFI1;SOGA1;SOCS2;SLC9A1;PTPN1;RELA;PARP1;XBP1
14141,GO:0060993,0.0714380039563827,0.973823143442938,6,60,kidney morphogenesis,BP,BMP2;LIF;SIX4;VEGFA;SOX4;WNT7B
17890,GO:1902110,0.0714662165154925,0.976695025346939,5,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1;BBC3;TP53BP2;TP53;GSK3B
7370,GO:0031410,0.0716130379041287,0.943720065987919,86,1605,cytoplasmic vesicle,CC,IL1B;TNF;HBEGF;PLAU;CXCL1;PLEKHF1;PLAUR;PTX3;NFKB1;EDN1;TICAM1;EHD1;SQSTM1;N4BP3;AMPD3;IFNGR2;ADAM8;IRAK2;STEAP4;AMOTL2;NMNAT2;ITGA5;RAP2B;ABCA5;IL7R;NEDD4L;CTSC;GCH1;RASSF9;B4GALT1;PHLDA1;RND3;VEGFA;RAB24;DKK1;ANXA8;CD55;TAP1;CDC42EP4;IFNAR1;ADAMTS1;CD47;CANT1;MREG;DUSP16;SAA1;WNT5A;VEGFC;SLC11A2;TGFA;SERPINB1;PDGFB;MMP9;LDLR;CAB39;ARRDC4;RASGEF1B;MMD;RHCG;PTPN1;WNT7B;TAB3;CLIC4;CAV1;RHOV;HLA-A;NECAP2;TLR2;TAPBP;RAB9A;HLA-B;ITGAV;IKBKE;UBE2D3;STX1A;ABCA7;PML;PLAT;FRK;HLA-F;HLA-E;OCLN;COTL1;VIM;MGAM;LMAN1
8253,GO:0033028,0.0716359281130073,0.985143936534839,3,22,myeloid cell apoptotic process,BP,HCAR2;IL6;NOD2
15170,GO:0071276,0.0716388719726117,0.985032402579651,3,24,cellular response to cadmium ion,BP,JUN;MMP9;MT2A
5456,GO:0016324,0.0716655646838672,0.961985040111117,13,172,apical plasma membrane,CC,AMOTL2;CLDN1;MREG;SLC11A2;SLC52A3;PARD6B;SLC9A1;RHCG;MUC1;CRB3;OSMR;OCLN;MGAM
4527,GO:0010586,0.0716961519299261,0.98519007333512,3,21,miRNA metabolic process,BP,ZC3H12A;NFKB1;RELA
13594,GO:0060047,0.0717409032907344,0.965650083210665,10,126,heart contraction,BP,HBEGF;ZC3H12A;EDN1;MAP2K3;NEDD4L;GCH1;ADM;SLC9A1;CAV1;GJC1
11609,GO:0046203,0.0717640798690707,0.998666554206538,1,2,spermidine catabolic process,BP,PAOX
18556,GO:1903747,0.0718076328670664,0.968945102644566,8,99,regulation of establishment of protein localization to mitochondrion,BP,PMAIP1;BBC3;PLAGL2;TP53BP2;NRG1;UGCG;TP53;UBE2D3
949,GO:0002363,0.0719245813689522,0.991358199447639,2,10,alpha-beta T cell lineage commitment,BP,IL23A;IL6
1316,GO:0003161,0.0719596982341984,0.991522021743822,2,9,cardiac conduction system development,BP,TBX3;NRG1
6073,GO:0019218,0.0719743184335518,0.970997377009148,7,80,regulation of steroid metabolic process,BP,IL1B;TNF;BMP2;NFKB1;CYP27B1;HMGCS1;LDLR
7301,GO:0031295,0.0719751775336196,0.980305974757252,4,34,T cell costimulation,BP,EFNB1;MAP3K8;CAV1;EFNB2
4294,GO:0009713,0.0719974411307564,0.991344465431833,2,10,catechol-containing compound biosynthetic process,BP,GCH1;NR4A2
10009,GO:0042423,0.0719974411307564,0.991344465431833,2,10,catecholamine biosynthetic process,BP,GCH1;NR4A2
8276,GO:0033077,0.0720188563500211,0.976533044554812,5,48,T cell differentiation in thymus,BP,ADAM8;ZFP36L1;FZD8;IL7R;NFKBID
5073,GO:0015293,0.0720540255508304,0.971026501549316,7,75,symporter activity,MF,SLC6A14;SLC28A3;SLC11A2;SLC38A2;SLC2A6;SLC16A13;SLC16A1
9797,GO:0040013,0.0723332189178338,0.959633080325899,15,209,negative regulation of locomotion,BP,PHLDB2;RAP2B;NAV3;TRIB1;SEMA4B;TRIM25;WNT5A;DUSP10;NRG1;GCSAM;IL24;NFE2L2;CLIC4;PML;PPARD
5913,GO:0018146,0.072520941753595,0.98494862578145,3,21,keratan sulfate biosynthetic process,BP,B4GALT1;B4GALT5;CHST2
5078,GO:0015298,0.072544033111447,0.985013537308909,3,20,solute:cation antiporter activity,MF,SLC9A1;SLC9A8;SLC41A1
7856,GO:0032412,0.0726360885380775,0.965150069083429,10,125,regulation of ion transmembrane transporter activity,BP,PPIF;NEDD4L;MMP9;RRAD;CAB39;SLC9A1;NEDD4;CAV1;GEM;JPH2
6987,GO:0030659,0.0726904674145653,0.950956432231387,31,508,cytoplasmic vesicle membrane,CC,HBEGF;PLAU;PLAUR;IFNGR2;ADAM8;RAP2B;IL7R;RASSF9;B4GALT1;RAB24;CD55;TAP1;CD47;WNT5A;TGFA;LDLR;WNT7B;CLIC4;CAV1;HLA-A;NECAP2;TLR2;TAPBP;RAB9A;HLA-B;ITGAV;STX1A;HLA-F;HLA-E;MGAM;LMAN1
12316,GO:0048645,0.0728208255381352,0.9799591089215,4,35,animal organ formation,BP,DKK1;TGFBR2;WNT5A;PIM1
4284,GO:0009648,0.0728822060621841,0.984842486299297,3,21,photoperiodism,BP,BHLHE40;TP53;PML
130,GO:0000270,0.07294854720825,0.998621308856,1,2,peptidoglycan metabolic process,BP,PGLYRP4
3965,GO:0008745,0.07294854720825,0.998621308856,1,2,N-acetylmuramoyl-L-alanine amidase activity,MF,PGLYRP4
4180,GO:0009253,0.07294854720825,0.998621308856,1,2,peptidoglycan catabolic process,BP,PGLYRP4
5314,GO:0016019,0.07294854720825,0.998621308856,1,2,peptidoglycan receptor activity,MF,PGLYRP4
13157,GO:0051710,0.07294854720825,0.998621308856,1,2,regulation of cytolysis in other organism,BP,PGLYRP4
13159,GO:0051714,0.07294854720825,0.998621308856,1,2,positive regulation of cytolysis in other organism,BP,PGLYRP4
2187,GO:0005041,0.0730336653174425,0.99132253882689,2,9,low-density lipoprotein particle receptor activity,MF,LDLR;CXCL16
4208,GO:0009314,0.0731452480316834,0.954333608007232,22,340,response to radiation,BP,JUN;BHLHE40;DUSP1;BCL3;GADD45A;N4BP1;JUNB;CDKN1A;DCUN1D3;ICAM1;CREB1;HMGCS1;PLK3;TNKS1BP1;NEDD4;TP53;RAD9B;PML;RELA;PARP1;NABP1;JUND
13035,GO:0051457,0.073184792124457,0.984687855455192,3,22,maintenance of protein location in nucleus,BP,BCL3;SOX4;PML
788,GO:0002043,0.073282888046366,0.991100799946944,2,10,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,VEGFA;NRARP
20224,GO:2001056,0.0734296288680509,0.96622515310748,9,119,positive regulation of cysteine-type endopeptidase activity,BP,TNF;PMAIP1;BBC3;TNFRSF10B;TNFSF15;RIPK2;SMAD3;CFLAR;PML
13992,GO:0060688,0.0734345773093733,0.979770925691826,4,34,regulation of morphogenesis of a branching structure,BP,TNF;SIX4;VEGFA;WNT5A
12848,GO:0051145,0.0734730931092885,0.979756752280281,4,34,smooth muscle cell differentiation,BP,EREG;VEGFA;ADM;PDGFB
16728,GO:0097708,0.0735032642339684,0.942148720595976,86,1607,intracellular vesicle,CC,IL1B;TNF;HBEGF;PLAU;CXCL1;PLEKHF1;PLAUR;PTX3;NFKB1;EDN1;TICAM1;EHD1;SQSTM1;N4BP3;AMPD3;IFNGR2;ADAM8;IRAK2;STEAP4;AMOTL2;NMNAT2;ITGA5;RAP2B;ABCA5;IL7R;NEDD4L;CTSC;GCH1;RASSF9;B4GALT1;PHLDA1;RND3;VEGFA;RAB24;DKK1;ANXA8;CD55;TAP1;CDC42EP4;IFNAR1;ADAMTS1;CD47;CANT1;MREG;DUSP16;SAA1;WNT5A;VEGFC;SLC11A2;TGFA;SERPINB1;PDGFB;MMP9;LDLR;CAB39;ARRDC4;RASGEF1B;MMD;RHCG;PTPN1;WNT7B;TAB3;CLIC4;CAV1;RHOV;HLA-A;NECAP2;TLR2;TAPBP;RAB9A;HLA-B;ITGAV;IKBKE;UBE2D3;STX1A;ABCA7;PML;PLAT;FRK;HLA-F;HLA-E;OCLN;COTL1;VIM;MGAM;LMAN1
8239,GO:0033005,0.0737121801856859,0.991018852796602,2,10,positive regulation of mast cell activation,BP,IL4R;NR4A3
16840,GO:0098719,0.0737732675641531,0.991184136828674,2,9,sodium ion import across plasma membrane,BP,SLC9A1;SLC9A8
11429,GO:0045834,0.073929077864469,0.970053370463115,7,78,positive regulation of lipid metabolic process,BP,IL1B;TNF;NOD2;CREB1;PDGFB;LDLR;NR4A3
7022,GO:0030730,0.0739614641528797,0.990971136176058,2,10,sequestering of triglyceride,BP,IL1B;TNF
4756,GO:0010927,0.0740472641422028,0.972618856588729,6,60,cellular component assembly involved in morphogenesis,BP,EDN1;SIX4;PHLDB2;CFLAR;TLR2;EPB41L3
6613,GO:0022821,0.0740486906971949,0.991132383705644,2,9,potassium ion antiporter activity,MF,SLC9A1;SLC9A8
18994,GO:1904754,0.0741220143906033,0.991118586421705,2,9,positive regulation of vascular associated smooth muscle cell migration,BP,PDGFB;DOCK4
6067,GO:0019211,0.0741923717209464,0.990926851271506,2,10,phosphatase activator activity,MF,PPP1R15A;BMP2
3191,GO:0006816,0.0741972121181638,0.958434195603877,15,211,calcium ion transport,BP,IL16;BDKRB1;PANX1;CYP27B1;ICAM1;PDGFB;RRAD;TRPV3;SLC9A1;CAV1;ITGAV;GEM;JPH2;PML;TSPAN13
12793,GO:0051055,0.0743155680661512,0.979407807122558,4,35,negative regulation of lipid biosynthetic process,BP,BMP2;NFKB1;CYP27B1;PDGFB
16351,GO:0090575,0.0746515213883363,0.963959524302307,10,131,RNA polymerase II transcription factor complex,CC,JUN;JUNB;CEBPB;CREB1;TAF4B;TLE1;TP53;PPARD;MXD3;JUND
7097,GO:0030888,0.0746864971694128,0.979270370378796,4,35,regulation of B cell proliferation,BP,PRDM1;TICAM1;PELI1;CDKN1A
18160,GO:1902883,0.0751440386381366,0.979063996299272,4,36,negative regulation of response to oxidative stress,BP,NCOA7;SOD2;NFE2L2;NR4A3
14904,GO:0070696,0.0752118040243998,0.990730353797654,2,10,transmembrane receptor protein serine/threonine kinase binding,MF,INHBA;BMP2
19236,GO:1905332,0.0752436922056308,0.984142964964005,3,21,positive regulation of morphogenesis of an epithelium,BP,LIF;SIX4;VEGFA
9068,GO:0035303,0.0752818074426205,0.960902650414685,12,158,regulation of dephosphorylation,BP,TNF;PLEKHF1;PPP1R15A;BMP2;SMAD3;PPP4R4;ANKLE2;MASTL;PPP1R3B;SH3RF2;PPP6R3;GSK3B
17907,GO:1902175,0.0753624142050469,0.983977493961018,3,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,SOD2;NFE2L2;PARP1
8406,GO:0033344,0.0754144527199893,0.984023788005072,3,22,cholesterol efflux,BP,NFKBIA;ABCA5;ABCA7
6759,GO:0030177,0.075458605562255,0.963470806559524,10,135,positive regulation of Wnt signaling pathway,BP,BMP2;NFKB1;BAMBI;NRARP;DKK1;SMURF2;WNT5A;SOX4;CAV1;TLR2
15478,GO:0071803,0.0755679880338064,0.990661321081732,2,10,positive regulation of podosome assembly,BP,CSF2;TNF
15494,GO:0071827,0.075802764215003,0.983907235947934,3,22,plasma lipoprotein particle organization,BP,PLAGL2;ABCA5;ABCA7
1146,GO:0002739,0.0759928809193808,0.99057871661193,2,10,regulation of cytokine secretion involved in immune response,BP,TNF;WNT5A
8230,GO:0032989,0.0761244188952692,0.944848288005897,45,750,cellular component morphogenesis,BP,EFNA1;EDN1;EPHA2;EFNB1;ADAM8;SIX4;PHLDB2;BAMBI;IL7R;NEDD4L;SGK1;ICAM1;RND3;VEGFA;FGD6;DKK1;ZSWIM4;CFLAR;KLF7;CDC42EP4;CREB1;NR4A2;VHL;SEMA4B;WNT5A;SLC11A2;NRG1;PARD6B;FEZ1;GRB7;NEDD4;ITSN2;WNT7B;SPTBN5;CLIC4;RHOV;TLR2;ABI1;EFNB2;ITGAV;RAPH1;AXL;NR4A3;DDR1;EPB41L3
7653,GO:0032060,0.0762858259523565,0.990521602997594,2,10,bleb assembly,BP,ANLN;EMP3
10120,GO:0042635,0.0764195189131147,0.990344787626599,2,11,positive regulation of hair cycle,BP,TNF;WNT5A
13205,GO:0051798,0.0764195189131147,0.990344787626599,2,11,positive regulation of hair follicle development,BP,TNF;WNT5A
7300,GO:0031294,0.0764537628448398,0.978612160830036,4,35,lymphocyte costimulation,BP,EFNB1;MAP3K8;CAV1;EFNB2
14103,GO:0060914,0.0765825277177992,0.99031243145216,2,11,heart formation,BP,DKK1;PIM1
10713,GO:0044003,0.0766340304144411,0.978584426591178,4,34,modification by symbiont of host morphology or physiology,BP,ZC3H12A;TNIP1;SMAD3;ITGAV
7329,GO:0031334,0.076814611795147,0.957699187257969,14,199,positive regulation of protein complex assembly,BP,CSF2;TNF;FOSL1;PMAIP1;JUN;NAV3;ICAM1;VEGFA;CDC42EP4;CREB1;TP53;GSK3B;PARP1;JMY
7614,GO:0031996,0.0770236086002868,0.990377179480043,2,10,thioesterase binding,MF,TRAF1;TRAF4
442,GO:0001190,0.0771362652759441,0.97439181368348,5,47,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,JUN;KDM6B;CREB1;SOX4;CITED4
4444,GO:0010332,0.0771576357300634,0.974303423009689,5,50,response to gamma radiation,BP,CDKN1A;DCUN1D3;TP53;PML;PARP1
16790,GO:0098589,0.0772094251217492,0.956502411994019,15,210,membrane region,CC,TNF;SDC4;BIRC3;EFNB1;BIRC2;RAP2B;ICAM1;CFLAR;CD55;TGFBR2;SMURF2;EFHD2;SLC9A1;CAV1;TLR2
14790,GO:0070486,0.0772508103289847,0.990179351063172,2,11,leukocyte aggregation,BP,IL1B;NR4A3
16886,GO:0098805,0.0774714876063035,0.940655180742121,66,1197,whole membrane,CC,TNF;HBEGF;PLAU;SDC4;BIRC3;PLEKHF1;PPP1R15A;PLAUR;PMAIP1;TICAM1;EHD1;EFNB1;BIRC2;ADAM8;CYP27B1;IRAK2;STEAP4;RAP2B;ABCA5;IL7R;NAV3;ICAM1;RASSF9;B4GALT1;RAB24;DKK1;CFLAR;ANXA8;VMP1;CD55;TAP1;CD47;TGFBR2;SMURF2;WNT5A;SLC11A2;TGFA;EFHD2;LDLR;SLC9A1;MAOA;BCL2L2;RNF152;MMD;WNT7B;TAB3;CAV1;RHOV;HLA-A;DRAM1;NECAP2;TLR2;TAPBP;RAB9A;HLA-B;ITGAV;IKBKE;UBE2D3;STX1A;ABCA7;PML;HLA-F;HLA-E;CYP24A1;MGAM;LMAN1
11282,GO:0045579,0.077508768665739,0.990281753892487,2,10,positive regulation of B cell differentiation,BP,PRDM1;XBP1
13495,GO:0055017,0.077538076586534,0.974219724316036,5,47,cardiac muscle tissue growth,BP,EDN1;SAV1;TGFBR2;SMAD1;PIM1
12655,GO:0050840,0.0775688752679037,0.978234284789025,4,34,extracellular matrix binding,MF,VEGFA;TINAGL1;ITGAV;ADAM9
9613,GO:0036474,0.0776046265955127,0.98329859689932,3,23,cell death in response to hydrogen peroxide,BP,NFE2L2;TP53;NR4A3
4647,GO:0010766,0.0779056151673886,0.990203431419412,2,10,negative regulation of sodium ion transport,BP,NEDD4L;NEDD4
2265,GO:0005178,0.0779768493065111,0.968038428117962,7,77,integrin binding,MF,IL1B;ITGA5;ICAM1;WISP1;NRG1;ITGAV;ADAM9
3397,GO:0007176,0.0779898460041631,0.983245839707388,3,22,regulation of epidermal growth factor-activated receptor activity,BP,EREG;ERRFI1;TGFA
8237,GO:0033003,0.0780213081159143,0.983236264292131,3,22,regulation of mast cell activation,BP,IL4R;ADGRE2;NR4A3
14018,GO:0060720,0.0780502533025736,0.998417443238877,1,2,spongiotrophoblast cell proliferation,BP,PHLDA2
14019,GO:0060721,0.0780502533025736,0.998417443238877,1,2,regulation of spongiotrophoblast cell proliferation,BP,PHLDA2
14020,GO:0060722,0.0780502533025736,0.998417443238877,1,2,cell proliferation involved in embryonic placenta development,BP,PHLDA2
14021,GO:0060723,0.0780502533025736,0.998417443238877,1,2,regulation of cell proliferation involved in embryonic placenta development,BP,PHLDA2
16204,GO:0090214,0.0780502533025736,0.998417443238877,1,2,spongiotrophoblast layer developmental growth,BP,PHLDA2
14346,GO:0061515,0.0780930066000697,0.973953626500501,5,48,myeloid cell development,BP,TJP2;SLC11A2;TLR2;ABI1;EVI2B
14830,GO:0070557,0.0782925965765882,0.998407394963199,1,2,PCNA-p21 complex,CC,CDKN1A
14650,GO:0070227,0.0783049288402021,0.973761572813943,5,52,lymphocyte apoptotic process,BP,EFNA1;ADAM8;NFKBID;WNT5A;TP53
10371,GO:0043183,0.0783663276370075,0.998404331280989,1,2,vascular endothelial growth factor receptor 1 binding,MF,VEGFA
14058,GO:0060788,0.0783675476086028,0.990111961139081,2,10,ectodermal placode formation,BP,TBX3;SIX4
15439,GO:0071697,0.0783675476086028,0.990111961139081,2,10,ectodermal placode morphogenesis,BP,TBX3;SIX4
3571,GO:0007616,0.0784434471497573,0.983179486139107,3,21,long-term memory,BP,SGK1;LDLR;PJA2
38,GO:0000077,0.0785103905414778,0.960246150633257,11,147,DNA damage checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;RAD9B;PML;MUC1
4442,GO:0010314,0.0785170730516524,0.990082283035183,2,10,phosphatidylinositol-5-phosphate binding,MF,PLEKHF1;JPH2
8886,GO:0034698,0.0786233344161871,0.983124791366021,3,21,response to gonadotropin,BP,INHBA;ICAM1;HMGCS1
40,GO:0000082,0.0786454782307557,0.955533506275551,15,221,G1/S transition of mitotic cell cycle,BP,BTG2;INHBA;GADD45A;CDKN1A;DCUN1D3;CDKN2B;PLK2;BACH1;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1;KMT2E
1264,GO:0003015,0.0786456868787246,0.961688192081151,10,128,heart process,BP,HBEGF;ZC3H12A;EDN1;MAP2K3;NEDD4L;GCH1;ADM;SLC9A1;CAV1;GJC1
1147,GO:0002740,0.0787543679731491,0.998388156827386,1,2,negative regulation of cytokine secretion involved in immune response,BP,TNF
1211,GO:0002874,0.0787543679731491,0.998388156827386,1,2,regulation of chronic inflammatory response to antigenic stimulus,BP,TNF
14007,GO:0060707,0.0790378182292206,0.989978659215454,2,10,trophoblast giant cell differentiation,BP,LIF;PRDM1
13008,GO:0051412,0.079095511772782,0.989967153352959,2,10,response to corticosterone,BP,FOSL1;CDKN1A
15820,GO:0072503,0.0791127915985345,0.955241980147019,15,218,cellular divalent inorganic cation homeostasis,BP,EDN1;BDKRB1;C1QTNF1;SMAD3;ABL2;CD55;ADM;SAA1;MT2A;CAV1;ITGAV;JPH2;PML;SLC39A14;SLC41A1
2098,GO:0004861,0.0791888832137099,0.989789504812137,2,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN1A;CDKN2B
11186,GO:0045259,0.0792472532954689,0.998367489620971,1,2,proton-transporting ATP synthase complex,CC,PPIF
9767,GO:0039528,0.0792472664797033,0.982934651468665,3,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,BIRC3;BIRC2;IFIH1
16403,GO:0097006,0.0795613253431632,0.973241678063777,5,51,regulation of plasma lipoprotein particle levels,BP,EHD1;PLAGL2;ABCA5;LDLR;ABCA7
3291,GO:0006983,0.079596323285933,0.989867064042847,2,10,ER overload response,BP,TP53;GSK3B
9037,GO:0035250,0.0796877333043166,0.982726638615031,3,22,UDP-galactosyltransferase activity,MF,B4GALT1;B3GNT5;B4GALT5
12155,GO:0048250,0.079747934222173,0.998346355011293,1,2,iron import into the mitochondrion,BP,SLC25A37
12659,GO:0050850,0.0798609746758385,0.982606550584415,3,23,positive regulation of calcium-mediated signaling,BP,NRG1;SLC9A1;JPH2
7099,GO:0030890,0.0799093446809455,0.982591618362261,3,23,positive regulation of B cell proliferation,BP,TICAM1;PELI1;CDKN1A
12638,GO:0050810,0.0799622289816683,0.969743900734316,6,65,regulation of steroid biosynthetic process,BP,IL1B;TNF;BMP2;NFKB1;CYP27B1;HMGCS1
13595,GO:0060048,0.0801438881351139,0.969676456843758,6,64,cardiac muscle contraction,BP,ZC3H12A;MAP2K3;NEDD4L;SLC9A1;CAV1;GJC1
5819,GO:0017080,0.0803497270282956,0.982522856899433,3,22,sodium channel regulator activity,MF,NEDD4L;SGK1;NEDD4
4179,GO:0009251,0.0807467850714774,0.982474942168592,3,21,glucan catabolic process,BP,PHKG2;PPP1R3B;MGAM
13591,GO:0060044,0.0807806476741706,0.989628861333769,2,10,negative regulation of cardiac muscle cell proliferation,BP,SAV1;TGFBR2
6635,GO:0022898,0.0809872550911512,0.960332818413049,10,128,regulation of transmembrane transporter activity,BP,PPIF;NEDD4L;MMP9;RRAD;CAB39;SLC9A1;NEDD4;CAV1;GEM;JPH2
12682,GO:0050873,0.0810257407700263,0.982245857328352,3,23,brown fat cell differentiation,BP,LAMB3;CEBPB;DUSP10
8922,GO:0034762,0.0810830208843291,0.951413028808247,18,266,regulation of transmembrane transport,BP,IL1B;TNF;PPIF;BDKRB1;NEDD4L;KCNJ15;MMP9;RRAD;CAB39;SLC9A1;NEDD4;NFE2L2;CLIC4;CAV1;GEM;JPH2;TSPAN13;NR4A3
9631,GO:0036496,0.0811058729987906,0.99828832018533,1,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,PPP1R15A
8189,GO:0032924,0.0811189080334792,0.982285134235848,3,22,activin receptor signaling pathway,BP,INHBA;SMAD3;TGIF2
4204,GO:0009310,0.0812329873670389,0.989235856006544,2,12,amine catabolic process,BP,PAOX;SAT1
13027,GO:0051447,0.0812475086188115,0.98953437982966,2,10,negative regulation of meiotic cell cycle,BP,LIF;DUSP1
18399,GO:1903391,0.0814240357201133,0.972540976796482,5,47,regulation of adherens junction organization,BP,SDC4;PHLDB2;SMAD3;VEGFA;SLC9A1
1188,GO:0002832,0.0815053865986457,0.97665983344358,4,36,negative regulation of response to biotic stimulus,BP,TNFAIP3;PRDM1;TRIB1;MAPKBP1
7185,GO:0031063,0.0815282211352133,0.982158219164564,3,22,regulation of histone deacetylation,BP,VEGFA;TP53;SDR16C5
12147,GO:0048237,0.0815639861006921,0.998268505990267,1,2,rough endoplasmic reticulum lumen,CC,EDN1
4676,GO:0010821,0.08162838799213,0.955717100165819,13,190,regulation of mitochondrion organization,BP,PLAUR;PMAIP1;PPIF;SQSTM1;BBC3;PLAGL2;TP53BP2;NRG1;MMP9;UGCG;TP53;UBE2D3;GSK3B
2095,GO:0004857,0.0816543618902,0.953548185285961,15,230,enzyme inhibitor activity,MF,BIRC3;SERPINB2;BIRC2;TNFAIP8;CDKN1A;CPEB2;TFPI2;TRIB1;SERPINB8;CDKN2B;SERPINB1;SOCS2;SPRY2;SH3RF2;ANXA5
1235,GO:0002920,0.0816626186915908,0.982047649683694,3,23,regulation of humoral immune response,BP,TNF;CD55;CFB
12798,GO:0051066,0.0817370046773212,0.998260991674609,1,2,dihydrobiopterin metabolic process,BP,GCH1
8614,GO:0034122,0.0817748682352223,0.982157538085554,3,21,negative regulation of toll-like receptor signaling pathway,BP,TNFAIP3;TICAM1;OTUD4
9070,GO:0035305,0.0817941994690043,0.966068948535147,7,79,negative regulation of dephosphorylation,BP,TNF;PLEKHF1;PPP1R15A;PPP4R4;MASTL;SH3RF2;GSK3B
963,GO:0002384,0.0820954158707806,0.998245371600457,1,2,hepatic immune response,BP,IL6
7176,GO:0031053,0.0822073637219225,0.989339097411242,2,10,primary miRNA processing,BP,SMAD3;SMAD1
7336,GO:0031342,0.0822955624961194,0.98915256780434,2,11,negative regulation of cell killing,BP,IL7R;HLA-E
16307,GO:0090398,0.0823227010244066,0.972037469441095,5,51,cellular senescence,BP,TBX3;CDKN1A;PLK2;TP53;PML
4027,GO:0009057,0.0824436451128515,0.93732794140787,60,1127,macromolecule catabolic process,BP,IL1B;TNFAIP3;TNF;EFNA1;SDC4;BTG2;NOCT;ZC3H12A;RNF19B;PMAIP1;ZFP36;PNRC1;SQSTM1;BIRC2;ADAM8;N4BP1;ZFP36L1;CYLD;ODC1;NEDD4L;CTSC;SMAD3;RNF144B;TRIB1;PLK2;RNF43;DENND3;USP43;PATL1;PHKG2;ABTB2;SMURF2;TINAGL1;PNRC2;TRIM25;WNT5A;PPP1R3B;PGLYRP4;NRG1;LDLR;PLK3;SLC9A1;RCHY1;TNKS1BP1;NEDD4;NFE2L2;PTPN1;CAV1;TP53;UBE2D3;PML;ADAM9;RELA;USP31;GSK3B;VIM;RNF145;XBP1;QKI;MGAM
13977,GO:0060669,0.082636617641552,0.981813105707928,3,22,embryonic placenta morphogenesis,BP,ZFP36L1;ADM;WNT7B
13366,GO:0052422,0.0827019519876062,0.998218771760832,1,2,modulation by host of symbiont catalytic activity,BP,PTX3
11165,GO:0045213,0.0829999663807912,0.998205625674664,1,2,neurotransmitter receptor metabolic process,BP,NRG1
5610,GO:0016647,0.0830128814182292,0.998205054822102,1,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,PAOX
11758,GO:0046592,0.0830128814182292,0.998205054822102,1,2,polyamine oxidase activity,MF,PAOX
13466,GO:0052901,0.0830128814182292,0.998205054822102,1,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,PAOX
7707,GO:0032182,0.0830176551643178,0.96539786927721,7,82,ubiquitin-like protein binding,MF,TNFAIP3;SQSTM1;BIRC2;DCUN1D3;SMAD3;NEDD4;PML
14308,GO:0061394,0.0830896035452427,0.99820166170236,1,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,ATF3
32,GO:0000060,0.0831171250084903,0.976000505131287,4,37,protein import into nucleus, translocation,BP,NFKBIA;TNF;BCL3;CDKN1A
12561,GO:0050700,0.083153884728358,0.988974000283552,2,11,CARD domain binding,MF,RIPK2;NOD2
4514,GO:0010561,0.0832274189918696,0.988958650068591,2,11,negative regulation of glycoprotein biosynthetic process,BP,HBEGF;ABCA7
1238,GO:0002923,0.0834297853142771,0.998186576471436,1,2,regulation of humoral immune response mediated by circulating immunoglobulin,BP,TNF
9578,GO:0036378,0.0834323028581146,0.998186464586569,1,2,calcitriol biosynthetic process from calciol,BP,CYP27B1
19734,GO:2000052,0.083433109361138,0.98908770942025,2,10,positive regulation of non-canonical Wnt signaling pathway,BP,DKK1;WNT5A
9874,GO:0042130,0.0835119097658323,0.975886826434874,4,36,negative regulation of T cell proliferation,BP,SDC4;PELI1;CEBPB;BTN2A2
11335,GO:0045650,0.0835506762403572,0.998181199757642,1,2,negative regulation of macrophage differentiation,BP,INHBA
13910,GO:0060538,0.0835542734366179,0.962721680703727,8,96,skeletal muscle organ development,BP,BTG2;MAFF;SIX4;DKK1;CFLAR;ATF3;CAV1;FOXN2
16873,GO:0098791,0.0836477416423576,0.940334555715138,39,662,Golgi subcompartment,CC,IFNGR2;STEAP4;NMNAT2;GBP2;ABCA5;CTSC;B4GALT1;B3GNT5;RND3;CD55;DSE;CANT1;CAMK1G;TGFA;PDGFB;PLK3;SYS1;B4GALT5;CYTH1;SGMS2;TPST1;CAV1;HLA-A;UGCG;GOLGA8B;TAPBP;RAB9A;HLA-B;PJA2;ABCA7;TMEM132A;HS3ST3B1;SLC9A8;PPP6R3;CHST2;SLC16A13;HLA-F;HLA-E;LMAN1
18220,GO:1902994,0.083703741183042,0.998174380151218,1,2,regulation of phospholipid efflux,BP,ABCA7
18221,GO:1902995,0.083703741183042,0.998174380151218,1,2,positive regulation of phospholipid efflux,BP,ABCA7
597,GO:0001759,0.0837743606821814,0.98884421954434,2,11,organ induction,BP,BMP2;DKK1
2139,GO:0004947,0.084255715713498,0.998149676893469,1,2,bradykinin receptor activity,MF,BDKRB1
17928,GO:1902226,0.0843631414340609,0.998144848955861,1,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,CSF1
18669,GO:1903969,0.0843631414340609,0.998144848955861,1,2,regulation of response to macrophage colony-stimulating factor,BP,CSF1
18672,GO:1903972,0.0843631414340609,0.998144848955861,1,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,CSF1
6998,GO:0030674,0.0845095636950328,0.958278642669513,10,128,protein binding, bridging,MF,BCL3;TJP2;TP53BP2;SOCS2;ARRDC4;SLC9A1;GRB7;ITSN2;CAV1;STX1A
16328,GO:0090500,0.0846225117277792,0.998133165207219,1,2,endocardial cushion to mesenchymal transition,BP,EFNA1
16883,GO:0098801,0.0846546481384294,0.988659097264386,2,11,regulation of renal system process,BP,EDN1;PDGFB
3496,GO:0007389,0.084682570416573,0.94978163148617,17,249,pattern specification process,BP,BTG2;BMP2;TBX3;EDN1;EFNB1;ETS2;SMAD3;DLX2;NRARP;DKK1;GORAB;TGFBR2;WNT5A;WNT7B;SMAD1;RTTN;ABI1
16824,GO:0098660,0.084739091111071,0.94452918199012,25,406,inorganic ion transmembrane transport,BP,PPIF;BDKRB1;PANX1;STEAP4;NEDD4L;KCNJ15;SLC28A3;NIPAL4;SLC11A2;RRAD;CAB39;TRPV3;SLC9A1;SLC25A37;NEDD4;SLC2A6;CLIC4;CAV1;ITGAV;GEM;JPH2;SLC9A8;TSPAN13;SLC39A14;SLC41A1
11066,GO:0045055,0.0847930026238506,0.942284773876509,30,514,regulated exocytosis,BP,PLAU;CXCL1;PLAUR;PTX3;NFKB1;AMPD3;ADAM8;RAP2B;CTSC;B4GALT1;VEGFA;RAB24;CD55;CD47;CANT1;VEGFC;SERPINB1;PDGFB;MMP9;CAB39;IL4R;TLR2;ITGAV;STX1A;ADGRE2;ANXA5;FRK;NR4A3;COTL1;MGAM
539,GO:0001657,0.0849572543827163,0.967389644972973,6,63,ureteric bud development,BP,SDC4;BMP2;SIX4;SMAD3;VEGFA;SMAD1
15862,GO:0072563,0.0851034882926992,0.998111397359572,1,2,endothelial microparticle,CC,ANXA5
12666,GO:0050857,0.0851140021550617,0.988562032138542,2,11,positive regulation of antigen receptor-mediated signaling pathway,BP,CYLD;RELA
14451,GO:0061757,0.0851205809125845,0.998110621361094,1,2,leukocyte adhesion to arterial endothelial cell,BP,TNF
19113,GO:1904997,0.0851205809125845,0.998110621361094,1,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,TNF
2950,GO:0006478,0.0851820395905117,0.998107829783411,1,2,peptidyl-tyrosine sulfation,BP,TPST1
3861,GO:0008476,0.0851820395905117,0.998107829783411,1,2,protein-tyrosine sulfotransferase activity,MF,TPST1
14276,GO:0061317,0.0852107208655571,0.998106526284349,1,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,DKK1
17622,GO:1901295,0.0852107208655571,0.998106526284349,1,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,DKK1
19143,GO:1905066,0.0852107208655571,0.998106526284349,1,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,DKK1
15601,GO:0072061,0.085377312895254,0.998098945773135,1,2,inner medullary collecting duct development,BP,WNT7B
19414,GO:1905897,0.0854927202343033,0.967050489135361,6,67,regulation of response to endoplasmic reticulum stress,BP,PPP1R15A;PMAIP1;NFE2L2;PTPN1;CAV1;XBP1
804,GO:0002070,0.0855558246643937,0.988468371852317,2,11,epithelial cell maturation,BP,CDKN1A;XBP1
2971,GO:0006509,0.0855603667530285,0.975090551032556,4,36,membrane protein ectodomain proteolysis,BP,IL1B;TNF;ADAM8;ADAM9
5790,GO:0017015,0.0856377589247554,0.964076196319166,7,80,regulation of transforming growth factor beta receptor signaling pathway,BP,BAMBI;ZNF451;SMAD3;CDKN2B;TGFBR2;SMURF2;CAV1
13160,GO:0051715,0.0857410541376638,0.997455826614332,1,3,cytolysis in other organism,BP,PGLYRP4
10132,GO:0042663,0.0857540113076539,0.998081746295463,1,2,regulation of endodermal cell fate specification,BP,DKK1
15202,GO:0071332,0.0859100001248144,0.998074600361696,1,2,cellular response to fructose stimulus,BP,XBP1
18037,GO:1902524,0.0859446921080051,0.998073009213766,1,2,positive regulation of protein K48-linked ubiquitination,BP,BIRC2
18500,GO:1903589,0.0859854942664551,0.998071136942882,1,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,VEGFA
10791,GO:0044249,0.0861283730099757,0.926966983634954,235,4837,cellular biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;EFNA1;BTG2;INHBA;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;EHF;PTX3;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;NMNAT2;CCDC85B;CPEB2;ZNF451;ODC1;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;GCH1;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;FGF5;ZBED2;CFLAR;KLF7;PIGA;BTG1;UPP1;IER5;CEBPB;CEBPD;NAMPT;ADM;DSE;ERRFI1;CREB1;TAF4B;CCNL1;USP43;NR4A2;SLC7A2;CANT1;VHL;PHKG2;SOGA1;BACH1;MYBL1;RUNX1;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;HMGCS1;WNT5A;SLC11A2;ABCF1;TGFA;SOX4;PPP1R3B;PDGFB;BAZ1A;NRG1;LDLR;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;B4GALT5;GRB7;NUP153;NEDD4;POU2F2;RAET1L;NFE2L2;SMAD1;SGMS2;TAB3;PAOX;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;UGCG;TP53;KLF3;TLR2;PDP1;UBE2D3;CD276;ELK3;RAD9B;SNAPC4;ABCA7;SDR16C5;ZNF148;HS3ST3B1;PML;POLR3A;PIM1;RELA;TRIM16;ESCO2;FOXN2;CHST2;MUC1;YARS2;ELL2;SAT1;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;LMAN1;JUND;DENND4A
672,GO:0001878,0.0861551302773147,0.998063342732353,1,2,response to yeast,BP,PTX3
4380,GO:0010008,0.0861849176926301,0.944552755953495,23,367,endosome membrane,CC,PLEKHF1;TICAM1;EHD1;IRAK2;STEAP4;RAP2B;ABCA5;DKK1;ANXA8;SLC11A2;LDLR;MMD;TAB3;CAV1;RHOV;HLA-A;HLA-B;IKBKE;UBE2D3;ABCA7;PML;HLA-F;HLA-E
9660,GO:0038001,0.086187453850958,0.998061855706724,1,2,paracrine signaling,BP,PDGFB
13718,GO:0060260,0.0862449258780972,0.980601230115773,3,23,regulation of transcription initiation from RNA polymerase II promoter,BP,ZNF451;CREB1;TP53
9050,GO:0035265,0.0862763324457726,0.961279679518078,8,93,organ growth,BP,EDN1;SAV1;TGFBR2;SPRY2;SMAD1;PIM1;COL27A1;EVC
10035,GO:0042476,0.0863065791931863,0.963729642139376,7,80,odontogenesis,BP,INHBA;BMP2;EDN1;CSF1;DLX2;ADM;TNC
10202,GO:0042803,0.0863626157974196,0.940731915548017,31,530,protein homodimerization activity,MF,NFKB1;JUN;SQSTM1;CSF1;BHLHE40;GADD45A;RIPK2;IRAK2;ODC1;IL6ST;GCH1;SMAD3;VEGFA;CEBPB;NAMPT;TAP1;NR4A2;CANT1;HMGCS1;PDGFB;ATF3;IKZF2;RCHY1;BCL2L2;SMAD1;TPST1;PML;RELA;YARS2;NR4A3;SLC16A1
6787,GO:0030218,0.0863914205922824,0.963670214549306,7,81,erythrocyte differentiation,BP,INHBA;ZFP36;ETS1;ZFP36L1;VEGFA;SLC11A2;KMT2E
20130,GO:2000777,0.0864073158241965,0.998051725251883,1,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,PLK3
19548,GO:1990418,0.0864215486579269,0.998051068501524,1,2,response to insulin-like growth factor stimulus,BP,XBP1
17888,GO:1902108,0.086426066472662,0.970147668430931,5,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1;BBC3;TP53BP2;TP53;GSK3B
2199,GO:0005070,0.0864431777311225,0.974788532402784,4,35,SH3/SH2 adaptor activity,MF,TP53BP2;SOCS2;GRB7;ITSN2
11832,GO:0046717,0.0864453757102984,0.970243254021235,5,50,acid secretion,BP,IL1B;EDN1;SGK1;SLC38A2;STX1A
18778,GO:1904245,0.0864917909702732,0.998047825591196,1,2,regulation of polynucleotide adenylyltransferase activity,BP,ZFP36
14538,GO:0070032,0.08662222404337,0.998041796342828,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,STX1A
14539,GO:0070033,0.08662222404337,0.998041796342828,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,STX1A
7248,GO:0031175,0.0868295916096424,0.937877743847718,39,648,neuron projection development,BP,EFNA1;SDC4;BTG2;JUN;EHD1;EFNB1;IL6;NEDD4L;SGK1;VEGFA;ZSWIM4;PLK2;ABL2;CFLAR;KLF7;ADM;CREB1;NR4A2;SEMA4B;WNT5A;SLC11A2;NRG1;TNC;PARD6B;FEZ1;GRB7;NEDD4;ITSN2;NFE2L2;WNT7B;SPTBN5;ABI1;EFNB2;RAPH1;NR4A3;GSK3B;VIM;DDR1;EPB41L3
6795,GO:0030228,0.0868549165407165,0.988374072712055,2,10,lipoprotein particle receptor activity,MF,LDLR;CXCL16
1038,GO:0002544,0.0868607875447434,0.988039346257756,2,12,chronic inflammatory response,BP,TNFAIP3;TNF
16384,GO:0090677,0.0869430504458312,0.998026924794133,1,2,reversible differentiation,BP,PDGFB
16385,GO:0090678,0.0869430504458312,0.998026924794133,1,2,cell dedifferentiation involved in phenotypic switching,BP,PDGFB
19180,GO:1905174,0.0869430504458312,0.998026924794133,1,2,regulation of vascular smooth muscle cell dedifferentiation,BP,PDGFB
19693,GO:1990936,0.0869430504458312,0.998026924794133,1,2,vascular smooth muscle cell dedifferentiation,BP,PDGFB
9335,GO:0035812,0.0870086485366459,0.998023876817589,1,2,renal sodium excretion,BP,EDN1
9336,GO:0035813,0.0870086485366459,0.998023876817589,1,2,regulation of renal sodium excretion,BP,EDN1
17914,GO:1902202,0.0870616644790591,0.998021411664024,1,2,regulation of hepatocyte growth factor receptor signaling pathway,BP,PTPN1
11115,GO:0045124,0.0871097751850466,0.980399245733838,3,22,regulation of bone resorption,BP,TNFAIP3;IL6;ADAM8
4420,GO:0010193,0.0871270350778018,0.998018369825049,1,2,response to ozone,BP,EDN1
1300,GO:0003130,0.0871831069855813,0.998015758726215,1,2,BMP signaling pathway involved in heart induction,BP,BMP2
1302,GO:0003133,0.0871831069855813,0.998015758726215,1,2,endodermal-mesodermal cell signaling,BP,BMP2
1303,GO:0003134,0.0871831069855813,0.998015758726215,1,2,endodermal-mesodermal cell signaling involved in heart induction,BP,BMP2
15653,GO:0072138,0.0871831069855813,0.998015758726215,1,2,mesenchymal cell proliferation involved in ureteric bud development,BP,BMP2
13334,GO:0052199,0.0872013788232486,0.998014907473361,1,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,PTX3
16669,GO:0097532,0.0872494723287724,0.998012665967867,1,2,stress response to acid chemical,BP,VEGFA
16670,GO:0097533,0.0872494723287724,0.998012665967867,1,2,cellular stress response to acid chemical,BP,VEGFA
13249,GO:0051899,0.0874048917634674,0.969787502846028,5,51,membrane depolarization,BP,EDN1;JUN;NEDD4L;CAV1;PARP1
6841,GO:0030299,0.0874246197831301,0.998004491636866,1,2,intestinal cholesterol absorption,BP,LDLR
10786,GO:0044241,0.0874246197831301,0.998004491636866,1,2,lipid digestion,BP,LDLR
16914,GO:0098856,0.0874246197831301,0.998004491636866,1,2,intestinal lipid absorption,BP,LDLR
12997,GO:0051387,0.0874501992221504,0.998003296345475,1,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2
5071,GO:0015291,0.0874606629286069,0.956552329054025,10,127,secondary active transmembrane transporter activity,MF,SLC6A14;SLC28A3;SLC11A2;SLC38A2;SLC9A1;SLC2A6;SLC9A8;SLC16A13;SLC16A1;SLC41A1
13822,GO:0060397,0.087579203214952,0.988220792385451,2,10,JAK-STAT cascade involved in growth hormone signaling pathway,BP,PTPN1;STAT5A
6316,GO:0019957,0.0875834910502713,0.997997061741561,1,2,C-C chemokine binding,MF,ZFP36
6303,GO:0019912,0.087654599857626,0.997993731529653,1,2,cyclin-dependent protein kinase activating kinase activity,MF,CDKN1A
8776,GO:0034452,0.0876703917578513,0.988201439326451,2,10,dynactin binding,MF,SPTBN5;GSK3B
6748,GO:0030163,0.0876918164593556,0.936408047184932,42,741,protein catabolic process,BP,IL1B;TNFAIP3;TNF;EFNA1;RNF19B;PMAIP1;SQSTM1;BIRC2;ADAM8;N4BP1;CYLD;ODC1;NEDD4L;CTSC;SMAD3;RNF144B;TRIB1;PLK2;RNF43;DENND3;USP43;ABTB2;SMURF2;TINAGL1;TRIM25;WNT5A;NRG1;LDLR;PLK3;RCHY1;NEDD4;NFE2L2;CAV1;TP53;UBE2D3;PML;ADAM9;RELA;USP31;GSK3B;RNF145;XBP1
17638,GO:1901329,0.087703906866286,0.99799142065268,1,2,regulation of odontoblast differentiation,BP,CEBPB
5244,GO:0015864,0.0877345609771107,0.997989983281044,1,2,pyrimidine nucleoside transport,BP,SLC28A3
14835,GO:0070564,0.0877582390548357,0.997988872647184,1,2,positive regulation of vitamin D receptor signaling pathway,BP,CYP27B1
7796,GO:0032332,0.0877808268109436,0.98817798513752,2,10,positive regulation of chondrocyte differentiation,BP,SMAD3;RELA
8885,GO:0034696,0.0878072371504628,0.997986573343239,1,2,response to prostaglandin F,BP,EDN1
6512,GO:0021882,0.0878333469447279,0.997985347542955,1,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,DLX2
6520,GO:0021893,0.0878333469447279,0.997985347542955,1,2,cerebral cortex GABAergic interneuron fate commitment,BP,DLX2
9369,GO:0035881,0.0878333469447279,0.997985347542955,1,2,amacrine cell differentiation,BP,DLX2
14192,GO:0061074,0.0878333469447279,0.997985347542955,1,2,regulation of neural retina development,BP,DLX2
14193,GO:0061075,0.0878333469447279,0.997985347542955,1,2,positive regulation of neural retina development,BP,DLX2
18155,GO:1902866,0.0878333469447279,0.997985347542955,1,2,regulation of retina development in camera-type eye,BP,DLX2
18156,GO:1902868,0.0878333469447279,0.997985347542955,1,2,positive regulation of retina development in camera-type eye,BP,DLX2
18157,GO:1902869,0.0878333469447279,0.997985347542955,1,2,regulation of amacrine cell differentiation,BP,DLX2
18158,GO:1902871,0.0878333469447279,0.997985347542955,1,2,positive regulation of amacrine cell differentiation,BP,DLX2
19207,GO:1905269,0.0878581519937478,0.962907291255188,7,81,positive regulation of chromatin organization,BP,IL1B;LIF;VEGFA;TP53;SDR16C5;MUC1;KMT2E
13692,GO:0060211,0.0879631154243817,0.987952914967879,2,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,BTG2;ZFP36
13694,GO:0060213,0.0879631154243817,0.987952914967879,2,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,BTG2;ZFP36
8473,GO:0033612,0.0880241179566494,0.987939740316898,2,11,receptor serine/threonine kinase binding,MF,INHBA;BMP2
2352,GO:0005415,0.0880979044005753,0.997972905089779,1,2,nucleoside:sodium symporter activity,MF,SLC28A3
5242,GO:0015860,0.0880979044005753,0.997972905089779,1,2,purine nucleoside transmembrane transport,BP,SLC28A3
17982,GO:1902359,0.088171504246105,0.997969436468519,1,2,Notch signaling pathway involved in somitogenesis,BP,NRARP
17986,GO:1902366,0.088171504246105,0.997969436468519,1,2,regulation of Notch signaling pathway involved in somitogenesis,BP,NRARP
17987,GO:1902367,0.088171504246105,0.997969436468519,1,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,NRARP
17770,GO:1901722,0.088172474812525,0.987907676685042,2,11,regulation of cell proliferation involved in kidney development,BP,CFLAR;PDGFB
16183,GO:0090190,0.088176854880216,0.987906729543955,2,11,positive regulation of branching involved in ureteric bud morphogenesis,BP,SIX4;VEGFA
6991,GO:0030665,0.0881806935349383,0.965740903934639,6,67,clathrin-coated vesicle membrane,CC,HBEGF;IL7R;RASSF9;WNT5A;LDLR;NECAP2
18455,GO:1903522,0.0882120452201576,0.956091386955714,10,129,regulation of blood circulation,BP,HBEGF;ZC3H12A;EDN1;ICAM1;GCH1;ADM;SLC9A1;CAV1;DOCK4;GJC1
19544,GO:1990410,0.0883777846182883,0.99795969831489,1,2,adrenomedullin receptor signaling pathway,BP,ADM
4393,GO:0010043,0.0884750770165895,0.97969201139245,3,26,response to zinc ion,BP,CREB1;MT2A;PARP1
9718,GO:0038129,0.0885094773712489,0.997953468556661,1,2,ERBB3 signaling pathway,BP,NRG1
18166,GO:1902894,0.088564668368944,0.988010996555144,2,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,PDGFB;PPARD
11331,GO:0045646,0.0885686664282904,0.973908307998768,4,36,regulation of erythrocyte differentiation,BP,INHBA;ZFP36;ETS1;ZFP36L1
14221,GO:0061136,0.0887944433799081,0.954015372280525,11,153,regulation of proteasomal protein catabolic process,BP,RNF19B;N4BP1;RNF144B;TRIB1;PLK2;PLK3;RCHY1;NFE2L2;CAV1;GSK3B;XBP1
13851,GO:0060437,0.0888174503892884,0.997938860977732,1,2,lung growth,BP,SPRY2
589,GO:0001741,0.0888278574408221,0.987765639621874,2,11,XY body,CC,BIRC2;ESCO2
12947,GO:0051291,0.0889014759332337,0.962123282686426,7,100,protein heterooligomerization,BP,BIRC3;SQSTM1;BIRC2;C1QTNF1;CLDN1;GCH1;CAB39
6997,GO:0030673,0.0890454807027212,0.987908117622961,2,10,axolemma,CC,NRG1;EPB41L3
6315,GO:0019956,0.089087966012441,0.987709090658357,2,11,chemokine binding,MF,ZFP36;ITGAV
2240,GO:0005146,0.0891049586668194,0.997925174941519,1,2,leukemia inhibitory factor receptor binding,MF,LIF
18438,GO:1903487,0.0891094174231653,0.997924962321078,1,2,regulation of lactation,BP,XBP1
2242,GO:0005150,0.0891411675542297,0.997923447952947,1,2,interleukin-1, Type I receptor binding,MF,IL1RN
15473,GO:0071798,0.0892693777167737,0.997917326896512,1,2,response to prostaglandin D,BP,TNC
15474,GO:0071799,0.0892693777167737,0.997917326896512,1,2,cellular response to prostaglandin D stimulus,BP,TNC
5657,GO:0016748,0.0893215032266436,0.997914835602073,1,2,succinyltransferase activity,MF,ALAS1
19255,GO:1905371,0.089404391220309,0.997910870826833,1,2,ceramide phosphoethanolamine metabolic process,BP,SGMS2
19256,GO:1905373,0.089404391220309,0.997910870826833,1,2,ceramide phosphoethanolamine biosynthetic process,BP,SGMS2
448,GO:0001221,0.0894135160292153,0.973573564927229,4,36,transcription cofactor binding,MF,CREB1;NFE2L2;TP53;NR4A3
3504,GO:0007411,0.0894203550623481,0.950873091989002,13,173,axon guidance,BP,EFNA1;EFNB1;VEGFA;ZSWIM4;KLF7;CREB1;SEMA4B;WNT5A;FEZ1;GRB7;SPTBN5;EFNB2;NR4A3
2335,GO:0005350,0.0894947748248817,0.99790654301625,1,2,pyrimidine nucleobase transmembrane transporter activity,MF,SLC28A3
5240,GO:0015855,0.0894947748248817,0.99790654301625,1,2,pyrimidine nucleobase transport,BP,SLC28A3
19026,GO:1904823,0.0894947748248817,0.99790654301625,1,2,purine nucleobase transmembrane transport,BP,SLC28A3
10119,GO:0042634,0.0895882945733226,0.979523673327176,3,23,regulation of hair cycle,BP,TNF;WNT5A;TRPV3
4859,GO:0014068,0.08960671908548,0.97349684821864,4,36,positive regulation of phosphatidylinositol 3-kinase signaling,BP,PDGFB;NRG1;NEDD4;PPARD
2080,GO:0004831,0.0896257803893526,0.997900261784648,1,2,tyrosine-tRNA ligase activity,MF,YARS2
2927,GO:0006437,0.0896257803893526,0.997900261784648,1,2,tyrosyl-tRNA aminoacylation,BP,YARS2
1005,GO:0002476,0.0897408061745039,0.997894738592711,1,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,HLA-E
8668,GO:0034236,0.0897572046065182,0.98756313254249,2,11,protein kinase A catalytic subunit binding,MF,PJA2;GSK3B
14664,GO:0070252,0.0898101550531881,0.968736669084782,5,50,actin-mediated cell contraction,BP,NEDD4L;SLC9A1;CAV1;VIM;GJC1
9849,GO:0042091,0.089968578309699,0.99788377921953,1,2,interleukin-10 biosynthetic process,BP,BCL3
11082,GO:0045074,0.089968578309699,0.99788377921953,1,2,regulation of interleukin-10 biosynthetic process,BP,BCL3
132,GO:0000272,0.0900810243465394,0.979441675137361,3,22,polysaccharide catabolic process,BP,PHKG2;PPP1R3B;MGAM
10789,GO:0044247,0.0900810243465394,0.979441675137361,3,22,cellular polysaccharide catabolic process,BP,PHKG2;PPP1R3B;MGAM
1092,GO:0002677,0.0902215647564838,0.997871571678985,1,2,negative regulation of chronic inflammatory response,BP,TNFAIP3
16570,GO:0097340,0.0902222933396261,0.987461307191453,2,11,inhibition of cysteine-type endopeptidase activity,BP,BIRC3;BIRC2
16571,GO:0097341,0.0902222933396261,0.987461307191453,2,11,zymogen inhibition,BP,BIRC3;BIRC2
4377,GO:0009996,0.0903730544189013,0.997864244114556,1,2,negative regulation of cell fate specification,BP,DKK1
4493,GO:0010512,0.0903771828254779,0.997864044238458,1,2,negative regulation of phosphatidylinositol biosynthetic process,BP,PDGFB
9320,GO:0035788,0.0903771828254779,0.997864044238458,1,2,cell migration involved in metanephros development,BP,PDGFB
9321,GO:0035789,0.0903771828254779,0.997864044238458,1,2,metanephric mesenchymal cell migration,BP,PDGFB
9324,GO:0035793,0.0903771828254779,0.997864044238458,1,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
17463,GO:1900238,0.0903771828254779,0.997864044238458,1,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
20018,GO:2000589,0.0903771828254779,0.997864044238458,1,2,regulation of metanephric mesenchymal cell migration,BP,PDGFB
20019,GO:2000591,0.0903771828254779,0.997864044238458,1,2,positive regulation of metanephric mesenchymal cell migration,BP,PDGFB
18612,GO:1903859,0.0904173912207145,0.987612706473004,2,10,regulation of dendrite extension,BP,NEDD4L;ITSN2
20215,GO:2001038,0.0904251332551113,0.979179224675906,3,24,regulation of cellular response to drug,BP,NFE2L2;TP53;NR4A3
13590,GO:0060043,0.0904288426629672,0.979328630266383,3,22,regulation of cardiac muscle cell proliferation,BP,SAV1;TGFBR2;PIM1
7699,GO:0032148,0.090432632990568,0.979176768537253,3,24,activation of protein kinase B activity,BP,WNT5A;PDGFB;NRG1
19372,GO:1905719,0.0904730915774253,0.997859398072234,1,2,protein localization to perinuclear region of cytoplasm,BP,SQSTM1
8616,GO:0034124,0.0905134242026493,0.997857442633172,1,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,IRF1
15663,GO:0072163,0.0906075727819249,0.964611773684531,6,64,mesonephric epithelium development,BP,SDC4;BMP2;SIX4;SMAD3;VEGFA;SMAD1
15664,GO:0072164,0.0906075727819249,0.964611773684531,6,64,mesonephric tubule development,BP,SDC4;BMP2;SIX4;SMAD3;VEGFA;SMAD1
1778,GO:0004382,0.0906344398387692,0.997851569835973,1,2,guanosine-diphosphatase activity,MF,CANT1
9554,GO:0036313,0.0906463897732101,0.997850989457409,1,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,FAM83B
5123,GO:0015467,0.0906653402193351,0.997850068912879,1,2,G-protein activated inward rectifier potassium channel activity,MF,KCNJ15
7730,GO:0032217,0.0907507062215051,0.997845919576203,1,2,riboflavin transmembrane transporter activity,MF,SLC52A3
7731,GO:0032218,0.0907507062215051,0.997845919576203,1,2,riboflavin transport,BP,SLC52A3
8115,GO:0032798,0.0907507062215051,0.997845919576203,1,2,Swi5-Sfr1 complex,CC,SFR1
19752,GO:2000097,0.0908382941453588,0.99784165787896,1,2,regulation of smooth muscle cell-matrix adhesion,BP,PLAU
6217,GO:0019732,0.090859198674359,0.99784064009065,1,2,antifungal humoral response,BP,IL36RN
12360,GO:0048713,0.0908603218247705,0.979108851404769,3,23,regulation of oligodendrocyte differentiation,BP,DLX2;DUSP10;TLR2
15228,GO:0071364,0.0909781019467745,0.972950527781448,4,36,cellular response to epidermal growth factor stimulus,BP,ZFP36;ZFP36L1;CFLAR;ERRFI1
13487,GO:0055008,0.090999351254366,0.972988192197341,4,35,cardiac muscle tissue morphogenesis,BP,BMP2;WNT5A;NRG1;EGLN1
19945,GO:2000418,0.0910208423472894,0.997832761575,1,2,positive regulation of eosinophil migration,BP,ADAM8
2103,GO:0004867,0.0910277573943406,0.972770225251287,4,40,serine-type endopeptidase inhibitor activity,MF,SERPINB2;TFPI2;SERPINB8;SERPINB1
4733,GO:0010893,0.0910290335649085,0.987283921661882,2,11,positive regulation of steroid biosynthetic process,BP,IL1B;TNF
4934,GO:0014888,0.0910619876431587,0.979122342674111,3,22,striated muscle adaptation,BP,SMAD3;CFLAR;ERRFI1
14845,GO:0070576,0.0910627190781665,0.997830718047952,1,2,vitamin D 24-hydroxylase activity,MF,CYP24A1
3102,GO:0006679,0.091079263676243,0.997829910415866,1,2,glucosylceramide biosynthetic process,BP,UGCG
18401,GO:1903393,0.0911352083313968,0.979098444071442,3,22,positive regulation of adherens junction organization,BP,SDC4;SMAD3;VEGFA
10747,GO:0044111,0.0912516129619209,0.997821487729261,1,2,development involved in symbiotic interaction,BP,NEDD4
6487,GO:0021826,0.0913098403484591,0.997818638296754,1,2,substrate-independent telencephalic tangential migration,BP,NRG1
6490,GO:0021830,0.0913098403484591,0.997818638296754,1,2,interneuron migration from the subpallium to the cortex,BP,NRG1
6494,GO:0021843,0.0913098403484591,0.997818638296754,1,2,substrate-independent telencephalic tangential interneuron migration,BP,NRG1
13522,GO:0055077,0.0913663611642507,0.99781587050873,1,2,gap junction hemi-channel activity,MF,PANX1
4603,GO:0010715,0.0914010101793586,0.987201807492007,2,11,regulation of extracellular matrix disassembly,BP,ETS1;DDR1
17658,GO:1901379,0.0914801927890059,0.972749733765681,4,36,regulation of potassium ion transmembrane transport,BP,NEDD4L;CAB39;NEDD4;CAV1
15325,GO:0071505,0.0915471211411809,0.997807006448335,1,2,response to mycophenolic acid,BP,PDGFB
15326,GO:0071506,0.0915471211411809,0.997807006448335,1,2,cellular response to mycophenolic acid,BP,PDGFB
2245,GO:0005153,0.0915592580036919,0.997806410609271,1,2,interleukin-8 receptor binding,MF,CXCL8
11518,GO:0045994,0.0915937792800653,0.997804715380363,1,2,positive regulation of translational initiation by iron,BP,TNF
5956,GO:0018312,0.0916058563297573,0.997804122153047,1,2,peptidyl-serine ADP-ribosylation,BP,PARP1
19538,GO:1990404,0.0916058563297573,0.997804122153047,1,2,protein ADP-ribosylase activity,MF,PARP1
6837,GO:0030295,0.0916232709491138,0.967859208431755,5,52,protein kinase activator activity,MF,CDKN1A;NRG1;CAB39;SPRY2;ABI1
12396,GO:0048806,0.0916325071174512,0.978935898572086,3,22,genitalia development,BP,TBX3;WNT5A;AXL
16308,GO:0090399,0.0917936400092598,0.987114912477251,2,11,replicative senescence,BP,CDKN1A;TP53
8277,GO:0033078,0.0918537351253186,0.997791927714093,1,2,extrathymic T cell differentiation,BP,PRDM1
243,GO:0000578,0.0918986204389545,0.978848752086999,3,22,embryonic axis specification,BP,TBX3;NRARP;WNT5A
5455,GO:0016323,0.0919079813988987,0.953914845478802,10,127,basolateral plasma membrane,CC,CLDN1;NOD2;B4GALT1;TGFA;PDGFB;LDLR;SLC9A1;RHCG;ADAM9;SLC41A1
4505,GO:0010533,0.0919470551830316,0.997065542176689,1,3,regulation of activation of Janus kinase activity,BP,IL23A
19591,GO:1990589,0.0921920778761376,0.997775225680958,1,2,ATF4-CREB1 transcription factor complex,CC,CREB1
9149,GO:0035497,0.0922093185192748,0.987022668667697,2,11,cAMP response element binding,MF,JUN;CREB1
15438,GO:0071696,0.0922787138518775,0.987007244248999,2,11,ectodermal placode development,BP,TBX3;SIX4
16640,GO:0097485,0.0922857114684257,0.949034571373897,13,174,neuron projection guidance,BP,EFNA1;EFNB1;VEGFA;ZSWIM4;KLF7;CREB1;SEMA4B;WNT5A;FEZ1;GRB7;SPTBN5;EFNB2;NR4A3
9739,GO:0038190,0.0922928337621467,0.997770239178416,1,2,VEGF-activated neuropilin signaling pathway,BP,VEGFA
17976,GO:1902336,0.0922928337621467,0.997770239178416,1,2,positive regulation of retinal ganglion cell axon guidance,BP,VEGFA
15479,GO:0071804,0.0922965754745231,0.960595005497934,7,80,cellular potassium ion transport,BP,NEDD4L;KCNJ15;CAB39;SLC9A1;NEDD4;CAV1;SLC9A8
15480,GO:0071805,0.0922965754745231,0.960595005497934,7,80,potassium ion transmembrane transport,BP,NEDD4L;KCNJ15;CAB39;SLC9A1;NEDD4;CAV1;SLC9A8
906,GO:0002285,0.0924962104593039,0.957766808057942,8,100,lymphocyte activation involved in immune response,BP,IL23A;BCL3;IL6;RIPK2;RELB;ICAM1;IL4R;XBP1
17389,GO:1900102,0.0925553887297261,0.986945677554864,2,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,PPP1R15A;PTPN1
2541,GO:0005796,0.0926203256898967,0.967434343349409,5,51,Golgi lumen,CC,SDC4;WNT5A;PDGFB;WNT7B;MUC1
3231,GO:0006885,0.0926251707786152,0.963510491363625,6,69,regulation of pH,BP,EDN1;SLC9A1;RHCG;CLIC4;TP53;SLC9A8
6592,GO:0022600,0.0927712814730559,0.97223150951833,4,36,digestive system process,BP,TJP2;NOD2;SGK1;LDLR
2243,GO:0005151,0.0928278548163393,0.997743662294222,1,2,interleukin-1, Type II receptor binding,MF,IL1RN
15621,GO:0072095,0.0928697376946662,0.99774157480696,1,2,regulation of branch elongation involved in ureteric bud branching,BP,SIX4
12432,GO:0048871,0.0928869358977841,0.947337601271739,14,201,multicellular organismal homeostasis,BP,IL1B;TNFAIP3;TNF;IL1A;IL1RN;CSF1;AMPD3;IL6;ADAM8;CLDN1;NOD2;VEGFA;SLC11A2;NR4A3
6238,GO:0019785,0.0929511767893758,0.997737512894363,1,2,ISG15-specific protease activity,MF,USP43
14580,GO:0070101,0.0930201569034905,0.997734069396682,1,2,positive regulation of chemokine-mediated signaling pathway,BP,EDN1
13838,GO:0060420,0.0930560573244337,0.972116838065814,4,36,regulation of heart growth,BP,EDN1;SAV1;TGFBR2;PIM1
18341,GO:1903279,0.0930670972038833,0.997731724557537,1,2,regulation of calcium:sodium antiporter activity,BP,SLC9A1
18342,GO:1903281,0.0930670972038833,0.997731724557537,1,2,positive regulation of calcium:sodium antiporter activity,BP,SLC9A1
18452,GO:1903518,0.0930891766570099,0.997730621167981,1,2,positive regulation of single strand break repair,BP,PARP1
11269,GO:0045509,0.0932246047169516,0.997723847176758,1,2,interleukin-27 receptor activity,MF,IL6ST
81,GO:0000164,0.0932309989536391,0.98679486509906,2,11,protein phosphatase type 1 complex,CC,PPP1R15A;PPP1R3B
15458,GO:0071731,0.093383060487064,0.986760828830388,2,11,response to nitric oxide,BP,CFLAR;EGLN1
13814,GO:0060389,0.0935895907494419,0.971856599336897,4,37,pathway-restricted SMAD protein phosphorylation,BP,INHBA;BMP2;DKK1;TGFBR2
18348,GO:1903292,0.0936102706730875,0.997704498409831,1,2,protein localization to Golgi membrane,BP,ARL5B
724,GO:0001947,0.0936131552861267,0.971939907425566,4,35,heart looping,BP,TBX3;SMAD3;TGFBR2;WNT5A
19141,GO:1905064,0.0936321744389108,0.997703396921647,1,2,negative regulation of vascular smooth muscle cell differentiation,BP,PDGFB
20029,GO:2000616,0.0936531488705861,0.997702341907328,1,2,negative regulation of histone H3-K9 acetylation,BP,ZNF451
1814,GO:0004461,0.0936585437264222,0.997702070504826,1,2,lactose synthase activity,MF,B4GALT1
3195,GO:0006824,0.0937067399303728,0.997699645120075,1,2,cobalt ion transport,BP,SLC11A2
9292,GO:0035728,0.0938342106525395,0.986659647173078,2,11,response to hepatocyte growth factor,BP,CREB1;RELA
12652,GO:0050832,0.0938702307723042,0.986219450029768,2,14,defense response to fungus,BP,COTL1;IL36RN
9546,GO:0036296,0.0939523561415038,0.978013911163374,3,24,response to increased oxygen levels,BP,CDKN1A;CAV1;TP53
4596,GO:0010701,0.094072674602126,0.997681186287874,1,2,positive regulation of norepinephrine secretion,BP,STX1A
12214,GO:0048382,0.0941038392778617,0.997679610667488,1,2,mesendoderm development,BP,ZFP36L1
11031,GO:0044868,0.0941397927650686,0.997677792236336,1,2,modulation by host of viral molecular function,BP,PTX3
5820,GO:0017081,0.0941782770918317,0.986412086859143,2,12,chloride channel regulator activity,MF,SGK1;STX1A
8673,GO:0034242,0.0943123951037868,0.997669052050328,1,2,negative regulation of syncytium formation by plasma membrane fusion,BP,CFLAR
8060,GO:0032717,0.0944296402969832,0.986354771855267,2,12,negative regulation of interleukin-8 production,BP,BCL3;MAPKBP1
553,GO:0001674,0.0944376512914224,0.997662698561315,1,2,female germ cell nucleus,CC,MARCKS
10088,GO:0042585,0.0944376512914224,0.997662698561315,1,2,germinal vesicle,CC,MARCKS
15492,GO:0071825,0.0944666837313285,0.977842297806987,3,24,protein-lipid complex subunit organization,BP,PLAGL2;ABCA5;ABCA7
286,GO:0000790,0.0944988515774875,0.942102364947945,18,304,nuclear chromatin,CC,IRF1;JUN;KDM6B;JUNB;SMAD3;CEBPB;CREB1;SFR1;BAZ1A;TNKS1BP1;MXD1;CHD4;TP53;RELA;ESCO2;MUC1;PPARD;JUND
13761,GO:0060319,0.0945286320834542,0.997658077957869,1,2,primitive erythrocyte differentiation,BP,VEGFA
12311,GO:0048640,0.0947905460420963,0.962515503883427,6,65,negative regulation of developmental growth,BP,SAV1;SEMA4B;TGFBR2;WNT5A;DUSP10;SOCS2
10430,GO:0043270,0.09480306683441,0.95411596717838,9,120,positive regulation of ion transport,BP,IL1B;EDN1;BDKRB1;PDGFB;TRPV3;SLC9A1;CAV1;JPH2;ABCA7
16068,GO:0086098,0.0948436126195554,0.997642044127292,1,2,angiotensin-activated signaling pathway involved in heart process,BP,CAV1
4816,GO:0014004,0.0949866305280492,0.99763474493317,1,2,microglia differentiation,BP,TLR2
4817,GO:0014005,0.0949866305280492,0.99763474493317,1,2,microglia development,BP,TLR2
13575,GO:0060024,0.0951010355268869,0.997628897516416,1,2,rhythmic synaptic transmission,BP,EDN1
13744,GO:0060298,0.0951062160151447,0.997628632554016,1,2,positive regulation of sarcomere organization,BP,EDN1
8943,GO:0034976,0.0951263786368234,0.943617294964008,16,242,response to endoplasmic reticulum stress,BP,CXCL8;PPP1R15A;PMAIP1;JUN;BBC3;TNFRSF10B;CEBPB;TRIM25;ATF3;NFE2L2;PTPN1;CAV1;TP53;PML;GSK3B;XBP1
636,GO:0001823,0.0952384974283911,0.962291740537193,6,65,mesonephros development,BP,SDC4;BMP2;SIX4;SMAD3;VEGFA;SMAD1
10143,GO:0042701,0.0954369965742516,0.997611682149723,1,2,progesterone secretion,BP,INHBA
14905,GO:0070697,0.0954369965742516,0.997611682149723,1,2,activin receptor binding,MF,INHBA
14906,GO:0070699,0.0954369965742516,0.997611682149723,1,2,type II activin receptor binding,MF,INHBA
6838,GO:0030296,0.0954496215853673,0.986294906107087,2,11,protein tyrosine kinase activator activity,MF,NRG1;ABI1
5371,GO:0016160,0.0954897049933238,0.99760897531453,1,2,amylase activity,MF,MGAM
19746,GO:2000077,0.0954936921016996,0.997608770491424,1,2,negative regulation of type B pancreatic cell development,BP,GSK3B
11933,GO:0046967,0.0955079193768777,0.99760803954202,1,2,cytosol to ER transport,BP,TAP1
18011,GO:1902445,0.0955089638213096,0.996828389936001,1,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,PPIF
2203,GO:0005085,0.0956082132679578,0.943342982426329,16,229,guanyl-nucleotide exchange factor activity,MF,CSF2;HBEGF;RAB3IP;EREG;ARHGEF3;FGD6;FGF5;DENND3;PDGFB;NRG1;RASGEF1B;CYTH1;ITSN2;SPTBN5;DOCK4;DENND4A
19130,GO:1905041,0.0957059609040943,0.997597852637857,1,2,regulation of epithelium regeneration,BP,DUSP10
19534,GO:1990399,0.0957059609040943,0.997597852637857,1,2,epithelium regeneration,BP,DUSP10
13648,GO:0060129,0.0957472408759847,0.997595726402333,1,2,thyroid-stimulating hormone-secreting cell differentiation,BP,BMP2
14163,GO:0061029,0.0958132620019793,0.986212274420121,2,11,eyelid development in camera-type eye,BP,INHBA;JUN
7111,GO:0030903,0.0958190202999719,0.986210964383955,2,11,notochord development,BP,EFNA1;WNT5A
4792,GO:0010979,0.095926239966348,0.997586495128749,1,2,regulation of vitamin D 24-hydroxylase activity,BP,CYP27B1
4793,GO:0010980,0.095926239966348,0.997586495128749,1,2,positive regulation of vitamin D 24-hydroxylase activity,BP,CYP27B1
3945,GO:0008631,0.0959606315766446,0.970807918700846,4,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,SOD2;NFE2L2;PML;PARP1
20071,GO:2000669,0.095984831498131,0.997583469426708,1,2,negative regulation of dendritic cell apoptotic process,BP,AXL
13849,GO:0060434,0.0960032243308026,0.997582519198577,1,2,bronchus morphogenesis,BP,TGFBR2
13065,GO:0051542,0.0960605289352476,0.99757955741356,1,2,elastin biosynthetic process,BP,HBEGF
2305,GO:0005287,0.0960844959351251,0.997578318114946,1,2,high-affinity basic amino acid transmembrane transporter activity,MF,SLC7A2
2306,GO:0005289,0.0960844959351251,0.997578318114946,1,2,high-affinity arginine transmembrane transporter activity,MF,SLC7A2
2308,GO:0005292,0.0960844959351251,0.997578318114946,1,2,high-affinity lysine transmembrane transporter activity,MF,SLC7A2
11317,GO:0045626,0.0961268520893731,0.997576127124097,1,2,negative regulation of T-helper 1 cell differentiation,BP,IL4R
8880,GO:0034685,0.0961861020863375,0.997573060503297,1,2,integrin alphav-beta6 complex,CC,ITGAV
3758,GO:0008298,0.0962041903284636,0.98594749105569,2,12,intracellular mRNA localization,BP,ZFP36;ZFP36L1
6053,GO:0019185,0.096210717191901,0.997571785891872,1,2,snRNA-activating protein complex,CC,SNAPC4
20036,GO:2000625,0.0962339821069245,0.997570580871993,1,2,regulation of miRNA catabolic process,BP,ZC3H12A
20037,GO:2000627,0.0962339821069245,0.997570580871993,1,2,positive regulation of miRNA catabolic process,BP,ZC3H12A
3940,GO:0008623,0.0962342185627566,0.997570568623011,1,2,CHRAC,CC,BAZ1A
14048,GO:0060763,0.0962389423040552,0.997570323915012,1,2,mammary duct terminal end bud growth,BP,CSF1
18677,GO:1903977,0.0962389423040552,0.997570323915012,1,2,positive regulation of glial cell migration,BP,CSF1
2732,GO:0006109,0.096252961736662,0.951283513991836,10,130,regulation of carbohydrate metabolic process,BP,PMAIP1;NFKB1;PHLDA2;C1QTNF1;PHKG2;SOGA1;PPP1R3B;PDGFB;NUP153;GSK3B
17479,GO:1900273,0.0965498012173825,0.986044316526143,2,11,positive regulation of long-term synaptic potentiation,BP,SQSTM1;CREB1
4837,GO:0014040,0.0965618784444563,0.997553563834267,1,2,positive regulation of Schwann cell differentiation,BP,RELA
16556,GO:0097296,0.096591615362323,0.985857955368903,2,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,TNFRSF10B;SMAD3
1445,GO:0003430,0.0966190212449228,0.997550591865057,1,2,growth plate cartilage chondrocyte growth,BP,TGFBR2
2124,GO:0004915,0.0967339535180947,0.997544608544442,1,2,interleukin-6 receptor activity,MF,IL6ST
6325,GO:0019981,0.0967339535180947,0.997544608544442,1,2,interleukin-6 binding,MF,IL6ST
14585,GO:0070110,0.0967339535180947,0.997544608544442,1,2,ciliary neurotrophic factor receptor complex,CC,IL6ST
17836,GO:1901979,0.0967541358800175,0.997543557067288,1,2,regulation of inward rectifier potassium channel activity,BP,CAV1
143,GO:0000294,0.0968195873416868,0.997540145493983,1,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,ZC3H12A
19402,GO:1905863,0.0968595181686763,0.997538062927355,1,2,invadopodium organization,BP,NAV3
12890,GO:0051205,0.0969061336813886,0.970380427144796,4,40,protein insertion into membrane,BP,PMAIP1;BBC3;TP53BP2;TP53
10438,GO:0043280,0.0969205092881141,0.95518920458009,8,109,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,TNF;PMAIP1;BBC3;TNFRSF10B;TNFSF15;SMAD3;CFLAR;PML
15596,GO:0072053,0.0969455136508846,0.997533574739018,1,2,renal inner medulla development,BP,WNT7B
15597,GO:0072054,0.0969455136508846,0.997533574739018,1,2,renal outer medulla development,BP,WNT7B
925,GO:0002317,0.0970471876875984,0.996722993205139,1,3,plasma cell differentiation,BP,XBP1
17936,GO:1902235,0.0970483739810565,0.976902202406164,3,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1;PTPN1;XBP1
16565,GO:0097325,0.0970498364421592,0.997528124255852,1,2,melanocyte proliferation,BP,WNT5A
4346,GO:0009895,0.0972464375802411,0.944442997404943,14,207,negative regulation of catabolic process,BP,IL1B;TNF;EFNA1;NOCT;ZFP36;HCAR2;N4BP1;SMAD3;NRG1;FEZ1;TAB3;PML;RELA;EGLN1
7664,GO:0032089,0.097279105125081,0.997516123558385,1,2,NACHT domain binding,MF,TRIM16
9194,GO:0035574,0.0973081314435894,0.997514602041274,1,2,histone H4-K20 demethylation,BP,KDM7A
9195,GO:0035575,0.0973081314435894,0.997514602041274,1,2,histone demethylase activity (H4-K20 specific),MF,KDM7A
19469,GO:1990108,0.0973081314435894,0.997514602041274,1,2,protein linear deubiquitination,BP,CYLD
7037,GO:0030806,0.0973171501151426,0.997514129195866,1,2,negative regulation of cyclic nucleotide catabolic process,BP,EGLN1
7052,GO:0030821,0.0973171501151426,0.997514129195866,1,2,negative regulation of cAMP catabolic process,BP,EGLN1
8296,GO:0033122,0.0973171501151426,0.997514129195866,1,2,negative regulation of purine nucleotide catabolic process,BP,EGLN1
15500,GO:0071847,0.0973355565907884,0.997513164004665,1,2,TNFSF11-mediated signaling pathway,BP,TJP2
7276,GO:0031252,0.0973842901121123,0.938561319065665,20,302,cell leading edge,CC,RAB3IP;EPHA2;PHLDB2;ITGA5;FRMD4B;FGD6;LAYN;NEDD9;NRG1;SLC9A1;SPRY2;ABI1;ITGAV;ABCA7;ADGRE2;RAPH1;JMY;VIM;EPB41L3;SLC39A14
9651,GO:0036518,0.0974716874881035,0.997506019505693,1,2,chemorepulsion of dopaminergic neuron axon,BP,WNT5A
14402,GO:0061643,0.0974716874881035,0.997506019505693,1,2,chemorepulsion of axon,BP,WNT5A
8600,GO:0034104,0.0974994588543052,0.985647284898228,2,12,negative regulation of tissue remodeling,BP,TNFAIP3;IL6
20101,GO:2000726,0.0975154194176504,0.985822924295506,2,11,negative regulation of cardiac muscle cell differentiation,BP,BMP2;DKK1
3617,GO:0008065,0.0975441516671711,0.997502211999536,1,2,establishment of blood-nerve barrier,BP,CLDN1
5117,GO:0015433,0.0977102933492959,0.997493470827593,1,2,peptide antigen-transporting ATPase activity,MF,TAPBP
9812,GO:0040037,0.0977361638203151,0.985772122866209,2,11,negative regulation of fibroblast growth factor receptor signaling pathway,BP,WNT5A;SPRY2
11760,GO:0046597,0.0977664572938463,0.985434154175984,2,13,negative regulation of viral entry into host cell,BP,PTX3;TRIM25
427,GO:0001134,0.0977691407975373,0.976809875581454,3,23,transcription factor activity, transcription factor recruiting,MF,MYBL1;SNAPC4;PPARD
566,GO:0001705,0.0977816270392004,0.997489712832582,1,2,ectoderm formation,BP,ETS2
573,GO:0001712,0.0977816270392004,0.997489712832582,1,2,ectodermal cell fate commitment,BP,ETS2
13191,GO:0051783,0.0978689093043375,0.948421221390951,11,154,regulation of nuclear division,BP,IL1B;IL1A;LIF;EDN1;EREG;DUSP1;WNT5A;TGFA;PDGFB;ANLN;ESPL1
6506,GO:0021871,0.0979600842349718,0.985720518281903,2,11,forebrain regionalization,BP,BMP2;WNT7B
8089,GO:0032765,0.0979785487169468,0.997479323236118,1,2,positive regulation of mast cell cytokine production,BP,NR4A3
16089,GO:0090036,0.0980436323887508,0.985701245188698,2,11,regulation of protein kinase C signaling,BP,VEGFA;WNT5A
4588,GO:0010675,0.0980944702225772,0.957474382510027,7,82,regulation of cellular carbohydrate metabolic process,BP,PMAIP1;PHLDA2;C1QTNF1;PHKG2;SOGA1;PPP1R3B;GSK3B
16023,GO:0086020,0.0982612550528039,0.997464368130784,1,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,GJC1
16024,GO:0086021,0.0982612550528039,0.997464368130784,1,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,GJC1
16042,GO:0086053,0.0982612550528039,0.997464368130784,1,2,AV node cell to bundle of His cell communication by electrical coupling,BP,GJC1
16058,GO:0086077,0.0982612550528039,0.997464368130784,1,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,GJC1
8964,GO:0035026,0.0982929594509365,0.997462688069683,1,2,leading edge cell differentiation,BP,JUN
2129,GO:0004923,0.0983951864461697,0.997457266924794,1,2,leukemia inhibitory factor receptor activity,MF,IL6ST
20197,GO:2001015,0.0985914859183377,0.997446839987153,1,2,negative regulation of skeletal muscle cell differentiation,BP,SIX4
4028,GO:0009058,0.0986541903059129,0.915838696682073,239,4943,biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;ITPKC;EFNA1;SDC4;BTG2;INHBA;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;EHF;PTX3;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;NMNAT2;CCDC85B;CPEB2;ZNF451;ODC1;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;GCH1;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;FGF5;ZBED2;CFLAR;KLF7;PIGA;BTG1;UPP1;IER5;CEBPB;CEBPD;NAMPT;ADM;DSE;ERRFI1;CREB1;TAF4B;CCNL1;USP43;NR4A2;SLC7A2;CANT1;VHL;PHKG2;SOGA1;BACH1;MYBL1;RUNX1;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;HMGCS1;WNT5A;SLC11A2;ABCF1;TGFA;SOX4;PPP1R3B;PDGFB;BAZ1A;NRG1;LDLR;ATF3;IKZF2;TLE1;PLK3;CHD2;SUCO;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;B4GALT5;GRB7;NUP153;NEDD4;POU2F2;RAET1L;NFE2L2;SMAD1;SGMS2;TAB3;PAOX;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;UGCG;TP53;KLF3;TLR2;PDP1;ITGAV;UBE2D3;CD276;ELK3;RAD9B;SNAPC4;ABCA7;SDR16C5;ZNF148;HS3ST3B1;PML;POLR3A;PIM1;RELA;TRIM16;ESCO2;FOXN2;CHST2;MUC1;YARS2;ELL2;SAT1;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;LMAN1;JUND;DENND4A
10921,GO:0044501,0.0986622814984864,0.997443073988437,1,2,modulation of signal transduction in other organism,BP,TNIP1
13310,GO:0052027,0.0986622814984864,0.997443073988437,1,2,modulation by symbiont of host signal transduction pathway,BP,TNIP1
13344,GO:0052250,0.0986622814984864,0.997443073988437,1,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,TNIP1
8075,GO:0032741,0.0986664124052384,0.997442854152954,1,2,positive regulation of interleukin-18 production,BP,TLR2
19713,GO:2000010,0.0986675913572067,0.985374435494209,2,12,positive regulation of protein localization to cell surface,BP,TNF;NRG1
13816,GO:0060391,0.0987461325637584,0.985538790636488,2,11,positive regulation of SMAD protein signal transduction,BP,SMAD3;PARP1
36,GO:0000075,0.098888432127917,0.943352581862613,14,208,cell cycle checkpoint,BP,BTG2;DUSP1;GADD45A;CDKN1A;CDKN2B;PLK2;SOX4;PLK3;TNKS1BP1;TP53;RAD9B;PML;MUC1;NABP1
6298,GO:0019904,0.0989092383995099,0.930420079830425,33,561,protein domain specific binding,MF,IL1B;PLAUR;JUN;SQSTM1;BHLHE40;ETS2;RIPK2;DAPP1;FZD8;TJP2;RAP2B;NOD2;TRAF4;TP53BP2;ERRFI1;WNT5A;TNKS1BP1;BCL2L2;NEDD4;POU2F2;NFE2L2;TP53;ABI1;STX1A;DOCK4;ADAM9;RELA;TRIM16;CRB3;OCLN;VIM;ZXDA;QKI
9830,GO:0042044,0.0989817695510963,0.985300709942787,2,12,fluid transport,BP,CSF2;EDN1
2652,GO:0005988,0.0989853332024336,0.997425852009861,1,2,lactose metabolic process,BP,B4GALT1
2653,GO:0005989,0.0989853332024336,0.997425852009861,1,2,lactose biosynthetic process,BP,B4GALT1
11647,GO:0046351,0.0989853332024336,0.997425852009861,1,2,disaccharide biosynthetic process,BP,B4GALT1
11869,GO:0046849,0.0990230253907341,0.964455071179285,5,52,bone remodeling,BP,TNFAIP3;EPHA2;IL6;ADAM8;SUCO
8879,GO:0034684,0.0991690647959623,0.997416030054937,1,2,integrin alphav-beta5 complex,CC,ITGAV
9715,GO:0038124,0.099242839953856,0.997412080624425,1,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,TLR2
10045,GO:0042494,0.099242839953856,0.997412080624425,1,2,detection of bacterial lipoprotein,BP,TLR2
10047,GO:0042496,0.099242839953856,0.997412080624425,1,2,detection of diacyl bacterial lipopeptide,BP,TLR2
14718,GO:0070340,0.099242839953856,0.997412080624425,1,2,detection of bacterial lipopeptide,BP,TLR2
15454,GO:0071724,0.099242839953856,0.997412080624425,1,2,response to diacyl bacterial lipopeptide,BP,TLR2
15456,GO:0071726,0.099242839953856,0.997412080624425,1,2,cellular response to diacyl bacterial lipopeptide,BP,TLR2
7115,GO:0030910,0.0992493610654641,0.997411731374678,1,2,olfactory placode formation,BP,SIX4
15440,GO:0071698,0.0992493610654641,0.997411731374678,1,2,olfactory placode development,BP,SIX4
15441,GO:0071699,0.0992493610654641,0.997411731374678,1,2,olfactory placode morphogenesis,BP,SIX4
9359,GO:0035868,0.099356103630973,0.997406011056421,1,2,alphav-beta3 integrin-HMGB1 complex,CC,ITGAV
3511,GO:0007422,0.0994099508735269,0.964274713386835,5,52,peripheral nervous system development,BP,CLDN1;RUNX1;NAB1;NRG1;RELA
8664,GO:0034220,0.0995444503351411,0.929551972107336,34,583,ion transmembrane transport,BP,PPIF;BDKRB1;PANX1;STEAP4;NEDD4L;SGK1;SLC6A14;KCNJ15;SLC28A3;NIPAL4;SLC7A2;SLC11A2;SLC38A2;MMP9;RRAD;CAB39;RHD;TRPV3;SLC9A1;SLC25A37;NEDD4;RHCG;SLC2A6;CLIC4;CAV1;ITGAV;GEM;JPH2;SLC9A8;TSPAN13;SLC16A1;SLC39A14;SLC41A1;GJC1
6320,GO:0019961,0.0995530220483898,0.997395440765299,1,2,interferon binding,MF,IFNAR1
10676,GO:0043903,0.0995614180138839,0.945674131939669,12,179,regulation of symbiosis, encompassing mutualism through parasitism,BP,CXCL8;TNF;ZC3H12A;PTX3;TNIP1;ZFP36;JUN;SQSTM1;TRIM25;CAV1;ITGAV;PML
1518,GO:0003876,0.09964508837473,0.997390491008883,1,2,AMP deaminase activity,MF,AMPD3
12031,GO:0047623,0.09964508837473,0.997390491008883,1,2,adenosine-phosphate deaminase activity,MF,AMPD3
14409,GO:0061659,0.0996637159100583,0.942863633451738,14,203,ubiquitin-like protein ligase activity,MF,RNF19B;PELI1;ZNF451;NEDD4L;RNF144B;RNF43;VHL;SMURF2;KIAA1586;RNF152;NEDD4;PJA2;UBE2Z;RNF145
20052,GO:2000648,0.0996783581652913,0.976161071432996,3,23,positive regulation of stem cell proliferation,BP,TBX3;VEGFA;VEGFC
16509,GO:0097194,0.0996966057483459,0.959938177555987,6,70,execution phase of apoptosis,BP,ZC3H12A;BBC3;BIRC2;CFLAR;TP53BP2;TP53
978,GO:0002429,0.0997337134673426,0.941555891203443,15,232,immune response-activating cell surface receptor signaling pathway,BP,NFKBIA;ZC3H12A;NFKB1;RIPK2;CYLD;RELB;RUNX1;GCSAM;BTN2A2;TAB3;ABI1;CD276;RELA;MUC1;NR4A3
15264,GO:0071421,0.0997636336809543,0.997384110370281,1,2,manganese ion transmembrane transport,BP,SLC11A2
1323,GO:0003169,0.0997790105944523,0.997383282114295,1,2,coronary vein morphogenesis,BP,VEGFA
14120,GO:0060948,0.0997790105944523,0.997383282114295,1,2,cardiac vascular smooth muscle cell development,BP,VEGFA
11344,GO:0045659,0.0999464594441044,0.997374253768899,1,2,negative regulation of neutrophil differentiation,BP,TRIB1
4421,GO:0010212,0.099982004296325,0.948973535068516,10,136,response to ionizing radiation,BP,GADD45A;CDKN1A;DCUN1D3;ICAM1;TNKS1BP1;TP53;RAD9B;PML;PARP1;NABP1
19553,GO:1990428,0.099994748913028,0.997371647098962,1,2,miRNA transport,BP,TGFBR2
14305,GO:0061384,0.100190152844644,0.975986168738082,3,23,heart trabecula morphogenesis,BP,ADAMTS1;NRG1;EGLN1
11856,GO:0046825,0.100210328856749,0.969054173315954,4,39,regulation of protein export from nucleus,BP,IL1B;SOX4;TP53;GSK3B
15224,GO:0071360,0.10026243138503,0.984998697546554,2,12,cellular response to exogenous dsRNA,BP,IFIH1;CAV1
19608,GO:1990666,0.100263305147735,0.997357125531557,1,2,PCSK9-LDLR complex,CC,LDLR
11351,GO:0045666,0.100323280947157,0.940117024762506,16,233,positive regulation of neuron differentiation,BP,BMP2;NEDD4L;DLX2;VEGFA;DKK1;ABL2;CFLAR;TGIF2;WNT5A;SOCS2;NRG1;FEZ1;MMD;ITSN2;NFE2L2;KCTD11
6612,GO:0022804,0.100498133199061,0.942315271026446,14,202,active transmembrane transporter activity,MF,ABCA5;SLC6A14;TAP1;SLC28A3;SLC11A2;SLC38A2;SLC9A1;SLC2A6;TAPBP;ABCA7;SLC9A8;SLC16A13;SLC16A1;SLC41A1
808,GO:0002076,0.100554445897177,0.985117332233431,2,11,osteoblast development,BP,SMAD3;JUND
17875,GO:1902074,0.100714097088579,0.984891613460598,2,12,response to salt,BP,ZC3H12A;EDN1
14700,GO:0070309,0.100722315104394,0.997332207932917,1,2,lens fiber cell morphogenesis,BP,EPHA2
16864,GO:0098770,0.1007265692623,0.997331976417031,1,2,FBXO family protein binding,MF,BIRC2
13837,GO:0060419,0.100760866449253,0.963674900572589,5,51,heart growth,BP,EDN1;SAV1;TGFBR2;SMAD1;PIM1
1112,GO:0002698,0.1008063323857,0.959353396464563,6,71,negative regulation of immune effector process,BP,TNF;IL7R;CD55;DUSP10;IL4R;HLA-E
2774,GO:0006196,0.100833252504686,0.997326167135135,1,2,AMP catabolic process,BP,AMPD3
154,GO:0000309,0.100887685117717,0.997323200518593,1,2,nicotinamide-nucleotide adenylyltransferase activity,MF,NMNAT2
6115,GO:0019355,0.100887685117717,0.997323200518593,1,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,NMNAT2
8841,GO:0034627,0.100887685117717,0.997323200518593,1,2,'de novo' NAD biosynthetic process,BP,NMNAT2
8842,GO:0034628,0.100887685117717,0.997323200518593,1,2,'de novo' NAD biosynthetic process from aspartate,BP,NMNAT2
9836,GO:0042058,0.100937672777777,0.959327715850777,6,69,regulation of epidermal growth factor receptor signaling pathway,BP,PLAUR;EREG;ERRFI1;TGFA;MMP9;SPRY2
9689,GO:0038064,0.101119377593781,0.997310553702037,1,2,collagen receptor activity,MF,DDR1
11855,GO:0046824,0.10118430621553,0.963444677179093,5,52,positive regulation of nucleocytoplasmic transport,BP,IL1B;ZC3H12A;NEDD4;TP53;GSK3B
7451,GO:0031581,0.101221998875072,0.984960555911061,2,11,hemidesmosome assembly,BP,LAMB3;LAMA3
4471,GO:0010464,0.101223479128519,0.975631777404141,3,23,regulation of mesenchymal cell proliferation,BP,VEGFA;TGFBR2;WNT5A
2150,GO:0004965,0.101284264700652,0.997301534272039,1,2,G-protein coupled GABA receptor activity,MF,GPR156
12049,GO:0047757,0.101807375248964,0.997272814335222,1,2,chondroitin-glucuronate 5-epimerase activity,MF,DSE
4811,GO:0012506,0.101841132189324,0.928967719255648,31,525,vesicle membrane,CC,HBEGF;PLAU;PLAUR;IFNGR2;ADAM8;RAP2B;IL7R;RASSF9;B4GALT1;RAB24;CD55;TAP1;CD47;WNT5A;TGFA;LDLR;WNT7B;CLIC4;CAV1;HLA-A;NECAP2;TLR2;TAPBP;RAB9A;HLA-B;ITGAV;STX1A;HLA-F;HLA-E;MGAM;LMAN1
4684,GO:0010829,0.101894574090229,0.984610337700508,2,12,negative regulation of glucose transmembrane transport,BP,IL1B;TNF
13846,GO:0060430,0.101924378177374,0.997266368657986,1,2,lung saccule development,BP,CREB1
10731,GO:0044068,0.101927645669423,0.975305171135568,3,24,modulation by symbiont of host cellular process,BP,ZC3H12A;TNIP1;ITGAV
138,GO:0000288,0.101989439191401,0.958729341461705,6,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,BTG2;NOCT;ZFP36;ZFP36L1;PATL1;TNKS1BP1
13559,GO:0060005,0.102256116171958,0.99724804958901,1,2,vestibular reflex,BP,NR4A3
15251,GO:0071397,0.102313466168415,0.984702842145848,2,11,cellular response to cholesterol,BP,INHBA;HMGCS1
6246,GO:0019808,0.102373975077767,0.99634404008314,1,3,polyamine binding,MF,SAT1
12265,GO:0048536,0.102490972338029,0.975110029340856,3,24,spleen development,BP,BCL3;NFKB2;CDKN2B
800,GO:0002066,0.102569670771899,0.968113204288769,4,38,columnar/cuboidal epithelial cell development,BP,PRDM1;CDKN1A;WNT5A;GSK3B
452,GO:0001225,0.102621257615776,0.997227811263152,1,2,RNA polymerase II transcription coactivator binding,MF,CREB1
18608,GO:1903847,0.102657069329986,0.997225822148291,1,2,regulation of aorta morphogenesis,BP,EFNB2
18609,GO:1903849,0.102657069329986,0.997225822148291,1,2,positive regulation of aorta morphogenesis,BP,EFNB2
4754,GO:0010922,0.102680485919826,0.975129230759205,3,23,positive regulation of phosphatase activity,BP,PPP1R15A;BMP2;SMAD3
9442,GO:0036017,0.102749519861184,0.995868500380966,1,4,response to erythropoietin,BP,MT2A
9443,GO:0036018,0.102749519861184,0.995868500380966,1,4,cellular response to erythropoietin,BP,MT2A
16710,GO:0097647,0.102758773146996,0.996315822534723,1,3,amylin receptor signaling pathway,BP,ADM
39,GO:0000079,0.102898703470311,0.958263471601159,6,72,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,TNFAIP3;GADD45A;CDKN1A;CDKN2B;CCNL1;PDGFB
10850,GO:0044342,0.10297041659113,0.984352233640303,2,12,type B pancreatic cell proliferation,BP,ERRFI1;NR4A3
15975,GO:0075732,0.103012136435185,0.997206059650269,1,2,viral penetration into host nucleus,BP,NUP153
18066,GO:1902594,0.103012136435185,0.997206059650269,1,2,multi-organism nuclear import,BP,NUP153
14187,GO:0061055,0.10312686870268,0.997199657991479,1,2,myotome development,BP,SIX4
9665,GO:0038018,0.103141808536504,0.997198823831802,1,2,Wnt receptor catabolic process,BP,RNF43
496,GO:0001550,0.103243206443154,0.99719315885327,1,2,ovarian cumulus expansion,BP,EREG
12123,GO:0048165,0.103243206443154,0.99719315885327,1,2,fused antrum stage,BP,EREG
13664,GO:0060157,0.103263093779857,0.997192047062885,1,2,urinary bladder development,BP,WNT5A
19044,GO:1904862,0.103271000195854,0.99719160499455,1,2,inhibitory synapse assembly,BP,WNT5A
16516,GO:0097201,0.103352026925899,0.984260279609603,2,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,JUN;VHL
1318,GO:0003163,0.103403652243487,0.997184182591808,1,2,sinoatrial node development,BP,TBX3
14107,GO:0060921,0.103403652243487,0.997184182591808,1,2,sinoatrial node cell differentiation,BP,TBX3
14112,GO:0060931,0.103403652243487,0.997184182591808,1,2,sinoatrial node cell development,BP,TBX3
1319,GO:0003164,0.103414720078607,0.997183562835369,1,2,His-Purkinje system development,BP,TBX3
18182,GO:1902930,0.103420212276764,0.962360495879374,5,53,regulation of alcohol biosynthetic process,BP,IL1B;TNF;NFKB1;CYP27B1;HMGCS1
13968,GO:0060644,0.10345622045878,0.984235136234204,2,12,mammary gland epithelial cell differentiation,BP,IRF6;CEBPB
4779,GO:0010961,0.103525494024558,0.997177355949678,1,2,cellular magnesium ion homeostasis,BP,SLC41A1
1420,GO:0003357,0.103536661477295,0.997176729814553,1,2,noradrenergic neuron differentiation,BP,SOX4
7479,GO:0031639,0.103584498688047,0.984204159344252,2,12,plasminogen activation,BP,PLAU;PLAT
8331,GO:0033173,0.1036304275799,0.974713791843078,3,24,calcineurin-NFAT signaling cascade,BP,NRG1;SLC9A1;NFAT5
19952,GO:2000427,0.103716223200006,0.997166652101905,1,2,positive regulation of apoptotic cell clearance,BP,ABCA7
19175,GO:1905167,0.103768351693206,0.997163722892687,1,2,positive regulation of lysosomal protein catabolic process,BP,LDLR
14285,GO:0061341,0.103786677217907,0.997162692763262,1,2,non-canonical Wnt signaling pathway involved in heart development,BP,WNT5A
14287,GO:0061346,0.103786677217907,0.997162692763262,1,2,planar cell polarity pathway involved in heart morphogenesis,BP,WNT5A
11163,GO:0045210,0.103803997100044,0.997161718982219,1,2,FasL biosynthetic process,BP,PHLDA1
17472,GO:1900248,0.103815249922378,0.997161086216748,1,2,negative regulation of cytoplasmic translational elongation,BP,CPEB2
7745,GO:0032240,0.103818099448994,0.997160925971164,1,2,negative regulation of nucleobase-containing compound transport,BP,NUP153
11860,GO:0046832,0.103818099448994,0.997160925971164,1,2,negative regulation of RNA export from nucleus,BP,NUP153
1351,GO:0003213,0.103818346688929,0.997160912067189,1,2,cardiac right atrium morphogenesis,BP,WNT5A
1436,GO:0003408,0.103818346688929,0.997160912067189,1,2,optic cup formation involved in camera-type eye development,BP,WNT5A
3918,GO:0008582,0.103818346688929,0.997160912067189,1,2,regulation of synaptic growth at neuromuscular junction,BP,SIX4
4649,GO:0010768,0.103818346688929,0.997160912067189,1,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,NEDD4
4895,GO:0014816,0.103818346688929,0.997160912067189,1,2,skeletal muscle satellite cell differentiation,BP,SIX4
8648,GO:0034188,0.103818346688929,0.997160912067189,1,2,apolipoprotein A-I receptor activity,MF,ABCA7
9357,GO:0035866,0.103818346688929,0.997160912067189,1,2,alphav-beta3 integrin-PKCalpha complex,CC,ITGAV
12083,GO:0048022,0.103818346688929,0.997160912067189,1,2,negative regulation of melanin biosynthetic process,BP,WNT5A
12415,GO:0048850,0.103818346688929,0.997160912067189,1,2,hypophysis morphogenesis,BP,WNT5A
15108,GO:0071109,0.103818346688929,0.997160912067189,1,2,superior temporal gyrus development,BP,GSK3B
15114,GO:0071144,0.103818346688929,0.997160912067189,1,2,heteromeric SMAD protein complex,CC,SMAD3
16343,GO:0090554,0.103818346688929,0.997160912067189,1,2,phosphatidylcholine-translocating ATPase activity,MF,ABCA7
16344,GO:0090556,0.103818346688929,0.997160912067189,1,2,phosphatidylserine-translocating ATPase activity,MF,ABCA7
16703,GO:0097638,0.103818346688929,0.997160912067189,1,2,L-arginine import across plasma membrane,BP,SLC7A2
17493,GO:1900377,0.103818346688929,0.997160912067189,1,2,negative regulation of secondary metabolite biosynthetic process,BP,WNT5A
7123,GO:0030934,0.103818346688929,0.997160912067189,1,2,anchoring collagen complex,CC,COL12A1
6297,GO:0019903,0.103853659981644,0.95137737345534,8,99,protein phosphatase binding,MF,PPP1R15A;ANKLE2;MASTL;SLC9A1;PTPN1;SH3RF2;TP53;PPP6R3
13515,GO:0055067,0.103941332353624,0.954241765519781,7,86,monovalent inorganic cation homeostasis,BP,EDN1;NEDD4L;SLC9A1;RHCG;CLIC4;TP53;SLC9A8
3920,GO:0008585,0.104080304974204,0.957719377531061,6,69,female gonad development,BP,INHBA;EREG;ICAM1;VEGFA;CEBPB;ADAMTS1
3233,GO:0006887,0.104133954982703,0.92596414881104,34,602,exocytosis,BP,PLAU;CXCL1;SDC4;PLAUR;PTX3;NFKB1;AMPD3;ADAM8;RAP2B;TNFAIP2;CTSC;B4GALT1;VEGFA;RAB24;VMP1;CD55;CD47;CANT1;VEGFC;SERPINB1;PDGFB;MMP9;CAB39;IL4R;TLR2;RAB9A;ITGAV;STX1A;ADGRE2;ANXA5;FRK;NR4A3;COTL1;MGAM
15577,GO:0072012,0.104597042171489,0.983958814876473,2,12,glomerulus vasculature development,BP,CFLAR;PDGFB
4716,GO:0010875,0.104981269595154,0.983865327873482,2,12,positive regulation of cholesterol efflux,BP,NFKBIA;ABCA7
3540,GO:0007548,0.105011193410564,0.942231462412514,12,170,sex differentiation,BP,INHBA;TBX3;EREG;SIX4;ICAM1;VEGFA;CEBPB;ADAMTS1;HMGCS1;WNT5A;BCL2L2;AXL
12820,GO:0051101,0.105051647517539,0.953556560733278,7,91,regulation of DNA binding,BP,NFKBIA;LIF;PLAUR;JUN;BCL3;MMP9;PARP1
6728,GO:0030135,0.105058619420417,0.939244383981964,14,208,coated vesicle,CC,HBEGF;EDN1;IL7R;CTSC;RASSF9;WNT5A;TGFA;LDLR;HLA-A;NECAP2;HLA-B;HLA-F;HLA-E;LMAN1
17388,GO:1900101,0.105273065362999,0.974058609310993,3,25,regulation of endoplasmic reticulum unfolded protein response,BP,PPP1R15A;PTPN1;XBP1
6988,GO:0030660,0.10553857499607,0.953335365711472,7,88,Golgi-associated vesicle membrane,CC,RASSF9;TGFA;HLA-A;HLA-B;HLA-F;HLA-E;LMAN1
17592,GO:1901201,0.105569532324879,0.983923894449102,2,11,regulation of extracellular matrix assembly,BP,PHLDB2;SMAD3
4578,GO:0010660,0.105787251776477,0.966756283200058,4,38,regulation of muscle cell apoptotic process,BP,ZC3H12A;EDN1;CFLAR;NFE2L2
12852,GO:0051149,0.105982819074766,0.961112629221174,5,54,positive regulation of muscle cell differentiation,BP,EDN1;EHD1;NRG1;IL4R;EFNB2
2272,GO:0005201,0.106026946005242,0.966756541938539,4,36,extracellular matrix structural constituent,MF,TFPI2;TINAGL1;COL12A1;COL27A1
12841,GO:0051133,0.106354838152552,0.996046606435083,1,3,regulation of NK T cell activation,BP,IL23A
12842,GO:0051135,0.106354838152552,0.996046606435083,1,3,positive regulation of NK T cell activation,BP,IL23A
17514,GO:1900543,0.106478386065592,0.973632974175184,3,25,negative regulation of purine nucleotide metabolic process,BP,PPIF;PARP1;EGLN1
7822,GO:0032371,0.106864503000908,0.973420771795882,3,26,regulation of sterol transport,BP,NFKBIA;NFKB1;ABCA7
7825,GO:0032374,0.106864503000908,0.973420771795882,3,26,regulation of cholesterol transport,BP,NFKBIA;NFKB1;ABCA7
3127,GO:0006706,0.107283270006714,0.983127217223367,2,13,steroid catabolic process,BP,CYP27B1;CYP24A1
8462,GO:0033598,0.107531284258095,0.973259323690641,3,25,mammary gland epithelial cell proliferation,BP,EPHA2;CEBPB;WNT5A
12412,GO:0048844,0.107742313742324,0.965974506635682,4,37,artery morphogenesis,BP,PRDM1;VEGFA;SOX4;EFNB2
19647,GO:1990782,0.107917220300579,0.960251525585063,5,52,protein tyrosine kinase binding,MF,SQSTM1;NRG1;PTPN1;TP53;DOCK4
5663,GO:0016763,0.108060874830722,0.965694415047192,4,40,transferase activity, transferring pentosyl groups,MF,UPP1;NAMPT;PARP8;PARP1
18941,GO:1904659,0.108148536669035,0.955663259570848,6,67,glucose transmembrane transport,BP,IL1B;TNF;SLC2A6;NFE2L2;NR4A3;PPARD
5411,GO:0016247,0.108243738200892,0.95550046623078,6,72,channel regulator activity,MF,NEDD4L;SGK1;NEDD4;CAV1;STX1A;TSPAN13
14463,GO:0061783,0.108452084822688,0.995884985096381,1,3,peptidoglycan muralytic activity,MF,PGLYRP4
4585,GO:0010667,0.108584713845913,0.982978253075323,2,12,negative regulation of cardiac muscle cell apoptotic process,BP,CFLAR;NFE2L2
15525,GO:0071889,0.108634539388879,0.972949767768416,3,24,14-3-3 protein binding,MF,ZFP36;ZFP36L1;TBC1D22B
14302,GO:0061371,0.108706158372588,0.965562585066732,4,37,determination of heart left/right asymmetry,BP,TBX3;SMAD3;TGFBR2;WNT5A
2664,GO:0006006,0.108747715231719,0.943585779214508,10,137,glucose metabolic process,BP,TNF;PMAIP1;PHLDA2;C1QTNF1;PHKG2;SOGA1;PPP1R3B;ATF3;GSK3B;PPARD
9020,GO:0035196,0.109205408344134,0.96529731277304,4,38,production of miRNAs involved in gene silencing by miRNA,BP,ZC3H12A;SMAD3;SMAD1;ZC3H7B
4738,GO:0010899,0.109247216498035,0.995822818033538,1,3,regulation of phosphatidylcholine catabolic process,BP,LDLR
17751,GO:1901668,0.109255586208426,0.995822161040672,1,3,regulation of superoxide dismutase activity,BP,TNF
11017,GO:0044843,0.109315708633634,0.935042311079074,15,233,cell cycle G1/S phase transition,BP,BTG2;INHBA;GADD45A;CDKN1A;DCUN1D3;CDKN2B;PLK2;BACH1;SOX4;PLK3;TNKS1BP1;TP53;PML;MUC1;KMT2E
4772,GO:0010954,0.109461337949388,0.982759641963232,2,12,positive regulation of protein processing,BP,ADAM8;CCBE1
6994,GO:0030669,0.109602336956869,0.972519369596074,3,25,clathrin-coated endocytic vesicle membrane,CC,HBEGF;WNT5A;LDLR
17345,GO:1900003,0.109668654483493,0.995789669021962,1,3,regulation of serine-type endopeptidase activity,BP,ANXA8
17346,GO:1900004,0.109668654483493,0.995789669021962,1,3,negative regulation of serine-type endopeptidase activity,BP,ANXA8
18060,GO:1902571,0.109668654483493,0.995789669021962,1,3,regulation of serine-type peptidase activity,BP,ANXA8
18061,GO:1902572,0.109668654483493,0.995789669021962,1,3,negative regulation of serine-type peptidase activity,BP,ANXA8
12480,GO:0050321,0.109753092188241,0.982686641807461,2,12,tau-protein kinase activity,MF,PHKG2;GSK3B
392,GO:0001047,0.109822280262324,0.945258012358415,9,117,core promoter binding,MF,GADD45A;RELB;CEBPB;RUNX1;SOX4;CHD2;TP53;NR4A3;XBP1
18272,GO:1903093,0.110100675161683,0.995755544347871,1,3,regulation of protein K48-linked deubiquitination,BP,OTUD4
3197,GO:0006826,0.110291659539842,0.964647986271591,4,42,iron ion transport,BP,STEAP4;SLC11A2;SLC25A37;SLC39A14
6673,GO:0030029,0.110333200337369,0.922435403369411,31,514,actin filament-based process,BP,TNF;NUAK2;CXCL1;SDC4;EDN1;SIX4;PHLDB2;AMOTL2;NEDD4L;ICAM1;SMAD3;RND3;FGD6;ABL2;CFLAR;CDC42EP4;NEDD9;AKAP2;ANLN;SLC9A1;MARCKS;PTPN1;SPTBN5;CAV1;RHOV;ABI1;TRIP10;JMY;VIM;EPB41L3;GJC1
8166,GO:0032892,0.110540410181089,0.982307497883602,2,13,positive regulation of organic acid transport,BP,IL1B;EDN1
12664,GO:0050855,0.110561268455287,0.982483794448794,2,12,regulation of B cell receptor signaling pathway,BP,RUNX1;GCSAM
3158,GO:0006766,0.110949360198943,0.950298265130439,7,91,vitamin metabolic process,BP,IL1B;TNF;NFKB1;CYP27B1;SLC52A3;PPARD;CYP24A1
1018,GO:0002507,0.111055546363559,0.982359276017615,2,12,tolerance induction,BP,TNFAIP3;TGFBR2
15343,GO:0071549,0.11135342135023,0.97180904058476,3,26,cellular response to dexamethasone stimulus,BP,ICAM1;CFLAR;ERRFI1
11878,GO:0046873,0.111442473686783,0.934992602887253,14,200,metal ion transmembrane transporter activity,MF,PANX1;SLC6A14;KCNJ15;SLC28A3;NIPAL4;SLC11A2;TRPV3;SLC9A1;SLC25A37;ITGAV;JPH2;SLC9A8;SLC39A14;SLC41A1
10028,GO:0042462,0.111459581602836,0.982257233794786,2,12,eye photoreceptor cell development,BP,PRDM1;VEGFA
16733,GO:0097720,0.111804604879274,0.971725329519869,3,25,calcineurin-mediated signaling,BP,NRG1;SLC9A1;NFAT5
18707,GO:1904044,0.111820668044617,0.995618244628278,1,3,response to aldosterone,BP,PARP1
1476,GO:0003730,0.111850146390878,0.95828768054582,5,54,mRNA 3'-UTR binding,MF,ZC3H12A;ZFP36;ZFP36L1;CPEB2;TP53
8978,GO:0035066,0.111991203944424,0.971577543026143,3,26,positive regulation of histone acetylation,BP,IL1B;LIF;MUC1
15257,GO:0071404,0.112026369415819,0.982113696843005,2,12,cellular response to low-density lipoprotein particle stimulus,BP,HMGCS1;LDLR
15943,GO:0072717,0.112094242263356,0.9955961939233,1,3,cellular response to actinomycin D,BP,TP53
3035,GO:0006584,0.11218010981953,0.971508856493923,3,26,catecholamine metabolic process,BP,GCH1;NR4A2;MAOA
4293,GO:0009712,0.11218010981953,0.971508856493923,3,26,catechol-containing compound metabolic process,BP,GCH1;NR4A2;MAOA
1341,GO:0003197,0.112214068429474,0.971664330589515,3,24,endocardial cushion development,BP,BMP2;TGFBR2;NEDD4
20165,GO:2000833,0.112237641735743,0.995584612283636,1,3,positive regulation of steroid hormone secretion,BP,C1QTNF1
11456,GO:0045898,0.112321205792152,0.981852894341189,2,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,CREB1;TP53
11508,GO:0045980,0.112382956703422,0.971435040554197,3,26,negative regulation of nucleotide metabolic process,BP,PPIF;PARP1;EGLN1
5121,GO:0015459,0.112451500769414,0.971490684135694,3,25,potassium channel regulator activity,MF,NEDD4L;SGK1;CAV1
17937,GO:1902236,0.112468301762741,0.981815140903393,2,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PTPN1;XBP1
3364,GO:0007113,0.112536222529192,0.995560445967974,1,3,endomitotic cell cycle,BP,PLK3
8044,GO:0032688,0.112763404451097,0.981739307188254,2,13,negative regulation of interferon-beta production,BP,REL;RELB
7444,GO:0031570,0.112787335644651,0.938981335576513,11,157,DNA integrity checkpoint,BP,BTG2;GADD45A;CDKN1A;PLK2;SOX4;PLK3;TNKS1BP1;TP53;RAD9B;PML;MUC1
8654,GO:0034198,0.112788957553913,0.96365030033765,4,40,cellular response to amino acid starvation,BP,CDKN1A;SLC38A2;ATF3;RNF152
13186,GO:0051771,0.112847956492774,0.995535140828591,1,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,EDN1
8077,GO:0032747,0.112855063105712,0.995534563061742,1,3,positive regulation of interleukin-23 production,BP,CSF2
660,GO:0001849,0.113324446735145,0.995496314887078,1,3,complement component C1q binding,MF,PTX3
14814,GO:0070534,0.113388081912115,0.963388871788292,4,40,protein K63-linked ubiquitination,BP,BIRC2;NOD2;RNF152;NEDD4
7809,GO:0032354,0.113401587136411,0.98176353662777,2,12,response to follicle-stimulating hormone,BP,INHBA;HMGCS1
4904,GO:0014829,0.113449054164073,0.981751402735352,2,12,vascular smooth muscle contraction,BP,EDN1;DOCK4
3484,GO:0007350,0.113644501733168,0.981701407360785,2,12,blastoderm segmentation,BP,TBX3;WNT5A
9607,GO:0036464,0.113679040181748,0.938386299161314,11,160,cytoplasmic ribonucleoprotein granule,CC,NFKBIZ;NOCT;ZC3H12A;ZFP36;PNRC1;SQSTM1;ZFP36L1;PATL1;DDX3Y;PNRC2;GRB7
11377,GO:0045730,0.113791944960753,0.981312795104978,2,14,respiratory burst,BP,CD55;DUSP10
13957,GO:0060612,0.113828303661486,0.970989171202638,3,25,adipose tissue development,BP,CSF1;PPARD;XBP1
11148,GO:0045185,0.114014317105317,0.948618999239165,7,89,maintenance of protein location,BP,NFKBIA;NFKBIE;BCL3;SOX4;CAV1;PML;EPB41L3
10363,GO:0043173,0.114131610805535,0.981224135696824,2,14,nucleotide salvage,BP,AMPD3;UPP1
4899,GO:0014823,0.114294374850391,0.962992389403474,4,40,response to activity,BP,EDN1;KDM6B;CREB1;PPARD
14968,GO:0070849,0.114358792152933,0.96301284109001,4,39,response to epidermal growth factor,BP,ZFP36;ZFP36L1;CFLAR;ERRFI1
5079,GO:0015299,0.114485723539288,0.981485607686058,2,12,solute:proton antiporter activity,MF,SLC9A1;SLC9A8
4437,GO:0010273,0.114614278328305,0.994498144184406,1,5,detoxification of copper ion,BP,MT2A
19489,GO:1990169,0.114614278328305,0.994498144184406,1,5,stress response to copper ion,BP,MT2A
5550,GO:0016538,0.114624974183761,0.970468260779424,3,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CDKN1A;CDKN2B;CCNL1
4856,GO:0014065,0.114739246614532,0.948283561634869,7,85,phosphatidylinositol 3-kinase signaling,BP,IER3;EDN1;ZFP36L1;PDGFB;NRG1;NEDD4;PPARD
6519,GO:0021892,0.114742023356164,0.995379756758916,1,3,cerebral cortex GABAergic interneuron differentiation,BP,DLX2
12578,GO:0050717,0.114888310465205,0.995367639007379,1,3,positive regulation of interleukin-1 alpha secretion,BP,PANX1
16609,GO:0097421,0.114910963553457,0.970433387336319,3,27,liver regeneration,BP,NFKBIA;CLDN1;CEBPB
977,GO:0002428,0.115006898049103,0.99535780345668,1,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,HLA-E
3003,GO:0006548,0.115108201741441,0.995349392692063,1,3,histidine catabolic process,BP,HAL
13429,GO:0052805,0.115108201741441,0.995349392692063,1,3,imidazole-containing compound catabolic process,BP,HAL
19880,GO:2000328,0.11520297279563,0.9953415170221,1,3,regulation of T-helper 17 cell lineage commitment,BP,IL23A
9071,GO:0035306,0.11536393242065,0.962572105641079,4,39,positive regulation of dephosphorylation,BP,PPP1R15A;BMP2;SMAD3;ANKLE2
11743,GO:0046545,0.115414560710549,0.951752327356893,6,71,development of primary female sexual characteristics,BP,INHBA;EREG;ICAM1;VEGFA;CEBPB;ADAMTS1
1162,GO:0002768,0.115442570868453,0.929561530448238,16,255,immune response-regulating cell surface receptor signaling pathway,BP,NFKBIA;ZC3H12A;NFKB1;JUN;RIPK2;CYLD;RELB;RUNX1;GCSAM;BTN2A2;TAB3;ABI1;CD276;RELA;MUC1;NR4A3
10490,GO:0043382,0.115647457899508,0.995304485468283,1,3,positive regulation of memory T cell differentiation,BP,IL23A
16182,GO:0090189,0.115768950369155,0.980959899993847,2,13,regulation of branching involved in ureteric bud morphogenesis,BP,SIX4;VEGFA
17709,GO:1901576,0.115777915791527,0.900577176093983,236,4900,organic substance biosynthetic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;IL1A;ITPKC;EFNA1;SDC4;BTG2;INHBA;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;RELB;ZNF217;CDKN1A;NMNAT2;CCDC85B;CPEB2;ZNF451;ODC1;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;GCH1;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;FGF5;ZBED2;CFLAR;KLF7;PIGA;BTG1;UPP1;IER5;CEBPB;CEBPD;NAMPT;ADM;DSE;ERRFI1;CREB1;TAF4B;CCNL1;USP43;NR4A2;CANT1;VHL;PHKG2;SOGA1;BACH1;MYBL1;RUNX1;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;HMGCS1;WNT5A;SLC11A2;ABCF1;TGFA;SOX4;PPP1R3B;PDGFB;BAZ1A;NRG1;LDLR;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;B4GALT5;GRB7;NUP153;NEDD4;POU2F2;RAET1L;NFE2L2;SMAD1;SGMS2;TAB3;PAOX;MXD1;CHD4;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;UGCG;TP53;KLF3;TLR2;PDP1;ITGAV;UBE2D3;CD276;ELK3;RAD9B;SNAPC4;ABCA7;SDR16C5;ZNF148;HS3ST3B1;PML;POLR3A;PIM1;RELA;TRIM16;ESCO2;FOXN2;CHST2;MUC1;YARS2;ELL2;SAT1;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;XBP1;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;LMAN1;JUND;DENND4A
12694,GO:0050892,0.11585111907602,0.981133217531778,2,12,intestinal absorption,BP,TJP2;LDLR
15631,GO:0072106,0.115884177188119,0.99528470037184,1,3,regulation of ureteric bud formation,BP,SIX4
15632,GO:0072107,0.115884177188119,0.99528470037184,1,3,positive regulation of ureteric bud formation,BP,SIX4
19213,GO:1905278,0.115884177188119,0.99528470037184,1,3,positive regulation of epithelial tube formation,BP,SIX4
4235,GO:0009411,0.115896713163735,0.941508872207236,9,123,response to UV,BP,BCL3;N4BP1;CDKN1A;DCUN1D3;NEDD4;TP53;PML;RELA;PARP1
791,GO:0002052,0.115939945283176,0.981110201780722,2,12,positive regulation of neuroblast proliferation,BP,VEGFA;VEGFC
8925,GO:0034765,0.116315756317293,0.931631665507289,14,209,regulation of ion transmembrane transport,BP,PPIF;BDKRB1;NEDD4L;KCNJ15;MMP9;RRAD;CAB39;SLC9A1;NEDD4;CLIC4;CAV1;GEM;JPH2;TSPAN13
1120,GO:0002706,0.116425595487821,0.951147677702814,6,74,regulation of lymphocyte mediated immunity,BP,IL1B;TNF;IL23A;IL6;IL7R;HLA-E
15633,GO:0072108,0.116836482213574,0.995204662075268,1,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF
3802,GO:0008378,0.117320307734577,0.969619148032488,3,26,galactosyltransferase activity,MF,B4GALT1;B3GNT5;B4GALT5
1093,GO:0002678,0.117354019527181,0.995160865956449,1,3,positive regulation of chronic inflammatory response,BP,TNF
5291,GO:0015942,0.117453923935382,0.995152387396577,1,3,formate metabolic process,BP,HAL
13691,GO:0060205,0.1174808084912,0.93072991097114,14,230,cytoplasmic vesicle lumen,CC,CXCL1;PTX3;NFKB1;AMPD3;CTSC;VEGFA;CANT1;SAA1;VEGFC;SERPINB1;PDGFB;CAB39;FRK;COTL1
7265,GO:0031228,0.117602301876371,0.96148710120625,4,41,intrinsic component of Golgi membrane,CC,SYS1;SGMS2;TPST1;CHST2
6282,GO:0019882,0.117695313153451,0.93571794377415,11,171,antigen processing and presentation,BP,RELB;NOD2;ICAM1;TAP1;KIF3C;HLA-A;TAPBP;HLA-B;ITGAV;HLA-F;HLA-E
1094,GO:0002679,0.117749935943383,0.995127219749701,1,3,respiratory burst involved in defense response,BP,DUSP10
13725,GO:0060268,0.117766976105143,0.995125768856748,1,3,negative regulation of respiratory burst,BP,DUSP10
3164,GO:0006776,0.117832683803628,0.995120172003889,1,3,vitamin A metabolic process,BP,PPARD
2104,GO:0004869,0.118333546458404,0.969020717195553,3,29,cysteine-type endopeptidase inhibitor activity,MF,BIRC3;BIRC2;TNFAIP8
6064,GO:0019208,0.118334825603869,0.950173100742389,6,72,phosphatase regulator activity,MF,PPP1R15A;BMP2;PPP4R4;ANKLE2;PPP1R3B;SH3RF2
17390,GO:1900103,0.118354651965942,0.980279119226084,2,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,PTPN1;XBP1
7839,GO:0032388,0.118454950195164,0.931690078960912,13,195,positive regulation of intracellular transport,BP,IL1B;ZC3H12A;EHD1;PLAGL2;NRG1;PLK3;FEZ1;IL4R;NEDD4;UGCG;TP53;UBE2D3;GSK3B
3442,GO:0007252,0.118655796627413,0.980199217905445,2,13,I-kappaB phosphorylation,BP,TLR2;IKBKE
18699,GO:1904029,0.118670302732088,0.949926691618331,6,75,regulation of cyclin-dependent protein kinase activity,BP,TNFAIP3;GADD45A;CDKN1A;CDKN2B;CCNL1;PDGFB
7074,GO:0030857,0.118991281533093,0.969083106901711,3,25,negative regulation of epithelial cell differentiation,BP,TBX3;CAV1;GSK3B
11379,GO:0045736,0.119339347735871,0.968866028800125,3,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,TNFAIP3;CDKN1A;CDKN2B
9965,GO:0042339,0.119381740371606,0.968850150845347,3,26,keratan sulfate metabolic process,BP,B4GALT1;B4GALT5;CHST2
283,GO:0000785,0.119516458276522,0.918570180717325,25,458,chromatin,CC,IRF1;JUN;KDM6B;JUNB;SMAD3;PLK2;CEBPB;CREB1;SFR1;BAZ1A;TNKS1BP1;H1FX;NEDD4;NFE2L2;MXD1;CHD4;TP53;SDR16C5;PML;RELA;ESCO2;MUC1;KMT2E;PPARD;JUND
610,GO:0001776,0.119751536727839,0.954304927926251,5,57,leukocyte homeostasis,BP,TNFAIP3;PMAIP1;HCAR2;IL6;AXL
4424,GO:0010225,0.119802535384687,0.979893789442233,2,13,response to UV-C,BP,BCL3;DCUN1D3
13287,GO:0051961,0.119849080056143,0.930788391060301,13,189,negative regulation of nervous system development,BP,EFNA1;DLX2;PLK2;SEMA4B;WNT5A;DUSP10;NRG1;LDLR;TLR2;EFNB2;GSK3B;VIM;KCTD11
985,GO:0002439,0.120155264939259,0.994920154689791,1,3,chronic inflammatory response to antigenic stimulus,BP,TNF
12409,GO:0048841,0.120243239878038,0.968710677395925,3,24,regulation of axon extension involved in axon guidance,BP,VEGFA;SEMA4B;WNT5A
13004,GO:0051402,0.120533018139632,0.933959958541596,11,160,neuron apoptotic process,BP,BTG2;SOD2;JUN;ADAM8;SIX4;CEBPB;NR4A2;TP53;AXL;NR4A3;PARP1
4463,GO:0010453,0.120609111783408,0.979677853357466,2,13,regulation of cell fate commitment,BP,IL23A;DKK1
16005,GO:0086002,0.120629074677186,0.968566322760244,3,24,cardiac muscle cell action potential involved in contraction,BP,NEDD4L;CAV1;GJC1
7607,GO:0031983,0.120656996213075,0.928546811298944,14,231,vesicle lumen,CC,CXCL1;PTX3;NFKB1;AMPD3;CTSC;VEGFA;CANT1;SAA1;VEGFC;SERPINB1;PDGFB;CAB39;FRK;COTL1
8420,GO:0033484,0.120701347895305,0.994872509003358,1,3,nitric oxide homeostasis,BP,CAV1
13533,GO:0055090,0.120879453301801,0.979428736875666,2,14,acylglycerol homeostasis,BP,MED13;XBP1
14711,GO:0070328,0.120879453301801,0.979428736875666,2,14,triglyceride homeostasis,BP,MED13;XBP1
4191,GO:0009266,0.120932820739419,0.931759583108455,12,177,response to temperature stimulus,BP,NFKBIA;IL1A;CDKN1A;IER5;ADM;SLC52A3;TRPV3;SLC9A1;NUP153;TP53;GSK3B;HSPA4L
13564,GO:0060011,0.120984186890913,0.994847738716018,1,3,Sertoli cell proliferation,BP,BCL2L2
5457,GO:0016327,0.121180697225956,0.979524275620725,2,13,apicolateral plasma membrane,CC,NEDD4;OCLN
747,GO:0001975,0.121211609855991,0.979515956720196,2,13,response to amphetamine,BP,ICAM1;NR4A2
6733,GO:0030141,0.121334937436415,0.914296944624412,30,539,secretory granule,CC,IL1B;PLAU;CXCL1;PLAUR;PTX3;NFKB1;EDN1;AMPD3;ADAM8;RAP2B;CTSC;B4GALT1;VEGFA;RAB24;CD55;CD47;CANT1;VEGFC;SERPINB1;PDGFB;MMP9;CAB39;CAV1;TLR2;ITGAV;STX1A;PLAT;FRK;COTL1;MGAM
17550,GO:1901032,0.12145648925922,0.97927220769953,2,14,negative regulation of response to reactive oxygen species,BP,NFE2L2;NR4A3
18316,GO:1903206,0.12145648925922,0.97927220769953,2,14,negative regulation of hydrogen peroxide-induced cell death,BP,NFE2L2;NR4A3
20216,GO:2001039,0.12145648925922,0.97927220769953,2,14,negative regulation of cellular response to drug,BP,NFE2L2;NR4A3
11491,GO:0045940,0.121553874723262,0.979245744154438,2,14,positive regulation of steroid metabolic process,BP,IL1B;TNF
7429,GO:0031526,0.121696985783177,0.968068347770794,3,25,brush border membrane,CC,B4GALT1;SLC6A14;SLC11A2
9080,GO:0035329,0.121699687598254,0.95981508341804,4,38,hippo signaling,BP,TJP2;AMOTL2;SAV1;PJA2
4691,GO:0010837,0.121800427524776,0.96802933761648,3,25,regulation of keratinocyte proliferation,BP,ZFP36;ZFP36L1;EFNB2
13884,GO:0060487,0.121896748796581,0.979331234907183,2,13,lung epithelial cell differentiation,BP,SAV1;CREB1
15476,GO:0071801,0.121956538364632,0.979315083693448,2,13,regulation of podosome assembly,BP,CSF2;TNF
2086,GO:0004843,0.122029252756155,0.948236832158238,6,70,thiol-dependent ubiquitin-specific protease activity,MF,TNFAIP3;ZC3H12A;CYLD;USP43;OTUD4;USP31
1282,GO:0003073,0.122050980742232,0.959499375001129,4,41,regulation of systemic arterial blood pressure,BP,SOD2;EDN1;ADM;PDGFB
11353,GO:0045668,0.122401959688074,0.967712081834945,3,26,negative regulation of osteoblast differentiation,BP,TNF;NOCT;SMAD3
1392,GO:0003299,0.122461230554496,0.979390288119423,2,12,muscle hypertrophy in response to stress,BP,SMAD3;ERRFI1
4933,GO:0014887,0.122461230554496,0.979390288119423,2,12,cardiac muscle adaptation,BP,SMAD3;ERRFI1
4941,GO:0014898,0.122461230554496,0.979390288119423,2,12,cardiac muscle hypertrophy in response to stress,BP,SMAD3;ERRFI1
16162,GO:0090162,0.122592658918556,0.967730046736053,3,25,establishment of epithelial cell polarity,BP,FRMD4B;WNT5A;CYTH1
16261,GO:0090304,0.122622779022445,0.894883865374464,203,4173,nucleic acid metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;WTAP;RELB;ZNF217;CDKN1A;CCDC85B;IL7R;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;ZC3H12C;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;KLF7;BTG1;IER5;CEBPB;CEBPD;NAMPT;CREB1;TAF4B;CCNL1;USP43;NR4A2;PATL1;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;OTUD4;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;NEDD4;POU2F2;DUS4L;NFE2L2;SMAD1;TAB3;MXD1;CHD4;ZC3H7B;DIEXF;NFAT5;STAT5A;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;PUS10;UBE2D3;MAPKBP1;ELK3;RAD9B;SNAPC4;CLK4;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;ESCO2;FOXN2;MUC1;YARS2;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ZXDA;XBP1;QKI;ZBTB5;ELF4;SREK1IP1;TFE3;EID3;ZMIZ2;JUND;DENND4A
13981,GO:0060674,0.122845311202412,0.967543884442658,3,26,placenta blood vessel development,BP,FOSL1;JUNB;ITGB8
13604,GO:0060057,0.122947270966553,0.994674072973591,1,3,apoptotic process involved in mammary gland involution,BP,B4GALT1
13605,GO:0060058,0.122947270966553,0.994674072973591,1,3,positive regulation of apoptotic process involved in mammary gland involution,BP,B4GALT1
17979,GO:1902339,0.122947270966553,0.994674072973591,1,3,positive regulation of apoptotic process involved in morphogenesis,BP,B4GALT1
18453,GO:1903519,0.122947270966553,0.994674072973591,1,3,regulation of mammary gland involution,BP,B4GALT1
18454,GO:1903521,0.122947270966553,0.994674072973591,1,3,positive regulation of mammary gland involution,BP,B4GALT1
18987,GO:1904747,0.122947270966553,0.994674072973591,1,3,positive regulation of apoptotic process involved in development,BP,B4GALT1
9583,GO:0036396,0.123205369894709,0.994651012989023,1,3,RNA N6-methyladenosine methyltransferase complex,CC,WTAP
11198,GO:0045293,0.123205369894709,0.994651012989023,1,3,mRNA editing complex,CC,WTAP
14459,GO:0061771,0.123240096083347,0.994647906327233,1,3,response to caloric restriction,BP,LDLR
6825,GO:0030279,0.123262892115576,0.959003456543545,4,40,negative regulation of ossification,BP,TNF;NOCT;SMAD3;DKK1
4502,GO:0010524,0.123346589016473,0.967269435693068,3,27,positive regulation of calcium ion transport into cytosol,BP,BDKRB1;CAV1;JPH2
19762,GO:2000110,0.123589777134559,0.994616569968017,1,3,negative regulation of macrophage apoptotic process,BP,NOD2
2264,GO:0005176,0.123657586315256,0.994610482076189,1,3,ErbB-2 class receptor binding,MF,NRG1
14816,GO:0070536,0.123796871237592,0.967273348264459,3,25,protein K63-linked deubiquitination,BP,TNFAIP3;CYLD;OTUD4
5714,GO:0016841,0.123808490536237,0.99459692083333,1,3,ammonia-lyase activity,MF,HAL
909,GO:0002291,0.123887109778969,0.99458984843014,1,3,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,ICAM1
903,GO:0002279,0.123900482532568,0.967057991713374,3,27,mast cell activation involved in immune response,BP,IL4R;ADGRE2;NR4A3
10450,GO:0043303,0.123900482532568,0.967057991713374,3,27,mast cell degranulation,BP,IL4R;ADGRE2;NR4A3
18799,GO:1904294,0.123904574117023,0.978786115315671,2,13,positive regulation of ERAD pathway,BP,NFE2L2;CAV1
12628,GO:0050796,0.12391323660282,0.939520121851829,8,107,regulation of insulin secretion,BP,IL1B;TNF;PIM3;SOX4;MARCKS;STX1A;PPARD;SLC16A1
6735,GO:0030145,0.124016202930942,0.958612111726856,4,41,manganese ion binding,MF,SOD2;B4GALT1;ABL2;PIM1
2044,GO:0004784,0.124127008214604,0.993911655160175,1,4,superoxide dismutase activity,MF,SOD2
5640,GO:0016721,0.124127008214604,0.993911655160175,1,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,SOD2
12831,GO:0051123,0.124224403388478,0.966855760285128,3,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,CREB1;TAF4B;TP53
7030,GO:0030799,0.124303179567325,0.958482079774722,4,41,regulation of cyclic nucleotide metabolic process,BP,VEGFA;ADM;WNT5A;EGLN1
10102,GO:0042608,0.124340953348589,0.994548925772068,1,3,T cell receptor binding,MF,HLA-E
3856,GO:0008467,0.124669652509381,0.99451918509288,1,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,HS3ST3B1
13336,GO:0052203,0.124975970883688,0.994491392113598,1,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,PTX3
8455,GO:0033590,0.125089336757211,0.994481087246623,1,3,response to cobalamin,BP,RELA
3717,GO:0008236,0.125138594386696,0.942231763667385,7,93,serine-type peptidase activity,MF,PLAU;ADAM8;CTSC;MMP9;PLAT;MMP10;CFB
14008,GO:0060708,0.12539859854757,0.994452923610297,1,3,spongiotrophoblast differentiation,BP,LIF
8732,GO:0034378,0.125562147364316,0.994437998894452,1,3,chylomicron assembly,BP,PLAGL2
15572,GO:0072006,0.125675983461329,0.942051686430266,7,86,nephron development,BP,BMP2;LIF;SIX4;VEGFA;CFLAR;PDGFB;WNT7B
11851,GO:0046813,0.125749330210199,0.994420891315791,1,3,receptor-mediated virion attachment to host cell,BP,ICAM1
7054,GO:0030823,0.12592153509024,0.978232847641047,2,13,regulation of cGMP metabolic process,BP,VEGFA;WNT5A
12642,GO:0050816,0.125922192550202,0.994405067782049,1,3,phosphothreonine residue binding,MF,NEDD4
18816,GO:1904340,0.125931801205732,0.994404187523412,1,3,positive regulation of dopaminergic neuron differentiation,BP,DKK1
19095,GO:1904958,0.125931801205732,0.994404187523412,1,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,DKK1
6700,GO:0030073,0.12602604563992,0.935242778015966,9,125,insulin secretion,BP,IL1B;TNF;IL1RN;PIM3;SOX4;MARCKS;STX1A;PPARD;SLC16A1
15107,GO:0071108,0.126559550171874,0.966217573308346,3,25,protein K48-linked deubiquitination,BP,TNFAIP3;CYLD;OTUD4
14878,GO:0070647,0.126568898836139,0.902718964246563,51,946,protein modification by small protein conjugation or removal,BP,NFKBIA;TNFAIP3;BIRC3;ZC3H12A;RNF19B;TNIP1;TICAM1;PELI1;BIRC2;N4BP1;RIPK2;KLHL21;CYLD;ZNF451;NEDD4L;NOD2;DCUN1D3;SMAD3;RNF144B;RNF43;USP43;VHL;BACH1;SMURF2;KLHL5;TRIM25;SOX4;SOCS2;IFIH1;KIAA1586;OTUD4;ARRDC4;RCHY1;NUP153;RNF152;NEDD4;NFE2L2;KBTBD7;SMAD1;CAV1;SH3RF2;INO80D;TNIP2;TP53;UBE2D3;PJA2;UBE2Z;RELA;USP31;RNF145;KCTD11
7681,GO:0032106,0.126571461396585,0.994345422165687,1,3,positive regulation of response to extracellular stimulus,BP,CYP27B1
7684,GO:0032109,0.126571461396585,0.994345422165687,1,3,positive regulation of response to nutrient levels,BP,CYP27B1
18184,GO:1902932,0.126600396835032,0.978045356370774,2,13,positive regulation of alcohol biosynthetic process,BP,IL1B;TNF
11223,GO:0045348,0.12672962511818,0.994330841432079,1,3,positive regulation of MHC class II biosynthetic process,BP,XBP1
7366,GO:0031404,0.126816123680475,0.994322858899733,1,3,chloride ion binding,MF,CTSC
10420,GO:0043255,0.126893946182503,0.950817460619834,5,54,regulation of carbohydrate biosynthetic process,BP,NFKB1;SOGA1;PPP1R3B;PDGFB;GSK3B
7174,GO:0031050,0.126936180527673,0.957283514785969,4,41,dsRNA fragmentation,BP,ZC3H12A;SMAD3;SMAD1;ZC3H7B
15008,GO:0070918,0.126936180527673,0.957283514785969,4,41,production of small RNA involved in gene silencing by RNA,BP,ZC3H12A;SMAD3;SMAD1;ZC3H7B
11214,GO:0045337,0.127192768910665,0.994288030568659,1,3,farnesyl diphosphate biosynthetic process,BP,HMGCS1
9590,GO:0036435,0.127233343589663,0.994284271880563,1,3,K48-linked polyubiquitin modification-dependent protein binding,MF,IKBKE
3773,GO:0008324,0.127256421715165,0.917775989999962,19,308,cation transmembrane transporter activity,MF,PANX1;SLC6A14;KCNJ15;SLC28A3;NIPAL4;SLC7A2;SLC11A2;SLC38A2;RHD;TRPV3;SLC9A1;SLC25A37;RHCG;SLC2A6;ITGAV;JPH2;SLC9A8;SLC39A14;SLC41A1
12975,GO:0051344,0.127310588343279,0.994277112580939,1,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,EGLN1
11892,GO:0046890,0.127487699857604,0.934319675383869,9,126,regulation of lipid biosynthetic process,BP,IL1B;TNF;BMP2;NFKB1;CYP27B1;CREB1;HMGCS1;PDGFB;LDLR
9927,GO:0042270,0.127498015902733,0.994259721376264,1,3,protection from natural killer cell mediated cytotoxicity,BP,HLA-E
17416,GO:1900138,0.127740853889694,0.994237146987003,1,3,negative regulation of phospholipase A2 activity,BP,ANXA8
18362,GO:1903313,0.127875657410012,0.950246313489929,5,56,positive regulation of mRNA metabolic process,BP,BTG2;ZC3H12A;ZFP36;ZFP36L1;QKI
15229,GO:0071371,0.127882885204248,0.977689404906944,2,13,cellular response to gonadotropin stimulus,BP,INHBA;HMGCS1
613,GO:0001779,0.127922723712738,0.977678311265574,2,13,natural killer cell differentiation,BP,PRDM1;AXL
10762,GO:0044194,0.128190326838161,0.994195239392053,1,3,cytolytic granule,CC,RNF19B
12764,GO:0051019,0.128198157945365,0.965490388181661,3,26,mitogen-activated protein kinase binding,MF,TNIP1;GCH1;DUSP10
13506,GO:0055037,0.128327119548723,0.931165233641123,10,143,recycling endosome,CC,TNF;EHD1;AMOTL2;RAP2B;RASSF9;SLC11A2;HLA-A;HLA-B;HLA-F;HLA-E
11247,GO:0045415,0.1283792695889,0.994177574705098,1,3,negative regulation of interleukin-8 biosynthetic process,BP,BCL3
391,GO:0001046,0.128633322450836,0.944592019655627,6,72,core promoter sequence-specific DNA binding,MF,GADD45A;CEBPB;SOX4;CHD2;TP53;NR4A3
5667,GO:0016772,0.12870882762019,0.902886731473172,44,779,transferase activity, transferring phosphorus-containing groups,MF,CSF2;HBEGF;NUAK2;ITPKC;MAP2K3;EPHA2;SQSTM1;EREG;PELI1;PIM3;RIPK2;IRAK2;TJP2;CDKN1A;NMNAT2;SGK1;FGF5;PLK2;MAP3K8;ABL2;ANKK1;MAST4;PHKG2;TGFBR2;MASTL;CAMK1G;PDGFB;NRG1;CAB39;PLK3;MMD;SGMS2;STAT5A;STK40;IKBKE;CLK4;POLR3A;PIM1;AXL;FRK;GSK3B;RIPK4;RPS6KA6;DDR1
11318,GO:0045627,0.128747092478459,0.994143104240636,1,3,positive regulation of T-helper 1 cell differentiation,BP,RIPK2
11484,GO:0045932,0.128829838356477,0.977230880973047,2,14,negative regulation of muscle contraction,BP,ZC3H12A;DOCK4
10425,GO:0043262,0.128875432251094,0.99413105143446,1,3,adenosine-diphosphatase activity,MF,CANT1
10034,GO:0042475,0.129038699625493,0.94965324048394,5,56,odontogenesis of dentin-containing tooth,BP,BMP2;CSF1;DLX2;ADM;TNC
10283,GO:0043024,0.129152865338644,0.977139711113744,2,14,ribosomal small subunit binding,MF,CPEB2;PIM1
13614,GO:0060070,0.129163975830548,0.921212547075548,15,239,canonical Wnt signaling pathway,BP,BMP2;NFKB1;CYLD;FZD8;BAMBI;SMAD3;NRARP;DKK1;NR4A2;SMURF2;WNT5A;SOX4;WNT7B;CAV1;GSK3B
5336,GO:0016064,0.129177804170714,0.949514019426619,5,58,immunoglobulin mediated immune response,BP,TNF;BCL3;CD55;IL4R;POU2F2
6213,GO:0019724,0.129177804170714,0.949514019426619,5,58,B cell mediated immunity,BP,TNF;BCL3;CD55;IL4R;POU2F2
6360,GO:0021537,0.12962700355944,0.928021392909582,11,158,telencephalon development,BP,BTG2;INHBA;BMP2;KDM6B;DLX2;WNT5A;NRG1;SLC38A2;FEZ1;NR4A3;GSK3B
14275,GO:0061316,0.12969916270995,0.994053378391668,1,3,canonical Wnt signaling pathway involved in heart development,BP,DKK1
9502,GO:0036146,0.129730779212931,0.99405038631012,1,3,cellular response to mycotoxin,BP,PDGFB
1273,GO:0003057,0.129758876227434,0.994047726629319,1,3,regulation of the force of heart contraction by chemical signal,BP,CAV1
19635,GO:1990756,0.129779018808044,0.99404581953094,1,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,ARRDC4
19188,GO:1905208,0.12985719563536,0.977136981859636,2,13,negative regulation of cardiocyte differentiation,BP,BMP2;DKK1
6510,GO:0021879,0.129943141642517,0.964722091083826,3,27,forebrain neuron differentiation,BP,INHBA;DLX2;WNT5A
13787,GO:0060351,0.130060709665029,0.977079730766177,2,13,cartilage development involved in endochondral bone morphogenesis,BP,TGFBR2;COL27A1
14253,GO:0061209,0.130157624969036,0.994009912634998,1,3,cell proliferation involved in mesonephros development,BP,BMP2
12229,GO:0048469,0.130225264738798,0.939323224292878,7,91,cell maturation,BP,EREG;CDKN1A;VEGFA;NR4A2;POU2F2;AXL;XBP1
3305,GO:0007006,0.130256988477925,0.939169061181706,7,99,mitochondrial membrane organization,BP,PMAIP1;PPIF;BBC3;TP53BP2;SLC9A1;TP53;GSK3B
14099,GO:0060907,0.130351309655965,0.993991499213175,1,3,positive regulation of macrophage cytokine production,BP,WNT5A
18936,GO:1904636,0.130359207599552,0.993990747724814,1,3,response to ionomycin,BP,ZC3H12A
18937,GO:1904637,0.130359207599552,0.993990747724814,1,3,cellular response to ionomycin,BP,ZC3H12A
10885,GO:0044420,0.130498614710535,0.939283730217155,7,85,extracellular matrix component,CC,LAMB3;ADAMTS1;TNC;COL12A1;COL27A1;LAMA3;COL8A1
4359,GO:0009952,0.130580620293562,0.9324324550331,9,122,anterior/posterior pattern specification,BP,BTG2;BMP2;TBX3;ETS2;SMAD3;NRARP;DKK1;WNT5A;ABI1
13880,GO:0060482,0.130620585761621,0.993965849401987,1,3,lobar bronchus development,BP,WNT7B
4575,GO:0010657,0.130904836285654,0.955458253019377,4,41,muscle cell apoptotic process,BP,ZC3H12A;EDN1;CFLAR;NFE2L2
17032,GO:0099172,0.130939754764003,0.976831786627985,2,13,presynapse organization,BP,WNT5A;CHD4
3950,GO:0008645,0.131281244662685,0.943160557354037,6,71,hexose transmembrane transport,BP,IL1B;TNF;SLC2A6;NFE2L2;NR4A3;PPARD
14491,GO:0061888,0.131343533688017,0.993896697437729,1,3,regulation of astrocyte activation,BP,LDLR
4874,GO:0014732,0.131370694999566,0.993894091205182,1,3,skeletal muscle atrophy,BP,CFLAR
3121,GO:0006700,0.131399850279273,0.976329340631159,2,15,C21-steroid hormone biosynthetic process,BP,BMP2;ADM
14956,GO:0070836,0.1314905280209,0.993882585691091,1,3,caveola assembly,BP,CAV1
3295,GO:0006990,0.13159162295988,0.993872870304019,1,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,XBP1
3480,GO:0007341,0.131633513429558,0.993868842156171,1,3,penetration of zona pellucida,BP,B4GALT1
1854,GO:0004514,0.131718465950165,0.993860668873409,1,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,NAMPT
16766,GO:0098533,0.131795959767518,0.976589259215243,2,13,ATPase dependent transmembrane transport complex,CC,SLC9A1;ABCA7
7624,GO:0032010,0.131815764651581,0.993851300639809,1,3,phagolysosome,CC,ADAM8
16577,GO:0097350,0.131832250274889,0.993849712596952,1,3,neutrophil clearance,BP,AXL
17864,GO:1902037,0.131965449441389,0.993836873648053,1,3,negative regulation of hematopoietic stem cell differentiation,BP,NFE2L2
6065,GO:0019209,0.131974887185154,0.948077906942821,5,58,kinase activator activity,MF,CDKN1A;NRG1;CAB39;SPRY2;ABI1
698,GO:0001915,0.132000717063795,0.993833471845462,1,3,negative regulation of T cell mediated cytotoxicity,BP,IL7R
18993,GO:1904753,0.132026986713106,0.993830937308937,1,3,negative regulation of vascular associated smooth muscle cell migration,BP,NFE2L2
6525,GO:0021898,0.132083192971227,0.993825512578531,1,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,DLX2
10426,GO:0043266,0.132236136390792,0.954840968636444,4,41,regulation of potassium ion transport,BP,NEDD4L;CAB39;NEDD4;CAV1
6952,GO:0030574,0.132284318473318,0.95487366214795,4,40,collagen catabolic process,BP,MMP9;COL12A1;MMP10;COL8A1
14874,GO:0070640,0.132318029713178,0.993802819901334,1,3,vitamin D3 metabolic process,BP,CYP27B1
12816,GO:0051097,0.132365798673872,0.993798198476343,1,3,negative regulation of helicase activity,BP,TP53
3924,GO:0008593,0.132558634824986,0.942376583249899,6,74,regulation of Notch signaling pathway,BP,NFKBIA;ELF3;NOD2;IL6ST;DLX2;NRARP
14871,GO:0070634,0.132656270730665,0.993770057135873,1,3,transepithelial ammonium transport,BP,RHCG
14254,GO:0061213,0.132675759726186,0.976136002608468,2,14,positive regulation of mesonephros development,BP,SIX4;VEGFA
15573,GO:0072007,0.132735239598613,0.993762394783913,1,3,mesangial cell differentiation,BP,PDGFB
15574,GO:0072008,0.132735239598613,0.993762394783913,1,3,glomerular mesangial cell differentiation,BP,PDGFB
15656,GO:0072143,0.132735239598613,0.993762394783913,1,3,mesangial cell development,BP,PDGFB
15657,GO:0072144,0.132735239598613,0.993762394783913,1,3,glomerular mesangial cell development,BP,PDGFB
18775,GO:1904238,0.132735239598613,0.993762394783913,1,3,pericyte cell differentiation,BP,PDGFB
9721,GO:0038145,0.132842112944413,0.993752016866983,1,3,macrophage colony-stimulating factor signaling pathway,BP,CSF1
13907,GO:0060535,0.132953499691264,0.993741190892425,1,3,trachea cartilage morphogenesis,BP,WNT7B
1306,GO:0003143,0.132991553341134,0.954545031474803,4,40,embryonic heart tube morphogenesis,BP,TBX3;SMAD3;TGFBR2;WNT5A
7773,GO:0032289,0.133027685716651,0.993733975013414,1,3,central nervous system myelin formation,BP,TLR2
13025,GO:0051445,0.13302786036372,0.963509207607906,3,27,regulation of meiotic cell cycle,BP,LIF;DUSP1;WNT5A
4508,GO:0010544,0.13303851879435,0.976031670887657,2,14,negative regulation of platelet activation,BP,C1QTNF1;PDGFB
10435,GO:0043277,0.133048436800024,0.963501071137646,3,27,apoptotic cell clearance,BP,ITGAV;ABCA7;AXL
8896,GO:0034711,0.133184790333554,0.993718679232357,1,3,inhibin binding,MF,INHBA
9774,GO:0039535,0.13322889732253,0.976181106720353,2,13,regulation of RIG-I signaling pathway,BP,BIRC3;BIRC2
4464,GO:0010454,0.133424438722518,0.993695308660588,1,3,negative regulation of cell fate commitment,BP,DKK1
13972,GO:0060664,0.133466457968834,0.993691206165778,1,3,epithelial cell proliferation involved in salivary gland morphogenesis,BP,TNF
1731,GO:0004322,0.133468596541976,0.99369099733091,1,3,ferroxidase activity,MF,HEPHL1
5643,GO:0016724,0.133468596541976,0.99369099733091,1,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,HEPHL1
1068,GO:0002606,0.133491390089435,0.993688771277942,1,3,positive regulation of dendritic cell antigen processing and presentation,BP,NOD2
11068,GO:0045058,0.133518676490771,0.963314960179225,3,27,T cell selection,BP,IL23A;IL6;CYLD
14506,GO:0061945,0.133621519338561,0.993676054637408,1,3,regulation of protein K48-linked ubiquitination,BP,BIRC2
13265,GO:0051930,0.13377684920151,0.975818759828558,2,14,regulation of sensory perception of pain,BP,EDN1;SLC9A1
13266,GO:0051931,0.13377684920151,0.975818759828558,2,14,regulation of sensory perception,BP,EDN1;SLC9A1
4836,GO:0014038,0.133954745125277,0.993643428539231,1,3,regulation of Schwann cell differentiation,BP,RELA
19711,GO:2000008,0.134034935997151,0.963023706007851,3,28,regulation of protein localization to cell surface,BP,TNF;NEDD4L;NRG1
15498,GO:0071839,0.134072318101432,0.993631895616786,1,3,apoptotic process in bone marrow,BP,PLK2
15707,GO:0072223,0.13409724202335,0.993629449357117,1,3,metanephric glomerular mesangium development,BP,PDGFB
15714,GO:0072239,0.13409724202335,0.993629449357117,1,3,metanephric glomerulus vasculature development,BP,PDGFB
17970,GO:1902308,0.134109414276344,0.993628254479764,1,3,regulation of peptidyl-serine dephosphorylation,BP,PPP1R15A
17701,GO:1901565,0.13415045602311,0.896143900743909,52,979,organonitrogen compound catabolic process,BP,IL1B;TNFAIP3;TNF;EFNA1;SDC4;RNF19B;PMAIP1;SQSTM1;AMPD3;BIRC2;ADAM8;N4BP1;CYLD;ODC1;NEDD4L;CTSC;SMAD3;RNF144B;TRIB1;PLK2;RNF43;UPP1;DENND3;USP43;ABTB2;SMURF2;TINAGL1;TRIM25;WNT5A;PGLYRP4;NRG1;LDLR;PLK3;SLC9A1;MAOA;RCHY1;HAL;NEDD4;NFE2L2;PAOX;CAV1;TP53;UBE2D3;PML;ADAM9;RELA;SAT1;USP31;GSK3B;EGLN1;RNF145;XBP1
3817,GO:0008406,0.134211096614776,0.927350516745235,10,144,gonad development,BP,INHBA;EREG;SIX4;ICAM1;VEGFA;CEBPB;ADAMTS1;HMGCS1;WNT5A;BCL2L2
16541,GO:0097252,0.13429261574999,0.99361025625062,1,3,oligodendrocyte apoptotic process,BP,TP53
3667,GO:0008157,0.134302675090745,0.97566666858032,2,14,protein phosphatase 1 binding,MF,PPP1R15A;SH3RF2
11248,GO:0045416,0.134306599935217,0.99360888129265,1,3,positive regulation of interleukin-8 biosynthetic process,BP,TNF
19663,GO:1990834,0.134341033216118,0.993605495059003,1,3,response to odorant,BP,IL4R
11383,GO:0045740,0.134547768006927,0.953659000871709,4,43,positive regulation of DNA replication,BP,CSF2;JUN;EREG;PDGFB
2197,GO:0005057,0.134635357693418,0.929918561693216,9,119,signal transducer activity, downstream of receptor,MF,EPHA2;SMAD3;MAP3K8;TGFBR2;IL4R;SMAD1;IKBKE;AXL;DDR1
6883,GO:0030374,0.134665774247205,0.946721377954205,5,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,NCOA7;SFR1;PPARD;MED13;ZMIZ2
19824,GO:2000242,0.134712805654176,0.962672942000698,3,29,negative regulation of reproductive process,BP,LIF;DUSP1;WNT5A
13015,GO:0051427,0.134713481868565,0.927034260659626,10,143,hormone receptor binding,MF,NCOA7;ETS2;SMAD3;CEBPB;NR4A2;SOCS2;NR4A3;PARP1;MED13;JUND
17858,GO:1902022,0.134720566210191,0.993568107678606,1,3,L-lysine transport,BP,SLC7A2
18404,GO:1903401,0.134720566210191,0.993568107678606,1,3,L-lysine transmembrane transport,BP,SLC7A2
1252,GO:0002950,0.135071372021007,0.993533446767843,1,3,ceramide phosphoethanolamine synthase activity,MF,SGMS2
8343,GO:0033188,0.135071372021007,0.993533446767843,1,3,sphingomyelin synthase activity,MF,SGMS2
12016,GO:0047493,0.135071372021007,0.993533446767843,1,3,ceramide cholinephosphotransferase activity,MF,SGMS2
19943,GO:2000416,0.135168574256005,0.993523825243072,1,3,regulation of eosinophil migration,BP,ADAM8
19850,GO:2000286,0.135228434613423,0.993517896191778,1,3,receptor internalization involved in canonical Wnt signaling pathway,BP,CAV1
4888,GO:0014805,0.13523850035366,0.99273578770836,1,4,smooth muscle adaptation,BP,IL1B
18450,GO:1903516,0.135241986738525,0.993516553478415,1,3,regulation of single strand break repair,BP,PARP1
6212,GO:0019722,0.135350027667356,0.936305820028467,7,92,calcium-mediated signaling,BP,CXCL8;CCL20;EDN1;NRG1;SLC9A1;NFAT5;JPH2
6545,GO:0021953,0.135375741289833,0.936349258446099,7,89,central nervous system neuron differentiation,BP,BTG2;INHBA;DLX2;DKK1;NR4A2;WNT5A;SOX4
19731,GO:2000049,0.13548120803842,0.99349282755253,1,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,WNT5A
7978,GO:0032587,0.135611871062372,0.940730208212387,6,72,ruffle membrane,CC,EPHA2;ITGA5;SPRY2;ITGAV;ABCA7;ADGRE2
9515,GO:0036166,0.13564303117816,0.993476751737122,1,3,phenotypic switching,BP,PDGFB
17464,GO:1900239,0.13564303117816,0.993476751737122,1,3,regulation of phenotypic switching,BP,PDGFB
9556,GO:0036315,0.13564564739428,0.975486331732709,2,13,cellular response to sterol,BP,INHBA;HMGCS1
994,GO:0002448,0.135664259921799,0.962373821178704,3,28,mast cell mediated immunity,BP,IL4R;ADGRE2;NR4A3
1904,GO:0004586,0.135809203503165,0.99346022183417,1,3,ornithine decarboxylase activity,MF,ODC1
8415,GO:0033387,0.135809203503165,0.99346022183417,1,3,putrescine biosynthetic process from ornithine,BP,ODC1
11470,GO:0045916,0.135829070994431,0.993458244031818,1,3,negative regulation of complement activation,BP,CD55
19834,GO:2000258,0.135829070994431,0.993458244031818,1,3,negative regulation of protein activation cascade,BP,CD55
4410,GO:0010159,0.135892750003864,0.9934519026558,1,3,specification of animal organ position,BP,TBX3
7918,GO:0032486,0.135906162790708,0.975410959323656,2,13,Rap protein signal transduction,BP,RAP2B;PLK2
18870,GO:1904468,0.136026614428949,0.993438561279736,1,3,negative regulation of tumor necrosis factor secretion,BP,ZC3H12A
15239,GO:0071383,0.136041462699925,0.91967943215846,13,195,cellular response to steroid hormone stimulus,BP,EDN1;ZFP36;ZFP36L1;ICAM1;CFLAR;ERRFI1;NR4A2;RUNX1;NEDD4;NR4A3;PPARD;PARP1;MED13
2227,GO:0005127,0.13618932712276,0.993422325270776,1,3,ciliary neurotrophic factor receptor binding,MF,IL6ST
11512,GO:0045988,0.136219882964155,0.993419273919258,1,3,negative regulation of striated muscle contraction,BP,ZC3H12A
13549,GO:0055118,0.136219882964155,0.993419273919258,1,3,negative regulation of cardiac muscle contraction,BP,ZC3H12A
14689,GO:0070294,0.136230817035336,0.9934181818432,1,3,renal sodium ion absorption,BP,SGK1
13993,GO:0060689,0.136232845971942,0.993417979185892,1,3,cell differentiation involved in salivary gland development,BP,XBP1
9009,GO:0035162,0.136331750081129,0.975287628175564,2,13,embryonic hemopoiesis,BP,VEGFA;TGFBR2
5156,GO:0015691,0.136431015421314,0.993398169273083,1,3,cadmium ion transport,BP,SLC11A2
14844,GO:0070574,0.136431015421314,0.993398169273083,1,3,cadmium ion transmembrane transport,BP,SLC11A2
7800,GO:0032345,0.136439714894081,0.99339729890625,1,3,negative regulation of aldosterone metabolic process,BP,BMP2
7803,GO:0032348,0.136439714894081,0.99339729890625,1,3,negative regulation of aldosterone biosynthetic process,BP,BMP2
19742,GO:2000065,0.136439714894081,0.99339729890625,1,3,negative regulation of cortisol biosynthetic process,BP,BMP2
14765,GO:0070432,0.136504387047573,0.993390826651442,1,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,TNFAIP3
13601,GO:0060054,0.13661427708176,0.993379821320617,1,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,B4GALT1
7866,GO:0032422,0.136729655326896,0.993368255831467,1,3,purine-rich negative regulatory element binding,MF,ELK3
1182,GO:0002826,0.136834231575877,0.993357763818621,1,3,negative regulation of T-helper 1 type immune response,BP,IL4R
4852,GO:0014061,0.136846686996627,0.993356513590539,1,3,regulation of norepinephrine secretion,BP,STX1A
7923,GO:0032493,0.136878667782916,0.993353302904518,1,3,response to bacterial lipoprotein,BP,TLR2
14717,GO:0070339,0.136878667782916,0.993353302904518,1,3,response to bacterial lipopeptide,BP,TLR2
15140,GO:0071220,0.136878667782916,0.993353302904518,1,3,cellular response to bacterial lipoprotein,BP,TLR2
15141,GO:0071221,0.136878667782916,0.993353302904518,1,3,cellular response to bacterial lipopeptide,BP,TLR2
11778,GO:0046626,0.136884097489411,0.952611842621927,4,42,regulation of insulin receptor signaling pathway,BP,IL1B;SOCS2;PTPN1;RELA
9380,GO:0035905,0.136887311322443,0.993352435000924,1,3,ascending aorta development,BP,SOX4
9383,GO:0035910,0.136887311322443,0.993352435000924,1,3,ascending aorta morphogenesis,BP,SOX4
6593,GO:0022602,0.13711216399201,0.961978677790423,3,26,ovulation cycle process,BP,INHBA;EREG;ADAMTS1
12870,GO:0051176,0.137421022420978,0.993298727450535,1,3,positive regulation of sulfur metabolic process,BP,NFE2L2
19798,GO:2000191,0.137480071383419,0.974739509501826,2,14,regulation of fatty acid transport,BP,IL1B;EDN1
7764,GO:0032276,0.137518829413891,0.993288860065486,1,3,regulation of gonadotropin secretion,BP,INHBA
7766,GO:0032278,0.137518829413891,0.993288860065486,1,3,positive regulation of gonadotropin secretion,BP,INHBA
11882,GO:0046880,0.137518829413891,0.993288860065486,1,3,regulation of follicle-stimulating hormone secretion,BP,INHBA
11883,GO:0046881,0.137518829413891,0.993288860065486,1,3,positive regulation of follicle-stimulating hormone secretion,BP,INHBA
1019,GO:0002513,0.137629942989958,0.993277640817832,1,3,tolerance induction to self antigen,BP,TGFBR2
8736,GO:0034382,0.137685787162658,0.992461968641952,1,4,chylomicron remnant clearance,BP,LDLR
15495,GO:0071830,0.137685787162658,0.992461968641952,1,4,triglyceride-rich lipoprotein particle clearance,BP,LDLR
4996,GO:0015129,0.137709510194677,0.993269600686984,1,3,lactate transmembrane transporter activity,MF,SLC16A1
14318,GO:0061437,0.137767424930509,0.974654974387859,2,14,renal system vasculature development,BP,CFLAR;PDGFB
14321,GO:0061440,0.137767424930509,0.974654974387859,2,14,kidney vasculature development,BP,CFLAR;PDGFB
17432,GO:1900165,0.137899557994064,0.993250375900375,1,3,negative regulation of interleukin-6 secretion,BP,ZC3H12A
3526,GO:0007501,0.13799229166085,0.993240984545206,1,3,mesodermal cell fate specification,BP,DKK1
10130,GO:0042661,0.13799229166085,0.993240984545206,1,3,regulation of mesodermal cell fate specification,BP,DKK1
19378,GO:1905770,0.13799229166085,0.993240984545206,1,3,regulation of mesodermal cell differentiation,BP,DKK1
19416,GO:1905902,0.13799229166085,0.993240984545206,1,3,regulation of mesoderm formation,BP,DKK1
4715,GO:0010874,0.138151004821581,0.974541953963863,2,14,regulation of cholesterol efflux,BP,NFKBIA;ABCA7
16311,GO:0090403,0.138182560229243,0.993221693756695,1,3,oxidative stress-induced premature senescence,BP,TP53
6669,GO:0030020,0.138305068736855,0.993209257418755,1,3,extracellular matrix structural constituent conferring tensile strength,MF,COL12A1
17300,GO:0140052,0.138328832268975,0.993206843674995,1,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,TICAM1
5189,GO:0015749,0.138332500486491,0.939207579347517,6,72,monosaccharide transmembrane transport,BP,IL1B;TNF;SLC2A6;NFE2L2;NR4A3;PPARD
14150,GO:0061002,0.138350741893721,0.993204617832815,1,3,negative regulation of dendritic spine morphogenesis,BP,EFNA1
1254,GO:0003002,0.138467243984276,0.917990406749434,13,196,regionalization,BP,BTG2;BMP2;TBX3;EDN1;ETS2;SMAD3;DLX2;NRARP;DKK1;GORAB;WNT5A;WNT7B;ABI1
13877,GO:0060479,0.138560690060348,0.97442101834075,2,14,lung cell differentiation,BP,SAV1;CREB1
4944,GO:0014902,0.138568160235292,0.944687111494749,5,57,myotube differentiation,BP,EHD1;SIX4;CFLAR;IL4R;XBP1
13986,GO:0060681,0.138596665254207,0.993179607252365,1,3,branch elongation involved in ureteric bud branching,BP,SIX4
19962,GO:2000466,0.138645676882409,0.993174616865757,1,3,negative regulation of glycogen (starch) synthase activity,BP,GSK3B
8759,GO:0034421,0.138776408569494,0.993161296162073,1,3,post-translational protein acetylation,BP,ESCO2
3662,GO:0008146,0.138828949431469,0.961100702179344,3,28,sulfotransferase activity,MF,TPST1;HS3ST3B1;CHST2
12605,GO:0050768,0.13885158896789,0.919686754773028,12,177,negative regulation of neurogenesis,BP,EFNA1;DLX2;PLK2;SEMA4B;WNT5A;DUSP10;NRG1;LDLR;EFNB2;GSK3B;VIM;KCTD11
9319,GO:0035787,0.138863879578592,0.993152375686114,1,3,cell migration involved in kidney development,BP,PDGFB
671,GO:0001875,0.139030307387753,0.993135385864472,1,3,lipopolysaccharide receptor activity,MF,TLR2
18700,GO:1904030,0.13910086667892,0.960990648726649,3,28,negative regulation of cyclin-dependent protein kinase activity,BP,TNFAIP3;CDKN1A;CDKN2B
11281,GO:0045578,0.139153688685733,0.993122775926741,1,3,negative regulation of B cell differentiation,BP,INHBA
8618,GO:0034128,0.139236344541375,0.99311432132981,1,3,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
2930,GO:0006447,0.13924663188798,0.99311326868217,1,3,regulation of translational initiation by iron,BP,TNF
4592,GO:0010693,0.139279258370746,0.993109929624373,1,3,negative regulation of alkaline phosphatase activity,BP,TNF
16404,GO:0097009,0.139363819023298,0.974183272512206,2,14,energy homeostasis,BP,AMPD3;NR4A3
13989,GO:0060685,0.139365982290722,0.993101049921897,1,3,regulation of prostatic bud formation,BP,WNT5A
13990,GO:0060686,0.139365982290722,0.993101049921897,1,3,negative regulation of prostatic bud formation,BP,WNT5A
6019,GO:0019065,0.139442503172242,0.993093209834795,1,3,receptor-mediated endocytosis of virus by host cell,BP,CAV1
15967,GO:0075509,0.139442503172242,0.993093209834795,1,3,endocytosis involved in viral entry into host cell,BP,CAV1
15506,GO:0071865,0.139579803297905,0.993079130561675,1,3,regulation of apoptotic process in bone marrow,BP,PLK2
15507,GO:0071866,0.139579803297905,0.993079130561675,1,3,negative regulation of apoptotic process in bone marrow,BP,PLK2
323,GO:0000902,0.139662600506472,0.895275366183674,40,692,cell morphogenesis,BP,EFNA1;EPHA2;EFNB1;ADAM8;BAMBI;IL7R;NEDD4L;SGK1;ICAM1;RND3;VEGFA;FGD6;DKK1;ZSWIM4;KLF7;CDC42EP4;CREB1;NR4A2;VHL;SEMA4B;WNT5A;SLC11A2;NRG1;PARD6B;FEZ1;GRB7;NEDD4;ITSN2;WNT7B;SPTBN5;CLIC4;RHOV;ABI1;EFNB2;ITGAV;RAPH1;AXL;NR4A3;DDR1;EPB41L3
5641,GO:0016722,0.139672270363411,0.974091728058383,2,14,oxidoreductase activity, oxidizing metal ions,MF,STEAP4;HEPHL1
4727,GO:0010886,0.139725760616286,0.993064146733391,1,3,positive regulation of cholesterol storage,BP,EHD1
11904,GO:0046915,0.139867033429533,0.960679993475246,3,28,transition metal ion transmembrane transporter activity,MF,SLC11A2;SLC25A37;SLC39A14
10239,GO:0042940,0.139868788758022,0.993049446797965,1,3,D-amino acid transport,BP,NFKBIE
4544,GO:0010614,0.139902993688112,0.97402316697215,2,14,negative regulation of cardiac muscle hypertrophy,BP,SMAD3;ERRFI1
4882,GO:0014741,0.139902993688112,0.97402316697215,2,14,negative regulation of muscle hypertrophy,BP,SMAD3;ERRFI1
18039,GO:1902527,0.140369757247944,0.992155461727685,1,4,positive regulation of protein monoubiquitination,BP,BIRC2
9367,GO:0035879,0.140371180977443,0.992997680717573,1,3,plasma membrane lactate transport,BP,SLC16A1
18375,GO:1903348,0.140505674479995,0.992983787746075,1,3,positive regulation of bicellular tight junction assembly,BP,CLDN1
16230,GO:0090259,0.140523617807249,0.992981933114114,1,3,regulation of retinal ganglion cell axon guidance,BP,VEGFA
16222,GO:0090244,0.140624357890164,0.992971515695168,1,3,Wnt signaling pathway involved in somitogenesis,BP,DKK1
7820,GO:0032369,0.140660131600899,0.97379766531882,2,14,negative regulation of lipid transport,BP,NFKB1;ITGAV
6239,GO:0019787,0.140669057161838,0.903158496293813,24,401,ubiquitin-like protein transferase activity,MF,TNFAIP3;BIRC3;RNF19B;PELI1;BIRC2;KLHL21;ZNF451;NEDD4L;RNF144B;RNF43;VHL;BACH1;SMURF2;KLHL5;TRIM25;KIAA1586;RCHY1;RNF152;NEDD4;KBTBD7;UBE2D3;PJA2;UBE2Z;RNF145
11902,GO:0046912,0.140707062825173,0.99296295709049,1,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,HMGCS1
16636,GO:0097475,0.140707962457206,0.992962863962685,1,3,motor neuron migration,BP,VEGFA
8979,GO:0035067,0.140805359802887,0.973754321589158,2,14,negative regulation of histone acetylation,BP,ZNF451;SDR16C5
3806,GO:0008384,0.140817498452552,0.992951520124044,1,3,IkappaB kinase activity,MF,IKBKE
16056,GO:0086075,0.140925229735722,0.992940353648761,1,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,GJC1
4231,GO:0009407,0.140927110465947,0.992090996168551,1,4,toxin catabolic process,BP,NFE2L2
3591,GO:0008016,0.140929737803689,0.929136844930799,8,108,regulation of heart contraction,BP,HBEGF;ZC3H12A;EDN1;GCH1;ADM;SLC9A1;CAV1;GJC1
17662,GO:1901385,0.141068785524216,0.973675627788608,2,14,regulation of voltage-gated calcium channel activity,BP,RRAD;GEM
3652,GO:0008131,0.141186044445856,0.992913280718121,1,3,primary amine oxidase activity,MF,MAOA
6802,GO:0030239,0.141259214366534,0.960206093201817,3,27,myofibril assembly,BP,EDN1;SIX4;CFLAR
8707,GO:0034343,0.14131711687891,0.992899654276254,1,3,type III interferon production,BP,IFIH1
8708,GO:0034344,0.14131711687891,0.992899654276254,1,3,regulation of type III interferon production,BP,IFIH1
10603,GO:0043569,0.141448368653153,0.992885995149564,1,3,negative regulation of insulin-like growth factor receptor signaling pathway,BP,BMP2
7313,GO:0031312,0.141537994208386,0.959999594834472,3,28,extrinsic component of organelle membrane,CC,PLEKHF1;ZC3H12A;PML
13107,GO:0051604,0.141666655043671,0.915663133432017,13,211,protein maturation,BP,PLAU;BIRC3;BIRC2;ADAM8;RIPK2;IL1R2;CD55;SOX4;SPCS2;CCBE1;PLAT;PARP1;CFB
12934,GO:0051271,0.141745382132112,0.915700707750169,13,197,negative regulation of cellular component movement,BP,PHLDB2;RAP2B;NAV3;TRIB1;SEMA4B;WNT5A;DUSP10;NRG1;GCSAM;IL24;NFE2L2;CLIC4;PPARD
8716,GO:0034358,0.141795847538979,0.973097184059189,2,16,plasma lipoprotein particle,CC,SAA1;LDLR
19645,GO:1990777,0.141795847538979,0.973097184059189,2,16,lipoprotein particle,CC,SAA1;LDLR
7935,GO:0032507,0.141888449040357,0.942799096578922,5,61,maintenance of protein location in cell,BP,BCL3;SOX4;CAV1;PML;EPB41L3
20314,GO:2001269,0.141911239007382,0.973230125742516,2,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,TNFRSF10B;SMAD3
3284,GO:0006972,0.142199018961718,0.973336912494207,2,14,hyperosmotic response,BP,CLDN1;ERRFI1
12657,GO:0050848,0.142396341651382,0.949885213688179,4,44,regulation of calcium-mediated signaling,BP,NRG1;SLC9A1;NFAT5;JPH2
14197,GO:0061082,0.142488531569056,0.973055495036849,2,15,myeloid leukocyte cytokine production,BP,WNT5A;NR4A3
1401,GO:0003323,0.142495005230466,0.97324792083694,2,14,type B pancreatic cell development,BP,WNT5A;GSK3B
921,GO:0002313,0.142535757942107,0.973041188822013,2,15,mature B cell differentiation involved in immune response,BP,BCL3;XBP1
13499,GO:0055022,0.142565075216782,0.973226835965254,2,14,negative regulation of cardiac muscle tissue growth,BP,SAV1;TGFBR2
14217,GO:0061117,0.142565075216782,0.973226835965254,2,14,negative regulation of heart growth,BP,SAV1;TGFBR2
10555,GO:0043504,0.142604200101018,0.992765102841573,1,3,mitochondrial DNA repair,BP,PARP1
4925,GO:0014866,0.142619990436618,0.992763443722303,1,3,skeletal myofibril assembly,BP,CFLAR
6834,GO:0030291,0.142649013668232,0.959376857717105,3,30,protein serine/threonine kinase inhibitor activity,MF,CDKN1A;CDKN2B;SPRY2
5870,GO:0017171,0.142774052398484,0.93182724566232,7,96,serine hydrolase activity,MF,PLAU;ADAM8;CTSC;MMP9;PLAT;MMP10;CFB
8625,GO:0034140,0.142963969592041,0.99272725063107,1,3,negative regulation of toll-like receptor 3 signaling pathway,BP,TNFAIP3
11876,GO:0046870,0.143055830552709,0.992717568760209,1,3,cadmium ion binding,MF,SLC11A2
18681,GO:1903984,0.143097240657222,0.992713202002365,1,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,ATF3
10699,GO:0043974,0.143182084725229,0.992704250687304,1,3,histone H3-K27 acetylation,BP,LIF
17754,GO:1901674,0.143182084725229,0.992704250687304,1,3,regulation of histone H3-K27 acetylation,BP,LIF
16243,GO:0090279,0.143210970832116,0.973032162588052,2,14,regulation of calcium ion import,BP,PDGFB;TRPV3
13743,GO:0060297,0.1433715435255,0.992684240935055,1,3,regulation of sarcomere organization,BP,EDN1
15953,GO:0072741,0.143443089393273,0.992676676956311,1,3,protein localization to cell division site,BP,ANLN
18280,GO:1903119,0.143443089393273,0.992676676956311,1,3,protein localization to actin cytoskeleton,BP,ANLN
18877,GO:1904498,0.143443089393273,0.992676676956311,1,3,protein localization to mitotic actomyosin contractile ring,BP,ANLN
19495,GO:1990179,0.143443089393273,0.992676676956311,1,3,protein localization to actomyosin contractile ring,BP,ANLN
12416,GO:0048852,0.14366115173991,0.992653597108872,1,3,diencephalon morphogenesis,BP,WNT5A
13815,GO:0060390,0.143679320375505,0.972890645413386,2,14,regulation of SMAD protein signal transduction,BP,SMAD3;PARP1
6458,GO:0021773,0.143684711309806,0.992651101220509,1,3,striatal medium spiny neuron differentiation,BP,INHBA
12807,GO:0051088,0.143761157128659,0.992642999461797,1,3,PMA-inducible membrane protein ectodomain proteolysis,BP,ADAM9
6839,GO:0030297,0.143788577588897,0.99264009226456,1,3,transmembrane receptor protein tyrosine kinase activator activity,MF,NRG1
19353,GO:1905651,0.143788713633586,0.992640077839171,1,3,regulation of artery morphogenesis,BP,EFNB2
19354,GO:1905653,0.143788713633586,0.992640077839171,1,3,positive regulation of artery morphogenesis,BP,EFNB2
12015,GO:0047485,0.143839286626301,0.931189484641453,7,96,protein N-terminus binding,MF,GADD45A;BIRC2;FEZ1;TP53;STX1A;RELA;PARP1
17908,GO:1902176,0.143860184772369,0.972467277717231,2,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,SOD2;NFE2L2
5761,GO:0016917,0.143912741050593,0.992626920386894,1,3,GABA receptor activity,MF,GPR156
20236,GO:2001137,0.143953716310191,0.992622570757134,1,3,positive regulation of endocytic recycling,BP,EHD1
6331,GO:0020016,0.143979911269387,0.992619789374025,1,3,ciliary pocket,CC,EHD1
6332,GO:0020018,0.143979911269387,0.992619789374025,1,3,ciliary pocket membrane,CC,EHD1
15691,GO:0072202,0.144247411671066,0.972718588403673,2,14,cell differentiation involved in metanephros development,BP,LIF;PDGFB
18403,GO:1903400,0.144297733822656,0.992585998168795,1,3,L-arginine transmembrane transport,BP,SLC7A2
19466,GO:1990086,0.144425114039894,0.992572431748365,1,3,lens fiber cell apoptotic process,BP,TGFBR2
15453,GO:0071723,0.144515509045363,0.992562796310633,1,3,lipopeptide binding,MF,TLR2
19932,GO:2000402,0.144563137297109,0.992557716797891,1,3,negative regulation of lymphocyte migration,BP,GCSAM
14362,GO:0061551,0.14456325825168,0.992557703895821,1,3,trigeminal ganglion development,BP,SIX4
13764,GO:0060324,0.1446189027206,0.948923054206969,4,42,face development,BP,CSRNP1;DKK1;WNT5A;ZFAND5
3278,GO:0006957,0.144761072643207,0.992536587237895,1,3,complement activation, alternative pathway,BP,CFB
2115,GO:0004897,0.144912610247001,0.992520388916544,1,3,ciliary neurotrophic factor receptor activity,MF,IL6ST
14587,GO:0070120,0.144912610247001,0.992520388916544,1,3,ciliary neurotrophic factor-mediated signaling pathway,BP,IL6ST
4648,GO:0010767,0.144958970951986,0.99251542951581,1,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,NEDD4
5160,GO:0015695,0.144990329626915,0.958581386346184,3,28,organic cation transport,BP,SLC38A2;RHD;RHCG
1381,GO:0003274,0.145092428028043,0.992501143205612,1,3,endocardial cushion fusion,BP,TGFBR2
6926,GO:0030514,0.145094201232365,0.958634461984879,3,27,negative regulation of BMP signaling pathway,BP,DKK1;SMURF2;WNT5A
8621,GO:0034136,0.145133198816594,0.992496775861487,1,3,negative regulation of toll-like receptor 2 signaling pathway,BP,TNFAIP3
8638,GO:0034162,0.145185658961395,0.972433459275443,2,14,toll-like receptor 9 signaling pathway,BP,IRAK2;TNIP2
18296,GO:1903169,0.145189996617748,0.935218344133796,6,76,regulation of calcium ion transmembrane transport,BP,BDKRB1;RRAD;SLC9A1;GEM;JPH2;TSPAN13
1388,GO:0003289,0.145316291390197,0.992477146271922,1,3,atrial septum primum morphogenesis,BP,SOX4
19829,GO:2000253,0.145417699877534,0.992466262299915,1,3,positive regulation of feeding behavior,BP,NR4A3
18960,GO:1904694,0.145456215335027,0.992462126300498,1,3,negative regulation of vascular smooth muscle contraction,BP,DOCK4
7036,GO:0030805,0.145464753795623,0.992461209229242,1,3,regulation of cyclic nucleotide catabolic process,BP,EGLN1
7051,GO:0030820,0.145464753795623,0.992461209229242,1,3,regulation of cAMP catabolic process,BP,EGLN1
8295,GO:0033121,0.145464753795623,0.992461209229242,1,3,regulation of purine nucleotide catabolic process,BP,EGLN1
801,GO:0002067,0.145540901413326,0.958353668014542,3,28,glandular epithelial cell differentiation,BP,BMP2;WNT5A;GSK3B
11891,GO:0046889,0.145684425663286,0.948299340971764,4,44,positive regulation of lipid biosynthetic process,BP,IL1B;TNF;CREB1;LDLR
451,GO:0001224,0.145709591851708,0.992434886993341,1,3,RNA polymerase II transcription cofactor binding,MF,CREB1
9240,GO:0035630,0.145949941869039,0.992408999380155,1,3,bone mineralization involved in bone maturation,BP,BMP2
3198,GO:0006828,0.146032200909082,0.992400128526466,1,3,manganese ion transport,BP,SLC11A2
8132,GO:0032817,0.146041723007362,0.991486258814046,1,4,regulation of natural killer cell proliferation,BP,IL23A
8133,GO:0032819,0.146041723007362,0.991486258814046,1,4,positive regulation of natural killer cell proliferation,BP,IL23A
4130,GO:0009187,0.146165734771931,0.940630253098732,5,58,cyclic nucleotide metabolic process,BP,EPHA2;VEGFA;ADM;WNT5A;EGLN1
17912,GO:1902187,0.146194427148086,0.972125561572747,2,14,negative regulation of viral release from host cell,BP,TRIM25;PML
9596,GO:0036446,0.146230007181099,0.992378774245801,1,3,myofibroblast differentiation,BP,PARP1
18995,GO:1904760,0.146230007181099,0.992378774245801,1,3,regulation of myofibroblast differentiation,BP,PARP1
2273,GO:0005212,0.146309987971552,0.991453882846213,1,4,structural constituent of eye lens,MF,VIM
19668,GO:1990851,0.146333664873609,0.992367570984454,1,3,Wnt-Frizzled-LRP5/6 complex,CC,FZD8
16053,GO:0086070,0.146358588585441,0.992364875927544,1,3,SA node cell to atrial cardiac muscle cell communication,BP,GJC1
6788,GO:0030219,0.146382053971305,0.939938177561112,5,79,megakaryocyte differentiation,BP,CDKN2B;RUNX1;ABI1;NR4A3;KMT2E
10870,GO:0044389,0.146466549500263,0.90592511410661,17,281,ubiquitin-like protein ligase binding,MF,NFKBIA;JUN;TRAF1;SQSTM1;FZD8;CDKN1A;SMAD3;TRAF4;TRIB1;CEBPB;ABTB2;TP53;IKBKE;UBE2Z;PML;RELA;GSK3B
3242,GO:0006898,0.146491997041559,0.916679614911547,11,164,receptor-mediated endocytosis,BP,CXCL8;VEGFA;DKK1;ADM;TGFBR2;SAA1;TINAGL1;LDLR;CXCL16;NEDD4;CAV1
17518,GO:1900623,0.146568803831011,0.992342124563206,1,3,regulation of monocyte aggregation,BP,NR4A3
17519,GO:1900625,0.146568803831011,0.992342124563206,1,3,positive regulation of monocyte aggregation,BP,NR4A3
6796,GO:0030229,0.146785701055823,0.992318611927518,1,3,very-low-density lipoprotein particle receptor activity,MF,LDLR
10434,GO:0043276,0.146861208895888,0.957805859071213,3,28,anoikis,BP,ITGA5;TLE1;CAV1
3568,GO:0007612,0.147057823086375,0.934203867102446,6,74,learning,BP,BTG2;FOSL1;JUN;DKK1;CREB1;TLR2
17405,GO:1900120,0.147116919215249,0.971461599663485,2,16,regulation of receptor binding,BP,PHLDA2;MMP9
6850,GO:0030314,0.147119305458913,0.992282372171939,1,3,junctional membrane complex,CC,JPH2
2506,GO:0005757,0.14724694398186,0.991340289454882,1,4,mitochondrial permeability transition pore complex,CC,PPIF
19950,GO:2000425,0.147297974006587,0.992262925581971,1,3,regulation of apoptotic cell clearance,BP,ABCA7
11160,GO:0045204,0.147313090940495,0.99226127902337,1,3,MAPK export from nucleus,BP,DUSP16
6288,GO:0019888,0.147319578113565,0.939904494652318,5,61,protein phosphatase regulator activity,MF,PPP1R15A;PPP4R4;ANKLE2;PPP1R3B;SH3RF2
11053,GO:0045026,0.14740675924053,0.971371391379723,2,16,plasma membrane fusion,BP,STX1A;ERVFRD-1
11111,GO:0045117,0.147469297901893,0.971351912066531,2,16,azole transport,BP,CSF2;EDN1
15268,GO:0071425,0.147555964076161,0.971707796358334,2,14,hematopoietic stem cell proliferation,BP,RUNX1;WNT5A
12,GO:0000023,0.147568887952069,0.992233388709384,1,3,maltose metabolic process,BP,MGAM
1882,GO:0004558,0.147568887952069,0.992233388709384,1,3,alpha-1,4-glucosidase activity,MF,MGAM
7887,GO:0032450,0.147568887952069,0.992233388709384,1,3,maltose alpha-glucosidase activity,MF,MGAM
11123,GO:0045137,0.147595831691649,0.918519039655922,10,147,development of primary sexual characteristics,BP,INHBA;EREG;SIX4;ICAM1;VEGFA;CEBPB;ADAMTS1;HMGCS1;WNT5A;BCL2L2
18701,GO:1904031,0.147610438615601,0.957318092380651,3,30,positive regulation of cyclin-dependent protein kinase activity,BP,CDKN1A;CCNL1;PDGFB
1206,GO:0002863,0.147626161761286,0.99129408637889,1,4,positive regulation of inflammatory response to antigenic stimulus,BP,TNF
17382,GO:1900086,0.147645996570448,0.992224970756353,1,3,positive regulation of peptidyl-tyrosine autophosphorylation,BP,VEGFA
10900,GO:0044440,0.147682478125096,0.8985369190787,23,394,endosomal part,CC,PLEKHF1;TICAM1;EHD1;IRAK2;STEAP4;RAP2B;ABCA5;DKK1;ANXA8;SLC11A2;LDLR;MMD;TAB3;CAV1;RHOV;HLA-A;HLA-B;IKBKE;UBE2D3;ABCA7;PML;HLA-F;HLA-E
2017,GO:0004741,0.147720657609854,0.992216815339059,1,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,PDP1
18233,GO:1903011,0.147946149011292,0.992192156454274,1,3,negative regulation of bone development,BP,TJP2
20278,GO:2001205,0.147946149011292,0.992192156454274,1,3,negative regulation of osteoclast development,BP,TJP2
3430,GO:0007219,0.14798352907637,0.921251579872211,9,128,Notch signaling pathway,BP,NFKBIA;ELF3;BMP2;NOD2;IL6ST;DLX2;NRARP;TGFBR2;NOTCH2NL
6904,GO:0030449,0.148025211054238,0.971357451633668,2,15,regulation of complement activation,BP,CD55;CFB
19833,GO:2000257,0.148025211054238,0.971357451633668,2,15,regulation of protein activation cascade,BP,CD55;CFB
14581,GO:0070102,0.148078200834213,0.971546888278144,2,14,interleukin-6-mediated signaling pathway,BP,IL6;IL6ST
1709,GO:0004222,0.14809559954794,0.939596959833901,5,58,metalloendopeptidase activity,MF,ADAM8;ADAMTS1;MMP9;ADAM9;MMP10
5795,GO:0017022,0.14814788421508,0.947101575597639,4,44,myosin binding,MF,GCSAM;SPTBN5;STX1A;AXL
9045,GO:0035258,0.148321196815379,0.933424695053808,6,76,steroid hormone receptor binding,MF,ETS2;SMAD3;CEBPB;NR4A2;NR4A3;PARP1
13572,GO:0060021,0.148525563793014,0.939405295706255,5,57,roof of mouth development,BP,INHBA;TBX3;CSRNP1;TGFBR2;WNT5A
18494,GO:1903579,0.148663147883137,0.971159110660521,2,15,negative regulation of ATP metabolic process,BP,PPIF;PARP1
7081,GO:0030865,0.148730314094529,0.946929081142867,4,42,cortical cytoskeleton organization,BP,TNF;ANLN;RHOV;EPB41L3
6319,GO:0019960,0.148791183573365,0.992099373822492,1,3,C-X3-C chemokine binding,MF,ITGAV
705,GO:0001922,0.148798821911693,0.992098532466563,1,3,B-1 B cell homeostasis,BP,TNFAIP3
15710,GO:0072234,0.148836789569624,0.971312497632285,2,14,metanephric nephron tubule development,BP,LIF;WNT7B
1855,GO:0004515,0.148843901311411,0.992093566031706,1,3,nicotinate-nucleotide adenylyltransferase activity,MF,NMNAT2
12844,GO:0051138,0.148871601011656,0.992090513500957,1,3,positive regulation of NK T cell differentiation,BP,TGFBR2
4801,GO:0010990,0.148988172358397,0.992077660298614,1,3,regulation of SMAD protein complex assembly,BP,PARP1
4602,GO:0010714,0.149147511996888,0.971008146434067,2,15,positive regulation of collagen metabolic process,BP,SUCO;VIM
8217,GO:0032967,0.149147511996888,0.971008146434067,2,15,positive regulation of collagen biosynthetic process,BP,SUCO;VIM
15712,GO:0072236,0.149208641005045,0.992053320670957,1,3,metanephric loop of Henle development,BP,WNT7B
16355,GO:0090596,0.149229921254361,0.917488023127818,10,142,sensory organ morphogenesis,BP,PRDM1;EDN1;EPHA2;SIX4;FJX1;VEGFA;WNT5A;SPRY2;NR4A3;COL8A1
125,GO:0000255,0.149402106090498,0.992031929161874,1,3,allantoin metabolic process,BP,STAT5A
17543,GO:1901020,0.149426836527046,0.970739476355546,2,16,negative regulation of calcium ion transmembrane transporter activity,BP,RRAD;GEM
7166,GO:0031032,0.149749990591825,0.920174654590927,9,123,actomyosin structure organization,BP,SDC4;EDN1;SIX4;PHLDB2;SMAD3;CFLAR;ANLN;SLC9A1;EPB41L3
11473,GO:0045919,0.150150617411798,0.990983157512122,1,4,positive regulation of cytolysis,BP,PGLYRP4
9315,GO:0035770,0.150415223219401,0.913963931018477,11,169,ribonucleoprotein granule,CC,NFKBIZ;NOCT;ZC3H12A;ZFP36;PNRC1;SQSTM1;ZFP36L1;PATL1;DDX3Y;PNRC2;GRB7
9680,GO:0038042,0.150448944982141,0.990946027494216,1,4,dimeric G-protein coupled receptor signaling pathway,BP,ADM
16709,GO:0097646,0.150448944982141,0.990946027494216,1,4,calcitonin family receptor signaling pathway,BP,ADM
12082,GO:0048021,0.150451839953586,0.991915320502235,1,3,regulation of melanin biosynthetic process,BP,WNT5A
13835,GO:0060415,0.150501820149596,0.946062903274372,4,42,muscle tissue morphogenesis,BP,BMP2;WNT5A;NRG1;EGLN1
15555,GO:0071947,0.15054975839775,0.991904396865911,1,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,TNFAIP3
11795,GO:0046645,0.150608014608956,0.991897894125457,1,3,positive regulation of gamma-delta T cell activation,BP,NOD2
16847,GO:0098735,0.151006943009172,0.991853289014244,1,3,positive regulation of the force of heart contraction,BP,SLC9A1
6296,GO:0019902,0.151015558428178,0.916296771026714,10,142,phosphatase binding,MF,PPP1R15A;CTSC;SMAD3;ANKLE2;MASTL;SLC9A1;PTPN1;SH3RF2;TP53;PPP6R3
14106,GO:0060920,0.151227047172327,0.991828622251488,1,3,cardiac pacemaker cell differentiation,BP,TBX3
14110,GO:0060926,0.151227047172327,0.991828622251488,1,3,cardiac pacemaker cell development,BP,TBX3
775,GO:0002027,0.151270258327741,0.945571686491541,4,44,regulation of heart rate,BP,EDN1;GCH1;ADM;CAV1
15178,GO:0071286,0.151342524345905,0.991815664839133,1,3,cellular response to magnesium ion,BP,SLC41A1
1423,GO:0003365,0.151442453700472,0.991804443093189,1,3,establishment of cell polarity involved in ameboidal cell migration,BP,AMOTL2
8663,GO:0034219,0.1515130434359,0.931639596163248,6,74,carbohydrate transmembrane transport,BP,IL1B;TNF;SLC2A6;NFE2L2;NR4A3;PPARD
7100,GO:0030891,0.151567737037607,0.990806053874052,1,4,VCB complex,CC,VHL
17690,GO:1901537,0.151604584700603,0.991786218698646,1,3,positive regulation of DNA demethylation,BP,OTUD4
6794,GO:0030226,0.151619783496959,0.99178450915555,1,3,apolipoprotein receptor activity,MF,ABCA7
9358,GO:0035867,0.151619783496959,0.99178450915555,1,3,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,ITGAV
18840,GO:1904396,0.151619783496959,0.99178450915555,1,3,regulation of neuromuscular junction development,BP,SIX4
7897,GO:0032461,0.151859447084043,0.969971106801518,2,16,positive regulation of protein oligomerization,BP,PMAIP1;TP53
4405,GO:0010138,0.152578697417289,0.990678581225861,1,4,pyrimidine ribonucleotide salvage,BP,UPP1
10764,GO:0044206,0.152578697417289,0.990678581225861,1,4,UMP salvage,BP,UPP1
4898,GO:0014821,0.152655926093728,0.990668804728607,1,4,phasic smooth muscle contraction,BP,EDN1
16540,GO:0097242,0.15290547227812,0.970042043827441,2,14,amyloid-beta clearance,BP,LDLR;ABCA7
13852,GO:0060438,0.1529270925645,0.969819180181157,2,15,trachea development,BP,TGFBR2;WNT7B
12201,GO:0048339,0.153276903245487,0.969924948999162,2,14,paraxial mesoderm development,BP,SMAD3;WNT5A
15942,GO:0072716,0.153348344698321,0.990580904871206,1,4,response to actinomycin D,BP,TP53
13983,GO:0060676,0.153675481490732,0.990539222379567,1,4,ureteric bud formation,BP,SIX4
15668,GO:0072172,0.153675481490732,0.990539222379567,1,4,mesonephric tubule formation,BP,SIX4
7161,GO:0031017,0.153687594981993,0.99053767703059,1,4,exocrine pancreas development,BP,XBP1
19419,GO:1905907,0.1537769774508,0.990526270096292,1,4,negative regulation of amyloid fibril formation,BP,LDLR
3221,GO:0006869,0.154307118646877,0.906840023973352,13,199,lipid transport,BP,IL1B;NFKBIA;INHBA;NFKB1;EDN1;STARD5;C1QTNF1;ABCA5;LDLR;CAV1;ITGAV;ABCA7;PPARD
19871,GO:2000318,0.154390982409879,0.990447711878233,1,4,positive regulation of T-helper 17 type immune response,BP,IL23A
16097,GO:0090050,0.154405499275055,0.969348830806379,2,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,VEGFA;PLK2
11854,GO:0046823,0.154890430021559,0.969002441767604,2,16,negative regulation of nucleocytoplasmic transport,BP,SOX4;NUP153
1054,GO:0002579,0.155631446065909,0.99028793952345,1,4,positive regulation of antigen processing and presentation,BP,NOD2
9615,GO:0036476,0.155769611291792,0.990270055704253,1,4,neuron death in response to hydrogen peroxide,BP,NR4A3
18317,GO:1903207,0.155769611291792,0.990270055704253,1,4,regulation of hydrogen peroxide-induced neuron death,BP,NR4A3
18318,GO:1903208,0.155769611291792,0.990270055704253,1,4,negative regulation of hydrogen peroxide-induced neuron death,BP,NR4A3
11733,GO:0046530,0.155938187340041,0.953974293412178,3,28,photoreceptor cell differentiation,BP,PRDM1;DLX2;VEGFA
18314,GO:1903204,0.155957213169554,0.968851974512926,2,15,negative regulation of oxidative stress-induced neuron death,BP,NCOA7;NR4A3
20087,GO:2000698,0.15614391057519,0.990221518422169,1,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,LIF
7386,GO:0031434,0.156195504573028,0.943250595347815,4,42,mitogen-activated protein kinase kinase binding,MF,EPHA2;TRIB1;AXL;DDR1
11279,GO:0045576,0.156298375757255,0.953630507311251,3,30,mast cell activation,BP,IL4R;ADGRE2;NR4A3
12751,GO:0051001,0.156410655192558,0.99018684913975,1,4,negative regulation of nitric-oxide synthase activity,BP,CAV1
17893,GO:1902117,0.156850261487847,0.934809209297962,5,59,positive regulation of organelle assembly,BP,CSF2;TNF;SDC4;EDN1;CEP135
3755,GO:0008295,0.157218810559623,0.990081409292479,1,4,spermidine biosynthetic process,BP,PAOX
7823,GO:0032372,0.157377554800247,0.99006062681857,1,4,negative regulation of sterol transport,BP,NFKB1
7826,GO:0032375,0.157377554800247,0.99006062681857,1,4,negative regulation of cholesterol transport,BP,NFKB1
6870,GO:0030336,0.157513106514922,0.909130866032817,11,165,negative regulation of cell migration,BP,PHLDB2;RAP2B;NAV3;TRIB1;DUSP10;NRG1;GCSAM;IL24;NFE2L2;CLIC4;PPARD
8930,GO:0034774,0.157624043657222,0.904321032711254,13,222,secretory granule lumen,CC,CXCL1;PTX3;NFKB1;AMPD3;CTSC;VEGFA;CANT1;VEGFC;SERPINB1;PDGFB;CAB39;FRK;COTL1
574,GO:0001714,0.157906158634909,0.989991254531426,1,4,endodermal cell fate specification,BP,DKK1
7470,GO:0031624,0.15792393839068,0.953120960453495,3,28,ubiquitin conjugating enzyme binding,MF,RNF19B;DCUN1D3;RNF144B
16559,GO:0097305,0.158048731531034,0.918276853907811,8,113,response to alcohol,BP,INHBA;BIRC2;CLDN1;ICAM1;TGFBR2;HMGCS1;TNC;TP53
7478,GO:0031638,0.158218229747335,0.952715118648354,3,31,zymogen activation,BP,PLAU;RIPK2;PLAT
7837,GO:0032386,0.15873873014591,0.894164247576324,19,320,regulation of intracellular transport,BP,IL1B;ZC3H12A;EHD1;PLAGL2;CDKN1A;SOX4;NRG1;PLK3;FEZ1;NUP153;IL4R;NEDD4;PTPN1;UGCG;TP53;UBE2D3;STX1A;ADGRE2;GSK3B
1398,GO:0003309,0.158829824317634,0.967923578628896,2,15,type B pancreatic cell differentiation,BP,WNT5A;GSK3B
12281,GO:0048566,0.158982583257742,0.967873896747727,2,15,embryonic digestive tract development,BP,CXCL8;TNF
12749,GO:0050999,0.159009789743764,0.952458379796398,3,30,regulation of nitric-oxide synthase activity,BP,IL1B;GCH1;CAV1
12153,GO:0048246,0.159084541898156,0.96731198092928,2,18,macrophage chemotaxis,BP,CSF1;SAA1
10489,GO:0043380,0.15910058569024,0.989833546138595,1,4,regulation of memory T cell differentiation,BP,IL23A
9395,GO:0035930,0.159544014621991,0.989774659592654,1,4,corticosteroid hormone secretion,BP,C1QTNF1
20170,GO:2000846,0.159544014621991,0.989774659592654,1,4,regulation of corticosteroid hormone secretion,BP,C1QTNF1
13931,GO:0060574,0.159711807982446,0.989752329229291,1,4,intestinal epithelial cell maturation,BP,CDKN1A
13632,GO:0060090,0.159893730815898,0.910275334219462,10,146,molecular adaptor activity,MF,BCL3;TJP2;TP53BP2;SOCS2;ARRDC4;SLC9A1;GRB7;ITSN2;CAV1;STX1A
6596,GO:0022605,0.159933329460111,0.989722808453546,1,4,mammalian oogenesis stage,BP,EREG
4582,GO:0010664,0.160037636836286,0.96752990219033,2,15,negative regulation of striated muscle cell apoptotic process,BP,CFLAR;NFE2L2
17542,GO:1901019,0.160044807079021,0.941146025273955,4,45,regulation of calcium ion transmembrane transporter activity,BP,RRAD;SLC9A1;GEM;JPH2
3268,GO:0006940,0.160131452595692,0.951970555901812,3,30,regulation of smooth muscle contraction,BP,EDN1;CAV1;DOCK4
1157,GO:0002762,0.16030140033347,0.951990820811482,3,29,negative regulation of myeloid leukocyte differentiation,BP,INHBA;TJP2;TRIB1
8731,GO:0034377,0.160340119149826,0.96722939506641,2,16,plasma lipoprotein particle assembly,BP,PLAGL2;ABCA7
4465,GO:0010455,0.160477135314774,0.989650145068065,1,4,positive regulation of cell fate commitment,BP,IL23A
4821,GO:0014012,0.160821717436405,0.98960395935281,1,4,peripheral nervous system axon regeneration,BP,TNC
12404,GO:0048820,0.160857181680994,0.967261659220738,2,15,hair follicle maturation,BP,WNT5A;NOM1
18525,GO:1903670,0.160989123314512,0.940726606020015,4,44,regulation of sprouting angiogenesis,BP,ITGA5;VEGFA;PLK2;SMAD1
12398,GO:0048812,0.161271811066919,0.885413405660115,26,434,neuron projection morphogenesis,BP,EFNA1;EFNB1;NEDD4L;SGK1;VEGFA;ZSWIM4;KLF7;CREB1;NR4A2;SEMA4B;WNT5A;SLC11A2;NRG1;PARD6B;FEZ1;GRB7;NEDD4;ITSN2;WNT7B;SPTBN5;ABI1;EFNB2;RAPH1;NR4A3;DDR1;EPB41L3
10030,GO:0042471,0.161383737740696,0.93227118491199,5,60,ear morphogenesis,BP,EDN1;SIX4;WNT5A;SPRY2;NR4A3
4238,GO:0009416,0.161490736643117,0.899684633030191,14,223,response to light stimulus,BP,BHLHE40;DUSP1;BCL3;N4BP1;CDKN1A;DCUN1D3;CREB1;HMGCS1;NEDD4;TP53;PML;RELA;PARP1;JUND
13064,GO:0051541,0.16157365807459,0.989502789295174,1,4,elastin metabolic process,BP,HBEGF
10831,GO:0044321,0.161696093289891,0.966986141075926,2,15,response to leptin,BP,EDN1;NR4A3
9675,GO:0038033,0.161724894556988,0.989482377411316,1,4,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,VEGFA
19998,GO:2000553,0.161768835028087,0.989476442909154,1,4,positive regulation of T-helper 2 cell cytokine production,BP,IL6
14209,GO:0061101,0.161832625125749,0.989467824352383,1,4,neuroendocrine cell differentiation,BP,BMP2
8310,GO:0033141,0.161891051376168,0.989459927160764,1,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,LIF
13781,GO:0060343,0.161968043571987,0.966896623078908,2,15,trabecula formation,BP,ADAMTS1;EGLN1
12288,GO:0048588,0.162127508329359,0.908796052608009,10,143,developmental cell growth,BP,EDN1;NEDD4L;VEGFA;SEMA4B;TGFBR2;WNT5A;NRG1;ITSN2;RAPH1;DDR1
4492,GO:0010511,0.162542107273419,0.989371711362639,1,4,regulation of phosphatidylinositol biosynthetic process,BP,PDGFB
13519,GO:0055074,0.162630866666375,0.900848625256681,13,205,calcium ion homeostasis,BP,EDN1;BDKRB1;CYP27B1;C1QTNF1;SMAD3;ABL2;CD55;ADM;SAA1;CAV1;ITGAV;JPH2;PML
10744,GO:0044107,0.162779356324016,0.98933946646493,1,4,cellular alcohol metabolic process,BP,CYP27B1
10745,GO:0044108,0.162779356324016,0.98933946646493,1,4,cellular alcohol biosynthetic process,BP,CYP27B1
14256,GO:0061217,0.162883094874506,0.966388287799023,2,16,regulation of mesonephros development,BP,SIX4;VEGFA
12402,GO:0048818,0.163086856760092,0.989297595266707,1,4,positive regulation of hair follicle maturation,BP,WNT5A
3715,GO:0008234,0.163194619921605,0.907985892793357,10,150,cysteine-type peptidase activity,MF,TNFAIP3;ZC3H12A;CYLD;CTSC;CFLAR;USP43;TINAGL1;OTUD4;ESPL1;USP31
15305,GO:0071479,0.16335735840105,0.93106132489666,5,63,cellular response to ionizing radiation,BP,GADD45A;CDKN1A;TNKS1BP1;TP53;RAD9B
18179,GO:1902914,0.163492998722109,0.966392811445563,2,15,regulation of protein polyubiquitination,BP,BIRC2;NOD2
9044,GO:0035257,0.163519197668784,0.911010100057536,9,131,nuclear hormone receptor binding,MF,NCOA7;ETS2;SMAD3;CEBPB;NR4A2;NR4A3;PARP1;MED13;JUND
1025,GO:0002523,0.163586405025258,0.98854526812597,1,5,leukocyte migration involved in inflammatory response,BP,ADAM8
1246,GO:0002943,0.164133369003343,0.989154432497462,1,4,tRNA dihydrouridine synthesis,BP,DUS4L
5857,GO:0017150,0.164133369003343,0.989154432497462,1,4,tRNA dihydrouridine synthase activity,MF,DUS4L
2678,GO:0006029,0.164384817771937,0.930643521929842,5,59,proteoglycan metabolic process,BP,BMP2;DSE;CANT1;HS3ST3B1;PPARD
8830,GO:0034605,0.164508484207166,0.914122339952915,8,113,cellular response to heat,BP,IL1A;CDKN1A;IER5;SLC52A3;NUP153;TP53;GSK3B;HSPA4L
14609,GO:0070161,0.164527495469527,0.882741639230251,26,464,anchoring junction,CC,PLAU;SDC4;PLAUR;EPHA2;PHLDB2;TJP2;ITGA5;ICAM1;FRMD4B;B4GALT1;RND3;LAYN;CDC42EP4;NEDD9;TNC;SLC9A1;TNKS1BP1;CYTH1;GRB7;MARCKS;CAV1;EFNB2;ITGAV;ADAM9;ANXA5;VIM
15612,GO:0072080,0.164612694605449,0.930475450183394,5,60,nephron tubule development,BP,BMP2;LIF;SIX4;VEGFA;WNT7B
10178,GO:0042762,0.164711345928234,0.965988052293249,2,15,regulation of sulfur metabolic process,BP,NFE2L2;PDP1
9289,GO:0035725,0.164883709862449,0.923737809247331,6,76,sodium ion transmembrane transport,BP,NEDD4L;SLC28A3;SLC9A1;NEDD4;SLC9A8;SLC41A1
12660,GO:0050851,0.164909676061767,0.906697753487149,10,161,antigen receptor-mediated signaling pathway,BP,NFKBIA;ZC3H12A;NFKB1;RIPK2;CYLD;RUNX1;GCSAM;BTN2A2;CD276;RELA
3446,GO:0007257,0.165117115918649,0.94998494035548,3,28,activation of JUN kinase activity,BP,WNT5A;PTPN1;WNT7B
17868,GO:1902043,0.165171142977035,0.965834781007011,2,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1;ATF3
6241,GO:0019789,0.165226373094938,0.965605508837063,2,16,SUMO transferase activity,MF,ZNF451;KIAA1586
2404,GO:0005547,0.165251429885006,0.949820233331337,3,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,DAPP1;ANXA8;JPH2
7824,GO:0032373,0.165323452968776,0.965572919463007,2,16,positive regulation of sterol transport,BP,NFKBIA;ABCA7
7827,GO:0032376,0.165323452968776,0.965572919463007,2,16,positive regulation of cholesterol transport,BP,NFKBIA;ABCA7
6017,GO:0019062,0.165617121087345,0.988949696098899,1,4,virion attachment to host cell,BP,ICAM1
10956,GO:0044650,0.165617121087345,0.988949696098899,1,4,adhesion of symbiont to host cell,BP,ICAM1
11215,GO:0045338,0.165763075526781,0.988929444878236,1,4,farnesyl diphosphate metabolic process,BP,HMGCS1
18281,GO:1903121,0.165813807304663,0.988922401143381,1,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,ATF3
2386,GO:0005520,0.166090650733516,0.965314927703779,2,16,insulin-like growth factor binding,MF,WISP1;ITGAV
9798,GO:0040014,0.166492027374591,0.937868741418266,4,45,regulation of multicellular organism growth,BP,CSF1;CREB1;SOCS2;STAT5A
6622,GO:0022840,0.166508098342651,0.988825760903967,1,4,leak channel activity,MF,PANX1
6624,GO:0022842,0.166508098342651,0.988825760903967,1,4,narrow pore channel activity,MF,PANX1
13263,GO:0051926,0.166550656925553,0.949053473755295,3,31,negative regulation of calcium ion transport,BP,ICAM1;RRAD;GEM
11277,GO:0045569,0.166631321718417,0.988808561760418,1,4,TRAIL binding,MF,TNFRSF10B
2610,GO:0005912,0.166950446894628,0.881626335836799,25,447,adherens junction,CC,PLAU;SDC4;PLAUR;EPHA2;PHLDB2;TJP2;ITGA5;ICAM1;FRMD4B;RND3;LAYN;CDC42EP4;NEDD9;TNC;SLC9A1;TNKS1BP1;CYTH1;GRB7;MARCKS;CAV1;EFNB2;ITGAV;ADAM9;ANXA5;VIM
15666,GO:0072170,0.166981572501817,0.96522852829697,2,15,metanephric tubule development,BP,LIF;WNT7B
8451,GO:0033574,0.167167937197596,0.948691649650714,3,32,response to testosterone,BP,EDN1;DUSP1;CFLAR
8846,GO:0034637,0.167640852654947,0.928700213512236,5,62,cellular carbohydrate biosynthetic process,BP,B4GALT1;B3GNT5;PHKG2;PPP1R3B;GSK3B
5852,GO:0017144,0.167713678887197,0.87859332717915,28,536,drug metabolic process,BP,IL1B;TNF;ZC3H12A;BMP2;PTX3;PPIF;EDN1;TICAM1;AMPD3;CYP27B1;GPX3;ICAM1;GCH1;SMAD3;ADM;DSE;NR4A2;SLC7A2;SLC52A3;MAOA;HAL;NUP153;PAOX;STAT5A;CAV1;TLR2;SAT1;PARP1
19723,GO:2000035,0.167767541922403,0.988649298321069,1,4,regulation of stem cell division,BP,EVI2B
15716,GO:0072243,0.167905860750924,0.964917322625575,2,15,metanephric nephron epithelium development,BP,LIF;WNT7B
955,GO:0002371,0.167908146046361,0.988629505382608,1,4,dendritic cell cytokine production,BP,NOD2
1141,GO:0002730,0.167908146046361,0.988629505382608,1,4,regulation of dendritic cell cytokine production,BP,NOD2
3248,GO:0006907,0.167944509977228,0.964688248645354,2,16,pinocytosis,BP,CAV1;AXL
4810,GO:0012505,0.167971110346249,0.855383015739855,156,3169,endomembrane system,CC,IL1B;TNF;PLAU;CXCL1;SDC4;PLEKHF1;ZC3H12A;PPP1R15A;RNF19B;ELF3;PLAUR;EHF;PTX3;NFKB1;EDN1;TICAM1;EHD1;SQSTM1;CSF1;NFKBIE;IL23A;AMPD3;IFNGR2;IL6;ADAM8;BDKRB1;PANX1;IRAK2;FZD8;WTAP;STEAP4;AMOTL2;NMNAT2;ITGA5;GBP2;RAP2B;ABCA5;NAV3;NEDD4L;CTSC;NOD2;TMCC3;SGK1;GCH1;RASSF9;SMAD3;B4GALT1;B3GNT5;RND3;VEGFA;RAB24;FGD6;DKK1;C3ORF52;RNF43;PIGA;ANXA8;VMP1;CD55;TAP1;ANKLE2;CDC42EP4;SLC28A3;IFNAR1;DSE;GORAB;NEDD9;CD47;CANT1;VHL;PDE4DIP;PNRC2;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;DUSP10;SERPINB1;PDGFB;TNC;MMP9;LDLR;COL12A1;CAB39;PLK3;ARRDC4;RASGEF1B;SUCO;SLC9A1;SYS1;FEZ1;B4GALT5;CYTH1;ARSJ;NUP153;NEDD4;MMD;RAET1L;NFE2L2;PTPN1;WNT7B;SMAD1;SGMS2;TAB3;TPST1;CAV1;RHOV;HLA-A;NECAP2;UGCG;GOLGA8B;TP53;TLR2;ABI1;TAPBP;RAB9A;HLA-B;ITGAV;IKBKE;UBE2D3;PJA2;STX1A;DOCK4;TRIP10;JPH2;ABCA7;SPCS2;TMEM132A;SDR16C5;ZNF148;HS3ST3B1;PML;MAMDC2;ESCO2;SLC9A8;PPP6R3;COL27A1;PLAT;CHST2;MUC1;SLC16A13;AKIRIN1;FRK;HLA-F;HLA-E;PARP1;LAMA3;TBC1D22B;COTL1;COL8A1;XBP1;MGAM;LMAN1;GJC1
6438,GO:0021700,0.168155919382695,0.90460533119711,10,149,developmental maturation,BP,BMP2;EREG;CDKN1A;VEGFA;NR4A2;WNT5A;POU2F2;NOM1;AXL;XBP1
11022,GO:0044854,0.1682206420954,0.988585448382082,1,4,plasma membrane raft assembly,BP,CAV1
11025,GO:0044857,0.1682206420954,0.988585448382082,1,4,plasma membrane raft organization,BP,CAV1
11848,GO:0046790,0.168230058720259,0.988584119358206,1,4,virion binding,MF,PTX3
748,GO:0001976,0.168263069137711,0.988579459742847,1,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,SOD2
4609,GO:0010721,0.168313527250104,0.896774458216517,13,202,negative regulation of cell development,BP,EFNA1;TJP2;DLX2;PLK2;SEMA4B;WNT5A;DUSP10;NRG1;LDLR;EFNB2;GSK3B;VIM;KCTD11
4395,GO:0010046,0.168527629682353,0.988542078343068,1,4,response to mycotoxin,BP,PDGFB
2618,GO:0005925,0.168528370189632,0.885380166692588,20,355,focal adhesion,CC,PLAU;SDC4;PLAUR;EPHA2;PHLDB2;ITGA5;ICAM1;RND3;LAYN;NEDD9;TNC;SLC9A1;GRB7;MARCKS;CAV1;EFNB2;ITGAV;ADAM9;ANXA5;VIM
3269,GO:0006941,0.168889893163442,0.921257579444896,6,79,striated muscle contraction,BP,ZC3H12A;MAP2K3;NEDD4L;SLC9A1;CAV1;GJC1
1328,GO:0003176,0.168892572431722,0.98849040497146,1,4,aortic valve development,BP,EFNA1
1331,GO:0003180,0.168892572431722,0.98849040497146,1,4,aortic valve morphogenesis,BP,EFNA1
3189,GO:0006813,0.168907794153801,0.915840100298364,7,94,potassium ion transport,BP,NEDD4L;KCNJ15;CAB39;SLC9A1;NEDD4;CAV1;SLC9A8
9389,GO:0035924,0.168927841585552,0.948085763874892,3,30,cellular response to vascular endothelial growth factor stimulus,BP,MAP2K3;VEGFA;CCBE1
8282,GO:0033083,0.169423886201589,0.988414949897209,1,4,regulation of immature T cell proliferation,BP,RIPK2
16047,GO:0086064,0.169486440290153,0.964163497879583,2,16,cell communication by electrical coupling involved in cardiac conduction,BP,CAV1;GJC1
10007,GO:0042420,0.169506676756979,0.988403168306737,1,4,dopamine catabolic process,BP,MAOA
7471,GO:0031625,0.169541774853018,0.890184660458393,16,268,ubiquitin protein ligase binding,MF,NFKBIA;JUN;TRAF1;SQSTM1;FZD8;CDKN1A;SMAD3;TRAF4;TRIB1;ABTB2;TP53;IKBKE;UBE2Z;PML;RELA;GSK3B
18194,GO:1902949,0.169601682231096,0.988389640482472,1,4,positive regulation of tau-protein kinase activity,BP,DKK1
11483,GO:0045931,0.169636756652615,0.910757171875838,8,115,positive regulation of mitotic cell cycle,BP,IL1B;IL1A;EDN1;EREG;TGFA;PDGFB;ESPL1;KMT2E
14545,GO:0070044,0.169652987248477,0.988382331618137,1,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,STX1A
695,GO:0001912,0.169704613282745,0.963896480097806,2,17,positive regulation of leukocyte mediated cytotoxicity,BP,IL23A;HLA-E
9768,GO:0039529,0.169734959481575,0.964298101978093,2,15,RIG-I signaling pathway,BP,BIRC3;BIRC2
7754,GO:0032264,0.170041968708104,0.988326836767849,1,4,IMP salvage,BP,AMPD3
10340,GO:0043130,0.170168468499692,0.927163291743786,5,65,ubiquitin binding,MF,TNFAIP3;SQSTM1;BIRC2;SMAD3;NEDD4
15701,GO:0072215,0.170329594233059,0.963875206270248,2,16,regulation of metanephros development,BP,LIF;PDGFB
12414,GO:0048846,0.170654535417375,0.947523231374059,3,28,axon extension involved in axon guidance,BP,VEGFA;SEMA4B;WNT5A
17958,GO:1902284,0.170654535417375,0.947523231374059,3,28,neuron projection extension involved in neuron projection guidance,BP,VEGFA;SEMA4B;WNT5A
10336,GO:0043125,0.170885910295844,0.988205942140758,1,4,ErbB-3 class receptor binding,MF,NRG1
18367,GO:1903321,0.170946125381073,0.92665371443942,5,67,negative regulation of protein modification by small protein conjugation or removal,BP,TNFAIP3;N4BP1;SOX4;CAV1;RELA
19558,GO:1990441,0.170952223000769,0.988196414289422,1,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,JUN
14571,GO:0070091,0.170960166467682,0.988195272687891,1,4,glucagon secretion,BP,IL6
15853,GO:0072553,0.171005213206076,0.988188797630935,1,4,terminal button organization,BP,CHD4
2617,GO:0005924,0.171196364711513,0.883304033847887,20,356,cell-substrate adherens junction,CC,PLAU;SDC4;PLAUR;EPHA2;PHLDB2;ITGA5;ICAM1;RND3;LAYN;NEDD9;TNC;SLC9A1;GRB7;MARCKS;CAV1;EFNB2;ITGAV;ADAM9;ANXA5;VIM
13908,GO:0060536,0.1712163345275,0.988158425267413,1,4,cartilage morphogenesis,BP,WNT7B
4936,GO:0014891,0.171351158229354,0.988139007157371,1,4,striated muscle atrophy,BP,CFLAR
3122,GO:0006701,0.171426884450623,0.988128093066212,1,4,progesterone biosynthetic process,BP,ADM
4233,GO:0009409,0.171636441459162,0.946772464048009,3,31,response to cold,BP,NFKBIA;ADM;SLC9A1
19094,GO:1904956,0.171775079092952,0.988077839359309,1,4,regulation of midbrain dopaminergic neuron differentiation,BP,DKK1
8256,GO:0033031,0.171780157520692,0.988077105557616,1,4,positive regulation of neutrophil apoptotic process,BP,HCAR2
1552,GO:0003945,0.171841242062462,0.988068277300171,1,4,N-acetyllactosamine synthase activity,MF,B4GALT1
1085,GO:0002666,0.172262619067357,0.988007281317829,1,4,positive regulation of T cell tolerance induction,BP,TGFBR2
9370,GO:0035883,0.172319923432766,0.963190893578379,2,16,enteroendocrine cell differentiation,BP,WNT5A;GSK3B
14314,GO:0061428,0.172421456887444,0.987984245214562,1,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,VHL
11121,GO:0045134,0.172908176696323,0.987913507609356,1,4,uridine-diphosphatase activity,MF,CANT1
11389,GO:0045746,0.173045242122759,0.946043684719283,3,32,negative regulation of Notch signaling pathway,BP,NFKBIA;DLX2;NRARP
1294,GO:0003104,0.173121624934157,0.987882415091378,1,4,positive regulation of glomerular filtration,BP,PDGFB
4305,GO:0009750,0.173146349059746,0.987878810788253,1,4,response to fructose,BP,XBP1
13251,GO:0051901,0.173215060960729,0.987100702718602,1,5,positive regulation of mitochondrial depolarization,BP,PARP1
1293,GO:0003100,0.173247179506993,0.987864105631331,1,4,regulation of systemic arterial blood pressure by endothelin,BP,EDN1
10729,GO:0044062,0.173248268403589,0.98786394677346,1,4,regulation of excretion,BP,EDN1
3749,GO:0008287,0.173434415374142,0.934219941957054,4,46,protein serine/threonine phosphatase complex,CC,PPP1R15A;IER5;PPP4R4;PPP1R3B
18349,GO:1903293,0.173434415374142,0.934219941957054,4,46,phosphatase complex,CC,PPP1R15A;IER5;PPP4R4;PPP1R3B
9804,GO:0040020,0.17344851037031,0.962800508267773,2,16,regulation of meiotic nuclear division,BP,LIF;WNT5A
14281,GO:0061326,0.173504673936352,0.925421783912318,5,61,renal tubule development,BP,BMP2;LIF;SIX4;VEGFA;WNT7B
19698,GO:1990966,0.173601455122577,0.987812361327796,1,4,ATP generation from poly-ADP-D-ribose,BP,PARP1
10286,GO:0043028,0.173604743678926,0.94578919509461,3,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,BIRC3;BIRC2;TNFAIP8
16588,GO:0097368,0.173667095892552,0.987802760960798,1,4,establishment of Sertoli cell barrier,BP,ICAM1
680,GO:0001887,0.173705348769838,0.987797164352998,1,4,selenium compound metabolic process,BP,TXNRD1
14047,GO:0060762,0.173850849455037,0.987775864088374,1,4,regulation of branching involved in mammary gland duct morphogenesis,BP,WNT5A
1290,GO:0003096,0.173888503620392,0.987770348508089,1,4,renal sodium ion transport,BP,SGK1
4900,GO:0014824,0.173899671401407,0.987768712392856,1,4,artery smooth muscle contraction,BP,EDN1
16008,GO:0086005,0.173942972003402,0.962856572038036,2,15,ventricular cardiac muscle cell action potential,BP,NEDD4L;CAV1
15275,GO:0071438,0.17397184504028,0.987758135866624,1,4,invadopodium membrane,CC,PLAUR
12650,GO:0050829,0.174047260865447,0.961674790859479,2,22,defense response to Gram-negative bacterium,BP,IL23A;IL6
2533,GO:0005787,0.174097992040982,0.986963600859046,1,5,signal peptidase complex,CC,SPCS2
8234,GO:0032994,0.174226730173524,0.962153062983205,2,18,protein-lipid complex,CC,SAA1;LDLR
11458,GO:0045900,0.174249488173315,0.987717403080904,1,4,negative regulation of translational elongation,BP,CPEB2
10203,GO:0042805,0.174347138505405,0.962716875517713,2,15,actinin binding,MF,NFKB1;RELA
18592,GO:1903817,0.174350305756256,0.987702594071023,1,4,negative regulation of voltage-gated potassium channel activity,BP,CAV1
4857,GO:0014066,0.17458468244513,0.924765348990441,5,62,regulation of phosphatidylinositol 3-kinase signaling,BP,IER3;PDGFB;NRG1;NEDD4;PPARD
12493,GO:0050431,0.174879658915622,0.96253248268678,2,15,transforming growth factor beta binding,MF,TGFBR2;ITGAV
11027,GO:0044860,0.174903277330905,0.987621196499132,1,4,protein localization to plasma membrane raft,BP,CAV1
4842,GO:0014045,0.174988497103184,0.987608626233547,1,4,establishment of endothelial blood-brain barrier,BP,WNT7B
6567,GO:0022009,0.174988497103184,0.987608626233547,1,4,central nervous system vasculogenesis,BP,WNT7B
11463,GO:0045907,0.175060072526256,0.962240106843916,2,16,positive regulation of vasoconstriction,BP,ICAM1;CAV1
19508,GO:1990254,0.175420642003937,0.987544776597384,1,4,keratin filament binding,MF,VIM
8086,GO:0032762,0.175607471329199,0.98751711736459,1,4,mast cell cytokine production,BP,NR4A3
8087,GO:0032763,0.175607471329199,0.98751711736459,1,4,regulation of mast cell cytokine production,BP,NR4A3
3334,GO:0007045,0.175726683808924,0.924196305784541,5,60,cell-substrate adherens junction assembly,BP,SDC4;PHLDB2;SMAD3;VEGFA;SLC9A1
12097,GO:0048041,0.175726683808924,0.924196305784541,5,60,focal adhesion assembly,BP,SDC4;PHLDB2;SMAD3;VEGFA;SLC9A1
11131,GO:0045159,0.17601763376984,0.987456277944342,1,4,myosin II binding,MF,GCSAM
17859,GO:1902023,0.176175937385614,0.98743275384154,1,4,L-arginine transport,BP,SLC7A2
13719,GO:0060261,0.176212962813396,0.961633468683665,2,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,CREB1;TP53
13786,GO:0060350,0.17633175890927,0.944735385610499,3,30,endochondral bone morphogenesis,BP,TGFBR2;NAB1;COL27A1
14509,GO:0061971,0.17633175890927,0.944735385610499,3,30,replacement bone morphogenesis,BP,TGFBR2;NAB1;COL27A1
6820,GO:0030274,0.176340331998871,0.987408299299728,1,4,LIM domain binding,MF,RIPK2
9474,GO:0036091,0.17635341551016,0.987406351952312,1,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,NFE2L2
3615,GO:0008063,0.176398360993463,0.987399661030164,1,4,Toll signaling pathway,BP,PELI1
19759,GO:2000107,0.176474638517758,0.944477262550738,3,32,negative regulation of leukocyte apoptotic process,BP,EFNA1;NOD2;AXL
18237,GO:1903018,0.176500173058301,0.94446554060128,3,32,regulation of glycoprotein metabolic process,BP,HBEGF;PTX3;ABCA7
6900,GO:0030430,0.176584961093877,0.987371861716183,1,4,host cell cytoplasm,CC,LMAN1
8496,GO:0033655,0.176584961093877,0.987371861716183,1,4,host cell cytoplasm part,CC,LMAN1
8617,GO:0034127,0.17660910831362,0.987368261881928,1,4,regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
15226,GO:0071362,0.176747475735562,0.987347623521393,1,4,cellular response to ether,BP,ZC3H12A
3508,GO:0007417,0.176805740500302,0.867957262729343,33,587,central nervous system development,BP,BTG2;INHBA;BMP2;LIF;TBX3;KDM6B;ETS1;IL6ST;DLX2;B3GNT5;DKK1;ANKLE2;CREB1;NR4A2;TGFBR2;HMGCS1;WNT5A;DUSP10;SOX4;NRG1;SLC38A2;LDLR;FEZ1;WNT7B;SMAD1;TLR2;ZNF148;AXL;NR4A3;GSK3B;KDM7A;VIM;RPS6KA6
4798,GO:0010986,0.176849363338076,0.987332414663907,1,4,positive regulation of lipoprotein particle clearance,BP,LDLR
6646,GO:0023029,0.177008330628969,0.987308665663551,1,4,MHC class Ib protein binding,MF,TAP1
3535,GO:0007528,0.177164627836049,0.944461307930287,3,29,neuromuscular junction development,BP,SIX4;TNC;NEDD4
5994,GO:0018958,0.177252947524294,0.932159451049982,4,47,phenol-containing compound metabolic process,BP,GCH1;NR4A2;WNT5A;MAOA
95,GO:0000185,0.17725974948263,0.961469598133594,2,16,activation of MAPKKK activity,BP,TNF;GADD45A
10521,GO:0043426,0.177420723314785,0.987246943474597,1,4,MRF binding,MF,BHLHE40
12377,GO:0048752,0.177491370779472,0.987236353466511,1,4,semicircular canal morphogenesis,BP,NR4A3
12217,GO:0048386,0.17758785738565,0.987221882479093,1,4,positive regulation of retinoic acid receptor signaling pathway,BP,TRIM16
18819,GO:1904352,0.177612709547186,0.987218153729186,1,4,positive regulation of protein catabolic process in the vacuole,BP,LDLR
18678,GO:1903978,0.177679386570107,0.987208146774146,1,4,regulation of microglial cell activation,BP,LDLR
10168,GO:0042749,0.177765126011159,0.986385771749357,1,5,regulation of circadian sleep/wake cycle,BP,CSF2
11150,GO:0045187,0.177765126011159,0.986385771749357,1,5,regulation of circadian sleep/wake cycle, sleep,BP,CSF2
16762,GO:0098528,0.177780727421008,0.987192929294545,1,4,skeletal muscle fiber differentiation,BP,SIX4
880,GO:0002230,0.177859819595034,0.961051839420935,2,17,positive regulation of defense response to virus by host,BP,ZC3H12A;IL23A
998,GO:0002457,0.177939898682092,0.987169008090139,1,4,T cell antigen processing and presentation,BP,ICAM1
18477,GO:1903553,0.178082826426027,0.987147507403003,1,4,positive regulation of extracellular exosome assembly,BP,SDC4
5841,GO:0017124,0.178083031400116,0.909982606022501,7,96,SH3 domain binding,MF,TP53BP2;ERRFI1;ABI1;DOCK4;ADAM9;CRB3;QKI
8057,GO:0032713,0.178328170758286,0.987110554558524,1,4,negative regulation of interleukin-4 production,BP,CD83
14982,GO:0070876,0.178542671573369,0.987078200036599,1,4,SOSS complex,CC,NABP1
9738,GO:0038189,0.178923694438245,0.987020619279446,1,4,neuropilin signaling pathway,BP,VEGFA
7279,GO:0031256,0.179219508852905,0.904511451569727,8,112,leading edge membrane,CC,EPHA2;ITGA5;NRG1;SPRY2;ITGAV;ABCA7;ADGRE2;EPB41L3
15098,GO:0071072,0.179229951131956,0.986974236463237,1,4,negative regulation of phospholipid biosynthetic process,BP,PDGFB
11234,GO:0045359,0.179367908608884,0.986953313324129,1,4,positive regulation of interferon-beta biosynthetic process,BP,TICAM1
18568,GO:1903763,0.179375221522155,0.986952203711492,1,4,gap junction channel activity involved in cell communication by electrical coupling,MF,GJC1
13940,GO:0060586,0.179406465388188,0.986947462398309,1,4,multicellular organismal iron ion homeostasis,BP,SLC11A2
7517,GO:0031698,0.179557425028877,0.986924540811712,1,4,beta-2 adrenergic receptor binding,MF,NEDD4
13651,GO:0060136,0.179579838398644,0.986921135720879,1,4,embryonic process involved in female pregnancy,BP,JUNB
6367,GO:0021544,0.179662458176602,0.960620598520178,2,16,subpallium development,BP,INHBA;DLX2
1002,GO:0002468,0.179712869502852,0.986900915411113,1,4,dendritic cell antigen processing and presentation,BP,NOD2
1066,GO:0002604,0.179712869502852,0.986900915411113,1,4,regulation of dendritic cell antigen processing and presentation,BP,NOD2
7584,GO:0031944,0.179748109817522,0.986895556149775,1,4,negative regulation of glucocorticoid metabolic process,BP,BMP2
7587,GO:0031947,0.179748109817522,0.986895556149775,1,4,negative regulation of glucocorticoid biosynthetic process,BP,BMP2
16086,GO:0090032,0.179748109817522,0.986895556149775,1,4,negative regulation of steroid hormone biosynthetic process,BP,BMP2
10734,GO:0044087,0.179757271484188,0.8632920856886,37,668,regulation of cellular component biogenesis,BP,CSF2;TNF;SDC4;FOSL1;PMAIP1;EDN1;JUN;EPHA2;BIRC2;SIX4;PHLDB2;CYLD;CLDN1;ZNF451;NAV3;ICAM1;SMAD3;VEGFA;DKK1;PLK2;CDC42EP4;CREB1;RUNX1;WNT5A;ANLN;SLC9A1;FEZ1;SPTBN5;CAV1;TP53;TLR2;STX1A;GSK3B;PARP1;OCLN;JMY;CEP135
14040,GO:0060750,0.179863611696961,0.986877982552606,1,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,WNT5A
20323,GO:2001286,0.17996776337061,0.986862124911936,1,4,regulation of caveolin-mediated endocytosis,BP,NEDD4L
11759,GO:0046596,0.18006267579323,0.959916590736349,2,19,regulation of viral entry into host cell,BP,PTX3;TRIM25
14612,GO:0070164,0.180074424217905,0.986845874446621,1,4,negative regulation of adiponectin secretion,BP,IL1B
8745,GO:0034392,0.180108465642616,0.986840685718219,1,4,negative regulation of smooth muscle cell apoptotic process,BP,EDN1
12927,GO:0051260,0.18017544656692,0.8880257284973,13,215,protein homooligomerization,BP,SOD2;EHD1;C1QTNF1;CLDN1;GPX3;GCH1;B4GALT1;MARCKS;SPTBN5;CAV1;TP53;IKBKE;KCTD11
3126,GO:0006705,0.180280131273245,0.986814502814966,1,4,mineralocorticoid biosynthetic process,BP,BMP2
3704,GO:0008212,0.180280131273245,0.986814502814966,1,4,mineralocorticoid metabolic process,BP,BMP2
7797,GO:0032341,0.180280131273245,0.986814502814966,1,4,aldosterone metabolic process,BP,BMP2
7798,GO:0032342,0.180280131273245,0.986814502814966,1,4,aldosterone biosynthetic process,BP,BMP2
7799,GO:0032344,0.180280131273245,0.986814502814966,1,4,regulation of aldosterone metabolic process,BP,BMP2
7802,GO:0032347,0.180280131273245,0.986814502814966,1,4,regulation of aldosterone biosynthetic process,BP,BMP2
13966,GO:0060633,0.180287511619894,0.986813376510324,1,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,ZNF451
19777,GO:2000143,0.180287511619894,0.986813376510324,1,4,negative regulation of DNA-templated transcription, initiation,BP,ZNF451
11735,GO:0046533,0.180396323202614,0.986796764852927,1,4,negative regulation of photoreceptor cell differentiation,BP,DLX2
8064,GO:0032727,0.180445445240738,0.96034226829862,2,16,positive regulation of interferon-alpha production,BP,RIPK2;IFIH1
3220,GO:0006868,0.180644514126436,0.986758832380717,1,4,glutamine transport,BP,SLC38A2
5026,GO:0015186,0.180644514126436,0.986758832380717,1,4,L-glutamine transmembrane transporter activity,MF,SLC38A2
18323,GO:1903224,0.180684152006056,0.986752768811767,1,4,regulation of endodermal cell differentiation,BP,DKK1
18597,GO:1903826,0.180876591709186,0.986723309065548,1,4,arginine transmembrane transport,BP,SLC7A2
9953,GO:0042311,0.180899887033211,0.959781398644946,2,18,vasodilation,BP,SOD2;GCH1
18561,GO:1903753,0.181288852374046,0.986660078092352,1,4,negative regulation of p38MAPK cascade,BP,DUSP10
5315,GO:0016020,0.181326471700719,0.84078789369493,273,5743,membrane,CC,NFKBIA;TNF;HBEGF;PLAU;EFNA1;SDC4;BIRC3;PLEKHF1;FOSL1;ZC3H12A;IL16;PPP1R15A;RNF19B;BMP2;PLAUR;CD83;SOD2;PMAIP1;IL1RN;IER3;PPIF;HCAR3;MAP2K3;SERPINB2;TICAM1;IFNAR2;EPHA2;GPR156;EHD1;HCAR2;CSF1;SPRR2D;EREG;BCL3;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ADAM8;TNFRSF10B;BDKRB1;PANX1;TNFSF15;CYP27B1;IRAK2;PHLDA2;DAPP1;PHLDB2;CYLD;FZD8;BAMBI;WTAP;TJP2;STEAP4;C1QTNF1;AMOTL2;CLDN1;NMNAT2;ITGA5;GBP2;RAP2B;ABCA5;IL7R;NAV3;NEDD4L;CTSC;NOD2;IL6ST;DCUN1D3;RELT;TMCC3;SGK1;ICAM1;GCH1;RASSF9;SMAD3;B4GALT1;B3GNT5;RNF144B;RND3;MARCKSL1;TM4SF1;NINJ1;TRAF4;VEGFA;RAB24;IL1R2;SLC6A14;DKK1;ABL2;C3ORF52;CDV3;CFLAR;RNF43;PIGA;ANXA8;TMEM217;LAYN;VMP1;CD55;KCNJ15;TAP1;TMEM106A;ANKLE2;HEPHL1;GJB3;CDC42EP4;SLC28A3;IFNAR1;DSE;ERRFI1;GJB4;NEDD9;NIPAL4;SLC7A2;CD47;CANT1;VHL;SEMA4B;TGFBR2;MREG;SMURF2;DDX3Y;GPBP1;TMEM265;IFNGR1;MASTL;ITGB8;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;SLC52A3;ROBO4;SERPINB1;PDGFB;PGLYRP4;CD82;EFHD2;NRG1;TNC;SLC38A2;TMEM154;LDLR;DCBLD2;RRAD;FAM83B;IL32;TRAF3IP3;RHD;ARRDC4;PARD6B;TRPV3;FAM57A;SUCO;SLC9A1;SLC25A37;SYS1;MAOA;SPRY2;FEZ1;B4GALT5;CYTH1;GRB7;CXCL16;NUP153;BCL2L2;RNF152;IL4R;NEDD4;MMD;RHCG;SLC2A6;GCSAM;TNFRSF6B;MARCKS;RAET1L;BTN2A2;NFE2L2;PTPN1;WNT7B;SMAD1;SGMS2;TAB3;SPTBN5;CHD4;SUSD6;TPRA1;CLIC4;TPST1;CAV1;RHOV;CACFD1;HLA-A;DRAM1;NECAP2;UGCG;GOLGA8B;TLR2;ABI1;TAPBP;EFNB2;RAB9A;HLA-B;ITGAV;PRRG1;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;JPH2;SPRR2A;ABCA7;SPCS2;TMEM132A;ADGRE2;SDR16C5;HS3ST3B1;PML;POLR3A;PIM1;ADAM9;SLC43A3;RAPH1;TRIM16;MAMDC2;EMP3;SLC9A8;PPP6R3;EVI2B;TSPAN13;CHST2;MUC1;AXL;SLC16A13;ANXA5;THSD1;AKIRIN1;CRB3;FRK;HLA-F;HLA-E;GSK3B;KMT2E;OSMR;SLC16A1;EVC;PARP1;CYP24A1;MED13;LCE1C;OCLN;VIM;CLDND1;RIPK4;RNF145;DDR1;XBP1;EPB41L3;SLC39A14;ERVFRD-1;MGAM;LMAN1;CFB;SLC41A1;GJC1
3502,GO:0007406,0.181359677095097,0.986649198817704,1,4,negative regulation of neuroblast proliferation,BP,KCTD11
4712,GO:0010871,0.18145884944267,0.98663395700126,1,4,negative regulation of receptor biosynthetic process,BP,ITGAV
19211,GO:1905276,0.181531595069875,0.959954821546772,2,16,regulation of epithelial tube formation,BP,SIX4;WNT5A
13222,GO:0051851,0.181663319470524,0.92970967064404,4,49,modification by host of symbiont morphology or physiology,BP,ZC3H12A;PTX3;JUN;RAB9A
3837,GO:0008440,0.181728496142283,0.986592467115167,1,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,ITPKC
8289,GO:0033093,0.181991524674935,0.986551928137654,1,4,Weibel-Palade body,CC,EDN1
7788,GO:0032309,0.182060204715452,0.959551952496518,2,17,icosanoid secretion,BP,IL1B;EDN1
5176,GO:0015727,0.182635468603733,0.986452399825075,1,4,lactate transport,BP,SLC16A1
9364,GO:0035873,0.182635468603733,0.986452399825075,1,4,lactate transmembrane transport,BP,SLC16A1
12150,GO:0048243,0.182838120955644,0.986420995126847,1,4,norepinephrine secretion,BP,STX1A
20118,GO:2000757,0.182842229964741,0.959270104273023,2,17,negative regulation of peptidyl-lysine acetylation,BP,ZNF451;SDR16C5
17351,GO:1900019,0.182848421935203,0.986419397744012,1,4,regulation of protein kinase C activity,BP,WNT5A
17352,GO:1900020,0.182848421935203,0.986419397744012,1,4,positive regulation of protein kinase C activity,BP,WNT5A
19574,GO:1990511,0.182915803120864,0.98640894635569,1,4,piRNA biosynthetic process,BP,MYBL1
16240,GO:0090276,0.182965330174958,0.90191334313203,8,118,regulation of peptide hormone secretion,BP,IL1B;TNF;PIM3;SOX4;MARCKS;STX1A;PPARD;SLC16A1
19895,GO:2000348,0.183028967034973,0.986391383832786,1,4,regulation of CD40 signaling pathway,BP,TNFAIP3
6011,GO:0019049,0.183086943457819,0.986382381373229,1,4,evasion or tolerance of host defenses by virus,BP,SMAD3
10879,GO:0044413,0.183086943457819,0.986382381373229,1,4,avoidance of host defenses,BP,SMAD3
10881,GO:0044415,0.183086943457819,0.986382381373229,1,4,evasion or tolerance of host defenses,BP,SMAD3
13217,GO:0051832,0.183086943457819,0.986382381373229,1,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,SMAD3
13219,GO:0051834,0.183086943457819,0.986382381373229,1,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,SMAD3
18600,GO:1903829,0.183189344658344,0.878195740285614,17,288,positive regulation of cellular protein localization,BP,IL1B;TNF;ZC3H12A;LIF;PMAIP1;EPHA2;SQSTM1;BBC3;PLAGL2;CYLD;TP53BP2;NRG1;PLK3;UGCG;TP53;UBE2D3;GSK3B
18038,GO:1902525,0.183275392827751,0.985491952112704,1,5,regulation of protein monoubiquitination,BP,BIRC2
11217,GO:0045341,0.183356197305143,0.986340529704417,1,4,MHC class I biosynthetic process,BP,PML
11219,GO:0045343,0.183356197305143,0.986340529704417,1,4,regulation of MHC class I biosynthetic process,BP,PML
11220,GO:0045345,0.183356197305143,0.986340529704417,1,4,positive regulation of MHC class I biosynthetic process,BP,PML
12203,GO:0048341,0.18338674187152,0.986335777570958,1,4,paraxial mesoderm formation,BP,WNT5A
11012,GO:0044828,0.183391072146013,0.986335103792614,1,4,negative regulation by host of viral genome replication,BP,ZC3H12A
13528,GO:0055085,0.183436130505806,0.856228253584604,46,875,transmembrane transport,BP,IL1B;TNF;PPIF;BDKRB1;PANX1;STEAP4;ABCA5;NEDD4L;SGK1;SLC6A14;KCNJ15;TAP1;GJB3;SLC28A3;NIPAL4;SLC7A2;SLC11A2;ABCF1;SLC38A2;MMP9;RRAD;CAB39;RHD;TRPV3;SLC9A1;SLC25A37;NEDD4;RHCG;SLC2A6;NFE2L2;CLIC4;CAV1;ITGAV;GEM;JPH2;ABCA7;SLC43A3;SLC9A8;TSPAN13;SLC16A13;NR4A3;PPARD;SLC16A1;SLC39A14;SLC41A1;GJC1
16967,GO:0098957,0.183778930969355,0.986274680677121,1,4,anterograde axonal transport of mitochondrion,BP,FEZ1
9158,GO:0035509,0.183812432840209,0.986269454730306,1,4,negative regulation of myosin-light-chain-phosphatase activity,BP,TNF
18374,GO:1903347,0.183812432840209,0.986269454730306,1,4,negative regulation of bicellular tight junction assembly,BP,TNF
8629,GO:0034144,0.183817916630671,0.986268599212281,1,4,negative regulation of toll-like receptor 4 signaling pathway,BP,TNFAIP3
9770,GO:0039531,0.183890380357026,0.959108004825564,2,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,BIRC3;BIRC2
6846,GO:0030307,0.184095154500834,0.901141999130205,8,119,positive regulation of cell growth,BP,HBEGF;EDN1;NEDD4L;VEGFA;NRG1;SLC9A1;CXCL16;ITSN2
2421,GO:0005593,0.184269273237708,0.986198084184241,1,4,FACIT collagen trimer,CC,COL12A1
1415,GO:0003348,0.184283090856949,0.986195922366285,1,4,cardiac endothelial cell differentiation,BP,NRG1
14121,GO:0060956,0.184283090856949,0.986195922366285,1,4,endocardial cell differentiation,BP,NRG1
3171,GO:0006783,0.1843072147441,0.958547415694549,2,18,heme biosynthetic process,BP,SLC11A2;ALAS1
14647,GO:0070212,0.184322120301111,0.986189815068173,1,4,protein poly-ADP-ribosylation,BP,PARP1
11349,GO:0045664,0.184384408263938,0.868622383680677,24,409,regulation of neuron differentiation,BP,EFNA1;BMP2;NEDD4L;DLX2;VEGFA;DKK1;ZSWIM4;PLK2;ABL2;CFLAR;SEMA4B;TGIF2;WNT5A;SOCS2;NRG1;FEZ1;NEDD4;MMD;ITSN2;NFE2L2;EFNB2;GSK3B;VIM;KCTD11
16425,GO:0097048,0.184488057425252,0.986163832920769,1,4,dendritic cell apoptotic process,BP,AXL
20070,GO:2000668,0.184488057425252,0.986163832920769,1,4,regulation of dendritic cell apoptotic process,BP,AXL
16335,GO:0090521,0.184491896478494,0.986163231493557,1,4,glomerular visceral epithelial cell migration,BP,ANLN
4955,GO:0015015,0.184580331374398,0.986149373313621,1,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,HS3ST3B1
19992,GO:2000542,0.184824382628215,0.986111090074409,1,4,negative regulation of gastrulation,BP,DKK1
19825,GO:2000243,0.184973970143799,0.940527877159765,3,32,positive regulation of reproductive process,BP,INHBA;SMURF2;WNT5A
14247,GO:0061196,0.185047316574738,0.986076069085114,1,4,fungiform papilla development,BP,SIX4
14248,GO:0061197,0.185047316574738,0.986076069085114,1,4,fungiform papilla morphogenesis,BP,SIX4
13944,GO:0060592,0.185099561236613,0.986067854949941,1,4,mammary gland formation,BP,TBX3
6601,GO:0022614,0.185143362893813,0.986060966226375,1,4,membrane to membrane docking,BP,ICAM1
2346,GO:0005384,0.185416343120559,0.986017992565221,1,4,manganese ion transmembrane transporter activity,MF,SLC11A2
9488,GO:0036120,0.185620829890808,0.958482065851087,2,16,cellular response to platelet-derived growth factor stimulus,BP,ERRFI1;CREB1
16071,GO:0089700,0.185632829201511,0.985983861171637,1,4,protein kinase D signaling,BP,VEGFA
13580,GO:0060029,0.185639416883229,0.985982821840474,1,4,convergent extension involved in organogenesis,BP,WNT5A
1375,GO:0003263,0.18575796984109,0.985079163541527,1,5,cardioblast proliferation,BP,PIM1
1387,GO:0003284,0.185890110665396,0.985943238939269,1,4,septum primum development,BP,SOX4
7237,GO:0031128,0.185905797327475,0.958158121342519,2,17,developmental induction,BP,BMP2;DKK1
1347,GO:0003207,0.185921586173639,0.985938264863142,1,4,cardiac chamber formation,BP,SOX4
1350,GO:0003211,0.185921586173639,0.985938264863142,1,4,cardiac ventricle formation,BP,SOX4
3471,GO:0007296,0.185935412992304,0.985936079506976,1,4,vitellogenesis,BP,FOSL1
34,GO:0000064,0.185944677443381,0.985934615138477,1,4,L-ornithine transmembrane transporter activity,MF,SLC7A2
10259,GO:0042994,0.18611663018801,0.957885819694616,2,18,cytoplasmic sequestering of transcription factor,BP,NFKBIA;NFKBIE
14361,GO:0061550,0.186170157426334,0.985898949422408,1,4,cranial ganglion development,BP,SIX4
6691,GO:0030055,0.186245016327705,0.871497040025212,20,360,cell-substrate junction,CC,PLAU;SDC4;PLAUR;EPHA2;PHLDB2;ITGA5;ICAM1;RND3;LAYN;NEDD9;TNC;SLC9A1;GRB7;MARCKS;CAV1;EFNB2;ITGAV;ADAM9;ANXA5;VIM
12391,GO:0048787,0.186271767957652,0.985882860887769,1,4,presynaptic active zone membrane,CC,STX1A
7752,GO:0032262,0.18628779582694,0.984990252146102,1,5,pyrimidine nucleotide salvage,BP,UPP1
8382,GO:0033278,0.186328021124383,0.98587394972282,1,4,cell proliferation in midbrain,BP,WNT5A
14119,GO:0060947,0.186344809222966,0.985871289695875,1,4,cardiac vascular smooth muscle cell differentiation,BP,VEGFA
4489,GO:0010508,0.186437597244097,0.904561976401882,7,98,positive regulation of autophagy,BP,PLEKHF1;ZC3H12A;TICAM1;RIPK2;PLK2;PLK3;RNF152
1821,GO:0004468,0.186481090168043,0.985849686255006,1,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,ESCO2
2085,GO:0004842,0.1865050808746,0.868987144342697,22,377,ubiquitin-protein transferase activity,MF,TNFAIP3;BIRC3;RNF19B;PELI1;BIRC2;KLHL21;NEDD4L;RNF144B;RNF43;VHL;BACH1;SMURF2;KLHL5;TRIM25;RCHY1;RNF152;NEDD4;KBTBD7;UBE2D3;PJA2;UBE2Z;RNF145
19062,GO:1904888,0.186507141728803,0.927289667605776,4,46,cranial skeletal system development,BP,SIX4;SMAD3;DLX2;TGFBR2
1439,GO:0003415,0.186805538412132,0.985798181821028,1,4,chondrocyte hypertrophy,BP,TGFBR2
2538,GO:0005793,0.186919098066405,0.90416115183371,7,102,endoplasmic reticulum-Golgi intermediate compartment,CC,CTSC;VMP1;CD55;TAP1;TGFA;TAPBP;LMAN1
12273,GO:0048549,0.187139941950758,0.98574499019944,1,4,positive regulation of pinocytosis,BP,AXL
13749,GO:0060306,0.187165132202618,0.957920106188861,2,16,regulation of membrane repolarization,BP,NEDD4L;CAV1
15176,GO:0071284,0.187226319243628,0.985731233035568,1,4,cellular response to lead ion,BP,CLDN1
7651,GO:0032058,0.187254228211171,0.985726786474349,1,4,positive regulation of translational initiation in response to stress,BP,PPP1R15A
6679,GO:0030036,0.187303889738866,0.863539405547625,27,470,actin cytoskeleton organization,BP,TNF;NUAK2;CXCL1;SDC4;EDN1;SIX4;PHLDB2;AMOTL2;ICAM1;SMAD3;RND3;FGD6;ABL2;CFLAR;CDC42EP4;NEDD9;AKAP2;ANLN;SLC9A1;MARCKS;PTPN1;SPTBN5;RHOV;ABI1;TRIP10;JMY;EPB41L3
8983,GO:0035088,0.187442055553369,0.939463859899869,3,31,establishment or maintenance of apical/basal cell polarity,BP,WNT5A;CLIC4;CRB3
14259,GO:0061245,0.187442055553369,0.939463859899869,3,31,establishment or maintenance of bipolar cell polarity,BP,WNT5A;CLIC4;CRB3
10608,GO:0043583,0.188012365759147,0.898589664468465,8,115,ear development,BP,SDC4;BMP2;EDN1;SIX4;WNT5A;SPRY2;NR4A3;DDR1
5223,GO:0015822,0.18812880995654,0.985587061662376,1,4,ornithine transport,BP,SLC7A2
18379,GO:1903352,0.18812880995654,0.985587061662376,1,4,L-ornithine transmembrane transport,BP,SLC7A2
2230,GO:0005131,0.188173196506305,0.985579950572937,1,4,growth hormone receptor binding,MF,SOCS2
9454,GO:0036041,0.188183307483442,0.984067643617306,1,6,long-chain fatty acid binding,MF,PPARD
16031,GO:0086036,0.188263982313549,0.98556539997836,1,4,regulation of cardiac muscle cell membrane potential,BP,SLC9A1
15318,GO:0071498,0.188307089354705,0.957277793277913,2,17,cellular response to fluid shear stress,BP,TFPI2;NFE2L2
1327,GO:0003175,0.188485507445994,0.985529861657165,1,4,tricuspid valve development,BP,TGFBR2
1335,GO:0003186,0.188485507445994,0.985529861657165,1,4,tricuspid valve morphogenesis,BP,TGFBR2
6173,GO:0019530,0.18849471389305,0.985528383673969,1,4,taurine metabolic process,BP,STAT5A
6207,GO:0019694,0.18849471389305,0.985528383673969,1,4,alkanesulfonate metabolic process,BP,STAT5A
13998,GO:0060696,0.188664844958501,0.984587816000897,1,5,regulation of phospholipid catabolic process,BP,LDLR
4686,GO:0010831,0.188781940587065,0.957102802318688,2,17,positive regulation of myotube differentiation,BP,EHD1;IL4R
10469,GO:0043325,0.188899035989233,0.957059604581897,2,17,phosphatidylinositol-3,4-bisphosphate binding,MF,DAPP1;ANXA8
10121,GO:0042636,0.188936406392561,0.985457378462956,1,4,negative regulation of hair cycle,BP,TRPV3
16836,GO:0098706,0.18971008337424,0.98533254684183,1,4,ferric iron import across plasma membrane,BP,STEAP4
10123,GO:0042640,0.189737471732743,0.98532811708867,1,4,anagen,BP,WNT5A
13237,GO:0051884,0.189737471732743,0.98532811708867,1,4,regulation of timing of anagen,BP,WNT5A
19732,GO:2000050,0.189836813461189,0.956940440317465,2,16,regulation of non-canonical Wnt signaling pathway,BP,DKK1;WNT5A
9681,GO:0038044,0.189952290557439,0.985293347258159,1,4,transforming growth factor-beta secretion,BP,ITGAV
11467,GO:0045913,0.190121877634306,0.925335521354357,4,46,positive regulation of carbohydrate metabolic process,BP,PMAIP1;NFKB1;PHKG2;PDGFB
19971,GO:2000483,0.190155885253169,0.984332422514324,1,5,negative regulation of interleukin-8 secretion,BP,MAPKBP1
852,GO:0002175,0.190290525481512,0.985238510569582,1,4,protein localization to paranode region of axon,BP,EPB41L3
4710,GO:0010869,0.190684074137399,0.956398830786829,2,17,regulation of receptor biosynthetic process,BP,EDN1;ITGAV
14286,GO:0061343,0.190696143060687,0.985172602296464,1,4,cell adhesion involved in heart morphogenesis,BP,TGFBR2
8008,GO:0032627,0.1907264343608,0.984234090911729,1,5,interleukin-23 production,BP,CSF2
8032,GO:0032667,0.1907264343608,0.984234090911729,1,5,regulation of interleukin-23 production,BP,CSF2
14535,GO:0070022,0.190790795733214,0.98515719921064,1,4,transforming growth factor beta receptor complex,CC,TGFBR2
3517,GO:0007442,0.190906423810261,0.985138370877206,1,4,hindgut morphogenesis,BP,WNT5A
17241,GO:0110020,0.19096897584224,0.915206731945953,5,63,regulation of actomyosin structure organization,BP,SDC4;EDN1;PHLDB2;SMAD3;SLC9A1
17813,GO:1901889,0.19104789082818,0.956493244212832,2,16,negative regulation of cell junction assembly,BP,TNF;PHLDB2
6102,GO:0019318,0.191125327145263,0.885300660766232,11,174,hexose metabolic process,BP,TNF;PMAIP1;PHLDA2;C1QTNF1;B4GALT1;PHKG2;SOGA1;PPP1R3B;ATF3;GSK3B;PPARD
2973,GO:0006513,0.191143757446406,0.915020319211835,5,65,protein monoubiquitination,BP,BIRC2;NEDD4L;TRIM25;NEDD4;UBE2D3
16514,GO:0097199,0.191239476390156,0.984145384162524,1,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,CFLAR
790,GO:0002051,0.191239983002674,0.985083982539406,1,4,osteoblast fate commitment,BP,SMAD1
7646,GO:0032052,0.191381122000203,0.984120845368821,1,5,bile acid binding,MF,STARD5
9180,GO:0035546,0.192036935451086,0.98495359583617,1,4,interferon-beta secretion,BP,IFIH1
9181,GO:0035547,0.192036935451086,0.98495359583617,1,4,regulation of interferon-beta secretion,BP,IFIH1
9182,GO:0035549,0.192036935451086,0.98495359583617,1,4,positive regulation of interferon-beta secretion,BP,IFIH1
8257,GO:0033032,0.192055998325018,0.955683467107373,2,18,regulation of myeloid cell apoptotic process,BP,HCAR2;NOD2
9720,GO:0038132,0.192359413157612,0.984900659919616,1,4,neuregulin binding,MF,ITGAV
19481,GO:1990138,0.192485445972848,0.895634037647177,8,112,neuron projection extension,BP,NEDD4L;VEGFA;SEMA4B;WNT5A;NRG1;ITSN2;RAPH1;DDR1
4176,GO:0009247,0.192501061180065,0.923642176120026,4,53,glycolipid biosynthetic process,BP,PLAUR;B3GNT5;PIGA;UGCG
4865,GO:0014701,0.192615086197676,0.984858617944094,1,4,junctional sarcoplasmic reticulum membrane,CC,JPH2
17840,GO:1901984,0.19269145797641,0.95544505433018,2,18,negative regulation of protein acetylation,BP,ZNF451;SDR16C5
3700,GO:0008207,0.192875812719011,0.955192369479219,2,19,C21-steroid hormone metabolic process,BP,BMP2;ADM
19996,GO:2000551,0.192997363730907,0.983839381018735,1,5,regulation of T-helper 2 cell cytokine production,BP,IL6
9254,GO:0035655,0.193186221910739,0.983806315850535,1,5,interleukin-18-mediated signaling pathway,BP,PDGFB
15216,GO:0071351,0.193186221910739,0.983806315850535,1,5,cellular response to interleukin-18,BP,PDGFB
802,GO:0002068,0.193321902797379,0.955414636926786,2,17,glandular epithelial cell development,BP,WNT5A;GSK3B
6457,GO:0021772,0.193343500973203,0.955640257406261,2,16,olfactory bulb development,BP,DLX2;WNT5A
17852,GO:1902003,0.193618864105599,0.955303260723251,2,17,regulation of amyloid-beta formation,BP,EFNA1;ABCA7
1997,GO:0004715,0.193814214809907,0.936424489377499,3,31,non-membrane spanning protein tyrosine kinase activity,MF,RIPK2;ABL2;FRK
8118,GO:0032801,0.193952590096097,0.936252729086782,3,32,receptor catabolic process,BP,RNF43;NEDD4;PTPN1
11794,GO:0046643,0.194287949558163,0.984581958497685,1,4,regulation of gamma-delta T cell activation,BP,NOD2
17783,GO:1901796,0.194342302124737,0.886136360678884,10,162,regulation of signal transduction by p53 class mediator,BP,PMAIP1;TP53BP2;TAF4B;PLK3;CHD4;TP53;RAD9B;PML;MUC1;JMY
9095,GO:0035356,0.194611458587614,0.983555596762574,1,5,cellular triglyceride homeostasis,BP,XBP1
9649,GO:0036515,0.194696397138366,0.984513992365228,1,4,serotonergic neuron axon guidance,BP,WNT5A
11681,GO:0046449,0.194775760817967,0.984500767160002,1,4,creatinine metabolic process,BP,STAT5A
6758,GO:0030176,0.195335413844311,0.893497349686848,8,123,integral component of endoplasmic reticulum membrane,CC,TAP1;ANKLE2;SGMS2;HLA-A;TAPBP;HLA-B;HLA-F;HLA-E
15437,GO:0071695,0.195377844542678,0.898702263871724,7,99,anatomical structure maturation,BP,BMP2;EREG;CDKN1A;NR4A2;WNT5A;NOM1;XBP1
14521,GO:0065005,0.195591796248475,0.954350087048185,2,18,protein-lipid complex assembly,BP,PLAGL2;ABCA7
17492,GO:1900376,0.195770157219184,0.984334535986123,1,4,regulation of secondary metabolite biosynthetic process,BP,WNT5A
14725,GO:0070358,0.195918898373793,0.983323749612146,1,5,actin polymerization-dependent cell motility,BP,JMY
1432,GO:0003402,0.196089652542588,0.98428092028834,1,4,planar cell polarity pathway involved in axis elongation,BP,WNT5A
15130,GO:0071205,0.196105710780097,0.984278222845493,1,4,protein localization to juxtaparanode region of axon,BP,EPB41L3
13044,GO:0051481,0.196165049724919,0.984268252962023,1,4,negative regulation of cytosolic calcium ion concentration,BP,SMAD3
13204,GO:0051797,0.196238203129036,0.954104526245407,2,18,regulation of hair follicle development,BP,TNF;WNT5A
3277,GO:0006956,0.196259115437909,0.954096572695482,2,18,complement activation,BP,CD55;CFB
18064,GO:1902581,0.196265751769927,0.983261944806141,1,5,multi-organism cellular localization,BP,NUP153
18065,GO:1902583,0.196265751769927,0.983261944806141,1,5,multi-organism intracellular transport,BP,NUP153
5898,GO:0018076,0.196339140333507,0.984238982985084,1,4,N-terminal peptidyl-lysine acetylation,BP,SOX4
3002,GO:0006547,0.196342117470688,0.983248320645442,1,5,histidine metabolic process,BP,HAL
13428,GO:0052803,0.196342117470688,0.983248320645442,1,5,imidazole-containing compound metabolic process,BP,HAL
16652,GO:0097501,0.196477698425902,0.982099782757996,1,7,stress response to metal ion,BP,MT2A
4981,GO:0015095,0.196493443009059,0.954219104159396,2,17,magnesium ion transmembrane transporter activity,MF,NIPAL4;SLC41A1
5158,GO:0015693,0.196493443009059,0.954219104159396,2,17,magnesium ion transport,BP,NIPAL4;SLC41A1
18601,GO:1903830,0.196493443009059,0.954219104159396,2,17,magnesium ion transmembrane transport,BP,NIPAL4;SLC41A1
10795,GO:0044262,0.196496280557196,0.87853656695693,12,191,cellular carbohydrate metabolic process,BP,PMAIP1;PHLDA2;C1QTNF1;IL6ST;B4GALT1;B3GNT5;PHKG2;SOGA1;PPP1R3B;STK40;GSK3B;MGAM
17529,GO:1900748,0.196520552257399,0.984208450331737,1,4,positive regulation of vascular endothelial growth factor signaling pathway,BP,CCBE1
6710,GO:0030111,0.196630353757619,0.871390330842109,15,257,regulation of Wnt signaling pathway,BP,BMP2;NFKB1;CYLD;BAMBI;NRARP;DKK1;RNF43;RUNX1;SMURF2;WNT5A;SOX4;TLE1;CAV1;TLR2;GSK3B
18534,GO:1903690,0.196871306546681,0.984149324505975,1,4,negative regulation of wound healing, spreading of epidermal cells,BP,PHLDB2
19729,GO:2000047,0.196908110284266,0.983147154855833,1,5,regulation of cell-cell adhesion mediated by cadherin,BP,WNT5A
20053,GO:2000649,0.197070038935731,0.934743810811407,3,32,regulation of sodium ion transmembrane transporter activity,BP,NEDD4L;SLC9A1;NEDD4
17269,GO:0120039,0.197124207523849,0.856377075369405,26,446,plasma membrane bounded cell projection morphogenesis,BP,EFNA1;EFNB1;NEDD4L;SGK1;VEGFA;ZSWIM4;KLF7;CREB1;NR4A2;SEMA4B;WNT5A;SLC11A2;NRG1;PARD6B;FEZ1;GRB7;NEDD4;ITSN2;WNT7B;SPTBN5;ABI1;EFNB2;RAPH1;NR4A3;DDR1;EPB41L3
11321,GO:0045630,0.197373898749565,0.983063649899853,1,5,positive regulation of T-helper 2 cell differentiation,BP,IL4R
3372,GO:0007143,0.197699702375762,0.953547279558893,2,18,female meiotic nuclear division,BP,EREG;MASTL
1298,GO:0003128,0.197784901378803,0.982989779367494,1,5,heart field specification,BP,DKK1
450,GO:0001223,0.197909060381317,0.953681180604167,2,17,transcription coactivator binding,MF,CREB1;NR4A3
8469,GO:0033605,0.198042786735484,0.982943339235354,1,5,positive regulation of catecholamine secretion,BP,STX1A
3353,GO:0007088,0.198051190452227,0.887281451927651,9,141,regulation of mitotic nuclear division,BP,IL1B;IL1A;EDN1;EREG;DUSP1;TGFA;PDGFB;ANLN;ESPL1
190,GO:0000407,0.198168292082848,0.934209231265348,3,32,phagophore assembly site,CC,PLEKHF1;SQSTM1;VMP1
20077,GO:2000676,0.198287648952185,0.982899180236317,1,5,positive regulation of type B pancreatic cell apoptotic process,BP,IL6
14418,GO:0061687,0.198325187460541,0.981746620395944,1,7,detoxification of inorganic compound,BP,MT2A
16233,GO:0090263,0.198465603903589,0.896429438798415,7,110,positive regulation of canonical Wnt signaling pathway,BP,NFKB1;BAMBI;NRARP;SMURF2;WNT5A;SOX4;CAV1
19788,GO:2000171,0.198600155975985,0.95341760693512,2,17,negative regulation of dendrite development,BP,EFNA1;PLK2
11376,GO:0045727,0.198603517745559,0.896418488771315,7,106,positive regulation of translation,BP,TNF;ZC3H12A;PPP1R15A;BCL3;IL6;SOX4;VIM
19872,GO:2000319,0.198661349120995,0.982831665933441,1,5,regulation of T-helper 17 cell differentiation,BP,IL23A
1554,GO:0003950,0.198734504659135,0.953366295021994,2,17,NAD+ ADP-ribosyltransferase activity,MF,PARP8;PARP1
3546,GO:0007569,0.198893115721139,0.902522518082855,6,86,cell aging,BP,TBX3;CDKN1A;ICAM1;PLK2;TP53;PML
2332,GO:0005345,0.199208395341903,0.982732571715985,1,5,purine nucleobase transmembrane transporter activity,MF,SLC28A3
3459,GO:0007272,0.199280351102258,0.902394467137719,6,82,ensheathment of neurons,BP,NAB1;NRG1;TLR2;PPARD;QKI;EPB41L3
3797,GO:0008366,0.199280351102258,0.902394467137719,6,82,axon ensheathment,BP,NAB1;NRG1;TLR2;PPARD;QKI;EPB41L3
8284,GO:0033085,0.19948250120691,0.982682801689727,1,5,negative regulation of T cell differentiation in thymus,BP,NFKBID
2107,GO:0004879,0.199518598683289,0.933549826106121,3,32,nuclear receptor activity,MF,NR4A2;NR4A3;PPARD
16764,GO:0098531,0.199518598683289,0.933549826106121,3,32,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,NR4A2;NR4A3;PPARD
14364,GO:0061564,0.199698122457758,0.860916040599999,20,335,axon development,BP,EFNA1;JUN;EFNB1;VEGFA;ZSWIM4;KLF7;CREB1;NR4A2;SEMA4B;WNT5A;NRG1;TNC;PARD6B;FEZ1;GRB7;SPTBN5;EFNB2;RAPH1;NR4A3;DDR1
10785,GO:0044238,0.199706995215947,0.824873347376608,359,7699,primary metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;ZNF267;SPRR2D;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;KLHL21;PHLDA2;DAPP1;JUNB;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;C1QTNF1;CDKN1A;NMNAT2;CCDC85B;ITGA5;RAP2B;IL7R;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;NOD2;ELMSAN1;IL6ST;DCUN1D3;SAV1;TFPI2;SGK1;ICAM1;SMAD3;ZC3H12C;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;RNF144B;NFKBID;TRAF4;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;SLC6A14;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ZBED2;ABL2;PPTC7;CFLAR;RNF43;TXNRD1;KLF7;PIGA;BTG1;ANXA8;UPP1;IER5;PPP4R4;CEBPB;CEBPD;CD55;DENND3;NAMPT;ANKLE2;ADM;DSE;ERRFI1;ADAMTS1;ANKK1;CREB1;TAF4B;CCNL1;USP43;MAST4;NR4A2;PATL1;SLC7A2;CANT1;VHL;PHKG2;SOGA1;BACH1;ABTB2;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;MASTL;NAB1;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;ABCF1;TGFA;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;KIAA1586;ATF3;OTUD4;IKZF2;CAB39;TLE1;PLK3;CHD2;ARRDC4;SLC9A1;ZBTB10;RCHY1;YAF2;SPRY2;TNKS1BP1;B4GALT5;HAL;GRB7;ARSJ;NUP153;RNF152;NEDD4;MMD;POU2F2;DUS4L;IL24;TNFRSF6B;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;TPRA1;ZC3H7B;DIEXF;NFAT5;STAT5A;TPST1;CAV1;VEZF1;SH3RF2;INO80D;TNIP2;ZNFX1;UGCG;TP53;KLF3;TLR2;ABI1;STK40;PUS10;PDP1;ITGAV;IKBKE;UBE2D3;PJA2;CD276;MAPKBP1;ELK3;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;ADAM9;RELA;TRIM16;ESCO2;FOXN2;CCBE1;PPP6R3;PLAT;CHST2;MUC1;YARS2;AXL;ELL2;FRK;CITED4;NR4A3;USP31;GSK3B;KMT2E;PPARD;PARP8;SLC16A1;PARP1;CYP24A1;MMP10;KDM7A;MED13;MXD3;CRAMP1;LCE1C;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;RNF145;ALAS1;ZXDA;RPS6KA6;DDR1;XBP1;QKI;KCTD11;ZBTB5;ELF4;SREK1IP1;TFE3;EID3;ZMIZ2;MGAM;LMAN1;CFB;JUND;DENND4A
10103,GO:0042609,0.199788230692176,0.982627197211002,1,5,CD4 receptor binding,MF,IL16
8971,GO:0035050,0.199850391023641,0.919928504502682,4,47,embryonic heart tube development,BP,TBX3;SMAD3;TGFBR2;WNT5A
20163,GO:2000831,0.199855330778875,0.982614980343357,1,5,regulation of steroid hormone secretion,BP,C1QTNF1
12422,GO:0048858,0.199975695200529,0.854030463569379,26,447,cell projection morphogenesis,BP,EFNA1;EFNB1;NEDD4L;SGK1;VEGFA;ZSWIM4;KLF7;CREB1;NR4A2;SEMA4B;WNT5A;SLC11A2;NRG1;PARD6B;FEZ1;GRB7;NEDD4;ITSN2;WNT7B;SPTBN5;ABI1;EFNB2;RAPH1;NR4A3;DDR1;EPB41L3
1179,GO:0002823,0.20003389574495,0.952651414296576,2,18,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,IL7R;IL4R
7338,GO:0031344,0.200118320928494,0.854837158758647,25,436,regulation of cell projection organization,BP,EFNA1;EPHA2;CYLD;NAV3;NEDD4L;ICAM1;VEGFA;ZSWIM4;PLK2;ABL2;CFLAR;CDC42EP4;SEMA4B;WNT5A;ANLN;NRG1;SPRY2;FEZ1;NEDD4;ITSN2;NFE2L2;CAV1;EFNB2;VIM;CEP135
17583,GO:1901165,0.200381226796259,0.982519067995061,1,5,positive regulation of trophoblast cell migration,BP,SMURF2
6993,GO:0030667,0.200381338601818,0.875613119315491,12,196,secretory granule membrane,CC,PLAU;PLAUR;ADAM8;RAP2B;B4GALT1;RAB24;CD55;CD47;CAV1;TLR2;ITGAV;MGAM
2401,GO:0005544,0.200449646152308,0.932991013851024,3,33,calcium-dependent phospholipid binding,MF,ANXA8;ANXA8L1;ANXA5
16101,GO:0090066,0.200535440429655,0.861594829270363,19,327,regulation of anatomical structure size,BP,PPP1R15A;SOD2;EDN1;IL7R;ICAM1;GCH1;VEGFA;ADM;CDC42EP4;CREB1;SEMA4B;WNT5A;NRG1;WNT7B;SPTBN5;CAV1;DOCK4;PPARD;JMY
16268,GO:0090311,0.201027542296205,0.932707011802059,3,33,regulation of protein deacetylation,BP,VEGFA;TP53;SDR16C5
11425,GO:0045824,0.20103255082932,0.932607715804554,3,34,negative regulation of innate immune response,BP,TNFAIP3;DUSP10;HLA-E
1408,GO:0003339,0.201225277908066,0.9823645267402,1,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF
13926,GO:0060563,0.20124172085382,0.932601646181603,3,33,neuroepithelial cell differentiation,BP,BMP2;CEBPB;SOX4
16128,GO:0090100,0.20147965817409,0.908803156898893,5,66,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,INHBA;BMP2;SMAD3;CDKN2B;PARP1
7179,GO:0031056,0.201868840822582,0.88912498997405,8,118,regulation of histone modification,BP,IL1B;LIF;ZNF451;VEGFA;TP53;SDR16C5;MUC1;KMT2E
10736,GO:0044089,0.202038002965408,0.856472052543994,22,384,positive regulation of cellular component biogenesis,BP,CSF2;TNF;SDC4;FOSL1;PMAIP1;EDN1;JUN;PHLDB2;CLDN1;NAV3;ICAM1;SMAD3;VEGFA;CDC42EP4;CREB1;ANLN;CAV1;TP53;GSK3B;PARP1;JMY;CEP135
19780,GO:2000146,0.202364144496739,0.877114650204181,11,175,negative regulation of cell motility,BP,PHLDB2;RAP2B;NAV3;TRIB1;DUSP10;NRG1;GCSAM;IL24;NFE2L2;CLIC4;PPARD
8052,GO:0032700,0.202424239893835,0.982143721784233,1,5,negative regulation of interleukin-17 production,BP,IL36RN
9729,GO:0038166,0.202500063371369,0.982129707253049,1,5,angiotensin-activated signaling pathway,BP,CAV1
18653,GO:1903936,0.202557385460797,0.982119108352843,1,5,cellular response to sodium arsenite,BP,ZC3H12A
13593,GO:0060046,0.202808387906091,0.982072657236387,1,5,regulation of acrosome reaction,BP,B4GALT1
9487,GO:0036119,0.202890878764628,0.9517670668578,2,17,response to platelet-derived growth factor,BP,ERRFI1;CREB1
10139,GO:0042695,0.202893798502558,0.982056835882622,1,5,thelarche,BP,WNT5A
14035,GO:0060744,0.202893798502558,0.982056835882622,1,5,mammary gland branching involved in thelarche,BP,WNT5A
18297,GO:1903170,0.203662002720119,0.951045802974549,2,19,negative regulation of calcium ion transmembrane transport,BP,RRAD;GEM
9290,GO:0035726,0.203667262968735,0.981913211821124,1,5,common myeloid progenitor cell proliferation,BP,NR4A3
15695,GO:0072207,0.203753028030187,0.951432485705019,2,17,metanephric epithelium development,BP,LIF;WNT7B
7484,GO:0031644,0.203784739365787,0.931346085098991,3,33,regulation of neurological system process,BP,EDN1;NRG1;SLC9A1
16813,GO:0098644,0.203799088661037,0.951667297600323,2,16,complex of collagen trimers,CC,COL27A1;COL8A1
10877,GO:0044406,0.203923788042063,0.981865439194061,1,5,adhesion of symbiont to host,BP,ICAM1
10488,GO:0043379,0.203958421414262,0.981858984131055,1,5,memory T cell differentiation,BP,IL23A
16388,GO:0090713,0.203958421414262,0.981858984131055,1,5,immunological memory process,BP,IL23A
16389,GO:0090715,0.203958421414262,0.981858984131055,1,5,immunological memory formation process,BP,IL23A
12853,GO:0051150,0.204608910078644,0.950874588278302,2,18,regulation of smooth muscle cell differentiation,BP,EREG;PDGFB
15398,GO:0071634,0.204854262995989,0.951003694524423,2,17,regulation of transforming growth factor beta production,BP,SMAD3;CREB1
18498,GO:1903587,0.205007222034235,0.981662908698714,1,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,VEGFA
1450,GO:0003677,0.205367957718577,0.826120659167227,96,1913,DNA binding,MF,TNFAIP3;TNF;IRF1;FOSL1;ZC3H12A;ELF3;PRDM1;TBX3;EHF;MAFF;NFKB1;ZFP36;JUN;KDM6B;ZNF697;ETS1;BHLHE40;ZNF267;KLF6;IRF6;REL;BCL3;GADD45A;PLAGL2;ETS2;ZNF436;CSRNP1;NFKB2;RFX5;ZFP36L1;SIX4;THAP10;JUNB;RELB;ZNF217;ELMSAN1;SMAD3;DLX2;ARNTL2;TRAF4;ZBED2;KLF7;CEBPB;CEBPD;CREB1;TAF4B;NR4A2;BACH1;MYBL1;RUNX1;DDX3Y;TGIF2;GPBP1;NFE2L3;WNT5A;SOX4;IFIH1;ATF3;IKZF2;CHD2;ZBTB10;H1FX;NUP153;POU2F2;NFE2L2;SMAD1;MXD1;CHD4;NFAT5;STAT5A;VEZF1;ZFAND5;TP53;KLF3;ELK3;SNAPC4;ZNF148;PML;POLR3A;RELA;TRIM16;FOXN2;MUC1;NR4A3;PPARD;PARP1;MXD3;CRAMP1;CREB5;NABP1;XBP1;ZBTB5;ELF4;TFE3;JUND;DENND4A
1349,GO:0003209,0.205527938380635,0.950740595082108,2,17,cardiac atrium morphogenesis,BP,WNT5A;SOX4
15475,GO:0071800,0.205719736115702,0.95043899211021,2,18,podosome assembly,BP,CSF2;TNF
17322,GO:0140112,0.205905138437405,0.950164066546567,2,19,extracellular vesicle biogenesis,BP,SDC4;ARRDC4
18381,GO:1903361,0.20601996074876,0.981472476881031,1,5,protein localization to basolateral plasma membrane,BP,CAV1
10059,GO:0042538,0.206141305030204,0.981449587261929,1,5,hyperosmotic salinity response,BP,CLDN1
11259,GO:0045471,0.206273111237659,0.905736691818921,5,70,response to ethanol,BP,BIRC2;CLDN1;ICAM1;TNC;TP53
13864,GO:0060453,0.206286649006771,0.981422150066753,1,5,regulation of gastric acid secretion,BP,SGK1
10871,GO:0044390,0.206488310248701,0.930002132809545,3,33,ubiquitin-like protein conjugating enzyme binding,MF,RNF19B;DCUN1D3;RNF144B
16665,GO:0097527,0.206591109440727,0.981364603602726,1,5,necroptotic signaling pathway,BP,TNF
14178,GO:0061046,0.206880341457613,0.981309844937866,1,5,regulation of branching involved in lung morphogenesis,BP,TNF
1987,GO:0004704,0.207787639813557,0.98113749839497,1,5,NF-kappaB-inducing kinase activity,MF,IKBKE
13818,GO:0060393,0.20787588142555,0.929207653181726,3,34,regulation of pathway-restricted SMAD protein phosphorylation,BP,INHBA;BMP2;DKK1
3228,GO:0006882,0.208214198808199,0.948899388680965,2,21,cellular zinc ion homeostasis,BP,MT2A;SLC39A14
13516,GO:0055069,0.208214198808199,0.948899388680965,2,21,zinc ion homeostasis,BP,MT2A;SLC39A14
885,GO:0002248,0.208224279508659,0.981054246258557,1,5,connective tissue replacement involved in inflammatory response wound healing,BP,IL1A
17722,GO:1901617,0.208399234876794,0.876042720443827,10,161,organic hydroxy compound biosynthetic process,BP,IL1B;TNF;ITPKC;BMP2;NFKB1;CYP27B1;GCH1;NR4A2;HMGCS1;WNT5A
3889,GO:0008519,0.208411264575302,0.949376781069287,2,18,ammonium transmembrane transporter activity,MF,RHD;RHCG
16943,GO:0098909,0.208445799780484,0.981011932920021,1,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,CAV1
6108,GO:0019336,0.208571914176368,0.980987820199901,1,5,phenol-containing compound catabolic process,BP,MAOA
6190,GO:0019614,0.208571914176368,0.980987820199901,1,5,catechol-containing compound catabolic process,BP,MAOA
10010,GO:0042424,0.208571914176368,0.980987820199901,1,5,catecholamine catabolic process,BP,MAOA
16639,GO:0097484,0.208781895198624,0.949461361777755,2,17,dendrite extension,BP,NEDD4L;ITSN2
10160,GO:0042737,0.209163824365822,0.903859069108314,5,73,drug catabolic process,BP,AMPD3;GPX3;MAOA;PAOX;SAT1
4232,GO:0009408,0.209282439333546,0.879367904024462,9,140,response to heat,BP,IL1A;CDKN1A;IER5;SLC52A3;TRPV3;NUP153;TP53;GSK3B;HSPA4L
5075,GO:0015295,0.209372023443732,0.948995300373026,2,18,solute:proton symporter activity,MF,SLC11A2;SLC2A6
20203,GO:2001024,0.209450436129651,0.948756880936916,2,19,negative regulation of response to drug,BP,NFE2L2;NR4A3
7104,GO:0030896,0.2095372014317,0.980802702550563,1,5,checkpoint clamp complex,CC,RAD9B
13105,GO:0051602,0.209608744360641,0.948901120395423,2,18,response to electrical stimulus,BP,BTG2;SLC9A1
5375,GO:0016176,0.209644829016122,0.980782001169649,1,5,superoxide-generating NADPH oxidase activator activity,MF,PDGFB
9375,GO:0035897,0.209806310590144,0.980750918345247,1,5,proteolysis in other organism,BP,MAP2K3
8630,GO:0034145,0.209912645793171,0.980730435295397,1,5,positive regulation of toll-like receptor 4 signaling pathway,BP,PELI1
10031,GO:0042472,0.209978537854112,0.914174161675941,4,48,inner ear morphogenesis,BP,SIX4;WNT5A;SPRY2;NR4A3
15616,GO:0072088,0.210117335492805,0.914029877887585,4,49,nephron epithelium morphogenesis,BP,BMP2;LIF;SIX4;VEGFA
15528,GO:0071895,0.210204941454877,0.980674069451639,1,5,odontoblast differentiation,BP,CEBPB
19140,GO:1905063,0.210733372285237,0.980571937694136,1,5,regulation of vascular smooth muscle cell differentiation,BP,PDGFB
15444,GO:0071704,0.210957027335381,0.814766388501104,368,7911,organic substance metabolic process,BP,NFKBIZ;CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;IL1A;ITPKC;EFNA1;SDC4;BTG2;INHBA;BIRC3;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;ZNF267;SPRR2D;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;KLHL21;PHLDA2;DAPP1;JUNB;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;C1QTNF1;CDKN1A;NMNAT2;CCDC85B;ITGA5;RAP2B;IL7R;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;NOD2;ELMSAN1;IL6ST;DCUN1D3;SAV1;TFPI2;SGK1;ICAM1;GCH1;SMAD3;ZC3H12C;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;RNF144B;NFKBID;TRAF4;TRIB1;SERPINB8;VEGFA;NRARP;IL1R2;SLC6A14;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ZBED2;ABL2;PPTC7;CFLAR;RNF43;TXNRD1;KLF7;PIGA;BTG1;ANXA8;UPP1;IER5;PPP4R4;CEBPB;CEBPD;CD55;DENND3;NAMPT;ANKLE2;ADM;DSE;ERRFI1;ADAMTS1;ANKK1;CREB1;TAF4B;CCNL1;USP43;MAST4;NR4A2;PATL1;SLC7A2;CANT1;VHL;PHKG2;SOGA1;BACH1;ABTB2;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;MASTL;NAB1;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;DUSP10;SLC52A3;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;PGLYRP4;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;KIAA1586;ATF3;OTUD4;IKZF2;CAB39;TLE1;PLK3;CHD2;ARRDC4;SLC9A1;ZBTB10;MAOA;RCHY1;YAF2;SPRY2;TNKS1BP1;B4GALT5;HAL;GRB7;ARSJ;NUP153;RNF152;NEDD4;MMD;POU2F2;DUS4L;IL24;TNFRSF6B;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;TPRA1;ZC3H7B;DIEXF;NFAT5;STAT5A;TPST1;CAV1;VEZF1;SH3RF2;INO80D;TNIP2;ZNFX1;UGCG;TP53;KLF3;TLR2;ABI1;STK40;PUS10;TAPBP;PDP1;ITGAV;IKBKE;UBE2D3;PJA2;CD276;MAPKBP1;ELK3;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;ADAM9;RELA;TRIM16;ESCO2;FOXN2;CCBE1;PPP6R3;PLAT;CHST2;MUC1;YARS2;AXL;ELL2;SAT1;FRK;CITED4;NR4A3;USP31;GSK3B;KMT2E;PPARD;PARP8;SLC16A1;PARP1;CYP24A1;MMP10;KDM7A;MED13;MXD3;CRAMP1;LCE1C;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;RNF145;ALAS1;ZXDA;RPS6KA6;DDR1;XBP1;QKI;KCTD11;ZBTB5;ELF4;SREK1IP1;TFE3;EID3;ZMIZ2;MGAM;LMAN1;CFB;JUND;DENND4A
6560,GO:0021988,0.21128372544497,0.948468330491793,2,17,olfactory lobe development,BP,DLX2;WNT5A
18950,GO:1904680,0.211370069848,0.947630075692936,2,21,peptide transmembrane transporter activity,MF,TAP1;TAPBP
12274,GO:0048550,0.21145859756397,0.980431288271697,1,5,negative regulation of pinocytosis,BP,CAV1
11449,GO:0045875,0.211531751079421,0.980417069941712,1,5,negative regulation of sister chromatid cohesion,BP,ESPL1
8278,GO:0033079,0.211592713833152,0.980405216699934,1,5,immature T cell proliferation,BP,RIPK2
11700,GO:0046476,0.211597446079626,0.980404296424395,1,5,glycosylceramide biosynthetic process,BP,UGCG
18939,GO:1904646,0.211609264978205,0.948102254927666,2,18,cellular response to amyloid-beta,BP,GSK3B;PARP1
10090,GO:0042587,0.211845550303154,0.980356014494479,1,5,glycogen granule,CC,PPP1R3B
6464,GO:0021781,0.21206007218923,0.980314215052811,1,5,glial cell fate commitment,BP,NRG1
8355,GO:0033216,0.21220607504832,0.980285738509958,1,5,ferric iron import,BP,STEAP4
2120,GO:0004908,0.212220604266288,0.980282903476506,1,5,interleukin-1 receptor activity,MF,IL1R2
6557,GO:0021984,0.212775377476438,0.980174484582374,1,5,adenohypophysis development,BP,BMP2
8852,GO:0034644,0.212820587508935,0.901757261638398,5,69,cellular response to UV,BP,N4BP1;CDKN1A;NEDD4;TP53;PARP1
11265,GO:0045499,0.212889572600387,0.947826594027818,2,17,chemorepellent activity,MF,SEMA4B;NRG1
19638,GO:1990763,0.212940058742105,0.980142237999273,1,5,arrestin family protein binding,MF,CREB1
19307,GO:1905517,0.212993273893653,0.9469720612966,2,21,macrophage migration,BP,CSF1;SAA1
6554,GO:0021978,0.213010040890004,0.98012852590551,1,5,telencephalon regionalization,BP,BMP2
7270,GO:0031234,0.213061305912382,0.901734433387635,5,66,extrinsic component of cytoplasmic side of plasma membrane,CC,CYLD;ABL2;ERRFI1;CYTH1;FRK
16277,GO:0090324,0.213151958884026,0.980100702902907,1,5,negative regulation of oxidative phosphorylation,BP,PPIF
20016,GO:2000587,0.213175499793127,0.980096085636694,1,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
797,GO:0002063,0.213650957577461,0.94752114020468,2,17,chondrocyte development,BP,TGFBR2;COL27A1
17502,GO:1900425,0.213761471882049,0.979980963980138,1,5,negative regulation of defense response to bacterium,BP,MAPKBP1
4583,GO:0010665,0.213769192325493,0.947233806121876,2,18,regulation of cardiac muscle cell apoptotic process,BP,CFLAR;NFE2L2
3404,GO:0007186,0.213885794744822,0.84805634212934,21,377,G-protein coupled receptor signaling pathway,BP,CXCL8;CXCL2;CXCL3;CXCL1;CCL20;CXCL5;EDN1;HCAR3;GPR156;HCAR2;EREG;BDKRB1;FZD8;ARHGEF3;ADM;SAA1;CXCL16;TPRA1;CAV1;ADGRE2;GSK3B
18192,GO:1902947,0.21390029674289,0.979953636447279,1,5,regulation of tau-protein kinase activity,BP,DKK1
11218,GO:0045342,0.214016186217531,0.979930807982854,1,5,MHC class II biosynthetic process,BP,XBP1
11221,GO:0045346,0.214016186217531,0.979930807982854,1,5,regulation of MHC class II biosynthetic process,BP,XBP1
20282,GO:2001214,0.214223943802543,0.979889847037392,1,5,positive regulation of vasculogenesis,BP,ADM
5973,GO:0018401,0.214425777575624,0.979850009914709,1,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,EGLN1
10027,GO:0042461,0.214729095342611,0.946845880434062,2,18,photoreceptor cell development,BP,PRDM1;VEGFA
13500,GO:0055023,0.214731333558294,0.946844974484321,2,18,positive regulation of cardiac muscle tissue growth,BP,EDN1;PIM1
3223,GO:0006874,0.214782865952628,0.864816450767638,12,198,cellular calcium ion homeostasis,BP,EDN1;BDKRB1;C1QTNF1;SMAD3;ABL2;CD55;ADM;SAA1;CAV1;ITGAV;JPH2;PML
11804,GO:0046661,0.214829819373903,0.885588428190291,7,104,male sex differentiation,BP,INHBA;TBX3;SIX4;ICAM1;HMGCS1;WNT5A;BCL2L2
8240,GO:0033006,0.214836783762961,0.946587128154414,2,19,regulation of mast cell activation involved in immune response,BP,IL4R;ADGRE2
10451,GO:0043304,0.214836783762961,0.946587128154414,2,19,regulation of mast cell degranulation,BP,IL4R;ADGRE2
4263,GO:0009597,0.214917643990018,0.979752745234776,1,5,detection of virus,BP,IFIH1
2428,GO:0005605,0.214992953809212,0.946980899764131,2,17,basal lamina,CC,LAMB3;LAMA3
16696,GO:0097629,0.215099925512543,0.979716634155899,1,5,extrinsic component of omegasome membrane,CC,PLEKHF1
7264,GO:0031227,0.215159125054202,0.879767184425387,8,126,intrinsic component of endoplasmic reticulum membrane,CC,TAP1;ANKLE2;SGMS2;HLA-A;TAPBP;HLA-B;HLA-F;HLA-E
5236,GO:0015849,0.215264458565255,0.867580101755119,11,176,organic acid transport,BP,IL1B;EDN1;STARD5;NFKBIE;SLC6A14;SLC7A2;SLC38A2;STX1A;SLC16A13;PPARD;SLC16A1
11919,GO:0046942,0.215264458565255,0.867580101755119,11,176,carboxylic acid transport,BP,IL1B;EDN1;STARD5;NFKBIE;SLC6A14;SLC7A2;SLC38A2;STX1A;SLC16A13;PPARD;SLC16A1
12359,GO:0048712,0.215309964246796,0.979674980186532,1,5,negative regulation of astrocyte differentiation,BP,LDLR
20050,GO:2000646,0.215330102413915,0.979670983996071,1,5,positive regulation of receptor catabolic process,BP,PTPN1
8030,GO:0032661,0.215513507688028,0.979634569353276,1,5,regulation of interleukin-18 production,BP,TLR2
5382,GO:0016192,0.215608974413124,0.820580966085573,73,1440,vesicle-mediated transport,BP,CXCL8;IL1B;TNF;PLAU;CXCL1;SDC4;PLAUR;PTX3;NFKB1;EHD1;SQSTM1;AMPD3;ADAM8;RAP2B;TNFAIP2;NEDD4L;CTSC;RASSF9;B4GALT1;VEGFA;RAB24;DKK1;ABL2;ANXA8;VMP1;CD55;DENND3;TAP1;ADM;CD47;CANT1;TGFBR2;SAA1;TINAGL1;KIF3C;WNT5A;VEGFC;TGFA;SERPINB1;PDGFB;MMP9;LDLR;CAB39;SYS1;CYTH1;CXCL16;IL4R;NEDD4;ITSN2;PTPN1;SPTBN5;CAV1;RHOV;CACFD1;NECAP2;TLR2;ABI1;TAPBP;RAB9A;ITGAV;STX1A;TRIP10;ABCA7;ADGRE2;PPP6R3;AXL;ANXA5;FRK;NR4A3;TBC1D22B;COTL1;MGAM;LMAN1
1236,GO:0002921,0.215633990326768,0.97961062826736,1,5,negative regulation of humoral immune response,BP,CD55
19775,GO:2000138,0.215657314271891,0.979605991776869,1,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,PIM1
8348,GO:0033198,0.21582531889747,0.946184757481149,2,19,response to ATP,BP,IL1B;PANX1
8254,GO:0033029,0.215962758853939,0.979545219755388,1,5,regulation of neutrophil apoptotic process,BP,HCAR2
2046,GO:0004791,0.216157176363505,0.978709610232892,1,6,thioredoxin-disulfide reductase activity,MF,TXNRD1
9436,GO:0036005,0.216178008584751,0.97950233318174,1,5,response to macrophage colony-stimulating factor,BP,CSF1
9437,GO:0036006,0.216178008584751,0.97950233318174,1,5,cellular response to macrophage colony-stimulating factor stimulus,BP,CSF1
9333,GO:0035810,0.216223966925159,0.979493169972954,1,5,positive regulation of urine volume,BP,EDN1
3986,GO:0008823,0.216398313784286,0.979458388009761,1,5,cupric reductase activity,MF,STEAP4
13459,GO:0052851,0.216398313784286,0.979458388009761,1,5,ferric-chelate reductase (NADPH) activity,MF,STEAP4
1021,GO:0002517,0.216419527177053,0.979454153746259,1,5,T cell tolerance induction,BP,TGFBR2
1078,GO:0002645,0.216419527177053,0.979454153746259,1,5,positive regulation of tolerance induction,BP,TGFBR2
1084,GO:0002664,0.216419527177053,0.979454153746259,1,5,regulation of T cell tolerance induction,BP,TGFBR2
14041,GO:0060751,0.216456200103428,0.979446832572329,1,5,branch elongation involved in mammary gland duct branching,BP,WNT5A
8847,GO:0034638,0.216588885564725,0.97862023372782,1,6,phosphatidylcholine catabolic process,BP,LDLR
19061,GO:1904886,0.216612973715716,0.946081017969956,2,18,beta-catenin destruction complex disassembly,BP,CAV1;GSK3B
8557,GO:0033962,0.216712434990796,0.946040506311198,2,18,cytoplasmic mRNA processing body assembly,BP,NOCT;PATL1
4814,GO:0014002,0.216716804331417,0.945820782824369,2,19,astrocyte development,BP,LDLR;VIM
11276,GO:0045545,0.217096330055049,0.979318808698452,1,5,syndecan binding,MF,TNC
6956,GO:0030579,0.21726275788461,0.97928545177614,1,5,ubiquitin-dependent SMAD protein catabolic process,BP,SMURF2
6630,GO:0022857,0.217385777701781,0.836824098167208,29,536,transmembrane transporter activity,MF,PANX1;ABCA5;SLC6A14;KCNJ15;TAP1;GJB3;SLC28A3;NIPAL4;SLC7A2;SLC11A2;SLC52A3;SLC38A2;RHD;TRPV3;SLC9A1;SLC25A37;RHCG;SLC2A6;CLIC4;TAPBP;ITGAV;JPH2;ABCA7;SLC9A8;SLC16A13;SLC16A1;SLC39A14;SLC41A1;GJC1
1176,GO:0002820,0.217417204889909,0.945534087932729,2,19,negative regulation of adaptive immune response,BP,IL7R;IL4R
5021,GO:0015181,0.217884704656401,0.979160532908485,1,5,arginine transmembrane transporter activity,MF,SLC7A2
5028,GO:0015189,0.217884704656401,0.979160532908485,1,5,L-lysine transmembrane transporter activity,MF,SLC7A2
8264,GO:0033043,0.217984629636338,0.823705792496678,53,1019,regulation of organelle organization,BP,IL1B;CSF2;TNF;IL1A;SDC4;LIF;PLAUR;PMAIP1;PPIF;EDN1;SQSTM1;BBC3;EREG;DUSP1;PLAGL2;PHLDB2;CYLD;ZNF451;NAV3;ICAM1;SMAD3;RND3;VEGFA;PLK2;ABL2;TP53BP2;CDC42EP4;PDE4DIP;WNT5A;TGFA;PDGFB;ANLN;NRG1;MMP9;SLC9A1;FEZ1;SPTBN5;CLIC4;RHOV;UGCG;TP53;UBE2D3;SDR16C5;PML;ESPL1;MUC1;GSK3B;KMT2E;PARP1;TBC1D22B;JMY;CEP135;LMAN1
14701,GO:0070314,0.218011013632456,0.979135112887378,1,5,G1 to G0 transition,BP,CYP27B1
10657,GO:0043696,0.218108433963089,0.979115495089145,1,5,dedifferentiation,BP,PDGFB
10658,GO:0043697,0.218108433963089,0.979115495089145,1,5,cell dedifferentiation,BP,PDGFB
12291,GO:0048593,0.218214796532122,0.898539924144157,5,66,camera-type eye morphogenesis,BP,EPHA2;FJX1;VEGFA;WNT5A;COL8A1
2483,GO:0005719,0.218241488565605,0.944820620931063,2,21,nuclear euchromatin,CC,JUN;CREB1
1071,GO:0002634,0.218454857565994,0.97904565229722,1,5,regulation of germinal center formation,BP,TNFAIP3
3190,GO:0006814,0.218491759084191,0.877563170213903,8,119,sodium ion transport,BP,NEDD4L;SGK1;SLC28A3;SLC38A2;SLC9A1;NEDD4;SLC9A8;SLC41A1
2949,GO:0006477,0.218519931789289,0.979032518245345,1,5,protein sulfation,BP,TPST1
8883,GO:0034694,0.218592143228519,0.945272430418855,2,18,response to prostaglandin,BP,EDN1;TNC
4642,GO:0010761,0.218758722848486,0.92378497691379,3,33,fibroblast migration,BP,SDC4;ZFAND5;PML
10485,GO:0043374,0.218979137338536,0.978939706626036,1,5,CD8-positive, alpha-beta T cell differentiation,BP,IRF1
13150,GO:0051702,0.219068629369299,0.908645346153684,4,53,interaction with symbiont,BP,ZC3H12A;PTX3;JUN;RAB9A
2111,GO:0004887,0.219474868486483,0.978839258302497,1,5,thyroid hormone receptor activity,MF,NR4A3
3004,GO:0006549,0.21950829120865,0.978832476460781,1,5,isoleucine metabolic process,BP,STAT5A
2219,GO:0005113,0.219560434838795,0.978821893539245,1,5,patched binding,MF,CAV1
10994,GO:0044788,0.219597765004246,0.944637373007929,2,19,modulation by host of viral process,BP,ZC3H12A;PTX3
13696,GO:0060215,0.219818751595435,0.97876942317329,1,5,primitive hemopoiesis,BP,VEGFA
1272,GO:0003056,0.219858044167348,0.978761435612592,1,5,regulation of vascular smooth muscle contraction,BP,DOCK4
16076,GO:0089720,0.220451638856587,0.977811338097463,1,6,caspase binding,MF,RIPK2
953,GO:0002369,0.220480295141708,0.944072317892027,2,20,T cell cytokine production,BP,IL6;CD55
16139,GO:0090118,0.220492411724662,0.978632248660961,1,5,receptor-mediated endocytosis involved in cholesterol transport,BP,LDLR
6214,GO:0019725,0.220588142836315,0.834092829713022,29,549,cellular homeostasis,BP,EDN1;BDKRB1;PIM3;C1QTNF1;NEDD4L;ICAM1;SMAD3;ABL2;TXNRD1;CD55;ADM;SAA1;SLC11A2;SOX4;MT2A;SLC9A1;RHCG;NFE2L2;CLIC4;CAV1;TP53;ITGAV;JPH2;PML;SLC9A8;EGLN1;XBP1;SLC39A14;SLC41A1
15452,GO:0071715,0.220678963645939,0.944190423117364,2,19,icosanoid transport,BP,IL1B;EDN1
17707,GO:1901571,0.220678963645939,0.944190423117364,2,19,fatty acid derivative transport,BP,IL1B;EDN1
3285,GO:0006974,0.220754169516773,0.827773144146529,38,740,cellular response to DNA damage stimulus,BP,TNF;BTG2;ZC3H12A;PPP1R15A;PMAIP1;IER3;EPHA2;BCL3;GADD45A;CDKN1A;SGK1;PLK2;USP43;BACH1;SFR1;TRIM25;MASTL;SOX4;PLK3;CHD2;RCHY1;TNKS1BP1;BCL2L2;NEDD4;SUSD6;INO80D;TP53;IKBKE;UBE2D3;RAD9B;PML;ESCO2;MUC1;PARP1;JMY;NABP1;RPS6KA6;EID3
13182,GO:0051766,0.220901723359844,0.978548663571327,1,5,inositol trisphosphate kinase activity,MF,ITPKC
15584,GO:0072028,0.221034666042663,0.907685577318151,4,50,nephron morphogenesis,BP,BMP2;LIF;SIX4;VEGFA
13509,GO:0055056,0.221070489262293,0.978514147493222,1,5,D-glucose transmembrane transporter activity,MF,SLC2A6
9316,GO:0035771,0.221285083597407,0.978470214212308,1,5,interleukin-4-mediated signaling pathway,BP,IL4R
14088,GO:0060872,0.221369822940112,0.978452852092357,1,5,semicircular canal development,BP,NR4A3
10339,GO:0043129,0.221615135270508,0.978402546735423,1,5,surfactant homeostasis,BP,VEGFA
19670,GO:1990868,0.221636740847185,0.978398113042826,1,5,response to chemokine,BP,ZC3H12A
19671,GO:1990869,0.221636740847185,0.978398113042826,1,5,cellular response to chemokine,BP,ZC3H12A
5252,GO:0015874,0.221650897446978,0.978395207685815,1,5,norepinephrine transport,BP,STX1A
592,GO:0001754,0.221884739082583,0.943915816036267,2,18,eye photoreceptor cell differentiation,BP,PRDM1;VEGFA
1344,GO:0003203,0.22209733895771,0.943827730267196,2,18,endocardial cushion morphogenesis,BP,BMP2;TGFBR2
6509,GO:0021877,0.22218023275692,0.978286416999865,1,5,forebrain neuron fate commitment,BP,DLX2
11086,GO:0045078,0.222218748464274,0.978278489320492,1,5,positive regulation of interferon-gamma biosynthetic process,BP,CD276
18068,GO:1902600,0.222535052175399,0.895250711748688,5,82,proton transmembrane transport,BP,PPIF;SLC11A2;SLC9A1;SLC2A6;SLC9A8
2554,GO:0005827,0.222593592468746,0.97820125156953,1,5,polar microtubule,CC,KLHL21
13893,GO:0060509,0.222598402802804,0.978200259398846,1,5,Type I pneumocyte differentiation,BP,CREB1
13531,GO:0055088,0.222682603907244,0.895572791920657,5,70,lipid homeostasis,BP,EHD1;LDLR;CAV1;MED13;XBP1
1121,GO:0002707,0.222723345416274,0.943137734460429,2,20,negative regulation of lymphocyte mediated immunity,BP,IL7R;HLA-E
17775,GO:1901727,0.222981971493682,0.978121064708658,1,5,positive regulation of histone deacetylase activity,BP,VEGFA
2097,GO:0004860,0.222982791965677,0.89534379312244,5,71,protein kinase inhibitor activity,MF,CDKN1A;TRIB1;CDKN2B;SOCS2;SPRY2
4566,GO:0010644,0.222987747981447,0.943230847039759,2,19,cell communication by electrical coupling,BP,CAV1;GJC1
12380,GO:0048755,0.223086118702808,0.978099534174366,1,5,branching morphogenesis of a nerve,BP,DLX2
17477,GO:1900271,0.223212534502255,0.943137045810769,2,19,regulation of long-term synaptic potentiation,BP,SQSTM1;CREB1
6287,GO:0019887,0.223309183726111,0.869205493263836,9,146,protein kinase regulator activity,MF,CDKN1A;TRIB1;CDKN2B;CCNL1;SOCS2;NRG1;CAB39;SPRY2;ABI1
474,GO:0001517,0.223351654076121,0.978044586493582,1,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,CHST2
11734,GO:0046532,0.22338457768471,0.978037768240499,1,5,regulation of photoreceptor cell differentiation,BP,DLX2
8857,GO:0034650,0.223547071698111,0.978004099665818,1,5,cortisol metabolic process,BP,BMP2
8858,GO:0034651,0.223547071698111,0.978004099665818,1,5,cortisol biosynthetic process,BP,BMP2
19741,GO:2000064,0.223547071698111,0.978004099665818,1,5,regulation of cortisol biosynthetic process,BP,BMP2
577,GO:0001726,0.224001827700462,0.868830489279924,9,138,ruffle,CC,EPHA2;ITGA5;FRMD4B;FGD6;LAYN;SPRY2;ITGAV;ABCA7;ADGRE2
16593,GO:0097381,0.224179910903236,0.977872703656703,1,5,photoreceptor disc membrane,CC,SPTBN5
4528,GO:0010587,0.224219586791615,0.977864451327239,1,5,miRNA catabolic process,BP,ZC3H12A
403,GO:0001083,0.224258175869086,0.977856423411325,1,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,TP53
15424,GO:0071675,0.224282663724195,0.94248411565938,2,20,regulation of mononuclear cell migration,BP,TNF;CSF1
15674,GO:0072178,0.224334036912638,0.977840636882178,1,5,nephric duct morphogenesis,BP,EFNB2
7032,GO:0030801,0.22439558088103,0.942436659499463,2,20,positive regulation of cyclic nucleotide metabolic process,BP,ADM;WNT5A
22,GO:0000041,0.224398020682227,0.894337518710764,5,74,transition metal ion transport,BP,STEAP4;HEPHL1;SLC11A2;SLC25A37;SLC39A14
15378,GO:0071604,0.224536364348272,0.942812922700547,2,18,transforming growth factor beta production,BP,SMAD3;CREB1
1976,GO:0004689,0.224575740164755,0.977790297333819,1,5,phosphorylase kinase activity,MF,PHKG2
2635,GO:0005964,0.224575740164755,0.977790297333819,1,5,phosphorylase kinase complex,CC,PHKG2
18598,GO:1903827,0.224813554313054,0.836575852252267,23,418,regulation of cellular protein localization,BP,IL1B;TNF;ZC3H12A;LIF;PMAIP1;EPHA2;SQSTM1;BBC3;PLAGL2;CYLD;CDKN1A;NEDD4L;TP53BP2;WNT5A;SOX4;NRG1;PLK3;PTPN1;UGCG;TP53;UBE2D3;GSK3B;PARP1
15160,GO:0071257,0.224820195540963,0.977739320183122,1,5,cellular response to electrical stimulus,BP,SLC9A1
20237,GO:2001138,0.224945952866951,0.976849283854636,1,6,regulation of phospholipid transport,BP,ABCA7
20238,GO:2001140,0.224945952866951,0.976849283854636,1,6,positive regulation of phospholipid transport,BP,ABCA7
12255,GO:0048520,0.224971145539404,0.977707809679425,1,5,positive regulation of behavior,BP,NR4A3
13635,GO:0060099,0.225059511466112,0.977689352003609,1,5,regulation of phagocytosis, engulfment,BP,ABCA7
13636,GO:0060100,0.225059511466112,0.977689352003609,1,5,positive regulation of phagocytosis, engulfment,BP,ABCA7
19170,GO:1905155,0.225059511466112,0.977689352003609,1,5,positive regulation of membrane invagination,BP,ABCA7
2553,GO:0005826,0.225060187584793,0.977689210744806,1,5,actomyosin contractile ring,CC,ANLN
4586,GO:0010668,0.225187282426752,0.97766264851274,1,5,ectodermal cell differentiation,BP,ETS2
19060,GO:1904885,0.225347529054493,0.977629132729099,1,5,beta-catenin destruction complex assembly,BP,GSK3B
495,GO:0001547,0.225485359014676,0.977600283124492,1,5,antral ovarian follicle growth,BP,EREG
7070,GO:0030853,0.226053990035587,0.977481043152207,1,5,negative regulation of granulocyte differentiation,BP,TRIB1
15694,GO:0072205,0.226157503740274,0.977459298893838,1,5,metanephric collecting duct development,BP,WNT7B
18490,GO:1903573,0.226240049823592,0.919582230658565,3,36,negative regulation of response to endoplasmic reticulum stress,BP,PPP1R15A;PTPN1;XBP1
14396,GO:0061630,0.226346426290817,0.856035324927542,12,198,ubiquitin protein ligase activity,MF,RNF19B;PELI1;NEDD4L;RNF144B;RNF43;VHL;SMURF2;RNF152;NEDD4;PJA2;UBE2Z;RNF145
11873,GO:0046854,0.226580645496535,0.893290459440883,5,66,phosphatidylinositol phosphorylation,BP,HBEGF;EREG;FGF5;PDGFB;NRG1
904,GO:0002281,0.226595328802177,0.977367199838363,1,5,macrophage activation involved in immune response,BP,TICAM1
9674,GO:0038031,0.226727198431166,0.977339419451027,1,5,non-canonical Wnt signaling pathway via JNK cascade,BP,WNT5A
10592,GO:0043552,0.226861006101881,0.94183842393767,2,18,positive regulation of phosphatidylinositol 3-kinase activity,BP,NOD2;PDGFB
133,GO:0000278,0.226931632803755,0.81805817712286,47,913,mitotic cell cycle,BP,IL1B;TNF;IL1A;BTG2;INHBA;BIRC3;EDN1;MAP2K3;EREG;DUSP1;GADD45A;BIRC2;PIM3;ZFP36L1;CYLD;CDKN1A;DCUN1D3;SMAD3;PHLDA1;CDKN2B;PLK2;MAP3K8;BTG1;ANKLE2;BACH1;MYBL1;MASTL;TGFA;SOX4;PDGFB;ANLN;BTG3;PLK3;SPRY2;TNKS1BP1;NUP153;TPRA1;TP53;GEM;RAD9B;PML;PIM1;ESPL1;MUC1;KMT2E;NABP1;CEP135
7763,GO:0032275,0.227023517719024,0.977276926177344,1,5,luteinizing hormone secretion,BP,TBX3
14032,GO:0060740,0.227085278919099,0.941744032055054,2,18,prostate gland epithelium morphogenesis,BP,WNT5A;TNC
1237,GO:0002922,0.227090550874324,0.976382244544601,1,6,positive regulation of humoral immune response,BP,TNF
6507,GO:0021872,0.227469270822164,0.919035472612259,3,35,forebrain generation of neurons,BP,INHBA;DLX2;WNT5A
13579,GO:0060028,0.227472648899817,0.97718202293448,1,5,convergent extension involved in axis elongation,BP,WNT5A
11369,GO:0045719,0.227485609189112,0.977179281112669,1,5,negative regulation of glycogen biosynthetic process,BP,GSK3B
14980,GO:0070874,0.227485609189112,0.977179281112669,1,5,negative regulation of glycogen metabolic process,BP,GSK3B
10419,GO:0043254,0.227507465178124,0.839857620903797,19,338,regulation of protein complex assembly,BP,CSF2;TNF;FOSL1;PMAIP1;JUN;BIRC2;ZNF451;NAV3;ICAM1;VEGFA;DKK1;CDC42EP4;CREB1;SPTBN5;TP53;STX1A;GSK3B;PARP1;JMY
17407,GO:1900122,0.227840647491365,0.976217673081705,1,6,positive regulation of receptor binding,BP,MMP9
13768,GO:0060330,0.227870431917884,0.940968037373642,2,20,regulation of response to interferon-gamma,BP,IFNGR2;IFNGR1
13772,GO:0060334,0.227870431917884,0.940968037373642,2,20,regulation of interferon-gamma-mediated signaling pathway,BP,IFNGR2;IFNGR1
13984,GO:0060677,0.228049025954134,0.977059910272067,1,5,ureteric bud elongation,BP,SIX4
8519,GO:0033700,0.228110619189033,0.976158286296333,1,6,phospholipid efflux,BP,ABCA7
12411,GO:0048843,0.228305355172525,0.941229368270519,2,18,negative regulation of axon extension involved in axon guidance,BP,SEMA4B;WNT5A
6986,GO:0030658,0.228359860253836,0.870443699927356,8,126,transport vesicle membrane,CC,RASSF9;TGFA;HLA-A;HLA-B;STX1A;HLA-F;HLA-E;LMAN1
3216,GO:0006863,0.228835346554265,0.975998459198666,1,6,purine nucleobase transport,BP,SLC28A3
9693,GO:0038084,0.228908080243554,0.940738126319264,2,19,vascular endothelial growth factor signaling pathway,BP,VEGFA;CCBE1
7404,GO:0031463,0.228917947402208,0.902994769095532,4,51,Cul3-RING ubiquitin ligase complex,CC,KLHL21;BACH1;KLHL5;KBTBD7
19119,GO:1905007,0.229028838360663,0.976851493680668,1,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2
1376,GO:0003264,0.229196262658954,0.975918644152887,1,6,regulation of cardioblast proliferation,BP,PIM1
17688,GO:1901535,0.229331049655913,0.976786998711581,1,5,regulation of DNA demethylation,BP,OTUD4
8718,GO:0034362,0.229363606713052,0.975881586901574,1,6,low-density lipoprotein particle,CC,LDLR
9802,GO:0040018,0.229788811462646,0.940363353285272,2,19,positive regulation of multicellular organism growth,BP,CSF1;CREB1
498,GO:0001553,0.229820132506901,0.976682412100659,1,5,luteinization,BP,INHBA
67,GO:0000138,0.229840198337136,0.975775875701371,1,6,Golgi trans cisterna,CC,B4GALT1
9832,GO:0042048,0.230234022171218,0.976593700749895,1,5,olfactory behavior,BP,GJB4
14557,GO:0070064,0.230362455486285,0.940118704020126,2,19,proline-rich region binding,MF,CYLD;NEDD4
564,GO:0001702,0.230557993348458,0.940273998153336,2,18,gastrulation with mouth forming second,BP,ETS2;WNT5A
19914,GO:2000378,0.230622623733918,0.917169534462267,3,37,negative regulation of reactive oxygen species metabolic process,BP,ZC3H12A;CFLAR;CAV1
14240,GO:0061179,0.23065328772322,0.974949107366737,1,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,PIM3
19761,GO:2000109,0.230709790680605,0.975582333581553,1,6,regulation of macrophage apoptotic process,BP,NOD2
5171,GO:0015718,0.231418120129898,0.881255093909671,6,87,monocarboxylic acid transport,BP,IL1B;EDN1;STARD5;SLC16A13;PPARD;SLC16A1
19006,GO:1904781,0.231802740625418,0.976255766575078,1,5,positive regulation of protein localization to centrosome,BP,GSK3B
18633,GO:1903900,0.231846915600167,0.873708981664026,7,112,regulation of viral life cycle,BP,CXCL8;TNF;ZC3H12A;PTX3;TNIP1;TRIM25;PML
7280,GO:0031258,0.231947859053153,0.939440302700498,2,19,lamellipodium membrane,CC,EPHA2;ITGAV
11292,GO:0045591,0.232223901581622,0.975243303137055,1,6,positive regulation of regulatory T cell differentiation,BP,DUSP10
9648,GO:0036514,0.232258205561566,0.9761571449866,1,5,dopaminergic neuron axon guidance,BP,WNT5A
19085,GO:1904938,0.232258205561566,0.9761571449866,1,5,planar cell polarity pathway involved in axon guidance,BP,WNT5A
4593,GO:0010694,0.232432669097292,0.976119308209467,1,5,positive regulation of alkaline phosphatase activity,BP,SMAD3
17877,GO:1902083,0.232436698288569,0.976118433984072,1,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,NCOA7
19787,GO:2000169,0.232436698288569,0.976118433984072,1,5,regulation of peptidyl-cysteine S-nitrosylation,BP,NCOA7
8515,GO:0033692,0.232526287824167,0.900787380123165,4,52,cellular polysaccharide biosynthetic process,BP,B3GNT5;PHKG2;PPP1R3B;GSK3B
6518,GO:0021891,0.232719582377417,0.976057011255873,1,5,olfactory bulb interneuron development,BP,WNT5A
10355,GO:0043161,0.232961820262061,0.83380622379638,20,370,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,RNF19B;BIRC2;N4BP1;NEDD4L;RNF144B;TRIB1;PLK2;ABTB2;SMURF2;TRIM25;PLK3;RCHY1;NEDD4;NFE2L2;CAV1;TP53;UBE2D3;PML;GSK3B;RNF145
14990,GO:0070888,0.232981450429961,0.938996241924383,2,19,E-box binding,MF,BHLHE40;ARNTL2
2096,GO:0004859,0.233672388768448,0.974253535278151,1,7,phospholipase inhibitor activity,MF,ANXA5
16356,GO:0090599,0.234022284093377,0.975773020649401,1,5,alpha-glucosidase activity,MF,MGAM
14350,GO:0061525,0.234052096371944,0.975766499697892,1,5,hindgut development,BP,WNT5A
7208,GO:0031093,0.234374346837671,0.915165511838748,3,37,platelet alpha granule lumen,CC,VEGFA;VEGFC;PDGFB
7082,GO:0030866,0.234549409661593,0.915385397891294,3,34,cortical actin cytoskeleton organization,BP,TNF;ANLN;EPB41L3
8308,GO:0033139,0.234580739301243,0.97471040517626,1,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,LIF
8620,GO:0034135,0.234675852361022,0.974688767022566,1,6,regulation of toll-like receptor 2 signaling pathway,BP,TNFAIP3
3167,GO:0006779,0.235095308173631,0.937665009828632,2,21,porphyrin-containing compound biosynthetic process,BP,SLC11A2;ALAS1
5871,GO:0017176,0.235130252045544,0.973913873945863,1,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,PIGA
16190,GO:0090197,0.235570501228272,0.974484731444921,1,6,positive regulation of chemokine secretion,BP,IL4R
14304,GO:0061383,0.2356077058867,0.914818458782381,3,34,trabecula morphogenesis,BP,ADAMTS1;NRG1;EGLN1
12299,GO:0048617,0.23594275879488,0.975350948661754,1,5,embryonic foregut morphogenesis,BP,SMAD3
17686,GO:1901533,0.236295568655038,0.974318702492528,1,6,negative regulation of hematopoietic progenitor cell differentiation,BP,NFE2L2
4897,GO:0014820,0.236374435261981,0.974300607167582,1,6,tonic smooth muscle contraction,BP,EDN1
15919,GO:0072677,0.236377642596174,0.974299871119854,1,6,eosinophil migration,BP,ADAM8
13106,GO:0051603,0.236617820404029,0.818806175525632,31,590,proteolysis involved in cellular protein catabolic process,BP,TNFAIP3;EFNA1;RNF19B;PMAIP1;SQSTM1;BIRC2;N4BP1;CYLD;NEDD4L;CTSC;RNF144B;TRIB1;PLK2;RNF43;USP43;ABTB2;SMURF2;TINAGL1;TRIM25;PLK3;RCHY1;NEDD4;NFE2L2;CAV1;TP53;UBE2D3;PML;USP31;GSK3B;RNF145;XBP1
803,GO:0002069,0.23667776615635,0.974230944185874,1,6,columnar/cuboidal epithelial cell maturation,BP,CDKN1A
139,GO:0000289,0.236743212624839,0.91409643907064,3,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,BTG2;ZFP36;TNKS1BP1
12973,GO:0051342,0.237074933917865,0.974139571972196,1,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,EGLN1
6875,GO:0030346,0.237133672337614,0.974126043364192,1,6,protein phosphatase 2B binding,MF,SLC9A1
3489,GO:0007368,0.237236737883699,0.886349469039448,5,69,determination of left/right symmetry,BP,TBX3;SMAD3;TGFBR2;WNT5A;RTTN
5148,GO:0015672,0.237370100041537,0.841844680943764,14,249,monovalent inorganic cation transport,BP,PPIF;NEDD4L;SGK1;KCNJ15;SLC28A3;SLC11A2;SLC38A2;CAB39;SLC9A1;NEDD4;SLC2A6;CAV1;SLC9A8;SLC41A1
12076,GO:0048015,0.237413208544701,0.870009704853214,7,104,phosphatidylinositol-mediated signaling,BP,IER3;EDN1;ZFP36L1;PDGFB;NRG1;NEDD4;PPARD
15763,GO:0072338,0.237621684777466,0.974978629187776,1,5,cellular lactam metabolic process,BP,STAT5A
8808,GO:0034511,0.237795588305072,0.973973318877591,1,6,U3 snoRNA binding,MF,DIEXF
3369,GO:0007135,0.23787835313595,0.973954187276176,1,6,meiosis II,BP,MASTL
14512,GO:0061983,0.23787835313595,0.973954187276176,1,6,meiosis II cell cycle process,BP,MASTL
873,GO:0002220,0.237883684157627,0.876578816755873,6,98,innate immune response activating cell surface receptor signaling pathway,BP,NFKBIA;NFKB1;RELB;TAB3;RELA;MUC1
875,GO:0002223,0.237883684157627,0.876578816755873,6,98,stimulatory C-type lectin receptor signaling pathway,BP,NFKBIA;NFKB1;RELB;TAB3;RELA;MUC1
3109,GO:0006686,0.238065889647582,0.973910808093668,1,6,sphingomyelin biosynthetic process,BP,SGMS2
3133,GO:0006721,0.238181489617174,0.897271111056881,4,54,terpenoid metabolic process,BP,SDC4;HMGCS1;SDR16C5;PPARD
2518,GO:0005769,0.238362578883985,0.838731934575374,15,258,early endosome,CC,EHD1;STEAP4;DKK1;SLC11A2;LDLR;ARRDC4;RASGEF1B;PTPN1;CAV1;HLA-A;HLA-B;ABCA7;PML;HLA-F;HLA-E
8259,GO:0033034,0.238516158913524,0.973806491908918,1,6,positive regulation of myeloid cell apoptotic process,BP,HCAR2
16476,GO:0097136,0.238753650772371,0.973751377562059,1,6,Bcl-2 family protein complex,CC,BCL2L2
3501,GO:0007405,0.238835132361021,0.913080826359019,3,34,neuroblast proliferation,BP,VEGFA;VEGFC;KCTD11
17876,GO:1902075,0.238971072241181,0.973700864338276,1,6,cellular response to salt,BP,ZC3H12A
884,GO:0002246,0.238977666941003,0.973699331355661,1,6,wound healing involved in inflammatory response,BP,IL1A
447,GO:0001206,0.239285968767374,0.974606478715137,1,5,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,BACH1
4844,GO:0014047,0.239353888003722,0.936227392382502,2,19,glutamate secretion,BP,SLC38A2;STX1A
11144,GO:0045180,0.239595597738366,0.974536903840886,1,5,basal cortex,CC,PHLDB2
9049,GO:0035264,0.239686229922443,0.868387547297291,7,105,multicellular organism growth,BP,CSF1;ZFP36L1;CREB1;SOCS2;CLIC4;STAT5A;STK40
17239,GO:0110011,0.239713312597955,0.974510424926189,1,5,regulation of basement membrane organization,BP,PHLDB2
18783,GO:1904259,0.239713312597955,0.974510424926189,1,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,PHLDB2
18784,GO:1904261,0.239713312597955,0.974510424926189,1,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,PHLDB2
20270,GO:2001197,0.239713312597955,0.974510424926189,1,5,basement membrane assembly involved in embryonic body morphogenesis,BP,PHLDB2
1270,GO:0003044,0.239767070999568,0.93561505511126,2,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,SOD2;EDN1
2344,GO:0005375,0.239982055651343,0.973465273035193,1,6,copper ion transmembrane transporter activity,MF,SLC11A2
9125,GO:0035434,0.239982055651343,0.973465273035193,1,6,copper ion transmembrane transport,BP,SLC11A2
11257,GO:0045453,0.240009256755662,0.912223816215786,3,36,bone resorption,BP,TNFAIP3;IL6;ADAM8
17122,GO:0101003,0.24017758928431,0.912030826844914,3,37,ficolin-1-rich granule membrane,CC,ADAM8;CD55;MGAM
2427,GO:0005604,0.240208253829902,0.884523113253959,5,67,basement membrane,CC,LAMB3;ADAMTS1;TNC;LAMA3;COL8A1
12641,GO:0050815,0.240238068932575,0.97340542796191,1,6,phosphoserine residue binding,MF,NEDD4
6755,GO:0030173,0.240453220229775,0.911880891712147,3,37,integral component of Golgi membrane,CC,SYS1;SGMS2;TPST1
16205,GO:0090218,0.241224083650345,0.93540463993687,2,19,positive regulation of lipid kinase activity,BP,NOD2;PDGFB
4500,GO:0010522,0.241323241067745,0.895369416348228,4,54,regulation of calcium ion transport into cytosol,BP,BDKRB1;CAV1;JPH2;PML
6066,GO:0019210,0.241420920621737,0.883469605616006,5,73,kinase inhibitor activity,MF,CDKN1A;TRIB1;CDKN2B;SOCS2;SPRY2
17266,GO:0120035,0.241460116319376,0.821511660925058,24,429,regulation of plasma membrane bounded cell projection organization,BP,EFNA1;EPHA2;CYLD;NAV3;NEDD4L;ICAM1;VEGFA;ZSWIM4;PLK2;ABL2;CFLAR;CDC42EP4;SEMA4B;WNT5A;ANLN;NRG1;FEZ1;NEDD4;ITSN2;NFE2L2;CAV1;EFNB2;VIM;CEP135
10720,GO:0044033,0.2414710910157,0.973116146353778,1,6,multi-organism metabolic process,BP,MAP2K3
19851,GO:2000288,0.24156307280601,0.973094496364548,1,6,positive regulation of myoblast proliferation,BP,PPARD
11225,GO:0045350,0.241787539675065,0.97304162221092,1,6,interferon-beta biosynthetic process,BP,TICAM1
11232,GO:0045357,0.241787539675065,0.97304162221092,1,6,regulation of interferon-beta biosynthetic process,BP,TICAM1
4974,GO:0015081,0.241792508757545,0.883495953689834,5,67,sodium ion transmembrane transporter activity,MF,SLC6A14;SLC28A3;SLC9A1;SLC9A8;SLC41A1
19840,GO:2000273,0.241899026830212,0.934669980365591,2,21,positive regulation of signaling receptor activity,BP,EREG;TGFA
5037,GO:0015205,0.241930360860866,0.973007949908646,1,6,nucleobase transmembrane transporter activity,MF,SLC28A3
18652,GO:1903935,0.241939121296295,0.973005883737273,1,6,response to sodium arsenite,BP,ZC3H12A
17721,GO:1901616,0.242071588202276,0.910998629058904,3,37,organic hydroxy compound catabolic process,BP,CYP27B1;MAOA;CYP24A1
3137,GO:0006729,0.242159153229575,0.972241460879538,1,7,tetrahydrobiopterin biosynthetic process,BP,GCH1
11593,GO:0046146,0.242159153229575,0.972241460879538,1,7,tetrahydrobiopterin metabolic process,BP,GCH1
15503,GO:0071855,0.242183631398455,0.972235535603257,1,7,neuropeptide receptor binding,MF,EDN1
9604,GO:0036459,0.242234528873341,0.87394330348068,6,87,thiol-dependent ubiquitinyl hydrolase activity,MF,TNFAIP3;ZC3H12A;CYLD;USP43;OTUD4;USP31
17123,GO:0101005,0.242234528873341,0.87394330348068,6,87,ubiquitinyl hydrolase activity,MF,TNFAIP3;ZC3H12A;CYLD;USP43;OTUD4;USP31
3795,GO:0008360,0.24232096958944,0.860463288201317,8,123,regulation of cell shape,BP,BAMBI;ICAM1;RND3;VEGFA;FGD6;CDC42EP4;RHOV;EPB41L3
4497,GO:0010519,0.242359595423776,0.972906610052296,1,6,negative regulation of phospholipase activity,BP,ANXA8
10793,GO:0044257,0.2424501680961,0.812240558048618,33,633,cellular protein catabolic process,BP,TNFAIP3;EFNA1;RNF19B;PMAIP1;SQSTM1;BIRC2;N4BP1;CYLD;NEDD4L;CTSC;RNF144B;TRIB1;PLK2;RNF43;DENND3;USP43;ABTB2;SMURF2;TINAGL1;TRIM25;LDLR;PLK3;RCHY1;NEDD4;NFE2L2;CAV1;TP53;UBE2D3;PML;USP31;GSK3B;RNF145;XBP1
11857,GO:0046826,0.242460197930621,0.972168539953657,1,7,negative regulation of protein export from nucleus,BP,SOX4
12290,GO:0048592,0.242495945766381,0.873799097670255,6,86,eye morphogenesis,BP,PRDM1;EPHA2;FJX1;VEGFA;WNT5A;COL8A1
3419,GO:0007205,0.242749678195888,0.934499248114035,2,20,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,EDN1;BDKRB1
6056,GO:0019199,0.242800229759297,0.894739430452599,4,50,transmembrane receptor protein kinase activity,MF,EPHA2;TGFBR2;AXL;DDR1
10254,GO:0042985,0.242818728699301,0.972797976650299,1,6,negative regulation of amyloid precursor protein biosynthetic process,BP,ABCA7
1994,GO:0004712,0.242831507420479,0.910686201215284,3,36,protein serine/threonine/tyrosine kinase activity,MF,MAP2K3;SGK1;CLK4
12074,GO:0048013,0.242855327285776,0.882577726503959,5,72,ephrin receptor signaling pathway,BP,EFNA1;EPHA2;EFNB1;MMP9;EFNB2
15244,GO:0071389,0.242873952566069,0.972784894038953,1,6,cellular response to mineralocorticoid stimulus,BP,EDN1
2327,GO:0005337,0.242913262102377,0.972775579415496,1,6,nucleoside transmembrane transporter activity,MF,SLC28A3
5241,GO:0015858,0.242913262102377,0.972775579415496,1,6,nucleoside transport,BP,SLC28A3
17736,GO:1901642,0.242913262102377,0.972775579415496,1,6,nucleoside transmembrane transport,BP,SLC28A3
1407,GO:0003338,0.243221456940252,0.934289365795846,2,20,metanephros morphogenesis,BP,LIF;WNT7B
9379,GO:0035904,0.243277428503159,0.910667793771498,3,34,aorta development,BP,PRDM1;SOX4;EFNB2
12297,GO:0048609,0.243315691780334,0.818762208549848,25,460,multicellular organismal reproductive process,BP,INHBA;BIRC3;FOSL1;LIF;PRDM1;EDN1;ETS1;EREG;CYP27B1;JUNB;B4GALT1;BTG1;GJB3;ADAMTS1;TAF4B;MYBL1;MASTL;BCL2L2;IL4R;SMAD1;ZNF148;SPATA2;AXL;PPARD;QKI
18675,GO:1903975,0.243403802322881,0.972659193382341,1,6,regulation of glial cell migration,BP,CSF1
15887,GO:0072595,0.243724563948924,0.909996322440102,3,38,maintenance of protein localization in organelle,BP,BCL3;SOX4;PML
7083,GO:0030867,0.243782688487593,0.933165323290918,2,25,rough endoplasmic reticulum membrane,CC,ZC3H12A;SUCO
14893,GO:0070671,0.243784072853302,0.909699858284305,3,41,response to interleukin-12,BP,SOD2;SERPINB2;RIPK2
17845,GO:1901990,0.243793409750805,0.82642892875582,19,357,regulation of mitotic cell cycle phase transition,BP,BTG2;DUSP1;GADD45A;ZFP36L1;CDKN1A;DCUN1D3;CDKN2B;PLK2;SOX4;ANLN;PLK3;TNKS1BP1;TPRA1;TP53;PML;ESPL1;MUC1;KMT2E;CEP135
10803,GO:0044275,0.24418249260062,0.909946635168012,3,36,cellular carbohydrate catabolic process,BP,PHKG2;PPP1R3B;MGAM
13129,GO:0051651,0.244203642746178,0.881615866481521,5,74,maintenance of location in cell,BP,BCL3;SOX4;CAV1;PML;EPB41L3
13895,GO:0060512,0.24433400504572,0.934026305789865,2,19,prostate gland morphogenesis,BP,WNT5A;TNC
11598,GO:0046165,0.244675670795907,0.864716864543873,7,111,alcohol biosynthetic process,BP,IL1B;TNF;ITPKC;NFKB1;CYP27B1;GCH1;HMGCS1
6659,GO:0030004,0.244748148722126,0.881300808330693,5,73,cellular monovalent inorganic cation homeostasis,BP,NEDD4L;SLC9A1;CLIC4;TP53;SLC9A8
1004,GO:0002475,0.244770197454881,0.972333538638197,1,6,antigen processing and presentation via MHC class Ib,BP,HLA-E
18938,GO:1904645,0.244808484021518,0.933581184165859,2,20,response to amyloid-beta,BP,GSK3B;PARP1
10214,GO:0042826,0.244966554797937,0.872010935999731,6,89,histone deacetylase binding,MF,PRDM1;CEBPB;CHD4;TP53;RELA;PARP1
2874,GO:0006367,0.245013387052846,0.853166660932032,9,152,transcription initiation from RNA polymerase II promoter,BP,CDKN1A;ZNF451;CREB1;TAF4B;NR4A2;TP53;NR4A3;PPARD;MED13
15996,GO:0080154,0.245210588447408,0.972228120479627,1,6,regulation of fertilization,BP,B4GALT1
5213,GO:0015809,0.245216071413049,0.972226806587979,1,6,arginine transport,BP,SLC7A2
16164,GO:0090166,0.245273404267753,0.972213065745303,1,6,Golgi disassembly,BP,PLK3
3161,GO:0006771,0.245318189520911,0.972202329516846,1,6,riboflavin metabolic process,BP,SLC52A3
13156,GO:0051709,0.245716532314216,0.971372950456469,1,7,regulation of killing of cells of other organism,BP,PGLYRP4
13158,GO:0051712,0.245716532314216,0.971372950456469,1,7,positive regulation of killing of cells of other organism,BP,PGLYRP4
15575,GO:0072009,0.24583822563111,0.880763980849622,5,69,nephron epithelium development,BP,BMP2;LIF;SIX4;VEGFA;WNT7B
13330,GO:0052173,0.245891433023385,0.972064702864259,1,6,response to defenses of other organism involved in symbiotic interaction,BP,SMAD3
13335,GO:0052200,0.245891433023385,0.972064702864259,1,6,response to host defenses,BP,SMAD3
15965,GO:0075136,0.245891433023385,0.972064702864259,1,6,response to host,BP,SMAD3
6086,GO:0019238,0.24589151111101,0.972064684090775,1,6,cyclohydrolase activity,MF,GCH1
7359,GO:0031397,0.245948192682693,0.892315880799996,4,58,negative regulation of protein ubiquitination,BP,TNFAIP3;N4BP1;SOX4;CAV1
13652,GO:0060137,0.245993924749966,0.972040056182583,1,6,maternal process involved in parturition,BP,EDN1
16367,GO:0090647,0.246114754199945,0.972010984130258,1,6,modulation of age-related behavioral decline,BP,DKK1
1007,GO:0002478,0.246208390791805,0.857303663223832,8,141,antigen processing and presentation of exogenous peptide antigen,BP,TAP1;KIF3C;HLA-A;TAPBP;HLA-B;ITGAV;HLA-F;HLA-E
4234,GO:0009410,0.246228657732056,0.847827769310633,10,171,response to xenobiotic stimulus,BP,EDN1;CLDN1;ICAM1;CFLAR;ERRFI1;NR4A2;PDGFB;STAT5A;TP53;RELA
16492,GO:0097164,0.246322584332433,0.857356262191863,8,133,ammonium ion metabolic process,BP,ODC1;GCH1;NR4A2;LDLR;MAOA;SGMS2;PAOX;SAT1
10061,GO:0042541,0.246324111749404,0.971960571863142,1,6,hemoglobin biosynthetic process,BP,INHBA
4590,GO:0010677,0.246366451961104,0.932882739821213,2,20,negative regulation of cellular carbohydrate metabolic process,BP,SOGA1;GSK3B
4674,GO:0010819,0.246454028727043,0.971929262984932,1,6,regulation of T cell chemotaxis,BP,WNT5A
4675,GO:0010820,0.246454028727043,0.971929262984932,1,6,positive regulation of T cell chemotaxis,BP,WNT5A
7285,GO:0031265,0.246595589642802,0.971895125770337,1,6,CD95 death-inducing signaling complex,CC,CFLAR
6674,GO:0030030,0.246757898994817,0.797449472633282,55,1049,cell projection organization,BP,EFNA1;SDC4;BTG2;JUN;RAB3IP;EPHA2;EHD1;EFNB1;IL6;CYLD;NAV3;NEDD4L;SGK1;ICAM1;VEGFA;FGD6;ZSWIM4;PLK2;ABL2;CFLAR;KLF7;ADM;CDC42EP4;CREB1;GORAB;NR4A2;SEMA4B;KIF3C;WNT5A;SLC11A2;ANLN;NRG1;TNC;PARD6B;SPRY2;FEZ1;GRB7;NEDD4;ITSN2;NFE2L2;WNT7B;SPTBN5;CAV1;RHOV;RTTN;ABI1;EFNB2;RAPH1;EMP3;NR4A3;GSK3B;VIM;DDR1;CEP135;EPB41L3
15563,GO:0071971,0.246781813984963,0.971850182688962,1,6,extracellular exosome assembly,BP,SDC4
18476,GO:1903551,0.246781813984963,0.971850182688962,1,6,regulation of extracellular exosome assembly,BP,SDC4
9723,GO:0038155,0.246803624845442,0.971844916263426,1,6,interleukin-23-mediated signaling pathway,BP,IL23A
14662,GO:0070244,0.246870304178631,0.971828812529935,1,6,negative regulation of thymocyte apoptotic process,BP,EFNA1
11212,GO:0045334,0.246913993348568,0.908339211435121,3,37,clathrin-coated endocytic vesicle,CC,HBEGF;WNT5A;LDLR
9382,GO:0035909,0.246928420396302,0.932866709066461,2,19,aorta morphogenesis,BP,SOX4;EFNB2
15314,GO:0071493,0.247131157345359,0.971765764355691,1,6,cellular response to UV-B,BP,CDKN1A
8167,GO:0032897,0.247240880872267,0.932275628708475,2,21,negative regulation of viral transcription,BP,ZFP36;JUN
562,GO:0001696,0.247272931659913,0.971731464446729,1,6,gastric acid secretion,BP,SGK1
4890,GO:0014807,0.247687943235742,0.971630925428083,1,6,regulation of somitogenesis,BP,NRARP
13481,GO:0055001,0.247740178978617,0.870140982466542,6,88,muscle cell development,BP,TBX3;EDN1;SIX4;VEGFA;CFLAR;ADM
11166,GO:0045214,0.248030738638303,0.932133097297679,2,20,sarcomere organization,BP,EDN1;SIX4
7950,GO:0032536,0.248171336503512,0.971513568647504,1,6,regulation of cell projection size,BP,WNT7B
9946,GO:0042301,0.248281183256734,0.971486862562527,1,6,phosphate ion binding,MF,RELA
18092,GO:1902668,0.248324510433337,0.932239048670994,2,19,negative regulation of axon guidance,BP,SEMA4B;WNT5A
14183,GO:0061051,0.24842134724106,0.971452765369481,1,6,positive regulation of cell growth involved in cardiac muscle cell development,BP,EDN1
715,GO:0001937,0.248444867013059,0.931945994603816,2,20,negative regulation of endothelial cell proliferation,BP,TNF;CAV1
9696,GO:0038089,0.248447215898753,0.971446469899499,1,6,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,VEGFA
3443,GO:0007253,0.248480148265099,0.970687916257992,1,7,cytoplasmic sequestering of NF-kappaB,BP,NFKBIA
8072,GO:0032736,0.24858424382258,0.971413109432579,1,6,positive regulation of interleukin-13 production,BP,HLA-E
6326,GO:0019985,0.248681452354712,0.907165969276811,3,39,translesion synthesis,BP,USP43;TRIM25;RCHY1
7440,GO:0031545,0.249609044925676,0.971162922134972,1,6,peptidyl-proline 4-dioxygenase activity,MF,EGLN1
18970,GO:1904714,0.249866658543943,0.971099838159087,1,6,regulation of chaperone-mediated autophagy,BP,PLK3
16729,GO:0097709,0.250020014500666,0.971062247942351,1,6,connective tissue replacement,BP,IL1A
12139,GO:0048207,0.250100519775638,0.889872257886041,4,56,vesicle targeting, rough ER to cis-Golgi,BP,CTSC;TGFA;PPP6R3;LMAN1
12140,GO:0048208,0.250100519775638,0.889872257886041,4,56,COPII vesicle coating,BP,CTSC;TGFA;PPP6R3;LMAN1
3577,GO:0007622,0.250147216711539,0.930760187724743,2,22,rhythmic behavior,BP,CSF2;TP53
12249,GO:0048512,0.250147216711539,0.930760187724743,2,22,circadian behavior,BP,CSF2;TP53
4580,GO:0010662,0.250171030784988,0.931163680506173,2,20,regulation of striated muscle cell apoptotic process,BP,CFLAR;NFE2L2
6687,GO:0030048,0.25024280286331,0.877872464210137,5,69,actin filament-based movement,BP,NEDD4L;SLC9A1;CAV1;VIM;GJC1
13854,GO:0060440,0.250518052535619,0.970939981263907,1,6,trachea formation,BP,TGFBR2
2987,GO:0006531,0.250564602206713,0.970928538710179,1,6,aspartate metabolic process,BP,NMNAT2
2645,GO:0005979,0.250579793820142,0.931219689611731,2,19,regulation of glycogen biosynthetic process,BP,PPP1R3B;GSK3B
4780,GO:0010962,0.250579793820142,0.931219689611731,2,19,regulation of glucan biosynthetic process,BP,PPP1R3B;GSK3B
15465,GO:0071774,0.250781427970132,0.860394084148933,7,110,response to fibroblast growth factor,BP,CXCL8;ZFP36;ZFP36L1;FGF5;WNT5A;TNC;SPRY2
4682,GO:0010827,0.250810344786592,0.88969045386474,4,52,regulation of glucose transmembrane transport,BP,IL1B;TNF;NFE2L2;NR4A3
12215,GO:0048384,0.250858964832639,0.93063250972884,2,21,retinoic acid receptor signaling pathway,BP,PML;TRIM16
8231,GO:0032990,0.25089717006331,0.811268670887076,26,465,cell part morphogenesis,BP,EFNA1;EFNB1;NEDD4L;SGK1;VEGFA;ZSWIM4;KLF7;CREB1;NR4A2;SEMA4B;WNT5A;SLC11A2;NRG1;PARD6B;FEZ1;GRB7;NEDD4;ITSN2;WNT7B;SPTBN5;ABI1;EFNB2;RAPH1;NR4A3;DDR1;EPB41L3
10197,GO:0042796,0.251300787679721,0.970747238291238,1,6,snRNA transcription by RNA polymerase III,BP,SNAPC4
8804,GO:0034504,0.25152354502248,0.836462530786968,12,205,protein localization to nucleus,BP,NFKBIA;TNF;ZC3H12A;LIF;BCL3;SIX4;CDKN1A;SOX4;NUP153;ABCA7;PML;GSK3B
18376,GO:1903349,0.251576103063389,0.970679273972806,1,6,omegasome membrane,CC,PLEKHF1
4577,GO:0010659,0.251597491768653,0.930514230005019,2,20,cardiac muscle cell apoptotic process,BP,CFLAR;NFE2L2
4484,GO:0010498,0.252292465456201,0.814834364950077,22,415,proteasomal protein catabolic process,BP,RNF19B;PMAIP1;BIRC2;N4BP1;NEDD4L;RNF144B;TRIB1;PLK2;ABTB2;SMURF2;TRIM25;PLK3;RCHY1;NEDD4;NFE2L2;CAV1;TP53;UBE2D3;PML;GSK3B;RNF145;XBP1
540,GO:0001658,0.252706868745337,0.905227660137793,3,36,branching involved in ureteric bud morphogenesis,BP,BMP2;SIX4;VEGFA
18848,GO:1904415,0.252742884633117,0.970390260140793,1,6,regulation of xenophagy,BP,RIPK2
18849,GO:1904417,0.252742884633117,0.970390260140793,1,6,positive regulation of xenophagy,BP,RIPK2
18206,GO:1902961,0.252758081309371,0.970386485403479,1,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,EFNA1
19201,GO:1905247,0.252758081309371,0.970386485403479,1,6,positive regulation of aspartic-type peptidase activity,BP,EFNA1
19656,GO:1990822,0.25285243984455,0.970363041426727,1,6,basic amino acid transmembrane transport,BP,SLC7A2
2972,GO:0006511,0.25288724482184,0.808435607339552,27,513,ubiquitin-dependent protein catabolic process,BP,TNFAIP3;RNF19B;SQSTM1;BIRC2;N4BP1;CYLD;NEDD4L;RNF144B;TRIB1;PLK2;RNF43;USP43;ABTB2;SMURF2;TRIM25;PLK3;RCHY1;NEDD4;NFE2L2;CAV1;TP53;UBE2D3;PML;USP31;GSK3B;RNF145;XBP1
12172,GO:0048273,0.253221817831129,0.970271166955154,1,6,mitogen-activated protein kinase p38 binding,MF,DUSP10
13862,GO:0060449,0.253368838834944,0.970234554374508,1,6,bud elongation involved in lung branching,BP,SPRY2
16004,GO:0086001,0.253535531243171,0.904879306067409,3,35,cardiac muscle cell action potential,BP,NEDD4L;CAV1;GJC1
7751,GO:0032261,0.253604868134335,0.969393609686699,1,7,purine nucleotide salvage,BP,AMPD3
16850,GO:0098742,0.253932763081284,0.858239268686057,7,106,cell-cell adhesion via plasma-membrane adhesion molecules,BP,BMP2;IL1RN;CLDN1;ITGA5;ICAM1;TGFBR2;CRB3
1533,GO:0003910,0.254044027265423,0.970066087538021,1,6,DNA ligase (ATP) activity,MF,PARP1
6278,GO:0019869,0.254393766388294,0.969191581166272,1,7,chloride channel inhibitor activity,MF,STX1A
7170,GO:0031045,0.254727524692489,0.969895003529204,1,6,dense core granule,CC,ADAM8
13996,GO:0060693,0.254749390526209,0.969889521322595,1,6,regulation of branching involved in salivary gland morphogenesis,BP,TNF
2646,GO:0005980,0.254806383796611,0.92904345361696,2,20,glycogen catabolic process,BP,PHKG2;PPP1R3B
11475,GO:0045921,0.255056650199344,0.88679546191606,4,56,positive regulation of exocytosis,BP,SDC4;IL4R;RAB9A;STX1A
4831,GO:0014032,0.255145526316171,0.88686606790516,4,54,neural crest cell development,BP,EDN1;EFNB1;SEMA4B;NRG1
16012,GO:0086009,0.255187644213418,0.928867802681023,2,20,membrane repolarization,BP,NEDD4L;CAV1
7229,GO:0031119,0.255382643009448,0.968937287782658,1,7,tRNA pseudouridine synthesis,BP,PUS10
12443,GO:0048934,0.255429082580487,0.969718829053988,1,6,peripheral nervous system neuron differentiation,BP,RUNX1
12444,GO:0048935,0.255429082580487,0.969718829053988,1,6,peripheral nervous system neuron development,BP,RUNX1
3893,GO:0008525,0.255565242585245,0.969684569756357,1,6,phosphatidylcholine transporter activity,MF,ABCA7
12661,GO:0050852,0.255615059353637,0.850407648939687,8,140,T cell receptor signaling pathway,BP,NFKBIA;ZC3H12A;NFKB1;RIPK2;CYLD;BTN2A2;CD276;RELA
8005,GO:0032621,0.25564440150617,0.969664642526687,1,6,interleukin-18 production,BP,TLR2
18034,GO:1902513,0.255712382875139,0.969647523226386,1,6,regulation of organelle transport along microtubule,BP,FEZ1
7119,GO:0030915,0.255713340937337,0.968851986010054,1,7,Smc5-Smc6 complex,CC,EID3
17222,GO:0106068,0.255713340937337,0.968851986010054,1,7,SUMO ligase complex,CC,EID3
15361,GO:0071578,0.255761085639375,0.969635255392555,1,6,zinc ion import across plasma membrane,BP,SLC39A14
11431,GO:0045836,0.255766482499714,0.969633895795444,1,6,positive regulation of meiotic nuclear division,BP,WNT5A
19839,GO:2000272,0.25576937851942,0.928374838427425,2,21,negative regulation of signaling receptor activity,BP,ERRFI1;MED13
14578,GO:0070099,0.255830589297795,0.969617743155477,1,6,regulation of chemokine-mediated signaling pathway,BP,EDN1
3335,GO:0007049,0.255854895588008,0.78330418217761,77,1548,cell cycle,BP,CXCL8;IL1B;TNFAIP3;TNF;IRF1;IL1A;BTG2;INHBA;BIRC3;FOSL1;PPP1R15A;BMP2;LIF;TBX3;EDN1;MAP2K3;JUN;IRF6;EREG;DUSP1;GADD45A;BIRC2;PIM3;ZFP36L1;CYP27B1;KLHL21;JUNB;CYLD;WTAP;CDKN1A;DCUN1D3;SMAD3;PHLDA1;RND3;CDKN2B;PLK2;MAP3K8;BTG1;TP53BP2;ANKLE2;CCNL1;NEDD9;BACH1;MYBL1;MASTL;WNT5A;TGFA;SOX4;PDGFB;ANLN;BTG3;CAB39;PLK3;PARD6B;YAF2;SPRY2;TNKS1BP1;NUP153;TPRA1;GOLGA8B;TP53;GEM;RAD9B;PML;PIM1;ESPL1;ESCO2;EVI2B;MUC1;NR4A3;KMT2E;SLC16A1;JMY;NABP1;CEP135;KCTD11;JUND
3170,GO:0006782,0.255935090142883,0.968794713500536,1,7,protoporphyrinogen IX biosynthetic process,BP,ALAS1
483,GO:0001533,0.255970266934781,0.902661666159648,3,44,cornified envelope,CC,SPRR2D;SPRR2A;LCE1C
13521,GO:0055076,0.256112458581472,0.864012012661536,6,99,transition metal ion homeostasis,BP,STEAP4;SLC11A2;MT2A;SLC25A37;EGLN1;SLC39A14
3392,GO:0007171,0.256117133137754,0.969545485239447,1,6,activation of transmembrane receptor protein tyrosine kinase activity,BP,NRG1
6880,GO:0030368,0.256226887706551,0.969517782810853,1,6,interleukin-17 receptor activity,MF,IL6ST
13571,GO:0060020,0.256658785490176,0.96940863280418,1,6,Bergmann glial cell differentiation,BP,VIM
18217,GO:1902991,0.256704938426031,0.927941082080603,2,21,regulation of amyloid precursor protein catabolic process,BP,EFNA1;ABCA7
7649,GO:0032056,0.257147151171045,0.969284947773521,1,6,positive regulation of translation in response to stress,BP,PPP1R15A
11365,GO:0045714,0.257168847157405,0.969279446467251,1,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
14996,GO:0070897,0.257383402745568,0.902285688565469,3,39,DNA-templated transcriptional preinitiation complex assembly,BP,CREB1;TAF4B;TP53
4507,GO:0010543,0.257481547431351,0.927580142318722,2,21,regulation of platelet activation,BP,C1QTNF1;PDGFB
4970,GO:0015075,0.257485703488229,0.80787773385851,24,445,ion transmembrane transporter activity,MF,PANX1;SLC6A14;KCNJ15;SLC28A3;NIPAL4;SLC7A2;SLC11A2;SLC52A3;SLC38A2;RHD;TRPV3;SLC9A1;SLC25A37;RHCG;SLC2A6;CLIC4;ITGAV;JPH2;SLC9A8;SLC16A13;SLC16A1;SLC39A14;SLC41A1;GJC1
7933,GO:0032504,0.257494866727945,0.806680403195597,25,465,multicellular organism reproduction,BP,INHBA;BIRC3;FOSL1;LIF;PRDM1;EDN1;ETS1;EREG;CYP27B1;JUNB;B4GALT1;BTG1;GJB3;ADAMTS1;TAF4B;MYBL1;MASTL;BCL2L2;IL4R;SMAD1;ZNF148;SPATA2;AXL;PPARD;QKI
18746,GO:1904181,0.257557938513284,0.968373773063085,1,7,positive regulation of membrane depolarization,BP,PARP1
7772,GO:0032288,0.257597030234568,0.927753337622524,2,20,myelin assembly,BP,TLR2;EPB41L3
12081,GO:0048020,0.257664326226906,0.967742887002221,1,8,CCR chemokine receptor binding,MF,CCL20
20306,GO:2001252,0.257665482072467,0.843753441472096,9,147,positive regulation of chromosome organization,BP,IL1B;LIF;VEGFA;TP53;SDR16C5;PML;ESPL1;MUC1;KMT2E
399,GO:0001075,0.257822022639901,0.969113565553987,1,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,TAF4B
12370,GO:0048739,0.257973386010564,0.969075053463935,1,6,cardiac muscle fiber development,BP,VEGFA
2644,GO:0005978,0.258177720501603,0.902040210839973,3,37,glycogen biosynthetic process,BP,PHKG2;PPP1R3B;GSK3B
4178,GO:0009250,0.258177720501603,0.902040210839973,3,37,glucan biosynthetic process,BP,PHKG2;PPP1R3B;GSK3B
4319,GO:0009798,0.258181064069582,0.884968941061952,4,54,axis specification,BP,TBX3;ETS2;NRARP;WNT5A
8701,GO:0034333,0.258204326033665,0.872592366220458,5,69,adherens junction assembly,BP,SDC4;PHLDB2;SMAD3;VEGFA;SLC9A1
5448,GO:0016311,0.258214780815313,0.812888448755905,20,359,dephosphorylation,BP,TNF;PLEKHF1;PPP1R15A;BMP2;DUSP1;DAPP1;SMAD3;PPTC7;PPP4R4;ANKLE2;DUSP16;MASTL;DUSP10;PPP1R3B;DUSP8;PTPN1;SH3RF2;PDP1;PPP6R3;GSK3B
14833,GO:0070562,0.258324085152793,0.968985719652971,1,6,regulation of vitamin D receptor signaling pathway,BP,CYP27B1
13758,GO:0060316,0.25833194031321,0.968171894094872,1,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,JPH2
17052,GO:0099516,0.258595358129885,0.901915080501464,3,36,ion antiporter activity,MF,SLC9A1;SLC9A8;SLC41A1
7942,GO:0032525,0.258755548682439,0.968875613652615,1,6,somite rostral/caudal axis specification,BP,NRARP
11430,GO:0045835,0.258757883045922,0.968875017344495,1,6,negative regulation of meiotic nuclear division,BP,LIF
20284,GO:2001223,0.259115340773191,0.968783629627264,1,6,negative regulation of neuron migration,BP,NRG1
15286,GO:0071455,0.259160270847386,0.968772132121677,1,6,cellular response to hyperoxia,BP,CAV1
13583,GO:0060033,0.259275318985869,0.968742680691348,1,6,anatomical structure regression,BP,NINJ1
1992,GO:0004709,0.259320989144439,0.884466076630749,4,51,MAP kinase kinase kinase activity,MF,EPHA2;MAP3K8;AXL;DDR1
14006,GO:0060706,0.259347488980961,0.926709662964218,2,21,cell differentiation involved in embryonic placenta development,BP,LIF;PRDM1
15296,GO:0071468,0.25951039942527,0.968682453308323,1,6,cellular response to acidic pH,BP,SLC9A1
1448,GO:0003674,0.259512644917435,0.797469054847833,519,11313,molecular_function,MF,NFKBIZ;CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;ITPKC;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;IL36G;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;HCAR3;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;RAB3IP;EPHA2;GPR156;EHD1;ZNF697;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;N4BP3;ZNF267;SPRR2D;SERTAD2;STARD5;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;PANX1;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;KLHL21;DAPP1;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;STEAP4;C1QTNF1;AMOTL2;CDKN1A;KIAA0040;CLDN1;NMNAT2;CCDC85B;ITGA5;C11ORF68;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;ODC1;TNFAIP2;NEDD4L;CTSC;ARL5B;GPX3;NOD2;ELMSAN1;IL6ST;DCUN1D3;RELT;SAV1;TMCC3;TFPI2;SGK1;ICAM1;GCH1;TRIM47;RASSF9;SMAD3;IRGQ;ZC3H12C;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;RNF144B;RND3;MARCKSL1;TM4SF1;NFKBID;NINJ1;TRAF4;TRIB1;KRT34;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;LGALSL;IL1R2;SLC6A14;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;MAP3K8;ZBED2;ABL2;PPTC7;C3ORF52;CDV3;LAMB3;CFLAR;RNF43;TXNRD1;LACC1;KLF7;PIGA;BTG1;ANXA8;UPP1;IER5;LAYN;PPP4R4;CEBPB;CEBPD;VMP1;CD55;KCNJ15;DENND3;NAMPT;TAP1;TMEM106A;ANXA8L1;TP53BP2;ANKLE2;HEPHL1;ADM;GJB3;CDC42EP4;SLC28A3;IFNAR1;DSE;ERRFI1;ADAMTS1;ANKK1;CREB1;TAF4B;GORAB;CCNL1;USP43;WISP1;NEDD9;MAST4;NR4A2;PATL1;MSANTD3;NIPAL4;SLC7A2;CD47;CANT1;VHL;PHKG2;SOGA1;SEMA4B;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;AKAP2;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;IFNGR1;MASTL;NAB1;KIF3C;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;NOTCH2NL;DUSP10;SLC52A3;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;ANLN;PGLYRP4;CD82;BAZ1A;IFIH1;DUSP8;EFHD2;NRG1;TNC;SLC38A2;MMP9;LDLR;GPATCH2L;KIAA1586;DCBLD2;RRAD;ATF3;OTUD4;BTG3;IKZF2;COL12A1;FAM83B;CAB39;IL32;TLE1;MFHAS1;TRAF3IP3;RHD;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;TRPV3;FAM57A;MT2A;SLC9A1;ZBTB10;SLC25A37;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;HAL;CYTH1;GRB7;CXCL16;ARSJ;NUP153;BCL2L2;RNF152;IL4R;NEDD4;MMD;RHCG;SLC2A6;POU2F2;ITSN2;DUS4L;GCSAM;IL24;TNFRSF6B;MARCKS;RAET1L;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;SUSD6;TPRA1;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;CACFD1;HLA-A;UACA;DRAM1;TNIP2;ZNFX1;UGCG;ZFAND5;TP53;NOM1;KLF3;TLR2;ABI1;STK40;PUS10;TAPBP;EFNB2;PDP1;RAB9A;HLA-B;ITGAV;PRRG1;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;ADGRE2;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;ADAM9;SLC43A3;RELA;RAPH1;TRIM16;ESCO2;EMP3;SPATA2;FOXN2;SLC9A8;CCBE1;PPP6R3;TSPAN13;COL27A1;PLAT;CHST2;MUC1;YARS2;AXL;SLC16A13;ANXA5;AKIRIN1;CRB3;ELL2;SAT1;FRK;HLA-F;CITED4;NR4A3;LIMS3;HLA-E;USP31;GSK3B;KMT2E;OSMR;PPARD;PARP8;SLC16A1;PARP1;CYP24A1;MMP10;LAMA3;KDM7A;MED13;MXD3;CRAMP1;TBC1D22B;LCE1C;OCLN;COTL1;JMY;COL8A1;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;RNF145;ALAS1;ZXDA;RPS6KA6;DDR1;CEP135;XBP1;HSPA4L;QKI;EPB41L3;KCTD11;ZBTB5;ELF4;IL36RN;CDRT1;SREK1IP1;SLC39A14;TFE3;EID3;ZMIZ2;MGAM;CCSER2;LMAN1;CFB;SLC41A1;JUND;GJC1;DENND4A
11142,GO:0045178,0.259549779570462,0.901374115630595,3,36,basal part of cell,CC,EDN1;PHLDB2;SLC11A2
15690,GO:0072201,0.259600047043002,0.968659468476214,1,6,negative regulation of mesenchymal cell proliferation,BP,WNT5A
12078,GO:0048017,0.259847752413468,0.853951405627733,7,107,inositol lipid-mediated signaling,BP,IER3;EDN1;ZFP36L1;PDGFB;NRG1;NEDD4;PPARD
1204,GO:0002861,0.260281602873423,0.967044590319596,1,8,regulation of inflammatory response to antigenic stimulus,BP,TNF
4663,GO:0010807,0.260306728007708,0.968477949271735,1,6,regulation of synaptic vesicle priming,BP,STX1A
3919,GO:0008584,0.260350701925963,0.861224125418265,6,93,male gonad development,BP,INHBA;SIX4;ICAM1;HMGCS1;WNT5A;BCL2L2
1352,GO:0003214,0.260687751709757,0.968379833781992,1,6,cardiac left ventricle morphogenesis,BP,TGFBR2
4953,GO:0015012,0.260838176655644,0.926242061010193,2,20,heparan sulfate proteoglycan biosynthetic process,BP,DSE;HS3ST3B1
20123,GO:2000766,0.260895699462559,0.968326213715652,1,6,negative regulation of cytoplasmic translation,BP,CPEB2
12647,GO:0050821,0.260901609838174,0.846594862490306,8,134,protein stabilization,BP,EFNA1;CDKN1A;SAV1;SMAD3;CREB1;VHL;SOX4;TNIP2
6517,GO:0021889,0.260918402325341,0.968320356601554,1,6,olfactory bulb interneuron differentiation,BP,WNT5A
883,GO:0002244,0.261057079180829,0.84609910045175,8,158,hematopoietic progenitor cell differentiation,BP,INHBA;RUNX1;SOX4;ANLN;CHD2;NFE2L2;ESCO2;C12ORF29
13896,GO:0060513,0.26125635522948,0.968233095908433,1,6,prostatic bud formation,BP,WNT5A
2519,GO:0005770,0.261278583936052,0.832263392700721,11,191,late endosome,CC,SQSTM1;NMNAT2;ABCA5;NEDD4L;ANXA8;IFNAR1;SLC11A2;LDLR;RASGEF1B;MMD;RAB9A
419,GO:0001106,0.261300438327917,0.925793666203914,2,21,RNA polymerase II transcription corepressor activity,MF,ZNF451;TLE1
5803,GO:0017049,0.261410217476557,0.925742026583821,2,21,GTP-Rho binding,MF,CDC42EP4;ANLN
18852,GO:1904427,0.261411183633467,0.900096048873525,3,38,positive regulation of calcium ion transmembrane transport,BP,BDKRB1;SLC9A1;JPH2
19751,GO:2000096,0.261623383066572,0.968138174658707,1,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,DKK1
8364,GO:0033240,0.261688983800314,0.967287929865354,1,7,positive regulation of cellular amine metabolic process,BP,PAOX
19173,GO:1905165,0.261724971836351,0.968111873412356,1,6,regulation of lysosomal protein catabolic process,BP,LDLR
19117,GO:1905005,0.261991800446886,0.96804273342126,1,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2
17551,GO:1901033,0.262035521949298,0.967195904923881,1,7,positive regulation of response to reactive oxygen species,BP,TNF
5347,GO:0016081,0.262132560128247,0.96800622608124,1,6,synaptic vesicle docking,BP,STX1A
5074,GO:0015294,0.262311896344023,0.882439072676507,4,53,solute:cation symporter activity,MF,SLC6A14;SLC28A3;SLC11A2;SLC2A6
9106,GO:0035374,0.26242232029595,0.96793100005446,1,6,chondroitin sulfate binding,MF,ADGRE2
8136,GO:0032825,0.26245805234977,0.967921716582135,1,6,positive regulation of natural killer cell differentiation,BP,AXL
19302,GO:1905477,0.262475172863007,0.859701298112984,6,94,positive regulation of protein localization to membrane,BP,PMAIP1;EPHA2;SQSTM1;BBC3;TP53BP2;TP53
7586,GO:0031946,0.262494261824027,0.967912307525889,1,6,regulation of glucocorticoid biosynthetic process,BP,BMP2
9898,GO:0042177,0.262598920130846,0.859524210247754,6,97,negative regulation of protein catabolic process,BP,EFNA1;N4BP1;SMAD3;NRG1;PML;RELA
19795,GO:2000179,0.26306914386837,0.924959735940315,2,21,positive regulation of neural precursor cell proliferation,BP,VEGFA;VEGFC
7214,GO:0031102,0.263124692047409,0.89911624281897,3,38,neuron projection regeneration,BP,JUN;ADM;TNC
10779,GO:0044224,0.263165729604305,0.967737543995619,1,6,juxtaparanode region of axon,CC,EPB41L3
11393,GO:0045760,0.263583358261505,0.967628577149588,1,6,positive regulation of action potential,BP,SLC9A1
18020,GO:1902474,0.263587519833694,0.967627490276803,1,6,positive regulation of protein localization to synapse,BP,WNT5A
16837,GO:0098711,0.263750932348566,0.967584795742275,1,6,iron ion import across plasma membrane,BP,STEAP4
787,GO:0002042,0.263807151552029,0.898833013403753,3,37,cell migration involved in sprouting angiogenesis,BP,VEGFA;PLK2;EFNB2
6801,GO:0030238,0.263885421251511,0.9675496342046,1,6,male sex determination,BP,SIX4
7792,GO:0032328,0.263915695191755,0.967541716247436,1,6,alanine transport,BP,SLC38A2
19961,GO:2000465,0.264002210802281,0.967519082626126,1,6,regulation of glycogen (starch) synthase activity,BP,GSK3B
10407,GO:0043236,0.264224366488137,0.92441282533628,2,21,laminin binding,MF,TINAGL1;ADAM9
16220,GO:0090240,0.264251374170787,0.966604031617535,1,7,positive regulation of histone H4 acetylation,BP,MUC1
10247,GO:0042976,0.264312242239462,0.966587689090896,1,7,activation of Janus kinase activity,BP,IL23A
11594,GO:0046148,0.264394450256337,0.898188049821369,3,40,pigment biosynthetic process,BP,WNT5A;SLC11A2;ALAS1
9303,GO:0035745,0.264649238812962,0.966497127038339,1,7,T-helper 2 cell cytokine production,BP,IL6
2299,GO:0005262,0.26488136746569,0.880813442188657,4,53,calcium channel activity,MF,PANX1;TRPV3;ITGAV;JPH2
7494,GO:0031658,0.26488412918412,0.966433922581063,1,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,CDKN2B
16937,GO:0098903,0.264902693538581,0.967282975409544,1,6,regulation of membrane repolarization during action potential,BP,CAV1
10376,GO:0043190,0.264963563193206,0.967266980487708,1,6,ATP-binding cassette (ABC) transporter complex,CC,ABCA7
15708,GO:0072224,0.26516144106913,0.967214952943818,1,6,metanephric glomerulus development,BP,PDGFB
9811,GO:0040036,0.265375071683826,0.923866299286175,2,21,regulation of fibroblast growth factor receptor signaling pathway,BP,WNT5A;SPRY2
4432,GO:0010259,0.265446052644693,0.923832529632289,2,21,multicellular organism aging,BP,EDN1;TP53
10170,GO:0042753,0.265756510992837,0.967058211314146,1,6,positive regulation of circadian rhythm,BP,ARNTL2
14069,GO:0060828,0.265756865663885,0.828691203973006,11,196,regulation of canonical Wnt signaling pathway,BP,BMP2;NFKB1;CYLD;BAMBI;NRARP;DKK1;SMURF2;WNT5A;SOX4;CAV1;GSK3B
9022,GO:0035198,0.265923222578541,0.923605339989036,2,21,miRNA binding,MF,ZC3H12A;ZC3H7B
326,GO:0000912,0.265934444755842,0.967011261442186,1,6,assembly of actomyosin apparatus involved in cytokinesis,BP,ANLN
327,GO:0000915,0.265934444755842,0.967011261442186,1,6,actomyosin contractile ring assembly,BP,ANLN
9673,GO:0038030,0.265991633212281,0.966996163584237,1,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,WNT5A
6914,GO:0030500,0.266102252534587,0.897514183450567,3,37,regulation of bone mineralization,BP,BMP2;CYP27B1;SMAD3
8019,GO:0032647,0.266252737854905,0.92344827576143,2,21,regulation of interferon-alpha production,BP,RIPK2;IFIH1
16050,GO:0086067,0.266335249828844,0.966905365939683,1,6,AV node cell to bundle of His cell communication,BP,GJC1
19168,GO:1905153,0.266356976196041,0.966899620199779,1,6,regulation of membrane invagination,BP,ABCA7
8512,GO:0033689,0.266544430459192,0.966850022753637,1,6,negative regulation of osteoblast proliferation,BP,SMAD3
19005,GO:1904779,0.266616809553944,0.966830861149498,1,6,regulation of protein localization to centrosome,BP,GSK3B
16606,GO:0097413,0.266876922772626,0.965894996884923,1,7,Lewy body,CC,SQSTM1
12763,GO:0051018,0.26694585825376,0.897027785302488,3,37,protein kinase A binding,MF,AKAP2;PJA2;GSK3B
5333,GO:0016055,0.266997365702294,0.803871170967099,21,390,Wnt signaling pathway,BP,BMP2;NFKB1;CYLD;FZD8;BAMBI;AMOTL2;SMAD3;NRARP;DKK1;RNF43;WISP1;NR4A2;RUNX1;SMURF2;WNT5A;SOX4;TLE1;WNT7B;CAV1;TLR2;GSK3B
490,GO:0001542,0.267457622697723,0.966607805728085,1,6,ovulation from ovarian follicle,BP,ADAMTS1
1985,GO:0004702,0.267469373604484,0.856416240181973,6,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,EPHA2;MAP3K8;TGFBR2;IKBKE;AXL;DDR1
6284,GO:0019884,0.268058400487145,0.841070800579397,8,144,antigen processing and presentation of exogenous antigen,BP,TAP1;KIF3C;HLA-A;TAPBP;HLA-B;ITGAV;HLA-F;HLA-E
7193,GO:0031077,0.26810133602728,0.965561466667842,1,7,post-embryonic camera-type eye development,BP,VEGFA
13839,GO:0060421,0.26816652907186,0.922533223519207,2,21,positive regulation of heart growth,BP,EDN1;PIM1
9156,GO:0035507,0.268575164366992,0.966310028614174,1,6,regulation of myosin-light-chain-phosphatase activity,BP,TNF
11814,GO:0046686,0.26933979084809,0.894976165833082,3,44,response to cadmium ion,BP,JUN;MMP9;MT2A
11744,GO:0046546,0.269443926562676,0.854775996959751,6,94,development of primary male sexual characteristics,BP,INHBA;SIX4;ICAM1;HMGCS1;WNT5A;BCL2L2
6753,GO:0030169,0.269549944156475,0.96604906902953,1,6,low-density lipoprotein particle binding,MF,LDLR
14076,GO:0060840,0.26955121273364,0.877839533913843,4,53,artery development,BP,PRDM1;VEGFA;SOX4;EFNB2
9606,GO:0036462,0.269628915544372,0.965142782901639,1,7,TRAIL-activated apoptotic signaling pathway,BP,ATF3
15899,GO:0072641,0.269784936141063,0.965985988415438,1,6,type I interferon secretion,BP,IFIH1
15900,GO:0072642,0.269784936141063,0.965985988415438,1,6,interferon-alpha secretion,BP,IFIH1
18116,GO:1902739,0.269784936141063,0.965985988415438,1,6,regulation of interferon-alpha secretion,BP,IFIH1
18117,GO:1902741,0.269784936141063,0.965985988415438,1,6,positive regulation of interferon-alpha secretion,BP,IFIH1
17098,GO:0099612,0.269829898654862,0.965973911240836,1,6,protein localization to axon,BP,EPB41L3
6634,GO:0022890,0.269949733679374,0.813068945146309,15,269,inorganic cation transmembrane transporter activity,MF,PANX1;SLC6A14;KCNJ15;SLC28A3;NIPAL4;SLC11A2;TRPV3;SLC9A1;SLC25A37;SLC2A6;ITGAV;JPH2;SLC9A8;SLC39A14;SLC41A1
3586,GO:0007635,0.26997013183581,0.96593622825052,1,6,chemosensory behavior,BP,GJB4
5238,GO:0015851,0.26997947856674,0.965046296166867,1,7,nucleobase transport,BP,SLC28A3
8306,GO:0033137,0.270115109483634,0.921376253594884,2,22,negative regulation of peptidyl-serine phosphorylation,BP,DKK1;CAV1
19869,GO:2000316,0.270416498816602,0.964925802396575,1,7,regulation of T-helper 17 type immune response,BP,IL23A
12278,GO:0048562,0.270608421016592,0.829151375378097,10,165,embryonic organ morphogenesis,BP,EFNA1;TBX3;EDN1;SIX4;SMAD3;DLX2;TGFBR2;WNT5A;SPRY2;NR4A3
8173,GO:0032906,0.270625148363931,0.965759901393493,1,6,transforming growth factor beta2 production,BP,SMAD3
8176,GO:0032909,0.270625148363931,0.965759901393493,1,6,regulation of transforming growth factor beta2 production,BP,SMAD3
12410,GO:0048842,0.271026584856168,0.965651581886422,1,6,positive regulation of axon extension involved in axon guidance,BP,VEGFA
3260,GO:0006929,0.271035382528397,0.921152445471459,2,21,substrate-dependent cell migration,BP,ADAM8;VEGFC
10520,GO:0043425,0.271046065091668,0.921147283603861,2,21,bHLH transcription factor binding,MF,BHLHE40;SMAD3
16189,GO:0090196,0.271063503321363,0.964746981979101,1,7,regulation of chemokine secretion,BP,IL4R
8322,GO:0033157,0.27139803185833,0.820624999998699,12,213,regulation of intracellular protein transport,BP,IL1B;ZC3H12A;PLAGL2;CDKN1A;SOX4;NRG1;PLK3;PTPN1;UGCG;TP53;UBE2D3;GSK3B
8843,GO:0034629,0.271610637410195,0.920652179093779,2,22,cellular protein-containing complex localization,BP,KLHL21;TNFAIP2
17375,GO:1900076,0.272511245458892,0.875800412691411,4,55,regulation of cellular response to insulin stimulus,BP,IL1B;SOCS2;PTPN1;RELA
10743,GO:0044106,0.272831575704708,0.861974253791929,5,87,cellular amine metabolic process,BP,ODC1;NR4A2;MAOA;PAOX;SAT1
1406,GO:0003337,0.272942301290362,0.964224798784254,1,7,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,LIF
806,GO:0002072,0.272942996891481,0.965131801776718,1,6,optic cup morphogenesis involved in camera-type eye development,BP,WNT5A
15722,GO:0072257,0.273062399740395,0.965099270075264,1,6,metanephric nephron tubule epithelial cell differentiation,BP,LIF
15746,GO:0072307,0.273062399740395,0.965099270075264,1,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,LIF
8608,GO:0034115,0.273289619408827,0.964127791008791,1,7,negative regulation of heterotypic cell-cell adhesion,BP,IL1RN
14852,GO:0070587,0.273289619408827,0.964127791008791,1,7,regulation of cell-cell adhesion involved in gastrulation,BP,IL1RN
14263,GO:0061299,0.27340848348839,0.96500488114212,1,6,retina vasculature morphogenesis in camera-type eye,BP,CLIC4
15850,GO:0072542,0.273945451592788,0.963944207979193,1,7,protein phosphatase activator activity,MF,PPP1R15A
13541,GO:0055102,0.273955987209665,0.963258806595234,1,8,lipase inhibitor activity,MF,ANXA5
7872,GO:0032429,0.274405961882699,0.963814982968451,1,7,regulation of phospholipase A2 activity,BP,ANXA8
16811,GO:0098642,0.274535411994473,0.964696525855976,1,6,network-forming collagen trimer,CC,COL8A1
16814,GO:0098645,0.274535411994473,0.964696525855976,1,6,collagen network,CC,COL8A1
16818,GO:0098651,0.274535411994473,0.964696525855976,1,6,basement membrane collagen trimer,CC,COL8A1
16354,GO:0090594,0.27453959632621,0.96377743442759,1,7,inflammatory response to wounding,BP,IL1A
9842,GO:0042074,0.27458308067375,0.96468344867179,1,6,cell migration involved in gastrulation,BP,WNT5A
17668,GO:1901409,0.274866718976254,0.963685426551749,1,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,CCNL1
17344,GO:0198738,0.274965214878169,0.797087216730823,21,392,cell-cell signaling by wnt,BP,BMP2;NFKB1;CYLD;FZD8;BAMBI;AMOTL2;SMAD3;NRARP;DKK1;RNF43;WISP1;NR4A2;RUNX1;SMURF2;WNT5A;SOX4;TLE1;WNT7B;CAV1;TLR2;GSK3B
8659,GO:0034205,0.274978072733232,0.919010948210296,2,22,amyloid-beta formation,BP,EFNA1;ABCA7
4261,GO:0009593,0.275466416028295,0.918376883838603,2,24,detection of chemical stimulus,BP,NOD2;TLR2
11799,GO:0046654,0.275728340689953,0.963442450057193,1,7,tetrahydrofolate biosynthetic process,BP,GCH1
3040,GO:0006591,0.275989536334269,0.96336861169535,1,7,ornithine metabolic process,BP,ODC1
9085,GO:0035335,0.276071907124217,0.860247939929998,5,74,peptidyl-tyrosine dephosphorylation,BP,DUSP1;DUSP16;DUSP10;DUSP8;PTPN1
2861,GO:0006352,0.27610853249548,0.820382925087863,11,207,DNA-templated transcription, initiation,BP,FOSL1;JUN;CDKN1A;ZNF451;CREB1;TAF4B;NR4A2;TP53;NR4A3;PPARD;MED13
9038,GO:0035251,0.276124713052242,0.963330364918771,1,7,UDP-glucosyltransferase activity,MF,UGCG
4935,GO:0014889,0.276519824716168,0.963218442620644,1,7,muscle atrophy,BP,CFLAR
1413,GO:0003344,0.276645930970512,0.964114899037616,1,6,pericardium morphogenesis,BP,WNT5A
3516,GO:0007440,0.276708260979999,0.964097639690549,1,6,foregut morphogenesis,BP,SMAD3
3630,GO:0008091,0.276862973889843,0.964054778877011,1,6,spectrin,CC,SPTBN5
12832,GO:0051124,0.276884113805277,0.964048920133135,1,6,synaptic growth at neuromuscular junction,BP,SIX4
19890,GO:2000343,0.276973706320063,0.962391963391513,1,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,TNF
10019,GO:0042445,0.276979261160233,0.841160405619382,7,117,hormone metabolic process,BP,IL1B;TNF;BMP2;NFKB1;CYP27B1;ADM;SDR16C5
6311,GO:0019941,0.277292244039678,0.787305544836551,27,521,modification-dependent protein catabolic process,BP,TNFAIP3;RNF19B;SQSTM1;BIRC2;N4BP1;CYLD;NEDD4L;RNF144B;TRIB1;PLK2;RNF43;USP43;ABTB2;SMURF2;TRIM25;PLK3;RCHY1;NEDD4;NFE2L2;CAV1;TP53;UBE2D3;PML;USP31;GSK3B;RNF145;XBP1
15842,GO:0072531,0.277430886300738,0.962959630892184,1,7,pyrimidine-containing compound transmembrane transport,BP,SLC28A3
10533,GO:0043467,0.277808293819785,0.848832932128642,6,93,regulation of generation of precursor metabolites and energy,BP,PPIF;PHLDA2;PHKG2;PPP1R3B;NUP153;GSK3B
13819,GO:0060394,0.277810344232861,0.962851531793937,1,7,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,DKK1
10494,GO:0043388,0.277888712079633,0.890119343072222,3,42,positive regulation of DNA binding,BP,PLAUR;MMP9;PARP1
4333,GO:0009855,0.278033611123339,0.858896966557845,5,74,determination of bilateral symmetry,BP,TBX3;SMAD3;TGFBR2;WNT5A;RTTN
4640,GO:0010759,0.278043870307019,0.962784916550669,1,7,positive regulation of macrophage chemotaxis,BP,CSF1
6083,GO:0019233,0.278209059283331,0.890121199225235,3,40,sensory perception of pain,BP,EDN1;BDKRB1;SLC9A1
3714,GO:0008233,0.278250804405831,0.795878268922395,20,377,peptidase activity,MF,TNFAIP3;PLAU;ZC3H12A;ADAM8;CYLD;CTSC;CFLAR;ADAMTS1;USP43;TINAGL1;MMP9;OTUD4;LACTB;SPCS2;ESPL1;ADAM9;PLAT;USP31;MMP10;CFB
3695,GO:0008201,0.278361059895144,0.858538325677995,5,77,heparin binding,MF,HBEGF;VEGFA;ADAMTS1;WISP1;SAA1
4830,GO:0014031,0.278384845878186,0.871932827014788,4,56,mesenchymal cell development,BP,EDN1;EFNB1;SEMA4B;NRG1
15319,GO:0071499,0.278394559167723,0.962684752387955,1,7,cellular response to laminar fluid shear stress,BP,NFE2L2
17544,GO:1901021,0.278509284069528,0.917273740030561,2,22,positive regulation of calcium ion transmembrane transporter activity,BP,SLC9A1;JPH2
14615,GO:0070167,0.278632201736968,0.890083668616685,3,38,regulation of biomineral tissue development,BP,BMP2;CYP27B1;SMAD3
19745,GO:2000074,0.278754251321846,0.962581857891784,1,7,regulation of type B pancreatic cell development,BP,GSK3B
8730,GO:0034375,0.278888540854752,0.961835984205015,1,8,high-density lipoprotein particle remodeling,BP,ABCA5
8100,GO:0032780,0.27918076463913,0.962459639827675,1,7,negative regulation of ATPase activity,BP,PPIF
14327,GO:0061450,0.279242768742182,0.961732625896659,1,8,trophoblast cell migration,BP,SMURF2
17581,GO:1901163,0.279242768742182,0.961732625896659,1,8,regulation of trophoblast cell migration,BP,SMURF2
10549,GO:0043495,0.279362077166824,0.962407615868207,1,7,protein membrane anchor,MF,NUP153
7644,GO:0032050,0.279613897239024,0.962335293302852,1,7,clathrin heavy chain binding,MF,LDLR
9077,GO:0035325,0.279820212315936,0.961563796824525,1,8,Toll-like receptor binding,MF,TLR2
6921,GO:0030509,0.279845431064864,0.847436184179849,6,91,BMP signaling pathway,BP,BMP2;DKK1;SMURF2;WNT5A;SMAD1;UBE2D3
18629,GO:1903896,0.279866357914002,0.962262707481209,1,7,positive regulation of IRE1-mediated unfolded protein response,BP,PTPN1
5415,GO:0016255,0.279867435063849,0.962262397616116,1,7,attachment of GPI anchor to protein,BP,PLAUR
4102,GO:0009154,0.279891944251331,0.916377897462245,2,23,purine ribonucleotide catabolic process,BP,AMPD3;EGLN1
8205,GO:0032947,0.280055599828631,0.857595689003818,5,72,protein-containing complex scaffold activity,MF,SAV1;PDE4DIP;OTUD4;SLC9A1;CAV1
9791,GO:0040001,0.280206351504461,0.916432965900289,2,22,establishment of mitotic spindle localization,BP,SPRY2;ESPL1
1463,GO:0003707,0.280256572459434,0.889120349307272,3,38,steroid hormone receptor activity,MF,NR4A2;NR4A3;PPARD
18533,GO:1903689,0.280282100864786,0.963100127160997,1,6,regulation of wound healing, spreading of epidermal cells,BP,PHLDB2
7994,GO:0032607,0.280304536166723,0.916384205484466,2,22,interferon-alpha production,BP,RIPK2;IFIH1
11741,GO:0046543,0.280395721116927,0.962110250624188,1,7,development of secondary female sexual characteristics,BP,WNT5A
15787,GO:0072376,0.280510000425788,0.916070325679497,2,23,protein activation cascade,BP,CD55;CFB
18152,GO:1902857,0.280695698167037,0.962023702000476,1,7,positive regulation of non-motile cilium assembly,BP,CEP135
17967,GO:1902305,0.281124793084381,0.888493425094985,3,39,regulation of sodium ion transmembrane transport,BP,NEDD4L;SLC9A1;NEDD4
16095,GO:0090045,0.281176854282823,0.961884645586174,1,7,positive regulation of deacetylase activity,BP,VEGFA
1362,GO:0003230,0.281252740381634,0.916146302935627,2,21,cardiac atrium development,BP,WNT5A;SOX4
9618,GO:0036480,0.281392095328205,0.961822346340114,1,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,PARP1
18390,GO:1903376,0.281392095328205,0.961822346340114,1,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,PARP1
17356,GO:1900027,0.281654192200342,0.915499585362141,2,23,regulation of ruffle assembly,BP,ICAM1;CAV1
5698,GO:0016814,0.281671631987058,0.915490872660747,2,23,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,AMPD3;GCH1
11588,GO:0046133,0.281911740093825,0.96094875837805,1,8,pyrimidine ribonucleoside catabolic process,BP,UPP1
9042,GO:0035255,0.282243365554232,0.915653572516262,2,21,ionotropic glutamate receptor binding,MF,SQSTM1;NEDD4
12356,GO:0048709,0.282427578434679,0.869162507140079,4,58,oligodendrocyte differentiation,BP,DLX2;DUSP10;NRG1;TLR2
2543,GO:0005798,0.282489149525841,0.830290218382435,8,136,Golgi-associated vesicle,CC,CTSC;RASSF9;TGFA;HLA-A;HLA-B;HLA-F;HLA-E;LMAN1
10978,GO:0044754,0.282570330002911,0.960753944383624,1,8,autolysosome,CC,SQSTM1
10588,GO:0043548,0.282732837066807,0.915409631966478,2,21,phosphatidylinositol 3-kinase binding,MF,FAM83B;AXL
15300,GO:0071474,0.283043295518975,0.961342497932597,1,7,cellular hyperosmotic response,BP,ERRFI1
15299,GO:0071472,0.283160359077526,0.961308349082466,1,7,cellular response to salt stress,BP,ZFP36L1
538,GO:0001656,0.283237287101668,0.86876297230898,4,56,metanephros development,BP,LIF;SIX4;PDGFB;WNT7B
2517,GO:0005768,0.283373178128841,0.774812895329502,35,677,endosome,CC,TNF;PLEKHF1;TICAM1;EHD1;SQSTM1;IRAK2;STEAP4;AMOTL2;NMNAT2;RAP2B;ABCA5;NEDD4L;RASSF9;RAB24;DKK1;ANXA8;IFNAR1;SLC11A2;LDLR;ARRDC4;RASGEF1B;MMD;PTPN1;TAB3;CAV1;RHOV;HLA-A;RAB9A;HLA-B;IKBKE;UBE2D3;ABCA7;PML;HLA-F;HLA-E
10152,GO:0042726,0.283542013248848,0.96119689675335,1,7,flavin-containing compound metabolic process,BP,SLC52A3
8484,GO:0033629,0.283567682852669,0.961189394052375,1,7,negative regulation of cell adhesion mediated by integrin,BP,MUC1
2286,GO:0005242,0.283651969141923,0.961164753083683,1,7,inward rectifier potassium channel activity,MF,KCNJ15
17798,GO:1901844,0.283780034848807,0.961127296224881,1,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,CAV1
13762,GO:0060322,0.283854921723229,0.782756928877001,26,482,head development,BP,BTG2;INHBA;BMP2;TBX3;KDM6B;ETS1;CSRNP1;DLX2;B3GNT5;DKK1;CREB1;NR4A2;TGFBR2;HMGCS1;WNT5A;NRG1;SLC38A2;FEZ1;WNT7B;SMAD1;ZFAND5;ZNF148;AXL;NR4A3;GSK3B;KDM7A
6915,GO:0030501,0.283876360472281,0.914601661541551,2,22,positive regulation of bone mineralization,BP,BMP2;SMAD3
14617,GO:0070169,0.283876360472281,0.914601661541551,2,22,positive regulation of biomineral tissue development,BP,BMP2;SMAD3
12762,GO:0051017,0.284382383611505,0.83583279797125,7,110,actin filament bundle assembly,BP,SDC4;PHLDB2;SMAD3;RND3;NEDD9;SLC9A1;MARCKS
3266,GO:0006937,0.28467412482299,0.854114668760326,5,78,regulation of muscle contraction,BP,ZC3H12A;EDN1;SLC9A1;CAV1;DOCK4
2004,GO:0004725,0.284976880384852,0.854035836451978,5,75,protein tyrosine phosphatase activity,MF,DUSP1;DUSP16;DUSP10;DUSP8;PTPN1
15302,GO:0071476,0.285066637627144,0.960749846999005,1,7,cellular hypotonic response,BP,CAB39
11496,GO:0045948,0.285802492580294,0.913415747221461,2,23,positive regulation of translational initiation,BP,TNF;PPP1R15A
12426,GO:0048864,0.285869092175661,0.866964776452365,4,57,stem cell development,BP,EDN1;EFNB1;SEMA4B;NRG1
9893,GO:0042168,0.285911592023359,0.912979100836326,2,25,heme metabolic process,BP,SLC11A2;ALAS1
13104,GO:0051601,0.286124109199533,0.960438060921108,1,7,exocyst localization,BP,TNFAIP2
4320,GO:0009799,0.286188753067084,0.853190061266354,5,75,specification of symmetry,BP,TBX3;SMAD3;TGFBR2;WNT5A;RTTN
13737,GO:0060291,0.286314243783009,0.88538598316578,3,39,long-term synaptic potentiation,BP,SQSTM1;PLK2;CREB1
3249,GO:0006909,0.286505740297601,0.821506331243808,9,152,phagocytosis,BP,IL1B;TNF;PTX3;CD47;TLR2;ABI1;ITGAV;ABCA7;AXL
6266,GO:0019855,0.286640822783788,0.95953763024422,1,8,calcium channel inhibitor activity,MF,STX1A
11542,GO:0046058,0.286787217950805,0.885101116636568,3,39,cAMP metabolic process,BP,EPHA2;ADM;EGLN1
1532,GO:0003909,0.287040310392652,0.960166789476365,1,7,DNA ligase activity,MF,PARP1
10895,GO:0044432,0.287106750893598,0.763809096078995,48,965,endoplasmic reticulum part,CC,ZC3H12A;PPP1R15A;RNF19B;PLAUR;EDN1;CSF1;IL23A;IFNGR2;IL6;PANX1;CTSC;SGK1;C3ORF52;RNF43;PIGA;TAP1;ANKLE2;SLC28A3;CANT1;WNT5A;TGFA;PDGFB;TNC;COL12A1;SUCO;SLC9A1;ARSJ;PTPN1;WNT7B;SGMS2;CAV1;HLA-A;TAPBP;RAB9A;HLA-B;PJA2;JPH2;SPCS2;TMEM132A;SDR16C5;PML;COL27A1;HLA-F;HLA-E;COL8A1;XBP1;LMAN1;GJC1
9210,GO:0035591,0.287120356873519,0.866277695954675,4,55,signaling adaptor activity,MF,TP53BP2;SOCS2;GRB7;ITSN2
3101,GO:0006678,0.287136726116276,0.960138180942454,1,7,glucosylceramide metabolic process,BP,UGCG
11260,GO:0045472,0.287248691621308,0.96010494376354,1,7,response to ether,BP,ZC3H12A
13492,GO:0055013,0.287450871264212,0.884814737418071,3,38,cardiac muscle cell development,BP,TBX3;EDN1;VEGFA
19568,GO:1990462,0.287904002717471,0.959910096357089,1,7,omegasome,CC,PLEKHF1
4576,GO:0010658,0.288157421309439,0.912442823768456,2,22,striated muscle cell apoptotic process,BP,CFLAR;NFE2L2
10784,GO:0044237,0.288486042668162,0.742133617859145,364,7890,cellular metabolic process,BP,NFKBIZ;CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;IL1A;ITPKC;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;ZNF267;SPRR2D;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;KLHL21;PHLDA2;DAPP1;JUNB;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;C1QTNF1;CDKN1A;NMNAT2;CCDC85B;ITGA5;RAP2B;IL7R;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;GPX3;NOD2;ELMSAN1;IL6ST;DCUN1D3;SAV1;TFPI2;SGK1;ICAM1;GCH1;SMAD3;ZC3H12C;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;RNF144B;NFKBID;TRAF4;TRIB1;SERPINB8;VEGFA;RAB24;NRARP;IL1R2;SLC6A14;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ZBED2;ABL2;PPTC7;CFLAR;RNF43;TXNRD1;KLF7;PIGA;BTG1;ANXA8;UPP1;IER5;PPP4R4;CEBPB;CEBPD;VMP1;CD55;DENND3;NAMPT;ANKLE2;ADM;DSE;ERRFI1;ANKK1;CREB1;TAF4B;CCNL1;USP43;MAST4;NR4A2;PATL1;SLC7A2;CANT1;VHL;PHKG2;SOGA1;BACH1;ABTB2;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;MASTL;NAB1;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;DUSP10;SLC52A3;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;KIAA1586;ATF3;OTUD4;IKZF2;CAB39;TLE1;PLK3;CHD2;ARRDC4;SLC9A1;ZBTB10;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;B4GALT5;HAL;GRB7;ARSJ;NUP153;RNF152;NEDD4;MMD;POU2F2;DUS4L;IL24;TNFRSF6B;RAET1L;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;ZC3H7B;DIEXF;NFAT5;STAT5A;TPST1;CAV1;VEZF1;SH3RF2;DRAM1;INO80D;TNIP2;ZNFX1;UGCG;TP53;KLF3;TLR2;ABI1;STK40;PUS10;TAPBP;PDP1;ITGAV;IKBKE;UBE2D3;PJA2;CD276;MAPKBP1;ELK3;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ADAM9;RELA;TRIM16;ESCO2;FOXN2;CCBE1;PPP6R3;PLAT;CHST2;MUC1;YARS2;AXL;ELL2;SAT1;FRK;CITED4;NR4A3;USP31;GSK3B;KMT2E;PPARD;PARP8;SLC16A1;PARP1;CYP24A1;KDM7A;MED13;MXD3;CRAMP1;LCE1C;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;RNF145;ALAS1;ZXDA;RPS6KA6;DDR1;XBP1;QKI;KCTD11;ZBTB5;ELF4;SREK1IP1;TFE3;EID3;ZMIZ2;MGAM;LMAN1;JUND;DENND4A
1973,GO:0004683,0.288532143084238,0.91225269999908,2,22,calmodulin-dependent protein kinase activity,MF,PHKG2;CAMK1G
17977,GO:1902337,0.288566319397518,0.959712615274225,1,7,regulation of apoptotic process involved in morphogenesis,BP,B4GALT1
18988,GO:1904748,0.288566319397518,0.959712615274225,1,7,regulation of apoptotic process involved in development,BP,B4GALT1
11370,GO:0045721,0.288663459629878,0.959683604660452,1,7,negative regulation of gluconeogenesis,BP,SOGA1
11364,GO:0045713,0.288736881551033,0.959661669531477,1,7,low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
4864,GO:0014075,0.288771706545327,0.911910139343514,2,23,response to amine,BP,ICAM1;NR4A2
13720,GO:0060263,0.289007171300961,0.958820811769239,1,8,regulation of respiratory burst,BP,DUSP10
11333,GO:0045648,0.289415035207531,0.911804005293591,2,22,positive regulation of erythrocyte differentiation,BP,INHBA;ETS1
10868,GO:0044387,0.289509361385206,0.959430474680234,1,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,DUSP10
3091,GO:0006664,0.289689653080371,0.839997977931148,6,100,glycolipid metabolic process,BP,PLAUR;B3GNT5;PIGA;ITGB8;ARSJ;UGCG
18445,GO:1903509,0.289689653080371,0.839997977931148,6,100,liposaccharide metabolic process,BP,PLAUR;B3GNT5;PIGA;ITGB8;ARSJ;UGCG
9414,GO:0035973,0.289734166044888,0.959363051288955,1,7,aggrephagy,BP,SQSTM1
18240,GO:1903025,0.289976220255342,0.957932211672162,1,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,LIF
18049,GO:1902554,0.290474116888013,0.850051773635069,5,78,serine/threonine protein kinase complex,CC,CDKN1A;CCNL1;PHKG2;TGFBR2;CAB39
3244,GO:0006901,0.290835552547764,0.86348362039775,4,60,vesicle coating,BP,CTSC;TGFA;PPP6R3;LMAN1
9800,GO:0040016,0.291108728643306,0.958949400451519,1,7,embryonic cleavage,BP,TPRA1
679,GO:0001886,0.291507807838245,0.958828855758636,1,7,endothelial cell morphogenesis,BP,CLIC4
14365,GO:0061572,0.291764335751063,0.830265313001902,7,111,actin filament bundle organization,BP,SDC4;PHLDB2;SMAD3;RND3;NEDD9;SLC9A1;MARCKS
13906,GO:0060534,0.291883844865421,0.958715086127777,1,7,trachea cartilage development,BP,WNT7B
8245,GO:0033014,0.292037841428167,0.910035210527217,2,24,tetrapyrrole biosynthetic process,BP,SLC11A2;ALAS1
5230,GO:0015838,0.292087372498011,0.95865343414065,1,7,amino-acid betaine transport,BP,SLC38A2
1148,GO:0002741,0.292353490705655,0.958572743002641,1,7,positive regulation of cytokine secretion involved in immune response,BP,WNT5A
16273,GO:0090316,0.292819291989927,0.816473326103342,9,157,positive regulation of intracellular protein transport,BP,IL1B;ZC3H12A;PLAGL2;NRG1;PLK3;UGCG;TP53;UBE2D3;GSK3B
19474,GO:1990124,0.292980024806055,0.958382412703058,1,7,messenger ribonucleoprotein complex,CC,CPEB2
7117,GO:0030913,0.29301694809062,0.95837118046359,1,7,paranodal junction assembly,BP,EPB41L3
4280,GO:0009642,0.29304681339207,0.958362094027237,1,7,response to light intensity,BP,HMGCS1
15431,GO:0071682,0.293509519158522,0.957437095714969,1,8,endocytic vesicle lumen,CC,SAA1
12436,GO:0048875,0.293518855892418,0.958218325607521,1,7,chemical homeostasis within a tissue,BP,VEGFA
1052,GO:0002577,0.293734917824251,0.957367136661256,1,8,regulation of antigen processing and presentation,BP,NOD2
12352,GO:0048704,0.293836177619163,0.861608830233425,4,58,embryonic skeletal system morphogenesis,BP,SIX4;SMAD3;DLX2;TGFBR2
17724,GO:1901620,0.293938592462766,0.958090249497569,1,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,GORAB
12996,GO:0051386,0.29401629163224,0.958066516177549,1,7,regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2
16338,GO:0090533,0.29402096073265,0.958065089749226,1,7,cation-transporting ATPase complex,CC,SLC9A1
4408,GO:0010155,0.294193019873307,0.956614316065005,1,9,regulation of proton transport,BP,PPIF
12353,GO:0048705,0.294256141024487,0.821352235728844,8,131,skeletal system morphogenesis,BP,CSRNP1;SIX4;SMAD3;DLX2;TGFBR2;NAB1;ZFAND5;COL27A1
12837,GO:0051129,0.294274513043909,0.77359738760766,26,493,negative regulation of cellular component organization,BP,TNF;EFNA1;LIF;PPIF;DUSP1;BIRC2;PHLDB2;ZNF451;NAV3;DKK1;PLK2;CFLAR;SEMA4B;WNT5A;LDLR;SPRY2;FEZ1;SPTBN5;CAV1;TLR2;EFNB2;SDR16C5;ESPL1;GSK3B;PARP1;VIM
8492,GO:0033646,0.294277824230832,0.957986574136283,1,7,host intracellular part,CC,LMAN1
10649,GO:0043656,0.294277824230832,0.957986574136283,1,7,intracellular region of host,CC,LMAN1
20015,GO:2000586,0.294281747536273,0.957985374245064,1,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFB
7606,GO:0031982,0.294587184333764,0.73906283420714,141,3059,vesicle,CC,IL1B;TNFAIP3;TNF;HBEGF;PLAU;CXCL1;EFNA1;SDC4;BTG2;PLEKHF1;PLAUR;SOD2;PTX3;IL1RN;NFKB1;EDN1;TICAM1;EHD1;SQSTM1;CSF1;N4BP3;IRF6;AMPD3;EFNB1;IFNGR2;ADAM8;RIPK2;IRAK2;STEAP4;AMOTL2;NMNAT2;ITGA5;RAP2B;ABCA5;IL7R;NEDD4L;CTSC;GPX3;NOD2;IL6ST;RELT;ICAM1;GCH1;RASSF9;B4GALT1;PHLDA1;RND3;MARCKSL1;KRT34;SERPINB8;VEGFA;RAB24;SLC6A14;DKK1;TXNRD1;ANXA8;CD55;NAMPT;TAP1;TMEM106A;ANXA8L1;CDC42EP4;IFNAR1;ADAMTS1;CD47;CANT1;SOGA1;MREG;DUSP16;SAA1;TINAGL1;ITGB8;WNT5A;VEGFC;SLC11A2;TGFA;ROBO4;SERPINB1;PDGFB;CD82;MMP9;LDLR;COL12A1;CAB39;CHD2;ARRDC4;RASGEF1B;PARD6B;SLC9A1;B4GALT5;BCL2L2;NEDD4;MMD;RHCG;ITSN2;MARCKS;BTN2A2;PTPN1;WNT7B;TAB3;SPTBN5;CLIC4;CAV1;RHOV;HLA-A;UACA;NECAP2;TLR2;ABI1;TAPBP;RAB9A;HLA-B;ITGAV;IKBKE;UBE2D3;STX1A;CD276;TRIP10;ABCA7;TMEM132A;PML;ADAM9;PLAT;MUC1;AXL;ANXA5;CRB3;FRK;HLA-F;HLA-E;SLC16A1;LAMA3;OCLN;COTL1;COL8A1;VIM;CREB5;DDR1;MGAM;LMAN1;CFB
11452,GO:0045880,0.294656011690885,0.909119113960325,2,22,positive regulation of smoothened signaling pathway,BP,GORAB;EVC
12665,GO:0050856,0.29477034112811,0.908624567253637,2,24,regulation of T cell receptor signaling pathway,BP,CYLD;RELA
4750,GO:0010917,0.294775042917039,0.957043452513661,1,8,negative regulation of mitochondrial membrane potential,BP,PMAIP1
11432,GO:0045837,0.294775042917039,0.957043452513661,1,8,negative regulation of membrane potential,BP,PMAIP1
2220,GO:0005114,0.294775092279447,0.957834334819211,1,7,type II transforming growth factor beta receptor binding,MF,BAMBI
8679,GO:0034249,0.294991208096796,0.80133265226249,12,232,negative regulation of cellular amide metabolic process,BP,BTG2;ZC3H12A;ZFP36;ZFP36L1;CPEB2;SMAD3;GRB7;NUP153;SMAD1;ZC3H7B;ABCA7;QKI
8747,GO:0034394,0.295029905062131,0.879981018091248,3,40,protein localization to cell surface,BP,TNF;NEDD4L;NRG1
17513,GO:1900542,0.295039042432206,0.827683417153287,7,115,regulation of purine nucleotide metabolic process,BP,PPIF;VEGFA;ADM;WNT5A;NUP153;PARP1;EGLN1
1996,GO:0004714,0.295096547537885,0.880169139218245,3,38,transmembrane receptor protein tyrosine kinase activity,MF,EPHA2;AXL;DDR1
19418,GO:1905906,0.295310186614009,0.95687637171904,1,8,regulation of amyloid fibril formation,BP,LDLR
16589,GO:0097371,0.295398683386225,0.957642975524377,1,7,MDM2/MDM4 family protein binding,MF,TP53
12065,GO:0048002,0.295527075474924,0.820020852394069,8,149,antigen processing and presentation of peptide antigen,BP,TAP1;KIF3C;HLA-A;TAPBP;HLA-B;ITGAV;HLA-F;HLA-E
11724,GO:0046513,0.295527776544039,0.879569586792909,3,41,ceramide biosynthetic process,BP,TNF;SGMS2;UGCG
984,GO:0002438,0.295561906683073,0.956797652215191,1,8,acute inflammatory response to antigenic stimulus,BP,ICAM1
10646,GO:0043652,0.29560968558253,0.956782701220275,1,8,engulfment of apoptotic cell,BP,ABCA7
15524,GO:0071888,0.295648398683155,0.956770584929032,1,8,macrophage apoptotic process,BP,NOD2
17267,GO:0120036,0.295655426736511,0.753895674700822,53,1028,plasma membrane bounded cell projection organization,BP,EFNA1;SDC4;BTG2;JUN;RAB3IP;EPHA2;EHD1;EFNB1;IL6;CYLD;NAV3;NEDD4L;SGK1;ICAM1;VEGFA;FGD6;ZSWIM4;PLK2;ABL2;CFLAR;KLF7;ADM;CDC42EP4;CREB1;GORAB;NR4A2;SEMA4B;KIF3C;WNT5A;SLC11A2;ANLN;NRG1;TNC;PARD6B;FEZ1;GRB7;NEDD4;ITSN2;NFE2L2;WNT7B;SPTBN5;CAV1;RTTN;ABI1;EFNB2;RAPH1;EMP3;NR4A3;GSK3B;VIM;DDR1;CEP135;EPB41L3
10912,GO:0044454,0.295693708821624,0.776124251318979,23,465,nuclear chromosome part,CC,IRF1;JUN;KDM6B;JUNB;SMAD3;CEBPB;CREB1;SFR1;BAZ1A;TNKS1BP1;MXD1;CHD4;TP53;RAD9B;PML;RELA;ESCO2;MUC1;PPARD;PARP1;NABP1;ZMIZ2;JUND
20280,GO:2001212,0.295770473832057,0.957528649117893,1,7,regulation of vasculogenesis,BP,ADM
10329,GO:0043116,0.295820984910018,0.957513103217044,1,7,negative regulation of vascular permeability,BP,ADM
3049,GO:0006606,0.296038724946817,0.826925813125953,7,115,protein import into nucleus,BP,NFKBIA;TNF;ZC3H12A;BCL3;CDKN1A;NUP153;PML
16084,GO:0090030,0.296077454834857,0.957434118603171,1,7,regulation of steroid hormone biosynthetic process,BP,BMP2
15549,GO:0071933,0.296085852333897,0.957431531017471,1,7,Arp2/3 complex binding,MF,JMY
6942,GO:0030546,0.296432081706899,0.957324766187264,1,7,receptor activator activity,MF,NRG1
14677,GO:0070273,0.296729311622567,0.907817092666777,2,23,phosphatidylinositol-4-phosphate binding,MF,PLEKHF1;JPH2
11548,GO:0046068,0.296743037110227,0.908039760966349,2,22,cGMP metabolic process,BP,VEGFA;WNT5A
13806,GO:0060379,0.296879922781896,0.957186440397344,1,7,cardiac muscle cell myoblast differentiation,BP,NRG1
9577,GO:0036376,0.296986444271587,0.95715350103963,1,7,sodium ion export across plasma membrane,BP,SLC9A1
11602,GO:0046173,0.297148451675896,0.878471044784523,3,42,polyol biosynthetic process,BP,ITPKC;CYP27B1;GCH1
8662,GO:0034214,0.29727322497621,0.957064748371097,1,7,protein hexamerization,BP,PANX1
4186,GO:0009261,0.297411877378937,0.907251398827265,2,24,ribonucleotide catabolic process,BP,AMPD3;EGLN1
11773,GO:0046621,0.29747067427952,0.907662080348497,2,22,negative regulation of organ growth,BP,SAV1;TGFBR2
9901,GO:0042181,0.297514850921141,0.90700431893331,2,25,ketone biosynthetic process,BP,BMP2;ADM
20202,GO:2001023,0.297610022220535,0.878089550279314,3,43,regulation of response to drug,BP,NFE2L2;TP53;NR4A3
18019,GO:1902473,0.297814219458581,0.956897034889402,1,7,regulation of protein localization to synapse,BP,WNT5A
1631,GO:0004065,0.29787881138977,0.956876985695971,1,7,arylsulfatase activity,MF,ARSJ
1263,GO:0003014,0.29799819249781,0.858816357261405,4,58,renal system process,BP,EDN1;SGK1;ADM;PDGFB
4949,GO:0014911,0.298208892378921,0.907278185434006,2,22,positive regulation of smooth muscle cell migration,BP,PDGFB;DOCK4
13031,GO:0051453,0.298243385535165,0.858459761996063,4,61,regulation of intracellular pH,BP,SLC9A1;CLIC4;TP53;SLC9A8
11015,GO:0044837,0.298632283907317,0.956642714062184,1,7,actomyosin contractile ring organization,BP,ANLN
9627,GO:0036491,0.298677565732107,0.956628611705741,1,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,PPP1R15A
14136,GO:0060982,0.29873622061738,0.956610340592285,1,7,coronary artery morphogenesis,BP,VEGFA
20277,GO:2001204,0.298847911351822,0.956575536488017,1,7,regulation of osteoclast development,BP,TJP2
16070,GO:0086103,0.298872874883881,0.956567755376284,1,7,G-protein coupled receptor signaling pathway involved in heart process,BP,CAV1
242,GO:0000506,0.29895467376207,0.955098176370547,1,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,PIGA
1124,GO:0002710,0.29907343789263,0.955690924449277,1,8,negative regulation of T cell mediated immunity,BP,IL7R
8258,GO:0033033,0.299203352058909,0.95564967168607,1,8,negative regulation of myeloid cell apoptotic process,BP,NOD2
12354,GO:0048706,0.299259837681847,0.843921280500782,5,76,embryonic skeletal system development,BP,SIX4;SMAD3;DLX2;TGFBR2;WNT5A
11079,GO:0045071,0.299661216069492,0.876638442751421,3,45,negative regulation of viral genome replication,BP,TNF;ZC3H12A;TNIP1
12896,GO:0051220,0.299722058857601,0.906042831174445,2,24,cytoplasmic sequestering of protein,BP,NFKBIA;NFKBIE
7299,GO:0031293,0.299911673576289,0.906156556262454,2,23,membrane protein intracellular domain proteolysis,BP,NFKB1;RELA
10128,GO:0042659,0.300077036229514,0.956191468032987,1,7,regulation of cell fate specification,BP,DKK1
12624,GO:0050792,0.300220245343263,0.810515707944843,9,164,regulation of viral process,BP,CXCL8;TNF;ZC3H12A;PTX3;TNIP1;ZFP36;JUN;TRIM25;PML
11772,GO:0046620,0.300221888599993,0.857385329976852,4,57,regulation of organ growth,BP,EDN1;SAV1;TGFBR2;PIM1
12417,GO:0048853,0.300887123728426,0.955937274574817,1,7,forebrain morphogenesis,BP,WNT5A
17601,GO:1901223,0.300903016817663,0.9551079336339,1,8,negative regulation of NIK/NF-kappaB signaling,BP,RELA
9991,GO:0042391,0.300960680387842,0.800520666176164,11,194,regulation of membrane potential,BP,PMAIP1;EDN1;JUN;NEDD4L;SLC9A1;NEDD4;CAV1;STX1A;GSK3B;PARP1;GJC1
12939,GO:0051281,0.301128001369816,0.905303818214964,2,24,positive regulation of release of sequestered calcium ion into cytosol,BP,BDKRB1;JPH2
4832,GO:0014033,0.301167055206632,0.856677073994242,4,58,neural crest cell differentiation,BP,EDN1;EFNB1;SEMA4B;NRG1
12656,GO:0050847,0.301203778389304,0.955837683168802,1,7,progesterone receptor signaling pathway,BP,NEDD4
5356,GO:0016114,0.301335377913381,0.954969524035409,1,8,terpenoid biosynthetic process,BP,HMGCS1
13548,GO:0055117,0.301350523694729,0.875972144543851,3,41,regulation of cardiac muscle contraction,BP,ZC3H12A;SLC9A1;CAV1
14208,GO:0061099,0.301513917694428,0.905100503986828,2,24,negative regulation of protein tyrosine kinase activity,BP,ERRFI1;CAV1
12322,GO:0048663,0.301543850237252,0.905299642822735,2,23,neuron fate commitment,BP,DLX2;NRG1
11498,GO:0045953,0.301617499555503,0.954879077999233,1,8,negative regulation of natural killer cell mediated cytotoxicity,BP,HLA-E
1993,GO:0004711,0.301672146492785,0.955690139113938,1,7,ribosomal protein S6 kinase activity,MF,RPS6KA6
11466,GO:0045912,0.301714717529372,0.90520972922007,2,23,negative regulation of carbohydrate metabolic process,BP,SOGA1;GSK3B
17121,GO:0101002,0.301810798277899,0.815182011677015,8,146,ficolin-1-rich granule,CC,AMPD3;ADAM8;CD55;CANT1;MMP9;CAB39;COTL1;MGAM
18553,GO:1903726,0.301905912634901,0.954786507289678,1,8,negative regulation of phospholipid metabolic process,BP,PDGFB
8578,GO:0034046,0.302040535322559,0.95557389136771,1,7,poly(G) binding,MF,PATL1
9203,GO:0035584,0.302313124346827,0.953496631924975,1,10,calcium-mediated signaling using intracellular calcium source,BP,CCL20
17773,GO:1901725,0.302418236890161,0.95545452297496,1,7,regulation of histone deacetylase activity,BP,VEGFA
3520,GO:0007494,0.302421626510314,0.955453450888724,1,7,midgut development,BP,WNT5A
4746,GO:0010911,0.30266019093497,0.955377959227611,1,7,regulation of isomerase activity,BP,NOD2
4747,GO:0010912,0.30266019093497,0.955377959227611,1,7,positive regulation of isomerase activity,BP,NOD2
18093,GO:1902669,0.302877251053501,0.955309208501526,1,7,positive regulation of axon guidance,BP,VEGFA
13578,GO:0060027,0.302915469271632,0.955297097113658,1,7,convergent extension involved in gastrulation,BP,WNT5A
19043,GO:1904861,0.303217780368388,0.955201227881668,1,7,excitatory synapse assembly,BP,WNT5A
11319,GO:0045628,0.303267216735922,0.954348104114788,1,8,regulation of T-helper 2 cell differentiation,BP,IL4R
2607,GO:0005903,0.303454198681827,0.855125973602837,4,58,brush border,CC,B4GALT1;SLC6A14;SLC11A2;SLC38A2
4818,GO:0014009,0.3034612803422,0.904288413367058,2,23,glial cell proliferation,BP,CREB1;SOX4
11226,GO:0045351,0.303701363010433,0.954207777613977,1,8,type I interferon biosynthetic process,BP,TICAM1
16107,GO:0090073,0.304115652243645,0.954073638581128,1,8,positive regulation of protein homodimerization activity,BP,TRAF4
6366,GO:0021543,0.304257108636186,0.820689236193298,7,114,pallium development,BP,BTG2;KDM6B;DLX2;SLC38A2;FEZ1;NR4A3;GSK3B
11704,GO:0046483,0.304465361733398,0.726064373000249,219,4710,heterocycle metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;WTAP;TJP2;RELB;ZNF217;CDKN1A;NMNAT2;CCDC85B;IL7R;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;GCH1;SMAD3;ZC3H12C;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;TXNRD1;KLF7;BTG1;UPP1;IER5;CEBPB;CEBPD;NAMPT;ADM;CREB1;TAF4B;CCNL1;USP43;NR4A2;PATL1;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;SLC11A2;TGFA;SLC52A3;SOX4;PDGFB;BAZ1A;NRG1;ATF3;OTUD4;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;HAL;NUP153;NEDD4;POU2F2;DUS4L;NFE2L2;PTPN1;SMAD1;TAB3;MXD1;CHD4;ZC3H7B;DIEXF;NFAT5;STAT5A;TPST1;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;PUS10;UBE2D3;MAPKBP1;ELK3;RAD9B;SNAPC4;CLK4;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;ESCO2;FOXN2;MUC1;YARS2;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;XBP1;QKI;ZBTB5;ELF4;SREK1IP1;TFE3;EID3;ZMIZ2;JUND;DENND4A
15672,GO:0072176,0.304789619853645,0.95470085738576,1,7,nephric duct development,BP,EFNB2
3046,GO:0006600,0.305090317667598,0.953757170515135,1,8,creatine metabolic process,BP,STAT5A
532,GO:0001650,0.305156578253314,0.81989458612338,7,118,fibrillar center,CC,NFKBIE;KLF6;TXNRD1;TMEM217;TAF4B;SPATA2;RPS6KA6
10022,GO:0042448,0.305183455176442,0.953726863899649,1,8,progesterone metabolic process,BP,ADM
4077,GO:0009128,0.305375129167707,0.953664457927151,1,8,purine nucleoside monophosphate catabolic process,BP,AMPD3
4106,GO:0009158,0.305375129167707,0.953664457927151,1,8,ribonucleoside monophosphate catabolic process,BP,AMPD3
4116,GO:0009169,0.305375129167707,0.953664457927151,1,8,purine ribonucleoside monophosphate catabolic process,BP,AMPD3
13982,GO:0060675,0.30539060360594,0.87356193018738,3,40,ureteric bud morphogenesis,BP,BMP2;SIX4;VEGFA
15667,GO:0072171,0.30539060360594,0.87356193018738,3,40,mesonephric tubule morphogenesis,BP,BMP2;SIX4;VEGFA
18662,GO:1903955,0.305397274474321,0.853486728301661,4,63,positive regulation of protein targeting to mitochondrion,BP,PLAGL2;NRG1;UGCG;UBE2D3
11437,GO:0045842,0.305415242214346,0.953651391642243,1,8,positive regulation of mitotic metaphase/anaphase transition,BP,ESPL1
17832,GO:1901970,0.305415242214346,0.953651391642243,1,8,positive regulation of mitotic sister chromatid separation,BP,ESPL1
17882,GO:1902101,0.305415242214346,0.953651391642243,1,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,ESPL1
6848,GO:0030309,0.305519997493901,0.953617259027188,1,8,poly-N-acetyllactosamine metabolic process,BP,B3GNT5
6849,GO:0030311,0.305519997493901,0.953617259027188,1,8,poly-N-acetyllactosamine biosynthetic process,BP,B3GNT5
2383,GO:0005516,0.306029140062966,0.812207568224946,8,130,calmodulin binding,MF,ITPKC;MARCKSL1;PHKG2;CAMK1G;RRAD;SLC9A1;MARCKS;GEM
10638,GO:0043632,0.30608392506371,0.761957301899912,27,530,modification-dependent macromolecule catabolic process,BP,TNFAIP3;RNF19B;SQSTM1;BIRC2;N4BP1;CYLD;NEDD4L;RNF144B;TRIB1;PLK2;RNF43;USP43;ABTB2;SMURF2;TRIM25;PLK3;RCHY1;NEDD4;NFE2L2;CAV1;TP53;UBE2D3;PML;USP31;GSK3B;RNF145;XBP1
1288,GO:0003093,0.306212443179371,0.953391274449901,1,8,regulation of glomerular filtration,BP,PDGFB
6587,GO:0022410,0.306601113033336,0.952600909710852,1,9,circadian sleep/wake cycle process,BP,CSF2
12631,GO:0050802,0.306601113033336,0.952600909710852,1,9,circadian sleep/wake cycle, sleep,BP,CSF2
737,GO:0001964,0.306663268759018,0.954100222923708,1,7,startle response,BP,NRG1
14851,GO:0070586,0.306691146341794,0.953234676673673,1,8,cell-cell adhesion involved in gastrulation,BP,IL1RN
8242,GO:0033008,0.307054087376815,0.953115746523946,1,8,positive regulation of mast cell activation involved in immune response,BP,IL4R
10453,GO:0043306,0.307054087376815,0.953115746523946,1,8,positive regulation of mast cell degranulation,BP,IL4R
17336,GO:0150011,0.307071201853501,0.953968847035796,1,7,regulation of neuron projection arborization,BP,WNT5A
17337,GO:0150012,0.307071201853501,0.953968847035796,1,7,positive regulation of neuron projection arborization,BP,WNT5A
13299,GO:0051974,0.307414867532512,0.952997352074723,1,8,negative regulation of telomerase activity,BP,TP53
7583,GO:0031943,0.3077189300859,0.952897436664578,1,8,regulation of glucocorticoid metabolic process,BP,BMP2
11520,GO:0046006,0.308023079890611,0.901250732237304,2,26,regulation of activated T cell proliferation,BP,IL23A;BTN2A2
3510,GO:0007420,0.308062676774603,0.764022978756378,24,449,brain development,BP,BTG2;INHBA;BMP2;TBX3;KDM6B;ETS1;DLX2;B3GNT5;DKK1;CREB1;NR4A2;TGFBR2;HMGCS1;WNT5A;NRG1;SLC38A2;FEZ1;WNT7B;SMAD1;ZNF148;AXL;NR4A3;GSK3B;KDM7A
2677,GO:0006027,0.3081449991637,0.871721627922697,3,41,glycosaminoglycan catabolic process,BP,SDC4;PGLYRP4;SLC9A1
19852,GO:2000291,0.308206809005845,0.952736863529255,1,8,regulation of myoblast proliferation,BP,PPARD
5329,GO:0016051,0.308257067716687,0.804211556159321,9,158,carbohydrate biosynthetic process,BP,NFKB1;B4GALT1;B3GNT5;PHKG2;SOGA1;PPP1R3B;PDGFB;ATF3;GSK3B
3949,GO:0008643,0.30858470767658,0.826174765226309,6,95,carbohydrate transport,BP,IL1B;TNF;SLC2A6;NFE2L2;NR4A3;PPARD
19838,GO:2000271,0.308935961272554,0.953365535277547,1,7,positive regulation of fibroblast apoptotic process,BP,BTG1
8724,GO:0034368,0.309143117228339,0.951753488505245,1,9,protein-lipid complex remodeling,BP,ABCA5
8725,GO:0034369,0.309143117228339,0.951753488505245,1,9,plasma lipoprotein particle remodeling,BP,ABCA5
12636,GO:0050807,0.309751418552701,0.825336020790927,6,94,regulation of synapse organization,BP,EFNA1;SIX4;DKK1;WNT5A;NEDD4;TLR2
13003,GO:0051400,0.309936816180013,0.952164935257784,1,8,BH domain binding,MF,BCL2L2
15841,GO:0072530,0.310065869220018,0.952122112219636,1,8,purine-containing compound transmembrane transport,BP,SLC28A3
3835,GO:0008432,0.310370629248315,0.952020897467274,1,8,JUN kinase binding,MF,DUSP10
7210,GO:0031095,0.310430072372168,0.952878864001115,1,7,platelet dense tubular network membrane,CC,EHD1
2398,GO:0005540,0.310762078981948,0.951890711026391,1,8,hyaluronic acid binding,MF,LAYN
8737,GO:0034383,0.310780866647309,0.899952460651029,2,25,low-density lipoprotein particle clearance,BP,EHD1;LDLR
4778,GO:0010960,0.311021060525451,0.952685557313506,1,7,magnesium ion homeostasis,BP,SLC41A1
4316,GO:0009791,0.311348066917988,0.835231501478272,5,76,post-embryonic development,BP,PRDM1;PLAGL2;CSRNP1;VEGFA;NR4A2
11521,GO:0046007,0.311427081675132,0.95166908096152,1,8,negative regulation of activated T cell proliferation,BP,BTN2A2
14095,GO:0060900,0.311737785023786,0.952450509214664,1,7,embryonic camera-type eye formation,BP,WNT5A
14907,GO:0070700,0.31179935437107,0.951544754327203,1,8,BMP receptor binding,MF,BMP2
10656,GO:0043691,0.311913934506889,0.95150645128198,1,8,reverse cholesterol transport,BP,ABCA5
7793,GO:0032329,0.312142963936578,0.951429836556551,1,8,serine transport,BP,NFKBIE
18252,GO:1903044,0.31214661257399,0.951428615452434,1,8,protein localization to membrane raft,BP,CAV1
13029,GO:0051451,0.312575522758088,0.95128494681981,1,8,myoblast migration,BP,SIX4
5265,GO:0015893,0.312674028111837,0.822931657824339,6,100,drug transport,BP,INHBA;EDN1;NFKBIE;CLDN1;SLC7A2;SLC52A3
14397,GO:0061631,0.312722354104343,0.898709317473675,2,26,ubiquitin conjugating enzyme activity,MF,UBE2D3;UBE2Z
12593,GO:0050746,0.312837916555258,0.95119693402321,1,8,regulation of lipoprotein metabolic process,BP,ITGAV
3294,GO:0006987,0.312882338220831,0.951182024912231,1,8,activation of signaling protein activity involved in unfolded protein response,BP,PTPN1
16156,GO:0090154,0.313118016061842,0.951102881057403,1,8,positive regulation of sphingolipid biosynthetic process,BP,TNF
19861,GO:2000304,0.313118016061842,0.951102881057403,1,8,positive regulation of ceramide biosynthetic process,BP,TNF
2180,GO:0005024,0.313331226529419,0.951925527586034,1,7,transforming growth factor beta-activated receptor activity,MF,TGFBR2
19310,GO:1905523,0.31355707334979,0.950955242034341,1,8,positive regulation of macrophage migration,BP,CSF1
7884,GO:0032446,0.313639913634154,0.744703492773306,39,786,protein modification by small protein conjugation,BP,TNFAIP3;BIRC3;RNF19B;TICAM1;PELI1;BIRC2;N4BP1;RIPK2;KLHL21;ZNF451;NEDD4L;NOD2;DCUN1D3;RNF144B;RNF43;VHL;BACH1;SMURF2;KLHL5;TRIM25;SOX4;SOCS2;IFIH1;KIAA1586;ARRDC4;RCHY1;NUP153;RNF152;NEDD4;NFE2L2;KBTBD7;CAV1;SH3RF2;UBE2D3;PJA2;UBE2Z;RELA;RNF145;KCTD11
14955,GO:0070831,0.313869497510796,0.951747432304269,1,7,basement membrane assembly,BP,PHLDB2
4761,GO:0010935,0.313890520414874,0.950842944021795,1,8,regulation of macrophage cytokine production,BP,WNT5A
17293,GO:0140030,0.313961851377419,0.813212900061243,7,114,modification-dependent protein binding,MF,TNFAIP3;TNIP1;SQSTM1;TNIP2;IKBKE;KMT2E;KDM7A
19234,GO:1905330,0.313965808950524,0.805660751017658,8,144,regulation of morphogenesis of an epithelium,BP,TNF;LIF;SIX4;PHLDB2;VEGFA;DKK1;SMURF2;WNT5A
17046,GO:0099503,0.31398633502167,0.751672943237943,30,609,secretory vesicle,CC,IL1B;PLAU;CXCL1;PLAUR;PTX3;NFKB1;EDN1;AMPD3;ADAM8;RAP2B;CTSC;B4GALT1;VEGFA;RAB24;CD55;CD47;CANT1;VEGFC;SERPINB1;PDGFB;MMP9;CAB39;CAV1;TLR2;ITGAV;STX1A;PLAT;FRK;COTL1;MGAM
7055,GO:0030825,0.313993438845088,0.950808253262467,1,8,positive regulation of cGMP metabolic process,BP,WNT5A
2655,GO:0005996,0.314151273757308,0.789643167094349,11,199,monosaccharide metabolic process,BP,TNF;PMAIP1;PHLDA2;C1QTNF1;B4GALT1;PHKG2;SOGA1;PPP1R3B;ATF3;GSK3B;PPARD
5084,GO:0015318,0.314430619747531,0.76292998814683,21,399,inorganic molecular entity transmembrane transporter activity,MF,PANX1;SLC6A14;KCNJ15;SLC28A3;NIPAL4;SLC7A2;SLC11A2;SLC38A2;TRPV3;SLC9A1;SLC25A37;SLC2A6;CLIC4;ITGAV;JPH2;SLC9A8;SLC16A13;SLC16A1;SLC39A14;SLC41A1;GJC1
8720,GO:0034364,0.314613939004587,0.949343263338099,1,10,high-density lipoprotein particle,CC,SAA1
2944,GO:0006471,0.31478007583071,0.897989926577931,2,24,protein ADP-ribosylation,BP,PARP8;PARP1
6365,GO:0021542,0.315531592912529,0.950288100132395,1,8,dentate gyrus development,BP,BTG2
8300,GO:0033129,0.315731112123525,0.950220397370485,1,8,positive regulation of histone phosphorylation,BP,IL1B
15097,GO:0071071,0.316044148640707,0.950114067380143,1,8,regulation of phospholipid biosynthetic process,BP,PDGFB
4202,GO:0009308,0.316305192367427,0.830970237669223,5,92,amine metabolic process,BP,ODC1;NR4A2;MAOA;PAOX;SAT1
1348,GO:0003208,0.316390400258187,0.866602427781322,3,40,cardiac ventricle morphogenesis,BP,TGFBR2;SOX4;NRG1
9688,GO:0038063,0.316517050896378,0.950865888324213,1,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,DDR1
17324,GO:0140131,0.316781052964349,0.949863242514716,1,8,positive regulation of lymphocyte chemotaxis,BP,WNT5A
6334,GO:0020027,0.317098419896647,0.949754993890744,1,8,hemoglobin metabolic process,BP,INHBA
3218,GO:0006865,0.31711883274056,0.830931927335162,5,78,amino acid transport,BP,NFKBIE;SLC6A14;SLC7A2;SLC38A2;STX1A
5856,GO:0017148,0.317887887397804,0.786359369321674,11,216,negative regulation of translation,BP,BTG2;ZC3H12A;ZFP36;ZFP36L1;CPEB2;SMAD3;GRB7;NUP153;SMAD1;ZC3H7B;QKI
6568,GO:0022010,0.317939165838301,0.949467575626143,1,8,central nervous system myelination,BP,TLR2
7775,GO:0032291,0.317939165838301,0.949467575626143,1,8,axon ensheathment in central nervous system,BP,TLR2
14594,GO:0070127,0.317974842349337,0.949455358211799,1,8,tRNA aminoacylation for mitochondrial protein translation,BP,YARS2
2396,GO:0005537,0.318142231537201,0.94939801296801,1,8,mannose binding,MF,LMAN1
20309,GO:2001257,0.318186433188202,0.830150328061932,5,78,regulation of cation channel activity,BP,MMP9;RRAD;CAV1;GEM;JPH2
12167,GO:0048265,0.318514077697466,0.949270488738705,1,8,response to pain,BP,GCH1
8897,GO:0034713,0.318566594339452,0.94925246322419,1,8,type I transforming growth factor beta receptor binding,MF,TGFBR2
2746,GO:0006139,0.318975282766969,0.712356049938449,214,4608,nucleobase-containing compound metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;WTAP;TJP2;RELB;ZNF217;CDKN1A;NMNAT2;CCDC85B;IL7R;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;SMAD3;ZC3H12C;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;TXNRD1;KLF7;BTG1;UPP1;IER5;CEBPB;CEBPD;NAMPT;ADM;CREB1;TAF4B;CCNL1;USP43;NR4A2;PATL1;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;OTUD4;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;NUP153;NEDD4;POU2F2;DUS4L;NFE2L2;PTPN1;SMAD1;TAB3;MXD1;CHD4;ZC3H7B;DIEXF;NFAT5;STAT5A;TPST1;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;PUS10;UBE2D3;MAPKBP1;ELK3;RAD9B;SNAPC4;CLK4;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;ESCO2;FOXN2;MUC1;YARS2;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ZXDA;XBP1;QKI;ZBTB5;ELF4;SREK1IP1;TFE3;EID3;ZMIZ2;JUND;DENND4A
2005,GO:0004726,0.319050198423918,0.949086299219853,1,8,non-membrane spanning protein tyrosine phosphatase activity,MF,DUSP1
4519,GO:0010566,0.319288434399729,0.949004326722803,1,8,regulation of ketone biosynthetic process,BP,BMP2
5459,GO:0016331,0.319723015079504,0.808705177154456,7,115,morphogenesis of embryonic epithelium,BP,SDC4;SIX4;ADM;WNT5A;VEGFC;SOX4;WNT7B
3125,GO:0006704,0.319814670141659,0.948822987918337,1,8,glucocorticoid biosynthetic process,BP,BMP2
12627,GO:0050795,0.319840609703741,0.895000539182464,2,25,regulation of behavior,BP,CSF2;NR4A3
343,GO:0000956,0.319910657613892,0.794257912778823,9,200,nuclear-transcribed mRNA catabolic process,BP,BTG2;NOCT;ZC3H12A;ZFP36;PNRC1;ZFP36L1;PATL1;PNRC2;TNKS1BP1
10612,GO:0043587,0.32032431704368,0.948647009636206,1,8,tongue morphogenesis,BP,SIX4
13049,GO:0051492,0.320362588126012,0.843404182928916,4,59,regulation of stress fiber assembly,BP,SDC4;PHLDB2;SMAD3;SLC9A1
11018,GO:0044848,0.320992999134255,0.948415585662018,1,8,biological phase,BP,WNT5A
11020,GO:0044851,0.320992999134255,0.948415585662018,1,8,hair cycle phase,BP,WNT5A
12403,GO:0048819,0.320992999134255,0.948415585662018,1,8,regulation of hair follicle maturation,BP,WNT5A
4743,GO:0010907,0.321313981268565,0.89463624503477,2,23,positive regulation of glucose metabolic process,BP,PMAIP1;PHKG2
2403,GO:0005546,0.321480498951772,0.862996111411454,3,43,phosphatidylinositol-4,5-bisphosphate binding,MF,ANXA8;SLC9A1;JPH2
15306,GO:0071480,0.321678280169375,0.893783406651886,2,26,cellular response to gamma radiation,BP,CDKN1A;TP53
15463,GO:0071772,0.321691816249266,0.816233091991213,6,96,response to BMP,BP,BMP2;DKK1;SMURF2;WNT5A;SMAD1;UBE2D3
15464,GO:0071773,0.321691816249266,0.816233091991213,6,96,cellular response to BMP stimulus,BP,BMP2;DKK1;SMURF2;WNT5A;SMAD1;UBE2D3
6236,GO:0019783,0.32176975750659,0.816137816416968,6,97,ubiquitin-like protein-specific protease activity,MF,TNFAIP3;ZC3H12A;CYLD;USP43;OTUD4;USP31
479,GO:0001523,0.321808006532988,0.862784152808769,3,43,retinoid metabolic process,BP,SDC4;SDR16C5;PPARD
7466,GO:0031618,0.32225192324708,0.947978245198733,1,8,nuclear pericentric heterochromatin,CC,ESCO2
15509,GO:0071868,0.322475118323061,0.89375689520787,2,24,cellular response to monoamine stimulus,BP,SLC9A1;NR4A3
15511,GO:0071870,0.322475118323061,0.89375689520787,2,24,cellular response to catecholamine stimulus,BP,SLC9A1;NR4A3
18817,GO:1904350,0.322575209756525,0.947865591900573,1,8,regulation of protein catabolic process in the vacuole,BP,LDLR
11862,GO:0046834,0.322606921862995,0.827000273226104,5,76,lipid phosphorylation,BP,HBEGF;EREG;FGF5;PDGFB;NRG1
8678,GO:0034248,0.322654567289766,0.755581102076147,21,427,regulation of cellular amide metabolic process,BP,TNF;EFNA1;BTG2;ZC3H12A;PPP1R15A;ZFP36;BCL3;IL6;ZFP36L1;CPEB2;SMAD3;SOX4;PLK3;GRB7;NUP153;NFE2L2;SMAD1;ZC3H7B;ABCA7;VIM;QKI
15344,GO:0071550,0.322914303448323,0.947011295290568,1,9,death-inducing signaling complex assembly,BP,TNF
10079,GO:0042574,0.323156533016091,0.947662666193875,1,8,retinal metabolic process,BP,SDR16C5
3283,GO:0006971,0.323215703977443,0.947641985375149,1,8,hypotonic response,BP,CAB39
3135,GO:0006725,0.323238586593138,0.708153511848401,219,4724,cellular aromatic compound metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;WTAP;TJP2;RELB;ZNF217;CDKN1A;NMNAT2;CCDC85B;IL7R;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;GCH1;SMAD3;ZC3H12C;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;TXNRD1;KLF7;BTG1;UPP1;IER5;CEBPB;CEBPD;NAMPT;ADM;CREB1;TAF4B;CCNL1;USP43;NR4A2;PATL1;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;WNT5A;SLC11A2;TGFA;SOX4;PDGFB;BAZ1A;NRG1;ATF3;OTUD4;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;MAOA;RCHY1;YAF2;TNKS1BP1;HAL;NUP153;NEDD4;POU2F2;DUS4L;NFE2L2;PTPN1;SMAD1;TAB3;MXD1;CHD4;ZC3H7B;DIEXF;NFAT5;STAT5A;TPST1;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;PUS10;UBE2D3;MAPKBP1;ELK3;RAD9B;SNAPC4;CLK4;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;ESCO2;FOXN2;MUC1;YARS2;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;XBP1;QKI;ZBTB5;ELF4;SREK1IP1;TFE3;EID3;ZMIZ2;JUND;DENND4A
3664,GO:0008152,0.323331860258459,0.709776663132125,380,8267,metabolic process,BP,NFKBIZ;CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;IL1A;ITPKC;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;ZNF267;SPRR2D;SERTAD2;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;KLHL21;PHLDA2;DAPP1;JUNB;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;STEAP4;C1QTNF1;CDKN1A;NMNAT2;CCDC85B;ITGA5;RAP2B;IL7R;CPEB2;ZNF451;ODC1;NEDD4L;CTSC;GPX3;NOD2;ELMSAN1;IL6ST;DCUN1D3;SAV1;TFPI2;SGK1;ICAM1;GCH1;SMAD3;ZC3H12C;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;RNF144B;NFKBID;TRAF4;TRIB1;SERPINB8;VEGFA;RAB24;NRARP;IL1R2;SLC6A14;DKK1;CDKN2B;FGF5;PLK2;MAP3K8;ZBED2;ABL2;PPTC7;CFLAR;RNF43;TXNRD1;KLF7;PIGA;BTG1;ANXA8;UPP1;IER5;PPP4R4;CEBPB;CEBPD;VMP1;CD55;DENND3;NAMPT;ANKLE2;HEPHL1;ADM;DSE;ERRFI1;ADAMTS1;ANKK1;CREB1;TAF4B;CCNL1;USP43;MAST4;NR4A2;PATL1;SLC7A2;CANT1;VHL;PHKG2;SOGA1;BACH1;ABTB2;MYBL1;RUNX1;TGFBR2;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;MASTL;NAB1;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;DUSP10;SLC52A3;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;PGLYRP4;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;KIAA1586;ATF3;OTUD4;IKZF2;COL12A1;CAB39;TLE1;PLK3;CHD2;ARRDC4;SUCO;SLC9A1;ZBTB10;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;B4GALT5;HAL;GRB7;ARSJ;NUP153;RNF152;NEDD4;MMD;POU2F2;DUS4L;IL24;TNFRSF6B;RAET1L;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;TPRA1;ZC3H7B;DIEXF;NFAT5;STAT5A;TPST1;CAV1;VEZF1;SH3RF2;DRAM1;INO80D;TNIP2;ZNFX1;UGCG;TP53;KLF3;TLR2;ABI1;STK40;PUS10;TAPBP;PDP1;ITGAV;IKBKE;UBE2D3;PJA2;CD276;MAPKBP1;ELK3;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;ADAM9;RELA;TRIM16;ESCO2;FOXN2;CCBE1;PPP6R3;PLAT;CHST2;MUC1;YARS2;AXL;ELL2;SAT1;FRK;CITED4;NR4A3;USP31;GSK3B;KMT2E;PPARD;PARP8;SLC16A1;PARP1;CYP24A1;MMP10;KDM7A;MED13;MXD3;CRAMP1;LCE1C;JMY;COL8A1;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;RNF145;ALAS1;ZXDA;RPS6KA6;DDR1;XBP1;QKI;KCTD11;ZBTB5;ELF4;SREK1IP1;TFE3;EID3;ZMIZ2;MGAM;LMAN1;CFB;JUND;DENND4A
8317,GO:0033148,0.323378931456464,0.947584911190688,1,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,PARP1
10015,GO:0042438,0.323452058796059,0.947559329734976,1,8,melanin biosynthetic process,BP,WNT5A
8818,GO:0034587,0.323822068337212,0.947429781512674,1,8,piRNA metabolic process,BP,MYBL1
19091,GO:1904953,0.323857422886777,0.947417393406788,1,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT5A
3657,GO:0008139,0.323964826559892,0.893166451843819,2,23,nuclear localization sequence binding,MF,NFKBIA;NUP153
1312,GO:0003157,0.324161897641412,0.947310636318142,1,8,endocardium development,BP,NRG1
19520,GO:1990314,0.324210617818909,0.94729354202161,1,8,cellular response to insulin-like growth factor stimulus,BP,CREB1
18204,GO:1902959,0.324497382125344,0.947192860579608,1,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,EFNA1
19199,GO:1905245,0.324497382125344,0.947192860579608,1,8,regulation of aspartic-type peptidase activity,BP,EFNA1
15496,GO:0071837,0.324585570896527,0.947161875500033,1,8,HMG box domain binding,MF,JUN
5389,GO:0016209,0.324728859406985,0.860041875711383,3,53,antioxidant activity,MF,SOD2;GPX3;TXNRD1
14407,GO:0061650,0.324873396164955,0.891813213844489,2,27,ubiquitin-like protein conjugating enzyme activity,MF,UBE2D3;UBE2Z
10527,GO:0043455,0.324920668663553,0.94704404266692,1,8,regulation of secondary metabolic process,BP,WNT5A
2336,GO:0005351,0.325307755979607,0.946907738292227,1,8,carbohydrate:proton symporter activity,MF,SLC2A6
1118,GO:0002704,0.325443857506997,0.89167989084809,2,26,negative regulation of leukocyte mediated immunity,BP,IL7R;HLA-E
6063,GO:0019207,0.3254851314442,0.790240531250065,9,162,kinase regulator activity,MF,CDKN1A;TRIB1;CDKN2B;CCNL1;SOCS2;NRG1;CAB39;SPRY2;ABI1
4224,GO:0009396,0.326145113737852,0.945861349321374,1,9,folic acid-containing compound biosynthetic process,BP,GCH1
6546,GO:0021954,0.326478271354624,0.859855569783894,3,42,central nervous system neuron development,BP,BTG2;NR4A2;WNT5A
14853,GO:0070588,0.326493541559811,0.789524696151532,9,156,calcium ion transmembrane transport,BP,BDKRB1;PANX1;RRAD;TRPV3;SLC9A1;ITGAV;GEM;JPH2;TSPAN13
15513,GO:0071872,0.327104613149785,0.946272342052637,1,8,cellular response to epinephrine stimulus,BP,SLC9A1
6,GO:0000012,0.327931085955577,0.945978609809713,1,8,single strand break repair,BP,PARP1
7043,GO:0030812,0.327959973428879,0.945968326190401,1,8,negative regulation of nucleotide catabolic process,BP,EGLN1
16284,GO:0090335,0.328179462241174,0.945890153352859,1,8,regulation of brown fat cell differentiation,BP,DUSP10
13717,GO:0060259,0.328686216648152,0.945709416744027,1,8,regulation of feeding behavior,BP,NR4A3
13518,GO:0055072,0.328758365565147,0.83710540283428,4,65,iron ion homeostasis,BP,STEAP4;SLC11A2;SLC25A37;EGLN1
20234,GO:2001135,0.328884973454559,0.945638433158,1,8,regulation of endocytic recycling,BP,EHD1
14292,GO:0061351,0.329207605919138,0.821963636761243,5,79,neural precursor cell proliferation,BP,BTG2;VEGFA;WNT5A;VEGFC;KCTD11
2747,GO:0006140,0.329255921922101,0.801087626826576,7,120,regulation of nucleotide metabolic process,BP,PPIF;VEGFA;ADM;WNT5A;NUP153;PARP1;EGLN1
16137,GO:0090114,0.329345884803989,0.836810644988738,4,63,COPII-coated vesicle budding,BP,CTSC;TGFA;PPP6R3;LMAN1
11527,GO:0046033,0.329560287546596,0.944630157048628,1,9,AMP metabolic process,BP,AMPD3
8797,GO:0034483,0.329596056673574,0.945384035437038,1,8,heparan sulfate sulfotransferase activity,MF,HS3ST3B1
6778,GO:0030208,0.3297044093701,0.945345210261461,1,8,dermatan sulfate biosynthetic process,BP,DSE
5676,GO:0016782,0.330101485522094,0.857073045775013,3,46,transferase activity, transferring sulfur-containing groups,MF,TPST1;HS3ST3B1;CHST2
1308,GO:0003149,0.330344719418935,0.945115444291791,1,8,membranous septum morphogenesis,BP,TGFBR2
13482,GO:0055002,0.3304148642302,0.821064303551583,5,79,striated muscle cell development,BP,TBX3;EDN1;SIX4;VEGFA;CFLAR
4415,GO:0010171,0.330417585755099,0.857274694043778,3,42,body morphogenesis,BP,CSRNP1;PHLDB2;DKK1
1336,GO:0003188,0.330472148517212,0.945069651100141,1,8,heart valve formation,BP,EFNA1
923,GO:0002315,0.330649733413093,0.94500579663924,1,8,marginal zone B cell differentiation,BP,BCL3
417,GO:0001104,0.330800798585417,0.820682810131768,5,81,RNA polymerase II transcription cofactor activity,MF,ZNF451;SOX4;TLE1;CITED4;MED13
6980,GO:0030641,0.331574512514227,0.835163326248997,4,64,regulation of cellular pH,BP,SLC9A1;CLIC4;TP53;SLC9A8
15591,GO:0072044,0.331817545544529,0.944584805501718,1,8,collecting duct development,BP,WNT7B
12113,GO:0048143,0.33195909410927,0.944533650453483,1,8,astrocyte activation,BP,LDLR
6771,GO:0030201,0.332048752210222,0.888378672034867,2,24,heparan sulfate proteoglycan metabolic process,BP,DSE;HS3ST3B1
16779,GO:0098562,0.332122360417817,0.79124739894847,8,139,cytoplasmic side of membrane,CC,BIRC2;CYLD;ABL2;ERRFI1;CYTH1;PTPN1;GEM;FRK
8272,GO:0033061,0.332389645015605,0.943597928273834,1,9,DNA recombinase mediator complex,CC,SFR1
12158,GO:0048255,0.332405160368213,0.88794928742345,2,25,mRNA stabilization,BP,NOCT;ZFP36
4705,GO:0010862,0.332597882618209,0.887839463322789,2,25,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,INHBA;BMP2
11718,GO:0046501,0.332601830296002,0.943520068920267,1,9,protoporphyrinogen IX metabolic process,BP,ALAS1
6672,GO:0030027,0.332621162775383,0.784534802432623,9,155,lamellipodium,CC,RAB3IP;EPHA2;FGD6;NEDD9;SLC9A1;ABI1;ITGAV;RAPH1;SLC39A14
600,GO:0001765,0.33267790937056,0.943492137175616,1,9,membrane raft assembly,BP,CAV1
9626,GO:0036490,0.333005143474028,0.944154757512288,1,8,regulation of translation in response to endoplasmic reticulum stress,BP,PPP1R15A
746,GO:0001974,0.333259348112583,0.887462138420293,2,25,blood vessel remodeling,BP,LIF;AXL
18588,GO:1903799,0.333466739340252,0.943987081872742,1,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,ZC3H12A
3270,GO:0006942,0.333646731117557,0.854927686128257,3,44,regulation of striated muscle contraction,BP,ZC3H12A;SLC9A1;CAV1
15698,GO:0072210,0.33367429584329,0.887225132743243,2,25,metanephric nephron development,BP,LIF;PDGFB
324,GO:0000904,0.333694705391401,0.738576493948046,26,485,cell morphogenesis involved in differentiation,BP,EFNA1;EPHA2;EFNB1;NEDD4L;VEGFA;DKK1;ZSWIM4;KLF7;CREB1;NR4A2;SEMA4B;WNT5A;SLC11A2;NRG1;PARD6B;FEZ1;GRB7;NEDD4;SPTBN5;CLIC4;ABI1;EFNB2;ITGAV;RAPH1;AXL;NR4A3
10175,GO:0042759,0.333734456832845,0.94310340214137,1,9,long-chain fatty acid biosynthetic process,BP,QKI
2789,GO:0006222,0.334000404351604,0.943005307118844,1,9,UMP biosynthetic process,BP,UPP1
4118,GO:0009173,0.334000404351604,0.943005307118844,1,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,UPP1
4119,GO:0009174,0.334000404351604,0.943005307118844,1,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,UPP1
11537,GO:0046049,0.334000404351604,0.943005307118844,1,9,UMP metabolic process,BP,UPP1
12135,GO:0048199,0.334050447002568,0.833395699867689,4,64,vesicle targeting, to, from or within Golgi,BP,CTSC;TGFA;PPP6R3;LMAN1
17842,GO:1901987,0.334325576739207,0.749015091486327,19,379,regulation of cell cycle phase transition,BP,BTG2;DUSP1;GADD45A;ZFP36L1;CDKN1A;DCUN1D3;CDKN2B;PLK2;SOX4;ANLN;PLK3;TNKS1BP1;TPRA1;TP53;PML;ESPL1;MUC1;KMT2E;CEP135
4379,GO:0010002,0.334343222434683,0.943667888438184,1,8,cardioblast differentiation,BP,NRG1
17323,GO:0140115,0.334377373073283,0.943655430148591,1,8,export across plasma membrane,BP,SLC9A1
2676,GO:0006026,0.334743135202395,0.854307122288342,3,43,aminoglycan catabolic process,BP,SDC4;PGLYRP4;SLC9A1
5149,GO:0015677,0.334975454673072,0.943436986279545,1,8,copper ion import,BP,STEAP4
19681,GO:1990909,0.335751884938776,0.943152664084462,1,8,Wnt signalosome,CC,GSK3B
749,GO:0001977,0.335834637537373,0.942326059359164,1,9,renal system process involved in regulation of blood volume,BP,PDGFB
820,GO:0002090,0.335959023709391,0.885915966659534,2,25,regulation of receptor internalization,BP,VEGFA;DKK1
14359,GO:0061548,0.336388562840401,0.942918895075797,1,8,ganglion development,BP,SIX4
7289,GO:0031272,0.33657685193224,0.94204986781888,1,9,regulation of pseudopodium assembly,BP,CDC42EP4
7290,GO:0031274,0.33657685193224,0.94204986781888,1,9,positive regulation of pseudopodium assembly,BP,CDC42EP4
13675,GO:0060174,0.336643723525917,0.94282505002112,1,8,limb bud formation,BP,SOX4
298,GO:0000803,0.336790498721727,0.885437760555433,2,25,sex chromosome,CC,BIRC2;ESCO2
8376,GO:0033270,0.336808028223491,0.942764572920602,1,8,paranode region of axon,CC,EPB41L3
10551,GO:0043497,0.336811474157484,0.941962400118564,1,9,regulation of protein heterodimerization activity,BP,NRG1
4197,GO:0009301,0.336967604617845,0.831124909386122,4,67,snRNA transcription,BP,POU2F2;SNAPC4;ELL2;NABP1
10196,GO:0042795,0.336967604617845,0.831124909386122,4,67,snRNA transcription by RNA polymerase II,BP,POU2F2;SNAPC4;ELL2;NABP1
2546,GO:0005811,0.3370354832148,0.83131916731429,4,63,lipid droplet,CC,G0S2;EHD1;CAV1;SDR16C5
18554,GO:1903727,0.337439745404104,0.885063704168132,2,25,positive regulation of phospholipid metabolic process,BP,NOD2;PDGFB
4074,GO:0009125,0.337663039725517,0.941644286192499,1,9,nucleoside monophosphate catabolic process,BP,AMPD3
3898,GO:0008532,0.337801185902918,0.94159258390312,1,9,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,B3GNT5
10066,GO:0042552,0.337936372257054,0.81537860368296,5,80,myelination,BP,NAB1;NRG1;TLR2;QKI;EPB41L3
1130,GO:0002716,0.338261634262127,0.941420064012755,1,9,negative regulation of natural killer cell mediated immunity,BP,HLA-E
5844,GO:0017127,0.338397380917178,0.940724594578979,1,10,cholesterol transporter activity,MF,STARD5
16917,GO:0098862,0.338490847306977,0.814913320078245,5,81,cluster of actin-based cell projections,CC,B4GALT1;SLC6A14;SLC11A2;SLC38A2;DOCK4
15304,GO:0071478,0.338690250761197,0.785862408127739,8,142,cellular response to radiation,BP,GADD45A;N4BP1;CDKN1A;TNKS1BP1;NEDD4;TP53;RAD9B;PARP1
3320,GO:0007028,0.338729694053878,0.942054464702148,1,8,cytoplasm organization,BP,FOSL1
1286,GO:0003085,0.338887784955065,0.941184981151465,1,9,negative regulation of systemic arterial blood pressure,BP,SOD2
6938,GO:0030539,0.338985447528445,0.941959569574091,1,8,male genitalia development,BP,TBX3
15508,GO:0071867,0.33919592769752,0.884049017880074,2,25,response to monoamine,BP,SLC9A1;NR4A3
15510,GO:0071869,0.33919592769752,0.884049017880074,2,25,response to catecholamine,BP,SLC9A1;NR4A3
16188,GO:0090195,0.339595874046487,0.940918470890095,1,9,chemokine secretion,BP,IL4R
3117,GO:0006694,0.339733922852782,0.792611535723186,7,126,steroid biosynthetic process,BP,IL1B;TNF;BMP2;NFKB1;CYP27B1;ADM;HMGCS1
5422,GO:0016266,0.34010964178282,0.850729685005259,3,43,O-glycan processing,BP,B3GNT5;B4GALT5;MUC1
15428,GO:0071679,0.34015292117168,0.941525231004652,1,8,commissural neuron axon guidance,BP,VEGFA
7255,GO:0031209,0.34028483358246,0.941476035739905,1,8,SCAR complex,CC,ABI1
10367,GO:0043177,0.340434936617061,0.801399781863395,6,107,organic acid binding,MF,STARD5;LAYN;HMGCS1;YARS2;PPARD;EGLN1
13261,GO:0051923,0.340654166240902,0.940518835082558,1,9,sulfation,BP,TPST1
12689,GO:0050884,0.340685572351736,0.941326435703519,1,8,neuromuscular process controlling posture,BP,GCH1
10252,GO:0042983,0.340751609629123,0.940481958806271,1,9,amyloid precursor protein biosynthetic process,BP,ABCA7
10253,GO:0042984,0.340751609629123,0.940481958806271,1,9,regulation of amyloid precursor protein biosynthetic process,BP,ABCA7
9709,GO:0038110,0.341049479829069,0.94119039087552,1,8,interleukin-2-mediated signaling pathway,BP,STAT5A
888,GO:0002251,0.341238171377256,0.93768809793725,1,15,organ or tissue specific immune response,BP,IL6
12814,GO:0051095,0.341387603545044,0.940240945447495,1,9,regulation of helicase activity,BP,TP53
8723,GO:0034367,0.341590302846726,0.939507234116839,1,10,protein-containing complex remodeling,BP,ABCA5
3599,GO:0008028,0.341696180984117,0.882380046455466,2,26,monocarboxylic acid transmembrane transporter activity,MF,SLC16A13;SLC16A1
19888,GO:2000341,0.341815011450944,0.9394210140156,1,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,TNF
2433,GO:0005614,0.341919502468212,0.940864387315499,1,8,interstitial matrix,CC,TNC
11098,GO:0045091,0.342003392858003,0.940007044438042,1,9,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,CXCL8
11019,GO:0044849,0.342048836669665,0.939989761856958,1,9,estrous cycle,BP,ETS1
409,GO:0001094,0.342087806163115,0.939974939176359,1,9,TFIID-class transcription factor binding,MF,TP53
287,GO:0000791,0.342309311972125,0.881634902837828,2,28,euchromatin,CC,JUN;CREB1
19393,GO:1905820,0.342480417848682,0.939825483123531,1,9,positive regulation of chromosome separation,BP,ESPL1
5280,GO:0015926,0.342551094801253,0.94062706167817,1,8,glucosidase activity,MF,MGAM
14927,GO:0070757,0.342793081277803,0.940535985358841,1,8,interleukin-35-mediated signaling pathway,BP,IL6ST
7284,GO:0031264,0.343238663209657,0.939536223325947,1,9,death-inducing signaling complex,CC,CFLAR
14584,GO:0070106,0.343254499150118,0.940362094274983,1,8,interleukin-27-mediated signaling pathway,BP,IL6ST
5207,GO:0015802,0.343346743007291,0.939494926125033,1,9,basic amino acid transport,BP,SLC7A2
482,GO:0001530,0.343387350580387,0.938815697901636,1,10,lipopolysaccharide binding,MF,TLR2
9701,GO:0038095,0.34397230375377,0.798539417925786,6,110,Fc-epsilon receptor signaling pathway,BP,NFKBIA;NFKB1;JUN;TAB3;RELA;NR4A3
18797,GO:1904292,0.344049214736623,0.881003738164779,2,26,regulation of ERAD pathway,BP,NFE2L2;CAV1
13225,GO:0051864,0.344060907208703,0.940057472117847,1,8,histone demethylase activity (H3-K36 specific),MF,KDM7A
14822,GO:0070544,0.344060907208703,0.940057472117847,1,8,histone H3-K36 demethylation,BP,KDM7A
12602,GO:0050765,0.344123729699957,0.939197552770604,1,9,negative regulation of phagocytosis,BP,TLR2
16528,GO:0097225,0.344253485831222,0.938480747355496,1,10,sperm midpiece,CC,SQSTM1
12407,GO:0048839,0.344255669680115,0.798674350076702,6,99,inner ear development,BP,SDC4;BMP2;SIX4;WNT5A;SPRY2;NR4A3
12226,GO:0048407,0.344394227365167,0.93993129305834,1,8,platelet-derived growth factor binding,MF,PDGFB
8734,GO:0034380,0.344571766584072,0.939025687921712,1,9,high-density lipoprotein particle assembly,BP,ABCA7
17667,GO:1901407,0.344595742242012,0.939016482939387,1,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,CCNL1
14847,GO:0070578,0.344685439343764,0.938982038262094,1,9,RISC-loading complex,CC,ZFP36
7631,GO:0032026,0.344933425082308,0.939726847953334,1,8,response to magnesium ion,BP,SLC41A1
5209,GO:0015804,0.345023936581045,0.880431394442233,2,26,neutral amino acid transport,BP,NFKBIE;SLC38A2
7794,GO:0032330,0.34503254662576,0.880646465522133,2,25,regulation of chondrocyte differentiation,BP,SMAD3;RELA
7209,GO:0031094,0.345173087187285,0.939635845104873,1,8,platelet dense tubular network,CC,EHD1
9769,GO:0039530,0.345526320695802,0.938658574665037,1,9,MDA-5 signaling pathway,BP,IFIH1
5551,GO:0016540,0.346138979827727,0.938422268626569,1,9,protein autoprocessing,BP,PARP1
8164,GO:0032890,0.34644971001268,0.879591853309476,2,26,regulation of organic acid transport,BP,IL1B;EDN1
16427,GO:0097050,0.346654821218189,0.938222891375554,1,9,type B pancreatic cell apoptotic process,BP,IL6
20075,GO:2000674,0.346654821218189,0.938222891375554,1,9,regulation of type B pancreatic cell apoptotic process,BP,IL6
12326,GO:0048667,0.346737468995111,0.734366696147194,21,388,cell morphogenesis involved in neuron differentiation,BP,EFNA1;EFNB1;NEDD4L;VEGFA;ZSWIM4;KLF7;CREB1;NR4A2;SEMA4B;WNT5A;SLC11A2;NRG1;PARD6B;FEZ1;GRB7;NEDD4;SPTBN5;ABI1;EFNB2;RAPH1;NR4A3
3503,GO:0007409,0.346787828155152,0.742602999473126,17,310,axonogenesis,BP,EFNA1;EFNB1;VEGFA;ZSWIM4;KLF7;CREB1;NR4A2;SEMA4B;WNT5A;NRG1;PARD6B;FEZ1;GRB7;SPTBN5;EFNB2;RAPH1;NR4A3
17062,GO:0099528,0.346927166827861,0.938117474478633,1,9,G-protein coupled neurotransmitter receptor activity,MF,GPR156
3312,GO:0007016,0.346954291297442,0.938956963284274,1,8,cytoskeletal anchoring at plasma membrane,BP,EPB41L3
10580,GO:0043539,0.347909004429939,0.878523973448618,2,27,protein serine/threonine kinase activator activity,MF,CAB39;SPRY2
15733,GO:0072283,0.348465596302898,0.937520007037902,1,9,metanephric renal vesicle morphogenesis,BP,LIF
17727,GO:1901623,0.348539700816215,0.937491142337832,1,9,regulation of lymphocyte chemotaxis,BP,WNT5A
4708,GO:0010867,0.348668578238978,0.937440924157833,1,9,positive regulation of triglyceride biosynthetic process,BP,LDLR
1372,GO:0003254,0.348684530776247,0.878063943126526,2,27,regulation of membrane depolarization,BP,NEDD4L;PARP1
14086,GO:0060856,0.349648422966621,0.93705834231761,1,9,establishment of blood-brain barrier,BP,WNT7B
1700,GO:0004175,0.350315632906462,0.754884469133462,12,231,endopeptidase activity,MF,PLAU;ADAM8;CTSC;CFLAR;ADAMTS1;TINAGL1;MMP9;ESPL1;ADAM9;PLAT;MMP10;CFB
11631,GO:0046325,0.350325449579555,0.936793193108992,1,9,negative regulation of glucose import,BP,TNF
5789,GO:0017014,0.35035766136539,0.93608963550547,1,10,protein nitrosylation,BP,NCOA7
5909,GO:0018119,0.35035766136539,0.93608963550547,1,10,peptidyl-cysteine S-nitrosylation,BP,NCOA7
8027,GO:0032656,0.350380509623563,0.936771600626185,1,9,regulation of interleukin-13 production,BP,HLA-E
5313,GO:0016018,0.350389691227692,0.936076947340695,1,10,cyclosporin A binding,MF,PPIF
16283,GO:0090331,0.350453488825016,0.936742974222416,1,9,negative regulation of platelet aggregation,BP,C1QTNF1
7980,GO:0032589,0.350740617426482,0.877273714440027,2,25,neuron projection membrane,CC,NRG1;EPB41L3
7612,GO:0031994,0.350752093362464,0.936625765739064,1,9,insulin-like growth factor I binding,MF,ITGAV
6760,GO:0030178,0.350909567734587,0.775660399933233,8,152,negative regulation of Wnt signaling pathway,BP,BMP2;CYLD;DKK1;RNF43;WNT5A;TLE1;CAV1;GSK3B
5017,GO:0015174,0.35097043758031,0.936539980119763,1,9,basic amino acid transmembrane transporter activity,MF,SLC7A2
17290,GO:0140013,0.351424995705854,0.792849773643386,6,104,meiotic nuclear division,BP,LIF;EREG;MYBL1;MASTL;WNT5A;ESPL1
17872,GO:1902065,0.351758695582918,0.936229710455204,1,9,response to L-glutamate,BP,CREB1
16856,GO:0098751,0.352015027041427,0.876514587155618,2,25,bone cell development,BP,TJP2;ABI1
12611,GO:0050774,0.352457465089322,0.935953917986837,1,9,negative regulation of dendrite morphogenesis,BP,EFNA1
4301,GO:0009743,0.352633029791088,0.774357150109156,8,146,response to carbohydrate,BP,IL1B;PIM3;ZFP36L1;ICAM1;TGFBR2;SOX4;PPARD;XBP1
19165,GO:1905146,0.352862298039011,0.935793815859625,1,9,lysosomal protein catabolic process,BP,LDLR
18008,GO:1902430,0.35287922551878,0.93578711629075,1,9,negative regulation of amyloid-beta formation,BP,ABCA7
9690,GO:0038065,0.352990744420475,0.936622859066489,1,8,collagen-activated signaling pathway,BP,DDR1
10017,GO:0042440,0.353548059598435,0.841096356050507,3,48,pigment metabolic process,BP,WNT5A;SLC11A2;ALAS1
4726,GO:0010885,0.353564293633848,0.935515633155077,1,9,regulation of cholesterol storage,BP,EHD1
13683,GO:0060192,0.353568277229293,0.934810410170926,1,10,negative regulation of lipase activity,BP,ANXA8
16002,GO:0085029,0.353599806833803,0.875567463850484,2,25,extracellular matrix assembly,BP,PHLDB2;SMAD3
17853,GO:1902004,0.353875203787291,0.935392200510404,1,9,positive regulation of amyloid-beta formation,BP,EFNA1
3027,GO:0006573,0.354036647076203,0.935328051840193,1,9,valine metabolic process,BP,STAT5A
18320,GO:1903214,0.354118599552559,0.818565796582011,4,68,regulation of protein targeting to mitochondrion,BP,PLAGL2;NRG1;UGCG;UBE2D3
15603,GO:0072070,0.354309978611669,0.935219359193938,1,9,loop of Henle development,BP,WNT7B
17650,GO:1901360,0.354337098118065,0.678178998762135,224,4857,organic cyclic compound metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;WTAP;TJP2;RELB;ZNF217;CDKN1A;NMNAT2;CCDC85B;IL7R;ZNF451;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;GCH1;SMAD3;ZC3H12C;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;TXNRD1;KLF7;BTG1;UPP1;IER5;CEBPB;CEBPD;NAMPT;ADM;CREB1;TAF4B;CCNL1;USP43;NR4A2;PATL1;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;HMGCS1;WNT5A;SLC11A2;TGFA;SLC52A3;SOX4;PDGFB;BAZ1A;NRG1;LDLR;ATF3;OTUD4;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;MAOA;RCHY1;YAF2;TNKS1BP1;HAL;NUP153;NEDD4;POU2F2;DUS4L;NFE2L2;PTPN1;SMAD1;TAB3;MXD1;CHD4;ZC3H7B;DIEXF;NFAT5;STAT5A;TPST1;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;TP53;KLF3;TLR2;PUS10;UBE2D3;MAPKBP1;ELK3;RAD9B;SNAPC4;CLK4;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;ESCO2;FOXN2;MUC1;YARS2;ELL2;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;CYP24A1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;XBP1;QKI;ZBTB5;ELF4;SREK1IP1;TFE3;EID3;ZMIZ2;JUND;DENND4A
7262,GO:0031225,0.354421796712631,0.818228528249879,4,70,anchored component of membrane,CC,EFNA1;PLAUR;CD55;RAET1L
10225,GO:0042887,0.354526701346215,0.874194329296547,2,29,amide transmembrane transporter activity,MF,TAP1;TAPBP
3352,GO:0007084,0.35505201093065,0.934214182363452,1,10,mitotic nuclear envelope reassembly,BP,ANKLE2
9799,GO:0040015,0.355374055492609,0.934795192071236,1,9,negative regulation of multicellular organism growth,BP,SOCS2
20048,GO:2000644,0.355442569300331,0.934767824702126,1,9,regulation of receptor catabolic process,BP,PTPN1
11411,GO:0045793,0.355810015797202,0.934620934843638,1,9,positive regulation of cell size,BP,EDN1
19158,GO:1905114,0.355893448999829,0.724300877058916,22,431,cell surface receptor signaling pathway involved in cell-cell signaling,BP,BMP2;NFKB1;CYLD;FZD8;BAMBI;AMOTL2;SMAD3;NRARP;DKK1;RNF43;WISP1;NR4A2;RUNX1;SMURF2;WNT5A;SOX4;TLE1;WNT7B;CAV1;TLR2;STX1A;GSK3B
369,GO:0000990,0.355922516191467,0.934575922783474,1,9,transcription factor activity, core RNA polymerase binding,MF,TP53
11781,GO:0046629,0.356009306188182,0.934541185082161,1,9,gamma-delta T cell activation,BP,NOD2
17201,GO:0106003,0.356020154561754,0.934536842253176,1,9,amyloid-beta complex,CC,TLR2
8049,GO:0032693,0.356422755037694,0.933660509277432,1,10,negative regulation of interleukin-10 production,BP,IL23A
11380,GO:0045737,0.356432066091132,0.873225567859054,2,28,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CCNL1;PDGFB
1219,GO:0002886,0.35659661541477,0.87332330163602,2,27,regulation of myeloid leukocyte mediated immunity,BP,IL4R;ADGRE2
266,GO:0000733,0.356760733020852,0.934239970264024,1,9,DNA strand renaturation,BP,TP53
20254,GO:2001170,0.357056201464872,0.934121305446687,1,9,negative regulation of ATP biosynthetic process,BP,PARP1
15512,GO:0071871,0.357376803267451,0.93399240341536,1,9,response to epinephrine,BP,SLC9A1
3034,GO:0006582,0.35765626984696,0.933879918626935,1,9,melanin metabolic process,BP,WNT5A
4571,GO:0010649,0.358179432754393,0.93366904159408,1,9,regulation of cell communication by electrical coupling,BP,CAV1
13485,GO:0055006,0.35822133225546,0.838393449990939,3,43,cardiac cell development,BP,TBX3;EDN1;VEGFA
13026,GO:0051446,0.358329192404606,0.933608603103303,1,9,positive regulation of meiotic cell cycle,BP,WNT5A
6806,GO:0030246,0.358895568344669,0.77717855508451,7,124,carbohydrate binding,MF,PTX3;LGALSL;LAYN;TINAGL1;EGLN1;MGAM;LMAN1
1077,GO:0002643,0.359036268839246,0.933322807785977,1,9,regulation of tolerance induction,BP,TGFBR2
11314,GO:0045623,0.359155139683723,0.933274689596255,1,9,negative regulation of T-helper cell differentiation,BP,IL4R
11774,GO:0046622,0.359211644021495,0.871952711753867,2,26,positive regulation of organ growth,BP,EDN1;PIM1
17263,GO:0120032,0.359488882277921,0.776720627830738,7,123,regulation of plasma membrane bounded cell projection assembly,BP,EPHA2;CYLD;ICAM1;CDC42EP4;ANLN;CAV1;CEP135
13765,GO:0060325,0.3595530922758,0.871745238496883,2,26,face morphogenesis,BP,CSRNP1;DKK1
6775,GO:0030205,0.359603010522285,0.933093209417175,1,9,dermatan sulfate metabolic process,BP,DSE
8597,GO:0034098,0.359888040281382,0.932977561333125,1,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,CAV1
15902,GO:0072655,0.3600501668609,0.767980460455972,8,158,establishment of protein localization to mitochondrion,BP,PMAIP1;BBC3;PLAGL2;TP53BP2;NRG1;UGCG;TP53;UBE2D3
5162,GO:0015697,0.360146248926731,0.932872693421742,1,9,quaternary ammonium group transport,BP,SLC38A2
4349,GO:0009898,0.360218601809685,0.776207415024115,7,120,cytoplasmic side of plasma membrane,CC,BIRC2;CYLD;ABL2;ERRFI1;CYTH1;GEM;FRK
2524,GO:0005776,0.360229126874121,0.798128290665526,5,84,autophagosome,CC,PLEKHF1;TICAM1;SQSTM1;RAB24;VMP1
10447,GO:0043300,0.360299053688864,0.871075250893814,2,27,regulation of leukocyte degranulation,BP,IL4R;ADGRE2
933,GO:0002328,0.360341395483127,0.932793372805302,1,9,pro-B cell differentiation,BP,SOX4
13784,GO:0060348,0.360807588394109,0.775754462448424,7,119,bone development,BP,BMP2;TJP2;TGFBR2;NAB1;SMAD1;ABI1;COL27A1
6752,GO:0030168,0.361110494215299,0.785134646020332,6,104,platelet activation,BP,IL6;C1QTNF1;RAP2B;SAA1;PDGFB;AXL
2337,GO:0005355,0.361137165448887,0.932469343252479,1,9,glucose transmembrane transporter activity,MF,SLC2A6
6663,GO:0030011,0.361208171391722,0.932440385406346,1,9,maintenance of cell polarity,BP,SLC9A1
13778,GO:0060340,0.361254649702819,0.932421426499868,1,9,positive regulation of type I interferon-mediated signaling pathway,BP,WNT5A
778,GO:0002031,0.361423179444583,0.931617425802541,1,10,G-protein coupled receptor internalization,BP,ADM
17938,GO:1902237,0.361499413472667,0.931585993804824,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
730,GO:0001956,0.361693995888391,0.932242057397542,1,9,positive regulation of neurotransmitter secretion,BP,STX1A
11337,GO:0045652,0.362394671459541,0.833721736691185,3,66,regulation of megakaryocyte differentiation,BP,RUNX1;NR4A3;KMT2E
12271,GO:0048546,0.362763018526136,0.87002323652963,2,25,digestive tract morphogenesis,BP,SMAD3;WNT5A
12637,GO:0050808,0.3628779825189,0.753568021833084,10,176,synapse organization,BP,EFNA1;SIX4;DKK1;WNT5A;NRG1;TNC;NEDD4;WNT7B;CHD4;TLR2
15173,GO:0071280,0.362903090946359,0.929898481634976,1,12,cellular response to copper ion,BP,MT2A
11387,GO:0045744,0.363225699012537,0.869082280716635,2,28,negative regulation of G-protein coupled receptor protein signaling pathway,BP,CXCL8;ADM
4972,GO:0015078,0.363620840742447,0.811116951758732,4,75,proton transmembrane transporter activity,MF,SLC11A2;SLC9A1;SLC2A6;SLC9A8
13028,GO:0051450,0.364123567998144,0.930498804755837,1,10,myoblast proliferation,BP,PPARD
19228,GO:1905314,0.364211325453758,0.931208874488223,1,9,semi-lunar valve development,BP,EFNA1
1137,GO:0002726,0.365077846205758,0.930100923044945,1,10,positive regulation of T cell cytokine production,BP,IL6
9288,GO:0035723,0.365272683649064,0.930770476163345,1,9,interleukin-15-mediated signaling pathway,BP,STAT5A
15215,GO:0071350,0.365272683649064,0.930770476163345,1,9,cellular response to interleukin-15,BP,STAT5A
3099,GO:0006672,0.365539860237057,0.810180591221533,4,66,ceramide metabolic process,BP,TNF;ITGB8;SGMS2;UGCG
6216,GO:0019731,0.365647730276798,0.927096125009156,1,17,antibacterial humoral response,BP,HLA-E
10165,GO:0042745,0.36619648243126,0.929017171174207,1,11,circadian sleep/wake cycle,BP,CSF2
2730,GO:0006107,0.366296718755349,0.929590757079768,1,10,oxaloacetate metabolic process,BP,STAT5A
15607,GO:0072075,0.366520290346826,0.930253027423831,1,9,metanephric mesenchyme development,BP,SIX4
7483,GO:0031643,0.367379291131162,0.929895420164682,1,9,positive regulation of myelination,BP,NRG1
14751,GO:0070411,0.36744320063105,0.929868770713043,1,9,I-SMAD binding,MF,SMAD1
19750,GO:2000095,0.367679449210614,0.929770205670407,1,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,DKK1
4791,GO:0010977,0.367875478749455,0.77972724376138,6,103,negative regulation of neuron projection development,BP,EFNA1;PLK2;SEMA4B;WNT5A;EFNB2;VIM
20207,GO:2001028,0.368223613827,0.928779741636739,1,10,positive regulation of endothelial cell chemotaxis,BP,VEGFA
19845,GO:2000279,0.368270328650621,0.866170727379004,2,27,negative regulation of DNA biosynthetic process,BP,DUSP1;TP53
15978,GO:0080009,0.368836613149207,0.928520575830463,1,10,mRNA methylation,BP,WTAP
9784,GO:0039692,0.368838215425528,0.928519897680801,1,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,CXCL8
7475,GO:0031629,0.369023912139402,0.928441277201136,1,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,STX1A
17044,GO:0099500,0.369023912139402,0.928441277201136,1,10,vesicle fusion to plasma membrane,BP,STX1A
4711,GO:0010870,0.369109458394148,0.928405041223102,1,10,positive regulation of receptor biosynthetic process,BP,EDN1
18359,GO:1903307,0.369603660768149,0.865134178386854,2,28,positive regulation of regulated secretory pathway,BP,IL4R;STX1A
17891,GO:1902115,0.370054236795012,0.759914043846026,8,143,regulation of organelle assembly,BP,CSF2;TNF;SDC4;EDN1;CYLD;PLK2;FEZ1;CEP135
15676,GO:0072182,0.370349488283548,0.928650499437004,1,9,regulation of nephron tubule epithelial cell differentiation,BP,LIF
11348,GO:0045663,0.370480813560411,0.928595154235235,1,9,positive regulation of myoblast differentiation,BP,BTG1
6729,GO:0030136,0.370600829154256,0.767556324139788,7,124,clathrin-coated vesicle,CC,HBEGF;EDN1;IL7R;RASSF9;WNT5A;LDLR;NECAP2
16515,GO:0097200,0.370694904621652,0.927100708074668,1,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,CFLAR
8360,GO:0033234,0.37072069871859,0.927720504702339,1,10,negative regulation of protein sumoylation,BP,RELA
8002,GO:0032616,0.370794790959313,0.927688933211782,1,10,interleukin-13 production,BP,HLA-E
16336,GO:0090527,0.370833535033904,0.92844637790959,1,9,actin filament reorganization,BP,NEDD9
14562,GO:0070076,0.370932716074647,0.864982002782855,2,25,histone lysine demethylation,BP,KDM6B;KDM7A
9833,GO:0042053,0.370955006181292,0.927620635709517,1,10,regulation of dopamine metabolic process,BP,NR4A2
9840,GO:0042069,0.370955006181292,0.927620635709517,1,10,regulation of catecholamine metabolic process,BP,NR4A2
1131,GO:0002717,0.371258677673823,0.927491079350511,1,10,positive regulation of natural killer cell mediated immunity,BP,HLA-E
3875,GO:0008499,0.371627146196305,0.927333692922953,1,10,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,B3GNT5
9635,GO:0036500,0.371694187864557,0.927305035087843,1,10,ATF6-mediated unfolded protein response,BP,XBP1
5723,GO:0016857,0.371877114598636,0.927226806394453,1,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,DSE
14891,GO:0070669,0.371946676336176,0.927975647027998,1,9,response to interleukin-2,BP,STAT5A
15217,GO:0071352,0.371946676336176,0.927975647027998,1,9,cellular response to interleukin-2,BP,STAT5A
13951,GO:0060601,0.372067590577211,0.927924403175808,1,9,lateral sprouting from an epithelium,BP,WNT5A
2001,GO:0004721,0.372115593676143,0.758158047933671,8,144,phosphoprotein phosphatase activity,MF,DUSP1;PPTC7;DUSP16;DUSP10;PPP1R3B;DUSP8;PTPN1;PDP1
5765,GO:0016925,0.372531811291685,0.788440957192658,5,85,protein sumoylation,BP,ZNF451;IFIH1;KIAA1586;NUP153;RELA
2833,GO:0006301,0.372832842801766,0.827495758800542,3,49,postreplication repair,BP,USP43;TRIM25;RCHY1
9553,GO:0036312,0.373074001631862,0.927497037610388,1,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,FAM83B
5713,GO:0016840,0.373283715840706,0.925984003187002,1,11,carbon-nitrogen lyase activity,MF,HAL
10614,GO:0043589,0.374066659633561,0.927074031929991,1,9,skin morphogenesis,BP,ERRFI1
7339,GO:0031345,0.374212653262773,0.764562135353825,7,124,negative regulation of cell projection organization,BP,EFNA1;PLK2;SEMA4B;WNT5A;SPRY2;EFNB2;VIM
11510,GO:0045986,0.374830937494391,0.925956644429222,1,10,negative regulation of smooth muscle contraction,BP,DOCK4
10680,GO:0043922,0.374952614567092,0.925904040964016,1,10,negative regulation by host of viral transcription,BP,JUN
2775,GO:0006198,0.374995393538295,0.926676933076313,1,9,cAMP catabolic process,BP,EGLN1
3783,GO:0008340,0.375073422137956,0.926643511609441,1,9,determination of adult lifespan,BP,TP53
7889,GO:0032452,0.375114307931346,0.862365707517724,2,25,histone demethylase activity,MF,KDM6B;KDM7A
11627,GO:0046321,0.375123141057704,0.926622211083239,1,9,positive regulation of fatty acid oxidation,BP,NR4A3
10320,GO:0043097,0.375196608448544,0.925152353609559,1,11,pyrimidine nucleoside salvage,BP,UPP1
19712,GO:2000009,0.37528110889167,0.925761914715412,1,10,negative regulation of protein localization to cell surface,BP,NEDD4L
5620,GO:0016668,0.375879839873028,0.924853967269055,1,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,TXNRD1
13562,GO:0060009,0.375880549785825,0.925502141175138,1,10,Sertoli cell development,BP,ICAM1
4512,GO:0010559,0.37588119611992,0.86119282675875,2,28,regulation of glycoprotein biosynthetic process,BP,HBEGF;ABCA7
7045,GO:0030814,0.37599611534507,0.861120160651269,2,28,regulation of cAMP metabolic process,BP,ADM;EGLN1
11350,GO:0045665,0.376108909398147,0.754811396061816,8,143,negative regulation of neuron differentiation,BP,EFNA1;DLX2;PLK2;SEMA4B;WNT5A;EFNB2;GSK3B;VIM
10953,GO:0044615,0.376346106805579,0.926097103318999,1,9,nuclear pore nuclear basket,CC,NUP153
17955,GO:1902275,0.376361929788675,0.754620308902539,8,142,regulation of chromatin organization,BP,IL1B;LIF;ZNF451;VEGFA;TP53;SDR16C5;MUC1;KMT2E
13888,GO:0060491,0.376372562274904,0.762738495847153,7,125,regulation of cell projection assembly,BP,EPHA2;CYLD;ICAM1;CDC42EP4;ANLN;CAV1;CEP135
6750,GO:0030166,0.376656957424298,0.825296470462588,3,44,proteoglycan biosynthetic process,BP,DSE;CANT1;HS3ST3B1
9362,GO:0035871,0.376783063434916,0.925908942235395,1,9,protein K11-linked deubiquitination,BP,TNFAIP3
13672,GO:0060170,0.377101955089724,0.824860949014723,3,45,ciliary membrane,CC,EHD1;SPTBN5;EVC
10601,GO:0043567,0.377172560279358,0.924940389839596,1,10,regulation of insulin-like growth factor receptor signaling pathway,BP,BMP2
6465,GO:0021782,0.377221356082932,0.801263991294362,4,67,glial cell development,BP,SOX4;LDLR;TLR2;VIM
510,GO:0001573,0.377449119913109,0.924819816771431,1,10,ganglioside metabolic process,BP,ITGB8
16945,GO:0098911,0.37778475035497,0.925476516058772,1,9,regulation of ventricular cardiac muscle cell action potential,BP,CAV1
13978,GO:0060670,0.378063228882786,0.924551666414268,1,10,branching involved in labyrinthine layer morphogenesis,BP,ADM
3589,GO:0008013,0.378085900704547,0.800877274775918,4,63,beta-catenin binding,MF,KDM6B;SMAD3;NR4A2;GSK3B
15426,GO:0071677,0.378148272278575,0.923858189426371,1,11,positive regulation of mononuclear cell migration,BP,TNF
4760,GO:0010934,0.378235996800233,0.924476124371793,1,10,macrophage cytokine production,BP,WNT5A
4796,GO:0010984,0.378374240981182,0.923758566275949,1,11,regulation of lipoprotein particle clearance,BP,LDLR
572,GO:0001711,0.378487360056412,0.924366136008481,1,10,endodermal cell fate commitment,BP,DKK1
2770,GO:0006188,0.378563616994565,0.924332749509369,1,10,IMP biosynthetic process,BP,AMPD3
10852,GO:0044344,0.378628577574757,0.770846069407738,6,107,cellular response to fibroblast growth factor stimulus,BP,CXCL8;ZFP36;ZFP36L1;FGF5;WNT5A;SPRY2
10033,GO:0042474,0.378993376734589,0.923485207789993,1,11,middle ear morphogenesis,BP,EDN1
11912,GO:0046930,0.379352322860482,0.92332645920067,1,11,pore complex,CC,PPIF
19527,GO:1990380,0.379377953638579,0.924785622474203,1,9,Lys48-specific deubiquitinase activity,MF,CYLD
15197,GO:0071322,0.379695289030192,0.782531656916384,5,90,cellular response to carbohydrate stimulus,BP,PIM3;ZFP36L1;ICAM1;SOX4;XBP1
12632,GO:0050803,0.379791597741189,0.770070920854372,6,102,regulation of synapse structure or activity,BP,EFNA1;SIX4;DKK1;WNT5A;NEDD4;TLR2
642,GO:0001829,0.379802888118887,0.9237889391909,1,10,trophectodermal cell differentiation,BP,JUNB
7438,GO:0031543,0.380000394726687,0.923702054763727,1,10,peptidyl-proline dioxygenase activity,MF,EGLN1
12399,GO:0048813,0.380009814386171,0.769929828797006,6,101,dendrite morphogenesis,BP,EFNA1;NEDD4L;KLF7;SLC11A2;NEDD4;ABI1
20028,GO:2000615,0.380240181960835,0.923596491058237,1,10,regulation of histone H3-K9 acetylation,BP,ZNF451
5229,GO:0015837,0.380240307785855,0.858222852470897,2,29,amine transport,BP,RHCG;STX1A
14182,GO:0061050,0.380278204176661,0.923579744157008,1,10,regulation of cell growth involved in cardiac muscle cell development,BP,EDN1
8041,GO:0032682,0.380529212784606,0.922804582559832,1,11,negative regulation of chemokine production,BP,IL6
5743,GO:0016886,0.380638029371339,0.923421150034192,1,10,ligase activity, forming phosphoric ester bonds,MF,PARP1
619,GO:0001786,0.380799642187261,0.858282625493973,2,27,phosphatidylserine binding,MF,JPH2;AXL
7031,GO:0030800,0.380926926637479,0.923293674919224,1,10,negative regulation of cyclic nucleotide metabolic process,BP,EGLN1
7046,GO:0030815,0.380926926637479,0.923293674919224,1,10,negative regulation of cAMP metabolic process,BP,EGLN1
17001,GO:0099068,0.381086614814447,0.924040404094847,1,9,postsynapse assembly,BP,WNT5A
12629,GO:0050798,0.381565729955313,0.857186777508978,2,30,activated T cell proliferation,BP,IL23A;BTN2A2
9346,GO:0035850,0.381726668789966,0.85769024869417,2,27,epithelial cell differentiation involved in kidney development,BP,LIF;PDGFB
15459,GO:0071732,0.381893190287097,0.922866389384706,1,10,cellular response to nitric oxide,BP,CFLAR
6522,GO:0021895,0.381969255095496,0.922832692754279,1,10,cerebral cortex neuron differentiation,BP,DLX2
12699,GO:0050901,0.382067621044995,0.922789103644969,1,10,leukocyte tethering or rolling,BP,TNF
14262,GO:0061298,0.382210870897555,0.923547659915727,1,9,retina vasculature development in camera-type eye,BP,CLIC4
18150,GO:1902855,0.382291559940851,0.922689814027208,1,10,regulation of non-motile cilium assembly,BP,CEP135
11423,GO:0045822,0.382298596866329,0.922686692766876,1,10,negative regulation of heart contraction,BP,ZC3H12A
10282,GO:0043023,0.382324453102956,0.922004419483487,1,11,ribosomal large subunit binding,MF,CPEB2
1915,GO:0004602,0.382403414339006,0.920189165700694,1,15,glutathione peroxidase activity,MF,GPX3
20051,GO:2000647,0.382443279584994,0.922622501322266,1,10,negative regulation of stem cell proliferation,BP,KCTD11
15308,GO:0071482,0.382581326132631,0.780355430577865,5,87,cellular response to light stimulus,BP,N4BP1;CDKN1A;NEDD4;TP53;PARP1
12701,GO:0050905,0.382617307412939,0.820889897136356,3,45,neuromuscular process,BP,GCH1;NRG1;NR4A3
14850,GO:0070585,0.382855259440402,0.748722874443595,8,161,protein localization to mitochondrion,BP,PMAIP1;BBC3;PLAGL2;TP53BP2;NRG1;UGCG;TP53;UBE2D3
14531,GO:0070011,0.383182898892852,0.707442047044185,18,360,peptidase activity, acting on L-amino acid peptides,MF,TNFAIP3;PLAU;ZC3H12A;ADAM8;CYLD;CTSC;CFLAR;ADAMTS1;USP43;TINAGL1;MMP9;OTUD4;ESPL1;ADAM9;PLAT;USP31;MMP10;CFB
14416,GO:0061684,0.383322156966424,0.922231881886644,1,10,chaperone-mediated autophagy,BP,PLK3
7895,GO:0032459,0.383709875732423,0.855807736620313,2,30,regulation of protein oligomerization,BP,PMAIP1;TP53
10112,GO:0042626,0.384061480355587,0.796074827095649,4,66,ATPase activity, coupled to transmembrane movement of substances,MF,ABCA5;TAP1;TAPBP;ABCA7
13289,GO:0051963,0.384185414984715,0.819873431237042,3,44,regulation of synapse assembly,BP,SIX4;WNT5A;TLR2
12662,GO:0050853,0.384453807432149,0.855721233595365,2,28,B cell receptor signaling pathway,BP,RUNX1;GCSAM
7862,GO:0032418,0.384900617860067,0.81880621785982,3,49,lysosome localization,BP,IL4R;ADGRE2;NR4A3
5353,GO:0016101,0.38520007350197,0.818688579711043,3,48,diterpenoid metabolic process,BP,SDC4;SDR16C5;PPARD
8849,GO:0034641,0.385256294979993,0.648041942295357,235,5143,cellular nitrogen compound metabolic process,BP,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;IL1A;EFNA1;BTG2;INHBA;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;ELF3;BMP2;LIF;SOD2;PRDM1;TBX3;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;JUN;TICAM1;KDM6B;EPHA2;ZNF697;ETS1;TRAF1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;RFX5;ZFP36L1;SIX4;RIPK2;IRAK2;THAP10;JUNB;CYLD;FZD8;BAMBI;WTAP;TJP2;RELB;ZNF217;CDKN1A;NMNAT2;CCDC85B;IL7R;CPEB2;ZNF451;ODC1;NEDD4L;NOD2;ELMSAN1;SAV1;SGK1;ICAM1;GCH1;SMAD3;ZC3H12C;NFKBIB;DLX2;ARNTL2;NFKBID;TRIB1;VEGFA;NRARP;DKK1;CDKN2B;ZBED2;CFLAR;TXNRD1;KLF7;BTG1;UPP1;IER5;CEBPB;CEBPD;NAMPT;ADM;CREB1;TAF4B;CCNL1;USP43;NR4A2;PATL1;SLC7A2;VHL;BACH1;MYBL1;RUNX1;SMURF2;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;NAB1;ITGB8;WNT5A;SLC11A2;ABCF1;TGFA;SLC52A3;SOX4;PDGFB;BAZ1A;NRG1;ATF3;OTUD4;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;MAOA;RCHY1;YAF2;TNKS1BP1;HAL;GRB7;NUP153;NEDD4;POU2F2;DUS4L;NFE2L2;PTPN1;SMAD1;SGMS2;TAB3;PAOX;MXD1;CHD4;ZC3H7B;DIEXF;NFAT5;STAT5A;TPST1;CAV1;VEZF1;INO80D;TNIP2;ZNFX1;UGCG;TP53;KLF3;TLR2;PUS10;TAPBP;UBE2D3;MAPKBP1;ELK3;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;SDR16C5;ZNF148;PML;POLR3A;PIM1;RELA;TRIM16;ESCO2;FOXN2;MUC1;YARS2;ELL2;SAT1;FRK;CITED4;NR4A3;KMT2E;PPARD;PARP1;KDM7A;MED13;MXD3;CRAMP1;JMY;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;XBP1;QKI;ZBTB5;ELF4;SREK1IP1;TFE3;EID3;ZMIZ2;JUND;DENND4A
11606,GO:0046184,0.3852778559751,0.921358421832962,1,10,aldehyde biosynthetic process,BP,BMP2
2412,GO:0005583,0.385584661416472,0.922057457026407,1,9,fibrillar collagen trimer,CC,COL27A1
16812,GO:0098643,0.385584661416472,0.922057457026407,1,9,banded collagen fibril,CC,COL27A1
5169,GO:0015711,0.385693501843221,0.716484952282381,14,267,organic anion transport,BP,IL1B;EDN1;STARD5;NFKBIE;SLC6A14;SLC7A2;SLC52A3;SLC38A2;LDLR;STX1A;ABCA7;SLC16A13;PPARD;SLC16A1
10626,GO:0043619,0.385727661465449,0.921156698337336,1,10,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,NFE2L2
12976,GO:0051345,0.386262170145162,0.687871767048276,28,561,positive regulation of hydrolase activity,BP,TNF;EFNA1;CCL20;PPP1R15A;BMP2;PMAIP1;JUN;EPHA2;BBC3;TNFRSF10B;TNFSF15;RIPK2;ICAM1;SMAD3;VEGFA;ABL2;CFLAR;CDC42EP4;ERRFI1;WNT5A;RASGEF1B;PTPN1;CAV1;DOCK4;TRIP10;PML;GSK3B;TBC1D22B
16096,GO:0090049,0.3864479262047,0.854433615599938,2,28,regulation of cell migration involved in sprouting angiogenesis,BP,VEGFA;PLK2
6929,GO:0030517,0.386519911517257,0.85460801228644,2,27,negative regulation of axon extension,BP,SEMA4B;WNT5A
5642,GO:0016723,0.386675867253331,0.920730439166957,1,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,STEAP4
16483,GO:0097153,0.386783659791212,0.919424943669373,1,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,CFLAR
12521,GO:0050651,0.386875738858515,0.920640411754195,1,10,dermatan sulfate proteoglycan biosynthetic process,BP,DSE
3265,GO:0006936,0.386892526709442,0.73855450773733,9,169,muscle contraction,BP,ZC3H12A;EDN1;MAP2K3;NEDD4L;SLC9A1;CAV1;DOCK4;VIM;GJC1
10809,GO:0044291,0.386918319951231,0.817766758141464,3,45,cell-cell contact zone,CC,RAP2B;SLC9A1;GJC1
810,GO:0002080,0.386962044264976,0.92060151851841,1,10,acrosomal membrane,CC,CAV1
16775,GO:0098554,0.387621215713287,0.918558033110174,1,13,cytoplasmic side of endoplasmic reticulum membrane,CC,PTPN1
13045,GO:0051482,0.388204336461235,0.919348927202385,1,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,EDN1
16874,GO:0098792,0.388391622355025,0.919955613743679,1,10,xenophagy,BP,RIPK2
7155,GO:0031010,0.388448388053485,0.919929901058187,1,10,ISWI-type complex,CC,BAZ1A
17527,GO:1900746,0.388692541849738,0.919819252006226,1,10,regulation of vascular endothelial growth factor signaling pathway,BP,CCBE1
18047,GO:1902547,0.388692541849738,0.919819252006226,1,10,regulation of cellular response to vascular endothelial growth factor stimulus,BP,CCBE1
5560,GO:0016567,0.388735914234346,0.679204939786721,34,706,protein ubiquitination,BP,TNFAIP3;BIRC3;RNF19B;TICAM1;PELI1;BIRC2;N4BP1;RIPK2;KLHL21;NEDD4L;NOD2;DCUN1D3;RNF144B;RNF43;VHL;BACH1;SMURF2;KLHL5;TRIM25;SOX4;SOCS2;ARRDC4;RCHY1;RNF152;NEDD4;NFE2L2;KBTBD7;CAV1;SH3RF2;UBE2D3;PJA2;UBE2Z;RNF145;KCTD11
13023,GO:0051443,0.388921172094114,0.852428939249279,2,30,positive regulation of ubiquitin-protein transferase activity,BP,DCUN1D3;ARRDC4
10164,GO:0042744,0.38895931357525,0.918427206840031,1,12,hydrogen peroxide catabolic process,BP,GPX3
15611,GO:0072079,0.388965560603578,0.919001228635497,1,11,nephron tubule formation,BP,SIX4
361,GO:0000979,0.38921742894779,0.852428733416427,2,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,GADD45A;CEBPB
12948,GO:0051292,0.38956355836024,0.919423761808445,1,10,nuclear pore complex assembly,BP,NUP153
16014,GO:0086011,0.389672380773942,0.91937426788068,1,10,membrane repolarization during action potential,BP,CAV1
3166,GO:0006778,0.390070591452145,0.851497764103296,2,31,porphyrin-containing compound metabolic process,BP,SLC11A2;ALAS1
5606,GO:0016641,0.390118858747866,0.919171011653323,1,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,MAOA
5007,GO:0015149,0.390156040220662,0.919154071101627,1,10,hexose transmembrane transporter activity,MF,SLC2A6
10482,GO:0043371,0.390334722711234,0.919072630246862,1,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,IL4R
8347,GO:0033197,0.390338777003045,0.918371716044791,1,11,response to vitamin E,BP,HMGCS1
10732,GO:0044070,0.390853352146491,0.814554792115351,3,48,regulation of anion transport,BP,IL1B;EDN1;ABCA7
6498,GO:0021854,0.39113781182869,0.918004068989313,1,11,hypothalamus development,BP,ETS1
6823,GO:0030277,0.391189507052184,0.918682347332345,1,10,maintenance of gastrointestinal epithelium,BP,NOD2
5802,GO:0017048,0.391449269779123,0.741838694880633,8,139,Rho GTPase binding,MF,ARHGEF3;FGD6;CDC42EP4;ANLN;PARD6B;ITSN2;CAV1;DOCK4
18170,GO:1902902,0.391605068097483,0.917788616287116,1,11,negative regulation of autophagosome assembly,BP,FEZ1
3796,GO:0008361,0.391828640080871,0.749817777374028,7,123,regulation of cell size,BP,EDN1;IL7R;VEGFA;CREB1;SEMA4B;WNT5A;NRG1
10115,GO:0042629,0.391988806149373,0.917611418977609,1,11,mast cell granule,CC,NR4A3
101,GO:0000212,0.392019732194661,0.918302192199,1,10,meiotic spindle organization,BP,ESPL1
7098,GO:0030889,0.392040761473934,0.918292549111433,1,10,negative regulation of B cell proliferation,BP,PRDM1
11156,GO:0045198,0.392392247537729,0.918131271525353,1,10,establishment of epithelial cell apical/basal polarity,BP,WNT5A
76,GO:0000153,0.392412054713092,0.917415710123005,1,11,cytoplasmic ubiquitin ligase complex,CC,VHL
3696,GO:0008202,0.392874475128965,0.727262250577881,10,197,steroid metabolic process,BP,IL1B;TNF;BMP2;NFKB1;CYP27B1;ADM;HMGCS1;LDLR;PPARD;CYP24A1
17117,GO:0099738,0.393091414624941,0.850103251030902,2,28,cell cortex region,CC,PHLDB2;ANLN
66,GO:0000137,0.393114382125241,0.917799320646064,1,10,Golgi cis cisterna,CC,GOLGA8B
7087,GO:0030877,0.393115984508044,0.917798583159902,1,10,beta-catenin destruction complex,CC,GSK3B
18552,GO:1903725,0.393270545057834,0.812882323765066,3,47,regulation of phospholipid metabolic process,BP,NOD2;PDGFB;LDLR
2968,GO:0006506,0.393534121105418,0.849051746995237,2,32,GPI anchor biosynthetic process,BP,PLAUR;PIGA
2667,GO:0006012,0.393617911803706,0.916856588395205,1,11,galactose metabolic process,BP,B4GALT1
14645,GO:0070208,0.393971825823349,0.917404116036594,1,10,protein heterotrimerization,BP,C1QTNF1
14510,GO:0061980,0.394091921216788,0.849445672588204,2,28,regulatory RNA binding,MF,ZC3H12A;ZC3H7B
13929,GO:0060572,0.394546152908397,0.917138761522335,1,10,morphogenesis of an epithelial bud,BP,WNT5A
10591,GO:0043551,0.394632241650537,0.849317426898846,2,27,regulation of phosphatidylinositol 3-kinase activity,BP,NOD2;PDGFB
2370,GO:0005488,0.394690956374051,0.65112654361786,466,10144,binding,MF,NFKBIZ;CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;ITPKC;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;IL36G;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;JUN;TICAM1;KDM6B;IFNAR2;RAB3IP;EPHA2;EHD1;ZNF697;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;N4BP3;ZNF267;STARD5;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;EFNB1;BIRC2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;PANX1;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;KLHL21;DAPP1;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;STEAP4;C1QTNF1;AMOTL2;CDKN1A;KIAA0040;CLDN1;NMNAT2;CCDC85B;ITGA5;C11ORF68;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;ODC1;TNFAIP2;NEDD4L;CTSC;ARL5B;GPX3;NOD2;ELMSAN1;IL6ST;DCUN1D3;SAV1;TMCC3;SGK1;ICAM1;GCH1;TRIM47;RASSF9;SMAD3;IRGQ;ZC3H12C;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;RNF144B;RND3;MARCKSL1;TM4SF1;NFKBID;NINJ1;TRAF4;TRIB1;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;LGALSL;IL1R2;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;MAP3K8;ZBED2;ABL2;PPTC7;C3ORF52;LAMB3;CFLAR;RNF43;TXNRD1;LACC1;KLF7;PIGA;BTG1;ANXA8;IER5;LAYN;PPP4R4;CEBPB;CEBPD;VMP1;CD55;KCNJ15;DENND3;NAMPT;TAP1;ANXA8L1;TP53BP2;ANKLE2;HEPHL1;ADM;CDC42EP4;IFNAR1;ERRFI1;ADAMTS1;ANKK1;CREB1;TAF4B;GORAB;CCNL1;WISP1;NEDD9;MAST4;NR4A2;PATL1;MSANTD3;CD47;CANT1;VHL;PHKG2;SEMA4B;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;TGFBR2;SMURF2;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;AKAP2;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;IFNGR1;MASTL;NAB1;KIF3C;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;NOTCH2NL;DUSP10;SOX4;PPP1R3B;SOCS2;PDGFB;IL20;ANLN;PGLYRP4;CD82;BAZ1A;IFIH1;EFHD2;NRG1;TNC;SLC38A2;MMP9;LDLR;GPATCH2L;DCBLD2;RRAD;ATF3;OTUD4;BTG3;IKZF2;FAM83B;CAB39;IL32;TLE1;MFHAS1;TRAF3IP3;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;FAM57A;MT2A;SLC9A1;ZBTB10;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;CYTH1;GRB7;CXCL16;ARSJ;NUP153;BCL2L2;RNF152;IL4R;NEDD4;RHCG;POU2F2;ITSN2;DUS4L;GCSAM;IL24;TNFRSF6B;MARCKS;RAET1L;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;TAB3;PAOX;SPTBN5;MXD1;CHD4;SUSD6;TPRA1;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;CACFD1;HLA-A;UACA;DRAM1;TNIP2;ZNFX1;ZFAND5;TP53;NOM1;KLF3;TLR2;ABI1;STK40;PUS10;TAPBP;EFNB2;PDP1;RAB9A;HLA-B;ITGAV;PRRG1;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;ADGRE2;SDR16C5;ZNF148;UBE2Z;PML;POLR3A;PIM1;ESPL1;ADAM9;RELA;RAPH1;TRIM16;ESCO2;EMP3;SPATA2;FOXN2;CCBE1;PPP6R3;COL27A1;PLAT;MUC1;YARS2;AXL;ANXA5;AKIRIN1;CRB3;ELL2;SAT1;FRK;HLA-F;NR4A3;LIMS3;HLA-E;GSK3B;KMT2E;OSMR;PPARD;SLC16A1;PARP1;CYP24A1;MMP10;LAMA3;KDM7A;MED13;MXD3;CRAMP1;TBC1D22B;OCLN;COTL1;JMY;COL8A1;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;RNF145;ALAS1;ZXDA;RPS6KA6;DDR1;CEP135;XBP1;HSPA4L;QKI;EPB41L3;KCTD11;ZBTB5;ELF4;IL36RN;SREK1IP1;TFE3;EID3;ZMIZ2;MGAM;CCSER2;LMAN1;CFB;JUND;DENND4A
14278,GO:0061323,0.394724188710339,0.916341634537499,1,11,cell proliferation involved in heart morphogenesis,BP,PIM1
2377,GO:0005504,0.394729252038665,0.914814936298879,1,14,fatty acid binding,MF,PPARD
16219,GO:0090239,0.394729810761662,0.916339012658328,1,11,regulation of histone H4 acetylation,BP,MUC1
12822,GO:0051103,0.394803128128086,0.916304816095819,1,11,DNA ligation involved in DNA repair,BP,PARP1
1280,GO:0003071,0.395159380010534,0.916138533472891,1,11,renal system process involved in regulation of systemic arterial blood pressure,BP,PDGFB
3204,GO:0006839,0.395466995253029,0.715123303808549,12,249,mitochondrial transport,BP,PMAIP1;PPIF;BBC3;PLAGL2;TP53BP2;NRG1;SLC9A1;SLC25A37;UGCG;TP53;UBE2D3;GSK3B
5124,GO:0015485,0.395535348173825,0.848085119501258,2,30,cholesterol binding,MF,STARD5;CAV1
2212,GO:0005095,0.395630720698937,0.915918225883914,1,11,GTPase inhibitor activity,MF,CPEB2
20055,GO:2000651,0.395891028461276,0.916515376742412,1,10,positive regulation of sodium ion transmembrane transporter activity,BP,SLC9A1
15610,GO:0072078,0.396173806014347,0.810735898967266,3,47,nephron tubule morphogenesis,BP,BMP2;SIX4;VEGFA
10564,GO:0043517,0.396308527001023,0.915600802203913,1,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
7974,GO:0032580,0.396704187635484,0.786154794078195,4,67,Golgi cisterna membrane,CC,B4GALT1;CANT1;B4GALT5;GOLGA8B
10317,GO:0043094,0.397534699950396,0.846400569948701,2,32,cellular metabolic compound salvage,BP,AMPD3;UPP1
322,GO:0000900,0.398659940039373,0.915222991017834,1,10,translation repressor activity, mRNA regulatory element binding,MF,CPEB2
13833,GO:0060413,0.39879963154545,0.915157471079392,1,10,atrial septum morphogenesis,BP,SOX4
14894,GO:0070672,0.399096188042617,0.915018274460775,1,10,response to interleukin-15,BP,STAT5A
10545,GO:0043489,0.399448979539486,0.845685636335736,2,29,RNA stabilization,BP,NOCT;ZFP36
331,GO:0000921,0.399588733353327,0.914786779285105,1,10,septin ring assembly,BP,ANLN
17911,GO:1902186,0.39993849309913,0.845359281274875,2,29,regulation of viral release from host cell,BP,TRIM25;PML
18176,GO:1902911,0.399944681248221,0.766202264306006,5,89,protein kinase complex,CC,CDKN1A;CCNL1;PHKG2;TGFBR2;CAB39
3955,GO:0008655,0.400063905721265,0.913218973561964,1,12,pyrimidine-containing compound salvage,BP,UPP1
12216,GO:0048385,0.400123600948985,0.913800638432854,1,11,regulation of retinoic acid receptor signaling pathway,BP,TRIM16
19773,GO:2000136,0.400174257758247,0.913776580790002,1,11,regulation of cell proliferation involved in heart morphogenesis,BP,PIM1
7740,GO:0032231,0.400483994944259,0.783243082301661,4,66,regulation of actin filament bundle assembly,BP,SDC4;PHLDB2;SMAD3;SLC9A1
12746,GO:0050996,0.400888901086805,0.91417386578202,1,10,positive regulation of lipid catabolic process,BP,IL1B
12497,GO:0050435,0.401169304440561,0.844537193655177,2,29,amyloid-beta metabolic process,BP,EFNA1;ABCA7
7288,GO:0031269,0.401179097857588,0.913298523987912,1,11,pseudopodium assembly,BP,CDC42EP4
17400,GO:1900115,0.401199894499093,0.913288613016005,1,11,extracellular regulation of signal transduction,BP,DKK1
17401,GO:1900116,0.401199894499093,0.913288613016005,1,11,extracellular negative regulation of signal transduction,BP,DKK1
2322,GO:0005328,0.401527625971049,0.913871783772887,1,10,neurotransmitter:sodium symporter activity,MF,SLC6A14
5836,GO:0017112,0.40175853560561,0.806361893705314,3,49,Rab guanyl-nucleotide exchange factor activity,MF,RAB3IP;DENND3;DENND4A
17901,GO:1902166,0.401923842983595,0.911807854537864,1,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,MUC1
2131,GO:0004930,0.401937124931638,0.7409149515399,7,134,G-protein coupled receptor activity,MF,HCAR3;GPR156;HCAR2;BDKRB1;FZD8;TPRA1;ADGRE2
2564,GO:0005845,0.402330819419248,0.912748616509272,1,11,mRNA cap binding complex,CC,ZFP36
14688,GO:0070293,0.402338810190564,0.912744793819505,1,11,renal absorption,BP,SGK1
8344,GO:0033189,0.402370750300621,0.912729513020539,1,11,response to vitamin A,BP,PPARD
4487,GO:0010506,0.402577425610306,0.70121386327123,14,273,regulation of autophagy,BP,PLEKHF1;ZC3H12A;TICAM1;RIPK2;PLK2;ABL2;SOGA1;PLK3;FEZ1;RNF152;NEDD4;TAB3;DRAM1;XBP1
18185,GO:1902936,0.402898203814537,0.781193337567015,4,68,phosphatidylinositol bisphosphate binding,MF,DAPP1;ANXA8;SLC9A1;JPH2
10053,GO:0042532,0.403303636382723,0.91228248430379,1,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,CAV1
15865,GO:0072567,0.403328932882467,0.911650426690419,1,12,chemokine (C-X-C motif) ligand 2 production,BP,TNF
2713,GO:0006084,0.403443721460414,0.843012347050892,2,29,acetyl-CoA metabolic process,BP,HMGCS1;PDP1
10609,GO:0043584,0.403542017063965,0.912914863533429,1,10,nose development,BP,SIX4
8050,GO:0032695,0.403557664452421,0.912160516447399,1,11,negative regulation of interleukin-12 production,BP,NFKB1
4517,GO:0010564,0.403610284424867,0.669259833071392,30,622,regulation of cell cycle process,BP,IL1B;IL1A;BTG2;LIF;EDN1;EREG;DUSP1;GADD45A;ZFP36L1;KLHL21;CDKN1A;DCUN1D3;CDKN2B;PLK2;WNT5A;TGFA;SOX4;PDGFB;ANLN;PLK3;YAF2;TNKS1BP1;TPRA1;TP53;PML;ESPL1;EVI2B;MUC1;KMT2E;CEP135
3114,GO:0006691,0.403687554058775,0.911477102889787,1,12,leukotriene metabolic process,BP,TLR2
11752,GO:0046579,0.403692453874315,0.84284513833721,2,29,positive regulation of Ras protein signal transduction,BP,CSF1;NRG1
15660,GO:0072160,0.403842819930508,0.912771417345362,1,10,nephron tubule epithelial cell differentiation,BP,LIF
2215,GO:0005104,0.404440149344003,0.912486138099244,1,10,fibroblast growth factor receptor binding,MF,FGF5
2728,GO:0006105,0.404597410345835,0.91166022364831,1,11,succinate metabolic process,BP,STAT5A
4975,GO:0015085,0.404599429068991,0.780051875555108,4,65,calcium ion transmembrane transporter activity,MF,PANX1;TRPV3;ITGAV;JPH2
14133,GO:0060977,0.405124615053919,0.912158545726917,1,10,coronary vasculature morphogenesis,BP,VEGFA
8837,GO:0034620,0.405161162421483,0.738226274953793,7,131,cellular response to unfolded protein,BP,CXCL8;PPP1R15A;ATF3;NFE2L2;PTPN1;XBP1;HSPA4L
1402,GO:0003333,0.405360599296958,0.803762846627617,3,48,amino acid transmembrane transport,BP,SLC6A14;SLC7A2;SLC38A2
4416,GO:0010172,0.405467426248085,0.911994192443152,1,10,embryonic body morphogenesis,BP,PHLDB2
2814,GO:0006273,0.405693723486874,0.911130839992201,1,11,lagging strand elongation,BP,PARP1
10256,GO:0042987,0.405841063650331,0.841192498957409,2,30,amyloid precursor protein catabolic process,BP,EFNA1;ABCA7
16017,GO:0086014,0.406117296397902,0.911682112505835,1,10,atrial cardiac muscle cell action potential,BP,GJC1
16027,GO:0086026,0.406117296397902,0.911682112505835,1,10,atrial cardiac muscle cell to AV node cell signaling,BP,GJC1
16049,GO:0086066,0.406117296397902,0.911682112505835,1,10,atrial cardiac muscle cell to AV node cell communication,BP,GJC1
4503,GO:0010528,0.406327070994513,0.910824134044468,1,11,regulation of transposition,BP,MYBL1
4504,GO:0010529,0.406327070994513,0.910824134044468,1,11,negative regulation of transposition,BP,MYBL1
6662,GO:0030010,0.406504685312304,0.747766945876932,6,104,establishment of cell polarity,BP,AMOTL2;FRMD4B;WNT5A;SPRY2;FEZ1;CYTH1
20298,GO:2001241,0.407297110471694,0.909721075989901,1,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,INHBA
12073,GO:0048012,0.407417101028606,0.910294767020299,1,11,hepatocyte growth factor receptor signaling pathway,BP,PTPN1
10683,GO:0043931,0.407694062182097,0.910922118008072,1,10,ossification involved in bone maturation,BP,BMP2
5569,GO:0016577,0.407979358472357,0.840408767336048,2,27,histone demethylation,BP,KDM6B;KDM7A
16553,GO:0097284,0.408734493894467,0.909652433087484,1,11,hepatocyte apoptotic process,BP,CFLAR
18785,GO:1904262,0.408825215303216,0.909608096332698,1,11,negative regulation of TORC1 signaling,BP,RNF152
2967,GO:0006505,0.409499586198554,0.83816507273991,2,33,GPI anchor metabolic process,BP,PLAUR;PIGA
3371,GO:0007141,0.409524492224051,0.90862698491461,1,12,male meiosis I,BP,MYBL1
18219,GO:1902993,0.409984277925003,0.909040478988576,1,11,positive regulation of amyloid precursor protein catabolic process,BP,EFNA1
4461,GO:0010447,0.410056255511083,0.909005158545348,1,11,response to acidic pH,BP,SLC9A1
10958,GO:0044666,0.410357627384639,0.908857180103937,1,11,MLL3/4 complex,CC,KDM6B
9241,GO:0035631,0.410363493964196,0.908854298065083,1,11,CD40 receptor complex,CC,BIRC2
16200,GO:0090208,0.410569675115774,0.908752973285574,1,11,positive regulation of triglyceride metabolic process,BP,LDLR
5532,GO:0016504,0.41087018846509,0.837397593181052,2,32,peptidase activator activity,MF,CTSC;CAV1
3362,GO:0007099,0.411127506325877,0.837805881971035,2,29,centriole replication,BP,PLK2;CEP135
6001,GO:0019003,0.41135607303155,0.798818123194411,3,52,GDP binding,MF,RAP2B;RAB9A;GEM
11155,GO:0045197,0.411835812720372,0.837321653462359,2,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,WNT5A;CRB3
8604,GO:0034111,0.411974988382306,0.908060520005629,1,11,negative regulation of homotypic cell-cell adhesion,BP,C1QTNF1
4719,GO:0010878,0.412556934912859,0.907772835099829,1,11,cholesterol storage,BP,EHD1
15609,GO:0072077,0.413025415911351,0.907540842544623,1,11,renal vesicle morphogenesis,BP,LIF
15615,GO:0072087,0.413025415911351,0.907540842544623,1,11,renal vesicle development,BP,LIF
6166,GO:0019511,0.41309209221853,0.90750779535905,1,11,peptidyl-proline hydroxylation,BP,EGLN1
5014,GO:0015171,0.413488165055793,0.797491599332587,3,49,amino acid transmembrane transporter activity,MF,SLC6A14;SLC7A2;SLC38A2
18218,GO:1902992,0.413634822469596,0.907238529906401,1,11,negative regulation of amyloid precursor protein catabolic process,BP,ABCA7
13532,GO:0055089,0.413724608207543,0.907193938229439,1,11,fatty acid homeostasis,BP,XBP1
3479,GO:0007340,0.413827860230475,0.906490365086715,1,12,acrosome reaction,BP,B4GALT1
12525,GO:0050655,0.414228559286018,0.906943409868129,1,11,dermatan sulfate proteoglycan metabolic process,BP,DSE
857,GO:0002182,0.414629704512248,0.906743693699549,1,11,cytoplasmic translational elongation,BP,CPEB2
17471,GO:1900247,0.414629704512248,0.906743693699549,1,11,regulation of cytoplasmic translational elongation,BP,CPEB2
16517,GO:0097202,0.414821053192541,0.905992957284359,1,12,activation of cysteine-type endopeptidase activity,BP,RIPK2
10866,GO:0044380,0.415415295057376,0.796241187571788,3,47,protein localization to cytoskeleton,BP,KLHL21;ANLN;GSK3B
4564,GO:0010642,0.415615830393695,0.906251621399961,1,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFB
12748,GO:0050998,0.415837033057524,0.906141024446507,1,11,nitric-oxide synthase binding,MF,CAV1
20085,GO:2000696,0.415850932599855,0.906134072279874,1,11,regulation of epithelial cell differentiation involved in kidney development,BP,LIF
17500,GO:1900409,0.416082157018322,0.905359048430077,1,12,positive regulation of cellular response to oxidative stress,BP,TNF
18161,GO:1902884,0.416082157018322,0.905359048430077,1,12,positive regulation of response to oxidative stress,BP,TNF
9994,GO:0042398,0.416093354010468,0.833628067296567,2,33,cellular modified amino acid biosynthetic process,BP,GCH1;NFE2L2
11110,GO:0045116,0.416115958266332,0.904309404517587,1,14,protein neddylation,BP,DCUN1D3
777,GO:0002029,0.416155540519676,0.905322081071231,1,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,ADM
6579,GO:0022401,0.416155540519676,0.905322081071231,1,12,negative adaptation of signaling pathway,BP,ADM
14981,GO:0070875,0.416192829381194,0.906756956263784,1,10,positive regulation of glycogen metabolic process,BP,PHKG2
7047,GO:0030816,0.41627652600377,0.905261114658974,1,12,positive regulation of cAMP metabolic process,BP,ADM
468,GO:0001508,0.416313497774202,0.77051210502056,4,67,action potential,BP,NEDD4L;SLC9A1;CAV1;GJC1
12134,GO:0048194,0.416857696389446,0.769803610883644,4,71,Golgi vesicle budding,BP,CTSC;TGFA;PPP6R3;LMAN1
10410,GO:0043242,0.416909587175552,0.794981160447684,3,48,negative regulation of protein complex disassembly,BP,TNF;NAV3;SPTBN5
2622,GO:0005938,0.41717404853155,0.69581747508663,12,227,cell cortex,CC,PHLDB2;TNFAIP2;RND3;NEDD9;ANLN;PARD6B;NEDD4;MARCKS;SPTBN5;CAV1;RHOV;TRIP10
11905,GO:0046916,0.417404651480006,0.769011577145208,4,77,cellular transition metal ion homeostasis,BP,SLC11A2;MT2A;EGLN1;SLC39A14
12312,GO:0048641,0.417671941884217,0.833304160313071,2,29,regulation of skeletal muscle tissue development,BP,SIX4;DKK1
7920,GO:0032488,0.417754311478011,0.905179072375038,1,11,Cdc42 protein signal transduction,BP,RHOV
15017,GO:0070935,0.418138985084945,0.904985346062989,1,11,3'-UTR-mediated mRNA stabilization,BP,ZFP36
7403,GO:0031462,0.418358327859633,0.904208295891762,1,12,Cul2-RING ubiquitin ligase complex,CC,ZSWIM4
15930,GO:0072697,0.418508444563834,0.904799053332502,1,11,protein localization to cell cortex,BP,ANLN
6070,GO:0019215,0.41868557375039,0.904709659961689,1,11,intermediate filament binding,MF,VIM
10553,GO:0043501,0.418775859683102,0.904664074737212,1,11,skeletal muscle adaptation,BP,CFLAR
9136,GO:0035458,0.418781600064973,0.903993364154991,1,12,cellular response to interferon-beta,BP,IRF1
3537,GO:0007530,0.418889480773645,0.904606688613876,1,11,sex determination,BP,SIX4
7287,GO:0031268,0.41916908993308,0.903796343211578,1,12,pseudopodium organization,BP,CDC42EP4
6928,GO:0030516,0.419356980102543,0.768044893382826,4,67,regulation of axon extension,BP,VEGFA;SEMA4B;WNT5A;NRG1
10797,GO:0044265,0.419536371974521,0.642357673174964,44,959,cellular macromolecule catabolic process,BP,TNFAIP3;EFNA1;BTG2;NOCT;ZC3H12A;RNF19B;PMAIP1;ZFP36;PNRC1;SQSTM1;BIRC2;N4BP1;ZFP36L1;CYLD;NEDD4L;CTSC;RNF144B;TRIB1;PLK2;RNF43;DENND3;USP43;PATL1;ABTB2;SMURF2;TINAGL1;PNRC2;TRIM25;LDLR;PLK3;RCHY1;TNKS1BP1;NEDD4;NFE2L2;CAV1;TP53;UBE2D3;PML;USP31;GSK3B;VIM;RNF145;XBP1;QKI
14140,GO:0060992,0.419887547434875,0.904101687769368,1,11,response to fungicide,BP,KDM6B
8390,GO:0033293,0.420196676433243,0.830607689877057,2,34,monocarboxylic acid binding,MF,STARD5;PPARD
2170,GO:0005003,0.420224615945942,0.903930768091356,1,11,ephrin receptor activity,MF,EPHA2
2172,GO:0005005,0.420224615945942,0.903930768091356,1,11,transmembrane-ephrin receptor activity,MF,EPHA2
9072,GO:0035307,0.420399976088294,0.831194543902018,2,30,positive regulation of protein dephosphorylation,BP,PPP1R15A;ANKLE2
10984,GO:0044772,0.420489683162756,0.662937724800213,23,484,mitotic cell cycle phase transition,BP,BTG2;INHBA;DUSP1;GADD45A;ZFP36L1;CDKN1A;DCUN1D3;PHLDA1;CDKN2B;PLK2;BACH1;MASTL;SOX4;ANLN;PLK3;TNKS1BP1;TPRA1;TP53;PML;ESPL1;MUC1;KMT2E;CEP135
16075,GO:0089718,0.420760545017932,0.903658625654052,1,11,amino acid import across plasma membrane,BP,SLC7A2
3132,GO:0006720,0.420884817505606,0.7664077896621,4,73,isoprenoid metabolic process,BP,SDC4;HMGCS1;SDR16C5;PPARD
6681,GO:0030038,0.420964329877915,0.766666820224031,4,68,contractile actin filament bundle assembly,BP,SDC4;PHLDB2;SMAD3;SLC9A1
10351,GO:0043149,0.420964329877915,0.766666820224031,4,68,stress fiber assembly,BP,SDC4;PHLDB2;SMAD3;SLC9A1
7480,GO:0031640,0.421102773295629,0.900962417290634,1,16,killing of cells of other organism,BP,PGLYRP4
10863,GO:0044364,0.421102773295629,0.900962417290634,1,16,disruption of cells of other organism,BP,PGLYRP4
4277,GO:0009635,0.421769847770989,0.902467556146954,1,12,response to herbicide,BP,ZC3H12A
16732,GO:0097718,0.421996538436602,0.830079413187914,2,30,disordered domain specific binding,MF,BCL2L2;TP53
2350,GO:0005402,0.422033364409279,0.903010395649661,1,11,carbohydrate:cation symporter activity,MF,SLC2A6
11590,GO:0046135,0.422062705787202,0.901744842842814,1,13,pyrimidine nucleoside catabolic process,BP,UPP1
3225,GO:0006878,0.422086488851683,0.901732564684715,1,13,cellular copper ion homeostasis,BP,MT2A
5006,GO:0015145,0.422706620751929,0.902666433354146,1,11,monosaccharide transmembrane transporter activity,MF,SLC2A6
12865,GO:0051170,0.422873719299155,0.722761456405962,7,135,import into nucleus,BP,NFKBIA;TNF;ZC3H12A;BCL3;CDKN1A;NUP153;PML
11790,GO:0046639,0.42287578246772,0.902579891920038,1,11,negative regulation of alpha-beta T cell differentiation,BP,IL4R
10951,GO:0044613,0.422882483478201,0.901895663047347,1,12,nuclear pore central transport channel,CC,NUP153
8774,GO:0034450,0.422916924115323,0.90187792782127,1,12,ubiquitin-ubiquitin ligase activity,MF,PELI1
6290,GO:0019896,0.422921656834598,0.902556414894815,1,11,axonal transport of mitochondrion,BP,FEZ1
10830,GO:0044320,0.423005967090197,0.902513258531802,1,11,cellular response to leptin stimulus,BP,NR4A3
20196,GO:2001014,0.423274529822384,0.902375709410268,1,11,regulation of skeletal muscle cell differentiation,BP,SIX4
6010,GO:0019048,0.423277274927948,0.829182181719885,2,30,modulation by virus of host morphology or physiology,BP,ZC3H12A;SMAD3
1342,GO:0003198,0.423358949660629,0.902332447623756,1,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2
1289,GO:0003094,0.423385970689949,0.902318597941901,1,11,glomerular filtration,BP,PDGFB
12495,GO:0050433,0.423688220672471,0.901480231531413,1,12,regulation of catecholamine secretion,BP,STX1A
12261,GO:0048531,0.424023931434894,0.901306823083527,1,12,beta-1,3-galactosyltransferase activity,MF,B3GNT5
13280,GO:0051954,0.424086224962027,0.90127462527049,1,12,positive regulation of amine transport,BP,STX1A
8362,GO:0033238,0.42411684845373,0.788253045712445,3,61,regulation of cellular amine metabolic process,BP,ODC1;NR4A2;PAOX
6158,GO:0019471,0.424199158931211,0.901216236325175,1,12,4-hydroxyproline metabolic process,BP,EGLN1
111,GO:0000228,0.424344767768535,0.659263396578949,23,496,nuclear chromosome,CC,IRF1;JUN;KDM6B;JUNB;SMAD3;CEBPB;CREB1;SFR1;BAZ1A;TNKS1BP1;MXD1;CHD4;TP53;RAD9B;PML;RELA;ESCO2;MUC1;PPARD;PARP1;NABP1;ZMIZ2;JUND
17646,GO:1901343,0.424360127395784,0.763894631625434,4,68,negative regulation of vasculature development,BP,PLK2;PDGFB;SPRY2;PML
16934,GO:0098900,0.424693640476721,0.828404854613171,2,29,regulation of action potential,BP,SLC9A1;CAV1
14282,GO:0061333,0.425098859105478,0.788538867500901,3,49,renal tubule morphogenesis,BP,BMP2;SIX4;VEGFA
1780,GO:0004385,0.425296162238986,0.901336457361926,1,11,guanylate kinase activity,MF,TJP2
1474,GO:0003727,0.425935264471177,0.762401941637471,4,71,single-stranded RNA binding,MF,ZFP36;DLX2;PATL1;IFIH1
4491,GO:0010510,0.4259707995983,0.900988138910572,1,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,PDP1
12264,GO:0048535,0.426146758503308,0.900205945623858,1,12,lymph node development,BP,IL7R
13250,GO:0051900,0.426190045191556,0.899599944127061,1,13,regulation of mitochondrial depolarization,BP,PARP1
11406,GO:0045780,0.426472342959589,0.900728698855933,1,11,positive regulation of bone resorption,BP,ADAM8
11872,GO:0046852,0.426472342959589,0.900728698855933,1,11,positive regulation of bone remodeling,BP,ADAM8
11077,GO:0045069,0.426584248865225,0.761625037068381,4,75,regulation of viral genome replication,BP,CXCL8;TNF;ZC3H12A;TNIP1
16767,GO:0098534,0.426629899002228,0.826822100727071,2,30,centriole assembly,BP,PLK2;CEP135
8485,GO:0033630,0.42673794965891,0.899898019810078,1,12,positive regulation of cell adhesion mediated by integrin,BP,ADAM9
5348,GO:0016082,0.426857104412601,0.900529384132931,1,11,synaptic vesicle priming,BP,STX1A
10310,GO:0043073,0.427167223592116,0.899674063121655,1,12,germ cell nucleus,CC,MARCKS
15020,GO:0070938,0.427232000674157,0.900334942380209,1,11,contractile ring,CC,ANLN
3279,GO:0006958,0.427342058709933,0.899582761385337,1,12,complement activation, classical pathway,BP,CD55
15245,GO:0071391,0.427411398508074,0.900241813897745,1,11,cellular response to estrogen stimulus,BP,SFR1
5791,GO:0017016,0.427658040869019,0.659988753931211,21,406,Ras GTPase binding,MF,CSF2;HBEGF;RAB3IP;EHD1;EREG;ARHGEF3;FGD6;FGF5;DENND3;CDC42EP4;PDGFB;ANLN;NRG1;RASGEF1B;PARD6B;ITSN2;SPTBN5;CAV1;DOCK4;TBC1D22B;DENND4A
7286,GO:0031267,0.427734636118111,0.656273401241457,23,446,small GTPase binding,MF,CSF2;HBEGF;RAB3IP;EHD1;EREG;ARHGEF3;FGD6;FGF5;DENND3;CDC42EP4;ERRFI1;PDGFB;ANLN;NRG1;RASGEF1B;PARD6B;RNF152;ITSN2;SPTBN5;CAV1;DOCK4;TBC1D22B;DENND4A
10558,GO:0043508,0.427866289915997,0.899308692249514,1,12,negative regulation of JUN kinase activity,BP,DUSP10
18232,GO:1903010,0.427963949669245,0.899954637570918,1,11,regulation of bone development,BP,TJP2
7269,GO:0031233,0.42808673501016,0.899193305483295,1,12,intrinsic component of external side of plasma membrane,CC,ADAM9
10321,GO:0043101,0.42850231082593,0.898385829048797,1,13,purine-containing compound salvage,BP,AMPD3
9888,GO:0042159,0.428712573660875,0.898865280590578,1,12,lipoprotein catabolic process,BP,LDLR
4623,GO:0010738,0.429053028879085,0.898686559307079,1,12,regulation of protein kinase A signaling,BP,PJA2
7493,GO:0031657,0.429971290294091,0.89820354803311,1,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,CDKN2B
8812,GO:0034518,0.430119400457965,0.898125508247296,1,12,RNA cap binding complex,CC,ZFP36
8735,GO:0034381,0.430611894253054,0.823414934703573,2,33,plasma lipoprotein particle clearance,BP,EHD1;LDLR
13577,GO:0060026,0.430692224120443,0.898529189435422,1,11,convergent extension,BP,WNT5A
7131,GO:0030950,0.430863461106978,0.897732900687174,1,12,establishment or maintenance of actin cytoskeleton polarity,BP,RND3
12949,GO:0051293,0.431049136158465,0.823685960215101,2,30,establishment of spindle localization,BP,SPRY2;ESPL1
6757,GO:0030175,0.431084633740826,0.758365892667172,4,68,filopodium,CC,B4GALT1;ABI1;ITGAV;RAPH1
6580,GO:0022402,0.431218759972789,0.625748136190155,54,1141,cell cycle process,BP,CXCL8;IL1B;IRF1;IL1A;BTG2;INHBA;BIRC3;PPP1R15A;LIF;EDN1;IRF6;EREG;DUSP1;GADD45A;BIRC2;ZFP36L1;CYP27B1;KLHL21;CDKN1A;DCUN1D3;SMAD3;PHLDA1;RND3;CDKN2B;PLK2;ANKLE2;BACH1;MYBL1;MASTL;WNT5A;TGFA;SOX4;PDGFB;ANLN;CAB39;PLK3;YAF2;SPRY2;TNKS1BP1;NUP153;TPRA1;GOLGA8B;TP53;GEM;RAD9B;PML;ESPL1;EVI2B;MUC1;KMT2E;SLC16A1;JMY;NABP1;CEP135
10727,GO:0044058,0.431715029220115,0.897282420217339,1,12,regulation of digestive system process,BP,SGK1
8893,GO:0034707,0.431742533864017,0.897267849816853,1,12,chloride channel complex,CC,CLIC4
13180,GO:0051764,0.431754171021997,0.897970975243252,1,11,actin crosslink formation,BP,MARCKS
11501,GO:0045956,0.432171517906943,0.897040432920124,1,12,positive regulation of calcium ion-dependent exocytosis,BP,STX1A
8298,GO:0033127,0.432214464497172,0.897017648554699,1,12,regulation of histone phosphorylation,BP,IL1B
4392,GO:0010042,0.43241094254807,0.896913371679322,1,12,response to manganese ion,BP,ADAM9
7328,GO:0031333,0.432641917354778,0.738677566439404,5,93,negative regulation of protein complex assembly,BP,BIRC2;ZNF451;DKK1;SPTBN5;GSK3B
6798,GO:0030234,0.432734067985068,0.63655906180221,35,733,enzyme regulator activity,MF,CXCL1;BIRC3;PPP1R15A;BMP2;SERPINB2;JUN;BIRC2;TNFAIP8;CDKN1A;CPEB2;CTSC;TFPI2;TRIB1;SERPINB8;CDKN2B;CFLAR;PPP4R4;ANKLE2;CDC42EP4;ERRFI1;CCNL1;PPP1R3B;SERPINB1;SOCS2;PDGFB;NRG1;CAB39;SPRY2;CAV1;SH3RF2;ABI1;DOCK4;TRIP10;ANXA5;TBC1D22B
3328,GO:0007039,0.433358185469552,0.896409724219484,1,12,protein catabolic process in the vacuole,BP,LDLR
18257,GO:1903051,0.433620828721078,0.781349538720911,3,54,negative regulation of proteolysis involved in cellular protein catabolic process,BP,EFNA1;N4BP1;PML
13558,GO:0060004,0.433942738594145,0.896814560816011,1,11,reflex,BP,NR4A3
9877,GO:0042135,0.434044018812462,0.896044118845296,1,12,neurotransmitter catabolic process,BP,MAOA
16997,GO:0099054,0.43410308726685,0.896729516547949,1,11,presynapse assembly,BP,WNT5A
7755,GO:0032266,0.434316945338351,0.821348424554426,2,30,phosphatidylinositol-3-phosphate binding,MF,PLEKHF1;JPH2
19680,GO:1990907,0.434348412526032,0.896599319044444,1,11,beta-catenin-TCF complex,CC,TLE1
18255,GO:1903047,0.43445748723918,0.634007182157971,36,760,mitotic cell cycle process,BP,IL1B;IL1A;BTG2;INHBA;BIRC3;EDN1;EREG;DUSP1;GADD45A;BIRC2;ZFP36L1;CDKN1A;DCUN1D3;PHLDA1;CDKN2B;PLK2;ANKLE2;BACH1;MASTL;TGFA;SOX4;PDGFB;ANLN;PLK3;SPRY2;TNKS1BP1;NUP153;TPRA1;TP53;RAD9B;PML;ESPL1;MUC1;KMT2E;NABP1;CEP135
11693,GO:0046467,0.434655377751061,0.723096754174784,6,118,membrane lipid biosynthetic process,BP,TNF;PLAUR;B3GNT5;PIGA;SGMS2;UGCG
2329,GO:0005342,0.434882527857447,0.73685315817504,5,91,organic acid transmembrane transporter activity,MF,SLC6A14;SLC7A2;SLC38A2;SLC16A13;SLC16A1
11920,GO:0046943,0.434882527857447,0.73685315817504,5,91,carboxylic acid transmembrane transporter activity,MF,SLC6A14;SLC7A2;SLC38A2;SLC16A13;SLC16A1
12333,GO:0048675,0.435576268792193,0.736454439842977,5,87,axon extension,BP,VEGFA;SEMA4B;WNT5A;NRG1;RAPH1
14925,GO:0070742,0.435807366104042,0.895100443188082,1,12,C2H2 zinc finger domain binding,MF,ZXDA
5110,GO:0015399,0.435872326080376,0.754062623375877,4,73,primary active transmembrane transporter activity,MF,ABCA5;TAP1;TAPBP;ABCA7
5111,GO:0015405,0.435872326080376,0.754062623375877,4,73,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCA5;TAP1;TAPBP;ABCA7
9564,GO:0036342,0.435995902870834,0.895722333720629,1,11,post-anal tail morphogenesis,BP,WNT5A
9924,GO:0042267,0.436238843528472,0.819199567876839,2,34,natural killer cell mediated cytotoxicity,BP,RAET1L;HLA-E
3513,GO:0007431,0.436756067083094,0.819382236641447,2,31,salivary gland development,BP,TNF;XBP1
4370,GO:0009982,0.437359331766971,0.893651535351086,1,13,pseudouridine synthase activity,MF,PUS10
7430,GO:0031527,0.43736336038702,0.894990917419783,1,11,filopodium membrane,CC,ITGAV
1357,GO:0003222,0.437609377576535,0.894858992043774,1,11,ventricular trabecula myocardium morphogenesis,BP,NRG1
10070,GO:0042559,0.437724065936923,0.892927790500162,1,14,pteridine-containing compound biosynthetic process,BP,GCH1
13763,GO:0060323,0.438391143493719,0.818199717290259,2,31,head morphogenesis,BP,CSRNP1;DKK1
15045,GO:0070977,0.438557535252411,0.89434958365164,1,11,bone maturation,BP,BMP2
10783,GO:0044233,0.438594232759373,0.893598215853963,1,12,ER-mitochondrion membrane contact site,CC,PLEKHF1
11534,GO:0046040,0.438845252510911,0.89346225495877,1,12,IMP metabolic process,BP,AMPD3
9445,GO:0036020,0.43892826648273,0.893417268002639,1,12,endolysosome membrane,CC,LDLR
9057,GO:0035278,0.438961102486924,0.893399470248728,1,12,miRNA mediated inhibition of translation,BP,ZFP36
9809,GO:0040033,0.438961102486924,0.893399470248728,1,12,negative regulation of translation, ncRNA-mediated,BP,ZFP36
11505,GO:0045974,0.438961102486924,0.893399470248728,1,12,regulation of translation, ncRNA-mediated,BP,ZFP36
2954,GO:0006482,0.439236461981307,0.818027488459385,2,29,protein demethylation,BP,KDM6B;KDM7A
3706,GO:0008214,0.439236461981307,0.818027488459385,2,29,protein dealkylation,BP,KDM6B;KDM7A
17900,GO:1902165,0.439713284707078,0.891381190292532,1,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,MUC1
8314,GO:0033145,0.439890647297067,0.89227388661085,1,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,PARP1
4154,GO:0009214,0.439892493916568,0.893629762915496,1,11,cyclic nucleotide catabolic process,BP,EGLN1
10696,GO:0043970,0.439953723631552,0.892860577773638,1,12,histone H3-K9 acetylation,BP,ZNF451
16500,GO:0097178,0.440134036926063,0.816735231109958,2,32,ruffle assembly,BP,ICAM1;CAV1
4466,GO:0010457,0.440359763324775,0.893377087958336,1,11,centriole-centriole cohesion,BP,CEP135
5721,GO:0016854,0.44077663804245,0.891789089182692,1,13,racemase and epimerase activity,MF,DSE
14124,GO:0060965,0.440913108668277,0.892338121937743,1,12,negative regulation of gene silencing by miRNA,BP,ZC3H12A
14132,GO:0060976,0.440947175552184,0.816557063266661,2,30,coronary vasculature development,BP,PRDM1;VEGFA
9041,GO:0035254,0.441533933230209,0.816129892002851,2,30,glutamate receptor binding,MF,SQSTM1;NEDD4
1991,GO:0004708,0.441558821280818,0.891985592864559,1,12,MAP kinase kinase activity,MF,MAP2K3
16048,GO:0086065,0.441695810232845,0.815797578782593,2,31,cell communication involved in cardiac conduction,BP,CAV1;GJC1
8110,GO:0032793,0.441998556028007,0.891745107261963,1,12,positive regulation of CREB transcription factor activity,BP,VEGFA
15149,GO:0071230,0.442611037088674,0.774487567832241,3,51,cellular response to amino acid stimulus,BP,TNF;CEBPB;XBP1
6654,GO:0023058,0.442826051455331,0.890662496874224,1,13,adaptation of signaling pathway,BP,ADM
8715,GO:0034356,0.4433398477545,0.891009511506655,1,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,NAMPT
12750,GO:0051000,0.443593483464066,0.890870062526844,1,12,positive regulation of nitric-oxide synthase activity,BP,GCH1
10025,GO:0042454,0.443616037827706,0.889686381464162,1,14,ribonucleoside catabolic process,BP,UPP1
15762,GO:0072337,0.443643107341527,0.89084276630087,1,12,modified amino acid transport,BP,SLC38A2
2459,GO:0005669,0.444272604512206,0.813175817082196,2,35,transcription factor TFIID complex,CC,TAF4B;TP53
12361,GO:0048714,0.444293910041507,0.890484390048324,1,12,positive regulation of oligodendrocyte differentiation,BP,TLR2
17903,GO:1902170,0.444768761657849,0.890222441849451,1,12,cellular response to reactive nitrogen species,BP,CFLAR
9019,GO:0035195,0.444832859025578,0.713713904675843,6,134,gene silencing by miRNA,BP,ZC3H12A;ZFP36;SMAD3;NUP153;SMAD1;ZC3H7B
8439,GO:0033555,0.444934937320974,0.813224712042783,2,32,multicellular organismal response to stress,BP,GCH1;NR4A2
11011,GO:0044827,0.445025408170311,0.890080702196424,1,12,modulation by host of viral genome replication,BP,ZC3H12A
14146,GO:0060998,0.445764276488251,0.772062235950113,3,50,regulation of dendritic spine development,BP,EFNA1;PLK2;NRG1
7206,GO:0031091,0.446090632447366,0.771485051699464,3,53,platelet alpha granule,CC,VEGFA;VEGFC;PDGFB
19982,GO:2000515,0.446099471728011,0.889486283381728,1,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,IL4R
2773,GO:0006195,0.446376687159362,0.811793767541342,2,34,purine nucleotide catabolic process,BP,AMPD3;EGLN1
10316,GO:0043090,0.446428067939101,0.889304028294138,1,12,amino acid import,BP,SLC7A2
12961,GO:0051307,0.446921527055246,0.889029979802519,1,12,meiotic chromosome separation,BP,ESPL1
15606,GO:0072074,0.447193449752568,0.888878783197795,1,12,kidney mesenchyme development,BP,SIX4
4813,GO:0012510,0.447336149709635,0.888157575085561,1,13,trans-Golgi network transport vesicle membrane,CC,RASSF9
11826,GO:0046710,0.447360270948432,0.888785962256826,1,12,GDP metabolic process,BP,TJP2
2484,GO:0005720,0.447397109052477,0.811219598292994,2,33,nuclear heterochromatin,CC,TNKS1BP1;ESCO2
8197,GO:0032934,0.447438570824113,0.811188953667882,2,33,sterol binding,MF,STARD5;CAV1
3703,GO:0008211,0.447493985956856,0.888069270664524,1,13,glucocorticoid metabolic process,BP,BMP2
6688,GO:0030049,0.447531723528118,0.887498856345503,1,14,muscle filament sliding,BP,VIM
8379,GO:0033275,0.447531723528118,0.887498856345503,1,14,actin-myosin filament sliding,BP,VIM
17501,GO:1900424,0.448418420459131,0.887551204008393,1,13,regulation of defense response to bacterium,BP,MAPKBP1
4835,GO:0014037,0.448723292928602,0.810635117885728,2,31,Schwann cell differentiation,BP,NAB1;RELA
16155,GO:0090153,0.448751853212589,0.88736397644239,1,13,regulation of sphingolipid biosynthetic process,BP,TNF
19127,GO:1905038,0.448751853212589,0.88736397644239,1,13,regulation of membrane lipid metabolic process,BP,TNF
19860,GO:2000303,0.448751853212589,0.88736397644239,1,13,regulation of ceramide biosynthetic process,BP,TNF
11931,GO:0046965,0.448982966149127,0.887880547987237,1,12,retinoid X receptor binding,MF,NR4A2
5604,GO:0016638,0.449249121893951,0.88773160247526,1,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,MAOA
5834,GO:0017110,0.449460909017012,0.88696518321065,1,13,nucleoside-diphosphatase activity,MF,CANT1
6901,GO:0030431,0.44952983163189,0.886372259600243,1,14,sleep,BP,CSF2
1221,GO:0002888,0.449566140226227,0.886905923054353,1,13,positive regulation of myeloid leukocyte mediated immunity,BP,IL4R
7215,GO:0031103,0.449758813522914,0.809662632393554,2,32,axon regeneration,BP,JUN;TNC
16131,GO:0090103,0.449848060598263,0.887395972747293,1,12,cochlea morphogenesis,BP,WNT5A
5205,GO:0015800,0.450012927328512,0.809679694861882,2,31,acidic amino acid transport,BP,SLC38A2;STX1A
15483,GO:0071813,0.450413220731441,0.887078695994953,1,12,lipoprotein particle binding,MF,LDLR
15484,GO:0071814,0.450413220731441,0.887078695994953,1,12,protein-lipid complex binding,MF,LDLR
3107,GO:0006684,0.452290725879948,0.885364817834819,1,13,sphingomyelin metabolic process,BP,SGMS2
1707,GO:0004197,0.452295073594409,0.740111541786759,4,75,cysteine-type endopeptidase activity,MF,CTSC;CFLAR;TINAGL1;ESPL1
10391,GO:0043217,0.452314896398411,0.886006996331866,1,12,myelin maintenance,BP,EPB41L3
20078,GO:2000677,0.45245835316224,0.807277196570377,2,34,regulation of transcription regulatory region DNA binding,BP,LIF;PARP1
12654,GO:0050839,0.452494510673859,0.640571684608093,19,394,cell adhesion molecule binding,MF,IL1B;EPHA2;EHD1;ADAM8;PHLDB2;TJP2;ITGA5;ICAM1;WISP1;TRIM25;ANLN;EFHD2;NRG1;TNKS1BP1;H1FX;PTPN1;ABI1;ITGAV;ADAM9
16234,GO:0090266,0.452549309797224,0.885217875965717,1,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,DUSP1
18441,GO:1903504,0.452549309797224,0.885217875965717,1,13,regulation of mitotic spindle checkpoint,BP,DUSP1
18627,GO:1903894,0.4529021006767,0.885017210092803,1,13,regulation of IRE1-mediated unfolded protein response,BP,PTPN1
4683,GO:0010828,0.453041013913104,0.807648313248538,2,30,positive regulation of glucose transmembrane transport,BP,NFE2L2;NR4A3
5267,GO:0015908,0.453220588373659,0.765802687024792,3,52,fatty acid transport,BP,IL1B;EDN1;PPARD
12640,GO:0050812,0.453252568917945,0.88547622639885,1,12,regulation of acyl-CoA biosynthetic process,BP,PDP1
7666,GO:0032091,0.453933727229182,0.738537918889017,4,78,negative regulation of protein binding,BP,DKK1;PDGFB;CAV1;GSK3B
13592,GO:0060045,0.453978769222886,0.885064096148658,1,12,positive regulation of cardiac muscle cell proliferation,BP,PIM1
16518,GO:0097205,0.454045888867464,0.885025957732414,1,12,renal filtration,BP,PDGFB
10449,GO:0043302,0.454404555137054,0.884160157442523,1,13,positive regulation of leukocyte degranulation,BP,IL4R
3152,GO:0006750,0.454802444475354,0.883365603693901,1,14,glutathione biosynthetic process,BP,NFE2L2
7876,GO:0032433,0.455014425501768,0.884474734657144,1,12,filopodium tip,CC,ABI1
3110,GO:0006687,0.455894963509473,0.76351340306679,3,53,glycosphingolipid metabolic process,BP,ITGB8;ARSJ;UGCG
5077,GO:0015297,0.456102621080753,0.763446263916025,3,52,antiporter activity,MF,SLC9A1;SLC9A8;SLC41A1
13703,GO:0060231,0.456338780593192,0.883050918579236,1,13,mesenchymal to epithelial transition,BP,LIF
3396,GO:0007175,0.456428126005469,0.882999520270867,1,13,negative regulation of epidermal growth factor-activated receptor activity,BP,ERRFI1
7140,GO:0030968,0.456489961046896,0.70382424432303,6,117,endoplasmic reticulum unfolded protein response,BP,CXCL8;PPP1R15A;ATF3;NFE2L2;PTPN1;XBP1
7601,GO:0031968,0.45669022799037,0.683443862381023,8,163,organelle outer membrane,CC,PPP1R15A;PMAIP1;CYP27B1;NAV3;SLC11A2;MAOA;BCL2L2;CYP24A1
17989,GO:1902373,0.456785519650215,0.80441120870145,2,32,negative regulation of mRNA catabolic process,BP,NOCT;ZFP36
1873,GO:0004535,0.456886665504703,0.883404482579285,1,12,poly(A)-specific ribonuclease activity,MF,NOCT
9349,GO:0035855,0.457003284787811,0.883337612464274,1,12,megakaryocyte development,BP,ABI1
7218,GO:0031106,0.457009982526078,0.883333771212429,1,12,septin ring organization,BP,ANLN
4639,GO:0010758,0.457334260533714,0.881904332326172,1,14,regulation of macrophage chemotaxis,BP,CSF1
3867,GO:0008484,0.457505004539124,0.883049648317835,1,12,sulfuric ester hydrolase activity,MF,ARSJ
1871,GO:0004532,0.457880701645422,0.803203187161808,2,34,exoribonuclease activity,MF,NOCT;ZC3H12A
1353,GO:0003215,0.458055896324081,0.882732946498824,1,12,cardiac right ventricle morphogenesis,BP,SOX4
7512,GO:0031690,0.458057423595448,0.88205973117375,1,13,adrenergic receptor binding,MF,NEDD4
8207,GO:0032956,0.458810243368827,0.657209577716382,12,241,regulation of actin cytoskeleton organization,BP,SDC4;EDN1;PHLDB2;ICAM1;SMAD3;RND3;ABL2;CDC42EP4;SLC9A1;SPTBN5;RHOV;JMY
16194,GO:0090201,0.459116677884164,0.880868721972844,1,14,negative regulation of release of cytochrome c from mitochondria,BP,PPIF
1467,GO:0003714,0.459203744087898,0.673702694279408,9,178,transcription corepressor activity,MF,BHLHE40;JUNB;RELB;ZNF451;ATF3;TLE1;YAF2;MXD1;ELK3
9545,GO:0036295,0.459336265499667,0.881318770131972,1,13,cellular response to increased oxygen levels,BP,CAV1
395,GO:0001056,0.459371283143826,0.880220355956983,1,15,RNA polymerase III activity,MF,POLR3A
16147,GO:0090136,0.459629450821807,0.881825351574809,1,12,epithelial cell-cell adhesion,BP,SERPINB8
5099,GO:0015370,0.459881373600602,0.80228550990762,2,31,solute:sodium symporter activity,MF,SLC6A14;SLC28A3
3701,GO:0008209,0.460166980718105,0.880835886831121,1,13,androgen metabolic process,BP,ADM
4707,GO:0010866,0.460255067008235,0.880784611016895,1,13,regulation of triglyceride biosynthetic process,BP,LDLR
14803,GO:0070509,0.46032612137047,0.801736783005467,2,32,calcium ion import,BP,PDGFB;TRPV3
1361,GO:0003229,0.460357967356627,0.801924669205104,2,31,ventricular cardiac muscle tissue development,BP,TBX3;NRG1
1435,GO:0003407,0.460522062009354,0.801800349066126,2,31,neural retina development,BP,FJX1;DLX2
7608,GO:0031984,0.46085311009383,0.594321959896538,60,1279,organelle subcompartment,CC,ZC3H12A;PPP1R15A;RNF19B;PLAUR;IFNGR2;PANX1;STEAP4;NMNAT2;GBP2;ABCA5;CTSC;SGK1;B4GALT1;B3GNT5;RND3;C3ORF52;RNF43;PIGA;CD55;TAP1;ANKLE2;SLC28A3;DSE;CANT1;CAMK1G;TGFA;PDGFB;PLK3;SUCO;SLC9A1;SYS1;B4GALT5;CYTH1;PTPN1;SGMS2;TPST1;CAV1;HLA-A;UGCG;GOLGA8B;TAPBP;RAB9A;HLA-B;PJA2;JPH2;ABCA7;SPCS2;TMEM132A;SDR16C5;HS3ST3B1;PML;SLC9A8;PPP6R3;CHST2;SLC16A13;HLA-F;HLA-E;XBP1;LMAN1;GJC1
1051,GO:0002576,0.461226839259448,0.732396627615115,4,76,platelet degranulation,BP,VEGFA;VEGFC;PDGFB;ANXA5
6024,GO:0019076,0.461791843156936,0.800424428179033,2,33,viral release from host cell,BP,TRIM25;PML
9373,GO:0035890,0.461791843156936,0.800424428179033,2,33,exit from host,BP,TRIM25;PML
9374,GO:0035891,0.461791843156936,0.800424428179033,2,33,exit from host cell,BP,TRIM25;PML
13324,GO:0052126,0.461791843156936,0.800424428179033,2,33,movement in host environment,BP,TRIM25;PML
13333,GO:0052192,0.461791843156936,0.800424428179033,2,33,movement in environment of other organism involved in symbiotic interaction,BP,TRIM25;PML
15295,GO:0071467,0.462029645176356,0.879748648179977,1,13,cellular response to pH,BP,SLC9A1
20205,GO:2001026,0.462427115783505,0.879515837282218,1,13,regulation of endothelial cell chemotaxis,BP,VEGFA
9007,GO:0035148,0.462789781017981,0.698304917334198,6,113,tube formation,BP,SDC4;SIX4;VEGFA;ADM;WNT5A;SOX4
14479,GO:0061844,0.462936433615778,0.875665271935499,1,23,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,PGLYRP4
16173,GO:0090179,0.46295222257099,0.879894310349199,1,12,planar cell polarity pathway involved in neural tube closure,BP,WNT5A
819,GO:0002089,0.46308499494176,0.879816737975225,1,12,lens morphogenesis in camera-type eye,BP,EPHA2
4078,GO:0009129,0.463188013252749,0.878481824052679,1,14,pyrimidine nucleoside monophosphate metabolic process,BP,UPP1
4079,GO:0009130,0.463188013252749,0.878481824052679,1,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,UPP1
4495,GO:0010517,0.463191172552351,0.799358233841115,2,33,regulation of phospholipase activity,BP,ABL2;ANXA8
4789,GO:0010975,0.463367556010672,0.638194359200712,16,317,regulation of neuron projection development,BP,EFNA1;NEDD4L;VEGFA;ZSWIM4;PLK2;ABL2;CFLAR;SEMA4B;WNT5A;NRG1;FEZ1;NEDD4;ITSN2;NFE2L2;EFNB2;VIM
12717,GO:0050922,0.46341308794009,0.79918887439969,2,33,negative regulation of chemotaxis,BP,SEMA4B;WNT5A
10692,GO:0043966,0.46362501399708,0.756941399876031,3,55,histone H3 acetylation,BP,LIF;ZNF451;TRIM16
13245,GO:0051895,0.463838407072069,0.879375956216615,1,12,negative regulation of focal adhesion assembly,BP,PHLDB2
9998,GO:0042405,0.463844541117164,0.879372363322378,1,12,nuclear inclusion body,CC,NUP153
6783,GO:0030214,0.463943664965518,0.878624933090414,1,13,hyaluronan catabolic process,BP,SLC9A1
5172,GO:0015721,0.463961917652364,0.878614185204087,1,13,bile acid and bile salt transport,BP,STARD5
12819,GO:0051100,0.463976138322598,0.696938995945612,6,122,negative regulation of binding,BP,NFKBIA;JUN;DKK1;PDGFB;CAV1;GSK3B
3111,GO:0006688,0.464029005737542,0.878574675960828,1,13,glycosphingolipid biosynthetic process,BP,UGCG
7378,GO:0031424,0.464362089757567,0.729199194453262,4,85,keratinization,BP,SPRR2D;KRT34;SPRR2A;LCE1C
18254,GO:1903046,0.464373118786012,0.69673969208455,6,117,meiotic cell cycle process,BP,LIF;EREG;MYBL1;MASTL;WNT5A;ESPL1
4450,GO:0010369,0.464434020144317,0.878335983860487,1,13,chromocenter,CC,ESCO2
2710,GO:0006081,0.465122683605571,0.755512332656061,3,57,cellular aldehyde metabolic process,BP,BMP2;SDR16C5;RELA
2945,GO:0006473,0.466512554453907,0.674430902550807,8,162,protein acetylation,BP,IL1B;LIF;ZNF451;SOX4;SDR16C5;TRIM16;ESCO2;MUC1
10841,GO:0044331,0.467418500665405,0.876567947187736,1,13,cell-cell adhesion mediated by cadherin,BP,WNT5A
4239,GO:0009435,0.467595771338485,0.795791982433318,2,34,NAD biosynthetic process,BP,NMNAT2;NAMPT
13785,GO:0060349,0.467860257189448,0.753719643588684,3,52,bone morphogenesis,BP,TGFBR2;NAB1;COL27A1
6922,GO:0030510,0.467988690969834,0.753612386530682,3,52,regulation of BMP signaling pathway,BP,DKK1;SMURF2;WNT5A
2684,GO:0006044,0.46853024786855,0.875905202356584,1,13,N-acetylglucosamine metabolic process,BP,CHST2
2249,GO:0005159,0.468537865754595,0.875900653349036,1,13,insulin-like growth factor receptor binding,MF,SOCS2
19739,GO:2000059,0.468741640989098,0.794558476334295,2,36,negative regulation of ubiquitin-dependent protein catabolic process,BP,N4BP1;PML
10181,GO:0042769,0.46875733379895,0.794385976949582,2,37,DNA damage response, detection of DNA damage,BP,SOX4;PARP1
10402,GO:0043230,0.468817892865902,0.578011723984082,89,2051,extracellular organelle,CC,IL1B;TNFAIP3;PLAU;EFNA1;SDC4;BTG2;PLAUR;SOD2;IL1RN;EHD1;SQSTM1;CSF1;IRF6;EFNB1;STEAP4;RAP2B;NEDD4L;CTSC;GPX3;IL6ST;RELT;ICAM1;RASSF9;B4GALT1;RND3;MARCKSL1;KRT34;SERPINB8;SLC6A14;TXNRD1;CD55;NAMPT;TMEM106A;ANXA8L1;CD47;CANT1;SOGA1;SAA1;TINAGL1;ITGB8;WNT5A;SLC11A2;ROBO4;SERPINB1;CD82;MMP9;COL12A1;CAB39;CHD2;ARRDC4;PARD6B;SLC9A1;B4GALT5;BCL2L2;NEDD4;RHCG;ITSN2;MARCKS;BTN2A2;WNT7B;TAB3;SPTBN5;CLIC4;UACA;ABI1;RAB9A;ITGAV;UBE2D3;CD276;TRIP10;TMEM132A;ADAM9;PLAT;MUC1;AXL;ANXA5;CRB3;FRK;HLA-E;SLC16A1;LAMA3;COTL1;COL8A1;VIM;CREB5;DDR1;MGAM;LMAN1;CFB
18481,GO:1903561,0.468817892865902,0.578011723984082,89,2051,extracellular vesicle,CC,IL1B;TNFAIP3;PLAU;EFNA1;SDC4;BTG2;PLAUR;SOD2;IL1RN;EHD1;SQSTM1;CSF1;IRF6;EFNB1;STEAP4;RAP2B;NEDD4L;CTSC;GPX3;IL6ST;RELT;ICAM1;RASSF9;B4GALT1;RND3;MARCKSL1;KRT34;SERPINB8;SLC6A14;TXNRD1;CD55;NAMPT;TMEM106A;ANXA8L1;CD47;CANT1;SOGA1;SAA1;TINAGL1;ITGB8;WNT5A;SLC11A2;ROBO4;SERPINB1;CD82;MMP9;COL12A1;CAB39;CHD2;ARRDC4;PARD6B;SLC9A1;B4GALT5;BCL2L2;NEDD4;RHCG;ITSN2;MARCKS;BTN2A2;WNT7B;TAB3;SPTBN5;CLIC4;UACA;ABI1;RAB9A;ITGAV;UBE2D3;CD276;TRIP10;TMEM132A;ADAM9;PLAT;MUC1;AXL;ANXA5;CRB3;FRK;HLA-E;SLC16A1;LAMA3;COTL1;COL8A1;VIM;CREB5;DDR1;MGAM;LMAN1;CFB
7153,GO:0031000,0.469059807805665,0.875588724717055,1,13,response to caffeine,BP,TP53
9538,GO:0036270,0.469059807805665,0.875588724717055,1,13,response to diuretic,BP,TP53
8693,GO:0034312,0.469290161820679,0.874326907619346,1,15,diol biosynthetic process,BP,GCH1
1969,GO:0004675,0.4695130083087,0.876023114686441,1,12,transmembrane receptor protein serine/threonine kinase activity,MF,TGFBR2
7891,GO:0032454,0.469760355825456,0.875875640847628,1,12,histone demethylase activity (H3-K9 specific),MF,KDM7A
7447,GO:0031573,0.469870367328916,0.874499121900149,1,14,intra-S DNA damage checkpoint,BP,RAD9B
16331,GO:0090503,0.470160060056146,0.793630887680812,2,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,NOCT;ZC3H12A
879,GO:0002228,0.470191525890386,0.793436033079848,2,36,natural killer cell mediated immunity,BP,RAET1L;HLA-E
8346,GO:0033194,0.470686140489949,0.874007339056383,1,14,response to hydroperoxide,BP,GPX3
7180,GO:0031057,0.471021169954063,0.793541845490039,2,32,negative regulation of histone modification,BP,ZNF451;SDR16C5
13544,GO:0055106,0.471235362884435,0.872691192127689,1,16,ubiquitin-protein transferase regulator activity,MF,TRIB1
19441,GO:1990000,0.471272018401403,0.873653393701939,1,14,amyloid fibril formation,BP,LDLR
1135,GO:0002724,0.47142517454768,0.87356076383242,1,14,regulation of T cell cytokine production,BP,IL6
593,GO:0001755,0.47201445455391,0.792566325355201,2,33,neural crest cell migration,BP,EFNB1;SEMA4B
18469,GO:1903541,0.472207920794162,0.873086680360628,1,14,regulation of exosomal secretion,BP,SDC4
18471,GO:1903543,0.472207920794162,0.873086680360628,1,14,positive regulation of exosomal secretion,BP,SDC4
1391,GO:0003298,0.472392243745598,0.873585421145358,1,13,physiological muscle hypertrophy,BP,EDN1
1394,GO:0003301,0.472392243745598,0.873585421145358,1,13,physiological cardiac muscle hypertrophy,BP,EDN1
14181,GO:0061049,0.472392243745598,0.873585421145358,1,13,cell growth involved in cardiac muscle cell development,BP,EDN1
6277,GO:0019867,0.472879258409047,0.668469797314625,8,165,outer membrane,CC,PPP1R15A;PMAIP1;CYP27B1;NAV3;SLC11A2;MAOA;BCL2L2;CYP24A1
2529,GO:0005783,0.472927051618786,0.582059178920641,61,1325,endoplasmic reticulum,CC,PLEKHF1;ZC3H12A;PPP1R15A;RNF19B;PLAUR;EDN1;SQSTM1;CSF1;IL23A;IFNGR2;IL6;BDKRB1;PANX1;ITGA5;CTSC;SGK1;B3GNT5;C3ORF52;RNF43;PIGA;VMP1;TAP1;ANKLE2;SLC28A3;DSE;CANT1;VHL;WNT5A;TGFA;PDGFB;TNC;COL12A1;SUCO;SLC9A1;ARSJ;RAET1L;PTPN1;WNT7B;SGMS2;CAV1;HLA-A;TP53;ABI1;TAPBP;RAB9A;HLA-B;PJA2;JPH2;SPCS2;TMEM132A;SDR16C5;PML;MAMDC2;COL27A1;HLA-F;HLA-E;LAMA3;COL8A1;XBP1;LMAN1;GJC1
5970,GO:0018394,0.472962200693851,0.677632303457142,7,140,peptidyl-lysine acetylation,BP,IL1B;LIF;ZNF451;SOX4;SDR16C5;TRIM16;MUC1
13235,GO:0051882,0.472994288496652,0.872079981652756,1,15,mitochondrial depolarization,BP,PARP1
3322,GO:0007030,0.4734460600536,0.688613675907931,6,114,Golgi organization,BP,VMP1;PDE4DIP;PLK3;SPTBN5;GOLGA8B;LMAN1
927,GO:0002320,0.473818031053986,0.872722083250346,1,13,lymphoid progenitor cell differentiation,BP,SOX4
426,GO:0001133,0.47399869394978,0.872612421809166,1,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,PPARD
13054,GO:0051497,0.474044947844845,0.872584336263327,1,13,negative regulation of stress fiber assembly,BP,PHLDB2
6765,GO:0030194,0.474561499331228,0.871654396345114,1,14,positive regulation of blood coagulation,BP,NFE2L2
17371,GO:1900048,0.474561499331228,0.871654396345114,1,14,positive regulation of hemostasis,BP,NFE2L2
812,GO:0002082,0.474651265754183,0.871599565982524,1,14,regulation of oxidative phosphorylation,BP,PPIF
7340,GO:0031346,0.474677263985441,0.637916089773047,13,258,positive regulation of cell projection organization,BP,NAV3;NEDD4L;VEGFA;ABL2;CFLAR;CDC42EP4;WNT5A;ANLN;NRG1;FEZ1;ITSN2;NFE2L2;CEP135
74,GO:0000151,0.474861344348228,0.637657185398475,13,266,ubiquitin ligase complex,CC,RNF19B;KLHL21;DCUN1D3;RNF144B;ZSWIM4;VHL;BACH1;ABTB2;SMURF2;KLHL5;RCHY1;NEDD4;KBTBD7
11629,GO:0046323,0.474905996420722,0.747803236078285,3,52,glucose import,BP,TNF;SLC2A6;NFE2L2
3267,GO:0006939,0.474951157278663,0.747553889112815,3,54,smooth muscle contraction,BP,EDN1;CAV1;DOCK4
13658,GO:0060149,0.475013364019612,0.871378240875593,1,14,negative regulation of posttranscriptional gene silencing,BP,ZC3H12A
14126,GO:0060967,0.475013364019612,0.871378240875593,1,14,negative regulation of gene silencing by RNA,BP,ZC3H12A
8710,GO:0034349,0.475365395713503,0.871780890980524,1,13,glial cell apoptotic process,BP,TP53
8315,GO:0033146,0.475399446018667,0.789928791048729,2,33,regulation of intracellular estrogen receptor signaling pathway,BP,RUNX1;PARP1
3478,GO:0007339,0.475538713992946,0.87052185951417,1,15,binding of sperm to zona pellucida,BP,B4GALT1
13965,GO:0060632,0.475632984098823,0.87099894784795,1,14,regulation of microtubule-based movement,BP,FEZ1
418,GO:0001105,0.476000789528484,0.789458374986801,2,33,RNA polymerase II transcription coactivator activity,MF,SOX4;CITED4
3245,GO:0006903,0.476152567083254,0.719334105617476,4,77,vesicle targeting,BP,CTSC;TGFA;PPP6R3;LMAN1
17969,GO:1902307,0.476234206505246,0.871250493955747,1,13,positive regulation of sodium ion transmembrane transport,BP,SLC9A1
6446,GO:0021756,0.476306577494992,0.871206249454109,1,13,striatum development,BP,INHBA
12795,GO:0051057,0.476420321519916,0.789129852926555,2,33,positive regulation of small GTPase mediated signal transduction,BP,CSF1;NRG1
3311,GO:0007015,0.476868797095153,0.631899393499233,14,282,actin filament organization,BP,SDC4;PHLDB2;ICAM1;SMAD3;RND3;CDC42EP4;NEDD9;AKAP2;SLC9A1;MARCKS;SPTBN5;RHOV;ABI1;JMY
12283,GO:0048569,0.477039450082352,0.87013535459683,1,14,post-embryonic animal organ development,BP,VEGFA
12194,GO:0048313,0.477145696693562,0.870069968210175,1,14,Golgi inheritance,BP,PLK3
4413,GO:0010165,0.477249723334252,0.788479569820356,2,33,response to X-ray,BP,CDKN1A;TP53
3433,GO:0007223,0.477357275877115,0.78860374117525,2,32,Wnt signaling pathway, calcium modulating pathway,BP,DKK1;WNT5A
4866,GO:0014704,0.477711414000209,0.788325901460212,2,32,intercalated disc,CC,SLC9A1;GJC1
15274,GO:0071437,0.478010590823973,0.870161684064482,1,13,invadopodium,CC,PLAUR
10067,GO:0042554,0.478028099921802,0.86898580933553,1,15,superoxide anion generation,BP,EDN1
12237,GO:0048485,0.478066904218217,0.870127071797443,1,13,sympathetic nervous system development,BP,SOX4
2715,GO:0006086,0.478114481671883,0.870097824373204,1,13,acetyl-CoA biosynthetic process from pyruvate,BP,PDP1
7679,GO:0032104,0.478254707401371,0.86938620625036,1,14,regulation of response to extracellular stimulus,BP,CYP27B1
7682,GO:0032107,0.478254707401371,0.86938620625036,1,14,regulation of response to nutrient levels,BP,CYP27B1
14671,GO:0070262,0.478465251658556,0.869256136258571,1,14,peptidyl-serine dephosphorylation,BP,PPP1R15A
16212,GO:0090231,0.47885989026698,0.86901211386789,1,14,regulation of spindle checkpoint,BP,DUSP1
12190,GO:0048306,0.479094271471927,0.786151440967715,2,38,calcium-dependent protein binding,MF,SLC9A1;STX1A
5340,GO:0016073,0.479541565429219,0.715954233512056,4,84,snRNA metabolic process,BP,POU2F2;SNAPC4;ELL2;NABP1
3565,GO:0007608,0.47975252931712,0.868459083762394,1,14,sensory perception of smell,BP,GJB4
8984,GO:0035089,0.480471885095557,0.86864337459032,1,13,establishment of apical/basal cell polarity,BP,WNT5A
7708,GO:0032183,0.480561887515198,0.868587640362036,1,13,SUMO binding,MF,PML
8219,GO:0032970,0.481044527762401,0.631761361563666,13,265,regulation of actin filament-based process,BP,SDC4;EDN1;PHLDB2;ICAM1;SMAD3;RND3;ABL2;CDC42EP4;SLC9A1;SPTBN5;CAV1;RHOV;JMY
9451,GO:0036035,0.481154522811988,0.868220271456325,1,13,osteoclast development,BP,TJP2
7949,GO:0032535,0.481218493092756,0.631594808204968,13,265,regulation of cellular component size,BP,PPP1R15A;EDN1;IL7R;ICAM1;VEGFA;CDC42EP4;CREB1;SEMA4B;WNT5A;NRG1;WNT7B;SPTBN5;JMY
12945,GO:0051289,0.481237675302249,0.741833010003408,3,58,protein homotetramerization,BP,SOD2;GPX3;TP53
4973,GO:0015079,0.481510694411509,0.742087736201245,3,53,potassium ion transmembrane transporter activity,MF,KCNJ15;SLC9A1;SLC9A8
7855,GO:0032411,0.482088105189778,0.741290725581599,3,56,positive regulation of transporter activity,BP,SGK1;SLC9A1;JPH2
7710,GO:0032185,0.482260516246582,0.867532919596222,1,13,septin cytoskeleton organization,BP,ANLN
4971,GO:0015077,0.482631666906176,0.65934265875481,8,166,monovalent inorganic cation transmembrane transporter activity,MF,SLC6A14;KCNJ15;SLC28A3;SLC11A2;SLC9A1;SLC2A6;SLC9A8;SLC41A1
17016,GO:0099094,0.482756173406859,0.784135105338286,2,33,ligand-gated cation channel activity,MF,KCNJ15;JPH2
3462,GO:0007276,0.483028189017938,0.613667116455457,18,376,gamete generation,BP,INHBA;BIRC3;FOSL1;PRDM1;EREG;BTG1;GJB3;ADAMTS1;TAF4B;MYBL1;MASTL;BCL2L2;IL4R;SMAD1;ZNF148;SPATA2;AXL;QKI
7431,GO:0031528,0.483341852542901,0.866220275100646,1,14,microvillus membrane,CC,ITGAV
12494,GO:0050432,0.483544152947269,0.86609337155851,1,14,catecholamine secretion,BP,STX1A
13517,GO:0055070,0.483562320716274,0.865046961142571,1,16,copper ion homeostasis,BP,MT2A
4693,GO:0010839,0.483948632782049,0.866479368138383,1,13,negative regulation of keratinocyte proliferation,BP,EFNB2
19308,GO:1905521,0.484041684616334,0.865227362739119,1,15,regulation of macrophage migration,BP,CSF1
6854,GO:0030318,0.484490733118872,0.866139907859542,1,13,melanocyte differentiation,BP,MREG
6940,GO:0030544,0.484775581972973,0.781964355912251,2,36,Hsp70 protein binding,MF,NOD2;CREB1
11401,GO:0045773,0.484775607695072,0.782529928172184,2,33,positive regulation of axon extension,BP,VEGFA;NRG1
3100,GO:0006677,0.485017607054088,0.865166742564512,1,14,glycosylceramide metabolic process,BP,UGCG
8700,GO:0034332,0.48509879068743,0.692483375516573,5,92,adherens junction organization,BP,SDC4;PHLDB2;SMAD3;VEGFA;SLC9A1
8267,GO:0033046,0.485357043073036,0.781500100032117,2,36,negative regulation of sister chromatid segregation,BP,DUSP1;ESPL1
13304,GO:0051985,0.485357043073036,0.781500100032117,2,36,negative regulation of chromosome segregation,BP,DUSP1;ESPL1
11732,GO:0046527,0.485617610349108,0.864788236579753,1,14,glucosyltransferase activity,MF,UGCG
20127,GO:2000773,0.485695668401277,0.864738944405884,1,14,negative regulation of cellular senescence,BP,PLK2
13610,GO:0060065,0.485945991106326,0.865225894705219,1,13,uterus development,BP,WNT5A
13561,GO:0060008,0.485969817198728,0.864565733279073,1,14,Sertoli cell differentiation,BP,ICAM1
14071,GO:0060831,0.486559600862808,0.864839302703384,1,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,GORAB
14307,GO:0061387,0.486625987746572,0.710245672679184,4,74,regulation of extent of cell growth,BP,VEGFA;SEMA4B;WNT5A;NRG1
8585,GO:0034063,0.486650182177703,0.864782173540912,1,13,stress granule assembly,BP,GRB7
2223,GO:0005123,0.486833905611937,0.864018858473764,1,14,death receptor binding,MF,CFLAR
10606,GO:0043576,0.4868479333837,0.864657398965765,1,13,regulation of respiratory gaseous exchange,BP,NR4A2
6919,GO:0030506,0.486871869542899,0.864642291006131,1,13,ankyrin binding,MF,RHCG
6307,GO:0019932,0.486897642001128,0.65541522573665,8,162,second-messenger-mediated signaling,BP,CXCL8;CCL20;EDN1;ADM;NRG1;SLC9A1;NFAT5;JPH2
10611,GO:0043586,0.487022062257708,0.863899587936882,1,14,tongue development,BP,SIX4
9018,GO:0035194,0.487788177638785,0.674674330975625,6,140,posttranscriptional gene silencing by RNA,BP,ZC3H12A;ZFP36;SMAD3;NUP153;SMAD1;ZC3H7B
10935,GO:0044550,0.487962501441891,0.863302445868425,1,14,secondary metabolite biosynthetic process,BP,WNT5A
17785,GO:1901798,0.488041775183897,0.862198357411074,1,16,positive regulation of signal transduction by p53 class mediator,BP,PMAIP1
16122,GO:0090090,0.488142090630345,0.674631205384593,6,129,negative regulation of canonical Wnt signaling pathway,BP,BMP2;CYLD;DKK1;WNT5A;CAV1;GSK3B
1594,GO:0004003,0.488748334899099,0.779353431368522,2,33,ATP-dependent DNA helicase activity,MF,CHD2;CHD4
17303,GO:0140058,0.488920807275765,0.863345023512129,1,13,neuron projection arborization,BP,WNT5A
3690,GO:0008194,0.489625639297599,0.688028009670772,5,99,UDP-glycosyltransferase activity,MF,B4GALT1;B3GNT5;PIGA;B4GALT5;UGCG
6221,GO:0019748,0.48974721941493,0.77780782976891,2,37,secondary metabolic process,BP,WNT5A;NFE2L2
4057,GO:0009100,0.489792033159075,0.615878943355069,15,311,glycoprotein metabolic process,BP,HBEGF;BMP2;PTX3;TNIP1;B4GALT1;PHLDA1;B3GNT5;DSE;CANT1;B4GALT5;ABCA7;HS3ST3B1;MUC1;PPARD;LMAN1
10364,GO:0043174,0.48988612851189,0.861014375947104,1,16,nucleoside salvage,BP,UPP1
9147,GO:0035493,0.49050543009877,0.861679356117409,1,14,SNARE complex assembly,BP,STX1A
1133,GO:0002719,0.491026102635093,0.860776331587023,1,15,negative regulation of cytokine production involved in immune response,BP,TNF
2537,GO:0005791,0.491056079186064,0.733042185413706,3,62,rough endoplasmic reticulum,CC,ZC3H12A;EDN1;SUCO
2946,GO:0006474,0.491245569108504,0.861204624057275,1,14,N-terminal protein amino acid acetylation,BP,SOX4
16171,GO:0090177,0.491285288211115,0.86183805295006,1,13,establishment of planar polarity involved in neural tube closure,BP,WNT5A
16172,GO:0090178,0.491285288211115,0.86183805295006,1,13,regulation of establishment of planar polarity involved in neural tube closure,BP,WNT5A
7713,GO:0032196,0.491539199105575,0.86101599658497,1,14,transposition,BP,MYBL1
10595,GO:0043558,0.491965200882893,0.860742040042649,1,14,regulation of translational initiation in response to stress,BP,PPP1R15A
18400,GO:1903392,0.492017184085676,0.861369426805056,1,13,negative regulation of adherens junction organization,BP,PHLDB2
10590,GO:0043550,0.492107822627128,0.776647819553447,2,33,regulation of lipid kinase activity,BP,NOD2;PDGFB
2815,GO:0006275,0.492437604606141,0.685450437633996,5,99,regulation of DNA replication,BP,CSF2;JUN;EREG;PDGFB;ESCO2
8942,GO:0034975,0.493576970793988,0.859702379371764,1,14,protein folding in endoplasmic reticulum,BP,SUCO
152,GO:0000307,0.49373811083662,0.774577528741019,2,37,cyclin-dependent protein kinase holoenzyme complex,CC,CDKN1A;CCNL1
8329,GO:0033169,0.493989663491565,0.860101359197836,1,13,histone H3-K9 demethylation,BP,KDM7A
3452,GO:0007265,0.494396630481601,0.602684001550674,18,366,Ras protein signal transduction,BP,JUN;SQSTM1;CSF1;CDKN1A;RAP2B;RND3;ARHGEF3;RAB24;FGD6;PLK2;CDC42EP4;NRG1;SPRY2;CYTH1;ITSN2;RHOV;TP53;RAB9A
7639,GO:0032042,0.494403511762588,0.859167287539811,1,14,mitochondrial DNA metabolic process,BP,PARP1
11798,GO:0046653,0.494608965570044,0.858456838407467,1,15,tetrahydrofolate metabolic process,BP,GCH1
12374,GO:0048745,0.494694075733663,0.859646696878065,1,13,smooth muscle tissue development,BP,ZFAND5
18587,GO:1903798,0.494989040250194,0.858787427484585,1,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,ZC3H12A
11415,GO:0045806,0.495505344866257,0.773311447672992,2,36,negative regulation of endocytosis,BP,CAV1;TLR2
8743,GO:0034390,0.496050722923374,0.8580969758756,1,14,smooth muscle cell apoptotic process,BP,EDN1
8744,GO:0034391,0.496050722923374,0.8580969758756,1,14,regulation of smooth muscle cell apoptotic process,BP,EDN1
11699,GO:0046475,0.496199738406265,0.857419057830037,1,15,glycerophospholipid catabolic process,BP,LDLR
5554,GO:0016556,0.496934722390509,0.85693791708083,1,15,mRNA modification,BP,WTAP
5503,GO:0016441,0.49707341071762,0.666000621837549,6,141,posttranscriptional gene silencing,BP,ZC3H12A;ZFP36;SMAD3;NUP153;SMAD1;ZC3H7B
325,GO:0000910,0.497483368331591,0.65475367972169,7,140,cytokinesis,BP,BIRC3;BIRC2;KLHL21;RND3;ANLN;PLK3;ESPL1
3359,GO:0007096,0.497506050379648,0.856563185771988,1,15,regulation of exit from mitosis,BP,ANLN
56,GO:0000118,0.498337491237506,0.727321010514792,3,55,histone deacetylase complex,CC,ZNF217;ELMSAN1;CHD4
2940,GO:0006465,0.49837333276003,0.855481641363279,1,16,signal peptide processing,BP,SPCS2
19022,GO:1904813,0.498405600729439,0.679554400146944,5,109,ficolin-1-rich granule lumen,CC,AMPD3;CANT1;MMP9;CAB39;COTL1
378,GO:0001010,0.498525783884054,0.856478879028724,1,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,PPARD
7486,GO:0031646,0.498842081142595,0.856271239474657,1,14,positive regulation of neurological system process,BP,NRG1
13130,GO:0051653,0.498970130610901,0.770857845854424,2,34,spindle localization,BP,SPRY2;ESPL1
15009,GO:0070920,0.499048914768418,0.855548056429335,1,15,regulation of production of small RNA involved in gene silencing by RNA,BP,ZC3H12A
12827,GO:0051119,0.499871864454332,0.855593868909438,1,14,sugar transmembrane transporter activity,MF,SLC2A6
4723,GO:0010882,0.499890757913469,0.854992208523657,1,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,SLC9A1
14153,GO:0061005,0.499896796904341,0.770097754769747,2,34,cell differentiation involved in kidney development,BP,LIF;PDGFB
16324,GO:0090482,0.500121547142588,0.855429321437636,1,14,vitamin transmembrane transporter activity,MF,SLC52A3
14656,GO:0070233,0.500550940688083,0.854555338020269,1,15,negative regulation of T cell apoptotic process,BP,EFNA1
9287,GO:0035722,0.50058556981387,0.76850561901515,2,40,interleukin-12-mediated signaling pathway,BP,SOD2;SERPINB2
15214,GO:0071349,0.50058556981387,0.76850561901515,2,40,cellular response to interleukin-12,BP,SOD2;SERPINB2
13641,GO:0060122,0.500591676566598,0.854528353473725,1,15,inner ear receptor cell stereocilium organization,BP,SDC4
19836,GO:2000269,0.501113906449175,0.854774127619376,1,14,regulation of fibroblast apoptotic process,BP,BTG1
2289,GO:0005245,0.501123836509727,0.854767561689748,1,14,voltage-gated calcium channel activity,MF,ITGAV
12191,GO:0048308,0.501461553147137,0.853951348456947,1,15,organelle inheritance,BP,PLK3
7487,GO:0031647,0.501742864436015,0.626782973030979,10,213,regulation of protein stability,BP,EFNA1;BMP2;CDKN1A;SAV1;SMAD3;CREB1;VHL;SOX4;TNIP2;XBP1
2456,GO:0005666,0.501766362212019,0.852774170623221,1,17,DNA-directed RNA polymerase III complex,CC,POLR3A
2495,GO:0005741,0.50182862477782,0.650438180621708,7,148,mitochondrial outer membrane,CC,PPP1R15A;PMAIP1;CYP27B1;SLC11A2;MAOA;BCL2L2;CYP24A1
7741,GO:0032232,0.502125262146512,0.85410441076258,1,14,negative regulation of actin filament bundle assembly,BP,PHLDB2
10548,GO:0043492,0.502444139915373,0.695848732423325,4,76,ATPase activity, coupled to movement of substances,MF,ABCA5;TAP1;TAPBP;ABCA7
3921,GO:0008589,0.502472552933711,0.723789589358591,3,54,regulation of smoothened signaling pathway,BP,GORAB;EVC;KCTD11
12646,GO:0050820,0.502614336401407,0.853184400795396,1,15,positive regulation of coagulation,BP,NFE2L2
776,GO:0002028,0.503134039176526,0.722997908496949,3,56,regulation of sodium ion transport,BP,NEDD4L;SLC9A1;NEDD4
15054,GO:0070988,0.503262273441488,0.722986579852211,3,55,demethylation,BP,KDM6B;OTUD4;KDM7A
6827,GO:0030282,0.50490101388307,0.721536896561801,3,55,bone mineralization,BP,BMP2;CYP27B1;SMAD3
13081,GO:0051571,0.505049842929431,0.852156469723144,1,14,positive regulation of histone H3-K4 methylation,BP,KMT2E
11390,GO:0045747,0.505612174318919,0.765180530627497,2,35,positive regulation of Notch signaling pathway,BP,ELF3;NOD2
6052,GO:0019184,0.50585891419734,0.850485347249461,1,16,nonribosomal peptide biosynthetic process,BP,NFE2L2
10233,GO:0042921,0.507182092682232,0.850725643567342,1,14,glucocorticoid receptor signaling pathway,BP,NEDD4
1597,GO:0004012,0.507333855777746,0.851324694389679,1,13,phospholipid-translocating ATPase activity,MF,ABCA7
5592,GO:0016607,0.507593806982492,0.595270935830144,16,340,nuclear speck,CC,NFKBIZ;ITPKC;IL16;GADD45A;WTAP;ZNF217;SGK1;NAMPT;CCNL1;NR4A2;PATL1;SMURF2;DUSP10;RCHY1;KMT2E;SRSF11
1379,GO:0003272,0.507826296643419,0.850291586999582,1,14,endocardial cushion formation,BP,TGFBR2
17855,GO:1902017,0.507865557777383,0.762938145136687,2,37,regulation of cilium assembly,BP,CYLD;CEP135
14945,GO:0070816,0.508218749407132,0.849418456690363,1,15,phosphorylation of RNA polymerase II C-terminal domain,BP,CCNL1
7941,GO:0032516,0.508546495247102,0.849805351541707,1,14,positive regulation of phosphoprotein phosphatase activity,BP,PPP1R15A
15834,GO:0072523,0.509393010381777,0.761491434198444,2,38,purine-containing compound catabolic process,BP,AMPD3;EGLN1
11913,GO:0046931,0.50968704493055,0.848421524370403,1,15,pore complex assembly,BP,NUP153
18173,GO:1902905,0.509865457946631,0.642855771545121,7,145,positive regulation of supramolecular fiber organization,BP,SDC4;EDN1;NAV3;ICAM1;SMAD3;CDC42EP4;JMY
15237,GO:0071379,0.509868962039608,0.848909815637326,1,14,cellular response to prostaglandin stimulus,BP,TNC
10719,GO:0044030,0.509948850997648,0.848855605657037,1,14,regulation of DNA methylation,BP,PARP1
7368,GO:0031406,0.510591045381967,0.668310176448359,5,106,carboxylic acid binding,MF,STARD5;LAYN;YARS2;PPARD;EGLN1
7659,GO:0032075,0.510657656040387,0.847224102922381,1,16,positive regulation of nuclease activity,BP,PTPN1
7810,GO:0032355,0.510667701091982,0.687944042911197,4,82,response to estradiol,BP,ETS1;DUSP1;CFLAR;SOCS2
1386,GO:0003283,0.51104437269325,0.848110937160952,1,14,atrial septum development,BP,SOX4
8692,GO:0034311,0.511279562736971,0.846324892539282,1,17,diol metabolic process,BP,GCH1
5533,GO:0016505,0.512336516934665,0.846072279230164,1,16,peptidase activator activity involved in apoptotic process,MF,CTSC
5823,GO:0017085,0.512524563730546,0.846482726823325,1,15,response to insecticide,BP,ZC3H12A
12884,GO:0051194,0.512986029386755,0.846785224113247,1,14,positive regulation of cofactor metabolic process,BP,NFE2L2
4706,GO:0010863,0.513409990998378,0.845874434920845,1,15,positive regulation of phospholipase C activity,BP,ABL2
8681,GO:0034260,0.513413007606604,0.758460036310584,2,36,negative regulation of GTPase activity,BP,CPEB2;SPRY2
10570,GO:0043525,0.513738125588406,0.757834167896169,2,38,positive regulation of neuron apoptotic process,BP,JUN;TP53
9228,GO:0035613,0.514207502906424,0.845325191446039,1,15,RNA stem-loop binding,MF,ZC3H12A
9859,GO:0042104,0.515623837022147,0.843319575213617,1,17,positive regulation of activated T cell proliferation,BP,IL23A
12634,GO:0050805,0.51574199008232,0.75649031073081,2,36,negative regulation of synaptic transmission,BP,IL1B;PLK2
134,GO:0000280,0.51578885504812,0.59043410100336,15,319,nuclear division,BP,IL1B;IL1A;BIRC3;LIF;EDN1;EREG;DUSP1;BIRC2;MYBL1;MASTL;WNT5A;TGFA;PDGFB;ANLN;ESPL1
478,GO:0001522,0.515859244309685,0.842728484532803,1,18,pseudouridine synthesis,BP,PUS10
687,GO:0001894,0.515883913751647,0.648715712709182,6,123,tissue homeostasis,BP,TNFAIP3;CSF1;IL6;ADAM8;NOD2;VEGFA
8139,GO:0032835,0.516101661805976,0.756377668050698,2,35,glomerulus development,BP,CFLAR;PDGFB
3748,GO:0008286,0.516300472163809,0.663138855880639,5,101,insulin receptor signaling pathway,BP,IL1B;SOGA1;SOCS2;PTPN1;RELA
3718,GO:0008237,0.516308738943152,0.663219287945411,5,99,metallopeptidase activity,MF,ADAM8;ADAMTS1;MMP9;ADAM9;MMP10
2347,GO:0005385,0.516827154544818,0.843512016266904,1,15,zinc ion transmembrane transporter activity,MF,SLC39A14
15360,GO:0071577,0.516827154544818,0.843512016266904,1,15,zinc ion transmembrane transport,BP,SLC39A14
5414,GO:0016254,0.516987313570132,0.842368469164659,1,17,preassembly of GPI anchor in ER membrane,BP,PIGA
6335,GO:0020037,0.517148763298477,0.710187157636297,3,59,heme binding,MF,CYP27B1;BACH1;CYP24A1
9411,GO:0035967,0.517707136943424,0.635301654118679,7,146,cellular response to topologically incorrect protein,BP,CXCL8;PPP1R15A;ATF3;NFE2L2;PTPN1;XBP1;HSPA4L
12395,GO:0048799,0.517743372620199,0.84350499848048,1,14,animal organ maturation,BP,BMP2
7088,GO:0030878,0.517761654233896,0.842861846833955,1,15,thyroid gland development,BP,SMAD3
7190,GO:0031072,0.517916911761497,0.661567584515656,5,102,heat shock protein binding,MF,NFKBIA;ZFP36;NOD2;CREB1;HSPA4L
13928,GO:0060571,0.518048537175987,0.842661895076308,1,15,morphogenesis of an epithelial fold,BP,WNT5A
10835,GO:0044325,0.518254878956698,0.681030309438584,4,80,ion channel binding,MF,PANX1;NEDD4L;CAV1;STX1A
11036,GO:0044877,0.518370894428699,0.556943834929362,31,667,protein-containing complex binding,MF,IL1B;ZC3H12A;PANX1;C1QTNF1;CDKN1A;ITGA5;CPEB2;ICAM1;SMAD3;ABL2;ANXA8;WISP1;PDGFB;IFIH1;NRG1;MMP9;LDLR;TNKS1BP1;MARCKS;PTPN1;CHD4;TLR2;ABI1;ITGAV;PIM1;ADAM9;CCBE1;HLA-E;JMY;VIM;DDR1
9916,GO:0042249,0.518445707702449,0.843016857424731,1,14,establishment of planar polarity of embryonic epithelium,BP,WNT5A
4589,GO:0010676,0.518533977382048,0.754310764371436,2,35,positive regulation of cellular carbohydrate metabolic process,BP,PMAIP1;PHKG2
4660,GO:0010801,0.518542021924414,0.842317554585646,1,15,negative regulation of peptidyl-threonine phosphorylation,BP,SPRY2
7297,GO:0031290,0.518688362709187,0.842847973179322,1,14,retinal ganglion cell axon guidance,BP,VEGFA
15999,GO:0080182,0.519386541787749,0.841173357573378,1,16,histone H3-K4 trimethylation,BP,KMT2E
4160,GO:0009220,0.519391820105488,0.840249207771071,1,18,pyrimidine ribonucleotide biosynthetic process,BP,UPP1
11587,GO:0046132,0.519391820105488,0.840249207771071,1,18,pyrimidine ribonucleoside biosynthetic process,BP,UPP1
17723,GO:1901618,0.519461689679347,0.841674512586815,1,15,organic hydroxy compound transmembrane transporter activity,MF,SLC16A1
18380,GO:1903358,0.519730157027084,0.841486472249449,1,15,regulation of Golgi organization,BP,PDE4DIP
473,GO:0001516,0.519929750544823,0.840303051888131,1,17,prostaglandin biosynthetic process,BP,EDN1
11684,GO:0046457,0.519929750544823,0.840303051888131,1,17,prostanoid biosynthetic process,BP,EDN1
650,GO:0001838,0.520019130692614,0.659707107186171,5,99,embryonic epithelial tube formation,BP,SDC4;SIX4;ADM;WNT5A;SOX4
10205,GO:0042809,0.520302168062998,0.841085332911282,1,15,vitamin D receptor binding,MF,MED13
1100,GO:0002686,0.52069969379757,0.83975967774851,1,17,negative regulation of leukocyte migration,BP,GCSAM
17438,GO:1900181,0.520865387081384,0.840689706322489,1,15,negative regulation of protein localization to nucleus,BP,GSK3B
3301,GO:0006999,0.520901531045296,0.840664295278104,1,15,nuclear pore organization,BP,NUP153
4304,GO:0009749,0.521970696904745,0.642790372032346,6,126,response to glucose,BP,PIM3;ICAM1;TGFBR2;SOX4;PPARD;XBP1
15203,GO:0071333,0.522146810323499,0.677165271426001,4,84,cellular response to glucose stimulus,BP,PIM3;ICAM1;SOX4;XBP1
17572,GO:1901136,0.522876706670418,0.641828299784279,6,129,carbohydrate derivative catabolic process,BP,SDC4;AMPD3;UPP1;PGLYRP4;SLC9A1;EGLN1
822,GO:0002092,0.522880198069885,0.839269109376621,1,15,positive regulation of receptor internalization,BP,VEGFA
753,GO:0001990,0.522981864032004,0.838636079583248,1,16,regulation of systemic arterial blood pressure by hormone,BP,EDN1
4587,GO:0010669,0.524450810105965,0.838155925094774,1,15,epithelial structure maintenance,BP,NOD2
11787,GO:0046636,0.525125068438508,0.83767647989252,1,15,negative regulation of alpha-beta T cell activation,BP,IL4R
7888,GO:0032451,0.525316847207601,0.748495321074163,2,35,demethylase activity,MF,KDM6B;KDM7A
13738,GO:0060292,0.525368130277154,0.837503415706095,1,15,long term synaptic depression,BP,PLK2
2907,GO:0006417,0.525793078971849,0.574202582961766,17,388,regulation of translation,BP,TNF;BTG2;ZC3H12A;PPP1R15A;ZFP36;BCL3;IL6;ZFP36L1;CPEB2;SMAD3;SOX4;GRB7;NUP153;SMAD1;ZC3H7B;VIM;QKI
5801,GO:0017046,0.526236903183499,0.836883836440736,1,15,peptide hormone binding,MF,INHBA
12610,GO:0050773,0.52661230489491,0.653474301943442,5,98,regulation of dendrite development,BP,EFNA1;NEDD4L;PLK2;NRG1;NEDD4
15294,GO:0071466,0.526631867789158,0.653033378258301,5,108,cellular response to xenobiotic stimulus,BP,ICAM1;CFLAR;ERRFI1;PDGFB;STAT5A
13588,GO:0060041,0.52669876913145,0.673314073279687,4,77,retina development in camera-type eye,BP,FJX1;DLX2;TGIF2;CLIC4
3252,GO:0006913,0.526809781210433,0.58306873006963,14,303,nucleocytoplasmic transport,BP,IL1B;NFKBIA;TNF;ZC3H12A;BCL3;CDKN1A;DUSP16;SOX4;NUP153;NEDD4;TP53;PML;GSK3B;SRSF11
4399,GO:0010092,0.526972372136747,0.835788762627567,1,16,specification of animal organ identity,BP,DKK1
20080,GO:2000679,0.52725370526616,0.83558678117816,1,16,positive regulation of transcription regulatory region DNA binding,BP,PARP1
2204,GO:0005086,0.52729299723269,0.836128562141562,1,15,ARF guanyl-nucleotide exchange factor activity,MF,CYTH1
4229,GO:0009404,0.52739697466448,0.834981714918473,1,17,toxin metabolic process,BP,NFE2L2
6291,GO:0019897,0.527486479872576,0.652546630543474,5,100,extrinsic component of plasma membrane,CC,CYLD;ABL2;ERRFI1;CYTH1;FRK
7067,GO:0030850,0.527653115551307,0.746276808125805,2,36,prostate gland development,BP,WNT5A;TNC
9926,GO:0042269,0.527995587920243,0.835053362244974,1,16,regulation of natural killer cell mediated cytotoxicity,BP,HLA-E
8969,GO:0035036,0.52822771823551,0.833935660819107,1,18,sperm-egg recognition,BP,B4GALT1
16022,GO:0086019,0.528266613083763,0.835430223033299,1,15,cell-cell signaling involved in cardiac conduction,BP,GJC1
4485,GO:0010499,0.528312670500702,0.832497032992074,1,22,proteasomal ubiquitin-independent protein catabolic process,BP,NFE2L2
6072,GO:0019217,0.528336573276987,0.700087039656615,3,58,regulation of fatty acid metabolic process,BP,CAV1;PDP1;NR4A3
37,GO:0000076,0.528428527604474,0.83474154649632,1,16,DNA replication checkpoint,BP,RAD9B
8916,GO:0034754,0.528626887910354,0.699370987356867,3,63,cellular hormone metabolic process,BP,BMP2;ADM;SDR16C5
13827,GO:0060402,0.529207867832888,0.670756097951026,4,80,calcium ion transport into cytosol,BP,BDKRB1;CAV1;JPH2;PML
10982,GO:0044770,0.529234299075788,0.557413729132508,23,511,cell cycle phase transition,BP,BTG2;INHBA;DUSP1;GADD45A;ZFP36L1;CDKN1A;DCUN1D3;PHLDA1;CDKN2B;PLK2;BACH1;MASTL;SOX4;ANLN;PLK3;TNKS1BP1;TPRA1;TP53;PML;ESPL1;MUC1;KMT2E;CEP135
5061,GO:0015267,0.529815433974105,0.614135295916902,8,164,channel activity,MF,PANX1;KCNJ15;GJB3;TRPV3;CLIC4;ITGAV;JPH2;GJC1
6611,GO:0022803,0.529815433974105,0.614135295916902,8,164,passive transmembrane transporter activity,MF,PANX1;KCNJ15;GJB3;TRPV3;CLIC4;ITGAV;JPH2;GJC1
15915,GO:0072673,0.529948169348074,0.834219459983842,1,15,lamellipodium morphogenesis,BP,ABI1
5934,GO:0018208,0.530541970998978,0.742773453148392,2,42,peptidyl-proline modification,BP,PPIF;EGLN1
6544,GO:0021952,0.531579353559646,0.833039327131222,1,15,central nervous system projection neuron axonogenesis,BP,NR4A2
15199,GO:0071326,0.531777128481425,0.668034378893539,4,85,cellular response to monosaccharide stimulus,BP,PIM3;ICAM1;SOX4;XBP1
15201,GO:0071331,0.531777128481425,0.668034378893539,4,85,cellular response to hexose stimulus,BP,PIM3;ICAM1;SOX4;XBP1
14015,GO:0060716,0.531820211280927,0.832285218697656,1,16,labyrinthine layer blood vessel development,BP,JUNB
6292,GO:0019898,0.532111834672303,0.603928936313023,9,187,extrinsic component of membrane,CC,PLEKHF1;ZC3H12A;PLAUR;CYLD;ABL2;ERRFI1;CYTH1;PML;FRK
19300,GO:1905475,0.532248536874308,0.632827076913083,6,127,regulation of protein localization to membrane,BP,PMAIP1;EPHA2;SQSTM1;BBC3;TP53BP2;TP53
7842,GO:0032392,0.532361653690276,0.667709035136422,4,81,DNA geometric change,BP,CHD2;CHD4;TP53;PARP1
7076,GO:0030859,0.532528096322848,0.832350366042609,1,15,polarized epithelial cell differentiation,BP,WNT5A
16688,GO:0097602,0.532566301295818,0.831230088939846,1,17,cullin family protein binding,MF,DCUN1D3
7432,GO:0031529,0.532772537563248,0.741446628619865,2,38,ruffle organization,BP,ICAM1;CAV1
3497,GO:0007398,0.532922656693861,0.83206328677397,1,15,ectoderm development,BP,ETS2
11210,GO:0045332,0.533225256294028,0.832509902782297,1,14,phospholipid translocation,BP,ABCA7
4963,GO:0015035,0.533344444609414,0.829433254613631,1,20,protein disulfide oxidoreductase activity,MF,TXNRD1
7133,GO:0030952,0.533421100014551,0.831117445842856,1,16,establishment or maintenance of cytoskeleton polarity,BP,RND3
11204,GO:0045309,0.533977420066942,0.740757875908709,2,36,protein phosphorylated amino acid binding,MF,ABL2;NEDD4
9444,GO:0036019,0.534424608719287,0.830382682168678,1,16,endolysosome,CC,LDLR
5573,GO:0016581,0.534441052714855,0.830955458393236,1,15,NuRD complex,CC,CHD4
16342,GO:0090545,0.534441052714855,0.830955458393236,1,15,CHD-type complex,CC,CHD4
14237,GO:0061162,0.534469039618098,0.830934993444737,1,15,establishment of monopolar cell polarity,BP,WNT5A
14284,GO:0061339,0.534469039618098,0.830934993444737,1,15,establishment or maintenance of monopolar cell polarity,BP,WNT5A
5567,GO:0016575,0.534474906490304,0.665762237631632,4,80,histone deacetylation,BP,VEGFA;CHD4;TP53;SDR16C5
12400,GO:0048814,0.534579750305663,0.694422174086507,3,57,regulation of dendrite morphogenesis,BP,EFNA1;NEDD4L;NEDD4
407,GO:0001091,0.534610114071343,0.830246623450601,1,16,RNA polymerase II basal transcription factor binding,MF,TP53
7488,GO:0031648,0.535881060965189,0.73871294403336,2,38,protein destabilization,BP,BMP2;XBP1
13053,GO:0051496,0.535923173164232,0.738855934400144,2,37,positive regulation of stress fiber assembly,BP,SDC4;SMAD3
8669,GO:0034237,0.536476532490868,0.829462733467343,1,15,protein kinase A regulatory subunit binding,MF,PJA2
3507,GO:0007416,0.536737647591139,0.663868638404013,4,76,synapse assembly,BP,SIX4;WNT5A;NRG1;TLR2
2726,GO:0006103,0.53708178829191,0.828426828290581,1,16,2-oxoglutarate metabolic process,BP,STAT5A
19088,GO:1904949,0.537230887164795,0.663073841867228,4,81,ATPase complex,CC,BAZ1A;SLC9A1;CHD4;ABCA7
16742,GO:0097734,0.537637118738555,0.827495314630392,1,17,extracellular exosome biogenesis,BP,SDC4
19497,GO:1990182,0.537637118738555,0.827495314630392,1,17,exosomal secretion,BP,SDC4
11859,GO:0046831,0.537718009762067,0.828547985699575,1,15,regulation of RNA export from nucleus,BP,NUP153
16916,GO:0098858,0.537831420733048,0.627514458873076,6,123,actin-based cell projection,CC,B4GALT1;CLIC4;ABI1;ITGAV;DOCK4;RAPH1
7412,GO:0031490,0.538491207217391,0.661282580151157,4,92,chromatin DNA binding,MF,KDM6B;SMAD3;CHD4;RELA
4303,GO:0009746,0.538625207561465,0.626578621521756,6,128,response to hexose,BP,PIM3;ICAM1;TGFBR2;SOX4;PPARD;XBP1
9055,GO:0035272,0.539059805740341,0.735900613224234,2,38,exocrine system development,BP,TNF;XBP1
9837,GO:0042059,0.539263396203732,0.735547943170259,2,39,negative regulation of epidermal growth factor receptor signaling pathway,BP,ERRFI1;SPRY2
17555,GO:1901071,0.539268322334137,0.826806155069051,1,16,glucosamine-containing compound metabolic process,BP,CHST2
17942,GO:1902254,0.539470416060829,0.825666455521225,1,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,MUC1
12864,GO:0051169,0.540332858952838,0.569575249798194,14,306,nuclear transport,BP,IL1B;NFKBIA;TNF;ZC3H12A;BCL3;CDKN1A;DUSP16;SOX4;NUP153;NEDD4;TP53;PML;GSK3B;SRSF11
3731,GO:0008266,0.540488353064788,0.825897427200654,1,16,poly(U) RNA binding,MF,PATL1
13756,GO:0060314,0.540901689573542,0.82506195315264,1,17,regulation of ryanodine-sensitive calcium-release channel activity,BP,JPH2
9699,GO:0038093,0.540919773064452,0.612450650061021,7,155,Fc receptor signaling pathway,BP,NFKBIA;NFKB1;JUN;TAB3;ABI1;RELA;NR4A3
10495,GO:0043392,0.541012458193107,0.733828097296098,2,40,negative regulation of DNA binding,BP,NFKBIA;JUN
4694,GO:0010842,0.541245610240649,0.825930868465173,1,15,retina layer formation,BP,FJX1
16282,GO:0090330,0.54166487063296,0.825018091500987,1,16,regulation of platelet aggregation,BP,C1QTNF1
6513,GO:0021884,0.541880367758587,0.824856706015097,1,16,forebrain neuron development,BP,WNT5A
15861,GO:0072562,0.541957893162194,0.732984467991127,2,40,blood microparticle,CC,ANXA5;CFB
14555,GO:0070062,0.542836013804568,0.504695036707043,87,2042,extracellular exosome,CC,IL1B;TNFAIP3;PLAU;EFNA1;SDC4;BTG2;PLAUR;SOD2;IL1RN;EHD1;SQSTM1;CSF1;IRF6;EFNB1;STEAP4;RAP2B;NEDD4L;CTSC;GPX3;IL6ST;RELT;ICAM1;RASSF9;B4GALT1;RND3;MARCKSL1;KRT34;SERPINB8;SLC6A14;TXNRD1;CD55;NAMPT;TMEM106A;ANXA8L1;CD47;CANT1;SOGA1;SAA1;TINAGL1;ITGB8;WNT5A;ROBO4;SERPINB1;CD82;MMP9;COL12A1;CAB39;CHD2;PARD6B;SLC9A1;B4GALT5;BCL2L2;NEDD4;RHCG;ITSN2;MARCKS;BTN2A2;WNT7B;TAB3;SPTBN5;CLIC4;UACA;ABI1;RAB9A;ITGAV;UBE2D3;CD276;TRIP10;TMEM132A;ADAM9;PLAT;MUC1;AXL;ANXA5;CRB3;FRK;HLA-E;SLC16A1;LAMA3;COTL1;COL8A1;VIM;CREB5;DDR1;MGAM;LMAN1;CFB
3451,GO:0007264,0.54297772487386,0.545626523001972,22,457,small GTPase mediated signal transduction,BP,JUN;SQSTM1;CSF1;CDKN1A;RAP2B;RND3;ARHGEF3;RAB24;FGD6;PLK2;CDC42EP4;NRG1;RRAD;RASGEF1B;SPRY2;CYTH1;ITSN2;RHOV;TP53;RAB9A;DOCK4;TRIP10
5019,GO:0015179,0.543032205599888,0.732361970195457,2,38,L-amino acid transmembrane transporter activity,MF,SLC7A2;SLC38A2
14519,GO:0065003,0.543306181092149,0.511545492292745,62,1423,protein-containing complex assembly,BP,TNFAIP3;CSF2;TNF;BIRC3;NOCT;FOSL1;ZC3H12A;SOD2;PMAIP1;JUN;EHD1;TRAF1;SQSTM1;PLAGL2;BIRC2;PANX1;CYLD;C1QTNF1;CLDN1;ZNF451;NAV3;CTSC;GPX3;NOD2;ICAM1;GCH1;SMAD3;B4GALT1;VEGFA;DKK1;CDC42EP4;CREB1;TAF4B;PATL1;PDE4DIP;TGFA;ANLN;NRG1;CAB39;TLE1;PARD6B;SLC9A1;H1FX;GRB7;NUP153;MARCKS;SMAD1;SPTBN5;CAV1;TP53;TAPBP;IKBKE;STX1A;ABCA7;PML;PPP6R3;GSK3B;PARP1;OCLN;JMY;KCTD11;LMAN1
18596,GO:1903825,0.543449725713114,0.657172504024003,4,80,organic acid transmembrane transport,BP,SLC6A14;SLC7A2;SLC38A2;SLC16A1
19128,GO:1905039,0.543449725713114,0.657172504024003,4,80,carboxylic acid transmembrane transport,BP,SLC6A14;SLC7A2;SLC38A2;SLC16A1
1486,GO:0003785,0.544060795196179,0.82221276582199,1,18,actin monomer binding,MF,ABL2
10534,GO:0043470,0.544716816162856,0.684742285422798,3,59,regulation of carbohydrate catabolic process,BP,PHKG2;PPP1R3B;NUP153
732,GO:0001958,0.544752483973201,0.822696239013313,1,16,endochondral ossification,BP,NAB1
9469,GO:0036075,0.544752483973201,0.822696239013313,1,16,replacement ossification,BP,NAB1
10681,GO:0043923,0.544843089622929,0.822627793917266,1,16,positive regulation by host of viral transcription,BP,JUN
12607,GO:0050770,0.545319837019813,0.620234137558247,6,121,regulation of axonogenesis,BP,EFNA1;VEGFA;ZSWIM4;SEMA4B;WNT5A;NRG1
5998,GO:0018995,0.545374145373694,0.683934238846272,3,61,host,CC,NUP153;AXL;LMAN1
10650,GO:0043657,0.545374145373694,0.683934238846272,3,61,host cell,CC,NUP153;AXL;LMAN1
10773,GO:0044215,0.545374145373694,0.683934238846272,3,61,other organism,CC,NUP153;AXL;LMAN1
10774,GO:0044216,0.545374145373694,0.683934238846272,3,61,other organism cell,CC,NUP153;AXL;LMAN1
10775,GO:0044217,0.545374145373694,0.683934238846272,3,61,other organism part,CC,NUP153;AXL;LMAN1
12591,GO:0050732,0.546401388167483,0.729164776534063,2,39,negative regulation of peptidyl-tyrosine phosphorylation,BP,ERRFI1;CAV1
11105,GO:0045109,0.546510332649792,0.821365156179591,1,16,intermediate filament organization,BP,VIM
15449,GO:0071711,0.546732898811484,0.821806799866967,1,15,basement membrane organization,BP,PHLDB2
1485,GO:0003779,0.547093541758273,0.562927075003754,14,291,actin binding,MF,PANX1;KLHL21;NOD2;MARCKSL1;ABL2;ANXA8;KLHL5;ANLN;GCSAM;MARCKS;SPTBN5;COTL1;JMY;EPB41L3
17988,GO:1902369,0.547559657756651,0.728295971880496,2,38,negative regulation of RNA catabolic process,BP,NOCT;ZFP36
15118,GO:0071157,0.547958474994381,0.819244485513078,1,18,negative regulation of cell cycle arrest,BP,EVI2B
69,GO:0000145,0.547984473791907,0.820243731978171,1,16,exocyst,CC,TNFAIP2
5468,GO:0016358,0.549191900281176,0.594995287740614,8,163,dendrite development,BP,EFNA1;NEDD4L;PLK2;KLF7;SLC11A2;NRG1;NEDD4;ABI1
15671,GO:0072175,0.549377460087739,0.631232359163717,5,102,epithelial tube formation,BP,SDC4;SIX4;ADM;WNT5A;SOX4
4562,GO:0010640,0.549628461282412,0.818987515397476,1,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFB
12873,GO:0051180,0.550049352612706,0.818121076806466,1,17,vitamin transport,BP,SLC52A3
18383,GO:1903363,0.550186487514157,0.679113193078315,3,64,negative regulation of cellular protein catabolic process,BP,EFNA1;N4BP1;PML
12292,GO:0048596,0.55031978134563,0.819075755036871,1,15,embryonic camera-type eye morphogenesis,BP,WNT5A
15053,GO:0070987,0.550435089912115,0.817341208256661,1,18,error-free translesion synthesis,BP,RCHY1
1307,GO:0003148,0.550558503734673,0.818274227500146,1,16,outflow tract septum morphogenesis,BP,TGFBR2
6350,GO:0021522,0.550862604023951,0.818040589315118,1,16,spinal cord motor neuron differentiation,BP,SOX4
6514,GO:0021885,0.5511358779153,0.725245734541467,2,37,forebrain cell migration,BP,NRG1;AXL
501,GO:0001556,0.551646668866822,0.816890401497461,1,17,oocyte maturation,BP,EREG
16878,GO:0098796,0.55172379568494,0.522262544350928,32,731,membrane protein complex,CC,BMP2;PPIF;BIRC2;IL6;ADAM8;FZD8;ITGA5;IL6ST;CFLAR;PIGA;TAP1;GJB3;GJB4;TGFBR2;ITGB8;SLC9A1;CLIC4;CAV1;HLA-A;NECAP2;TLR2;TAPBP;HLA-B;ITGAV;STX1A;ABCA7;SPCS2;HLA-F;HLA-E;OSMR;EVC;GJC1
12596,GO:0050750,0.551732786389758,0.816823891745559,1,17,low-density lipoprotein particle receptor binding,MF,DKK1
2931,GO:0006448,0.551781453778651,0.816786298036147,1,17,regulation of translational elongation,BP,CPEB2
7387,GO:0031435,0.552441571064226,0.816824215249349,1,16,mitogen-activated protein kinase kinase kinase binding,MF,TGFBR2
14810,GO:0070527,0.552849824739281,0.723154799868893,2,40,platelet aggregation,BP,C1QTNF1;RAP2B
7409,GO:0031468,0.552913072326399,0.815423403089284,1,18,nuclear envelope reassembly,BP,ANKLE2
17437,GO:1900180,0.552954768645965,0.647721396429879,4,84,regulation of protein localization to nucleus,BP,ZC3H12A;LIF;CDKN1A;GSK3B
16111,GO:0090079,0.553159800037292,0.815719411400957,1,17,translation regulator activity, nucleic acid binding,MF,CPEB2
13095,GO:0051590,0.553276461151789,0.815628919421533,1,17,positive regulation of neurotransmitter transport,BP,STX1A
8924,GO:0034764,0.553584725203558,0.627002665421313,5,104,positive regulation of transmembrane transport,BP,BDKRB1;SLC9A1;NFE2L2;JPH2;NR4A3
4862,GO:0014072,0.553919418875365,0.815129648891349,1,17,response to isoquinoline alkaloid,BP,RELA
10436,GO:0043278,0.553919418875365,0.815129648891349,1,17,response to morphine,BP,RELA
7817,GO:0032366,0.553988891193858,0.815075647430109,1,17,intracellular sterol transport,BP,LDLR
7818,GO:0032367,0.553988891193858,0.815075647430109,1,17,intracellular cholesterol transport,BP,LDLR
7838,GO:0032387,0.554470282402087,0.721362050857953,2,42,negative regulation of intracellular transport,BP,SOX4;NUP153
15443,GO:0071702,0.554540652232401,0.49293135423192,87,1938,organic substance transport,BP,IL1B;NFKBIA;CSF2;TNF;IL1A;INHBA;ZC3H12A;IL1RN;NFKB1;EDN1;ZFP36;RAB3IP;EHD1;HCAR2;STARD5;NFKBIE;BCL3;PLAGL2;IL6;ADAM8;PIM3;PANX1;ZFP36L1;RIPK2;C1QTNF1;CDKN1A;ABCA5;NOD2;RASSF9;RAB24;IL1R2;SLC6A14;TAP1;SLC28A3;SLC7A2;TGFBR2;DUSP16;SAA1;WNT5A;VEGFC;SLC52A3;SOX4;IFIH1;NRG1;SLC38A2;LDLR;RHD;PLK3;ARRDC4;SYS1;NUP153;IL4R;NEDD4;RHCG;SLC2A6;POU2F2;MARCKS;BTN2A2;NFE2L2;PTPN1;CAV1;NECAP2;UGCG;TP53;TLR2;TAPBP;RAB9A;ITGAV;UBE2D3;STX1A;MAPKBP1;ABCA7;SPCS2;PML;ADAM9;TRIM16;SLC16A13;NR4A3;HLA-E;GSK3B;PPARD;SLC16A1;TBC1D22B;SRSF11;XBP1;QKI;IL36RN
4790,GO:0010976,0.554833963828232,0.581309076015166,9,187,positive regulation of neuron projection development,BP,NEDD4L;VEGFA;ABL2;CFLAR;WNT5A;NRG1;FEZ1;ITSN2;NFE2L2
7594,GO:0031958,0.55517490883479,0.814705570869149,1,16,corticosteroid receptor signaling pathway,BP,NEDD4
2442,GO:0005640,0.555996865861366,0.813510209684252,1,17,nuclear outer membrane,CC,NAV3
6920,GO:0030507,0.556102306786314,0.813982976439686,1,16,spectrin binding,MF,SPTBN5
19844,GO:2000278,0.556876058156718,0.643887279878738,4,84,regulation of DNA biosynthetic process,BP,DUSP1;CDKN1A;PDGFB;TP53
16869,GO:0098780,0.55697143868548,0.812747194964406,1,17,response to mitochondrial depolarisation,BP,SQSTM1
14157,GO:0061013,0.557426145789364,0.595921684644755,7,160,regulation of mRNA catabolic process,BP,BTG2;NOCT;ZC3H12A;ZFP36;ZFP36L1;VIM;QKI
17720,GO:1901615,0.557839969618961,0.548350415977565,15,328,organic hydroxy compound metabolic process,BP,IL1B;TNF;ITPKC;BMP2;NFKB1;CYP27B1;GCH1;NR4A2;HMGCS1;WNT5A;LDLR;MAOA;SDR16C5;PPARD;CYP24A1
8658,GO:0034204,0.558093006047515,0.813060293487775,1,15,lipid translocation,BP,ABCA7
2276,GO:0005217,0.558492090154331,0.81211213062338,1,16,intracellular ligand-gated ion channel activity,MF,JPH2
5067,GO:0015278,0.558492090154331,0.81211213062338,1,16,calcium-release channel activity,MF,JPH2
8571,GO:0034035,0.558586146308046,0.81098160804187,1,18,purine ribonucleoside bisphosphate metabolic process,BP,TPST1
12491,GO:0050427,0.558586146308046,0.81098160804187,1,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,TPST1
8323,GO:0033158,0.55861698456957,0.811454055197794,1,17,regulation of protein import into nucleus, translocation,BP,CDKN1A
15729,GO:0072273,0.558894874230109,0.811235080607748,1,17,metanephric nephron morphogenesis,BP,LIF
7040,GO:0030809,0.559162496738847,0.81102403307062,1,17,negative regulation of nucleotide biosynthetic process,BP,PARP1
17490,GO:1900372,0.559162496738847,0.81102403307062,1,17,negative regulation of purine nucleotide biosynthetic process,BP,PARP1
11356,GO:0045671,0.559513746072737,0.81130843681554,1,16,negative regulation of osteoclast differentiation,BP,TJP2
9000,GO:0035116,0.559669430585467,0.810623824451547,1,17,embryonic hindlimb morphogenesis,BP,TBX3
19467,GO:1990089,0.559875122016116,0.716876310877093,2,39,response to nerve growth factor,BP,EHD1;CREB1
19468,GO:1990090,0.559875122016116,0.716876310877093,2,39,cellular response to nerve growth factor stimulus,BP,EHD1;CREB1
4607,GO:0010719,0.560221312770292,0.809688005475078,1,18,negative regulation of epithelial to mesenchymal transition,BP,EFNA1
17571,GO:1901135,0.560396054604203,0.506194512031246,40,912,carbohydrate derivative metabolic process,BP,IL1B;HBEGF;SDC4;BMP2;PLAUR;PTX3;NFKB1;PPIF;TNIP1;EPHA2;AMPD3;TJP2;B4GALT1;PHLDA1;B3GNT5;VEGFA;PIGA;UPP1;ADM;DSE;CANT1;ITGB8;WNT5A;PDGFB;PGLYRP4;SLC9A1;B4GALT5;ARSJ;NUP153;TPST1;UGCG;ABCA7;HS3ST3B1;PIM1;CHST2;MUC1;PPARD;PARP1;EGLN1;LMAN1
7744,GO:0032239,0.56114472696934,0.810020565763947,1,16,regulation of nucleobase-containing compound transport,BP,NUP153
5848,GO:0017134,0.561226813976981,0.808889557980525,1,18,fibroblast growth factor binding,MF,ITGAV
10356,GO:0043162,0.561303705813366,0.808828406115063,1,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,NEDD4
17291,GO:0140014,0.561325976492188,0.56200835673373,11,240,mitotic nuclear division,BP,IL1B;IL1A;BIRC3;EDN1;EREG;DUSP1;BIRC2;TGFA;PDGFB;ANLN;ESPL1
4622,GO:0010737,0.561608345028381,0.808585996430083,1,18,protein kinase A signaling,BP,PJA2
17480,GO:1900274,0.561850176067014,0.808895613006408,1,17,regulation of phospholipase C activity,BP,ABL2
2192,GO:0005048,0.56199114596307,0.714917613513109,2,39,signal sequence binding,MF,NFKBIA;NUP153
10206,GO:0042813,0.562198231556995,0.809185509363635,1,16,Wnt-activated receptor activity,MF,FZD8
5632,GO:0016706,0.562223333549056,0.714702208496958,2,39,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,KDM7A;EGLN1
17708,GO:1901575,0.562258634460393,0.488987971037232,72,1627,organic substance catabolic process,BP,IL1B;TNFAIP3;TNF;EFNA1;SDC4;BTG2;NOCT;ZC3H12A;RNF19B;PMAIP1;ZFP36;PNRC1;HCAR2;SQSTM1;AMPD3;BIRC2;ADAM8;N4BP1;ZFP36L1;CYP27B1;CYLD;ODC1;NEDD4L;CTSC;SMAD3;RNF144B;TRIB1;PLK2;RNF43;UPP1;DENND3;USP43;PATL1;PHKG2;ABTB2;SMURF2;TINAGL1;PNRC2;TRIM25;WNT5A;PPP1R3B;PGLYRP4;NRG1;LDLR;PLK3;SLC9A1;MAOA;RCHY1;TNKS1BP1;HAL;NUP153;NEDD4;NFE2L2;PTPN1;PAOX;CAV1;TP53;UBE2D3;PML;ADAM9;RELA;SAT1;USP31;GSK3B;PPARD;CYP24A1;VIM;EGLN1;RNF145;XBP1;QKI;MGAM
10970,GO:0044728,0.562335246999919,0.667713931839528,3,61,DNA methylation or demethylation,BP,OTUD4;KMT2E;PARP1
3243,GO:0006900,0.562493769124152,0.638245911500435,4,86,vesicle budding from membrane,BP,CTSC;TGFA;PPP6R3;LMAN1
18271,GO:1903078,0.56250476986505,0.714440986847151,2,39,positive regulation of protein localization to plasma membrane,BP,EPHA2;SQSTM1
4158,GO:0009218,0.562822955521046,0.806763000698076,1,20,pyrimidine ribonucleotide metabolic process,BP,UPP1
6531,GO:0021915,0.562976018255774,0.602570868675354,6,124,neural tube development,BP,SDC4;ZFP36L1;ADM;GORAB;WNT5A;SOX4
3327,GO:0007035,0.563045863539434,0.806988944313638,1,19,vacuolar acidification,BP,CLIC4
3076,GO:0006643,0.563541440835724,0.580252333461844,8,179,membrane lipid metabolic process,BP,TNF;PLAUR;B3GNT5;PIGA;ITGB8;ARSJ;SGMS2;UGCG
6313,GO:0019953,0.563735901799628,0.528625046753831,20,439,sexual reproduction,BP,INHBA;BIRC3;FOSL1;PRDM1;EREG;B4GALT1;BTG1;GJB3;ADAMTS1;TAF4B;MYBL1;MASTL;BCL2L2;IL4R;SMAD1;CLIC4;ZNF148;SPATA2;AXL;QKI
4058,GO:0009101,0.564273595311832,0.55395513274321,12,259,glycoprotein biosynthetic process,BP,HBEGF;TNIP1;B4GALT1;PHLDA1;B3GNT5;DSE;CANT1;B4GALT5;ABCA7;HS3ST3B1;MUC1;LMAN1
3199,GO:0006829,0.564569520503243,0.806725543944232,1,17,zinc ion transport,BP,SLC39A14
11762,GO:0046599,0.565026731338395,0.806359039510516,1,17,regulation of centriole replication,BP,PLK2
2492,GO:0005737,0.565958026818325,0.471419255614522,378,8364,cytoplasm,CC,NFKBIZ;IL1B;NFKBIA;TNFAIP3;TNF;IRF1;HBEGF;NUAK2;PLAU;CXCL1;IL1A;ITPKC;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;FOSL1;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;LIF;PLAUR;SOD2;PRDM1;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;RAB3IP;EPHA2;EHD1;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;N4BP3;SPRR2D;SERTAD2;STARD5;NFKBIE;BBC3;KLF6;IRF6;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;NFKB2;ADAM8;BDKRB1;PIM3;PANX1;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;KLHL21;PHLDA2;DAPP1;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;TJP2;RELB;ZNF217;STEAP4;AMOTL2;CDKN1A;CLDN1;NMNAT2;CCDC85B;ITGA5;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ODC1;TNFAIP2;NEDD4L;CTSC;NOD2;DCUN1D3;RELT;SAV1;SGK1;GCH1;FRMD4B;TRIM47;RASSF9;SMAD3;B4GALT1;NFKBIB;ARNTL2;C15ORF39;PHLDA1;B3GNT5;RNF144B;RND3;MARCKSL1;TRAF4;TRIB1;KRT34;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;IL1R2;DKK1;CDKN2B;PLK2;MAP3K8;ABL2;PPTC7;C3ORF52;CDV3;CFLAR;RNF43;TXNRD1;LACC1;PIGA;BTG1;ANXA8;UPP1;IER5;PPP4R4;CEBPB;VMP1;CD55;DENND3;NAMPT;TAP1;TP53BP2;ANKLE2;ADM;GJB3;CDC42EP4;SLC28A3;IFNAR1;DSE;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;WISP1;NEDD9;MAST4;NR4A2;PATL1;CD47;CANT1;VHL;PHKG2;BACH1;ABTB2;PDE4DIP;RUNX1;TGFBR2;MREG;SMURF2;DUSP16;DDX3Y;SAA1;GPBP1;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;MASTL;KIF3C;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;NOTCH2NL;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;ANLN;NBPF8;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;BTG3;COL12A1;FAM83B;CAB39;IL32;TLE1;PLK3;ARRDC4;RASGEF1B;PARD6B;MT2A;SUCO;SLC9A1;SLC25A37;SYS1;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;B4GALT5;HAL;CYTH1;GRB7;ARSJ;NUP153;BCL2L2;RNF152;NEDD4;MMD;RHCG;POU2F2;ITSN2;DUS4L;GCSAM;MARCKS;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;CLIC4;NFAT5;STAT5A;TPST1;CAV1;RHOV;RTTN;HLA-A;UACA;DRAM1;TNIP2;NECAP2;UGCG;ZFAND5;GOLGA8B;TP53;TLR2;ABI1;STK40;TAPBP;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;UBE2D3;PJA2;STX1A;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;SPRR2A;ABCA7;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;RELA;RAPH1;TRIM16;MAMDC2;ESCO2;SPATA2;SLC9A8;PPP6R3;LRRC49;COL27A1;PLAT;CHST2;MUC1;YARS2;AXL;SLC16A13;ANXA5;THSD1;SAT1;FRK;HLA-F;CITED4;NR4A3;LIMS3;HLA-E;GSK3B;KMT2E;SLC16A1;EVC;PARP1;CYP24A1;LAMA3;LCE1C;OCLN;COTL1;JMY;COL8A1;VIM;EGLN1;NABP1;RIPK4;ALAS1;RPS6KA6;DDR1;CEP135;XBP1;HSPA4L;QKI;EPB41L3;KCTD11;SLC39A14;TFE3;EID3;ZMIZ2;MGAM;LMAN1;GJC1;DENND4A
1129,GO:0002715,0.566460879683685,0.804696388071575,1,18,regulation of natural killer cell mediated immunity,BP,HLA-E
8244,GO:0033013,0.566633533318888,0.709949374218487,2,43,tetrapyrrole metabolic process,BP,SLC11A2;ALAS1
5674,GO:0016780,0.567144592651727,0.804144046555241,1,18,phosphotransferase activity, for other substituted phosphate groups,MF,SGMS2
16616,GO:0097435,0.567144760622286,0.521085910808318,22,470,supramolecular fiber organization,BP,SDC4;EDN1;SIX4;PHLDB2;NAV3;ICAM1;SMAD3;RND3;CFLAR;CDC42EP4;NEDD9;AKAP2;LDLR;COL12A1;PLK3;SLC9A1;MARCKS;SPTBN5;RHOV;ABI1;JMY;VIM
5053,GO:0015238,0.567170112565499,0.662919923955595,3,62,drug transmembrane transporter activity,MF,SLC7A2;SLC52A3;SLC38A2
8687,GO:0034284,0.567280031124704,0.597986222553222,6,132,response to monosaccharide,BP,PIM3;ICAM1;TGFBR2;SOX4;PPARD;XBP1
13713,GO:0060251,0.568090216939114,0.80389104450248,1,17,regulation of glial cell proliferation,BP,CREB1
6595,GO:0022604,0.568718621816827,0.534121265825918,16,337,regulation of cell morphogenesis,BP,EFNA1;BAMBI;NEDD4L;ICAM1;RND3;VEGFA;FGD6;ZSWIM4;CDC42EP4;SEMA4B;WNT5A;NRG1;NEDD4;ITSN2;RHOV;EPB41L3
7188,GO:0031069,0.569036694697945,0.803124210467161,1,17,hair follicle morphogenesis,BP,GORAB
10854,GO:0044346,0.569224830615485,0.802971538495298,1,17,fibroblast apoptotic process,BP,BTG1
17573,GO:1901137,0.569681422183041,0.513197522458345,25,556,carbohydrate derivative biosynthetic process,BP,IL1B;HBEGF;SDC4;PLAUR;NFKB1;TNIP1;AMPD3;B4GALT1;PHLDA1;B3GNT5;PIGA;UPP1;ADM;DSE;CANT1;PDGFB;B4GALT5;NUP153;UGCG;ABCA7;HS3ST3B1;CHST2;MUC1;PARP1;LMAN1
13584,GO:0060037,0.569739679901201,0.802553323738018,1,17,pharyngeal system development,BP,SIX4
15911,GO:0072666,0.570542513943605,0.70674661337041,2,40,establishment of protein localization to vacuole,BP,TNFAIP3;NEDD4
19960,GO:2000463,0.570648047018386,0.801813966448425,1,17,positive regulation of excitatory postsynaptic potential,BP,STX1A
4111,GO:0009164,0.570707134070601,0.800371817529475,1,20,nucleoside catabolic process,BP,UPP1
12425,GO:0048863,0.570887540313677,0.572430207829243,8,201,stem cell differentiation,BP,LIF;EDN1;EFNB1;SEMA4B;RUNX1;NRG1;CHD2;NFE2L2
12434,GO:0048873,0.571166709155872,0.800873071562467,1,18,homeostasis of number of cells within a tissue,BP,CSF1
16676,GO:0097542,0.571421375946909,0.705750899308811,2,41,ciliary tip,CC,CYLD;KIF3C
7669,GO:0032094,0.572916343217867,0.79943855568796,1,18,response to food,BP,SLC16A1
7375,GO:0031418,0.57301995807717,0.79935338017014,1,18,L-ascorbic acid binding,MF,EGLN1
20106,GO:2000737,0.573079088043284,0.799825881569361,1,17,negative regulation of stem cell differentiation,BP,NFE2L2
6347,GO:0021517,0.573110315018299,0.799800255507919,1,17,ventral spinal cord development,BP,SOX4
2274,GO:0005215,0.573508947024183,0.501282231913849,31,682,transporter activity,MF,STARD5;PANX1;ABCA5;RASSF9;SLC6A14;KCNJ15;TAP1;GJB3;SLC28A3;NIPAL4;SLC7A2;SLC11A2;SLC52A3;SLC38A2;RHD;TRPV3;SLC9A1;SLC25A37;RHCG;SLC2A6;CLIC4;TAPBP;ITGAV;JPH2;ABCA7;SLC9A8;SLC16A13;SLC16A1;SLC39A14;SLC41A1;GJC1
6625,GO:0022843,0.573764978135872,0.70387403634485,2,39,voltage-gated cation channel activity,MF,KCNJ15;ITGAV
10544,GO:0043488,0.573899159939098,0.591033110148853,6,141,regulation of mRNA stability,BP,NOCT;ZC3H12A;ZFP36;ZFP36L1;VIM;QKI
15530,GO:0071897,0.574570845393405,0.56905881978716,8,178,DNA biosynthetic process,BP,DUSP1;CDKN1A;USP43;TRIM25;PDGFB;RCHY1;TNKS1BP1;TP53
10077,GO:0042572,0.57460102984636,0.798050585172228,1,18,retinol metabolic process,BP,SDR16C5
6345,GO:0021515,0.574848355973869,0.798370384002302,1,17,cell differentiation in spinal cord,BP,SOX4
14708,GO:0070325,0.575672192852839,0.797164647595304,1,18,lipoprotein particle receptor binding,MF,DKK1
14692,GO:0070300,0.575914815117476,0.79696360787391,1,18,phosphatidic acid binding,MF,JPH2
5565,GO:0016573,0.576026786923879,0.589149832181712,6,131,histone acetylation,BP,IL1B;LIF;ZNF451;SDR16C5;TRIM16;MUC1
65,GO:0000132,0.576628474346033,0.796371464149096,1,18,establishment of mitotic spindle orientation,BP,SPRY2
5542,GO:0016525,0.57678279442442,0.65356148952152,3,61,negative regulation of angiogenesis,BP,PLK2;SPRY2;PML
11511,GO:0045987,0.577068723631112,0.796005582521501,1,18,positive regulation of smooth muscle contraction,BP,EDN1
3763,GO:0008306,0.577171144438374,0.700455761314914,2,40,associative learning,BP,BTG2;CREB1
2207,GO:0005089,0.578669660026577,0.651993198224225,3,58,Rho guanyl-nucleotide exchange factor activity,MF,ARHGEF3;FGD6;ITSN2
11509,GO:0045981,0.579194537302304,0.698190236143827,2,42,positive regulation of nucleotide metabolic process,BP,ADM;WNT5A
17515,GO:1900544,0.579194537302304,0.698190236143827,2,42,positive regulation of purine nucleotide metabolic process,BP,ADM;WNT5A
8209,GO:0032958,0.579508418857709,0.7945018093241,1,17,inositol phosphate biosynthetic process,BP,ITPKC
5608,GO:0016645,0.58023722743994,0.79288259473309,1,19,oxidoreductase activity, acting on the CH-NH group of donors,MF,PAOX
18720,GO:1904064,0.580751120587841,0.649258536397259,3,65,positive regulation of cation transmembrane transport,BP,BDKRB1;SLC9A1;JPH2
7449,GO:0031579,0.581570569479656,0.791759733593166,1,19,membrane raft organization,BP,CAV1
10328,GO:0043114,0.581659645573636,0.792698742299453,1,17,regulation of vascular permeability,BP,ADM
10594,GO:0043555,0.581903074379247,0.791957890854063,1,18,regulation of translation in response to stress,BP,PPP1R15A
11373,GO:0045724,0.581915415183568,0.791947487576637,1,18,positive regulation of cilium assembly,BP,CEP135
11626,GO:0046320,0.582356654361676,0.792112191863098,1,17,regulation of fatty acid oxidation,BP,NR4A3
10251,GO:0042982,0.58268587812708,0.694829662407498,2,42,amyloid precursor protein metabolic process,BP,EFNA1;ABCA7
11899,GO:0046906,0.582863145711358,0.64714941982653,3,65,tetrapyrrole binding,MF,CYP27B1;BACH1;CYP24A1
4026,GO:0009056,0.582891767159403,0.463921223524306,88,1987,catabolic process,BP,IL1B;TNFAIP3;TNF;EFNA1;SDC4;BTG2;PLEKHF1;NOCT;ZC3H12A;RNF19B;PMAIP1;ZFP36;PNRC1;TICAM1;HCAR2;SQSTM1;AMPD3;BIRC2;ADAM8;N4BP1;ZFP36L1;CYP27B1;RIPK2;CYLD;ODC1;NEDD4L;CTSC;GPX3;SMAD3;RNF144B;TRIB1;RAB24;PLK2;ABL2;RNF43;UPP1;VMP1;DENND3;USP43;PATL1;PHKG2;SOGA1;ABTB2;SMURF2;TINAGL1;PNRC2;TRIM25;WNT5A;PPP1R3B;PGLYRP4;NRG1;MMP9;LDLR;COL12A1;PLK3;SLC9A1;MAOA;RCHY1;FEZ1;TNKS1BP1;HAL;NUP153;RNF152;NEDD4;NFE2L2;PTPN1;TAB3;PAOX;CAV1;DRAM1;TP53;UBE2D3;PML;ADAM9;RELA;SAT1;USP31;GSK3B;PPARD;CYP24A1;MMP10;COL8A1;VIM;EGLN1;RNF145;XBP1;QKI;MGAM
10292,GO:0043034,0.583017693297458,0.791554846409389,1,17,costamere,CC,SDC4
13859,GO:0060445,0.583358260753997,0.791267296769921,1,17,branching involved in salivary gland morphogenesis,BP,TNF
15448,GO:0071709,0.583496827724693,0.790611367856329,1,18,membrane assembly,BP,CAV1
5650,GO:0016740,0.583811777591412,0.46323443630439,87,1894,transferase activity,MF,TNFAIP3;CSF2;HBEGF;NUAK2;ITPKC;BIRC3;RNF19B;PRDM1;MAP2K3;EPHA2;SQSTM1;EREG;PELI1;BIRC2;PIM3;RIPK2;IRAK2;KLHL21;TJP2;CDKN1A;NMNAT2;ZNF451;NEDD4L;SGK1;B4GALT1;B3GNT5;RNF144B;FGF5;PLK2;MAP3K8;ABL2;RNF43;PIGA;UPP1;NAMPT;ANKK1;MAST4;VHL;PHKG2;BACH1;TGFBR2;SMURF2;KLHL5;TRIM25;MASTL;HMGCS1;CAMK1G;PDGFB;NRG1;KIAA1586;CAB39;PLK3;RCHY1;B4GALT5;RNF152;NEDD4;MMD;KBTBD7;SGMS2;STAT5A;TPST1;SH3RF2;UGCG;STK40;IKBKE;UBE2D3;PJA2;CLK4;UBE2Z;HS3ST3B1;POLR3A;PIM1;ESCO2;CHST2;AXL;SAT1;FRK;GSK3B;KMT2E;PARP8;PARP1;RIPK4;RNF145;ALAS1;RPS6KA6;DDR1;KCTD11
6749,GO:0030165,0.584400430952108,0.645972565950766,3,61,PDZ domain binding,MF,DAPP1;FZD8;DOCK4
8116,GO:0032799,0.584851476125629,0.788978782231824,1,19,low-density lipoprotein receptor particle metabolic process,BP,ITGAV
14675,GO:0070268,0.58506278767121,0.644410009394479,3,72,cornification,BP,SPRR2D;KRT34;SPRR2A
3293,GO:0006986,0.585077233783715,0.567878023951256,7,157,response to unfolded protein,BP,CXCL8;PPP1R15A;ATF3;NFE2L2;PTPN1;XBP1;HSPA4L
10782,GO:0044232,0.5861345181563,0.78836955396852,1,18,organelle membrane contact site,CC,PLEKHF1
16065,GO:0086091,0.58661833588205,0.788500743170769,1,17,regulation of heart rate by cardiac conduction,BP,CAV1
13924,GO:0060561,0.586658833362235,0.787921947677549,1,18,apoptotic process involved in morphogenesis,BP,B4GALT1
2378,GO:0005506,0.586773180617684,0.613711490956574,4,89,iron ion binding,MF,CYP27B1;CYP24A1;KDM7A;EGLN1
2288,GO:0005244,0.586884407145064,0.643290845148886,3,63,voltage-gated ion channel activity,MF,KCNJ15;CLIC4;ITGAV
6616,GO:0022832,0.586884407145064,0.643290845148886,3,63,voltage-gated channel activity,MF,KCNJ15;CLIC4;ITGAV
13108,GO:0051606,0.586935151792677,0.593024855460034,5,114,detection of stimulus,BP,NOD2;SOX4;PGLYRP4;TLR2;PARP1
7609,GO:0031985,0.587443819555863,0.613193353139565,4,86,Golgi cisterna,CC,B4GALT1;CANT1;B4GALT5;GOLGA8B
14499,GO:0061912,0.587568454026103,0.690255771679207,2,41,selective autophagy,BP,SQSTM1;RIPK2
892,GO:0002260,0.587722971275208,0.689786351857246,2,43,lymphocyte homeostasis,BP,TNFAIP3;PMAIP1
7849,GO:0032402,0.587866590510082,0.786400445168778,1,19,melanosome transport,BP,MREG
13254,GO:0051904,0.587866590510082,0.786400445168778,1,19,pigment granule transport,BP,MREG
18704,GO:1904037,0.587923645659964,0.786839464821756,1,18,positive regulation of epithelial cell apoptotic process,BP,IL6
6784,GO:0030215,0.588196530602668,0.787152320054403,1,17,semaphorin receptor binding,MF,SEMA4B
12635,GO:0050806,0.588247208050473,0.61243105682279,4,85,positive regulation of synaptic transmission,BP,SQSTM1;PLK2;CREB1;STX1A
9896,GO:0042175,0.588893592074403,0.480416279882941,36,812,nuclear outer membrane-endoplasmic reticulum membrane network,CC,ZC3H12A;PPP1R15A;RNF19B;PLAUR;IFNGR2;PANX1;NAV3;SGK1;C3ORF52;RNF43;PIGA;TAP1;ANKLE2;SLC28A3;CANT1;TGFA;SUCO;SLC9A1;PTPN1;SGMS2;CAV1;HLA-A;TAPBP;RAB9A;HLA-B;PJA2;JPH2;SPCS2;TMEM132A;SDR16C5;PML;HLA-F;HLA-E;XBP1;LMAN1;GJC1
16290,GO:0090344,0.589056306268988,0.785377061060442,1,19,negative regulation of cell aging,BP,PLK2
9079,GO:0035327,0.589387370069586,0.784651170137451,1,20,transcriptionally active chromatin,CC,KMT2E
4483,GO:0010494,0.589434621817691,0.688606447674402,2,40,cytoplasmic stress granule,CC,ZFP36;GRB7
15986,GO:0080111,0.589464290399411,0.785025329656659,1,19,DNA demethylation,BP,OTUD4
10503,GO:0043401,0.589684397726002,0.563263647910439,7,151,steroid hormone mediated signaling pathway,BP,NR4A2;RUNX1;NEDD4;NR4A3;PPARD;PARP1;MED13
2485,GO:0005721,0.589788734460684,0.785236209051666,1,18,pericentric heterochromatin,CC,ESCO2
2298,GO:0005261,0.589803507131668,0.590434811229301,5,105,cation channel activity,MF,PANX1;KCNJ15;TRPV3;ITGAV;JPH2
12967,GO:0051321,0.58996526624048,0.562899131066397,7,154,meiotic cell cycle,BP,LIF;EREG;DUSP1;MYBL1;MASTL;WNT5A;ESPL1
9949,GO:0042306,0.59024566867757,0.687476357848106,2,42,regulation of protein import into nucleus,BP,ZC3H12A;CDKN1A
11477,GO:0045923,0.590344690705824,0.784756675527702,1,18,positive regulation of fatty acid metabolic process,BP,NR4A3
5066,GO:0015276,0.590768700625689,0.68730071346028,2,40,ligand-gated ion channel activity,MF,KCNJ15;JPH2
6617,GO:0022834,0.590768700625689,0.68730071346028,2,40,ligand-gated channel activity,MF,KCNJ15;JPH2
16199,GO:0090207,0.59077373333286,0.78389371149621,1,19,regulation of triglyceride metabolic process,BP,LDLR
9740,GO:0038191,0.59143400531466,0.784367400193964,1,17,neuropilin binding,MF,SEMA4B
2714,GO:0006085,0.592212535463934,0.78314009886462,1,18,acetyl-CoA biosynthetic process,BP,PDP1
9313,GO:0035767,0.592714872923212,0.782208524199451,1,19,endothelial cell chemotaxis,BP,VEGFA
10159,GO:0042734,0.593080032023625,0.685213299673946,2,39,presynaptic membrane,CC,FOSL1;STX1A
2275,GO:0005216,0.593231628333015,0.55961042027631,7,150,ion channel activity,MF,PANX1;KCNJ15;TRPV3;CLIC4;ITGAV;JPH2;GJC1
5764,GO:0016922,0.594084612562115,0.781511338757429,1,18,ligand-dependent nuclear receptor binding,MF,JUND
19206,GO:1905268,0.594146097010962,0.68398025846401,2,40,negative regulation of chromatin organization,BP,ZNF451;SDR16C5
3319,GO:0007026,0.594178965945029,0.781429022097239,1,18,negative regulation of microtubule depolymerization,BP,NAV3
6528,GO:0021904,0.594577604153898,0.781080997974984,1,18,dorsal/ventral neural tube patterning,BP,GORAB
3607,GO:0008047,0.594664661614053,0.501647493107118,18,393,enzyme activator activity,MF,CXCL1;PPP1R15A;BMP2;JUN;CDKN1A;CTSC;CFLAR;CDC42EP4;ERRFI1;PDGFB;NRG1;CAB39;SPRY2;CAV1;ABI1;DOCK4;TRIP10;TBC1D22B
20201,GO:2001022,0.595594676495165,0.634122899427016,3,67,positive regulation of response to DNA damage stimulus,BP,PMAIP1;PARP1;EID3
5056,GO:0015248,0.595858274566603,0.779010675179639,1,20,sterol transporter activity,MF,STARD5
8851,GO:0034643,0.595919954541745,0.779405924044757,1,19,establishment of mitochondrion localization, microtubule-mediated,BP,FEZ1
12018,GO:0047497,0.595919954541745,0.779405924044757,1,19,mitochondrion transport along microtubule,BP,FEZ1
10819,GO:0044304,0.5959203683687,0.682227353805169,2,40,main axon,CC,NRG1;EPB41L3
1128,GO:0002714,0.596559749120327,0.778843455059517,1,19,positive regulation of B cell mediated immunity,BP,TNF
1224,GO:0002891,0.596559749120327,0.778843455059517,1,19,positive regulation of immunoglobulin mediated immune response,BP,TNF
13234,GO:0051881,0.596885798738505,0.680081657660496,2,48,regulation of mitochondrial membrane potential,BP,PMAIP1;PARP1
10910,GO:0044452,0.597259073961848,0.55511326323475,7,163,nucleolar part,CC,NFKBIE;KLF6;TXNRD1;TMEM217;TAF4B;SPATA2;RPS6KA6
17740,GO:1901655,0.59730370679306,0.632544874554634,3,65,cellular response to ketone,BP,ICAM1;CFLAR;ERRFI1
14849,GO:0070584,0.597571772678028,0.777091759745403,1,21,mitochondrion morphogenesis,BP,FEZ1
5969,GO:0018393,0.598101015613061,0.566310253559869,6,134,internal peptidyl-lysine acetylation,BP,IL1B;LIF;ZNF451;SDR16C5;TRIM16;MUC1
288,GO:0000792,0.598362998313553,0.631375521854746,3,66,heterochromatin,CC,TNKS1BP1;PML;ESCO2
4401,GO:0010107,0.598420388962725,0.777706104492722,1,18,potassium ion import,BP,KCNJ15
13052,GO:0051495,0.598736292739454,0.553682330325761,7,158,positive regulation of cytoskeleton organization,BP,SDC4;EDN1;NAV3;ICAM1;SMAD3;CDC42EP4;JMY
7325,GO:0031330,0.598811346296784,0.543971435360219,8,180,negative regulation of cellular catabolic process,BP,EFNA1;NOCT;ZFP36;N4BP1;FEZ1;TAB3;PML;EGLN1
16870,GO:0098781,0.599099015646845,0.600780521753104,4,94,ncRNA transcription,BP,POU2F2;SNAPC4;ELL2;NABP1
2812,GO:0006271,0.599184443739966,0.77607139231345,1,20,DNA strand elongation involved in DNA replication,BP,PARP1
15445,GO:0071705,0.59983710328374,0.449777839200452,75,1707,nitrogen compound transport,BP,IL1B;NFKBIA;CSF2;TNF;IL1A;ZC3H12A;IL1RN;EDN1;ZFP36;RAB3IP;EHD1;HCAR2;NFKBIE;BCL3;PLAGL2;IL6;ADAM8;PIM3;PANX1;ZFP36L1;RIPK2;CDKN1A;NOD2;RASSF9;RAB24;IL1R2;SLC6A14;TAP1;SLC28A3;SLC7A2;TGFBR2;DUSP16;SAA1;WNT5A;VEGFC;SLC52A3;SOX4;IFIH1;NRG1;SLC38A2;RHD;PLK3;ARRDC4;SYS1;NUP153;IL4R;NEDD4;RHCG;POU2F2;MARCKS;BTN2A2;PTPN1;NECAP2;UGCG;TP53;TLR2;TAPBP;RAB9A;ITGAV;UBE2D3;STX1A;MAPKBP1;SPCS2;PML;ADAM9;TRIM16;HLA-E;GSK3B;PPARD;SLC16A1;TBC1D22B;SRSF11;XBP1;QKI;IL36RN
17094,GO:0099604,0.60033706952832,0.776009165125536,1,18,ligand-gated calcium channel activity,MF,JPH2
19796,GO:2000181,0.600363267730244,0.629588360266701,3,63,negative regulation of blood vessel morphogenesis,BP,PLK2;SPRY2;PML
8359,GO:0033233,0.60039137201757,0.774998075548556,1,20,regulation of protein sumoylation,BP,RELA
11531,GO:0046037,0.600959733160619,0.774947857953796,1,19,GMP metabolic process,BP,TJP2
1844,GO:0004497,0.601117481009992,0.67655549553172,2,43,monooxygenase activity,MF,CYP27B1;CYP24A1
6776,GO:0030206,0.601304320150112,0.77514934186005,1,18,chondroitin sulfate biosynthetic process,BP,DSE
202,GO:0000423,0.603232929545372,0.772916385553852,1,19,mitophagy,BP,SQSTM1
13271,GO:0051937,0.603608924699842,0.772118973415006,1,20,catecholamine transport,BP,STX1A
7025,GO:0030742,0.603757381315387,0.771985507397707,1,20,GTP-dependent protein binding,MF,GCH1
1115,GO:0002701,0.603775819558924,0.77196892711594,1,20,negative regulation of production of molecular mediator of immune response,BP,TNF
3226,GO:0006879,0.604169194162409,0.673055362103496,2,46,cellular iron ion homeostasis,BP,SLC11A2;EGLN1
17941,GO:1902253,0.60433024890704,0.770330350076648,1,23,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,MUC1
13623,GO:0060079,0.605138978173552,0.672677856844664,2,42,excitatory postsynaptic potential,BP,STX1A;GSK3B
17838,GO:1901981,0.605586062317523,0.573854766515493,5,109,phosphatidylinositol phosphate binding,MF,PLEKHF1;DAPP1;ANXA8;SLC9A1;JPH2
556,GO:0001678,0.605692118060903,0.594013525869031,4,92,cellular glucose homeostasis,BP,PIM3;ICAM1;SOX4;XBP1
99,GO:0000209,0.606261371937575,0.510400408266074,12,276,protein polyubiquitination,BP,TNFAIP3;RNF19B;PELI1;BIRC2;NEDD4L;NOD2;RNF144B;SMURF2;RNF152;NEDD4;UBE2D3;RNF145
5005,GO:0015144,0.606485331715472,0.769987291081174,1,19,carbohydrate transmembrane transporter activity,MF,SLC2A6
4439,GO:0010288,0.606970134636208,0.769083572544028,1,20,response to lead ion,BP,CLDN1
5661,GO:0016757,0.607453403240329,0.52684672457158,9,206,transferase activity, transferring glycosyl groups,MF,B4GALT1;B3GNT5;PIGA;UPP1;NAMPT;B4GALT5;UGCG;PARP8;PARP1
20042,GO:2000637,0.607539087430663,0.769032559858264,1,19,positive regulation of gene silencing by miRNA,BP,ZFP36
7905,GO:0032469,0.607666189374518,0.768451420525222,1,20,endoplasmic reticulum calcium ion homeostasis,BP,PML
7171,GO:0031047,0.60806706179282,0.555322618355994,6,155,gene silencing by RNA,BP,ZC3H12A;ZFP36;SMAD3;NUP153;SMAD1;ZC3H7B
17552,GO:1901068,0.608248306721984,0.668931869666039,2,46,guanosine-containing compound metabolic process,BP,AMPD3;TJP2
12364,GO:0048730,0.608390219565875,0.768259356106987,1,19,epidermis morphogenesis,BP,GORAB
2535,GO:0005789,0.608872459480758,0.460673140612798,35,797,endoplasmic reticulum membrane,CC,ZC3H12A;PPP1R15A;RNF19B;PLAUR;IFNGR2;PANX1;SGK1;C3ORF52;RNF43;PIGA;TAP1;ANKLE2;SLC28A3;CANT1;TGFA;SUCO;SLC9A1;PTPN1;SGMS2;CAV1;HLA-A;TAPBP;RAB9A;HLA-B;PJA2;JPH2;SPCS2;TMEM132A;SDR16C5;PML;HLA-F;HLA-E;XBP1;LMAN1;GJC1
7848,GO:0032401,0.609879571243908,0.766433062566512,1,20,establishment of melanosome localization,BP,MREG
13255,GO:0051905,0.609879571243908,0.766433062566512,1,20,establishment of pigment granule localization,BP,MREG
2641,GO:0005975,0.610190437738047,0.480630322532238,20,449,carbohydrate metabolic process,BP,TNF;PMAIP1;NFKB1;PHLDA2;C1QTNF1;IL6ST;B4GALT1;B3GNT5;PHKG2;SOGA1;PPP1R3B;PDGFB;ATF3;B4GALT5;NUP153;STK40;CHST2;GSK3B;PPARD;MGAM
4652,GO:0010771,0.610831964810576,0.618656509003528,3,64,negative regulation of cell morphogenesis involved in differentiation,BP,EFNA1;SEMA4B;WNT5A
3321,GO:0007029,0.610959925641786,0.666616936107622,2,43,endoplasmic reticulum organization,BP,VMP1;LMAN1
12895,GO:0051219,0.611413881734035,0.618048789355975,3,64,phosphoprotein binding,MF,ABL2;NEDD4;PLAT
6620,GO:0022838,0.611534510354494,0.540346391336472,7,153,substrate-specific channel activity,MF,PANX1;KCNJ15;TRPV3;CLIC4;ITGAV;JPH2;GJC1
264,GO:0000731,0.611607643753419,0.617504136851701,3,68,DNA synthesis involved in DNA repair,BP,USP43;TRIM25;RCHY1
2248,GO:0005158,0.612081505090864,0.765409985357976,1,18,insulin receptor binding,MF,PTPN1
6903,GO:0030433,0.612342171915097,0.616735706951089,3,68,ubiquitin-dependent ERAD pathway,BP,TRIM25;NFE2L2;CAV1
7742,GO:0032233,0.612376765596183,0.665170917957248,2,43,positive regulation of actin filament bundle assembly,BP,SDC4;SMAD3
653,GO:0001841,0.61378278497726,0.585778070573102,4,87,neural tube formation,BP,SDC4;ADM;WNT5A;SOX4
2391,GO:0005525,0.614394546817814,0.501816305407263,12,278,GTP binding,MF,EHD1;GBP2;RAP2B;ARL5B;GCH1;IRGQ;RND3;RAB24;RRAD;RHOV;RAB9A;GEM
6726,GO:0030133,0.614428079904723,0.506877207218249,11,253,transport vesicle,CC,EDN1;RASSF9;CD55;TGFA;HLA-A;RAB9A;HLA-B;STX1A;HLA-F;HLA-E;LMAN1
20305,GO:2001251,0.614893251839362,0.563950808420526,5,111,negative regulation of chromosome organization,BP,DUSP1;ZNF451;SDR16C5;ESPL1;PARP1
6961,GO:0030594,0.614906790446915,0.761372355335489,1,21,neurotransmitter receptor activity,MF,GPR156
17810,GO:1901880,0.615747339644733,0.66187907403843,2,42,negative regulation of protein depolymerization,BP,NAV3;SPTBN5
5634,GO:0016709,0.616260160630224,0.760544435474732,1,20,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,CYP27B1
13131,GO:0051654,0.616318998637649,0.760489644912731,1,20,establishment of mitochondrion localization,BP,FEZ1
253,GO:0000717,0.617082226445691,0.758952775633231,1,22,nucleotide-excision repair, DNA duplex unwinding,BP,PARP1
6698,GO:0030071,0.617450222368402,0.659511962295513,2,46,regulation of mitotic metaphase/anaphase transition,BP,DUSP1;ESPL1
17880,GO:1902099,0.617450222368402,0.659511962295513,2,46,regulation of metaphase/anaphase transition of cell cycle,BP,DUSP1;ESPL1
10437,GO:0043279,0.617458899165649,0.61144093165906,3,67,response to alkaloid,BP,ICAM1;TP53;RELA
15981,GO:0080025,0.617949273988601,0.758967934387064,1,20,phosphatidylinositol-3,5-bisphosphate binding,MF,JPH2
19857,GO:2000300,0.618939029816316,0.758522231457132,1,19,regulation of synaptic vesicle exocytosis,BP,STX1A
6058,GO:0019201,0.619130130889554,0.757861385726619,1,20,nucleotide kinase activity,MF,TJP2
18172,GO:1902904,0.619234446807259,0.579827195749108,4,90,negative regulation of supramolecular fiber organization,BP,PHLDB2;NAV3;LDLR;SPTBN5
17760,GO:1901681,0.619668127271368,0.543382319910327,6,140,sulfur compound binding,MF,HBEGF;VEGFA;ADAMTS1;WISP1;SAA1;ADGRE2
79,GO:0000159,0.619915639202901,0.75712328667456,1,20,protein phosphatase type 2A complex,CC,IER5
6881,GO:0030371,0.620037135793913,0.757008978551302,1,20,translation repressor activity,MF,CPEB2
3885,GO:0008514,0.620327016920781,0.542850815467493,6,134,organic anion transmembrane transporter activity,MF,SLC6A14;SLC7A2;SLC52A3;SLC38A2;SLC16A13;SLC16A1
3563,GO:0007605,0.620932163377325,0.60760450686163,3,69,sensory perception of sound,BP,ICAM1;SLC52A3;SPRY2
11268,GO:0045505,0.620980756678603,0.755682332124425,1,21,dynein intermediate chain binding,MF,SPTBN5
6013,GO:0019054,0.621019334270249,0.75608346941602,1,20,modulation by virus of host process,BP,ZC3H12A
16897,GO:0098827,0.621044273201234,0.447993297614624,35,801,endoplasmic reticulum subcompartment,CC,ZC3H12A;PPP1R15A;RNF19B;PLAUR;IFNGR2;PANX1;SGK1;C3ORF52;RNF43;PIGA;TAP1;ANKLE2;SLC28A3;CANT1;TGFA;SUCO;SLC9A1;PTPN1;SGMS2;CAV1;HLA-A;TAPBP;RAB9A;HLA-B;PJA2;JPH2;SPCS2;TMEM132A;SDR16C5;PML;HLA-F;HLA-E;XBP1;LMAN1;GJC1
2468,GO:0005682,0.62192623133602,0.754389675413661,1,22,U5 snRNP,CC,MAPKBP1
13022,GO:0051438,0.622045370031782,0.654476512641332,2,48,regulation of ubiquitin-protein transferase activity,BP,DCUN1D3;ARRDC4
3324,GO:0007032,0.622331204385995,0.606118878321154,3,69,endosome organization,BP,PLEKHF1;SQSTM1;ANXA8
16935,GO:0098901,0.622879203245419,0.754811027467201,1,19,regulation of cardiac muscle cell action potential,BP,CAV1
18464,GO:1903533,0.62308707323102,0.575409806570302,4,96,regulation of protein targeting,BP,PLAGL2;NRG1;UGCG;UBE2D3
2827,GO:0006293,0.623095723517101,0.753678350325075,1,21,nucleotide-excision repair, preincision complex stabilization,BP,PARP1
2829,GO:0006295,0.623095723517101,0.753678350325075,1,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,PARP1
2947,GO:0006475,0.62349357936784,0.539345639971895,6,138,internal protein amino acid acetylation,BP,IL1B;LIF;ZNF451;SDR16C5;TRIM16;MUC1
7629,GO:0032024,0.623496562891755,0.653376599754627,2,45,positive regulation of insulin secretion,BP,SOX4;PPARD
3684,GO:0008187,0.623845367873341,0.753406362475063,1,20,poly-pyrimidine tract binding,MF,PATL1
13826,GO:0060401,0.624078124212066,0.57465319891299,4,90,cytosolic calcium ion transport,BP,BDKRB1;CAV1;JPH2;PML
19724,GO:2000036,0.624214971891735,0.753543587109994,1,19,regulation of stem cell population maintenance,BP,SAV1
5911,GO:0018126,0.624897597339211,0.752404181296972,1,20,protein hydroxylation,BP,EGLN1
252,GO:0000715,0.625060396994498,0.751037915429587,1,23,nucleotide-excision repair, DNA damage recognition,BP,PARP1
8771,GO:0034446,0.625222859090821,0.603201648387309,3,67,substrate adhesion-dependent cell spreading,BP,EFNA1;ITGAV;AXL
3239,GO:0006895,0.625655937845138,0.752171020080329,1,19,Golgi to endosome transport,BP,SYS1
8603,GO:0034110,0.626563837042098,0.750366571380568,1,21,regulation of homotypic cell-cell adhesion,BP,C1QTNF1
599,GO:0001764,0.626724694930776,0.571981237892739,4,87,neuron migration,BP,VEGFA;NR4A2;NRG1;AXL
1866,GO:0004527,0.627059410439457,0.601074297541965,3,69,exonuclease activity,MF,NOCT;ZC3H12A;RAD9B
606,GO:0001772,0.627385397808335,0.75002298258054,1,20,immunological synapse,CC,ICAM1
10543,GO:0043487,0.627489977857419,0.534788225167834,6,148,regulation of RNA stability,BP,NOCT;ZC3H12A;ZFP36;ZFP36L1;VIM;QKI
3818,GO:0008408,0.627895056130011,0.648618469155526,2,46,3'-5' exonuclease activity,MF,NOCT;RAD9B
13657,GO:0060148,0.62849332467774,0.748957201765808,1,20,positive regulation of posttranscriptional gene silencing,BP,ZFP36
12390,GO:0048786,0.628563416718333,0.749384681722874,1,19,presynaptic active zone,CC,STX1A
13192,GO:0051784,0.628646713317482,0.647686902896259,2,47,negative regulation of nuclear division,BP,LIF;DUSP1
5516,GO:0016469,0.62865897252079,0.747235288965187,1,24,proton-transporting two-sector ATPase complex,CC,PPIF
12072,GO:0048011,0.628746132569137,0.748713549025451,1,20,neurotrophin TRK receptor signaling pathway,BP,SPRY2
11589,GO:0046134,0.628809841142048,0.747089171132324,1,24,pyrimidine nucleoside biosynthetic process,BP,UPP1
8999,GO:0035115,0.628974735277176,0.748045428310406,1,21,embryonic forelimb morphogenesis,BP,TBX3
7956,GO:0032550,0.629385343302989,0.485860216684884,12,281,purine ribonucleoside binding,MF,EHD1;GBP2;RAP2B;ARL5B;GCH1;IRGQ;RND3;RAB24;RRAD;RHOV;RAB9A;GEM
5590,GO:0016604,0.629646650263457,0.445423600346437,29,652,nuclear body,CC,NFKBIZ;ITPKC;IL16;SQSTM1;BHLHE40;GADD45A;N4BP1;WTAP;ZNF217;CDKN1A;ZNF451;SGK1;NAMPT;CCNL1;NR4A2;PATL1;SMURF2;TRIM25;DUSP10;RCHY1;TP53;IKBKE;PML;RAPH1;TRIM16;YARS2;KMT2E;SRSF11;ELF4
14283,GO:0061337,0.62979856830238,0.598385515899087,3,66,cardiac conduction,BP,SLC9A1;CAV1;GJC1
4518,GO:0010565,0.63006994096411,0.547230903856146,5,124,regulation of cellular ketone metabolic process,BP,BMP2;ODC1;CAV1;PDP1;NR4A3
13682,GO:0060191,0.631075517944504,0.645258201137644,2,46,regulation of lipase activity,BP,ABL2;ANXA8
15886,GO:0072594,0.63124652407242,0.462900771659386,18,462,establishment of protein localization to organelle,BP,NFKBIA;TNFAIP3;TNF;ZC3H12A;PMAIP1;BBC3;BCL3;PLAGL2;CDKN1A;TP53BP2;NRG1;NUP153;NEDD4;UGCG;TP53;UBE2D3;SPCS2;PML
16460,GO:0097110,0.631656420616073,0.644788583471308,2,45,scaffold protein binding,MF,PANX1;VIM
10245,GO:0042974,0.631888735779999,0.745670366893904,1,20,retinoic acid receptor binding,MF,NR4A2
2447,GO:0005654,0.631946572863165,0.406769754967481,135,3045,nucleoplasm,CC,NFKBIZ;IRF1;ITPKC;BIRC3;NOCT;FOSL1;ZC3H12A;IL16;ELF3;PRDM1;EHF;MAFF;NFKB1;TNIP1;MAP2K3;JUN;KDM6B;ETS1;SQSTM1;BHLHE40;SERTAD2;REL;BCL3;GADD45A;ETS2;ZNF436;NFKB2;N4BP1;JUNB;TNFAIP8;WTAP;TJP2;RELB;ZNF217;CDKN1A;GBP2;ZNF451;NEDD4L;CTSC;ELMSAN1;SGK1;GCH1;SMAD3;TXNRD1;UPP1;CEBPB;CEBPD;NAMPT;TP53BP2;DSE;CREB1;TAF4B;GORAB;CCNL1;USP43;NEDD9;NR4A2;PATL1;VHL;ABTB2;RUNX1;SMURF2;DUSP16;TGIF2;PNRC2;TRIM25;MASTL;ABCF1;DUSP10;SOX4;ANLN;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;NUP153;POU2F2;NFE2L2;SMAD1;MXD1;CHD4;DIEXF;NFAT5;STAT5A;VEZF1;SH3RF2;INO80D;TNIP2;TP53;KLF3;STK40;IKBKE;UBE2D3;TRIP10;ELK3;RAD9B;SNAPC4;UBE2Z;PML;POLR3A;PIM1;RELA;RAPH1;TRIM16;ESCO2;PPP6R3;YARS2;AKIRIN1;ELL2;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;CYP24A1;KDM7A;MED13;JMY;SRSF11;NABP1;ALAS1;RPS6KA6;XBP1;ELF4;TFE3;EID3;ZMIZ2;JUND
2439,GO:0005637,0.631950763648877,0.644476295780407,2,45,nuclear inner membrane,CC,SMAD3;SMAD1
8408,GO:0033363,0.632293581770354,0.744824531066105,1,21,secretory granule organization,BP,CREB1
3759,GO:0008299,0.632313830582748,0.744394613453954,1,22,isoprenoid biosynthetic process,BP,HMGCS1
12089,GO:0048029,0.63258782676916,0.643653243210112,2,46,monosaccharide binding,MF,EGLN1;LMAN1
10281,GO:0043022,0.63278363717133,0.643304894252538,2,47,ribosome binding,MF,ZC3H12A;CPEB2
18171,GO:1902903,0.633354210438735,0.48673380850344,11,251,regulation of supramolecular fiber organization,BP,SDC4;EDN1;PHLDB2;NAV3;ICAM1;SMAD3;CDC42EP4;LDLR;SLC9A1;SPTBN5;JMY
18918,GO:1904589,0.633448418451565,0.642737862599684,2,46,regulation of protein import,BP,ZC3H12A;CDKN1A
12405,GO:0048821,0.633617090249105,0.743531753938454,1,21,erythrocyte development,BP,SLC11A2
12520,GO:0050650,0.633979878687746,0.743630549181747,1,20,chondroitin sulfate proteoglycan biosynthetic process,BP,DSE
6547,GO:0021955,0.634250834098298,0.743365372244396,1,20,central nervous system neuron axonogenesis,BP,NR4A2
8927,GO:0034767,0.634275277558025,0.593225349572863,3,70,positive regulation of ion transmembrane transport,BP,BDKRB1;SLC9A1;JPH2
4960,GO:0015026,0.634870184265405,0.742758477205071,1,20,coreceptor activity,MF,ITGAV
11630,GO:0046324,0.635071628973664,0.641469752685639,2,43,regulation of glucose import,BP,TNF;NFE2L2
10801,GO:0044272,0.635202791895203,0.526575849932855,6,143,sulfur compound biosynthetic process,BP,B4GALT1;DSE;B4GALT5;NFE2L2;PDP1;CHST2
16007,GO:0086004,0.635393442987306,0.742244923306697,1,20,regulation of cardiac muscle cell contraction,BP,CAV1
18133,GO:1902803,0.636439131057509,0.741216380378765,1,20,regulation of synaptic vesicle transport,BP,STX1A
5328,GO:0016050,0.637016888080637,0.46935125161047,14,319,vesicle organization,BP,SDC4;PLEKHF1;SQSTM1;CTSC;ANXA8;TAP1;CREB1;TGFA;CAV1;TAPBP;STX1A;PPP6R3;TBC1D22B;LMAN1
3344,GO:0007063,0.63755167725108,0.739660249808169,1,21,regulation of sister chromatid cohesion,BP,ESPL1
12937,GO:0051279,0.637878706580584,0.638001686050459,2,46,regulation of release of sequestered calcium ion into cytosol,BP,BDKRB1;JPH2
2948,GO:0006476,0.637953476667876,0.559590952856186,4,91,protein deacetylation,BP,VEGFA;CHD4;TP53;SDR16C5
676,GO:0001883,0.638515168294703,0.476050084287687,12,283,purine nucleoside binding,MF,EHD1;GBP2;RAP2B;ARL5B;GCH1;IRGQ;RND3;RAB24;RRAD;RHOV;RAB9A;GEM
8233,GO:0032993,0.638749679773171,0.536850555093374,5,163,protein-DNA complex,CC,H1FX;NFE2L2;CHD4;PARP1;JUND
2837,GO:0006305,0.638829989426163,0.637282481836497,2,44,DNA alkylation,BP,KMT2E;PARP1
2838,GO:0006306,0.638829989426163,0.637282481836497,2,44,DNA methylation,BP,KMT2E;PARP1
7064,GO:0030838,0.639173882627242,0.587748476080591,3,72,positive regulation of actin filament polymerization,BP,ICAM1;CDC42EP4;JMY
7761,GO:0032273,0.639241457121151,0.557977636171664,4,95,positive regulation of protein polymerization,BP,NAV3;ICAM1;CDC42EP4;JMY
3193,GO:0006820,0.639379956922219,0.463297694195216,15,338,anion transport,BP,IL1B;EDN1;STARD5;NFKBIE;SLC6A14;SLC7A2;SLC52A3;SLC38A2;LDLR;CLIC4;STX1A;ABCA7;SLC16A13;PPARD;SLC16A1
15124,GO:0071168,0.640050857287227,0.736759924293689,1,22,protein localization to chromatin,BP,ESCO2
3157,GO:0006760,0.640083595904888,0.736727267990337,1,22,folic acid-containing compound metabolic process,BP,GCH1
5799,GO:0017038,0.640390136913943,0.509047162960522,7,167,protein import,BP,NFKBIA;TNF;ZC3H12A;BCL3;CDKN1A;NUP153;PML
4361,GO:0009954,0.640503004296357,0.736728244354838,1,21,proximal/distal pattern formation,BP,DLX2
14317,GO:0061436,0.640853909551501,0.736378028846805,1,21,establishment of skin barrier,BP,CLDN1
5458,GO:0016328,0.641955372091809,0.633756807286277,2,45,lateral plasma membrane,CC,CLDN1;OCLN
2540,GO:0005795,0.642425506040232,0.534089926175199,5,115,Golgi stack,CC,B4GALT1;CANT1;PLK3;B4GALT5;GOLGA8B
11451,GO:0045879,0.642476760787271,0.735218682482039,1,20,negative regulation of smoothened signaling pathway,BP,KCTD11
16560,GO:0097306,0.642888203828243,0.633066194427538,2,43,cellular response to alcohol,BP,INHBA;HMGCS1
12560,GO:0050699,0.642948362541738,0.73385814138121,1,22,WW domain binding,MF,TRAF4
6025,GO:0019079,0.643049647131218,0.553704904490988,4,97,viral genome replication,BP,CXCL8;TNF;ZC3H12A;TNIP1
18828,GO:1904377,0.643218046041985,0.632389290925689,2,45,positive regulation of protein localization to cell periphery,BP,EPHA2;SQSTM1
2807,GO:0006266,0.643773222779338,0.732641779276955,1,23,DNA ligation,BP,PARP1
5271,GO:0015914,0.644317512870075,0.631046509898863,2,46,phospholipid transport,BP,LDLR;ABCA7
13079,GO:0051569,0.644792192548819,0.732423887093401,1,21,regulation of histone H3-K4 methylation,BP,KMT2E
7847,GO:0032400,0.64484183074169,0.73194918236264,1,22,melanosome localization,BP,MREG
13230,GO:0051875,0.64484183074169,0.73194918236264,1,22,pigment granule localization,BP,MREG
8247,GO:0033017,0.645013838853084,0.732200054380573,1,21,sarcoplasmic reticulum membrane,CC,JPH2
9005,GO:0035137,0.645056271650506,0.732157187219147,1,21,hindlimb morphogenesis,BP,TBX3
12233,GO:0048477,0.645065178046513,0.630233322720465,2,46,oogenesis,BP,EREG;TAF4B
616,GO:0001782,0.645205078670884,0.731581809617932,1,22,B cell homeostasis,BP,TNFAIP3
13698,GO:0060218,0.64563715391748,0.579171510698567,3,100,hematopoietic stem cell differentiation,BP,RUNX1;CHD2;NFE2L2
1914,GO:0004601,0.645691853392105,0.729181772663572,1,28,peroxidase activity,MF,GPX3
638,GO:0001825,0.645951027066449,0.730826223478393,1,22,blastocyst formation,BP,JUNB
12765,GO:0051020,0.647025924174423,0.434193477859384,24,522,GTPase binding,MF,CSF2;HBEGF;RAB3IP;EHD1;EREG;ARHGEF3;FGD6;FGF5;DENND3;CDC42EP4;ERRFI1;PDGFB;ANLN;NRG1;RASGEF1B;PARD6B;CYTH1;RNF152;ITSN2;SPTBN5;CAV1;DOCK4;TBC1D22B;DENND4A
12608,GO:0050771,0.647239318925038,0.628169044914823,2,44,negative regulation of axonogenesis,BP,SEMA4B;WNT5A
3060,GO:0006622,0.648115098542759,0.729053637715468,1,21,protein targeting to lysosome,BP,NEDD4
13146,GO:0051693,0.648159298126111,0.729008597397001,1,21,actin filament capping,BP,SPTBN5
4193,GO:0009268,0.648371186307187,0.728363948260895,1,22,response to pH,BP,SLC9A1
2703,GO:0006066,0.648739914865126,0.475795987138394,10,234,alcohol metabolic process,BP,IL1B;TNF;ITPKC;NFKB1;CYP27B1;GCH1;HMGCS1;LDLR;SDR16C5;PPARD
12335,GO:0048678,0.648831075018912,0.625706252957322,2,49,response to axon injury,BP,JUN;TNC
19826,GO:2000249,0.648845698448503,0.727487917538048,1,23,regulation of actin cytoskeleton reorganization,BP,ABL2
14913,GO:0070717,0.649141392345641,0.728006387266364,1,21,poly-purine tract binding,MF,PATL1
6589,GO:0022412,0.649416802475428,0.489695514641552,8,186,cellular process involved in reproduction in multicellular organism,BP,INHBA;FOSL1;PRDM1;EREG;TAF4B;MYBL1;MASTL;QKI
8865,GO:0034661,0.649672577154005,0.72664084732406,1,23,ncRNA catabolic process,BP,ZC3H12A
4646,GO:0010765,0.650022229763082,0.727105166982664,1,21,positive regulation of sodium ion transport,BP,SLC9A1
7967,GO:0032561,0.650276806261596,0.463314388266459,12,285,guanyl ribonucleotide binding,MF,EHD1;GBP2;RAP2B;ARL5B;GCH1;IRGQ;RND3;RAB24;RRAD;RHOV;RAB9A;GEM
19646,GO:1990778,0.650645667698053,0.480464462018308,9,207,protein localization to cell periphery,BP,TNF;PLEKHF1;EPHA2;SQSTM1;ANLN;SYS1;CAV1;CRB3;EPB41L3
6201,GO:0019674,0.651128442852147,0.623313041764317,2,48,NAD metabolic process,BP,NMNAT2;NAMPT
11708,GO:0046488,0.651159428389754,0.497404119529699,7,160,phosphatidylinositol metabolic process,BP,HBEGF;PLAUR;EREG;FGF5;PIGA;PDGFB;NRG1
3800,GO:0008375,0.651181708209683,0.623254363746114,2,48,acetylglucosaminyltransferase activity,MF,B3GNT5;PIGA
7955,GO:0032549,0.651578550957982,0.461899669972104,12,285,ribonucleoside binding,MF,EHD1;GBP2;RAP2B;ARL5B;GCH1;IRGQ;RND3;RAB24;RRAD;RHOV;RAB9A;GEM
10368,GO:0043178,0.651924526455182,0.622435437834552,2,48,alcohol binding,MF,STARD5;CAV1
18278,GO:1903115,0.652187586098125,0.724880255644574,1,21,regulation of actin filament-based movement,BP,CAV1
14128,GO:0060969,0.652568898946697,0.724053571843296,1,22,negative regulation of gene silencing,BP,ZC3H12A
15188,GO:0071312,0.652574344194913,0.72404794759481,1,22,cellular response to alkaloid,BP,ICAM1
8587,GO:0034067,0.65282873695583,0.724218883941354,1,21,protein localization to Golgi apparatus,BP,ARL5B
637,GO:0001824,0.654127169523621,0.620000245391678,2,48,blastocyst development,BP,ELF3;JUNB
5855,GO:0017147,0.654423305586278,0.722568877223789,1,21,Wnt-protein binding,MF,FZD8
7936,GO:0032508,0.654465565222688,0.570937310446558,3,71,DNA duplex unwinding,BP,CHD2;CHD4;PARP1
5999,GO:0019001,0.655246843915852,0.457895969995438,12,286,guanyl nucleotide binding,MF,EHD1;GBP2;RAP2B;ARL5B;GCH1;IRGQ;RND3;RAB24;RRAD;RHOV;RAB9A;GEM
6923,GO:0030511,0.655264414711375,0.721258966084128,1,22,positive regulation of transforming growth factor beta receptor signaling pathway,BP,CDKN2B
18607,GO:1903846,0.655264414711375,0.721258966084128,1,22,positive regulation of cellular response to transforming growth factor beta stimulus,BP,CDKN2B
7226,GO:0031116,0.65614378695505,0.720342706887881,1,22,positive regulation of microtubule polymerization,BP,NAV3
7700,GO:0032153,0.656302853157752,0.568959811745922,3,70,cell division site,CC,RND3;MASTL;ANLN
11586,GO:0046131,0.656390346004153,0.718675313131009,1,26,pyrimidine ribonucleoside metabolic process,BP,UPP1
3355,GO:0007091,0.656443998557383,0.617294245186283,2,49,metaphase/anaphase transition of mitotic cell cycle,BP,DUSP1;ESPL1
10991,GO:0044784,0.656443998557383,0.617294245186283,2,49,metaphase/anaphase transition of cell cycle,BP,DUSP1;ESPL1
19305,GO:1905515,0.656463803652867,0.617544892222598,2,47,non-motile cilium assembly,BP,GORAB;CEP135
3201,GO:0006835,0.656865733730468,0.617243050788566,2,46,dicarboxylic acid transport,BP,SLC38A2;STX1A
2100,GO:0004864,0.657196243670272,0.718843076309727,1,23,protein phosphatase inhibitor activity,MF,SH3RF2
7259,GO:0031214,0.658210162208824,0.566900343372529,3,69,biomineral tissue development,BP,BMP2;CYP27B1;SMAD3
3052,GO:0006611,0.658539910850364,0.489028026494843,7,170,protein export from nucleus,BP,IL1B;DUSP16;SOX4;NUP153;TP53;GSK3B;SRSF11
3370,GO:0007140,0.659237676050207,0.716698883007823,1,23,male meiotic nuclear division,BP,MYBL1
2882,GO:0006383,0.659952550298764,0.613123762581189,2,51,transcription by RNA polymerase III,BP,SNAPC4;POLR3A
5471,GO:0016363,0.660057860213227,0.534937824421564,4,94,nuclear matrix,CC,CEBPB;CLIC4;TP53;PML
5631,GO:0016705,0.660767668122476,0.534088376465985,4,95,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,CYP27B1;CYP24A1;KDM7A;EGLN1
15246,GO:0071392,0.660827024945891,0.71502104559631,1,23,cellular response to estradiol stimulus,BP,CFLAR
12731,GO:0050954,0.660908748477743,0.56354975111069,3,73,sensory perception of mechanical stimulus,BP,ICAM1;SLC52A3;SPRY2
4782,GO:0010965,0.661500555816165,0.611509670660328,2,50,regulation of mitotic sister chromatid separation,BP,DUSP1;ESPL1
2520,GO:0005771,0.661547556112044,0.71354721453829,1,25,multivesicular body,CC,NEDD4L
4307,GO:0009755,0.661916987236228,0.485444446157276,7,162,hormone-mediated signaling pathway,BP,NR4A2;RUNX1;NEDD4;NR4A3;PPARD;PARP1;MED13
11802,GO:0046658,0.662928010422159,0.712419904333319,1,24,anchored component of plasma membrane,CC,EFNA1
6087,GO:0019239,0.662965071350712,0.712380424628718,1,24,deaminase activity,MF,AMPD3
4046,GO:0009081,0.663046287398945,0.712665721506542,1,23,branched-chain amino acid metabolic process,BP,STAT5A
96,GO:0000186,0.663104211027733,0.610409180828132,2,45,activation of MAPKK activity,BP,MAP3K8;ADAM9
12117,GO:0048147,0.663126625544824,0.712208278876999,1,24,negative regulation of fibroblast proliferation,BP,TP53
2734,GO:0006111,0.663867424547761,0.7121975806081,1,22,regulation of gluconeogenesis,BP,SOGA1
17249,GO:0110053,0.663919649326682,0.47364979193308,8,188,regulation of actin filament organization,BP,SDC4;PHLDB2;ICAM1;SMAD3;CDC42EP4;SLC9A1;SPTBN5;JMY
17383,GO:1900087,0.664071463961052,0.711572747656114,1,23,positive regulation of G1/S transition of mitotic cell cycle,BP,KMT2E
1428,GO:0003382,0.66407849931203,0.71197250721282,1,22,epithelial cell morphogenesis,BP,CLIC4
7392,GO:0031440,0.664087132967545,0.711963298135129,1,22,regulation of mRNA 3'-end processing,BP,ZFP36L1
17932,GO:1902230,0.664706430009014,0.709861353647515,1,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,MUC1
5292,GO:0015949,0.664804449205071,0.70946357843282,1,27,nucleobase-containing small molecule interconversion,BP,TXNRD1
18118,GO:1902742,0.665658132866209,0.710283881280501,1,22,apoptotic process involved in development,BP,B4GALT1
1451,GO:0003678,0.666018710462799,0.60696225135024,2,46,DNA helicase activity,MF,CHD2;CHD4
10738,GO:0044091,0.666092434345387,0.709408924567353,1,23,membrane biogenesis,BP,CAV1
2992,GO:0006536,0.666106120565019,0.70939422918077,1,23,glutamate metabolic process,BP,HAL
14144,GO:0060996,0.666182240071722,0.557884524224298,3,69,dendritic spine development,BP,EFNA1;PLK2;NRG1
13195,GO:0051787,0.666406489597898,0.709071570357327,1,23,misfolded protein binding,MF,HSPA4L
10158,GO:0042733,0.66844897592449,0.604053866860921,2,47,embryonic digit morphogenesis,BP,TBX3;WNT5A
2606,GO:0005902,0.668769670759468,0.603411044278044,2,49,microvillus,CC,CLIC4;ITGAV
7841,GO:0032391,0.669142082361812,0.706120451658582,1,23,photoreceptor connecting cilium,CC,SPTBN5
17784,GO:1901797,0.669423117784334,0.705090826211166,1,25,negative regulation of signal transduction by p53 class mediator,BP,MUC1
17359,GO:1900034,0.670030454809098,0.553253023581197,3,72,regulation of cellular response to heat,BP,IER5;NUP153;GSK3B
6931,GO:0030520,0.670210540682555,0.602044510599062,2,47,intracellular estrogen receptor signaling pathway,BP,RUNX1;PARP1
7224,GO:0031114,0.670294597967399,0.705284118051118,1,22,regulation of microtubule depolymerization,BP,NAV3
9823,GO:0042026,0.670351396638087,0.704429824785554,1,24,protein refolding,BP,HSPA4L
10411,GO:0043243,0.670409861683389,0.704745101653881,1,23,positive regulation of protein complex disassembly,BP,TNF
7858,GO:0032414,0.670904861434001,0.60097229268517,2,49,positive regulation of ion transmembrane transporter activity,BP,SLC9A1;JPH2
15764,GO:0072341,0.670929778542364,0.600687774786422,2,51,modified amino acid binding,MF,JPH2;AXL
17082,GO:0099565,0.670959277613204,0.60118837299504,2,47,chemical synaptic transmission, postsynaptic,BP,STX1A;GSK3B
12726,GO:0050931,0.671683118804275,0.703358881126243,1,23,pigment cell differentiation,BP,MREG
20122,GO:2000765,0.67198955816015,0.703024514916708,1,23,regulation of cytoplasmic translation,BP,CPEB2
9122,GO:0035418,0.672406111341027,0.702569538764209,1,23,protein localization to synapse,BP,WNT5A
17265,GO:0120034,0.673177172763338,0.549640555754692,3,72,positive regulation of plasma membrane bounded cell projection assembly,BP,CDC42EP4;ANLN;CEP135
6068,GO:0019212,0.673746018766494,0.700720378138766,1,24,phosphatase inhibitor activity,MF,SH3RF2
4360,GO:0009953,0.673812089250255,0.597772221153266,2,48,dorsal/ventral pattern formation,BP,EDN1;GORAB
12070,GO:0048009,0.674530361402989,0.700659250502468,1,22,insulin-like growth factor receptor signaling pathway,BP,BMP2
8444,GO:0033561,0.675037655603545,0.699682936009432,1,23,regulation of water loss via skin,BP,CLDN1
16174,GO:0090181,0.675290961437419,0.595930854536913,2,49,regulation of cholesterol metabolic process,BP,HMGCS1;LDLR
12950,GO:0051294,0.675295907948626,0.699398502238042,1,23,establishment of spindle orientation,BP,SPRY2
5730,GO:0016866,0.67546952551093,0.69847094292044,1,25,intramolecular transferase activity,MF,PUS10
12893,GO:0051213,0.675502600381276,0.546883884904473,3,73,dioxygenase activity,MF,KDM6B;KDM7A;EGLN1
11808,GO:0046676,0.675726709628554,0.698539630688912,1,24,negative regulation of insulin secretion,BP,PIM3
16242,GO:0090278,0.675726709628554,0.698539630688912,1,24,negative regulation of peptide hormone secretion,BP,PIM3
5233,GO:0015844,0.676303639809412,0.697902146341066,1,24,monoamine transport,BP,STX1A
16130,GO:0090102,0.676824470780665,0.697710743608227,1,23,cochlea development,BP,WNT5A
18420,GO:1903432,0.676994710534789,0.697137181289202,1,24,regulation of TORC1 signaling,BP,RNF152
10655,GO:0043687,0.677446798063676,0.429057980598828,13,319,post-translational protein modification,BP,CSF1;IL6;KLHL21;DCUN1D3;VHL;KLHL5;SOCS2;TNC;ARSJ;RAET1L;KBTBD7;TMEM132A;ESCO2
12098,GO:0048048,0.677585498526186,0.697289124923762,1,22,embryonic eye morphogenesis,BP,WNT5A
4389,GO:0010039,0.677689664546602,0.696366419563713,1,24,response to iron ion,BP,SLC11A2
2788,GO:0006221,0.677876258609158,0.694894716607429,1,28,pyrimidine nucleotide biosynthetic process,BP,UPP1
15046,GO:0070979,0.677964209626225,0.695077306694791,1,27,protein K11-linked ubiquitination,BP,UBE2D3
675,GO:0001882,0.678355635698741,0.432417685663724,12,291,nucleoside binding,MF,EHD1;GBP2;RAP2B;ARL5B;GCH1;IRGQ;RND3;RAB24;RRAD;RHOV;RAB9A;GEM
8265,GO:0033044,0.678530654774084,0.432324491787613,12,280,regulation of chromosome organization,BP,IL1B;LIF;DUSP1;ZNF451;VEGFA;TP53;SDR16C5;PML;ESPL1;MUC1;KMT2E;PARP1
4373,GO:0009988,0.678561465329763,0.694714648446437,1,26,cell-cell recognition,BP,B4GALT1
10563,GO:0043516,0.679172237427189,0.694361319963055,1,25,regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
18357,GO:1903305,0.679223458279497,0.542572952077287,3,73,regulation of regulated secretory pathway,BP,IL4R;STX1A;ADGRE2
12806,GO:0051087,0.679630382320313,0.541686799472934,3,79,chaperone binding,MF,BIRC2;CTSC;TP53
7934,GO:0032506,0.679726832308631,0.69448608480428,1,23,cytokinetic process,BP,ANLN
8751,GO:0034399,0.68027217799733,0.491462153699498,5,119,nuclear periphery,CC,CEBPB;NUP153;CLIC4;TP53;PML
13050,GO:0051493,0.680383412634338,0.412673754001718,17,395,regulation of cytoskeleton organization,BP,SDC4;EDN1;PHLDB2;CYLD;NAV3;ICAM1;SMAD3;RND3;PLK2;ABL2;CDC42EP4;SLC9A1;SPTBN5;CLIC4;RHOV;GSK3B;JMY
6708,GO:0030104,0.680499558959955,0.590025913383709,2,48,water homeostasis,BP,CLDN1;NEDD4L
18493,GO:1903578,0.681859388065126,0.539429781775686,3,74,regulation of ATP metabolic process,BP,PPIF;NUP153;PARP1
5862,GO:0017157,0.681919597399234,0.489463189612518,5,122,regulation of exocytosis,BP,SDC4;IL4R;RAB9A;STX1A;ADGRE2
16365,GO:0090630,0.68202204005682,0.539548113378916,3,70,activation of GTPase activity,BP,EPHA2;WNT5A;TBC1D22B
2547,GO:0005813,0.682348320286705,0.40555832243247,19,440,centrosome,CC,CYLD;RELB;CCDC85B;CTSC;PLK2;PDE4DIP;MASTL;PLK3;FEZ1;ITSN2;MARCKS;NFE2L2;CHD4;CLIC4;RTTN;ESPL1;GSK3B;SLC16A1;CEP135
7864,GO:0032420,0.682471989771138,0.691021409366174,1,24,stereocilium,CC,DOCK4
5018,GO:0015175,0.682596709640757,0.690881050927437,1,24,neutral amino acid transmembrane transporter activity,MF,SLC38A2
1,GO:0000002,0.68287316176856,0.690569758885963,1,24,mitochondrial genome maintenance,BP,PARP1
3304,GO:0007005,0.683317187937487,0.404295741109723,19,487,mitochondrion organization,BP,PLAUR;SOD2;PMAIP1;PPIF;JUN;SQSTM1;BBC3;PLAGL2;TP53BP2;NRG1;MMP9;SLC9A1;FEZ1;UGCG;TP53;UBE2D3;GSK3B;PARP1;ALAS1
13622,GO:0060078,0.683374332847789,0.586664822858719,2,48,regulation of postsynaptic membrane potential,BP,STX1A;GSK3B
12960,GO:0051306,0.683626495266268,0.585847801191854,2,52,mitotic sister chromatid separation,BP,DUSP1;ESPL1
41,GO:0000083,0.683875745797991,0.689438789374303,1,24,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,BACH1
9159,GO:0035510,0.68422475926954,0.688684166442546,1,25,DNA dealkylation,BP,OTUD4
13639,GO:0060119,0.684863183864535,0.688321779628639,1,24,inner ear receptor cell development,BP,SDC4
10679,GO:0043921,0.684931106911024,0.688244829433018,1,24,modulation by host of viral transcription,BP,JUN
13350,GO:0052312,0.684931106911024,0.688244829433018,1,24,modulation of transcription in other organism involved in symbiotic interaction,BP,JUN
13369,GO:0052472,0.684931106911024,0.688244829433018,1,24,modulation by host of symbiont transcription,BP,JUN
9785,GO:0039694,0.685153503491329,0.687992772687856,1,24,viral RNA genome replication,BP,CXCL8
6867,GO:0030332,0.685183615313758,0.687958632825276,1,24,cyclin binding,MF,CDKN1A
6719,GO:0030125,0.685525131084733,0.687571229870708,1,24,clathrin vesicle coat,CC,NECAP2
7345,GO:0031365,0.685682366053082,0.687392742892541,1,24,N-terminal protein amino acid modification,BP,SOX4
3434,GO:0007224,0.686006659518969,0.505074212619413,4,97,smoothened signaling pathway,BP,GORAB;TGFBR2;EVC;KCTD11
12176,GO:0048285,0.686442224073901,0.411878611602469,15,356,organelle fission,BP,IL1B;IL1A;BIRC3;LIF;EDN1;EREG;DUSP1;BIRC2;MYBL1;MASTL;WNT5A;TGFA;PDGFB;ANLN;ESPL1
3253,GO:0006914,0.686804699194697,0.402977247164981,18,428,autophagy,BP,PLEKHF1;ZC3H12A;TICAM1;SQSTM1;RIPK2;RAB24;PLK2;ABL2;VMP1;SOGA1;PLK3;FEZ1;RNF152;NEDD4;TAB3;DRAM1;TP53;XBP1
14500,GO:0061919,0.686804699194697,0.402977247164981,18,428,process utilizing autophagic mechanism,BP,PLEKHF1;ZC3H12A;TICAM1;SQSTM1;RIPK2;RAB24;PLK2;ABL2;VMP1;SOGA1;PLK3;FEZ1;RNF152;NEDD4;TAB3;DRAM1;TP53;XBP1
920,GO:0002312,0.687464760912089,0.581577102483125,2,50,B cell activation involved in immune response,BP,BCL3;XBP1
7222,GO:0031112,0.687529576896346,0.685289925284877,1,24,positive regulation of microtubule polymerization or depolymerization,BP,NAV3
13278,GO:0051952,0.687915985675954,0.684485287524103,1,25,regulation of amine transport,BP,STX1A
11683,GO:0046456,0.687991972588891,0.683753443847974,1,27,icosanoid biosynthetic process,BP,EDN1
11485,GO:0045933,0.688362240588568,0.683974693980093,1,25,positive regulation of muscle contraction,BP,EDN1
10163,GO:0042743,0.689296501915418,0.681968371223236,1,28,hydrogen peroxide metabolic process,BP,GPX3
17743,GO:1901658,0.689412779120475,0.682123026871111,1,27,glycosyl compound catabolic process,BP,UPP1
160,GO:0000323,0.689643293111898,0.391445049387983,22,519,lytic vacuole,CC,IL1B;TNFAIP3;SDC4;PLEKHF1;RNF19B;SQSTM1;BBC3;ADAM8;ABCA5;CTSC;B4GALT1;IFNAR1;TINAGL1;SLC11A2;LDLR;RNF152;MMD;DRAM1;RAB9A;TRIP10;FRK;NR4A3
2513,GO:0005764,0.689643293111898,0.391445049387983,22,519,lysosome,CC,IL1B;TNFAIP3;SDC4;PLEKHF1;RNF19B;SQSTM1;BBC3;ADAM8;ABCA5;CTSC;B4GALT1;IFNAR1;TINAGL1;SLC11A2;LDLR;RNF152;MMD;DRAM1;RAB9A;TRIP10;FRK;NR4A3
10497,GO:0043394,0.690449230575755,0.68234172947868,1,23,proteoglycan binding,MF,TNC
11258,GO:0045454,0.69054101989018,0.577125979201769,2,57,cell redox homeostasis,BP,TXNRD1;NFE2L2
2719,GO:0006094,0.690674421865829,0.577518462101245,2,52,gluconeogenesis,BP,SOGA1;ATF3
15840,GO:0072529,0.691894804455842,0.679259125227028,1,27,pyrimidine-containing compound catabolic process,BP,UPP1
11533,GO:0046039,0.692056268918351,0.679072123213276,1,27,GTP metabolic process,BP,AMPD3
9410,GO:0035966,0.692137278313012,0.451002002771631,7,174,response to topologically incorrect protein,BP,CXCL8;PPP1R15A;ATF3;NFE2L2;PTPN1;XBP1;HSPA4L
18149,GO:1902850,0.692612028139024,0.477073748335164,5,122,microtubule cytoskeleton organization involved in mitosis,BP,BIRC3;BIRC2;PLK2;SPRY2;ESPL1
2406,GO:0005575,0.692960458640139,0.399017706869861,531,11705,cellular_component,CC,NFKBIZ;CXCL8;IL1B;CXCL2;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;CXCL3;HBEGF;NUAK2;PLAU;CXCL1;IL1A;ITPKC;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;CXCL5;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;IL36G;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;HCAR3;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;RAB3IP;EPHA2;GPR156;EHD1;ZNF697;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;N4BP3;ZNF267;SPRR2D;SERTAD2;STARD5;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;PANX1;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;KLHL21;PHLDA2;DAPP1;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;STEAP4;C1QTNF1;AMOTL2;CDKN1A;CLDN1;NMNAT2;FJX1;CCDC85B;ITGA5;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;ODC1;TNFAIP2;NEDD4L;CTSC;ARL5B;GPX3;NOD2;ELMSAN1;IL6ST;DCUN1D3;RELT;SAV1;TMCC3;TFPI2;SGK1;ICAM1;GCH1;FRMD4B;TRIM47;ESRG;RASSF9;SMAD3;ZC3H12C;B4GALT1;NFKBIB;DLX2;ARNTL2;C15ORF39;PHLDA1;B3GNT5;RNF144B;RND3;MARCKSL1;TM4SF1;NFKBID;NINJ1;TRAF4;TRIB1;KRT34;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;LGALSL;IL1R2;SLC6A14;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;MAP3K8;ABL2;PPTC7;C3ORF52;CDV3;LAMB3;CFLAR;RNF43;TXNRD1;LACC1;KLF7;PIGA;BTG1;ANXA8;TMEM217;UPP1;IER5;LAYN;PPP4R4;CEBPB;CEBPD;VMP1;CD55;KCNJ15;DENND3;NAMPT;TAP1;TMEM106A;ANXA8L1;TP53BP2;ANKLE2;HEPHL1;ADM;GJB3;CDC42EP4;SLC28A3;IFNAR1;DSE;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;WISP1;NEDD9;MAST4;NR4A2;PATL1;NIPAL4;SLC7A2;CD47;CANT1;VHL;PHKG2;SOGA1;SEMA4B;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;TGFBR2;MREG;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TMEM265;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;IFNGR1;MASTL;NAB1;KIF3C;C9ORF47;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;NOTCH2NL;DUSP10;SLC52A3;ROBO4;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;IL20;ANLN;NBPF8;PGLYRP4;CD82;BAZ1A;IFIH1;DUSP8;EFHD2;NRG1;TNC;SLC38A2;MMP9;TMEM154;LDLR;DCBLD2;RRAD;ATF3;BTG3;IKZF2;COL12A1;FAM83B;CAB39;IL32;TLE1;TRAF3IP3;RHD;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;TRPV3;FAM57A;MT2A;SUCO;SLC9A1;ZBTB10;SLC25A37;SYS1;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;HAL;CYTH1;GRB7;CXCL16;ARSJ;NUP153;BCL2L2;RNF152;IL4R;NEDD4;MMD;RHCG;SLC2A6;POU2F2;ITSN2;DUS4L;GCSAM;IL24;TNFRSF6B;MARCKS;RAET1L;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;SUSD6;TPRA1;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;CACFD1;RTTN;HLA-A;UACA;DRAM1;INO80D;TNIP2;NECAP2;ZNFX1;UGCG;ZFAND5;GOLGA8B;TP53;NOM1;KLF3;TLR2;ABI1;STK40;TAPBP;EFNB2;PDP1;RAB9A;HLA-B;ITGAV;PRRG1;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;ADGRE2;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;ADAM9;SLC43A3;RELA;RAPH1;TRIM16;MAMDC2;ESCO2;EMP3;SPATA2;FOXN2;SLC9A8;CCBE1;PPP6R3;EVI2B;LRRC49;TSPAN13;COL27A1;PLAT;CHST2;MUC1;YARS2;AXL;SLC16A13;ANXA5;THSD1;AKIRIN1;CRB3;ELL2;SAT1;FRK;HLA-F;CITED4;NR4A3;LIMS3;HLA-E;USP31;GSK3B;KMT2E;OSMR;PPARD;PARP8;SLC16A1;EVC;PARP1;CYP24A1;MMP10;LAMA3;KDM7A;MED13;MXD3;CRAMP1;TBC1D22B;LCE1C;OCLN;COTL1;JMY;COL8A1;VIM;SRSF11;CLDND1;CREB5;EGLN1;NABP1;RIPK4;RNF145;ALAS1;ZXDA;RPS6KA6;DDR1;CEP135;XBP1;HSPA4L;QKI;EPB41L3;KCTD11;ZBTB5;ELF4;IL36RN;CDRT1;SLC39A14;TFE3;EID3;ZMIZ2;ERVFRD-1;MGAM;CCSER2;LMAN1;CFB;SLC41A1;JUND;GJC1;DENND4A
5783,GO:0017001,0.693055855632801,0.677621648224274,1,28,antibiotic catabolic process,BP,GPX3
14652,GO:0070229,0.693140617440135,0.678127735517962,1,26,negative regulation of lymphocyte apoptotic process,BP,EFNA1
6603,GO:0022616,0.693423208403277,0.678138837079888,1,25,DNA strand elongation,BP,PARP1
19391,GO:1905818,0.693873470393182,0.573580419011642,2,53,regulation of chromosome separation,BP,DUSP1;ESPL1
2762,GO:0006171,0.694364505673108,0.677044182513257,1,25,cAMP biosynthetic process,BP,ADM
7878,GO:0032435,0.695284066379269,0.675631120539533,1,26,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,N4BP1
10583,GO:0043543,0.695530527489481,0.437791768937672,8,198,protein acylation,BP,IL1B;LIF;ZNF451;SOX4;SDR16C5;TRIM16;ESCO2;MUC1
16892,GO:0098815,0.696176837101781,0.675298867573056,1,24,modulation of excitatory postsynaptic potential,BP,STX1A
5805,GO:0017053,0.696417806377176,0.522316363595702,3,73,transcriptional repressor complex,CC,JUN;CHD4;SDR16C5
4467,GO:0010458,0.69645500833549,0.674260843229195,1,26,exit from mitosis,BP,ANLN
4643,GO:0010762,0.69674500035659,0.674633809173527,1,24,regulation of fibroblast migration,BP,SDC4
10642,GO:0043648,0.697047019992702,0.521211031784786,3,78,dicarboxylic acid metabolic process,BP,NMNAT2;HAL;STAT5A
18599,GO:1903828,0.697067161907678,0.521253854659024,3,77,negative regulation of cellular protein localization,BP,NEDD4L;SOX4;GSK3B
7205,GO:0031090,0.697383674871458,0.343607850916934,96,2224,organelle membrane,CC,HBEGF;PLAU;PLEKHF1;ZC3H12A;PPP1R15A;PLAUR;SOD2;PMAIP1;PPIF;TICAM1;EHD1;IFNGR2;ADAM8;CYP27B1;IRAK2;WTAP;STEAP4;NMNAT2;GBP2;RAP2B;ABCA5;IL7R;NAV3;CTSC;GCH1;RASSF9;SMAD3;B4GALT1;B3GNT5;RNF144B;RND3;RAB24;DKK1;ANXA8;VMP1;CD55;TAP1;DSE;CD47;CANT1;WNT5A;CAMK1G;SLC11A2;TGFA;PDGFB;LDLR;SUCO;SLC25A37;SYS1;MAOA;B4GALT5;CYTH1;NUP153;BCL2L2;RNF152;MMD;WNT7B;SMAD1;SGMS2;TAB3;SPTBN5;CLIC4;TPST1;CAV1;RHOV;HLA-A;DRAM1;NECAP2;UGCG;GOLGA8B;TLR2;TAPBP;RAB9A;HLA-B;ITGAV;IKBKE;UBE2D3;PJA2;STX1A;JPH2;ABCA7;SPCS2;TMEM132A;HS3ST3B1;PML;SLC9A8;PPP6R3;CHST2;SLC16A13;AKIRIN1;HLA-F;HLA-E;EVC;CYP24A1;MGAM;LMAN1
13292,GO:0051966,0.697500143865995,0.673748222345889,1,24,regulation of synaptic transmission, glutamatergic,BP,DKK1
12418,GO:0048854,0.697557419705161,0.674085561490334,1,23,brain morphogenesis,BP,WNT5A
3309,GO:0007010,0.697800272651841,0.35985930443799,44,982,cytoskeleton organization,BP,TNF;NUAK2;CXCL1;SDC4;BIRC3;EDN1;GADD45A;BIRC2;SIX4;PHLDB2;CYLD;AMOTL2;NAV3;ICAM1;SMAD3;RND3;FGD6;PLK2;ABL2;CFLAR;CDC42EP4;NEDD9;MAST4;AKAP2;ANLN;PLK3;SLC9A1;SPRY2;MARCKS;PTPN1;SPTBN5;CLIC4;RHOV;GOLGA8B;ABI1;TRIP10;ESPL1;GSK3B;SLC16A1;JMY;VIM;CEP135;EPB41L3;CCSER2
12235,GO:0048483,0.698227167865068,0.672893817718019,1,24,autonomic nervous system development,BP,SOX4
14746,GO:0070405,0.698370575868444,0.671691860063531,1,27,ammonium ion binding,MF,SAT1
10276,GO:0043015,0.698451531949895,0.672257317397715,1,25,gamma-tubulin binding,MF,FEZ1
3115,GO:0006692,0.698947901921383,0.671010473620849,1,27,prostanoid metabolic process,BP,EDN1
3116,GO:0006693,0.698947901921383,0.671010473620849,1,27,prostaglandin metabolic process,BP,EDN1
200,GO:0000421,0.699314756085873,0.670895109144489,1,26,autophagosome membrane,CC,VMP1
2321,GO:0005326,0.699376865965196,0.67153907854561,1,24,neurotransmitter transporter activity,MF,SLC6A14
2293,GO:0005249,0.699708114415763,0.671147932529413,1,24,voltage-gated potassium channel activity,MF,KCNJ15
7564,GO:0031902,0.699853185913172,0.488415770144586,4,105,late endosome membrane,CC,ABCA5;ANXA8;SLC11A2;MMD
6666,GO:0030016,0.700127698205951,0.468165681591692,5,125,myofibril,CC,SDC4;SQSTM1;PDE4DIP;JPH2;LMAN1
7061,GO:0030835,0.700469058291778,0.670247996446467,1,24,negative regulation of actin filament depolymerization,BP,SPTBN5
7435,GO:0031532,0.700498070625034,0.517139587336726,3,77,actin cytoskeleton reorganization,BP,ABL2;NEDD9;PTPN1
3251,GO:0006911,0.70059714375047,0.66972201248818,1,25,phagocytosis, engulfment,BP,ABCA7
5628,GO:0016684,0.700787461395088,0.667538647071235,1,32,oxidoreductase activity, acting on peroxide as acceptor,MF,GPX3
4496,GO:0010518,0.701029363224957,0.669209420359987,1,25,positive regulation of phospholipase activity,BP,ABL2
4815,GO:0014003,0.701739427202279,0.668019978200439,1,26,oligodendrocyte development,BP,TLR2
12826,GO:0051117,0.701865063140124,0.563817908678536,2,54,ATPase binding,MF,BBC3;CAV1
3423,GO:0007212,0.702082482496098,0.66761158934567,1,26,dopamine receptor signaling pathway,BP,GSK3B
9004,GO:0035136,0.702122071189733,0.667910708854693,1,25,forelimb morphogenesis,BP,TBX3
1189,GO:0002833,0.702504563636729,0.667108578203877,1,26,positive regulation of response to biotic stimulus,BP,RIPK2
9886,GO:0042157,0.703418601311308,0.464067266009321,5,132,lipoprotein metabolic process,BP,PLAUR;PIGA;LDLR;RAET1L;ITGAV
2269,GO:0005198,0.704038075891875,0.381331440508105,19,511,structural molecule activity,MF,SPRR2D;CLDN1;SAV1;TFPI2;KRT34;LAMB3;PDE4DIP;TINAGL1;OTUD4;COL12A1;SLC9A1;NUP153;CAV1;SPRR2A;COL27A1;LAMA3;LCE1C;VIM;EPB41L3
1542,GO:0003924,0.704074310089303,0.420249322278403,9,227,GTPase activity,MF,GBP2;RAP2B;GCH1;RND3;RAB24;RRAD;RHOV;RAB9A;GEM
14149,GO:0061001,0.704255303236734,0.665741090873292,1,24,regulation of dendritic spine morphogenesis,BP,EFNA1
6150,GO:0019432,0.704477226290009,0.665097786455706,1,25,triglyceride biosynthetic process,BP,LDLR
195,GO:0000413,0.704584612862921,0.663463319911606,1,30,protein peptidyl-prolyl isomerization,BP,PPIF
1481,GO:0003755,0.704584612862921,0.663463319911606,1,30,peptidyl-prolyl cis-trans isomerase activity,MF,PPIF
12804,GO:0051085,0.704589974162902,0.664614435636338,1,26,chaperone cofactor-dependent protein refolding,BP,HSPA4L
2589,GO:0005881,0.704904396343196,0.560345446688078,2,52,cytoplasmic microtubule,CC,CYLD;SAA1
4529,GO:0010591,0.705168565490721,0.664268486606065,1,25,regulation of lamellipodium assembly,BP,EPHA2
4206,GO:0009312,0.705693269214103,0.663288903229847,1,26,oligosaccharide biosynthetic process,BP,B4GALT1
3066,GO:0006629,0.705792712306544,0.3524438012389,42,977,lipid metabolic process,BP,IL1B;TNF;HBEGF;SDC4;BMP2;PLAUR;IL1RN;NFKB1;EDN1;G0S2;HCAR2;EREG;PLAGL2;CYP27B1;NOD2;B3GNT5;FGF5;TXNRD1;PIGA;ADM;CREB1;ITGB8;HMGCS1;PDGFB;NRG1;LDLR;ARSJ;LACTB;SGMS2;TPRA1;STAT5A;CAV1;UGCG;PDP1;SDR16C5;NR4A3;PPARD;SLC16A1;CYP24A1;ALAS1;XBP1;QKI
3896,GO:0008528,0.706160210713858,0.662403481245537,1,27,G-protein coupled peptide receptor activity,MF,BDKRB1
9216,GO:0035601,0.706572539047562,0.4806107102442,4,100,protein deacylation,BP,VEGFA;CHD4;TP53;SDR16C5
3741,GO:0008277,0.706900608662365,0.509333108675034,3,78,regulation of G-protein coupled receptor protein signaling pathway,BP,CXCL8;EDN1;ADM
6736,GO:0030148,0.707136352993071,0.509046601227653,3,78,sphingolipid biosynthetic process,BP,TNF;SGMS2;UGCG
14836,GO:0070566,0.70765178819756,0.661276212057989,1,25,adenylyltransferase activity,MF,NMNAT2
4070,GO:0009119,0.708234297688487,0.507398840423215,3,83,ribonucleoside metabolic process,BP,AMPD3;TJP2;UPP1
11107,GO:0045111,0.708362208697605,0.478283565054091,4,104,intermediate filament cytoskeleton,CC,PHLDB2;KRT34;PJA2;VIM
16241,GO:0090277,0.708938248828919,0.555267352595286,2,53,positive regulation of peptide hormone secretion,BP,SOX4;PPARD
1475,GO:0003729,0.710096250322763,0.430046523515646,7,180,mRNA binding,MF,NOCT;ZC3H12A;ZFP36;ZFP36L1;CPEB2;TP53;QKI
15910,GO:0072665,0.710927276596778,0.552929804418985,2,52,protein localization to vacuole,BP,TNFAIP3;NEDD4
5807,GO:0017056,0.711339111907519,0.656793685775653,1,25,structural constituent of nuclear pore,MF,NUP153
2836,GO:0006304,0.711761407459494,0.503337533346956,3,79,DNA modification,BP,OTUD4;KMT2E;PARP1
13589,GO:0060042,0.711857681947409,0.656543385260295,1,24,retina morphogenesis in camera-type eye,BP,FJX1
655,GO:0001843,0.712818995518368,0.502315109474681,3,75,neural tube closure,BP,SDC4;ADM;WNT5A
13955,GO:0060606,0.712818995518368,0.502315109474681,3,75,tube closure,BP,SDC4;ADM;WNT5A
16845,GO:0098732,0.712991414539998,0.472828500110649,4,101,macromolecule deacylation,BP,VEGFA;CHD4;TP53;SDR16C5
3074,GO:0006641,0.713181069415084,0.550010012883189,2,53,triglyceride metabolic process,BP,LDLR;CAV1
6927,GO:0030515,0.713732495891622,0.652322173253324,1,30,snoRNA binding,MF,DIEXF
7346,GO:0031369,0.714121623005415,0.65239004300311,1,28,translation initiation factor binding,MF,GCH1
9900,GO:0042180,0.714135133891142,0.436515519519444,6,163,cellular ketone metabolic process,BP,BMP2;ODC1;ADM;CAV1;PDP1;NR4A3
10065,GO:0042551,0.714218004620702,0.653260917024813,1,25,neuron maturation,BP,NR4A2
18050,GO:1902555,0.714677643590828,0.651419303671143,1,29,endoribonuclease complex,CC,ZFP36
19244,GO:1905348,0.714677643590828,0.651419303671143,1,29,endonuclease complex,CC,ZFP36
20283,GO:2001222,0.714988610194728,0.652696873828018,1,24,regulation of neuron migration,BP,NRG1
3681,GO:0008180,0.714991549182834,0.651620843024265,1,27,COP9 signalosome,CC,NOD2
5724,GO:0016859,0.71502505615481,0.650476705404125,1,31,cis-trans isomerase activity,MF,PPIF
10069,GO:0042558,0.715788633973782,0.650328020343597,1,28,pteridine-containing compound metabolic process,BP,GCH1
18086,GO:1902652,0.716132282857607,0.468885220140091,4,104,secondary alcohol metabolic process,BP,CYP27B1;HMGCS1;LDLR;PPARD
6693,GO:0030057,0.716694156108318,0.650586925954179,1,24,desmosome,CC,B4GALT1
2828,GO:0006294,0.716840711881396,0.648736182295745,1,29,nucleotide-excision repair, preincision complex assembly,BP,PARP1
14556,GO:0070063,0.717583240734851,0.544507815118914,2,53,RNA polymerase binding,MF,ZFP36;NEDD4
13303,GO:0051984,0.718253354261018,0.647900811902735,1,26,positive regulation of chromosome segregation,BP,ESPL1
7481,GO:0031641,0.719629680541889,0.646180676001551,1,26,regulation of myelination,BP,NRG1
6103,GO:0019319,0.719698292082253,0.541615331950244,2,55,hexose biosynthetic process,BP,SOGA1;ATF3
3092,GO:0006665,0.719903693406309,0.444457950378585,5,129,sphingolipid metabolic process,BP,TNF;ITGB8;ARSJ;SGMS2;UGCG
17847,GO:1901992,0.720426618850087,0.540696239626488,2,55,positive regulation of mitotic cell cycle phase transition,BP,ESPL1;KMT2E
535,GO:0001653,0.7205063882948,0.644438683007152,1,28,peptide receptor activity,MF,BDKRB1
2681,GO:0006040,0.720620415261929,0.644604696433101,1,27,amino sugar metabolic process,BP,CHST2
11932,GO:0046966,0.720756055767081,0.644434222334073,1,27,thyroid hormone receptor binding,MF,MED13
5481,GO:0016410,0.720771347184708,0.492155696071048,3,80,N-acyltransferase activity,MF,ESCO2;SAT1;ALAS1
16614,GO:0097431,0.721461970739299,0.643880077422668,1,26,mitotic spindle pole,CC,MAPKBP1
6368,GO:0021545,0.722008764203396,0.643191175082665,1,26,cranial nerve development,BP,SIX4
15069,GO:0071011,0.722344524920121,0.641312798614786,1,31,precatalytic spliceosome,CC,MAPKBP1
9894,GO:0042169,0.722720783082466,0.64265475912049,1,25,SH2 domain binding,MF,SQSTM1
18824,GO:1904357,0.724440712338505,0.640113977431414,1,26,negative regulation of telomere maintenance via telomere lengthening,BP,PARP1
4205,GO:0009311,0.724490058163225,0.535657731440421,2,54,oligosaccharide metabolic process,BP,B4GALT1;MGAM
2371,GO:0005496,0.725014490506802,0.534875534822668,2,55,steroid binding,MF,STARD5;CAV1
5707,GO:0016831,0.725594645068996,0.637996661393578,1,28,carboxy-lyase activity,MF,ODC1
11849,GO:0046794,0.725849833917219,0.533809895537206,2,55,transport of virus,BP,NUP153;CAV1
10287,GO:0043029,0.72623230649914,0.637182661078666,1,28,T cell homeostasis,BP,PMAIP1
12883,GO:0051193,0.72658120293688,0.485029269279573,3,78,regulation of cofactor metabolic process,BP,NUP153;NFE2L2;PDP1
1126,GO:0002712,0.726714087504454,0.636879977860633,1,27,regulation of B cell mediated immunity,BP,TNF
1222,GO:0002889,0.726714087504454,0.636879977860633,1,27,regulation of immunoglobulin mediated immune response,BP,TNF
7192,GO:0031076,0.727156767697193,0.637017297059216,1,25,embryonic camera-type eye development,BP,WNT5A
3070,GO:0006636,0.72795411386691,0.634685058365982,1,29,unsaturated fatty acid biosynthetic process,BP,EDN1
11686,GO:0046460,0.727998866140277,0.63523388500308,1,27,neutral lipid biosynthetic process,BP,LDLR
11689,GO:0046463,0.727998866140277,0.63523388500308,1,27,acylglycerol biosynthetic process,BP,LDLR
16419,GO:0097035,0.728282436239218,0.635208669133104,1,26,regulation of membrane lipid distribution,BP,ABCA7
19633,GO:1990752,0.728753529865667,0.634970259000922,1,25,microtubule end,CC,NAV3
2895,GO:0006402,0.72893441760907,0.379287172180484,11,322,mRNA catabolic process,BP,BTG2;NOCT;ZC3H12A;ZFP36;PNRC1;ZFP36L1;PATL1;PNRC2;TNKS1BP1;VIM;QKI
8602,GO:0034109,0.729102068517482,0.529643797997521,2,55,homotypic cell-cell adhesion,BP,C1QTNF1;RAP2B
16274,GO:0090317,0.729218559761183,0.633057659484556,1,29,negative regulation of intracellular protein transport,BP,SOX4
8410,GO:0033365,0.729644871960497,0.337264946520138,29,731,protein localization to organelle,BP,NFKBIA;TNFAIP3;TNF;ZC3H12A;PPP1R15A;LIF;PMAIP1;EHD1;BBC3;BCL3;PLAGL2;SIX4;KLHL21;CDKN1A;ARL5B;TP53BP2;SOX4;ANLN;NRG1;NUP153;NEDD4;UGCG;TP53;UBE2D3;ABCA7;SPCS2;PML;ESCO2;GSK3B
11126,GO:0045143,0.729651256540783,0.632792547860231,1,28,homologous chromosome segregation,BP,ESPL1
3564,GO:0007606,0.729758126182852,0.632361398480157,1,29,sensory perception of chemical stimulus,BP,GJB4
9990,GO:0042383,0.730076534678308,0.480629458763361,3,78,sarcolemma,CC,SLC38A2;SLC9A1;CAV1
2717,GO:0006090,0.731622114086374,0.449833901627536,4,104,pyruvate metabolic process,BP,NUP153;PDP1;NR4A3;SLC16A1
7914,GO:0032482,0.733275669023234,0.523936169624622,2,58,Rab protein signal transduction,BP,RAB24;RAB9A
11751,GO:0046578,0.733539447110028,0.393483374314336,8,190,regulation of Ras protein signal transduction,BP,SQSTM1;CSF1;ARHGEF3;FGD6;NRG1;SPRY2;CYTH1;ITSN2
9732,GO:0038179,0.733738309836907,0.627804995760021,1,27,neurotrophin signaling pathway,BP,SPRY2
12690,GO:0050885,0.733745358505962,0.628138519154939,1,26,neuromuscular process controlling balance,BP,NR4A3
12206,GO:0048365,0.733916473577569,0.523784494069986,2,52,Rac GTPase binding,MF,CAV1;DOCK4
15333,GO:0071539,0.734313278644651,0.627397043021671,1,26,protein localization to centrosome,BP,GSK3B
12955,GO:0051301,0.734689371867231,0.343128255123939,21,507,cell division,BP,IL1B;IL1A;BIRC3;EREG;BIRC2;KLHL21;RND3;VEGFA;FGF5;ANKLE2;NEDD9;MASTL;VEGFC;TGFA;PDGFB;ANLN;PLK3;PARD6B;TPRA1;ESPL1;EVI2B
7654,GO:0032069,0.735038325293246,0.625489973081821,1,29,regulation of nuclease activity,BP,PTPN1
10790,GO:0044248,0.735060552815181,0.307506954197714,76,1801,cellular catabolic process,BP,IL1B;TNFAIP3;TNF;EFNA1;BTG2;PLEKHF1;NOCT;ZC3H12A;RNF19B;PMAIP1;ZFP36;PNRC1;TICAM1;SQSTM1;AMPD3;BIRC2;ADAM8;N4BP1;ZFP36L1;CYP27B1;RIPK2;CYLD;NEDD4L;CTSC;GPX3;RNF144B;TRIB1;RAB24;PLK2;ABL2;RNF43;UPP1;VMP1;DENND3;USP43;PATL1;PHKG2;SOGA1;ABTB2;SMURF2;TINAGL1;PNRC2;TRIM25;PPP1R3B;LDLR;PLK3;SLC9A1;MAOA;RCHY1;FEZ1;TNKS1BP1;HAL;NUP153;RNF152;NEDD4;NFE2L2;PTPN1;TAB3;PAOX;CAV1;DRAM1;TP53;UBE2D3;PML;ADAM9;SAT1;USP31;GSK3B;PPARD;CYP24A1;VIM;EGLN1;RNF145;XBP1;QKI;MGAM
6732,GO:0030140,0.735236992488309,0.625525856360311,1,28,trans-Golgi network transport vesicle,CC,RASSF9
4223,GO:0009395,0.735407830706808,0.625301740670359,1,28,phospholipid catabolic process,BP,LDLR
9950,GO:0042307,0.736691993424065,0.623933256302719,1,27,positive regulation of protein import into nucleus,BP,ZC3H12A
7865,GO:0032421,0.736919221154304,0.623314139451592,1,28,stereocilium bundle,CC,DOCK4
2319,GO:0005319,0.737041846920779,0.471653215886043,3,80,lipid transporter activity,MF,STARD5;ABCA5;ABCA7
7221,GO:0031111,0.73813997131749,0.622022993524361,1,27,negative regulation of microtubule polymerization or depolymerization,BP,NAV3
3514,GO:0007435,0.738232472706899,0.621900684903782,1,27,salivary gland morphogenesis,BP,TNF
6355,GO:0021532,0.738834619571045,0.621103695386338,1,27,neural tube patterning,BP,GORAB
3453,GO:0007266,0.738915777320427,0.406982183558392,6,149,Rho protein signal transduction,BP,RND3;ARHGEF3;FGD6;CDC42EP4;ITSN2;RHOV
10280,GO:0043021,0.739330115190966,0.439950413153246,4,110,ribonucleoprotein complex binding,MF,ZC3H12A;CPEB2;IFIH1;PIM1
8694,GO:0034314,0.739515396263769,0.619580414876574,1,29,Arp2/3 complex-mediated actin nucleation,BP,JMY
3357,GO:0007094,0.739682501685941,0.619358343283181,1,29,mitotic spindle assembly checkpoint,BP,DUSP1
15126,GO:0071173,0.739682501685941,0.619358343283181,1,29,spindle assembly checkpoint,BP,DUSP1
15127,GO:0071174,0.739682501685941,0.619358343283181,1,29,mitotic spindle checkpoint,BP,DUSP1
2528,GO:0005782,0.739917256930311,0.61876719693466,1,30,peroxisomal matrix,CC,PAOX
7569,GO:0031907,0.739917256930311,0.61876719693466,1,30,microbody lumen,CC,PAOX
2521,GO:0005773,0.740236040757897,0.330494627605568,25,602,vacuole,CC,IL1B;TNFAIP3;SDC4;PLEKHF1;RNF19B;TICAM1;SQSTM1;BBC3;ADAM8;ABCA5;CTSC;B4GALT1;RAB24;VMP1;IFNAR1;TINAGL1;SLC11A2;LDLR;RNF152;MMD;DRAM1;RAB9A;TRIP10;FRK;NR4A3
12792,GO:0051054,0.740501961457027,0.393796392063353,7,181,positive regulation of DNA metabolic process,BP,CSF2;JUN;EREG;PDGFB;OTUD4;PML;PARP1
11632,GO:0046326,0.741567542761361,0.617816809606214,1,26,positive regulation of glucose import,BP,NFE2L2
2605,GO:0005901,0.741802426241114,0.513342973146663,2,53,caveola,CC,TGFBR2;CAV1
12295,GO:0048599,0.742011251471026,0.616552725269827,1,28,oocyte development,BP,EREG
16349,GO:0090568,0.742126666677448,0.616721463643548,1,27,nuclear transcriptional repressor complex,CC,CHD4
6774,GO:0030204,0.742280472203125,0.616515687521676,1,27,chondroitin sulfate metabolic process,BP,DSE
829,GO:0002102,0.74233317242277,0.616445158608114,1,27,podosome,CC,ADAM8
10682,GO:0043928,0.74279828380157,0.614178934882108,1,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,PATL1
11635,GO:0046329,0.742859672017079,0.615416319776413,1,28,negative regulation of JNK cascade,BP,DUSP10
10412,GO:0043244,0.743153168877499,0.463871227004982,3,79,regulation of protein complex disassembly,BP,TNF;NAV3;SPTBN5
5853,GO:0017145,0.743547699919603,0.614816720848384,1,27,stem cell division,BP,EVI2B
137,GO:0000287,0.743703236582793,0.400947738850725,6,156,magnesium ion binding,MF,NUAK2;MAP3K8;ABL2;MAST4;GEM;RPS6KA6
17931,GO:1902229,0.744649867185596,0.611684755669214,1,33,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,MUC1
14123,GO:0060964,0.744953964819914,0.460340336820882,3,103,regulation of gene silencing by miRNA,BP,ZC3H12A;ZFP36;NUP153
7402,GO:0031461,0.745482764891852,0.39873486642889,6,157,cullin-RING ubiquitin ligase complex,CC,KLHL21;ZSWIM4;BACH1;ABTB2;KLHL5;KBTBD7
4650,GO:0010769,0.745559362465819,0.378944656093516,8,197,regulation of cell morphogenesis involved in differentiation,BP,EFNA1;NEDD4L;VEGFA;ZSWIM4;SEMA4B;WNT5A;NRG1;NEDD4
13489,GO:0055010,0.745673285181015,0.611952692333767,1,27,ventricular cardiac muscle tissue morphogenesis,BP,NRG1
12161,GO:0048259,0.745864590429828,0.507613650264675,2,56,regulation of receptor-mediated endocytosis,BP,VEGFA;DKK1
727,GO:0001953,0.746489603740161,0.610848001286318,1,27,negative regulation of cell-matrix adhesion,BP,PHLDB2
87,GO:0000175,0.747539878641336,0.608509501047386,1,30,3'-5'-exoribonuclease activity,MF,NOCT
14794,GO:0070491,0.747541310326743,0.505379014053779,2,56,repressing transcription factor binding,MF,CHD4;RELA
416,GO:0001103,0.747749996448619,0.608506690480833,1,29,RNA polymerase II repressing transcription factor binding,MF,CHD4
4964,GO:0015036,0.748284970666028,0.606529488105008,1,34,disulfide oxidoreductase activity,MF,TXNRD1
5694,GO:0016810,0.748367678392598,0.428505356361697,4,110,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,AMPD3;GCH1;PGLYRP4;CHD4
19304,GO:1905508,0.748515152018824,0.608095378648795,1,27,protein localization to microtubule organizing center,BP,GSK3B
12375,GO:0048747,0.748717277805125,0.607492537074912,1,28,muscle fiber development,BP,VEGFA
6912,GO:0030496,0.748800899105497,0.394659529266238,6,156,midbody,CC,BCL3;CYLD;ANLN;RASGEF1B;CLIC4;GEM
10441,GO:0043292,0.749512634218604,0.407854480472867,5,134,contractile fiber,CC,SDC4;SQSTM1;PDE4DIP;JPH2;LMAN1
5564,GO:0016572,0.749583409673084,0.606004402256754,1,29,histone phosphorylation,BP,IL1B
5443,GO:0016303,0.750579176991141,0.605627559663594,1,26,1-phosphatidylinositol-3-kinase activity,MF,FGF5
618,GO:0001784,0.750621650778923,0.605215195256565,1,27,phosphotyrosine residue binding,MF,ABL2
4826,GO:0014020,0.750682537583046,0.454025558974982,3,80,primary neural tube formation,BP,SDC4;ADM;WNT5A
11844,GO:0046782,0.751044809987694,0.500273416032006,2,60,regulation of viral transcription,BP,ZFP36;JUN
8995,GO:0035107,0.751116568533831,0.425235438747408,4,104,appendage morphogenesis,BP,TBX3;DKK1;WNT5A;SOX4
8996,GO:0035108,0.751116568533831,0.425235438747408,4,104,limb morphogenesis,BP,TBX3;DKK1;WNT5A;SOX4
7605,GO:0031981,0.751614519748661,0.280133968960495,152,3519,nuclear lumen,CC,NFKBIZ;IRF1;ITPKC;BIRC3;NOCT;FOSL1;ZC3H12A;IL16;ELF3;PRDM1;EHF;MAFF;NFKB1;TNIP1;MAP2K3;JUN;KDM6B;ETS1;SQSTM1;BHLHE40;SERTAD2;NFKBIE;KLF6;REL;BCL3;GADD45A;ETS2;ZNF436;NFKB2;N4BP1;JUNB;TNFAIP8;WTAP;TJP2;RELB;ZNF217;CDKN1A;GBP2;ZNF451;NEDD4L;CTSC;ELMSAN1;SGK1;GCH1;SMAD3;ARNTL2;PHLDA1;TXNRD1;TMEM217;UPP1;CEBPB;CEBPD;VMP1;NAMPT;TP53BP2;DSE;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;NEDD9;NR4A2;PATL1;VHL;ABTB2;RUNX1;SMURF2;DUSP16;SFR1;DDX3Y;TGIF2;PNRC2;TRIM25;MASTL;ABCF1;DUSP10;SOX4;ANLN;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;H1FX;NUP153;POU2F2;NFE2L2;SMAD1;MXD1;CHD4;DIEXF;CLIC4;NFAT5;STAT5A;VEZF1;SH3RF2;INO80D;TNIP2;TP53;NOM1;KLF3;STK40;IKBKE;UBE2D3;DOCK4;TRIP10;ELK3;RAD9B;SNAPC4;UBE2Z;PML;POLR3A;PIM1;RELA;RAPH1;TRIM16;ESCO2;SPATA2;PPP6R3;MUC1;YARS2;AKIRIN1;ELL2;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;CYP24A1;KDM7A;MED13;JMY;SRSF11;NABP1;ALAS1;RPS6KA6;XBP1;ELF4;TFE3;EID3;ZMIZ2;JUND
1980,GO:0004693,0.752044518105033,0.602338528295458,1,30,cyclin-dependent protein serine/threonine kinase activity,MF,CDKN1A
11436,GO:0045841,0.752766594059883,0.601341673595044,1,30,negative regulation of mitotic metaphase/anaphase transition,BP,DUSP1
17881,GO:1902100,0.752766594059883,0.601341673595044,1,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,DUSP1
17809,GO:1901879,0.752810048530959,0.498418457437775,2,55,regulation of protein depolymerization,BP,NAV3;SPTBN5
20199,GO:2001020,0.75281776855218,0.38954792742211,6,162,regulation of response to DNA damage stimulus,BP,PMAIP1;IER3;PML;MUC1;PARP1;EID3
3906,GO:0008543,0.75340897808025,0.450208237979086,3,84,fibroblast growth factor receptor signaling pathway,BP,FGF5;WNT5A;SPRY2
4376,GO:0009994,0.754024325123047,0.599886741934618,1,29,oocyte differentiation,BP,EREG
5408,GO:0016242,0.754033556817915,0.599873940487756,1,29,negative regulation of macroautophagy,BP,FEZ1
15005,GO:0070911,0.754277172030254,0.598730564921667,1,32,global genome nucleotide-excision repair,BP,PARP1
12524,GO:0050654,0.75428100850947,0.59983814978209,1,28,chondroitin sulfate proteoglycan metabolic process,BP,DSE
2297,GO:0005254,0.754312412353431,0.599487090229502,1,29,chloride channel activity,MF,CLIC4
10026,GO:0042455,0.754426024912596,0.598066713862715,1,34,ribonucleoside biosynthetic process,BP,UPP1
7042,GO:0030811,0.7544868046235,0.496151176087157,2,55,regulation of nucleotide catabolic process,BP,NUP153;EGLN1
6450,GO:0021762,0.754838746675301,0.598200938825798,1,31,substantia nigra development,BP,ZNF148
17439,GO:1900182,0.754969463579016,0.495275854544597,2,57,positive regulation of protein localization to nucleus,BP,ZC3H12A;LIF
10266,GO:0043001,0.755155881317632,0.59831500864134,1,29,Golgi to plasma membrane protein transport,BP,SYS1
10572,GO:0043531,0.756109942283767,0.596985696113943,1,29,ADP binding,MF,TAP1
7816,GO:0032365,0.756163302959961,0.596911235946814,1,29,intracellular lipid transport,BP,LDLR
12863,GO:0051168,0.756183879419775,0.374517499456527,7,187,nuclear export,BP,IL1B;DUSP16;SOX4;NUP153;TP53;GSK3B;SRSF11
17833,GO:1901976,0.756253643435161,0.596497461864308,1,30,regulation of cell cycle checkpoint,BP,DUSP1
3064,GO:0006626,0.756400055770614,0.417823349595089,4,121,protein targeting to mitochondrion,BP,PLAGL2;NRG1;UGCG;UBE2D3
18138,GO:1902808,0.756416507117255,0.596269980838173,1,30,positive regulation of cell cycle G1/S phase transition,BP,KMT2E
3559,GO:0007600,0.756569745461764,0.365391574497711,8,209,sensory perception,BP,EDN1;BDKRB1;ICAM1;GJB4;SLC52A3;SLC9A1;SPRY2;GJC1
9931,GO:0042274,0.756615417907809,0.49191504816674,2,70,ribosomal small subunit biogenesis,BP,DIEXF;NOM1
8976,GO:0035064,0.756915731891767,0.492739817395033,2,56,methylated histone binding,MF,KMT2E;KDM7A
17296,GO:0140034,0.756915731891767,0.492739817395033,2,56,methylation-dependent protein binding,MF,KMT2E;KDM7A
13132,GO:0051656,0.757741509936787,0.333708291294362,14,349,establishment of organelle localization,BP,CTSC;MREG;KIF3C;TGFA;SPRY2;FEZ1;IL4R;GEM;STX1A;ADGRE2;ESPL1;PPP6R3;NR4A3;LMAN1
19392,GO:1905819,0.757935188909622,0.593873772357767,1,31,negative regulation of chromosome separation,BP,DUSP1
20152,GO:2000816,0.757935188909622,0.593873772357767,1,31,negative regulation of mitotic sister chromatid separation,BP,DUSP1
10902,GO:0044444,0.758527455348289,0.269938054929634,317,7177,cytoplasmic part,CC,NFKBIZ;IL1B;NFKBIA;TNFAIP3;TNF;IRF1;HBEGF;PLAU;CXCL1;IL1A;ITPKC;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;FOSL1;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;LIF;PLAUR;SOD2;PMAIP1;EHF;PTX3;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;JUN;TICAM1;RAB3IP;EHD1;TRAF1;SQSTM1;CSF1;N4BP3;SPRR2D;SERTAD2;STARD5;NFKBIE;BBC3;KLF6;IRF6;IL23A;REL;BCL3;PELI1;AMPD3;BIRC2;IFNGR2;IL6;ETS2;ZNF436;NFKB2;ADAM8;BDKRB1;PIM3;PANX1;ZFP36L1;CYP27B1;RIPK2;IRAK2;KLHL21;DAPP1;PHLDB2;CYLD;FZD8;TJP2;RELB;ZNF217;STEAP4;AMOTL2;CDKN1A;NMNAT2;ITGA5;GBP2;RAP2B;ABCA5;IL7R;ODC1;TNFAIP2;NEDD4L;CTSC;NOD2;DCUN1D3;SAV1;SGK1;GCH1;TRIM47;RASSF9;SMAD3;B4GALT1;NFKBIB;C15ORF39;PHLDA1;B3GNT5;RNF144B;RND3;TRAF4;KRT34;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;DKK1;CDKN2B;PLK2;MAP3K8;ABL2;PPTC7;C3ORF52;CDV3;CFLAR;RNF43;TXNRD1;LACC1;PIGA;ANXA8;UPP1;PPP4R4;VMP1;CD55;DENND3;NAMPT;TAP1;TP53BP2;ANKLE2;CDC42EP4;SLC28A3;IFNAR1;DSE;ERRFI1;ADAMTS1;CREB1;GORAB;WISP1;NEDD9;PATL1;CD47;CANT1;VHL;PHKG2;BACH1;ABTB2;PDE4DIP;RUNX1;TGFBR2;MREG;SMURF2;DUSP16;DDX3Y;SAA1;GPBP1;TINAGL1;PNRC2;KLHL5;TRIM25;KIF3C;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;ANLN;IFIH1;TNC;MMP9;LDLR;COL12A1;CAB39;IL32;TLE1;PLK3;ARRDC4;RASGEF1B;PARD6B;MT2A;SUCO;SLC9A1;SLC25A37;SYS1;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;B4GALT5;HAL;CYTH1;GRB7;ARSJ;NUP153;BCL2L2;RNF152;NEDD4;MMD;RHCG;DUS4L;MARCKS;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CLIC4;NFAT5;STAT5A;TPST1;CAV1;RHOV;HLA-A;UACA;DRAM1;TNIP2;NECAP2;UGCG;GOLGA8B;TP53;TLR2;ABI1;STK40;TAPBP;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;UBE2D3;PJA2;STX1A;DOCK4;TRIP10;ELK3;JPH2;SPRR2A;ABCA7;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;RELA;RAPH1;TRIM16;MAMDC2;ESCO2;SLC9A8;PPP6R3;COL27A1;PLAT;CHST2;MUC1;YARS2;SLC16A13;ANXA5;THSD1;SAT1;FRK;HLA-F;NR4A3;HLA-E;GSK3B;SLC16A1;PARP1;CYP24A1;LAMA3;OCLN;COTL1;COL8A1;VIM;EGLN1;NABP1;ALAS1;RPS6KA6;CEP135;XBP1;HSPA4L;EPB41L3;TFE3;ZMIZ2;MGAM;LMAN1;GJC1;DENND4A
5152,GO:0015682,0.759063305407687,0.592034261826591,1,32,ferric iron transport,BP,STEAP4
15827,GO:0072512,0.759063305407687,0.592034261826591,1,32,trivalent inorganic cation transport,BP,STEAP4
11653,GO:0046364,0.759096727631889,0.489350155780917,2,60,monosaccharide biosynthetic process,BP,SOGA1;ATF3
17892,GO:1902116,0.760506900962407,0.590520278149299,1,30,negative regulation of organelle assembly,BP,FEZ1
3621,GO:0008076,0.760926172569409,0.590217029335172,1,29,voltage-gated potassium channel complex,CC,STX1A
5671,GO:0016776,0.760966961883228,0.589344168150385,1,32,phosphotransferase activity, phosphate group as acceptor,MF,TJP2
141,GO:0000291,0.761361856559948,0.58811027690578,1,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,PATL1
14344,GO:0061512,0.761553728355686,0.589037452694148,1,30,protein localization to cilium,BP,EHD1
3361,GO:0007098,0.761743422432736,0.41135675780822,4,108,centrosome cycle,BP,GADD45A;PLK2;SLC16A1;CEP135
12101,GO:0048066,0.762059486113483,0.588319379917766,1,30,developmental pigmentation,BP,MREG
2608,GO:0005905,0.762240706181746,0.485448218321773,2,56,clathrin-coated pit,CC,LDLR;NECAP2
20126,GO:2000772,0.762597402552602,0.587282574413003,1,31,regulation of cellular senescence,BP,PLK2
12772,GO:0051028,0.762671550576792,0.391155530355537,5,135,mRNA transport,BP,ZFP36;ZFP36L1;NUP153;SRSF11;QKI
13656,GO:0060147,0.762746132807851,0.436834476863284,3,106,regulation of posttranscriptional gene silencing,BP,ZC3H12A;ZFP36;NUP153
14125,GO:0060966,0.762746132807851,0.436834476863284,3,106,regulation of gene silencing by RNA,BP,ZC3H12A;ZFP36;NUP153
10675,GO:0043902,0.762875062170431,0.390712476715186,5,142,positive regulation of multi-organism process,BP,INHBA;JUN;RIPK2;SMURF2;PGLYRP4
6621,GO:0022839,0.762956638456804,0.409816715844371,4,107,ion gated channel activity,MF,KCNJ15;CLIC4;ITGAV;JPH2
16634,GO:0097472,0.763523431938535,0.585962404078191,1,31,cyclin-dependent protein kinase activity,MF,CDKN1A
9638,GO:0036503,0.763524733196986,0.436688735293946,3,86,ERAD pathway,BP,TRIM25;NFE2L2;CAV1
11720,GO:0046503,0.764067386490714,0.585185214603094,1,31,glycerolipid catabolic process,BP,LDLR
11583,GO:0046128,0.764309019737948,0.481992619079065,2,62,purine ribonucleoside metabolic process,BP,AMPD3;TJP2
3416,GO:0007200,0.764764233186801,0.58418771664369,1,31,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,EDN1
3113,GO:0006690,0.765142788718413,0.480838065184449,2,62,icosanoid metabolic process,BP,EDN1;TLR2
5720,GO:0016853,0.765375311489411,0.406162643571721,4,121,isomerase activity,MF,PPIF;DSE;HMGCS1;PUS10
5683,GO:0016791,0.765406320811487,0.354582347951613,8,206,phosphatase activity,MF,DUSP1;PPTC7;DUSP16;DUSP10;PPP1R3B;DUSP8;PTPN1;PDP1
12230,GO:0048471,0.766060386883048,0.307282645070552,21,514,perinuclear region of cytoplasm,CC,INHBA;PLEKHF1;NOCT;CSF1;NFKBIE;BCL3;CYLD;CDKN1A;GBP2;ODC1;DCUN1D3;TRAF4;TP53BP2;SLC11A2;TGFA;MT2A;SLC9A1;NEDD4;CLIC4;CAV1;TRIP10
10693,GO:0043967,0.766141427538169,0.479737662493816,2,59,histone H4 acetylation,BP,TRIM16;MUC1
8527,GO:0033762,0.766338798487808,0.582199720143423,1,30,response to glucagon,BP,CREB1
18920,GO:1904591,0.766481057681194,0.581994922835929,1,30,positive regulation of protein import,BP,ZC3H12A
12879,GO:0051187,0.767154848325009,0.579812433999822,1,35,cofactor catabolic process,BP,GPX3
12803,GO:0051084,0.76720421903954,0.580678458419837,1,31,'de novo' posttranslational protein folding,BP,HSPA4L
15906,GO:0072659,0.767960803329036,0.359951772773441,7,183,protein localization to plasma membrane,BP,TNF;PLEKHF1;EPHA2;SQSTM1;SYS1;CRB3;EPB41L3
4539,GO:0010608,0.768983391788728,0.30750272115076,19,507,posttranscriptional regulation of gene expression,BP,TNF;BTG2;NOCT;ZC3H12A;PPP1R15A;ZFP36;BCL3;IL6;ZFP36L1;CPEB2;SMAD3;SOX4;GRB7;NUP153;SMAD1;ZC3H7B;CAV1;VIM;QKI
6619,GO:0022836,0.769067793742028,0.401773919063062,4,108,gated channel activity,MF,KCNJ15;CLIC4;ITGAV;JPH2
2724,GO:0006101,0.769785936534484,0.576679323628219,1,32,citrate metabolic process,BP,STAT5A
7702,GO:0032155,0.770148526236998,0.47425058557376,2,58,cell division site part,CC,MASTL;ANLN
8268,GO:0033047,0.770248309859963,0.473815134272291,2,61,regulation of mitotic sister chromatid segregation,BP,DUSP1;ESPL1
20311,GO:2001259,0.770560100132882,0.576085045040023,1,30,positive regulation of cation channel activity,BP,JPH2
13684,GO:0060193,0.770994328194865,0.575175823872186,1,31,positive regulation of lipase activity,BP,ABL2
7448,GO:0031577,0.771646660852101,0.573963790042334,1,32,spindle checkpoint,BP,DUSP1
8891,GO:0034705,0.772218145212698,0.57366181529007,1,30,potassium channel complex,CC,STX1A
12633,GO:0050804,0.772633521690374,0.354089032161203,7,183,modulation of chemical synaptic transmission,BP,IL1B;EDN1;SQSTM1;DKK1;PLK2;CREB1;STX1A
17036,GO:0099177,0.772633521690374,0.354089032161203,7,183,regulation of trans-synaptic signaling,BP,IL1B;EDN1;SQSTM1;DKK1;PLK2;CREB1;STX1A
9746,GO:0038202,0.77285714660147,0.572448021828302,1,31,TORC1 signaling,BP,RNF152
6769,GO:0030199,0.77306191507701,0.572720071154096,1,29,collagen fibril organization,BP,COL12A1
4561,GO:0010639,0.773231970362003,0.326954334465347,11,282,negative regulation of organelle organization,BP,LIF;PPIF;DUSP1;PHLDB2;ZNF451;NAV3;FEZ1;SPTBN5;SDR16C5;ESPL1;PARP1
6222,GO:0019751,0.773515560984467,0.423212069061981,3,86,polyol metabolic process,BP,ITPKC;CYP27B1;GCH1
5753,GO:0016896,0.773811944447446,0.570784393351156,1,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,NOCT
10315,GO:0043087,0.774486190679242,0.310885041241677,15,362,regulation of GTPase activity,BP,CCL20;JUN;EPHA2;CPEB2;ICAM1;FGD6;CDC42EP4;ERRFI1;WNT5A;RASGEF1B;SPRY2;DOCK4;TRIP10;GSK3B;TBC1D22B
7637,GO:0032040,0.774680014983887,0.569260011627351,1,33,small-subunit processome,CC,DIEXF
7184,GO:0031062,0.774907992962798,0.569704473395825,1,30,positive regulation of histone methylation,BP,KMT2E
12905,GO:0051233,0.775441071173937,0.568638547741635,1,31,spindle midzone,CC,GEM
10760,GO:0044183,0.775762405293609,0.567658140905144,1,33,protein binding involved in protein folding,MF,HSPA4L
18021,GO:1902475,0.775785158124081,0.568128988829206,1,31,L-alpha-amino acid transmembrane transport,BP,SLC7A2
19033,GO:1904837,0.776151574994636,0.565559973659561,1,41,beta-catenin-TCF complex assembly,BP,TLE1
8541,GO:0033865,0.776231696171403,0.566961972016634,1,33,nucleoside bisphosphate metabolic process,BP,TPST1
8547,GO:0033875,0.776231696171403,0.566961972016634,1,33,ribonucleoside bisphosphate metabolic process,BP,TPST1
8568,GO:0034032,0.776231696171403,0.566961972016634,1,33,purine nucleoside bisphosphate metabolic process,BP,TPST1
2783,GO:0006213,0.776635663818075,0.565710741829354,1,36,pyrimidine nucleoside metabolic process,BP,UPP1
15839,GO:0072528,0.777145717159207,0.564951507843191,1,36,pyrimidine-containing compound biosynthetic process,BP,UPP1
13232,GO:0051879,0.777674513813769,0.565321451038572,1,31,Hsp90 protein binding,MF,NOD2
9935,GO:0042278,0.778205489037686,0.462300557352402,2,64,purine nucleoside metabolic process,BP,AMPD3;TJP2
7414,GO:0031492,0.778740678530023,0.56154640228046,1,42,nucleosomal DNA binding,MF,CHD4
5300,GO:0015980,0.778752526230819,0.345880444550069,7,217,energy derivation by oxidation of organic compounds,BP,PHLDA2;IL6ST;PHKG2;PPP1R3B;STK40;NR4A3;GSK3B
12530,GO:0050660,0.778914097492145,0.461653336304333,2,60,flavin adenine dinucleotide binding,MF,TXNRD1;DUS4L
8862,GO:0034656,0.779256562052656,0.562002125180406,1,35,nucleobase-containing small molecule catabolic process,BP,UPP1
15195,GO:0071320,0.780649562284739,0.561147531331453,1,30,cellular response to cAMP,BP,ZFP36L1
15328,GO:0071526,0.78109106403619,0.560783199358171,1,29,semaphorin-plexin signaling pathway,BP,SEMA4B
2966,GO:0006501,0.781393746339153,0.559006160491863,1,34,C-terminal protein lipidation,BP,RAET1L
8260,GO:0033036,0.781413278611477,0.253497875959902,97,2268,macromolecule localization,BP,IL1B;NFKBIA;TNFAIP3;TNF;IL1A;INHBA;PLEKHF1;ZC3H12A;PPP1R15A;LIF;PMAIP1;IL1RN;NFKB1;EDN1;ZFP36;RAB3IP;EPHA2;EHD1;HCAR2;SQSTM1;STARD5;NFKBIE;BBC3;BCL3;PLAGL2;IL6;ADAM8;PIM3;PANX1;ZFP36L1;SIX4;RIPK2;KLHL21;PHLDB2;CYLD;C1QTNF1;CDKN1A;ABCA5;TNFAIP2;NEDD4L;ARL5B;NOD2;RASSF9;RAB24;IL1R2;TAP1;TP53BP2;TGFBR2;DUSP16;SAA1;WNT5A;VEGFC;SOX4;ANLN;IFIH1;NRG1;LDLR;PLK3;ARRDC4;SYS1;NUP153;IL4R;NEDD4;MMD;POU2F2;MARCKS;BTN2A2;PTPN1;CAV1;NECAP2;UGCG;TP53;TLR2;RAB9A;ITGAV;IKBKE;UBE2D3;STX1A;MAPKBP1;ABCA7;SPCS2;PML;ADAM9;TRIM16;ESCO2;CRB3;HLA-E;GSK3B;PPARD;SLC16A1;PARP1;TBC1D22B;SRSF11;XBP1;QKI;EPB41L3;IL36RN
14147,GO:0060999,0.782051295003264,0.559035387145451,1,30,positive regulation of dendritic spine development,BP,NRG1
223,GO:0000462,0.782267113939623,0.557067027304852,1,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,DIEXF
5284,GO:0015932,0.782753252756391,0.557183137929036,1,33,nucleobase-containing compound transmembrane transporter activity,MF,SLC28A3
2369,GO:0005484,0.783437671628008,0.555912995301205,1,34,SNAP receptor activity,MF,STX1A
7059,GO:0030833,0.784727483541829,0.380623695604271,4,116,regulation of actin filament polymerization,BP,ICAM1;CDC42EP4;SPTBN5;JMY
17677,GO:1901505,0.784908407886608,0.553908107688124,1,33,carbohydrate derivative transmembrane transporter activity,MF,SLC28A3
11910,GO:0046928,0.785388332580204,0.553687950324325,1,31,regulation of neurotransmitter secretion,BP,STX1A
3410,GO:0007193,0.785935727913184,0.552851798833441,1,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,EDN1
3905,GO:0008542,0.786732953812623,0.551631478667648,1,31,visual learning,BP,CREB1
135,GO:0000281,0.787058405982617,0.449919778374927,2,60,mitotic cytokinesis,BP,ANLN;ESPL1
20253,GO:2001169,0.787352901846055,0.449491516594659,2,60,regulation of ATP biosynthetic process,BP,NUP153;PARP1
10890,GO:0044427,0.787379600372544,0.271087937403949,30,774,chromosomal part,CC,IRF1;JUN;KDM6B;JUNB;SMAD3;PLK2;CEBPB;CREB1;SFR1;BAZ1A;TNKS1BP1;H1FX;NEDD4;NFE2L2;MXD1;CHD4;TP53;RAD9B;SDR16C5;PML;RELA;ESCO2;MUC1;KMT2E;PPARD;PARP1;NABP1;EID3;ZMIZ2;JUND
13637,GO:0060113,0.788379232852053,0.548836523243663,1,32,inner ear receptor cell differentiation,BP,SDC4
8269,GO:0033048,0.788634027502392,0.547960389948313,1,34,negative regulation of mitotic sister chromatid segregation,BP,DUSP1
4488,GO:0010507,0.788973320632532,0.447130031439832,2,60,negative regulation of autophagy,BP,FEZ1;TAB3
9036,GO:0035249,0.790284949309405,0.546157366676245,1,31,synaptic transmission, glutamatergic,BP,DKK1
15771,GO:0072350,0.790333280625039,0.545331787836142,1,34,tricarboxylic acid metabolic process,BP,STAT5A
3068,GO:0006633,0.790691894154687,0.399112109749827,3,93,fatty acid biosynthetic process,BP,EDN1;XBP1;QKI
14330,GO:0061462,0.790711341814262,0.545229874153889,1,32,protein localization to lysosome,BP,NEDD4
18361,GO:1903312,0.791562479274007,0.44324306739879,2,61,negative regulation of mRNA metabolic process,BP,NOCT;ZFP36
2902,GO:0006409,0.791569876673429,0.54389548623957,1,32,tRNA export from nucleus,BP,NUP153
15272,GO:0071431,0.791569876673429,0.54389548623957,1,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,NUP153
5584,GO:0016597,0.792257160289694,0.542574252617299,1,33,amino acid binding,MF,YARS2
7060,GO:0030834,0.792351226885404,0.542677933384554,1,32,regulation of actin filament depolymerization,BP,SPTBN5
3308,GO:0007009,0.793141354089699,0.441016301211678,2,60,plasma membrane organization,BP,CAV1;EPB41L3
6754,GO:0030170,0.79314193305013,0.541192020750078,1,33,pyridoxal phosphate binding,MF,ALAS1
14680,GO:0070279,0.79314193305013,0.541192020750078,1,33,vitamin B6 binding,MF,ALAS1
18022,GO:1902476,0.794172800071714,0.53982778535298,1,32,chloride transmembrane transport,BP,CLIC4
7080,GO:0030864,0.794423913007816,0.439222724835894,2,59,cortical actin cytoskeleton,CC,ANLN;SPTBN5
6851,GO:0030315,0.794429723200048,0.539692133751592,1,31,T-tubule,CC,SLC9A1
11147,GO:0045184,0.794923937038992,0.244988667074718,65,1584,establishment of protein localization,BP,IL1B;NFKBIA;TNFAIP3;TNF;IL1A;ZC3H12A;PMAIP1;IL1RN;RAB3IP;EHD1;HCAR2;BBC3;BCL3;PLAGL2;IL6;ADAM8;PIM3;PANX1;RIPK2;PHLDB2;CDKN1A;NOD2;RASSF9;RAB24;IL1R2;TAP1;TP53BP2;DUSP16;SAA1;WNT5A;VEGFC;SOX4;IFIH1;NRG1;PLK3;ARRDC4;SYS1;NUP153;IL4R;NEDD4;POU2F2;MARCKS;BTN2A2;PTPN1;NECAP2;UGCG;TP53;TLR2;RAB9A;ITGAV;UBE2D3;STX1A;MAPKBP1;SPCS2;PML;ADAM9;TRIM16;HLA-E;GSK3B;PPARD;SLC16A1;TBC1D22B;SRSF11;XBP1;IL36RN
5579,GO:0016592,0.795084545853825,0.537684574843005,1,35,mediator complex,CC,MED13
12162,GO:0048260,0.795127717687164,0.538075683765638,1,33,positive regulation of receptor-mediated endocytosis,BP,VEGFA
9352,GO:0035861,0.795640954760988,0.537518670851579,1,32,site of double-strand break,CC,ESCO2
3234,GO:0006888,0.795767179581198,0.334492530489882,6,170,ER to Golgi vesicle-mediated transport,BP,CTSC;CD55;TGFA;SPTBN5;PPP6R3;LMAN1
16264,GO:0090307,0.795804889249719,0.436983248948695,2,61,mitotic spindle assembly,BP,BIRC3;BIRC2
15927,GO:0072686,0.795811468926332,0.392137732925273,3,88,mitotic spindle,CC,GEM;MAPKBP1;ESPL1
3628,GO:0008089,0.795942885669889,0.536554089675172,1,34,anterograde axonal transport,BP,FEZ1
6866,GO:0030331,0.798245697881452,0.533142934075278,1,33,estrogen receptor binding,MF,PARP1
11103,GO:0045104,0.798626275454383,0.532537500663254,1,33,intermediate filament cytoskeleton organization,BP,VIM
3315,GO:0007019,0.79867697928953,0.532709421270784,1,32,microtubule depolymerization,BP,NAV3
5781,GO:0016999,0.798820504126655,0.387432284395889,3,97,antibiotic metabolic process,BP,GPX3;HAL;STAT5A
3786,GO:0008347,0.799458473202848,0.531211061573138,1,33,glial cell migration,BP,CSF1
11201,GO:0045296,0.800075091019108,0.293818000797284,11,298,cadherin binding,MF,EPHA2;EHD1;PHLDB2;TJP2;TRIM25;ANLN;EFHD2;TNKS1BP1;H1FX;PTPN1;ABI1
13030,GO:0051452,0.800677702215584,0.528387070635718,1,37,intracellular pH reduction,BP,CLIC4
12952,GO:0051298,0.801236716595242,0.428879889747972,2,61,centrosome duplication,BP,PLK2;CEP135
14239,GO:0061178,0.801389156465173,0.527445329090444,1,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,PIM3
2300,GO:0005267,0.801543159265389,0.527872797279335,1,33,potassium channel activity,MF,KCNJ15
5228,GO:0015833,0.801633328669582,0.238370929564997,62,1521,peptide transport,BP,IL1B;NFKBIA;TNF;IL1A;ZC3H12A;IL1RN;EDN1;RAB3IP;EHD1;HCAR2;BCL3;PLAGL2;IL6;ADAM8;PIM3;PANX1;RIPK2;CDKN1A;NOD2;RASSF9;RAB24;IL1R2;TAP1;DUSP16;SAA1;WNT5A;VEGFC;SOX4;IFIH1;NRG1;PLK3;ARRDC4;SYS1;NUP153;IL4R;NEDD4;POU2F2;MARCKS;BTN2A2;PTPN1;NECAP2;UGCG;TP53;TLR2;TAPBP;RAB9A;ITGAV;UBE2D3;STX1A;MAPKBP1;SPCS2;PML;ADAM9;TRIM16;HLA-E;GSK3B;PPARD;SLC16A1;TBC1D22B;SRSF11;XBP1;IL36RN
12775,GO:0051031,0.801691643514165,0.527634176523785,1,33,tRNA transport,BP,NUP153
13525,GO:0055081,0.801770551219148,0.527760987926394,1,32,anion homeostasis,BP,XBP1
2961,GO:0006493,0.802526623657964,0.382454995301293,3,90,protein O-linked glycosylation,BP,B3GNT5;B4GALT5;MUC1
14643,GO:0070206,0.802847286892818,0.525309312636785,1,35,protein trimerization,BP,C1QTNF1
3801,GO:0008376,0.80304603932698,0.525452358979922,1,33,acetylgalactosaminyltransferase activity,MF,B3GNT5
3881,GO:0008509,0.803308738087908,0.3146605747323,7,189,anion transmembrane transporter activity,MF,SLC6A14;SLC7A2;SLC52A3;SLC38A2;CLIC4;SLC16A13;SLC16A1
10041,GO:0042490,0.80376361548451,0.524053444775501,1,34,mechanoreceptor differentiation,BP,SDC4
6861,GO:0030326,0.80390542537061,0.380575162190187,3,88,embryonic limb morphogenesis,BP,TBX3;DKK1;WNT5A
8998,GO:0035113,0.80390542537061,0.380575162190187,3,88,embryonic appendage morphogenesis,BP,TBX3;DKK1;WNT5A
3598,GO:0008026,0.804136072609497,0.380296040568789,3,87,ATP-dependent helicase activity,MF,DDX3Y;CHD2;CHD4
14541,GO:0070035,0.804136072609497,0.380296040568789,3,87,purine NTP-dependent helicase activity,MF,DDX3Y;CHD2;CHD4
2830,GO:0006296,0.804420061006209,0.52235073017738,1,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,PARP1
6930,GO:0030518,0.804647456802832,0.353355583205733,4,115,intracellular steroid hormone receptor signaling pathway,BP,RUNX1;NEDD4;PARP1;MED13
7893,GO:0032456,0.804687041765652,0.522796110142885,1,33,endocytic recycling,BP,EHD1
13615,GO:0060071,0.80483350569427,0.378727634227462,3,99,Wnt signaling pathway, planar cell polarity pathway,BP,DKK1;SMURF2;WNT5A
16992,GO:0099024,0.805016335345693,0.522021909448641,1,34,plasma membrane invagination,BP,ABCA7
980,GO:0002431,0.805120476733523,0.422930920047364,2,62,Fc receptor mediated stimulatory signaling pathway,BP,ABI1;NR4A3
7165,GO:0031023,0.805389860870811,0.352320577527606,4,115,microtubule organizing center organization,BP,GADD45A;PLK2;SLC16A1;CEP135
13248,GO:0051898,0.80609046427102,0.520273462458413,1,34,negative regulation of protein kinase B signaling,BP,EPHA2
8312,GO:0033143,0.806695576591996,0.420451037333236,2,63,regulation of intracellular steroid hormone receptor signaling pathway,BP,RUNX1;PARP1
18027,GO:1902495,0.807406932029685,0.34953608991863,4,114,transmembrane transporter complex,CC,SLC9A1;CLIC4;STX1A;ABCA7
3151,GO:0006749,0.807410127511978,0.516612606083282,1,42,glutathione metabolic process,BP,NFE2L2
8160,GO:0032886,0.807597630275913,0.318884902963702,6,166,regulation of microtubule-based process,BP,PHLDB2;CYLD;NAV3;PLK2;FEZ1;GSK3B
4430,GO:0010256,0.807655754932612,0.273640577669829,14,358,endomembrane system organization,BP,PLEKHF1;SQSTM1;ANXA8;VMP1;ANKLE2;CREB1;PDE4DIP;PLK3;NUP153;SPTBN5;CAV1;GOLGA8B;EPB41L3;LMAN1
17702,GO:1901566,0.807782734149824,0.232060712413189,60,1535,organonitrogen compound biosynthetic process,BP,IL1B;TNF;HBEGF;IL1A;SDC4;BTG2;INHBA;CCL20;ZC3H12A;PPP1R15A;PLAUR;NFKB1;TNIP1;ZFP36;TICAM1;EREG;BCL3;AMPD3;IL6;ZFP36L1;NMNAT2;CPEB2;ODC1;GCH1;B4GALT1;PHLDA1;B3GNT5;PIGA;UPP1;CEBPB;NAMPT;ADM;DSE;NR4A2;CANT1;DDX3Y;SLC11A2;ABCF1;SOX4;PDGFB;B4GALT5;GRB7;NUP153;RAET1L;NFE2L2;SGMS2;PAOX;UGCG;ITGAV;ABCA7;HS3ST3B1;CHST2;MUC1;YARS2;SAT1;PARP1;VIM;ALAS1;QKI;LMAN1
10587,GO:0043547,0.808228785348627,0.279705994193635,12,302,positive regulation of GTPase activity,BP,CCL20;JUN;EPHA2;ICAM1;CDC42EP4;ERRFI1;WNT5A;RASGEF1B;DOCK4;TRIP10;GSK3B;TBC1D22B
20135,GO:2000785,0.808255134290131,0.516731382265517,1,34,regulation of autophagosome assembly,BP,FEZ1
11102,GO:0045103,0.808470592232977,0.516377465998869,1,34,intermediate filament-based process,BP,VIM
11021,GO:0044853,0.808519538160622,0.417855119662984,2,61,plasma membrane raft,CC,TGFBR2;CAV1
4256,GO:0009566,0.808553776449094,0.417288202208173,2,67,fertilization,BP,B4GALT1;CLIC4
17844,GO:1901989,0.808616393189842,0.41727172700088,2,66,positive regulation of cell cycle phase transition,BP,ESPL1;KMT2E
8425,GO:0033500,0.808628789224072,0.330147527007218,5,147,carbohydrate homeostasis,BP,PIM3;ICAM1;SOX4;SLC16A1;XBP1
10095,GO:0042593,0.808628789224072,0.330147527007218,5,147,glucose homeostasis,BP,PIM3;ICAM1;SOX4;SLC16A1;XBP1
175,GO:0000381,0.808686686398886,0.516022256301213,1,34,regulation of alternative mRNA splicing, via spliceosome,BP,WTAP
4068,GO:0009116,0.80917018506996,0.372448681851904,3,99,nucleoside metabolic process,BP,AMPD3;TJP2;UPP1
11440,GO:0045851,0.809505166934223,0.513839972590092,1,38,pH reduction,BP,CLIC4
3932,GO:0008610,0.809984637249438,0.257315966196306,20,512,lipid biosynthetic process,BP,IL1B;TNF;BMP2;PLAUR;NFKB1;EDN1;CYP27B1;B3GNT5;FGF5;PIGA;ADM;CREB1;HMGCS1;PDGFB;LDLR;SGMS2;UGCG;PPARD;XBP1;QKI
4110,GO:0009163,0.81039505717731,0.512015577427074,1,40,nucleoside biosynthetic process,BP,UPP1
4133,GO:0009190,0.810772614347054,0.512353454819254,1,35,cyclic nucleotide biosynthetic process,BP,ADM
13397,GO:0052652,0.810772614347054,0.512353454819254,1,35,cyclic purine nucleotide metabolic process,BP,ADM
569,GO:0001708,0.810843661081445,0.512462984683999,1,34,cell fate specification,BP,DKK1
7979,GO:0032588,0.811008457103564,0.413690503427725,2,65,trans-Golgi network membrane,CC,SYS1;RAB9A
5950,GO:0018279,0.811520752838057,0.510503946062872,1,38,protein N-linked glycosylation via asparagine,BP,LMAN1
1472,GO:0003725,0.812824393371385,0.4110672373349,2,63,double-stranded RNA binding,MF,IFIH1;VIM
19666,GO:1990841,0.813072022442638,0.509001355632344,1,33,promoter-specific chromatin binding,MF,PRDM1
2787,GO:0006220,0.813096744851313,0.50736042691655,1,41,pyrimidine nucleotide metabolic process,BP,UPP1
16831,GO:0098693,0.813120295810134,0.508920841877594,1,33,regulation of synaptic vesicle cycle,BP,STX1A
5927,GO:0018198,0.813177926152673,0.507744697037474,1,38,peptidyl-cysteine modification,BP,NCOA7
12527,GO:0050657,0.813208015867207,0.311232614751853,6,173,nucleic acid transport,BP,ZFP36;ZFP36L1;TGFBR2;NUP153;SRSF11;QKI
12528,GO:0050658,0.813208015867207,0.311232614751853,6,173,RNA transport,BP,ZFP36;ZFP36L1;TGFBR2;NUP153;SRSF11;QKI
17863,GO:1902036,0.813478872841429,0.408197176779024,2,95,regulation of hematopoietic stem cell differentiation,BP,RUNX1;NFE2L2
9464,GO:0036064,0.813914104278664,0.365828039764329,3,92,ciliary basal body,CC,CYLD;RTTN;EVC
3330,GO:0007041,0.813946836864607,0.365877201884568,3,90,lysosomal transport,BP,DENND3;NEDD4;SPTBN5
18269,GO:1903076,0.814177089704835,0.408806751073114,2,65,regulation of protein localization to plasma membrane,BP,EPHA2;SQSTM1
18119,GO:1902743,0.814434697109352,0.506481506820599,1,34,regulation of lamellipodium organization,BP,EPHA2
3583,GO:0007631,0.815151190159134,0.504835909197392,1,36,feeding behavior,BP,NR4A3
1453,GO:0003682,0.815457673332583,0.256451882949291,17,437,chromatin binding,MF,ZC3H12A;PRDM1;NFKB1;JUN;KDM6B;REL;NFKB2;RELB;SMAD3;DLX2;CEBPB;CHD4;NFAT5;TP53;POLR3A;RELA;CRAMP1
5402,GO:0016235,0.816114884106104,0.503658587639965,1,34,aggresome,CC,SQSTM1
17035,GO:0099175,0.816410334601897,0.50316057776156,1,34,regulation of postsynapse organization,BP,EFNA1
9197,GO:0035578,0.816945227863069,0.404198535787277,2,69,azurophil granule lumen,CC,CTSC;FRK
16169,GO:0090175,0.817188446965863,0.360619258528403,3,101,regulation of establishment of planar polarity,BP,DKK1;SMURF2;WNT5A
5323,GO:0016042,0.817274824852521,0.296055236197411,7,202,lipid catabolic process,BP,IL1B;TNF;HCAR2;CYP27B1;LDLR;PPARD;CYP24A1
962,GO:0002381,0.817355377879782,0.501335507816324,1,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,POU2F2
2894,GO:0006401,0.817605797530619,0.271470544016845,11,346,RNA catabolic process,BP,BTG2;NOCT;ZC3H12A;ZFP36;PNRC1;ZFP36L1;PATL1;PNRC2;TNKS1BP1;VIM;QKI
3061,GO:0006623,0.817825401554664,0.500768600021482,1,34,protein targeting to vacuole,BP,NEDD4
7621,GO:0032007,0.817963858984352,0.500304961846478,1,35,negative regulation of TOR signaling,BP,RNF152
9633,GO:0036498,0.818386367247088,0.40210159049558,2,67,IRE1-mediated unfolded protein response,BP,PTPN1;XBP1
3365,GO:0007127,0.818977377755643,0.401100787777352,2,68,meiosis I,BP,MYBL1;ESPL1
17715,GO:1901605,0.819151245143346,0.315569572160576,5,151,alpha-amino acid metabolic process,BP,NMNAT2;ODC1;HAL;STAT5A;EGLN1
16288,GO:0090342,0.819377296282862,0.497482181651573,1,37,regulation of cell aging,BP,PLK2
2817,GO:0006281,0.819603485882515,0.249274622275343,18,484,DNA repair,BP,BTG2;GADD45A;USP43;BACH1;SFR1;TRIM25;RCHY1;TNKS1BP1;INO80D;TP53;UBE2D3;RAD9B;PML;ESCO2;PARP1;JMY;NABP1;EID3
3584,GO:0007632,0.8198533726468,0.497091540757259,1,35,visual behavior,BP,CREB1
6574,GO:0022029,0.820998446854637,0.495364037042082,1,34,telencephalon cell migration,BP,NRG1
10907,GO:0044449,0.821083470514205,0.329942572315787,4,121,contractile fiber part,CC,SDC4;SQSTM1;JPH2;LMAN1
10980,GO:0044766,0.821308826317142,0.397442371709207,2,68,multi-organism transport,BP,NUP153;CAV1
18063,GO:1902579,0.821308826317142,0.397442371709207,2,68,multi-organism localization,BP,NUP153;CAV1
8507,GO:0033683,0.821564316014848,0.493364567558511,1,39,nucleotide-excision repair, DNA incision,BP,PARP1
5925,GO:0018196,0.821601820367567,0.493300185504562,1,39,peptidyl-asparagine modification,BP,LMAN1
8689,GO:0034308,0.822019803917265,0.49296021541062,1,37,primary alcohol metabolic process,BP,SDR16C5
6289,GO:0019894,0.822107908471683,0.493460806490662,1,34,kinesin binding,MF,SPTBN5
17651,GO:1901361,0.822387213714853,0.242235736488706,20,570,organic cyclic compound catabolic process,BP,BTG2;NOCT;ZC3H12A;ZFP36;PNRC1;AMPD3;ZFP36L1;CYP27B1;UPP1;PATL1;PNRC2;MAOA;TNKS1BP1;HAL;NUP153;NFE2L2;CYP24A1;VIM;EGLN1;QKI
6683,GO:0030042,0.822666659903002,0.492269516396948,1,35,actin filament depolymerization,BP,SPTBN5
13124,GO:0051646,0.822782972023322,0.492069178554625,1,35,mitochondrion localization,BP,FEZ1
6936,GO:0030534,0.822977607967467,0.395048085013497,2,65,adult behavior,BP,NR4A2;NR4A3
591,GO:0001750,0.823472883321498,0.490879258724223,1,35,photoreceptor outer segment,CC,SPTBN5
16395,GO:0090734,0.824275274359759,0.489491872805113,1,35,site of DNA damage,CC,ESCO2
10224,GO:0042886,0.824362961070912,0.212897209973532,62,1535,amide transport,BP,IL1B;NFKBIA;TNF;IL1A;ZC3H12A;IL1RN;EDN1;RAB3IP;EHD1;HCAR2;BCL3;PLAGL2;IL6;ADAM8;PIM3;PANX1;RIPK2;CDKN1A;NOD2;RASSF9;RAB24;IL1R2;TAP1;DUSP16;SAA1;WNT5A;VEGFC;SOX4;IFIH1;NRG1;PLK3;ARRDC4;SYS1;NUP153;IL4R;NEDD4;POU2F2;MARCKS;BTN2A2;PTPN1;NECAP2;UGCG;TP53;TLR2;TAPBP;RAB9A;ITGAV;UBE2D3;STX1A;MAPKBP1;SPCS2;PML;ADAM9;TRIM16;HLA-E;GSK3B;PPARD;SLC16A1;TBC1D22B;SRSF11;XBP1;IL36RN
6811,GO:0030258,0.824469601232991,0.2865116813623,7,196,lipid modification,BP,HBEGF;EREG;FGF5;PDGFB;NRG1;NR4A3;PPARD
13419,GO:0052742,0.824758526227285,0.489129856310776,1,33,phosphatidylinositol kinase activity,MF,FGF5
1528,GO:0003899,0.824923289315002,0.487224624674636,1,41,DNA-directed 5'-3' RNA polymerase activity,MF,POLR3A
7223,GO:0031113,0.825062432383113,0.487909569336404,1,36,regulation of microtubule polymerization,BP,NAV3
5188,GO:0015748,0.825114730539149,0.391502438842242,2,67,organophosphate ester transport,BP,LDLR;ABCA7
2929,GO:0006446,0.825119858395037,0.391271445901241,2,70,regulation of translational initiation,BP,TNF;PPP1R15A
7603,GO:0031974,0.82580633506522,0.198911193880942,183,4311,membrane-enclosed lumen,CC,NFKBIZ;IRF1;CXCL1;ITPKC;SDC4;BIRC3;NOCT;FOSL1;ZC3H12A;IL16;ELF3;PLAUR;SOD2;PRDM1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;JUN;KDM6B;ETS1;SQSTM1;CSF1;BHLHE40;SERTAD2;NFKBIE;KLF6;IL23A;REL;BCL3;AMPD3;GADD45A;IL6;ETS2;ZNF436;NFKB2;N4BP1;JUNB;TNFAIP8;WTAP;TJP2;RELB;ZNF217;CDKN1A;GBP2;ZNF451;NEDD4L;CTSC;ELMSAN1;SGK1;GCH1;SMAD3;ARNTL2;PHLDA1;VEGFA;TXNRD1;TMEM217;UPP1;CEBPB;CEBPD;VMP1;NAMPT;TP53BP2;DSE;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;NEDD9;NR4A2;PATL1;CANT1;VHL;ABTB2;RUNX1;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;PNRC2;TRIM25;MASTL;WNT5A;VEGFC;ABCF1;DUSP10;SOX4;SERPINB1;PDGFB;ANLN;BAZ1A;NRG1;TNC;MMP9;ATF3;IKZF2;COL12A1;CAB39;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;H1FX;ARSJ;NUP153;POU2F2;NFE2L2;WNT7B;SMAD1;PAOX;MXD1;CHD4;DIEXF;CLIC4;NFAT5;STAT5A;VEZF1;SH3RF2;INO80D;TNIP2;TP53;NOM1;KLF3;STK40;PDP1;IKBKE;UBE2D3;DOCK4;TRIP10;ELK3;RAD9B;SNAPC4;TMEM132A;UBE2Z;PML;POLR3A;PIM1;RELA;RAPH1;TRIM16;ESCO2;SPATA2;PPP6R3;COL27A1;MUC1;YARS2;AKIRIN1;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;CYP24A1;KDM7A;MED13;COTL1;JMY;COL8A1;SRSF11;NABP1;ALAS1;RPS6KA6;XBP1;ELF4;TFE3;EID3;ZMIZ2;JUND
10405,GO:0043233,0.82580633506522,0.198911193880942,183,4311,organelle lumen,CC,NFKBIZ;IRF1;CXCL1;ITPKC;SDC4;BIRC3;NOCT;FOSL1;ZC3H12A;IL16;ELF3;PLAUR;SOD2;PRDM1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;JUN;KDM6B;ETS1;SQSTM1;CSF1;BHLHE40;SERTAD2;NFKBIE;KLF6;IL23A;REL;BCL3;AMPD3;GADD45A;IL6;ETS2;ZNF436;NFKB2;N4BP1;JUNB;TNFAIP8;WTAP;TJP2;RELB;ZNF217;CDKN1A;GBP2;ZNF451;NEDD4L;CTSC;ELMSAN1;SGK1;GCH1;SMAD3;ARNTL2;PHLDA1;VEGFA;TXNRD1;TMEM217;UPP1;CEBPB;CEBPD;VMP1;NAMPT;TP53BP2;DSE;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;NEDD9;NR4A2;PATL1;CANT1;VHL;ABTB2;RUNX1;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;PNRC2;TRIM25;MASTL;WNT5A;VEGFC;ABCF1;DUSP10;SOX4;SERPINB1;PDGFB;ANLN;BAZ1A;NRG1;TNC;MMP9;ATF3;IKZF2;COL12A1;CAB39;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;H1FX;ARSJ;NUP153;POU2F2;NFE2L2;WNT7B;SMAD1;PAOX;MXD1;CHD4;DIEXF;CLIC4;NFAT5;STAT5A;VEZF1;SH3RF2;INO80D;TNIP2;TP53;NOM1;KLF3;STK40;PDP1;IKBKE;UBE2D3;DOCK4;TRIP10;ELK3;RAD9B;SNAPC4;TMEM132A;UBE2Z;PML;POLR3A;PIM1;RELA;RAPH1;TRIM16;ESCO2;SPATA2;PPP6R3;COL27A1;MUC1;YARS2;AKIRIN1;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;CYP24A1;KDM7A;MED13;COTL1;JMY;COL8A1;SRSF11;NABP1;ALAS1;RPS6KA6;XBP1;ELF4;TFE3;EID3;ZMIZ2;JUND
14533,GO:0070013,0.82580633506522,0.198911193880942,183,4311,intracellular organelle lumen,CC,NFKBIZ;IRF1;CXCL1;ITPKC;SDC4;BIRC3;NOCT;FOSL1;ZC3H12A;IL16;ELF3;PLAUR;SOD2;PRDM1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;JUN;KDM6B;ETS1;SQSTM1;CSF1;BHLHE40;SERTAD2;NFKBIE;KLF6;IL23A;REL;BCL3;AMPD3;GADD45A;IL6;ETS2;ZNF436;NFKB2;N4BP1;JUNB;TNFAIP8;WTAP;TJP2;RELB;ZNF217;CDKN1A;GBP2;ZNF451;NEDD4L;CTSC;ELMSAN1;SGK1;GCH1;SMAD3;ARNTL2;PHLDA1;VEGFA;TXNRD1;TMEM217;UPP1;CEBPB;CEBPD;VMP1;NAMPT;TP53BP2;DSE;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;NEDD9;NR4A2;PATL1;CANT1;VHL;ABTB2;RUNX1;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;PNRC2;TRIM25;MASTL;WNT5A;VEGFC;ABCF1;DUSP10;SOX4;SERPINB1;PDGFB;ANLN;BAZ1A;NRG1;TNC;MMP9;ATF3;IKZF2;COL12A1;CAB39;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;H1FX;ARSJ;NUP153;POU2F2;NFE2L2;WNT7B;SMAD1;PAOX;MXD1;CHD4;DIEXF;CLIC4;NFAT5;STAT5A;VEZF1;SH3RF2;INO80D;TNIP2;TP53;NOM1;KLF3;STK40;PDP1;IKBKE;UBE2D3;DOCK4;TRIP10;ELK3;RAD9B;SNAPC4;TMEM132A;UBE2Z;PML;POLR3A;PIM1;RELA;RAPH1;TRIM16;ESCO2;SPATA2;PPP6R3;COL27A1;MUC1;YARS2;AKIRIN1;ELL2;FRK;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;CYP24A1;KDM7A;MED13;COTL1;JMY;COL8A1;SRSF11;NABP1;ALAS1;RPS6KA6;XBP1;ELF4;TFE3;EID3;ZMIZ2;JUND
3665,GO:0008154,0.825838490169637,0.306276706117051,5,149,actin polymerization or depolymerization,BP,ICAM1;CDC42EP4;SPTBN5;ABI1;JMY
3246,GO:0006904,0.826261798278834,0.485617129874988,1,37,vesicle docking involved in exocytosis,BP,STX1A
12892,GO:0051209,0.826449516694682,0.3894579929809,2,66,release of sequestered calcium ion into cytosol,BP,BDKRB1;JPH2
12941,GO:0051283,0.826449516694682,0.3894579929809,2,66,negative regulation of sequestering of calcium ion,BP,BDKRB1;JPH2
2450,GO:0005657,0.826563403853263,0.389121177417481,2,68,replication fork,CC,TP53;ZMIZ2
7720,GO:0032205,0.826669267131019,0.485330176798329,1,35,negative regulation of telomere maintenance,BP,PARP1
12908,GO:0051236,0.827055324244141,0.29234424463082,6,176,establishment of RNA localization,BP,ZFP36;ZFP36L1;TGFBR2;NUP153;SRSF11;QKI
9245,GO:0035637,0.827185003658949,0.346139877792294,3,91,multicellular organismal signaling,BP,SLC9A1;CAV1;GJC1
3073,GO:0006639,0.827279342830883,0.388055608512655,2,67,acylglycerol metabolic process,BP,LDLR;CAV1
5889,GO:0018023,0.827482386666186,0.48348475005318,1,37,peptidyl-lysine trimethylation,BP,KMT2E
17744,GO:1901659,0.827662781681122,0.482287353689649,1,42,glycosyl compound biosynthetic process,BP,UPP1
16686,GO:0097581,0.828294008077493,0.386593681276576,2,65,lamellipodium organization,BP,EPHA2;ABI1
4083,GO:0009135,0.828304604686976,0.344311204628434,3,94,purine nucleoside diphosphate metabolic process,BP,AMPD3;TJP2;NUP153
4122,GO:0009179,0.828304604686976,0.344311204628434,3,94,purine ribonucleoside diphosphate metabolic process,BP,AMPD3;TJP2;NUP153
14858,GO:0070603,0.828466587418134,0.386157323881342,2,67,SWI/SNF superfamily-type complex,CC,BAZ1A;CHD4
12801,GO:0051082,0.828728379303689,0.343340362012691,3,102,unfolded protein binding,MF,TAPBP;HSPA4L;LMAN1
9475,GO:0036092,0.828788206723637,0.482095575617421,1,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGF5
5975,GO:0018410,0.829116647750784,0.480235230298291,1,39,C-terminal protein amino acid modification,BP,RAET1L
5662,GO:0016758,0.829578132808649,0.300971011233408,5,151,transferase activity, transferring hexosyl groups,MF,B4GALT1;B3GNT5;PIGA;B4GALT5;UGCG
6254,GO:0019827,0.830327788860341,0.316587314357043,4,121,stem cell population maintenance,BP,LIF;TBX3;SAV1;SOX4
12124,GO:0048167,0.830475423472463,0.341070341967864,3,93,regulation of synaptic plasticity,BP,SQSTM1;PLK2;CREB1
12958,GO:0051304,0.830647161239963,0.382505878340304,2,69,chromosome separation,BP,DUSP1;ESPL1
3088,GO:0006661,0.830680796437305,0.316133287245675,4,119,phosphatidylinositol biosynthetic process,BP,PLAUR;FGF5;PIGA;PDGFB
4987,GO:0015108,0.830973579571707,0.477543432174455,1,36,chloride transmembrane transporter activity,MF,CLIC4
16438,GO:0097064,0.831148858300487,0.477026068286809,1,37,ncRNA export from nucleus,BP,NUP153
14145,GO:0060997,0.831210378158423,0.477342636184998,1,35,dendritic spine morphogenesis,BP,EFNA1
5383,GO:0016197,0.831338250535341,0.286455621708958,6,175,endosomal transport,BP,EHD1;SQSTM1;RASSF9;ANXA8;TINAGL1;RAB9A
3247,GO:0006906,0.832075135101897,0.314037978569851,4,121,vesicle fusion,BP,TAP1;TAPBP;STX1A;TBC1D22B
7063,GO:0030837,0.832260849926948,0.474855312550674,1,38,negative regulation of actin filament polymerization,BP,SPTBN5
9493,GO:0036126,0.83247686707795,0.474285018298198,1,39,sperm flagellum,CC,SQSTM1
16737,GO:0097729,0.83247686707795,0.474285018298198,1,39,9+2 motile cilium,CC,SQSTM1
14511,GO:0061982,0.83265226974475,0.379198158471492,2,70,meiosis I cell cycle process,BP,MYBL1;ESPL1
14704,GO:0070317,0.832713402856768,0.474245369248003,1,37,negative regulation of G0 to G1 transition,BP,YAF2
12940,GO:0051282,0.832974464506167,0.378898840013027,2,67,regulation of sequestering of calcium ion,BP,BDKRB1;JPH2
2380,GO:0005509,0.833017973703751,0.24200777492389,14,368,calcium ion binding,MF,EHD1;ADAM8;GCH1;ANXA8;ANXA8L1;CANT1;NOTCH2NL;EFHD2;LDLR;ITSN2;PRRG1;ADGRE2;CCBE1;ANXA5
11046,GO:0045010,0.833497011547943,0.472650911916404,1,38,actin nucleation,BP,JMY
3072,GO:0006638,0.833599149021818,0.377810315509485,2,68,neutral lipid metabolic process,BP,LDLR;CAV1
12929,GO:0051262,0.833635213474412,0.335365401982694,3,118,protein tetramerization,BP,SOD2;GPX3;TP53
7305,GO:0031300,0.83367675133615,0.295066463171862,5,156,intrinsic component of organelle membrane,CC,SYS1;RNF152;SGMS2;TPST1;CHST2
8150,GO:0032873,0.834013068120349,0.471924074239393,1,37,negative regulation of stress-activated MAPK cascade,BP,DUSP10
14695,GO:0070303,0.834013068120349,0.471924074239393,1,37,negative regulation of stress-activated protein kinase signaling cascade,BP,DUSP10
8584,GO:0034062,0.83415236293813,0.470636159292903,1,43,5'-3' RNA polymerase activity,MF,POLR3A
16746,GO:0097747,0.83415236293813,0.470636159292903,1,43,RNA polymerase activity,MF,POLR3A
12609,GO:0050772,0.834213285859478,0.376968427717567,2,66,positive regulation of axonogenesis,BP,VEGFA;NRG1
4679,GO:0010824,0.834249826209237,0.471500089052955,1,37,regulation of centrosome duplication,BP,PLK2
8266,GO:0033045,0.834316020844933,0.376500968474523,2,70,regulation of sister chromatid segregation,BP,DUSP1;ESPL1
12790,GO:0051052,0.834952920258751,0.245759404303483,12,323,regulation of DNA metabolic process,BP,CSF2;JUN;EREG;DUSP1;CDKN1A;IL7R;PDGFB;OTUD4;TP53;PML;ESCO2;PARP1
4104,GO:0009156,0.83542566429733,0.308958691089671,4,127,ribonucleoside monophosphate biosynthetic process,BP,AMPD3;UPP1;NUP153;PARP1
5695,GO:0016811,0.835821972176734,0.374049906089394,2,70,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,PGLYRP4;CHD4
12496,GO:0050434,0.835875252242821,0.46802038994706,1,40,positive regulation of viral transcription,BP,JUN
14405,GO:0061647,0.836030800442824,0.468507211290359,1,36,histone H3-K9 modification,BP,ZNF451
3785,GO:0008344,0.836518839742605,0.467222555974148,1,38,adult locomotory behavior,BP,NR4A2
5544,GO:0016529,0.836561438567532,0.467342209883617,1,37,sarcoplasmic reticulum,CC,JPH2
4128,GO:0009185,0.837198471579518,0.330666413071633,3,96,ribonucleoside diphosphate metabolic process,BP,AMPD3;TJP2;NUP153
9317,GO:0035773,0.837208812967139,0.465611723197431,1,40,insulin secretion involved in cellular response to glucose stimulus,BP,PIM3
4113,GO:0009166,0.837734180838557,0.305584749713642,4,126,nucleotide catabolic process,BP,AMPD3;UPP1;NUP153;EGLN1
14507,GO:0061951,0.838522153267774,0.463592417816499,1,38,establishment of protein localization to plasma membrane,BP,SYS1
3299,GO:0006997,0.838872863634199,0.303956773489587,4,124,nucleus organization,BP,ETS1;ANKLE2;NUP153;PML
2556,GO:0005829,0.839041159411586,0.18474157066625,176,4103,cytosol,CC,IL1B;NFKBIA;TNFAIP3;IRF1;IL1A;ITPKC;BTG2;BIRC3;FOSL1;IL16;PPP1R15A;RNF19B;ELF3;LIF;PMAIP1;NFKB1;IER3;TNIP1;MAP2K3;ZFP36;JUN;TICAM1;RAB3IP;TRAF1;SQSTM1;SPRR2D;SERTAD2;STARD5;NFKBIE;KLF6;IRF6;REL;BCL3;PELI1;AMPD3;BIRC2;ETS2;ZNF436;NFKB2;PIM3;ZFP36L1;RIPK2;IRAK2;KLHL21;DAPP1;PHLDB2;CYLD;TJP2;RELB;AMOTL2;CDKN1A;GBP2;RAP2B;ODC1;NEDD4L;NOD2;SAV1;SGK1;GCH1;TRIM47;RASSF9;SMAD3;NFKBIB;C15ORF39;PHLDA1;RNF144B;KRT34;SERPINB8;ARHGEF3;RAB24;CDKN2B;PLK2;MAP3K8;ABL2;CDV3;CFLAR;TXNRD1;ANXA8;UPP1;PPP4R4;DENND3;NAMPT;TP53BP2;DSE;ERRFI1;GORAB;WISP1;NEDD9;PATL1;VHL;PHKG2;BACH1;ABTB2;RUNX1;TGFBR2;SMURF2;DUSP16;DDX3Y;GPBP1;PNRC2;KLHL5;TRIM25;KIF3C;HMGCS1;ABCF1;DUSP10;SOCS2;IFIH1;CAB39;IL32;TLE1;PARD6B;MT2A;SYS1;RCHY1;YAF2;SPRY2;TNKS1BP1;HAL;CYTH1;GRB7;NUP153;BCL2L2;NEDD4;DUS4L;NFE2L2;KBTBD7;PTPN1;SMAD1;LACTB;TAB3;SPTBN5;MXD1;CLIC4;NFAT5;STAT5A;RHOV;UACA;TNIP2;GOLGA8B;TP53;ABI1;STK40;RAB9A;ITGAV;IKBKE;UBE2D3;STX1A;DOCK4;TRIP10;SPRR2A;UBE2Z;PML;POLR3A;PIM1;ESPL1;RELA;RAPH1;TRIM16;PPP6R3;YARS2;ANXA5;THSD1;SAT1;FRK;GSK3B;VIM;EGLN1;NABP1;ALAS1;RPS6KA6;CEP135;HSPA4L;EPB41L3;TFE3;DENND4A
15792,GO:0072384,0.839058718428483,0.368895667569189,2,68,organelle transport along microtubule,BP,KIF3C;FEZ1
16587,GO:0097367,0.839563952281477,0.194314629734545,68,1583,carbohydrate derivative binding,MF,HBEGF;NUAK2;ITPKC;MAP2K3;EPHA2;EHD1;PIM3;RIPK2;IRAK2;NMNAT2;GBP2;RAP2B;ABCA5;NAV3;ARL5B;NOD2;SGK1;GCH1;IRGQ;RND3;VEGFA;RAB24;PLK2;MAP3K8;ABL2;LAYN;TAP1;ADAMTS1;ANKK1;WISP1;MAST4;PHKG2;RUNX1;TGFBR2;DDX3Y;SAA1;MASTL;KIF3C;CAMK1G;ABCF1;PGLYRP4;IFIH1;TNC;RRAD;PLK3;CHD2;CHD4;RHOV;TP53;TLR2;STK40;RAB9A;IKBKE;GEM;UBE2D3;ABCA7;CLK4;ADGRE2;UBE2Z;PIM1;YARS2;AXL;FRK;GSK3B;RIPK4;RPS6KA6;DDR1;HSPA4L
19523,GO:1990351,0.839660273584704,0.302847560469222,4,122,transporter complex,CC,SLC9A1;CLIC4;STX1A;ABCA7
6061,GO:0019205,0.839859857275538,0.46062166002668,1,41,nucleobase-containing compound kinase activity,MF,TJP2
16843,GO:0098727,0.840150130438192,0.302092852255068,4,123,maintenance of cell number,BP,LIF;TBX3;SAV1;SOX4
9298,GO:0035735,0.840533653455231,0.459734991314824,1,39,intraciliary transport involved in cilium assembly,BP,KIF3C
12267,GO:0048538,0.840683332697761,0.45984485275254,1,37,thymus development,BP,SIX4
11016,GO:0044839,0.841012439753768,0.256621382931404,8,239,cell cycle G2/M phase transition,BP,CDKN1A;PHLDA1;CDKN2B;BACH1;MASTL;PLK3;TP53;CEP135
2590,GO:0005882,0.841047282500003,0.365403275918476,2,71,intermediate filament,CC,KRT34;VIM
10735,GO:0044088,0.84115274309345,0.458786944431123,1,38,regulation of vacuole organization,BP,FEZ1
14801,GO:0070507,0.841447924759689,0.284108927583132,5,148,regulation of microtubule cytoskeleton organization,BP,PHLDB2;CYLD;NAV3;PLK2;GSK3B
12760,GO:0051015,0.841605462376406,0.2999889507192,4,121,actin filament binding,MF,PANX1;ABL2;ANXA8;MARCKS
7901,GO:0032465,0.841726563100324,0.364494458446483,2,68,regulation of cytokinesis,BP,KLHL21;PLK3
7462,GO:0031594,0.841880352368797,0.457647245622509,1,37,neuromuscular junction,CC,NRG1
6682,GO:0030041,0.842245800761602,0.298869603826781,4,127,actin filament polymerization,BP,ICAM1;CDC42EP4;SPTBN5;JMY
3407,GO:0007189,0.842458983235898,0.456384227536587,1,38,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,ADM
17033,GO:0099173,0.842856930680403,0.362696416898841,2,67,postsynapse organization,BP,EFNA1;WNT5A
14399,GO:0061640,0.842977932007416,0.36234609976973,2,69,cytoskeleton-dependent cytokinesis,BP,ANLN;ESPL1
3029,GO:0006575,0.843841505986671,0.29631603847639,4,134,cellular modified amino acid metabolic process,BP,GCH1;NFE2L2;STAT5A;EGLN1
4678,GO:0010823,0.844348610325831,0.452354638803418,1,41,negative regulation of mitochondrion organization,BP,PPIF
11145,GO:0045182,0.844369818575893,0.452484273942813,1,40,translation regulator activity,MF,CPEB2
6118,GO:0019359,0.84457646365164,0.319184775975102,3,97,nicotinamide nucleotide biosynthetic process,BP,NMNAT2;NAMPT;NUP153
6120,GO:0019363,0.84457646365164,0.319184775975102,3,97,pyridine nucleotide biosynthetic process,BP,NMNAT2;NAMPT;NUP153
7759,GO:0032271,0.844763924200167,0.279200393875832,5,154,regulation of protein polymerization,BP,NAV3;ICAM1;CDC42EP4;SPTBN5;JMY
2820,GO:0006284,0.844771609754643,0.451568828633931,1,41,base-excision repair,BP,TP53
4962,GO:0015031,0.844863323946423,0.190178592753825,60,1503,protein transport,BP,IL1B;NFKBIA;TNF;IL1A;ZC3H12A;IL1RN;RAB3IP;EHD1;HCAR2;BCL3;PLAGL2;IL6;ADAM8;PIM3;PANX1;RIPK2;CDKN1A;NOD2;RASSF9;RAB24;IL1R2;TAP1;DUSP16;SAA1;WNT5A;VEGFC;SOX4;IFIH1;NRG1;PLK3;ARRDC4;SYS1;NUP153;IL4R;NEDD4;POU2F2;MARCKS;BTN2A2;PTPN1;NECAP2;UGCG;TP53;TLR2;RAB9A;ITGAV;UBE2D3;STX1A;MAPKBP1;SPCS2;PML;ADAM9;TRIM16;HLA-E;GSK3B;PPARD;SLC16A1;TBC1D22B;SRSF11;XBP1;IL36RN
2893,GO:0006400,0.845653778531888,0.357550394367358,2,74,tRNA modification,BP,DUS4L;PUS10
9189,GO:0035567,0.845812214154343,0.293416198938263,4,132,non-canonical Wnt signaling pathway,BP,FZD8;DKK1;SMURF2;WNT5A
5283,GO:0015931,0.846497814360623,0.25628610294936,7,208,nucleobase-containing compound transport,BP,ZFP36;ZFP36L1;SLC28A3;TGFBR2;NUP153;SRSF11;QKI
5706,GO:0016830,0.84658942110944,0.448178404568124,1,41,carbon-carbon lyase activity,MF,ODC1
5401,GO:0016234,0.846986875979063,0.355727512050563,2,68,inclusion body,CC,SQSTM1;NUP153
2525,GO:0005777,0.847224170205128,0.314766676753657,3,104,peroxisome,CC,LACC1;PAOX;VIM
10083,GO:0042579,0.847224170205128,0.314766676753657,3,104,microbody,CC,LACC1;PAOX;VIM
3697,GO:0008203,0.848619974301334,0.31271850278343,3,100,cholesterol metabolic process,BP,HMGCS1;LDLR;PPARD
284,GO:0000786,0.848764788162532,0.440651823147648,1,84,nucleosome,CC,H1FX
3624,GO:0008080,0.849625257095534,0.351004658941413,2,72,N-acetyltransferase activity,MF,ESCO2;SAT1
13051,GO:0051494,0.849627289804691,0.311207645693451,3,98,negative regulation of cytoskeleton organization,BP,PHLDB2;NAV3;SPTBN5
11382,GO:0045739,0.849680316904861,0.442532292297175,1,40,positive regulation of DNA repair,BP,PARP1
12891,GO:0051208,0.850766060498068,0.349210408528757,2,70,sequestering of calcium ion,BP,BDKRB1;JPH2
15768,GO:0072347,0.851190811320271,0.439845245566921,1,39,response to anesthetic,BP,RELA
11434,GO:0045839,0.851229290443346,0.439262583553059,1,42,negative regulation of mitotic nuclear division,BP,DUSP1
12886,GO:0051196,0.852082436437578,0.347046675803702,2,69,regulation of coenzyme metabolic process,BP,NUP153;PDP1
12421,GO:0048857,0.852911451373508,0.436213779407976,1,41,neural nucleus development,BP,ZNF148
3176,GO:0006790,0.853673811124973,0.23363285941224,9,272,sulfur compound metabolic process,BP,B4GALT1;DSE;HMGCS1;B4GALT5;NFE2L2;STAT5A;TPST1;PDP1;CHST2
16168,GO:0090174,0.853803617579307,0.281498511710274,4,126,organelle membrane fusion,BP,TAP1;TAPBP;STX1A;TBC1D22B
10615,GO:0043596,0.853911528397849,0.434295923610255,1,41,nuclear replication fork,CC,ZMIZ2
12794,GO:0051056,0.853935896543782,0.228767538340329,10,266,regulation of small GTPase mediated signal transduction,BP,SQSTM1;CSF1;ARHGEF3;FGD6;NRG1;SPRY2;CYTH1;ITSN2;RHOV;TRIP10
2296,GO:0005253,0.854386460970219,0.433552516237097,1,40,anion channel activity,MF,CLIC4
4036,GO:0009066,0.854528154649397,0.433109923058862,1,41,aspartate family amino acid metabolic process,BP,NMNAT2
346,GO:0000959,0.85468692740576,0.432804111304681,1,41,mitochondrial RNA metabolic process,BP,YARS2
10807,GO:0044283,0.855279383912788,0.201937504100713,20,543,small molecule biosynthetic process,BP,IL1B;TNF;ITPKC;BMP2;NFKB1;EDN1;AMPD3;CYP27B1;GCH1;UPP1;ADM;DSE;SOGA1;HMGCS1;PDGFB;ATF3;NUP153;EGLN1;XBP1;QKI
3202,GO:0006836,0.855338009844639,0.279133422294122,4,127,neurotransmitter transport,BP,CSF2;EDN1;SLC6A14;STX1A
3635,GO:0008104,0.855726007843963,0.173015291295932,85,2059,protein localization,BP,IL1B;NFKBIA;TNFAIP3;TNF;IL1A;PLEKHF1;ZC3H12A;PPP1R15A;LIF;PMAIP1;IL1RN;RAB3IP;EPHA2;EHD1;HCAR2;SQSTM1;NFKBIE;BBC3;BCL3;PLAGL2;IL6;ADAM8;PIM3;PANX1;SIX4;RIPK2;KLHL21;PHLDB2;CYLD;CDKN1A;TNFAIP2;NEDD4L;ARL5B;NOD2;RASSF9;RAB24;IL1R2;TAP1;TP53BP2;DUSP16;SAA1;WNT5A;VEGFC;SOX4;ANLN;IFIH1;NRG1;PLK3;ARRDC4;SYS1;NUP153;IL4R;NEDD4;MMD;POU2F2;MARCKS;BTN2A2;PTPN1;CAV1;NECAP2;UGCG;TP53;TLR2;RAB9A;ITGAV;UBE2D3;STX1A;MAPKBP1;ABCA7;SPCS2;PML;ADAM9;TRIM16;ESCO2;CRB3;HLA-E;GSK3B;PPARD;SLC16A1;PARP1;TBC1D22B;SRSF11;XBP1;EPB41L3;IL36RN
16959,GO:0098930,0.856284813617278,0.429716500238179,1,41,axonal transport,BP,FEZ1
14420,GO:0061695,0.85637754011688,0.235599185582237,8,240,transferase complex, transferring phosphorus-containing groups,CC,CDKN1A;TAF4B;CCNL1;PHKG2;TGFBR2;CAB39;TP53;POLR3A
12900,GO:0051225,0.856998214393301,0.299427093260803,3,99,spindle assembly,BP,BIRC3;BIRC2;GOLGA8B
5890,GO:0018024,0.85710121089841,0.428301940082253,1,40,histone-lysine N-methyltransferase activity,MF,KMT2E
17786,GO:1901799,0.858031665357984,0.426158395257004,1,42,negative regulation of proteasomal protein catabolic process,BP,N4BP1
17620,GO:1901292,0.858141267443886,0.274742468097336,4,131,nucleoside phosphate catabolic process,BP,AMPD3;UPP1;NUP153;EGLN1
8961,GO:0035023,0.858412967770319,0.297313403689414,3,95,regulation of Rho protein signal transduction,BP,ARHGEF3;FGD6;ITSN2
488,GO:0001540,0.858425288269786,0.425390049314742,1,42,amyloid-beta binding,MF,LDLR
585,GO:0001736,0.858547083008056,0.296583407507905,3,109,establishment of planar polarity,BP,DKK1;SMURF2;WNT5A
3386,GO:0007164,0.858547083008056,0.296583407507905,3,109,establishment of tissue polarity,BP,DKK1;SMURF2;WNT5A
15836,GO:0072525,0.859370181482198,0.295569069640916,3,100,pyridine-containing compound biosynthetic process,BP,NMNAT2;NAMPT;NUP153
7251,GO:0031201,0.860265894688977,0.421628023890432,1,43,SNARE complex,CC,STX1A
17685,GO:1901532,0.860566722785013,0.330840820480459,2,103,regulation of hematopoietic progenitor cell differentiation,BP,RUNX1;NFE2L2
258,GO:0000724,0.860708315608128,0.293367700651731,3,101,double-strand break repair via homologous recombination,BP,SFR1;PARP1;NABP1
11273,GO:0045540,0.860898395435236,0.420698726841465,1,41,regulation of cholesterol biosynthetic process,BP,HMGCS1
14703,GO:0070316,0.861110583624003,0.420280246397757,1,41,regulation of G0 to G1 transition,BP,YAF2
4688,GO:0010833,0.861418639558139,0.330637187540668,2,74,telomere maintenance via telomere lengthening,BP,TNKS1BP1;PARP1
15904,GO:0072657,0.861688140401452,0.202714716330455,15,452,protein localization to membrane,BP,TNF;PLEKHF1;PMAIP1;RAB3IP;EPHA2;SQSTM1;BBC3;ARL5B;TP53BP2;SYS1;CAV1;TP53;STX1A;CRB3;EPB41L3
3750,GO:0008289,0.861908878874725,0.19853257266091,17,455,lipid binding,MF,PLEKHF1;STARD5;DAPP1;ANXA8;CD55;ANXA8L1;WNT5A;SLC9A1;CYTH1;GRB7;CAV1;TLR2;TRIP10;JPH2;AXL;ANXA5;PPARD
18577,GO:1903779,0.862469886835852,0.417761711471437,1,40,regulation of cardiac conduction,BP,CAV1
2979,GO:0006521,0.8628802176121,0.415342324065197,1,52,regulation of cellular amino acid metabolic process,BP,ODC1
412,GO:0001098,0.862906688494964,0.416562585271831,1,42,basal transcription machinery binding,MF,TP53
413,GO:0001099,0.862906688494964,0.416562585271831,1,42,basal RNA polymerase II transcription machinery binding,MF,TP53
16680,GO:0097553,0.86300624323356,0.327989681046468,2,72,calcium ion transmembrane import into cytosol,BP,BDKRB1;JPH2
3616,GO:0008064,0.863035219636647,0.267169560755176,4,132,regulation of actin polymerization or depolymerization,BP,ICAM1;CDC42EP4;SPTBN5;JMY
5932,GO:0018205,0.863076426509526,0.209001887407267,12,337,peptidyl-lysine modification,BP,IL1B;LIF;ZNF451;SOX4;IFIH1;KIAA1586;NUP153;SDR16C5;RELA;TRIM16;MUC1;KMT2E
13297,GO:0051972,0.863494970887586,0.415392740098136,1,42,regulation of telomerase activity,BP,TP53
18826,GO:1904375,0.863533962793515,0.327000501501742,2,73,regulation of protein localization to cell periphery,BP,EPHA2;SQSTM1
2956,GO:0006487,0.863704343045682,0.326405720146753,2,78,protein N-linked glycosylation,BP,B4GALT1;LMAN1
282,GO:0000784,0.864354652069766,0.287014139900326,3,114,nuclear chromosome, telomeric region,CC,PML;PARP1;NABP1
10918,GO:0044464,0.864899782393577,0.17169176667202,499,11095,cell part,CC,NFKBIZ;CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;CXCL1;IL1A;ITPKC;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;HCAR3;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;RAB3IP;EPHA2;GPR156;EHD1;ZNF697;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;N4BP3;ZNF267;SPRR2D;SERTAD2;STARD5;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;PANX1;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;KLHL21;PHLDA2;DAPP1;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;STEAP4;C1QTNF1;AMOTL2;CDKN1A;CLDN1;NMNAT2;CCDC85B;ITGA5;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;ODC1;TNFAIP2;NEDD4L;CTSC;ARL5B;NOD2;ELMSAN1;IL6ST;DCUN1D3;RELT;SAV1;TMCC3;SGK1;ICAM1;GCH1;FRMD4B;TRIM47;ESRG;RASSF9;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;C15ORF39;PHLDA1;B3GNT5;RNF144B;RND3;MARCKSL1;TM4SF1;NFKBID;TRAF4;TRIB1;KRT34;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;LGALSL;IL1R2;SLC6A14;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;MAP3K8;ABL2;PPTC7;C3ORF52;CDV3;CFLAR;RNF43;TXNRD1;LACC1;KLF7;PIGA;BTG1;ANXA8;TMEM217;UPP1;IER5;LAYN;PPP4R4;CEBPB;CEBPD;VMP1;CD55;KCNJ15;DENND3;NAMPT;TAP1;TP53BP2;ANKLE2;ADM;GJB3;CDC42EP4;SLC28A3;IFNAR1;DSE;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;WISP1;NEDD9;MAST4;NR4A2;PATL1;SLC7A2;CD47;CANT1;VHL;PHKG2;SEMA4B;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;TGFBR2;MREG;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;IFNGR1;MASTL;NAB1;KIF3C;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;NOTCH2NL;DUSP10;SLC52A3;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;ANLN;NBPF8;PGLYRP4;CD82;BAZ1A;IFIH1;DUSP8;NRG1;TNC;SLC38A2;MMP9;LDLR;DCBLD2;RRAD;ATF3;BTG3;IKZF2;COL12A1;FAM83B;CAB39;IL32;TLE1;RHD;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;TRPV3;FAM57A;MT2A;SUCO;SLC9A1;ZBTB10;SLC25A37;SYS1;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;HAL;CYTH1;GRB7;CXCL16;ARSJ;NUP153;BCL2L2;RNF152;IL4R;NEDD4;MMD;RHCG;SLC2A6;POU2F2;ITSN2;DUS4L;GCSAM;TNFRSF6B;MARCKS;RAET1L;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;RTTN;HLA-A;UACA;DRAM1;INO80D;TNIP2;NECAP2;ZNFX1;UGCG;ZFAND5;GOLGA8B;TP53;NOM1;KLF3;TLR2;ABI1;STK40;TAPBP;EFNB2;PDP1;RAB9A;HLA-B;ITGAV;PRRG1;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;ADGRE2;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;ADAM9;RELA;RAPH1;TRIM16;MAMDC2;ESCO2;EMP3;SPATA2;FOXN2;SLC9A8;PPP6R3;EVI2B;LRRC49;TSPAN13;COL27A1;PLAT;CHST2;MUC1;YARS2;AXL;SLC16A13;ANXA5;THSD1;AKIRIN1;CRB3;ELL2;SAT1;FRK;HLA-F;CITED4;NR4A3;LIMS3;HLA-E;USP31;GSK3B;KMT2E;OSMR;PPARD;PARP8;SLC16A1;EVC;PARP1;CYP24A1;LAMA3;KDM7A;MED13;MXD3;CRAMP1;TBC1D22B;LCE1C;OCLN;COTL1;JMY;COL8A1;VIM;SRSF11;CLDND1;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;RPS6KA6;DDR1;CEP135;XBP1;HSPA4L;QKI;EPB41L3;KCTD11;ZBTB5;ELF4;SLC39A14;TFE3;EID3;ZMIZ2;ERVFRD-1;MGAM;CCSER2;LMAN1;CFB;SLC41A1;JUND;GJC1;DENND4A
259,GO:0000725,0.865097219814695,0.286187417933876,3,102,recombinational repair,BP,SFR1;PARP1;NABP1
4443,GO:0010324,0.865120657766644,0.412146381418408,1,42,membrane invagination,BP,ABCA7
4486,GO:0010501,0.865259934825558,0.41202936600077,1,41,RNA secondary structure unwinding,BP,DDX3Y
3337,GO:0007051,0.865288248541676,0.2489193933233,5,155,spindle organization,BP,BIRC3;BIRC2;PLK2;GOLGA8B;ESPL1
6263,GO:0019843,0.865979372947804,0.408769762363491,1,56,rRNA binding,MF,DIEXF
8271,GO:0033059,0.86605971732916,0.40996034828452,1,44,cellular pigmentation,BP,MREG
2834,GO:0006302,0.86640069392788,0.236342433930098,6,194,double-strand break repair,BP,SFR1;TNKS1BP1;PML;ESCO2;PARP1;NABP1
2962,GO:0006497,0.866742058028102,0.283256135588165,3,109,protein lipidation,BP,PLAUR;PIGA;RAET1L
12368,GO:0048736,0.867263382652343,0.260732754908516,4,126,appendage development,BP,TBX3;DKK1;WNT5A;SOX4
13674,GO:0060173,0.867263382652343,0.260732754908516,4,126,limb development,BP,TBX3;DKK1;WNT5A;SOX4
7058,GO:0030832,0.867497744545633,0.260197162903542,4,133,regulation of actin filament length,BP,ICAM1;CDC42EP4;SPTBN5;JMY
3406,GO:0007188,0.868076535930981,0.318982469217323,2,73,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,EDN1;ADM
3349,GO:0007077,0.868542095437236,0.405248093591965,1,42,mitotic nuclear envelope disassembly,BP,NUP153
11051,GO:0045023,0.868543228402667,0.405245794306719,1,42,G0 to G1 transition,BP,YAF2
16821,GO:0098656,0.868625067528514,0.243909778114767,5,154,anion transmembrane transport,BP,SLC6A14;SLC7A2;SLC38A2;CLIC4;SLC16A1
3194,GO:0006821,0.868638122156106,0.405053177532716,1,42,chloride transport,BP,CLIC4
12880,GO:0051188,0.868705130203878,0.21837360333999,8,243,cofactor biosynthetic process,BP,NMNAT2;GCH1;NAMPT;SLC11A2;NUP153;NFE2L2;PDP1;ALAS1
3071,GO:0006637,0.868713529219522,0.317611674266899,2,77,acyl-CoA metabolic process,BP,HMGCS1;PDP1
9109,GO:0035383,0.868713529219522,0.317611674266899,2,77,thioester metabolic process,BP,HMGCS1;PDP1
4073,GO:0009124,0.869358997425074,0.257213123408791,4,136,nucleoside monophosphate biosynthetic process,BP,AMPD3;UPP1;NUP153;PARP1
10906,GO:0044448,0.869791527732181,0.25674302289817,4,127,cell cortex part,CC,PHLDB2;TNFAIP2;ANLN;SPTBN5
16262,GO:0090305,0.871104156693241,0.214948472880799,8,248,nucleic acid phosphodiester bond hydrolysis,BP,NOCT;ZC3H12A;ZFP36;PNRC1;ZC3H12C;PNRC2;RAD9B;PARP1
11867,GO:0046847,0.871227908831463,0.400101411677521,1,40,filopodium assembly,BP,FGD6
5595,GO:0016616,0.872241969806473,0.310990332940199,2,83,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,BMP2;SDR16C5
1861,GO:0004521,0.87245981710677,0.39653151281286,1,47,endoribonuclease activity,MF,ZC3H12A
1788,GO:0004407,0.872649977812112,0.396844816272076,1,42,histone deacetylase activity,MF,CHD4
10072,GO:0042562,0.872766867596776,0.396302093686241,1,44,hormone binding,MF,INHBA
9887,GO:0042158,0.872828597067288,0.273130190268494,3,111,lipoprotein biosynthetic process,BP,PLAUR;PIGA;RAET1L
7625,GO:0032011,0.873293791830535,0.39584787578421,1,40,ARF protein signal transduction,BP,CYTH1
7626,GO:0032012,0.873293791830535,0.39584787578421,1,40,regulation of ARF protein signal transduction,BP,CYTH1
2611,GO:0005913,0.873401977608267,0.309388887388835,2,74,cell-cell adherens junction,CC,CDC42EP4;TNKS1BP1
4184,GO:0009259,0.87362404737205,0.194768786573287,12,371,ribonucleotide metabolic process,BP,PPIF;EPHA2;AMPD3;TJP2;VEGFA;UPP1;ADM;WNT5A;NUP153;TPST1;PARP1;EGLN1
2436,GO:0005623,0.874035793242741,0.160982795015073,499,11101,cell,CC,NFKBIZ;CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;CXCL1;IL1A;ITPKC;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TIFA;CD83;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;HCAR3;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;RAB3IP;EPHA2;GPR156;EHD1;ZNF697;ETS1;TRAF1;HCAR2;SQSTM1;CSF1;BHLHE40;N4BP3;ZNF267;SPRR2D;SERTAD2;STARD5;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;PANX1;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;KLHL21;PHLDA2;DAPP1;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;STEAP4;C1QTNF1;AMOTL2;CDKN1A;CLDN1;NMNAT2;CCDC85B;ITGA5;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;ODC1;TNFAIP2;NEDD4L;CTSC;ARL5B;NOD2;ELMSAN1;IL6ST;DCUN1D3;RELT;SAV1;TMCC3;SGK1;ICAM1;GCH1;FRMD4B;TRIM47;ESRG;RASSF9;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;C15ORF39;PHLDA1;B3GNT5;RNF144B;RND3;MARCKSL1;TM4SF1;NFKBID;TRAF4;TRIB1;KRT34;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;LGALSL;IL1R2;SLC6A14;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;MAP3K8;ABL2;PPTC7;C3ORF52;CDV3;CFLAR;RNF43;TXNRD1;LACC1;KLF7;PIGA;BTG1;ANXA8;TMEM217;UPP1;IER5;LAYN;PPP4R4;CEBPB;CEBPD;VMP1;CD55;KCNJ15;DENND3;NAMPT;TAP1;TP53BP2;ANKLE2;ADM;GJB3;CDC42EP4;SLC28A3;IFNAR1;DSE;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;WISP1;NEDD9;MAST4;NR4A2;PATL1;SLC7A2;CD47;CANT1;VHL;PHKG2;SEMA4B;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;TGFBR2;MREG;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;IFNGR1;MASTL;NAB1;KIF3C;ITGB8;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;NOTCH2NL;DUSP10;SLC52A3;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;ANLN;NBPF8;PGLYRP4;CD82;BAZ1A;IFIH1;DUSP8;NRG1;TNC;SLC38A2;MMP9;LDLR;DCBLD2;RRAD;ATF3;BTG3;IKZF2;COL12A1;FAM83B;CAB39;IL32;TLE1;RHD;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;TRPV3;FAM57A;MT2A;SUCO;SLC9A1;ZBTB10;SLC25A37;SYS1;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;HAL;CYTH1;GRB7;CXCL16;ARSJ;NUP153;BCL2L2;RNF152;IL4R;NEDD4;MMD;RHCG;SLC2A6;POU2F2;ITSN2;DUS4L;GCSAM;TNFRSF6B;MARCKS;RAET1L;BTN2A2;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;RTTN;HLA-A;UACA;DRAM1;INO80D;TNIP2;NECAP2;ZNFX1;UGCG;ZFAND5;GOLGA8B;TP53;NOM1;KLF3;TLR2;ABI1;STK40;TAPBP;EFNB2;PDP1;RAB9A;HLA-B;ITGAV;PRRG1;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;ADGRE2;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;ADAM9;RELA;RAPH1;TRIM16;MAMDC2;ESCO2;EMP3;SPATA2;FOXN2;SLC9A8;PPP6R3;EVI2B;LRRC49;TSPAN13;COL27A1;PLAT;CHST2;MUC1;YARS2;AXL;SLC16A13;ANXA5;THSD1;AKIRIN1;CRB3;ELL2;SAT1;FRK;HLA-F;CITED4;NR4A3;LIMS3;HLA-E;USP31;GSK3B;KMT2E;OSMR;PPARD;PARP8;SLC16A1;EVC;PARP1;CYP24A1;LAMA3;KDM7A;MED13;MXD3;CRAMP1;TBC1D22B;LCE1C;OCLN;COTL1;JMY;COL8A1;VIM;SRSF11;CLDND1;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;RPS6KA6;DDR1;CEP135;XBP1;HSPA4L;QKI;EPB41L3;KCTD11;ZBTB5;ELF4;SLC39A14;TFE3;EID3;ZMIZ2;ERVFRD-1;MGAM;CCSER2;LMAN1;CFB;SLC41A1;JUND;GJC1;DENND4A
279,GO:0000781,0.874209187841696,0.249358284398086,4,146,chromosome, telomeric region,CC,PML;PARP1;NABP1;EID3
5211,GO:0015807,0.874718776291796,0.392407182820702,1,43,L-amino acid transport,BP,SLC7A2
11753,GO:0046580,0.874772814452093,0.392611167097907,1,41,negative regulation of Ras protein signal transduction,BP,SPRY2
2061,GO:0004812,0.874980988768502,0.391714597337645,1,44,aminoacyl-tRNA ligase activity,MF,YARS2
5734,GO:0016875,0.874980988768502,0.391714597337645,1,44,ligase activity, forming carbon-oxygen bonds,MF,YARS2
9110,GO:0035384,0.875030313012209,0.391759150495282,1,43,thioester biosynthetic process,BP,PDP1
15387,GO:0071616,0.875030313012209,0.391759150495282,1,43,acyl-CoA biosynthetic process,BP,PDP1
5324,GO:0016043,0.875464142154447,0.144102266127835,198,4602,cellular component organization,BP,IL1B;TNFAIP3;CSF2;TNF;HBEGF;NUAK2;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;FOSL1;ZC3H12A;PPP1R15A;ELF3;LIF;PLAUR;SOD2;PMAIP1;PTX3;PPIF;EDN1;JUN;KDM6B;RAB3IP;EPHA2;EHD1;ETS1;TRAF1;SQSTM1;SERTAD2;BBC3;EREG;DUSP1;BCL3;GADD45A;PLAGL2;EFNB1;BIRC2;IL6;NFKB2;ADAM8;BDKRB1;PANX1;CYP27B1;SIX4;PHLDB2;CYLD;BAMBI;C1QTNF1;AMOTL2;CDKN1A;CLDN1;CCDC85B;ITGA5;ABCA5;IL7R;ZNF451;NAV3;NEDD4L;CTSC;GPX3;NOD2;DCUN1D3;SGK1;ICAM1;GCH1;SMAD3;B4GALT1;RND3;VEGFA;FGD6;DKK1;ZSWIM4;PLK2;ABL2;LAMB3;CFLAR;KLF7;BTG1;ANXA8;VMP1;TAP1;TP53BP2;ANKLE2;ADM;CDC42EP4;CREB1;TAF4B;GORAB;WISP1;NEDD9;MAST4;NR4A2;PATL1;CD47;VHL;SEMA4B;PDE4DIP;MYBL1;RUNX1;AKAP2;MASTL;KIF3C;ITGB8;WNT5A;SLC11A2;TGFA;SOCS2;PDGFB;ANLN;BAZ1A;NRG1;TNC;MMP9;LDLR;DCBLD2;COL12A1;CAB39;TLE1;PLK3;CHD2;PARD6B;SLC9A1;SPRY2;FEZ1;TNKS1BP1;H1FX;GRB7;CXCL16;NUP153;IL4R;NEDD4;ITSN2;MARCKS;NFE2L2;PTPN1;WNT7B;SMAD1;SPTBN5;CHD4;CLIC4;CAV1;RHOV;RTTN;UGCG;GOLGA8B;TP53;TLR2;ABI1;TAPBP;EFNB2;ITGAV;IKBKE;GEM;UBE2D3;STX1A;TRIP10;ABCA7;SDR16C5;PML;ESPL1;ADAM9;RAPH1;TRIM16;EMP3;PPP6R3;COL27A1;MUC1;AXL;CRB3;NR4A3;GSK3B;KMT2E;PPARD;SLC16A1;PARP1;MMP10;LAMA3;KDM7A;TBC1D22B;OCLN;JMY;COL8A1;VIM;ALAS1;DDR1;CEP135;EPB41L3;KCTD11;ERVFRD-1;CCSER2;LMAN1;GJC1
3463,GO:0007281,0.87552154602498,0.247538269883516,4,133,germ cell development,BP,PRDM1;EREG;TAF4B;QKI
3661,GO:0008144,0.876464476599821,0.155586380307837,53,1266,drug binding,MF,NUAK2;ITPKC;PPIF;MAP2K3;EPHA2;EHD1;PIM3;RIPK2;IRAK2;NMNAT2;ABCA5;NAV3;NOD2;SGK1;PLK2;MAP3K8;ABL2;NAMPT;TAP1;ANKK1;MAST4;PHKG2;RUNX1;TGFBR2;DDX3Y;MASTL;KIF3C;HMGCS1;CAMK1G;ABCF1;IFIH1;PLK3;CHD2;MT2A;CHD4;TP53;STK40;IKBKE;UBE2D3;ABCA7;CLK4;UBE2Z;PIM1;YARS2;AXL;FRK;GSK3B;PPARD;RIPK4;ALAS1;RPS6KA6;DDR1;HSPA4L
3235,GO:0006890,0.877543901811557,0.301699898796255,2,77,retrograde vesicle-mediated transport, Golgi to ER,BP,KIF3C;TAPBP
42,GO:0000086,0.877722817540202,0.211748464014858,7,225,G2/M transition of mitotic cell cycle,BP,CDKN1A;PHLDA1;CDKN2B;BACH1;MASTL;PLK3;CEP135
2405,GO:0005548,0.87792457501402,0.38585457836852,1,42,phospholipid transporter activity,MF,ABCA7
5543,GO:0016528,0.878559777507685,0.384361246820927,1,43,sarcoplasm,CC,JPH2
8441,GO:0033558,0.87870938565558,0.384045354348564,1,43,protein deacetylase activity,MF,CHD4
6137,GO:0019395,0.879277699328609,0.298419301525255,2,79,fatty acid oxidation,BP,NR4A3;PPARD
5863,GO:0017158,0.880237326203153,0.380808256437134,1,43,regulation of calcium ion-dependent exocytosis,BP,STX1A
5619,GO:0016667,0.881007719431825,0.378265002509581,1,50,oxidoreductase activity, acting on a sulfur group of donors,MF,TXNRD1
17742,GO:1901657,0.88139654193356,0.258596150991408,3,115,glycosyl compound metabolic process,BP,AMPD3;TJP2;UPP1
13078,GO:0051568,0.881460923343077,0.377914266706254,1,45,histone H3-K4 methylation,BP,KMT2E
15931,GO:0072698,0.881723832687686,0.377793739757109,1,42,protein localization to microtubule cytoskeleton,BP,GSK3B
3338,GO:0007052,0.881769211364241,0.258260538080797,3,105,mitotic spindle organization,BP,BIRC3;BIRC2;PLK2
14127,GO:0060968,0.881955316121937,0.257350357750773,3,127,regulation of gene silencing,BP,ZC3H12A;ZFP36;NUP153
14160,GO:0061024,0.882318715083613,0.162400868755414,25,663,membrane organization,BP,PMAIP1;PPIF;BBC3;IL7R;CTSC;TAP1;TP53BP2;ANKLE2;WNT5A;TGFA;LDLR;SLC9A1;NUP153;CAV1;TP53;TAPBP;STX1A;TRIP10;ABCA7;PPP6R3;GSK3B;TBC1D22B;EPB41L3;ERVFRD-1;LMAN1
2937,GO:0006458,0.882345155849876,0.375888464796946,1,46,'de novo' protein folding,BP,HSPA4L
7719,GO:0032204,0.88264577991796,0.292373197570237,2,76,regulation of telomere maintenance,BP,PML;PARP1
3654,GO:0008135,0.882974977168205,0.291497794001884,2,81,translation factor activity, RNA binding,MF,CPEB2;ABCF1
8769,GO:0034440,0.883299453251553,0.290946005905744,2,80,lipid oxidation,BP,NR4A3;PPARD
6418,GO:0021675,0.883327952369123,0.374198893393622,1,43,nerve development,BP,SIX4
9196,GO:0035577,0.883328874310878,0.373647701558007,1,47,azurophil granule membrane,CC,B4GALT1
18360,GO:1903311,0.883546219333009,0.197167332389173,8,251,regulation of mRNA metabolic process,BP,BTG2;NOCT;ZC3H12A;ZFP36;ZFP36L1;WTAP;VIM;QKI
6667,GO:0030017,0.884120935600291,0.254148305835012,3,108,sarcomere,CC,SQSTM1;JPH2;LMAN1
13128,GO:0051650,0.884397266234195,0.209664192799002,6,188,establishment of vesicle localization,BP,CTSC;MREG;TGFA;STX1A;PPP6R3;LMAN1
7306,GO:0031301,0.884694912125303,0.232610861288546,4,142,integral component of organelle membrane,CC,SYS1;RNF152;SGMS2;TPST1
12928,GO:0051261,0.884933275019969,0.288176334082275,2,75,protein depolymerization,BP,NAV3;SPTBN5
4080,GO:0009132,0.885583706506344,0.251577636582612,3,110,nucleoside diphosphate metabolic process,BP,AMPD3;TJP2;NUP153
5850,GO:0017137,0.885654024082076,0.217672062850129,5,158,Rab GTPase binding,MF,RAB3IP;EHD1;DENND3;TBC1D22B;DENND4A
2544,GO:0005801,0.88644733230711,0.367022285952108,1,46,cis-Golgi network,CC,GOLGA8B
5330,GO:0016052,0.886583197217917,0.229658037656559,4,136,carbohydrate catabolic process,BP,PHKG2;PPP1R3B;NUP153;MGAM
3238,GO:0006893,0.886600927770806,0.36682115719502,1,45,Golgi to plasma membrane transport,BP,SYS1
5358,GO:0016125,0.887175514418212,0.248835100761531,3,110,sterol metabolic process,BP,HMGCS1;LDLR;PPARD
3405,GO:0007187,0.888960725348606,0.280447807180876,2,78,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,EDN1;ADM
3631,GO:0008092,0.889693731002659,0.152312537389204,26,671,cytoskeletal protein binding,MF,NFKB1;PANX1;KLHL21;NAV3;NOD2;B4GALT1;MARCKSL1;ABL2;ANXA8;KLHL5;KIF3C;ANLN;FEZ1;RHCG;GCSAM;MARCKS;SPTBN5;ABI1;STX1A;RELA;AXL;GSK3B;COTL1;JMY;EPB41L3;CCSER2
5600,GO:0016627,0.889770381629397,0.359361339283288,1,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,DUS4L
6712,GO:0030118,0.889851275938152,0.359683291053641,1,45,clathrin coat,CC,NECAP2
10685,GO:0043933,0.889917006619358,0.137212464830324,64,1674,protein-containing complex subunit organization,BP,TNFAIP3;CSF2;TNF;BIRC3;NOCT;FOSL1;ZC3H12A;SOD2;PMAIP1;JUN;EHD1;TRAF1;SQSTM1;PLAGL2;BIRC2;PANX1;CYLD;C1QTNF1;CLDN1;ABCA5;ZNF451;NAV3;CTSC;GPX3;NOD2;ICAM1;GCH1;SMAD3;B4GALT1;VEGFA;DKK1;CDC42EP4;CREB1;TAF4B;PATL1;PDE4DIP;TGFA;ANLN;NRG1;COL12A1;CAB39;TLE1;PARD6B;SLC9A1;H1FX;GRB7;NUP153;MARCKS;SMAD1;SPTBN5;CAV1;TP53;TAPBP;IKBKE;STX1A;ABCA7;PML;PPP6R3;GSK3B;PARP1;OCLN;JMY;KCTD11;LMAN1
6597,GO:0022607,0.890211056281813,0.133163257434188,90,2217,cellular component assembly,BP,TNFAIP3;CSF2;TNF;SDC4;BIRC3;NOCT;FOSL1;ZC3H12A;SOD2;PMAIP1;EDN1;JUN;RAB3IP;EPHA2;EHD1;TRAF1;SQSTM1;PLAGL2;BIRC2;PANX1;SIX4;PHLDB2;CYLD;C1QTNF1;CLDN1;ITGA5;ZNF451;NAV3;CTSC;GPX3;NOD2;ICAM1;GCH1;SMAD3;B4GALT1;RND3;VEGFA;FGD6;DKK1;PLK2;LAMB3;CFLAR;VMP1;CDC42EP4;CREB1;TAF4B;GORAB;NEDD9;PATL1;PDE4DIP;RUNX1;KIF3C;WNT5A;TGFA;ANLN;NRG1;CAB39;TLE1;PARD6B;SLC9A1;FEZ1;H1FX;GRB7;NUP153;MARCKS;SMAD1;SPTBN5;CAV1;RHOV;GOLGA8B;TP53;TLR2;TAPBP;IKBKE;STX1A;ABCA7;PML;EMP3;PPP6R3;CRB3;GSK3B;PARP1;LAMA3;OCLN;JMY;CEP135;EPB41L3;KCTD11;LMAN1;GJC1
17083,GO:0099568,0.890307353398127,0.172222666094555,12,340,cytoplasmic region,CC,PHLDB2;TNFAIP2;RND3;NEDD9;ANLN;PARD6B;NEDD4;MARCKS;SPTBN5;CAV1;RHOV;TRIP10
514,GO:0001578,0.890375342116504,0.358523261494242,1,45,microtubule bundle formation,BP,CCSER2
94,GO:0000184,0.891717326542503,0.273812912009197,2,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,PNRC1;PNRC2
174,GO:0000380,0.891969625244768,0.354845109889576,1,46,alternative mRNA splicing, via spliceosome,BP,WTAP
12693,GO:0050891,0.892271207297166,0.354305100323192,1,45,multicellular organismal water homeostasis,BP,CLDN1
3464,GO:0007283,0.892401866770303,0.179577801583676,9,275,spermatogenesis,BP,BIRC3;BTG1;GJB3;TAF4B;MYBL1;BCL2L2;SPATA2;AXL;QKI
6891,GO:0030397,0.89243538044429,0.353804999476331,1,46,membrane disassembly,BP,NUP153
12800,GO:0051081,0.89243538044429,0.353804999476331,1,46,nuclear envelope disassembly,BP,NUP153
8986,GO:0035091,0.892500466105527,0.197334634192317,6,187,phosphatidylinositol binding,MF,PLEKHF1;DAPP1;ANXA8;SLC9A1;GRB7;JPH2
3077,GO:0006644,0.892581621688088,0.169067636583937,12,345,phospholipid metabolic process,BP,HBEGF;PLAUR;EREG;NOD2;FGF5;PIGA;HMGCS1;PDGFB;NRG1;LDLR;SGMS2;PPARD
16825,GO:0098661,0.89289767054551,0.352903743792115,1,45,inorganic anion transmembrane transport,BP,CLIC4
3300,GO:0006998,0.893117992381027,0.272439810821016,2,80,nuclear envelope organization,BP,ANKLE2;NUP153
3596,GO:0008023,0.893158474402584,0.352186092138026,1,46,transcription elongation factor complex,CC,ELL2
10531,GO:0043462,0.893214896276932,0.351473356845494,1,51,regulation of ATPase activity,BP,PPIF
6911,GO:0030490,0.893390384605787,0.350876654607336,1,53,maturation of SSU-rRNA,BP,DIEXF
2271,GO:0005200,0.894435569260461,0.26991269490976,2,80,structural constituent of cytoskeleton,MF,VIM;EPB41L3
5686,GO:0016796,0.895158469460398,0.347433108739057,1,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,NOCT
2908,GO:0006418,0.895687375970357,0.346118914531137,1,49,tRNA aminoacylation for protein translation,BP,YARS2
1875,GO:0004540,0.895700717001964,0.267200084128409,2,86,ribonuclease activity,MF,NOCT;ZC3H12A
3212,GO:0006855,0.895778927154319,0.346276797220985,1,46,drug transmembrane transport,BP,SLC7A2
7760,GO:0032272,0.895983985038453,0.34556280644232,1,48,negative regulation of protein polymerization,BP,SPTBN5
4667,GO:0010812,0.896198365936397,0.34545744818412,1,45,negative regulation of cell-substrate adhesion,BP,PHLDB2
2582,GO:0005871,0.89646496020439,0.344990213422951,1,44,kinesin complex,CC,KIF3C
11007,GO:0044815,0.89665092683946,0.341367371335108,1,91,DNA packaging complex,CC,H1FX
11525,GO:0046031,0.896666802158205,0.26560865537654,2,80,ADP metabolic process,BP,AMPD3;NUP153
5430,GO:0016279,0.897441907497976,0.342364710822951,1,47,protein-lysine N-methyltransferase activity,MF,KMT2E
12791,GO:0051053,0.898033246651458,0.229846333925207,3,109,negative regulation of DNA metabolic process,BP,DUSP1;TP53;PARP1
6262,GO:0019842,0.898197035770352,0.262451508643204,2,84,vitamin binding,MF,EGLN1;ALAS1
6588,GO:0022411,0.898369523169594,0.152569539545295,16,476,cellular component disassembly,BP,TNF;ETS1;SQSTM1;ADAM8;NAV3;DKK1;LAMB3;MMP9;PLK3;NUP153;SPTBN5;CAV1;GSK3B;MMP10;LAMA3;DDR1
3627,GO:0008088,0.899232935622702,0.338135933123225,1,48,axo-dendritic transport,BP,FEZ1
9841,GO:0042073,0.899467857875668,0.337478577181717,1,49,intraciliary transport,BP,KIF3C
4098,GO:0009150,0.899572473168727,0.162026918146457,11,357,purine ribonucleotide metabolic process,BP,PPIF;EPHA2;AMPD3;TJP2;VEGFA;ADM;WNT5A;NUP153;TPST1;PARP1;EGLN1
9360,GO:0035869,0.899650286850119,0.337057977794919,1,49,ciliary transition zone,CC,SPTBN5
3633,GO:0008094,0.899695975710262,0.259764660827602,2,79,DNA-dependent ATPase activity,MF,CHD2;CHD4
2400,GO:0005543,0.899737769260405,0.165193448064342,10,295,phospholipid binding,MF,PLEKHF1;DAPP1;ANXA8;ANXA8L1;WNT5A;SLC9A1;GRB7;JPH2;AXL;ANXA5
13712,GO:0060249,0.900093269730154,0.168382363597145,9,287,anatomical structure homeostasis,BP,TNFAIP3;CSF1;IL6;ADAM8;NOD2;VEGFA;TNKS1BP1;PML;PARP1
7875,GO:0032432,0.900405959714173,0.335549260249792,1,47,actin filament bundle,CC,MARCKS
13093,GO:0051588,0.900632203501828,0.3349042819805,1,48,regulation of neurotransmitter transport,BP,STX1A
9247,GO:0035639,0.90117348173221,0.125200029516253,58,1404,purine ribonucleoside triphosphate binding,MF,NUAK2;ITPKC;MAP2K3;EPHA2;EHD1;PIM3;RIPK2;IRAK2;NMNAT2;GBP2;RAP2B;ABCA5;NAV3;ARL5B;NOD2;SGK1;GCH1;IRGQ;RND3;RAB24;PLK2;MAP3K8;ABL2;TAP1;ANKK1;MAST4;PHKG2;RUNX1;TGFBR2;DDX3Y;MASTL;KIF3C;CAMK1G;ABCF1;IFIH1;RRAD;PLK3;CHD2;CHD4;RHOV;TP53;STK40;RAB9A;IKBKE;GEM;UBE2D3;ABCA7;CLK4;UBE2Z;PIM1;YARS2;AXL;FRK;GSK3B;RIPK4;RPS6KA6;DDR1;HSPA4L
6206,GO:0019693,0.901544969539499,0.156469939060259,12,385,ribose phosphate metabolic process,BP,PPIF;EPHA2;AMPD3;TJP2;VEGFA;UPP1;ADM;WNT5A;NUP153;TPST1;PARP1;EGLN1
13126,GO:0051648,0.901882270039831,0.182717536681219,6,194,vesicle localization,BP,CTSC;MREG;TGFA;STX1A;PPP6R3;LMAN1
15041,GO:0070972,0.902060832371308,0.253681888572199,2,125,protein localization to endoplasmic reticulum,BP,PPP1R15A;SPCS2
5429,GO:0016278,0.90222528835098,0.33120028392275,1,48,lysine N-methyltransferase activity,MF,KMT2E
4034,GO:0009064,0.902592585623322,0.330226766791339,1,49,glutamine family amino acid metabolic process,BP,HAL
7701,GO:0032154,0.90265158665161,0.330204602982714,1,48,cleavage furrow,CC,MASTL
6822,GO:0030276,0.903168758976949,0.329114761493668,1,47,clathrin binding,MF,LDLR
3780,GO:0008333,0.903721249349935,0.327697764633408,1,48,endosome to lysosome transport,BP,DENND3
4076,GO:0009127,0.904007979284712,0.218951286421756,3,116,purine nucleoside monophosphate biosynthetic process,BP,AMPD3;NUP153;PARP1
4115,GO:0009168,0.904007979284712,0.218951286421756,3,116,purine ribonucleoside monophosphate biosynthetic process,BP,AMPD3;NUP153;PARP1
10891,GO:0044428,0.904386147845628,0.112884842528839,158,3797,nuclear part,CC,NFKBIZ;IRF1;ITPKC;BIRC3;NOCT;FOSL1;ZC3H12A;IL16;ELF3;PRDM1;EHF;MAFF;NFKB1;TNIP1;MAP2K3;JUN;KDM6B;ETS1;SQSTM1;BHLHE40;SERTAD2;NFKBIE;KLF6;REL;BCL3;GADD45A;ETS2;ZNF436;NFKB2;N4BP1;JUNB;TNFAIP8;WTAP;TJP2;RELB;ZNF217;CDKN1A;GBP2;ZNF451;NAV3;NEDD4L;CTSC;NOD2;ELMSAN1;SGK1;GCH1;SMAD3;ARNTL2;PHLDA1;RNF43;TXNRD1;TMEM217;UPP1;CEBPB;CEBPD;VMP1;NAMPT;TP53BP2;DSE;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;NEDD9;NR4A2;PATL1;VHL;ABTB2;RUNX1;SMURF2;DUSP16;SFR1;DDX3Y;TGIF2;PNRC2;TRIM25;MASTL;ABCF1;DUSP10;SOX4;ANLN;BAZ1A;NRG1;ATF3;IKZF2;TLE1;PLK3;CHD2;SLC9A1;ZBTB10;RCHY1;YAF2;TNKS1BP1;H1FX;NUP153;POU2F2;NFE2L2;SMAD1;MXD1;CHD4;DIEXF;CLIC4;NFAT5;STAT5A;VEZF1;SH3RF2;INO80D;TNIP2;TP53;NOM1;KLF3;STK40;IKBKE;UBE2D3;STX1A;DOCK4;TRIP10;MAPKBP1;ELK3;RAD9B;SNAPC4;UBE2Z;PML;POLR3A;PIM1;RELA;RAPH1;TRIM16;ESCO2;SPATA2;PPP6R3;MUC1;YARS2;AKIRIN1;ELL2;CITED4;NR4A3;GSK3B;KMT2E;PPARD;PARP1;CYP24A1;KDM7A;MED13;MXD3;JMY;SRSF11;NABP1;ALAS1;RPS6KA6;XBP1;ELF4;TFE3;EID3;ZMIZ2;JUND
3477,GO:0007338,0.904526679360191,0.325367337473981,1,52,single fertilization,BP,B4GALT1
2818,GO:0006282,0.904695660397866,0.249716971434386,2,83,regulation of DNA repair,BP,PML;PARP1
8957,GO:0035019,0.905052766701108,0.324334077150498,1,50,somatic stem cell population maintenance,BP,SOX4
6340,GO:0021510,0.905567523363595,0.323462249442589,1,47,spinal cord development,BP,SOX4
12944,GO:0051287,0.905622927124475,0.322776625769189,1,52,NAD binding,MF,PARP1
7721,GO:0032206,0.905629239349712,0.323080472438281,1,49,positive regulation of telomere maintenance,BP,PML
7079,GO:0030863,0.906473660108536,0.246358633650226,2,79,cortical cytoskeleton,CC,ANLN;SPTBN5
20132,GO:2000779,0.906715966081356,0.320498733166307,1,49,regulation of double-strand break repair,BP,PML
2718,GO:0006091,0.906732354458737,0.151834083124965,11,366,generation of precursor metabolites and energy,BP,PPIF;PHLDA2;IL6ST;TXNRD1;PHKG2;PPP1R3B;NUP153;STK40;NR4A3;GSK3B;PPARD
10295,GO:0043039,0.906872735602735,0.319807019391662,1,52,tRNA aminoacylation,BP,YARS2
11674,GO:0046434,0.907124538655353,0.183121602515059,5,173,organophosphate catabolic process,BP,AMPD3;UPP1;LDLR;NUP153;EGLN1
11120,GO:0045132,0.907198975155426,0.319236745906568,1,50,meiotic chromosome segregation,BP,ESPL1
586,GO:0001738,0.907305318236585,0.21284691856571,3,121,morphogenesis of a polarized epithelium,BP,DKK1;SMURF2;WNT5A
4112,GO:0009165,0.907615110227239,0.166939202443349,7,234,nucleotide biosynthetic process,BP,AMPD3;NMNAT2;UPP1;NAMPT;ADM;NUP153;PARP1
7598,GO:0031965,0.907617571394991,0.161728156402991,8,251,nuclear membrane,CC,WTAP;NAV3;GCH1;SMAD3;NUP153;SMAD1;STX1A;AKIRIN1
2390,GO:0005524,0.908270366648584,0.119350744480062,47,1150,ATP binding,MF,NUAK2;ITPKC;MAP2K3;EPHA2;EHD1;PIM3;RIPK2;IRAK2;NMNAT2;ABCA5;NAV3;NOD2;SGK1;PLK2;MAP3K8;ABL2;TAP1;ANKK1;MAST4;PHKG2;RUNX1;TGFBR2;DDX3Y;MASTL;KIF3C;CAMK1G;ABCF1;IFIH1;PLK3;CHD2;CHD4;TP53;STK40;IKBKE;UBE2D3;ABCA7;CLK4;UBE2Z;PIM1;YARS2;AXL;FRK;GSK3B;RIPK4;RPS6KA6;DDR1;HSPA4L
12796,GO:0051058,0.908427524328367,0.316640563749724,1,47,negative regulation of small GTPase mediated signal transduction,BP,SPRY2
9834,GO:0042054,0.908576790953582,0.315937498984671,1,50,histone methyltransferase activity,MF,KMT2E
6002,GO:0019005,0.910083952207046,0.312097276172668,1,52,SCF ubiquitin ligase complex,CC,ABTB2
6559,GO:0021987,0.910395140368132,0.238317421254989,2,82,cerebral cortex development,BP,SLC38A2;GSK3B
1781,GO:0004386,0.910434380126187,0.18961670316243,4,137,helicase activity,MF,DDX3Y;IFIH1;CHD2;CHD4
4555,GO:0010633,0.910511772294111,0.311377598735704,1,49,negative regulation of epithelial cell migration,BP,DUSP10
3067,GO:0006631,0.910619366653887,0.15713459141717,8,261,fatty acid metabolic process,BP,EDN1;STAT5A;CAV1;PDP1;NR4A3;PPARD;XBP1;QKI
10294,GO:0043038,0.911482042997108,0.308606787960005,1,53,amino acid activation,BP,YARS2
6676,GO:0030032,0.911604648983457,0.308720981891591,1,49,lamellipodium assembly,BP,EPHA2
11767,GO:0046605,0.911632201936689,0.30854433064791,1,50,regulation of centrosome cycle,BP,PLK2
6996,GO:0030672,0.911991034290353,0.307462967182551,1,52,synaptic vesicle membrane,CC,STX1A
17045,GO:0099501,0.911991034290353,0.307462967182551,1,52,exocytic vesicle membrane,CC,STX1A
549,GO:0001669,0.912201100997739,0.306949907581178,1,52,acrosomal vesicle,CC,CAV1
15976,GO:0075733,0.912895797447143,0.305249509919809,1,52,intracellular transport of virus,BP,NUP153
5593,GO:0016614,0.913146891121511,0.232276837462472,2,93,oxidoreductase activity, acting on CH-OH group of donors,MF,BMP2;SDR16C5
2515,GO:0005766,0.913371161588389,0.201661679023821,3,122,primary lysosome,CC,CTSC;B4GALT1;FRK
10085,GO:0042582,0.913371161588389,0.201661679023821,3,122,azurophil granule,CC,CTSC;B4GALT1;FRK
17621,GO:1901293,0.913445433048711,0.157886750790508,7,237,nucleoside phosphate biosynthetic process,BP,AMPD3;NMNAT2;UPP1;NAMPT;ADM;NUP153;PARP1
11664,GO:0046394,0.913483094639418,0.148651872961742,9,287,carboxylic acid biosynthetic process,BP,IL1B;NFKB1;EDN1;GCH1;DSE;PDGFB;NUP153;XBP1;QKI
14520,GO:0065004,0.913741512361594,0.171810014642772,5,213,protein-DNA complex assembly,BP,CREB1;TAF4B;H1FX;TP53;PARP1
12146,GO:0048232,0.913990114852593,0.147905239233449,9,285,male gamete generation,BP,BIRC3;BTG1;GJB3;TAF4B;MYBL1;BCL2L2;SPATA2;AXL;QKI
12175,GO:0048284,0.914546428457605,0.182314452833644,4,146,organelle fusion,BP,TAP1;TAPBP;STX1A;TBC1D22B
6069,GO:0019213,0.914623123268735,0.301097151830291,1,51,deacetylase activity,MF,CHD4
6714,GO:0030120,0.915381678444107,0.299117750882918,1,52,vesicle coat,CC,NECAP2
5331,GO:0016053,0.915404414038256,0.145775080046779,9,288,organic acid biosynthetic process,BP,IL1B;NFKB1;EDN1;GCH1;DSE;PDGFB;NUP153;XBP1;QKI
7332,GO:0031338,0.915799999198526,0.298391627798217,1,49,regulation of vesicle fusion,BP,TBC1D22B
5478,GO:0016407,0.916269679746071,0.226029032611339,2,88,acetyltransferase activity,MF,ESCO2;SAT1
7039,GO:0030808,0.917072400472001,0.224442019356616,2,86,regulation of nucleotide biosynthetic process,BP,NUP153;PARP1
17489,GO:1900371,0.917072400472001,0.224442019356616,2,86,regulation of purine nucleotide biosynthetic process,BP,NUP153;PARP1
110,GO:0000226,0.917224036514622,0.128573844729851,15,427,microtubule cytoskeleton organization,BP,BIRC3;GADD45A;BIRC2;PHLDB2;CYLD;NAV3;PLK2;PLK3;SPRY2;GOLGA8B;ESPL1;GSK3B;SLC16A1;CEP135;CCSER2
5345,GO:0016079,0.917260820489576,0.294636546918181,1,50,synaptic vesicle exocytosis,BP,STX1A
8894,GO:0034708,0.91735774002428,0.223696706308079,2,90,methyltransferase complex,CC,KDM6B;WTAP
10805,GO:0044281,0.917709509730957,0.105581212409794,57,1505,small molecule metabolic process,BP,IL1B;TNF;ITPKC;BMP2;PMAIP1;NFKB1;PPIF;EDN1;EPHA2;AMPD3;CYP27B1;PHLDA2;TJP2;C1QTNF1;NMNAT2;ODC1;GCH1;B4GALT1;VEGFA;SLC6A14;TXNRD1;UPP1;NAMPT;ADM;DSE;SLC7A2;PHKG2;SOGA1;HMGCS1;WNT5A;SLC52A3;PPP1R3B;PDGFB;LDLR;ATF3;SLC9A1;B4GALT5;HAL;NUP153;STAT5A;TPST1;CAV1;TLR2;PDP1;SDR16C5;PIM1;CHST2;YARS2;NR4A3;GSK3B;PPARD;SLC16A1;PARP1;CYP24A1;EGLN1;XBP1;QKI
7233,GO:0031124,0.918048347067866,0.222333079489064,2,88,mRNA 3'-end processing,BP,ZFP36L1;SRSF11
25,GO:0000049,0.918835003010923,0.290286364387974,1,54,tRNA binding,MF,YARS2
16739,GO:0097731,0.918903484530973,0.290400754607458,1,51,9+0 non-motile cilium,CC,SPTBN5
16741,GO:0097733,0.918903484530973,0.290400754607458,1,51,photoreceptor cell cilium,CC,SPTBN5
16526,GO:0097223,0.918979134405841,0.220315265646929,2,90,sperm part,CC,SQSTM1;CAV1
16436,GO:0097061,0.919120387170259,0.289956115140129,1,50,dendritic spine organization,BP,EFNA1
2896,GO:0006403,0.919309714276233,0.154789924666803,6,209,RNA localization,BP,ZFP36;ZFP36L1;TGFBR2;NUP153;SRSF11;QKI
11822,GO:0046700,0.919917865605734,0.121826823646733,17,545,heterocycle catabolic process,BP,BTG2;NOCT;ZC3H12A;ZFP36;PNRC1;AMPD3;ZFP36L1;UPP1;PATL1;PNRC2;TNKS1BP1;HAL;NUP153;NFE2L2;VIM;EGLN1;QKI
10618,GO:0043603,0.92006304217732,0.111029342867113,30,909,cellular amide metabolic process,BP,TNF;EFNA1;BTG2;ZC3H12A;PPP1R15A;TNIP1;ZFP36;BCL3;IL6;ZFP36L1;CPEB2;GCH1;DDX3Y;ITGB8;ABCF1;SOX4;PLK3;HAL;GRB7;NUP153;NFE2L2;SGMS2;STAT5A;UGCG;TAPBP;ABCA7;SPCS2;YARS2;VIM;QKI
12963,GO:0051310,0.920349848153614,0.286447958368642,1,54,metaphase plate congression,BP,GEM
7961,GO:0032555,0.92052007307888,0.102042620576794,58,1423,purine ribonucleotide binding,MF,NUAK2;ITPKC;MAP2K3;EPHA2;EHD1;PIM3;RIPK2;IRAK2;NMNAT2;GBP2;RAP2B;ABCA5;NAV3;ARL5B;NOD2;SGK1;GCH1;IRGQ;RND3;RAB24;PLK2;MAP3K8;ABL2;TAP1;ANKK1;MAST4;PHKG2;RUNX1;TGFBR2;DDX3Y;MASTL;KIF3C;CAMK1G;ABCF1;IFIH1;RRAD;PLK3;CHD2;CHD4;RHOV;TP53;STK40;RAB9A;IKBKE;GEM;UBE2D3;ABCA7;CLK4;UBE2Z;PIM1;YARS2;AXL;FRK;GSK3B;RIPK4;RPS6KA6;DDR1;HSPA4L
14161,GO:0061025,0.920617048122529,0.160611502089741,5,177,membrane fusion,BP,TAP1;TAPBP;STX1A;TBC1D22B;ERVFRD-1
10641,GO:0043647,0.920661409151173,0.286044008178011,1,50,inositol phosphate metabolic process,BP,ITPKC
17615,GO:1901264,0.921109349045552,0.284339116399972,1,56,carbohydrate derivative transport,BP,SLC28A3
13226,GO:0051865,0.921326038832655,0.284145382367284,1,52,protein autoubiquitination,BP,UBE2D3
13302,GO:0051983,0.921373641991568,0.215319388541596,2,89,regulation of chromosome segregation,BP,DUSP1;ESPL1
7231,GO:0031122,0.922057965323178,0.282369190640287,1,51,cytoplasmic microtubule organization,BP,PLK3
7182,GO:0031060,0.92221408126963,0.281968323833308,1,51,regulation of histone methylation,BP,KMT2E
4185,GO:0009260,0.922264087902951,0.157743072434927,5,184,ribonucleotide biosynthetic process,BP,AMPD3;UPP1;ADM;NUP153;PARP1
2803,GO:0006260,0.92257413279347,0.138824824731339,8,260,DNA replication,BP,CSF2;JUN;EREG;PDGFB;BAZ1A;RAD9B;ESCO2;PARP1
3954,GO:0008654,0.923287817858188,0.142421001235897,7,231,phospholipid biosynthetic process,BP,PLAUR;FGF5;PIGA;HMGCS1;PDGFB;SGMS2;PPARD
2755,GO:0006163,0.923429314698257,0.127633025879051,11,372,purine nucleotide metabolic process,BP,PPIF;EPHA2;AMPD3;TJP2;VEGFA;ADM;WNT5A;NUP153;TPST1;PARP1;EGLN1
13505,GO:0055029,0.923490279090724,0.182467395332761,3,127,nuclear DNA-directed RNA polymerase complex,CC,TAF4B;TP53;POLR3A
10029,GO:0042470,0.923967689999683,0.209710055663833,2,92,melanosome,CC,MREG;RAB9A
12388,GO:0048770,0.923967689999683,0.209710055663833,2,92,pigment granule,CC,MREG;RAB9A
3326,GO:0007034,0.924174225582519,0.181315898073011,3,119,vacuolar transport,BP,DENND3;NEDD4;SPTBN5
2733,GO:0006110,0.924770401075362,0.275259769713088,1,52,regulation of glycolytic process,BP,NUP153
16330,GO:0090502,0.92577182714588,0.272056168742875,1,59,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,ZC3H12A
11695,GO:0046470,0.925864753169643,0.272047504116243,1,56,phosphatidylcholine metabolic process,BP,LDLR
203,GO:0000428,0.926266040451144,0.177101219614562,3,128,DNA-directed RNA polymerase complex,CC,TAF4B;TP53;POLR3A
16663,GO:0097525,0.926326873826895,0.270391362360965,1,62,spliceosomal snRNP complex,CC,MAPKBP1
2978,GO:0006520,0.926480330926008,0.132641100555853,8,279,cellular amino acid metabolic process,BP,NMNAT2;ODC1;SLC6A14;SLC7A2;HAL;STAT5A;YARS2;EGLN1
2549,GO:0005815,0.926945552774459,0.1072908356594,22,610,microtubule organizing center,CC,CYLD;RELB;CCDC85B;CTSC;PLK2;TAP1;PDE4DIP;MASTL;PLK3;FEZ1;ITSN2;MARCKS;NFE2L2;CHD4;CLIC4;RTTN;ESPL1;GSK3B;KMT2E;SLC16A1;EVC;CEP135
5511,GO:0016458,0.927088882385237,0.141824676496858,6,237,gene silencing,BP,ZC3H12A;ZFP36;SMAD3;NUP153;SMAD1;ZC3H7B
17211,GO:0106027,0.927209604170829,0.268869038240033,1,52,neuron projection organization,BP,EFNA1
7965,GO:0032559,0.927397244597356,0.0959213532706181,47,1169,adenyl ribonucleotide binding,MF,NUAK2;ITPKC;MAP2K3;EPHA2;EHD1;PIM3;RIPK2;IRAK2;NMNAT2;ABCA5;NAV3;NOD2;SGK1;PLK2;MAP3K8;ABL2;TAP1;ANKK1;MAST4;PHKG2;RUNX1;TGFBR2;DDX3Y;MASTL;KIF3C;CAMK1G;ABCF1;IFIH1;PLK3;CHD2;CHD4;TP53;STK40;IKBKE;UBE2D3;ABCA7;CLK4;UBE2Z;PIM1;YARS2;AXL;FRK;GSK3B;RIPK4;RPS6KA6;DDR1;HSPA4L
11662,GO:0046390,0.928498482021221,0.147024560666083,5,187,ribose phosphate biosynthetic process,BP,AMPD3;UPP1;ADM;NUP153;PARP1
2563,GO:0005844,0.928705921446886,0.263695691045029,1,69,polysome,CC,VIM
17292,GO:0140029,0.929019090617299,0.263721823516527,1,56,exocytic process,BP,STX1A
2523,GO:0005775,0.929163123334822,0.171502572797456,3,126,vacuolar lumen,CC,SDC4;CTSC;FRK
7090,GO:0030880,0.929249023676797,0.171262360930851,3,130,RNA polymerase complex,CC,TAF4B;TP53;POLR3A
12173,GO:0048278,0.929436544525075,0.262609271365439,1,56,vesicle docking,BP,STX1A
20008,GO:2000573,0.929491841773401,0.262461708243909,1,56,positive regulation of DNA biosynthetic process,BP,PDGFB
7959,GO:0032553,0.929925014109348,0.090640142629183,58,1434,ribonucleotide binding,MF,NUAK2;ITPKC;MAP2K3;EPHA2;EHD1;PIM3;RIPK2;IRAK2;NMNAT2;GBP2;RAP2B;ABCA5;NAV3;ARL5B;NOD2;SGK1;GCH1;IRGQ;RND3;RAB24;PLK2;MAP3K8;ABL2;TAP1;ANKK1;MAST4;PHKG2;RUNX1;TGFBR2;DDX3Y;MASTL;KIF3C;CAMK1G;ABCF1;IFIH1;RRAD;PLK3;CHD2;CHD4;RHOV;TP53;STK40;RAB9A;IKBKE;GEM;UBE2D3;ABCA7;CLK4;UBE2Z;PIM1;YARS2;AXL;FRK;GSK3B;RIPK4;RPS6KA6;DDR1;HSPA4L
17347,GO:1900006,0.930255527443718,0.260769606802451,1,52,positive regulation of dendrite development,BP,NRG1
6153,GO:0019439,0.930378720036768,0.107363294975635,17,554,aromatic compound catabolic process,BP,BTG2;NOCT;ZC3H12A;ZFP36;PNRC1;AMPD3;ZFP36L1;UPP1;PATL1;PNRC2;MAOA;TNKS1BP1;HAL;NUP153;VIM;EGLN1;QKI
17706,GO:1901570,0.931213046098111,0.257615618946924,1,59,fatty acid derivative biosynthetic process,BP,EDN1
10260,GO:0042995,0.931421213547638,0.0898737594767213,52,1312,cell projection,CC,FOSL1;PLAUR;RAB3IP;EPHA2;EHD1;SQSTM1;N4BP3;BDKRB1;PANX1;CYLD;ITGA5;CPEB2;IL6ST;GCH1;FRMD4B;B4GALT1;FGD6;SLC6A14;PLK2;LAYN;CREB1;NEDD9;KIF3C;CAMK1G;SLC11A2;ANLN;NRG1;SLC38A2;PLK3;SLC9A1;SPRY2;FEZ1;GRB7;NEDD4;SPTBN5;CLIC4;CAV1;RHOV;RTTN;TLR2;ABI1;ITGAV;STX1A;DOCK4;TRIP10;ABCA7;ADGRE2;RAPH1;EVC;VIM;EPB41L3;SLC39A14
5818,GO:0017076,0.931763207878374,0.0883990323080649,58,1437,purine nucleotide binding,MF,NUAK2;ITPKC;MAP2K3;EPHA2;EHD1;PIM3;RIPK2;IRAK2;NMNAT2;GBP2;RAP2B;ABCA5;NAV3;ARL5B;NOD2;SGK1;GCH1;IRGQ;RND3;RAB24;PLK2;MAP3K8;ABL2;TAP1;ANKK1;MAST4;PHKG2;RUNX1;TGFBR2;DDX3Y;MASTL;KIF3C;CAMK1G;ABCF1;IFIH1;RRAD;PLK3;CHD2;CHD4;RHOV;TP53;STK40;RAB9A;IKBKE;GEM;UBE2D3;ABCA7;CLK4;UBE2Z;PIM1;YARS2;AXL;FRK;GSK3B;RIPK4;RPS6KA6;DDR1;HSPA4L
2875,GO:0006368,0.931801375598897,0.192585049576514,2,97,transcription elongation from RNA polymerase II promoter,BP,TAF4B;ELL2
7413,GO:0031491,0.932270976276579,0.254304136620651,1,66,nucleosome binding,MF,CHD4
4254,GO:0009451,0.93267707321108,0.164501407090818,3,131,RNA modification,BP,WTAP;DUS4L;PUS10
10124,GO:0042641,0.933168721128169,0.252714358590105,1,54,actomyosin,CC,STX1A
10298,GO:0043044,0.933738884762531,0.2501476695427,1,69,ATP-dependent chromatin remodeling,BP,CHD4
2478,GO:0005694,0.933939369672957,0.0927006197300451,31,884,chromosome,CC,IRF1;JUN;KDM6B;BIRC2;JUNB;SMAD3;PLK2;CEBPB;CREB1;SFR1;BAZ1A;TNKS1BP1;H1FX;NEDD4;NFE2L2;MXD1;CHD4;TP53;RAD9B;SDR16C5;PML;RELA;ESCO2;MUC1;KMT2E;PPARD;PARP1;NABP1;EID3;ZMIZ2;JUND
20105,GO:2000736,0.934724341476027,0.185544290893026,2,122,regulation of stem cell differentiation,BP,RUNX1;NFE2L2
10525,GO:0043436,0.935043824627849,0.0921774359820094,29,822,oxoacid metabolic process,BP,IL1B;NFKB1;EDN1;NMNAT2;ODC1;GCH1;B4GALT1;SLC6A14;DSE;SLC7A2;PDGFB;SLC9A1;B4GALT5;HAL;NUP153;STAT5A;TPST1;CAV1;TLR2;PDP1;PIM1;CHST2;YARS2;NR4A3;PPARD;SLC16A1;EGLN1;XBP1;QKI
2488,GO:0005730,0.935122848768192,0.0920659287355917,29,833,nucleolus,CC,NFKBIE;KLF6;N4BP1;CDKN1A;ARNTL2;PHLDA1;TXNRD1;TMEM217;VMP1;TAF4B;GORAB;GJB4;DDX3Y;ATF3;PLK3;CHD2;H1FX;NUP153;DIEXF;TP53;NOM1;DOCK4;PML;PIM1;SPATA2;PARP1;KDM7A;RPS6KA6;EID3
18231,GO:1903008,0.936134051020349,0.182988415533103,2,96,organelle disassembly,BP,SQSTM1;PLK3
72,GO:0000149,0.936698952599182,0.181809440195671,2,93,SNARE binding,MF,TNFAIP2;STX1A
10359,GO:0043168,0.936742405494498,0.0795669203275983,82,1999,anion binding,MF,HBEGF;NUAK2;ITPKC;PLEKHF1;MAP2K3;EPHA2;EHD1;STARD5;PIM3;RIPK2;IRAK2;DAPP1;NMNAT2;GBP2;RAP2B;ABCA5;NAV3;CTSC;ARL5B;NOD2;SGK1;GCH1;IRGQ;RND3;VEGFA;RAB24;PLK2;MAP3K8;ABL2;TXNRD1;ANXA8;LAYN;TAP1;ANXA8L1;ADAMTS1;ANKK1;WISP1;MAST4;PHKG2;RUNX1;TGFBR2;DDX3Y;SAA1;MASTL;KIF3C;WNT5A;CAMK1G;ABCF1;IFIH1;RRAD;PLK3;CHD2;SLC9A1;GRB7;DUS4L;CHD4;RHOV;TP53;STK40;RAB9A;IKBKE;GEM;UBE2D3;JPH2;ABCA7;CLK4;ADGRE2;UBE2Z;PIM1;RELA;YARS2;AXL;ANXA5;FRK;GSK3B;PPARD;EGLN1;RIPK4;ALAS1;RPS6KA6;DDR1;HSPA4L
11062,GO:0045047,0.936760915372887,0.240695990653474,1,101,protein targeting to ER,BP,SPCS2
6950,GO:0030554,0.937044320773444,0.0839264259210069,47,1181,adenyl nucleotide binding,MF,NUAK2;ITPKC;MAP2K3;EPHA2;EHD1;PIM3;RIPK2;IRAK2;NMNAT2;ABCA5;NAV3;NOD2;SGK1;PLK2;MAP3K8;ABL2;TAP1;ANKK1;MAST4;PHKG2;RUNX1;TGFBR2;DDX3Y;MASTL;KIF3C;CAMK1G;ABCF1;IFIH1;PLK3;CHD2;CHD4;TP53;STK40;IKBKE;UBE2D3;ABCA7;CLK4;UBE2Z;PIM1;YARS2;AXL;FRK;GSK3B;RIPK4;RPS6KA6;DDR1;HSPA4L
2586,GO:0005876,0.937050097745482,0.241854555629981,1,56,spindle microtubule,CC,KLHL21
19503,GO:1990234,0.937160643961854,0.0915043933486035,25,713,transferase complex,CC,RNF19B;KDM6B;KLHL21;WTAP;CDKN1A;DCUN1D3;RNF144B;ZSWIM4;PIGA;TAF4B;CCNL1;VHL;PHKG2;BACH1;ABTB2;TGFBR2;SMURF2;KLHL5;CAB39;RCHY1;NEDD4;KBTBD7;TP53;POLR3A;EID3
16730,GO:0097711,0.938018010566924,0.178803802435852,2,94,ciliary basal body-plasma membrane docking,BP,RAB3IP;CEP135
7220,GO:0031110,0.938284221513398,0.238326076095759,1,57,regulation of microtubule polymerization or depolymerization,BP,NAV3
4860,GO:0014069,0.938621426620979,0.138690539376418,4,148,postsynaptic density,CC,ABI1;PJA2;STX1A;EPB41L3
469,GO:0001510,0.938635596185325,0.237055699584675,1,61,RNA methylation,BP,WTAP
3118,GO:0006695,0.938667527764812,0.237102662745585,1,59,cholesterol biosynthetic process,BP,HMGCS1
17716,GO:1901606,0.938739752376586,0.236762823970147,1,61,alpha-amino acid catabolic process,BP,HAL
3069,GO:0006635,0.938762570988392,0.23669863615469,1,61,fatty acid beta-oxidation,BP,PPARD
2842,GO:0006310,0.938855108054808,0.122159929515943,6,215,DNA recombination,BP,IL7R;SFR1;INO80D;PARP1;NABP1;EID3
3155,GO:0006754,0.939175487874105,0.176120300927888,2,96,ATP biosynthetic process,BP,NUP153;PARP1
15838,GO:0072527,0.939723112261808,0.233741987167729,1,65,pyrimidine-containing compound metabolic process,BP,UPP1
12532,GO:0050662,0.939921830650518,0.120291929508119,6,221,coenzyme binding,MF,GCH1;TXNRD1;DUS4L;PARP1;EGLN1;ALAS1
10082,GO:0042578,0.940126027603862,0.111003289374461,8,266,phosphoric ester hydrolase activity,MF,DUSP1;PPTC7;DUSP16;DUSP10;PPP1R3B;DUSP8;PTPN1;PDP1
6932,GO:0030521,0.940323330709728,0.232494377660919,1,58,androgen receptor signaling pathway,BP,MED13
18823,GO:1904356,0.940476420065957,0.232059278357062,1,58,regulation of telomere maintenance via telomere lengthening,BP,PARP1
9,GO:0000018,0.940546640350268,0.231859567141757,1,58,regulation of DNA recombination,BP,IL7R
17086,GO:0099572,0.940756093495001,0.134647671520549,4,149,postsynaptic specialization,CC,ABI1;PJA2;STX1A;EPB41L3
10909,GO:0044451,0.940869928596423,0.0819011705094322,36,975,nucleoplasm part,CC,NFKBIZ;ITPKC;IL16;KDM6B;SQSTM1;BHLHE40;GADD45A;N4BP1;WTAP;ZNF217;CDKN1A;ZNF451;ELMSAN1;SGK1;NAMPT;TAF4B;CCNL1;NR4A2;PATL1;SMURF2;TRIM25;DUSP10;RCHY1;CHD4;TP53;IKBKE;PML;POLR3A;RAPH1;TRIM16;YARS2;ELL2;KMT2E;MED13;SRSF11;ELF4
2711,GO:0006082,0.941279000677982,0.0839643604765693,29,829,organic acid metabolic process,BP,IL1B;NFKB1;EDN1;NMNAT2;ODC1;GCH1;B4GALT1;SLC6A14;DSE;SLC7A2;PDGFB;SLC9A1;B4GALT5;HAL;NUP153;STAT5A;TPST1;CAV1;TLR2;PDP1;PIM1;CHST2;YARS2;NR4A3;PPARD;SLC16A1;EGLN1;XBP1;QKI
18087,GO:1902653,0.941400035898959,0.229285858595102,1,60,secondary alcohol biosynthetic process,BP,HMGCS1
20200,GO:2001021,0.941606121646335,0.228565870783893,1,62,negative regulation of response to DNA damage stimulus,BP,MUC1
5405,GO:0016239,0.942414948392131,0.226514113430993,1,58,positive regulation of macroautophagy,BP,RIPK2
17704,GO:1901568,0.942538260606582,0.16830738255869,2,100,fatty acid derivative metabolic process,BP,EDN1;TLR2
7767,GO:0032279,0.942640913962832,0.131051703806498,4,150,asymmetric synapse,CC,ABI1;PJA2;STX1A;EPB41L3
982,GO:0002433,0.942825954814569,0.225329820355109,1,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,ABI1
9702,GO:0038096,0.942825954814569,0.225329820355109,1,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,ABI1
16153,GO:0090150,0.942874821966519,0.114974168160718,6,265,establishment of protein localization to membrane,BP,PMAIP1;RAB3IP;BBC3;TP53BP2;SYS1;TP53
8442,GO:0033559,0.943018072621752,0.224445487533128,1,63,unsaturated fatty acid metabolic process,BP,EDN1
6029,GO:0019083,0.943355872794325,0.142458714999502,3,171,viral transcription,BP,ZFP36;JUN;NUP153
2977,GO:0006518,0.943751046343243,0.0831251671796537,24,785,peptide metabolic process,BP,TNF;EFNA1;BTG2;ZC3H12A;PPP1R15A;TNIP1;ZFP36;BCL3;IL6;ZFP36L1;CPEB2;DDX3Y;ABCF1;SOX4;PLK3;GRB7;NUP153;NFE2L2;TAPBP;ABCA7;SPCS2;YARS2;VIM;QKI
3455,GO:0007268,0.943878007318703,0.101794889217636,9,293,chemical synaptic transmission,BP,IL1B;EDN1;SQSTM1;DKK1;PLK2;CREB1;STX1A;GSK3B;GJC1
16949,GO:0098916,0.943878007318703,0.101794889217636,9,293,anterograde trans-synaptic signaling,BP,IL1B;EDN1;SQSTM1;DKK1;PLK2;CREB1;STX1A;GSK3B;GJC1
6119,GO:0019362,0.944379020011794,0.140834464771694,3,130,pyridine nucleotide metabolic process,BP,NMNAT2;NAMPT;NUP153
11713,GO:0046496,0.944379020011794,0.140834464771694,3,130,nicotinamide nucleotide metabolic process,BP,NMNAT2;NAMPT;NUP153
555,GO:0001676,0.944717761549025,0.219573151935363,1,62,long-chain fatty acid metabolic process,BP,QKI
15499,GO:0071840,0.944724669971106,0.0660834513933619,201,4811,cellular component organization or biogenesis,BP,IL1B;TNFAIP3;CSF2;TNF;HBEGF;NUAK2;CXCL1;IL1A;EFNA1;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;FOSL1;ZC3H12A;PPP1R15A;ELF3;LIF;PLAUR;SOD2;PMAIP1;PTX3;PPIF;EDN1;JUN;KDM6B;RAB3IP;EPHA2;EHD1;ETS1;TRAF1;SQSTM1;SERTAD2;BBC3;EREG;DUSP1;BCL3;GADD45A;PLAGL2;EFNB1;BIRC2;IL6;NFKB2;ADAM8;BDKRB1;PANX1;CYP27B1;SIX4;PHLDB2;CYLD;BAMBI;C1QTNF1;AMOTL2;CDKN1A;CLDN1;CCDC85B;ITGA5;ABCA5;IL7R;ZNF451;NAV3;NEDD4L;CTSC;GPX3;NOD2;DCUN1D3;SGK1;ICAM1;GCH1;SMAD3;B4GALT1;RND3;VEGFA;FGD6;DKK1;ZSWIM4;PLK2;ABL2;LAMB3;CFLAR;KLF7;BTG1;ANXA8;VMP1;TAP1;TP53BP2;ANKLE2;ADM;CDC42EP4;CREB1;TAF4B;GORAB;WISP1;NEDD9;MAST4;NR4A2;PATL1;CD47;VHL;SEMA4B;PDE4DIP;MYBL1;RUNX1;AKAP2;MASTL;KIF3C;ITGB8;WNT5A;SLC11A2;TGFA;SOCS2;PDGFB;ANLN;BAZ1A;NRG1;TNC;MMP9;LDLR;DCBLD2;COL12A1;CAB39;TLE1;PLK3;CHD2;ARRDC4;PARD6B;SLC9A1;SPRY2;FEZ1;TNKS1BP1;H1FX;GRB7;CXCL16;NUP153;IL4R;NEDD4;ITSN2;MARCKS;NFE2L2;PTPN1;WNT7B;SMAD1;SPTBN5;CHD4;DIEXF;CLIC4;CAV1;RHOV;RTTN;UGCG;GOLGA8B;TP53;NOM1;TLR2;ABI1;TAPBP;EFNB2;ITGAV;IKBKE;GEM;UBE2D3;STX1A;TRIP10;ABCA7;SDR16C5;PML;ESPL1;ADAM9;RAPH1;TRIM16;EMP3;PPP6R3;COL27A1;MUC1;AXL;CRB3;NR4A3;GSK3B;KMT2E;PPARD;SLC16A1;PARP1;MMP10;LAMA3;KDM7A;TBC1D22B;OCLN;JMY;COL8A1;VIM;ALAS1;DDR1;CEP135;EPB41L3;KCTD11;ERVFRD-1;CCSER2;LMAN1;GJC1
8753,GO:0034404,0.945067600202266,0.126215548612035,4,167,nucleobase-containing small molecule biosynthetic process,BP,AMPD3;UPP1;NUP153;EGLN1
5578,GO:0016591,0.945143761817273,0.162180238800884,2,103,DNA-directed RNA polymerase II, holoenzyme,CC,TAF4B;TP53
11846,GO:0046785,0.945207264392382,0.218337567335709,1,59,microtubule polymerization,BP,NAV3
9700,GO:0038094,0.94521369883965,0.218318721284868,1,59,Fc-gamma receptor signaling pathway,BP,ABI1
19579,GO:1990542,0.945371011088108,0.21737671929976,1,67,mitochondrial transmembrane transport,BP,SLC25A37
3595,GO:0008022,0.945673764628214,0.125109595602408,4,161,protein C-terminus binding,MF,TJP2;TP53;VIM;CEP135
4061,GO:0009108,0.945800975288069,0.116266542923718,5,193,coenzyme biosynthetic process,BP,NMNAT2;GCH1;NAMPT;NUP153;PDP1
15888,GO:0072599,0.946206333278575,0.21367598776298,1,104,establishment of protein localization to endoplasmic reticulum,BP,SPCS2
16981,GO:0098984,0.946604277423154,0.123412366059993,4,152,neuron to neuron synapse,CC,ABI1;PJA2;STX1A;EPB41L3
6935,GO:0030532,0.947336433178713,0.21148098928842,1,69,small nuclear ribonucleoprotein complex,CC,MAPKBP1
5612,GO:0016651,0.947503444817604,0.210414307460433,1,83,oxidoreductase activity, acting on NAD(P)H,MF,TXNRD1
10619,GO:0043604,0.947592181526658,0.07906552434539,22,735,amide biosynthetic process,BP,TNF;BTG2;ZC3H12A;PPP1R15A;TNIP1;ZFP36;BCL3;IL6;ZFP36L1;CPEB2;GCH1;DDX3Y;ABCF1;SOX4;GRB7;NUP153;NFE2L2;SGMS2;UGCG;YARS2;VIM;QKI
1595,GO:0004004,0.947772099261148,0.21076228244263,1,59,ATP-dependent RNA helicase activity,MF,DDX3Y
2002,GO:0004722,0.94783020226628,0.210396769114829,1,62,protein serine/threonine phosphatase activity,MF,PDP1
17067,GO:0099537,0.948171549175624,0.0948917709670656,9,296,trans-synaptic signaling,BP,IL1B;EDN1;SQSTM1;DKK1;PLK2;CREB1;STX1A;GSK3B;GJC1
3182,GO:0006805,0.948511909394844,0.20808094515927,1,67,xenobiotic metabolic process,BP,STAT5A
3079,GO:0006650,0.948532481508253,0.0972223912107581,8,272,glycerophospholipid metabolic process,BP,HBEGF;PLAUR;EREG;FGF5;PIGA;PDGFB;NRG1;LDLR
6583,GO:0022406,0.948876360189033,0.118877680477696,4,163,membrane docking,BP,RAB3IP;ICAM1;STX1A;CEP135
3602,GO:0008037,0.949019650461284,0.206839757604855,1,62,cell recognition,BP,B4GALT1
6308,GO:0019933,0.949028988981019,0.206811718160418,1,62,cAMP-mediated signaling,BP,ADM
7416,GO:0031497,0.949374299682301,0.151643095409847,2,134,chromatin assembly,BP,H1FX;TP53
17066,GO:0099536,0.949602708267382,0.0925729358234162,9,297,synaptic signaling,BP,IL1B;EDN1;SQSTM1;DKK1;PLK2;CREB1;STX1A;GSK3B;GJC1
10799,GO:0044270,0.949650829522752,0.0809930070839979,16,545,cellular nitrogen compound catabolic process,BP,BTG2;NOCT;ZC3H12A;ZFP36;PNRC1;AMPD3;ZFP36L1;UPP1;PATL1;PNRC2;TNKS1BP1;HAL;NUP153;VIM;EGLN1;QKI
1471,GO:0003724,0.95023990571738,0.203284959788791,1,60,RNA helicase activity,MF,DDX3Y
3303,GO:0007004,0.950255233466006,0.202997995596648,1,64,telomere maintenance via telomerase,BP,TNKS1BP1
4069,GO:0009117,0.950443861599957,0.0821179256303277,14,476,nucleotide metabolic process,BP,PPIF;EPHA2;AMPD3;TJP2;NMNAT2;VEGFA;UPP1;NAMPT;ADM;WNT5A;NUP153;TPST1;PARP1;EGLN1
3683,GO:0008186,0.950445247995101,0.202662666848063,1,60,RNA-dependent ATPase activity,MF,DDX3Y
5359,GO:0016126,0.950768260219994,0.201442247750597,1,64,sterol biosynthetic process,BP,HMGCS1
14194,GO:0061077,0.950963757499182,0.200687424107835,1,67,chaperone-mediated protein folding,BP,HSPA4L
13547,GO:0055114,0.951107023857088,0.0736300457125735,23,720,oxidation-reduction process,BP,BMP2;SOD2;KDM6B;CYP27B1;PHLDA2;STEAP4;GPX3;IL6ST;TXNRD1;HEPHL1;PHKG2;PPP1R3B;MAOA;DUS4L;PAOX;STK40;SDR16C5;NR4A3;GSK3B;PPARD;CYP24A1;KDM7A;EGLN1
1879,GO:0004553,0.951145746184717,0.200409642047731,1,62,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,MGAM
10360,GO:0043169,0.951523870097015,0.0597449034292598,124,2974,cation binding,MF,TNFAIP3;NUAK2;IL1A;BIRC3;PLEKHF1;NOCT;ZC3H12A;RNF19B;SOD2;PRDM1;ZFP36;KDM6B;EHD1;ZNF697;TRAF1;SQSTM1;ZNF267;KLF6;AMPD3;PLAGL2;BIRC2;ZNF436;ADAM8;ZFP36L1;CYP27B1;THAP10;CYLD;ZNF217;STEAP4;CDKN1A;ITGA5;ZNF451;GCH1;TRIM47;SMAD3;ZC3H12C;B4GALT1;RNF144B;TRAF4;FGD6;ZSWIM4;MAP3K8;ZBED2;ABL2;PPTC7;RNF43;LACC1;KLF7;ANXA8;ANXA8L1;HEPHL1;ADAMTS1;MAST4;NR4A2;CANT1;TGFBR2;TRIM25;SLC11A2;NOTCH2NL;PGLYRP4;BAZ1A;IFIH1;EFHD2;MMP9;LDLR;IKZF2;MT2A;ZBTB10;RCHY1;YAF2;B4GALT5;ARSJ;NUP153;RNF152;ITSN2;PTPN1;SMAD1;TAB3;CHD4;ZC3H7B;VEZF1;RHOV;SH3RF2;TNIP2;ZNFX1;ZFAND5;TP53;KLF3;PDP1;ITGAV;PRRG1;GEM;PJA2;ADGRE2;ZNF148;PML;POLR3A;PIM1;ADAM9;TRIM16;ESCO2;CCBE1;COL27A1;YARS2;ANXA5;SAT1;NR4A3;LIMS3;KMT2E;PPARD;PARP1;CYP24A1;MMP10;KDM7A;CREB5;EGLN1;RNF145;ZXDA;RPS6KA6;DDR1;ZBTB5;SREK1IP1;ZMIZ2;LMAN1
15832,GO:0072521,0.951535441018397,0.0850040493148981,11,393,purine-containing compound metabolic process,BP,PPIF;EPHA2;AMPD3;TJP2;VEGFA;ADM;WNT5A;NUP153;TPST1;PARP1;EGLN1
8861,GO:0034655,0.951714959926048,0.0790231157423787,15,519,nucleobase-containing compound catabolic process,BP,BTG2;NOCT;ZC3H12A;ZFP36;PNRC1;AMPD3;ZFP36L1;UPP1;PATL1;PNRC2;TNKS1BP1;NUP153;VIM;EGLN1;QKI
3159,GO:0006767,0.952083670899178,0.197373078289513,1,65,water-soluble vitamin metabolic process,BP,SLC52A3
10540,GO:0043484,0.953151202938668,0.143118507366695,2,101,regulation of RNA splicing,BP,WTAP;CLK4
4147,GO:0009206,0.953157702385461,0.143014380163329,2,105,purine ribonucleoside triphosphate biosynthetic process,BP,NUP153;PARP1
856,GO:0002181,0.953395041677716,0.192520439161842,1,85,cytoplasmic translation,BP,CPEB2
15835,GO:0072524,0.953711095806815,0.121041224231866,3,135,pyridine-containing compound metabolic process,BP,NMNAT2;NAMPT;NUP153
11877,GO:0046872,0.954038955338987,0.0568352128110273,122,2932,metal ion binding,MF,TNFAIP3;NUAK2;IL1A;BIRC3;PLEKHF1;NOCT;ZC3H12A;RNF19B;SOD2;PRDM1;ZFP36;KDM6B;EHD1;ZNF697;TRAF1;SQSTM1;ZNF267;KLF6;AMPD3;PLAGL2;BIRC2;ZNF436;ADAM8;ZFP36L1;CYP27B1;THAP10;CYLD;ZNF217;STEAP4;CDKN1A;ITGA5;ZNF451;GCH1;TRIM47;SMAD3;ZC3H12C;B4GALT1;RNF144B;TRAF4;FGD6;ZSWIM4;MAP3K8;ZBED2;ABL2;PPTC7;RNF43;LACC1;KLF7;ANXA8;ANXA8L1;HEPHL1;ADAMTS1;MAST4;NR4A2;CANT1;TGFBR2;TRIM25;SLC11A2;NOTCH2NL;PGLYRP4;BAZ1A;IFIH1;EFHD2;MMP9;LDLR;IKZF2;MT2A;ZBTB10;RCHY1;YAF2;B4GALT5;ARSJ;NUP153;RNF152;ITSN2;PTPN1;SMAD1;TAB3;CHD4;ZC3H7B;VEZF1;RHOV;SH3RF2;TNIP2;ZNFX1;ZFAND5;TP53;KLF3;PDP1;ITGAV;PRRG1;GEM;PJA2;ADGRE2;ZNF148;PML;POLR3A;PIM1;ADAM9;TRIM16;ESCO2;CCBE1;COL27A1;ANXA5;NR4A3;LIMS3;KMT2E;PPARD;PARP1;CYP24A1;MMP10;KDM7A;CREB5;EGLN1;RNF145;ZXDA;RPS6KA6;DDR1;ZBTB5;SREK1IP1;ZMIZ2;LMAN1
12548,GO:0050684,0.954044286732524,0.140959300452196,2,100,regulation of mRNA processing,BP,ZFP36L1;WTAP
12085,GO:0048024,0.954496303178643,0.189966876401319,1,64,regulation of mRNA splicing, via spliceosome,BP,WTAP
2876,GO:0006369,0.954524941651113,0.189624326305272,1,69,termination of RNA polymerase II transcription,BP,SRSF11
4100,GO:0009152,0.954561763663535,0.107575006772078,4,172,purine ribonucleotide biosynthetic process,BP,AMPD3;ADM;NUP153;PARP1
2899,GO:0006406,0.954834667569073,0.13895168675105,2,103,mRNA export from nucleus,BP,NUP153;SRSF11
15270,GO:0071427,0.954834667569073,0.13895168675105,2,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,NUP153;SRSF11
4093,GO:0009145,0.954882122952839,0.138771735201728,2,106,purine nucleoside triphosphate biosynthetic process,BP,NUP153;PARP1
5733,GO:0016874,0.954919113585234,0.118427068856597,3,135,ligase activity,MF,TRIM25;YARS2;PARP1
3154,GO:0006753,0.954962047188984,0.0753193238643644,14,481,nucleoside phosphate metabolic process,BP,PPIF;EPHA2;AMPD3;TJP2;NMNAT2;VEGFA;UPP1;NAMPT;ADM;WNT5A;NUP153;TPST1;PARP1;EGLN1
12133,GO:0048193,0.954979617292045,0.0837505643671553,9,309,Golgi vesicle transport,BP,CTSC;CD55;KIF3C;TGFA;SYS1;SPTBN5;TAPBP;PPP6R3;LMAN1
2816,GO:0006278,0.955046384445033,0.188141915016817,1,66,RNA-dependent DNA biosynthetic process,BP,TNKS1BP1
16738,GO:0097730,0.955233282865603,0.187716912456631,1,63,non-motile cilium,CC,SPTBN5
16991,GO:0099023,0.955482652032806,0.186825410995937,1,65,tethering complex,CC,TNFAIP2
1859,GO:0004519,0.955932308801269,0.136140889014118,2,108,endonuclease activity,MF,ZC3H12A;ZC3H12C
16312,GO:0090407,0.956003166058474,0.0717089959570434,16,500,organophosphate biosynthetic process,BP,ITPKC;PLAUR;AMPD3;NMNAT2;GCH1;FGF5;PIGA;UPP1;NAMPT;ADM;HMGCS1;PDGFB;NUP153;SGMS2;PPARD;PARP1
15491,GO:0071824,0.95610215352973,0.0968808804823732,5,237,protein-DNA complex subunit organization,BP,CREB1;TAF4B;H1FX;TP53;PARP1
12957,GO:0051303,0.956208061448285,0.184488697084613,1,66,establishment of chromosome localization,BP,GEM
3581,GO:0007626,0.956784607339646,0.13417158482775,2,101,locomotory behavior,BP,NR4A2;NRG1
16923,GO:0098876,0.957065849878141,0.181821800256613,1,65,vesicle-mediated transport to the plasma membrane,BP,SYS1
2545,GO:0005802,0.957383565586036,0.101939871209301,4,168,trans-Golgi network,CC,NMNAT2;SYS1;RAB9A;CHST2
16435,GO:0097060,0.957615482820573,0.101551379144433,4,159,synaptic membrane,CC,FOSL1;ABI1;PJA2;STX1A
6675,GO:0030031,0.957985471856685,0.0707926781215717,14,438,cell projection assembly,BP,RAB3IP;EPHA2;EHD1;CYLD;ICAM1;FGD6;CDC42EP4;GORAB;KIF3C;ANLN;CAV1;RHOV;EMP3;CEP135
1454,GO:0003684,0.958324769651533,0.177749348290118,1,66,damaged DNA binding,MF,TP53
12446,GO:0050000,0.958553541638729,0.176965442153229,1,67,chromosome localization,BP,GEM
8888,GO:0034702,0.958925142216791,0.128812084822745,2,101,ion channel complex,CC,CLIC4;STX1A
14916,GO:0070727,0.959486966756066,0.0544681076769499,54,1470,cellular macromolecule localization,BP,IL1B;NFKBIA;TNFAIP3;TNF;PLEKHF1;ZC3H12A;PPP1R15A;LIF;PMAIP1;ZFP36;RAB3IP;EPHA2;EHD1;SQSTM1;BBC3;BCL3;PLAGL2;ZFP36L1;SIX4;KLHL21;CYLD;CDKN1A;TNFAIP2;NEDD4L;ARL5B;RASSF9;RAB24;TP53BP2;DUSP16;WNT5A;SOX4;ANLN;NRG1;PLK3;SYS1;NUP153;NEDD4;PTPN1;CAV1;UGCG;TP53;RAB9A;UBE2D3;STX1A;ABCA7;SPCS2;PML;ESCO2;CRB3;GSK3B;PARP1;TBC1D22B;SRSF11;EPB41L3
2825,GO:0006289,0.9594970124337,0.12713871931779,2,113,nucleotide-excision repair,BP,TP53;PARP1
2756,GO:0006164,0.959850027982895,0.0968626248286107,4,176,purine nucleotide biosynthetic process,BP,AMPD3;ADM;NUP153;PARP1
13791,GO:0060359,0.960112142917229,0.171923638201775,1,67,response to ammonium ion,BP,RELA
6310,GO:0019935,0.960245815887648,0.171488321604182,1,67,cyclic-nucleotide-mediated signaling,BP,ADM
17261,GO:0120025,0.960260375463975,0.0542966135917982,48,1262,plasma membrane bounded cell projection,CC,FOSL1;PLAUR;RAB3IP;EPHA2;EHD1;SQSTM1;N4BP3;BDKRB1;PANX1;CYLD;ITGA5;CPEB2;IL6ST;GCH1;FRMD4B;B4GALT1;FGD6;SLC6A14;PLK2;LAYN;CREB1;NEDD9;KIF3C;CAMK1G;SLC11A2;ANLN;NRG1;SLC38A2;PLK3;SLC9A1;SPRY2;FEZ1;NEDD4;SPTBN5;CLIC4;CAV1;RTTN;ABI1;ITGAV;STX1A;DOCK4;ABCA7;ADGRE2;RAPH1;EVC;VIM;EPB41L3;SLC39A14
290,GO:0000794,0.960576793031336,0.170408457533772,1,67,condensed nuclear chromosome,CC,RAD9B
2740,GO:0006119,0.960584664136559,0.16942963135558,1,96,oxidative phosphorylation,BP,PPIF
15758,GO:0072330,0.960834579543615,0.0879996795577658,5,204,monocarboxylic acid biosynthetic process,BP,EDN1;DSE;NUP153;XBP1;QKI
10297,GO:0043043,0.960852710335824,0.0621630349790719,19,674,peptide biosynthetic process,BP,TNF;BTG2;ZC3H12A;PPP1R15A;TNIP1;ZFP36;BCL3;IL6;ZFP36L1;CPEB2;DDX3Y;ABCF1;SOX4;GRB7;NUP153;NFE2L2;YARS2;VIM;QKI
6223,GO:0019752,0.9609084717085,0.0590284982172659,25,756,carboxylic acid metabolic process,BP,IL1B;NFKB1;EDN1;NMNAT2;ODC1;GCH1;SLC6A14;DSE;SLC7A2;PDGFB;SLC9A1;HAL;NUP153;STAT5A;CAV1;TLR2;PDP1;PIM1;YARS2;NR4A3;PPARD;SLC16A1;EGLN1;XBP1;QKI
4108,GO:0009161,0.961063955379606,0.0825560647084151,6,259,ribonucleoside monophosphate metabolic process,BP,PPIF;AMPD3;TJP2;UPP1;NUP153;PARP1
5562,GO:0016570,0.961256636132653,0.0681731029210181,12,389,histone modification,BP,IL1B;LIF;KDM6B;ZNF451;VEGFA;CHD4;TP53;SDR16C5;TRIM16;MUC1;KMT2E;KDM7A
1858,GO:0004518,0.96150356084979,0.0934625469200354,4,177,nuclease activity,MF,NOCT;ZC3H12A;ZC3H12C;RAD9B
7013,GO:0030695,0.961909341295004,0.0774885901866199,7,248,GTPase regulator activity,MF,JUN;CPEB2;CDC42EP4;ERRFI1;DOCK4;TRIP10;TBC1D22B
3466,GO:0007286,0.961952398971714,0.165798493625161,1,69,spermatid development,BP,QKI
257,GO:0000723,0.962539323195086,0.101379001116455,3,153,telomere maintenance,BP,TNKS1BP1;PML;PARP1
10792,GO:0044255,0.962543683494954,0.056359358222166,26,761,cellular lipid metabolic process,BP,TNF;HBEGF;SDC4;PLAUR;EDN1;EREG;NOD2;B3GNT5;FGF5;PIGA;ITGB8;HMGCS1;PDGFB;NRG1;LDLR;ARSJ;SGMS2;STAT5A;CAV1;UGCG;PDP1;SDR16C5;NR4A3;PPARD;XBP1;QKI
5525,GO:0016491,0.962597455564474,0.0626657018880991,15,529,oxidoreductase activity,MF,BMP2;SOD2;KDM6B;CYP27B1;STEAP4;GPX3;TXNRD1;HEPHL1;MAOA;DUS4L;PAOX;SDR16C5;CYP24A1;KDM7A;EGLN1
2955,GO:0006486,0.962678182957797,0.0844286895476279,5,203,protein glycosylation,BP,B4GALT1;B3GNT5;B4GALT5;MUC1;LMAN1
10513,GO:0043413,0.962678182957797,0.0844286895476279,5,203,macromolecule glycosylation,BP,B4GALT1;B3GNT5;B4GALT5;MUC1;LMAN1
15011,GO:0070925,0.96282862925881,0.0581935907447236,21,636,organelle assembly,BP,CSF2;TNF;SDC4;BIRC3;NOCT;EDN1;RAB3IP;EHD1;BIRC2;SIX4;CYLD;PLK2;CFLAR;GORAB;PATL1;KIF3C;ANLN;FEZ1;GRB7;GOLGA8B;CEP135
4142,GO:0009201,0.962878795568468,0.118539506695713,2,111,ribonucleoside triphosphate biosynthetic process,BP,NUP153;PARP1
4025,GO:0009055,0.962988761322223,0.161714380616721,1,88,electron transfer activity,MF,TXNRD1
5861,GO:0017156,0.963064456215515,0.162197994510205,1,67,calcium ion regulated exocytosis,BP,STX1A
9883,GO:0042147,0.963145532734115,0.161882090362183,1,68,retrograde transport, endosome to Golgi,BP,RAB9A
2904,GO:0006413,0.963534430522956,0.0988837787127487,3,186,translational initiation,BP,TNF;PPP1R15A;DDX3Y
16882,GO:0098800,0.963657830652337,0.159225831662151,1,99,inner mitochondrial membrane protein complex,CC,PPIF
2438,GO:0005635,0.963969340511809,0.0652154889826165,11,375,nuclear envelope,CC,WTAP;NAV3;GCH1;SMAD3;RNF43;ABCF1;NUP153;SMAD1;STX1A;AKIRIN1;PARP1
10385,GO:0043202,0.964704413103372,0.15651973931708,1,71,lysosomal lumen,CC,SDC4
7005,GO:0030684,0.964829288748583,0.155981595982586,1,74,preribosome,CC,DIEXF
12925,GO:0051258,0.964834309093385,0.0801916702267032,5,206,protein polymerization,BP,NAV3;ICAM1;CDC42EP4;SPTBN5;JMY
332,GO:0000922,0.964892541071951,0.0961438306137502,3,142,spindle pole,CC,KLHL21;NEDD9;MAPKBP1
10898,GO:0044438,0.9649180144944,0.155718875084468,1,73,microbody part,CC,PAOX
10899,GO:0044439,0.9649180144944,0.155718875084468,1,73,peroxisomal part,CC,PAOX
17287,GO:0120114,0.965071356706943,0.154989205518297,1,79,Sm-like protein family complex,CC,MAPKBP1
6026,GO:0019080,0.965159464956195,0.0951944668283011,3,185,viral gene expression,BP,ZFP36;JUN;NUP153
2853,GO:0006338,0.965181765954616,0.0953594453772784,3,155,chromatin remodeling,BP,KDM6B;BAZ1A;CHD4
3140,GO:0006733,0.965461627829868,0.0948103642964535,3,145,oxidoreduction coenzyme metabolic process,BP,NMNAT2;NAMPT;NUP153
8803,GO:0034502,0.965945398741262,0.152263091191178,1,72,protein localization to chromosome,BP,ESCO2
2903,GO:0006412,0.966040480879227,0.0551560893774807,18,655,translation,BP,TNF;BTG2;ZC3H12A;PPP1R15A;TNIP1;ZFP36;BCL3;IL6;ZFP36L1;CPEB2;DDX3Y;ABCF1;SOX4;GRB7;NUP153;YARS2;VIM;QKI
8991,GO:0035097,0.966417702748489,0.150725041658426,1,70,histone methyltransferase complex,CC,KDM6B
19252,GO:1905368,0.966847471386072,0.148748506488286,1,85,peptidase complex,CC,SPCS2
3740,GO:0008276,0.966952388229751,0.148806896985642,1,72,protein methyltransferase activity,MF,KMT2E
10536,GO:0043473,0.967426216841761,0.147132225003076,1,73,pigmentation,BP,MREG
17317,GO:0140101,0.967823386520818,0.105475129770349,2,117,catalytic activity, acting on a tRNA,MF,DUS4L;YARS2
2213,GO:0005096,0.96787305305178,0.0699415167978562,6,225,GTPase activator activity,MF,JUN;CDC42EP4;ERRFI1;DOCK4;TRIP10;TBC1D22B
6668,GO:0030018,0.967934997494273,0.145441921630751,1,71,Z disc,CC,JPH2
5561,GO:0016569,0.967965544105037,0.057417031113839,12,397,covalent chromatin modification,BP,IL1B;LIF;KDM6B;ZNF451;VEGFA;CHD4;TP53;SDR16C5;TRIM16;MUC1;KMT2E;KDM7A
12252,GO:0048515,0.96825734330108,0.144243429920587,1,73,spermatid differentiation,BP,QKI
11706,GO:0046486,0.968582501842706,0.0608080754114437,9,319,glycerolipid metabolic process,BP,HBEGF;PLAUR;EREG;FGF5;PIGA;PDGFB;NRG1;LDLR;CAV1
3600,GO:0008033,0.968582563819927,0.10340304486838,2,120,tRNA processing,BP,DUS4L;PUS10
4033,GO:0009063,0.968792847347009,0.14229964369846,1,75,cellular amino acid catabolic process,BP,HAL
6193,GO:0019637,0.968946660822355,0.0467208835499256,28,850,organophosphate metabolic process,BP,HBEGF;ITPKC;PLAUR;PPIF;EPHA2;EREG;AMPD3;TJP2;NMNAT2;NOD2;GCH1;VEGFA;FGF5;PIGA;UPP1;NAMPT;ADM;HMGCS1;WNT5A;PDGFB;NRG1;LDLR;NUP153;SGMS2;TPST1;PPARD;PARP1;EGLN1
14568,GO:0070085,0.96897261374819,0.0719528564383155,5,209,glycosylation,BP,B4GALT1;B3GNT5;B4GALT5;MUC1;LMAN1
6286,GO:0019886,0.969367853865375,0.140312682828864,1,74,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,KIF3C
2573,GO:0005856,0.969571980194925,0.0410089165687274,60,1567,cytoskeleton,CC,ZC3H12A;RAB3IP;ADAM8;RIPK2;KLHL21;PHLDB2;CYLD;RELB;CCDC85B;GBP2;NAV3;CTSC;NOD2;FRMD4B;TRAF4;KRT34;FGD6;PLK2;ABL2;TAP1;CDC42EP4;NEDD9;PDE4DIP;SAA1;KLHL5;MASTL;KIF3C;ANLN;PLK3;SPRY2;FEZ1;TNKS1BP1;ITSN2;MARCKS;NFE2L2;SPTBN5;CHD4;CLIC4;RHOV;RTTN;UACA;ABI1;GEM;PJA2;STX1A;TRIP10;MAPKBP1;ESPL1;RAPH1;LRRC49;GSK3B;KMT2E;SLC16A1;EVC;COTL1;JMY;VIM;CEP135;EPB41L3;CCSER2
7715,GO:0032200,0.969807118931099,0.0845442158618962,3,166,telomere organization,BP,TNKS1BP1;PML;PARP1
2514,GO:0005765,0.970174945019939,0.0600001889718829,8,298,lysosomal membrane,CC,PLEKHF1;ABCA5;B4GALT1;SLC11A2;LDLR;RNF152;MMD;DRAM1
16913,GO:0098852,0.970174945019939,0.0600001889718829,8,298,lytic vacuole membrane,CC,PLEKHF1;ABCA5;B4GALT1;SLC11A2;LDLR;RNF152;MMD;DRAM1
2802,GO:0006259,0.970209312584188,0.0449506272172874,28,843,DNA metabolic process,BP,CSF2;BTG2;JUN;EREG;DUSP1;GADD45A;CDKN1A;IL7R;USP43;BACH1;SFR1;TRIM25;PDGFB;BAZ1A;OTUD4;RCHY1;TNKS1BP1;INO80D;TP53;UBE2D3;RAD9B;PML;ESCO2;KMT2E;PARP1;JMY;NABP1;EID3
5136,GO:0015629,0.970237998283621,0.0563030278651013,10,346,actin cytoskeleton,CC,ADAM8;KLHL21;GBP2;ABL2;CDC42EP4;ANLN;MARCKS;SPTBN5;CLIC4;STX1A
17262,GO:0120031,0.970571281443067,0.0521357242315672,13,428,plasma membrane bounded cell projection assembly,BP,RAB3IP;EPHA2;EHD1;CYLD;ICAM1;FGD6;CDC42EP4;GORAB;KIF3C;ANLN;CAV1;EMP3;CEP135
15833,GO:0072522,0.970945203084468,0.073478481897013,4,186,purine-containing compound biosynthetic process,BP,AMPD3;ADM;NUP153;PARP1
10109,GO:0042623,0.971140940465296,0.0582918606943307,8,289,ATPase activity, coupled,MF,ABCA5;TAP1;DDX3Y;CHD2;CHD4;TAPBP;ABCA7;HSPA4L
11528,GO:0046034,0.971433352610135,0.072312072234357,4,208,ATP metabolic process,BP,PPIF;AMPD3;NUP153;PARP1
4651,GO:0010770,0.971510036845013,0.0956031078119002,2,110,positive regulation of cell morphogenesis involved in differentiation,BP,VEGFA;NRG1
2548,GO:0005814,0.971518166125253,0.0955657882745717,2,111,centriole,CC,PLK2;CEP135
10901,GO:0044441,0.971556664677754,0.0598582103914475,7,269,ciliary part,CC,EHD1;SQSTM1;CYLD;KIF3C;SPTBN5;RTTN;EVC
4072,GO:0009123,0.971568011526126,0.0627001002645474,6,271,nucleoside monophosphate metabolic process,BP,PPIF;AMPD3;TJP2;UPP1;NUP153;PARP1
1014,GO:0002495,0.971756342906847,0.131726241200391,1,76,antigen processing and presentation of peptide antigen via MHC class II,BP,KIF3C
201,GO:0000422,0.971785674328773,0.131588763694694,1,77,autophagy of mitochondrion,BP,SQSTM1
14432,GO:0061726,0.971785674328773,0.131588763694694,1,77,mitochondrion disassembly,BP,SQSTM1
3672,GO:0008170,0.971973737278747,0.130940765226827,1,76,N-methyltransferase activity,MF,KMT2E
2951,GO:0006479,0.972265983545546,0.0788370033754374,3,149,protein methylation,BP,BTG2;BTG1;KMT2E
3705,GO:0008213,0.972265983545546,0.0788370033754374,3,149,protein alkylation,BP,BTG2;BTG1;KMT2E
2863,GO:0006354,0.972600701637175,0.0924481183663821,2,121,DNA-templated transcription, elongation,BP,TAF4B;ELL2
15102,GO:0071103,0.972863588255688,0.0639251255221668,5,245,DNA conformation change,BP,CHD2;H1FX;CHD4;TP53;PARP1
7232,GO:0031123,0.972874309959445,0.0917151393797,2,119,RNA 3'-end processing,BP,ZFP36L1;SRSF11
16329,GO:0090501,0.97296001134273,0.0914288709314408,2,123,RNA phosphodiester bond hydrolysis,BP,NOCT;ZC3H12A
7425,GO:0031514,0.973027686230768,0.127076614006418,1,77,motile cilium,CC,SQSTM1
4090,GO:0009142,0.973094091120548,0.0910927517618293,2,120,nucleoside triphosphate biosynthetic process,BP,NUP153;PARP1
8107,GO:0032787,0.973264393578375,0.0487207990434237,12,420,monocarboxylic acid metabolic process,BP,EDN1;DSE;HAL;NUP153;STAT5A;CAV1;PDP1;NR4A3;PPARD;SLC16A1;XBP1;QKI
1017,GO:0002504,0.973272058057818,0.126181913863514,1,77,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,KIF3C
5407,GO:0016241,0.974088356199753,0.0744297327286951,3,151,regulation of macroautophagy,BP,RIPK2;FEZ1;NEDD4
7620,GO:0032006,0.974844533540575,0.120398254990921,1,76,regulation of TOR signaling,BP,RNF152
2445,GO:0005643,0.974869183277136,0.120306309868549,1,76,nuclear pore,CC,NUP153
3456,GO:0007269,0.974974388814163,0.119944392466896,1,75,neurotransmitter secretion,BP,STX1A
17115,GO:0099643,0.974974388814163,0.119944392466896,1,75,signal release from synapse,BP,STX1A
8889,GO:0034703,0.975354555287128,0.118521259784261,1,75,cation channel complex,CC,STX1A
2720,GO:0006096,0.975415939382921,0.11826035778083,1,76,glycolytic process,BP,NUP153
3156,GO:0006757,0.975415939382921,0.11826035778083,1,76,ATP generation from ADP,BP,NUP153
11048,GO:0045017,0.975543143790423,0.058504326595671,5,212,glycerolipid biosynthetic process,BP,PLAUR;FGF5;PIGA;PDGFB;LDLR
5744,GO:0016887,0.975547196609336,0.0471807083681539,10,348,ATPase activity,MF,ABCA5;TAP1;DDX3Y;KIF3C;ABCF1;CHD2;CHD4;TAPBP;ABCA7;HSPA4L
7506,GO:0031674,0.975759048265862,0.116940452977722,1,77,I band,CC,JPH2
8832,GO:0034613,0.975763796832474,0.0336408058752804,52,1460,cellular protein localization,BP,IL1B;NFKBIA;TNFAIP3;TNF;PLEKHF1;ZC3H12A;PPP1R15A;LIF;PMAIP1;RAB3IP;EPHA2;EHD1;SQSTM1;BBC3;BCL3;PLAGL2;SIX4;KLHL21;CYLD;CDKN1A;TNFAIP2;NEDD4L;ARL5B;RASSF9;RAB24;TP53BP2;DUSP16;WNT5A;SOX4;ANLN;NRG1;PLK3;SYS1;NUP153;NEDD4;PTPN1;CAV1;UGCG;TP53;RAB9A;UBE2D3;STX1A;ABCA7;SPCS2;PML;ESCO2;CRB3;GSK3B;PARP1;TBC1D22B;SRSF11;EPB41L3
7419,GO:0031503,0.975835939993169,0.0578670392899251,5,219,protein-containing complex localization,BP,KLHL21;TNFAIP2;KIF3C;NUP153;SRSF11
15269,GO:0071426,0.975936629668298,0.083089910614537,2,121,ribonucleoprotein complex export from nucleus,BP,NUP153;SRSF11
12241,GO:0048489,0.976077066627489,0.115769490778085,1,76,synaptic vesicle transport,BP,STX1A
16638,GO:0097480,0.976077066627489,0.115769490778085,1,76,establishment of synaptic vesicle localization,BP,STX1A
13119,GO:0051640,0.976628957898352,0.0402071592468709,16,523,organelle localization,BP,RAB3IP;CTSC;MREG;KIF3C;TGFA;SPRY2;FEZ1;IL4R;GEM;STX1A;ADGRE2;ESPL1;PPP6R3;NR4A3;CEP135;LMAN1
15123,GO:0071166,0.976859094576552,0.0804424792039418,2,122,ribonucleoprotein complex localization,BP,NUP153;SRSF11
10733,GO:0044085,0.977199301647986,0.0296770123748005,93,2480,cellular component biogenesis,BP,TNFAIP3;CSF2;TNF;SDC4;BIRC3;NOCT;FOSL1;ZC3H12A;SOD2;PMAIP1;EDN1;JUN;RAB3IP;EPHA2;EHD1;TRAF1;SQSTM1;PLAGL2;BIRC2;PANX1;SIX4;PHLDB2;CYLD;C1QTNF1;CLDN1;ITGA5;ZNF451;NAV3;CTSC;GPX3;NOD2;ICAM1;GCH1;SMAD3;B4GALT1;RND3;VEGFA;FGD6;DKK1;PLK2;LAMB3;CFLAR;VMP1;CDC42EP4;CREB1;TAF4B;GORAB;NEDD9;PATL1;PDE4DIP;RUNX1;KIF3C;WNT5A;TGFA;ANLN;NRG1;CAB39;TLE1;ARRDC4;PARD6B;SLC9A1;FEZ1;H1FX;GRB7;NUP153;MARCKS;SMAD1;SPTBN5;DIEXF;CAV1;RHOV;GOLGA8B;TP53;NOM1;TLR2;TAPBP;IKBKE;STX1A;ABCA7;PML;EMP3;PPP6R3;CRB3;GSK3B;PARP1;LAMA3;OCLN;JMY;CEP135;EPB41L3;KCTD11;LMAN1;GJC1
10821,GO:0044306,0.977441689065619,0.110483758287938,1,79,neuron projection terminus,CC,GCH1
5655,GO:0016746,0.977475112341653,0.0590185732853951,4,190,transferase activity, transferring acyl groups,MF,HMGCS1;ESCO2;SAT1;ALAS1
17302,GO:0140056,0.977595090350988,0.0657833446656713,3,155,organelle localization by membrane tethering,BP,RAB3IP;STX1A;CEP135
10223,GO:0042866,0.977637592387054,0.109757354044602,1,78,pyruvate biosynthetic process,BP,NUP153
4984,GO:0015103,0.978261165610364,0.107374196968575,1,77,inorganic anion transmembrane transporter activity,MF,CLIC4
5673,GO:0016779,0.978380231465868,0.0759950873844969,2,127,nucleotidyltransferase activity,MF,NMNAT2;POLR3A
4075,GO:0009126,0.978386256659031,0.0524115135628435,5,248,purine nucleoside monophosphate metabolic process,BP,PPIF;AMPD3;TJP2;NUP153;PARP1
4114,GO:0009167,0.978386256659031,0.0524115135628435,5,248,purine ribonucleoside monophosphate metabolic process,BP,PPIF;AMPD3;TJP2;NUP153;PARP1
5705,GO:0016829,0.978646375464057,0.0752005229686581,2,129,lyase activity,MF,ODC1;HAL
13529,GO:0055086,0.979208140937168,0.0366327554633189,15,546,nucleobase-containing small molecule metabolic process,BP,PPIF;EPHA2;AMPD3;TJP2;NMNAT2;VEGFA;TXNRD1;UPP1;NAMPT;ADM;WNT5A;NUP153;TPST1;PARP1;EGLN1
12093,GO:0048037,0.979238025374146,0.0418996470086933,9,355,cofactor binding,MF,CYP27B1;GCH1;TXNRD1;BACH1;DUS4L;PARP1;CYP24A1;EGLN1;ALAS1
17064,GO:0099531,0.979243050880049,0.103461667011297,1,80,presynaptic process involved in chemical synaptic transmission,BP,STX1A
2849,GO:0006334,0.979448727022892,0.102035646402784,1,116,nucleosome assembly,BP,H1FX
2848,GO:0006333,0.979691378182397,0.0719333698424848,2,156,chromatin assembly or disassembly,BP,H1FX;TP53
16637,GO:0097479,0.97971433170492,0.101630254106789,1,79,synaptic vesicle localization,BP,STX1A
2522,GO:0005774,0.97980287408598,0.0408889548033107,9,343,vacuolar membrane,CC,PLEKHF1;ABCA5;B4GALT1;VMP1;SLC11A2;LDLR;RNF152;MMD;DRAM1
5687,GO:0016798,0.980360438503685,0.0989481770821629,1,84,hydrolase activity, acting on glycosyl bonds,MF,MGAM
11164,GO:0045211,0.980865181523912,0.0687823726253788,2,116,postsynaptic membrane,CC,ABI1;PJA2
8864,GO:0034660,0.980867499821119,0.0345017806593262,14,545,ncRNA metabolic process,BP,ZC3H12A;NFKB1;SMAD3;MYBL1;POU2F2;DUS4L;SMAD1;DIEXF;PUS10;SNAPC4;RELA;YARS2;ELL2;NABP1
9477,GO:0036094,0.980894932762468,0.0258817979304633,69,1810,small molecule binding,MF,NUAK2;ITPKC;MAP2K3;EPHA2;EHD1;STARD5;PIM3;RIPK2;IRAK2;NMNAT2;GBP2;RAP2B;ABCA5;NAV3;ARL5B;NOD2;SGK1;GCH1;IRGQ;RND3;RAB24;PLK2;MAP3K8;ABL2;TXNRD1;LAYN;TAP1;ANKK1;MAST4;PHKG2;RUNX1;TGFBR2;DDX3Y;MASTL;KIF3C;HMGCS1;CAMK1G;ABCF1;IFIH1;RRAD;PLK3;CHD2;DUS4L;CHD4;CAV1;RHOV;TP53;STK40;RAB9A;IKBKE;GEM;UBE2D3;ABCA7;CLK4;UBE2Z;PIM1;YARS2;AXL;FRK;GSK3B;PPARD;PARP1;EGLN1;RIPK4;ALAS1;RPS6KA6;DDR1;HSPA4L;LMAN1
3048,GO:0006605,0.981176798817364,0.0396873927894386,8,368,protein targeting,BP,RAB3IP;PLAGL2;RASSF9;NRG1;NEDD4;UGCG;UBE2D3;SPCS2
17047,GO:0099504,0.981554326477371,0.0942687778476753,1,79,synaptic vesicle cycle,BP,STX1A
6898,GO:0030426,0.982195665581995,0.0647275815087094,2,121,growth cone,CC,FEZ1;ABI1
3560,GO:0007601,0.982480508357391,0.0904234115386915,1,82,visual perception,BP,GJC1
12730,GO:0050953,0.982480508357391,0.0904234115386915,1,82,sensory perception of light stimulus,BP,GJC1
23,GO:0000045,0.982633429498135,0.0897525483714425,1,84,autophagosome assembly,BP,FEZ1
4032,GO:0009062,0.982742118453765,0.0892261035168888,1,88,fatty acid catabolic process,BP,PPARD
2936,GO:0006457,0.982921214176639,0.046371951982468,4,210,protein folding,BP,PPIF;SUCO;HSPA4L;LMAN1
12878,GO:0051186,0.983381907219281,0.0323388626397017,11,430,cofactor metabolic process,BP,NMNAT2;GPX3;GCH1;NAMPT;HMGCS1;SLC11A2;NUP153;NFE2L2;STAT5A;PDP1;ALAS1
5137,GO:0015630,0.9837037446006,0.0248094513666275,33,967,microtubule cytoskeleton,CC,KLHL21;CYLD;RELB;CCDC85B;NAV3;CTSC;PLK2;TAP1;CDC42EP4;NEDD9;PDE4DIP;SAA1;MASTL;KIF3C;PLK3;SPRY2;FEZ1;ITSN2;MARCKS;NFE2L2;CHD4;CLIC4;RTTN;GEM;MAPKBP1;ESPL1;LRRC49;GSK3B;KMT2E;SLC16A1;EVC;CEP135;CCSER2
2757,GO:0006165,0.983812018843418,0.0848064249389266,1,87,nucleoside diphosphate phosphorylation,BP,NUP153
83,GO:0000166,0.984200559471398,0.0219233064701026,61,1628,nucleotide binding,MF,NUAK2;ITPKC;MAP2K3;EPHA2;EHD1;PIM3;RIPK2;IRAK2;NMNAT2;GBP2;RAP2B;ABCA5;NAV3;ARL5B;NOD2;SGK1;GCH1;IRGQ;RND3;RAB24;PLK2;MAP3K8;ABL2;TXNRD1;TAP1;ANKK1;MAST4;PHKG2;RUNX1;TGFBR2;DDX3Y;MASTL;KIF3C;CAMK1G;ABCF1;IFIH1;RRAD;PLK3;CHD2;DUS4L;CHD4;RHOV;TP53;STK40;RAB9A;IKBKE;GEM;UBE2D3;ABCA7;CLK4;UBE2Z;PIM1;YARS2;AXL;FRK;GSK3B;PARP1;RIPK4;RPS6KA6;DDR1;HSPA4L
17616,GO:1901265,0.984337143418523,0.0217423089165141,61,1629,nucleoside phosphate binding,MF,NUAK2;ITPKC;MAP2K3;EPHA2;EHD1;PIM3;RIPK2;IRAK2;NMNAT2;GBP2;RAP2B;ABCA5;NAV3;ARL5B;NOD2;SGK1;GCH1;IRGQ;RND3;RAB24;PLK2;MAP3K8;ABL2;TXNRD1;TAP1;ANKK1;MAST4;PHKG2;RUNX1;TGFBR2;DDX3Y;MASTL;KIF3C;CAMK1G;ABCF1;IFIH1;RRAD;PLK3;CHD2;DUS4L;CHD4;RHOV;TP53;STK40;RAB9A;IKBKE;GEM;UBE2D3;ABCA7;CLK4;UBE2Z;PIM1;YARS2;AXL;FRK;GSK3B;PARP1;RIPK4;RPS6KA6;DDR1;HSPA4L
11698,GO:0046474,0.984603371551086,0.0424207416669938,4,194,glycerophospholipid biosynthetic process,BP,PLAUR;FGF5;PIGA;PDGFB
5163,GO:0015698,0.984853854381981,0.0804502930936282,1,85,inorganic anion transport,BP,CLIC4
19126,GO:1905037,0.985123580722894,0.0792638502188976,1,87,autophagosome organization,BP,FEZ1
1484,GO:0003777,0.985173073514271,0.0791474954920788,1,82,microtubule motor activity,MF,KIF3C
6899,GO:0030427,0.985256550713118,0.055247545283515,2,125,site of polarized growth,CC,FEZ1;ABI1
7219,GO:0031109,0.985274350248204,0.0786372260829383,1,86,microtubule polymerization or depolymerization,BP,NAV3
7110,GO:0030902,0.985322830652448,0.0784480111685645,1,85,hindbrain development,BP,SMAD1
9805,GO:0040029,0.985330989855908,0.0349107020972328,6,291,regulation of gene expression, epigenetic,BP,ZC3H12A;ZFP36;SMAD3;NUP153;SMAD1;ZC3H7B
9993,GO:0042393,0.985331676841562,0.0457401492284273,3,172,histone binding,MF,CHD2;KMT2E;KDM7A
2898,GO:0006405,0.98540862669002,0.0547086402479116,2,133,RNA export from nucleus,BP,NUP153;SRSF11
10989,GO:0044782,0.985444081463684,0.0329465944234012,7,291,cilium organization,BP,RAB3IP;EHD1;CYLD;GORAB;KIF3C;RTTN;CEP135
13941,GO:0060589,0.985456798185213,0.0329333510439759,7,283,nucleoside-triphosphatase regulator activity,MF,JUN;CPEB2;CDC42EP4;ERRFI1;DOCK4;TRIP10;TBC1D22B
10514,GO:0043414,0.985680505997594,0.0365328637570479,5,234,macromolecule methylation,BP,BTG2;WTAP;BTG1;KMT2E;PARP1
4786,GO:0010970,0.985785187630004,0.0535343721464231,2,131,transport along microtubule,BP,KIF3C;FEZ1
17020,GO:0099111,0.985785187630004,0.0535343721464231,2,131,microtubule-based transport,BP,KIF3C;FEZ1
5403,GO:0016236,0.985825828473887,0.0338939737411009,6,270,macroautophagy,BP,PLEKHF1;SQSTM1;RIPK2;VMP1;FEZ1;NEDD4
15071,GO:0071013,0.98589395879351,0.0758105556811714,1,96,catalytic step 2 spliceosome,CC,MAPKBP1
10358,GO:0043167,0.985900807532454,0.0177458707303573,182,4373,ion binding,MF,TNFAIP3;HBEGF;NUAK2;IL1A;ITPKC;BIRC3;PLEKHF1;NOCT;ZC3H12A;RNF19B;SOD2;PRDM1;MAP2K3;ZFP36;KDM6B;EPHA2;EHD1;ZNF697;TRAF1;SQSTM1;ZNF267;STARD5;KLF6;AMPD3;PLAGL2;BIRC2;ZNF436;ADAM8;PIM3;ZFP36L1;CYP27B1;RIPK2;IRAK2;THAP10;DAPP1;CYLD;ZNF217;STEAP4;CDKN1A;NMNAT2;ITGA5;GBP2;RAP2B;ABCA5;ZNF451;NAV3;CTSC;ARL5B;NOD2;SGK1;GCH1;TRIM47;SMAD3;IRGQ;ZC3H12C;B4GALT1;RNF144B;RND3;TRAF4;VEGFA;RAB24;FGD6;ZSWIM4;PLK2;MAP3K8;ZBED2;ABL2;PPTC7;RNF43;TXNRD1;LACC1;KLF7;ANXA8;LAYN;TAP1;ANXA8L1;HEPHL1;ADAMTS1;ANKK1;WISP1;MAST4;NR4A2;CANT1;PHKG2;RUNX1;TGFBR2;DDX3Y;SAA1;TRIM25;MASTL;KIF3C;WNT5A;CAMK1G;SLC11A2;ABCF1;NOTCH2NL;PGLYRP4;BAZ1A;IFIH1;EFHD2;MMP9;LDLR;RRAD;IKZF2;PLK3;CHD2;MT2A;SLC9A1;ZBTB10;RCHY1;YAF2;B4GALT5;GRB7;ARSJ;NUP153;RNF152;ITSN2;DUS4L;PTPN1;SMAD1;TAB3;CHD4;ZC3H7B;VEZF1;RHOV;SH3RF2;TNIP2;ZNFX1;ZFAND5;TP53;KLF3;STK40;PDP1;RAB9A;ITGAV;PRRG1;IKBKE;GEM;UBE2D3;PJA2;JPH2;ABCA7;CLK4;ADGRE2;ZNF148;UBE2Z;PML;POLR3A;PIM1;ADAM9;RELA;TRIM16;ESCO2;CCBE1;COL27A1;YARS2;AXL;ANXA5;SAT1;FRK;NR4A3;LIMS3;GSK3B;KMT2E;PPARD;PARP1;CYP24A1;MMP10;KDM7A;CREB5;EGLN1;RIPK4;RNF145;ALAS1;ZXDA;RPS6KA6;DDR1;HSPA4L;ZBTB5;SREK1IP1;ZMIZ2;LMAN1
5835,GO:0017111,0.986120873138164,0.0235967968381242,20,646,nucleoside-triphosphatase activity,MF,GBP2;RAP2B;ABCA5;GCH1;RND3;RAB24;TAP1;DDX3Y;KIF3C;ABCF1;IFIH1;RRAD;CHD2;CHD4;RHOV;TAPBP;RAB9A;GEM;ABCA7;HSPA4L
3232,GO:0006886,0.986691860491378,0.0211269507665048,28,920,intracellular protein transport,BP,IL1B;NFKBIA;TNF;ZC3H12A;RAB3IP;EHD1;BCL3;PLAGL2;CDKN1A;RASSF9;RAB24;DUSP16;SOX4;NRG1;PLK3;NUP153;NEDD4;PTPN1;UGCG;TP53;RAB9A;UBE2D3;STX1A;SPCS2;PML;GSK3B;TBC1D22B;SRSF11
4146,GO:0009205,0.986694378994335,0.0372469917277484,4,233,purine ribonucleoside triphosphate metabolic process,BP,PPIF;AMPD3;NUP153;PARP1
12259,GO:0048524,0.986938574547425,0.0712694822286283,1,95,positive regulation of viral process,BP,JUN
8938,GO:0034968,0.986965743579946,0.0712396114721654,1,89,histone lysine methylation,BP,KMT2E
2846,GO:0006323,0.987002896377628,0.0494611390755228,2,166,DNA packaging,BP,H1FX;TP53
5656,GO:0016747,0.987172176877351,0.0407545570717633,3,172,transferase activity, transferring acyl groups other than amino-acyl groups,MF,ESCO2;SAT1;ALAS1
2437,GO:0005634,0.987189048056427,0.0160190998636734,234,5701,nucleus,CC,NFKBIZ;NFKBIA;TNFAIP3;IRF1;NUAK2;ITPKC;BTG2;BIRC3;PLEKHF1;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;ELF3;PRDM1;TBX3;PMAIP1;EHF;MAFF;NFKB1;IER3;TNIP1;MAP2K3;ZFP36;PNRC1;JUN;KDM6B;RAB3IP;ZNF697;ETS1;SQSTM1;BHLHE40;ZNF267;SERTAD2;NFKBIE;KLF6;IRF6;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;EFNB1;BIRC2;ETS2;ZNF436;CSRNP1;NFKB2;N4BP1;RFX5;ZFP36L1;SIX4;IRAK2;JUNB;TNFAIP8;WTAP;TJP2;RELB;ZNF217;CDKN1A;CCDC85B;GBP2;CPEB2;ZNF451;NAV3;NEDD4L;CTSC;NOD2;ELMSAN1;RELT;SAV1;SGK1;GCH1;TRIM47;ESRG;SMAD3;NFKBIB;DLX2;ARNTL2;PHLDA1;NFKBID;TRAF4;TRIB1;CDKN2B;RNF43;TXNRD1;KLF7;BTG1;TMEM217;UPP1;IER5;CEBPB;CEBPD;VMP1;NAMPT;TP53BP2;DSE;ERRFI1;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;NEDD9;NR4A2;PATL1;VHL;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;SMURF2;DUSP16;SFR1;DDX3Y;TGIF2;GPBP1;PNRC2;NFE2L3;TRIM25;MASTL;NAB1;SLC11A2;ABCF1;DUSP10;SOX4;ANLN;BAZ1A;IFIH1;DUSP8;NRG1;ATF3;BTG3;IKZF2;TLE1;PLK3;CHD2;PARD6B;MT2A;SLC9A1;ZBTB10;RCHY1;YAF2;SPRY2;TNKS1BP1;H1FX;NUP153;POU2F2;MARCKS;NFE2L2;SMAD1;MXD1;CHD4;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;VEZF1;SH3RF2;UACA;INO80D;TNIP2;ZNFX1;TP53;NOM1;KLF3;ABI1;STK40;IKBKE;GEM;UBE2D3;STX1A;DOCK4;TRIP10;MAPKBP1;ELK3;RAD9B;SNAPC4;CLK4;SDR16C5;ZNF148;UBE2Z;PML;POLR3A;PIM1;ESPL1;RELA;RAPH1;TRIM16;ESCO2;SPATA2;FOXN2;PPP6R3;MUC1;YARS2;AKIRIN1;ELL2;FRK;CITED4;NR4A3;USP31;GSK3B;KMT2E;PPARD;PARP1;CYP24A1;KDM7A;MED13;MXD3;CRAMP1;COTL1;JMY;SRSF11;CREB5;EGLN1;NABP1;ALAS1;ZXDA;RPS6KA6;XBP1;HSPA4L;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;JUND;DENND4A
3237,GO:0006892,0.98722365137048,0.0701002341179552,1,89,post-Golgi vesicle-mediated transport,BP,SYS1
11917,GO:0046939,0.987421224280186,0.0691637420694806,1,93,nucleotide phosphorylation,BP,NUP153
2892,GO:0006399,0.987620901454131,0.0394829744650719,3,183,tRNA metabolic process,BP,DUS4L;PUS10;YARS2
6711,GO:0030117,0.987724409173853,0.0678274702781952,1,92,membrane coat,CC,NECAP2
12231,GO:0048475,0.987724409173853,0.0678274702781952,1,92,coated membrane,CC,NECAP2
5522,GO:0016482,0.987782017810407,0.0471260351304843,2,131,cytosolic transport,BP,SYS1;RAB9A
7572,GO:0031929,0.988271188982822,0.0653715162116068,1,92,TOR signaling,BP,RNF152
10400,GO:0043228,0.988296865815467,0.0152034898877286,125,3276,non-membrane-bounded organelle,CC,NFKBIZ;IRF1;SDC4;NOCT;ZC3H12A;ZFP36;PNRC1;G0S2;JUN;KDM6B;RAB3IP;EHD1;SQSTM1;NFKBIE;KLF6;BIRC2;ADAM8;N4BP1;ZFP36L1;RIPK2;KLHL21;JUNB;PHLDB2;CYLD;RELB;CDKN1A;CCDC85B;GBP2;NAV3;CTSC;NOD2;FRMD4B;SMAD3;ARNTL2;PHLDA1;TRAF4;KRT34;FGD6;PLK2;ABL2;TXNRD1;TMEM217;CEBPB;VMP1;TAP1;CDC42EP4;CREB1;TAF4B;GORAB;GJB4;NEDD9;PATL1;PDE4DIP;SFR1;DDX3Y;SAA1;PNRC2;KLHL5;MASTL;KIF3C;ABCF1;ANLN;BAZ1A;ATF3;PLK3;CHD2;SPRY2;FEZ1;TNKS1BP1;H1FX;GRB7;NUP153;NEDD4;ITSN2;MARCKS;NFE2L2;SPTBN5;MXD1;CHD4;DIEXF;CLIC4;CAV1;RHOV;RTTN;UACA;TP53;NOM1;ABI1;GEM;PJA2;STX1A;DOCK4;TRIP10;MAPKBP1;JPH2;RAD9B;SDR16C5;PML;PIM1;ESPL1;RELA;RAPH1;ESCO2;SPATA2;LRRC49;MUC1;GSK3B;KMT2E;PPARD;SLC16A1;EVC;PARP1;KDM7A;COTL1;JMY;VIM;NABP1;RPS6KA6;CEP135;EPB41L3;EID3;ZMIZ2;CCSER2;LMAN1;JUND
10404,GO:0043232,0.988296865815467,0.0152034898877286,125,3276,intracellular non-membrane-bounded organelle,CC,NFKBIZ;IRF1;SDC4;NOCT;ZC3H12A;ZFP36;PNRC1;G0S2;JUN;KDM6B;RAB3IP;EHD1;SQSTM1;NFKBIE;KLF6;BIRC2;ADAM8;N4BP1;ZFP36L1;RIPK2;KLHL21;JUNB;PHLDB2;CYLD;RELB;CDKN1A;CCDC85B;GBP2;NAV3;CTSC;NOD2;FRMD4B;SMAD3;ARNTL2;PHLDA1;TRAF4;KRT34;FGD6;PLK2;ABL2;TXNRD1;TMEM217;CEBPB;VMP1;TAP1;CDC42EP4;CREB1;TAF4B;GORAB;GJB4;NEDD9;PATL1;PDE4DIP;SFR1;DDX3Y;SAA1;PNRC2;KLHL5;MASTL;KIF3C;ABCF1;ANLN;BAZ1A;ATF3;PLK3;CHD2;SPRY2;FEZ1;TNKS1BP1;H1FX;GRB7;NUP153;NEDD4;ITSN2;MARCKS;NFE2L2;SPTBN5;MXD1;CHD4;DIEXF;CLIC4;CAV1;RHOV;RTTN;UACA;TP53;NOM1;ABI1;GEM;PJA2;STX1A;DOCK4;TRIP10;MAPKBP1;JPH2;RAD9B;SDR16C5;PML;PIM1;ESPL1;RELA;RAPH1;ESCO2;SPATA2;LRRC49;MUC1;GSK3B;KMT2E;PPARD;SLC16A1;EVC;PARP1;KDM7A;COTL1;JMY;VIM;NABP1;RPS6KA6;CEP135;EPB41L3;EID3;ZMIZ2;CCSER2;LMAN1;JUND
5515,GO:0016462,0.988398630818764,0.019744853383876,21,684,pyrophosphatase activity,MF,GBP2;RAP2B;ABCA5;GCH1;RND3;RAB24;TAP1;CANT1;DDX3Y;KIF3C;ABCF1;IFIH1;RRAD;CHD2;CHD4;RHOV;TAPBP;RAB9A;GEM;ABCA7;HSPA4L
16876,GO:0098794,0.988440450146908,0.0282765224343402,6,259,postsynapse,CC,NEDD4;ABI1;PJA2;STX1A;GSK3B;EPB41L3
2804,GO:0006261,0.988540000717987,0.0446071630114849,2,137,DNA-dependent DNA replication,BP,BAZ1A;PARP1
5700,GO:0016817,0.98867050330571,0.0193119858189424,21,686,hydrolase activity, acting on acid anhydrides,MF,GBP2;RAP2B;ABCA5;GCH1;RND3;RAB24;TAP1;CANT1;DDX3Y;KIF3C;ABCF1;IFIH1;RRAD;CHD2;CHD4;RHOV;TAPBP;RAB9A;GEM;ABCA7;HSPA4L
5701,GO:0016818,0.98867050330571,0.0193119858189424,21,686,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,GBP2;RAP2B;ABCA5;GCH1;RND3;RAB24;TAP1;CANT1;DDX3Y;KIF3C;ABCF1;IFIH1;RRAD;CHD2;CHD4;RHOV;TAPBP;RAB9A;GEM;ABCA7;HSPA4L
10897,GO:0044437,0.988692383504093,0.0222016621674186,12,453,vacuolar part,CC,SDC4;PLEKHF1;ABCA5;CTSC;B4GALT1;VMP1;SLC11A2;LDLR;RNF152;MMD;DRAM1;FRK
16986,GO:0099003,0.988713399492153,0.0633941034588621,1,90,vesicle-mediated transport in synapse,BP,STX1A
8232,GO:0032991,0.988860397582286,0.0143125478412723,147,3846,protein-containing complex,CC,NFKBIZ;NFKBIA;INHBA;NOCT;ZC3H12A;PPP1R15A;RNF19B;BMP2;NFKB1;PPIF;ZFP36;PNRC1;JUN;TICAM1;KDM6B;EPHA2;ETS1;SQSTM1;CSF1;IL23A;REL;BCL3;BIRC2;IL6;NFKB2;ADAM8;ZFP36L1;RIPK2;KLHL21;JUNB;FZD8;WTAP;RELB;ZNF217;C1QTNF1;CDKN1A;ITGA5;CPEB2;TNFAIP2;NOD2;ELMSAN1;IL6ST;DCUN1D3;GCH1;SMAD3;ARNTL2;RNF144B;ZSWIM4;LAMB3;CFLAR;PIGA;IER5;PPP4R4;CEBPB;TAP1;GJB3;CREB1;TAF4B;CCNL1;GJB4;NR4A2;PATL1;VHL;PHKG2;BACH1;ABTB2;TGFBR2;SMURF2;SFR1;DDX3Y;SAA1;PNRC2;KLHL5;KIF3C;ITGB8;CAMK1G;SLC11A2;ABCF1;SOX4;PPP1R3B;PGLYRP4;BAZ1A;LDLR;ATF3;COL12A1;CAB39;TLE1;TRPV3;SLC9A1;RCHY1;TNKS1BP1;H1FX;GRB7;NUP153;BCL2L2;IL4R;NEDD4;NFE2L2;KBTBD7;SMAD1;CHD4;DIEXF;CLIC4;NFAT5;CAV1;HLA-A;NECAP2;TP53;TLR2;ABI1;TAPBP;HLA-B;ITGAV;STX1A;MAPKBP1;JPH2;RAD9B;SNAPC4;ABCA7;SPCS2;SDR16C5;POLR3A;RELA;CCBE1;COL27A1;AXL;ELL2;HLA-F;NR4A3;HLA-E;GSK3B;KMT2E;OSMR;PPARD;EVC;PARP1;LAMA3;MED13;MXD3;COL8A1;VIM;NABP1;DDR1;EID3;SLC41A1;JUND;GJC1
289,GO:0000793,0.988964509862944,0.0357723216816775,3,176,condensed chromosome,CC,CEBPB;RAD9B;EID3
18026,GO:1902494,0.989112715691155,0.0163778630175169,40,1230,catalytic complex,CC,PPP1R15A;RNF19B;ZFP36;TICAM1;KDM6B;KLHL21;WTAP;ZNF217;CDKN1A;ELMSAN1;DCUN1D3;RNF144B;ZSWIM4;CFLAR;PIGA;IER5;PPP4R4;TAF4B;CCNL1;VHL;PHKG2;BACH1;ABTB2;TGFBR2;SMURF2;KLHL5;PPP1R3B;BAZ1A;CAB39;SLC9A1;RCHY1;NEDD4;KBTBD7;CHD4;TP53;MAPKBP1;ABCA7;SPCS2;POLR3A;EID3
4140,GO:0009199,0.989155467207965,0.0311227468454186,4,239,ribonucleoside triphosphate metabolic process,BP,PPIF;AMPD3;NUP153;PARP1
4092,GO:0009144,0.989199188342708,0.031010723895186,4,240,purine nucleoside triphosphate metabolic process,BP,PPIF;AMPD3;NUP153;PARP1
1460,GO:0003697,0.989297416576005,0.0606376540805726,1,96,single-stranded DNA binding,MF,NABP1
15757,GO:0072329,0.989606924333776,0.059171278320988,1,99,monocarboxylic acid catabolic process,BP,PPARD
17315,GO:0140097,0.98985696862445,0.0332456844575901,3,178,catalytic activity, acting on DNA,MF,CHD2;CHD4;PARP1
5888,GO:0018022,0.990198106661782,0.0564577518101293,1,95,peptidyl-lysine methylation,BP,KMT2E
35,GO:0000070,0.990349663753671,0.0385316426221991,2,142,mitotic sister chromatid segregation,BP,DUSP1;ESPL1
2905,GO:0006414,0.990512360201119,0.0547079494426584,1,125,translational elongation,BP,CPEB2
10399,GO:0043227,0.990574501447535,0.0122492435491561,396,9247,membrane-bounded organelle,CC,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;CXCL1;ITPKC;EFNA1;SDC4;BTG2;BIRC3;PLEKHF1;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;JUN;TICAM1;KDM6B;RAB3IP;EHD1;ZNF697;ETS1;SQSTM1;CSF1;BHLHE40;N4BP3;ZNF267;SERTAD2;STARD5;NFKBIE;BBC3;KLF6;IRF6;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;BDKRB1;N4BP1;RFX5;PANX1;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;JUNB;FZD8;TNFAIP8;WTAP;TJP2;RELB;ZNF217;STEAP4;AMOTL2;CDKN1A;NMNAT2;CCDC85B;ITGA5;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;NEDD4L;CTSC;GPX3;NOD2;ELMSAN1;IL6ST;RELT;SAV1;SGK1;ICAM1;GCH1;TRIM47;ESRG;RASSF9;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;RNF144B;RND3;MARCKSL1;NFKBID;TRAF4;TRIB1;KRT34;SERPINB8;VEGFA;RAB24;FGD6;SLC6A14;DKK1;CDKN2B;PPTC7;C3ORF52;RNF43;TXNRD1;LACC1;KLF7;PIGA;BTG1;ANXA8;TMEM217;UPP1;IER5;CEBPB;CEBPD;VMP1;CD55;NAMPT;TAP1;TMEM106A;ANXA8L1;TP53BP2;ANKLE2;GJB3;CDC42EP4;SLC28A3;IFNAR1;DSE;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;NEDD9;NR4A2;PATL1;CD47;CANT1;VHL;SOGA1;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;MREG;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TINAGL1;PNRC2;NFE2L3;TRIM25;MASTL;NAB1;ITGB8;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;DUSP10;ROBO4;SOX4;PPP1R3B;SERPINB1;PDGFB;ANLN;CD82;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;ATF3;BTG3;IKZF2;COL12A1;CAB39;TLE1;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;MT2A;SUCO;SLC9A1;ZBTB10;SLC25A37;SYS1;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;CYTH1;ARSJ;NUP153;BCL2L2;RNF152;NEDD4;MMD;RHCG;POU2F2;ITSN2;MARCKS;RAET1L;BTN2A2;NFE2L2;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;HLA-A;UACA;DRAM1;INO80D;TNIP2;NECAP2;ZNFX1;UGCG;GOLGA8B;TP53;NOM1;KLF3;TLR2;ABI1;STK40;TAPBP;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;ADAM9;RELA;RAPH1;TRIM16;MAMDC2;ESCO2;SPATA2;FOXN2;SLC9A8;PPP6R3;COL27A1;PLAT;CHST2;MUC1;YARS2;AXL;SLC16A13;ANXA5;AKIRIN1;CRB3;ELL2;FRK;HLA-F;CITED4;NR4A3;HLA-E;USP31;GSK3B;KMT2E;PPARD;SLC16A1;EVC;PARP1;CYP24A1;LAMA3;KDM7A;MED13;MXD3;CRAMP1;OCLN;COTL1;JMY;COL8A1;VIM;SRSF11;CREB5;EGLN1;NABP1;ALAS1;ZXDA;RPS6KA6;DDR1;XBP1;HSPA4L;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;MGAM;LMAN1;CFB;JUND;GJC1;DENND4A
6605,GO:0022618,0.990627299657295,0.030999805569299,3,194,ribonucleoprotein complex assembly,BP,NOCT;PATL1;GRB7
2584,GO:0005874,0.990921568998507,0.0205814746152495,8,333,microtubule,CC,KLHL21;CYLD;NAV3;SAA1;KIF3C;SPRY2;FEZ1;LRRC49
1483,GO:0003774,0.99098677155707,0.052727498454093,1,94,motor activity,MF,KIF3C
10787,GO:0044242,0.991220374410652,0.0355291821493121,2,147,cellular lipid catabolic process,BP,LDLR;PPARD
2862,GO:0006353,0.991390046787208,0.0506567209203891,1,107,DNA-templated transcription, termination,BP,SRSF11
2620,GO:0005929,0.991491540386005,0.0194000408764236,8,340,cilium,CC,EHD1;SQSTM1;CYLD;KIF3C;SPTBN5;CAV1;RTTN;EVC
7750,GO:0032259,0.991515759347296,0.0214057772634232,6,285,methylation,BP,BTG2;PRDM1;WTAP;BTG1;KMT2E;PARP1
8227,GO:0032984,0.991772418649616,0.0222937341692513,5,275,protein-containing complex disassembly,BP,TNF;NAV3;SPTBN5;CAV1;GSK3B
3594,GO:0008021,0.991838436276975,0.0485052109455948,1,104,synaptic vesicle,CC,STX1A
7953,GO:0032543,0.99185467341781,0.0482456103699956,1,129,mitochondrial translation,BP,YARS2
277,GO:0000779,0.99187985358922,0.0483027080474773,1,104,condensed chromosome, centromeric region,CC,CEBPB
5332,GO:0016054,0.992277547368288,0.0261967404428936,3,190,organic acid catabolic process,BP,SLC9A1;HAL;PPARD
11665,GO:0046395,0.992277547368288,0.0261967404428936,3,190,carboxylic acid catabolic process,BP,SLC9A1;HAL;PPARD
3139,GO:0006732,0.993003965304428,0.0179878402694349,6,296,coenzyme metabolic process,BP,NMNAT2;GCH1;NAMPT;HMGCS1;NUP153;PDP1
13120,GO:0051641,0.993023266218974,0.00968439276796187,79,2186,cellular localization,BP,IL1B;NFKBIA;TNFAIP3;TNF;PLEKHF1;ZC3H12A;PPP1R15A;LIF;PMAIP1;ZFP36;RAB3IP;EPHA2;EHD1;SQSTM1;BBC3;BCL3;PLAGL2;BDKRB1;PIM3;ZFP36L1;SIX4;KLHL21;CYLD;CDKN1A;TNFAIP2;NEDD4L;CTSC;ARL5B;RASSF9;RAB24;ANXA8;CD55;DENND3;TAP1;TP53BP2;MREG;DUSP16;TINAGL1;KIF3C;WNT5A;TGFA;SOX4;ANLN;NRG1;LDLR;PLK3;PARD6B;SYS1;SPRY2;FEZ1;NUP153;IL4R;NEDD4;PTPN1;SPTBN5;CAV1;UGCG;TP53;RAB9A;GEM;UBE2D3;STX1A;JPH2;ABCA7;SPCS2;ADGRE2;PML;ESPL1;ESCO2;PPP6R3;CRB3;NR4A3;GSK3B;PARP1;TBC1D22B;SRSF11;CEP135;EPB41L3;LMAN1
10380,GO:0043197,0.993064072535912,0.0424485220807874,1,100,dendritic spine,CC,NEDD4
8908,GO:0034728,0.993125869527045,0.0418899174459437,1,139,nucleosome organization,BP,H1FX
13726,GO:0060271,0.993205194025968,0.0175307461857756,6,285,cilium assembly,BP,RAB3IP;EHD1;CYLD;GORAB;KIF3C;CEP135
13127,GO:0051649,0.99333169474188,0.00969646991677925,57,1674,establishment of localization in cell,BP,IL1B;NFKBIA;TNF;ZC3H12A;PMAIP1;RAB3IP;EHD1;SQSTM1;BBC3;BCL3;PLAGL2;BDKRB1;PIM3;CDKN1A;CTSC;RASSF9;RAB24;ANXA8;CD55;DENND3;TAP1;TP53BP2;MREG;DUSP16;TINAGL1;KIF3C;TGFA;SOX4;NRG1;LDLR;PLK3;SYS1;SPRY2;FEZ1;NUP153;IL4R;NEDD4;PTPN1;SPTBN5;CAV1;UGCG;TP53;RAB9A;GEM;UBE2D3;STX1A;JPH2;SPCS2;ADGRE2;PML;ESPL1;PPP6R3;NR4A3;GSK3B;TBC1D22B;SRSF11;LMAN1
10806,GO:0044282,0.993649416939504,0.0164805419904739,6,302,small molecule catabolic process,BP,CYP27B1;UPP1;SLC9A1;HAL;PPARD;CYP24A1
15493,GO:0071826,0.99369192588398,0.0219217044294125,3,205,ribonucleoprotein complex subunit organization,BP,NOCT;PATL1;GRB7
10824,GO:0044309,0.993786911869193,0.038734009322786,1,102,neuron spine,CC,NEDD4
4089,GO:0009141,0.993805417452467,0.0189585470511205,4,257,nucleoside triphosphate metabolic process,BP,PPIF;AMPD3;NUP153;PARP1
10908,GO:0044450,0.993944823760649,0.0258437399588001,2,147,microtubule organizing center part,CC,PLK2;CEP135
6636,GO:0022900,0.993992722112279,0.0374427036506368,1,142,electron transport chain,BP,TXNRD1
17009,GO:0099081,0.994079195536954,0.011088816132982,17,606,supramolecular polymer,CC,SDC4;SQSTM1;KLHL21;CYLD;NAV3;KRT34;PDE4DIP;SAA1;KIF3C;SPRY2;FEZ1;JPH2;LRRC49;COL27A1;COL8A1;VIM;LMAN1
17008,GO:0099080,0.994240037870391,0.0108071108577737,17,607,supramolecular complex,CC,SDC4;SQSTM1;KLHL21;CYLD;NAV3;KRT34;PDE4DIP;SAA1;KIF3C;SPRY2;FEZ1;JPH2;LRRC49;COL27A1;COL8A1;VIM;LMAN1
10917,GO:0044463,0.994443072885457,0.00927655320020394,28,892,cell projection part,CC,PLAUR;EPHA2;EHD1;SQSTM1;N4BP3;CYLD;ITGA5;IL6ST;GCH1;B4GALT1;SLC6A14;PLK2;KIF3C;SLC11A2;NRG1;SLC38A2;PLK3;SPRY2;FEZ1;NEDD4;SPTBN5;RTTN;ABI1;ITGAV;ABCA7;ADGRE2;EVC;EPB41L3
17268,GO:0120038,0.994443072885457,0.00927655320020394,28,892,plasma membrane bounded cell projection part,CC,PLAUR;EPHA2;EHD1;SQSTM1;N4BP3;CYLD;ITGA5;IL6ST;GCH1;B4GALT1;SLC6A14;PLK2;KIF3C;SLC11A2;NRG1;SLC38A2;PLK3;SPRY2;FEZ1;NEDD4;SPTBN5;RTTN;ABI1;ITGAV;ABCA7;ADGRE2;EVC;EPB41L3
7017,GO:0030705,0.994495816397425,0.0237893561083326,2,152,cytoskeleton-dependent intracellular transport,BP,KIF3C;FEZ1
3313,GO:0007017,0.994665504644689,0.010059972325225,17,605,microtubule-based process,BP,BIRC3;GADD45A;BIRC2;PHLDB2;CYLD;NAV3;PLK2;KIF3C;PLK3;SPRY2;FEZ1;GOLGA8B;ESPL1;GSK3B;SLC16A1;CEP135;CCSER2
14737,GO:0070382,0.995103969299185,0.031688313639738,1,114,exocytic vesicle,CC,STX1A
10630,GO:0043624,0.995136760493495,0.0213153048557406,2,179,cellular protein complex disassembly,BP,NAV3;SPTBN5
10903,GO:0044445,0.995242958300404,0.0208717912986182,2,203,cytosolic part,CC,TICAM1;CFLAR
16830,GO:0098687,0.995310948898904,0.0125234038756225,6,312,chromosomal region,CC,CEBPB;PML;ESCO2;PARP1;NABP1;EID3
2493,GO:0005739,0.995359135933066,0.00717744816832286,43,1424,mitochondrion,CC,PPP1R15A;SOD2;PMAIP1;MAFF;NFKB1;PPIF;G0S2;STARD5;BBC3;CYP27B1;ZNF217;NOD2;SGK1;RNF144B;RAB24;PPTC7;TXNRD1;TAP1;TP53BP2;CREB1;VHL;SLC11A2;SOX4;SLC9A1;SLC25A37;MAOA;FEZ1;BCL2L2;LACTB;MXD1;CLIC4;TP53;PDP1;IKBKE;ELK3;YARS2;GSK3B;SLC16A1;PARP1;CYP24A1;ALAS1;RPS6KA6;ZMIZ2
5563,GO:0016571,0.995514284620867,0.0294642117592475,1,111,histone methylation,BP,KMT2E
2552,GO:0005819,0.995551540743229,0.0119473655775576,6,299,spindle,CC,KLHL21;CYLD;NEDD9;GEM;MAPKBP1;ESPL1
11900,GO:0046907,0.995833275226236,0.00637641244458553,47,1460,intracellular transport,BP,IL1B;NFKBIA;TNF;ZC3H12A;RAB3IP;EHD1;SQSTM1;BCL3;PLAGL2;CDKN1A;CTSC;RASSF9;RAB24;ANXA8;CD55;DENND3;TAP1;MREG;DUSP16;TINAGL1;KIF3C;TGFA;SOX4;NRG1;LDLR;PLK3;SYS1;FEZ1;NUP153;IL4R;NEDD4;PTPN1;SPTBN5;UGCG;TP53;RAB9A;UBE2D3;STX1A;SPCS2;ADGRE2;PML;PPP6R3;NR4A3;GSK3B;TBC1D22B;SRSF11;LMAN1
6897,GO:0030425,0.996237417444081,0.00920665876010798,8,361,dendrite,CC,N4BP3;IL6ST;PLK2;NRG1;SLC38A2;PLK3;FEZ1;NEDD4
16622,GO:0097447,0.996237417444081,0.00920665876010798,8,361,dendritic tree,CC,N4BP3;IL6ST;PLK2;NRG1;SLC38A2;PLK3;FEZ1;NEDD4
3343,GO:0007062,0.996338291915393,0.0248004253231039,1,120,sister chromatid cohesion,BP,ESPL1
6896,GO:0030424,0.996452777416109,0.00872190316795478,8,362,axon,CC,N4BP3;CREB1;NRG1;SLC38A2;FEZ1;ABI1;STX1A;EPB41L3
17048,GO:0099512,0.996469741727741,0.006949530274122,16,600,supramolecular fiber,CC,SDC4;SQSTM1;KLHL21;CYLD;NAV3;KRT34;PDE4DIP;SAA1;KIF3C;SPRY2;FEZ1;JPH2;LRRC49;COL27A1;VIM;LMAN1
1449,GO:0003676,0.996534262001529,0.00470014950736738,120,3233,nucleic acid binding,MF,TNFAIP3;TNF;IRF1;NOCT;FOSL1;ZC3H12A;ELF3;PRDM1;TBX3;EHF;MAFF;NFKB1;ZFP36;JUN;KDM6B;ZNF697;ETS1;BHLHE40;ZNF267;KLF6;IRF6;REL;BCL3;GADD45A;PLAGL2;ETS2;ZNF436;CSRNP1;NFKB2;RFX5;ZFP36L1;SIX4;THAP10;JUNB;RELB;ZNF217;C11ORF68;CPEB2;ZNF451;ELMSAN1;SMAD3;DLX2;ARNTL2;TRAF4;ZBED2;KLF7;CEBPB;CEBPD;CDC42EP4;CREB1;TAF4B;NR4A2;PATL1;BACH1;MYBL1;RUNX1;DDX3Y;TGIF2;GPBP1;NFE2L3;TRIM25;WNT5A;ABCF1;SOX4;IFIH1;ATF3;OTUD4;IKZF2;CHD2;ZBTB10;H1FX;GRB7;NUP153;POU2F2;NFE2L2;PTPN1;SMAD1;MXD1;CHD4;ZC3H7B;DIEXF;NFAT5;STAT5A;VEZF1;HLA-A;ZNFX1;ZFAND5;TP53;NOM1;KLF3;PUS10;MAPKBP1;ELK3;SNAPC4;ZNF148;PML;POLR3A;RELA;TRIM16;FOXN2;MUC1;YARS2;NR4A3;PPARD;PARP1;MXD3;CRAMP1;VIM;SRSF11;CREB5;NABP1;ZXDA;XBP1;QKI;ZBTB5;ELF4;SREK1IP1;TFE3;JUND;DENND4A
10813,GO:0044297,0.996843094268392,0.00874548192318369,6,310,cell body,CC,IL6ST;NRG1;SLC38A2;PLK3;FEZ1;TLR2
19679,GO:1990904,0.996843575646976,0.00624750765856382,16,701,ribonucleoprotein complex,CC,NFKBIZ;NOCT;ZC3H12A;ZFP36;PNRC1;SQSTM1;ZFP36L1;CPEB2;PATL1;DDX3Y;PNRC2;ABCF1;GRB7;DIEXF;MAPKBP1;VIM
2508,GO:0005759,0.9970163163446,0.007804436113978,7,393,mitochondrial matrix,CC,SOD2;PPIF;CREB1;TP53;PDP1;YARS2;ALAS1
2585,GO:0005875,0.997017155306893,0.0208542946556548,1,119,microtubule associated complex,CC,KIF3C
3053,GO:0006612,0.997023352569257,0.0206964218623844,1,165,protein targeting to membrane,BP,RAB3IP
7599,GO:0031966,0.99725253622421,0.00598461678833215,12,577,mitochondrial membrane,CC,PPP1R15A;SOD2;PMAIP1;PPIF;CYP27B1;RNF144B;SLC11A2;SLC25A37;MAOA;BCL2L2;IKBKE;CYP24A1
11211,GO:0045333,0.997349270290177,0.0187709754472317,1,155,cellular respiration,BP,NR4A3
17301,GO:0140053,0.997382840412301,0.0185722837975779,1,153,mitochondrial gene expression,BP,YARS2
8373,GO:0033267,0.997395306889635,0.00874687324723246,4,243,axon part,CC,NRG1;FEZ1;ABI1;EPB41L3
17316,GO:0140098,0.997401540795442,0.00731739180164325,6,330,catalytic activity, acting on RNA,MF,NOCT;ZC3H12A;DDX3Y;DUS4L;POLR3A;YARS2
273,GO:0000775,0.997536809413718,0.0117890253979438,2,173,chromosome, centromeric region,CC,CEBPB;ESCO2
3670,GO:0008168,0.997620106448384,0.0114336120288177,2,177,methyltransferase activity,MF,PRDM1;KMT2E
3970,GO:0008757,0.997917186435455,0.0153231601263976,1,132,S-adenosylmethionine-dependent methyltransferase activity,MF,KMT2E
2435,GO:0005622,0.998104438327835,0.00277003208260131,456,10522,intracellular,CC,NFKBIZ;CXCL8;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;CXCL1;IL1A;ITPKC;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;CCL20;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;TIFA;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;IFNAR2;RAB3IP;EPHA2;EHD1;ZNF697;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;N4BP3;ZNF267;SPRR2D;SERTAD2;STARD5;NFKBIE;BBC3;KLF6;IRF6;EREG;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;TNFRSF10B;BDKRB1;N4BP1;PIM3;RFX5;PANX1;ZFP36L1;TNFSF15;CYP27B1;SIX4;RIPK2;IRAK2;KLHL21;PHLDA2;DAPP1;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;STEAP4;AMOTL2;CDKN1A;CLDN1;NMNAT2;CCDC85B;ITGA5;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;ODC1;TNFAIP2;NEDD4L;CTSC;ARL5B;NOD2;ELMSAN1;DCUN1D3;RELT;SAV1;SGK1;GCH1;FRMD4B;TRIM47;ESRG;RASSF9;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;C15ORF39;PHLDA1;B3GNT5;RNF144B;RND3;MARCKSL1;NFKBID;TRAF4;TRIB1;KRT34;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;LGALSL;IL1R2;DKK1;CDKN2B;ZSWIM4;FGF5;PLK2;MAP3K8;ABL2;PPTC7;C3ORF52;CDV3;CFLAR;RNF43;TXNRD1;LACC1;KLF7;PIGA;BTG1;ANXA8;TMEM217;UPP1;IER5;PPP4R4;CEBPB;CEBPD;VMP1;CD55;DENND3;NAMPT;TAP1;TP53BP2;ANKLE2;ADM;GJB3;CDC42EP4;SLC28A3;IFNAR1;DSE;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;WISP1;NEDD9;MAST4;NR4A2;PATL1;CD47;CANT1;VHL;PHKG2;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;TGFBR2;MREG;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;MASTL;NAB1;KIF3C;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;NOTCH2NL;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;ANLN;NBPF8;PGLYRP4;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;RRAD;ATF3;BTG3;IKZF2;COL12A1;FAM83B;CAB39;IL32;TLE1;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;MT2A;SUCO;SLC9A1;ZBTB10;SLC25A37;SYS1;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;HAL;CYTH1;GRB7;ARSJ;NUP153;BCL2L2;RNF152;NEDD4;MMD;RHCG;POU2F2;ITSN2;DUS4L;GCSAM;MARCKS;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;RTTN;HLA-A;UACA;DRAM1;INO80D;TNIP2;NECAP2;ZNFX1;UGCG;ZFAND5;GOLGA8B;TP53;NOM1;KLF3;TLR2;ABI1;STK40;TAPBP;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;RELA;RAPH1;TRIM16;MAMDC2;ESCO2;SPATA2;FOXN2;SLC9A8;PPP6R3;LRRC49;COL27A1;PLAT;CHST2;MUC1;YARS2;AXL;SLC16A13;ANXA5;THSD1;AKIRIN1;ELL2;SAT1;FRK;HLA-F;CITED4;NR4A3;LIMS3;HLA-E;USP31;GSK3B;KMT2E;PPARD;PARP8;SLC16A1;EVC;PARP1;CYP24A1;LAMA3;KDM7A;MED13;MXD3;CRAMP1;TBC1D22B;LCE1C;OCLN;COTL1;JMY;COL8A1;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;RPS6KA6;DDR1;CEP135;XBP1;HSPA4L;QKI;EPB41L3;KCTD11;ZBTB5;ELF4;SLC39A14;TFE3;EID3;ZMIZ2;MGAM;CCSER2;LMAN1;JUND;GJC1;DENND4A
10913,GO:0044455,0.998105500286475,0.0140687536075846,1,166,mitochondrial membrane part,CC,PPIF
10269,GO:0043005,0.998116921833928,0.00356995731816026,21,756,neuron projection,CC,FOSL1;EPHA2;N4BP3;BDKRB1;CPEB2;IL6ST;GCH1;PLK2;CREB1;CAMK1G;NRG1;SLC38A2;PLK3;FEZ1;NEDD4;SPTBN5;ABI1;STX1A;DOCK4;VIM;EPB41L3
3592,GO:0008017,0.998325426552953,0.00675889256019912,3,213,microtubule binding,MF,NAV3;KIF3C;CCSER2
5651,GO:0016741,0.998342727457807,0.00830704856689719,2,185,transferase activity, transferring one-carbon groups,MF,PRDM1;KMT2E
10893,GO:0044430,0.998426483147066,0.00262949303821964,37,1191,cytoskeletal part,CC,ADAM8;KLHL21;CYLD;RELB;CCDC85B;NAV3;CTSC;KRT34;PLK2;TAP1;NEDD9;PDE4DIP;SAA1;MASTL;KIF3C;ANLN;PLK3;SPRY2;FEZ1;ITSN2;MARCKS;NFE2L2;SPTBN5;CHD4;CLIC4;RTTN;GEM;STX1A;MAPKBP1;ESPL1;LRRC49;GSK3B;KMT2E;SLC16A1;EVC;VIM;CEP135
3341,GO:0007059,0.998430462252039,0.00499161514815589,5,302,chromosome segregation,BP,DUSP1;DDX3Y;GEM;ESPL1;ESCO2
10904,GO:0044446,0.998449319078185,0.002053847390501,286,7077,intracellular organelle part,CC,NFKBIZ;IRF1;HBEGF;PLAU;CXCL1;ITPKC;SDC4;BIRC3;PLEKHF1;NOCT;FOSL1;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;PLAUR;SOD2;PRDM1;PMAIP1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;JUN;TICAM1;KDM6B;EHD1;ETS1;SQSTM1;CSF1;BHLHE40;SERTAD2;NFKBIE;KLF6;IL23A;REL;BCL3;AMPD3;GADD45A;IFNGR2;IL6;ETS2;ZNF436;NFKB2;ADAM8;N4BP1;PANX1;CYP27B1;IRAK2;KLHL21;JUNB;CYLD;TNFAIP8;WTAP;TJP2;RELB;ZNF217;STEAP4;CDKN1A;NMNAT2;CCDC85B;GBP2;RAP2B;ABCA5;IL7R;ZNF451;NAV3;NEDD4L;CTSC;NOD2;ELMSAN1;SGK1;GCH1;RASSF9;SMAD3;B4GALT1;ARNTL2;PHLDA1;B3GNT5;RNF144B;RND3;KRT34;VEGFA;RAB24;DKK1;PLK2;C3ORF52;RNF43;TXNRD1;PIGA;ANXA8;TMEM217;UPP1;CEBPB;CEBPD;VMP1;CD55;NAMPT;TAP1;TP53BP2;ANKLE2;SLC28A3;DSE;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;NEDD9;NR4A2;PATL1;CD47;CANT1;VHL;ABTB2;PDE4DIP;RUNX1;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;PNRC2;TRIM25;MASTL;KIF3C;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;DUSP10;SOX4;SERPINB1;PDGFB;ANLN;BAZ1A;NRG1;TNC;MMP9;LDLR;ATF3;IKZF2;COL12A1;CAB39;TLE1;PLK3;CHD2;SUCO;SLC9A1;ZBTB10;SLC25A37;SYS1;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;CYTH1;ARSJ;NUP153;BCL2L2;RNF152;NEDD4;MMD;POU2F2;ITSN2;MARCKS;NFE2L2;PTPN1;WNT7B;SMAD1;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;RTTN;HLA-A;DRAM1;INO80D;TNIP2;NECAP2;UGCG;GOLGA8B;TP53;NOM1;KLF3;TLR2;STK40;TAPBP;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;RAD9B;SNAPC4;ABCA7;SPCS2;TMEM132A;SDR16C5;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;RELA;RAPH1;TRIM16;ESCO2;SPATA2;SLC9A8;PPP6R3;LRRC49;COL27A1;CHST2;MUC1;YARS2;SLC16A13;AKIRIN1;ELL2;FRK;HLA-F;CITED4;NR4A3;HLA-E;GSK3B;KMT2E;PPARD;SLC16A1;EVC;PARP1;CYP24A1;KDM7A;MED13;MXD3;COTL1;JMY;COL8A1;VIM;SRSF11;NABP1;ALAS1;RPS6KA6;CEP135;XBP1;ELF4;TFE3;EID3;ZMIZ2;MGAM;LMAN1;JUND;GJC1
17343,GO:0150034,0.998454290349153,0.00781590291210747,2,179,distal axon,CC,FEZ1;ABI1
5681,GO:0016788,0.998479773907092,0.00336010837897358,13,553,hydrolase activity, acting on ester bonds,MF,NOCT;ZC3H12A;DUSP1;ZC3H12C;PPTC7;DUSP16;DUSP10;PPP1R3B;DUSP8;ARSJ;PTPN1;PDP1;RAD9B
18123,GO:1902749,0.998560771739407,0.00732577778416287,2,195,regulation of cell cycle G2/M phase transition,BP,TP53;CEP135
5338,GO:0016071,0.998712590033318,0.00264128250603736,17,738,mRNA metabolic process,BP,BTG2;NOCT;ZC3H12A;ZFP36;PNRC1;EREG;ZFP36L1;WTAP;PATL1;PNRC2;TNKS1BP1;TP53;PPARD;VIM;SRSF11;QKI;SREK1IP1
11159,GO:0045202,0.998716380659983,0.00294590967717132,12,512,synapse,CC,FOSL1;EFNB1;NMNAT2;ITGA5;CPEB2;NRG1;NEDD4;ABI1;PJA2;STX1A;GSK3B;EPB41L3
10284,GO:0043025,0.998793592089918,0.00435601394861732,4,266,neuronal cell body,CC,IL6ST;SLC38A2;PLK3;FEZ1
16489,GO:0097159,0.998888201950012,0.00150491006954787,178,4613,organic cyclic compound binding,MF,TNFAIP3;TNF;IRF1;NUAK2;ITPKC;NOCT;FOSL1;ZC3H12A;ELF3;PRDM1;TBX3;EHF;MAFF;NFKB1;MAP2K3;ZFP36;JUN;KDM6B;EPHA2;EHD1;ZNF697;ETS1;BHLHE40;ZNF267;STARD5;KLF6;IRF6;REL;BCL3;GADD45A;PLAGL2;ETS2;ZNF436;CSRNP1;NFKB2;PIM3;RFX5;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;JUNB;RELB;ZNF217;NMNAT2;C11ORF68;GBP2;RAP2B;ABCA5;CPEB2;ZNF451;NAV3;ARL5B;NOD2;ELMSAN1;SGK1;GCH1;SMAD3;IRGQ;DLX2;ARNTL2;RND3;TRAF4;RAB24;PLK2;MAP3K8;ZBED2;ABL2;TXNRD1;KLF7;CEBPB;CEBPD;TAP1;CDC42EP4;ANKK1;CREB1;TAF4B;MAST4;NR4A2;PATL1;PHKG2;BACH1;MYBL1;RUNX1;TGFBR2;DDX3Y;TGIF2;GPBP1;NFE2L3;TRIM25;MASTL;KIF3C;WNT5A;CAMK1G;ABCF1;SOX4;IFIH1;RRAD;ATF3;OTUD4;IKZF2;PLK3;CHD2;ZBTB10;H1FX;GRB7;NUP153;POU2F2;DUS4L;NFE2L2;PTPN1;SMAD1;MXD1;CHD4;ZC3H7B;DIEXF;NFAT5;STAT5A;CAV1;VEZF1;RHOV;HLA-A;ZNFX1;ZFAND5;TP53;NOM1;KLF3;STK40;PUS10;RAB9A;IKBKE;GEM;UBE2D3;MAPKBP1;ELK3;SNAPC4;ABCA7;CLK4;ZNF148;UBE2Z;PML;POLR3A;PIM1;RELA;TRIM16;FOXN2;MUC1;YARS2;AXL;FRK;NR4A3;GSK3B;PPARD;SLC16A1;PARP1;CYP24A1;MXD3;CRAMP1;VIM;SRSF11;CREB5;NABP1;RIPK4;ALAS1;ZXDA;RPS6KA6;DDR1;XBP1;HSPA4L;QKI;ZBTB5;ELF4;SREK1IP1;TFE3;JUND;DENND4A
3325,GO:0007033,0.998921316502499,0.00867635489389656,1,142,vacuole organization,BP,FEZ1
2494,GO:0005740,0.998931475910689,0.00247526959308237,12,616,mitochondrial envelope,CC,PPP1R15A;SOD2;PMAIP1;PPIF;CYP27B1;RNF144B;SLC11A2;SLC25A37;MAOA;BCL2L2;IKBKE;CYP24A1
3298,GO:0006996,0.999082227528758,0.00130478715521121,111,3097,organelle organization,BP,IL1B;CSF2;TNF;NUAK2;CXCL1;IL1A;SDC4;BIRC3;PLEKHF1;NOCT;LIF;PLAUR;SOD2;PMAIP1;PPIF;EDN1;JUN;KDM6B;RAB3IP;EHD1;ETS1;SQSTM1;BBC3;EREG;DUSP1;GADD45A;PLAGL2;BIRC2;SIX4;PHLDB2;CYLD;AMOTL2;ZNF451;NAV3;CTSC;ICAM1;SMAD3;RND3;VEGFA;FGD6;PLK2;ABL2;CFLAR;ANXA8;VMP1;TAP1;TP53BP2;ANKLE2;CDC42EP4;CREB1;GORAB;NEDD9;MAST4;PATL1;PDE4DIP;MYBL1;AKAP2;MASTL;KIF3C;WNT5A;TGFA;PDGFB;ANLN;BAZ1A;NRG1;MMP9;PLK3;CHD2;SLC9A1;SPRY2;FEZ1;TNKS1BP1;H1FX;GRB7;NUP153;MARCKS;PTPN1;SPTBN5;CHD4;CLIC4;CAV1;RHOV;RTTN;UGCG;GOLGA8B;TP53;ABI1;TAPBP;GEM;UBE2D3;STX1A;TRIP10;SDR16C5;PML;ESPL1;TRIM16;PPP6R3;MUC1;GSK3B;KMT2E;SLC16A1;PARP1;KDM7A;TBC1D22B;JMY;VIM;ALAS1;CEP135;EPB41L3;CCSER2;LMAN1
17049,GO:0099513,0.999083398171857,0.00229209405667486,10,472,polymeric cytoskeletal fiber,CC,KLHL21;CYLD;NAV3;KRT34;SAA1;KIF3C;SPRY2;FEZ1;LRRC49;VIM
2847,GO:0006325,0.999133076896115,0.00189093444000424,15,661,chromatin organization,BP,IL1B;LIF;KDM6B;ZNF451;VEGFA;BAZ1A;CHD2;H1FX;CHD4;TP53;SDR16C5;TRIM16;MUC1;KMT2E;KDM7A
17653,GO:1901363,0.999270613850447,0.000998849988134143,175,4575,heterocyclic compound binding,MF,TNFAIP3;TNF;IRF1;NUAK2;ITPKC;NOCT;FOSL1;ZC3H12A;ELF3;PRDM1;TBX3;EHF;MAFF;NFKB1;MAP2K3;ZFP36;JUN;KDM6B;EPHA2;EHD1;ZNF697;ETS1;BHLHE40;ZNF267;KLF6;IRF6;REL;BCL3;GADD45A;PLAGL2;ETS2;ZNF436;CSRNP1;NFKB2;PIM3;RFX5;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;THAP10;JUNB;RELB;ZNF217;NMNAT2;C11ORF68;GBP2;RAP2B;ABCA5;CPEB2;ZNF451;NAV3;ARL5B;NOD2;ELMSAN1;SGK1;GCH1;SMAD3;IRGQ;DLX2;ARNTL2;RND3;TRAF4;RAB24;PLK2;MAP3K8;ZBED2;ABL2;TXNRD1;KLF7;CEBPB;CEBPD;TAP1;CDC42EP4;ANKK1;CREB1;TAF4B;MAST4;NR4A2;PATL1;PHKG2;BACH1;MYBL1;RUNX1;TGFBR2;DDX3Y;TGIF2;GPBP1;NFE2L3;TRIM25;MASTL;KIF3C;WNT5A;CAMK1G;ABCF1;SOX4;IFIH1;RRAD;ATF3;OTUD4;IKZF2;PLK3;CHD2;ZBTB10;H1FX;GRB7;NUP153;POU2F2;DUS4L;NFE2L2;PTPN1;SMAD1;MXD1;CHD4;ZC3H7B;DIEXF;NFAT5;STAT5A;VEZF1;RHOV;HLA-A;ZNFX1;ZFAND5;TP53;NOM1;KLF3;STK40;PUS10;RAB9A;IKBKE;GEM;UBE2D3;MAPKBP1;ELK3;SNAPC4;ABCA7;CLK4;ZNF148;UBE2Z;PML;POLR3A;PIM1;RELA;TRIM16;FOXN2;MUC1;YARS2;AXL;FRK;NR4A3;GSK3B;PPARD;PARP1;CYP24A1;MXD3;CRAMP1;VIM;SRSF11;CREB5;NABP1;RIPK4;ALAS1;ZXDA;RPS6KA6;DDR1;XBP1;HSPA4L;QKI;ZBTB5;ELF4;SREK1IP1;TFE3;JUND;DENND4A
5138,GO:0015631,0.999338351991471,0.00251906401003855,4,276,tubulin binding,MF,NAV3;KIF3C;FEZ1;CCSER2
2562,GO:0005840,0.999424632595667,0.00497043557430634,1,225,ribosome,CC,ABCF1
16890,GO:0098813,0.999450598748441,0.0024655474126196,3,254,nuclear chromosome segregation,BP,DUSP1;GEM;ESPL1
16875,GO:0098793,0.999489779570342,0.00290167727977471,2,209,presynapse,CC,FOSL1;STX1A
16880,GO:0098798,0.999542678694222,0.00406276998981537,1,218,mitochondrial protein complex,CC,PPIF
308,GO:0000819,0.999557023169169,0.00255397643413547,2,216,sister chromatid segregation,BP,DUSP1;ESPL1
7600,GO:0031967,0.999605373746413,0.000787141933467455,23,971,organelle envelope,CC,PPP1R15A;SOD2;PMAIP1;PPIF;CYP27B1;WTAP;NAV3;GCH1;SMAD3;RNF144B;RNF43;SLC11A2;ABCF1;SLC25A37;MAOA;NUP153;BCL2L2;SMAD1;IKBKE;STX1A;AKIRIN1;PARP1;CYP24A1
7604,GO:0031975,0.999605373746413,0.000787141933467455,23,971,envelope,CC,PPP1R15A;SOD2;PMAIP1;PPIF;CYP27B1;WTAP;NAV3;GCH1;SMAD3;RNF144B;RNF43;SLC11A2;ABCF1;SLC25A37;MAOA;NUP153;BCL2L2;SMAD1;IKBKE;STX1A;AKIRIN1;PARP1;CYP24A1
10887,GO:0044422,0.99960920055063,0.000535025626708623,286,7173,organelle part,CC,NFKBIZ;IRF1;HBEGF;PLAU;CXCL1;ITPKC;SDC4;BIRC3;PLEKHF1;NOCT;FOSL1;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;PLAUR;SOD2;PRDM1;PMAIP1;EHF;PTX3;MAFF;NFKB1;PPIF;TNIP1;EDN1;MAP2K3;JUN;TICAM1;KDM6B;EHD1;ETS1;SQSTM1;CSF1;BHLHE40;SERTAD2;NFKBIE;KLF6;IL23A;REL;BCL3;AMPD3;GADD45A;IFNGR2;IL6;ETS2;ZNF436;NFKB2;ADAM8;N4BP1;PANX1;CYP27B1;IRAK2;KLHL21;JUNB;CYLD;TNFAIP8;WTAP;TJP2;RELB;ZNF217;STEAP4;CDKN1A;NMNAT2;CCDC85B;GBP2;RAP2B;ABCA5;IL7R;ZNF451;NAV3;NEDD4L;CTSC;NOD2;ELMSAN1;SGK1;GCH1;RASSF9;SMAD3;B4GALT1;ARNTL2;PHLDA1;B3GNT5;RNF144B;RND3;KRT34;VEGFA;RAB24;DKK1;PLK2;C3ORF52;RNF43;TXNRD1;PIGA;ANXA8;TMEM217;UPP1;CEBPB;CEBPD;VMP1;CD55;NAMPT;TAP1;TP53BP2;ANKLE2;SLC28A3;DSE;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;NEDD9;NR4A2;PATL1;CD47;CANT1;VHL;ABTB2;PDE4DIP;RUNX1;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;PNRC2;TRIM25;MASTL;KIF3C;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;DUSP10;SOX4;SERPINB1;PDGFB;ANLN;BAZ1A;NRG1;TNC;MMP9;LDLR;ATF3;IKZF2;COL12A1;CAB39;TLE1;PLK3;CHD2;SUCO;SLC9A1;ZBTB10;SLC25A37;SYS1;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;CYTH1;ARSJ;NUP153;BCL2L2;RNF152;NEDD4;MMD;POU2F2;ITSN2;MARCKS;NFE2L2;PTPN1;WNT7B;SMAD1;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;RTTN;HLA-A;DRAM1;INO80D;TNIP2;NECAP2;UGCG;GOLGA8B;TP53;NOM1;KLF3;TLR2;STK40;TAPBP;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;RAD9B;SNAPC4;ABCA7;SPCS2;TMEM132A;SDR16C5;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;RELA;RAPH1;TRIM16;ESCO2;SPATA2;SLC9A8;PPP6R3;LRRC49;COL27A1;CHST2;MUC1;YARS2;SLC16A13;AKIRIN1;ELL2;FRK;HLA-F;CITED4;NR4A3;HLA-E;GSK3B;KMT2E;PPARD;SLC16A1;EVC;PARP1;CYP24A1;KDM7A;MED13;MXD3;COTL1;JMY;COL8A1;VIM;SRSF11;NABP1;ALAS1;RPS6KA6;CEP135;XBP1;ELF4;TFE3;EID3;ZMIZ2;MGAM;LMAN1;JUND;GJC1
3804,GO:0008380,0.999621556845235,0.00123911953106308,6,392,RNA splicing,BP,WTAP;MAPKBP1;CLK4;SRSF11;QKI;SREK1IP1
1490,GO:0003824,0.999626546676014,0.000522595722816841,163,4348,catalytic activity,MF,TNFAIP3;CSF2;HBEGF;NUAK2;PLAU;ITPKC;BIRC3;NOCT;ZC3H12A;RNF19B;BMP2;SOD2;PRDM1;PPIF;MAP2K3;KDM6B;EPHA2;SQSTM1;EREG;DUSP1;PELI1;AMPD3;BIRC2;ADAM8;PIM3;CYP27B1;RIPK2;IRAK2;KLHL21;CYLD;TJP2;STEAP4;CDKN1A;NMNAT2;GBP2;RAP2B;ABCA5;ZNF451;ODC1;NEDD4L;CTSC;GPX3;SGK1;GCH1;ZC3H12C;B4GALT1;B3GNT5;RNF144B;RND3;RAB24;FGF5;PLK2;MAP3K8;ABL2;PPTC7;CFLAR;RNF43;TXNRD1;PIGA;UPP1;NAMPT;TAP1;HEPHL1;DSE;ADAMTS1;ANKK1;USP43;MAST4;CANT1;VHL;PHKG2;BACH1;TGFBR2;SMURF2;DUSP16;DDX3Y;TINAGL1;KLHL5;TRIM25;MASTL;KIF3C;HMGCS1;CAMK1G;ABCF1;DUSP10;PPP1R3B;PDGFB;PGLYRP4;IFIH1;DUSP8;NRG1;MMP9;KIAA1586;RRAD;OTUD4;CAB39;PLK3;CHD2;MAOA;RCHY1;B4GALT5;HAL;ARSJ;RNF152;NEDD4;MMD;DUS4L;KBTBD7;PTPN1;LACTB;SGMS2;PAOX;CHD4;STAT5A;TPST1;RHOV;SH3RF2;UGCG;STK40;PUS10;TAPBP;PDP1;RAB9A;IKBKE;GEM;UBE2D3;PJA2;RAD9B;ABCA7;CLK4;SPCS2;SDR16C5;UBE2Z;HS3ST3B1;POLR3A;PIM1;ESPL1;ADAM9;ESCO2;PLAT;CHST2;YARS2;AXL;SAT1;FRK;USP31;GSK3B;KMT2E;PARP8;PARP1;CYP24A1;MMP10;KDM7A;EGLN1;RIPK4;RNF145;ALAS1;RPS6KA6;DDR1;HSPA4L;KCTD11;MGAM;CFB
8838,GO:0034622,0.999631370078367,0.000768301195292592,20,884,cellular protein-containing complex assembly,BP,NOCT;NAV3;ICAM1;SMAD3;CDC42EP4;CREB1;TAF4B;PATL1;PDE4DIP;ANLN;NRG1;H1FX;GRB7;NUP153;SMAD1;SPTBN5;TP53;STX1A;PARP1;JMY
8788,GO:0034470,0.99966341827782,0.00120870736532525,5,396,ncRNA processing,BP,SMAD3;DUS4L;SMAD1;DIEXF;PUS10
2467,GO:0005681,0.999698022640456,0.00282410920332133,1,181,spliceosomal complex,CC,MAPKBP1
4454,GO:0010389,0.999707223253332,0.00274798593556532,1,180,regulation of G2/M transition of mitotic cell cycle,BP,CEP135
9616,GO:0036477,0.999709034477202,0.000815013804287715,9,473,somatodendritic compartment,CC,N4BP3;IL6ST;PLK2;NRG1;SLC38A2;LDLR;PLK3;FEZ1;NEDD4
10401,GO:0043229,0.99978342406883,0.000312540008196817,388,9300,intracellular organelle,CC,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;CXCL1;ITPKC;SDC4;BTG2;BIRC3;PLEKHF1;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;JUN;TICAM1;KDM6B;RAB3IP;EHD1;ZNF697;ETS1;SQSTM1;CSF1;BHLHE40;N4BP3;ZNF267;SERTAD2;STARD5;NFKBIE;BBC3;KLF6;IRF6;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;BDKRB1;N4BP1;RFX5;PANX1;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;KLHL21;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;WTAP;TJP2;RELB;ZNF217;STEAP4;AMOTL2;CDKN1A;NMNAT2;CCDC85B;ITGA5;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;NEDD4L;CTSC;NOD2;ELMSAN1;RELT;SAV1;SGK1;GCH1;FRMD4B;TRIM47;ESRG;RASSF9;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;RNF144B;RND3;NFKBID;TRAF4;TRIB1;KRT34;VEGFA;RAB24;FGD6;DKK1;CDKN2B;PLK2;ABL2;PPTC7;C3ORF52;RNF43;TXNRD1;LACC1;KLF7;PIGA;BTG1;ANXA8;TMEM217;UPP1;IER5;CEBPB;CEBPD;VMP1;CD55;NAMPT;TAP1;TP53BP2;ANKLE2;GJB3;CDC42EP4;SLC28A3;IFNAR1;DSE;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;NEDD9;NR4A2;PATL1;CD47;CANT1;VHL;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;MREG;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;MASTL;NAB1;KIF3C;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;DUSP10;SOX4;PPP1R3B;SERPINB1;PDGFB;ANLN;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;ATF3;BTG3;IKZF2;COL12A1;CAB39;TLE1;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;MT2A;SUCO;SLC9A1;ZBTB10;SLC25A37;SYS1;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;CYTH1;GRB7;ARSJ;NUP153;BCL2L2;RNF152;NEDD4;MMD;RHCG;POU2F2;ITSN2;MARCKS;RAET1L;NFE2L2;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;RTTN;HLA-A;UACA;DRAM1;INO80D;TNIP2;NECAP2;ZNFX1;UGCG;GOLGA8B;TP53;NOM1;KLF3;TLR2;ABI1;STK40;TAPBP;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;RELA;RAPH1;TRIM16;MAMDC2;ESCO2;SPATA2;FOXN2;SLC9A8;PPP6R3;LRRC49;COL27A1;PLAT;CHST2;MUC1;YARS2;SLC16A13;AKIRIN1;ELL2;FRK;HLA-F;CITED4;NR4A3;HLA-E;USP31;GSK3B;KMT2E;PPARD;SLC16A1;EVC;PARP1;CYP24A1;LAMA3;KDM7A;MED13;MXD3;CRAMP1;OCLN;COTL1;JMY;COL8A1;VIM;SRSF11;CREB5;EGLN1;NABP1;ALAS1;ZXDA;RPS6KA6;CEP135;XBP1;HSPA4L;QKI;EPB41L3;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;MGAM;CCSER2;LMAN1;JUND;GJC1;DENND4A
3314,GO:0007018,0.999823960301425,0.00110790998931309,2,228,microtubule-based movement,BP,KIF3C;FEZ1
10914,GO:0044456,0.999841395768191,0.000513929473021141,7,421,synapse part,CC,FOSL1;NEDD4;ABI1;PJA2;STX1A;GSK3B;EPB41L3
5680,GO:0016787,0.99984731496696,0.000254841971149042,56,1817,hydrolase activity,MF,TNFAIP3;PLAU;NOCT;ZC3H12A;DUSP1;AMPD3;ADAM8;CYLD;GBP2;RAP2B;ABCA5;CTSC;GCH1;ZC3H12C;RND3;RAB24;PPTC7;CFLAR;TAP1;ADAMTS1;USP43;CANT1;DUSP16;DDX3Y;TINAGL1;KIF3C;ABCF1;DUSP10;PPP1R3B;PGLYRP4;IFIH1;DUSP8;MMP9;RRAD;OTUD4;CHD2;ARSJ;PTPN1;LACTB;CHD4;RHOV;TAPBP;PDP1;RAB9A;GEM;RAD9B;ABCA7;SPCS2;ESPL1;ADAM9;PLAT;USP31;MMP10;HSPA4L;MGAM;CFB
10403,GO:0043231,0.999853958366085,0.000206895717469089,337,8301,intracellular membrane-bounded organelle,CC,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;IRF1;NUAK2;ITPKC;SDC4;BTG2;BIRC3;PLEKHF1;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;JUN;TICAM1;KDM6B;RAB3IP;EHD1;ZNF697;ETS1;SQSTM1;CSF1;BHLHE40;ZNF267;SERTAD2;STARD5;NFKBIE;BBC3;KLF6;IRF6;IL23A;REL;DUSP1;BCL3;PELI1;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;BDKRB1;N4BP1;RFX5;PANX1;ZFP36L1;CYP27B1;SIX4;IRAK2;JUNB;FZD8;TNFAIP8;WTAP;TJP2;RELB;ZNF217;STEAP4;CDKN1A;NMNAT2;CCDC85B;ITGA5;GBP2;ABCA5;CPEB2;ZNF451;NAV3;NEDD4L;CTSC;NOD2;ELMSAN1;RELT;SAV1;SGK1;GCH1;TRIM47;ESRG;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;RNF144B;RND3;NFKBID;TRAF4;TRIB1;RAB24;FGD6;CDKN2B;PPTC7;C3ORF52;RNF43;TXNRD1;LACC1;KLF7;PIGA;BTG1;TMEM217;UPP1;IER5;CEBPB;CEBPD;VMP1;CD55;NAMPT;TAP1;TP53BP2;ANKLE2;GJB3;SLC28A3;IFNAR1;DSE;ERRFI1;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;NEDD9;NR4A2;PATL1;CANT1;VHL;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;SMURF2;DUSP16;SFR1;DDX3Y;TGIF2;GPBP1;TINAGL1;PNRC2;NFE2L3;TRIM25;MASTL;NAB1;WNT5A;CAMK1G;SLC11A2;ABCF1;TGFA;DUSP10;SOX4;PPP1R3B;PDGFB;ANLN;BAZ1A;IFIH1;DUSP8;NRG1;TNC;LDLR;ATF3;BTG3;IKZF2;COL12A1;TLE1;PLK3;CHD2;PARD6B;MT2A;SUCO;SLC9A1;ZBTB10;SLC25A37;SYS1;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;CYTH1;ARSJ;NUP153;BCL2L2;RNF152;NEDD4;MMD;POU2F2;MARCKS;RAET1L;NFE2L2;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;PAOX;MXD1;CHD4;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;HLA-A;UACA;DRAM1;INO80D;TNIP2;ZNFX1;UGCG;GOLGA8B;TP53;NOM1;KLF3;TLR2;ABI1;STK40;TAPBP;PDP1;RAB9A;HLA-B;IKBKE;GEM;UBE2D3;PJA2;STX1A;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;RELA;RAPH1;TRIM16;MAMDC2;ESCO2;SPATA2;FOXN2;SLC9A8;PPP6R3;COL27A1;CHST2;MUC1;YARS2;SLC16A13;AKIRIN1;ELL2;FRK;HLA-F;CITED4;NR4A3;HLA-E;USP31;GSK3B;KMT2E;PPARD;SLC16A1;PARP1;CYP24A1;LAMA3;KDM7A;MED13;MXD3;CRAMP1;COTL1;JMY;COL8A1;VIM;SRSF11;CREB5;EGLN1;NABP1;ALAS1;ZXDA;RPS6KA6;XBP1;HSPA4L;QKI;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;LMAN1;JUND;GJC1;DENND4A
16629,GO:0097458,0.999864116226541,0.000280688695878477,24,941,neuron part,CC,FOSL1;EPHA2;SQSTM1;N4BP3;BDKRB1;CPEB2;IL6ST;GCH1;PLK2;CREB1;CAMK1G;NRG1;SLC38A2;LDLR;PLK3;FEZ1;NEDD4;SPTBN5;ABI1;PJA2;STX1A;DOCK4;VIM;EPB41L3
10892,GO:0044429,0.999864270931511,0.000312131288271216,17,850,mitochondrial part,CC,PPP1R15A;SOD2;PMAIP1;PPIF;CYP27B1;RNF144B;CREB1;SLC11A2;SLC25A37;MAOA;BCL2L2;TP53;PDP1;IKBKE;YARS2;CYP24A1;ALAS1
10398,GO:0043226,0.999905003348818,0.00014284262046196,410,9783,organelle,CC,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;CXCL1;ITPKC;EFNA1;SDC4;BTG2;BIRC3;PLEKHF1;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;JUN;TICAM1;KDM6B;RAB3IP;EHD1;ZNF697;ETS1;SQSTM1;CSF1;BHLHE40;N4BP3;ZNF267;SERTAD2;STARD5;NFKBIE;BBC3;KLF6;IRF6;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;BDKRB1;N4BP1;RFX5;PANX1;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;KLHL21;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;WTAP;TJP2;RELB;ZNF217;STEAP4;AMOTL2;CDKN1A;NMNAT2;CCDC85B;ITGA5;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;NEDD4L;CTSC;GPX3;NOD2;ELMSAN1;IL6ST;RELT;SAV1;SGK1;ICAM1;GCH1;FRMD4B;TRIM47;ESRG;RASSF9;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;PHLDA1;B3GNT5;RNF144B;RND3;MARCKSL1;NFKBID;TRAF4;TRIB1;KRT34;SERPINB8;VEGFA;RAB24;FGD6;SLC6A14;DKK1;CDKN2B;PLK2;ABL2;PPTC7;C3ORF52;RNF43;TXNRD1;LACC1;KLF7;PIGA;BTG1;ANXA8;TMEM217;UPP1;IER5;CEBPB;CEBPD;VMP1;CD55;NAMPT;TAP1;TMEM106A;ANXA8L1;TP53BP2;ANKLE2;GJB3;CDC42EP4;SLC28A3;IFNAR1;DSE;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;NEDD9;NR4A2;PATL1;CD47;CANT1;VHL;SOGA1;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;MREG;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;MASTL;NAB1;KIF3C;ITGB8;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;DUSP10;ROBO4;SOX4;PPP1R3B;SERPINB1;PDGFB;ANLN;CD82;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;ATF3;BTG3;IKZF2;COL12A1;CAB39;TLE1;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;MT2A;SUCO;SLC9A1;ZBTB10;SLC25A37;SYS1;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;CYTH1;GRB7;ARSJ;NUP153;BCL2L2;RNF152;NEDD4;MMD;RHCG;POU2F2;ITSN2;MARCKS;RAET1L;BTN2A2;NFE2L2;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;RTTN;HLA-A;UACA;DRAM1;INO80D;TNIP2;NECAP2;ZNFX1;UGCG;GOLGA8B;TP53;NOM1;KLF3;TLR2;ABI1;STK40;TAPBP;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;CD276;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;ADAM9;RELA;RAPH1;TRIM16;MAMDC2;ESCO2;SPATA2;FOXN2;SLC9A8;PPP6R3;LRRC49;COL27A1;PLAT;CHST2;MUC1;YARS2;AXL;SLC16A13;ANXA5;AKIRIN1;CRB3;ELL2;FRK;HLA-F;CITED4;NR4A3;HLA-E;USP31;GSK3B;KMT2E;PPARD;SLC16A1;EVC;PARP1;CYP24A1;LAMA3;KDM7A;MED13;MXD3;CRAMP1;OCLN;COTL1;JMY;COL8A1;VIM;SRSF11;CREB5;EGLN1;NABP1;ALAS1;ZXDA;RPS6KA6;DDR1;CEP135;XBP1;HSPA4L;QKI;EPB41L3;ZBTB5;ELF4;TFE3;EID3;ZMIZ2;MGAM;CCSER2;LMAN1;CFB;JUND;GJC1;DENND4A
10888,GO:0044424,0.999923510487808,0.000121000613053337,442,10399,intracellular part,CC,NFKBIZ;IL1B;NFKBIA;TNFAIP3;CSF2;TNF;IRF1;HBEGF;NUAK2;PLAU;CXCL1;IL1A;ITPKC;SDC4;BTG2;INHBA;BIRC3;PLEKHF1;NOCT;FOSL1;NCOA7;ZC3H12A;IL16;PPP1R15A;RNF19B;ELF3;BMP2;LIF;PLAUR;SOD2;PRDM1;TBX3;PMAIP1;EHF;PTX3;IL1RN;MAFF;NFKB1;IER3;PPIF;TNIP1;EDN1;MAP2K3;ZFP36;PNRC1;G0S2;SERPINB2;JUN;TICAM1;KDM6B;RAB3IP;EPHA2;EHD1;ZNF697;ETS1;TRAF1;SQSTM1;CSF1;BHLHE40;N4BP3;ZNF267;SPRR2D;SERTAD2;STARD5;NFKBIE;BBC3;KLF6;IRF6;IL23A;REL;DUSP1;BCL3;PELI1;AMPD3;GADD45A;PLAGL2;EFNB1;BIRC2;IFNGR2;IL6;ETS2;ZNF436;CSRNP1;NFKB2;ADAM8;BDKRB1;N4BP1;PIM3;RFX5;PANX1;ZFP36L1;CYP27B1;SIX4;RIPK2;IRAK2;KLHL21;PHLDA2;DAPP1;JUNB;PHLDB2;CYLD;FZD8;TNFAIP8;BAMBI;WTAP;TJP2;RELB;ZNF217;STEAP4;AMOTL2;CDKN1A;CLDN1;NMNAT2;CCDC85B;ITGA5;GBP2;RAP2B;ABCA5;IL7R;CPEB2;ZNF451;NAV3;ODC1;TNFAIP2;NEDD4L;CTSC;NOD2;ELMSAN1;DCUN1D3;RELT;SAV1;SGK1;GCH1;FRMD4B;TRIM47;ESRG;RASSF9;SMAD3;B4GALT1;NFKBIB;DLX2;ARNTL2;C15ORF39;PHLDA1;B3GNT5;RNF144B;RND3;MARCKSL1;NFKBID;TRAF4;TRIB1;KRT34;SERPINB8;VEGFA;ARHGEF3;RAB24;FGD6;IL1R2;DKK1;CDKN2B;ZSWIM4;PLK2;MAP3K8;ABL2;PPTC7;C3ORF52;CDV3;CFLAR;RNF43;TXNRD1;LACC1;KLF7;PIGA;BTG1;ANXA8;TMEM217;UPP1;IER5;PPP4R4;CEBPB;CEBPD;VMP1;CD55;DENND3;NAMPT;TAP1;TP53BP2;ANKLE2;ADM;GJB3;CDC42EP4;SLC28A3;IFNAR1;DSE;ERRFI1;ADAMTS1;CREB1;TAF4B;GORAB;CCNL1;USP43;GJB4;WISP1;NEDD9;MAST4;NR4A2;PATL1;CD47;CANT1;VHL;PHKG2;BACH1;ABTB2;PDE4DIP;MYBL1;RUNX1;TGFBR2;MREG;SMURF2;DUSP16;SFR1;DDX3Y;SAA1;TGIF2;GPBP1;TINAGL1;PNRC2;KLHL5;NFE2L3;TRIM25;MASTL;NAB1;KIF3C;HMGCS1;WNT5A;CAMK1G;VEGFC;SLC11A2;ABCF1;TGFA;NOTCH2NL;DUSP10;SOX4;PPP1R3B;SERPINB1;SOCS2;PDGFB;ANLN;NBPF8;BAZ1A;IFIH1;DUSP8;NRG1;TNC;MMP9;LDLR;ATF3;BTG3;IKZF2;COL12A1;FAM83B;CAB39;IL32;TLE1;PLK3;CHD2;ARRDC4;RASGEF1B;PARD6B;MT2A;SUCO;SLC9A1;ZBTB10;SLC25A37;SYS1;MAOA;RCHY1;YAF2;SPRY2;FEZ1;TNKS1BP1;H1FX;B4GALT5;HAL;CYTH1;GRB7;ARSJ;NUP153;BCL2L2;RNF152;NEDD4;MMD;RHCG;POU2F2;ITSN2;DUS4L;GCSAM;MARCKS;RAET1L;NFE2L2;KBTBD7;PTPN1;WNT7B;SMAD1;LACTB;SGMS2;TAB3;PAOX;SPTBN5;MXD1;CHD4;ZC3H7B;DIEXF;CLIC4;NFAT5;STAT5A;TPST1;CAV1;VEZF1;RHOV;SH3RF2;RTTN;HLA-A;UACA;DRAM1;INO80D;TNIP2;NECAP2;ZNFX1;UGCG;ZFAND5;GOLGA8B;TP53;NOM1;KLF3;TLR2;ABI1;STK40;TAPBP;PDP1;RAB9A;HLA-B;ITGAV;IKBKE;GEM;UBE2D3;PJA2;STX1A;DOCK4;TRIP10;MAPKBP1;ELK3;JPH2;SPRR2A;RAD9B;SNAPC4;ABCA7;CLK4;SPCS2;TMEM132A;SDR16C5;ZNF148;UBE2Z;HS3ST3B1;PML;POLR3A;PIM1;ESPL1;RELA;RAPH1;TRIM16;MAMDC2;ESCO2;SPATA2;FOXN2;SLC9A8;PPP6R3;LRRC49;COL27A1;PLAT;CHST2;MUC1;YARS2;AXL;SLC16A13;ANXA5;THSD1;AKIRIN1;ELL2;SAT1;FRK;HLA-F;CITED4;NR4A3;LIMS3;HLA-E;USP31;GSK3B;KMT2E;PPARD;SLC16A1;EVC;PARP1;CYP24A1;LAMA3;KDM7A;MED13;MXD3;CRAMP1;LCE1C;OCLN;COTL1;JMY;COL8A1;VIM;SRSF11;CREB5;EGLN1;NABP1;RIPK4;ALAS1;ZXDA;RPS6KA6;DDR1;CEP135;XBP1;HSPA4L;QKI;EPB41L3;KCTD11;ZBTB5;ELF4;SLC39A14;TFE3;EID3;ZMIZ2;MGAM;CCSER2;LMAN1;JUND;GJC1;DENND4A
6276,GO:0019866,0.999925711064626,0.000296377856424589,5,450,organelle inner membrane,CC,SOD2;PPIF;SMAD3;SLC25A37;SMAD1
2872,GO:0006364,0.999941963151167,0.000640404467933799,1,255,rRNA processing,BP,DIEXF
2890,GO:0006397,0.999943650724562,0.00020918032181069,6,440,mRNA processing,BP,NOCT;ZFP36L1;WTAP;SRSF11;QKI;SREK1IP1
9918,GO:0042254,0.999949461318031,0.000352232132124469,2,317,ribosome biogenesis,BP,DIEXF;NOM1
6600,GO:0022613,0.99995174138652,0.00019806259108316,5,448,ribonucleoprotein complex biogenesis,BP,NOCT;PATL1;GRB7;DIEXF;NOM1
172,GO:0000377,0.999982008676171,0.000136142585508948,2,299,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,WTAP;SRSF11
184,GO:0000398,0.999982008676171,0.000136142585508948,2,299,mRNA splicing, via spliceosome,BP,WTAP;SRSF11
171,GO:0000375,0.999983987331172,0.000122212736139176,2,302,RNA splicing, via transesterification reactions,BP,WTAP;SRSF11
2497,GO:0005743,0.999984365935671,9.21123652520498e-05,3,406,mitochondrial inner membrane,CC,SOD2;PPIF;SLC25A37
5339,GO:0016072,0.999985770158827,0.000177897013816646,1,284,rRNA metabolic process,BP,DIEXF
2889,GO:0006396,0.999988808031915,2.9317343838258e-05,16,877,RNA processing,BP,NOCT;ZC3H12A;ZFP36L1;WTAP;SMAD3;CCNL1;DUS4L;SMAD1;ZC3H7B;DIEXF;PUS10;MAPKBP1;CLK4;SRSF11;QKI;SREK1IP1
1470,GO:0003723,0.999994674148204,1.10256004101894e-05,35,1483,RNA binding,MF,NOCT;ZC3H12A;ZFP36;JUN;ZFP36L1;C11ORF68;CPEB2;SMAD3;DLX2;CDC42EP4;PATL1;DDX3Y;TRIM25;ABCF1;IFIH1;OTUD4;CHD2;H1FX;GRB7;PTPN1;SMAD1;ZC3H7B;DIEXF;HLA-A;ZNFX1;TP53;NOM1;PUS10;MAPKBP1;YARS2;PARP1;VIM;SRSF11;NABP1;QKI
12936,GO:0051276,0.999997798054615,5.53879821259716e-06,21,1050,chromosome organization,BP,IL1B;LIF;KDM6B;DUSP1;ZNF451;VEGFA;BAZ1A;CHD2;TNKS1BP1;H1FX;CHD4;TP53;GEM;SDR16C5;PML;ESPL1;TRIM16;MUC1;KMT2E;PARP1;KDM7A
9242,GO:0035633,0.99999999995946,0.905015559684451,0,2,maintenance of permeability of blood-brain barrier,BP,
7365,GO:0031403,0.999999999966479,0.900748464838282,0,2,lithium ion binding,MF,
7347,GO:0031370,0.999999999967615,0.947102335959929,0,1,eukaryotic initiation factor 4G binding,MF,
15650,GO:0072135,0.999999999968036,0.901973997382474,0,2,kidney mesenchymal cell proliferation,BP,
15651,GO:0072136,0.999999999968036,0.901973997382474,0,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
12401,GO:0048817,0.999999999969164,0.897506730279161,0,2,negative regulation of hair follicle maturation,BP,
20264,GO:2001184,0.999999999969891,0.905012520241822,0,2,positive regulation of interleukin-12 secretion,BP,
9677,GO:0038036,0.999999999969919,0.748596673291121,0,6,sphingosine-1-phosphate receptor activity,MF,
8741,GO:0034388,0.999999999970268,0.747066304416427,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
5808,GO:0017057,0.999999999970831,0.919354481202416,0,2,6-phosphogluconolactonase activity,MF,
3525,GO:0007500,0.99999999997232,0.913601251145097,0,2,mesodermal cell fate determination,BP,
2351,GO:0005412,0.999999999972637,0.905003279869486,0,2,glucose:sodium symporter activity,MF,
10144,GO:0042704,0.999999999973261,0.901729573762134,0,2,uterine wall breakdown,BP,
19683,GO:1990911,0.999999999973493,0.913728808966954,0,2,response to psychosocial stress,BP,
18996,GO:1904761,0.999999999974009,0.899789777436292,0,2,negative regulation of myofibroblast differentiation,BP,
17160,GO:0102485,0.9999999999742,0.902955248205783,0,2,dATP phosphohydrolase activity,MF,
17161,GO:0102486,0.9999999999742,0.902955248205783,0,2,dCTP phosphohydrolase activity,MF,
17162,GO:0102487,0.9999999999742,0.902955248205783,0,2,dUTP phosphohydrolase activity,MF,
17163,GO:0102488,0.9999999999742,0.902955248205783,0,2,dTTP phosphohydrolase activity,MF,
17164,GO:0102489,0.9999999999742,0.902955248205783,0,2,GTP phosphohydrolase activity,MF,
17165,GO:0102490,0.9999999999742,0.902955248205783,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17166,GO:0102491,0.9999999999742,0.902955248205783,0,2,dGTP phosphohydrolase activity,MF,
18851,GO:1904426,0.9999999999742,0.902955248205783,0,2,positive regulation of GTP binding,BP,
6879,GO:0030366,0.999999999974618,0.9244493719705,0,2,molybdopterin synthase activity,MF,
19325,GO:1905573,0.999999999975458,0.912759258497305,0,2,ganglioside GM1 binding,MF,
19328,GO:1905576,0.999999999975458,0.912759258497305,0,2,ganglioside GT1b binding,MF,
8504,GO:0033680,0.999999999975823,0.903839735371788,0,2,ATP-dependent DNA/RNA helicase activity,MF,
122,GO:0000252,0.999999999975852,0.960454054448683,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
11952,GO:0047012,0.999999999975852,0.960454054448683,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
17194,GO:0103066,0.999999999975852,0.960454054448683,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17195,GO:0103067,0.999999999975852,0.960454054448683,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
3250,GO:0006910,0.999999999976023,0.742746351597308,0,6,phagocytosis, recognition,BP,
3104,GO:0006681,0.999999999976462,0.749452050560893,0,6,galactosylceramide metabolic process,BP,
6130,GO:0019374,0.999999999976462,0.749452050560893,0,6,galactolipid metabolic process,BP,
18244,GO:1903031,0.999999999976605,0.913591116753356,0,2,regulation of microtubule plus-end binding,BP,
18245,GO:1903033,0.999999999976605,0.913591116753356,0,2,positive regulation of microtubule plus-end binding,BP,
15389,GO:0071619,0.999999999976854,0.955128301050215,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20249,GO:2001163,0.999999999976854,0.955128301050215,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20250,GO:2001165,0.999999999976854,0.955128301050215,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
2068,GO:0004819,0.999999999976882,0.903997276201365,0,2,glutamine-tRNA ligase activity,MF,
2915,GO:0006425,0.999999999976882,0.903997276201365,0,2,glutaminyl-tRNA aminoacylation,BP,
12738,GO:0050966,0.999999999977374,0.904996783002846,0,2,detection of mechanical stimulus involved in sensory perception of pain,BP,
4494,GO:0010513,0.99999999997743,0.920678168094838,0,2,positive regulation of phosphatidylinositol biosynthetic process,BP,
8417,GO:0033391,0.999999999977478,0.73488850320825,0,6,chromatoid body,CC,
2010,GO:0004731,0.999999999978144,0.904037098434111,0,2,purine-nucleoside phosphorylase activity,MF,
1036,GO:0002542,0.999999999978252,0.956087738085749,0,1,Factor XII activation,BP,
13259,GO:0051919,0.999999999978252,0.956087738085749,0,1,positive regulation of fibrinolysis,BP,
3017,GO:0006562,0.999999999978364,0.909625728429288,0,2,proline catabolic process,BP,
4404,GO:0010133,0.999999999978364,0.909625728429288,0,2,proline catabolic process to glutamate,BP,
3927,GO:0008597,0.999999999978418,0.915780242957961,0,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
13307,GO:0051990,0.99999999997846,0.911302336057929,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
3760,GO:0008300,0.999999999978573,0.904004795132944,0,2,isoprenoid catabolic process,BP,
3826,GO:0008422,0.999999999978651,0.899777423408259,0,2,beta-glucosidase activity,MF,
1524,GO:0003883,0.999999999978665,0.904977849395448,0,2,CTP synthase activity,MF,
10768,GO:0044210,0.999999999978665,0.904977849395448,0,2,'de novo' CTP biosynthetic process,BP,
500,GO:0001555,0.999999999978761,0.909191073514615,0,2,oocyte growth,BP,
7458,GO:0031590,0.999999999978761,0.909191073514615,0,2,wybutosine metabolic process,BP,
7459,GO:0031591,0.999999999978761,0.909191073514615,0,2,wybutosine biosynthetic process,BP,
12759,GO:0051014,0.999999999978778,0.738047561693476,0,6,actin filament severing,BP,
15079,GO:0071029,0.999999999978797,0.790856436900557,0,6,nuclear ncRNA surveillance,BP,
15084,GO:0071035,0.999999999978797,0.790856436900557,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15090,GO:0071046,0.999999999978797,0.790856436900557,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
3735,GO:0008271,0.999999999978802,0.775985935001678,0,5,secondary active sulfate transmembrane transporter activity,MF,
6174,GO:0019531,0.999999999978802,0.775985935001678,0,5,oxalate transmembrane transporter activity,MF,
6175,GO:0019532,0.999999999978802,0.775985935001678,0,5,oxalate transport,BP,
16907,GO:0098840,0.99999999997886,0.929187896178805,0,2,protein transport along microtubule,BP,
17022,GO:0099118,0.99999999997886,0.929187896178805,0,2,microtubule-based protein transport,BP,
9153,GO:0035502,0.999999999979197,0.864748409227899,0,3,metanephric part of ureteric bud development,BP,
1522,GO:0003881,0.999999999979265,0.957382392391137,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
2884,GO:0006386,0.999999999979327,0.976991460038211,0,1,termination of RNA polymerase III transcription,BP,
8642,GO:0034166,0.999999999979362,0.951903996929681,0,1,toll-like receptor 10 signaling pathway,BP,
15488,GO:0071819,0.999999999979403,0.93444720267018,0,2,DUBm complex,CC,
15586,GO:0072034,0.999999999979406,0.900984250927061,0,2,renal vesicle induction,BP,
12706,GO:0050910,0.999999999979414,0.903396153590271,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
16582,GO:0097360,0.999999999979414,0.903396153590271,0,2,chorionic trophoblast cell proliferation,BP,
17661,GO:1901382,0.999999999979414,0.903396153590271,0,2,regulation of chorionic trophoblast cell proliferation,BP,
2194,GO:0005052,0.999999999979515,0.905440139818716,0,2,peroxisome matrix targeting signal-1 binding,MF,
15649,GO:0072134,0.999999999979678,0.898151981477498,0,2,nephrogenic mesenchyme morphogenesis,BP,
7510,GO:0031685,0.999999999979744,0.903850427205306,0,2,adenosine receptor binding,MF,
17327,GO:0140161,0.999999999979857,0.88066768516119,0,3,monocarboxylate:sodium symporter activity,MF,
970,GO:0002414,0.999999999980015,0.908602315795324,0,2,immunoglobulin transcytosis in epithelial cells,BP,
6225,GO:0019763,0.999999999980015,0.908602315795324,0,2,immunoglobulin receptor activity,MF,
20000,GO:2000562,0.999999999980113,0.908610578795516,0,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
1817,GO:0004464,0.999999999980133,0.957885962334199,0,2,leukotriene-C4 synthase activity,MF,
11168,GO:0045217,0.999999999980136,0.737078971863297,0,6,cell-cell junction maintenance,BP,
5652,GO:0016742,0.999999999980149,0.748760848942492,0,6,hydroxymethyl-, formyl- and related transferase activity,MF,
19566,GO:1990459,0.999999999980154,0.757369236012809,0,6,transferrin receptor binding,MF,
20195,GO:2001013,0.999999999980243,0.896405791734792,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
1494,GO:0003829,0.999999999980299,0.900616195248995,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
4594,GO:0010698,0.999999999980475,0.93470686249813,0,2,acetyltransferase activator activity,MF,
10670,GO:0043874,0.99999999998048,0.95635085893674,0,1,acireductone synthase activity,MF,
13072,GO:0051552,0.999999999980611,0.954868209600837,0,1,flavone metabolic process,BP,
15047,GO:0070980,0.999999999980611,0.954868209600837,0,1,biphenyl catabolic process,BP,
10104,GO:0042610,0.99999999998067,0.955982138184284,0,1,CD8 receptor binding,MF,
19276,GO:1905429,0.99999999998067,0.955982138184284,0,1,response to glycine,BP,
19277,GO:1905430,0.99999999998067,0.955982138184284,0,1,cellular response to glycine,BP,
924,GO:0002316,0.999999999980875,0.948024298257441,0,1,follicular B cell differentiation,BP,
5957,GO:0018315,0.999999999980875,0.948024298257441,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
9828,GO:0042040,0.999999999980875,0.948024298257441,0,1,metal incorporation into metallo-molybdopterin complex,BP,
14377,GO:0061598,0.999999999980875,0.948024298257441,0,1,molybdopterin adenylyltransferase activity,MF,
14378,GO:0061599,0.999999999980875,0.948024298257441,0,1,molybdopterin molybdotransferase activity,MF,
15874,GO:0072579,0.999999999980875,0.948024298257441,0,1,glycine receptor clustering,BP,
16462,GO:0097112,0.999999999980875,0.948024298257441,0,1,gamma-aminobutyric acid receptor clustering,BP,
8447,GO:0033566,0.999999999980901,0.91035018348682,0,2,gamma-tubulin complex localization,BP,
15873,GO:0072578,0.999999999980971,0.745167794393792,0,6,neurotransmitter-gated ion channel clustering,BP,
12529,GO:0050659,0.999999999981047,0.896679123502793,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
15406,GO:0071642,0.999999999981082,0.90778044214747,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16677,GO:0097543,0.9999999999811,0.90279449889369,0,2,ciliary inversin compartment,CC,
10456,GO:0043309,0.999999999981113,0.919042648639521,0,2,regulation of eosinophil degranulation,BP,
10457,GO:0043311,0.999999999981113,0.919042648639521,0,2,positive regulation of eosinophil degranulation,BP,
18057,GO:1902566,0.999999999981113,0.919042648639521,0,2,regulation of eosinophil activation,BP,
18058,GO:1902568,0.999999999981113,0.919042648639521,0,2,positive regulation of eosinophil activation,BP,
18168,GO:1902896,0.99999999998113,0.904986414642628,0,2,terminal web assembly,BP,
5527,GO:0016493,0.999999999981157,0.909681220358375,0,2,C-C chemokine receptor activity,MF,
19111,GO:1904995,0.999999999981238,0.931017722594105,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
17393,GO:1900107,0.999999999981261,0.907682849949204,0,2,regulation of nodal signaling pathway,BP,
17420,GO:1900145,0.999999999981261,0.907682849949204,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17435,GO:1900175,0.999999999981261,0.907682849949204,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
11154,GO:0045196,0.999999999981271,0.899086919614395,0,2,establishment or maintenance of neuroblast polarity,BP,
11158,GO:0045200,0.999999999981271,0.899086919614395,0,2,establishment of neuroblast polarity,BP,
16911,GO:0098845,0.999999999981317,0.75758024223614,0,6,postsynaptic endosome,CC,
10477,GO:0043366,0.999999999981441,0.906134649383737,0,2,beta selection,BP,
2935,GO:0006452,0.999999999981443,0.91377250739586,0,2,translational frameshifting,BP,
11461,GO:0045905,0.999999999981443,0.91377250739586,0,2,positive regulation of translational termination,BP,
8374,GO:0033268,0.999999999981504,0.620201847579558,0,9,node of Ranvier,CC,
1809,GO:0004452,0.999999999981507,0.921617984170762,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
12742,GO:0050992,0.999999999981507,0.921617984170762,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12743,GO:0050993,0.999999999981507,0.921617984170762,0,2,dimethylallyl diphosphate metabolic process,BP,
14372,GO:0061582,0.999999999981538,0.897864500310805,0,2,intestinal epithelial cell migration,BP,
2881,GO:0006382,0.999999999981544,0.76853325794789,0,5,adenosine to inosine editing,BP,
1890,GO:0004568,0.999999999981589,0.9065388466745,0,2,chitinase activity,MF,
2679,GO:0006030,0.999999999981589,0.9065388466745,0,2,chitin metabolic process,BP,
2680,GO:0006032,0.999999999981589,0.9065388466745,0,2,chitin catabolic process,BP,
3614,GO:0008061,0.999999999981589,0.9065388466745,0,2,chitin binding,MF,
15405,GO:0071641,0.99999999998159,0.909704446930835,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
3095,GO:0006668,0.999999999981619,0.907482338545895,0,2,sphinganine-1-phosphate metabolic process,BP,
17091,GO:0099590,0.999999999981623,0.744902561403366,0,6,neurotransmitter receptor internalization,BP,
4364,GO:0009957,0.999999999981637,0.903938128108199,0,2,epidermal cell fate specification,BP,
13883,GO:0060486,0.999999999981637,0.903938128108199,0,2,Clara cell differentiation,BP,
17588,GO:1901187,0.999999999981637,0.903938128108199,0,2,regulation of ephrin receptor signaling pathway,BP,
9922,GO:0042264,0.9999999999817,0.899731912283967,0,2,peptidyl-aspartic acid hydroxylation,BP,
6979,GO:0030638,0.999999999981792,0.819585326198543,0,5,polyketide metabolic process,BP,
6983,GO:0030647,0.999999999981792,0.819585326198543,0,5,aminoglycoside antibiotic metabolic process,BP,
10942,GO:0044597,0.999999999981792,0.819585326198543,0,5,daunorubicin metabolic process,BP,
10943,GO:0044598,0.999999999981792,0.819585326198543,0,5,doxorubicin metabolic process,BP,
9666,GO:0038021,0.999999999981877,0.948037667788595,0,1,leptin receptor activity,MF,
18865,GO:1904455,0.999999999981908,0.896370359415849,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
17111,GO:0099638,0.999999999981956,0.745270531368503,0,6,endosome to plasma membrane protein transport,BP,
17112,GO:0099639,0.999999999981956,0.745270531368503,0,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,
7611,GO:0031990,0.999999999981967,0.904037040019997,0,2,mRNA export from nucleus in response to heat stress,BP,
8752,GO:0034402,0.999999999981967,0.904037040019997,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
17860,GO:1902031,0.999999999982083,0.756844929831921,0,6,regulation of NADP metabolic process,BP,
1536,GO:0003918,0.99999999998215,0.896249467913091,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
14341,GO:0061505,0.99999999998215,0.896249467913091,0,2,DNA topoisomerase II activity,MF,
20146,GO:2000807,0.999999999982195,0.848903278933523,0,3,regulation of synaptic vesicle clustering,BP,
6357,GO:0021534,0.999999999982286,0.786473276712088,0,5,cell proliferation in hindbrain,BP,
6532,GO:0021924,0.999999999982286,0.786473276712088,0,5,cell proliferation in external granule layer,BP,
6533,GO:0021930,0.999999999982286,0.786473276712088,0,5,cerebellar granule cell precursor proliferation,BP,
6144,GO:0019408,0.999999999982291,0.903620688432416,0,2,dolichol biosynthetic process,BP,
7576,GO:0031933,0.999999999982303,0.868185265054005,0,3,telomeric heterochromatin,CC,
10228,GO:0042903,0.999999999982374,0.907477012105978,0,2,tubulin deacetylase activity,MF,
15104,GO:0071105,0.999999999982407,0.947063206685453,0,1,response to interleukin-11,BP,
15213,GO:0071348,0.999999999982407,0.947063206685453,0,1,cellular response to interleukin-11,BP,
14073,GO:0060837,0.999999999982521,0.744635254926856,0,6,blood vessel endothelial cell differentiation,BP,
8940,GO:0034970,0.999999999982541,0.90960724231477,0,2,histone H3-R2 methylation,BP,
7204,GO:0031089,0.999999999982605,0.791956005272084,0,5,platelet dense granule lumen,CC,
13448,GO:0052836,0.999999999982659,0.914606543211993,0,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
13449,GO:0052839,0.999999999982659,0.914606543211993,0,2,inositol diphosphate tetrakisphosphate kinase activity,MF,
10666,GO:0043813,0.999999999982753,0.765206445113211,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
1443,GO:0003419,0.999999999982768,0.909873654431272,0,2,growth plate cartilage chondrocyte proliferation,BP,
1444,GO:0003420,0.999999999982768,0.909873654431272,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1317,GO:0003162,0.99999999998282,0.896181783268097,0,2,atrioventricular node development,BP,
16175,GO:0090182,0.999999999982894,0.918753396047108,0,2,regulation of secretion of lysosomal enzymes,BP,
8080,GO:0032754,0.999999999982908,0.741431837105431,0,6,positive regulation of interleukin-5 production,BP,
16000,GO:0080184,0.999999999982922,0.911438656659416,0,2,response to phenylpropanoid,BP,
16564,GO:0097322,0.999999999982961,0.747907613014472,0,6,7SK snRNA binding,MF,
5187,GO:0015747,0.999999999982963,0.913738098647235,0,2,urate transport,BP,
19463,GO:1990072,0.999999999982975,0.932276173688667,0,2,TRAPPIII protein complex,CC,
4840,GO:0014043,0.99999999998307,0.909193961515118,0,2,negative regulation of neuron maturation,BP,
16909,GO:0098843,0.99999999998312,0.765932187859834,0,6,postsynaptic endocytic zone,CC,
17169,GO:0102521,0.999999999983225,0.908731588044778,0,2,tRNA-4-demethylwyosine synthase activity,MF,
18459,GO:1903526,0.999999999983232,0.900618618701192,0,2,negative regulation of membrane tubulation,BP,
14687,GO:0070292,0.999999999983271,0.902762599023771,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
4084,GO:0009136,0.999999999983285,0.928468327160645,0,2,purine nucleoside diphosphate biosynthetic process,BP,
4123,GO:0009180,0.999999999983285,0.928468327160645,0,2,purine ribonucleoside diphosphate biosynthetic process,BP,
4131,GO:0009188,0.999999999983285,0.928468327160645,0,2,ribonucleoside diphosphate biosynthetic process,BP,
582,GO:0001732,0.999999999983297,0.90573927269436,0,2,formation of cytoplasmic translation initiation complex,BP,
1884,GO:0004560,0.99999999998337,0.913598807700672,0,2,alpha-L-fucosidase activity,MF,
5281,GO:0015928,0.99999999998337,0.913598807700672,0,2,fucosidase activity,MF,
8206,GO:0032954,0.999999999983429,0.901099604468523,0,2,regulation of cytokinetic process,BP,
18424,GO:1903436,0.999999999983429,0.901099604468523,0,2,regulation of mitotic cytokinetic process,BP,
18425,GO:1903438,0.999999999983429,0.901099604468523,0,2,positive regulation of mitotic cytokinetic process,BP,
18440,GO:1903490,0.999999999983429,0.901099604468523,0,2,positive regulation of mitotic cytokinesis,BP,
8249,GO:0033023,0.999999999983436,0.900048745202732,0,2,mast cell homeostasis,BP,
8250,GO:0033024,0.999999999983436,0.900048745202732,0,2,mast cell apoptotic process,BP,
8251,GO:0033025,0.999999999983436,0.900048745202732,0,2,regulation of mast cell apoptotic process,BP,
20221,GO:2001053,0.999999999983438,0.745027209577991,0,6,regulation of mesenchymal cell apoptotic process,BP,
13708,GO:0060244,0.999999999983508,0.869082995512485,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
13408,GO:0052696,0.999999999983554,0.794679844539922,0,5,flavonoid glucuronidation,BP,
13409,GO:0052697,0.999999999983554,0.794679844539922,0,5,xenobiotic glucuronidation,BP,
11974,GO:0047166,0.999999999983574,0.957039447878309,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
2785,GO:0006216,0.999999999983584,0.786260818148434,0,6,cytidine catabolic process,BP,
4368,GO:0009972,0.999999999983584,0.786260818148434,0,6,cytidine deamination,BP,
11562,GO:0046087,0.999999999983584,0.786260818148434,0,6,cytidine metabolic process,BP,
9114,GO:0035402,0.999999999983602,0.909326173486478,0,2,histone kinase activity (H3-T11 specific),MF,
9119,GO:0035407,0.999999999983602,0.909326173486478,0,2,histone H3-T11 phosphorylation,BP,
10843,GO:0044334,0.999999999983614,0.902785450533561,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
6835,GO:0030292,0.999999999983624,0.865962111293186,0,3,protein tyrosine kinase inhibitor activity,MF,
9174,GO:0035526,0.999999999983676,0.897626838179642,0,2,retrograde transport, plasma membrane to Golgi,BP,
6478,GO:0021814,0.999999999983708,0.697676690034791,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
5872,GO:0017177,0.999999999983722,0.949234061986971,0,1,glucosidase II complex,CC,
8554,GO:0033919,0.999999999983722,0.949234061986971,0,1,glucan 1,3-alpha-glucosidase activity,MF,
16357,GO:0090600,0.999999999983722,0.949234061986971,0,1,alpha-1,3-glucosidase activity,MF,
1808,GO:0004450,0.999999999983737,0.915545099908827,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
2721,GO:0006097,0.999999999983737,0.915545099908827,0,2,glyoxylate cycle,BP,
2167,GO:0004999,0.999999999983739,0.953825797570673,0,1,vasoactive intestinal polypeptide receptor activity,MF,
3339,GO:0007056,0.999999999983742,0.912772339869365,0,2,spindle assembly involved in female meiosis,BP,
3340,GO:0007057,0.999999999983742,0.912772339869365,0,2,spindle assembly involved in female meiosis I,BP,
8303,GO:0033132,0.999999999983764,0.920543515309243,0,2,negative regulation of glucokinase activity,BP,
18355,GO:1903300,0.999999999983764,0.920543515309243,0,2,negative regulation of hexokinase activity,BP,
18573,GO:1903772,0.99999999998378,0.808117019064597,0,5,regulation of viral budding via host ESCRT complex,BP,
13823,GO:0060398,0.999999999983794,0.84894232444028,0,3,regulation of growth hormone receptor signaling pathway,BP,
12143,GO:0048211,0.99999999998384,0.90565224264249,0,2,Golgi vesicle docking,BP,
1434,GO:0003406,0.999999999983871,0.860913020612105,0,3,retinal pigment epithelium development,BP,
1737,GO:0004332,0.999999999983877,0.922652680234999,0,2,fructose-bisphosphate aldolase activity,MF,
5450,GO:0016314,0.999999999983886,0.896487724770967,0,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
9142,GO:0035482,0.999999999983932,0.937063029615316,0,2,gastric motility,BP,
19237,GO:1905333,0.999999999983932,0.937063029615316,0,2,regulation of gastric motility,BP,
2106,GO:0004874,0.999999999983964,0.896540157041724,0,2,aryl hydrocarbon receptor activity,MF,
7085,GO:0030870,0.999999999983983,0.774206057672097,0,5,Mre11 complex,CC,
10135,GO:0042668,0.99999999998402,0.929408504117124,0,2,auditory receptor cell fate determination,BP,
20187,GO:2000977,0.99999999998402,0.929408504117124,0,2,regulation of forebrain neuron differentiation,BP,
20188,GO:2000978,0.99999999998402,0.929408504117124,0,2,negative regulation of forebrain neuron differentiation,BP,
11459,GO:0045901,0.999999999984026,0.871038028354715,0,3,positive regulation of translational elongation,BP,
11543,GO:0046060,0.999999999984032,0.833207090842547,0,5,dATP metabolic process,BP,
3642,GO:0008113,0.99999999998406,0.928334848380286,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
12740,GO:0050974,0.999999999984062,0.78089128564781,0,5,detection of mechanical stimulus involved in sensory perception,BP,
4007,GO:0008962,0.999999999984174,0.912732848567504,0,2,phosphatidylglycerophosphatase activity,MF,
19342,GO:1905602,0.999999999984183,0.915211554103302,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
15531,GO:0071898,0.999999999984188,0.870979974097915,0,3,regulation of estrogen receptor binding,BP,
15532,GO:0071899,0.999999999984188,0.870979974097915,0,3,negative regulation of estrogen receptor binding,BP,
10711,GO:0043997,0.999999999984288,0.952699734292512,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
17228,GO:0106075,0.999999999984288,0.952699734292512,0,1,peptide N-succinyltransferase activity,MF,
17230,GO:0106078,0.999999999984288,0.952699734292512,0,1,histone succinyltransferase activity,MF,
14474,GO:0061827,0.99999999998429,0.917537207407527,0,2,sperm head,CC,
6496,GO:0021847,0.999999999984316,0.897942556602046,0,2,ventricular zone neuroblast division,BP,
9222,GO:0035607,0.999999999984316,0.897942556602046,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
19314,GO:1905538,0.99999999998436,0.90326953204142,0,2,polysome binding,MF,
9605,GO:0036461,0.999999999984383,0.932130684016542,0,2,BLOC-2 complex binding,MF,
15313,GO:0071492,0.999999999984445,0.906625004852804,0,2,cellular response to UV-A,BP,
3593,GO:0008020,0.999999999984531,0.909353645168323,0,2,G-protein coupled photoreceptor activity,MF,
16072,GO:0089701,0.999999999984557,0.831322306050451,0,5,U2AF,CC,
5013,GO:0015168,0.999999999984584,0.912934794608797,0,2,glycerol transmembrane transporter activity,MF,
5059,GO:0015254,0.999999999984584,0.912934794608797,0,2,glycerol channel activity,MF,
5202,GO:0015793,0.999999999984584,0.912934794608797,0,2,glycerol transport,BP,
1510,GO:0003865,0.999999999984602,0.911378058442447,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
8529,GO:0033765,0.999999999984602,0.911378058442447,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9264,GO:0035671,0.999999999984602,0.911378058442447,0,2,enone reductase activity,MF,
12047,GO:0047751,0.999999999984602,0.911378058442447,0,2,cholestenone 5-alpha-reductase activity,MF,
16035,GO:0086042,0.999999999984628,0.730415667768713,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
4279,GO:0009637,0.99999999998463,0.902965126355433,0,2,response to blue light,BP,
4311,GO:0009785,0.99999999998463,0.902965126355433,0,2,blue light signaling pathway,BP,
4336,GO:0009882,0.99999999998463,0.902965126355433,0,2,blue light photoreceptor activity,MF,
15309,GO:0071483,0.99999999998463,0.902965126355433,0,2,cellular response to blue light,BP,
16184,GO:0090191,0.999999999984714,0.916110937624998,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
14159,GO:0061015,0.999999999984739,0.930626069813226,0,2,snRNA import into nucleus,BP,
19432,GO:1905941,0.999999999984771,0.750273113398881,0,6,positive regulation of gonad development,BP,
11468,GO:0045914,0.999999999984779,0.909788135234697,0,2,negative regulation of catecholamine metabolic process,BP,
11502,GO:0045963,0.999999999984779,0.909788135234697,0,2,negative regulation of dopamine metabolic process,BP,
828,GO:0002101,0.999999999984781,0.8721597086375,0,3,tRNA wobble cytosine modification,BP,
204,GO:0000429,0.999999999984841,0.871055146679141,0,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
209,GO:0000436,0.999999999984841,0.871055146679141,0,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
16841,GO:0098722,0.999999999984844,0.747087431248611,0,6,asymmetric stem cell division,BP,
16539,GO:0097241,0.999999999984853,0.911608468820812,0,2,hematopoietic stem cell migration to bone marrow,BP,
2054,GO:0004801,0.999999999984892,0.966536929105353,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
15232,GO:0071374,0.999999999984898,0.901885282604665,0,2,cellular response to parathyroid hormone stimulus,BP,
1782,GO:0004392,0.999999999984906,0.921450119293519,0,2,heme oxygenase (decyclizing) activity,MF,
3174,GO:0006788,0.999999999984906,0.921450119293519,0,2,heme oxidation,BP,
10248,GO:0042978,0.999999999984913,0.90394812640765,0,2,ornithine decarboxylase activator activity,MF,
17953,GO:1902269,0.999999999984913,0.90394812640765,0,2,positive regulation of polyamine transmembrane transport,BP,
16303,GO:0090386,0.999999999984917,0.89723315085298,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
16304,GO:0090387,0.999999999984917,0.89723315085298,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
6375,GO:0021555,0.99999999998492,0.911428006361129,0,2,midbrain-hindbrain boundary morphogenesis,BP,
1459,GO:0003696,0.999999999984935,0.82445632517051,0,4,satellite DNA binding,MF,
1704,GO:0004181,0.999999999984981,0.669578395455129,0,8,metallocarboxypeptidase activity,MF,
6094,GO:0019262,0.999999999985029,0.808240726329221,0,5,N-acetylneuraminate catabolic process,BP,
11522,GO:0046015,0.99999999998506,0.836826073092667,0,4,regulation of transcription by glucose,BP,
12505,GO:0050508,0.999999999985091,0.904077441487522,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12506,GO:0050509,0.999999999985091,0.904077441487522,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
6526,GO:0021902,0.999999999985202,0.896216870610298,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
5810,GO:0017060,0.999999999985205,0.910365697281612,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
11089,GO:0045081,0.999999999985302,0.950485312914712,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
1718,GO:0004307,0.999999999985317,0.926630972038021,0,2,ethanolaminephosphotransferase activity,MF,
9494,GO:0036128,0.99999999998538,0.912793808604095,0,2,CatSper complex,CC,
6527,GO:0021903,0.999999999985416,0.788649150806301,0,5,rostrocaudal neural tube patterning,BP,
9239,GO:0035627,0.999999999985433,0.747945923566835,0,6,ceramide transport,BP,
183,GO:0000395,0.999999999985437,0.761186052930153,0,6,mRNA 5'-splice site recognition,BP,
13568,GO:0060017,0.999999999985482,0.781727044507767,0,5,parathyroid gland development,BP,
3736,GO:0008272,0.999999999985491,0.706988187606052,0,7,sulfate transport,BP,
16569,GO:0097338,0.999999999985513,0.947522572646757,0,1,response to clozapine,BP,
5420,GO:0016263,0.999999999985517,0.916682786910552,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5423,GO:0016267,0.999999999985517,0.916682786910552,0,2,O-glycan processing, core 1,BP,
10229,GO:0042904,0.999999999985682,0.908518420032444,0,2,9-cis-retinoic acid biosynthetic process,BP,
10230,GO:0042905,0.999999999985682,0.908518420032444,0,2,9-cis-retinoic acid metabolic process,BP,
1621,GO:0004047,0.999999999985699,0.919540943204319,0,2,aminomethyltransferase activity,MF,
6497,GO:0021849,0.999999999985843,0.903910826298923,0,2,neuroblast division in subventricular zone,BP,
15191,GO:0071315,0.999999999985853,0.860065261085756,0,3,cellular response to morphine,BP,
15193,GO:0071317,0.999999999985853,0.860065261085756,0,3,cellular response to isoquinoline alkaloid,BP,
14898,GO:0070679,0.999999999985916,0.723205232421986,0,6,inositol 1,4,5 trisphosphate binding,MF,
16551,GO:0097278,0.99999999998595,0.910324394722919,0,2,complement-dependent cytotoxicity,BP,
18135,GO:1902805,0.999999999986027,0.896878159720799,0,2,positive regulation of synaptic vesicle transport,BP,
19859,GO:2000302,0.999999999986027,0.896878159720799,0,2,positive regulation of synaptic vesicle exocytosis,BP,
2210,GO:0005093,0.999999999986088,0.911481128782395,0,2,Rab GDP-dissociation inhibitor activity,MF,
14223,GO:0061140,0.999999999986088,0.883391857005891,0,3,lung secretory cell differentiation,BP,
17642,GO:1901339,0.999999999986094,0.733512699150065,0,6,regulation of store-operated calcium channel activity,BP,
13905,GO:0060532,0.999999999986128,0.899699706751429,0,2,bronchus cartilage development,BP,
14225,GO:0061145,0.999999999986128,0.899699706751429,0,2,lung smooth muscle development,BP,
12193,GO:0048312,0.999999999986148,0.730129997018469,0,6,intracellular distribution of mitochondria,BP,
10011,GO:0042426,0.999999999986162,0.900728103928161,0,2,choline catabolic process,BP,
320,GO:0000836,0.999999999986178,0.782330003655162,0,5,Hrd1p ubiquitin ligase complex,CC,
8955,GO:0035005,0.999999999986194,0.726769636456406,0,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
18810,GO:1904321,0.999999999986201,0.660424847140374,0,8,response to forskolin,BP,
18811,GO:1904322,0.999999999986201,0.660424847140374,0,8,cellular response to forskolin,BP,
9807,GO:0040031,0.999999999986229,0.804683923250829,0,6,snRNA modification,BP,
7410,GO:0031475,0.999999999986233,0.961630473350258,0,1,myosin V complex,CC,
14953,GO:0070829,0.999999999986293,0.896642451005581,0,2,heterochromatin maintenance,BP,
7077,GO:0030860,0.999999999986293,0.90361331061294,0,2,regulation of polarized epithelial cell differentiation,BP,
3465,GO:0007284,0.999999999986301,0.898717745437768,0,2,spermatogonial cell division,BP,
9200,GO:0035581,0.999999999986301,0.740673188306658,0,6,sequestering of extracellular ligand from receptor,BP,
16041,GO:0086048,0.999999999986301,0.900645580738133,0,2,membrane depolarization during bundle of His cell action potential,BP,
15588,GO:0072038,0.999999999986309,0.90071860208936,0,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
15589,GO:0072039,0.999999999986309,0.90071860208936,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15590,GO:0072040,0.999999999986309,0.90071860208936,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
17576,GO:1901145,0.999999999986309,0.90071860208936,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18946,GO:1904673,0.999999999986309,0.90071860208936,0,2,negative regulation of somatic stem cell population maintenance,BP,
8872,GO:0034673,0.999999999986315,0.896239575404273,0,2,inhibin-betaglycan-ActRII complex,CC,
7533,GO:0031749,0.999999999986323,0.904915145375621,0,2,D2 dopamine receptor binding,MF,
18985,GO:1904744,0.999999999986333,0.928098385313647,0,2,positive regulation of telomeric DNA binding,BP,
215,GO:0000448,0.999999999986403,0.903871380713757,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
9340,GO:0035822,0.999999999986408,0.901768350010681,0,2,gene conversion,BP,
3022,GO:0006567,0.999999999986409,0.925721797778124,0,2,threonine catabolic process,BP,
19483,GO:1990145,0.999999999986517,0.906240410589385,0,2,maintenance of translational fidelity,BP,
20219,GO:2001045,0.99999999998654,0.899136275428639,0,2,negative regulation of integrin-mediated signaling pathway,BP,
8726,GO:0034370,0.999999999986547,0.933478579592296,0,2,triglyceride-rich lipoprotein particle remodeling,BP,
8728,GO:0034372,0.999999999986547,0.933478579592296,0,2,very-low-density lipoprotein particle remodeling,BP,
13512,GO:0055062,0.999999999986548,0.732035468428896,0,6,phosphate ion homeostasis,BP,
15821,GO:0072505,0.999999999986548,0.732035468428896,0,6,divalent inorganic anion homeostasis,BP,
15822,GO:0072506,0.999999999986548,0.732035468428896,0,6,trivalent inorganic anion homeostasis,BP,
5394,GO:0016222,0.999999999986568,0.910103972680204,0,2,procollagen-proline 4-dioxygenase complex,CC,
11206,GO:0045322,0.999999999986596,0.909010352632888,0,2,unmethylated CpG binding,MF,
1695,GO:0004167,0.999999999986647,0.964665357878979,0,2,dopachrome isomerase activity,MF,
5727,GO:0016862,0.999999999986647,0.964665357878979,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
12463,GO:0050178,0.999999999986647,0.964665357878979,0,2,phenylpyruvate tautomerase activity,MF,
18888,GO:1904529,0.999999999986658,0.901987819066472,0,2,regulation of actin filament binding,BP,
18930,GO:1904616,0.999999999986658,0.901987819066472,0,2,regulation of actin binding,BP,
7103,GO:0030895,0.999999999986682,0.95395892304665,0,1,apolipoprotein B mRNA editing enzyme complex,CC,
13600,GO:0060053,0.999999999986687,0.903863743263783,0,2,neurofilament cytoskeleton,CC,
14742,GO:0070401,0.999999999986694,0.916555219996826,0,2,NADP+ binding,MF,
3136,GO:0006726,0.99999999998672,0.947014643941318,0,1,eye pigment biosynthetic process,BP,
5377,GO:0016182,0.99999999998672,0.947014643941318,0,1,synaptic vesicle budding from endosome,BP,
10018,GO:0042441,0.99999999998672,0.947014643941318,0,1,eye pigment metabolic process,BP,
10468,GO:0043324,0.99999999998672,0.947014643941318,0,1,pigment metabolic process involved in developmental pigmentation,BP,
10537,GO:0043474,0.99999999998672,0.947014643941318,0,1,pigment metabolic process involved in pigmentation,BP,
16900,GO:0098830,0.99999999998672,0.947014643941318,0,1,presynaptic endosome,CC,
2239,GO:0005143,0.999999999986734,0.905557223421707,0,2,interleukin-12 receptor binding,MF,
18736,GO:1904154,0.999999999986764,0.871054678735147,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
15864,GO:0072566,0.999999999986768,0.912769350465928,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
19886,GO:2000338,0.999999999986768,0.912769350465928,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19887,GO:2000340,0.999999999986768,0.912769350465928,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
14448,GO:0061752,0.99999999998677,0.912439986426814,0,2,telomeric repeat-containing RNA binding,MF,
319,GO:0000835,0.999999999986887,0.7410580924148,0,6,ER ubiquitin ligase complex,CC,
5558,GO:0016560,0.999999999986889,0.82092581063118,0,4,protein import into peroxisome matrix, docking,BP,
16512,GO:0097197,0.999999999986904,0.749977207085786,0,6,tetraspanin-enriched microdomain,CC,
17556,GO:1901072,0.999999999986935,0.793524401337401,0,5,glucosamine-containing compound catabolic process,BP,
4350,GO:0009912,0.999999999986957,0.795437095979991,0,5,auditory receptor cell fate commitment,BP,
13640,GO:0060120,0.999999999986957,0.795437095979991,0,5,inner ear receptor cell fate commitment,BP,
14634,GO:0070194,0.999999999986991,0.911474289874496,0,2,synaptonemal complex disassembly,BP,
14738,GO:0070383,0.999999999986995,0.771352612539809,0,6,DNA cytosine deamination,BP,
5536,GO:0016509,0.999999999987007,0.868983321237367,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
9258,GO:0035663,0.999999999987064,0.907120562883207,0,2,Toll-like receptor 2 binding,MF,
931,GO:0002326,0.999999999987066,0.852099204528953,0,3,B cell lineage commitment,BP,
19008,GO:1904783,0.999999999987093,0.903544763009276,0,2,positive regulation of NMDA glutamate receptor activity,BP,
15732,GO:0072282,0.999999999987107,0.750558863679878,0,6,metanephric nephron tubule morphogenesis,BP,
1988,GO:0004705,0.999999999987116,0.866460619977415,0,3,JUN kinase activity,MF,
5760,GO:0016909,0.999999999987116,0.866460619977415,0,3,SAP kinase activity,MF,
1399,GO:0003310,0.999999999987116,0.962723166036277,0,1,pancreatic A cell differentiation,BP,
6377,GO:0021558,0.999999999987116,0.962723166036277,0,1,trochlear nerve development,BP,
11507,GO:0045977,0.999999999987116,0.962723166036277,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
13668,GO:0060164,0.999999999987116,0.962723166036277,0,1,regulation of timing of neuron differentiation,BP,
14210,GO:0061102,0.999999999987116,0.962723166036277,0,1,stomach neuroendocrine cell differentiation,BP,
14211,GO:0061105,0.999999999987116,0.962723166036277,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14212,GO:0061106,0.999999999987116,0.962723166036277,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15489,GO:0071820,0.999999999987116,0.962723166036277,0,1,N-box binding,MF,
15604,GO:0072071,0.999999999987116,0.962723166036277,0,1,kidney interstitial fibroblast differentiation,BP,
15655,GO:0072141,0.999999999987116,0.962723166036277,0,1,renal interstitial fibroblast development,BP,
19816,GO:2000226,0.999999999987116,0.962723166036277,0,1,regulation of pancreatic A cell differentiation,BP,
19817,GO:2000227,0.999999999987116,0.962723166036277,0,1,negative regulation of pancreatic A cell differentiation,BP,
9102,GO:0035370,0.999999999987141,0.911432880944081,0,2,UBC13-UEV1A complex,CC,
12328,GO:0048669,0.999999999987175,0.866237459335856,0,3,collateral sprouting in absence of injury,BP,
7714,GO:0032197,0.999999999987185,0.949134776924071,0,1,transposition, RNA-mediated,BP,
19494,GO:1990175,0.999999999987185,0.949134776924071,0,1,EH domain binding,MF,
3350,GO:0007079,0.999999999987198,0.855391103609956,0,3,mitotic chromosome movement towards spindle pole,BP,
2056,GO:0004803,0.999999999987225,0.898904572736557,0,2,transposase activity,MF,
5977,GO:0018444,0.999999999987234,0.857834426102891,0,3,translation release factor complex,CC,
4889,GO:0014806,0.999999999987242,0.91752485511577,0,2,smooth muscle hyperplasia,BP,
8445,GO:0033564,0.999999999987278,0.896354642724803,0,2,anterior/posterior axon guidance,BP,
9485,GO:0036117,0.999999999987315,0.9126200504854,0,2,hyaluranon cable,CC,
5454,GO:0016322,0.999999999987385,0.736336252051047,0,6,neuron remodeling,BP,
13618,GO:0060074,0.999999999987387,0.637895030988338,0,9,synapse maturation,BP,
7482,GO:0031642,0.999999999987464,0.751124715598333,0,6,negative regulation of myelination,BP,
10153,GO:0042727,0.999999999987509,0.912668011316821,0,2,flavin-containing compound biosynthetic process,BP,
18613,GO:1903860,0.999999999987522,0.905983860337661,0,2,negative regulation of dendrite extension,BP,
19789,GO:2000172,0.999999999987522,0.905983860337661,0,2,regulation of branching morphogenesis of a nerve,BP,
13999,GO:0060697,0.99999999998753,0.953845759119905,0,1,positive regulation of phospholipid catabolic process,BP,
17429,GO:1900161,0.99999999998753,0.953845759119905,0,1,regulation of phospholipid scramblase activity,BP,
17430,GO:1900163,0.99999999998753,0.953845759119905,0,1,positive regulation of phospholipid scramblase activity,BP,
20113,GO:2000752,0.99999999998753,0.953845759119905,0,1,regulation of glucosylceramide catabolic process,BP,
20114,GO:2000753,0.99999999998753,0.953845759119905,0,1,positive regulation of glucosylceramide catabolic process,BP,
20115,GO:2000754,0.99999999998753,0.953845759119905,0,1,regulation of sphingomyelin catabolic process,BP,
20116,GO:2000755,0.99999999998753,0.953845759119905,0,1,positive regulation of sphingomyelin catabolic process,BP,
10357,GO:0043163,0.999999999987542,0.902987840983021,0,2,cell envelope organization,BP,
11176,GO:0045229,0.999999999987542,0.902987840983021,0,2,external encapsulating structure organization,BP,
17671,GO:1901474,0.999999999987548,0.791957326768457,0,5,azole transmembrane transporter activity,MF,
6178,GO:0019541,0.999999999987651,0.864042306182138,0,3,propionate metabolic process,BP,
3435,GO:0007225,0.999999999987702,0.947108577773422,0,1,patched ligand maturation,BP,
9246,GO:0035638,0.999999999987702,0.947108577773422,0,1,signal maturation,BP,
6971,GO:0030621,0.999999999987729,0.743510675287342,0,6,U4 snRNA binding,MF,
14061,GO:0060800,0.999999999987765,0.902868796559025,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
19403,GO:1905867,0.999999999987766,0.878716324387957,0,3,epididymis development,BP,
11688,GO:0046462,0.999999999987774,0.91372966189722,0,2,monoacylglycerol metabolic process,BP,
13396,GO:0052651,0.999999999987774,0.91372966189722,0,2,monoacylglycerol catabolic process,BP,
1816,GO:0004463,0.999999999987777,0.955998502165598,0,1,leukotriene-A4 hydrolase activity,MF,
13086,GO:0051580,0.999999999987781,0.667403250194592,0,9,regulation of neurotransmitter uptake,BP,
12108,GO:0048102,0.999999999987797,0.723154562011754,0,7,autophagic cell death,BP,
2801,GO:0006258,0.999999999987801,0.921768064117964,0,2,UDP-glucose catabolic process,BP,
11506,GO:0045976,0.999999999987809,0.903046889319991,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
6431,GO:0021693,0.999999999987813,0.901118761860804,0,2,cerebellar Purkinje cell layer structural organization,BP,
6436,GO:0021698,0.999999999987813,0.901118761860804,0,2,cerebellar cortex structural organization,BP,
17478,GO:1900272,0.99999999998786,0.759256198582106,0,6,negative regulation of long-term synaptic potentiation,BP,
2224,GO:0005124,0.999999999987888,0.912537025961838,0,2,scavenger receptor binding,MF,
8302,GO:0033131,0.999999999987915,0.773169241906048,0,6,regulation of glucokinase activity,BP,
14381,GO:0061608,0.999999999987949,0.65946337814653,0,9,nuclear import signal receptor activity,MF,
19837,GO:2000270,0.999999999987951,0.746129036345987,0,6,negative regulation of fibroblast apoptotic process,BP,
30,GO:0000055,0.999999999987983,0.723596577900207,0,8,ribosomal large subunit export from nucleus,BP,
18126,GO:1902766,0.999999999987985,0.923444404381746,0,2,skeletal muscle satellite cell migration,BP,
9534,GO:0036261,0.999999999987994,0.950124151526934,0,1,7-methylguanosine cap hypermethylation,BP,
15122,GO:0071164,0.999999999987994,0.950124151526934,0,1,RNA trimethylguanosine synthase activity,MF,
120,GO:0000248,0.999999999987995,0.903631076337538,0,2,C-5 sterol desaturase activity,MF,
14911,GO:0070704,0.999999999987995,0.903631076337538,0,2,sterol desaturase activity,MF,
17097,GO:0099609,0.999999999988,0.896181658693752,0,2,microtubule lateral binding,MF,
16902,GO:0098833,0.999999999988001,0.94689855822062,0,1,presynaptic endocytic zone,CC,
16903,GO:0098835,0.999999999988001,0.94689855822062,0,1,presynaptic endocytic zone membrane,CC,
7374,GO:0031417,0.999999999988007,0.855850116946548,0,3,NatC complex,CC,
1136,GO:0002725,0.999999999988009,0.87774438972279,0,3,negative regulation of T cell cytokine production,BP,
10686,GO:0043946,0.999999999988013,0.958623482935802,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10687,GO:0043947,0.999999999988013,0.958623482935802,0,1,positive regulation by host of symbiont catalytic activity,BP,
3608,GO:0008048,0.999999999988037,0.955147198761214,0,1,calcium sensitive guanylate cyclase activator activity,MF,
4699,GO:0010851,0.999999999988037,0.955147198761214,0,1,cyclase regulator activity,MF,
4700,GO:0010853,0.999999999988037,0.955147198761214,0,1,cyclase activator activity,MF,
6808,GO:0030249,0.999999999988037,0.955147198761214,0,1,guanylate cyclase regulator activity,MF,
6809,GO:0030250,0.999999999988037,0.955147198761214,0,1,guanylate cyclase activator activity,MF,
3720,GO:0008239,0.999999999988052,0.755097991531249,0,6,dipeptidyl-peptidase activity,MF,
13954,GO:0060605,0.999999999988057,0.873587245964463,0,3,tube lumen cavitation,BP,
13971,GO:0060662,0.999999999988057,0.873587245964463,0,3,salivary gland cavitation,BP,
14493,GO:0061890,0.999999999988059,0.917547063846745,0,2,positive regulation of astrocyte activation,BP,
18680,GO:1903980,0.999999999988059,0.917547063846745,0,2,positive regulation of microglial cell activation,BP,
11991,GO:0047288,0.999999999988081,0.908373850408495,0,2,monosialoganglioside sialyltransferase activity,MF,
18085,GO:1902636,0.999999999988087,0.928032376631758,0,2,kinociliary basal body,CC,
6380,GO:0021561,0.999999999988101,0.739775362337776,0,6,facial nerve development,BP,
6403,GO:0021610,0.999999999988101,0.739775362337776,0,6,facial nerve morphogenesis,BP,
4521,GO:0010571,0.99999999998815,0.730683901129686,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
19216,GO:1905286,0.999999999988163,0.911655264264301,0,2,serine-type peptidase complex,CC,
15703,GO:0072217,0.999999999988187,0.784255320193688,0,5,negative regulation of metanephros development,BP,
16055,GO:0086073,0.999999999988211,0.765192409615441,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16063,GO:0086083,0.999999999988211,0.765192409615441,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
18222,GO:1902996,0.999999999988236,0.902827689730586,0,2,regulation of neurofibrillary tangle assembly,BP,
16973,GO:0098971,0.999999999988246,0.899088970268366,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
13881,GO:0060484,0.99999999998827,0.78178565808928,0,5,lung-associated mesenchyme development,BP,
1502,GO:0003845,0.999999999988277,0.922319468249913,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
9237,GO:0035624,0.999999999988278,0.9000259212325,0,2,receptor transactivation,BP,
4909,GO:0014839,0.999999999988294,0.922637825287231,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
1154,GO:0002759,0.999999999988303,0.838741794733771,0,4,regulation of antimicrobial humoral response,BP,
5220,GO:0015819,0.999999999988307,0.957264682343901,0,1,lysine transport,BP,
10319,GO:0043096,0.999999999988307,0.827512506593704,0,5,purine nucleobase salvage,BP,
13608,GO:0060061,0.99999999998832,0.910700499068024,0,2,Spemann organizer formation,BP,
10717,GO:0044028,0.999999999988326,0.901948194607663,0,2,DNA hypomethylation,BP,
10718,GO:0044029,0.999999999988326,0.901948194607663,0,2,hypomethylation of CpG island,BP,
14195,GO:0061078,0.999999999988328,0.983337038110588,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
16276,GO:0090323,0.999999999988328,0.983337038110588,0,1,prostaglandin secretion involved in immune response,BP,
18516,GO:1903636,0.999999999988328,0.983337038110588,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18517,GO:1903638,0.999999999988328,0.983337038110588,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18519,GO:1903645,0.999999999988328,0.983337038110588,0,1,negative regulation of chaperone-mediated protein folding,BP,
10157,GO:0042732,0.999999999988337,0.927362017656121,0,2,D-xylose metabolic process,BP,
11820,GO:0046696,0.999999999988338,0.909907468252827,0,2,lipopolysaccharide receptor complex,CC,
5669,GO:0016774,0.999999999988348,0.868096254979538,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
12004,GO:0047374,0.999999999988357,0.918368518829038,0,2,methylumbelliferyl-acetate deacetylase activity,MF,
10147,GO:0042713,0.999999999988372,0.850118933808072,0,3,sperm ejaculation,BP,
8122,GO:0032805,0.999999999988415,0.919879637321942,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
6696,GO:0030062,0.999999999988471,0.762260035495872,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
17004,GO:0099074,0.9999999999885,0.908323182905119,0,2,mitochondrion to lysosome transport,BP,
17005,GO:0099075,0.9999999999885,0.908323182905119,0,2,mitochondrion-derived vesicle mediated transport,BP,
12999,GO:0051389,0.999999999988519,0.896458316470286,0,2,inactivation of MAPKK activity,BP,
20185,GO:2000973,0.999999999988554,0.752209929061572,0,6,regulation of pro-B cell differentiation,BP,
19927,GO:2000393,0.99999999998856,0.902784508141088,0,2,negative regulation of lamellipodium morphogenesis,BP,
503,GO:0001560,0.999999999988569,0.898088757129445,0,2,regulation of cell growth by extracellular stimulus,BP,
9985,GO:0042374,0.99999999998857,0.923303732323205,0,2,phylloquinone metabolic process,BP,
9986,GO:0042376,0.99999999998857,0.923303732323205,0,2,phylloquinone catabolic process,BP,
17747,GO:1901662,0.99999999998857,0.923303732323205,0,2,quinone catabolic process,BP,
6047,GO:0019150,0.999999999988577,0.956079230314558,0,1,D-ribulokinase activity,MF,
17608,GO:1901252,0.999999999988638,0.922522930545294,0,2,regulation of intracellular transport of viral material,BP,
14264,GO:0061300,0.99999999998864,0.910344397046681,0,2,cerebellum vasculature development,BP,
14068,GO:0060825,0.99999999998866,0.918601692615574,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19867,GO:2000313,0.99999999998866,0.918601692615574,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
10258,GO:0042989,0.999999999988696,0.827812782390766,0,6,sequestering of actin monomers,BP,
6048,GO:0019153,0.999999999988726,0.96048198558123,0,1,protein-disulfide reductase (glutathione) activity,MF,
15855,GO:0072555,0.999999999988726,0.96048198558123,0,1,17-beta-ketosteroid reductase activity,MF,
15875,GO:0072582,0.999999999988726,0.96048198558123,0,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
2633,GO:0005958,0.999999999988743,0.861859557906815,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
7900,GO:0032464,0.999999999988745,0.772478662981131,0,6,positive regulation of protein homooligomerization,BP,
5469,GO:0016361,0.999999999988748,0.913485328993935,0,2,activin receptor activity, type I,MF,
12129,GO:0048179,0.999999999988748,0.913485328993935,0,2,activin receptor complex,CC,
12014,GO:0047484,0.999999999988748,0.750351701618716,0,6,regulation of response to osmotic stress,BP,
18685,GO:1903999,0.999999999988749,0.924471697068021,0,2,negative regulation of eating behavior,BP,
19828,GO:2000252,0.999999999988749,0.924471697068021,0,2,negative regulation of feeding behavior,BP,
16568,GO:0097332,0.999999999988761,0.921721274622461,0,2,response to antipsychotic drug,BP,
1212,GO:0002875,0.999999999988775,0.96005775852027,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
2237,GO:0005141,0.999999999988775,0.96005775852027,0,1,interleukin-10 receptor binding,MF,
18715,GO:1904057,0.999999999988775,0.96005775852027,0,1,negative regulation of sensory perception of pain,BP,
6234,GO:0019781,0.999999999988794,0.915476841832969,0,2,NEDD8 activating enzyme activity,MF,
333,GO:0000923,0.99999999998886,0.738870980204786,0,6,equatorial microtubule organizing center,CC,
13011,GO:0051415,0.99999999998886,0.738870980204786,0,6,microtubule nucleation by interphase microtubule organizing center,BP,
5545,GO:0016530,0.999999999988877,0.824180093242212,0,6,metallochaperone activity,MF,
7559,GO:0031871,0.999999999988884,0.86255700011874,0,3,proteinase activated receptor binding,MF,
2477,GO:0005691,0.99999999998892,0.947738118804349,0,1,U6atac snRNP,CC,
6974,GO:0030624,0.99999999998892,0.947738118804349,0,1,U6atac snRNA binding,MF,
18496,GO:1903584,0.99999999998892,0.947738118804349,0,1,regulation of histone deubiquitination,BP,
18497,GO:1903586,0.99999999998892,0.947738118804349,0,1,positive regulation of histone deubiquitination,BP,
14435,GO:0061732,0.999999999988968,0.754489750338991,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
4383,GO:0010025,0.999999999988987,0.904925718985197,0,2,wax biosynthetic process,BP,
4414,GO:0010166,0.999999999988987,0.904925718985197,0,2,wax metabolic process,BP,
15979,GO:0080019,0.999999999988987,0.904925718985197,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17188,GO:0102965,0.999999999988987,0.904925718985197,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
929,GO:0002323,0.999999999988998,0.675314314787156,0,9,natural killer cell activation involved in immune response,BP,
2706,GO:0006069,0.999999999989003,0.749560107941616,0,6,ethanol oxidation,BP,
247,GO:0000703,0.999999999989014,0.932377655499364,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
5306,GO:0016004,0.99999999998904,0.689173609637211,0,8,phospholipase activator activity,MF,
13702,GO:0060229,0.99999999998904,0.689173609637211,0,8,lipase activator activity,MF,
18369,GO:1903332,0.999999999989053,0.733241557476269,0,7,regulation of protein folding,BP,
3390,GO:0007168,0.999999999989055,0.908611405256011,0,2,receptor guanylyl cyclase signaling pathway,BP,
13659,GO:0060151,0.999999999989096,0.8979154350674,0,2,peroxisome localization,BP,
13660,GO:0060152,0.999999999989096,0.8979154350674,0,2,microtubule-based peroxisome localization,BP,
4924,GO:0014859,0.999999999989102,0.951822987234844,0,1,negative regulation of skeletal muscle cell proliferation,BP,
18108,GO:1902723,0.999999999989102,0.951822987234844,0,1,negative regulation of skeletal muscle satellite cell proliferation,BP,
19346,GO:1905616,0.999999999989141,0.902755179694227,0,2,regulation of miRNA mediated inhibition of translation,BP,
19347,GO:1905618,0.999999999989141,0.902755179694227,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
1632,GO:0004066,0.999999999989148,0.911571452570027,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
2986,GO:0006529,0.999999999989148,0.911571452570027,0,2,asparagine biosynthetic process,BP,
14037,GO:0060746,0.999999999989151,0.706084691009971,0,7,parental behavior,BP,
891,GO:0002254,0.999999999989153,0.913532472539937,0,2,kinin cascade,BP,
945,GO:0002353,0.999999999989153,0.913532472539937,0,2,plasma kallikrein-kinin cascade,BP,
9549,GO:0036302,0.999999999989161,0.77123059342311,0,5,atrioventricular canal development,BP,
14469,GO:0061817,0.999999999989204,0.850574227819913,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
12144,GO:0048213,0.999999999989211,0.953723021344487,0,1,Golgi vesicle prefusion complex stabilization,BP,
12179,GO:0048290,0.999999999989213,0.75482638373214,0,6,isotype switching to IgA isotypes,BP,
3805,GO:0008381,0.99999999998923,0.861815052825776,0,3,mechanosensitive ion channel activity,MF,
8457,GO:0033592,0.999999999989267,0.774996478371984,0,5,RNA strand annealing activity,MF,
8488,GO:0033633,0.999999999989279,0.946988641724284,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
1473,GO:0003726,0.999999999989304,0.896401463610307,0,2,double-stranded RNA adenosine deaminase activity,MF,
6551,GO:0021965,0.999999999989304,0.896401463610307,0,2,spinal cord ventral commissure morphogenesis,BP,
18327,GO:1903233,0.999999999989304,0.896401463610307,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
9233,GO:0035620,0.999999999989313,0.866084669060548,0,3,ceramide transporter activity,MF,
14733,GO:0070375,0.999999999989315,0.861928361987606,0,3,ERK5 cascade,BP,
6967,GO:0030617,0.999999999989343,0.952860091889107,0,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
16926,GO:0098881,0.99999999998937,0.862432485792035,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16969,GO:0098967,0.99999999998937,0.862432485792035,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
13587,GO:0060040,0.999999999989384,0.907134597130555,0,2,retinal bipolar neuron differentiation,BP,
954,GO:0002370,0.999999999989403,0.876542851571829,0,3,natural killer cell cytokine production,BP,
1138,GO:0002727,0.999999999989403,0.876542851571829,0,3,regulation of natural killer cell cytokine production,BP,
5840,GO:0017121,0.999999999989427,0.715316729904637,0,7,phospholipid scrambling,BP,
3179,GO:0006797,0.99999999998943,0.779208506711321,0,5,polyphosphate metabolic process,BP,
8055,GO:0032707,0.999999999989433,0.954831716065704,0,1,negative regulation of interleukin-23 production,BP,
12045,GO:0047747,0.999999999989433,0.954831716065704,0,1,cholate-CoA ligase activity,MF,
17830,GO:1901963,0.999999999989437,0.911638087273471,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
7555,GO:0031860,0.999999999989468,0.852214712156696,0,3,telomeric 3' overhang formation,BP,
11109,GO:0045113,0.999999999989478,0.930577308562915,0,2,regulation of integrin biosynthetic process,BP,
3808,GO:0008391,0.999999999989527,0.913682274897638,0,2,arachidonic acid monooxygenase activity,MF,
3809,GO:0008392,0.999999999989527,0.913682274897638,0,2,arachidonic acid epoxygenase activity,MF,
14392,GO:0061626,0.999999999989538,0.752229526328886,0,6,pharyngeal arch artery morphogenesis,BP,
17705,GO:1901569,0.999999999989541,0.792564313293157,0,5,fatty acid derivative catabolic process,BP,
639,GO:0001826,0.999999999989606,0.767627294112389,0,5,inner cell mass cell differentiation,BP,
10322,GO:0043102,0.999999999989622,0.765053396123535,0,6,amino acid salvage,BP,
15167,GO:0071267,0.999999999989622,0.765053396123535,0,6,L-methionine salvage,BP,
19261,GO:1905394,0.999999999989623,0.863274122749762,0,3,retromer complex binding,MF,
10382,GO:0043199,0.999999999989625,0.86912309306692,0,3,sulfate binding,MF,
5547,GO:0016532,0.999999999989638,0.894942840091015,0,3,superoxide dismutase copper chaperone activity,MF,
6376,GO:0021557,0.999999999989641,0.916455712509364,0,2,oculomotor nerve development,BP,
4227,GO:0009400,0.999999999989652,0.953691065822255,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
8722,GO:0034366,0.999999999989652,0.953691065822255,0,1,spherical high-density lipoprotein particle,CC,
14347,GO:0061517,0.999999999989652,0.953691065822255,0,1,macrophage proliferation,BP,
14348,GO:0061518,0.999999999989652,0.953691065822255,0,1,microglial cell proliferation,BP,
18148,GO:1902847,0.999999999989652,0.953691065822255,0,1,regulation of neuronal signal transduction,BP,
18224,GO:1902998,0.999999999989652,0.953691065822255,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19410,GO:1905891,0.999999999989652,0.953691065822255,0,1,regulation of cellular response to thapsigargin,BP,
19411,GO:1905892,0.999999999989652,0.953691065822255,0,1,negative regulation of cellular response to thapsigargin,BP,
19412,GO:1905894,0.999999999989652,0.953691065822255,0,1,regulation of cellular response to tunicamycin,BP,
19413,GO:1905895,0.999999999989652,0.953691065822255,0,1,negative regulation of cellular response to tunicamycin,BP,
15277,GO:0071440,0.999999999989654,0.783807691680287,0,5,regulation of histone H3-K14 acetylation,BP,
8538,GO:0033860,0.999999999989679,0.909995858599402,0,3,regulation of NAD(P)H oxidase activity,BP,
8540,GO:0033864,0.999999999989679,0.909995858599402,0,3,positive regulation of NAD(P)H oxidase activity,BP,
11571,GO:0046104,0.999999999989695,0.866392023716602,0,3,thymidine metabolic process,BP,
11581,GO:0046125,0.999999999989695,0.866392023716602,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
11177,GO:0045234,0.999999999989714,0.95820491886398,0,1,protein palmitoleylation,BP,
14203,GO:0061088,0.999999999989731,0.741467462730817,0,6,regulation of sequestering of zinc ion,BP,
7580,GO:0031938,0.99999999998975,0.918643549507729,0,2,regulation of chromatin silencing at telomere,BP,
7516,GO:0031697,0.999999999989753,0.812102627881873,0,4,beta-1 adrenergic receptor binding,MF,
4215,GO:0009368,0.999999999989757,0.924753630067907,0,2,endopeptidase Clp complex,CC,
19294,GO:1905462,0.999999999989768,0.897950815090305,0,2,regulation of DNA duplex unwinding,BP,
17204,GO:0106014,0.99999999998978,0.919620759224015,0,2,regulation of inflammatory response to wounding,BP,
17205,GO:0106015,0.99999999998978,0.919620759224015,0,2,negative regulation of inflammatory response to wounding,BP,
1961,GO:0004662,0.999999999989786,0.916227916534784,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2629,GO:0005953,0.999999999989786,0.916227916534784,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
16930,GO:0098886,0.999999999989795,0.902794497610668,0,2,modification of dendritic spine,BP,
12219,GO:0048388,0.999999999989817,0.913600743086065,0,2,endosomal lumen acidification,BP,
8768,GO:0034437,0.999999999989827,0.906080051996555,0,2,glycoprotein transporter activity,MF,
663,GO:0001855,0.999999999989839,0.960672529858159,0,1,complement component C4b binding,MF,
18708,GO:1904045,0.999999999989865,0.95535803993557,0,1,cellular response to aldosterone,BP,
3852,GO:0008459,0.999999999989873,0.904084145782278,0,2,chondroitin 6-sulfotransferase activity,MF,
5002,GO:0015141,0.999999999989908,0.864771524356637,0,3,succinate transmembrane transporter activity,MF,
5185,GO:0015744,0.999999999989908,0.864771524356637,0,3,succinate transport,BP,
15265,GO:0071422,0.999999999989908,0.864771524356637,0,3,succinate transmembrane transport,BP,
9213,GO:0035597,0.999999999989911,0.956282568181514,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
11560,GO:0046085,0.999999999989945,0.751177848651371,0,6,adenosine metabolic process,BP,
8443,GO:0033560,0.999999999989954,0.949186154669628,0,1,folate reductase activity,MF,
13228,GO:0051870,0.999999999989954,0.949186154669628,0,1,methotrexate binding,MF,
3838,GO:0008441,0.999999999989965,0.903682933177051,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
14884,GO:0070662,0.99999999998997,0.902139739495248,0,2,mast cell proliferation,BP,
14888,GO:0070666,0.99999999998997,0.902139739495248,0,2,regulation of mast cell proliferation,BP,
14890,GO:0070668,0.99999999998997,0.902139739495248,0,2,positive regulation of mast cell proliferation,BP,
10263,GO:0042998,0.999999999989975,0.899819710153229,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
3879,GO:0008507,0.999999999990002,0.950639397017728,0,1,sodium:iodide symporter activity,MF,
7691,GO:0032137,0.999999999990053,0.861900188099987,0,3,guanine/thymine mispair binding,MF,
681,GO:0001888,0.999999999990054,0.902762527749175,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
5270,GO:0015911,0.999999999990059,0.772520822609186,0,5,plasma membrane long-chain fatty acid transport,BP,
18070,GO:1902605,0.999999999990066,0.953968697304287,0,1,heterotrimeric G-protein complex assembly,BP,
11125,GO:0045142,0.999999999990071,0.899040834956837,0,2,triplex DNA binding,MF,
14548,GO:0070052,0.999999999990072,0.90172091331174,0,2,collagen V binding,MF,
9587,GO:0036403,0.999999999990088,0.954230802245415,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
14983,GO:0070877,0.999999999990092,0.903576649935332,0,2,microprocessor complex,CC,
18274,GO:1903095,0.999999999990092,0.903576649935332,0,2,ribonuclease III complex,CC,
13885,GO:0060488,0.99999999999011,0.896213322782065,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13886,GO:0060489,0.99999999999011,0.896213322782065,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13887,GO:0060490,0.99999999999011,0.896213322782065,0,2,lateral sprouting involved in lung morphogenesis,BP,
9178,GO:0035542,0.999999999990112,0.7029657032085,0,7,regulation of SNARE complex assembly,BP,
10623,GO:0043615,0.999999999990114,0.787917261822718,0,5,astrocyte cell migration,BP,
19581,GO:1990564,0.999999999990153,0.81245831126347,0,5,protein polyufmylation,BP,
19593,GO:1990592,0.999999999990153,0.81245831126347,0,5,protein K69-linked ufmylation,BP,
5219,GO:0015817,0.999999999990158,0.9538417890177,0,1,histidine transport,BP,
7535,GO:0031753,0.999999999990158,0.9538417890177,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7536,GO:0031755,0.999999999990158,0.9538417890177,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
6410,GO:0021631,0.999999999990166,0.84864229322841,0,3,optic nerve morphogenesis,BP,
5206,GO:0015801,0.999999999990169,0.911774374116459,0,2,aromatic amino acid transport,BP,
5227,GO:0015827,0.999999999990169,0.911774374116459,0,2,tryptophan transport,BP,
16708,GO:0097644,0.999999999990177,0.922411427763244,0,2,calcitonin family binding,MF,
18426,GO:1903439,0.999999999990177,0.922411427763244,0,2,calcitonin family receptor complex,CC,
19540,GO:1990406,0.999999999990177,0.922411427763244,0,2,CGRP receptor complex,CC,
19542,GO:1990408,0.999999999990177,0.922411427763244,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
8501,GO:0033677,0.999999999990204,0.862262172189956,0,3,DNA/RNA helicase activity,MF,
10379,GO:0043196,0.999999999990206,0.865880693049508,0,3,varicosity,CC,
16393,GO:0090725,0.999999999990211,0.925224136059661,0,2,peripheral region of growth cone,CC,
6114,GO:0019353,0.99999999999026,0.954047238440544,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
8432,GO:0033526,0.99999999999026,0.954047238440544,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
7164,GO:0031022,0.999999999990273,0.898551354931966,0,2,nuclear migration along microfilament,BP,
18265,GO:1903070,0.999999999990315,0.873026552097391,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
7873,GO:0032430,0.999999999990329,0.878768514742597,0,3,positive regulation of phospholipase A2 activity,BP,
4281,GO:0009644,0.999999999990353,0.905002616608093,0,2,response to high light intensity,BP,
16673,GO:0097536,0.999999999990363,0.954072682838567,0,1,thymus epithelium morphogenesis,BP,
1835,GO:0004487,0.999999999990366,0.867574728427868,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
16448,GO:0097090,0.999999999990384,0.777878044990435,0,5,presynaptic membrane organization,BP,
10145,GO:0042709,0.999999999990395,0.954871056686046,0,1,succinate-CoA ligase complex,CC,
11181,GO:0045244,0.999999999990395,0.954871056686046,0,1,succinate-CoA ligase complex (GDP-forming),CC,
17870,GO:1902045,0.999999999990395,0.954871056686046,0,1,negative regulation of Fas signaling pathway,BP,
19978,GO:2000504,0.999999999990395,0.954871056686046,0,1,positive regulation of blood vessel remodeling,BP,
3213,GO:0006857,0.999999999990406,0.677966375268308,0,8,oligopeptide transport,BP,
15541,GO:0071918,0.99999999999043,0.903830546419369,0,2,urea transmembrane transport,BP,
673,GO:0001880,0.999999999990436,0.899773084789095,0,2,Mullerian duct regression,BP,
8392,GO:0033300,0.99999999999044,0.901849026318534,0,2,dehydroascorbic acid transmembrane transporter activity,MF,
14957,GO:0070837,0.99999999999044,0.901849026318534,0,2,dehydroascorbic acid transport,BP,
7627,GO:0032020,0.999999999990443,0.791433785943675,0,6,ISG15-protein conjugation,BP,
17728,GO:1901626,0.999999999990444,0.750724684142222,0,6,regulation of postsynaptic membrane organization,BP,
611,GO:0001777,0.999999999990493,0.976578517040839,0,1,T cell homeostatic proliferation,BP,
947,GO:0002358,0.999999999990493,0.976578517040839,0,1,B cell homeostatic proliferation,BP,
8220,GO:0032976,0.999999999990493,0.976578517040839,0,1,release of matrix enzymes from mitochondria,BP,
16477,GO:0097144,0.999999999990493,0.976578517040839,0,1,BAX complex,CC,
19473,GO:1990117,0.999999999990493,0.976578517040839,0,1,B cell receptor apoptotic signaling pathway,BP,
3165,GO:0006777,0.999999999990499,0.752919265768466,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
6211,GO:0019720,0.999999999990499,0.752919265768466,0,6,Mo-molybdopterin cofactor metabolic process,BP,
3967,GO:0008747,0.999999999990502,0.961041920579247,0,1,N-acetylneuraminate lyase activity,MF,
5842,GO:0017125,0.999999999990505,0.947104202221549,0,1,deoxycytidyl transferase activity,MF,
7880,GO:0032437,0.999999999990511,0.861804355367057,0,3,cuticular plate,CC,
18197,GO:1902952,0.999999999990512,0.916946684255619,0,2,positive regulation of dendritic spine maintenance,BP,
2259,GO:0005171,0.999999999990535,0.956168586699261,0,1,hepatocyte growth factor receptor binding,MF,
15070,GO:0071012,0.99999999999055,0.752201686443352,0,6,catalytic step 1 spliceosome,CC,
2318,GO:0005316,0.999999999990552,0.952002332420449,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
19176,GO:1905168,0.999999999990604,0.950070364729203,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
14604,GO:0070143,0.999999999990616,0.947045410506516,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
18786,GO:1904263,0.999999999990632,0.694443451257477,0,8,positive regulation of TORC1 signaling,BP,
11392,GO:0045759,0.999999999990638,0.911394867729655,0,2,negative regulation of action potential,BP,
13899,GO:0060523,0.999999999990648,0.897941331467953,0,2,prostate epithelial cord elongation,BP,
13945,GO:0060594,0.999999999990648,0.897941331467953,0,2,mammary gland specification,BP,
18743,GO:1904177,0.999999999990689,0.852653318215472,0,3,regulation of adipose tissue development,BP,
18744,GO:1904179,0.999999999990689,0.852653318215472,0,3,positive regulation of adipose tissue development,BP,
3421,GO:0007207,0.999999999990692,0.911694575606878,0,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
5147,GO:0015671,0.999999999990703,0.913585243739718,0,2,oxygen transport,BP,
4103,GO:0009155,0.999999999990723,0.780419983742744,0,6,purine deoxyribonucleotide catabolic process,BP,
1593,GO:0004001,0.999999999990731,0.956104842768931,0,1,adenosine kinase activity,MF,
2006,GO:0004727,0.999999999990731,0.956104842768931,0,1,prenylated protein tyrosine phosphatase activity,MF,
2761,GO:0006169,0.999999999990731,0.956104842768931,0,1,adenosine salvage,BP,
2764,GO:0006175,0.999999999990731,0.956104842768931,0,1,dATP biosynthetic process,BP,
4156,GO:0009216,0.999999999990731,0.956104842768931,0,1,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
9984,GO:0042373,0.999999999990755,0.824844052684382,0,5,vitamin K metabolic process,BP,
3,GO:0000009,0.999999999990781,0.954815188350266,0,1,alpha-1,6-mannosyltransferase activity,MF,
13474,GO:0052917,0.999999999990781,0.954815188350266,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
13809,GO:0060382,0.999999999990784,0.897950705640907,0,2,regulation of DNA strand elongation,BP,
6734,GO:0030144,0.999999999990796,0.86421010588963,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
9752,GO:0039019,0.999999999990823,0.899695817344117,0,2,pronephric nephron development,BP,
17441,GO:1900193,0.999999999990826,0.791759174356867,0,5,regulation of oocyte maturation,BP,
13018,GO:0051430,0.999999999990832,0.906561801929024,0,2,corticotropin-releasing hormone receptor 1 binding,MF,
3373,GO:0007144,0.999999999990851,0.764269797055267,0,6,female meiosis I,BP,
18045,GO:1902544,0.999999999990873,0.92914514909735,0,2,regulation of DNA N-glycosylase activity,BP,
16699,GO:0097632,0.99999999999088,0.902751836983082,0,2,extrinsic component of phagophore assembly site membrane,CC,
3051,GO:0006610,0.999999999990895,0.677067365838505,0,8,ribosomal protein import into nucleus,BP,
15340,GO:0071546,0.999999999990903,0.905762129846155,0,2,pi-body,CC,
2565,GO:0005846,0.99999999999091,0.904956078901785,0,2,nuclear cap binding complex,CC,
349,GO:0000962,0.999999999990911,0.904251204174932,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
11052,GO:0045025,0.999999999990911,0.904251204174932,0,2,mitochondrial degradosome,CC,
13628,GO:0060086,0.999999999990917,0.908762370250492,0,2,circadian temperature homeostasis,BP,
8536,GO:0033857,0.999999999990931,0.896225393129904,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
17135,GO:0102092,0.999999999990931,0.896225393129904,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
2408,GO:0005577,0.999999999990933,0.855240606686154,0,3,fibrinogen complex,CC,
10032,GO:0042473,0.99999999999095,0.756843678476316,0,6,outer ear morphogenesis,BP,
13824,GO:0060399,0.999999999990963,0.896223699576017,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
11658,GO:0046380,0.999999999990982,0.949701038509273,0,1,N-acetylneuraminate biosynthetic process,BP,
12456,GO:0050124,0.999999999990982,0.949701038509273,0,1,N-acylneuraminate-9-phosphatase activity,MF,
1869,GO:0004530,0.999999999990985,0.90198080167053,0,2,deoxyribonuclease I activity,MF,
20287,GO:2001226,0.999999999990999,0.908323043163605,0,2,negative regulation of chloride transport,BP,
4086,GO:0009138,0.999999999991014,0.880459352499962,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
18625,GO:1903892,0.99999999999107,0.906893849133139,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
5154,GO:0015688,0.99999999999107,0.932771742969194,0,2,iron chelate transport,BP,
5264,GO:0015891,0.99999999999107,0.932771742969194,0,2,siderophore transport,BP,
9989,GO:0042382,0.999999999991075,0.744412177621389,0,6,paraspeckles,CC,
17270,GO:0120043,0.999999999991089,0.947107324620352,0,1,stereocilium shaft,CC,
17271,GO:0120044,0.999999999991089,0.947107324620352,0,1,stereocilium base,CC,
17245,GO:0110025,0.999999999991094,0.952969237805743,0,1,DNA strand resection involved in replication fork processing,BP,
17246,GO:0110026,0.999999999991094,0.952969237805743,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
6045,GO:0019144,0.999999999991098,0.929959170995617,0,2,ADP-sugar diphosphatase activity,MF,
12148,GO:0048239,0.999999999991098,0.911368986526716,0,2,negative regulation of DNA recombination at telomere,BP,
15929,GO:0072695,0.999999999991098,0.911368986526716,0,2,regulation of DNA recombination at telomere,BP,
16966,GO:0098953,0.9999999999911,0.866922764629373,0,3,receptor diffusion trapping,BP,
16972,GO:0098970,0.9999999999911,0.866922764629373,0,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,
17105,GO:0099628,0.9999999999911,0.866922764629373,0,3,neurotransmitter receptor diffusion trapping,BP,
13861,GO:0060448,0.999999999991102,0.86246643850795,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
321,GO:0000839,0.999999999991104,0.866343771623136,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
14768,GO:0070435,0.999999999991113,0.908380397141935,0,2,Shc-EGFR complex,CC,
19118,GO:1905006,0.999999999991116,0.906287904885403,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
11727,GO:0046520,0.999999999991129,0.664993625142279,0,9,sphingoid biosynthetic process,BP,
11707,GO:0046487,0.999999999991153,0.767037559204884,0,6,glyoxylate metabolic process,BP,
3768,GO:0008311,0.999999999991159,0.920322534755049,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
16368,GO:0090649,0.99999999999119,0.776932379715691,0,5,response to oxygen-glucose deprivation,BP,
16369,GO:0090650,0.99999999999119,0.776932379715691,0,5,cellular response to oxygen-glucose deprivation,BP,
13112,GO:0051611,0.999999999991202,0.901718928881834,0,2,regulation of serotonin uptake,BP,
13113,GO:0051612,0.999999999991202,0.901718928881834,0,2,negative regulation of serotonin uptake,BP,
9422,GO:0035986,0.999999999991211,0.883474390298985,0,3,senescence-associated heterochromatin focus assembly,BP,
6916,GO:0030502,0.999999999991212,0.733335010954259,0,6,negative regulation of bone mineralization,BP,
7711,GO:0032190,0.999999999991228,0.928087086828114,0,2,acrosin binding,MF,
9331,GO:0035803,0.999999999991228,0.928087086828114,0,2,egg coat formation,BP,
11906,GO:0046920,0.999999999991241,0.783455382038158,0,5,alpha-(1->3)-fucosyltransferase activity,MF,
19567,GO:1990460,0.999999999991242,0.863760238583281,0,3,leptin receptor binding,MF,
3057,GO:0006617,0.999999999991283,0.931045333609992,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
15410,GO:0071650,0.999999999991293,0.876668464172579,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
7095,GO:0030885,0.999999999991302,0.91682463315592,0,2,regulation of myeloid dendritic cell activation,BP,
7096,GO:0030886,0.999999999991302,0.91682463315592,0,2,negative regulation of myeloid dendritic cell activation,BP,
8522,GO:0033745,0.999999999991336,0.865941097824373,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
3792,GO:0008355,0.999999999991344,0.947680076501032,0,1,olfactory learning,BP,
10707,GO:0043990,0.999999999991353,0.952820476696015,0,1,histone H2A-S1 phosphorylation,BP,
2778,GO:0006207,0.999999999991357,0.737997341501879,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
6267,GO:0019856,0.999999999991357,0.737997341501879,0,6,pyrimidine nucleobase biosynthetic process,BP,
20140,GO:2000794,0.999999999991358,0.737972877646171,0,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
1028,GO:0002528,0.999999999991369,0.90241957458533,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
17236,GO:0106104,0.999999999991379,0.903721502262228,0,2,regulation of glutamate receptor clustering,BP,
18973,GO:1904717,0.999999999991379,0.903721502262228,0,2,regulation of AMPA glutamate receptor clustering,BP,
3639,GO:0008109,0.99999999999143,0.901361623150118,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1712,GO:0004300,0.99999999999144,0.706530077328695,0,8,enoyl-CoA hydratase activity,MF,
20191,GO:2000983,0.999999999991467,0.94770921465102,0,2,regulation of ATP citrate synthase activity,BP,
20192,GO:2000984,0.999999999991467,0.94770921465102,0,2,negative regulation of ATP citrate synthase activity,BP,
5445,GO:0016308,0.999999999991469,0.738480926390962,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
11395,GO:0045762,0.99999999999148,0.899651983148201,0,2,positive regulation of adenylate cyclase activity,BP,
8956,GO:0035014,0.999999999991492,0.730240206903895,0,6,phosphatidylinositol 3-kinase regulator activity,MF,
19317,GO:1905550,0.999999999991522,0.922560572291112,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19318,GO:1905552,0.999999999991522,0.922560572291112,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
5499,GO:0016433,0.999999999991536,0.768307751830898,0,6,rRNA (adenine) methyltransferase activity,MF,
18195,GO:1902950,0.99999999999158,0.759071498242667,0,6,regulation of dendritic spine maintenance,BP,
1758,GO:0004357,0.999999999991585,0.905241439797131,0,2,glutamate-cysteine ligase activity,MF,
5833,GO:0017109,0.999999999991585,0.905241439797131,0,2,glutamate-cysteine ligase complex,CC,
16443,GO:0097069,0.999999999991585,0.905241439797131,0,2,cellular response to thyroxine stimulus,BP,
18837,GO:1904387,0.999999999991585,0.905241439797131,0,2,cellular response to L-phenylalanine derivative,BP,
13828,GO:0060405,0.999999999991585,0.868148635637382,0,3,regulation of penile erection,BP,
5367,GO:0016149,0.999999999991599,0.950155627856792,0,1,translation release factor activity, codon specific,MF,
901,GO:0002277,0.999999999991634,0.974455822346422,0,1,myeloid dendritic cell activation involved in immune response,BP,
1057,GO:0002582,0.999999999991634,0.974455822346422,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1060,GO:0002585,0.999999999991634,0.974455822346422,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
1063,GO:0002588,0.999999999991634,0.974455822346422,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
5796,GO:0017024,0.999999999991634,0.974455822346422,0,1,myosin I binding,MF,
17113,GO:0099640,0.999999999991634,0.974455822346422,0,1,axo-dendritic protein transport,BP,
17114,GO:0099641,0.999999999991634,0.974455822346422,0,1,anterograde axonal protein transport,BP,
3217,GO:0006864,0.999999999991639,0.91175330528407,0,2,pyrimidine nucleotide transport,BP,
5043,GO:0015218,0.999999999991639,0.91175330528407,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
19576,GO:1990519,0.999999999991639,0.91175330528407,0,2,pyrimidine nucleotide import into mitochondrion,BP,
11834,GO:0046719,0.999999999991695,0.726165421367203,0,7,regulation by virus of viral protein levels in host cell,BP,
169,GO:0000350,0.999999999991708,0.878459567134357,0,3,generation of catalytic spliceosome for second transesterification step,BP,
4762,GO:0010936,0.999999999991711,0.788997740727883,0,5,negative regulation of macrophage cytokine production,BP,
525,GO:0001631,0.999999999991726,0.91479448074151,0,2,cysteinyl leukotriene receptor activity,MF,
526,GO:0001632,0.999999999991726,0.91479448074151,0,2,leukotriene B4 receptor activity,MF,
2156,GO:0004974,0.999999999991726,0.91479448074151,0,2,leukotriene receptor activity,MF,
14439,GO:0061737,0.999999999991726,0.91479448074151,0,2,leukotriene signaling pathway,BP,
10491,GO:0043383,0.999999999991726,0.870039720658919,0,3,negative T cell selection,BP,
11070,GO:0045060,0.999999999991726,0.870039720658919,0,3,negative thymic T cell selection,BP,
6147,GO:0019418,0.999999999991726,0.873775970125473,0,4,sulfide oxidation,BP,
14649,GO:0070221,0.999999999991726,0.873775970125473,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
2499,GO:0005745,0.999999999991734,0.909484141294454,0,2,m-AAA complex,CC,
14049,GO:0060764,0.999999999991739,0.913545328103001,0,2,cell-cell signaling involved in mammary gland development,BP,
3757,GO:0008297,0.999999999991755,0.76066374952824,0,6,single-stranded DNA exodeoxyribonuclease activity,MF,
6269,GO:0019858,0.999999999991761,0.924368325552661,0,2,cytosine metabolic process,BP,
1541,GO:0003923,0.999999999991767,0.790009419558987,0,5,GPI-anchor transamidase activity,MF,
10179,GO:0042765,0.999999999991767,0.790009419558987,0,5,GPI-anchor transamidase complex,CC,
15897,GO:0072616,0.999999999991772,0.948866329590972,0,1,interleukin-18 secretion,BP,
9426,GO:0035990,0.999999999991809,0.913719872983632,0,2,tendon cell differentiation,BP,
9427,GO:0035992,0.999999999991809,0.913719872983632,0,2,tendon formation,BP,
15022,GO:0070940,0.99999999999181,0.786583765664195,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
16278,GO:0090325,0.999999999991831,0.902769803556855,0,2,regulation of locomotion involved in locomotory behavior,BP,
14834,GO:0070563,0.999999999991833,0.905030234199105,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
19457,GO:1990047,0.999999999991847,0.955106273488956,0,1,spindle matrix,CC,
17878,GO:1902093,0.999999999991849,0.900526274860791,0,3,positive regulation of flagellated sperm motility,BP,
2685,GO:0006045,0.99999999999185,0.899093060034851,0,2,N-acetylglucosamine biosynthetic process,BP,
17557,GO:1901073,0.99999999999185,0.899093060034851,0,2,glucosamine-containing compound biosynthetic process,BP,
1585,GO:0003993,0.999999999991855,0.774170134274434,0,6,acid phosphatase activity,MF,
6876,GO:0030348,0.999999999991859,0.906470683424252,0,2,syntaxin-3 binding,MF,
5623,GO:0016672,0.999999999991859,0.940185819887924,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
11139,GO:0045174,0.999999999991859,0.940185819887924,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
12516,GO:0050610,0.999999999991859,0.940185819887924,0,2,methylarsonate reductase activity,MF,
17440,GO:1900186,0.999999999991867,0.866224412951896,0,3,negative regulation of clathrin-dependent endocytosis,BP,
18005,GO:1902423,0.999999999991871,0.904651682061521,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
18006,GO:1902425,0.999999999991871,0.904651682061521,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
15369,GO:0071586,0.999999999991871,0.91673779577001,0,2,CAAX-box protein processing,BP,
15987,GO:0080120,0.999999999991871,0.91673779577001,0,2,CAAX-box protein maturation,BP,
7249,GO:0031177,0.999999999991876,0.910476689062007,0,3,phosphopantetheine binding,MF,
18329,GO:1903237,0.999999999991877,0.976501388653157,0,1,negative regulation of leukocyte tethering or rolling,BP,
3994,GO:0008889,0.999999999991881,0.859645969549709,0,3,glycerophosphodiester phosphodiesterase activity,MF,
9685,GO:0038052,0.999999999991903,0.903694181395436,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
13327,GO:0052151,0.999999999991911,0.918257813259209,0,2,positive regulation by symbiont of host apoptotic process,BP,
13653,GO:0060139,0.999999999991911,0.918257813259209,0,2,positive regulation of apoptotic process by virus,BP,
1615,GO:0004040,0.999999999991931,0.906559494454941,0,2,amidase activity,MF,
6362,GO:0021539,0.999999999991931,0.917714967774704,0,2,subthalamus development,BP,
3668,GO:0008158,0.999999999991942,0.921671801054273,0,2,hedgehog receptor activity,MF,
17641,GO:1901338,0.999999999991959,0.874052250596726,0,3,catecholamine binding,MF,
456,GO:0001300,0.999999999991987,0.90744274928265,0,2,chronological cell aging,BP,
15497,GO:0071838,0.999999999991993,0.858992417070054,0,3,cell proliferation in bone marrow,BP,
6021,GO:0019072,0.999999999991999,0.898192624751003,0,2,viral genome packaging,BP,
6022,GO:0019074,0.999999999991999,0.898192624751003,0,2,viral RNA genome packaging,BP,
4440,GO:0010309,0.999999999992003,0.959475529208775,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
19582,GO:1990565,0.999999999992003,0.959475529208775,0,1,HSP90-CDC37 chaperone complex,CC,
2453,GO:0005663,0.999999999992016,0.77211394595246,0,6,DNA replication factor C complex,CC,
19547,GO:1990416,0.999999999992022,0.738109197494013,0,6,cellular response to brain-derived neurotrophic factor stimulus,BP,
5100,GO:0015373,0.999999999992027,0.899938495751821,0,2,anion:sodium symporter activity,MF,
222,GO:0000461,0.999999999992077,0.957529923869173,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
9772,GO:0039533,0.999999999992093,0.749000830885085,0,6,regulation of MDA-5 signaling pathway,BP,
5697,GO:0016813,0.999999999992098,0.767149073531217,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
19499,GO:1990189,0.999999999992111,0.927680529543642,0,2,peptide-serine-N-acetyltransferase activity,MF,
5050,GO:0015230,0.999999999992117,0.910348077455877,0,2,FAD transmembrane transporter activity,MF,
9091,GO:0035350,0.999999999992117,0.910348077455877,0,2,FAD transmembrane transport,BP,
9128,GO:0035438,0.99999999999212,0.959278264293062,0,1,cyclic-di-GMP binding,MF,
14342,GO:0061507,0.99999999999212,0.959278264293062,0,1,cyclic-GMP-AMP binding,MF,
14371,GO:0061580,0.999999999992122,0.948448769137609,0,1,colon epithelial cell migration,BP,
14962,GO:0070843,0.999999999992122,0.948448769137609,0,1,misfolded protein transport,BP,
14963,GO:0070844,0.999999999992122,0.948448769137609,0,1,polyubiquitinated protein transport,BP,
14964,GO:0070845,0.999999999992122,0.948448769137609,0,1,polyubiquitinated misfolded protein transport,BP,
14965,GO:0070846,0.999999999992122,0.948448769137609,0,1,Hsp90 deacetylation,BP,
15595,GO:0072050,0.999999999992132,0.763011826326642,0,6,S-shaped body morphogenesis,BP,
8172,GO:0032905,0.999999999992138,0.741897554921017,0,6,transforming growth factor beta1 production,BP,
8175,GO:0032908,0.999999999992138,0.741897554921017,0,6,regulation of transforming growth factor beta1 production,BP,
1664,GO:0004117,0.999999999992142,0.954054210781079,0,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
2043,GO:0004782,0.999999999992142,0.954054210781079,0,1,sulfinoalanine decarboxylase activity,MF,
3848,GO:0008455,0.999999999992142,0.954054210781079,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
3897,GO:0008531,0.999999999992142,0.954054210781079,0,1,riboflavin kinase activity,MF,
4168,GO:0009231,0.999999999992142,0.954054210781079,0,1,riboflavin biosynthetic process,BP,
4226,GO:0009398,0.999999999992142,0.954054210781079,0,1,FMN biosynthetic process,BP,
10001,GO:0042412,0.999999999992142,0.954054210781079,0,1,taurine biosynthetic process,BP,
11622,GO:0046305,0.999999999992142,0.954054210781079,0,1,alkanesulfonate biosynthetic process,BP,
11679,GO:0046444,0.999999999992142,0.954054210781079,0,1,FMN metabolic process,BP,
17649,GO:1901355,0.999999999992154,0.904617374364862,0,2,response to rapamycin,BP,
14566,GO:0070081,0.999999999992176,0.866164381718669,0,3,clathrin-sculpted monoamine transport vesicle,CC,
14567,GO:0070083,0.999999999992176,0.866164381718669,0,3,clathrin-sculpted monoamine transport vesicle membrane,CC,
5379,GO:0016188,0.999999999992185,0.78662992272443,0,5,synaptic vesicle maturation,BP,
14690,GO:0070295,0.99999999999219,0.871232656928713,0,3,renal water absorption,BP,
5135,GO:0015616,0.999999999992202,0.809799201850025,0,4,DNA translocase activity,MF,
7987,GO:0032596,0.999999999992207,0.788925206062941,0,5,protein transport into membrane raft,BP,
12137,GO:0048203,0.999999999992208,0.912563938978572,0,2,vesicle targeting, trans-Golgi to endosome,BP,
859,GO:0002184,0.999999999992213,0.902844266102686,0,2,cytoplasmic translational termination,BP,
8028,GO:0032658,0.999999999992214,0.958225348436986,0,1,regulation of interleukin-15 production,BP,
8073,GO:0032738,0.999999999992214,0.958225348436986,0,1,positive regulation of interleukin-15 production,BP,
9259,GO:0035664,0.999999999992214,0.958225348436986,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9260,GO:0035665,0.999999999992214,0.958225348436986,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
16860,GO:0098758,0.99999999999222,0.909366786124521,0,2,response to interleukin-8,BP,
16861,GO:0098759,0.99999999999222,0.909366786124521,0,2,cellular response to interleukin-8,BP,
4043,GO:0009074,0.999999999992228,0.730627249550272,0,8,aromatic amino acid family catabolic process,BP,
14838,GO:0070568,0.999999999992244,0.792681527322497,0,5,guanylyltransferase activity,MF,
3065,GO:0006627,0.999999999992258,0.780683108066843,0,6,protein processing involved in protein targeting to mitochondrion,BP,
7253,GO:0031205,0.999999999992261,0.93087204515415,0,2,endoplasmic reticulum Sec complex,CC,
11469,GO:0045915,0.999999999992271,0.805900916516171,0,5,positive regulation of catecholamine metabolic process,BP,
11503,GO:0045964,0.999999999992271,0.805900916516171,0,5,positive regulation of dopamine metabolic process,BP,
4230,GO:0009405,0.999999999992283,0.896202142685876,0,2,pathogenesis,BP,
14202,GO:0061087,0.999999999992312,0.741095267738632,0,6,positive regulation of histone H3-K27 methylation,BP,
3445,GO:0007256,0.999999999992325,0.726306277488009,0,6,activation of JNKK activity,BP,
10622,GO:0043614,0.999999999992328,0.897772648174776,0,2,multi-eIF complex,CC,
8358,GO:0033227,0.999999999992329,0.866385061752452,0,3,dsRNA transport,BP,
17664,GO:1901387,0.999999999992338,0.854565188080716,0,3,positive regulation of voltage-gated calcium channel activity,BP,
5068,GO:0015279,0.999999999992344,0.781412658459083,0,5,store-operated calcium channel activity,MF,
13257,GO:0051917,0.999999999992374,0.747551322310613,0,6,regulation of fibrinolysis,BP,
9377,GO:0035900,0.999999999992392,0.77940253598108,0,6,response to isolation stress,BP,
2779,GO:0006208,0.999999999992403,0.910262825561768,0,2,pyrimidine nucleobase catabolic process,BP,
2780,GO:0006210,0.999999999992403,0.910262825561768,0,2,thymine catabolic process,BP,
6270,GO:0019859,0.999999999992403,0.910262825561768,0,2,thymine metabolic process,BP,
153,GO:0000308,0.999999999992423,0.898654871527492,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
19427,GO:1905936,0.999999999992447,0.946902292107778,0,2,regulation of germ cell proliferation,BP,
19830,GO:2000254,0.999999999992447,0.946902292107778,0,2,regulation of male germ cell proliferation,BP,
972,GO:0002416,0.999999999992448,0.958450076003345,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
6226,GO:0019770,0.999999999992448,0.958450076003345,0,1,IgG receptor activity,MF,
6274,GO:0019864,0.999999999992448,0.958450076003345,0,1,IgG binding,MF,
10864,GO:0044375,0.99999999999245,0.929965962804029,0,2,regulation of peroxisome size,BP,
4050,GO:0009085,0.999999999992457,0.902782628488603,0,2,lysine biosynthetic process,BP,
6281,GO:0019878,0.999999999992457,0.902782628488603,0,2,lysine biosynthetic process via aminoadipic acid,BP,
236,GO:0000493,0.999999999992468,0.913949144795128,0,2,box H/ACA snoRNP assembly,BP,
13036,GO:0051458,0.999999999992477,0.901791036983446,0,2,corticotropin secretion,BP,
13037,GO:0051459,0.999999999992477,0.901791036983446,0,2,regulation of corticotropin secretion,BP,
13038,GO:0051461,0.999999999992477,0.901791036983446,0,2,positive regulation of corticotropin secretion,BP,
14618,GO:0070170,0.999999999992479,0.901173942003528,0,2,regulation of tooth mineralization,BP,
7705,GO:0032173,0.999999999992496,0.953180915628457,0,1,septin collar,CC,
15937,GO:0072709,0.999999999992502,0.909256628563359,0,2,cellular response to sorbitol,BP,
7688,GO:0032129,0.999999999992503,0.911448619433332,0,2,histone deacetylase activity (H3-K9 specific),MF,
11935,GO:0046969,0.999999999992503,0.911448619433332,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
19600,GO:1990619,0.999999999992503,0.911448619433332,0,2,histone H3-K9 deacetylation,BP,
15519,GO:0071879,0.999999999992517,0.857753915759757,0,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
667,GO:0001868,0.999999999992541,0.957227576205068,0,1,regulation of complement activation, lectin pathway,BP,
668,GO:0001869,0.999999999992541,0.957227576205068,0,1,negative regulation of complement activation, lectin pathway,BP,
9808,GO:0040032,0.999999999992541,0.957227576205068,0,1,post-embryonic body morphogenesis,BP,
13279,GO:0051953,0.99999999999255,0.781900564002488,0,5,negative regulation of amine transport,BP,
5546,GO:0016531,0.999999999992556,0.870620719077371,0,5,copper chaperone activity,MF,
15051,GO:0070985,0.99999999999256,0.926917633729743,0,2,TFIIK complex,CC,
557,GO:0001680,0.999999999992561,0.955119789997207,0,1,tRNA 3'-terminal CCA addition,BP,
2060,GO:0004810,0.999999999992561,0.955119789997207,0,1,tRNA adenylyltransferase activity,MF,
13478,GO:0052927,0.999999999992561,0.955119789997207,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13479,GO:0052928,0.999999999992561,0.955119789997207,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13480,GO:0052929,0.999999999992561,0.955119789997207,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
19655,GO:1990817,0.999999999992561,0.955119789997207,0,1,RNA adenylyltransferase activity,MF,
15993,GO:0080144,0.999999999992574,0.907451006332429,0,2,amino acid homeostasis,BP,
1698,GO:0004170,0.999999999992579,0.957390932869648,0,1,dUTP diphosphatase activity,MF,
11556,GO:0046080,0.999999999992579,0.957390932869648,0,1,dUTP metabolic process,BP,
11557,GO:0046081,0.999999999992579,0.957390932869648,0,1,dUTP catabolic process,BP,
8591,GO:0034087,0.999999999992598,0.899977811610465,0,2,establishment of mitotic sister chromatid cohesion,BP,
13662,GO:0060155,0.999999999992613,0.748326787330638,0,7,platelet dense granule organization,BP,
5467,GO:0016344,0.999999999992628,0.905500638363764,0,2,meiotic chromosome movement towards spindle pole,BP,
6135,GO:0019389,0.999999999992657,0.954198048250047,0,1,glucuronoside metabolic process,BP,
6136,GO:0019391,0.999999999992657,0.954198048250047,0,1,glucuronoside catabolic process,BP,
17157,GO:0102390,0.999999999992657,0.954198048250047,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
13705,GO:0060235,0.999999999992671,0.85874585133752,0,3,lens induction in camera-type eye,BP,
5032,GO:0015194,0.999999999992685,0.720796242575674,0,7,L-serine transmembrane transporter activity,MF,
5225,GO:0015825,0.999999999992685,0.720796242575674,0,7,L-serine transport,BP,
6633,GO:0022889,0.999999999992685,0.720796242575674,0,7,serine transmembrane transporter activity,MF,
15292,GO:0071462,0.999999999992687,0.900115211121576,0,2,cellular response to water stimulus,BP,
5065,GO:0015275,0.999999999992703,0.903806567830867,0,2,stretch-activated, cation-selective, calcium channel activity,MF,
17325,GO:0140135,0.999999999992703,0.903806567830867,0,2,mechanosensitive cation channel activity,MF,
18392,GO:1903378,0.999999999992714,0.901845205720524,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
6715,GO:0030121,0.999999999992719,0.74635805150694,0,6,AP-1 adaptor complex,CC,
1656,GO:0004105,0.999999999992733,0.909467422891698,0,2,choline-phosphate cytidylyltransferase activity,MF,
8394,GO:0033306,0.999999999992734,0.909309220646796,0,2,phytol metabolic process,BP,
18298,GO:1903173,0.999999999992734,0.909309220646796,0,2,fatty alcohol metabolic process,BP,
63,GO:0000126,0.999999999992742,0.899762242058713,0,2,transcription factor TFIIIB complex,CC,
385,GO:0001026,0.999999999992742,0.899762242058713,0,2,TFIIIB-type transcription factor activity,MF,
3865,GO:0008482,0.999999999992747,0.95493520914038,0,1,sulfite oxidase activity,MF,
9872,GO:0042128,0.999999999992747,0.95493520914038,0,1,nitrate assimilation,BP,
7380,GO:0031428,0.999999999992753,0.811611371774547,0,5,box C/D snoRNP complex,CC,
19487,GO:1990167,0.999999999992762,0.859735205848524,0,3,protein K27-linked deubiquitination,BP,
18780,GO:1904247,0.999999999992771,0.952891547371322,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
1492,GO:0003827,0.9999999999928,0.909281439769177,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
6833,GO:0030290,0.999999999992801,0.950662461611705,0,1,sphingolipid activator protein activity,MF,
7871,GO:0032428,0.999999999992801,0.950662461611705,0,1,beta-N-acetylgalactosaminidase activity,MF,
13829,GO:0060406,0.999999999992819,0.903053209675313,0,2,positive regulation of penile erection,BP,
17771,GO:1901723,0.999999999992821,0.787767822211632,0,5,negative regulation of cell proliferation involved in kidney development,BP,
2480,GO:0005712,0.999999999992828,0.903669534612335,0,2,chiasma,CC,
16360,GO:0090615,0.99999999999285,0.906584671070645,0,2,mitochondrial mRNA processing,BP,
1754,GO:0004351,0.999999999992851,0.904968157141413,0,2,glutamate decarboxylase activity,MF,
8912,GO:0034750,0.999999999992853,0.900706101117291,0,2,Scrib-APC-beta-catenin complex,CC,
4151,GO:0009211,0.999999999992856,0.794472965219183,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
20153,GO:2000819,0.999999999992856,0.906218075396327,0,2,regulation of nucleotide-excision repair,BP,
3008,GO:0006553,0.999999999992856,0.64427636403593,0,9,lysine metabolic process,BP,
31,GO:0000056,0.999999999992862,0.759787071427177,0,7,ribosomal small subunit export from nucleus,BP,
11676,GO:0046439,0.999999999992865,0.77936357248547,0,5,L-cysteine metabolic process,BP,
6342,GO:0021512,0.999999999992902,0.948053827293476,0,1,spinal cord anterior/posterior patterning,BP,
2399,GO:0005542,0.999999999992907,0.782933432585779,0,6,folic acid binding,MF,
7619,GO:0032002,0.999999999992908,0.912426347963712,0,2,interleukin-28 receptor complex,CC,
7246,GO:0031166,0.999999999992922,0.858144839655243,0,3,integral component of vacuolar membrane,CC,
7312,GO:0031310,0.999999999992922,0.858144839655243,0,3,intrinsic component of vacuolar membrane,CC,
15116,GO:0071149,0.999999999992929,0.904628276758146,0,2,TEAD-2-YAP complex,CC,
11207,GO:0045323,0.999999999992947,0.866598221843423,0,3,interleukin-1 receptor complex,CC,
8113,GO:0032796,0.999999999992949,0.908906244086234,0,2,uropod organization,BP,
12160,GO:0048257,0.99999999999295,0.91037453786697,0,2,3'-flap endonuclease activity,MF,
16716,GO:0097677,0.999999999992956,0.772130943370064,0,6,STAT family protein binding,MF,
18887,GO:1904528,0.999999999992971,0.754894264576537,0,6,positive regulation of microtubule binding,BP,
14230,GO:0061152,0.999999999992972,0.920394480671111,0,2,trachea submucosa development,BP,
14231,GO:0061153,0.999999999992972,0.920394480671111,0,2,trachea gland development,BP,
3056,GO:0006616,0.999999999992976,0.806567662247574,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
10865,GO:0044378,0.999999999992981,0.911143960144145,0,2,non-sequence-specific DNA binding, bending,MF,
18207,GO:1902962,0.999999999992994,0.89902564375376,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18208,GO:1902963,0.999999999992994,0.89902564375376,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
6305,GO:0019918,0.999999999993011,0.828713223610786,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
9032,GO:0035243,0.999999999993011,0.828713223610786,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
16922,GO:0098875,0.999999999993026,0.947114879582188,0,1,epididymosome,CC,
18028,GO:1902498,0.999999999993038,0.854669741970807,0,3,regulation of protein autoubiquitination,BP,
6799,GO:0030235,0.999999999993052,0.7239710032137,0,7,nitric-oxide synthase regulator activity,MF,
15442,GO:0071701,0.99999999999306,0.946985612716669,0,1,regulation of MAPK export from nucleus,BP,
3957,GO:0008670,0.999999999993099,0.928291069855129,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
16464,GO:0097114,0.999999999993107,0.916296258816949,0,2,NMDA glutamate receptor clustering,BP,
17730,GO:1901629,0.999999999993107,0.916296258816949,0,2,regulation of presynaptic membrane organization,BP,
1191,GO:0002835,0.999999999993109,0.90832490270199,0,2,negative regulation of response to tumor cell,BP,
1194,GO:0002838,0.999999999993109,0.90832490270199,0,2,negative regulation of immune response to tumor cell,BP,
1199,GO:0002856,0.999999999993109,0.90832490270199,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1202,GO:0002859,0.999999999993109,0.90832490270199,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
13687,GO:0060199,0.99999999999311,0.904970694617312,0,2,clathrin-sculpted glutamate transport vesicle,CC,
13690,GO:0060203,0.99999999999311,0.904970694617312,0,2,clathrin-sculpted glutamate transport vesicle membrane,CC,
1142,GO:0002731,0.999999999993111,0.921479155310348,0,2,negative regulation of dendritic cell cytokine production,BP,
5967,GO:0018364,0.999999999993121,0.951508956176894,0,2,peptidyl-glutamine methylation,BP,
1853,GO:0004513,0.999999999993133,0.955008715762095,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
11993,GO:0047291,0.999999999993133,0.955008715762095,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
13556,GO:0060002,0.999999999993144,0.898952759859988,0,2,plus-end directed microfilament motor activity,MF,
2995,GO:0006540,0.999999999993163,0.90400192050523,0,2,glutamate decarboxylation to succinate,BP,
15858,GO:0072558,0.999999999993164,0.895054119890843,0,3,NLRP1 inflammasome complex,CC,
11929,GO:0046963,0.999999999993191,0.914152598171936,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11930,GO:0046964,0.999999999993191,0.914152598171936,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
18051,GO:1902559,0.999999999993191,0.914152598171936,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
18436,GO:1903464,0.999999999993195,0.910396533899946,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
6649,GO:0023041,0.999999999993201,0.87314411608959,0,3,neuronal signal transduction,BP,
12923,GO:0051256,0.999999999993218,0.681092034619193,0,8,mitotic spindle midzone assembly,BP,
5702,GO:0016822,0.999999999993219,0.923570979675611,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5703,GO:0016823,0.999999999993219,0.923570979675611,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
19667,GO:1990845,0.999999999993235,0.740892077477939,0,6,adaptive thermogenesis,BP,
8446,GO:0033565,0.999999999993236,0.860410098573327,0,3,ESCRT-0 complex,CC,
18460,GO:1903527,0.999999999993249,0.84993930850517,0,3,positive regulation of membrane tubulation,BP,
11104,GO:0045105,0.999999999993251,0.95063478593297,0,1,intermediate filament polymerization or depolymerization,BP,
18654,GO:1903937,0.999999999993251,0.95063478593297,0,1,response to acrylamide,BP,
8729,GO:0034374,0.999999999993261,0.883956671819263,0,3,low-density lipoprotein particle remodeling,BP,
5582,GO:0016595,0.999999999993267,0.737457076994753,0,6,glutamate binding,MF,
5397,GO:0016230,0.999999999993268,0.916295240390042,0,2,sphingomyelin phosphodiesterase activator activity,MF,
7534,GO:0031752,0.999999999993277,0.897198159350421,0,2,D5 dopamine receptor binding,MF,
11958,GO:0047025,0.999999999993285,0.924668677904726,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
3505,GO:0007412,0.999999999993288,0.919767817074419,0,2,axon target recognition,BP,
6425,GO:0021684,0.999999999993298,0.861853362082869,0,3,cerebellar granular layer formation,BP,
6440,GO:0021707,0.999999999993298,0.861853362082869,0,3,cerebellar granule cell differentiation,BP,
158,GO:0000320,0.999999999993317,0.898618815305616,0,2,re-entry into mitotic cell cycle,BP,
14736,GO:0070381,0.999999999993349,0.903589467734048,0,2,endosome to plasma membrane transport vesicle,CC,
16715,GO:0097676,0.999999999993363,0.856380898714861,0,3,histone H3-K36 dimethylation,BP,
6695,GO:0030061,0.999999999993368,0.787644822777978,0,5,mitochondrial crista,CC,
19186,GO:1905206,0.99999999999338,0.790014310632569,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
15133,GO:0071209,0.999999999993399,0.897499431887665,0,3,U7 snRNA binding,MF,
9231,GO:0035616,0.999999999993404,0.854147033334782,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
12247,GO:0048505,0.999999999993405,0.753570252227253,0,6,regulation of timing of cell differentiation,BP,
554,GO:0001675,0.999999999993417,0.66593485452546,0,8,acrosome assembly,BP,
19690,GO:1990928,0.99999999999343,0.898680661303855,0,2,response to amino acid starvation,BP,
5093,GO:0015350,0.999999999993432,0.902847011577162,0,2,methotrexate transmembrane transporter activity,MF,
13284,GO:0051958,0.999999999993432,0.902847011577162,0,2,methotrexate transport,BP,
18795,GO:1904289,0.999999999993433,0.903121269236401,0,2,regulation of mitotic DNA damage checkpoint,BP,
12244,GO:0048496,0.999999999993437,0.856611182027991,0,3,maintenance of animal organ identity,BP,
2824,GO:0006288,0.999999999993449,0.878596588845439,0,3,base-excision repair, DNA ligation,BP,
19036,GO:1904844,0.999999999993454,0.936264854435042,0,2,response to L-glutamine,BP,
19037,GO:1904845,0.999999999993454,0.936264854435042,0,2,cellular response to L-glutamine,BP,
1581,GO:0003988,0.999999999993457,0.766450826486696,0,6,acetyl-CoA C-acyltransferase activity,MF,
12006,GO:0047391,0.999999999993472,0.912862369428104,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
12168,GO:0048266,0.999999999993499,0.787582610745946,0,5,behavioral response to pain,BP,
19984,GO:2000520,0.999999999993507,0.920120534424871,0,2,regulation of immunological synapse formation,BP,
19985,GO:2000521,0.999999999993507,0.920120534424871,0,2,negative regulation of immunological synapse formation,BP,
20268,GO:2001188,0.999999999993507,0.920120534424871,0,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20269,GO:2001189,0.999999999993507,0.920120534424871,0,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
14354,GO:0061535,0.999999999993514,0.850841287413172,0,3,glutamate secretion, neurotransmission,BP,
14774,GO:0070458,0.999999999993523,0.886585626368146,0,3,cellular detoxification of nitrogen compound,BP,
12695,GO:0050893,0.999999999993527,0.871482215988796,0,3,sensory processing,BP,
16359,GO:0090611,0.999999999993557,0.791130456721928,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
1699,GO:0004174,0.999999999993568,0.909226528533675,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
5611,GO:0016649,0.999999999993568,0.909226528533675,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
2366,GO:0005476,0.99999999999357,0.908377089291166,0,2,carnitine:acyl carnitine antiporter activity,MF,
1714,GO:0004303,0.999999999993574,0.757471527194228,0,7,estradiol 17-beta-dehydrogenase activity,MF,
18781,GO:1904251,0.999999999993583,0.753928889446635,0,6,regulation of bile acid metabolic process,BP,
5951,GO:0018282,0.999999999993585,0.903884207279972,0,2,metal incorporation into metallo-sulfur cluster,BP,
5952,GO:0018283,0.999999999993585,0.903884207279972,0,2,iron incorporation into metallo-sulfur cluster,BP,
13958,GO:0060613,0.999999999993585,0.753184381144198,0,6,fat pad development,BP,
13681,GO:0060187,0.999999999993594,0.89671212608119,0,2,cell pole,CC,
15945,GO:0072719,0.999999999993603,0.745009140853099,0,6,cellular response to cisplatin,BP,
3487,GO:0007354,0.999999999993628,0.869422873478856,0,3,zygotic determination of anterior/posterior axis, embryo,BP,
6543,GO:0021943,0.999999999993654,0.813813408862308,0,4,formation of radial glial scaffolds,BP,
3678,GO:0008176,0.999999999993667,0.926353555350818,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
17202,GO:0106004,0.999999999993667,0.926353555350818,0,2,tRNA (guanine-N7)-methylation,BP,
590,GO:0001743,0.999999999993671,0.900750638934542,0,2,optic placode formation,BP,
12196,GO:0048319,0.999999999993671,0.900750638934542,0,2,axial mesoderm morphogenesis,BP,
12438,GO:0048880,0.999999999993677,0.86177517988371,0,3,sensory system development,BP,
5255,GO:0015879,0.999999999993685,0.789704942264167,0,5,carnitine transport,BP,
20137,GO:2000790,0.999999999993697,0.898844846982113,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
20138,GO:2000791,0.999999999993697,0.898844846982113,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
19183,GO:1905203,0.999999999993699,0.913775302513206,0,2,regulation of connective tissue replacement,BP,
18073,GO:1902612,0.999999999993699,0.953956470119746,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18074,GO:1902613,0.999999999993699,0.953956470119746,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19513,GO:1990262,0.999999999993699,0.953956470119746,0,1,anti-Mullerian hormone signaling pathway,BP,
13084,GO:0051574,0.999999999993707,0.706156767070506,0,7,positive regulation of histone H3-K9 methylation,BP,
1978,GO:0004691,0.999999999993716,0.735673769598812,0,6,cAMP-dependent protein kinase activity,MF,
18935,GO:1904631,0.99999999999372,0.955245396156711,0,1,response to glucoside,BP,
2145,GO:0004955,0.999999999993745,0.911024327891932,0,2,prostaglandin receptor activity,MF,
9212,GO:0035596,0.99999999999376,0.910413596148951,0,2,methylthiotransferase activity,MF,
9215,GO:0035600,0.99999999999376,0.910413596148951,0,2,tRNA methylthiolation,BP,
12503,GO:0050497,0.99999999999376,0.910413596148951,0,2,transferase activity, transferring alkylthio groups,MF,
15546,GO:0071929,0.99999999999376,0.908440741996279,0,2,alpha-tubulin acetylation,BP,
3124,GO:0006703,0.999999999993763,0.722712849191776,0,8,estrogen biosynthetic process,BP,
7260,GO:0031223,0.999999999993765,0.726539756873763,0,6,auditory behavior,BP,
147,GO:0000301,0.999999999993773,0.867004286577079,0,3,retrograde transport, vesicle recycling within Golgi,BP,
1390,GO:0003294,0.999999999993774,0.907477679766346,0,2,atrial ventricular junction remodeling,BP,
4567,GO:0010645,0.999999999993774,0.907477679766346,0,2,regulation of cell communication by chemical coupling,BP,
4573,GO:0010652,0.999999999993774,0.907477679766346,0,2,positive regulation of cell communication by chemical coupling,BP,
11776,GO:0046624,0.999999999993794,0.742917348102933,0,6,sphingolipid transporter activity,MF,
14257,GO:0061218,0.9999999999938,0.872981608962994,0,3,negative regulation of mesonephros development,BP,
19348,GO:1905634,0.999999999993808,0.739340801938581,0,6,regulation of protein localization to chromatin,BP,
2081,GO:0004832,0.999999999993819,0.853124599508331,0,3,valine-tRNA ligase activity,MF,
2928,GO:0006438,0.999999999993819,0.853124599508331,0,3,valyl-tRNA aminoacylation,BP,
12711,GO:0050916,0.999999999993822,0.863587184198711,0,3,sensory perception of sweet taste,BP,
15816,GO:0072497,0.99999999999384,0.737537223046617,0,6,mesenchymal stem cell differentiation,BP,
15620,GO:0072093,0.999999999993843,0.851299443493473,0,3,metanephric renal vesicle formation,BP,
16473,GO:0097129,0.999999999993863,0.880572309674422,0,3,cyclin D2-CDK4 complex,CC,
10227,GO:0042895,0.999999999993871,0.75169672409174,0,6,antibiotic transmembrane transporter activity,MF,
10704,GO:0043985,0.999999999993874,0.757372586784724,0,6,histone H4-R3 methylation,BP,
16891,GO:0098814,0.999999999993875,0.784688991718849,0,5,spontaneous synaptic transmission,BP,
12300,GO:0048619,0.999999999993876,0.953705669282823,0,1,embryonic hindgut morphogenesis,BP,
13979,GO:0060671,0.999999999993884,0.864190820009762,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
13980,GO:0060672,0.999999999993884,0.864190820009762,0,3,epithelial cell morphogenesis involved in placental branching,BP,
20047,GO:2000643,0.999999999993888,0.661027502706444,0,8,positive regulation of early endosome to late endosome transport,BP,
13242,GO:0051892,0.999999999993896,0.948057887008391,0,1,negative regulation of cardioblast differentiation,BP,
20083,GO:2000690,0.999999999993896,0.948057887008391,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
20084,GO:2000691,0.999999999993896,0.948057887008391,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
2065,GO:0004816,0.999999999993903,0.910800378345875,0,2,asparagine-tRNA ligase activity,MF,
7406,GO:0031465,0.999999999993925,0.801569919797849,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
17799,GO:1901856,0.99999999999394,0.90966715183331,0,2,negative regulation of cellular respiration,BP,
6882,GO:0030372,0.999999999993951,0.947043154268761,0,1,high molecular weight B cell growth factor receptor binding,MF,
7890,GO:0032453,0.999999999993951,0.726442572833381,0,6,histone demethylase activity (H3-K4 specific),MF,
8902,GO:0034720,0.999999999993951,0.726442572833381,0,6,histone H3-K4 demethylation,BP,
8575,GO:0034040,0.999999999993972,0.858030713073636,0,3,lipid-transporting ATPase activity,MF,
11023,GO:0044855,0.999999999993985,0.95398445588623,0,1,plasma membrane raft distribution,BP,
11024,GO:0044856,0.999999999993985,0.95398445588623,0,1,plasma membrane raft localization,BP,
11026,GO:0044858,0.999999999993985,0.95398445588623,0,1,plasma membrane raft polarization,BP,
18638,GO:1903906,0.999999999993985,0.95398445588623,0,1,regulation of plasma membrane raft polarization,BP,
3880,GO:0008508,0.999999999994005,0.92077011877335,0,2,bile acid:sodium symporter activity,MF,
3200,GO:0006833,0.999999999994019,0.754490743146143,0,6,water transport,BP,
2021,GO:0004747,0.999999999994029,0.967477244473384,0,1,ribokinase activity,MF,
7012,GO:0030692,0.999999999994037,0.915174382126659,0,2,Noc4p-Nop14p complex,CC,
1722,GO:0004311,0.999999999994043,0.868960253128815,0,3,farnesyltranstransferase activity,MF,
1590,GO:0003998,0.999999999994082,0.948701232898896,0,2,acylphosphatase activity,MF,
1056,GO:0002581,0.99999999999409,0.912694597432982,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
13296,GO:0051971,0.999999999994094,0.903821259941559,0,2,positive regulation of transmission of nerve impulse,BP,
11549,GO:0046069,0.999999999994104,0.897628269694905,0,2,cGMP catabolic process,BP,
18928,GO:1904612,0.999999999994104,0.897628269694905,0,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18929,GO:1904613,0.999999999994104,0.897628269694905,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18943,GO:1904667,0.999999999994105,0.855725108133345,0,6,negative regulation of ubiquitin protein ligase activity,BP,
19621,GO:1990729,0.999999999994117,0.956711808376256,0,1,primary miRNA modification,BP,
19629,GO:1990744,0.999999999994117,0.956711808376256,0,1,primary miRNA methylation,BP,
19122,GO:1905031,0.999999999994119,0.850590257067816,0,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
16091,GO:0090038,0.999999999994129,0.90436567379238,0,2,negative regulation of protein kinase C signaling,BP,
19953,GO:2000434,0.999999999994146,0.953617743168684,0,2,regulation of protein neddylation,BP,
19954,GO:2000435,0.999999999994146,0.953617743168684,0,2,negative regulation of protein neddylation,BP,
7982,GO:0032591,0.999999999994152,0.728785455735283,0,6,dendritic spine membrane,CC,
19462,GO:1990071,0.999999999994153,0.925552971810286,0,2,TRAPPII protein complex,CC,
8988,GO:0035093,0.999999999994157,0.896188163498121,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
17193,GO:0103053,0.999999999994165,0.928793680158018,0,2,1-ethyladenine demethylase activity,MF,
19564,GO:1990454,0.99999999999417,0.858905425878569,0,3,L-type voltage-gated calcium channel complex,CC,
17939,GO:1902238,0.99999999999417,0.948228342389686,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17940,GO:1902239,0.99999999999417,0.948228342389686,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19476,GO:1990127,0.99999999999417,0.948228342389686,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19565,GO:1990456,0.999999999994223,0.949517824577901,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
11961,GO:0047045,0.999999999994227,0.966617420902699,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
4041,GO:0009071,0.999999999994247,0.732531700581993,0,7,serine family amino acid catabolic process,BP,
6414,GO:0021648,0.99999999999427,0.903634297782653,0,2,vestibulocochlear nerve morphogenesis,BP,
14134,GO:0060978,0.99999999999427,0.903634297782653,0,2,angiogenesis involved in coronary vascular morphogenesis,BP,
5638,GO:0016715,0.99999999999428,0.905344595359869,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
8320,GO:0033152,0.999999999994291,0.82249058198377,0,4,immunoglobulin V(D)J recombination,BP,
596,GO:0001758,0.999999999994296,0.865445508240262,0,3,retinal dehydrogenase activity,MF,
7254,GO:0031208,0.999999999994297,0.903461711857808,0,2,POZ domain binding,MF,
475,GO:0001518,0.999999999994301,0.720630805164895,0,6,voltage-gated sodium channel complex,CC,
19976,GO:2000501,0.999999999994302,0.92501428593355,0,2,regulation of natural killer cell chemotaxis,BP,
19977,GO:2000503,0.999999999994302,0.92501428593355,0,2,positive regulation of natural killer cell chemotaxis,BP,
10772,GO:0044214,0.999999999994314,0.857166725202437,0,3,spanning component of plasma membrane,CC,
1658,GO:0004109,0.999999999994317,0.910636332375969,0,2,coproporphyrinogen oxidase activity,MF,
16753,GO:0098502,0.999999999994323,0.891189693751353,0,3,DNA dephosphorylation,BP,
13162,GO:0051717,0.999999999994342,0.902830078481805,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
17015,GO:0099093,0.999999999994368,0.902704152637455,0,2,calcium export from the mitochondrion,BP,
3536,GO:0007529,0.999999999994371,0.900286267748972,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
10487,GO:0043376,0.999999999994376,0.950505959620623,0,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
17003,GO:0099073,0.999999999994376,0.901899723865132,0,2,mitochondrion-derived vesicle,CC,
19444,GO:1990005,0.999999999994378,0.914463615809922,0,2,granular vesicle,CC,
17943,GO:1902255,0.9999999999944,0.935504665654851,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19002,GO:1904776,0.999999999994416,0.737301134461453,0,6,regulation of protein localization to cell cortex,BP,
20072,GO:2000670,0.999999999994435,0.902116862592621,0,2,positive regulation of dendritic cell apoptotic process,BP,
3206,GO:0006843,0.999999999994446,0.960412302284595,0,1,mitochondrial citrate transmembrane transport,BP,
16094,GO:0090044,0.999999999994446,0.960412302284595,0,1,positive regulation of tubulin deacetylation,BP,
19580,GO:1990546,0.999999999994446,0.960412302284595,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
7441,GO:0031547,0.999999999994448,0.896668434487654,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
10823,GO:0044308,0.999999999994448,0.896668434487654,0,2,axonal spine,CC,
6379,GO:0021560,0.999999999994457,0.908539010135518,0,2,abducens nerve development,BP,
6398,GO:0021598,0.999999999994457,0.908539010135518,0,2,abducens nerve morphogenesis,BP,
6399,GO:0021599,0.999999999994457,0.908539010135518,0,2,abducens nerve formation,BP,
1382,GO:0003275,0.999999999994463,0.900637245578844,0,2,apoptotic process involved in outflow tract morphogenesis,BP,
17944,GO:1902256,0.999999999994463,0.900637245578844,0,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
11300,GO:0045602,0.999999999994469,0.779995683028616,0,5,negative regulation of endothelial cell differentiation,BP,
14917,GO:0070728,0.999999999994478,0.739656081692727,0,6,leucine binding,MF,
5644,GO:0016725,0.999999999994494,0.732882334526549,0,6,oxidoreductase activity, acting on CH or CH2 groups,MF,
1763,GO:0004363,0.999999999994499,0.957110387198718,0,1,glutathione synthase activity,MF,
19928,GO:2000394,0.999999999994517,0.772659508867893,0,5,positive regulation of lamellipodium morphogenesis,BP,
6369,GO:0021546,0.999999999994535,0.914105681425574,0,2,rhombomere development,BP,
8929,GO:0034773,0.999999999994536,0.738552807011784,0,6,histone H4-K20 trimethylation,BP,
17520,GO:1900673,0.99999999999454,0.9116771932745,0,2,olefin metabolic process,BP,
2368,GO:0005483,0.99999999999455,0.86367749536674,0,3,soluble NSF attachment protein activity,MF,
5141,GO:0015651,0.999999999994552,0.746823980425547,0,6,quaternary ammonium group transmembrane transporter activity,MF,
518,GO:0001588,0.999999999994569,0.934398905206703,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
2142,GO:0004952,0.999999999994569,0.934398905206703,0,2,dopamine neurotransmitter receptor activity,MF,
12268,GO:0048539,0.999999999994571,0.822507013377259,0,4,bone marrow development,BP,
13388,GO:0052593,0.999999999994613,0.905373604487506,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13389,GO:0052594,0.999999999994613,0.905373604487506,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13390,GO:0052595,0.999999999994613,0.905373604487506,0,2,aliphatic-amine oxidase activity,MF,
13391,GO:0052596,0.999999999994613,0.905373604487506,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
8171,GO:0032902,0.999999999994626,0.902658983733792,0,2,nerve growth factor production,BP,
2574,GO:0005858,0.999999999994626,0.672662500124966,0,8,axonemal dynein complex,CC,
4845,GO:0014048,0.999999999994644,0.786942681367203,0,5,regulation of glutamate secretion,BP,
2027,GO:0004756,0.999999999994677,0.911501091098404,0,2,selenide, water dikinase activity,MF,
5418,GO:0016260,0.999999999994677,0.911501091098404,0,2,selenocysteine biosynthetic process,BP,
5675,GO:0016781,0.999999999994677,0.911501091098404,0,2,phosphotransferase activity, paired acceptors,MF,
14712,GO:0070329,0.999999999994677,0.911501091098404,0,2,tRNA seleno-modification,BP,
14200,GO:0061085,0.999999999994688,0.639737644165078,0,9,regulation of histone H3-K27 methylation,BP,
1630,GO:0004064,0.999999999994688,0.878300606543122,0,3,arylesterase activity,MF,
16416,GO:0097027,0.999999999994695,0.731806826380144,0,7,ubiquitin-protein transferase activator activity,MF,
1493,GO:0003828,0.999999999994703,0.897994893030072,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
8514,GO:0033691,0.999999999994703,0.897994893030072,0,2,sialic acid binding,MF,
18352,GO:1903297,0.999999999994712,0.795321212479274,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18353,GO:1903298,0.999999999994712,0.795321212479274,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
13747,GO:0060302,0.99999999999472,0.919026389963004,0,2,negative regulation of cytokine activity,BP,
15355,GO:0071567,0.999999999994741,0.928208270338561,0,2,UFM1 hydrolase activity,MF,
4785,GO:0010968,0.999999999994743,0.762347794199539,0,6,regulation of microtubule nucleation,BP,
12727,GO:0050932,0.999999999994763,0.71003857046385,0,7,regulation of pigment cell differentiation,BP,
2458,GO:0005668,0.999999999994767,0.922563729643935,0,2,RNA polymerase transcription factor SL1 complex,CC,
7779,GO:0032299,0.999999999994769,0.887718841471539,0,3,ribonuclease H2 complex,CC,
2619,GO:0005927,0.99999999999479,0.961205053423662,0,1,muscle tendon junction,CC,
8661,GO:0034213,0.99999999999479,0.961205053423662,0,1,quinolinate catabolic process,BP,
11879,GO:0046874,0.99999999999479,0.961205053423662,0,1,quinolinate metabolic process,BP,
1803,GO:0004441,0.999999999994805,0.955904647559538,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
13441,GO:0052829,0.999999999994805,0.955904647559538,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
1059,GO:0002584,0.999999999994813,0.883620590270631,0,3,negative regulation of antigen processing and presentation of peptide antigen,BP,
2173,GO:0005006,0.999999999994815,0.910466921869256,0,2,epidermal growth factor-activated receptor activity,MF,
3437,GO:0007228,0.999999999994821,0.899487193400349,0,2,positive regulation of hh target transcription factor activity,BP,
307,GO:0000818,0.999999999994823,0.911746292382908,0,2,nuclear MIS12/MIND complex,CC,
18106,GO:1902715,0.999999999994832,0.896374522701127,0,2,positive regulation of interferon-gamma secretion,BP,
19496,GO:1990180,0.99999999999484,0.886220791229355,0,3,mitochondrial tRNA 3'-end processing,BP,
3219,GO:0006867,0.999999999994848,0.953873248200845,0,1,asparagine transport,BP,
5022,GO:0015182,0.999999999994848,0.953873248200845,0,1,L-asparagine transmembrane transporter activity,MF,
5029,GO:0015190,0.999999999994848,0.953873248200845,0,1,L-leucine transmembrane transporter activity,MF,
5030,GO:0015191,0.999999999994848,0.953873248200845,0,1,L-methionine transmembrane transporter activity,MF,
5142,GO:0015658,0.999999999994848,0.953873248200845,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5222,GO:0015821,0.999999999994848,0.953873248200845,0,1,methionine transport,BP,
10669,GO:0043865,0.999999999994848,0.953873248200845,0,1,methionine transmembrane transporter activity,MF,
2014,GO:0004738,0.999999999994899,0.786498488570796,0,5,pyruvate dehydrogenase activity,MF,
8828,GO:0034603,0.999999999994899,0.786498488570796,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8829,GO:0034604,0.999999999994899,0.786498488570796,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
13915,GO:0060545,0.999999999994902,0.908536512285033,0,2,positive regulation of necroptotic process,BP,
10100,GO:0042602,0.999999999994921,0.975406468082905,0,1,riboflavin reductase (NADPH) activity,MF,
14166,GO:0061032,0.999999999994922,0.953169981114051,0,1,visceral serous pericardium development,BP,
15665,GO:0072166,0.999999999994922,0.953169981114051,0,1,posterior mesonephric tubule development,BP,
15739,GO:0072299,0.999999999994922,0.953169981114051,0,1,negative regulation of metanephric glomerulus development,BP,
15742,GO:0072302,0.999999999994922,0.953169981114051,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
11916,GO:0046935,0.999999999994927,0.850541717463572,0,3,1-phosphatidylinositol-3-kinase regulator activity,MF,
5224,GO:0015824,0.999999999994931,0.731202801450134,0,6,proline transport,BP,
305,GO:0000814,0.999999999994938,0.888638899949456,0,3,ESCRT II complex,CC,
3203,GO:0006837,0.999999999994946,0.74947403495179,0,6,serotonin transport,BP,
9138,GO:0035461,0.999999999994949,0.674862185411341,0,8,vitamin transmembrane transport,BP,
6273,GO:0019863,0.999999999994949,0.963508795342849,0,1,IgE binding,MF,
15988,GO:0080121,0.999999999994959,0.90993569127047,0,2,AMP transport,BP,
19870,GO:2000317,0.999999999994967,0.862829541677794,0,3,negative regulation of T-helper 17 type immune response,BP,
19873,GO:2000320,0.999999999994967,0.862829541677794,0,3,negative regulation of T-helper 17 cell differentiation,BP,
7238,GO:0031133,0.999999999995007,0.91165884572257,0,2,regulation of axon diameter,BP,
12232,GO:0048476,0.99999999999501,0.81638663791593,0,5,Holliday junction resolvase complex,CC,
2823,GO:0006287,0.999999999995042,0.786600476853121,0,5,base-excision repair, gap-filling,BP,
2052,GO:0004798,0.999999999995047,0.923480758021865,0,2,thymidylate kinase activity,MF,
2791,GO:0006227,0.999999999995047,0.923480758021865,0,2,dUDP biosynthetic process,BP,
2794,GO:0006233,0.999999999995047,0.923480758021865,0,2,dTDP biosynthetic process,BP,
4087,GO:0009139,0.999999999995047,0.923480758021865,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4138,GO:0009196,0.999999999995047,0.923480758021865,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4139,GO:0009197,0.999999999995047,0.923480758021865,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
11551,GO:0046072,0.999999999995047,0.923480758021865,0,2,dTDP metabolic process,BP,
11554,GO:0046077,0.999999999995047,0.923480758021865,0,2,dUDP metabolic process,BP,
16159,GO:0090158,0.999999999995047,0.792735488316895,0,5,endoplasmic reticulum membrane organization,BP,
12182,GO:0048294,0.999999999995067,0.903878300753591,0,2,negative regulation of isotype switching to IgE isotypes,BP,
1850,GO:0004506,0.999999999995102,0.953208095649826,0,1,squalene monooxygenase activity,MF,
578,GO:0001727,0.999999999995102,0.780610341238596,0,5,lipid kinase activity,MF,
11761,GO:0046598,0.999999999995106,0.78738860687123,0,6,positive regulation of viral entry into host cell,BP,
6686,GO:0030047,0.999999999995123,0.857503537008199,0,3,actin modification,BP,
15527,GO:0071894,0.999999999995125,0.909231512261787,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
928,GO:0002322,0.999999999995139,0.898088450774573,0,2,B cell proliferation involved in immune response,BP,
17078,GO:0099552,0.999999999995147,0.949649464610402,0,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
17079,GO:0099553,0.999999999995147,0.949649464610402,0,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
17414,GO:1900134,0.999999999995147,0.949649464610402,0,1,negative regulation of renin secretion into blood stream,BP,
12966,GO:0051316,0.999999999995151,0.910821625810571,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
2708,GO:0006072,0.999999999995161,0.69629753494895,0,7,glycerol-3-phosphate metabolic process,BP,
10300,GO:0043046,0.999999999995169,0.710578472075908,0,7,DNA methylation involved in gamete generation,BP,
10049,GO:0042500,0.99999999999517,0.748677268168142,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
1360,GO:0003228,0.999999999995173,0.871135808505868,0,3,atrial cardiac muscle tissue development,BP,
13488,GO:0055009,0.999999999995173,0.871135808505868,0,3,atrial cardiac muscle tissue morphogenesis,BP,
14859,GO:0070611,0.999999999995188,0.954208992539801,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14860,GO:0070612,0.999999999995188,0.954208992539801,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
8452,GO:0033577,0.999999999995201,0.910051670556495,0,2,protein glycosylation in endoplasmic reticulum,BP,
3851,GO:0008458,0.999999999995216,0.952161433007241,0,1,carnitine O-octanoyltransferase activity,MF,
5484,GO:0016414,0.999999999995216,0.952161433007241,0,1,O-octanoyltransferase activity,MF,
5485,GO:0016415,0.999999999995216,0.952161433007241,0,1,octanoyltransferase activity,MF,
310,GO:0000821,0.999999999995222,0.904203026643606,0,2,regulation of arginine metabolic process,BP,
8274,GO:0033065,0.999999999995235,0.928913714839069,0,2,Rad51C-XRCC3 complex,CC,
14806,GO:0070513,0.999999999995237,0.70938951052262,0,8,death domain binding,MF,
16778,GO:0098560,0.999999999995239,0.910065210626103,0,2,cytoplasmic side of late endosome membrane,CC,
11421,GO:0045820,0.999999999995252,0.744532697680545,0,6,negative regulation of glycolytic process,BP,
12888,GO:0051198,0.999999999995252,0.744532697680545,0,6,negative regulation of coenzyme metabolic process,BP,
16315,GO:0090416,0.99999999999526,0.954365083078698,0,1,nicotinate transmembrane transporter activity,MF,
20240,GO:2001142,0.99999999999526,0.954365083078698,0,1,nicotinate transport,BP,
3580,GO:0007625,0.99999999999526,0.784918448223675,0,6,grooming behavior,BP,
6271,GO:0019860,0.99999999999529,0.915218517610492,0,2,uracil metabolic process,BP,
5064,GO:0015272,0.9999999999953,0.952887627096825,0,1,ATP-activated inward rectifier potassium channel activity,MF,
4615,GO:0010729,0.9999999999953,0.95627644451742,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
18487,GO:1903569,0.999999999995302,0.954834489709942,0,1,positive regulation of protein localization to ciliary membrane,BP,
6523,GO:0021896,0.999999999995309,0.89621092565201,0,2,forebrain astrocyte differentiation,BP,
6524,GO:0021897,0.999999999995309,0.89621092565201,0,2,forebrain astrocyte development,BP,
20260,GO:2001180,0.999999999995314,0.909810181578513,0,2,negative regulation of interleukin-10 secretion,BP,
8530,GO:0033768,0.999999999995316,0.908502449617739,0,2,SUMO-targeted ubiquitin ligase complex,CC,
9876,GO:0042134,0.999999999995319,0.928522629144681,0,2,rRNA primary transcript binding,MF,
7107,GO:0030899,0.999999999995323,0.971705669061843,0,1,calcium-dependent ATPase activity,MF,
7396,GO:0031444,0.999999999995323,0.971705669061843,0,1,slow-twitch skeletal muscle fiber contraction,BP,
6344,GO:0021514,0.999999999995323,0.803369616724667,0,4,ventral spinal cord interneuron differentiation,BP,
19889,GO:2000342,0.999999999995327,0.910370261612037,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
14267,GO:0061303,0.999999999995329,0.830480007686894,0,4,cornea development in camera-type eye,BP,
15356,GO:0071568,0.999999999995331,0.924100512816704,0,2,UFM1 transferase activity,MF,
8787,GO:0034465,0.999999999995332,0.840222275515062,0,4,response to carbon monoxide,BP,
768,GO:0002017,0.999999999995335,0.957331522257409,0,1,regulation of blood volume by renal aldosterone,BP,
15094,GO:0071051,0.999999999995354,0.840906500319177,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
19551,GO:1990425,0.99999999999536,0.865864811012828,0,3,ryanodine receptor complex,CC,
3830,GO:0008427,0.999999999995364,0.928552957835832,0,2,calcium-dependent protein kinase inhibitor activity,MF,
4703,GO:0010858,0.999999999995364,0.928552957835832,0,2,calcium-dependent protein kinase regulator activity,MF,
15080,GO:0071030,0.999999999995377,0.914792037933719,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15092,GO:0071048,0.999999999995377,0.914792037933719,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
4243,GO:0009439,0.999999999995381,0.932570734659539,0,2,cyanate metabolic process,BP,
4244,GO:0009440,0.999999999995381,0.932570734659539,0,2,cyanate catabolic process,BP,
20302,GO:2001245,0.999999999995382,0.899594702791863,0,2,regulation of phosphatidylcholine biosynthetic process,BP,
46,GO:0000098,0.999999999995388,0.713615319930712,0,7,sulfur amino acid catabolic process,BP,
18330,GO:1903238,0.99999999999539,0.89780911100048,0,2,positive regulation of leukocyte tethering or rolling,BP,
9969,GO:0042352,0.99999999999539,0.949158421260315,0,1,GDP-L-fucose salvage,BP,
12465,GO:0050201,0.99999999999539,0.949158421260315,0,1,fucokinase activity,MF,
4253,GO:0009450,0.999999999995393,0.896516692372717,0,2,gamma-aminobutyric acid catabolic process,BP,
10008,GO:0042421,0.999999999995399,0.869201882089567,0,3,norepinephrine biosynthetic process,BP,
15082,GO:0071033,0.999999999995406,0.811874390195404,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
20220,GO:2001046,0.999999999995406,0.790972996410698,0,5,positive regulation of integrin-mediated signaling pathway,BP,
16133,GO:0090108,0.999999999995409,0.95601498131054,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16180,GO:0090187,0.999999999995409,0.95601498131054,0,1,positive regulation of pancreatic juice secretion,BP,
16286,GO:0090340,0.999999999995409,0.95601498131054,0,1,positive regulation of secretion of lysosomal enzymes,BP,
7640,GO:0032044,0.999999999995412,0.913997411726764,0,2,DSIF complex,CC,
15175,GO:0071283,0.99999999999543,0.929376493566483,0,2,cellular response to iron(III) ion,BP,
19899,GO:2000353,0.999999999995431,0.662334024621672,0,8,positive regulation of endothelial cell apoptotic process,BP,
8899,GO:0034715,0.999999999995444,0.81868198721685,0,6,pICln-Sm protein complex,CC,
6856,GO:0030321,0.999999999995464,0.903279551579568,0,2,transepithelial chloride transport,BP,
19269,GO:1905407,0.999999999995465,0.95201123248606,0,1,regulation of creatine transmembrane transporter activity,BP,
19270,GO:1905408,0.999999999995465,0.95201123248606,0,1,negative regulation of creatine transmembrane transporter activity,BP,
575,GO:0001715,0.999999999995482,0.949475877981691,0,1,ectodermal cell fate specification,BP,
10133,GO:0042665,0.999999999995482,0.949475877981691,0,1,regulation of ectodermal cell fate specification,BP,
10134,GO:0042666,0.999999999995482,0.949475877981691,0,1,negative regulation of ectodermal cell fate specification,BP,
19919,GO:2000383,0.999999999995482,0.949475877981691,0,1,regulation of ectoderm development,BP,
19920,GO:2000384,0.999999999995482,0.949475877981691,0,1,negative regulation of ectoderm development,BP,
1062,GO:0002587,0.999999999995485,0.964112835377276,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
10828,GO:0044317,0.999999999995485,0.964112835377276,0,1,rod spherule,CC,
1762,GO:0004362,0.999999999995508,0.955140299108032,0,1,glutathione-disulfide reductase activity,MF,
5198,GO:0015786,0.999999999995508,0.955140299108032,0,1,UDP-glucose transmembrane transport,BP,
12059,GO:0047915,0.999999999995512,0.959376251143392,0,1,ganglioside galactosyltransferase activity,MF,
13089,GO:0051583,0.999999999995513,0.791028673440316,0,6,dopamine uptake involved in synaptic transmission,BP,
13269,GO:0051934,0.999999999995513,0.791028673440316,0,6,catecholamine uptake involved in synaptic transmission,BP,
16325,GO:0090493,0.999999999995513,0.791028673440316,0,6,catecholamine uptake,BP,
16326,GO:0090494,0.999999999995513,0.791028673440316,0,6,dopamine uptake,BP,
17508,GO:1900453,0.999999999995558,0.914281100680619,0,2,negative regulation of long term synaptic depression,BP,
6424,GO:0021683,0.99999999999556,0.779290526811173,0,5,cerebellar granular layer morphogenesis,BP,
14406,GO:0061649,0.999999999995591,0.85697696559348,0,3,ubiquitin modification-dependent histone binding,MF,
4283,GO:0009646,0.999999999995594,0.951980052659567,0,1,response to absence of light,BP,
6959,GO:0030586,0.999999999995594,0.951980052659567,0,1,[methionine synthase] reductase activity,MF,
7351,GO:0031380,0.999999999995594,0.951980052659567,0,1,nuclear RNA-directed RNA polymerase complex,CC,
12499,GO:0050444,0.999999999995594,0.951980052659567,0,1,aquacobalamin reductase (NADPH) activity,MF,
15311,GO:0071485,0.999999999995594,0.951980052659567,0,1,cellular response to absence of light,BP,
18705,GO:1904041,0.999999999995594,0.951980052659567,0,1,regulation of cystathionine beta-synthase activity,BP,
18706,GO:1904042,0.999999999995594,0.951980052659567,0,1,negative regulation of cystathionine beta-synthase activity,BP,
19596,GO:1990603,0.999999999995594,0.951980052659567,0,1,dark adaptation,BP,
6170,GO:0019520,0.999999999995597,0.912376923523639,0,2,aldonic acid metabolic process,BP,
6171,GO:0019521,0.999999999995597,0.912376923523639,0,2,D-gluconate metabolic process,BP,
1935,GO:0004631,0.999999999995598,0.965493884701902,0,1,phosphomevalonate kinase activity,MF,
5845,GO:0017128,0.999999999995598,0.748577929257046,0,6,phospholipid scramblase activity,MF,
3257,GO:0006924,0.99999999999561,0.703840979999392,0,8,activation-induced cell death of T cells,BP,
7296,GO:0031289,0.999999999995613,0.953007560083544,0,1,actin phosphorylation,BP,
10579,GO:0043538,0.999999999995613,0.953007560083544,0,1,regulation of actin phosphorylation,BP,
1839,GO:0004491,0.999999999995617,0.955464081229624,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
4740,GO:0010904,0.999999999995617,0.955464081229624,0,1,regulation of UDP-glucose catabolic process,BP,
4741,GO:0010905,0.999999999995617,0.955464081229624,0,1,negative regulation of UDP-glucose catabolic process,BP,
5980,GO:0018478,0.999999999995617,0.955464081229624,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
18767,GO:1904226,0.999999999995617,0.955464081229624,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18768,GO:1904227,0.999999999995617,0.955464081229624,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
14413,GO:0061669,0.999999999995618,0.896894899092886,0,2,spontaneous neurotransmitter secretion,BP,
12501,GO:0050473,0.999999999995626,0.904130715702358,0,2,arachidonate 15-lipoxygenase activity,MF,
18957,GO:1904690,0.999999999995636,0.826699469019995,0,4,positive regulation of cytoplasmic translational initiation,BP,
19286,GO:1905449,0.999999999995644,0.906424777033379,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19287,GO:1905451,0.999999999995644,0.906424777033379,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19636,GO:1990758,0.999999999995656,0.957738156882701,0,1,mitotic sister chromatid biorientation,BP,
2232,GO:0005134,0.999999999995659,0.870037789260593,0,3,interleukin-2 receptor binding,MF,
11579,GO:0046122,0.999999999995667,0.934084951987041,0,2,purine deoxyribonucleoside metabolic process,BP,
12234,GO:0048478,0.999999999995676,0.714471389703364,0,7,replication fork protection,BP,
7958,GO:0032552,0.999999999995682,0.785095193145753,0,6,deoxyribonucleotide binding,MF,
5259,GO:0015884,0.999999999995683,0.797911678441153,0,5,folic acid transport,BP,
12351,GO:0048703,0.999999999995688,0.701095147977218,0,7,embryonic viscerocranium morphogenesis,BP,
10924,GO:0044530,0.999999999995705,0.856792628357281,0,3,supraspliceosomal complex,CC,
4868,GO:0014717,0.999999999995714,0.917693857070126,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4869,GO:0014718,0.999999999995714,0.917693857070126,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4943,GO:0014901,0.999999999995714,0.917693857070126,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
15866,GO:0072570,0.999999999995722,0.952207369935545,0,1,ADP-D-ribose binding,MF,
10689,GO:0043950,0.999999999995736,0.775096418083866,0,5,positive regulation of cAMP-mediated signaling,BP,
7729,GO:0032216,0.999999999995739,0.955203563523162,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
18292,GO:1903147,0.999999999995759,0.688414230298553,0,8,negative regulation of autophagy of mitochondrion,BP,
1752,GO:0004349,0.99999999999579,0.951162579552335,0,1,glutamate 5-kinase activity,MF,
1753,GO:0004350,0.99999999999579,0.951162579552335,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
3041,GO:0006592,0.99999999999579,0.951162579552335,0,1,ornithine biosynthetic process,BP,
5822,GO:0017084,0.99999999999579,0.951162579552335,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6059,GO:0019202,0.99999999999579,0.951162579552335,0,1,amino acid kinase activity,MF,
13976,GO:0060668,0.999999999995792,0.950483019926699,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
1881,GO:0004557,0.999999999995796,0.915085504659332,0,2,alpha-galactosidase activity,MF,
14629,GO:0070187,0.999999999995802,0.753542898548895,0,6,shelterin complex,CC,
17475,GO:1900262,0.999999999995814,0.769134844921519,0,6,regulation of DNA-directed DNA polymerase activity,BP,
17476,GO:1900264,0.999999999995814,0.769134844921519,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
9229,GO:0035614,0.999999999995831,0.885018042152619,0,3,snRNA stem-loop binding,MF,
13213,GO:0051818,0.999999999995842,0.780614393807823,0,6,disruption of cells of other organism involved in symbiotic interaction,BP,
13236,GO:0051883,0.999999999995842,0.780614393807823,0,6,killing of cells in other organism involved in symbiotic interaction,BP,
9176,GO:0035538,0.999999999995854,0.952132885818476,0,1,carbohydrate response element binding,MF,
6888,GO:0030388,0.999999999995854,0.837983063401992,0,4,fructose 1,6-bisphosphate metabolic process,BP,
14668,GO:0070257,0.999999999995859,0.763132950462473,0,6,positive regulation of mucus secretion,BP,
6767,GO:0030197,0.999999999995873,0.947664818178191,0,1,extracellular matrix constituent, lubricant activity,MF,
12019,GO:0047498,0.999999999995876,0.742952777291829,0,6,calcium-dependent phospholipase A2 activity,MF,
15158,GO:0071253,0.999999999995877,0.780084524482402,0,5,connexin binding,MF,
14599,GO:0070138,0.999999999995877,0.856196038705479,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
14601,GO:0070140,0.999999999995877,0.856196038705479,0,3,SUMO-specific isopeptidase activity,MF,
4887,GO:0014802,0.999999999995883,0.874422416433571,0,3,terminal cisterna,CC,
2731,GO:0006108,0.999999999995886,0.769449224310829,0,6,malate metabolic process,BP,
1601,GO:0004017,0.999999999995886,0.7852050166126,0,5,adenylate kinase activity,MF,
14430,GO:0061723,0.999999999995887,0.903714627543675,0,2,glycophagy,BP,
438,GO:0001172,0.999999999995898,0.939070443873629,0,2,transcription, RNA-templated,BP,
1567,GO:0003968,0.999999999995898,0.939070443873629,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
17487,GO:1900369,0.999999999995898,0.939070443873629,0,2,negative regulation of RNA interference,BP,
8178,GO:0032911,0.999999999995903,0.8575072932766,0,3,negative regulation of transforming growth factor beta1 production,BP,
13673,GO:0060171,0.99999999999591,0.947090031167632,0,1,stereocilium membrane,CC,
14739,GO:0070384,0.999999999995917,0.860897762852554,0,3,Harderian gland development,BP,
15310,GO:0071484,0.999999999995919,0.901259223704502,0,2,cellular response to light intensity,BP,
5151,GO:0015680,0.999999999995924,0.9058615652106,0,3,intracellular copper ion transport,BP,
5092,GO:0015349,0.999999999995924,0.904034533971341,0,2,thyroid hormone transmembrane transporter activity,MF,
20247,GO:2001160,0.999999999995931,0.917134224400467,0,2,regulation of histone H3-K79 methylation,BP,
20248,GO:2001162,0.999999999995931,0.917134224400467,0,2,positive regulation of histone H3-K79 methylation,BP,
8650,GO:0034190,0.999999999995935,0.821853230312886,0,4,apolipoprotein receptor binding,MF,
18821,GO:1904354,0.999999999995936,0.659919568135356,0,8,negative regulation of telomere capping,BP,
9619,GO:0036481,0.99999999999594,0.777825943479798,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
4966,GO:0015038,0.999999999995942,0.843498466989717,0,5,glutathione disulfide oxidoreductase activity,MF,
3710,GO:0008218,0.999999999995953,0.951102346152854,0,1,bioluminescence,BP,
16158,GO:0090156,0.999999999995955,0.881371314958391,0,3,cellular sphingolipid homeostasis,BP,
19135,GO:1905049,0.999999999995966,0.746437172588166,0,6,negative regulation of metallopeptidase activity,BP,
13611,GO:0060066,0.999999999995986,0.91236899824511,0,2,oviduct development,BP,
14591,GO:0070124,0.999999999995994,0.925967120002758,0,2,mitochondrial translational initiation,BP,
4557,GO:0010635,0.999999999996,0.684146824880432,0,8,regulation of mitochondrial fusion,BP,
1285,GO:0003084,0.999999999996003,0.770681400581903,0,6,positive regulation of systemic arterial blood pressure,BP,
603,GO:0001768,0.999999999996027,0.772884492710376,0,5,establishment of T cell polarity,BP,
19484,GO:1990164,0.999999999996038,0.908740746197215,0,2,histone H2A phosphorylation,BP,
2201,GO:0005078,0.999999999996041,0.690403543199546,0,7,MAP-kinase scaffold activity,MF,
5559,GO:0016561,0.999999999996042,0.910048810113009,0,2,protein import into peroxisome matrix, translocation,BP,
3974,GO:0008781,0.999999999996052,0.926676396027891,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
15399,GO:0071635,0.99999999999606,0.741271471799753,0,6,negative regulation of transforming growth factor beta production,BP,
15422,GO:0071673,0.999999999996081,0.952693625052879,0,1,positive regulation of smooth muscle cell chemotaxis,BP,
18900,GO:1904565,0.999999999996081,0.952693625052879,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18901,GO:1904566,0.999999999996081,0.952693625052879,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
772,GO:0002024,0.999999999996094,0.782647724105894,0,5,diet induced thermogenesis,BP,
423,GO:0001128,0.999999999996107,0.964587841474762,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
1986,GO:0004703,0.999999999996126,0.909813460698455,0,2,G-protein coupled receptor kinase activity,MF,
12039,GO:0047696,0.999999999996126,0.909813460698455,0,2,beta-adrenergic receptor kinase activity,MF,
5446,GO:0016309,0.999999999996136,0.856357051495821,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
13010,GO:0051414,0.99999999999614,0.77881087733473,0,5,response to cortisol,BP,
6845,GO:0030306,0.999999999996147,0.72872961614958,0,6,ADP-ribosylation factor binding,MF,
19335,GO:1905595,0.999999999996164,0.912302299110855,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
19609,GO:1990667,0.999999999996164,0.912302299110855,0,2,PCSK9-AnxA2 complex,CC,
14627,GO:0070183,0.999999999996178,0.95376696698552,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
17973,GO:1902311,0.999999999996184,0.958349618139277,0,1,regulation of copper ion transmembrane transport,BP,
14485,GO:0061851,0.999999999996203,0.954021447838375,0,1,leading edge of lamellipodium,CC,
18813,GO:1904328,0.999999999996203,0.954021447838375,0,1,regulation of myofibroblast contraction,BP,
19639,GO:1990764,0.999999999996203,0.954021447838375,0,1,myofibroblast contraction,BP,
3491,GO:0007371,0.999999999996205,0.949928092339461,0,1,ventral midline determination,BP,
13709,GO:0060245,0.999999999996205,0.949928092339461,0,1,detection of cell density,BP,
13710,GO:0060246,0.999999999996205,0.949928092339461,0,1,detection of cell density by contact stimulus,BP,
13711,GO:0060248,0.999999999996205,0.949928092339461,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14216,GO:0061113,0.999999999996205,0.949928092339461,0,1,pancreas morphogenesis,BP,
15587,GO:0072036,0.999999999996205,0.949928092339461,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15735,GO:0072285,0.999999999996205,0.949928092339461,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
1746,GO:0004343,0.999999999996212,0.949146584303968,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
2983,GO:0006526,0.999999999996221,0.784868346731935,0,5,arginine biosynthetic process,BP,
9404,GO:0035947,0.999999999996226,0.776169744987311,0,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
5708,GO:0016832,0.99999999999623,0.72816769591241,0,7,aldehyde-lyase activity,MF,
14582,GO:0070103,0.999999999996235,0.959109911380359,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14583,GO:0070104,0.999999999996235,0.959109911380359,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
17915,GO:1902205,0.999999999996235,0.959109911380359,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17916,GO:1902206,0.999999999996235,0.959109911380359,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17920,GO:1902215,0.999999999996235,0.959109911380359,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17929,GO:1902227,0.999999999996235,0.959109911380359,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17935,GO:1902233,0.999999999996235,0.959109911380359,0,1,negative regulation of positive thymic T cell selection,BP,
18670,GO:1903970,0.999999999996235,0.959109911380359,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18673,GO:1903973,0.999999999996235,0.959109911380359,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
3689,GO:0008193,0.999999999996255,0.915618777770244,0,2,tRNA guanylyltransferase activity,MF,
5806,GO:0017055,0.999999999996261,0.908281257597249,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
16671,GO:0097534,0.999999999996266,0.903188989022577,0,2,lymphoid lineage cell migration,BP,
16672,GO:0097535,0.999999999996266,0.903188989022577,0,2,lymphoid lineage cell migration into thymus,BP,
8248,GO:0033018,0.999999999996274,0.910573580971726,0,2,sarcoplasmic reticulum lumen,CC,
13233,GO:0051880,0.999999999996302,0.690751522654969,0,7,G-quadruplex DNA binding,MF,
11908,GO:0046922,0.999999999996308,0.906821388607003,0,2,peptide-O-fucosyltransferase activity,MF,
11989,GO:0047277,0.99999999999631,0.956790797079376,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
8381,GO:0033277,0.999999999996322,0.904242770331025,0,2,abortive mitotic cell cycle,BP,
18412,GO:1903422,0.999999999996323,0.85141755005152,0,3,negative regulation of synaptic vesicle recycling,BP,
19459,GO:1990050,0.999999999996325,0.780801569402234,0,6,phosphatidic acid transporter activity,MF,
17818,GO:1901897,0.999999999996326,0.852964064973339,0,3,regulation of relaxation of cardiac muscle,BP,
64,GO:0000127,0.999999999996349,0.755600157647223,0,6,transcription factor TFIIIC complex,CC,
10195,GO:0042791,0.999999999996349,0.755600157647223,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10198,GO:0042797,0.999999999996349,0.755600157647223,0,6,tRNA transcription by RNA polymerase III,BP,
19929,GO:2000395,0.999999999996353,0.934178415441091,0,2,regulation of ubiquitin-dependent endocytosis,BP,
19930,GO:2000397,0.999999999996353,0.934178415441091,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
7172,GO:0031048,0.999999999996355,0.903450770630756,0,2,chromatin silencing by small RNA,BP,
10136,GO:0042670,0.999999999996359,0.859108389903057,0,3,retinal cone cell differentiation,BP,
11746,GO:0046549,0.999999999996359,0.859108389903057,0,3,retinal cone cell development,BP,
5989,GO:0018894,0.999999999996361,0.867409775887835,0,3,dibenzo-p-dioxin metabolic process,BP,
462,GO:0001405,0.999999999996363,0.799399987997414,0,5,presequence translocase-associated import motor,CC,
3752,GO:0008291,0.999999999996364,0.954187073573686,0,1,acetylcholine metabolic process,BP,
3753,GO:0008292,0.999999999996364,0.954187073573686,0,1,acetylcholine biosynthetic process,BP,
5249,GO:0015870,0.999999999996364,0.954187073573686,0,1,acetylcholine transport,BP,
7910,GO:0032475,0.999999999996364,0.954187073573686,0,1,otolith formation,BP,
9268,GO:0035675,0.999999999996364,0.954187073573686,0,1,neuromast hair cell development,BP,
12439,GO:0048882,0.999999999996364,0.954187073573686,0,1,lateral line development,BP,
12440,GO:0048884,0.999999999996364,0.954187073573686,0,1,neuromast development,BP,
12441,GO:0048886,0.999999999996364,0.954187073573686,0,1,neuromast hair cell differentiation,BP,
12442,GO:0048925,0.999999999996364,0.954187073573686,0,1,lateral line system development,BP,
14351,GO:0061526,0.999999999996364,0.954187073573686,0,1,acetylcholine secretion,BP,
17516,GO:1900619,0.999999999996364,0.954187073573686,0,1,acetate ester metabolic process,BP,
17517,GO:1900620,0.999999999996364,0.954187073573686,0,1,acetate ester biosynthetic process,BP,
17655,GO:1901374,0.999999999996364,0.954187073573686,0,1,acetate ester transport,BP,
6454,GO:0021768,0.999999999996375,0.951028177845529,0,1,nucleus accumbens development,BP,
17532,GO:1900756,0.999999999996381,0.903105459372423,0,2,protein processing in phagocytic vesicle,BP,
18646,GO:1903921,0.999999999996381,0.903105459372423,0,2,regulation of protein processing in phagocytic vesicle,BP,
18647,GO:1903923,0.999999999996381,0.903105459372423,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
167,GO:0000347,0.999999999996381,0.774861739630216,0,6,THO complex,CC,
213,GO:0000445,0.999999999996381,0.774861739630216,0,6,THO complex part of transcription export complex,CC,
7495,GO:0031659,0.999999999996393,0.775537528149989,0,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
1903,GO:0004584,0.999999999996406,0.954851247967946,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
5949,GO:0018277,0.999999999996406,0.954851247967946,0,1,protein deamination,BP,
43,GO:0000095,0.999999999996417,0.955292168426974,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
5210,GO:0015805,0.999999999996417,0.955292168426974,0,1,S-adenosyl-L-methionine transport,BP,
17829,GO:1901962,0.999999999996417,0.955292168426974,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
16646,GO:0097493,0.999999999996436,0.719713777124423,0,6,structural molecule activity conferring elasticity,MF,
1218,GO:0002885,0.999999999996442,0.91247669533919,0,2,positive regulation of hypersensitivity,BP,
4611,GO:0010724,0.99999999999645,0.859934510237481,0,3,regulation of definitive erythrocyte differentiation,BP,
587,GO:0001739,0.999999999996459,0.753508711111641,0,6,sex chromatin,CC,
9356,GO:0035865,0.999999999996463,0.886370908420462,0,3,cellular response to potassium ion,BP,
9391,GO:0035926,0.999999999996464,0.785831096326031,0,5,chemokine (C-C motif) ligand 2 secretion,BP,
626,GO:0001807,0.999999999996504,0.921537884476363,0,2,regulation of type IV hypersensitivity,BP,
18113,GO:1902731,0.999999999996517,0.896186232818407,0,2,negative regulation of chondrocyte proliferation,BP,
10171,GO:0042754,0.999999999996525,0.642496806899578,0,9,negative regulation of circadian rhythm,BP,
3538,GO:0007538,0.999999999996527,0.898557394114853,0,2,primary sex determination,BP,
3539,GO:0007542,0.999999999996527,0.898557394114853,0,2,primary sex determination, germ-line,BP,
5996,GO:0018992,0.999999999996527,0.898557394114853,0,2,germ-line sex determination,BP,
6036,GO:0019100,0.999999999996527,0.898557394114853,0,2,male germ-line sex determination,BP,
179,GO:0000389,0.999999999996527,0.75270681394157,0,6,mRNA 3'-splice site recognition,BP,
19195,GO:1905224,0.999999999996533,0.89692807979685,0,2,clathrin-coated pit assembly,BP,
16701,GO:0097636,0.999999999996539,0.904410502511574,0,2,intrinsic component of autophagosome membrane,CC,
16702,GO:0097637,0.999999999996539,0.904410502511574,0,2,integral component of autophagosome membrane,CC,
15056,GO:0070990,0.999999999996571,0.785885613548796,0,6,snRNP binding,MF,
11561,GO:0046086,0.999999999996576,0.907015856059554,0,2,adenosine biosynthetic process,BP,
352,GO:0000965,0.99999999999658,0.801348431997822,0,5,mitochondrial RNA 3'-end processing,BP,
7556,GO:0031862,0.99999999999658,0.89887265507114,0,2,prostanoid receptor binding,MF,
3645,GO:0008118,0.999999999996594,0.955305514047668,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
12022,GO:0047536,0.999999999996594,0.955305514047668,0,1,2-aminoadipate transaminase activity,MF,
18431,GO:1903445,0.999999999996606,0.885931753772994,0,3,protein transport from ciliary membrane to plasma membrane,BP,
13799,GO:0060371,0.999999999996607,0.859303920530466,0,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,
11044,GO:0045008,0.999999999996615,0.709345612794285,0,8,depyrimidination,BP,
5991,GO:0018916,0.999999999996615,0.854713702248835,0,4,nitrobenzene metabolic process,BP,
12372,GO:0048742,0.999999999996622,0.772605959354256,0,5,regulation of skeletal muscle fiber development,BP,
8345,GO:0033192,0.999999999996623,0.772637390544884,0,5,calmodulin-dependent protein phosphatase activity,MF,
17919,GO:1902214,0.999999999996647,0.907958031095331,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
16748,GO:0097752,0.999999999996648,0.867268044966628,0,3,regulation of DNA stability,BP,
4011,GO:0008973,0.999999999996666,0.952183335534462,0,1,phosphopentomutase activity,MF,
10836,GO:0044326,0.999999999996674,0.906446183291789,0,2,dendritic spine neck,CC,
4848,GO:0014052,0.999999999996676,0.851073040372839,0,3,regulation of gamma-aminobutyric acid secretion,BP,
6744,GO:0030158,0.999999999996678,0.858180551617215,0,3,protein xylosyltransferase activity,MF,
10330,GO:0043117,0.999999999996687,0.86292547111808,0,3,positive regulation of vascular permeability,BP,
9419,GO:0035983,0.999999999996695,0.867021277908313,0,3,response to trichostatin A,BP,
9420,GO:0035984,0.999999999996695,0.867021277908313,0,3,cellular response to trichostatin A,BP,
9265,GO:0035672,0.999999999996699,0.743205473822984,0,6,oligopeptide transmembrane transport,BP,
8058,GO:0032714,0.999999999996701,0.903857812385117,0,2,negative regulation of interleukin-5 production,BP,
2013,GO:0004736,0.999999999996734,0.94879534589495,0,1,pyruvate carboxylase activity,MF,
3425,GO:0007214,0.999999999996739,0.74289446190501,0,6,gamma-aminobutyric acid signaling pathway,BP,
13483,GO:0055003,0.99999999999674,0.64594294960437,0,8,cardiac myofibril assembly,BP,
10235,GO:0042923,0.999999999996741,0.91437920941126,0,2,neuropeptide binding,MF,
1633,GO:0004069,0.999999999996773,0.912338249542291,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
2988,GO:0006532,0.999999999996773,0.912338249542291,0,2,aspartate biosynthetic process,BP,
2989,GO:0006533,0.999999999996773,0.912338249542291,0,2,aspartate catabolic process,BP,
6183,GO:0019550,0.999999999996773,0.912338249542291,0,2,glutamate catabolic process to aspartate,BP,
6184,GO:0019551,0.999999999996773,0.912338249542291,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
16016,GO:0086013,0.999999999996785,0.706252584377095,0,7,membrane repolarization during cardiac muscle cell action potential,BP,
5491,GO:0016421,0.99999999999679,0.743041607682028,0,6,CoA carboxylase activity,MF,
2596,GO:0005889,0.999999999996801,0.9037461429733,0,2,potassium:proton exchanging ATPase complex,CC,
7281,GO:0031260,0.999999999996827,0.969985605806513,0,1,pseudopodium membrane,CC,
14215,GO:0061110,0.99999999999683,0.899608928454622,0,2,dense core granule biogenesis,BP,
20092,GO:2000705,0.99999999999683,0.899608928454622,0,2,regulation of dense core granule biogenesis,BP,
12474,GO:0050290,0.999999999996834,0.947106073864687,0,1,sphingomyelin phosphodiesterase D activity,MF,
5774,GO:0016971,0.999999999996838,0.862333679736928,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6224,GO:0019755,0.999999999996841,0.830709071882939,0,4,one-carbon compound transport,BP,
12266,GO:0048537,0.999999999996846,0.786526496947499,0,5,mucosal-associated lymphoid tissue development,BP,
12269,GO:0048541,0.999999999996846,0.786526496947499,0,5,Peyer's patch development,BP,
10928,GO:0044539,0.999999999996849,0.85809855117568,0,3,long-chain fatty acid import,BP,
6467,GO:0021784,0.999999999996854,0.980061563497208,0,1,postganglionic parasympathetic fiber development,BP,
2012,GO:0004735,0.999999999996859,0.918217852033212,0,2,pyrroline-5-carboxylate reductase activity,MF,
2542,GO:0005797,0.999999999996916,0.731085075972463,0,7,Golgi medial cisterna,CC,
2284,GO:0005234,0.999999999996917,0.946797901443607,0,1,extracellularly glutamate-gated ion channel activity,MF,
6627,GO:0022849,0.999999999996917,0.946797901443607,0,1,glutamate-gated calcium ion channel activity,MF,
5809,GO:0017059,0.99999999999692,0.689505894346941,0,8,serine C-palmitoyltransferase complex,CC,
7257,GO:0031211,0.99999999999692,0.689505894346941,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
19440,GO:1905961,0.99999999999692,0.689505894346941,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
19801,GO:2000194,0.99999999999693,0.737875503367506,0,7,regulation of female gonad development,BP,
14973,GO:0070857,0.999999999996938,0.78664032895598,0,5,regulation of bile acid biosynthetic process,BP,
6697,GO:0030070,0.999999999996941,0.861767163328517,0,3,insulin processing,BP,
15115,GO:0071148,0.99999999999695,0.896225801123522,0,2,TEAD-1-YAP complex,CC,
1666,GO:0004122,0.999999999996956,0.954285009763213,0,1,cystathionine beta-synthase activity,MF,
2991,GO:0006535,0.999999999996956,0.954285009763213,0,1,cysteine biosynthetic process from serine,BP,
4054,GO:0009093,0.999999999996956,0.954285009763213,0,1,cysteine catabolic process,BP,
5618,GO:0016662,0.999999999996956,0.954285009763213,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
6155,GO:0019448,0.999999999996956,0.954285009763213,0,1,L-cysteine catabolic process,BP,
12490,GO:0050421,0.999999999996956,0.954285009763213,0,1,nitrite reductase (NO-forming) activity,MF,
14536,GO:0070025,0.999999999996956,0.954285009763213,0,1,carbon monoxide binding,MF,
16888,GO:0098809,0.999999999996956,0.954285009763213,0,1,nitrite reductase activity,MF,
17815,GO:1901894,0.999999999996957,0.869387695162032,0,3,regulation of calcium-transporting ATPase activity,BP,
470,GO:0001512,0.999999999996965,0.96870752077158,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
18845,GO:1904408,0.999999999996965,0.96870752077158,0,1,melatonin binding,MF,
19334,GO:1905594,0.999999999996965,0.96870752077158,0,1,resveratrol binding,MF,
18566,GO:1903760,0.999999999996974,0.898515989955363,0,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19120,GO:1905024,0.999999999996974,0.898515989955363,0,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
2355,GO:0005432,0.999999999996976,0.862208787593698,0,3,calcium:sodium antiporter activity,MF,
9184,GO:0035553,0.999999999996994,0.866500044000639,0,3,oxidative single-stranded RNA demethylation,BP,
11274,GO:0045541,0.999999999996995,0.814400074031172,0,5,negative regulation of cholesterol biosynthetic process,BP,
16198,GO:0090206,0.999999999996995,0.814400074031172,0,5,negative regulation of cholesterol metabolic process,BP,
8676,GO:0034245,0.999999999997014,0.94960674322057,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
18485,GO:1903567,0.999999999997017,0.908503201859991,0,2,regulation of protein localization to ciliary membrane,BP,
5311,GO:0016013,0.999999999997027,0.903980408202422,0,2,syntrophin complex,CC,
1163,GO:0002774,0.999999999997043,0.952940265161573,0,1,Fc receptor mediated inhibitory signaling pathway,BP,
14889,GO:0070667,0.999999999997043,0.952940265161573,0,1,negative regulation of mast cell proliferation,BP,
1598,GO:0004013,0.999999999997047,0.857921563441794,0,3,adenosylhomocysteinase activity,MF,
5690,GO:0016802,0.999999999997047,0.857921563441794,0,3,trialkylsulfonium hydrolase activity,MF,
16459,GO:0097109,0.99999999999705,0.898979688900489,0,2,neuroligin family protein binding,MF,
6000,GO:0019002,0.999999999997068,0.908910478553349,0,2,GMP binding,MF,
1989,GO:0004706,0.999999999997071,0.856148350534189,0,3,JUN kinase kinase kinase activity,MF,
4718,GO:0010877,0.999999999997072,0.924510771668037,0,2,lipid transport involved in lipid storage,BP,
17457,GO:1900222,0.999999999997081,0.910767564277266,0,2,negative regulation of amyloid-beta clearance,BP,
9810,GO:0040034,0.999999999997094,0.727539685171753,0,7,regulation of development, heterochronic,BP,
4783,GO:0010966,0.999999999997099,0.849924981544173,0,3,regulation of phosphate transport,BP,
2178,GO:0005011,0.999999999997104,0.947062623985585,0,1,macrophage colony-stimulating factor receptor activity,MF,
5150,GO:0015679,0.999999999997109,0.896559929317004,0,2,plasma membrane copper ion transport,BP,
11975,GO:0047179,0.999999999997127,0.938731038442619,0,2,platelet-activating factor acetyltransferase activity,MF,
1665,GO:0004118,0.999999999997129,0.94819925391321,0,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
14190,GO:0061072,0.999999999997135,0.750030682141872,0,6,iris morphogenesis,BP,
12773,GO:0051029,0.999999999997144,0.789735499517579,0,6,rRNA transport,BP,
2035,GO:0004772,0.999999999997146,0.951481132664703,0,1,sterol O-acyltransferase activity,MF,
8910,GO:0034736,0.999999999997146,0.951481132664703,0,1,cholesterol O-acyltransferase activity,MF,
18483,GO:1903565,0.999999999997146,0.951481132664703,0,1,negative regulation of protein localization to cilium,BP,
18486,GO:1903568,0.999999999997146,0.951481132664703,0,1,negative regulation of protein localization to ciliary membrane,BP,
19016,GO:1904799,0.999999999997153,0.949033716377971,0,1,regulation of neuron remodeling,BP,
19017,GO:1904800,0.999999999997153,0.949033716377971,0,1,negative regulation of neuron remodeling,BP,
19790,GO:2000173,0.999999999997153,0.949033716377971,0,1,negative regulation of branching morphogenesis of a nerve,BP,
7747,GO:0032252,0.999999999997156,0.854726434291198,0,3,secretory granule localization,BP,
8756,GO:0034416,0.999999999997171,0.909383299805327,0,2,bisphosphoglycerate phosphatase activity,MF,
1965,GO:0004671,0.999999999997177,0.947029807151017,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
10208,GO:0042819,0.999999999997187,0.860613995921135,0,3,vitamin B6 biosynthetic process,BP,
13598,GO:0060051,0.99999999999719,0.914751236529933,0,2,negative regulation of protein glycosylation,BP,
16248,GO:0090285,0.99999999999719,0.914751236529933,0,2,negative regulation of protein glycosylation in Golgi,BP,
677,GO:0001884,0.99999999999719,0.903508852846902,0,2,pyrimidine nucleoside binding,MF,
837,GO:0002134,0.99999999999719,0.903508852846902,0,2,UTP binding,MF,
7957,GO:0032551,0.99999999999719,0.903508852846902,0,2,pyrimidine ribonucleoside binding,MF,
13624,GO:0060080,0.999999999997196,0.721698710471591,0,6,inhibitory postsynaptic potential,BP,
16481,GO:0097151,0.999999999997196,0.721698710471591,0,6,positive regulation of inhibitory postsynaptic potential,BP,
16898,GO:0098828,0.999999999997196,0.721698710471591,0,6,modulation of inhibitory postsynaptic potential,BP,
17466,GO:1900242,0.999999999997201,0.733415483091538,0,6,regulation of synaptic vesicle endocytosis,BP,
13724,GO:0060267,0.999999999997202,0.883436382742396,0,3,positive regulation of respiratory burst,BP,
9548,GO:0036301,0.999999999997204,0.866185108114684,0,3,macrophage colony-stimulating factor production,BP,
17612,GO:1901256,0.999999999997204,0.866185108114684,0,3,regulation of macrophage colony-stimulating factor production,BP,
1612,GO:0004032,0.999999999997207,0.829153136308191,0,5,alditol:NADP+ 1-oxidoreductase activity,MF,
18521,GO:1903650,0.999999999997211,0.945137484897962,0,2,negative regulation of cytoplasmic transport,BP,
20046,GO:2000642,0.999999999997211,0.945137484897962,0,2,negative regulation of early endosome to late endosome transport,BP,
1672,GO:0004132,0.999999999997215,0.956249060793528,0,1,dCMP deaminase activity,MF,
17909,GO:1902177,0.999999999997218,0.813789571138417,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17056,GO:0099522,0.999999999997222,0.956227956746719,0,1,region of cytosol,CC,
17057,GO:0099523,0.999999999997222,0.956227956746719,0,1,presynaptic cytosol,CC,
17058,GO:0099524,0.999999999997222,0.956227956746719,0,1,postsynaptic cytosol,CC,
18998,GO:1904764,0.999999999997222,0.956227956746719,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
19661,GO:1990832,0.999999999997222,0.956227956746719,0,1,slow axonal transport,BP,
19662,GO:1990833,0.999999999997222,0.956227956746719,0,1,clathrin-uncoating ATPase activity,MF,
5214,GO:0015810,0.999999999997226,0.90365258599484,0,2,aspartate transmembrane transport,BP,
10546,GO:0043490,0.999999999997226,0.90365258599484,0,2,malate-aspartate shuttle,BP,
513,GO:0001576,0.999999999997228,0.955917820481454,0,1,globoside biosynthetic process,BP,
1553,GO:0003948,0.999999999997228,0.955917820481454,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
12508,GO:0050512,0.999999999997228,0.955917820481454,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
9880,GO:0042138,0.999999999997232,0.954932228280369,0,1,meiotic DNA double-strand break formation,BP,
10502,GO:0043400,0.999999999997234,0.925281034241929,0,2,cortisol secretion,BP,
13039,GO:0051462,0.999999999997234,0.925281034241929,0,2,regulation of cortisol secretion,BP,
180,GO:0000390,0.999999999997241,0.922517559983512,0,2,spliceosomal complex disassembly,BP,
16302,GO:0090385,0.999999999997244,0.76166195398563,0,6,phagosome-lysosome fusion,BP,
17373,GO:1900062,0.999999999997251,0.950043556598588,0,1,regulation of replicative cell aging,BP,
5502,GO:0016436,0.999999999997256,0.906054986967159,0,2,rRNA (uridine) methyltransferase activity,MF,
4731,GO:0010890,0.999999999997257,0.921643580525893,0,2,positive regulation of sequestering of triglyceride,BP,
1491,GO:0003826,0.999999999997257,0.914428666306296,0,2,alpha-ketoacid dehydrogenase activity,MF,
1509,GO:0003863,0.999999999997257,0.914428666306296,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
17413,GO:1900133,0.999999999997293,0.862588319882609,0,3,regulation of renin secretion into blood stream,BP,
8656,GO:0034201,0.999999999997296,0.792019129509729,0,5,response to oleic acid,BP,
6479,GO:0021815,0.999999999997318,0.770517323791117,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
8951,GO:0034992,0.999999999997318,0.770517323791117,0,5,microtubule organizing center attachment site,CC,
8952,GO:0034993,0.999999999997318,0.770517323791117,0,5,meiotic nuclear membrane microtubule tethering complex,CC,
16249,GO:0090286,0.999999999997318,0.770517323791117,0,5,cytoskeletal anchoring at nuclear membrane,BP,
17231,GO:0106083,0.999999999997318,0.770517323791117,0,5,nuclear membrane protein complex,CC,
17234,GO:0106094,0.999999999997318,0.770517323791117,0,5,nuclear membrane microtubule tethering complex,CC,
17289,GO:0140009,0.999999999997325,0.950318567803522,0,1,L-aspartate import across plasma membrane,BP,
1924,GO:0004615,0.999999999997343,0.922229399739683,0,2,phosphomannomutase activity,MF,
15675,GO:0072179,0.999999999997351,0.913126696412219,0,2,nephric duct formation,BP,
3682,GO:0008184,0.999999999997354,0.904557606682302,0,2,glycogen phosphorylase activity,MF,
17145,GO:0102250,0.999999999997354,0.904557606682302,0,2,linear malto-oligosaccharide phosphorylase activity,MF,
17167,GO:0102499,0.999999999997354,0.904557606682302,0,2,SHG alpha-glucan phosphorylase activity,MF,
10562,GO:0043515,0.999999999997362,0.785692660013529,0,5,kinetochore binding,MF,
16942,GO:0098908,0.999999999997362,0.904859556283975,0,2,regulation of neuronal action potential,BP,
9821,GO:0042023,0.999999999997367,0.659343514441568,0,8,DNA endoreduplication,BP,
15788,GO:0072378,0.999999999997371,0.736392846802384,0,7,blood coagulation, fibrin clot formation,BP,
6473,GO:0021798,0.999999999997376,0.896422333865921,0,2,forebrain dorsal/ventral pattern formation,BP,
15809,GO:0072429,0.999999999997386,0.869329672757263,0,3,response to intra-S DNA damage checkpoint signaling,BP,
651,GO:0001839,0.999999999997405,0.779545892413571,0,5,neural plate morphogenesis,BP,
2316,GO:0005314,0.99999999999742,0.906532700940445,0,2,high-affinity glutamate transmembrane transporter activity,MF,
5128,GO:0015501,0.99999999999742,0.906532700940445,0,2,glutamate:sodium symporter activity,MF,
20025,GO:2000609,0.999999999997432,0.866052569408846,0,3,regulation of thyroid hormone generation,BP,
9559,GO:0036324,0.999999999997434,0.917972954766851,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
9386,GO:0035915,0.999999999997437,0.956171522833003,0,1,pore formation in membrane of other organism,BP,
19912,GO:2000374,0.999999999997437,0.956171522833003,0,1,regulation of oxygen metabolic process,BP,
6626,GO:0022848,0.999999999997443,0.824427395906287,0,4,acetylcholine-gated cation-selective channel activity,MF,
11948,GO:0046985,0.999999999997464,0.877329928957239,0,3,positive regulation of hemoglobin biosynthetic process,BP,
19488,GO:1990168,0.999999999997466,0.859946092401574,0,3,protein K33-linked deubiquitination,BP,
15461,GO:0071763,0.999999999997468,0.744983361332578,0,6,nuclear membrane organization,BP,
5798,GO:0017034,0.999999999997481,0.768970317513891,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
9882,GO:0042144,0.999999999997484,0.903824265224348,0,2,vacuole fusion, non-autophagic,BP,
16684,GO:0097576,0.999999999997484,0.903824265224348,0,2,vacuole fusion,BP,
16040,GO:0086047,0.999999999997491,0.948613510838464,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
18751,GO:1904199,0.999999999997491,0.948613510838464,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
19623,GO:1990736,0.999999999997491,0.948613510838464,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
16759,GO:0098508,0.999999999997492,0.912459150937352,0,2,endothelial to hematopoietic transition,BP,
7150,GO:0030991,0.999999999997492,0.658360066689404,0,8,intraciliary transport particle A,CC,
6975,GO:0030626,0.999999999997492,0.908925260603655,0,2,U12 snRNA binding,MF,
18089,GO:1902659,0.999999999997507,0.877635694509528,0,3,regulation of glucose mediated signaling pathway,BP,
18090,GO:1902661,0.999999999997507,0.877635694509528,0,3,positive regulation of glucose mediated signaling pathway,BP,
1338,GO:0003192,0.999999999997525,0.853328764160729,0,3,mitral valve formation,BP,
6816,GO:0030263,0.999999999997525,0.814728337567752,0,4,apoptotic chromosome condensation,BP,
9621,GO:0036483,0.999999999997542,0.947384130543614,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
18393,GO:1903381,0.999999999997542,0.947384130543614,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18394,GO:1903382,0.999999999997542,0.947384130543614,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
7908,GO:0032472,0.999999999997542,0.909820423802071,0,2,Golgi calcium ion transport,BP,
9992,GO:0042392,0.999999999997552,0.798467667137635,0,5,sphingosine-1-phosphate phosphatase activity,MF,
839,GO:0002138,0.99999999999756,0.800524103910789,0,5,retinoic acid biosynthetic process,BP,
5354,GO:0016102,0.99999999999756,0.800524103910789,0,5,diterpenoid biosynthetic process,BP,
4713,GO:0010872,0.999999999997571,0.828677504960205,0,5,regulation of cholesterol esterification,BP,
20043,GO:2000638,0.999999999997587,0.906269632012818,0,2,regulation of SREBP signaling pathway,BP,
20044,GO:2000639,0.999999999997587,0.906269632012818,0,2,negative regulation of SREBP signaling pathway,BP,
2168,GO:0005000,0.999999999997596,0.902586998500069,0,2,vasopressin receptor activity,MF,
9664,GO:0038016,0.999999999997599,0.908336605105675,0,2,insulin receptor internalization,BP,
1358,GO:0003223,0.999999999997599,0.730689032902643,0,6,ventricular compact myocardium morphogenesis,BP,
5409,GO:0016243,0.999999999997634,0.948853479311755,0,1,regulation of autophagosome size,BP,
5941,GO:0018217,0.999999999997634,0.948853479311755,0,1,peptidyl-aspartic acid phosphorylation,BP,
14164,GO:0061030,0.999999999997634,0.948853479311755,0,1,epithelial cell differentiation involved in mammary gland alveolus development,BP,
19157,GO:1905103,0.999999999997634,0.948853479311755,0,1,integral component of lysosomal membrane,CC,
19694,GO:1990938,0.999999999997634,0.948853479311755,0,1,peptidyl-aspartic acid autophosphorylation,BP,
20184,GO:2000969,0.999999999997652,0.905212515197808,0,2,positive regulation of AMPA receptor activity,BP,
10654,GO:0043686,0.999999999997657,0.881638131302825,0,3,co-translational protein modification,BP,
9168,GO:0035520,0.999999999997661,0.626857783377481,0,9,monoubiquitinated protein deubiquitination,BP,
7665,GO:0032090,0.999999999997661,0.926592682035341,0,2,Pyrin domain binding,MF,
8192,GO:0032927,0.999999999997664,0.749907055958667,0,6,positive regulation of activin receptor signaling pathway,BP,
16806,GO:0098633,0.999999999997668,0.954435038064065,0,1,collagen fibril binding,MF,
18697,GO:1904027,0.999999999997668,0.954435038064065,0,1,negative regulation of collagen fibril organization,BP,
7282,GO:0031261,0.999999999997675,0.798335999878761,0,5,DNA replication preinitiation complex,CC,
3989,GO:0008852,0.999999999997678,0.95372876337308,0,1,exodeoxyribonuclease I activity,MF,
15085,GO:0071038,0.999999999997681,0.829129456554197,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
11099,GO:0045092,0.999999999997698,0.950551901608598,0,1,interleukin-18 receptor complex,CC,
15359,GO:0071575,0.999999999997698,0.950551901608598,0,1,integral component of external side of plasma membrane,CC,
6004,GO:0019034,0.999999999997702,0.897457988085337,0,2,viral replication complex,CC,
2064,GO:0004815,0.999999999997706,0.908789791421855,0,2,aspartate-tRNA ligase activity,MF,
17288,GO:0140007,0.999999999997726,0.833426979802534,0,4,KICSTOR complex,CC,
14702,GO:0070315,0.999999999997731,0.906948014071804,0,2,G1 to G0 transition involved in cell differentiation,BP,
12323,GO:0048664,0.99999999999775,0.888078845168251,0,3,neuron fate determination,BP,
16082,GO:0090026,0.999999999997753,0.704054163505551,0,8,positive regulation of monocyte chemotaxis,BP,
14808,GO:0070524,0.999999999997766,0.963430323441695,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
3860,GO:0008475,0.999999999997783,0.861931825416726,0,3,procollagen-lysine 5-dioxygenase activity,MF,
11921,GO:0046946,0.999999999997783,0.861931825416726,0,3,hydroxylysine metabolic process,BP,
11922,GO:0046947,0.999999999997783,0.861931825416726,0,3,hydroxylysine biosynthetic process,BP,
14415,GO:0061676,0.999999999997795,0.746002711841652,0,6,importin-alpha family protein binding,MF,
14786,GO:0070478,0.9999999999978,0.948234204106101,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
18954,GO:1904685,0.999999999997811,0.90442770283165,0,2,positive regulation of metalloendopeptidase activity,BP,
7136,GO:0030956,0.999999999997814,0.893189457776176,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
12514,GO:0050567,0.999999999997814,0.893189457776176,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
14899,GO:0070681,0.999999999997814,0.893189457776176,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
17070,GO:0099541,0.999999999997816,0.857649107963033,0,3,trans-synaptic signaling by lipid,BP,
17071,GO:0099542,0.999999999997816,0.857649107963033,0,3,trans-synaptic signaling by endocannabinoid,BP,
6665,GO:0030015,0.999999999997823,0.783460473190184,0,5,CCR4-NOT core complex,CC,
6481,GO:0021817,0.999999999997843,0.853602424644311,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
10607,GO:0043578,0.999999999997843,0.853602424644311,0,3,nuclear matrix organization,BP,
16254,GO:0090292,0.999999999997843,0.853602424644311,0,3,nuclear matrix anchoring at nuclear membrane,BP,
19479,GO:1990134,0.999999999997845,0.946834096046956,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
18336,GO:1903251,0.99999999999786,0.783523492579798,0,5,multi-ciliated epithelial cell differentiation,BP,
2422,GO:0005594,0.999999999997862,0.910245199224721,0,2,collagen type IX trimer,CC,
16214,GO:0090233,0.999999999997865,0.954115912462002,0,1,negative regulation of spindle checkpoint,BP,
18007,GO:1902426,0.999999999997865,0.954115912462002,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19241,GO:1905341,0.999999999997865,0.954115912462002,0,1,negative regulation of protein localization to kinetochore,BP,
7770,GO:0032286,0.999999999997881,0.860886504119765,0,3,central nervous system myelin maintenance,BP,
5304,GO:0015990,0.999999999997881,0.977146998539565,0,1,electron transport coupled proton transport,BP,
15543,GO:0071921,0.999999999997886,0.744713508290462,0,6,cohesin loading,BP,
6475,GO:0021800,0.999999999997895,0.766767516208783,0,5,cerebral cortex tangential migration,BP,
504,GO:0001561,0.999999999997905,0.755024963049846,0,6,fatty acid alpha-oxidation,BP,
18955,GO:1904688,0.999999999997905,0.801072644254555,0,5,regulation of cytoplasmic translational initiation,BP,
16409,GO:0097016,0.999999999997918,0.896653751612224,0,2,L27 domain binding,MF,
11764,GO:0046601,0.99999999999794,0.860090346550227,0,3,positive regulation of centriole replication,BP,
900,GO:0002276,0.999999999997942,0.906336208355491,0,2,basophil activation involved in immune response,BP,
11278,GO:0045575,0.999999999997942,0.906336208355491,0,2,basophil activation,BP,
3983,GO:0008808,0.999999999997952,0.949668766050953,0,1,cardiolipin synthase activity,MF,
6951,GO:0030572,0.999999999997952,0.949668766050953,0,1,phosphatidyltransferase activity,MF,
10474,GO:0043337,0.999999999997952,0.949668766050953,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
19369,GO:1905711,0.999999999997952,0.949668766050953,0,1,response to phosphatidylethanolamine,BP,
8595,GO:0034093,0.999999999997957,0.796652080918946,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8645,GO:0034184,0.999999999997957,0.796652080918946,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
11200,GO:0045295,0.99999999999796,0.617070022577626,0,9,gamma-catenin binding,MF,
7648,GO:0032055,0.999999999997966,0.744402755870361,0,6,negative regulation of translation in response to stress,BP,
16152,GO:0090149,0.999999999997968,0.904728110568582,0,2,mitochondrial membrane fission,BP,
2690,GO:0006050,0.999999999997969,0.960779893373391,0,1,mannosamine metabolic process,BP,
2691,GO:0006051,0.999999999997969,0.960779893373391,0,1,N-acetylmannosamine metabolic process,BP,
11117,GO:0045127,0.999999999997969,0.960779893373391,0,1,N-acetylglucosamine kinase activity,MF,
9913,GO:0042245,0.999999999997969,0.904646604923567,0,2,RNA repair,BP,
3019,GO:0006564,0.999999999997971,0.762923230605204,0,6,L-serine biosynthetic process,BP,
11175,GO:0045226,0.999999999997981,0.908359911553361,0,2,extracellular polysaccharide biosynthetic process,BP,
11657,GO:0046379,0.999999999997981,0.908359911553361,0,2,extracellular polysaccharide metabolic process,BP,
13,GO:0000026,0.999999999997983,0.862023791861217,0,3,alpha-1,2-mannosyltransferase activity,MF,
1268,GO:0003025,0.999999999997993,0.904516293550482,0,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
6692,GO:0030056,0.999999999997994,0.719714504069007,0,6,hemidesmosome,CC,
18107,GO:1902722,0.999999999998002,0.882452234124225,0,3,positive regulation of prolactin secretion,BP,
3105,GO:0006682,0.999999999998012,0.86742662577713,0,3,galactosylceramide biosynthetic process,BP,
6131,GO:0019375,0.999999999998012,0.86742662577713,0,3,galactolipid biosynthetic process,BP,
14993,GO:0070893,0.999999999998012,0.902990861581657,0,2,transposon integration,BP,
14994,GO:0070894,0.999999999998012,0.902990861581657,0,2,regulation of transposon integration,BP,
14995,GO:0070895,0.999999999998012,0.902990861581657,0,2,negative regulation of transposon integration,BP,
2256,GO:0005168,0.999999999998017,0.727939463679933,0,6,neurotrophin TRKA receptor binding,MF,
11694,GO:0046469,0.999999999998023,0.786577430648479,0,5,platelet activating factor metabolic process,BP,
12048,GO:0047756,0.999999999998043,0.90506473749452,0,2,chondroitin 4-sulfotransferase activity,MF,
13780,GO:0060342,0.999999999998055,0.957323105790126,0,1,photoreceptor inner segment membrane,CC,
15468,GO:0071787,0.999999999998058,0.829780064835135,0,4,endoplasmic reticulum tubular network formation,BP,
232,GO:0000480,0.999999999998066,0.747274430930321,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
3737,GO:0008273,0.999999999998067,0.897099886222493,0,2,calcium, potassium:sodium antiporter activity,MF,
11756,GO:0046587,0.99999999999807,0.953146168510956,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
18902,GO:1904567,0.99999999999807,0.953146168510956,0,1,response to wortmannin,BP,
18903,GO:1904568,0.99999999999807,0.953146168510956,0,1,cellular response to wortmannin,BP,
19606,GO:1990646,0.99999999999807,0.953146168510956,0,1,cellular response to prolactin,BP,
1889,GO:0004567,0.999999999998073,0.951850042609167,0,1,beta-mannosidase activity,MF,
4456,GO:0010412,0.999999999998073,0.951850042609167,0,1,mannan metabolic process,BP,
11648,GO:0046355,0.999999999998073,0.951850042609167,0,1,mannan catabolic process,BP,
8262,GO:0033038,0.999999999998077,0.881504740254375,0,4,bitter taste receptor activity,MF,
168,GO:0000349,0.9999999999981,0.911094042078577,0,2,generation of catalytic spliceosome for first transesterification step,BP,
1039,GO:0002545,0.999999999998108,0.957314706938334,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1214,GO:0002880,0.999999999998108,0.957314706938334,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1215,GO:0002882,0.999999999998108,0.957314706938334,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1538,GO:0003920,0.999999999998108,0.957314706938334,0,1,GMP reductase activity,MF,
5293,GO:0015950,0.999999999998108,0.957314706938334,0,1,purine nucleotide interconversion,BP,
5294,GO:0015951,0.999999999998108,0.957314706938334,0,1,purine ribonucleotide interconversion,BP,
5616,GO:0016657,0.999999999998108,0.957314706938334,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
18052,GO:1902560,0.999999999998108,0.957314706938334,0,1,GMP reductase complex,CC,
5374,GO:0016175,0.999999999998125,0.935633175679349,0,2,superoxide-generating NADPH oxidase activity,MF,
2496,GO:0005742,0.999999999998128,0.74622721560047,0,8,mitochondrial outer membrane translocase complex,CC,
5216,GO:0015812,0.999999999998143,0.729462925627965,0,6,gamma-aminobutyric acid transport,BP,
11170,GO:0045219,0.999999999998155,0.946686442368269,0,1,regulation of FasL biosynthetic process,BP,
11171,GO:0045221,0.999999999998155,0.946686442368269,0,1,negative regulation of FasL biosynthetic process,BP,
14471,GO:0061820,0.999999999998166,0.636614178940028,0,9,telomeric D-loop disassembly,BP,
5869,GO:0017169,0.999999999998172,0.736545528357351,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
5263,GO:0015889,0.999999999998184,0.916107137476453,0,2,cobalamin transport,BP,
7690,GO:0032135,0.999999999998199,0.747933178739039,0,6,DNA insertion or deletion binding,MF,
15952,GO:0072740,0.999999999998199,0.957215285574875,0,1,cellular response to anisomycin,BP,
17473,GO:1900259,0.999999999998199,0.957215285574875,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17474,GO:1900260,0.999999999998199,0.957215285574875,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
8932,GO:0034776,0.999999999998202,0.897235364121426,0,2,response to histamine,BP,
15263,GO:0071420,0.999999999998202,0.897235364121426,0,2,cellular response to histamine,BP,
2569,GO:0005851,0.999999999998203,0.764192250851876,0,6,eukaryotic translation initiation factor 2B complex,CC,
10108,GO:0042622,0.999999999998203,0.734521641492831,0,6,photoreceptor outer segment membrane,CC,
19306,GO:1905516,0.999999999998214,0.796029433698931,0,5,positive regulation of fertilization,BP,
7424,GO:0031510,0.999999999998215,0.876852249334975,0,3,SUMO activating enzyme complex,CC,
14080,GO:0060844,0.999999999998218,0.908917892674042,0,2,arterial endothelial cell fate commitment,BP,
1200,GO:0002857,0.999999999998219,0.903318057886525,0,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1203,GO:0002860,0.999999999998219,0.903318057886525,0,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
19865,GO:2000311,0.999999999998222,0.63168135990334,0,9,regulation of AMPA receptor activity,BP,
9221,GO:0035606,0.999999999998228,0.948699085823052,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
3686,GO:0008190,0.99999999999823,0.694174700572051,0,8,eukaryotic initiation factor 4E binding,MF,
16921,GO:0098871,0.999999999998238,0.959229756848793,0,1,postsynaptic actin cytoskeleton,CC,
17085,GO:0099571,0.999999999998238,0.959229756848793,0,1,postsynaptic cytoskeleton,CC,
11618,GO:0046292,0.999999999998244,0.874345161668609,0,3,formaldehyde metabolic process,BP,
4000,GO:0008900,0.999999999998248,0.950653233971168,0,1,potassium:proton exchanging ATPase activity,MF,
4120,GO:0009176,0.999999999998248,0.806153522365532,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4121,GO:0009177,0.999999999998248,0.806153522365532,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
11532,GO:0046038,0.999999999998254,0.963317589591522,0,1,GMP catabolic process,BP,
13401,GO:0052657,0.999999999998254,0.963317589591522,0,1,guanine phosphoribosyltransferase activity,MF,
4125,GO:0009182,0.999999999998257,0.934842291780337,0,2,purine deoxyribonucleoside diphosphate metabolic process,BP,
11546,GO:0046066,0.999999999998257,0.934842291780337,0,2,dGDP metabolic process,BP,
4597,GO:0010705,0.999999999998272,0.947354995384567,0,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
17626,GO:1901299,0.999999999998272,0.797936286034919,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
966,GO:0002396,0.999999999998279,0.957047262741959,0,1,MHC protein complex assembly,BP,
967,GO:0002397,0.999999999998279,0.957047262741959,0,1,MHC class I protein complex assembly,BP,
1015,GO:0002501,0.999999999998279,0.957047262741959,0,1,peptide antigen assembly with MHC protein complex,BP,
1016,GO:0002502,0.999999999998279,0.957047262741959,0,1,peptide antigen assembly with MHC class I protein complex,BP,
16989,GO:0099011,0.999999999998294,0.898560745782244,0,2,neuronal dense core vesicle exocytosis,BP,
17059,GO:0099525,0.999999999998294,0.898560745782244,0,2,presynaptic dense core vesicle exocytosis,BP,
15740,GO:0072300,0.9999999999983,0.902116146482383,0,2,positive regulation of metanephric glomerulus development,BP,
2257,GO:0005169,0.999999999998323,0.920230510693709,0,2,neurotrophin TRKB receptor binding,MF,
2164,GO:0004993,0.999999999998337,0.88058327254969,0,3,G-protein coupled serotonin receptor activity,MF,
3422,GO:0007210,0.999999999998337,0.88058327254969,0,3,serotonin receptor signaling pathway,BP,
10366,GO:0043176,0.999999999998337,0.88058327254969,0,3,amine binding,MF,
12989,GO:0051378,0.999999999998337,0.88058327254969,0,3,serotonin binding,MF,
16827,GO:0098664,0.999999999998337,0.88058327254969,0,3,G-protein coupled serotonin receptor signaling pathway,BP,
17090,GO:0099589,0.999999999998337,0.88058327254969,0,3,serotonin receptor activity,MF,
18350,GO:1903294,0.999999999998341,0.898781138596074,0,2,regulation of glutamate secretion, neurotransmission,BP,
18351,GO:1903296,0.999999999998341,0.898781138596074,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
19572,GO:1990504,0.999999999998348,0.850632629793188,0,3,dense core granule exocytosis,BP,
18423,GO:1903435,0.999999999998356,0.953813685077376,0,1,positive regulation of constitutive secretory pathway,BP,
18031,GO:1902510,0.999999999998362,0.779947715966276,0,6,regulation of apoptotic DNA fragmentation,BP,
13147,GO:0051694,0.999999999998366,0.904786321934742,0,2,pointed-end actin filament capping,BP,
1366,GO:0003247,0.999999999998368,0.959938107100708,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1560,GO:0003956,0.999999999998368,0.959938107100708,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
2486,GO:0005724,0.999999999998368,0.959938107100708,0,1,nuclear telomeric heterochromatin,CC,
7423,GO:0031509,0.999999999998368,0.959938107100708,0,1,telomeric heterochromatin assembly,BP,
7581,GO:0031940,0.999999999998368,0.959938107100708,0,1,positive regulation of chromatin silencing at telomere,BP,
18114,GO:1902732,0.999999999998368,0.959938107100708,0,1,positive regulation of chondrocyte proliferation,BP,
19315,GO:1905547,0.999999999998368,0.959938107100708,0,1,regulation of telomeric heterochromatin assembly,BP,
19316,GO:1905549,0.999999999998368,0.959938107100708,0,1,positive regulation of telomeric heterochromatin assembly,BP,
11130,GO:0045155,0.999999999998371,0.915653569316295,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
18209,GO:1902965,0.999999999998376,0.726640823768079,0,6,regulation of protein localization to early endosome,BP,
18210,GO:1902966,0.999999999998376,0.726640823768079,0,6,positive regulation of protein localization to early endosome,BP,
9473,GO:0036090,0.999999999998379,0.914588306274897,0,2,cleavage furrow ingression,BP,
13991,GO:0060687,0.999999999998382,0.73224224244196,0,6,regulation of branching involved in prostate gland morphogenesis,BP,
1940,GO:0004638,0.999999999998387,0.951750600269398,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1941,GO:0004639,0.999999999998387,0.951750600269398,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
5024,GO:0015184,0.999999999998393,0.898719607168547,0,2,L-cystine transmembrane transporter activity,MF,
5215,GO:0015811,0.999999999998393,0.898719607168547,0,2,L-cystine transport,BP,
7693,GO:0032139,0.999999999998396,0.870510842990195,0,3,dinucleotide insertion or deletion binding,MF,
17563,GO:1901090,0.999999999998404,0.911457174045675,0,2,regulation of protein tetramerization,BP,
17564,GO:1901091,0.999999999998404,0.911457174045675,0,2,negative regulation of protein tetramerization,BP,
17565,GO:1901093,0.999999999998404,0.911457174045675,0,2,regulation of protein homotetramerization,BP,
17566,GO:1901094,0.999999999998404,0.911457174045675,0,2,negative regulation of protein homotetramerization,BP,
1584,GO:0003991,0.999999999998404,0.956003982384788,0,1,acetylglutamate kinase activity,MF,
1616,GO:0004042,0.999999999998404,0.956003982384788,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
6530,GO:0021914,0.999999999998404,0.905756683325631,0,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
17191,GO:0103045,0.999999999998404,0.956003982384788,0,1,methione N-acyltransferase activity,MF,
5102,GO:0015377,0.999999999998407,0.727422576543047,0,6,cation:chloride symporter activity,MF,
5104,GO:0015379,0.999999999998407,0.727422576543047,0,6,potassium:chloride symporter activity,MF,
3993,GO:0008887,0.999999999998418,0.952222632135025,0,1,glycerate kinase activity,MF,
4739,GO:0010900,0.999999999998419,0.986145439285818,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
8950,GO:0034991,0.999999999998425,0.905788027848276,0,2,nuclear meiotic cohesin complex,CC,
16213,GO:0090232,0.99999999999843,0.685658619720732,0,8,positive regulation of spindle checkpoint,BP,
19461,GO:1990070,0.999999999998441,0.977694279225426,0,1,TRAPPI protein complex,CC,
3864,GO:0008481,0.99999999999846,0.912753629664874,0,2,sphinganine kinase activity,MF,
5804,GO:0017050,0.99999999999846,0.912753629664874,0,2,D-erythro-sphingosine kinase activity,MF,
10937,GO:0044565,0.999999999998498,0.917734735167088,0,2,dendritic cell proliferation,BP,
370,GO:0000991,0.9999999999985,0.911347369328632,0,2,transcription factor activity, core RNA polymerase II binding,MF,
1247,GO:0002944,0.999999999998503,0.904188404992171,0,2,cyclin K-CDK12 complex,CC,
1248,GO:0002945,0.999999999998503,0.904188404992171,0,2,cyclin K-CDK13 complex,CC,
14970,GO:0070852,0.999999999998511,0.861618231751582,0,3,cell body fiber,CC,
15435,GO:0071692,0.999999999998511,0.777871360031063,0,5,protein localization to extracellular region,BP,
15436,GO:0071694,0.999999999998511,0.777871360031063,0,5,maintenance of protein location in extracellular region,BP,
1452,GO:0003680,0.999999999998514,0.751498887361763,0,6,AT DNA binding,MF,
13000,GO:0051391,0.999999999998531,0.949039483585557,0,1,tRNA acetylation,BP,
13001,GO:0051392,0.999999999998531,0.949039483585557,0,1,tRNA N-acetyltransferase activity,MF,
19021,GO:1904812,0.999999999998531,0.949039483585557,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
19675,GO:1990882,0.999999999998531,0.949039483585557,0,1,rRNA acetylation,BP,
19676,GO:1990883,0.999999999998531,0.949039483585557,0,1,rRNA cytidine N-acetyltransferase activity,MF,
19677,GO:1990884,0.999999999998531,0.949039483585557,0,1,RNA acetylation,BP,
19619,GO:1990723,0.999999999998546,0.902237915498092,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
126,GO:0000257,0.999999999998547,0.964257793587948,0,1,nitrilase activity,MF,
5699,GO:0016815,0.999999999998547,0.964257793587948,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6041,GO:0019118,0.999999999998547,0.964257793587948,0,1,phenanthrene-epoxide hydrolase activity,MF,
6042,GO:0019119,0.999999999998547,0.964257793587948,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
9972,GO:0042356,0.999999999998547,0.964257793587948,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
12515,GO:0050577,0.999999999998547,0.964257793587948,0,1,GDP-L-fucose synthase activity,MF,
1828,GO:0004478,0.999999999998552,0.95376277021922,0,1,methionine adenosyltransferase activity,MF,
3001,GO:0006546,0.999999999998566,0.873152416570312,0,3,glycine catabolic process,BP,
6156,GO:0019464,0.999999999998566,0.873152416570312,0,3,glycine decarboxylation via glycine cleavage system,BP,
5586,GO:0016600,0.999999999998574,0.665430313491726,0,8,flotillin complex,CC,
4522,GO:0010572,0.999999999998611,0.909701160229989,0,2,positive regulation of platelet activation,BP,
17776,GO:1901731,0.999999999998611,0.909701160229989,0,2,positive regulation of platelet aggregation,BP,
14517,GO:0065001,0.999999999998613,0.896186626700549,0,2,specification of axis polarity,BP,
6844,GO:0030305,0.999999999998618,0.958423460303928,0,1,heparanase activity,MF,
15209,GO:0071344,0.999999999998619,0.927247761438188,0,2,diphosphate metabolic process,BP,
2262,GO:0005174,0.999999999998622,0.955099561512033,0,1,CD40 receptor binding,MF,
17443,GO:1900195,0.999999999998627,0.913996507402326,0,2,positive regulation of oocyte maturation,BP,
15425,GO:0071676,0.999999999998628,0.905409518854994,0,2,negative regulation of mononuclear cell migration,BP,
16083,GO:0090027,0.999999999998628,0.905409518854994,0,2,negative regulation of monocyte chemotaxis,BP,
121,GO:0000250,0.999999999998629,0.948049775521891,0,1,lanosterol synthase activity,MF,
7443,GO:0031559,0.999999999998629,0.948049775521891,0,1,oxidosqualene cyclase activity,MF,
16245,GO:0090281,0.99999999999863,0.869310764985838,0,3,negative regulation of calcium ion import,BP,
18581,GO:1903789,0.999999999998633,0.782593783538799,0,5,regulation of amino acid transmembrane transport,BP,
15421,GO:0071672,0.999999999998636,0.881622963253654,0,3,negative regulation of smooth muscle cell chemotaxis,BP,
10255,GO:0042986,0.999999999998641,0.910350947072498,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
7874,GO:0032431,0.999999999998646,0.928064800633174,0,2,activation of phospholipase A2 activity,BP,
1947,GO:0004647,0.99999999999865,0.914116174861643,0,2,phosphoserine phosphatase activity,MF,
8454,GO:0033588,0.999999999998671,0.794084127104746,0,5,Elongator holoenzyme complex,CC,
15291,GO:0071461,0.999999999998676,0.922434465000288,0,2,cellular response to redox state,BP,
7544,GO:0031802,0.999999999998683,0.863355275631252,0,3,type 5 metabotropic glutamate receptor binding,MF,
4689,GO:0010835,0.999999999998695,0.715236642007516,0,7,regulation of protein ADP-ribosylation,BP,
19763,GO:2000111,0.9999999999987,0.919448937936792,0,2,positive regulation of macrophage apoptotic process,BP,
2613,GO:0005916,0.999999999998706,0.734259976666535,0,6,fascia adherens,CC,
8733,GO:0034379,0.999999999998708,0.771331835708112,0,6,very-low-density lipoprotein particle assembly,BP,
10466,GO:0043321,0.999999999998708,0.90350916376424,0,2,regulation of natural killer cell degranulation,BP,
10467,GO:0043323,0.999999999998708,0.90350916376424,0,2,positive regulation of natural killer cell degranulation,BP,
5712,GO:0016838,0.999999999998708,0.930451654601852,0,2,carbon-oxygen lyase activity, acting on phosphates,MF,
16984,GO:0098989,0.999999999998712,0.910543479996518,0,2,NMDA selective glutamate receptor signaling pathway,BP,
946,GO:0002357,0.999999999998718,0.953911644867367,0,1,defense response to tumor cell,BP,
15341,GO:0071547,0.999999999998718,0.953911644867367,0,1,piP-body,CC,
5301,GO:0015985,0.999999999998722,0.724391766480879,0,8,energy coupled proton transport, down electrochemical gradient,BP,
5302,GO:0015986,0.999999999998722,0.724391766480879,0,8,ATP synthesis coupled proton transport,BP,
3917,GO:0008579,0.999999999998728,0.946721087498234,0,1,JUN kinase phosphatase activity,MF,
13402,GO:0052658,0.999999999998737,0.73647833955477,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
9329,GO:0035801,0.999999999998738,0.91329968349482,0,2,adrenal cortex development,BP,
9330,GO:0035802,0.999999999998738,0.91329968349482,0,2,adrenal cortex formation,BP,
292,GO:0000796,0.999999999998739,0.68428056155534,0,7,condensin complex,CC,
8479,GO:0033623,0.999999999998747,0.737355407477803,0,6,regulation of integrin activation,BP,
9481,GO:0036112,0.999999999998754,0.917323846206319,0,2,medium-chain fatty-acyl-CoA metabolic process,BP,
8793,GO:0034475,0.999999999998754,0.753363203066359,0,8,U4 snRNA 3'-end processing,BP,
19333,GO:1905590,0.999999999998761,0.952679344251461,0,1,fibronectin fibril organization,BP,
19881,GO:2000329,0.999999999998761,0.952679344251461,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
13748,GO:0060304,0.999999999998763,0.766504127800141,0,5,regulation of phosphatidylinositol dephosphorylation,BP,
4453,GO:0010387,0.999999999998767,0.955066456501111,0,1,COP9 signalosome assembly,BP,
6165,GO:0019510,0.999999999998767,0.955066456501111,0,1,S-adenosylhomocysteine catabolic process,BP,
15168,GO:0071268,0.999999999998767,0.955066456501111,0,1,homocysteine biosynthetic process,BP,
6644,GO:0023025,0.99999999999877,0.90990940750614,0,2,MHC class Ib protein complex binding,MF,
6647,GO:0023030,0.99999999999877,0.90990940750614,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
8786,GO:0034464,0.999999999998793,0.655061514418565,0,9,BBSome,CC,
1949,GO:0004649,0.999999999998803,0.909414154712038,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2268,GO:0005184,0.999999999998809,0.904129026705405,0,3,neuropeptide hormone activity,MF,
6157,GO:0019470,0.99999999999882,0.827993927326629,0,4,4-hydroxyproline catabolic process,BP,
14678,GO:0070274,0.999999999998822,0.919572035597212,0,2,RES complex,CC,
13730,GO:0060281,0.999999999998822,0.709527068012517,0,7,regulation of oocyte development,BP,
19406,GO:1905879,0.999999999998822,0.709527068012517,0,7,regulation of oogenesis,BP,
5726,GO:0016861,0.999999999998823,0.712882660618247,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
8537,GO:0033858,0.999999999998825,0.952515759508489,0,1,N-acetylgalactosamine kinase activity,MF,
17237,GO:0110008,0.999999999998828,0.952986526767861,0,1,ncRNA deadenylation,BP,
20273,GO:2001200,0.999999999998829,0.917779002742488,0,2,positive regulation of dendritic cell differentiation,BP,
13699,GO:0060219,0.999999999998845,0.730736288976397,0,6,camera-type eye photoreceptor cell differentiation,BP,
19166,GO:1905150,0.999999999998854,0.897083814422078,0,2,regulation of voltage-gated sodium channel activity,BP,
2446,GO:0005652,0.999999999998857,0.647349462248309,0,9,nuclear lamina,CC,
7057,GO:0030828,0.99999999999886,0.757585309021933,0,6,positive regulation of cGMP biosynthetic process,BP,
3722,GO:0008242,0.999999999998861,0.692868514424407,0,8,omega peptidase activity,MF,
8196,GO:0032933,0.999999999998862,0.672952652139692,0,8,SREBP signaling pathway,BP,
15321,GO:0071501,0.999999999998862,0.672952652139692,0,8,cellular response to sterol depletion,BP,
6349,GO:0021521,0.999999999998863,0.848619221142304,0,3,ventral spinal cord interneuron specification,BP,
6459,GO:0021775,0.999999999998863,0.848619221142304,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6460,GO:0021776,0.999999999998863,0.848619221142304,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
13930,GO:0060573,0.999999999998863,0.848619221142304,0,3,cell fate specification involved in pattern specification,BP,
13936,GO:0060579,0.999999999998863,0.848619221142304,0,3,ventral spinal cord interneuron fate commitment,BP,
13937,GO:0060581,0.999999999998863,0.848619221142304,0,3,cell fate commitment involved in pattern specification,BP,
14573,GO:0070094,0.999999999998864,0.954323927029901,0,1,positive regulation of glucagon secretion,BP,
15737,GO:0072289,0.999999999998865,0.901107838993568,0,2,metanephric nephron tubule formation,BP,
9523,GO:0036219,0.999999999998892,0.979121638368973,0,1,GTP diphosphatase activity,MF,
10962,GO:0044713,0.999999999998892,0.979121638368973,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10963,GO:0044714,0.999999999998892,0.979121638368973,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
12038,GO:0047693,0.999999999998892,0.979121638368973,0,1,ATP diphosphatase activity,MF,
19910,GO:2000371,0.999999999998892,0.735992284653123,0,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19911,GO:2000373,0.999999999998892,0.735992284653123,0,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
1599,GO:0004014,0.999999999998896,0.952106462131893,0,1,adenosylmethionine decarboxylase activity,MF,
3012,GO:0006557,0.999999999998896,0.952106462131893,0,1,S-adenosylmethioninamine biosynthetic process,BP,
6248,GO:0019810,0.999999999998896,0.952106462131893,0,1,putrescine binding,MF,
11716,GO:0046499,0.999999999998896,0.952106462131893,0,1,S-adenosylmethioninamine metabolic process,BP,
13834,GO:0060414,0.999999999998909,0.896187726559296,0,2,aorta smooth muscle tissue morphogenesis,BP,
211,GO:0000439,0.999999999998921,0.66004860060326,0,9,core TFIIH complex,CC,
7561,GO:0031893,0.999999999998922,0.955391986930881,0,1,vasopressin receptor binding,MF,
7562,GO:0031896,0.999999999998922,0.955391986930881,0,1,V2 vasopressin receptor binding,MF,
4714,GO:0010873,0.999999999998923,0.911700156205459,0,3,positive regulation of cholesterol esterification,BP,
647,GO:0001835,0.999999999998925,0.952165817506553,0,1,blastocyst hatching,BP,
1500,GO:0003842,0.999999999998925,0.952165817506553,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
9016,GO:0035188,0.999999999998925,0.952165817506553,0,1,hatching,BP,
15432,GO:0071684,0.999999999998925,0.952165817506553,0,1,organism emergence from protective structure,BP,
9039,GO:0035252,0.999999999998925,0.744630736995221,0,6,UDP-xylosyltransferase activity,MF,
9939,GO:0042285,0.999999999998925,0.744630736995221,0,6,xylosyltransferase activity,MF,
17366,GO:1900042,0.999999999998925,0.896182989351568,0,2,positive regulation of interleukin-2 secretion,BP,
13911,GO:0060539,0.999999999998928,0.782533725663168,0,5,diaphragm development,BP,
1602,GO:0004018,0.999999999998928,0.96226316004433,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
14865,GO:0070626,0.999999999998928,0.96226316004433,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
7830,GO:0032379,0.999999999998929,0.881570862198177,0,3,positive regulation of intracellular lipid transport,BP,
7833,GO:0032382,0.999999999998929,0.881570862198177,0,3,positive regulation of intracellular sterol transport,BP,
7836,GO:0032385,0.999999999998929,0.881570862198177,0,3,positive regulation of intracellular cholesterol transport,BP,
17107,GO:0099631,0.999999999998931,0.937694536527187,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
3058,GO:0006620,0.999999999998934,0.732468690616205,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
19699,GO:1990967,0.999999999998938,0.913960149367851,0,2,multi-organism toxin transport,BP,
11569,GO:0046102,0.999999999998945,0.87591616763765,0,3,inosine metabolic process,BP,
2008,GO:0004729,0.999999999998946,0.958634498146878,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
14946,GO:0070818,0.999999999998946,0.958634498146878,0,1,protoporphyrinogen oxidase activity,MF,
19797,GO:2000182,0.999999999998949,0.902396168799414,0,2,regulation of progesterone biosynthetic process,BP,
9312,GO:0035766,0.999999999998956,0.851006839015143,0,3,cell chemotaxis to fibroblast growth factor,BP,
9314,GO:0035768,0.999999999998956,0.851006839015143,0,3,endothelial cell chemotaxis to fibroblast growth factor,BP,
19038,GO:1904847,0.999999999998956,0.851006839015143,0,3,regulation of cell chemotaxis to fibroblast growth factor,BP,
19994,GO:2000544,0.999999999998956,0.851006839015143,0,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
9162,GO:0035514,0.999999999998959,0.886447941195309,0,3,DNA demethylase activity,MF,
2348,GO:0005388,0.999999999998959,0.654544905319982,0,8,calcium-transporting ATPase activity,MF,
19233,GO:1905323,0.999999999998961,0.745552426172228,0,6,telomerase holoenzyme complex assembly,BP,
8403,GO:0033341,0.999999999998965,0.903548801666641,0,2,regulation of collagen binding,BP,
10460,GO:0043314,0.99999999999897,0.896233706327201,0,2,negative regulation of neutrophil degranulation,BP,
18055,GO:1902564,0.99999999999897,0.896233706327201,0,2,negative regulation of neutrophil activation,BP,
16585,GO:0097363,0.999999999998973,0.902702519951651,0,2,protein O-GlcNAc transferase activity,MF,
28,GO:0000053,0.999999999998973,0.957808162546731,0,1,argininosuccinate metabolic process,BP,
1624,GO:0004055,0.999999999998973,0.957808162546731,0,1,argininosuccinate synthase activity,MF,
2254,GO:0005166,0.999999999998975,0.972034823790109,0,1,neurotrophin p75 receptor binding,MF,
3499,GO:0007402,0.999999999998975,0.972034823790109,0,1,ganglion mother cell fate determination,BP,
3611,GO:0008052,0.999999999998975,0.972034823790109,0,1,sensory organ boundary specification,BP,
4411,GO:0010160,0.999999999998975,0.972034823790109,0,1,formation of animal organ boundary,BP,
12429,GO:0048867,0.999999999998975,0.972034823790109,0,1,stem cell fate determination,BP,
14246,GO:0061193,0.999999999998975,0.972034823790109,0,1,taste bud development,BP,
17010,GO:0099082,0.999999999998975,0.972034823790109,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
17011,GO:0099083,0.999999999998975,0.972034823790109,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17068,GO:0099538,0.999999999998975,0.972034823790109,0,1,synaptic signaling via neuropeptide,BP,
17069,GO:0099540,0.999999999998975,0.972034823790109,0,1,trans-synaptic signaling by neuropeptide,BP,
17077,GO:0099551,0.999999999998975,0.972034823790109,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
5762,GO:0016918,0.99999999999898,0.83201476811401,0,5,retinal binding,MF,
17569,GO:1901098,0.999999999998982,0.731130869998924,0,6,positive regulation of autophagosome maturation,BP,
12367,GO:0048733,0.999999999999014,0.778131929186362,0,5,sebaceous gland development,BP,
7617,GO:0031999,0.999999999999016,0.902774042406157,0,2,negative regulation of fatty acid beta-oxidation,BP,
3033,GO:0006580,0.999999999999016,0.954080711476997,0,1,ethanolamine metabolic process,BP,
18293,GO:1903165,0.999999999999016,0.954080711476997,0,1,response to polycyclic arene,BP,
18951,GO:1904681,0.999999999999016,0.954080711476997,0,1,response to 3-methylcholanthrene,BP,
1000,GO:0002461,0.999999999999019,0.954971482921281,0,1,tolerance induction dependent upon immune response,BP,
1022,GO:0002519,0.999999999999019,0.954971482921281,0,1,natural killer cell tolerance induction,BP,
1081,GO:0002652,0.999999999999019,0.954971482921281,0,1,regulation of tolerance induction dependent upon immune response,BP,
8056,GO:0032712,0.999999999999019,0.954971482921281,0,1,negative regulation of interleukin-3 production,BP,
15413,GO:0071656,0.999999999999019,0.954971482921281,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
17613,GO:1901257,0.999999999999019,0.954971482921281,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
6330,GO:0020012,0.999999999999024,0.903238237261638,0,2,evasion or tolerance of host immune response,BP,
7003,GO:0030682,0.999999999999024,0.903238237261638,0,2,evasion or tolerance of host defense response,BP,
7004,GO:0030683,0.999999999999024,0.903238237261638,0,2,evasion or tolerance by virus of host immune response,BP,
13208,GO:0051805,0.999999999999024,0.903238237261638,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
13210,GO:0051807,0.999999999999024,0.903238237261638,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14070,GO:0060830,0.99999999999903,0.875171786781537,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
17497,GO:1900402,0.999999999999034,0.658456199749749,0,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
5097,GO:0015368,0.999999999999038,0.732208224076248,0,6,calcium:cation antiporter activity,MF,
7334,GO:0031340,0.999999999999041,0.748505080044985,0,6,positive regulation of vesicle fusion,BP,
18818,GO:1904351,0.999999999999042,0.862848776491375,0,3,negative regulation of protein catabolic process in the vacuole,BP,
19174,GO:1905166,0.999999999999042,0.862848776491375,0,3,negative regulation of lysosomal protein catabolic process,BP,
11209,GO:0045329,0.999999999999045,0.793710974849371,0,5,carnitine biosynthetic process,BP,
7939,GO:0032511,0.999999999999052,0.714958455301738,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
2022,GO:0004748,0.999999999999055,0.858246773980853,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2640,GO:0005971,0.999999999999055,0.858246773980853,0,3,ribonucleoside-diphosphate reductase complex,CC,
5647,GO:0016728,0.999999999999055,0.858246773980853,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
14434,GO:0061731,0.999999999999055,0.858246773980853,0,3,ribonucleoside-diphosphate reductase activity,MF,
6229,GO:0019776,0.999999999999055,0.872046297629922,0,3,Atg8 ligase activity,MF,
10833,GO:0044323,0.999999999999061,0.901102116618485,0,2,retinoic acid-responsive element binding,MF,
2051,GO:0004797,0.999999999999063,0.909418728243176,0,2,thymidine kinase activity,MF,
18132,GO:1902775,0.999999999999063,0.856852460932262,0,3,mitochondrial large ribosomal subunit assembly,BP,
3687,GO:0008191,0.999999999999083,0.741803231815556,0,7,metalloendopeptidase inhibitor activity,MF,
8426,GO:0033503,0.999999999999089,0.822602977065315,0,4,HULC complex,CC,
8811,GO:0034515,0.9999999999991,0.907808016470239,0,2,proteasome storage granule,CC,
5434,GO:0016287,0.999999999999112,0.954090989067345,0,1,glycerone-phosphate O-acyltransferase activity,MF,
6908,GO:0030479,0.999999999999118,0.762229037463699,0,5,actin cortical patch,CC,
13904,GO:0060529,0.999999999999118,0.898497672734761,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
14403,GO:0061645,0.999999999999118,0.762229037463699,0,5,endocytic patch,CC,
7056,GO:0030826,0.999999999999122,0.718033069383656,0,7,regulation of cGMP biosynthetic process,BP,
216,GO:0000451,0.999999999999123,0.906771930347559,0,2,rRNA 2'-O-methylation,BP,
217,GO:0000453,0.999999999999123,0.906771930347559,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
14543,GO:0070039,0.999999999999123,0.906771930347559,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
6245,GO:0019800,0.999999999999142,0.962030456613302,0,1,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
8946,GO:0034983,0.999999999999143,0.737519780380899,0,6,peptidyl-lysine deacetylation,BP,
5747,GO:0016890,0.999999999999144,0.91170294636225,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
4806,GO:0010997,0.999999999999149,0.782343497482837,0,5,anaphase-promoting complex binding,MF,
16608,GO:0097418,0.999999999999155,0.776699161776193,0,5,neurofibrillary tangle,CC,
15259,GO:0071409,0.999999999999173,0.866326187225944,0,3,cellular response to cycloheximide,BP,
5221,GO:0015820,0.999999999999195,0.905298316648122,0,2,leucine transport,BP,
4210,GO:0009330,0.999999999999195,0.899244280400609,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
383,GO:0001018,0.999999999999211,0.911622760904392,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
12877,GO:0051185,0.99999999999922,0.749332107765266,0,6,coenzyme transmembrane transporter activity,MF,
229,GO:0000472,0.999999999999224,0.862141674680461,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
354,GO:0000967,0.999999999999224,0.862141674680461,0,3,rRNA 5'-end processing,BP,
14373,GO:0061588,0.999999999999232,0.817437153808706,0,4,calcium activated phospholipid scrambling,BP,
14374,GO:0061589,0.999999999999232,0.817437153808706,0,4,calcium activated phosphatidylserine scrambling,BP,
14375,GO:0061590,0.999999999999232,0.817437153808706,0,4,calcium activated phosphatidylcholine scrambling,BP,
14376,GO:0061591,0.999999999999232,0.817437153808706,0,4,calcium activated galactosylceramide scrambling,BP,
4581,GO:0010663,0.999999999999245,0.738249558390378,0,6,positive regulation of striated muscle cell apoptotic process,BP,
4584,GO:0010666,0.999999999999245,0.738249558390378,0,6,positive regulation of cardiac muscle cell apoptotic process,BP,
19380,GO:1905773,0.999999999999251,0.850723794583068,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
6016,GO:0019061,0.999999999999255,0.955123188550467,0,1,uncoating of virus,BP,
6309,GO:0019934,0.999999999999255,0.781945859120132,0,5,cGMP-mediated signaling,BP,
3380,GO:0007158,0.999999999999257,0.727572395245616,0,6,neuron cell-cell adhesion,BP,
1818,GO:0004465,0.999999999999264,0.864740330732601,0,3,lipoprotein lipase activity,MF,
709,GO:0001931,0.999999999999273,0.671104025727639,0,8,uropod,CC,
7278,GO:0031254,0.999999999999273,0.671104025727639,0,8,cell trailing edge,CC,
7645,GO:0032051,0.999999999999282,0.766481493257426,0,5,clathrin light chain binding,MF,
2047,GO:0004792,0.999999999999282,0.890241503309509,0,3,thiosulfate sulfurtransferase activity,MF,
14554,GO:0070061,0.999999999999288,0.872039787154466,0,3,fructose binding,MF,
7618,GO:0032000,0.999999999999288,0.762221080680632,0,5,positive regulation of fatty acid beta-oxidation,BP,
2901,GO:0006408,0.99999999999929,0.916312408650947,0,2,snRNA export from nucleus,BP,
10231,GO:0042908,0.999999999999301,0.730319082916058,0,6,xenobiotic transport,BP,
10232,GO:0042910,0.999999999999301,0.730319082916058,0,6,xenobiotic transmembrane transporter activity,MF,
6395,GO:0021590,0.999999999999316,0.898686442942591,0,2,cerebellum maturation,BP,
6429,GO:0021691,0.999999999999316,0.898686442942591,0,2,cerebellar Purkinje cell layer maturation,BP,
6437,GO:0021699,0.999999999999316,0.898686442942591,0,2,cerebellar cortex maturation,BP,
18610,GO:1903850,0.999999999999334,0.95415393651243,0,1,regulation of cristae formation,BP,
18611,GO:1903852,0.999999999999334,0.95415393651243,0,1,positive regulation of cristae formation,BP,
18894,GO:1904542,0.999999999999334,0.95415393651243,0,1,regulation of free ubiquitin chain polymerization,BP,
18895,GO:1904544,0.999999999999334,0.95415393651243,0,1,positive regulation of free ubiquitin chain polymerization,BP,
19057,GO:1904881,0.999999999999334,0.95415393651243,0,1,cellular response to hydrogen sulfide,BP,
17719,GO:1901612,0.999999999999347,0.766890626999162,0,6,cardiolipin binding,MF,
14928,GO:0070761,0.999999999999353,0.769979934556327,0,6,pre-snoRNP complex,CC,
15565,GO:0071986,0.999999999999355,0.752351183126699,0,6,Ragulator complex,CC,
7547,GO:0031821,0.999999999999355,0.749973612315166,0,6,G-protein coupled serotonin receptor binding,MF,
3427,GO:0007216,0.999999999999367,0.745490454913704,0,6,G-protein coupled glutamate receptor signaling pathway,BP,
10846,GO:0044338,0.99999999999937,0.911814585545119,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
19876,GO:2000323,0.999999999999399,0.739575915270374,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
7120,GO:0030916,0.999999999999404,0.85228345179214,0,3,otic vesicle formation,BP,
14030,GO:0060737,0.999999999999404,0.85228345179214,0,3,prostate gland morphogenetic growth,BP,
15375,GO:0071600,0.999999999999404,0.85228345179214,0,3,otic vesicle morphogenesis,BP,
5352,GO:0016098,0.999999999999417,0.952683428168594,0,1,monoterpenoid metabolic process,BP,
8517,GO:0033695,0.999999999999417,0.952683428168594,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
8934,GO:0034875,0.999999999999417,0.952683428168594,0,1,caffeine oxidase activity,MF,
15386,GO:0071615,0.999999999999417,0.952683428168594,0,1,oxidative deethylation,BP,
15482,GO:0071812,0.999999999999417,0.952683428168594,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15501,GO:0071848,0.999999999999417,0.952683428168594,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
3509,GO:0007418,0.99999999999942,0.899265061991227,0,2,ventral midline development,BP,
6538,GO:0021937,0.99999999999942,0.899265061991227,0,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6539,GO:0021938,0.99999999999942,0.899265061991227,0,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6540,GO:0021940,0.99999999999942,0.899265061991227,0,2,positive regulation of cerebellar granule cell precursor proliferation,BP,
2070,GO:0004821,0.999999999999424,0.913119289294557,0,2,histidine-tRNA ligase activity,MF,
2917,GO:0006427,0.999999999999424,0.913119289294557,0,2,histidyl-tRNA aminoacylation,BP,
17682,GO:1901525,0.999999999999427,0.737804256619367,0,6,negative regulation of mitophagy,BP,
19383,GO:1905777,0.999999999999427,0.867232032358944,0,3,regulation of exonuclease activity,BP,
8822,GO:0034594,0.999999999999433,0.772356540356404,0,5,phosphatidylinositol trisphosphate phosphatase activity,MF,
13868,GO:0060457,0.999999999999434,0.75880431241172,0,6,negative regulation of digestive system process,BP,
12757,GO:0051012,0.999999999999434,0.907916931348566,0,2,microtubule sliding,BP,
15320,GO:0071500,0.999999999999438,0.821695775728996,0,5,cellular response to nitrosative stress,BP,
13085,GO:0051575,0.999999999999438,0.783269295489367,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
18651,GO:1903929,0.999999999999443,0.952532519763454,0,1,primary palate development,BP,
14139,GO:0060988,0.999999999999444,0.905480148529238,0,2,lipid tube assembly,BP,
6862,GO:0030327,0.999999999999452,0.860651502083713,0,3,prenylated protein catabolic process,BP,
523,GO:0001614,0.999999999999454,0.758566462347202,0,6,purinergic nucleotide receptor activity,MF,
5530,GO:0016502,0.999999999999454,0.758566462347202,0,6,nucleotide receptor activity,MF,
17574,GO:1901142,0.999999999999457,0.73624702695595,0,6,insulin metabolic process,BP,
6857,GO:0030322,0.999999999999457,0.911795596104097,0,2,stabilization of membrane potential,BP,
10462,GO:0043316,0.999999999999459,0.90722356076567,0,2,cytotoxic T cell degranulation,BP,
11261,GO:0045475,0.99999999999946,0.700261919193896,0,7,locomotor rhythm,BP,
1663,GO:0004115,0.999999999999466,0.731462308538946,0,6,3',5'-cyclic-AMP phosphodiesterase activity,MF,
8301,GO:0033130,0.999999999999467,0.735012692269813,0,6,acetylcholine receptor binding,MF,
3023,GO:0006568,0.999999999999469,0.799307812179797,0,5,tryptophan metabolic process,BP,
3037,GO:0006586,0.999999999999469,0.799307812179797,0,5,indolalkylamine metabolic process,BP,
15100,GO:0071074,0.999999999999472,0.957070808006793,0,1,eukaryotic initiation factor eIF2 binding,MF,
18529,GO:1903674,0.999999999999472,0.957070808006793,0,1,regulation of cap-dependent translational initiation,BP,
18530,GO:1903676,0.999999999999472,0.957070808006793,0,1,positive regulation of cap-dependent translational initiation,BP,
16964,GO:0098943,0.999999999999482,0.912288855881128,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
9130,GO:0035442,0.999999999999502,0.915569782161324,0,2,dipeptide transmembrane transport,BP,
10237,GO:0042938,0.999999999999502,0.915569782161324,0,2,dipeptide transport,BP,
16120,GO:0090088,0.999999999999502,0.915569782161324,0,2,regulation of oligopeptide transport,BP,
16121,GO:0090089,0.999999999999502,0.915569782161324,0,2,regulation of dipeptide transport,BP,
20181,GO:2000878,0.999999999999502,0.915569782161324,0,2,positive regulation of oligopeptide transport,BP,
20182,GO:2000880,0.999999999999502,0.915569782161324,0,2,positive regulation of dipeptide transport,BP,
20243,GO:2001148,0.999999999999502,0.915569782161324,0,2,regulation of dipeptide transmembrane transport,BP,
20244,GO:2001150,0.999999999999502,0.915569782161324,0,2,positive regulation of dipeptide transmembrane transport,BP,
16295,GO:0090362,0.999999999999516,0.90564346034565,0,2,positive regulation of platelet-derived growth factor production,BP,
3103,GO:0006680,0.999999999999527,0.865557844217813,0,3,glucosylceramide catabolic process,BP,
1919,GO:0004609,0.999999999999534,0.911847195742582,0,2,phosphatidylserine decarboxylase activity,MF,
10325,GO:0043111,0.999999999999548,0.914369649904935,0,2,replication fork arrest,BP,
176,GO:0000384,0.999999999999574,0.921538696417468,0,2,first spliceosomal transesterification activity,MF,
7671,GO:0032096,0.99999999999958,0.776299534515974,0,6,negative regulation of response to food,BP,
7674,GO:0032099,0.99999999999958,0.776299534515974,0,6,negative regulation of appetite,BP,
2029,GO:0004758,0.999999999999582,0.782354587227907,0,5,serine C-palmitoyltransferase activity,MF,
5510,GO:0016454,0.999999999999582,0.782354587227907,0,5,C-palmitoyltransferase activity,MF,
4877,GO:0014735,0.999999999999585,0.912541415653098,0,2,regulation of muscle atrophy,BP,
4878,GO:0014736,0.999999999999585,0.912541415653098,0,2,negative regulation of muscle atrophy,BP,
1750,GO:0004347,0.999999999999588,0.955923111369453,0,1,glucose-6-phosphate isomerase activity,MF,
6089,GO:0019242,0.999999999999588,0.955923111369453,0,1,methylglyoxal biosynthetic process,BP,
4748,GO:0010915,0.99999999999961,0.947524591085598,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4749,GO:0010916,0.99999999999961,0.947524591085598,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
14445,GO:0061744,0.999999999999613,0.931628862270051,0,2,motor behavior,BP,
12164,GO:0048262,0.999999999999614,0.805194780745451,0,5,determination of dorsal/ventral asymmetry,BP,
205,GO:0000430,0.999999999999622,0.920131828665339,0,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,
207,GO:0000432,0.999999999999622,0.920131828665339,0,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
2963,GO:0006498,0.999999999999622,0.774036840832117,0,5,N-terminal protein lipidation,BP,
932,GO:0002327,0.999999999999626,0.720584748576364,0,6,immature B cell differentiation,BP,
15854,GO:0072554,0.999999999999627,0.954863949835112,0,1,blood vessel lumenization,BP,
17589,GO:1901189,0.999999999999627,0.954863949835112,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17624,GO:1901297,0.999999999999627,0.954863949835112,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19145,GO:1905068,0.999999999999627,0.954863949835112,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
4858,GO:0014067,0.999999999999637,0.638843285271525,0,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
9351,GO:0035860,0.999999999999639,0.90345719200972,0,2,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
1777,GO:0004379,0.999999999999642,0.896620387258851,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
5882,GO:0018008,0.999999999999642,0.896620387258851,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6040,GO:0019107,0.999999999999642,0.896620387258851,0,2,myristoyltransferase activity,MF,
2303,GO:0005280,0.999999999999645,0.859138672484576,0,3,amino acid:proton symporter activity,MF,
17403,GO:1900118,0.999999999999652,0.742099160759199,0,6,negative regulation of execution phase of apoptosis,BP,
16960,GO:0098935,0.999999999999652,0.851132728067682,0,3,dendritic transport,BP,
16962,GO:0098937,0.999999999999652,0.851132728067682,0,3,anterograde dendritic transport,BP,
9056,GO:0035276,0.999999999999656,0.946678241117496,0,1,ethanol binding,MF,
9262,GO:0035668,0.999999999999656,0.946678241117496,0,1,TRAM-dependent toll-like receptor signaling pathway,BP,
9263,GO:0035669,0.999999999999656,0.946678241117496,0,1,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
20208,GO:2001029,0.999999999999656,0.946678241117496,0,1,regulation of cellular glucuronidation,BP,
20209,GO:2001031,0.999999999999656,0.946678241117496,0,1,positive regulation of cellular glucuronidation,BP,
17835,GO:1901978,0.999999999999664,0.653786763818463,0,9,positive regulation of cell cycle checkpoint,BP,
14784,GO:0070475,0.999999999999664,0.693546388345409,0,9,rRNA base methylation,BP,
14081,GO:0060846,0.999999999999665,0.867594223046254,0,3,blood vessel endothelial cell fate commitment,BP,
14082,GO:0060847,0.999999999999665,0.867594223046254,0,3,endothelial cell fate specification,BP,
16452,GO:0097101,0.999999999999665,0.867594223046254,0,3,blood vessel endothelial cell fate specification,BP,
9540,GO:0036289,0.99999999999969,0.738530584255359,0,6,peptidyl-serine autophosphorylation,BP,
17695,GO:1901552,0.999999999999694,0.90200290471259,0,2,positive regulation of endothelial cell development,BP,
18289,GO:1903142,0.999999999999694,0.90200290471259,0,2,positive regulation of establishment of endothelial barrier,BP,
6387,GO:0021571,0.999999999999711,0.951705192516282,0,1,rhombomere 5 development,BP,
6388,GO:0021572,0.999999999999711,0.951705192516282,0,1,rhombomere 6 development,BP,
9062,GO:0035283,0.999999999999711,0.951705192516282,0,1,central nervous system segmentation,BP,
9063,GO:0035284,0.999999999999711,0.951705192516282,0,1,brain segmentation,BP,
3570,GO:0007614,0.999999999999712,0.772169941538577,0,6,short-term memory,BP,
15276,GO:0071439,0.999999999999717,0.681312073401755,0,8,clathrin complex,CC,
15179,GO:0071287,0.999999999999726,0.742336043220222,0,6,cellular response to manganese ion,BP,
3145,GO:0006740,0.999999999999754,0.863727827954541,0,3,NADPH regeneration,BP,
2530,GO:0005784,0.99999999999976,0.886012812457891,0,4,Sec61 translocon complex,CC,
15159,GO:0071256,0.99999999999976,0.886012812457891,0,4,translocon complex,CC,
13685,GO:0060197,0.999999999999761,0.907692286849276,0,2,cloacal septation,BP,
2555,GO:0005828,0.999999999999783,0.695413006694756,0,7,kinetochore microtubule,CC,
7135,GO:0030955,0.999999999999783,0.631834296268799,0,9,potassium ion binding,MF,
2792,GO:0006228,0.999999999999787,0.755078794668386,0,8,UTP biosynthetic process,BP,
1719,GO:0004308,0.999999999999789,0.831491123413044,0,4,exo-alpha-sialidase activity,MF,
5779,GO:0016997,0.999999999999789,0.831491123413044,0,4,alpha-sialidase activity,MF,
12149,GO:0048240,0.999999999999789,0.742079055660477,0,7,sperm capacitation,BP,
2822,GO:0006286,0.999999999999796,0.929448959012161,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
2389,GO:0005523,0.999999999999804,0.753067858094501,0,7,tropomyosin binding,MF,
11730,GO:0046525,0.999999999999806,0.958853454642079,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
860,GO:0002188,0.999999999999812,0.854040631641421,0,3,translation reinitiation,BP,
861,GO:0002189,0.999999999999812,0.954425128566126,0,1,ribose phosphate diphosphokinase complex,CC,
14065,GO:0060819,0.999999999999814,0.896182327784959,0,2,inactivation of X chromosome by genetic imprinting,BP,
8397,GO:0033316,0.999999999999819,0.953066247074205,0,1,meiotic spindle assembly checkpoint,BP,
10988,GO:0044779,0.999999999999819,0.953066247074205,0,1,meiotic spindle checkpoint,BP,
10992,GO:0044785,0.999999999999819,0.953066247074205,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
17883,GO:1902102,0.999999999999819,0.953066247074205,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17884,GO:1902103,0.999999999999819,0.953066247074205,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
18275,GO:1903096,0.999999999999819,0.953066247074205,0,1,protein localization to meiotic spindle midzone,BP,
19160,GO:1905132,0.999999999999819,0.953066247074205,0,1,regulation of meiotic chromosome separation,BP,
19161,GO:1905133,0.999999999999819,0.953066247074205,0,1,negative regulation of meiotic chromosome separation,BP,
19248,GO:1905359,0.999999999999819,0.953066247074205,0,1,protein localization to meiotic spindle,BP,
18981,GO:1904734,0.99999999999982,0.987269911637557,0,1,positive regulation of electron transfer activity,BP,
19097,GO:1904960,0.99999999999982,0.987269911637557,0,1,positive regulation of cytochrome-c oxidase activity,BP,
16073,GO:0089709,0.99999999999982,0.910792762501109,0,2,L-histidine transmembrane transport,BP,
18501,GO:1903593,0.999999999999822,0.89116706280409,0,3,regulation of histamine secretion by mast cell,BP,
18502,GO:1903595,0.999999999999822,0.89116706280409,0,3,positive regulation of histamine secretion by mast cell,BP,
19771,GO:2000124,0.999999999999822,0.904822592596986,0,2,regulation of endocannabinoid signaling pathway,BP,
219,GO:0000455,0.99999999999983,0.915695914743885,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
750,GO:0001978,0.999999999999832,0.955474628424932,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
751,GO:0001983,0.999999999999832,0.955474628424932,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
752,GO:0001985,0.999999999999832,0.955474628424932,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
757,GO:0001994,0.999999999999832,0.955474628424932,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
759,GO:0001997,0.999999999999832,0.955474628424932,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
1292,GO:0003099,0.999999999999832,0.955474628424932,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
2134,GO:0004936,0.999999999999832,0.955474628424932,0,1,alpha-adrenergic receptor activity,MF,
2135,GO:0004937,0.999999999999832,0.955474628424932,0,1,alpha1-adrenergic receptor activity,MF,
18682,GO:1903995,0.999999999999832,0.955474628424932,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18683,GO:1903997,0.999999999999832,0.955474628424932,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
6982,GO:0030644,0.999999999999839,0.91179976060414,0,2,cellular chloride ion homeostasis,BP,
3400,GO:0007181,0.999999999999845,0.912456872720318,0,2,transforming growth factor beta receptor complex assembly,BP,
14311,GO:0061408,0.99999999999985,0.870109300780906,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
7357,GO:0031394,0.99999999999985,0.912905877820968,0,2,positive regulation of prostaglandin biosynthetic process,BP,
20322,GO:2001280,0.99999999999985,0.912905877820968,0,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,
177,GO:0000386,0.999999999999856,0.863142631186139,0,3,second spliceosomal transesterification activity,MF,
15514,GO:0071873,0.999999999999858,0.951144050076925,0,1,response to norepinephrine,BP,
15515,GO:0071874,0.999999999999858,0.951144050076925,0,1,cellular response to norepinephrine stimulus,BP,
2261,GO:0005173,0.999999999999861,0.849620513589659,0,3,stem cell factor receptor binding,MF,
9813,GO:0040038,0.999999999999864,0.901391159367013,0,2,polar body extrusion after meiotic divisions,BP,
14879,GO:0070649,0.999999999999864,0.901391159367013,0,2,formin-nucleated actin cable assembly,BP,
17238,GO:0110009,0.999999999999864,0.901391159367013,0,2,formin-nucleated actin cable organization,BP,
7894,GO:0032458,0.999999999999923,0.94935986651949,0,1,slow endocytic recycling,BP,
14624,GO:0070180,0.999999999999925,0.982834151379331,0,1,large ribosomal subunit rRNA binding,MF,
14785,GO:0070476,0.999999999999925,0.982834151379331,0,1,rRNA (guanine-N7)-methylation,BP,
2132,GO:0004931,0.999999999999929,0.956233969189377,0,1,extracellularly ATP-gated cation channel activity,MF,
5539,GO:0016519,0.999999999999929,0.956233969189377,0,1,gastric inhibitory peptide receptor activity,MF,
9108,GO:0035381,0.999999999999929,0.956233969189377,0,1,ATP-gated ion channel activity,MF,
9741,GO:0038192,0.999999999999929,0.956233969189377,0,1,gastric inhibitory peptide signaling pathway,BP,
7673,GO:0032098,0.999999999999932,0.703603974211248,0,8,regulation of appetite,BP,
5793,GO:0017018,0.999999999999937,0.896450673134678,0,2,myosin phosphatase activity,MF,
16795,GO:0098597,0.999999999999941,0.763244877695763,0,5,observational learning,BP,
13754,GO:0060312,0.999999999999945,0.760176118496437,0,6,regulation of blood vessel remodeling,BP,
853,GO:0002176,0.999999999999955,0.903626772312973,0,3,male germ cell proliferation,BP,
9476,GO:0036093,0.999999999999955,0.903626772312973,0,3,germ cell proliferation,BP,
2277,GO:0005219,0.999999999999981,0.871614982735685,0,3,ryanodine-sensitive calcium-release channel activity,MF,
17611,GO:1901255,0.999999999999983,0.90943071450371,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
17684,GO:1901529,0.999999999999993,0.904331128098874,0,2,positive regulation of anion channel activity,BP,
14087,GO:0060857,0.999999999999994,0.955116399239125,0,1,establishment of glial blood-brain barrier,BP,
11,GO:0000022,1,0.614356576726199,0,10,mitotic spindle elongation,BP,
14,GO:0000027,1,0.38381384517632,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.606053349272646,0,18,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.375757057017936,0,22,mannosyltransferase activity,MF,
21,GO:0000038,1,0.342520476873069,0,23,very long-chain fatty acid metabolic process,BP,
26,GO:0000050,1,0.6310252776407,0,10,urea cycle,BP,
29,GO:0000054,1,0.59765773779532,0,13,ribosomal subunit export from nucleus,BP,
33,GO:0000062,1,0.47373091678211,0,17,fatty-acyl-CoA binding,MF,
44,GO:0000096,1,0.240513572754731,0,30,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.522254314569074,0,14,sulfur amino acid biosynthetic process,BP,
52,GO:0000109,1,0.62736872016673,0,10,nucleotide-excision repair complex,CC,
60,GO:0000123,1,0.0244374012690477,0,79,histone acetyltransferase complex,CC,
61,GO:0000124,1,0.571911974431557,0,13,SAGA complex,CC,
70,GO:0000146,1,0.466071657080803,0,14,microfilament motor activity,MF,
75,GO:0000152,1,0.170512286359653,0,40,nuclear ubiquitin ligase complex,CC,
77,GO:0000154,1,0.239049468212983,0,34,rRNA modification,BP,
88,GO:0000176,1,0.617940358045738,0,13,nuclear exosome (RNase complex),CC,
89,GO:0000177,1,0.525883051957166,0,15,cytoplasmic exosome (RNase complex),CC,
90,GO:0000178,1,0.39162570796021,0,22,exosome (RNase complex),CC,
92,GO:0000182,1,0.602131056949002,0,10,rDNA binding,MF,
93,GO:0000183,1,0.394440523112421,0,39,chromatin silencing at rDNA,BP,
105,GO:0000217,1,0.327285897659504,0,23,DNA secondary structure binding,MF,
114,GO:0000242,1,0.379578456062556,0,19,pericentriolar material,CC,
116,GO:0000244,1,0.553692725105202,0,12,spliceosomal tri-snRNP complex assembly,BP,
117,GO:0000245,1,0.085835861071872,0,54,spliceosomal complex assembly,BP,
128,GO:0000266,1,0.201353700837732,0,33,mitochondrial fission,BP,
144,GO:0000295,1,0.60150890993854,0,11,adenine nucleotide transmembrane transporter activity,MF,
155,GO:0000313,1,0.0623932708294729,0,84,organellar ribosome,CC,
156,GO:0000314,1,0.393065722622914,0,28,organellar small ribosomal subunit,CC,
157,GO:0000315,1,0.185750546649678,0,51,organellar large ribosomal subunit,CC,
163,GO:0000338,1,0.646028399313361,0,10,protein deneddylation,BP,
164,GO:0000339,1,0.450835539138846,0,17,RNA cap binding,MF,
166,GO:0000346,1,0.558084288778427,0,13,transcription export complex,CC,
178,GO:0000387,1,0.205796934060077,0,37,spliceosomal snRNP assembly,BP,
182,GO:0000394,1,0.488411968101867,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
185,GO:0000400,1,0.471074614254164,0,16,four-way junction DNA binding,MF,
221,GO:0000460,1,0.244080634421489,0,33,maturation of 5.8S rRNA,BP,
224,GO:0000463,1,0.676635351980565,0,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000466,1,0.382733327555226,0,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000469,1,0.326405729686707,0,26,cleavage involved in rRNA processing,BP,
228,GO:0000470,1,0.383118372543997,0,24,maturation of LSU-rRNA,BP,
230,GO:0000478,1,0.505827613484863,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
231,GO:0000479,1,0.529892008234665,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
241,GO:0000502,1,0.0850518299716979,0,63,proteasome complex,CC,
256,GO:0000722,1,0.514324715149146,0,14,telomere maintenance via recombination,BP,
260,GO:0000726,1,0.0455695680467939,0,74,non-recombinational repair,BP,
262,GO:0000729,1,0.336270795816081,0,22,DNA double-strand break processing,BP,
263,GO:0000730,1,0.636954110006722,0,10,DNA recombinase assembly,BP,
265,GO:0000732,1,0.287111033238253,0,25,strand displacement,BP,
267,GO:0000737,1,0.379377999915921,0,21,DNA catabolic process, endonucleolytic,BP,
272,GO:0000774,1,0.608012506904446,0,11,adenyl-nucleotide exchange factor activity,MF,
274,GO:0000776,1,0.00347383454319978,0,121,kinetochore,CC,
275,GO:0000777,1,0.0145044384502212,0,92,condensed chromosome kinetochore,CC,
276,GO:0000778,1,0.575528351320526,0,12,condensed nuclear chromosome kinetochore,CC,
278,GO:0000780,1,0.3935403368668,0,20,condensed nuclear chromosome, centromeric region,CC,
280,GO:0000782,1,0.622811098598071,0,10,telomere cap complex,CC,
281,GO:0000783,1,0.622811098598071,0,10,nuclear telomere cap complex,CC,
285,GO:0000788,1,0.570432428330457,0,31,nuclear nucleosome,CC,
291,GO:0000795,1,0.429493566486812,0,18,synaptonemal complex,CC,
303,GO:0000812,1,0.639790009888705,0,10,Swr1 complex,CC,
306,GO:0000815,1,0.588875105227967,0,12,ESCRT III complex,CC,
330,GO:0000920,1,0.476240214397892,0,17,cell separation after cytokinesis,BP,
335,GO:0000930,1,0.394114382061463,0,19,gamma-tubulin complex,CC,
340,GO:0000940,1,0.530145973614419,0,13,condensed chromosome outer kinetochore,CC,
350,GO:0000963,1,0.480271359478025,0,16,mitochondrial RNA processing,BP,
353,GO:0000966,1,0.413658957155487,0,21,RNA 5'-end processing,BP,
357,GO:0000974,1,0.551349719992752,0,13,Prp19 complex,CC,
372,GO:0000993,1,0.275227450668085,0,27,RNA polymerase II core binding,MF,
393,GO:0001054,1,0.649466967155272,0,11,RNA polymerase I activity,MF,
394,GO:0001055,1,0.650250593142218,0,11,RNA polymerase II activity,MF,
433,GO:0001161,1,0.613606260153014,0,10,intronic transcription regulatory region sequence-specific DNA binding,MF,
449,GO:0001222,1,0.542221275862311,0,13,transcription corepressor binding,MF,
460,GO:0001325,1,0.471001008703044,0,15,formation of extrachromosomal circular DNA,BP,
464,GO:0001502,1,0.577923784302368,0,11,cartilage condensation,BP,
466,GO:0001504,1,0.471079020480597,0,16,neurotransmitter uptake,BP,
487,GO:0001539,1,0.483930868560212,0,15,cilium or flagellum-dependent cell motility,BP,
544,GO:0001662,1,0.429900714769341,0,18,behavioral fear response,BP,
550,GO:0001671,1,0.368950949317878,0,22,ATPase activator activity,MF,
552,GO:0001673,1,0.632623647104112,0,10,male germ cell nucleus,CC,
559,GO:0001682,1,0.628155157991207,0,12,tRNA 5'-leader removal,BP,
570,GO:0001709,1,0.453485929775883,0,17,cell fate determination,BP,
576,GO:0001725,1,0.118674871841656,0,43,stress fiber,CC,
617,GO:0001783,1,0.369786989185293,0,22,B cell apoptotic process,BP,
644,GO:0001832,1,0.47071646423987,0,15,blastocyst growth,BP,
645,GO:0001833,1,0.609565369953141,0,10,inner cell mass cell proliferation,BP,
674,GO:0001881,1,0.255949656322836,0,28,receptor recycling,BP,
688,GO:0001895,1,0.226754461524965,0,32,retina homeostasis,BP,
700,GO:0001917,1,0.338330297398163,0,22,photoreceptor inner segment,CC,
702,GO:0001919,1,0.369963733488446,0,20,regulation of receptor recycling,BP,
704,GO:0001921,1,0.519727230528655,0,13,positive regulation of receptor recycling,BP,
719,GO:0001941,1,0.380824280459627,0,20,postsynaptic membrane organization,BP,
736,GO:0001963,1,0.548215657278691,0,14,synaptic transmission, dopaminergic,BP,
738,GO:0001965,1,0.485813663359861,0,16,G-protein alpha-subunit binding,MF,
771,GO:0002021,1,0.633672245215443,0,10,response to dietary excess,BP,
825,GO:0002097,1,0.477917758594675,0,16,tRNA wobble base modification,BP,
826,GO:0002098,1,0.578957594516445,0,12,tRNA wobble uridine modification,BP,
831,GO:0002115,1,0.532405613716973,0,13,store-operated calcium entry,BP,
832,GO:0002116,1,0.582834321485402,0,10,semaphorin receptor complex,CC,
848,GO:0002161,1,0.582590279074923,0,11,aminoacyl-tRNA editing activity,MF,
855,GO:0002178,1,0.599925933785576,0,11,palmitoyltransferase complex,CC,
858,GO:0002183,1,0.438977927061645,0,18,cytoplasmic translational initiation,BP,
868,GO:0002200,1,0.0705169775208038,0,54,somatic diversification of immune receptors,BP,
869,GO:0002204,1,0.199403455637001,0,33,somatic recombination of immunoglobulin genes involved in immune response,BP,
870,GO:0002208,1,0.199403455637001,0,33,somatic diversification of immunoglobulins involved in immune response,BP,
871,GO:0002209,1,0.429900714769341,0,18,behavioral defense response,BP,
878,GO:0002227,1,0.838754649539653,0,10,innate immune response in mucosa,BP,
941,GO:0002347,1,0.623190472037442,0,10,response to tumor cell,BP,
964,GO:0002385,1,0.717718016108424,0,13,mucosal immune response,BP,
968,GO:0002407,1,0.602306717533763,0,11,dendritic cell chemotaxis,BP,
1046,GO:0002562,1,0.109384126866634,0,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1047,GO:0002566,1,0.487823608587114,0,15,somatic diversification of immune receptors via somatic mutation,BP,
1228,GO:0002902,1,0.473094224355061,0,17,regulation of B cell apoptotic process,BP,
1229,GO:0002903,1,0.59099631022752,0,12,negative regulation of B cell apoptotic process,BP,
1258,GO:0003009,1,0.446468552550335,0,18,skeletal muscle contraction,BP,
1283,GO:0003081,1,0.639132929706376,0,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1287,GO:0003091,1,0.366539529123177,0,20,renal water homeostasis,BP,
1314,GO:0003159,1,0.600557558016004,0,11,morphogenesis of an endothelium,BP,
1403,GO:0003334,1,0.583507908687182,0,11,keratinocyte development,BP,
1410,GO:0003341,1,0.320437897962055,0,25,cilium movement,BP,
1417,GO:0003351,1,0.656198491172599,0,10,epithelial cilium movement,BP,
1455,GO:0003688,1,0.506977032550288,0,14,DNA replication origin binding,MF,
1477,GO:0003735,1,0.0130548110576741,0,154,structural constituent of ribosome,MF,
1478,GO:0003743,1,0.111974418599351,0,49,translation initiation factor activity,MF,
1479,GO:0003746,1,0.48335975540612,0,16,translation elongation factor activity,MF,
1482,GO:0003756,1,0.443493947199309,0,17,protein disulfide isomerase activity,MF,
1499,GO:0003841,1,0.387586016291458,0,19,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1526,GO:0003887,1,0.293420560558241,0,26,DNA-directed DNA polymerase activity,MF,
1530,GO:0003906,1,0.581569176359654,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1555,GO:0003951,1,0.517231142067198,0,13,NAD+ kinase activity,MF,
1558,GO:0003954,1,0.339721079644612,0,40,NADH dehydrogenase activity,MF,
1587,GO:0003995,1,0.538924583165372,0,13,acyl-CoA dehydrogenase activity,MF,
1609,GO:0004029,1,0.530517296108196,0,13,aldehyde dehydrogenase (NAD) activity,MF,
1613,GO:0004033,1,0.520057826467385,0,16,aldo-keto reductase (NADP) activity,MF,
1660,GO:0004112,1,0.54586561424394,0,12,cyclic-nucleotide phosphodiesterase activity,MF,
1662,GO:0004114,1,0.576603976787208,0,11,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1671,GO:0004129,1,0.640085285648272,0,18,cytochrome-c oxidase activity,MF,
1702,GO:0004177,1,0.20268032273801,0,33,aminopeptidase activity,MF,
1703,GO:0004180,1,0.442994046699877,0,17,carboxypeptidase activity,MF,
1706,GO:0004190,1,0.511272975434841,0,14,aspartic-type endopeptidase activity,MF,
1708,GO:0004198,1,0.486054553545695,0,16,calcium-dependent cysteine-type endopeptidase activity,MF,
1711,GO:0004298,1,0.581077244304445,0,18,threonine-type endopeptidase activity,MF,
1764,GO:0004364,1,0.545729804992184,0,18,glutathione transferase activity,MF,
1787,GO:0004402,1,0.0850207300991063,0,51,histone acetyltransferase activity,MF,
1800,GO:0004435,1,0.492394493950868,0,14,phosphatidylinositol phospholipase C activity,MF,
1801,GO:0004438,1,0.4790107608462,0,14,phosphatidylinositol-3-phosphatase activity,MF,
1860,GO:0004520,1,0.125254044509806,0,45,endodeoxyribonuclease activity,MF,
1865,GO:0004526,1,0.654445137355663,0,11,ribonuclease P activity,MF,
1868,GO:0004529,1,0.451904879832627,0,17,exodeoxyribonuclease activity,MF,
1874,GO:0004536,1,0.0609002564890721,0,61,deoxyribonuclease activity,MF,
1876,GO:0004549,1,0.51919330862265,0,16,tRNA-specific ribonuclease activity,MF,
1877,GO:0004550,1,0.660337372054044,0,11,nucleoside diphosphate kinase activity,MF,
1878,GO:0004551,1,0.607115250853936,0,12,nucleotide diphosphatase activity,MF,
1883,GO:0004559,1,0.511028216855983,0,13,alpha-mannosidase activity,MF,
1896,GO:0004576,1,0.665161240071178,0,10,oligosaccharyl transferase activity,MF,
1911,GO:0004596,1,0.6331611211886,0,10,peptide alpha-N-acetyltransferase activity,MF,
1929,GO:0004620,1,0.0542189728482723,0,60,phospholipase activity,MF,
1931,GO:0004622,1,0.462956144531702,0,16,lysophospholipase activity,MF,
1932,GO:0004623,1,0.392692195584879,0,20,phospholipase A2 activity,MF,
1933,GO:0004629,1,0.469200081195842,0,15,phospholipase C activity,MF,
1952,GO:0004653,1,0.543583732426026,0,12,polypeptide N-acetylgalactosaminyltransferase activity,MF,
1958,GO:0004659,1,0.495862307313514,0,15,prenyltransferase activity,MF,
1982,GO:0004697,1,0.514819102815206,0,13,protein kinase C activity,MF,
1990,GO:0004707,1,0.562369071359523,0,12,MAP kinase activity,MF,
2057,GO:0004806,1,0.608844923216831,0,10,triglyceride lipase activity,MF,
2169,GO:0005001,1,0.586372080853399,0,10,transmembrane receptor protein tyrosine phosphatase activity,MF,
2209,GO:0005092,1,0.553318515371726,0,13,GDP-dissociation inhibitor activity,MF,
2218,GO:0005112,1,0.466711901883265,0,15,Notch binding,MF,
2280,GO:0005227,1,0.532370118166889,0,13,calcium activated cation channel activity,MF,
2281,GO:0005229,1,0.599462066670736,0,10,intracellular calcium activated chloride channel activity,MF,
2301,GO:0005272,1,0.460048222527222,0,15,sodium channel activity,MF,
2314,GO:0005310,1,0.368041122096932,0,20,dicarboxylic acid transmembrane transporter activity,MF,
2328,GO:0005338,1,0.603554563082317,0,11,nucleotide-sugar transmembrane transporter activity,MF,
2330,GO:0005343,1,0.524960055663989,0,13,organic acid:sodium symporter activity,MF,
2333,GO:0005346,1,0.60150890993854,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2358,GO:0005452,1,0.515734279344853,0,13,inorganic anion exchanger activity,MF,
2374,GO:0005501,1,0.58187419927854,0,12,retinoid binding,MF,
2387,GO:0005521,1,0.514097200774632,0,14,lamin binding,MF,
2388,GO:0005522,1,0.606221327718903,0,10,profilin binding,MF,
2392,GO:0005527,1,0.617117243115911,0,12,macrolide binding,MF,
2393,GO:0005528,1,0.617117243115911,0,12,FK506 binding,MF,
2402,GO:0005545,1,0.532206297595238,0,12,1-phosphatidylinositol binding,MF,
2452,GO:0005662,1,0.522661128202925,0,14,DNA replication factor A complex,CC,
2455,GO:0005665,1,0.509224106355985,0,17,DNA-directed RNA polymerase II, core complex,CC,
2460,GO:0005671,1,0.514767933515572,0,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2464,GO:0005675,1,0.561396076408232,0,13,holo TFIIH complex,CC,
2466,GO:0005680,1,0.411915109699574,0,21,anaphase-promoting complex,CC,
2470,GO:0005684,1,0.0839825271253506,0,58,U2-type spliceosomal complex,CC,
2471,GO:0005685,1,0.451599550417848,0,20,U1 snRNP,CC,
2472,GO:0005686,1,0.461666162136118,0,20,U2 snRNP,CC,
2473,GO:0005687,1,0.670391114856199,0,11,U4 snRNP,CC,
2475,GO:0005689,1,0.380137305832542,0,26,U12-type spliceosomal complex,CC,
2479,GO:0005697,1,0.390869970989094,0,22,telomerase holoenzyme complex,CC,
2490,GO:0005732,1,0.445878737329118,0,24,small nucleolar ribonucleoprotein complex,CC,
2491,GO:0005736,1,0.615462279833603,0,12,DNA-directed RNA polymerase I complex,CC,
2498,GO:0005744,1,0.590286095378547,0,13,mitochondrial inner membrane presequence translocase complex,CC,
2500,GO:0005746,1,0.116226004627122,0,72,mitochondrial respiratory chain,CC,
2501,GO:0005747,1,0.323005870903184,0,42,mitochondrial respiratory chain complex I,CC,
2503,GO:0005750,1,0.653509396600881,0,11,mitochondrial respiratory chain complex III,CC,
2504,GO:0005751,1,0.789125014303237,0,10,mitochondrial respiratory chain complex IV,CC,
2507,GO:0005758,1,0.0592728737522375,0,71,mitochondrial intermembrane space,CC,
2510,GO:0005761,1,0.0623932708294729,0,84,mitochondrial ribosome,CC,
2511,GO:0005762,1,0.185750546649678,0,51,mitochondrial large ribosomal subunit,CC,
2512,GO:0005763,1,0.393065722622914,0,28,mitochondrial small ribosomal subunit,CC,
2526,GO:0005778,1,0.0911283638191705,0,51,peroxisomal membrane,CC,
2527,GO:0005779,1,0.519103502290633,0,15,integral component of peroxisomal membrane,CC,
2536,GO:0005790,1,0.324396494957671,0,24,smooth endoplasmic reticulum,CC,
2557,GO:0005832,1,0.625334040125558,0,10,chaperonin-containing T-complex,CC,
2559,GO:0005834,1,0.410441061058467,0,19,heterotrimeric G-protein complex,CC,
2560,GO:0005838,1,0.420478690121437,0,21,proteasome regulatory particle,CC,
2561,GO:0005839,1,0.521281399575734,0,20,proteasome core complex,CC,
2566,GO:0005847,1,0.45712855468295,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2567,GO:0005849,1,0.414783288578636,0,18,mRNA cleavage factor complex,CC,
2570,GO:0005852,1,0.487272371013323,0,17,eukaryotic translation initiation factor 3 complex,CC,
2579,GO:0005865,1,0.611897096308183,0,11,striated muscle thin filament,CC,
2580,GO:0005868,1,0.418145380189448,0,20,cytoplasmic dynein complex,CC,
2592,GO:0005884,1,0.0301109376205433,0,73,actin filament,CC,
2593,GO:0005885,1,0.670184575985345,0,10,Arp2/3 protein complex,CC,
2598,GO:0005891,1,0.592757742289261,0,11,voltage-gated calcium channel complex,CC,
2621,GO:0005930,1,0.0508262209499,0,62,axoneme,CC,
2624,GO:0005942,1,0.438534492295081,0,16,phosphatidylinositol 3-kinase complex,CC,
2659,GO:0006000,1,0.599827455856594,0,11,fructose metabolic process,BP,
2663,GO:0006004,1,0.528482349619656,0,13,fucose metabolic process,BP,
2665,GO:0006007,1,0.381688500969681,0,21,glucose catabolic process,BP,
2671,GO:0006020,1,0.59965665312555,0,10,inositol metabolic process,BP,
2687,GO:0006047,1,0.541268556669388,0,13,UDP-N-acetylglucosamine metabolic process,BP,
2692,GO:0006054,1,0.625103714699944,0,10,N-acetylneuraminate metabolic process,BP,
2700,GO:0006063,1,0.588064239361893,0,12,uronic acid metabolic process,BP,
2704,GO:0006067,1,0.607564032969613,0,11,ethanol metabolic process,BP,
2707,GO:0006071,1,0.602662185100785,0,11,glycerol metabolic process,BP,
2716,GO:0006089,1,0.604490537427661,0,11,lactate metabolic process,BP,
2722,GO:0006098,1,0.480829759109378,0,17,pentose-phosphate shunt,BP,
2723,GO:0006099,1,0.285702094580372,0,28,tricarboxylic acid cycle,BP,
2741,GO:0006120,1,0.280293502867563,0,45,mitochondrial electron transport, NADH to ubiquinone,BP,
2743,GO:0006122,1,0.587947020651179,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2744,GO:0006123,1,0.696238323430886,0,14,mitochondrial electron transport, cytochrome c to oxygen,BP,
2748,GO:0006144,1,0.412907332377869,0,19,purine nucleobase metabolic process,BP,
2767,GO:0006182,1,0.496483665972398,0,14,cGMP biosynthetic process,BP,
2777,GO:0006206,1,0.460109442145877,0,17,pyrimidine nucleobase metabolic process,BP,
2797,GO:0006241,1,0.638482240691035,0,12,CTP biosynthetic process,BP,
2798,GO:0006244,1,0.610773254521379,0,12,pyrimidine nucleotide catabolic process,BP,
2805,GO:0006264,1,0.612347694237477,0,10,mitochondrial DNA replication,BP,
2811,GO:0006270,1,0.147643119253865,0,41,DNA replication initiation,BP,
2819,GO:0006283,1,0.0424332959519676,0,73,transcription-coupled nucleotide-excision repair,BP,
2821,GO:0006285,1,0.658838619287894,0,10,base-excision repair, AP site formation,BP,
2831,GO:0006297,1,0.363524258520393,0,23,nucleotide-excision repair, DNA gap filling,BP,
2832,GO:0006298,1,0.23318147756992,0,31,mismatch repair,BP,
2835,GO:0006303,1,0.0635952418723595,0,67,double-strand break repair via nonhomologous end joining,BP,
2839,GO:0006307,1,0.650908455305898,0,10,DNA dealkylation involved in DNA repair,BP,
2840,GO:0006308,1,0.263495354402313,0,29,DNA catabolic process,BP,
2841,GO:0006309,1,0.480466302523324,0,16,apoptotic DNA fragmentation,BP,
2844,GO:0006312,1,0.349534700746744,0,22,mitotic recombination,BP,
2850,GO:0006335,1,0.501483258228813,0,32,DNA replication-dependent nucleosome assembly,BP,
2851,GO:0006336,1,0.169838412474079,0,50,DNA replication-independent nucleosome assembly,BP,
2852,GO:0006337,1,0.466241584026742,0,16,nucleosome disassembly,BP,
2854,GO:0006342,1,0.0243112353361083,0,107,chromatin silencing,BP,
2857,GO:0006346,1,0.470885098037956,0,15,methylation-dependent chromatin silencing,BP,
2859,GO:0006349,1,0.509013742292598,0,13,regulation of gene expression by genetic imprinting,BP,
2865,GO:0006356,1,0.237090099894848,0,30,regulation of transcription by RNA polymerase I,BP,
2867,GO:0006359,1,0.301769539260144,0,25,regulation of transcription by RNA polymerase III,BP,
2868,GO:0006360,1,0.0654077273142294,0,59,transcription by RNA polymerase I,BP,
2869,GO:0006361,1,0.218164549346774,0,35,transcription initiation from RNA polymerase I promoter,BP,
2870,GO:0006362,1,0.288272984312624,0,29,transcription elongation from RNA polymerase I promoter,BP,
2871,GO:0006363,1,0.275247809780525,0,30,termination of RNA polymerase I transcription,BP,
2877,GO:0006370,1,0.254993066759316,0,32,7-methylguanosine mRNA capping,BP,
2878,GO:0006376,1,0.290647549261829,0,26,mRNA splice site selection,BP,
2879,GO:0006378,1,0.147972572174494,0,39,mRNA polyadenylation,BP,
2880,GO:0006379,1,0.294597734047757,0,27,mRNA cleavage,BP,
2885,GO:0006388,1,0.565946647976447,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
2886,GO:0006390,1,0.544683438994591,0,13,mitochondrial transcription,BP,
2906,GO:0006415,1,0.0291563356182371,0,100,translational termination,BP,
2933,GO:0006450,1,0.467388747549761,0,18,regulation of translational fidelity,BP,
2957,GO:0006488,1,0.395994002848926,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
2959,GO:0006490,1,0.377919028248554,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
2960,GO:0006491,1,0.447263425895019,0,16,N-glycan processing,BP,
2974,GO:0006515,1,0.315623039112615,0,24,protein quality control for misfolded or incompletely synthesized proteins,BP,
2975,GO:0006516,1,0.498814865624298,0,15,glycoprotein catabolic process,BP,
2976,GO:0006517,1,0.21439264150104,0,32,protein deglycosylation,BP,
2982,GO:0006525,1,0.475510525361639,0,16,arginine metabolic process,BP,
2990,GO:0006534,1,0.59102274427593,0,11,cysteine metabolic process,BP,
2996,GO:0006541,1,0.423799626311508,0,17,glutamine metabolic process,BP,
3010,GO:0006555,1,0.449788613987874,0,17,methionine metabolic process,BP,
3018,GO:0006563,1,0.639202950026964,0,10,L-serine metabolic process,BP,
3031,GO:0006577,1,0.538445002850524,0,13,amino-acid betaine metabolic process,BP,
3050,GO:0006607,1,0.356557499250509,0,20,NLS-bearing protein import into nucleus,BP,
3054,GO:0006613,1,0.0757796367820511,0,96,cotranslational protein targeting to membrane,BP,
3055,GO:0006614,1,0.0959813860943707,0,91,SRP-dependent cotranslational protein targeting to membrane,BP,
3063,GO:0006625,1,0.438913568763888,0,17,protein targeting to peroxisome,BP,
3078,GO:0006646,1,0.584342704708059,0,11,phosphatidylethanolamine biosynthetic process,BP,
3081,GO:0006654,1,0.233365108677279,0,29,phosphatidic acid biosynthetic process,BP,
3082,GO:0006655,1,0.618858853891046,0,10,phosphatidylglycerol biosynthetic process,BP,
3083,GO:0006656,1,0.258865856815221,0,29,phosphatidylcholine biosynthetic process,BP,
3085,GO:0006658,1,0.364120766795313,0,21,phosphatidylserine metabolic process,BP,
3097,GO:0006670,1,0.645029051354308,0,10,sphingosine metabolic process,BP,
3120,GO:0006699,1,0.405599399340252,0,19,bile acid biosynthetic process,BP,
3138,GO:0006730,1,0.365719762031955,0,21,one-carbon metabolic process,BP,
3141,GO:0006734,1,0.301155441924145,0,26,NADH metabolic process,BP,
3142,GO:0006735,1,0.460655192346605,0,17,NADH regeneration,BP,
3144,GO:0006739,1,0.29041055935263,0,28,NADP metabolic process,BP,
3148,GO:0006743,1,0.527283426833046,0,15,ubiquinone metabolic process,BP,
3149,GO:0006744,1,0.556551048771665,0,14,ubiquinone biosynthetic process,BP,
3160,GO:0006768,1,0.586938780577322,0,11,biotin metabolic process,BP,
3192,GO:0006817,1,0.549441232092007,0,12,phosphate ion transport,BP,
3210,GO:0006851,1,0.393707951835859,0,20,mitochondrial calcium ion transmembrane transport,BP,
3211,GO:0006853,1,0.604308098017868,0,10,carnitine shuttle,BP,
3215,GO:0006862,1,0.477867755846939,0,16,nucleotide transport,BP,
3230,GO:0006884,1,0.427886040302034,0,17,cell volume homeostasis,BP,
3236,GO:0006891,1,0.241179055043533,0,30,intra-Golgi vesicle-mediated transport,BP,
3240,GO:0006896,1,0.501741411787198,0,14,Golgi to vacuole transport,BP,
3256,GO:0006921,1,0.315123764033744,0,25,cellular component disassembly involved in execution phase of apoptosis,BP,
3297,GO:0006995,1,0.670015441768178,0,10,cellular response to nitrogen starvation,BP,
3306,GO:0007007,1,0.411398627313627,0,22,inner mitochondrial membrane organization,BP,
3316,GO:0007020,1,0.275413619393259,0,26,microtubule nucleation,BP,
3323,GO:0007031,1,0.27427816997809,0,28,peroxisome organization,BP,
3329,GO:0007040,1,0.0905806505113646,0,51,lysosome organization,BP,
3345,GO:0007064,1,0.345609986998351,0,22,mitotic sister chromatid cohesion,BP,
3348,GO:0007076,1,0.440542564943689,0,16,mitotic chromosome condensation,BP,
3351,GO:0007080,1,0.137836682934962,0,43,mitotic metaphase plate congression,BP,
3358,GO:0007095,1,0.384417532136593,0,19,mitotic G2 DNA damage checkpoint,BP,
3360,GO:0007097,1,0.430911281976554,0,16,nuclear migration,BP,
3363,GO:0007100,1,0.53441865278292,0,13,mitotic centrosome separation,BP,
3366,GO:0007129,1,0.41248404306139,0,19,synapsis,BP,
3368,GO:0007131,1,0.182409532477932,0,36,reciprocal meiotic recombination,BP,
3378,GO:0007156,1,0.0314886057121419,0,66,homophilic cell adhesion via plasma membrane adhesion molecules,BP,
3408,GO:0007190,1,0.49719054229971,0,14,activation of adenylate cyclase activity,BP,
3417,GO:0007202,1,0.638996222514323,0,10,activation of phospholipase C activity,BP,
3424,GO:0007213,1,0.632445502842115,0,10,G-protein coupled acetylcholine receptor signaling pathway,BP,
3426,GO:0007215,1,0.181091151529965,0,34,glutamate receptor signaling pathway,BP,
3429,GO:0007218,1,0.498361835007039,0,17,neuropeptide signaling pathway,BP,
3431,GO:0007220,1,0.487496898763343,0,15,Notch receptor processing,BP,
3432,GO:0007221,1,0.430361409594128,0,16,positive regulation of transcription of Notch receptor target,BP,
3458,GO:0007271,1,0.616806613166035,0,10,synaptic transmission, cholinergic,BP,
3467,GO:0007288,1,0.6214086279548,0,10,sperm axoneme assembly,BP,
3468,GO:0007289,1,0.583715531077946,0,11,spermatid nucleus differentiation,BP,
3492,GO:0007379,1,0.590693978687868,0,11,segment specification,BP,
3506,GO:0007413,1,0.486136599471168,0,14,axonal fasciculation,BP,
3541,GO:0007549,1,0.545624149524016,0,12,dosage compensation,BP,
3561,GO:0007602,1,0.329128793924151,0,23,phototransduction,BP,
3562,GO:0007603,1,0.460963918439643,0,16,phototransduction, visible light,BP,
3572,GO:0007617,1,0.587775046123766,0,11,mating behavior,BP,
3573,GO:0007618,1,0.426116130483308,0,18,mating,BP,
3582,GO:0007628,1,0.551926188946254,0,12,adult walking behavior,BP,
3603,GO:0008038,1,0.318851316056319,0,22,neuron recognition,BP,
3605,GO:0008045,1,0.492375092874995,0,14,motor neuron axon guidance,BP,
3612,GO:0008053,1,0.417524543499902,0,20,mitochondrial fusion,BP,
3625,GO:0008081,1,0.0614592548847345,0,57,phosphoric diester hydrolase activity,MF,
3632,GO:0008093,1,0.580721523541199,0,11,cytoskeletal adaptor activity,MF,
3634,GO:0008097,1,0.703874365472295,0,10,5S rRNA binding,MF,
3636,GO:0008106,1,0.611901250362313,0,12,alcohol dehydrogenase (NADP+) activity,MF,
3655,GO:0008137,1,0.370567549493132,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3660,GO:0008143,1,0.502229896678346,0,14,poly(A) binding,MF,
3666,GO:0008156,1,0.204292566559391,0,33,negative regulation of DNA replication,BP,
3673,GO:0008171,1,0.380719157597748,0,21,O-methyltransferase activity,MF,
3675,GO:0008173,1,0.0794963259533421,0,55,RNA methyltransferase activity,MF,
3677,GO:0008175,1,0.265066858052765,0,28,tRNA methyltransferase activity,MF,
3680,GO:0008179,1,0.613719731876788,0,10,adenylate cyclase binding,MF,
3692,GO:0008198,1,0.469834600096012,0,17,ferrous iron binding,MF,
3699,GO:0008206,1,0.294324555536958,0,26,bile acid metabolic process,BP,
3702,GO:0008210,1,0.470611842774593,0,17,estrogen metabolic process,BP,
3716,GO:0008235,1,0.21543905374287,0,31,metalloexopeptidase activity,MF,
3719,GO:0008238,1,0.0446972586054496,0,64,exopeptidase activity,MF,
3723,GO:0008250,1,0.635161265275535,0,12,oligosaccharyltransferase complex,CC,
3725,GO:0008252,1,0.619623837748189,0,10,nucleotidase activity,MF,
3761,GO:0008301,1,0.528776889455321,0,13,DNA binding, bending,MF,
3764,GO:0008307,1,0.305703435264626,0,25,structural constituent of muscle,MF,
3765,GO:0008308,1,0.572395159721256,0,12,voltage-gated anion channel activity,MF,
3771,GO:0008320,1,0.624428905172607,0,13,protein transmembrane transporter activity,MF,
3774,GO:0008327,1,0.467324682174895,0,16,methyl-CpG binding,MF,
3775,GO:0008328,1,0.403333282778225,0,18,ionotropic glutamate receptor complex,CC,
3781,GO:0008334,1,0.355519731228746,0,24,histone mRNA metabolic process,BP,
3788,GO:0008349,1,0.594021030115395,0,10,MAP kinase kinase kinase kinase activity,MF,
3790,GO:0008353,1,0.487389453865147,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
3793,GO:0008356,1,0.529646257999778,0,13,asymmetric cell division,BP,
3798,GO:0008373,1,0.506001506902948,0,14,sialyltransferase activity,MF,
3799,GO:0008374,1,0.155380625612424,0,38,O-acyltransferase activity,MF,
3819,GO:0008409,1,0.451779917855683,0,16,5'-3' exonuclease activity,MF,
3822,GO:0008417,1,0.610906952979926,0,10,fucosyltransferase activity,MF,
3859,GO:0008474,1,0.631281979370237,0,10,palmitoyl-(protein) hydrolase activity,MF,
3866,GO:0008483,1,0.561629640461825,0,12,transaminase activity,MF,
3900,GO:0008535,1,0.363412431852017,0,24,respiratory chain complex IV assembly,BP,
3901,GO:0008536,1,0.208469485479986,0,32,Ran GTPase binding,MF,
3903,GO:0008540,1,0.606459395112969,0,12,proteasome regulatory particle, base subcomplex,CC,
3913,GO:0008565,1,0.0414727891806104,0,71,protein transporter activity,MF,
3914,GO:0008568,1,0.612099364731126,0,10,microtubule-severing ATPase activity,MF,
3915,GO:0008569,1,0.565561835178675,0,11,ATP-dependent microtubule motor activity, minus-end-directed,MF,
3916,GO:0008574,1,0.3194370764117,0,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,
3930,GO:0008608,1,0.263582153852108,0,28,attachment of spindle microtubules to kinetochore,BP,
3948,GO:0008641,1,0.615374273266477,0,10,ubiquitin-like modifier activating enzyme activity,MF,
3951,GO:0008649,1,0.502461373852262,0,16,rRNA methyltransferase activity,MF,
3953,GO:0008652,1,0.0651158375648714,0,58,cellular amino acid biosynthetic process,BP,
3956,GO:0008656,1,0.536089264251201,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4022,GO:0009048,1,0.596764335672591,0,10,dosage compensation by inactivation of X chromosome,BP,
4030,GO:0009060,1,0.0681963391503297,0,68,aerobic respiration,BP,
4035,GO:0009065,1,0.385591253738653,0,20,glutamine family amino acid catabolic process,BP,
4037,GO:0009067,1,0.371019555674598,0,21,aspartate family amino acid biosynthetic process,BP,
4038,GO:0009068,1,0.570530813308635,0,12,aspartate family amino acid catabolic process,BP,
4039,GO:0009069,1,0.237335639251231,0,31,serine family amino acid metabolic process,BP,
4040,GO:0009070,1,0.526329647603806,0,14,serine family amino acid biosynthetic process,BP,
4042,GO:0009072,1,0.634813462370976,0,11,aromatic amino acid family metabolic process,BP,
4048,GO:0009083,1,0.396245390879982,0,20,branched-chain amino acid catabolic process,BP,
4049,GO:0009084,1,0.507850092373366,0,14,glutamine family amino acid biosynthetic process,BP,
4051,GO:0009086,1,0.600204276946143,0,11,methionine biosynthetic process,BP,
4062,GO:0009109,1,0.622065732510398,0,11,coenzyme catabolic process,BP,
4065,GO:0009112,1,0.19919438687989,0,35,nucleobase metabolic process,BP,
4066,GO:0009113,1,0.560119197633953,0,13,purine nucleobase biosynthetic process,BP,
4091,GO:0009143,1,0.629849761240609,0,11,nucleoside triphosphate catabolic process,BP,
4095,GO:0009147,1,0.458064040527337,0,20,pyrimidine nucleoside triphosphate metabolic process,BP,
4096,GO:0009148,1,0.517403333397954,0,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4109,GO:0009162,1,0.630037161899183,0,11,deoxyribonucleoside monophosphate metabolic process,BP,
4141,GO:0009200,1,0.551249318368344,0,15,deoxyribonucleoside triphosphate metabolic process,BP,
4149,GO:0009208,1,0.576697770831512,0,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4150,GO:0009209,1,0.604405656656093,0,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4159,GO:0009219,1,0.480644344407581,0,18,pyrimidine deoxyribonucleotide metabolic process,BP,
4163,GO:0009223,1,0.640637561263533,0,11,pyrimidine deoxyribonucleotide catabolic process,BP,
4165,GO:0009225,1,0.221666970663159,0,33,nucleotide-sugar metabolic process,BP,
4166,GO:0009226,1,0.389457174283636,0,21,nucleotide-sugar biosynthetic process,BP,
4171,GO:0009235,1,0.575370168016939,0,12,cobalamin metabolic process,BP,
4187,GO:0009262,1,0.278512087493782,0,31,deoxyribonucleotide metabolic process,BP,
4188,GO:0009263,1,0.573013884160825,0,13,deoxyribonucleotide biosynthetic process,BP,
4189,GO:0009264,1,0.479266059170556,0,18,deoxyribonucleotide catabolic process,BP,
4190,GO:0009265,1,0.667731573782139,0,10,2'-deoxyribonucleotide biosynthetic process,BP,
4194,GO:0009295,1,0.156752611353336,0,40,nucleoid,CC,
4198,GO:0009303,1,0.289942939047202,0,27,rRNA transcription,BP,
4222,GO:0009394,1,0.338577075797933,0,27,2'-deoxyribonucleotide metabolic process,BP,
4237,GO:0009415,1,0.6258618701753,0,10,response to water,BP,
4241,GO:0009437,1,0.566374814281429,0,12,carnitine metabolic process,BP,
4255,GO:0009452,1,0.242244172974856,0,33,7-methylguanosine RNA capping,BP,
4257,GO:0009581,1,0.0990037242625121,0,47,detection of external stimulus,BP,
4258,GO:0009582,1,0.0937118960007471,0,48,detection of abiotic stimulus,BP,
4259,GO:0009583,1,0.256460059237614,0,28,detection of light stimulus,BP,
4260,GO:0009584,1,0.342767506612881,0,22,detection of visible light,BP,
4286,GO:0009650,1,0.576050164273002,0,12,UV protection,BP,
4337,GO:0009886,1,0.640795102310511,0,10,post-embryonic animal morphogenesis,BP,
4355,GO:0009925,1,0.343274466522707,0,21,basal plasma membrane,CC,
4358,GO:0009950,1,0.5730468150115,0,11,dorsal/ventral axis specification,BP,
4417,GO:0010181,1,0.61686473477939,0,10,FMN binding,MF,
4425,GO:0010226,1,0.500469264170281,0,14,response to lithium ion,BP,
4431,GO:0010257,1,0.181947816697877,0,55,NADH dehydrogenase complex assembly,BP,
4441,GO:0010310,1,0.628984858195703,0,10,regulation of hydrogen peroxide metabolic process,BP,
4455,GO:0010390,1,0.237424294372072,0,29,histone monoubiquitination,BP,
4458,GO:0010421,1,0.612664484390898,0,11,hydrogen peroxide-mediated programmed cell death,BP,
4482,GO:0010485,1,0.410643563302706,0,18,H4 histone acetyltransferase activity,MF,
4501,GO:0010523,1,0.56323586774183,0,13,negative regulation of calcium ion transport into cytosol,BP,
4513,GO:0010560,1,0.506452032062165,0,14,positive regulation of glycoprotein biosynthetic process,BP,
4520,GO:0010569,1,0.297774804459124,0,25,regulation of double-strand break repair via homologous recombination,BP,
4530,GO:0010592,1,0.505982052063022,0,14,positive regulation of lamellipodium assembly,BP,
4534,GO:0010596,1,0.187368383912211,0,34,negative regulation of endothelial cell migration,BP,
4579,GO:0010661,1,0.477895461953486,0,15,positive regulation of muscle cell apoptotic process,BP,
4662,GO:0010804,1,0.565178901669804,0,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4681,GO:0010826,1,0.564746622362453,0,12,negative regulation of centrosome duplication,BP,
4721,GO:0010880,1,0.499266409656916,0,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4722,GO:0010881,1,0.615434303268554,0,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
4787,GO:0010971,1,0.403971316046573,0,19,positive regulation of G2/M transition of mitotic cell cycle,BP,
4788,GO:0010972,1,0.0266922170211342,0,87,negative regulation of G2/M transition of mitotic cell cycle,BP,
4805,GO:0010996,1,0.54468445476021,0,12,response to auditory stimulus,BP,
4807,GO:0010998,1,0.60807771445233,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
4829,GO:0014029,1,0.615728361135083,0,10,neural crest formation,BP,
4841,GO:0014044,1,0.301073826166567,0,24,Schwann cell development,BP,
4891,GO:0014808,1,0.45554844628724,0,17,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
4916,GO:0014850,1,0.522405775632226,0,14,response to muscle activity,BP,
4945,GO:0014904,1,0.431370868116368,0,17,myotube cell development,BP,
4952,GO:0015002,1,0.640085285648272,0,18,heme-copper terminal oxidase activity,MF,
4959,GO:0015020,1,0.512530226328458,0,14,glucuronosyltransferase activity,MF,
4961,GO:0015030,1,0.104034085603628,0,51,Cajal body,CC,
4965,GO:0015037,1,0.63276980290914,0,12,peptide disulfide oxidoreductase activity,MF,
4969,GO:0015074,1,0.610314341657683,0,10,DNA integration,BP,
4983,GO:0015101,1,0.420754918780458,0,18,organic cation transmembrane transporter activity,MF,
4986,GO:0015106,1,0.564322226199588,0,11,bicarbonate transmembrane transporter activity,MF,
5040,GO:0015215,1,0.501625947752579,0,15,nucleotide transmembrane transporter activity,MF,
5041,GO:0015216,1,0.60150890993854,0,11,purine nucleotide transmembrane transporter activity,MF,
5080,GO:0015301,1,0.410566501819163,0,18,anion:anion antiporter activity,MF,
5134,GO:0015605,1,0.351150623155456,0,22,organophosphate ester transmembrane transporter activity,MF,
5140,GO:0015645,1,0.611258577099041,0,10,fatty acid ligase activity,MF,
5144,GO:0015662,1,0.333800494908679,0,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5165,GO:0015701,1,0.388164854537356,0,19,bicarbonate transport,BP,
5195,GO:0015780,1,0.576454919266454,0,12,nucleotide-sugar transmembrane transport,BP,
5217,GO:0015813,1,0.527398278945891,0,13,L-glutamate transmembrane transport,BP,
5245,GO:0015865,1,0.573029218732885,0,12,purine nucleotide transport,BP,
5248,GO:0015868,1,0.573029218732885,0,12,purine ribonucleotide transport,BP,
5251,GO:0015872,1,0.512579221398813,0,15,dopamine transport,BP,
5268,GO:0015909,1,0.165302035366693,0,37,long-chain fatty acid transport,BP,
5275,GO:0015919,1,0.458694699862897,0,16,peroxisomal membrane transport,BP,
5277,GO:0015923,1,0.486392958652056,0,14,mannosidase activity,MF,
5282,GO:0015929,1,0.566926908808555,0,12,hexosaminidase activity,MF,
5285,GO:0015934,1,0.0293671157825325,0,115,large ribosomal subunit,CC,
5286,GO:0015935,1,0.136882900718394,0,68,small ribosomal subunit,CC,
5287,GO:0015936,1,0.507449339118222,0,15,coenzyme A metabolic process,BP,
5288,GO:0015937,1,0.642967987697203,0,10,coenzyme A biosynthetic process,BP,
5303,GO:0015988,1,0.417978533399539,0,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5305,GO:0015991,1,0.427769700075819,0,20,ATP hydrolysis coupled proton transport,BP,
5308,GO:0016010,1,0.550043764645521,0,12,dystrophin-associated glycoprotein complex,CC,
5317,GO:0016024,1,0.522407185395467,0,13,CDP-diacylglycerol biosynthetic process,BP,
5334,GO:0016056,1,0.526644941447008,0,13,rhodopsin mediated signaling pathway,BP,
5341,GO:0016074,1,0.64881507858371,0,12,snoRNA metabolic process,BP,
5342,GO:0016075,1,0.532297979165429,0,15,rRNA catabolic process,BP,
5365,GO:0016137,1,0.567724262493054,0,13,glycoside metabolic process,BP,
5376,GO:0016180,1,0.376811121678342,0,22,snRNA processing,BP,
5395,GO:0016226,1,0.453777302806218,0,20,iron-sulfur cluster assembly,BP,
5396,GO:0016229,1,0.458003911865975,0,19,steroid dehydrogenase activity,MF,
5400,GO:0016233,1,0.13682625750592,0,51,telomere capping,BP,
5410,GO:0016246,1,0.503483009657015,0,15,RNA interference,BP,
5426,GO:0016273,1,0.603028359333129,0,11,arginine N-methyltransferase activity,MF,
5427,GO:0016274,1,0.603028359333129,0,11,protein-arginine N-methyltransferase activity,MF,
5435,GO:0016289,1,0.573593988444031,0,13,CoA hydrolase activity,MF,
5440,GO:0016298,1,0.0245381003379551,0,76,lipase activity,MF,
5444,GO:0016307,1,0.4927266509695,0,14,phosphatidylinositol phosphate kinase activity,MF,
5464,GO:0016339,1,0.429962574721228,0,17,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
5466,GO:0016342,1,0.515035507058179,0,13,catenin complex,CC,
5476,GO:0016405,1,0.501835376198092,0,14,CoA-ligase activity,MF,
5479,GO:0016408,1,0.554779579739702,0,13,C-acyltransferase activity,MF,
5480,GO:0016409,1,0.210488974754765,0,33,palmitoyltransferase activity,MF,
5482,GO:0016411,1,0.320399477086289,0,23,acylglycerol O-acyltransferase activity,MF,
5487,GO:0016417,1,0.281703912587862,0,27,S-acyltransferase activity,MF,
5493,GO:0016423,1,0.544152966702842,0,13,tRNA (guanine) methyltransferase activity,MF,
5504,GO:0016442,1,0.575596988612775,0,11,RISC complex,CC,
5505,GO:0016444,1,0.109384126866634,0,45,somatic cell DNA recombination,BP,
5506,GO:0016445,1,0.111516219642842,0,45,somatic diversification of immunoglobulins,BP,
5507,GO:0016446,1,0.515338113615364,0,14,somatic hypermutation of immunoglobulin genes,BP,
5508,GO:0016447,1,0.163667846051862,0,37,somatic recombination of immunoglobulin gene segments,BP,
5512,GO:0016459,1,0.175253779924613,0,35,myosin complex,CC,
5513,GO:0016460,1,0.535080663622476,0,13,myosin II complex,CC,
5517,GO:0016471,1,0.615968191205621,0,11,vacuolar proton-transporting V-type ATPase complex,CC,
5524,GO:0016486,1,0.447200475312519,0,17,peptide hormone processing,BP,
5537,GO:0016514,1,0.5203486403813,0,13,SWI/SNF complex,CC,
5552,GO:0016553,1,0.589963189458608,0,11,base conversion or substitution editing,BP,
5556,GO:0016558,1,0.562355052250706,0,12,protein import into peroxisome matrix,BP,
5566,GO:0016574,1,0.106487840749809,0,45,histone ubiquitination,BP,
5570,GO:0016578,1,0.369035762173307,0,21,histone deubiquitination,BP,
5572,GO:0016580,1,0.578778866327271,0,11,Sin3 complex,CC,
5587,GO:0016601,1,0.18767158096286,0,34,Rac protein signal transduction,BP,
5597,GO:0016620,1,0.283384389837864,0,26,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5601,GO:0016628,1,0.406726245130017,0,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5609,GO:0016646,1,0.527163407651658,0,14,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5614,GO:0016653,1,0.56303340922048,0,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5615,GO:0016655,1,0.242755064349736,0,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5622,GO:0016671,1,0.604556630629772,0,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5624,GO:0016675,1,0.610930397544872,0,19,oxidoreductase activity, acting on a heme group of donors,MF,
5625,GO:0016676,1,0.640085285648272,0,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5629,GO:0016701,1,0.536824500738229,0,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
5630,GO:0016702,1,0.536824500738229,0,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
5636,GO:0016712,1,0.624846939898087,0,10,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
5664,GO:0016765,1,0.147213808006849,0,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
5666,GO:0016769,1,0.542057706991722,0,13,transferase activity, transferring nitrogenous groups,MF,
5677,GO:0016783,1,0.62324514491613,0,12,sulfurtransferase activity,MF,
5682,GO:0016790,1,0.290913832833907,0,28,thiolester hydrolase activity,MF,
5688,GO:0016799,1,0.428980328082083,0,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
5689,GO:0016801,1,0.549679529369647,0,13,hydrolase activity, acting on ether bonds,MF,
5691,GO:0016803,1,0.64079028411328,0,10,ether hydrolase activity,MF,
5710,GO:0016835,1,0.0960939756490399,0,53,carbon-oxygen lyase activity,MF,
5711,GO:0016836,1,0.200295441792029,0,36,hydro-lyase activity,MF,
5725,GO:0016860,1,0.178921573138535,0,40,intramolecular oxidoreductase activity,MF,
5728,GO:0016863,1,0.69805789783324,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
5729,GO:0016864,1,0.443493947199309,0,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
5735,GO:0016877,1,0.257591980454899,0,28,ligase activity, forming carbon-sulfur bonds,MF,
5736,GO:0016878,1,0.418916111688936,0,18,acid-thiol ligase activity,MF,
5737,GO:0016879,1,0.12835304824821,0,43,ligase activity, forming carbon-nitrogen bonds,MF,
5739,GO:0016881,1,0.46371892662459,0,16,acid-amino acid ligase activity,MF,
5741,GO:0016884,1,0.629400717521423,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
5745,GO:0016888,1,0.591637730500097,0,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5746,GO:0016889,1,0.423015829382565,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
5748,GO:0016891,1,0.313239778542406,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
5750,GO:0016893,1,0.214774807247011,0,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
5751,GO:0016894,1,0.328133537739882,0,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
5752,GO:0016895,1,0.451904879832627,0,17,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5758,GO:0016903,1,0.194175191374241,0,34,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
5776,GO:0016973,1,0.631958971545198,0,10,poly(A)+ mRNA export from nucleus,BP,
5782,GO:0017000,1,0.517076090655348,0,14,antibiotic biosynthetic process,BP,
5786,GO:0017004,1,0.23614859539351,0,34,cytochrome complex assembly,BP,
5797,GO:0017025,1,0.354496404555688,0,23,TBP-class protein binding,MF,
5815,GO:0017069,1,0.19837116453322,0,38,snRNA binding,MF,
5816,GO:0017070,1,0.636092222226145,0,11,U6 snRNA binding,MF,
5817,GO:0017075,1,0.491861492783719,0,14,syntaxin-1 binding,MF,
5830,GO:0017101,1,0.578687965530605,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
5839,GO:0017119,1,0.555334379466734,0,12,Golgi transport complex,CC,
5849,GO:0017136,1,0.459287208200753,0,16,NAD-dependent histone deacetylase activity,MF,
5860,GO:0017154,1,0.582834321485402,0,10,semaphorin receptor activity,MF,
5864,GO:0017160,1,0.497780594179975,0,14,Ral GTPase binding,MF,
5867,GO:0017166,1,0.592743178958547,0,10,vinculin binding,MF,
5893,GO:0018027,1,0.509417590375483,0,14,peptidyl-lysine dimethylation,BP,
5897,GO:0018065,1,0.680153552094699,0,11,protein-cofactor linkage,BP,
5924,GO:0018195,1,0.474067349765182,0,17,peptidyl-arginine modification,BP,
5929,GO:0018200,1,0.482913018106168,0,16,peptidyl-glutamic acid modification,BP,
5931,GO:0018202,1,0.605171209786438,0,11,peptidyl-histidine modification,BP,
5933,GO:0018206,1,0.630299865963513,0,10,peptidyl-methionine modification,BP,
5940,GO:0018216,1,0.545197012957187,0,13,peptidyl-arginine methylation,BP,
5942,GO:0018230,1,0.439792252986844,0,18,peptidyl-L-cysteine S-palmitoylation,BP,
5943,GO:0018231,1,0.439792252986844,0,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
5944,GO:0018242,1,0.518305637291688,0,13,protein O-linked glycosylation via serine,BP,
5945,GO:0018243,1,0.543583732426026,0,12,protein O-linked glycosylation via threonine,BP,
5965,GO:0018345,1,0.283242411563178,0,27,protein palmitoylation,BP,
5990,GO:0018904,1,0.575245977715767,0,13,ether metabolic process,BP,
6006,GO:0019042,1,0.597742278060411,0,11,viral latency,BP,
6020,GO:0019068,1,0.202575722401161,0,36,virion assembly,BP,
6027,GO:0019081,1,0.519067071350894,0,14,viral translation,BP,
6035,GO:0019098,1,0.438284160654401,0,17,reproductive behavior,BP,
6039,GO:0019104,1,0.548613177936115,0,15,DNA N-glycosylase activity,MF,
6055,GO:0019198,1,0.586372080853399,0,10,transmembrane receptor protein phosphatase activity,MF,
6057,GO:0019200,1,0.402851307826133,0,19,carbohydrate kinase activity,MF,
6062,GO:0019206,1,0.64904836061164,0,10,nucleoside kinase activity,MF,
6078,GO:0019226,1,0.267125329332615,0,27,transmission of nerve impulse,BP,
6080,GO:0019228,1,0.523382886814755,0,13,neuronal action potential,BP,
6104,GO:0019320,1,0.172250531680488,0,38,hexose catabolic process,BP,
6105,GO:0019321,1,0.640495954365633,0,11,pentose metabolic process,BP,
6125,GO:0019369,1,0.274718423414599,0,27,arachidonic acid metabolic process,BP,
6133,GO:0019377,1,0.598856101618201,0,11,glycolipid catabolic process,BP,
6138,GO:0019400,1,0.534383295426999,0,14,alditol metabolic process,BP,
6151,GO:0019433,1,0.602380910947706,0,11,triglyceride catabolic process,BP,
6188,GO:0019585,1,0.588064239361893,0,12,glucuronate metabolic process,BP,
6192,GO:0019627,1,0.6310252776407,0,10,urea metabolic process,BP,
6195,GO:0019646,1,0.696238323430886,0,14,aerobic electron transport chain,BP,
6204,GO:0019682,1,0.398298801611587,0,21,glyceraldehyde-3-phosphate metabolic process,BP,
6205,GO:0019692,1,0.309061664827324,0,29,deoxyribose phosphate metabolic process,BP,
6209,GO:0019706,1,0.344218767625906,0,23,protein-cysteine S-palmitoyltransferase activity,MF,
6210,GO:0019707,1,0.344218767625906,0,23,protein-cysteine S-acyltransferase activity,MF,
6228,GO:0019774,1,0.75528978644527,0,10,proteasome core complex, beta-subunit complex,CC,
6252,GO:0019825,1,0.590539373317507,0,11,oxygen binding,MF,
6256,GO:0019829,1,0.208919243772257,0,34,cation-transporting ATPase activity,MF,
6260,GO:0019840,1,0.555080817227653,0,13,isoprenoid binding,MF,
6299,GO:0019905,1,0.0450196514519533,0,63,syntaxin binding,MF,
6301,GO:0019908,1,0.472097271190751,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6358,GO:0021535,1,0.598029518200017,0,10,cell migration in hindbrain,BP,
6372,GO:0021549,1,0.0618997573040144,0,56,cerebellum development,BP,
6389,GO:0021575,1,0.273140333097749,0,26,hindbrain morphogenesis,BP,
6393,GO:0021587,1,0.299761103464897,0,24,cerebellum morphogenesis,BP,
6396,GO:0021591,1,0.456827028522811,0,17,ventricular system development,BP,
6400,GO:0021602,1,0.470333294153009,0,15,cranial nerve morphogenesis,BP,
6421,GO:0021680,1,0.465588521435491,0,15,cerebellar Purkinje cell layer development,BP,
6433,GO:0021695,1,0.2196157310534,0,31,cerebellar cortex development,BP,
6434,GO:0021696,1,0.386698733142756,0,19,cerebellar cortex morphogenesis,BP,
6435,GO:0021697,1,0.55119268051686,0,12,cerebellar cortex formation,BP,
6466,GO:0021783,1,0.616949832688018,0,10,preganglionic parasympathetic fiber development,BP,
6470,GO:0021795,1,0.219362225769138,0,30,cerebral cortex cell migration,BP,
6474,GO:0021799,1,0.349569962630595,0,21,cerebral cortex radially oriented cell migration,BP,
6476,GO:0021801,1,0.429812823028309,0,17,cerebral cortex radial glia guided migration,BP,
6482,GO:0021819,1,0.617472439750716,0,10,layer formation in cerebral cortex,BP,
6495,GO:0021846,1,0.481846389615568,0,14,cell proliferation in forebrain,BP,
6569,GO:0022011,1,0.346966668442957,0,21,myelination in peripheral nervous system,BP,
6575,GO:0022030,1,0.429812823028309,0,17,telencephalon glial cell migration,BP,
6576,GO:0022037,1,0.0479207932619988,0,61,metencephalon development,BP,
6577,GO:0022038,1,0.546608123979081,0,13,corpus callosum development,BP,
6578,GO:0022400,1,0.579305877157494,0,11,regulation of rhodopsin mediated signaling pathway,BP,
6607,GO:0022624,1,0.379008059658585,0,24,proteasome accessory complex,CC,
6608,GO:0022625,1,0.165563977448272,0,63,cytosolic large ribosomal subunit,CC,
6609,GO:0022626,1,0.0436237166779908,0,110,cytosolic ribosome,CC,
6610,GO:0022627,1,0.313443499828002,0,43,cytosolic small ribosomal subunit,CC,
6629,GO:0022853,1,0.197930475936183,0,35,active ion transmembrane transporter activity,MF,
6632,GO:0022884,1,0.592618500333138,0,14,macromolecule transmembrane transporter activity,MF,
6637,GO:0022904,1,0.0436326451268275,0,94,respiratory electron transport chain,BP,
6642,GO:0023023,1,0.589339595291696,0,12,MHC protein complex binding,MF,
6645,GO:0023026,1,0.647738876902389,0,10,MHC class II protein complex binding,MF,
6661,GO:0030008,1,0.605112148054866,0,13,TRAPP complex,CC,
6677,GO:0030033,1,0.472447514601214,0,15,microvillus assembly,BP,
6713,GO:0030119,1,0.120723133415387,0,43,AP-type membrane coat adaptor complex,CC,
6716,GO:0030122,1,0.553328658211702,0,12,AP-2 adaptor complex,CC,
6720,GO:0030126,1,0.508433546031703,0,15,COPI vesicle coat,CC,
6721,GO:0030127,1,0.503808782582504,0,14,COPII vesicle coat,CC,
6722,GO:0030128,1,0.52409007365361,0,13,clathrin coat of endocytic vesicle,CC,
6723,GO:0030130,1,0.596457592440689,0,11,clathrin coat of trans-Golgi network vesicle,CC,
6724,GO:0030131,1,0.250744626397371,0,28,clathrin adaptor complex,CC,
6725,GO:0030132,1,0.44340558041104,0,17,clathrin coat of coated pit,CC,
6730,GO:0030137,1,0.353571431966132,0,23,COPI-coated vesicle,CC,
6737,GO:0030149,1,0.418949199896756,0,19,sphingolipid catabolic process,BP,
6738,GO:0030150,1,0.481342179620843,0,18,protein import into mitochondrial matrix,BP,
6745,GO:0030159,1,0.382371303194538,0,19,receptor signaling complex scaffold activity,MF,
6789,GO:0030220,1,0.508052462735428,0,14,platelet formation,BP,
6814,GO:0030261,1,0.246819855763209,0,28,chromosome condensation,BP,
6815,GO:0030262,1,0.3444833490172,0,23,apoptotic nuclear changes,BP,
6821,GO:0030275,1,0.480235318594578,0,16,LRR domain binding,MF,
6826,GO:0030280,1,0.628849466062267,0,11,structural constituent of epidermis,MF,
6831,GO:0030286,1,0.205158719590095,0,34,dynein complex,CC,
6853,GO:0030317,1,0.263309327474381,0,29,flagellated sperm motility,BP,
6860,GO:0030325,1,0.604010816198131,0,11,adrenal gland development,BP,
6910,GO:0030488,1,0.231108087486461,0,32,tRNA methylation,BP,
6913,GO:0030497,1,0.632233637486576,0,10,fatty acid elongation,BP,
6925,GO:0030513,1,0.342036702907066,0,22,positive regulation of BMP signaling pathway,BP,
6947,GO:0030551,1,0.449554679018194,0,16,cyclic nucleotide binding,MF,
6948,GO:0030552,1,0.566320141430628,0,11,cAMP binding,MF,
6990,GO:0030663,1,0.449569731452806,0,18,COPI-coated vesicle membrane,CC,
6999,GO:0030676,1,0.564960656001151,0,11,Rac guanyl-nucleotide exchange factor activity,MF,
7000,GO:0030677,1,0.607204086561569,0,13,ribonuclease P complex,CC,
7002,GO:0030681,1,0.685832490500471,0,10,multimeric ribonuclease P complex,CC,
7006,GO:0030686,1,0.228382495618967,0,32,90S preribosome,CC,
7007,GO:0030687,1,0.347990179226139,0,24,preribosome, large subunit precursor,CC,
7008,GO:0030688,1,0.564614215711416,0,12,preribosome, small subunit precursor,CC,
7033,GO:0030802,1,0.299485117554829,0,26,regulation of cyclic nucleotide biosynthetic process,BP,
7035,GO:0030804,1,0.507140489217292,0,15,positive regulation of cyclic nucleotide biosynthetic process,BP,
7041,GO:0030810,1,0.209089318237389,0,33,positive regulation of nucleotide biosynthetic process,BP,
7044,GO:0030813,1,0.530627899633498,0,12,positive regulation of nucleotide catabolic process,BP,
7048,GO:0030817,1,0.417311230631211,0,19,regulation of cAMP biosynthetic process,BP,
7102,GO:0030894,1,0.306835650425206,0,26,replisome,CC,
7105,GO:0030897,1,0.491689580560342,0,14,HOPS complex,CC,
7112,GO:0030904,1,0.382541067435152,0,20,retromer complex,CC,
7118,GO:0030914,1,0.588201442614641,0,12,STAGA complex,CC,
7137,GO:0030957,1,0.627995755870269,0,10,Tat protein binding,MF,
7139,GO:0030964,1,0.323005870903184,0,42,NADH dehydrogenase complex,CC,
7142,GO:0030970,1,0.313520988137457,0,25,retrograde protein transport, ER to cytosol,BP,
7147,GO:0030983,1,0.534967300582859,0,13,mismatched DNA binding,MF,
7149,GO:0030990,1,0.238366624672409,0,30,intraciliary transport particle,CC,
7151,GO:0030992,1,0.416836332929748,0,19,intraciliary transport particle B,CC,
7154,GO:0031005,1,0.604533532899417,0,10,filamin binding,MF,
7156,GO:0031011,1,0.527832970586691,0,15,Ino80 complex,CC,
7177,GO:0031054,1,0.536644958458124,0,13,pre-miRNA processing,BP,
7178,GO:0031055,1,0.251955631984082,0,42,chromatin remodeling at centromere,BP,
7183,GO:0031061,1,0.4428851706388,0,16,negative regulation of histone methylation,BP,
7194,GO:0031078,1,0.575995416427222,0,11,histone deacetylase activity (H3-K14 specific),MF,
7195,GO:0031080,1,0.617194533633331,0,10,nuclear pore outer ring,CC,
7197,GO:0031082,1,0.447758408063,0,18,BLOC complex,CC,
7198,GO:0031083,1,0.578295357480532,0,13,BLOC-1 complex,CC,
7207,GO:0031092,1,0.578282787230034,0,11,platelet alpha granule membrane,CC,
7234,GO:0031125,1,0.652208620093472,0,12,rRNA 3'-end processing,BP,
7240,GO:0031143,1,0.562744716111473,0,12,pseudopodium,CC,
7241,GO:0031145,1,0.0501191319757589,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7242,GO:0031146,1,0.0593905791353372,0,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7245,GO:0031163,1,0.453777302806218,0,20,metallo-sulfur cluster assembly,BP,
7247,GO:0031167,1,0.405607107660952,0,21,rRNA methylation,BP,
7256,GO:0031210,1,0.588053480772222,0,12,phosphatidylcholine binding,MF,
7267,GO:0031231,1,0.519103502290633,0,15,intrinsic component of peroxisomal membrane,CC,
7271,GO:0031235,1,0.562146549356832,0,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7273,GO:0031248,1,0.0160945730839132,0,88,protein acetyltransferase complex,CC,
7291,GO:0031279,1,0.424595039733242,0,18,regulation of cyclase activity,BP,
7303,GO:0031297,1,0.280069201757625,0,26,replication fork processing,BP,
7308,GO:0031304,1,0.214592637076171,0,36,intrinsic component of mitochondrial inner membrane,CC,
7309,GO:0031305,1,0.214592637076171,0,36,integral component of mitochondrial inner membrane,CC,
7310,GO:0031306,1,0.373425716348882,0,22,intrinsic component of mitochondrial outer membrane,CC,
7311,GO:0031307,1,0.394239885895125,0,21,integral component of mitochondrial outer membrane,CC,
7327,GO:0031332,1,0.575596988612775,0,11,RNAi effector complex,CC,
7352,GO:0031386,1,0.654632006358306,0,12,protein tag,MF,
7377,GO:0031420,1,0.515901231801719,0,13,alkali metal ion binding,MF,
7382,GO:0031430,1,0.539008635710699,0,13,M band,CC,
7405,GO:0031464,1,0.575696683093926,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7411,GO:0031489,1,0.552154000048076,0,13,myosin V binding,MF,
7417,GO:0031498,1,0.443853499642328,0,17,chromatin disassembly,BP,
7421,GO:0031507,1,0.628739732810106,0,10,heterochromatin assembly,BP,
7427,GO:0031519,1,0.101351391156584,0,47,PcG protein complex,CC,
7446,GO:0031572,1,0.190512465565792,0,33,G2 DNA damage checkpoint,BP,
7464,GO:0031597,1,0.595502483218407,0,12,cytosolic proteasome complex,CC,
7504,GO:0031672,1,0.391969148371338,0,19,A band,CC,
7509,GO:0031683,1,0.565969566942419,0,12,G-protein beta/gamma-subunit complex binding,MF,
7551,GO:0031848,1,0.611980347919237,0,10,protection from non-homologous end joining at telomere,BP,
7565,GO:0031903,1,0.0911283638191705,0,51,microbody membrane,CC,
7566,GO:0031904,1,0.468037879860671,0,17,endosome lumen,CC,
7575,GO:0031932,1,0.544410313634335,0,13,TORC2 complex,CC,
7577,GO:0031935,1,0.358834636828023,0,20,regulation of chromatin silencing,BP,
7582,GO:0031941,1,0.309750687203893,0,26,filamentous actin,CC,
7602,GO:0031970,1,0.041978280276894,0,78,organelle envelope lumen,CC,
7616,GO:0031998,1,0.560515738532044,0,11,regulation of fatty acid beta-oxidation,BP,
7622,GO:0032008,1,0.242068845105607,0,30,positive regulation of TOR signaling,BP,
7630,GO:0032025,1,0.631460924640427,0,10,response to cobalt ion,BP,
7636,GO:0032039,1,0.516442906635681,0,13,integrator complex,CC,
7638,GO:0032041,1,0.575995416427222,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
7642,GO:0032048,1,0.514505925484376,0,14,cardiolipin metabolic process,BP,
7703,GO:0032156,1,0.60109843235535,0,10,septin cytoskeleton,CC,
7716,GO:0032201,1,0.296099245803706,0,27,telomere maintenance via semi-conservative replication,BP,
7724,GO:0032210,1,0.0850518206136981,0,51,regulation of telomere maintenance via telomerase,BP,
7725,GO:0032211,1,0.39508768225554,0,19,negative regulation of telomere maintenance via telomerase,BP,
7726,GO:0032212,1,0.208970423301392,0,33,positive regulation of telomere maintenance via telomerase,BP,
7734,GO:0032225,1,0.607553005212262,0,11,regulation of synaptic transmission, dopaminergic,BP,
7737,GO:0032228,1,0.463976258376839,0,15,regulation of synaptic transmission, GABAergic,BP,
7769,GO:0032281,1,0.59009926298551,0,11,AMPA glutamate receptor complex,CC,
7776,GO:0032292,1,0.346966668442957,0,21,peripheral nervous system axon ensheathment,BP,
7780,GO:0032300,1,0.549140899798696,0,12,mismatch repair complex,CC,
7795,GO:0032331,1,0.565692959620187,0,12,negative regulation of chondrocyte differentiation,BP,
7811,GO:0032356,1,0.623373100930959,0,10,oxidized DNA binding,MF,
7881,GO:0032438,1,0.375075326666029,0,22,melanosome organization,BP,
7896,GO:0032460,1,0.547787871553268,0,13,negative regulation of protein oligomerization,BP,
7898,GO:0032462,1,0.479162759060245,0,17,regulation of protein homooligomerization,BP,
7899,GO:0032463,1,0.61130642712231,0,11,negative regulation of protein homooligomerization,BP,
7903,GO:0032467,1,0.294838422437748,0,25,positive regulation of cytokinesis,BP,
7937,GO:0032509,1,0.397723951240917,0,20,endosome transport via multivesicular body sorting pathway,BP,
7944,GO:0032527,1,0.201441321820742,0,34,protein exit from endoplasmic reticulum,BP,
7945,GO:0032528,1,0.407829476035944,0,18,microvillus organization,BP,
7977,GO:0032585,1,0.641803180871114,0,10,multivesicular body membrane,CC,
7981,GO:0032590,1,0.481187152118737,0,15,dendrite membrane,CC,
7983,GO:0032592,1,0.0577054234741604,0,65,integral component of mitochondrial membrane,CC,
7985,GO:0032594,1,0.370442758467038,0,21,protein transport within lipid bilayer,BP,
8101,GO:0032781,1,0.178640049267313,0,40,positive regulation of ATPase activity,BP,
8104,GO:0032784,1,0.148677877135636,0,40,regulation of DNA-templated transcription, elongation,BP,
8105,GO:0032785,1,0.59167688620881,0,11,negative regulation of DNA-templated transcription, elongation,BP,
8106,GO:0032786,1,0.322467350577321,0,24,positive regulation of DNA-templated transcription, elongation,BP,
8111,GO:0032794,1,0.496034410468221,0,14,GTPase activating protein binding,MF,
8114,GO:0032797,1,0.607726893564947,0,11,SMN complex,CC,
8119,GO:0032802,1,0.553622936382994,0,13,low-density lipoprotein particle receptor catabolic process,BP,
8123,GO:0032806,1,0.310646406131996,0,25,carboxy-terminal domain protein kinase complex,CC,
8141,GO:0032838,1,0.00299440546967882,0,122,plasma membrane bounded cell projection cytoplasm,CC,
8142,GO:0032839,1,0.342260273350746,0,22,dendrite cytoplasm,CC,
8155,GO:0032878,1,0.356382049491648,0,20,regulation of establishment or maintenance of cell polarity,BP,
8190,GO:0032925,1,0.471239213405774,0,16,regulation of activin receptor signaling pathway,BP,
8193,GO:0032928,1,0.632736392038949,0,11,regulation of superoxide anion generation,BP,
8200,GO:0032941,1,0.458199130619632,0,17,secretion by tissue,BP,
8218,GO:0032968,1,0.487335672316016,0,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8225,GO:0032981,1,0.181947816697877,0,55,mitochondrial respiratory chain complex I assembly,BP,
8228,GO:0032986,1,0.437510842062154,0,18,protein-DNA complex disassembly,BP,
8229,GO:0032988,1,0.551984065175064,0,13,ribonucleoprotein complex disassembly,BP,
8291,GO:0033108,1,0.0436182440015803,0,89,mitochondrial respiratory chain complex assembly,BP,
8293,GO:0033119,1,0.357280401293921,0,23,negative regulation of RNA splicing,BP,
8294,GO:0033120,1,0.295261388452871,0,25,positive regulation of RNA splicing,BP,
8313,GO:0033144,1,0.272653736115551,0,26,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8316,GO:0033147,1,0.575057018924673,0,11,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8319,GO:0033151,1,0.550344520572298,0,12,V(D)J recombination,BP,
8325,GO:0033160,1,0.600077934099142,0,10,positive regulation of protein import into nucleus, translocation,BP,
8332,GO:0033176,1,0.437151546969895,0,20,proton-transporting V-type ATPase complex,CC,
8334,GO:0033178,1,0.657607190949926,0,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8338,GO:0033182,1,0.605294188898745,0,10,regulation of histone ubiquitination,BP,
8349,GO:0033202,1,0.527832970586691,0,15,DNA helicase complex,CC,
8361,GO:0033235,1,0.635818435222516,0,10,positive regulation of protein sumoylation,BP,
8369,GO:0033260,1,0.107141310876183,0,49,nuclear DNA replication,BP,
8370,GO:0033262,1,0.557142446440869,0,12,regulation of nuclear cell cycle DNA replication,BP,
8380,GO:0033276,1,0.532009785465437,0,14,transcription factor TFTC complex,CC,
8430,GO:0033522,1,0.288718319486601,0,25,histone H2A ubiquitination,BP,
8431,GO:0033523,1,0.552139165334463,0,12,histone H2B ubiquitination,BP,
8433,GO:0033539,1,0.57661093111874,0,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
8434,GO:0033540,1,0.552213134183619,0,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
8450,GO:0033572,1,0.276341771598735,0,29,transferrin transport,BP,
8463,GO:0033599,1,0.453251801316389,0,17,regulation of mammary gland epithelial cell proliferation,BP,
8476,GO:0033617,1,0.435867778928863,0,20,mitochondrial respiratory chain complex IV assembly,BP,
8478,GO:0033622,1,0.570046784818092,0,11,integrin activation,BP,
8525,GO:0033750,1,0.59765773779532,0,13,ribosome localization,BP,
8528,GO:0033764,1,0.526359429365029,0,16,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
8542,GO:0033866,1,0.479604064244115,0,16,nucleoside bisphosphate biosynthetic process,BP,
8566,GO:0034030,1,0.479604064244115,0,16,ribonucleoside bisphosphate biosynthetic process,BP,
8569,GO:0034033,1,0.479604064244115,0,16,purine nucleoside bisphosphate biosynthetic process,BP,
8577,GO:0034045,1,0.449862675149681,0,16,phagophore assembly site membrane,CC,
8581,GO:0034058,1,0.595784093430099,0,10,endosomal vesicle fusion,BP,
8583,GO:0034061,1,0.207859492235397,0,34,DNA polymerase activity,MF,
8588,GO:0034080,1,0.273183236177669,0,40,CENP-A containing nucleosome assembly,BP,
8590,GO:0034086,1,0.568080388229391,0,12,maintenance of sister chromatid cohesion,BP,
8592,GO:0034088,1,0.568080388229391,0,12,maintenance of mitotic sister chromatid cohesion,BP,
8646,GO:0034185,1,0.541712474382718,0,12,apolipoprotein binding,MF,
8655,GO:0034199,1,0.595953685474782,0,10,activation of protein kinase A activity,BP,
8660,GO:0034212,1,0.0562665525323128,0,60,peptide N-acetyltransferase activity,MF,
8674,GO:0034243,1,0.298116020601223,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
8675,GO:0034244,1,0.622853215541591,0,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
8695,GO:0034315,1,0.499729135992549,0,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,
8742,GO:0034389,1,0.513731703648944,0,14,lipid particle organization,BP,
8761,GO:0034427,1,0.679288279759462,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8775,GO:0034451,1,0.328382898627139,0,22,centriolar satellite,CC,
8777,GO:0034453,1,0.311056632260642,0,23,microtubule anchoring,BP,
8789,GO:0034471,1,0.459946530952556,0,19,ncRNA 5'-end processing,BP,
8790,GO:0034472,1,0.553331204418385,0,14,snRNA 3'-end processing,BP,
8799,GO:0034497,1,0.550756806432849,0,12,protein localization to phagophore assembly site,BP,
8802,GO:0034501,1,0.477709709369947,0,16,protein localization to kinetochore,BP,
8805,GO:0034505,1,0.540482254891675,0,12,tooth mineralization,BP,
8807,GO:0034508,1,0.166098326913366,0,50,centromere complex assembly,BP,
8821,GO:0034593,1,0.301535841279929,0,23,phosphatidylinositol bisphosphate phosphatase activity,MF,
8823,GO:0034595,1,0.511612490915621,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
8884,GO:0034695,1,0.488589108032436,0,14,response to prostaglandin E,BP,
8890,GO:0034704,1,0.305425572515121,0,25,calcium channel complex,CC,
8895,GO:0034709,1,0.66928000333882,0,12,methylosome,CC,
8901,GO:0034719,1,0.544413635135145,0,16,SMN-Sm protein complex,CC,
8905,GO:0034723,1,0.501483258228813,0,32,DNA replication-dependent nucleosome organization,BP,
8906,GO:0034724,1,0.160836135404546,0,51,DNA replication-independent nucleosome organization,BP,
8939,GO:0034969,1,0.627610911107259,0,10,histone arginine methylation,BP,
8944,GO:0034979,1,0.437483656086779,0,17,NAD-dependent protein deacetylase activity,MF,
8945,GO:0034982,1,0.652833455628752,0,10,mitochondrial protein processing,BP,
8958,GO:0035020,1,0.475569569581738,0,15,regulation of Rac protein signal transduction,BP,
8962,GO:0035024,1,0.423839546769437,0,17,negative regulation of Rho protein signal transduction,BP,
8963,GO:0035025,1,0.535601935029304,0,13,positive regulation of Rho protein signal transduction,BP,
8981,GO:0035082,1,0.338899995978001,0,23,axoneme assembly,BP,
8992,GO:0035098,1,0.44727640231458,0,16,ESC/E(Z) complex,CC,
8994,GO:0035102,1,0.560335526150278,0,12,PRC1 complex,CC,
9006,GO:0035145,1,0.371587267490633,0,21,exon-exon junction complex,CC,
9011,GO:0035173,1,0.511522822442797,0,14,histone kinase activity,MF,
9014,GO:0035176,1,0.208580144167089,0,31,social behavior,BP,
9033,GO:0035246,1,0.603028359333129,0,11,peptidyl-arginine N-methylation,BP,
9051,GO:0035267,1,0.421212394039456,0,19,NuA4 histone acetyltransferase complex,CC,
9052,GO:0035268,1,0.44030498721816,0,18,protein mannosylation,BP,
9053,GO:0035269,1,0.608966910542009,0,12,protein O-linked mannosylation,BP,
9076,GO:0035315,1,0.282532960367879,0,26,hair cell differentiation,BP,
9081,GO:0035330,1,0.562911078729998,0,11,regulation of hippo signaling,BP,
9084,GO:0035333,1,0.56465239785055,0,12,Notch receptor processing, ligand-dependent,BP,
9086,GO:0035336,1,0.406957817108562,0,19,long-chain fatty-acyl-CoA metabolic process,BP,
9087,GO:0035337,1,0.221665848787756,0,32,fatty-acyl-CoA metabolic process,BP,
9088,GO:0035338,1,0.54003356147477,0,13,long-chain fatty-acyl-CoA biosynthetic process,BP,
9096,GO:0035357,1,0.493196655056387,0,14,peroxisome proliferator activated receptor signaling pathway,BP,
9103,GO:0035371,1,0.392646125399161,0,18,microtubule plus-end,CC,
9104,GO:0035372,1,0.517933172146046,0,13,protein localization to microtubule,BP,
9127,GO:0035437,1,0.594809973817577,0,11,maintenance of protein localization in endoplasmic reticulum,BP,
9137,GO:0035459,1,0.36383619043697,0,20,cargo loading into vesicle,BP,
9166,GO:0035518,1,0.435336497131061,0,17,histone H2A monoubiquitination,BP,
9186,GO:0035561,1,0.356567593861082,0,21,regulation of chromatin binding,BP,
9188,GO:0035563,1,0.565116764023118,0,12,positive regulation of chromatin binding,BP,
9206,GO:0035587,1,0.631673603464408,0,10,purinergic receptor signaling pathway,BP,
9230,GO:0035615,1,0.585318179692478,0,11,clathrin adaptor activity,MF,
9248,GO:0035640,1,0.562807444141611,0,12,exploration behavior,BP,
9251,GO:0035646,1,0.637225189188498,0,10,endosome to melanosome transport,BP,
9286,GO:0035721,1,0.571345390953688,0,12,intraciliary retrograde transport,BP,
9308,GO:0035751,1,0.633965351531343,0,11,regulation of lysosomal lumen pH,BP,
9318,GO:0035774,1,0.424401751383171,0,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
9341,GO:0035825,1,0.182409532477932,0,36,homologous recombination,BP,
9350,GO:0035859,1,0.540808164755012,0,13,Seh1-associated complex,CC,
9378,GO:0035902,1,0.442383326491721,0,17,response to immobilization stress,BP,
9433,GO:0036002,1,0.229329774925191,0,32,pre-mRNA binding,MF,
9439,GO:0036010,1,0.398406900500157,0,18,protein localization to endosome,BP,
9453,GO:0036038,1,0.566025078203139,0,13,MKS complex,CC,
9465,GO:0036065,1,0.319523455030163,0,23,fucosylation,BP,
9466,GO:0036066,1,0.497662949841572,0,14,protein O-linked fucosylation,BP,
9479,GO:0036109,1,0.602776906351089,0,11,alpha-linolenic acid metabolic process,BP,
9491,GO:0036124,1,0.493874712176892,0,14,histone H3-K9 trimethylation,BP,
9503,GO:0036148,1,0.575586667541165,0,11,phosphatidylglycerol acyl-chain remodeling,BP,
9505,GO:0036150,1,0.551429433294467,0,12,phosphatidylserine acyl-chain remodeling,BP,
9506,GO:0036151,1,0.425369556303969,0,18,phosphatidylcholine acyl-chain remodeling,BP,
9507,GO:0036152,1,0.484549436687931,0,15,phosphatidylethanolamine acyl-chain remodeling,BP,
9531,GO:0036257,1,0.261302670394053,0,30,multivesicular body organization,BP,
9532,GO:0036258,1,0.273986288224761,0,29,multivesicular body assembly,BP,
9533,GO:0036260,1,0.242244172974856,0,33,RNA capping,BP,
9547,GO:0036297,1,0.102437322260202,0,48,interstrand cross-link repair,BP,
9562,GO:0036336,1,0.491994726777711,0,15,dendritic cell migration,BP,
9566,GO:0036344,1,0.486678559666803,0,15,platelet morphogenesis,BP,
9579,GO:0036379,1,0.581306352512617,0,12,myofilament,CC,
9593,GO:0036442,1,0.389652877228631,0,22,proton-exporting ATPase activity,MF,
9595,GO:0036445,1,0.593700131476734,0,10,neuronal stem cell division,BP,
9599,GO:0036452,1,0.314258145739085,0,26,ESCRT complex,CC,
9608,GO:0036465,1,0.149862951117763,0,37,synaptic vesicle recycling,BP,
9641,GO:0036507,1,0.349698916327372,0,22,protein demannosylation,BP,
9642,GO:0036508,1,0.349698916327372,0,22,protein alpha-1,2-demannosylation,BP,
9647,GO:0036513,1,0.614987947593221,0,10,Derlin-1 retrotranslocation complex,CC,
9745,GO:0038201,1,0.466504661400755,0,16,TOR complex,CC,
9771,GO:0039532,1,0.617045518128806,0,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
9787,GO:0039702,1,0.416069963203766,0,20,viral budding via host ESCRT complex,BP,
9889,GO:0042162,1,0.178415122409178,0,35,telomeric DNA binding,MF,
9890,GO:0042165,1,0.430859942392662,0,18,neurotransmitter binding,MF,
9895,GO:0042171,1,0.369647827576175,0,20,lysophosphatidic acid acyltransferase activity,MF,
9899,GO:0042178,1,0.661289345324108,0,10,xenobiotic catabolic process,BP,
9904,GO:0042219,1,0.460861386955628,0,17,cellular modified amino acid catabolic process,BP,
9905,GO:0042220,1,0.27443192034289,0,26,response to cocaine,BP,
9919,GO:0042255,1,0.145650061432059,0,54,ribosome assembly,BP,
9930,GO:0042273,1,0.0784496934266397,0,67,ribosomal large subunit biogenesis,BP,
9933,GO:0042276,1,0.436302171743295,0,19,error-prone translesion synthesis,BP,
9948,GO:0042304,1,0.268658810405051,0,28,regulation of fatty acid biosynthetic process,BP,
9997,GO:0042403,1,0.60265205493802,0,10,thyroid hormone metabolic process,BP,
10000,GO:0042407,1,0.530914771498893,0,15,cristae formation,BP,
10024,GO:0042451,1,0.458371758482505,0,20,purine nucleoside biosynthetic process,BP,
10042,GO:0042491,1,0.376350012165964,0,20,inner ear auditory receptor cell differentiation,BP,
10058,GO:0042537,1,0.573208830130326,0,13,benzene-containing compound metabolic process,BP,
10068,GO:0042555,1,0.585819827111275,0,11,MCM complex,CC,
10078,GO:0042573,1,0.60958601421787,0,11,retinoic acid metabolic process,BP,
10080,GO:0042575,1,0.502358904747896,0,16,DNA polymerase complex,CC,
10098,GO:0042596,1,0.429900714769341,0,18,fear response,BP,
10099,GO:0042599,1,0.592361561043907,0,12,lamellar body,CC,
10111,GO:0042625,1,0.197930475936183,0,35,ATPase coupled ion transmembrane transporter activity,MF,
10126,GO:0042645,1,0.156752611353336,0,40,mitochondrial nucleoid,CC,
10172,GO:0042755,1,0.527024232899964,0,14,eating behavior,BP,
10177,GO:0042761,1,0.632233637486576,0,10,very long-chain fatty acid biosynthetic process,BP,
10185,GO:0042773,1,0.0801373931376178,0,80,ATP synthesis coupled electron transport,BP,
10187,GO:0042775,1,0.0840595875265248,0,79,mitochondrial ATP synthesis coupled electron transport,BP,
10192,GO:0042788,1,0.440647294033384,0,29,polysomal ribosome,CC,
10193,GO:0042789,1,0.504178613133852,0,14,mRNA transcription by RNA polymerase II,BP,
10194,GO:0042790,1,0.566670550872133,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10200,GO:0042800,1,0.47746824119841,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10215,GO:0042827,1,0.598667495497203,0,11,platelet dense granule,CC,
10275,GO:0043014,1,0.326999845838033,0,23,alpha-tubulin binding,MF,
10301,GO:0043047,1,0.586502849151169,0,11,single-stranded telomeric DNA binding,MF,
10327,GO:0043113,1,0.229623324882109,0,30,receptor clustering,BP,
10345,GO:0043138,1,0.550492213761647,0,12,3'-5' DNA helicase activity,MF,
10349,GO:0043142,1,0.536528338356751,0,13,single-stranded DNA-dependent ATPase activity,MF,
10362,GO:0043171,1,0.329520496144479,0,23,peptide catabolic process,BP,
10365,GO:0043175,1,0.184636469468936,0,35,RNA polymerase core enzyme binding,MF,
10375,GO:0043189,1,0.421212394039456,0,19,H4/H2A histone acetyltransferase complex,CC,
10378,GO:0043195,1,0.140270668874468,0,41,terminal bouton,CC,
10381,GO:0043198,1,0.349503923877246,0,21,dendritic shaft,CC,
10384,GO:0043201,1,0.595269216304376,0,10,response to leucine,BP,
10387,GO:0043204,1,0.0602529608370413,0,58,perikaryon,CC,
10390,GO:0043209,1,0.0016244572041961,0,139,myelin sheath,CC,
10392,GO:0043218,1,0.567049333746116,0,12,compact myelin,CC,
10409,GO:0043240,1,0.585580793182326,0,11,Fanconi anaemia nuclear complex,CC,
10413,GO:0043247,1,0.527958975874259,0,13,telomere maintenance in response to DNA damage,BP,
10414,GO:0043248,1,0.637263263448512,0,12,proteasome assembly,BP,
10418,GO:0043252,1,0.577889366424005,0,11,sodium-independent organic anion transport,BP,
10428,GO:0043268,1,0.473777217136133,0,15,positive regulation of potassium ion transport,BP,
10433,GO:0043274,1,0.568185719096989,0,11,phospholipase binding,MF,
10443,GO:0043295,1,0.644606966820009,0,11,glutathione binding,MF,
10498,GO:0043395,1,0.599380123918404,0,10,heparan sulfate proteoglycan binding,MF,
10518,GO:0043422,1,0.601770692058905,0,11,protein kinase B binding,MF,
10529,GO:0043457,1,0.482127151922111,0,16,regulation of cellular respiration,BP,
10538,GO:0043476,1,0.571018248788734,0,12,pigment accumulation,BP,
10539,GO:0043482,1,0.571018248788734,0,12,cellular pigment accumulation,BP,
10541,GO:0043485,1,0.637225189188498,0,10,endosome to pigment granule transport,BP,
10542,GO:0043486,1,0.191178897164312,0,48,histone exchange,BP,
10565,GO:0043518,1,0.581398056157468,0,12,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
10567,GO:0043522,1,0.641435583712822,0,10,leucine zipper domain binding,MF,
10578,GO:0043537,1,0.328239203661541,0,23,negative regulation of blood vessel endothelial cell migration,BP,
10597,GO:0043560,1,0.596985435063075,0,10,insulin receptor substrate binding,MF,
10598,GO:0043562,1,0.670015441768178,0,10,cellular response to nitrogen levels,BP,
10605,GO:0043574,1,0.417047956901718,0,18,peroxisomal transport,BP,
10616,GO:0043601,1,0.332912297018448,0,24,nuclear replisome,CC,
10634,GO:0043628,1,0.325203021262732,0,27,ncRNA 3'-end processing,BP,
10637,GO:0043631,1,0.133305837052732,0,41,RNA polyadenylation,BP,
10643,GO:0043649,1,0.577506210254148,0,12,dicarboxylic acid catabolic process,BP,
10645,GO:0043651,1,0.528276503878486,0,14,linoleic acid metabolic process,BP,
10652,GO:0043679,1,0.0424396889112476,0,66,axon terminus,CC,
10688,GO:0043949,1,0.455942645677915,0,16,regulation of cAMP-mediated signaling,BP,
10691,GO:0043954,1,0.296852802313494,0,24,cellular component maintenance,BP,
10694,GO:0043968,1,0.483503516637778,0,16,histone H2A acetylation,BP,
10700,GO:0043981,1,0.486589400285445,0,15,histone H4-K5 acetylation,BP,
10701,GO:0043982,1,0.486589400285445,0,15,histone H4-K8 acetylation,BP,
10703,GO:0043984,1,0.391347804515565,0,19,histone H4-K16 acetylation,BP,
10709,GO:0043995,1,0.610042035301088,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
10710,GO:0043996,1,0.610042035301088,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
10737,GO:0044090,1,0.543509065603791,0,12,positive regulation of vacuole organization,BP,
10771,GO:0044213,1,0.613606260153014,0,10,intronic transcription regulatory region DNA binding,MF,
10802,GO:0044273,1,0.238018702518688,0,31,sulfur compound catabolic process,BP,
10810,GO:0044292,1,0.61944634716682,0,10,dendrite terminus,CC,
10812,GO:0044295,1,0.362262409195737,0,20,axonal growth cone,CC,
10832,GO:0044322,1,0.289699059552025,0,26,endoplasmic reticulum quality control compartment,CC,
10867,GO:0044381,1,0.477894330046077,0,14,glucose import in response to insulin stimulus,BP,
10872,GO:0044391,1,0.00415037681069785,0,182,ribosomal subunit,CC,
10905,GO:0044447,1,0.458780671010203,0,16,axoneme part,CC,
10915,GO:0044458,1,0.582442883058958,0,12,motile cilium assembly,BP,
10933,GO:0044548,1,0.62244957081564,0,11,S100 protein binding,MF,
10957,GO:0044665,1,0.258117904396021,0,29,MLL1/2 complex,CC,
10975,GO:0044743,1,0.203247461703509,0,38,protein transmembrane import into intracellular organelle,BP,
10981,GO:0044769,1,0.47379428621135,0,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
10993,GO:0044786,1,0.070523237331158,0,57,cell cycle DNA replication,BP,
10998,GO:0044794,1,0.543428917252113,0,13,positive regulation by host of viral process,BP,
11004,GO:0044804,1,0.422655531349569,0,18,autophagy of nucleus,BP,
11008,GO:0044818,1,0.277259802424815,0,26,mitotic G2/M transition checkpoint,BP,
11039,GO:0045003,1,0.636954110006722,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11041,GO:0045005,1,0.211321728106973,0,32,DNA-dependent DNA replication maintenance of fidelity,BP,
11042,GO:0045006,1,0.678873535153949,0,10,DNA deamination,BP,
11050,GO:0045022,1,0.160843149430878,0,38,early endosome to late endosome transport,BP,
11067,GO:0045056,1,0.504384336530594,0,14,transcytosis,BP,
11071,GO:0045061,1,0.581451715669714,0,11,thymic T cell selection,BP,
11078,GO:0045070,1,0.226823032472375,0,31,positive regulation of viral genome replication,BP,
11100,GO:0045095,1,0.313419160317922,0,26,keratin filament,CC,
11112,GO:0045120,1,0.556499320358023,0,12,pronucleus,CC,
11116,GO:0045125,1,0.625373601381466,0,10,bioactive lipid receptor activity,MF,
11138,GO:0045171,1,0.10535616680234,0,48,intercellular bridge,CC,
11152,GO:0045190,1,0.199403455637001,0,33,isotype switching,BP,
11153,GO:0045191,1,0.330167105562544,0,23,regulation of isotype switching,BP,
11179,GO:0045239,1,0.537975389675879,0,13,tricarboxylic acid cycle enzyme complex,CC,
11180,GO:0045240,1,0.588065637447296,0,11,dihydrolipoyl dehydrogenase complex,CC,
11188,GO:0045271,1,0.323005870903184,0,42,respiratory chain complex I,CC,
11192,GO:0045275,1,0.653509396600881,0,11,respiratory chain complex III,CC,
11193,GO:0045277,1,0.778323069712114,0,11,respiratory chain complex IV,CC,
11197,GO:0045292,1,0.458142242395323,0,17,mRNA cis splicing, via spliceosome,BP,
11208,GO:0045324,1,0.615406472111439,0,11,late endosome to vacuole transport,BP,
11263,GO:0045494,1,0.391136347493907,0,19,photoreceptor cell maintenance,BP,
11266,GO:0045503,1,0.461201947983946,0,15,dynein light chain binding,MF,
11267,GO:0045504,1,0.61649775565673,0,10,dynein heavy chain binding,MF,
11303,GO:0045605,1,0.617210657473363,0,10,negative regulation of epidermal cell differentiation,BP,
11338,GO:0045653,1,0.756704236099819,0,17,negative regulation of megakaryocyte differentiation,BP,
11359,GO:0045683,1,0.526134495452729,0,13,negative regulation of epidermis development,BP,
11368,GO:0045717,1,0.576035704211113,0,12,negative regulation of fatty acid biosynthetic process,BP,
11381,GO:0045738,1,0.363500200360476,0,21,negative regulation of DNA repair,BP,
11388,GO:0045745,1,0.527010777853475,0,13,positive regulation of G-protein coupled receptor protein signaling pathway,BP,
11394,GO:0045761,1,0.58807263795366,0,11,regulation of adenylate cyclase activity,BP,
11403,GO:0045777,1,0.558274466836583,0,13,positive regulation of blood pressure,BP,
11418,GO:0045814,1,0.0118953373414929,0,121,negative regulation of gene expression, epigenetic,BP,
11419,GO:0045815,1,0.0687334331399311,0,77,positive regulation of gene expression, epigenetic,BP,
11422,GO:0045821,1,0.560551908761422,0,11,positive regulation of glycolytic process,BP,
11427,GO:0045830,1,0.465478207547134,0,16,positive regulation of isotype switching,BP,
11433,GO:0045838,1,0.632884046977377,0,10,positive regulation of membrane potential,BP,
11450,GO:0045876,1,0.618759091427079,0,10,positive regulation of sister chromatid cohesion,BP,
11464,GO:0045910,1,0.345308604811289,0,21,negative regulation of DNA recombination,BP,
11465,GO:0045911,1,0.399397482306178,0,19,positive regulation of DNA recombination,BP,
11474,GO:0045920,1,0.418480637834862,0,18,negative regulation of exocytosis,BP,
11476,GO:0045922,1,0.496349263160999,0,15,negative regulation of fatty acid metabolic process,BP,
11492,GO:0045943,1,0.352553204747184,0,21,positive regulation of transcription by RNA polymerase I,BP,
11494,GO:0045945,1,0.603671134399675,0,10,positive regulation of transcription by RNA polymerase III,BP,
11495,GO:0045947,1,0.441993607777012,0,18,negative regulation of translational initiation,BP,
11524,GO:0046030,1,0.569572799338663,0,11,inositol trisphosphate phosphatase activity,MF,
11530,GO:0046036,1,0.638482240691035,0,12,CTP metabolic process,BP,
11575,GO:0046112,1,0.413233890361854,0,19,nucleobase biosynthetic process,BP,
11584,GO:0046129,1,0.458371758482505,0,20,purine ribonucleoside biosynthetic process,BP,
11597,GO:0046164,1,0.24348409855025,0,30,alcohol catabolic process,BP,
11603,GO:0046174,1,0.414289432997346,0,18,polyol catabolic process,BP,
11640,GO:0046337,1,0.478431597005258,0,15,phosphatidylethanolamine metabolic process,BP,
11642,GO:0046339,1,0.530225154221654,0,13,diacylglycerol metabolic process,BP,
11644,GO:0046341,1,0.500117657490929,0,14,CDP-diacylglycerol metabolic process,BP,
11646,GO:0046349,1,0.590420920010538,0,11,amino sugar biosynthetic process,BP,
11654,GO:0046365,1,0.126005219040513,0,46,monosaccharide catabolic process,BP,
11660,GO:0046385,1,0.667731573782139,0,10,deoxyribose phosphate biosynthetic process,BP,
11661,GO:0046386,1,0.456319110461604,0,19,deoxyribose phosphate catabolic process,BP,
11685,GO:0046459,1,0.581405791611602,0,12,short-chain fatty acid metabolic process,BP,
11687,GO:0046461,1,0.449151104247905,0,17,neutral lipid catabolic process,BP,
11690,GO:0046464,1,0.449151104247905,0,17,acylglycerol catabolic process,BP,
11692,GO:0046466,1,0.370267544097352,0,22,membrane lipid catabolic process,BP,
11696,GO:0046471,1,0.295435140344034,0,25,phosphatidylglycerol metabolic process,BP,
11697,GO:0046473,1,0.221244169811629,0,30,phosphatidic acid metabolic process,BP,
11703,GO:0046479,1,0.626593629578696,0,10,glycosphingolipid catabolic process,BP,
11717,GO:0046500,1,0.636797810161269,0,10,S-adenosylmethionine metabolic process,BP,
11725,GO:0046514,1,0.614891845697549,0,11,ceramide catabolic process,BP,
11726,GO:0046519,1,0.57976192928604,0,12,sphingoid metabolic process,BP,
11739,GO:0046540,1,0.372203867437907,0,24,U4/U6 x U5 tri-snRNP complex,CC,
11768,GO:0046606,1,0.539701159006734,0,13,negative regulation of centrosome cycle,BP,
11777,GO:0046625,1,0.596158583896661,0,11,sphingolipid binding,MF,
11800,GO:0046655,1,0.447782044992,0,17,folic acid metabolic process,BP,
11831,GO:0046716,1,0.56043858416913,0,12,muscle cell cellular homeostasis,BP,
11841,GO:0046755,1,0.36285321539961,0,23,viral budding,BP,
11863,GO:0046835,1,0.31564734888467,0,24,carbohydrate phosphorylation,BP,
11865,GO:0046838,1,0.607262010372808,0,10,phosphorylated carbohydrate dephosphorylation,BP,
11866,GO:0046839,1,0.227763688530821,0,29,phospholipid dephosphorylation,BP,
11874,GO:0046855,1,0.607262010372808,0,10,inositol phosphate dephosphorylation,BP,
11875,GO:0046856,1,0.332885547548315,0,21,phosphatidylinositol dephosphorylation,BP,
11923,GO:0046949,1,0.30843322373758,0,25,fatty-acyl-CoA biosynthetic process,BP,
11928,GO:0046961,1,0.47379428621135,0,18,proton-transporting ATPase activity, rotational mechanism,MF,
11937,GO:0046972,1,0.610042035301088,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
12017,GO:0047496,1,0.173588016747776,0,36,vesicle transport along microtubule,BP,
12028,GO:0047617,1,0.616946639390986,0,11,acyl-CoA hydrolase activity,MF,
12086,GO:0048025,1,0.428761785009526,0,18,negative regulation of mRNA splicing, via spliceosome,BP,
12087,GO:0048026,1,0.566152220786749,0,12,positive regulation of mRNA splicing, via spliceosome,BP,
12088,GO:0048027,1,0.414566205297997,0,22,mRNA 5'-UTR binding,MF,
12094,GO:0048038,1,0.57271295433805,0,14,quinone binding,MF,
12103,GO:0048070,1,0.562836060839862,0,12,regulation of developmental pigmentation,BP,
12109,GO:0048103,1,0.415344770622344,0,17,somatic stem cell division,BP,
12120,GO:0048156,1,0.596019605629439,0,11,tau protein binding,MF,
12125,GO:0048168,1,0.240698237934193,0,29,regulation of neuronal synaptic plasticity,BP,
12126,GO:0048169,1,0.437957839951309,0,17,regulation of long-term neuronal synaptic plasticity,BP,
12131,GO:0048185,1,0.59366069963516,0,11,activin binding,MF,
12132,GO:0048188,1,0.573841195481729,0,12,Set1C/COMPASS complex,CC,
12163,GO:0048261,1,0.516942679085038,0,14,negative regulation of receptor-mediated endocytosis,BP,
12169,GO:0048268,1,0.484909879699021,0,15,clathrin coat assembly,BP,
12174,GO:0048280,1,0.634073775569852,0,10,vesicle fusion with Golgi apparatus,BP,
12192,GO:0048311,1,0.478759584857872,0,14,mitochondrion distribution,BP,
12238,GO:0048486,1,0.604637782401428,0,11,parasympathetic nervous system development,BP,
12239,GO:0048487,1,0.237983066356277,0,32,beta-tubulin binding,MF,
12240,GO:0048488,1,0.22558835980751,0,29,synaptic vesicle endocytosis,BP,
12242,GO:0048490,1,0.511995289198194,0,15,anterograde synaptic vesicle transport,BP,
12262,GO:0048532,1,0.604405167419961,0,10,anatomical structure arrangement,BP,
12314,GO:0048643,1,0.493377572912188,0,14,positive regulation of skeletal muscle tissue development,BP,
12327,GO:0048668,1,0.445297872004522,0,17,collateral sprouting,BP,
12329,GO:0048670,1,0.577861553239575,0,12,regulation of collateral sprouting,BP,
12336,GO:0048679,1,0.427509445948858,0,18,regulation of axon regeneration,BP,
12338,GO:0048681,1,0.592044360046089,0,11,negative regulation of axon regeneration,BP,
12371,GO:0048741,1,0.4978543549919,0,14,skeletal muscle fiber development,BP,
12378,GO:0048753,1,0.356092789005611,0,23,pigment granule organization,BP,
12381,GO:0048757,1,0.637225189188498,0,10,pigment granule maturation,BP,
12393,GO:0048791,1,0.394476132075848,0,18,calcium ion-regulated exocytosis of neurotransmitter,BP,
12458,GO:0050136,1,0.370567549493132,0,38,NADH dehydrogenase (quinone) activity,MF,
12502,GO:0050482,1,0.566753958554202,0,12,arachidonic acid secretion,BP,
12531,GO:0050661,1,0.191602691333783,0,36,NADP binding,MF,
12535,GO:0050665,1,0.636630959036165,0,10,hydrogen peroxide biosynthetic process,BP,
12537,GO:0050667,1,0.592995042877762,0,11,homocysteine metabolic process,BP,
12546,GO:0050681,1,0.15205154841251,0,39,androgen receptor binding,MF,
12549,GO:0050685,1,0.365833726088551,0,21,positive regulation of mRNA processing,BP,
12550,GO:0050686,1,0.260170297071967,0,28,negative regulation of mRNA processing,BP,
12551,GO:0050687,1,0.370130608669666,0,21,negative regulation of defense response to virus,BP,
12554,GO:0050690,1,0.376145737108743,0,21,regulation of defense response to virus by virus,BP,
12612,GO:0050775,1,0.273845117445019,0,25,positive regulation of dendrite morphogenesis,BP,
12617,GO:0050780,1,0.608492913334137,0,10,dopamine receptor binding,MF,
12658,GO:0050849,1,0.591666283505868,0,12,negative regulation of calcium-mediated signaling,BP,
12667,GO:0050858,1,0.478795380282357,0,16,negative regulation of antigen receptor-mediated signaling pathway,BP,
12669,GO:0050860,1,0.527277783491135,0,14,negative regulation of T cell receptor signaling pathway,BP,
12685,GO:0050879,1,0.293187021372276,0,26,multicellular organismal movement,BP,
12687,GO:0050881,1,0.293187021372276,0,26,musculoskeletal movement,BP,
12702,GO:0050906,1,0.31403848952836,0,26,detection of stimulus involved in sensory perception,BP,
12703,GO:0050907,1,0.682730592539244,0,10,detection of chemical stimulus involved in sensory perception,BP,
12705,GO:0050909,1,0.593282077374091,0,12,sensory perception of taste,BP,
12741,GO:0050982,1,0.538819669907715,0,12,detection of mechanical stimulus,BP,
12747,GO:0050997,1,0.588053480772222,0,12,quaternary ammonium group binding,MF,
12752,GO:0051004,1,0.637303028364867,0,10,regulation of lipoprotein lipase activity,BP,
12755,GO:0051010,1,0.501190828885149,0,13,microtubule plus-end binding,MF,
12756,GO:0051011,1,0.597647080968149,0,10,microtubule minus-end binding,MF,
12761,GO:0051016,1,0.562707823457017,0,12,barbed-end actin filament capping,BP,
12833,GO:0051125,1,0.334654661818277,0,22,regulation of actin nucleation,BP,
12835,GO:0051127,1,0.536247398293221,0,12,positive regulation of actin nucleation,BP,
12839,GO:0051131,1,0.464595821157626,0,17,chaperone-mediated protein complex assembly,BP,
12859,GO:0051156,1,0.376698044963986,0,22,glucose 6-phosphate metabolic process,BP,
12874,GO:0051181,1,0.264434285527498,0,29,cofactor transport,BP,
12876,GO:0051184,1,0.452008701937442,0,16,cofactor transmembrane transporter activity,MF,
12887,GO:0051197,1,0.560551908761422,0,11,positive regulation of coenzyme metabolic process,BP,
12903,GO:0051231,1,0.586574612472246,0,11,spindle elongation,BP,
12909,GO:0051238,1,0.649066270460802,0,11,sequestering of metal ion,BP,
12922,GO:0051255,1,0.618570906597244,0,10,spindle midzone assembly,BP,
12938,GO:0051280,1,0.657680661972881,0,10,negative regulation of release of sequestered calcium ion into cytosol,BP,
12942,GO:0051284,1,0.657680661972881,0,10,positive regulation of sequestering of calcium ion,BP,
12946,GO:0051290,1,0.307384440387321,0,43,protein heterotetramerization,BP,
12953,GO:0051299,1,0.507608362292381,0,14,centrosome separation,BP,
12965,GO:0051315,1,0.538844344884912,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
12970,GO:0051339,1,0.412085270764535,0,19,regulation of lyase activity,BP,
12992,GO:0051382,1,0.514522354063921,0,14,kinetochore assembly,BP,
12993,GO:0051383,1,0.402165731781126,0,19,kinetochore organization,BP,
13002,GO:0051393,1,0.561567008295742,0,11,alpha-actinin binding,MF,
13024,GO:0051444,1,0.606858481286727,0,13,negative regulation of ubiquitin-protein transferase activity,BP,
13046,GO:0051489,1,0.230034159653818,0,29,regulation of filopodium assembly,BP,
13048,GO:0051491,1,0.322762158774728,0,22,positive regulation of filopodium assembly,BP,
13057,GO:0051503,1,0.573029218732885,0,12,adenine nucleotide transport,BP,
13059,GO:0051536,1,0.0683970358870552,0,61,iron-sulfur cluster binding,MF,
13060,GO:0051537,1,0.458466884551124,0,19,2 iron, 2 sulfur cluster binding,MF,
13062,GO:0051539,1,0.159136421831905,0,41,4 iron, 4 sulfur cluster binding,MF,
13063,GO:0051540,1,0.0683970358870552,0,61,metal cluster binding,MF,
13073,GO:0051560,1,0.432972623628187,0,18,mitochondrial calcium ion homeostasis,BP,
13077,GO:0051567,1,0.267961353095969,0,26,histone H3-K9 methylation,BP,
13080,GO:0051570,1,0.427092993935015,0,17,regulation of histone H3-K9 methylation,BP,
13094,GO:0051589,1,0.532307127054306,0,13,negative regulation of neurotransmitter transport,BP,
13121,GO:0051642,1,0.330715884610691,0,22,centrosome localization,BP,
13123,GO:0051645,1,0.560322276129941,0,12,Golgi localization,BP,
13125,GO:0051647,1,0.393209964856035,0,18,nucleus localization,BP,
13139,GO:0051668,1,0.0165157790813091,0,84,localization within membrane,BP,
13151,GO:0051703,1,0.208580144167089,0,31,intraspecies interaction between organisms,BP,
13153,GO:0051705,1,0.147902727616485,0,38,multi-organism behavior,BP,
13187,GO:0051775,1,0.656453769337353,0,10,response to redox state,BP,
13190,GO:0051782,1,0.520349577395431,0,14,negative regulation of cell division,BP,
13196,GO:0051788,1,0.349232933620982,0,22,response to misfolded protein,BP,
13224,GO:0051861,1,0.541305011934487,0,13,glycolipid binding,MF,
13267,GO:0051932,1,0.387413620716274,0,19,synaptic transmission, GABAergic,BP,
13281,GO:0051955,1,0.531934251180592,0,13,regulation of amino acid transport,BP,
13285,GO:0051959,1,0.320638960177974,0,23,dynein light intermediate chain binding,MF,
13291,GO:0051965,1,0.173723373657729,0,34,positive regulation of synapse assembly,BP,
13294,GO:0051968,1,0.508104493295525,0,13,positive regulation of synaptic transmission, glutamatergic,BP,
13298,GO:0051973,1,0.208867311325818,0,33,positive regulation of telomerase activity,BP,
13306,GO:0051988,1,0.554983015586948,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
13392,GO:0052629,1,0.55915160319745,0,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
13405,GO:0052689,1,0.017881865759314,0,86,carboxylic ester hydrolase activity,MF,
13420,GO:0052743,1,0.567723949845867,0,11,inositol tetrakisphosphate phosphatase activity,MF,
13421,GO:0052744,1,0.4790107608462,0,14,phosphatidylinositol monophosphate phosphatase activity,MF,
13422,GO:0052745,1,0.382547049580218,0,19,inositol phosphate phosphatase activity,MF,
13461,GO:0052866,1,0.257543813418553,0,26,phosphatidylinositol phosphate phosphatase activity,MF,
13510,GO:0055057,1,0.593700131476734,0,10,neuroblast division,BP,
13520,GO:0055075,1,0.484298295660718,0,14,potassium ion homeostasis,BP,
13527,GO:0055083,1,0.460612310577175,0,15,monovalent inorganic anion homeostasis,BP,
13550,GO:0055119,1,0.58534675695358,0,11,relaxation of cardiac muscle,BP,
13596,GO:0060049,1,0.591253569136751,0,11,regulation of protein glycosylation,BP,
13620,GO:0060076,1,0.480825313659828,0,14,excitatory synapse,CC,
13638,GO:0060117,1,0.577603691320853,0,11,auditory receptor cell development,BP,
13697,GO:0060216,1,0.489883160325521,0,14,definitive hemopoiesis,BP,
13706,GO:0060236,1,0.181831099698198,0,35,regulation of mitotic spindle organization,BP,
13734,GO:0060285,1,0.483930868560212,0,15,cilium-dependent cell motility,BP,
13750,GO:0060307,1,0.598421272943138,0,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
13811,GO:0060384,1,0.465467000375722,0,15,innervation,BP,
13942,GO:0060590,1,0.200795546819025,0,35,ATPase regulator activity,MF,
13950,GO:0060600,1,0.610482358208396,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
13963,GO:0060628,1,0.557301131691255,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
14050,GO:0060765,1,0.352346403420016,0,22,regulation of androgen receptor signaling pathway,BP,
14130,GO:0060972,1,0.469945131621877,0,16,left/right pattern formation,BP,
14131,GO:0060973,1,0.573660160704025,0,11,cell migration involved in heart development,BP,
14151,GO:0061003,1,0.529403430501652,0,12,positive regulation of dendritic spine morphogenesis,BP,
14170,GO:0061037,1,0.515398131509997,0,14,negative regulation of cartilage development,BP,
14232,GO:0061154,1,0.600557558016004,0,11,endothelial tube morphogenesis,BP,
14277,GO:0061318,1,0.543742243235718,0,12,renal filtration cell differentiation,BP,
14315,GO:0061430,1,0.590997957231767,0,10,bone trabecula morphogenesis,BP,
14384,GO:0061615,1,0.444175747529972,0,18,glycolytic process through fructose-6-phosphate,BP,
14387,GO:0061620,1,0.444175747529972,0,18,glycolytic process through glucose-6-phosphate,BP,
14388,GO:0061621,1,0.460655192346605,0,17,canonical glycolysis,BP,
14400,GO:0061641,1,0.273183236177669,0,40,CENP-A containing chromatin organization,BP,
14429,GO:0061718,1,0.460655192346605,0,17,glucose catabolic process to pyruvate,BP,
14436,GO:0061733,1,0.0767784237208134,0,53,peptide-lysine-N-acetyltransferase activity,MF,
14461,GO:0061778,1,0.599462066670736,0,10,intracellular chloride channel activity,MF,
14478,GO:0061842,1,0.301601432681188,0,24,microtubule organizing center localization,BP,
14518,GO:0065002,1,0.119915266257909,0,50,intracellular protein transmembrane transport,BP,
14526,GO:0070001,1,0.511272975434841,0,14,aspartic-type peptidase activity,MF,
14527,GO:0070003,1,0.581077244304445,0,18,threonine-type peptidase activity,MF,
14529,GO:0070006,1,0.47438359161106,0,15,metalloaminopeptidase activity,MF,
14530,GO:0070008,1,0.613237747401005,0,10,serine-type exopeptidase activity,MF,
14534,GO:0070016,1,0.600686150464299,0,10,armadillo repeat domain binding,MF,
14540,GO:0070034,1,0.39289000465009,0,21,telomerase RNA binding,MF,
14558,GO:0070069,1,0.472250101583879,0,23,cytochrome complex,CC,
14560,GO:0070071,1,0.555138458112265,0,12,proton-transporting two-sector ATPase complex assembly,BP,
14592,GO:0070125,1,0.0563500340937095,0,86,mitochondrial translational elongation,BP,
14593,GO:0070126,1,0.0515117463476374,0,88,mitochondrial translational termination,BP,
14595,GO:0070129,1,0.44268740154745,0,18,regulation of mitochondrial translation,BP,
14597,GO:0070131,1,0.609574875709207,0,11,positive regulation of mitochondrial translation,BP,
14626,GO:0070182,1,0.448657833676366,0,18,DNA polymerase binding,MF,
14632,GO:0070192,1,0.16707737438709,0,37,chromosome organization involved in meiotic cell cycle,BP,
14633,GO:0070193,1,0.60621859275684,0,11,synaptonemal complex organization,BP,
14637,GO:0070198,1,0.289506745121308,0,26,protein localization to chromosome, telomeric region,BP,
14638,GO:0070199,1,0.353338857911505,0,23,establishment of protein localization to chromosome,BP,
14639,GO:0070200,1,0.517513936655576,0,14,establishment of protein localization to telomere,BP,
14641,GO:0070202,1,0.602905819001123,0,11,regulation of establishment of protein localization to chromosome,BP,
14642,GO:0070203,1,0.632301703947311,0,10,regulation of establishment of protein localization to telomere,BP,
14644,GO:0070207,1,0.448624360454184,0,18,protein homotrimerization,BP,
14683,GO:0070286,1,0.594208480357337,0,11,axonemal dynein complex assembly,BP,
14691,GO:0070296,1,0.431220866842021,0,18,sarcoplasmic reticulum calcium ion transport,BP,
14743,GO:0070402,1,0.558881384530023,0,13,NADPH binding,MF,
14744,GO:0070403,1,0.577393484665261,0,12,NAD+ binding,MF,
14777,GO:0070461,1,0.302049280850016,0,26,SAGA-type complex,CC,
14779,GO:0070469,1,0.090347811741913,0,78,respiratory chain,CC,
14809,GO:0070525,1,0.562592274153359,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
14840,GO:0070570,1,0.386341273608752,0,20,regulation of neuron projection regeneration,BP,
14841,GO:0070571,1,0.535063928999978,0,13,negative regulation of neuron projection regeneration,BP,
14846,GO:0070577,1,0.432709762903505,0,16,lysine-acetylated histone binding,MF,
14867,GO:0070628,1,0.474243845371719,0,18,proteasome binding,MF,
14919,GO:0070734,1,0.43684276991772,0,18,histone H3-K27 methylation,BP,
14949,GO:0070822,1,0.504696885568577,0,14,Sin3-type complex,CC,
14952,GO:0070828,1,0.480884183394354,0,15,heterochromatin organization,BP,
14959,GO:0070840,1,0.389050250228755,0,18,dynein complex binding,MF,
14960,GO:0070841,1,0.419392498277313,0,18,inclusion body assembly,BP,
14976,GO:0070861,1,0.396320927119335,0,19,regulation of protein exit from endoplasmic reticulum,BP,
14977,GO:0070862,1,0.629795222890059,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
15006,GO:0070914,1,0.601406106738086,0,11,UV-damage excision repair,BP,
15014,GO:0070932,1,0.37118541473187,0,20,histone H3 deacetylation,BP,
15040,GO:0070971,1,0.477653936686921,0,15,endoplasmic reticulum exit site,CC,
15052,GO:0070986,1,0.562359576225524,0,12,left/right axis specification,BP,
15055,GO:0070989,1,0.59385001158055,0,11,oxidative demethylation,BP,
15063,GO:0071004,1,0.481825246138492,0,17,U2-type prespliceosome,CC,
15066,GO:0071007,1,0.294001450142936,0,29,U2-type catalytic step 2 spliceosome,CC,
15068,GO:0071010,1,0.390134239879824,0,22,prespliceosome,CC,
15075,GO:0071025,1,0.542856647168657,0,15,RNA surveillance,BP,
15077,GO:0071027,1,0.596513654226775,0,13,nuclear RNA surveillance,BP,
15078,GO:0071028,1,0.596513654226775,0,13,nuclear mRNA surveillance,BP,
15088,GO:0071044,1,0.595300006977013,0,11,histone mRNA catabolic process,BP,
15138,GO:0071218,1,0.383072998706791,0,20,cellular response to misfolded protein,BP,
15153,GO:0071242,1,0.20757145904523,0,33,cellular response to ammonium ion,BP,
15194,GO:0071318,1,0.56891505570897,0,12,cellular response to ATP,BP,
15207,GO:0071339,1,0.258117904396021,0,29,MLL1 complex,CC,
15235,GO:0071377,1,0.345257928579178,0,22,cellular response to glucagon stimulus,BP,
15238,GO:0071380,1,0.538230146085129,0,12,cellular response to prostaglandin E stimulus,BP,
15271,GO:0071428,1,0.548293049363019,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
15289,GO:0071459,1,0.396517052964083,0,20,protein localization to chromosome, centromeric region,BP,
15307,GO:0071481,1,0.565577136031971,0,11,cellular response to X-ray,BP,
15327,GO:0071514,1,0.40025927778715,0,18,genetic imprinting,BP,
15339,GO:0071545,1,0.555469171654108,0,12,inositol phosphate catabolic process,BP,
15352,GO:0071564,1,0.555484360041959,0,12,npBAF complex,CC,
15353,GO:0071565,1,0.544276294849444,0,12,nBAF complex,CC,
15388,GO:0071617,1,0.369647827576175,0,20,lysophospholipid acyltransferase activity,MF,
15394,GO:0071625,1,0.560125938766911,0,11,vocalization behavior,BP,
15450,GO:0071712,1,0.600823963499245,0,11,ER-associated misfolded protein catabolic process,BP,
15466,GO:0071782,1,0.421584100919929,0,18,endoplasmic reticulum tubular network,CC,
15467,GO:0071786,1,0.488367213684892,0,15,endoplasmic reticulum tubular network organization,BP,
15481,GO:0071806,1,0.102311357423474,0,54,protein transmembrane transport,BP,
15516,GO:0071875,1,0.574571821040184,0,11,adrenergic receptor signaling pathway,BP,
15552,GO:0071941,1,0.60256492696089,0,11,nitrogen cycle metabolic process,BP,
15556,GO:0071949,1,0.367800339587833,0,21,FAD binding,MF,
15564,GO:0071985,1,0.271725148375322,0,28,multivesicular body sorting pathway,BP,
15576,GO:0072010,1,0.517231651557551,0,13,glomerular epithelium development,BP,
15637,GO:0072112,1,0.543742243235718,0,12,glomerular visceral epithelial cell differentiation,BP,
15658,GO:0072148,1,0.593800472957085,0,11,epithelial cell fate commitment,BP,
15750,GO:0072311,1,0.543742243235718,0,12,glomerular epithelial cell differentiation,BP,
15756,GO:0072321,1,0.678137200329972,0,10,chaperone-mediated protein transport,BP,
15769,GO:0072348,1,0.34170756436289,0,22,sulfur compound transport,BP,
15798,GO:0072393,1,0.562029753322609,0,11,microtubule anchoring at microtubule organizing center,BP,
15807,GO:0072425,1,0.576546855499039,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
15817,GO:0072498,1,0.634787893842329,0,10,embryonic skeletal joint development,BP,
15831,GO:0072520,1,0.624130104744943,0,10,seminiferous tubule development,BP,
15852,GO:0072546,1,0.619278004499415,0,10,ER membrane protein complex,CC,
15876,GO:0072583,1,0.164970014054032,0,36,clathrin-dependent endocytosis,BP,
15908,GO:0072662,1,0.438913568763888,0,17,protein localization to peroxisome,BP,
15909,GO:0072663,1,0.438913568763888,0,17,establishment of protein localization to peroxisome,BP,
15970,GO:0075522,1,0.62452417440123,0,10,IRES-dependent viral translational initiation,BP,
15977,GO:0080008,1,0.2115693143678,0,32,Cul4-RING E3 ubiquitin ligase complex,CC,
15998,GO:0080171,1,0.0905806505113646,0,51,lytic vacuole organization,BP,
16013,GO:0086010,1,0.357632301189392,0,20,membrane depolarization during action potential,BP,
16015,GO:0086012,1,0.572699969553587,0,11,membrane depolarization during cardiac muscle cell action potential,BP,
16081,GO:0090025,1,0.607396134336508,0,11,regulation of monocyte chemotaxis,BP,
16098,GO:0090051,1,0.526485703326835,0,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,
16104,GO:0090069,1,0.537245116544616,0,13,regulation of ribosome biogenesis,BP,
16109,GO:0090075,1,0.471575708629891,0,16,relaxation of muscle,BP,
16115,GO:0090083,1,0.518826076387435,0,14,regulation of inclusion body assembly,BP,
16116,GO:0090084,1,0.61840057848591,0,10,negative regulation of inclusion body assembly,BP,
16135,GO:0090110,1,0.514839671020145,0,13,cargo loading into COPII-coated vesicle,BP,
16149,GO:0090140,1,0.401510000500751,0,19,regulation of mitochondrial fission,BP,
16150,GO:0090141,1,0.550169462585806,0,13,positive regulation of mitochondrial fission,BP,
16151,GO:0090148,1,0.546290696583259,0,12,membrane fission,BP,
16154,GO:0090151,1,0.658460910101266,0,12,establishment of protein localization to mitochondrial membrane,BP,
16161,GO:0090161,1,0.56580367017155,0,11,Golgi ribbon formation,BP,
16166,GO:0090169,1,0.295131665050286,0,25,regulation of spindle assembly,BP,
16209,GO:0090224,1,0.155754628262617,0,38,regulation of spindle organization,BP,
16270,GO:0090313,1,0.287630770442681,0,27,regulation of protein targeting to membrane,BP,
16271,GO:0090314,1,0.347862598489505,0,23,positive regulation of protein targeting to membrane,BP,
16281,GO:0090329,1,0.126777743668783,0,43,regulation of DNA-dependent DNA replication,BP,
16289,GO:0090343,1,0.652610671763671,0,10,positive regulation of cell aging,BP,
16300,GO:0090382,1,0.232610164291562,0,33,phagosome maturation,BP,
16301,GO:0090383,1,0.41338657375345,0,21,phagosome acidification,BP,
16323,GO:0090481,1,0.634844968643496,0,10,pyrimidine nucleotide-sugar transmembrane transport,BP,
16341,GO:0090543,1,0.288776005448889,0,26,Flemming body,CC,
16366,GO:0090646,1,0.582078510033872,0,12,mitochondrial tRNA processing,BP,
16370,GO:0090656,1,0.471001008703044,0,15,t-circle formation,BP,
16371,GO:0090657,1,0.575472923964808,0,11,telomeric loop disassembly,BP,
16372,GO:0090659,1,0.522461803167491,0,13,walking behavior,BP,
16374,GO:0090662,1,0.40529822577116,0,21,ATP hydrolysis coupled transmembrane transport,BP,
16375,GO:0090665,1,0.550043764645521,0,12,glycoprotein complex,CC,
16380,GO:0090670,1,0.441669749301757,0,19,RNA localization to Cajal body,BP,
16381,GO:0090671,1,0.441669749301757,0,19,telomerase RNA localization to Cajal body,BP,
16382,GO:0090672,1,0.441669749301757,0,19,telomerase RNA localization,BP,
16386,GO:0090685,1,0.441669749301757,0,19,RNA localization to nucleus,BP,
16391,GO:0090723,1,0.593084427582373,0,11,growth cone part,CC,
16396,GO:0090735,1,0.636954110006722,0,10,DNA repair complex assembly,BP,
16397,GO:0090737,1,0.471001008703044,0,15,telomere maintenance via telomere trimming,BP,
16400,GO:0095500,1,0.572068091659072,0,12,acetylcholine receptor signaling pathway,BP,
16408,GO:0097014,1,0.0482736943014928,0,63,ciliary plasm,CC,
16422,GO:0097038,1,0.62064186146644,0,10,perinuclear endoplasmic reticulum,CC,
16437,GO:0097062,1,0.525513934554587,0,13,dendritic spine maintenance,BP,
16440,GO:0097066,1,0.489115998591396,0,15,response to thyroid hormone,BP,
16441,GO:0097067,1,0.613041957776479,0,10,cellular response to thyroid hormone stimulus,BP,
16450,GO:0097094,1,0.583458090925022,0,11,craniofacial suture morphogenesis,BP,
16469,GO:0097120,1,0.371386461271872,0,20,receptor localization to synapse,BP,
16480,GO:0097150,1,0.419724955958093,0,17,neuronal stem cell population maintenance,BP,
16503,GO:0097186,1,0.469417112624694,0,15,amelogenesis,BP,
16531,GO:0097228,1,0.573778478666192,0,12,sperm principal piece,CC,
16563,GO:0097320,1,0.493466843979945,0,14,plasma membrane tubulation,BP,
16567,GO:0097329,1,0.542736589484745,0,12,response to antimetabolite,BP,
16576,GO:0097346,1,0.366176633223148,0,23,INO80-type complex,CC,
16578,GO:0097352,1,0.21537967888093,0,34,autophagosome maturation,BP,
16597,GO:0097386,1,0.585162057961611,0,11,glial cell projection,CC,
16613,GO:0097428,1,0.704184894453165,0,10,protein maturation by iron-sulfur cluster transfer,BP,
16617,GO:0097440,1,0.570142545954066,0,11,apical dendrite,CC,
16632,GO:0097468,1,0.612664484390898,0,11,programmed cell death in response to reactive oxygen species,BP,
16653,GO:0097502,1,0.275677695320051,0,28,mannosylation,BP,
16654,GO:0097503,1,0.506001506902948,0,14,sialylation,BP,
16655,GO:0097504,1,0.605092278493628,0,11,Gemini of coiled bodies,CC,
16661,GO:0097517,1,0.118674871841656,0,43,contractile actin filament bundle,CC,
16664,GO:0097526,1,0.322887713087933,0,29,spliceosomal tri-snRNP complex,CC,
16674,GO:0097539,1,0.599731905216321,0,10,ciliary transition fiber,CC,
16678,GO:0097546,1,0.302621060410566,0,25,ciliary base,CC,
16690,GO:0097617,1,0.522295914904309,0,13,annealing activity,MF,
16734,GO:0097722,1,0.249234235116366,0,30,sperm motility,BP,
16756,GO:0098505,1,0.619571746127849,0,10,G-rich strand telomeric DNA binding,MF,
16780,GO:0098563,1,0.494165103681174,0,15,intrinsic component of synaptic vesicle membrane,CC,
16781,GO:0098573,1,0.0546484456407044,0,66,intrinsic component of mitochondrial membrane,CC,
16797,GO:0098599,1,0.631281979370237,0,10,palmitoyl hydrolase activity,MF,
16804,GO:0098631,1,0.19158671896084,0,35,cell adhesion mediator activity,MF,
16805,GO:0098632,1,0.2570556314301,0,29,cell-cell adhesion mediator activity,MF,
16810,GO:0098641,1,0.43764940840255,0,19,cadherin binding involved in cell-cell adhesion,MF,
16846,GO:0098734,1,0.631281979370237,0,10,macromolecule depalmitoylation,BP,
16851,GO:0098743,1,0.577923784302368,0,11,cell aggregation,BP,
16854,GO:0098748,1,0.585318179692478,0,11,endocytic adaptor activity,MF,
16871,GO:0098787,1,0.499158375960333,0,14,mRNA cleavage involved in mRNA processing,BP,
16872,GO:0098789,1,0.578395234652573,0,11,pre-mRNA cleavage required for polyadenylation,BP,
16881,GO:0098799,1,0.61780723539481,0,12,outer mitochondrial membrane protein complex,CC,
16885,GO:0098803,1,0.146855059322202,0,66,respiratory chain complex,CC,
16912,GO:0098847,1,0.537226906966462,0,13,sequence-specific single stranded DNA binding,MF,
16924,GO:0098877,1,0.614068244443015,0,10,neurotransmitter receptor transport to plasma membrane,BP,
16925,GO:0098878,1,0.403333282778225,0,18,neurotransmitter receptor complex,CC,
16957,GO:0098927,1,0.138336310757162,0,41,vesicle-mediated transport between endosomal compartments,BP,
17002,GO:0099072,1,0.456654022682978,0,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,
17013,GO:0099086,1,0.429493566486812,0,18,synaptonemal structure,CC,
17021,GO:0099116,1,0.533583880065745,0,16,tRNA 5'-end processing,BP,
17025,GO:0099131,1,0.40529822577116,0,21,ATP hydrolysis coupled ion transmembrane transport,BP,
17026,GO:0099132,1,0.250697680288166,0,30,ATP hydrolysis coupled cation transmembrane transport,BP,
17050,GO:0099514,1,0.511995289198194,0,15,synaptic vesicle cytoskeletal transport,BP,
17053,GO:0099517,1,0.511995289198194,0,15,synaptic vesicle transport along microtubule,BP,
17054,GO:0099518,1,0.126442179645681,0,42,vesicle cytoskeletal trafficking,BP,
17081,GO:0099563,1,0.545620529063561,0,12,modification of synaptic structure,BP,
17092,GO:0099601,1,0.301065405213335,0,24,regulation of neurotransmitter receptor activity,BP,
17100,GO:0099622,1,0.47028810769549,0,15,cardiac muscle cell membrane repolarization,BP,
17101,GO:0099623,1,0.566479342897114,0,11,regulation of cardiac muscle cell membrane repolarization,BP,
17103,GO:0099625,1,0.570594036706374,0,11,ventricular cardiac muscle cell membrane repolarization,BP,
17108,GO:0099632,1,0.530258654360865,0,13,protein transport within plasma membrane,BP,
17110,GO:0099637,1,0.530258654360865,0,13,neurotransmitter receptor transport,BP,
17126,GO:0101023,1,0.574372007547165,0,11,vascular endothelial cell proliferation,BP,
17128,GO:0101031,1,0.599971413069928,0,11,chaperone complex,CC,
17172,GO:0102567,1,0.557359304854418,0,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
17173,GO:0102568,1,0.557359304854418,0,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
17207,GO:0106018,1,0.477368162681301,0,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
17208,GO:0106019,1,0.596267467062075,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
17213,GO:0106030,1,0.486136599471168,0,14,neuron projection fasciculation,BP,
17227,GO:0106074,1,0.582590279074923,0,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
17264,GO:0120033,1,0.401287213079874,0,19,negative regulation of plasma membrane bounded cell projection assembly,BP,
17286,GO:0120111,1,0.0620806091969492,0,59,neuron projection cytoplasm,CC,
17295,GO:0140033,1,0.432709762903505,0,16,acetylation-dependent protein binding,MF,
17312,GO:0140078,1,0.659895335275131,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17313,GO:0140080,1,0.659895335275131,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17318,GO:0140102,1,0.502461373852262,0,16,catalytic activity, acting on a rRNA,MF,
17319,GO:0140103,1,0.400785270046633,0,19,catalytic activity, acting on a glycoprotein,MF,
17320,GO:0140104,1,0.318336655307019,0,27,molecular carrier activity,MF,
17326,GO:0140142,1,0.419938895892092,0,18,nucleocytoplasmic carrier activity,MF,
17335,GO:0150005,1,0.642891996592042,0,10,enzyme activator complex,CC,
17353,GO:1900024,1,0.155762515767221,0,39,regulation of substrate adhesion-dependent cell spreading,BP,
17354,GO:1900025,1,0.552513106665271,0,12,negative regulation of substrate adhesion-dependent cell spreading,BP,
17355,GO:1900026,1,0.29781641389037,0,26,positive regulation of substrate adhesion-dependent cell spreading,BP,
17358,GO:1900029,1,0.603850222899574,0,11,positive regulation of ruffle assembly,BP,
17361,GO:1900037,1,0.644506775234972,0,10,regulation of cellular response to hypoxia,BP,
17377,GO:1900078,1,0.35104284418079,0,20,positive regulation of cellular response to insulin stimulus,BP,
17406,GO:1900121,1,0.638682683744284,0,10,negative regulation of receptor binding,BP,
17483,GO:1900363,1,0.549768114030108,0,12,regulation of mRNA polyadenylation,BP,
17491,GO:1900373,1,0.209089318237389,0,33,positive regulation of purine nucleotide biosynthetic process,BP,
17504,GO:1900449,1,0.3622359961201,0,20,regulation of glutamate receptor signaling pathway,BP,
17530,GO:1900750,1,0.644606966820009,0,11,oligopeptide binding,MF,
17554,GO:1901070,1,0.624617134470992,0,13,guanosine-containing compound biosynthetic process,BP,
17567,GO:1901096,1,0.601941180382841,0,10,regulation of autophagosome maturation,BP,
17660,GO:1901381,1,0.581718246031318,0,11,positive regulation of potassium ion transmembrane transport,BP,
17681,GO:1901524,1,0.50595695367146,0,14,regulation of mitophagy,BP,
17703,GO:1901567,1,0.419785351824139,0,21,fatty acid derivative binding,MF,
17717,GO:1901607,1,0.0842303300087173,0,53,alpha-amino acid biosynthetic process,BP,
17746,GO:1901661,1,0.382473985919434,0,23,quinone metabolic process,BP,
17748,GO:1901663,1,0.556551048771665,0,14,quinone biosynthetic process,BP,
17753,GO:1901673,1,0.403442059867933,0,19,regulation of mitotic spindle assembly,BP,
17761,GO:1901682,1,0.391574155345731,0,19,sulfur compound transmembrane transporter activity,MF,
17762,GO:1901685,1,0.595432401339977,0,16,glutathione derivative metabolic process,BP,
17763,GO:1901687,1,0.595432401339977,0,16,glutathione derivative biosynthetic process,BP,
17792,GO:1901836,1,0.593386986063901,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17850,GO:1901998,1,0.213809994198529,0,33,toxin transport,BP,
17851,GO:1902001,1,0.466730406458432,0,15,fatty acid transmembrane transport,BP,
17913,GO:1902188,1,0.497305045683985,0,15,positive regulation of viral release from host cell,BP,
17959,GO:1902285,1,0.524604411150418,0,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
17960,GO:1902287,1,0.554173574227755,0,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,
18025,GO:1902493,1,0.0160945730839132,0,88,acetyltransferase complex,CC,
18053,GO:1902562,1,0.147008433263742,0,41,H4 histone acetyltransferase complex,CC,
18121,GO:1902745,1,0.390827015491265,0,19,positive regulation of lamellipodium organization,BP,
18124,GO:1902750,1,0.0164153385352178,0,97,negative regulation of cell cycle G2/M phase transition,BP,
18125,GO:1902751,1,0.336335557544221,0,23,positive regulation of cell cycle G2/M phase transition,BP,
18239,GO:1903020,1,0.462423353435841,0,16,positive regulation of glycoprotein metabolic process,BP,
18270,GO:1903077,1,0.433892955502403,0,17,negative regulation of protein localization to plasma membrane,BP,
18291,GO:1903146,1,0.124144842710128,0,44,regulation of autophagy of mitochondrion,BP,
18319,GO:1903209,1,0.60853927249212,0,11,positive regulation of oxidative stress-induced cell death,BP,
18358,GO:1903306,1,0.552436133340727,0,12,negative regulation of regulated secretory pathway,BP,
18377,GO:1903350,1,0.589791804029298,0,11,response to dopamine,BP,
18378,GO:1903351,1,0.589791804029298,0,11,cellular response to dopamine,BP,
18411,GO:1903421,1,0.519212577106822,0,13,regulation of synaptic vesicle recycling,BP,
18417,GO:1903429,1,0.492956172486962,0,15,regulation of cell maturation,BP,
18447,GO:1903513,1,0.313520988137457,0,25,endoplasmic reticulum to cytosol transport,BP,
18448,GO:1903514,1,0.45554844628724,0,17,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
18495,GO:1903580,1,0.348455827916549,0,22,positive regulation of ATP metabolic process,BP,
18505,GO:1903599,1,0.450420627951827,0,17,positive regulation of autophagy of mitochondrion,BP,
18520,GO:1903649,1,0.401707507464478,0,19,regulation of cytoplasmic transport,BP,
18526,GO:1903671,1,0.348974704712502,0,21,negative regulation of sprouting angiogenesis,BP,
18582,GO:1903792,1,0.512506044394637,0,13,negative regulation of anion transport,BP,
18602,GO:1903831,1,0.572068091659072,0,12,signal transduction involved in cellular response to ammonium ion,BP,
18635,GO:1903902,1,0.0935726331757075,0,51,positive regulation of viral life cycle,BP,
18663,GO:1903959,1,0.422660816812697,0,17,regulation of anion transmembrane transport,BP,
18664,GO:1903960,1,0.600177273649241,0,10,negative regulation of anion transmembrane transport,BP,
18666,GO:1903963,1,0.566753958554202,0,12,arachidonate transport,BP,
18727,GO:1904115,1,0.180233072000348,0,37,axon cytoplasm,CC,
18734,GO:1904152,1,0.57497674520375,0,12,regulation of retrograde protein transport, ER to cytosol,BP,
18798,GO:1904293,1,0.546633624641564,0,13,negative regulation of ERAD pathway,BP,
18820,GO:1904353,1,0.289591223732128,0,25,regulation of telomere capping,BP,
18822,GO:1904355,1,0.463863998424259,0,16,positive regulation of telomere capping,BP,
18825,GO:1904358,1,0.188045402483991,0,35,positive regulation of telomere maintenance via telomere lengthening,BP,
18827,GO:1904376,1,0.393603630538936,0,19,negative regulation of protein localization to cell periphery,BP,
18831,GO:1904380,1,0.411529246779509,0,19,endoplasmic reticulum mannose trimming,BP,
18942,GO:1904666,1,0.507928659888233,0,18,regulation of ubiquitin protein ligase activity,BP,
18944,GO:1904668,1,0.593654891990147,0,12,positive regulation of ubiquitin protein ligase activity,BP,
18965,GO:1904706,1,0.613722542199791,0,11,negative regulation of vascular smooth muscle cell proliferation,BP,
19023,GO:1904814,1,0.547637715426732,0,13,regulation of protein localization to chromosome, telomeric region,BP,
19025,GO:1904816,1,0.60026454501887,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
19049,GO:1904872,1,0.461289899391239,0,18,regulation of telomerase RNA localization to Cajal body,BP,
19050,GO:1904874,1,0.53614933513634,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
19069,GO:1904896,1,0.638837849748883,0,10,ESCRT complex disassembly,BP,
19071,GO:1904903,1,0.638837849748883,0,10,ESCRT III complex disassembly,BP,
19078,GO:1904923,1,0.564922098179072,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19080,GO:1904925,1,0.591732461727125,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19134,GO:1905048,1,0.540206782066533,0,13,regulation of metallopeptidase activity,BP,
19163,GO:1905144,1,0.572068091659072,0,12,response to acetylcholine,BP,
19164,GO:1905145,1,0.572068091659072,0,12,cellular response to acetylcholine,BP,
19190,GO:1905214,1,0.593630991943736,0,11,regulation of RNA binding,BP,
19246,GO:1905354,1,0.39162570796021,0,22,exoribonuclease complex,CC,
19249,GO:1905360,1,0.410441061058467,0,19,GTPase complex,CC,
19253,GO:1905369,1,0.0811848727144447,0,64,endopeptidase complex,CC,
19301,GO:1905476,1,0.342543919781758,0,22,negative regulation of protein localization to membrane,BP,
19321,GO:1905562,1,0.574372007547165,0,11,regulation of vascular endothelial cell proliferation,BP,
19323,GO:1905564,1,0.599874528962984,0,10,positive regulation of vascular endothelial cell proliferation,BP,
19430,GO:1905939,1,0.602956532549624,0,11,regulation of gonad development,BP,
19447,GO:1990023,1,0.52991660605246,0,13,mitotic spindle midzone,CC,
19475,GO:1990126,1,0.461351840419777,0,16,retrograde transport, endosome to plasma membrane,BP,
19492,GO:1990173,1,0.628910563694254,0,10,protein localization to nucleoplasm,BP,
19501,GO:1990204,1,0.0394619213642006,0,89,oxidoreductase complex,CC,
19528,GO:1990381,1,0.52902642080973,0,13,ubiquitin-specific protease binding,MF,
19532,GO:1990391,1,0.170748747363719,0,36,DNA repair complex,CC,
19658,GO:1990825,1,0.624839497942317,0,10,sequence-specific mRNA binding,MF,
19695,GO:1990939,1,0.180447943539525,0,34,ATP-dependent microtubule motor activity,MF,
19704,GO:2000001,1,0.468139577099995,0,16,regulation of DNA damage checkpoint,BP,
19756,GO:2000104,1,0.396653830782923,0,19,negative regulation of DNA-dependent DNA replication,BP,
19757,GO:2000105,1,0.554214385207349,0,12,positive regulation of DNA-dependent DNA replication,BP,
19766,GO:2000114,1,0.395361850234198,0,18,regulation of establishment of cell polarity,BP,
19820,GO:2000232,1,0.595212998047605,0,11,regulation of rRNA processing,BP,
19827,GO:2000251,1,0.645244844348056,0,10,positive regulation of actin cytoskeleton reorganization,BP,
19908,GO:2000369,1,0.460995518632003,0,15,regulation of clathrin-dependent endocytosis,BP,
19967,GO:2000479,1,0.564925996168237,0,12,regulation of cAMP-dependent protein kinase activity,BP,
20045,GO:2000641,1,0.445077737634852,0,17,regulation of early endosome to late endosome transport,BP,
20079,GO:2000678,1,0.553383965678204,0,14,negative regulation of transcription regulatory region DNA binding,BP,
20107,GO:2000738,1,0.603921511378042,0,10,positive regulation of stem cell differentiation,BP,
20133,GO:2000780,1,0.39071482522205,0,19,negative regulation of double-strand break repair,BP,
20134,GO:2000781,1,0.500253649469803,0,14,positive regulation of double-strand break repair,BP,
20136,GO:2000786,1,0.566211903784202,0,11,positive regulation of autophagosome assembly,BP,
20204,GO:2001025,1,0.598334062147517,0,12,positive regulation of response to drug,BP,
20210,GO:2001032,1,0.592887634369251,0,11,regulation of double-strand break repair via nonhomologous end joining,BP,
20218,GO:2001044,1,0.630154538243191,0,10,regulation of integrin-mediated signaling pathway,BP,
20255,GO:2001171,1,0.412742672930354,0,18,positive regulation of ATP biosynthetic process,BP,
20285,GO:2001224,1,0.477787899702673,0,14,positive regulation of neuron migration,BP,
20318,GO:2001273,1,0.477894330046077,0,14,regulation of glucose import in response to insulin stimulus,BP,
20320,GO:2001275,1,0.556148443561741,0,11,positive regulation of glucose import in response to insulin stimulus,BP,
15966,GO:0075341,1,0.95505504584134,0,1,host cell PML body,CC,
1771,GO:0004372,1.00000000000001,0.911875688006616,0,2,glycine hydroxymethyltransferase activity,MF,
2048,GO:0004793,1.00000000000001,0.911875688006616,0,2,threonine aldolase activity,MF,
3000,GO:0006545,1.00000000000001,0.911875688006616,0,2,glycine biosynthetic process,BP,
3964,GO:0008732,1.00000000000001,0.911875688006616,0,2,L-allo-threonine aldolase activity,MF,
6095,GO:0019264,1.00000000000001,0.911875688006616,0,2,glycine biosynthetic process from serine,BP,
11939,GO:0046975,1.00000000000001,0.743073342735266,0,6,histone methyltransferase activity (H3-K36 specific),MF,
9141,GO:0035473,1.00000000000002,0.910349472801252,0,2,lipase binding,MF,
4928,GO:0014876,1.00000000000002,0.963951039561249,0,1,response to injury involved in regulation of muscle adaptation,BP,
12301,GO:0048625,1.00000000000002,0.8578197589951,0,3,myoblast fate commitment,BP,
14882,GO:0070652,1.00000000000004,0.690873476343053,0,8,HAUS complex,CC,
16948,GO:0098915,1.00000000000006,0.856764150552934,0,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
18980,GO:1904732,1.00000000000006,0.934618812638161,0,2,regulation of electron transfer activity,BP,
19096,GO:1904959,1.00000000000006,0.934618812638161,0,2,regulation of cytochrome-c oxidase activity,BP,
5020,GO:0015180,1.00000000000007,0.777342207832174,0,5,L-alanine transmembrane transporter activity,MF,
5212,GO:0015808,1.00000000000007,0.777342207832174,0,5,L-alanine transport,BP,
6631,GO:0022858,1.00000000000007,0.777342207832174,0,5,alanine transmembrane transporter activity,MF,
17226,GO:0106073,1.00000000000008,0.901896839980966,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
15373,GO:0071598,1.00000000000009,0.798994034952468,0,5,neuronal ribonucleoprotein granule,CC,
5585,GO:0016598,1.0000000000001,0.914964478376578,0,2,protein arginylation,BP,
13643,GO:0060124,1.0000000000001,0.901740950540184,0,2,positive regulation of growth hormone secretion,BP,
15048,GO:0070981,1.00000000000011,0.954953228811953,0,1,L-asparagine biosynthetic process,BP,
15049,GO:0070982,1.00000000000011,0.954953228811953,0,1,L-asparagine metabolic process,BP,
14431,GO:0061724,1.00000000000011,0.745304964915109,0,6,lipophagy,BP,
18555,GO:1903729,1.00000000000012,0.648104452787296,0,9,regulation of plasma membrane organization,BP,
11980,GO:0047220,1.00000000000013,0.95385760412824,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
7520,GO:0031701,1.00000000000013,0.664476768569212,0,8,angiotensin receptor binding,MF,
19263,GO:1905397,1.00000000000013,0.919568200349112,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19264,GO:1905402,1.00000000000013,0.919568200349112,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
9542,GO:0036292,1.00000000000015,0.915385678347762,0,2,DNA rewinding,BP,
5451,GO:0016316,1.00000000000015,0.897956973585228,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5865,GO:0017161,1.00000000000015,0.897956973585228,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
8825,GO:0034597,1.00000000000015,0.897956973585228,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
13440,GO:0052828,1.00000000000015,0.897956973585228,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
2462,GO:0005673,1.00000000000015,0.916230325804033,0,2,transcription factor TFIIE complex,CC,
11288,GO:0045586,1.00000000000016,0.850359409641734,0,3,regulation of gamma-delta T cell differentiation,BP,
5756,GO:0016900,1.00000000000016,0.942837581046333,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
8677,GO:0034247,1.00000000000016,0.965629113935554,0,1,snoRNA splicing,BP,
9272,GO:0035692,1.00000000000016,0.913921229826343,0,2,macrophage migration inhibitory factor receptor complex,CC,
11962,GO:0047057,1.00000000000016,0.942837581046333,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
15471,GO:0071796,1.00000000000016,0.965629113935554,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
6890,GO:0030395,1.00000000000016,0.983449129922399,0,1,lactose binding,MF,
8610,GO:0034117,1.00000000000016,0.983449129922399,0,1,erythrocyte aggregation,BP,
8611,GO:0034118,1.00000000000016,0.983449129922399,0,1,regulation of erythrocyte aggregation,BP,
8612,GO:0034120,1.00000000000016,0.983449129922399,0,1,positive regulation of erythrocyte aggregation,BP,
12090,GO:0048030,1.00000000000016,0.983449129922399,0,1,disaccharide binding,MF,
15670,GO:0072174,1.00000000000018,0.855364698320743,0,3,metanephric tubule formation,BP,
4958,GO:0015019,1.00000000000019,0.946740572073728,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
15608,GO:0072076,1.00000000000019,0.857878432512424,0,3,nephrogenic mesenchyme development,BP,
16493,GO:0097165,1.0000000000002,0.782694169529791,0,5,nuclear stress granule,CC,
4170,GO:0009234,1.00000000000021,0.950341326191176,0,1,menaquinone biosynthetic process,BP,
7712,GO:0032194,1.00000000000021,0.950341326191176,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
9983,GO:0042371,1.00000000000021,0.950341326191176,0,1,vitamin K biosynthetic process,BP,
5118,GO:0015439,1.00000000000021,0.953233259932855,0,1,heme-transporting ATPase activity,MF,
7655,GO:0032070,1.00000000000021,0.675269869978415,0,9,regulation of deoxyribonuclease activity,BP,
18030,GO:1902504,1.00000000000021,0.953233259932855,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
1688,GO:0004152,1.00000000000022,0.956026031718173,0,1,dihydroorotate dehydrogenase activity,MF,
18492,GO:1903576,1.00000000000022,0.956026031718173,0,1,response to L-arginine,BP,
13407,GO:0052695,1.00000000000022,0.717815161343593,0,7,cellular glucuronidation,BP,
19799,GO:2000192,1.00000000000022,0.766047019252758,0,5,negative regulation of fatty acid transport,BP,
18665,GO:1903961,1.00000000000023,0.863771506216914,0,3,positive regulation of anion transmembrane transport,BP,
11956,GO:0047021,1.00000000000024,0.966577144329483,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12468,GO:0050221,1.00000000000024,0.966577144329483,0,1,prostaglandin-E2 9-reductase activity,MF,
4214,GO:0009360,1.00000000000024,0.954068080861819,0,1,DNA polymerase III complex,CC,
6819,GO:0030272,1.00000000000024,0.974754266953578,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
10473,GO:0043335,1.00000000000024,0.915851409137675,0,2,protein unfolding,BP,
20030,GO:2000617,1.00000000000024,0.751699523427433,0,6,positive regulation of histone H3-K9 acetylation,BP,
14453,GO:0061762,1.00000000000026,0.896311687091712,0,2,CAMKK-AMPK signaling cascade,BP,
16987,GO:0099004,1.00000000000026,0.896311687091712,0,2,calmodulin dependent kinase signaling pathway,BP,
20286,GO:2001225,1.00000000000026,0.788543469440306,0,5,regulation of chloride transport,BP,
1269,GO:0003032,1.00000000000026,0.909766727220097,0,2,detection of oxygen,BP,
11749,GO:0046573,1.00000000000026,0.959924910789705,0,1,lactonohydrolase activity,MF,
17130,GO:0102007,1.00000000000026,0.959924910789705,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
6235,GO:0019782,1.00000000000027,0.951809440734217,0,1,ISG15 activating enzyme activity,MF,
17971,GO:1902309,1.00000000000027,0.906885035917895,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,
13431,GO:0052811,1.00000000000028,0.808462426325227,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
10504,GO:0043402,1.00000000000028,0.854543784665013,0,3,glucocorticoid mediated signaling pathway,BP,
4024,GO:0009052,1.0000000000003,0.802286188454529,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
10261,GO:0042996,1.00000000000031,0.776485265892398,0,5,regulation of Golgi to plasma membrane protein transport,BP,
1354,GO:0003219,1.00000000000032,0.908117420793275,0,2,cardiac right ventricle formation,BP,
7244,GO:0031161,1.00000000000033,0.952613607247119,0,1,phosphatidylinositol catabolic process,BP,
14991,GO:0070889,1.00000000000033,0.91114801980571,0,2,platelet alpha granule organization,BP,
9591,GO:0036438,1.00000000000034,0.823562665799117,0,4,maintenance of lens transparency,BP,
4362,GO:0009955,1.00000000000034,0.955385946258768,0,1,adaxial/abaxial pattern specification,BP,
9280,GO:0035709,1.00000000000034,0.955385946258768,0,1,memory T cell activation,BP,
16318,GO:0090427,1.00000000000034,0.955385946258768,0,1,activation of meiosis,BP,
19714,GO:2000011,1.00000000000034,0.955385946258768,0,1,regulation of adaxial/abaxial pattern formation,BP,
20004,GO:2000567,1.00000000000034,0.955385946258768,0,1,regulation of memory T cell activation,BP,
20005,GO:2000568,1.00000000000034,0.955385946258768,0,1,positive regulation of memory T cell activation,BP,
20223,GO:2001055,1.00000000000034,0.955385946258768,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
7573,GO:0031930,1.00000000000036,0.96255727834434,0,1,mitochondria-nucleus signaling pathway,BP,
717,GO:0001939,1.00000000000037,0.746359873141662,0,6,female pronucleus,CC,
739,GO:0001967,1.00000000000038,0.707135582028861,0,7,suckling behavior,BP,
2752,GO:0006152,1.00000000000039,0.774932655020726,0,6,purine nucleoside catabolic process,BP,
11585,GO:0046130,1.00000000000039,0.774932655020726,0,6,purine ribonucleoside catabolic process,BP,
6471,GO:0021796,1.00000000000039,0.862176574524118,0,3,cerebral cortex regionalization,BP,
6128,GO:0019372,1.0000000000004,0.678993211063326,0,9,lipoxygenase pathway,BP,
11231,GO:0045356,1.00000000000041,0.902397916496426,0,2,positive regulation of interferon-alpha biosynthetic process,BP,
922,GO:0002314,1.00000000000042,0.917934828036108,0,2,germinal center B cell differentiation,BP,
11471,GO:0045917,1.00000000000042,0.906815573400355,0,2,positive regulation of complement activation,BP,
19835,GO:2000259,1.00000000000042,0.906815573400355,0,2,positive regulation of protein activation cascade,BP,
18081,GO:1902626,1.00000000000043,0.917889712625068,0,3,assembly of large subunit precursor of preribosome,BP,
2071,GO:0004822,1.00000000000043,0.900855382548436,0,2,isoleucine-tRNA ligase activity,MF,
2918,GO:0006428,1.00000000000043,0.900855382548436,0,2,isoleucyl-tRNA aminoacylation,BP,
9151,GO:0035500,1.00000000000044,0.905877161489959,0,2,MH2 domain binding,MF,
12102,GO:0048069,1.00000000000044,0.773679633556154,0,5,eye pigmentation,BP,
5048,GO:0015228,1.00000000000044,0.868441556663543,0,3,coenzyme A transmembrane transporter activity,MF,
5256,GO:0015880,1.00000000000044,0.868441556663543,0,3,coenzyme A transport,BP,
9090,GO:0035349,1.00000000000044,0.868441556663543,0,3,coenzyme A transmembrane transport,BP,
15101,GO:0071077,1.00000000000044,0.868441556663543,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15105,GO:0071106,1.00000000000044,0.868441556663543,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15989,GO:0080122,1.00000000000044,0.868441556663543,0,3,AMP transmembrane transporter activity,MF,
16246,GO:0090283,1.00000000000045,0.865961043194344,0,3,regulation of protein glycosylation in Golgi,BP,
5777,GO:0016979,1.00000000000045,0.96338687820296,0,1,lipoate-protein ligase activity,MF,
5529,GO:0016500,1.00000000000047,0.730492580895339,0,6,protein-hormone receptor activity,MF,
7784,GO:0032304,1.00000000000048,0.946833124416447,0,1,negative regulation of icosanoid secretion,BP,
17417,GO:1900139,1.00000000000048,0.946833124416447,0,1,negative regulation of arachidonic acid secretion,BP,
19525,GO:1990357,1.00000000000048,0.874776580984419,0,3,terminal web,CC,
10393,GO:0043219,1.00000000000049,0.826570539533113,0,4,lateral loop,CC,
3857,GO:0008469,1.00000000000049,0.694166336781701,0,8,histone-arginine N-methyltransferase activity,MF,
8009,GO:0032632,1.0000000000005,0.904198547178783,0,2,interleukin-3 production,BP,
8033,GO:0032672,1.0000000000005,0.904198547178783,0,2,regulation of interleukin-3 production,BP,
6639,GO:0023016,1.0000000000005,0.901237292800172,0,2,signal transduction by trans-phosphorylation,BP,
10759,GO:0044154,1.00000000000052,0.713559028662867,0,7,histone H3-K14 acetylation,BP,
7695,GO:0032143,1.00000000000052,0.902917933252363,0,2,single thymine insertion binding,MF,
7781,GO:0032301,1.00000000000052,0.902917933252363,0,2,MutSalpha complex,CC,
8465,GO:0033601,1.00000000000053,0.663098742058568,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
304,GO:0000813,1.00000000000053,0.698532658539031,0,8,ESCRT I complex,CC,
14603,GO:0070142,1.00000000000053,0.739950448758314,0,6,synaptic vesicle budding,BP,
2320,GO:0005324,1.00000000000053,0.907523569755956,0,2,long-chain fatty acid transporter activity,MF,
5269,GO:0015910,1.00000000000053,0.907523569755956,0,2,peroxisomal long-chain fatty acid import,BP,
2072,GO:0004823,1.00000000000054,0.897866069804152,0,2,leucine-tRNA ligase activity,MF,
2919,GO:0006429,1.00000000000054,0.897866069804152,0,2,leucyl-tRNA aminoacylation,BP,
14936,GO:0070777,1.00000000000054,0.901302882902303,0,2,D-aspartate transport,BP,
14938,GO:0070779,1.00000000000054,0.901302882902303,0,2,D-aspartate import across plasma membrane,BP,
8874,GO:0034677,1.00000000000054,0.949826985187467,0,1,integrin alpha7-beta1 complex,CC,
8877,GO:0034681,1.00000000000054,0.949826985187467,0,1,integrin alpha11-beta1 complex,CC,
2323,GO:0005329,1.00000000000056,0.896891557443504,0,2,dopamine transmembrane transporter activity,MF,
4690,GO:0010836,1.00000000000056,0.876439584051056,0,3,negative regulation of protein ADP-ribosylation,BP,
20308,GO:2001256,1.00000000000057,0.677926335315259,0,8,regulation of store-operated calcium entry,BP,
7641,GO:0032045,1.00000000000057,0.681134048158698,0,8,guanyl-nucleotide exchange factor complex,CC,
14395,GO:0061629,1.00000000000059,0.832450389744839,0,4,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
11748,GO:0046570,1.0000000000006,0.966237279321298,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
11970,GO:0047134,1.0000000000006,0.825827681823089,0,5,protein-disulfide reductase activity,MF,
15579,GO:0072015,1.00000000000061,0.623143893752982,0,9,glomerular visceral epithelial cell development,BP,
15749,GO:0072310,1.00000000000061,0.623143893752982,0,9,glomerular epithelial cell development,BP,
8572,GO:0034036,1.00000000000061,0.746098117594251,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
12492,GO:0050428,1.00000000000061,0.746098117594251,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
2066,GO:0004817,1.00000000000063,0.913526386504396,0,2,cysteine-tRNA ligase activity,MF,
2913,GO:0006423,1.00000000000063,0.913526386504396,0,2,cysteinyl-tRNA aminoacylation,BP,
8339,GO:0033183,1.00000000000063,0.855623565593372,0,3,negative regulation of histone ubiquitination,BP,
17632,GO:1901314,1.00000000000063,0.855623565593372,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17633,GO:1901315,1.00000000000063,0.855623565593372,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
15253,GO:0071400,1.00000000000063,0.903700987904112,0,2,cellular response to oleic acid,BP,
8391,GO:0033299,1.00000000000065,0.793202950373745,0,5,secretion of lysosomal enzymes,BP,
4604,GO:0010716,1.00000000000065,0.890801539524091,0,3,negative regulation of extracellular matrix disassembly,BP,
13394,GO:0052646,1.00000000000066,0.666990179970969,0,8,alditol phosphate metabolic process,BP,
11341,GO:0045656,1.00000000000066,0.780809151914209,0,5,negative regulation of monocyte differentiation,BP,
793,GO:0002054,1.00000000000067,0.890980585436413,0,3,nucleobase binding,MF,
795,GO:0002060,1.00000000000067,0.890980585436413,0,3,purine nucleobase binding,MF,
16100,GO:0090065,1.00000000000068,0.99197186429668,0,1,regulation of production of siRNA involved in RNA interference,BP,
16829,GO:0098680,1.00000000000068,0.99197186429668,0,1,template-free RNA nucleotidyltransferase,MF,
18539,GO:1903704,1.00000000000068,0.99197186429668,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19585,GO:1990572,1.00000000000068,0.99197186429668,0,1,TERT-RMRP complex,CC,
19966,GO:2000474,1.00000000000068,0.948685637203273,0,1,regulation of opioid receptor signaling pathway,BP,
5096,GO:0015367,1.00000000000068,0.958266448524386,0,1,oxoglutarate:malate antiporter activity,MF,
5183,GO:0015742,1.00000000000068,0.958266448524386,0,1,alpha-ketoglutarate transport,BP,
701,GO:0001918,1.00000000000068,0.953847080052524,0,1,farnesylated protein binding,MF,
7771,GO:0032287,1.00000000000068,0.671499579618277,0,8,peripheral nervous system myelin maintenance,BP,
7132,GO:0030951,1.0000000000007,0.819968297489109,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
4157,GO:0009217,1.00000000000071,0.811558235846726,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
14930,GO:0070765,1.00000000000071,0.761098597051285,0,6,gamma-secretase complex,CC,
12293,GO:0048597,1.00000000000071,0.900833268408174,0,3,post-embryonic camera-type eye morphogenesis,BP,
10665,GO:0043812,1.00000000000072,0.856808927303312,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
8711,GO:0034350,1.00000000000072,0.705565837825821,0,7,regulation of glial cell apoptotic process,BP,
8712,GO:0034351,1.00000000000072,0.705565837825821,0,7,negative regulation of glial cell apoptotic process,BP,
15558,GO:0071953,1.00000000000074,0.910619783115733,0,2,elastic fiber,CC,
19569,GO:1990481,1.00000000000074,0.83435642205989,0,4,mRNA pseudouridine synthesis,BP,
20155,GO:2000821,1.00000000000074,0.926935263168658,0,2,regulation of grooming behavior,BP,
12534,GO:0050664,1.00000000000074,0.765134999819338,0,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
181,GO:0000393,1.00000000000075,0.800341649820119,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
14059,GO:0060789,1.00000000000075,0.762026656654261,0,6,hair follicle placode formation,BP,
9355,GO:0035864,1.00000000000075,0.767655054885026,0,6,response to potassium ion,BP,
6420,GO:0021679,1.00000000000075,0.907114192288262,0,2,cerebellar molecular layer development,BP,
6427,GO:0021687,1.00000000000075,0.907114192288262,0,2,cerebellar molecular layer morphogenesis,BP,
15661,GO:0072161,1.00000000000076,0.824566563258004,0,4,mesenchymal cell differentiation involved in kidney development,BP,
20194,GO:2001012,1.00000000000076,0.824566563258004,0,4,mesenchymal cell differentiation involved in renal system development,BP,
9408,GO:0035964,1.00000000000076,0.752452215347912,0,6,COPI-coated vesicle budding,BP,
12136,GO:0048200,1.00000000000076,0.752452215347912,0,6,Golgi transport vesicle coating,BP,
12138,GO:0048205,1.00000000000076,0.752452215347912,0,6,COPI coating of Golgi vesicle,BP,
10661,GO:0043739,1.00000000000076,0.952178959038598,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
12982,GO:0051351,1.00000000000077,0.739456222380019,0,7,positive regulation of ligase activity,BP,
5384,GO:0016198,1.00000000000077,0.768982632082259,0,5,axon choice point recognition,BP,
8140,GO:0032836,1.00000000000078,0.66799374217013,0,8,glomerular basement membrane development,BP,
8824,GO:0034596,1.00000000000079,0.656820946954491,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
5201,GO:0015791,1.0000000000008,0.738982252237743,0,6,polyol transport,BP,
13688,GO:0060200,1.00000000000081,0.947027614177662,0,1,clathrin-sculpted acetylcholine transport vesicle,CC,
13689,GO:0060201,1.00000000000081,0.947027614177662,0,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
16853,GO:0098746,1.00000000000081,0.947027614177662,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
11645,GO:0046348,1.00000000000082,0.698554014397056,0,8,amino sugar catabolic process,BP,
10842,GO:0044332,1.00000000000082,0.761079852705114,0,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
5218,GO:0015816,1.00000000000083,0.742168978394535,0,6,glycine transport,BP,
18180,GO:1902915,1.00000000000084,0.730200134089282,0,6,negative regulation of protein polyubiquitination,BP,
11996,GO:0047322,1.00000000000084,0.896295901968119,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12489,GO:0050405,1.00000000000084,0.896295901968119,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
3556,GO:0007597,1.00000000000085,0.808129070380034,0,5,blood coagulation, intrinsic pathway,BP,
9255,GO:0035658,1.00000000000085,0.868213363676279,0,3,Mon1-Ccz1 complex,CC,
13686,GO:0060198,1.00000000000086,0.753012267588685,0,6,clathrin-sculpted vesicle,CC,
6003,GO:0019008,1.00000000000088,0.913416488367334,0,2,molybdopterin synthase complex,CC,
2697,GO:0006060,1.00000000000088,0.919662263129663,0,2,sorbitol metabolic process,BP,
11656,GO:0046370,1.00000000000088,0.919662263129663,0,2,fructose biosynthetic process,BP,
4923,GO:0014858,1.0000000000009,0.896426832377493,0,2,positive regulation of skeletal muscle cell proliferation,BP,
18109,GO:1902724,1.0000000000009,0.896426832377493,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18111,GO:1902728,1.0000000000009,0.896426832377493,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
5372,GO:0016165,1.0000000000009,0.911136858888217,0,2,linoleate 13S-lipoxygenase activity,MF,
7034,GO:0030803,1.00000000000091,0.685862736290238,0,8,negative regulation of cyclic nucleotide biosynthetic process,BP,
7049,GO:0030818,1.00000000000091,0.685862736290238,0,8,negative regulation of cAMP biosynthetic process,BP,
16649,GO:0097498,1.00000000000091,0.905975699193107,0,2,endothelial tube lumen extension,BP,
15949,GO:0072737,1.00000000000092,0.911931547676324,0,2,response to diamide,BP,
15950,GO:0072738,1.00000000000092,0.911931547676324,0,2,cellular response to diamide,BP,
16018,GO:0086015,1.00000000000092,0.901738744947216,0,2,SA node cell action potential,BP,
16021,GO:0086018,1.00000000000092,0.901738744947216,0,2,SA node cell to atrial cardiac muscle cell signaling,BP,
7661,GO:0032077,1.00000000000092,0.812699394625749,0,5,positive regulation of deoxyribonuclease activity,BP,
2572,GO:0005854,1.00000000000092,0.918341234341462,0,2,nascent polypeptide-associated complex,CC,
5465,GO:0016340,1.00000000000093,0.89618193577942,0,2,calcium-dependent cell-matrix adhesion,BP,
1998,GO:0004716,1.00000000000094,0.732654062886112,0,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
3123,GO:0006702,1.00000000000094,0.781367083164023,0,5,androgen biosynthetic process,BP,
4434,GO:0010265,1.00000000000094,0.760777937852563,0,6,SCF complex assembly,BP,
7859,GO:0032415,1.00000000000095,0.86566697773657,0,3,regulation of sodium:proton antiporter activity,BP,
1717,GO:0004306,1.00000000000095,0.957521192099858,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
13047,GO:0051490,1.00000000000095,0.872229238877211,0,3,negative regulation of filopodium assembly,BP,
1925,GO:0004616,1.00000000000095,0.869441502096277,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
7455,GO:0031587,1.00000000000097,0.85087447640273,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
8238,GO:0033004,1.00000000000097,0.872395049972978,0,3,negative regulation of mast cell activation,BP,
8241,GO:0033007,1.00000000000097,0.872395049972978,0,3,negative regulation of mast cell activation involved in immune response,BP,
198,GO:0000416,1.00000000000097,0.949994563025563,0,1,positive regulation of histone H3-K36 methylation,BP,
3522,GO:0007497,1.00000000000097,0.946942008055598,0,1,posterior midgut development,BP,
2325,GO:0005332,1.00000000000098,0.956453286280249,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
5025,GO:0015185,1.00000000000098,0.956453286280249,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
6548,GO:0021956,1.00000000000098,0.956453286280249,0,1,central nervous system interneuron axonogenesis,BP,
1625,GO:0004056,1.00000000000099,0.95648606112118,0,1,argininosuccinate lyase activity,MF,
10023,GO:0042450,1.00000000000099,0.95648606112118,0,1,arginine biosynthetic process via ornithine,BP,
4653,GO:0010792,1.00000000000099,0.749984152030802,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
9724,GO:0038158,1.00000000000099,0.912863028023094,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
18547,GO:1903719,1.000000000001,0.880200685479123,0,3,regulation of I-kappaB phosphorylation,BP,
18548,GO:1903721,1.000000000001,0.880200685479123,0,3,positive regulation of I-kappaB phosphorylation,BP,
13135,GO:0051661,1.00000000000101,0.770956135048826,0,5,maintenance of centrosome location,BP,
17869,GO:1902044,1.00000000000101,0.904590526172414,0,2,regulation of Fas signaling pathway,BP,
7919,GO:0032487,1.00000000000101,0.852412560475963,0,3,regulation of Rap protein signal transduction,BP,
9366,GO:0035878,1.00000000000101,0.707203044230408,0,7,nail development,BP,
4101,GO:0009153,1.00000000000103,0.929455370291475,0,2,purine deoxyribonucleotide biosynthetic process,BP,
1739,GO:0004334,1.00000000000103,0.962656598704174,0,1,fumarylacetoacetase activity,MF,
4853,GO:0014062,1.00000000000104,0.917200925795002,0,2,regulation of serotonin secretion,BP,
18000,GO:1902410,1.00000000000105,0.750323710968876,0,6,mitotic cytokinetic process,BP,
1701,GO:0004176,1.00000000000106,0.81827278716793,0,4,ATP-dependent peptidase activity,MF,
3812,GO:0008398,1.00000000000106,0.952899377846672,0,1,sterol 14-demethylase activity,MF,
8421,GO:0033488,1.00000000000106,0.952899377846672,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
2063,GO:0004814,1.00000000000106,0.874164095347895,0,3,arginine-tRNA ligase activity,MF,
2910,GO:0006420,1.00000000000106,0.874164095347895,0,3,arginyl-tRNA aminoacylation,BP,
16322,GO:0090480,1.00000000000107,0.859661301227081,0,3,purine nucleotide-sugar transmembrane transport,BP,
6328,GO:0019992,1.00000000000108,0.675683769837122,0,8,diacylglycerol binding,MF,
5114,GO:0015421,1.00000000000109,0.950865949049925,0,1,oligopeptide-transporting ATPase activity,MF,
12815,GO:0051096,1.0000000000011,0.759144070936971,0,6,positive regulation of helicase activity,BP,
1365,GO:0003245,1.00000000000111,0.914824985089939,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
20073,GO:2000671,1.00000000000111,0.861938028469656,0,3,regulation of motor neuron apoptotic process,BP,
20074,GO:2000672,1.00000000000111,0.861938028469656,0,3,negative regulation of motor neuron apoptotic process,BP,
377,GO:0001007,1.00000000000111,0.814798858878312,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
13755,GO:0060313,1.00000000000111,0.876097962920714,0,3,negative regulation of blood vessel remodeling,BP,
11013,GO:0044829,1.00000000000112,0.712048743354494,0,7,positive regulation by host of viral genome replication,BP,
11893,GO:0046898,1.00000000000112,0.826985227012653,0,4,response to cycloheximide,BP,
10856,GO:0044351,1.00000000000112,0.75903478450157,0,6,macropinocytosis,BP,
2077,GO:0004828,1.00000000000113,0.915041366222453,0,2,serine-tRNA ligase activity,MF,
2924,GO:0006434,1.00000000000113,0.915041366222453,0,2,seryl-tRNA aminoacylation,BP,
4369,GO:0009975,1.00000000000114,0.628949015116823,0,9,cyclase activity,MF,
13626,GO:0060083,1.00000000000114,0.897820982272117,0,2,smooth muscle contraction involved in micturition,BP,
6227,GO:0019773,1.00000000000115,0.805836747106402,0,7,proteasome core complex, alpha-subunit complex,CC,
16760,GO:0098518,1.00000000000115,0.872091365541513,0,3,polynucleotide phosphatase activity,MF,
18726,GO:1904106,1.00000000000115,0.953515687018002,0,1,protein localization to microvillus,BP,
19098,GO:1904970,1.00000000000115,0.953515687018002,0,1,brush border assembly,BP,
1339,GO:0003193,1.00000000000116,0.952540883962605,0,1,pulmonary valve formation,BP,
9388,GO:0035922,1.00000000000116,0.952540883962605,0,1,foramen ovale closure,BP,
16037,GO:0086044,1.00000000000116,0.952540883962605,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
16043,GO:0086054,1.00000000000116,0.952540883962605,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
16044,GO:0086055,1.00000000000116,0.952540883962605,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
16057,GO:0086076,1.00000000000116,0.952540883962605,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
16059,GO:0086078,1.00000000000116,0.952540883962605,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
16060,GO:0086079,1.00000000000116,0.952540883962605,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
16940,GO:0098906,1.00000000000116,0.952540883962605,0,1,regulation of Purkinje myocyte action potential,BP,
19449,GO:1990029,1.00000000000116,0.952540883962605,0,1,vasomotion,BP,
10377,GO:0043194,1.00000000000117,0.638631934143232,0,9,axon initial segment,CC,
11014,GO:0044830,1.00000000000117,0.903692509856357,0,2,modulation by host of viral RNA genome replication,BP,
3075,GO:0006642,1.00000000000118,0.858269789813546,0,3,triglyceride mobilization,BP,
14679,GO:0070278,1.00000000000118,0.909698173286836,0,2,extracellular matrix constituent secretion,BP,
10389,GO:0043208,1.00000000000118,0.827765115718445,0,4,glycosphingolipid binding,MF,
16327,GO:0090498,1.00000000000119,0.904266471872921,0,2,extrinsic component of Golgi membrane,CC,
11325,GO:0045636,1.0000000000012,0.850917557192205,0,3,positive regulation of melanocyte differentiation,BP,
15351,GO:0071561,1.00000000000121,0.946825490188065,0,1,nucleus-vacuole junction,CC,
7738,GO:0032229,1.00000000000121,0.91890945350068,0,2,negative regulation of synaptic transmission, GABAergic,BP,
4245,GO:0009441,1.00000000000121,0.921579510811819,0,2,glycolate metabolic process,BP,
19847,GO:2000282,1.00000000000121,0.921579510811819,0,2,regulation of cellular amino acid biosynthetic process,BP,
15000,GO:0070901,1.00000000000121,0.841223356126193,0,4,mitochondrial tRNA methylation,BP,
14408,GO:0061656,1.00000000000122,0.967435699933054,0,1,SUMO conjugating enzyme activity,MF,
18303,GO:1903182,1.00000000000122,0.967435699933054,0,1,regulation of SUMO transferase activity,BP,
18562,GO:1903755,1.00000000000122,0.967435699933054,0,1,positive regulation of SUMO transferase activity,BP,
19524,GO:1990356,1.00000000000122,0.967435699933054,0,1,sumoylated E2 ligase complex,CC,
1691,GO:0004161,1.00000000000122,0.917686813777727,0,2,dimethylallyltranstransferase activity,MF,
1742,GO:0004337,1.00000000000122,0.917686813777727,0,2,geranyltranstransferase activity,MF,
8411,GO:0033383,1.00000000000122,0.917686813777727,0,2,geranyl diphosphate metabolic process,BP,
8412,GO:0033384,1.00000000000122,0.917686813777727,0,2,geranyl diphosphate biosynthetic process,BP,
8967,GO:0035034,1.00000000000122,0.910503092387347,0,2,histone acetyltransferase regulator activity,MF,
10262,GO:0042997,1.00000000000123,0.862958640889739,0,3,negative regulation of Golgi to plasma membrane protein transport,BP,
3610,GO:0008050,1.00000000000124,0.903781241080581,0,2,female courtship behavior,BP,
11478,GO:0045924,1.00000000000124,0.903781241080581,0,2,regulation of female receptivity,BP,
7882,GO:0032440,1.00000000000124,0.966396660217352,0,1,2-alkenal reductase [NAD(P)] activity,MF,
19349,GO:1905636,1.00000000000124,0.966396660217352,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
24,GO:0000048,1.00000000000124,0.954844240950219,0,1,peptidyltransferase activity,MF,
1253,GO:0002951,1.00000000000124,0.954844240950219,0,1,leukotriene-C(4) hydrolase,MF,
1715,GO:0004304,1.00000000000126,0.958245858256263,0,1,estrone sulfotransferase activity,MF,
3087,GO:0006660,1.00000000000126,0.958245858256263,0,1,phosphatidylserine catabolic process,BP,
3130,GO:0006711,1.00000000000126,0.958245858256263,0,1,estrogen catabolic process,BP,
14532,GO:0070012,1.00000000000126,0.910532681608505,0,2,oligopeptidase activity,MF,
521,GO:0001608,1.00000000000127,0.793300412369203,0,5,G-protein coupled nucleotide receptor activity,MF,
9208,GO:0035589,1.00000000000127,0.793300412369203,0,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
11055,GO:0045028,1.00000000000127,0.793300412369203,0,5,G-protein coupled purinergic nucleotide receptor activity,MF,
12220,GO:0048389,1.00000000000127,0.958235593303191,0,1,intermediate mesoderm development,BP,
12221,GO:0048390,1.00000000000127,0.958235593303191,0,1,intermediate mesoderm morphogenesis,BP,
12222,GO:0048391,1.00000000000127,0.958235593303191,0,1,intermediate mesoderm formation,BP,
12223,GO:0048392,1.00000000000127,0.958235593303191,0,1,intermediate mesodermal cell differentiation,BP,
13496,GO:0055018,1.00000000000127,0.958235593303191,0,1,regulation of cardiac muscle fiber development,BP,
13497,GO:0055020,1.00000000000127,0.958235593303191,0,1,positive regulation of cardiac muscle fiber development,BP,
13892,GO:0060503,1.00000000000127,0.958235593303191,0,1,bud dilation involved in lung branching,BP,
14227,GO:0061149,1.00000000000127,0.958235593303191,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
14228,GO:0061150,1.00000000000127,0.958235593303191,0,1,renal system segmentation,BP,
14229,GO:0061151,1.00000000000127,0.958235593303191,0,1,BMP signaling pathway involved in renal system segmentation,BP,
14233,GO:0061155,1.00000000000127,0.958235593303191,0,1,pulmonary artery endothelial tube morphogenesis,BP,
14255,GO:0061216,1.00000000000127,0.958235593303191,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
14258,GO:0061227,1.00000000000127,0.958235593303191,0,1,pattern specification involved in mesonephros development,BP,
15526,GO:0071893,1.00000000000127,0.958235593303191,0,1,BMP signaling pathway involved in nephric duct formation,BP,
15622,GO:0072096,1.00000000000127,0.958235593303191,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
15623,GO:0072097,1.00000000000127,0.958235593303191,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
15624,GO:0072098,1.00000000000127,0.958235593303191,0,1,anterior/posterior pattern specification involved in kidney development,BP,
15625,GO:0072099,1.00000000000127,0.958235593303191,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
15626,GO:0072100,1.00000000000127,0.958235593303191,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
15627,GO:0072101,1.00000000000127,0.958235593303191,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
15683,GO:0072192,1.00000000000127,0.958235593303191,0,1,ureter epithelial cell differentiation,BP,
15687,GO:0072198,1.00000000000127,0.958235593303191,0,1,mesenchymal cell proliferation involved in ureter development,BP,
15688,GO:0072199,1.00000000000127,0.958235593303191,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
15689,GO:0072200,1.00000000000127,0.958235593303191,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
17831,GO:1901964,1.00000000000127,0.958235593303191,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19707,GO:2000004,1.00000000000127,0.958235593303191,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
19708,GO:2000005,1.00000000000127,0.958235593303191,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
19709,GO:2000006,1.00000000000127,0.958235593303191,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
19710,GO:2000007,1.00000000000127,0.958235593303191,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
10987,GO:0044778,1.00000000000128,0.912105880849243,0,2,meiotic DNA integrity checkpoint,BP,
1654,GO:0004103,1.00000000000129,0.915893102299494,0,2,choline kinase activity,MF,
7632,GO:0032027,1.0000000000013,0.861745216664688,0,3,myosin light chain binding,MF,
707,GO:0001927,1.00000000000131,0.856937049580694,0,3,exocyst assembly,BP,
2826,GO:0006290,1.00000000000132,0.723370121422599,0,7,pyrimidine dimer repair,BP,
9183,GO:0035552,1.00000000000132,0.869199033684972,0,3,oxidative single-stranded DNA demethylation,BP,
18191,GO:1902946,1.00000000000134,0.656630776524062,0,8,protein localization to early endosome,BP,
10648,GO:0043654,1.00000000000134,0.858729345971613,0,3,recognition of apoptotic cell,BP,
14142,GO:0060994,1.00000000000135,0.910404772735993,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
15713,GO:0072237,1.00000000000135,0.904699937053065,0,2,metanephric proximal tubule development,BP,
2729,GO:0006106,1.00000000000135,0.874145256929204,0,3,fumarate metabolic process,BP,
10176,GO:0042760,1.00000000000135,0.788593456293394,0,5,very long-chain fatty acid catabolic process,BP,
14335,GO:0061478,1.00000000000135,0.632650412860998,0,9,response to platelet aggregation inhibitor,BP,
9067,GO:0035299,1.00000000000135,0.947682268944389,0,1,inositol pentakisphosphate 2-kinase activity,MF,
11864,GO:0046836,1.00000000000136,0.803637706690217,0,5,glycolipid transport,BP,
3007,GO:0006552,1.00000000000136,0.793709558608604,0,5,leucine catabolic process,BP,
2160,GO:0004984,1.00000000000137,0.902713078991755,0,3,olfactory receptor activity,MF,
12707,GO:0050911,1.00000000000137,0.902713078991755,0,3,detection of chemical stimulus involved in sensory perception of smell,BP,
1748,GO:0004345,1.00000000000137,0.903987356140606,0,2,glucose-6-phosphate dehydrogenase activity,MF,
3813,GO:0008401,1.00000000000138,0.904079604671866,0,2,retinoic acid 4-hydroxylase activity,MF,
17596,GO:1901213,1.00000000000138,0.68031192141782,0,8,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
15551,GO:0071936,1.0000000000014,0.65930653243117,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
18,GO:0000033,1.00000000000141,0.879331846528734,0,3,alpha-1,3-mannosyltransferase activity,MF,
5296,GO:0015960,1.00000000000141,0.866242880700279,0,3,diadenosine polyphosphate biosynthetic process,BP,
5298,GO:0015965,1.00000000000141,0.866242880700279,0,3,diadenosine tetraphosphate metabolic process,BP,
5299,GO:0015966,1.00000000000141,0.866242880700279,0,3,diadenosine tetraphosphate biosynthetic process,BP,
627,GO:0001808,1.00000000000142,0.956180351578125,0,1,negative regulation of type IV hypersensitivity,BP,
1208,GO:0002865,1.00000000000142,0.956180351578125,0,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1217,GO:0002884,1.00000000000142,0.956180351578125,0,1,negative regulation of hypersensitivity,BP,
1846,GO:0004499,1.00000000000143,0.955649910246572,0,1,N,N-dimethylaniline monooxygenase activity,MF,
16142,GO:0090129,1.00000000000143,0.788568207032649,0,5,positive regulation of synapse maturation,BP,
7383,GO:0031431,1.00000000000144,0.905334576281618,0,2,Dbf4-dependent protein kinase complex,CC,
528,GO:0001637,1.00000000000145,0.752935891164899,0,6,G-protein coupled chemoattractant receptor activity,MF,
2141,GO:0004950,1.00000000000145,0.752935891164899,0,6,chemokine receptor activity,MF,
16306,GO:0090394,1.00000000000145,0.817145834543749,0,4,negative regulation of excitatory postsynaptic potential,BP,
4060,GO:0009107,1.00000000000146,0.959456816478601,0,1,lipoate biosynthetic process,BP,
5778,GO:0016992,1.00000000000146,0.959456816478601,0,1,lipoate synthase activity,MF,
14682,GO:0070283,1.00000000000146,0.959456816478601,0,1,radical SAM enzyme activity,MF,
15150,GO:0071233,1.00000000000146,0.65993805352767,0,8,cellular response to leucine,BP,
15542,GO:0071920,1.00000000000147,0.912308701117427,0,2,cleavage body,CC,
10599,GO:0043564,1.00000000000147,0.909107370137005,0,2,Ku70:Ku80 complex,CC,
6346,GO:0021516,1.00000000000147,0.903181011264937,0,2,dorsal spinal cord development,BP,
5639,GO:0016717,1.00000000000147,0.777616937995099,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
2025,GO:0004751,1.00000000000148,0.957710451285004,0,1,ribose-5-phosphate isomerase activity,MF,
18004,GO:1902416,1.00000000000148,0.724898087494946,0,7,positive regulation of mRNA binding,BP,
18791,GO:1904274,1.00000000000148,0.955311267539807,0,1,tricellular tight junction assembly,BP,
14036,GO:0060745,1.00000000000148,0.805712482746115,0,4,mammary gland branching involved in pregnancy,BP,
14934,GO:0070775,1.0000000000015,0.698647991290788,0,7,H3 histone acetyltransferase complex,CC,
14935,GO:0070776,1.0000000000015,0.698647991290788,0,7,MOZ/MORF histone acetyltransferase complex,CC,
3887,GO:0008517,1.00000000000151,0.817804202436872,0,4,folic acid transmembrane transporter activity,MF,
189,GO:0000406,1.00000000000151,0.902327785284398,0,2,double-strand/single-strand DNA junction binding,MF,
7706,GO:0032181,1.00000000000151,0.902327785284398,0,2,dinucleotide repeat insertion binding,MF,
7782,GO:0032302,1.00000000000151,0.902327785284398,0,2,MutSbeta complex,CC,
19605,GO:1990641,1.00000000000151,0.906625126106997,0,2,response to iron ion starvation,BP,
2087,GO:0004844,1.00000000000152,0.810575892195205,0,5,uracil DNA N-glycosylase activity,MF,
16657,GO:0097506,1.00000000000152,0.810575892195205,0,5,deaminated base DNA N-glycosylase activity,MF,
16574,GO:0097344,1.00000000000152,0.915824613074097,0,2,Rix1 complex,CC,
5955,GO:0018307,1.00000000000152,0.929313878776289,0,2,enzyme active site formation,BP,
809,GO:0002079,1.00000000000153,0.901416787595652,0,2,inner acrosomal membrane,CC,
3691,GO:0008195,1.00000000000154,0.638397356777808,0,9,phosphatidate phosphatase activity,MF,
15893,GO:0072608,1.00000000000154,0.776731082318355,0,6,interleukin-10 secretion,BP,
4308,GO:0009756,1.00000000000154,0.769554353640405,0,6,carbohydrate mediated signaling,BP,
3024,GO:0006569,1.00000000000155,0.88044207959837,0,3,tryptophan catabolic process,BP,
6154,GO:0019441,1.00000000000155,0.88044207959837,0,3,tryptophan catabolic process to kynurenine,BP,
10014,GO:0042436,1.00000000000155,0.88044207959837,0,3,indole-containing compound catabolic process,BP,
11614,GO:0046218,1.00000000000155,0.88044207959837,0,3,indolalkylamine catabolic process,BP,
8467,GO:0033603,1.00000000000155,0.885252959372754,0,3,positive regulation of dopamine secretion,BP,
3726,GO:0008253,1.00000000000156,0.685712739747797,0,8,5'-nucleotidase activity,MF,
1033,GO:0002538,1.00000000000156,0.952547150091742,0,1,arachidonic acid metabolite production involved in inflammatory response,BP,
1034,GO:0002540,1.00000000000156,0.952547150091742,0,1,leukotriene production involved in inflammatory response,BP,
9145,GO:0035490,1.00000000000156,0.952547150091742,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9146,GO:0035491,1.00000000000156,0.952547150091742,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
14176,GO:0061044,1.00000000000156,0.952547150091742,0,1,negative regulation of vascular wound healing,BP,
17639,GO:1901331,1.00000000000156,0.952547150091742,0,1,positive regulation of odontoblast differentiation,BP,
18178,GO:1902913,1.00000000000156,0.952547150091742,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19753,GO:2000098,1.00000000000156,0.952547150091742,0,1,negative regulation of smooth muscle cell-matrix adhesion,BP,
11075,GO:0045065,1.00000000000157,0.912111067828486,0,2,cytotoxic T cell differentiation,BP,
11286,GO:0045583,1.00000000000157,0.912111067828486,0,2,regulation of cytotoxic T cell differentiation,BP,
11287,GO:0045585,1.00000000000157,0.912111067828486,0,2,positive regulation of cytotoxic T cell differentiation,BP,
11819,GO:0046695,1.00000000000157,0.881468422098664,0,3,SLIK (SAGA-like) complex,CC,
14607,GO:0070159,1.00000000000157,0.954793448896882,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
14939,GO:0070780,1.00000000000158,0.920968721472869,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
13061,GO:0051538,1.00000000000158,0.878468192767173,0,3,3 iron, 4 sulfur cluster binding,MF,
20066,GO:2000664,1.00000000000158,0.866494613328957,0,3,positive regulation of interleukin-5 secretion,BP,
20069,GO:2000667,1.00000000000158,0.866494613328957,0,3,positive regulation of interleukin-13 secretion,BP,
10644,GO:0043650,1.00000000000158,0.674171881959717,0,8,dicarboxylic acid biosynthetic process,BP,
11992,GO:0047290,1.00000000000158,0.959820050388657,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
18421,GO:1903433,1.00000000000159,0.905571372284687,0,2,regulation of constitutive secretory pathway,BP,
18765,GO:1904220,1.00000000000159,0.831320682645673,0,4,regulation of serine C-palmitoyltransferase activity,BP,
3317,GO:0007021,1.00000000000159,0.778399650812226,0,7,tubulin complex assembly,BP,
18616,GO:1903867,1.00000000000159,0.663887143495854,0,8,extraembryonic membrane development,BP,
11058,GO:0045039,1.0000000000016,0.818797285274848,0,6,protein import into mitochondrial inner membrane,BP,
2666,GO:0006011,1.0000000000016,0.751991728830748,0,6,UDP-glucose metabolic process,BP,
9758,GO:0039506,1.00000000000161,0.903117188614823,0,2,modulation by virus of host molecular function,BP,
9759,GO:0039507,1.00000000000161,0.903117188614823,0,2,suppression by virus of host molecular function,BP,
13319,GO:0052055,1.00000000000161,0.903117188614823,0,2,modulation by symbiont of host molecular function,BP,
13320,GO:0052056,1.00000000000161,0.903117188614823,0,2,negative regulation by symbiont of host molecular function,BP,
1605,GO:0004021,1.00000000000161,0.949170287583947,0,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,
2980,GO:0006522,1.00000000000161,0.949170287583947,0,1,alanine metabolic process,BP,
2981,GO:0006524,1.00000000000161,0.949170287583947,0,1,alanine catabolic process,BP,
4044,GO:0009078,1.00000000000161,0.949170287583947,0,1,pyruvate family amino acid metabolic process,BP,
4045,GO:0009080,1.00000000000161,0.949170287583947,0,1,pyruvate family amino acid catabolic process,BP,
10221,GO:0042851,1.00000000000161,0.949170287583947,0,1,L-alanine metabolic process,BP,
10222,GO:0042853,1.00000000000161,0.949170287583947,0,1,L-alanine catabolic process,BP,
12033,GO:0047635,1.00000000000161,0.949170287583947,0,1,alanine-oxo-acid transaminase activity,MF,
18632,GO:1903899,1.00000000000162,0.866449503721295,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
15062,GO:0071001,1.00000000000162,0.883068611108873,0,3,U4/U6 snRNP,CC,
3990,GO:0008853,1.00000000000162,0.868931704007429,0,3,exodeoxyribonuclease III activity,MF,
2307,GO:0005290,1.00000000000163,0.909840468500369,0,2,L-histidine transmembrane transporter activity,MF,
6797,GO:0030233,1.00000000000163,0.959859224938248,0,1,deoxynucleotide transmembrane transporter activity,MF,
6843,GO:0030302,1.00000000000163,0.959859224938248,0,1,deoxynucleotide transport,BP,
15089,GO:0071045,1.00000000000163,0.959859224938248,0,1,nuclear histone mRNA catabolic process,BP,
15395,GO:0071629,1.00000000000163,0.959859224938248,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
4834,GO:0014036,1.00000000000164,0.94916237344883,0,1,neural crest cell fate specification,BP,
9235,GO:0035622,1.00000000000164,0.94916237344883,0,1,intrahepatic bile duct development,BP,
12428,GO:0048866,1.00000000000164,0.94916237344883,0,1,stem cell fate specification,BP,
13569,GO:0060018,1.00000000000164,0.94916237344883,0,1,astrocyte fate commitment,BP,
13700,GO:0060221,1.00000000000164,0.94916237344883,0,1,retinal rod cell differentiation,BP,
13897,GO:0060516,1.00000000000164,0.94916237344883,0,1,primary prostatic bud elongation,BP,
13898,GO:0060517,1.00000000000164,0.94916237344883,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14057,GO:0060784,1.00000000000164,0.94916237344883,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14298,GO:0061364,1.00000000000164,0.84858132529188,0,3,apoptotic process involved in luteolysis,BP,
3026,GO:0006572,1.00000000000164,0.889793046591912,0,3,tyrosine catabolic process,BP,
17961,GO:1902292,1.00000000000164,0.967895942824293,0,1,cell cycle DNA replication initiation,BP,
17974,GO:1902315,1.00000000000164,0.967895942824293,0,1,nuclear cell cycle DNA replication initiation,BP,
18212,GO:1902975,1.00000000000164,0.967895942824293,0,1,mitotic DNA replication initiation,BP,
4324,GO:0009814,1.00000000000164,0.955398049228206,0,1,defense response, incompatible interaction,BP,
4325,GO:0009817,1.00000000000164,0.955398049228206,0,1,defense response to fungus, incompatible interaction,BP,
19227,GO:1905313,1.00000000000164,0.955398049228206,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
19536,GO:1990402,1.00000000000164,0.955398049228206,0,1,embryonic liver development,BP,
4764,GO:0010940,1.00000000000164,0.824978624274246,0,5,positive regulation of necrotic cell death,BP,
7114,GO:0030906,1.00000000000165,0.837078741174282,0,4,retromer, cargo-selective complex,CC,
2602,GO:0005898,1.00000000000165,0.948831561099546,0,1,interleukin-13 receptor complex,CC,
4819,GO:0014010,1.00000000000167,0.768035264805377,0,5,Schwann cell proliferation,BP,
9274,GO:0035694,1.00000000000167,0.822520209787105,0,4,mitochondrial protein catabolic process,BP,
1916,GO:0004605,1.00000000000168,0.861875264706748,0,3,phosphatidate cytidylyltransferase activity,MF,
2161,GO:0004985,1.00000000000168,0.877837883173134,0,3,opioid receptor activity,MF,
411,GO:0001097,1.00000000000169,0.86736137833973,0,3,TFIIH-class transcription factor binding,MF,
5,GO:0000011,1.00000000000169,0.953547606718511,0,1,vacuole inheritance,BP,
334,GO:0000928,1.00000000000169,0.953547606718511,0,1,gamma-tubulin small complex, spindle pole body,CC,
1568,GO:0003972,1.00000000000169,0.953547606718511,0,1,RNA ligase (ATP) activity,MF,
1643,GO:0004083,1.00000000000169,0.953547606718511,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
1770,GO:0004371,1.00000000000169,0.953547606718511,0,1,glycerone kinase activity,MF,
1856,GO:0004516,1.00000000000169,0.953547606718511,0,1,nicotinate phosphoribosyltransferase activity,MF,
2019,GO:0004743,1.00000000000169,0.953547606718511,0,1,pyruvate kinase activity,MF,
2736,GO:0006113,1.00000000000169,0.953547606718511,0,1,fermentation,BP,
2952,GO:0006480,1.00000000000169,0.953547606718511,0,1,N-terminal protein amino acid methylation,BP,
3374,GO:0007146,1.00000000000169,0.953547606718511,0,1,meiotic recombination nodule assembly,BP,
3845,GO:0008452,1.00000000000169,0.953547606718511,0,1,RNA ligase activity,MF,
3846,GO:0008453,1.00000000000169,0.953547606718511,0,1,alanine-glyoxylate transaminase activity,MF,
3959,GO:0008700,1.00000000000169,0.953547606718511,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
3977,GO:0008792,1.00000000000169,0.953547606718511,0,1,arginine decarboxylase activity,MF,
4107,GO:0009159,1.00000000000169,0.953547606718511,0,1,deoxyribonucleoside monophosphate catabolic process,BP,
4240,GO:0009436,1.00000000000169,0.953547606718511,0,1,glyoxylate catabolic process,BP,
4433,GO:0010260,1.00000000000169,0.953547606718511,0,1,animal organ senescence,BP,
4447,GO:0010348,1.00000000000169,0.953547606718511,0,1,lithium:proton antiporter activity,MF,
4820,GO:0014011,1.00000000000169,0.953547606718511,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5035,GO:0015203,1.00000000000169,0.953547606718511,0,1,polyamine transmembrane transporter activity,MF,
5072,GO:0015292,1.00000000000169,0.953547606718511,0,1,uniporter activity,MF,
5125,GO:0015489,1.00000000000169,0.953547606718511,0,1,putrescine transmembrane transporter activity,MF,
5235,GO:0015847,1.00000000000169,0.953547606718511,0,1,putrescine transport,BP,
5498,GO:0016430,1.00000000000169,0.953547606718511,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5583,GO:0016596,1.00000000000169,0.953547606718511,0,1,thienylcyclohexylpiperidine binding,MF,
5693,GO:0016807,1.00000000000169,0.953547606718511,0,1,cysteine-type carboxypeptidase activity,MF,
5716,GO:0016843,1.00000000000169,0.953547606718511,0,1,amine-lyase activity,MF,
5717,GO:0016844,1.00000000000169,0.953547606718511,0,1,strictosidine synthase activity,MF,
5821,GO:0017082,1.00000000000169,0.953547606718511,0,1,mineralocorticoid receptor activity,MF,
5873,GO:0017178,1.00000000000169,0.953547606718511,0,1,diphthine-ammonia ligase activity,MF,
5884,GO:0018011,1.00000000000169,0.953547606718511,0,1,N-terminal peptidyl-alanine methylation,BP,
5885,GO:0018012,1.00000000000169,0.953547606718511,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5886,GO:0018013,1.00000000000169,0.953547606718511,0,1,N-terminal peptidyl-glycine methylation,BP,
5887,GO:0018016,1.00000000000169,0.953547606718511,0,1,N-terminal peptidyl-proline dimethylation,BP,
5891,GO:0018025,1.00000000000169,0.953547606718511,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5923,GO:0018194,1.00000000000169,0.953547606718511,0,1,peptidyl-alanine modification,BP,
6116,GO:0019357,1.00000000000169,0.953547606718511,0,1,nicotinate nucleotide biosynthetic process,BP,
6117,GO:0019358,1.00000000000169,0.953547606718511,0,1,nicotinate nucleotide salvage,BP,
6122,GO:0019365,1.00000000000169,0.953547606718511,0,1,pyridine nucleotide salvage,BP,
6196,GO:0019659,1.00000000000169,0.953547606718511,0,1,glucose catabolic process to lactate,BP,
6197,GO:0019660,1.00000000000169,0.953547606718511,0,1,glycolytic fermentation,BP,
6198,GO:0019661,1.00000000000169,0.953547606718511,0,1,glucose catabolic process to lactate via pyruvate,BP,
6199,GO:0019666,1.00000000000169,0.953547606718511,0,1,nitrogenous compound fermentation,BP,
6244,GO:0019799,1.00000000000169,0.953547606718511,0,1,tubulin N-acetyltransferase activity,MF,
6329,GO:0020003,1.00000000000169,0.953547606718511,0,1,symbiont-containing vacuole,CC,
6817,GO:0030264,1.00000000000169,0.953547606718511,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
6906,GO:0030474,1.00000000000169,0.953547606718511,0,1,spindle pole body duplication,BP,
6978,GO:0030629,1.00000000000169,0.953547606718511,0,1,U6 snRNA 3'-end binding,MF,
7024,GO:0030735,1.00000000000169,0.953547606718511,0,1,carnosine N-methyltransferase activity,MF,
7138,GO:0030961,1.00000000000169,0.953547606718511,0,1,peptidyl-arginine hydroxylation,BP,
7668,GO:0032093,1.00000000000169,0.953547606718511,0,1,SAM domain binding,MF,
7748,GO:0032253,1.00000000000169,0.953547606718511,0,1,dense core granule localization,BP,
8270,GO:0033058,1.00000000000169,0.953547606718511,0,1,directional locomotion,BP,
8471,GO:0033608,1.00000000000169,0.953547606718511,0,1,formyl-CoA transferase activity,MF,
8472,GO:0033609,1.00000000000169,0.953547606718511,0,1,oxalate metabolic process,BP,
8563,GO:0034012,1.00000000000169,0.953547606718511,0,1,FAD-AMP lyase (cyclizing) activity,MF,
8713,GO:0034353,1.00000000000169,0.953547606718511,0,1,RNA pyrophosphohydrolase activity,MF,
8714,GO:0034355,1.00000000000169,0.953547606718511,0,1,NAD salvage,BP,
8795,GO:0034477,1.00000000000169,0.953547606718511,0,1,U6 snRNA 3'-end processing,BP,
8809,GO:0034512,1.00000000000169,0.953547606718511,0,1,box C/D snoRNA binding,MF,
8953,GO:0034998,1.00000000000169,0.953547606718511,0,1,oligosaccharyltransferase I complex,CC,
9150,GO:0035498,1.00000000000169,0.953547606718511,0,1,carnosine metabolic process,BP,
9190,GO:0035568,1.00000000000169,0.953547606718511,0,1,N-terminal peptidyl-proline methylation,BP,
9191,GO:0035570,1.00000000000169,0.953547606718511,0,1,N-terminal peptidyl-serine methylation,BP,
9192,GO:0035572,1.00000000000169,0.953547606718511,0,1,N-terminal peptidyl-serine dimethylation,BP,
9193,GO:0035573,1.00000000000169,0.953547606718511,0,1,N-terminal peptidyl-serine trimethylation,BP,
9204,GO:0035585,1.00000000000169,0.953547606718511,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9558,GO:0036317,1.00000000000169,0.953547606718511,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9725,GO:0038161,1.00000000000169,0.953547606718511,0,1,prolactin signaling pathway,BP,
9881,GO:0042140,1.00000000000169,0.953547606718511,0,1,late meiotic recombination nodule assembly,BP,
10186,GO:0042774,1.00000000000169,0.953547606718511,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10204,GO:0042806,1.00000000000169,0.953547606718511,0,1,fucose binding,MF,
10241,GO:0042946,1.00000000000169,0.953547606718511,0,1,glucoside transport,BP,
10242,GO:0042947,1.00000000000169,0.953547606718511,0,1,glucoside transmembrane transporter activity,MF,
10532,GO:0043465,1.00000000000169,0.953547606718511,0,1,regulation of fermentation,BP,
10838,GO:0044328,1.00000000000169,0.953547606718511,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10839,GO:0044329,1.00000000000169,0.953547606718511,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10840,GO:0044330,1.00000000000169,0.953547606718511,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10944,GO:0044599,1.00000000000169,0.953547606718511,0,1,AP-5 adaptor complex,CC,
10955,GO:0044648,1.00000000000169,0.953547606718511,0,1,histone H3-K4 dimethylation,BP,
10973,GO:0044732,1.00000000000169,0.953547606718511,0,1,mitotic spindle pole body,CC,
10974,GO:0044736,1.00000000000169,0.953547606718511,0,1,acid-sensing ion channel activity,MF,
11146,GO:0045183,1.00000000000169,0.953547606718511,0,1,translation factor activity, non-nucleic acid binding,MF,
11604,GO:0046176,1.00000000000169,0.953547606718511,0,1,aldonic acid catabolic process,BP,
11605,GO:0046177,1.00000000000169,0.953547606718511,0,1,D-gluconate catabolic process,BP,
11623,GO:0046316,1.00000000000169,0.953547606718511,0,1,gluconokinase activity,MF,
11714,GO:0046497,1.00000000000169,0.953547606718511,0,1,nicotinate nucleotide metabolic process,BP,
11840,GO:0046745,1.00000000000169,0.953547606718511,0,1,viral capsid secondary envelopment,BP,
11950,GO:0046996,1.00000000000169,0.953547606718511,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11955,GO:0047017,1.00000000000169,0.953547606718511,0,1,prostaglandin-F synthase activity,MF,
12002,GO:0047369,1.00000000000169,0.953547606718511,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12044,GO:0047734,1.00000000000169,0.953547606718511,0,1,CDP-glycerol diphosphatase activity,MF,
12450,GO:0050046,1.00000000000169,0.953547606718511,0,1,lathosterol oxidase activity,MF,
12459,GO:0050144,1.00000000000169,0.953547606718511,0,1,nucleoside deoxyribosyltransferase activity,MF,
12471,GO:0050262,1.00000000000169,0.953547606718511,0,1,ribosylnicotinamide kinase activity,MF,
12483,GO:0050346,1.00000000000169,0.953547606718511,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
12486,GO:0050354,1.00000000000169,0.953547606718511,0,1,triokinase activity,MF,
12710,GO:0050915,1.00000000000169,0.953547606718511,0,1,sensory perception of sour taste,BP,
12954,GO:0051300,1.00000000000169,0.953547606718511,0,1,spindle pole body organization,BP,
12962,GO:0051308,1.00000000000169,0.953547606718511,0,1,male meiosis chromosome separation,BP,
13012,GO:0051417,1.00000000000169,0.953547606718511,0,1,microtubule nucleation by spindle pole body,BP,
13033,GO:0051455,1.00000000000169,0.953547606718511,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13144,GO:0051685,1.00000000000169,0.953547606718511,0,1,maintenance of ER location,BP,
13472,GO:0052907,1.00000000000169,0.953547606718511,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
13473,GO:0052909,1.00000000000169,0.953547606718511,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13767,GO:0060327,1.00000000000169,0.953547606718511,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
13960,GO:0060620,1.00000000000169,0.953547606718511,0,1,regulation of cholesterol import,BP,
14092,GO:0060887,1.00000000000169,0.953547606718511,0,1,limb epidermis development,BP,
14101,GO:0060912,1.00000000000169,0.953547606718511,0,1,cardiac cell fate specification,BP,
14188,GO:0061056,1.00000000000169,0.953547606718511,0,1,sclerotome development,BP,
14238,GO:0061163,1.00000000000169,0.953547606718511,0,1,endoplasmic reticulum polarization,BP,
14310,GO:0061400,1.00000000000169,0.953547606718511,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
14339,GO:0061495,1.00000000000169,0.953547606718511,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14366,GO:0061573,1.00000000000169,0.953547606718511,0,1,actin filament bundle retrograde transport,BP,
14417,GO:0061685,1.00000000000169,0.953547606718511,0,1,diphthine methylesterase activity,MF,
14457,GO:0061769,1.00000000000169,0.953547606718511,0,1,ribosylnicotinate kinase activity,MF,
14525,GO:0065010,1.00000000000169,0.953547606718511,0,1,extracellular membrane-bounded organelle,CC,
14528,GO:0070004,1.00000000000169,0.953547606718511,0,1,cysteine-type exopeptidase activity,MF,
14596,GO:0070130,1.00000000000169,0.953547606718511,0,1,negative regulation of mitochondrial translation,BP,
14670,GO:0070260,1.00000000000169,0.953547606718511,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14826,GO:0070551,1.00000000000169,0.953547606718511,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14831,GO:0070560,1.00000000000169,0.953547606718511,0,1,protein secretion by platelet,BP,
14843,GO:0070573,1.00000000000169,0.953547606718511,0,1,metallodipeptidase activity,MF,
14868,GO:0070631,1.00000000000169,0.953547606718511,0,1,spindle pole body localization,BP,
14869,GO:0070632,1.00000000000169,0.953547606718511,0,1,establishment of spindle pole body localization,BP,
14880,GO:0070650,1.00000000000169,0.953547606718511,0,1,actin filament bundle distribution,BP,
14902,GO:0070694,1.00000000000169,0.953547606718511,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
14929,GO:0070762,1.00000000000169,0.953547606718511,0,1,nuclear pore transmembrane ring,CC,
15267,GO:0071424,1.00000000000169,0.953547606718511,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
15469,GO:0071789,1.00000000000169,0.953547606718511,0,1,spindle pole body localization to nuclear envelope,BP,
15470,GO:0071790,1.00000000000169,0.953547606718511,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
15522,GO:0071885,1.00000000000169,0.953547606718511,0,1,N-terminal protein N-methyltransferase activity,MF,
15548,GO:0071931,1.00000000000169,0.953547606718511,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15946,GO:0072720,1.00000000000169,0.953547606718511,0,1,response to dithiothreitol,BP,
16032,GO:0086038,1.00000000000169,0.953547606718511,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16362,GO:0090624,1.00000000000169,0.953547606718511,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16363,GO:0090625,1.00000000000169,0.953547606718511,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16562,GO:0097310,1.00000000000169,0.953547606718511,0,1,cap2 mRNA methylation,BP,
16675,GO:0097541,1.00000000000169,0.953547606718511,0,1,axonemal basal plate,CC,
16697,GO:0097630,1.00000000000169,0.953547606718511,0,1,intrinsic component of omegasome membrane,CC,
16698,GO:0097631,1.00000000000169,0.953547606718511,0,1,integral component of omegasome membrane,CC,
16713,GO:0097655,1.00000000000169,0.953547606718511,0,1,serpin family protein binding,MF,
16731,GO:0097712,1.00000000000169,0.953547606718511,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16803,GO:0098629,1.00000000000169,0.953547606718511,0,1,trans-Golgi network membrane organization,BP,
16842,GO:0098725,1.00000000000169,0.953547606718511,0,1,symmetric cell division,BP,
17055,GO:0099519,1.00000000000169,0.953547606718511,0,1,dense core granule cytoskeletal transport,BP,
17104,GO:0099627,1.00000000000169,0.953547606718511,0,1,neurotransmitter receptor cycle,BP,
17106,GO:0099630,1.00000000000169,0.953547606718511,0,1,postsynaptic neurotransmitter receptor cycle,BP,
17171,GO:0102524,1.00000000000169,0.953547606718511,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17272,GO:0120048,1.00000000000169,0.953547606718511,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
17273,GO:0120049,1.00000000000169,0.953547606718511,0,1,snRNA (adenine-N6)-methylation,BP,
17423,GO:1900148,1.00000000000169,0.953547606718511,0,1,negative regulation of Schwann cell migration,BP,
17434,GO:1900170,1.00000000000169,0.953547606718511,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
17536,GO:1901003,1.00000000000169,0.953547606718511,0,1,negative regulation of fermentation,BP,
17635,GO:1901318,1.00000000000169,0.953547606718511,0,1,negative regulation of flagellated sperm motility,BP,
17680,GO:1901523,1.00000000000169,0.953547606718511,0,1,icosanoid catabolic process,BP,
17828,GO:1901950,1.00000000000169,0.953547606718511,0,1,dense core granule transport,BP,
17895,GO:1902145,1.00000000000169,0.953547606718511,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17896,GO:1902151,1.00000000000169,0.953547606718511,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17897,GO:1902153,1.00000000000169,0.953547606718511,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17917,GO:1902211,1.00000000000169,0.953547606718511,0,1,regulation of prolactin signaling pathway,BP,
17918,GO:1902213,1.00000000000169,0.953547606718511,0,1,positive regulation of prolactin signaling pathway,BP,
17993,GO:1902387,1.00000000000169,0.953547606718511,0,1,ceramide 1-phosphate binding,MF,
17994,GO:1902388,1.00000000000169,0.953547606718511,0,1,ceramide 1-phosphate transporter activity,MF,
17995,GO:1902389,1.00000000000169,0.953547606718511,0,1,ceramide 1-phosphate transport,BP,
18099,GO:1902688,1.00000000000169,0.953547606718511,0,1,regulation of NAD metabolic process,BP,
18100,GO:1902689,1.00000000000169,0.953547606718511,0,1,negative regulation of NAD metabolic process,BP,
18177,GO:1902912,1.00000000000169,0.953547606718511,0,1,pyruvate kinase complex,CC,
18188,GO:1902939,1.00000000000169,0.953547606718511,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
18337,GO:1903259,1.00000000000169,0.953547606718511,0,1,exon-exon junction complex disassembly,BP,
18694,GO:1904023,1.00000000000169,0.953547606718511,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18695,GO:1904024,1.00000000000169,0.953547606718511,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18698,GO:1904028,1.00000000000169,0.953547606718511,0,1,positive regulation of collagen fibril organization,BP,
18969,GO:1904713,1.00000000000169,0.953547606718511,0,1,beta-catenin destruction complex binding,MF,
19003,GO:1904777,1.00000000000169,0.953547606718511,0,1,negative regulation of protein localization to cell cortex,BP,
19019,GO:1904806,1.00000000000169,0.953547606718511,0,1,regulation of protein oxidation,BP,
19020,GO:1904808,1.00000000000169,0.953547606718511,0,1,positive regulation of protein oxidation,BP,
19132,GO:1905044,1.00000000000169,0.953547606718511,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19133,GO:1905045,1.00000000000169,0.953547606718511,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19214,GO:1905279,1.00000000000169,0.953547606718511,0,1,regulation of retrograde transport, endosome to Golgi,BP,
19230,GO:1905319,1.00000000000169,0.953547606718511,0,1,mesenchymal stem cell migration,BP,
19231,GO:1905320,1.00000000000169,0.953547606718511,0,1,regulation of mesenchymal stem cell migration,BP,
19232,GO:1905322,1.00000000000169,0.953547606718511,0,1,positive regulation of mesenchymal stem cell migration,BP,
19243,GO:1905344,1.00000000000169,0.953547606718511,0,1,prostaglandin catabolic process,BP,
19350,GO:1905642,1.00000000000169,0.953547606718511,0,1,negative regulation of DNA methylation,BP,
19458,GO:1990048,1.00000000000169,0.953547606718511,0,1,anterograde neuronal dense core vesicle transport,BP,
19512,GO:1990261,1.00000000000169,0.953547606718511,0,1,pre-mRNA catabolic process,BP,
19584,GO:1990570,1.00000000000169,0.953547606718511,0,1,GDP-mannose transmembrane transport,BP,
19625,GO:1990738,1.00000000000169,0.953547606718511,0,1,pseudouridine 5'-phosphatase activity,MF,
19634,GO:1990755,1.00000000000169,0.953547606718511,0,1,mitotic spindle microtubule depolymerization,BP,
19706,GO:2000003,1.00000000000169,0.953547606718511,0,1,positive regulation of DNA damage checkpoint,BP,
20098,GO:2000722,1.00000000000169,0.953547606718511,0,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,
20099,GO:2000724,1.00000000000169,0.953547606718511,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
20183,GO:2000909,1.00000000000169,0.953547606718511,0,1,regulation of sterol import,BP,
339,GO:0000939,1.0000000000017,0.87788436341203,0,3,condensed chromosome inner kinetochore,CC,
5916,GO:0018158,1.00000000000171,0.680465035346507,0,9,protein oxidation,BP,
9291,GO:0035727,1.00000000000172,0.90867158232237,0,2,lysophosphatidic acid binding,MF,
12988,GO:0051377,1.00000000000173,0.858529268751549,0,3,mannose-ethanolamine phosphotransferase activity,MF,
8875,GO:0034678,1.00000000000174,0.899799725270458,0,2,integrin alpha8-beta1 complex,CC,
15958,GO:0072757,1.00000000000175,0.819910972508795,0,4,cellular response to camptothecin,BP,
10063,GO:0042543,1.00000000000175,0.983701780503057,0,1,protein N-linked glycosylation via arginine,BP,
19628,GO:1990743,1.00000000000175,0.868234684359738,0,3,protein sialylation,BP,
17678,GO:1901509,1.00000000000176,0.902813112209632,0,2,regulation of endothelial tube morphogenesis,BP,
13661,GO:0060154,1.00000000000176,0.876562873572196,0,3,cellular process regulating host cell cycle in response to virus,BP,
9843,GO:0042078,1.00000000000178,0.919393251443888,0,2,germ-line stem cell division,BP,
12112,GO:0048133,1.00000000000178,0.919393251443888,0,2,male germ-line stem cell asymmetric division,BP,
16844,GO:0098728,1.00000000000178,0.919393251443888,0,2,germline stem cell asymmetric division,BP,
12453,GO:0050104,1.00000000000179,0.961927374899532,0,1,L-gulonate 3-dehydrogenase activity,MF,
9704,GO:0038098,1.0000000000018,0.956212985919673,0,1,sequestering of BMP from receptor via BMP binding,BP,
6657,GO:0030002,1.00000000000181,0.739811033750753,0,6,cellular anion homeostasis,BP,
6855,GO:0030320,1.00000000000181,0.739811033750753,0,6,cellular monovalent inorganic anion homeostasis,BP,
1950,GO:0004651,1.00000000000182,0.909532206827996,0,2,polynucleotide 5'-phosphatase activity,MF,
16758,GO:0098507,1.00000000000182,0.909532206827996,0,2,polynucleotide 5' dephosphorylation,BP,
15280,GO:0071447,1.00000000000182,0.749465933965561,0,6,cellular response to hydroperoxide,BP,
12166,GO:0048264,1.00000000000182,0.953149842718238,0,1,determination of ventral identity,BP,
20307,GO:2001253,1.00000000000182,0.953149842718238,0,1,regulation of histone H3-K36 trimethylation,BP,
8493,GO:0033647,1.00000000000183,0.781560938965289,0,5,host intracellular organelle,CC,
8494,GO:0033648,1.00000000000183,0.781560938965289,0,5,host intracellular membrane-bounded organelle,CC,
1627,GO:0004060,1.00000000000184,0.95633206411583,0,1,arylamine N-acetyltransferase activity,MF,
15029,GO:0070949,1.00000000000184,0.918073422905741,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
15033,GO:0070960,1.00000000000184,0.918073422905741,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
15034,GO:0070961,1.00000000000184,0.918073422905741,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
6159,GO:0019474,1.00000000000184,0.862452931914245,0,3,L-lysine catabolic process to acetyl-CoA,BP,
6160,GO:0019477,1.00000000000184,0.862452931914245,0,3,L-lysine catabolic process,BP,
8429,GO:0033512,1.00000000000184,0.862452931914245,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
11677,GO:0046440,1.00000000000184,0.862452931914245,0,3,L-lysine metabolic process,BP,
16990,GO:0099022,1.00000000000185,0.915716530694598,0,2,vesicle tethering,BP,
16994,GO:0099044,1.00000000000185,0.915716530694598,0,2,vesicle tethering to endoplasmic reticulum,BP,
11701,GO:0046477,1.00000000000185,0.755190267700826,0,6,glycosylceramide catabolic process,BP,
5500,GO:0016434,1.00000000000185,0.862074539567793,0,3,rRNA (cytosine) methyltransferase activity,MF,
2489,GO:0005731,1.00000000000185,0.95894556068092,0,1,nucleolus organizer region,CC,
3347,GO:0007072,1.00000000000185,0.95894556068092,0,1,positive regulation of transcription involved in exit from mitosis,BP,
7086,GO:0030874,1.00000000000185,0.95894556068092,0,1,nucleolar chromatin,CC,
14669,GO:0070259,1.00000000000185,0.906213436785386,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
16590,GO:0097372,1.00000000000185,0.95894556068092,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
20017,GO:2000588,1.00000000000186,0.896961964588504,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
16650,GO:0097499,1.00000000000186,0.75849721239741,0,6,protein localization to non-motile cilium,BP,
10174,GO:0042758,1.00000000000187,0.829389498769633,0,4,long-chain fatty acid catabolic process,BP,
2295,GO:0005251,1.00000000000187,0.666629568092671,0,8,delayed rectifier potassium channel activity,MF,
19821,GO:2000233,1.00000000000188,0.902810937049199,0,2,negative regulation of rRNA processing,BP,
16414,GO:0097025,1.0000000000019,0.848891310976723,0,3,MPP7-DLG1-LIN7 complex,CC,
3080,GO:0006651,1.0000000000019,0.920576365653058,0,2,diacylglycerol biosynthetic process,BP,
2705,GO:0006068,1.00000000000191,0.737638301656494,0,7,ethanol catabolic process,BP,
8691,GO:0034310,1.00000000000191,0.737638301656494,0,7,primary alcohol catabolic process,BP,
1790,GO:0004415,1.00000000000191,0.789380897637554,0,5,hyalurononglucosaminidase activity,MF,
14796,GO:0070493,1.00000000000191,0.708866822727619,0,7,thrombin-activated receptor signaling pathway,BP,
1064,GO:0002589,1.00000000000192,0.916516954935442,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1065,GO:0002590,1.00000000000192,0.916516954935442,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
19288,GO:1905456,1.00000000000192,0.71380165122694,0,7,regulation of lymphoid progenitor cell differentiation,BP,
5378,GO:0016185,1.00000000000192,0.816844374515744,0,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
16910,GO:0098844,1.00000000000192,0.816844374515744,0,4,postsynaptic endocytic zone membrane,CC,
16928,GO:0098884,1.00000000000192,0.816844374515744,0,4,postsynaptic neurotransmitter receptor internalization,BP,
4744,GO:0010908,1.00000000000192,0.860841295025268,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4745,GO:0010909,1.00000000000192,0.860841295025268,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
10869,GO:0044388,1.00000000000192,0.825802644782829,0,5,small protein activating enzyme binding,MF,
18112,GO:1902730,1.00000000000192,0.860841295025268,0,3,positive regulation of proteoglycan biosynthetic process,BP,
18952,GO:1904683,1.00000000000192,0.729401557243354,0,6,regulation of metalloendopeptidase activity,BP,
19486,GO:1990166,1.00000000000193,0.868194710879453,0,3,protein localization to site of double-strand break,BP,
10207,GO:0042816,1.00000000000193,0.779375059562557,0,5,vitamin B6 metabolic process,BP,
4386,GO:0010034,1.00000000000194,0.950852052648151,0,1,response to acetate,BP,
18120,GO:1902744,1.00000000000195,0.809216061264005,0,4,negative regulation of lamellipodium organization,BP,
2581,GO:0005869,1.00000000000196,0.710135293113546,0,8,dynactin complex,CC,
11914,GO:0046933,1.00000000000196,0.906585952375014,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
2558,GO:0005833,1.00000000000196,0.953229677185015,0,1,hemoglobin complex,CC,
8539,GO:0033862,1.00000000000196,0.953229677185015,0,1,UMP kinase activity,MF,
2712,GO:0006083,1.00000000000197,0.855109088928942,0,3,acetate metabolic process,BP,
19696,GO:1990948,1.00000000000197,0.876473543288645,0,5,ubiquitin ligase inhibitor activity,MF,
8102,GO:0032782,1.00000000000198,0.914819103784882,0,2,bile acid secretion,BP,
11410,GO:0045792,1.00000000000199,0.701536397850831,0,7,negative regulation of cell size,BP,
1414,GO:0003345,1.000000000002,0.949370135541947,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
12195,GO:0048318,1.000000000002,0.812875699153824,0,5,axial mesoderm development,BP,
1617,GO:0004043,1.000000000002,0.950736361419399,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
3981,GO:0008802,1.000000000002,0.950736361419399,0,1,betaine-aldehyde dehydrogenase activity,MF,
6097,GO:0019285,1.000000000002,0.950736361419399,0,1,glycine betaine biosynthetic process from choline,BP,
7399,GO:0031455,1.000000000002,0.950736361419399,0,1,glycine betaine metabolic process,BP,
7400,GO:0031456,1.000000000002,0.950736361419399,0,1,glycine betaine biosynthetic process,BP,
19691,GO:1990930,1.00000000000201,0.960823138505223,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
12331,GO:0048672,1.00000000000202,0.675386938191603,0,9,positive regulation of collateral sprouting,BP,
19319,GO:1905553,1.00000000000203,0.876692259504521,0,3,regulation of blood vessel branching,BP,
5540,GO:0016520,1.00000000000203,0.94732338519395,0,1,growth hormone-releasing hormone receptor activity,MF,
7304,GO:0031298,1.00000000000204,0.655955303449998,0,9,replication fork protection complex,CC,
3685,GO:0008188,1.00000000000204,0.811916216264941,0,5,neuropeptide receptor activity,MF,
373,GO:0000994,1.00000000000205,0.958287119444132,0,1,RNA polymerase III core binding,MF,
15460,GO:0071733,1.00000000000206,0.867125953436739,0,3,transcriptional activation by promoter-enhancer looping,BP,
16195,GO:0090202,1.00000000000206,0.867125953436739,0,3,gene looping,BP,
16353,GO:0090579,1.00000000000206,0.867125953436739,0,3,dsDNA loop formation,BP,
13856,GO:0060442,1.00000000000206,0.629790007511074,0,9,branching involved in prostate gland morphogenesis,BP,
3894,GO:0008526,1.00000000000207,0.669087704521864,0,8,phosphatidylinositol transporter activity,MF,
6486,GO:0021825,1.00000000000207,0.809978594067707,0,4,substrate-dependent cerebral cortex tangential migration,BP,
8965,GO:0035032,1.00000000000207,0.749713513280738,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
17076,GO:0099550,1.00000000000207,0.874125457599161,0,3,trans-synaptic signaling, modulating synaptic transmission,BP,
1652,GO:0004096,1.00000000000207,0.883512072281321,0,3,catalase activity,MF,
6240,GO:0019788,1.00000000000207,0.793521210728906,0,6,NEDD8 transferase activity,MF,
6385,GO:0021569,1.00000000000208,0.960495980021283,0,1,rhombomere 3 development,BP,
6386,GO:0021570,1.00000000000208,0.960495980021283,0,1,rhombomere 4 development,BP,
3175,GO:0006789,1.00000000000208,0.911724361497994,0,2,bilirubin conjugation,BP,
1926,GO:0004617,1.00000000000208,0.956307203234019,0,1,phosphoglycerate dehydrogenase activity,MF,
8518,GO:0033699,1.00000000000208,0.956307203234019,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
17285,GO:0120108,1.00000000000208,0.956307203234019,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
19485,GO:1990165,1.00000000000208,0.956307203234019,0,1,single-strand break-containing DNA binding,MF,
16726,GO:0097699,1.00000000000209,0.947570390888877,0,1,vascular endothelial cell response to fluid shear stress,BP,
14022,GO:0060729,1.00000000000209,0.867268779355835,0,3,intestinal epithelial structure maintenance,BP,
17,GO:0000032,1.0000000000021,0.958328704048794,0,1,cell wall mannoprotein biosynthetic process,BP,
1826,GO:0004476,1.0000000000021,0.958328704048794,0,1,mannose-6-phosphate isomerase activity,MF,
2694,GO:0006056,1.0000000000021,0.958328704048794,0,1,mannoprotein metabolic process,BP,
2695,GO:0006057,1.0000000000021,0.958328704048794,0,1,mannoprotein biosynthetic process,BP,
7420,GO:0031506,1.0000000000021,0.958328704048794,0,1,cell wall glycoprotein biosynthetic process,BP,
10064,GO:0042546,1.0000000000021,0.958328704048794,0,1,cell wall biogenesis,BP,
10723,GO:0044038,1.0000000000021,0.958328704048794,0,1,cell wall macromolecule biosynthetic process,BP,
14382,GO:0061611,1.0000000000021,0.958328704048794,0,1,mannose to fructose-6-phosphate metabolic process,BP,
14854,GO:0070589,1.0000000000021,0.958328704048794,0,1,cellular component macromolecule biosynthetic process,BP,
13597,GO:0060050,1.0000000000021,0.682839802217887,0,8,positive regulation of protein glycosylation,BP,
4422,GO:0010216,1.00000000000212,0.731288637596063,0,6,maintenance of DNA methylation,BP,
2151,GO:0004966,1.00000000000213,0.89412317647528,0,3,galanin receptor activity,MF,
16108,GO:0090074,1.00000000000213,0.786710207458941,0,5,negative regulation of protein homodimerization activity,BP,
19477,GO:1990130,1.00000000000214,0.7879621786725,0,5,GATOR1 complex,CC,
345,GO:0000958,1.00000000000215,0.858043783287287,0,3,mitochondrial mRNA catabolic process,BP,
12171,GO:0048270,1.00000000000215,0.955936393104808,0,1,methionine adenosyltransferase regulator activity,MF,
245,GO:0000701,1.00000000000216,0.923886909721431,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
9226,GO:0035611,1.00000000000217,0.953698383779357,0,1,protein branching point deglutamylation,BP,
8868,GO:0034666,1.00000000000218,0.856846697873598,0,3,integrin alpha2-beta1 complex,CC,
8580,GO:0034057,1.00000000000218,0.905537592011544,0,2,RNA strand-exchange activity,MF,
5534,GO:0016507,1.00000000000218,0.952992273825272,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
9492,GO:0036125,1.00000000000218,0.952992273825272,0,1,fatty acid beta-oxidation multienzyme complex,CC,
2024,GO:0004750,1.00000000000219,0.95504372477654,0,1,ribulose-phosphate 3-epimerase activity,MF,
16691,GO:0097621,1.00000000000219,0.95504372477654,0,1,monoamine oxidase activity,MF,
9511,GO:0036157,1.00000000000219,0.878188590466269,0,3,outer dynein arm,CC,
14143,GO:0060995,1.00000000000219,0.902161292301272,0,2,cell-cell signaling involved in kidney development,BP,
14260,GO:0061289,1.00000000000219,0.902161292301272,0,2,Wnt signaling pathway involved in kidney development,BP,
14261,GO:0061290,1.00000000000219,0.902161292301272,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15693,GO:0072204,1.00000000000219,0.902161292301272,0,2,cell-cell signaling involved in metanephros development,BP,
11386,GO:0045743,1.0000000000022,0.792736242083627,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12971,GO:0051340,1.0000000000022,0.705076473791237,0,8,regulation of ligase activity,BP,
773,GO:0002025,1.00000000000221,0.956210002063056,0,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
2136,GO:0004939,1.00000000000221,0.956210002063056,0,1,beta-adrenergic receptor activity,MF,
2137,GO:0004941,1.00000000000221,0.956210002063056,0,1,beta2-adrenergic receptor activity,MF,
12991,GO:0051380,1.00000000000221,0.956210002063056,0,1,norepinephrine binding,MF,
14489,GO:0061884,1.00000000000221,0.956210002063056,0,1,regulation of mini excitatory postsynaptic potential,BP,
14490,GO:0061885,1.00000000000221,0.956210002063056,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
16893,GO:0098816,1.00000000000221,0.956210002063056,0,1,mini excitatory postsynaptic potential,BP,
14797,GO:0070494,1.00000000000222,0.865829429327839,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
14798,GO:0070495,1.00000000000222,0.865829429327839,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
4445,GO:0010335,1.00000000000222,0.94750123529093,0,1,response to non-ionic osmotic stress,BP,
8555,GO:0033925,1.00000000000222,0.94750123529093,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
15298,GO:0071471,1.00000000000222,0.94750123529093,0,1,cellular response to non-ionic osmotic stress,BP,
6670,GO:0030021,1.00000000000223,0.952879776513597,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
6874,GO:0030345,1.00000000000223,0.952879776513597,0,1,structural constituent of tooth enamel,MF,
8778,GO:0034454,1.00000000000226,0.624131967132271,0,9,microtubule anchoring at centrosome,BP,
18419,GO:1903431,1.00000000000227,0.697193723671558,0,7,positive regulation of cell maturation,BP,
5488,GO:0016418,1.00000000000227,0.897259915634548,0,2,S-acetyltransferase activity,MF,
4169,GO:0009233,1.00000000000227,0.905122702520014,0,2,menaquinone metabolic process,BP,
11757,GO:0046588,1.00000000000228,0.974159028640028,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
16523,GO:0097212,1.00000000000229,0.913776876307098,0,2,lysosomal membrane organization,BP,
7579,GO:0031937,1.00000000000229,0.66227745745264,0,8,positive regulation of chromatin silencing,BP,
3059,GO:0006621,1.00000000000229,0.693591236496851,0,8,protein retention in ER lumen,BP,
18760,GO:1904211,1.0000000000023,0.907365654227344,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
6907,GO:0030478,1.0000000000023,0.813031723974229,0,4,actin cap,CC,
605,GO:0001771,1.0000000000023,0.747419042380532,0,6,immunological synapse formation,BP,
16392,GO:0090724,1.00000000000231,0.821655955829133,0,4,central region of growth cone,CC,
1600,GO:0004016,1.00000000000231,0.723992544354688,0,6,adenylate cyclase activity,MF,
1779,GO:0004383,1.00000000000231,0.723992544354688,0,6,guanylate cyclase activity,MF,
3620,GO:0008074,1.00000000000231,0.723992544354688,0,6,guanylate cyclase complex, soluble,CC,
4330,GO:0009841,1.00000000000231,0.954862532797361,0,1,mitochondrial endopeptidase Clp complex,CC,
12207,GO:0048368,1.00000000000232,0.672395614933924,0,8,lateral mesoderm development,BP,
1723,GO:0004312,1.00000000000233,0.662460933920509,0,9,fatty acid synthase activity,MF,
18033,GO:1902512,1.00000000000233,0.903968187915891,0,3,positive regulation of apoptotic DNA fragmentation,BP,
13973,GO:0060665,1.00000000000234,0.946672577316048,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
16239,GO:0090272,1.00000000000234,0.946672577316048,0,1,negative regulation of fibroblast growth factor production,BP,
18437,GO:1903465,1.00000000000234,0.946672577316048,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
20162,GO:2000830,1.00000000000234,0.946672577316048,0,1,positive regulation of parathyroid hormone secretion,BP,
13745,GO:0060300,1.00000000000234,0.877243944194827,0,3,regulation of cytokine activity,BP,
19533,GO:1990393,1.00000000000236,0.772398855498006,0,5,3M complex,CC,
8532,GO:0033814,1.00000000000236,0.963248577006003,0,1,propanoyl-CoA C-acyltransferase activity,MF,
12519,GO:0050632,1.00000000000236,0.963248577006003,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
14818,GO:0070538,1.00000000000236,0.963248577006003,0,1,oleic acid binding,MF,
17654,GO:1901373,1.00000000000236,0.963248577006003,0,1,lipid hydroperoxide transport,BP,
9669,GO:0038025,1.00000000000236,0.901237334673648,0,2,reelin receptor activity,MF,
2074,GO:0004825,1.00000000000236,0.909054743757958,0,2,methionine-tRNA ligase activity,MF,
2921,GO:0006431,1.00000000000236,0.909054743757958,0,2,methionyl-tRNA aminoacylation,BP,
6623,GO:0022841,1.00000000000236,0.873774621411039,0,3,potassium ion leak channel activity,MF,
14191,GO:0061073,1.00000000000236,0.903171500438109,0,2,ciliary body morphogenesis,BP,
12821,GO:0051102,1.00000000000237,0.948675225713496,0,1,DNA ligation involved in DNA recombination,BP,
19389,GO:1905799,1.00000000000237,0.980196752115358,0,1,regulation of intraciliary retrograde transport,BP,
8508,GO:0033684,1.00000000000238,0.902634067444857,0,2,regulation of luteinizing hormone secretion,BP,
8509,GO:0033686,1.00000000000238,0.902634067444857,0,2,positive regulation of luteinizing hormone secretion,BP,
8593,GO:0034091,1.00000000000238,0.695824871173075,0,8,regulation of maintenance of sister chromatid cohesion,BP,
8643,GO:0034182,1.00000000000238,0.695824871173075,0,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,
1769,GO:0004370,1.00000000000239,0.899647672718766,0,2,glycerol kinase activity,MF,
11600,GO:0046167,1.00000000000239,0.899647672718766,0,2,glycerol-3-phosphate biosynthetic process,BP,
1606,GO:0004022,1.0000000000024,0.954191467287239,0,1,alcohol dehydrogenase (NAD) activity,MF,
5979,GO:0018467,1.0000000000024,0.954191467287239,0,1,formaldehyde dehydrogenase activity,MF,
13253,GO:0051903,1.0000000000024,0.954191467287239,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
6253,GO:0019826,1.0000000000024,0.904800321633672,0,2,oxygen sensor activity,MF,
7116,GO:0030911,1.0000000000024,0.665626978495472,0,8,TPR domain binding,MF,
817,GO:0002087,1.0000000000024,0.767808024590685,0,5,regulation of respiratory gaseous exchange by neurological system process,BP,
6428,GO:0021688,1.00000000000241,0.951886035915485,0,1,cerebellar molecular layer formation,BP,
14085,GO:0060853,1.00000000000241,0.951886035915485,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
12141,GO:0048209,1.00000000000242,0.904644458765522,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
2365,GO:0005471,1.00000000000244,0.879521806765805,0,3,ATP:ADP antiporter activity,MF,
5038,GO:0015207,1.00000000000244,0.879521806765805,0,3,adenine transmembrane transporter activity,MF,
16765,GO:0098532,1.00000000000245,0.800494822556468,0,6,histone H3-K27 trimethylation,BP,
15553,GO:0071942,1.00000000000245,0.874490886153353,0,3,XPC complex,CC,
12507,GO:0050510,1.00000000000247,0.815077250177935,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
863,GO:0002191,1.00000000000248,0.866873987727576,0,3,cap-dependent translational initiation,BP,
516,GO:0001580,1.00000000000249,0.83565191781317,0,5,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
1556,GO:0003952,1.00000000000249,0.954640000882268,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1583,GO:0003990,1.00000000000249,0.954640000882268,0,1,acetylcholinesterase activity,MF,
4825,GO:0014016,1.00000000000249,0.954640000882268,0,1,neuroblast differentiation,BP,
11680,GO:0046448,1.00000000000249,0.954640000882268,0,1,tropane alkaloid metabolic process,BP,
12618,GO:0050783,1.00000000000249,0.954640000882268,0,1,cocaine metabolic process,BP,
13974,GO:0060666,1.00000000000249,0.766671832330256,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
1955,GO:0004656,1.0000000000025,0.869354099243953,0,3,procollagen-proline 4-dioxygenase activity,MF,
5603,GO:0016635,1.00000000000251,0.775513357905891,0,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
7948,GO:0032534,1.00000000000251,0.732964798806423,0,6,regulation of microvillus assembly,BP,
1562,GO:0003958,1.00000000000251,0.777573400989363,0,5,NADPH-hemoprotein reductase activity,MF,
849,GO:0002162,1.00000000000251,0.681327676922729,0,7,dystroglycan binding,MF,
18491,GO:1903575,1.00000000000252,0.915838037034263,0,2,cornified envelope assembly,BP,
666,GO:0001867,1.00000000000252,0.837354573960193,0,4,complement activation, lectin pathway,BP,
13576,GO:0060025,1.00000000000252,0.90339173481709,0,2,regulation of synaptic activity,BP,
3168,GO:0006780,1.00000000000253,0.921481601131229,0,2,uroporphyrinogen III biosynthetic process,BP,
11719,GO:0046502,1.00000000000253,0.921481601131229,0,2,uroporphyrinogen III metabolic process,BP,
1576,GO:0003980,1.00000000000254,0.896389240660308,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
16581,GO:0097359,1.00000000000254,0.896389240660308,0,2,UDP-glucosylation,BP,
845,GO:0002155,1.00000000000254,0.863550110234625,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
10706,GO:0043988,1.00000000000255,0.877423547575867,0,3,histone H3-S28 phosphorylation,BP,
20259,GO:2001179,1.00000000000255,0.814546823346625,0,5,regulation of interleukin-10 secretion,BP,
11715,GO:0046498,1.00000000000256,0.771449724925277,0,6,S-adenosylhomocysteine metabolic process,BP,
16020,GO:0086017,1.00000000000256,0.903588944869848,0,2,Purkinje myocyte action potential,BP,
16030,GO:0086029,1.00000000000256,0.903588944869848,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
16051,GO:0086068,1.00000000000256,0.903588944869848,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
12445,GO:0048936,1.00000000000256,0.867225003649878,0,3,peripheral nervous system neuron axonogenesis,BP,
20217,GO:2001040,1.00000000000256,0.753300876507983,0,6,positive regulation of cellular response to drug,BP,
16839,GO:0098713,1.00000000000257,0.95516109417704,0,1,leucine import across plasma membrane,BP,
18590,GO:1903801,1.00000000000257,0.95516109417704,0,1,L-leucine import across plasma membrane,BP,
5719,GO:0016849,1.00000000000258,0.629772365520766,0,9,phosphorus-oxygen lyase activity,MF,
10936,GO:0044557,1.00000000000258,0.807424149393157,0,5,relaxation of smooth muscle,BP,
1799,GO:0004430,1.00000000000258,0.740285321557857,0,6,1-phosphatidylinositol 4-kinase activity,MF,
6093,GO:0019255,1.00000000000259,0.914014254533377,0,2,glucose 1-phosphate metabolic process,BP,
12427,GO:0048865,1.0000000000026,0.87423143075093,0,3,stem cell fate commitment,BP,
6555,GO:0021979,1.00000000000261,0.83437354946027,0,4,hypothalamus cell differentiation,BP,
4850,GO:0014054,1.00000000000261,0.948426478561606,0,1,positive regulation of gamma-aminobutyric acid secretion,BP,
5526,GO:0016492,1.00000000000261,0.948426478561606,0,1,G-protein coupled neurotensin receptor activity,MF,
5399,GO:0016232,1.00000000000261,0.953776712305889,0,1,HNK-1 sulfotransferase activity,MF,
4391,GO:0010041,1.00000000000262,0.801701894222793,0,5,response to iron(III) ion,BP,
9636,GO:0036501,1.00000000000263,0.947722278556833,0,1,UFD1-NPL4 complex,CC,
3842,GO:0008446,1.00000000000263,0.959438148980492,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4435,GO:0010266,1.00000000000263,0.881734284632374,0,3,response to vitamin B1,BP,
18759,GO:1904210,1.00000000000264,0.963861742433583,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18776,GO:1904239,1.00000000000264,0.963861742433583,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18777,GO:1904240,1.00000000000264,0.963861742433583,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
7578,GO:0031936,1.00000000000264,0.662110469982065,0,8,negative regulation of chromatin silencing,BP,
6680,GO:0030037,1.00000000000265,0.946879650979406,0,1,actin filament reorganization involved in cell cycle,BP,
745,GO:0001973,1.00000000000265,0.801494181595217,0,5,adenosine receptor signaling pathway,BP,
7909,GO:0032474,1.00000000000266,0.857984810111754,0,3,otolith morphogenesis,BP,
3756,GO:0008296,1.00000000000266,0.703702149825043,0,8,3'-5'-exodeoxyribonuclease activity,MF,
3415,GO:0007198,1.00000000000266,0.921804653854219,0,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
5449,GO:0016312,1.00000000000266,0.817399726770423,0,4,inositol bisphosphate phosphatase activity,MF,
4009,GO:0008967,1.00000000000266,0.911038789943016,0,2,phosphoglycolate phosphatase activity,MF,
15794,GO:0072386,1.00000000000267,0.652441358402441,0,8,plus-end-directed organelle transport along microtubule,BP,
5366,GO:0016139,1.00000000000267,0.723847232616826,0,7,glycoside catabolic process,BP,
3999,GO:0008897,1.00000000000267,0.953643470552992,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
7126,GO:0030942,1.00000000000268,0.88348292609082,0,3,endoplasmic reticulum signal peptide binding,MF,
2430,GO:0005607,1.00000000000269,0.896308950922076,0,2,laminin-2 complex,CC,
20319,GO:2001274,1.00000000000269,0.903268978897904,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
7743,GO:0032237,1.00000000000269,0.811934079616062,0,4,activation of store-operated calcium channel activity,BP,
17644,GO:1901341,1.00000000000269,0.811934079616062,0,4,positive regulation of store-operated calcium channel activity,BP,
6742,GO:0030156,1.00000000000269,0.978483758651224,0,1,benzodiazepine receptor binding,MF,
100,GO:0000210,1.00000000000269,0.951083806623857,0,1,NAD+ diphosphatase activity,MF,
3147,GO:0006742,1.00000000000269,0.951083806623857,0,1,NADP catabolic process,BP,
6121,GO:0019364,1.00000000000269,0.951083806623857,0,1,pyridine nucleotide catabolic process,BP,
6203,GO:0019677,1.00000000000269,0.951083806623857,0,1,NAD catabolic process,BP,
17854,GO:1902010,1.00000000000269,0.951083806623857,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
18409,GO:1903416,1.0000000000027,0.868718512286517,0,3,response to glycoside,BP,
7422,GO:0031508,1.0000000000027,0.922473957679969,0,2,pericentric heterochromatin assembly,BP,
9508,GO:0036153,1.00000000000271,0.95379600435015,0,1,triglyceride acyl-chain remodeling,BP,
12930,GO:0051264,1.00000000000271,0.95379600435015,0,1,mono-olein transacylation activity,MF,
12931,GO:0051265,1.00000000000271,0.95379600435015,0,1,diolein transacylation activity,MF,
3928,GO:0008603,1.00000000000271,0.791086557834224,0,5,cAMP-dependent protein kinase regulator activity,MF,
15025,GO:0070944,1.00000000000271,0.914873286348678,0,2,neutrophil mediated killing of bacterium,BP,
15026,GO:0070945,1.00000000000271,0.914873286348678,0,2,neutrophil mediated killing of gram-negative bacterium,BP,
5549,GO:0016534,1.00000000000272,0.949463345488079,0,1,cyclin-dependent protein kinase 5 activator activity,MF,
6392,GO:0021586,1.00000000000272,0.949463345488079,0,1,pons maturation,BP,
6441,GO:0021718,1.00000000000272,0.949463345488079,0,1,superior olivary nucleus development,BP,
6442,GO:0021722,1.00000000000272,0.949463345488079,0,1,superior olivary nucleus maturation,BP,
20324,GO:2001287,1.00000000000272,0.913113867009067,0,2,negative regulation of caveolin-mediated endocytosis,BP,
13695,GO:0060214,1.00000000000272,0.961115790528591,0,1,endocardium formation,BP,
19162,GO:1905143,1.00000000000272,0.961115790528591,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
2415,GO:0005587,1.00000000000272,0.760277988123431,0,5,collagen type IV trimer,CC,
2196,GO:0005055,1.00000000000273,0.925208161998687,0,2,laminin receptor activity,MF,
4847,GO:0014051,1.00000000000273,0.762691638803273,0,5,gamma-aminobutyric acid secretion,BP,
9256,GO:0035659,1.00000000000275,0.959003796005067,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
11136,GO:0045167,1.00000000000275,0.959003796005067,0,1,asymmetric protein localization involved in cell fate determination,BP,
14740,GO:0070390,1.00000000000275,0.959003796005067,0,1,transcription export complex 2,CC,
19063,GO:1904889,1.00000000000275,0.959003796005067,0,1,regulation of excitatory synapse assembly,BP,
19064,GO:1904891,1.00000000000275,0.959003796005067,0,1,positive regulation of excitatory synapse assembly,BP,
6685,GO:0030046,1.00000000000276,0.857085673092065,0,3,parallel actin filament bundle assembly,BP,
1897,GO:0004577,1.00000000000277,0.924979437627867,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
10574,GO:0043533,1.00000000000277,0.773256769876034,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
19154,GO:1905097,1.00000000000277,0.737824796113756,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
19893,GO:2000346,1.00000000000277,0.90353584439648,0,2,negative regulation of hepatocyte proliferation,BP,
1963,GO:0004666,1.00000000000278,0.897119244558828,0,2,prostaglandin-endoperoxide synthase activity,MF,
17334,GO:0150003,1.00000000000278,0.869281493906062,0,3,regulation of spontaneous synaptic transmission,BP,
4595,GO:0010700,1.00000000000279,0.952792554374432,0,1,negative regulation of norepinephrine secretion,BP,
7511,GO:0031686,1.00000000000279,0.952792554374432,0,1,A1 adenosine receptor binding,MF,
11057,GO:0045032,1.00000000000279,0.952792554374432,0,1,ADP-activated adenosine receptor activity,MF,
7972,GO:0032574,1.00000000000279,0.949006907614905,0,1,5'-3' RNA helicase activity,MF,
7973,GO:0032575,1.00000000000279,0.949006907614905,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8283,GO:0033084,1.00000000000279,0.907553542419999,0,2,regulation of immature T cell proliferation in thymus,BP,
8286,GO:0033088,1.00000000000279,0.907553542419999,0,2,negative regulation of immature T cell proliferation in thymus,BP,
12066,GO:0048003,1.0000000000028,0.85340379587653,0,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12068,GO:0048007,1.0000000000028,0.85340379587653,0,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
15581,GO:0072019,1.00000000000281,0.955668599116365,0,1,proximal convoluted tubule development,BP,
15709,GO:0072229,1.00000000000281,0.955668599116365,0,1,metanephric proximal convoluted tubule development,BP,
18153,GO:1902858,1.00000000000281,0.955668599116365,0,1,propionyl-CoA metabolic process,BP,
18154,GO:1902860,1.00000000000281,0.955668599116365,0,1,propionyl-CoA biosynthetic process,BP,
17963,GO:1902298,1.00000000000281,0.904299265836604,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19552,GO:1990426,1.00000000000281,0.904299265836604,0,2,mitotic recombination-dependent replication fork processing,BP,
19573,GO:1990505,1.00000000000281,0.904299265836604,0,2,mitotic DNA replication maintenance of fidelity,BP,
11845,GO:0046784,1.00000000000281,0.704511279831129,0,8,viral mRNA export from host cell nucleus,BP,
16906,GO:0098839,1.00000000000281,0.701609618729911,0,7,postsynaptic density membrane,CC,
17109,GO:0099634,1.00000000000281,0.701609618729911,0,7,postsynaptic specialization membrane,CC,
652,GO:0001840,1.00000000000282,0.664590277577732,0,8,neural plate development,BP,
5963,GO:0018343,1.00000000000282,0.873709201254182,0,3,protein farnesylation,BP,
4219,GO:0009383,1.00000000000282,0.904078674903722,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
11824,GO:0046707,1.00000000000284,0.910134101409319,0,2,IDP metabolic process,BP,
11825,GO:0046709,1.00000000000284,0.910134101409319,0,2,IDP catabolic process,BP,
14000,GO:0060698,1.00000000000284,0.903539355794837,0,2,endoribonuclease inhibitor activity,MF,
14003,GO:0060701,1.00000000000284,0.903539355794837,0,2,negative regulation of ribonuclease activity,BP,
14004,GO:0060702,1.00000000000284,0.903539355794837,0,2,negative regulation of endoribonuclease activity,BP,
19935,GO:2000405,1.00000000000287,0.946682025797252,0,1,negative regulation of T cell migration,BP,
19640,GO:1990769,1.00000000000288,0.909980938410338,0,2,proximal neuron projection,CC,
4228,GO:0009403,1.00000000000289,0.793964927420576,0,5,toxin biosynthetic process,BP,
14244,GO:0061187,1.00000000000289,0.896210021615226,0,2,regulation of chromatin silencing at rDNA,BP,
14245,GO:0061188,1.00000000000289,0.896210021615226,0,2,negative regulation of chromatin silencing at rDNA,BP,
11765,GO:0046602,1.00000000000289,0.684138812168075,0,8,regulation of mitotic centrosome separation,BP,
5083,GO:0015317,1.0000000000029,0.95936393205733,0,1,phosphate:proton symporter activity,MF,
14760,GO:0070426,1.00000000000291,0.911221731229717,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14767,GO:0070434,1.00000000000291,0.911221731229717,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
18067,GO:1902595,1.00000000000292,0.919072497419627,0,2,regulation of DNA replication origin binding,BP,
19240,GO:1905340,1.00000000000293,0.833437824797768,0,4,regulation of protein localization to kinetochore,BP,
19242,GO:1905342,1.00000000000293,0.833437824797768,0,4,positive regulation of protein localization to kinetochore,BP,
2093,GO:0004855,1.00000000000293,0.946671318571064,0,1,xanthine oxidase activity,MF,
5646,GO:0016727,1.00000000000293,0.946671318571064,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
20281,GO:2001213,1.00000000000293,0.946671318571064,0,1,negative regulation of vasculogenesis,BP,
8318,GO:0033149,1.00000000000293,0.899553130214357,0,2,FFAT motif binding,MF,
4709,GO:0010868,1.00000000000294,0.899730714780885,0,2,negative regulation of triglyceride biosynthetic process,BP,
9368,GO:0035880,1.00000000000294,0.907434948420571,0,2,embryonic nail plate morphogenesis,BP,
17575,GO:1901143,1.00000000000294,0.900503710041804,0,2,insulin catabolic process,BP,
8535,GO:0033842,1.00000000000296,0.904807418867598,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
382,GO:0001016,1.00000000000297,0.726158926931288,0,7,RNA polymerase III regulatory region DNA binding,MF,
7144,GO:0030974,1.00000000000297,0.915882049335167,0,2,thiamine pyrophosphate transmembrane transport,BP,
16317,GO:0090422,1.00000000000297,0.915882049335167,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
11894,GO:0046899,1.00000000000298,0.909869570695572,0,2,nucleoside triphosphate adenylate kinase activity,MF,
581,GO:0001731,1.00000000000298,0.684540555841117,0,8,formation of translation preinitiation complex,BP,
12875,GO:0051182,1.00000000000298,0.713292260972402,0,7,coenzyme transport,BP,
7717,GO:0032202,1.00000000000298,0.83042021022397,0,4,telomere assembly,BP,
13423,GO:0052746,1.00000000000298,0.90232555418709,0,2,inositol phosphorylation,BP,
15129,GO:0071204,1.00000000000299,0.76511279846249,0,6,histone pre-mRNA 3'end processing complex,CC,
16656,GO:0097505,1.00000000000301,0.946671325720667,0,1,Rad6-Rad18 complex,CC,
2067,GO:0004818,1.00000000000301,0.898711880987609,0,2,glutamate-tRNA ligase activity,MF,
2914,GO:0006424,1.00000000000301,0.898711880987609,0,2,glutamyl-tRNA aminoacylation,BP,
18273,GO:1903094,1.00000000000301,0.940035763207689,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19784,GO:2000157,1.00000000000301,0.940035763207689,0,2,negative regulation of ubiquitin-specific protease activity,BP,
11535,GO:0046041,1.00000000000302,0.925183254091632,0,2,ITP metabolic process,BP,
16296,GO:0090365,1.00000000000303,0.955476745431051,0,1,regulation of mRNA modification,BP,
16297,GO:0090367,1.00000000000303,0.955476745431051,0,1,negative regulation of mRNA modification,BP,
18321,GO:1903215,1.00000000000303,0.955476745431051,0,1,negative regulation of protein targeting to mitochondrion,BP,
19159,GO:1905123,1.00000000000303,0.898652004814125,0,2,regulation of glucosylceramidase activity,BP,
20241,GO:2001144,1.00000000000303,0.955476745431051,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20242,GO:2001145,1.00000000000303,0.955476745431051,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
5404,GO:0016237,1.00000000000304,0.946878886814612,0,1,lysosomal microautophagy,BP,
6231,GO:0019778,1.00000000000304,0.946878886814612,0,1,Atg12 activating enzyme activity,MF,
6232,GO:0019779,1.00000000000304,0.946878886814612,0,1,Atg8 activating enzyme activity,MF,
8907,GO:0034727,1.00000000000304,0.946878886814612,0,1,piecemeal microautophagy of the nucleus,BP,
9765,GO:0039521,1.00000000000304,0.946878886814612,0,1,suppression by virus of host autophagy,BP,
7186,GO:0031064,1.00000000000305,0.896181868380574,0,2,negative regulation of histone deacetylation,BP,
10610,GO:0043585,1.00000000000305,0.896181868380574,0,2,nose morphogenesis,BP,
8453,GO:0033578,1.00000000000306,0.786663140112173,0,5,protein glycosylation in Golgi,BP,
13545,GO:0055108,1.00000000000306,0.95658661995285,0,1,Golgi to transport vesicle transport,BP,
19530,GO:1990386,1.00000000000306,0.95658661995285,0,1,mitotic cleavage furrow ingression,BP,
19590,GO:1990583,1.00000000000306,0.95658661995285,0,1,phospholipase D activator activity,MF,
12346,GO:0048696,1.00000000000306,0.96200660052409,0,1,regulation of collateral sprouting in absence of injury,BP,
12347,GO:0048697,1.00000000000306,0.96200660052409,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13609,GO:0060064,1.00000000000306,0.96200660052409,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
19299,GO:1905474,1.00000000000306,0.96200660052409,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
5312,GO:0016015,1.00000000000307,0.916832267373427,0,2,morphogen activity,MF,
7739,GO:0032230,1.00000000000307,0.700218967752956,0,7,positive regulation of synaptic transmission, GABAergic,BP,
12330,GO:0048671,1.00000000000308,0.855696035372916,0,3,negative regulation of collateral sprouting,BP,
9569,GO:0036353,1.00000000000308,0.682717375556877,0,8,histone H2A-K119 monoubiquitination,BP,
11169,GO:0045218,1.00000000000308,0.859307279494126,0,3,zonula adherens maintenance,BP,
12056,GO:0047874,1.00000000000309,0.955794509098071,0,1,dolichyldiphosphatase activity,MF,
4843,GO:0014046,1.00000000000309,0.667754133680062,0,9,dopamine secretion,BP,
4851,GO:0014059,1.00000000000309,0.667754133680062,0,9,regulation of dopamine secretion,BP,
5984,GO:0018738,1.0000000000031,0.967539672648594,0,1,S-formylglutathione hydrolase activity,MF,
161,GO:0000332,1.0000000000031,0.986519198229667,0,1,template for synthesis of G-rich strand of telomere DNA activity,MF,
239,GO:0000496,1.0000000000031,0.986519198229667,0,1,base pairing,MF,
240,GO:0000497,1.0000000000031,0.986519198229667,0,1,base pairing with DNA,MF,
1469,GO:0003721,1.0000000000031,0.986519198229667,0,1,telomerase RNA reverse transcriptase activity,MF,
11275,GO:0045542,1.00000000000311,0.774537838111208,0,5,positive regulation of cholesterol biosynthetic process,BP,
9822,GO:0042025,1.00000000000311,0.857114032736229,0,3,host cell nucleus,CC,
10741,GO:0044094,1.00000000000311,0.857114032736229,0,3,host cell nuclear part,CC,
14322,GO:0061441,1.00000000000311,0.903774449133852,0,2,renal artery morphogenesis,BP,
12476,GO:0050294,1.00000000000311,0.895313836222494,0,3,steroid sulfotransferase activity,MF,
20222,GO:2001054,1.00000000000312,0.779834166437459,0,5,negative regulation of mesenchymal cell apoptotic process,BP,
4617,GO:0010731,1.00000000000312,0.954915946208459,0,1,protein glutathionylation,BP,
4618,GO:0010732,1.00000000000312,0.954915946208459,0,1,regulation of protein glutathionylation,BP,
4619,GO:0010734,1.00000000000312,0.954915946208459,0,1,negative regulation of protein glutathionylation,BP,
7844,GO:0032395,1.00000000000313,0.895690673015808,0,3,MHC class II receptor activity,MF,
3829,GO:0008426,1.00000000000313,0.893476368637685,0,3,protein kinase C inhibitor activity,MF,
2856,GO:0006344,1.00000000000313,0.811943323842068,0,4,maintenance of chromatin silencing,BP,
2661,GO:0006002,1.00000000000313,0.758937625242193,0,6,fructose 6-phosphate metabolic process,BP,
1075,GO:0002638,1.00000000000314,0.779217029288771,0,5,negative regulation of immunoglobulin production,BP,
107,GO:0000221,1.00000000000315,0.861871247595324,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
6336,GO:0021501,1.00000000000315,0.955933730515048,0,1,prechordal plate formation,BP,
6370,GO:0021547,1.00000000000315,0.955933730515048,0,1,midbrain-hindbrain boundary initiation,BP,
20111,GO:2000742,1.00000000000315,0.955933730515048,0,1,regulation of anterior head development,BP,
20112,GO:2000744,1.00000000000315,0.955933730515048,0,1,positive regulation of anterior head development,BP,
5001,GO:0015140,1.00000000000316,0.917295658201229,0,2,malate transmembrane transporter activity,MF,
9284,GO:0035718,1.00000000000317,0.928640707248355,0,2,macrophage migration inhibitory factor binding,MF,
9561,GO:0036335,1.00000000000317,0.946729473736151,0,1,intestinal stem cell homeostasis,BP,
9979,GO:0042364,1.00000000000317,0.676493539869291,0,8,water-soluble vitamin biosynthetic process,BP,
9179,GO:0035544,1.00000000000319,0.947540300302343,0,1,negative regulation of SNARE complex assembly,BP,
389,GO:0001034,1.0000000000032,0.958019713493586,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
18405,GO:1903405,1.0000000000032,0.664275507741811,0,9,protein localization to nuclear body,BP,
19045,GO:1904867,1.0000000000032,0.664275507741811,0,9,protein localization to Cajal body,BP,
19047,GO:1904869,1.00000000000321,0.693761877220645,0,8,regulation of protein localization to Cajal body,BP,
19048,GO:1904871,1.00000000000321,0.693761877220645,0,8,positive regulation of protein localization to Cajal body,BP,
7557,GO:0031867,1.00000000000322,0.949513618176703,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
19587,GO:1990575,1.00000000000322,0.905940362102571,0,2,mitochondrial L-ornithine transmembrane transport,BP,
6383,GO:0021564,1.00000000000322,0.910098215753521,0,2,vagus nerve development,BP,
9964,GO:0042335,1.00000000000324,0.856159797938354,0,3,cuticle development,BP,
14769,GO:0070436,1.00000000000324,0.902494028220427,0,2,Grb2-EGFR complex,CC,
6351,GO:0021523,1.00000000000325,0.915712850483521,0,2,somatic motor neuron differentiation,BP,
4985,GO:0015105,1.00000000000325,0.965784613356202,0,1,arsenite transmembrane transporter activity,MF,
5164,GO:0015700,1.00000000000325,0.965784613356202,0,1,arsenite transport,BP,
3840,GO:0008443,1.00000000000326,0.738554063692683,0,6,phosphofructokinase activity,MF,
11810,GO:0046680,1.00000000000326,0.955907275950829,0,1,response to DDT,BP,
20129,GO:2000775,1.00000000000326,0.955907275950829,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
1190,GO:0002834,1.00000000000326,0.745439269082382,0,6,regulation of response to tumor cell,BP,
1193,GO:0002837,1.00000000000326,0.745439269082382,0,6,regulation of immune response to tumor cell,BP,
1274,GO:0003062,1.00000000000326,0.82249704652379,0,4,regulation of heart rate by chemical signal,BP,
7852,GO:0032407,1.00000000000327,0.792095458405691,0,5,MutSalpha complex binding,MF,
18201,GO:1902956,1.00000000000327,0.88475585694234,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
6356,GO:0021533,1.00000000000328,0.633588269237686,0,9,cell differentiation in hindbrain,BP,
6378,GO:0021559,1.00000000000328,0.738714340988942,0,6,trigeminal nerve development,BP,
1751,GO:0004348,1.00000000000328,0.90744762900522,0,2,glucosylceramidase activity,MF,
16287,GO:0090341,1.00000000000329,0.961027202990433,0,1,negative regulation of secretion of lysosomal enzymes,BP,
9643,GO:0036509,1.00000000000329,0.912966937108722,0,2,trimming of terminal mannose on B branch,BP,
9645,GO:0036511,1.00000000000329,0.912966937108722,0,2,trimming of first mannose on A branch,BP,
9646,GO:0036512,1.00000000000329,0.912966937108722,0,2,trimming of second mannose on A branch,BP,
11367,GO:0045716,1.00000000000329,0.874173454950688,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
7513,GO:0031691,1.0000000000033,0.914427495365652,0,2,alpha-1A adrenergic receptor binding,MF,
7514,GO:0031692,1.0000000000033,0.914427495365652,0,2,alpha-1B adrenergic receptor binding,MF,
7537,GO:0031762,1.0000000000033,0.914427495365652,0,2,follicle-stimulating hormone receptor binding,MF,
10141,GO:0042699,1.0000000000033,0.914427495365652,0,2,follicle-stimulating hormone signaling pathway,BP,
7507,GO:0031681,1.0000000000033,0.783220259703561,0,5,G-protein beta-subunit binding,MF,
4252,GO:0009449,1.0000000000033,0.859223662773989,0,3,gamma-aminobutyric acid biosynthetic process,BP,
129,GO:0000268,1.0000000000033,0.828039326065108,0,4,peroxisome targeting sequence binding,MF,
2759,GO:0006167,1.0000000000033,0.81955850679374,0,5,AMP biosynthetic process,BP,
186,GO:0000403,1.00000000000331,0.730755553578114,0,6,Y-form DNA binding,MF,
8649,GO:0034189,1.00000000000331,0.903359561857208,0,2,very-low-density lipoprotein particle binding,MF,
5042,GO:0015217,1.00000000000332,0.658041262778112,0,9,ADP transmembrane transporter activity,MF,
5246,GO:0015866,1.00000000000332,0.658041262778112,0,9,ADP transport,BP,
344,GO:0000957,1.00000000000332,0.774527115386858,0,5,mitochondrial RNA catabolic process,BP,
9161,GO:0035513,1.00000000000333,0.826907889048601,0,4,oxidative RNA demethylation,BP,
9163,GO:0035515,1.00000000000333,0.826907889048601,0,4,oxidative RNA demethylase activity,MF,
12277,GO:0048561,1.00000000000333,0.955318970742264,0,1,establishment of animal organ orientation,BP,
3412,GO:0007195,1.00000000000333,0.903736503700462,0,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
15629,GO:0072103,1.00000000000334,0.907130262305338,0,2,glomerulus vasculature morphogenesis,BP,
15630,GO:0072104,1.00000000000334,0.907130262305338,0,2,glomerular capillary formation,BP,
19774,GO:2000137,1.00000000000334,0.907130262305338,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
18141,GO:1902816,1.00000000000334,0.820758699727535,0,4,regulation of protein localization to microtubule,BP,
18142,GO:1902817,1.00000000000334,0.820758699727535,0,4,negative regulation of protein localization to microtubule,BP,
973,GO:0002418,1.00000000000335,0.68525503347978,0,8,immune response to tumor cell,BP,
2809,GO:0006268,1.00000000000335,0.714596260599826,0,7,DNA unwinding involved in DNA replication,BP,
5811,GO:0017061,1.00000000000335,0.946922889435204,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
16426,GO:0097049,1.00000000000335,0.781536121128848,0,5,motor neuron apoptotic process,BP,
15007,GO:0070915,1.00000000000336,0.835473832656839,0,4,lysophosphatidic acid receptor activity,MF,
1607,GO:0004027,1.00000000000337,0.966901067287384,0,1,alcohol sulfotransferase activity,MF,
62,GO:0000125,1.00000000000337,0.814025884619433,0,5,PCAF complex,CC,
7397,GO:0031445,1.00000000000338,0.9087421331816,0,2,regulation of heterochromatin assembly,BP,
7398,GO:0031453,1.00000000000338,0.9087421331816,0,2,positive regulation of heterochromatin assembly,BP,
11414,GO:0045799,1.00000000000338,0.9087421331816,0,2,positive regulation of chromatin assembly or disassembly,BP,
2159,GO:0004980,1.00000000000338,0.952824452806909,0,1,melanocyte-stimulating hormone receptor activity,MF,
19,GO:0000035,1.00000000000339,0.961770307817546,0,2,acyl binding,MF,
20,GO:0000036,1.00000000000339,0.961770307817546,0,2,acyl carrier activity,MF,
4175,GO:0009245,1.00000000000339,0.961770307817546,0,2,lipid A biosynthetic process,BP,
10954,GO:0044620,1.00000000000339,0.961770307817546,0,2,ACP phosphopantetheine attachment site binding,MF,
11711,GO:0046493,1.00000000000339,0.961770307817546,0,2,lipid A metabolic process,BP,
12882,GO:0051192,1.00000000000339,0.961770307817546,0,2,prosthetic group binding,MF,
17617,GO:1901269,1.00000000000339,0.961770307817546,0,2,lipooligosaccharide metabolic process,BP,
17618,GO:1901271,1.00000000000339,0.961770307817546,0,2,lipooligosaccharide biosynthetic process,BP,
16238,GO:0090271,1.0000000000034,0.896967414785355,0,2,positive regulation of fibroblast growth factor production,BP,
4803,GO:0010992,1.0000000000034,0.72897138693032,0,7,ubiquitin recycling,BP,
16019,GO:0086016,1.00000000000341,0.775013813388118,0,5,AV node cell action potential,BP,
16028,GO:0086027,1.00000000000341,0.775013813388118,0,5,AV node cell to bundle of His cell signaling,BP,
6091,GO:0019249,1.00000000000341,0.878763700174783,0,3,lactate biosynthetic process,BP,
15928,GO:0072687,1.00000000000341,0.825362819018032,0,4,meiotic spindle,CC,
13913,GO:0060542,1.00000000000342,0.946671287726381,0,1,regulation of strand invasion,BP,
14716,GO:0070337,1.00000000000342,0.946671287726381,0,1,3'-flap-structured DNA binding,MF,
16763,GO:0098530,1.00000000000342,0.946671287726381,0,1,positive regulation of strand invasion,BP,
3721,GO:0008240,1.00000000000343,0.900563814313291,0,2,tripeptidyl-peptidase activity,MF,
1885,GO:0004561,1.00000000000344,0.953870652508134,0,1,alpha-N-acetylglucosaminidase activity,MF,
4155,GO:0009215,1.00000000000344,0.732879971245836,0,8,purine deoxyribonucleoside triphosphate metabolic process,BP,
15932,GO:0072702,1.00000000000344,0.946672867752265,0,1,response to methyl methanesulfonate,BP,
15933,GO:0072703,1.00000000000344,0.946672867752265,0,1,cellular response to methyl methanesulfonate,BP,
1943,GO:0004642,1.00000000000346,0.946693096904323,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
17257,GO:0120012,1.00000000000346,0.946693096904323,0,1,intermembrane sphingolipid transfer,BP,
17259,GO:0120016,1.00000000000346,0.946693096904323,0,1,intermembrane sphingolipid transfer activity,MF,
17260,GO:0120017,1.00000000000346,0.946693096904323,0,1,intermembrane ceramide transfer activity,MF,
18418,GO:1903430,1.00000000000346,0.845347473413969,0,4,negative regulation of cell maturation,BP,
2334,GO:0005347,1.00000000000346,0.689498742706086,0,8,ATP transmembrane transporter activity,MF,
16410,GO:0097017,1.00000000000347,0.91056779222437,0,2,renal protein absorption,BP,
11262,GO:0045485,1.00000000000348,0.947656168689358,0,1,omega-6 fatty acid desaturase activity,MF,
19101,GO:1904975,1.00000000000348,0.898556558085276,0,2,response to bleomycin,BP,
19102,GO:1904976,1.00000000000348,0.898556558085276,0,2,cellular response to bleomycin,BP,
16092,GO:0090042,1.00000000000348,0.651788243675604,0,9,tubulin deacetylation,BP,
10016,GO:0042439,1.00000000000348,0.749858475957848,0,6,ethanolamine-containing compound metabolic process,BP,
165,GO:0000340,1.00000000000348,0.637873652104609,0,9,RNA 7-methylguanosine cap binding,MF,
2153,GO:0004969,1.00000000000349,0.903587856215431,0,2,histamine receptor activity,MF,
3261,GO:0006930,1.0000000000035,0.672443773622194,0,8,substrate-dependent cell migration, cell extension,BP,
15812,GO:0072434,1.00000000000352,0.902394257966311,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
1291,GO:0003097,1.00000000000352,0.829665302068019,0,4,renal water transport,BP,
444,GO:0001192,1.00000000000352,0.975004217916984,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
445,GO:0001193,1.00000000000352,0.975004217916984,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
1061,GO:0002586,1.00000000000353,0.939483707063894,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
3134,GO:0006722,1.00000000000353,0.95473402668169,0,1,triterpenoid metabolic process,BP,
6219,GO:0019742,1.00000000000353,0.95473402668169,0,1,pentacyclic triterpenoid metabolic process,BP,
19079,GO:1904924,1.00000000000353,0.95473402668169,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19254,GO:1905370,1.00000000000353,0.95473402668169,0,1,serine-type endopeptidase complex,CC,
8666,GO:0034227,1.00000000000353,0.804739385607913,0,5,tRNA thio-modification,BP,
16521,GO:0097210,1.00000000000354,0.904840532266454,0,2,response to gonadotropin-releasing hormone,BP,
16522,GO:0097211,1.00000000000354,0.904840532266454,0,2,cellular response to gonadotropin-releasing hormone,BP,
4728,GO:0010887,1.00000000000357,0.751488570052241,0,6,negative regulation of cholesterol storage,BP,
16453,GO:0097102,1.00000000000359,0.908612391473692,0,2,endothelial tip cell fate specification,BP,
779,GO:0002032,1.00000000000359,0.915210497521184,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
7348,GO:0031371,1.0000000000036,0.692373049955114,0,8,ubiquitin conjugating enzyme complex,CC,
15754,GO:0072319,1.00000000000363,0.740493281794086,0,6,vesicle uncoating,BP,
2188,GO:0005042,1.00000000000363,0.946854003451118,0,1,netrin receptor activity,MF,
9764,GO:0039520,1.00000000000363,0.946676978118605,0,1,induction by virus of host autophagy,BP,
14064,GO:0060816,1.00000000000364,0.900900128613589,0,2,random inactivation of X chromosome,BP,
15301,GO:0071475,1.00000000000364,0.875975006207696,0,3,cellular hyperosmotic salinity response,BP,
17307,GO:0140066,1.00000000000364,0.900900128613589,0,2,peptidyl-lysine crotonylation,BP,
15004,GO:0070905,1.00000000000365,0.912392161449236,0,2,serine binding,MF,
17509,GO:1900477,1.00000000000365,0.955976708999858,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
9482,GO:0036114,1.00000000000365,0.961469238748416,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
9483,GO:0036115,1.00000000000365,0.961469238748416,0,1,fatty-acyl-CoA catabolic process,BP,
9484,GO:0036116,1.00000000000365,0.961469238748416,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
17511,GO:1900533,1.00000000000365,0.961469238748416,0,1,palmitic acid metabolic process,BP,
17512,GO:1900535,1.00000000000365,0.961469238748416,0,1,palmitic acid biosynthetic process,BP,
17834,GO:1901977,1.00000000000366,0.752669473899744,0,6,negative regulation of cell cycle checkpoint,BP,
18131,GO:1902774,1.00000000000366,0.756849616704272,0,6,late endosome to lysosome transport,BP,
18388,GO:1903373,1.00000000000366,0.856199999702727,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
7593,GO:0031957,1.00000000000368,0.71270428858064,0,7,very long-chain fatty acid-CoA ligase activity,MF,
14052,GO:0060767,1.00000000000369,0.659400037822387,0,9,epithelial cell proliferation involved in prostate gland development,BP,
2315,GO:0005313,1.00000000000369,0.739688576106613,0,6,L-glutamate transmembrane transporter activity,MF,
5015,GO:0015172,1.00000000000369,0.739688576106613,0,6,acidic amino acid transmembrane transporter activity,MF,
3693,GO:0008199,1.00000000000369,0.820682651949035,0,5,ferric iron binding,MF,
9504,GO:0036149,1.00000000000369,0.711495274221068,0,7,phosphatidylinositol acyl-chain remodeling,BP,
20161,GO:2000828,1.0000000000037,0.90617714916156,0,2,regulation of parathyroid hormone secretion,BP,
19192,GO:1905216,1.0000000000037,0.686235438158014,0,8,positive regulation of RNA binding,BP,
13722,GO:0060265,1.0000000000037,0.975608655692212,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
6110,GO:0019343,1.0000000000037,0.914817761657623,0,2,cysteine biosynthetic process via cystathionine,BP,
5453,GO:0016321,1.0000000000037,0.869292708198926,0,3,female meiosis chromosome segregation,BP,
14542,GO:0070037,1.00000000000371,0.970733306232817,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
18016,GO:1902463,1.00000000000372,0.926802678877657,0,2,protein localization to cell leading edge,BP,
7106,GO:0030898,1.00000000000373,0.667219740364425,0,8,actin-dependent ATPase activity,MF,
2372,GO:0005497,1.00000000000373,0.934747961005614,0,2,androgen binding,MF,
17503,GO:1900426,1.00000000000373,0.744458796730312,0,7,positive regulation of defense response to bacterium,BP,
4019,GO:0009020,1.00000000000374,0.956718910486919,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
13404,GO:0052666,1.00000000000374,0.956718910486919,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
17218,GO:0106050,1.00000000000374,0.956718910486919,0,1,tRNA 2'-O-methyltransferase activity,MF,
19082,GO:1904929,1.00000000000376,0.735647307617758,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
13491,GO:0055012,1.00000000000376,0.649602509608336,0,9,ventricular cardiac muscle cell differentiation,BP,
12547,GO:0050682,1.00000000000376,0.904290564825845,0,2,AF-2 domain binding,MF,
1521,GO:0003880,1.00000000000377,0.87190792409502,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
2953,GO:0006481,1.00000000000377,0.87190792409502,0,3,C-terminal protein methylation,BP,
10161,GO:0042738,1.00000000000377,0.652914490661143,0,9,exogenous drug catabolic process,BP,
19470,GO:1990111,1.00000000000377,0.8622817817983,0,4,spermatoproteasome complex,CC,
13075,GO:0051562,1.00000000000378,0.909033658717882,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
9294,GO:0035730,1.00000000000378,0.972868432541892,0,1,S-nitrosoglutathione binding,MF,
9295,GO:0035731,1.00000000000378,0.972868432541892,0,1,dinitrosyl-iron complex binding,MF,
9296,GO:0035732,1.00000000000378,0.972868432541892,0,1,nitric oxide storage,BP,
2632,GO:0005956,1.00000000000378,0.924376939637333,0,2,protein kinase CK2 complex,CC,
7364,GO:0031402,1.00000000000378,0.662752248941364,0,8,sodium ion binding,MF,
481,GO:0001527,1.00000000000379,0.677106983087039,0,8,microfibril,CC,
8489,GO:0033634,1.0000000000038,0.872845018218157,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
4732,GO:0010891,1.0000000000038,0.776595529927792,0,5,negative regulation of sequestering of triglyceride,BP,
7778,GO:0032298,1.0000000000038,0.955238039589542,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
16470,GO:0097123,1.0000000000038,0.955238039589542,0,1,cyclin A1-CDK2 complex,CC,
9670,GO:0038026,1.00000000000381,0.853934926730667,0,3,reelin-mediated signaling pathway,BP,
12339,GO:0048682,1.00000000000381,0.903728407697377,0,2,sprouting of injured axon,BP,
18710,GO:1904047,1.00000000000381,0.869963765219619,0,3,S-adenosyl-L-methionine binding,MF,
18885,GO:1904526,1.00000000000381,0.648287315855476,0,9,regulation of microtubule binding,BP,
3367,GO:0007130,1.00000000000381,0.697073696346705,0,8,synaptonemal complex assembly,BP,
16352,GO:0090576,1.00000000000382,0.679823919981305,0,8,RNA polymerase III transcription factor complex,CC,
19687,GO:1990923,1.00000000000382,0.905279754414671,0,2,PET complex,CC,
14951,GO:0070827,1.00000000000383,0.810222593246114,0,4,chromatin maintenance,BP,
864,GO:0002192,1.00000000000384,0.936263892048732,0,2,IRES-dependent translational initiation of linear mRNA,BP,
17240,GO:0110017,1.00000000000384,0.936263892048732,0,2,cap-independent translational initiation of linear mRNA,BP,
1209,GO:0002866,1.00000000000385,0.888289620820348,0,3,positive regulation of acute inflammatory response to antigenic stimulus,BP,
13181,GO:0051765,1.00000000000385,0.91226840753716,0,2,inositol tetrakisphosphate kinase activity,MF,
13715,GO:0060253,1.00000000000386,0.656229221070652,0,9,negative regulation of glial cell proliferation,BP,
6164,GO:0019509,1.00000000000387,0.799878403147209,0,5,L-methionine salvage from methylthioadenosine,BP,
7258,GO:0031213,1.00000000000387,0.898849165891442,0,2,RSF complex,CC,
4216,GO:0009372,1.00000000000388,0.952033452504737,0,1,quorum sensing,BP,
9584,GO:0036398,1.00000000000388,0.952033452504737,0,1,TCR signalosome,CC,
9585,GO:0036399,1.00000000000388,0.952033452504737,0,1,TCR signalosome assembly,BP,
12435,GO:0048874,1.00000000000388,0.952033452504737,0,1,homeostasis of number of cells in a free-living population,BP,
13322,GO:0052097,1.00000000000388,0.952033452504737,0,1,interspecies quorum sensing,BP,
13323,GO:0052106,1.00000000000388,0.952033452504737,0,1,quorum sensing involved in interaction with host,BP,
14023,GO:0060730,1.00000000000388,0.952033452504737,0,1,regulation of intestinal epithelial structure maintenance,BP,
14024,GO:0060731,1.00000000000388,0.952033452504737,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14912,GO:0070715,1.00000000000388,0.952033452504737,0,1,sodium-dependent organic cation transport,BP,
6312,GO:0019948,1.00000000000389,0.91079427657026,0,2,SUMO activating enzyme activity,MF,
19856,GO:2000299,1.0000000000039,0.951668780818139,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
2292,GO:0005248,1.00000000000391,0.620203231760127,0,9,voltage-gated sodium channel activity,MF,
9160,GO:0035511,1.00000000000391,0.805479863543345,0,5,oxidative DNA demethylation,BP,
11060,GO:0045041,1.00000000000392,0.91839619522226,0,2,protein import into mitochondrial intermembrane space,BP,
5063,GO:0015271,1.00000000000392,0.80672107956913,0,4,outward rectifier potassium channel activity,MF,
14273,GO:0061312,1.00000000000392,0.794040251282066,0,5,BMP signaling pathway involved in heart development,BP,
9773,GO:0039534,1.00000000000393,0.835798852112778,0,4,negative regulation of MDA-5 signaling pathway,BP,
11926,GO:0046952,1.00000000000394,0.864506452548556,0,3,ketone body catabolic process,BP,
1732,GO:0004324,1.00000000000395,0.957182700509449,0,1,ferredoxin-NADP+ reductase activity,MF,
4967,GO:0015039,1.00000000000395,0.957182700509449,0,1,NADPH-adrenodoxin reductase activity,MF,
5648,GO:0016730,1.00000000000395,0.957182700509449,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5649,GO:0016731,1.00000000000395,0.957182700509449,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
14075,GO:0060839,1.00000000000396,0.74895551769742,0,6,endothelial cell fate commitment,BP,
6485,GO:0021824,1.00000000000397,0.903635046327941,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6489,GO:0021828,1.00000000000397,0.903635046327941,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6500,GO:0021856,1.00000000000397,0.903635046327941,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
13812,GO:0060385,1.00000000000397,0.903635046327941,0,2,axonogenesis involved in innervation,BP,
18389,GO:1903375,1.00000000000397,0.903635046327941,0,2,facioacoustic ganglion development,BP,
7134,GO:0030953,1.00000000000397,0.693075905930743,0,7,astral microtubule organization,BP,
16662,GO:0097524,1.00000000000398,0.819952157653363,0,4,sperm plasma membrane,CC,
16944,GO:0098910,1.00000000000399,0.768418896754851,0,5,regulation of atrial cardiac muscle cell action potential,BP,
15402,GO:0071638,1.000000000004,0.921858800919651,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
16319,GO:0090435,1.00000000000401,0.732735767912286,0,7,protein localization to nuclear envelope,BP,
11320,GO:0045629,1.00000000000401,0.868115688305754,0,3,negative regulation of T-helper 2 cell differentiation,BP,
16163,GO:0090164,1.00000000000402,0.903238435610445,0,2,asymmetric Golgi ribbon formation,BP,
18691,GO:1904020,1.00000000000403,0.906048354959731,0,2,regulation of G-protein coupled receptor internalization,BP,
2092,GO:0004854,1.00000000000404,0.89638927167787,0,2,xanthine dehydrogenase activity,MF,
4067,GO:0009115,1.00000000000404,0.89638927167787,0,2,xanthine catabolic process,BP,
5645,GO:0016726,1.00000000000404,0.89638927167787,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
7001,GO:0030678,1.00000000000404,0.885428050083291,0,3,mitochondrial ribonuclease P complex,CC,
16744,GO:0097745,1.00000000000404,0.885428050083291,0,3,mitochondrial tRNA 5'-end processing,BP,
1049,GO:0002572,1.00000000000404,0.904291889217001,0,2,pro-T cell differentiation,BP,
5170,GO:0015712,1.00000000000405,0.828964317065149,0,4,hexose phosphate transport,BP,
5190,GO:0015760,1.00000000000405,0.828964317065149,0,4,glucose-6-phosphate transport,BP,
8760,GO:0034423,1.00000000000405,0.954215545805777,0,1,autophagosome lumen,CC,
19948,GO:2000422,1.00000000000405,0.954215545805777,0,1,regulation of eosinophil chemotaxis,BP,
19949,GO:2000424,1.00000000000405,0.954215545805777,0,1,positive regulation of eosinophil chemotaxis,BP,
8997,GO:0035112,1.00000000000405,0.730560278808826,0,6,genitalia morphogenesis,BP,
19360,GO:1905671,1.00000000000405,0.864551177221513,0,3,regulation of lysosome organization,BP,
8481,GO:0033625,1.00000000000406,0.904601222057098,0,2,positive regulation of integrin activation,BP,
17140,GO:0102148,1.00000000000407,0.872827212009631,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
1329,GO:0003177,1.00000000000407,0.733091174271712,0,6,pulmonary valve development,BP,
1334,GO:0003184,1.00000000000407,0.733091174271712,0,6,pulmonary valve morphogenesis,BP,
5602,GO:0016634,1.00000000000408,0.754845739774737,0,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
4994,GO:0015125,1.00000000000408,0.832731648868565,0,4,bile acid transmembrane transporter activity,MF,
16619,GO:0097442,1.00000000000408,0.946672051584811,0,1,CA3 pyramidal cell dendrite,CC,
8354,GO:0033211,1.00000000000408,0.79338428280976,0,5,adiponectin-activated signaling pathway,BP,
2474,GO:0005688,1.00000000000409,0.773113293251316,0,8,U6 snRNP,CC,
12621,GO:0050787,1.00000000000409,0.921714909808205,0,2,detoxification of mercury ion,BP,
9486,GO:0036118,1.0000000000041,0.865842906952228,0,3,hyaluranon cable assembly,BP,
17391,GO:1900104,1.0000000000041,0.865842906952228,0,3,regulation of hyaluranon cable assembly,BP,
17392,GO:1900106,1.0000000000041,0.865842906952228,0,3,positive regulation of hyaluranon cable assembly,BP,
13258,GO:0051918,1.0000000000041,0.819771487711656,0,4,negative regulation of fibrinolysis,BP,
8169,GO:0032899,1.00000000000411,0.94930676004346,0,1,regulation of neurotrophin production,BP,
8170,GO:0032901,1.00000000000411,0.94930676004346,0,1,positive regulation of neurotrophin production,BP,
8856,GO:0034649,1.00000000000411,0.94930676004346,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
12224,GO:0048403,1.00000000000411,0.94930676004346,0,1,brain-derived neurotrophic factor binding,MF,
18639,GO:1903909,1.00000000000411,0.779725925560679,0,5,regulation of receptor clustering,BP,
5514,GO:0016461,1.00000000000411,0.737198205460731,0,7,unconventional myosin complex,CC,
2363,GO:0005462,1.00000000000412,0.904643043627994,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
14837,GO:0070567,1.00000000000412,0.658357019030505,0,9,cytidylyltransferase activity,MF,
19583,GO:1990569,1.00000000000412,0.904643043627994,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
12037,GO:0047685,1.00000000000412,0.961840751594794,0,1,amine sulfotransferase activity,MF,
1573,GO:0003977,1.00000000000412,0.908760670382745,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
10817,GO:0044301,1.00000000000412,0.947523551126889,0,1,climbing fiber,CC,
19451,GO:1990032,1.00000000000412,0.947523551126889,0,1,parallel fiber,CC,
2270,GO:0005199,1.00000000000414,0.951636861665626,0,1,structural constituent of cell wall,MF,
15418,GO:0071665,1.00000000000414,0.951636861665626,0,1,gamma-catenin-TCF7L2 complex,CC,
7938,GO:0032510,1.00000000000414,0.74499434021653,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
11812,GO:0046684,1.00000000000415,0.906314169154155,0,2,response to pyrethroid,BP,
6261,GO:0019841,1.00000000000415,0.873920583248701,0,4,retinol binding,MF,
17223,GO:0106070,1.00000000000415,0.776090494104458,0,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
14817,GO:0070537,1.00000000000416,0.86740418377624,0,3,histone H2A K63-linked deubiquitination,BP,
16979,GO:0098982,1.00000000000416,0.896788247300236,0,2,GABA-ergic synapse,CC,
16980,GO:0098983,1.00000000000416,0.896788247300236,0,2,symmetric, GABA-ergic, inhibitory synapse,CC,
10702,GO:0043983,1.00000000000417,0.724720684836689,0,7,histone H4-K12 acetylation,BP,
15775,GO:0072357,1.00000000000417,0.70068846167462,0,7,PTW/PP1 phosphatase complex,CC,
11988,GO:0047275,1.00000000000417,0.950828897345553,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
14323,GO:0061443,1.00000000000418,0.90247943113406,0,2,endocardial cushion cell differentiation,BP,
11565,GO:0046098,1.00000000000418,0.831523927320005,0,4,guanine metabolic process,BP,
14778,GO:0070463,1.00000000000418,0.951148682807987,0,1,tubulin-dependent ATPase activity,MF,
1561,GO:0003957,1.00000000000418,0.947200966916696,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
3966,GO:0008746,1.00000000000418,0.947200966916696,0,1,NAD(P)+ transhydrogenase activity,MF,
3968,GO:0008750,1.00000000000418,0.947200966916696,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
5613,GO:0016652,1.00000000000418,0.947200966916696,0,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
3119,GO:0006696,1.00000000000418,0.913443388309599,0,2,ergosterol biosynthetic process,BP,
3698,GO:0008204,1.00000000000418,0.913443388309599,0,2,ergosterol metabolic process,BP,
17447,GO:1900208,1.00000000000419,0.92479942218136,0,2,regulation of cardiolipin metabolic process,BP,
17448,GO:1900210,1.00000000000419,0.92479942218136,0,2,positive regulation of cardiolipin metabolic process,BP,
13630,GO:0060088,1.0000000000042,0.790242738067478,0,5,auditory receptor cell stereocilium organization,BP,
12513,GO:0050561,1.00000000000422,0.949182183065627,0,1,glutamate-tRNA(Gln) ligase activity,MF,
53,GO:0000110,1.00000000000423,0.865667026685673,0,3,nucleotide-excision repair factor 1 complex,CC,
4167,GO:0009227,1.00000000000423,0.8788600214751,0,3,nucleotide-sugar catabolic process,BP,
4071,GO:0009120,1.00000000000423,0.775948706463653,0,6,deoxyribonucleoside metabolic process,BP,
6384,GO:0021566,1.00000000000423,0.946903457352084,0,1,hypoglossal nerve development,BP,
6406,GO:0021618,1.00000000000423,0.946903457352084,0,1,hypoglossal nerve morphogenesis,BP,
14404,GO:0061646,1.00000000000423,0.946903457352084,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
4298,GO:0009726,1.00000000000423,0.902535912141043,0,2,detection of endogenous stimulus,BP,
13554,GO:0055131,1.00000000000424,0.79918334440657,0,5,C3HC4-type RING finger domain binding,MF,
5290,GO:0015939,1.00000000000424,0.796025357137456,0,5,pantothenate metabolic process,BP,
5132,GO:0015562,1.00000000000425,0.819576454264659,0,4,efflux transmembrane transporter activity,MF,
15396,GO:0071630,1.00000000000425,0.855304819934372,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
9609,GO:0036466,1.00000000000426,0.897203489042757,0,2,synaptic vesicle recycling via endosome,BP,
9902,GO:0042182,1.00000000000429,0.804042216286523,0,5,ketone catabolic process,BP,
4105,GO:0009157,1.00000000000429,0.679710792062206,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
15377,GO:0071603,1.00000000000429,0.900978630607429,0,2,endothelial cell-cell adhesion,BP,
19056,GO:1904880,1.00000000000429,0.910770786432122,0,2,response to hydrogen sulfide,BP,
9513,GO:0036159,1.00000000000429,0.787429475432652,0,5,inner dynein arm assembly,BP,
472,GO:0001515,1.0000000000043,0.956593444435465,0,1,opioid peptide activity,MF,
9932,GO:0042275,1.0000000000043,0.961615030143726,0,1,error-free postreplication DNA repair,BP,
14572,GO:0070092,1.0000000000043,0.856602057529,0,3,regulation of glucagon secretion,BP,
12406,GO:0048822,1.00000000000434,0.856572581576435,0,3,enucleate erythrocyte development,BP,
942,GO:0002349,1.00000000000434,0.811236020993876,0,5,histamine production involved in inflammatory response,BP,
987,GO:0002441,1.00000000000434,0.811236020993876,0,5,histamine secretion involved in inflammatory response,BP,
1042,GO:0002553,1.00000000000434,0.811236020993876,0,5,histamine secretion by mast cell,BP,
14727,GO:0070369,1.00000000000434,0.854632383747841,0,3,beta-catenin-TCF7L2 complex,CC,
11128,GO:0045145,1.00000000000434,0.908138069990039,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
6542,GO:0021942,1.00000000000435,0.862596374807157,0,3,radial glia guided migration of Purkinje cell,BP,
5626,GO:0016679,1.00000000000435,0.745550194714344,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
12236,GO:0048484,1.00000000000435,0.789743598470632,0,5,enteric nervous system development,BP,
5768,GO:0016936,1.00000000000435,0.919418815779604,0,2,galactoside binding,MF,
16978,GO:0098978,1.00000000000435,0.896240864706469,0,2,glutamatergic synapse,CC,
16982,GO:0098985,1.00000000000435,0.896240864706469,0,2,asymmetric, glutamatergic, excitatory synapse,CC,
2887,GO:0006391,1.00000000000435,0.870689890698308,0,3,transcription initiation from mitochondrial promoter,BP,
5749,GO:0016892,1.00000000000436,0.776010391661379,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
7227,GO:0031117,1.00000000000437,0.908892857517247,0,2,positive regulation of microtubule depolymerization,BP,
2796,GO:0006238,1.00000000000437,0.966516844526736,0,1,CMP salvage,BP,
4164,GO:0009224,1.00000000000437,0.966516844526736,0,1,CMP biosynthetic process,BP,
11529,GO:0046035,1.00000000000437,0.966516844526736,0,1,CMP metabolic process,BP,
4266,GO:0009608,1.00000000000438,0.920892633951943,0,2,response to symbiont,BP,
4267,GO:0009609,1.00000000000438,0.920892633951943,0,2,response to symbiotic bacterium,BP,
18253,GO:1903045,1.0000000000044,0.946672069947758,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
20272,GO:2001199,1.00000000000441,0.960722499440203,0,1,negative regulation of dendritic cell differentiation,BP,
14709,GO:0070326,1.00000000000441,0.883849527672331,0,3,very-low-density lipoprotein particle receptor binding,MF,
15954,GO:0072749,1.00000000000441,0.957975680992768,0,1,cellular response to cytochalasin B,BP,
16951,GO:0098918,1.00000000000441,0.957975680992768,0,1,structural constituent of synapse,MF,
16975,GO:0098973,1.00000000000441,0.957975680992768,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16976,GO:0098974,1.00000000000441,0.957975680992768,0,1,postsynaptic actin cytoskeleton organization,BP,
17037,GO:0099186,1.00000000000441,0.957975680992768,0,1,structural constituent of postsynapse,MF,
17038,GO:0099188,1.00000000000441,0.957975680992768,0,1,postsynaptic cytoskeleton organization,BP,
17637,GO:1901328,1.00000000000441,0.957975680992768,0,1,response to cytochalasin B,BP,
15957,GO:0072755,1.00000000000442,0.949840114437974,0,1,cellular response to benomyl,BP,
17698,GO:1901561,1.00000000000442,0.949840114437974,0,1,response to benomyl,BP,
729,GO:0001955,1.00000000000442,0.792163163464065,0,5,blood vessel maturation,BP,
6468,GO:0021785,1.00000000000442,0.728943805528774,0,6,branchiomotor neuron axon guidance,BP,
7530,GO:0031730,1.00000000000443,0.809016728928577,0,5,CCR5 chemokine receptor binding,MF,
1798,GO:0004427,1.00000000000443,0.890077059542596,0,3,inorganic diphosphatase activity,MF,
3847,GO:0008454,1.00000000000444,0.903205241757557,0,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
2222,GO:0005119,1.00000000000444,0.900826602487451,0,2,smoothened binding,MF,
7371,GO:0031414,1.00000000000444,0.660461262117018,0,9,N-terminal protein acetyltransferase complex,CC,
2082,GO:0004833,1.00000000000445,0.960852063514189,0,1,tryptophan 2,3-dioxygenase activity,MF,
8526,GO:0033754,1.00000000000445,0.960852063514189,0,1,indoleamine 2,3-dioxygenase activity,MF,
8685,GO:0034275,1.00000000000445,0.960852063514189,0,1,kynurenic acid metabolic process,BP,
8686,GO:0034276,1.00000000000445,0.960852063514189,0,1,kynurenic acid biosynthetic process,BP,
9537,GO:0036269,1.00000000000445,0.960852063514189,0,1,swimming behavior,BP,
18215,GO:1902988,1.00000000000446,0.854672378997877,0,3,neurofibrillary tangle assembly,BP,
14442,GO:0061740,1.00000000000446,0.865061011022968,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
6550,GO:0021960,1.00000000000446,0.854997964604934,0,3,anterior commissure morphogenesis,BP,
6146,GO:0019417,1.00000000000446,0.902529755236103,0,2,sulfur oxidation,BP,
4612,GO:0010726,1.00000000000447,0.910868785369673,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
2532,GO:0005786,1.00000000000448,0.785649160385592,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
10818,GO:0044302,1.00000000000448,0.857828307274716,0,3,dentate gyrus mossy fiber,CC,
12712,GO:0050917,1.0000000000045,0.903478166761,0,2,sensory perception of umami taste,BP,
17689,GO:1901536,1.00000000000453,0.908410185913229,0,2,negative regulation of DNA demethylation,BP,
9929,GO:0042272,1.00000000000453,0.896205160393756,0,2,nuclear RNA export factor complex,CC,
14719,GO:0070341,1.00000000000453,0.738116619364279,0,6,fat cell proliferation,BP,
14721,GO:0070344,1.00000000000453,0.738116619364279,0,6,regulation of fat cell proliferation,BP,
1650,GO:0004092,1.00000000000454,0.953757155741434,0,1,carnitine O-acetyltransferase activity,MF,
14427,GO:0061711,1.00000000000454,0.917869347841935,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
12700,GO:0050904,1.00000000000456,0.902464588140209,0,2,diapedesis,BP,
807,GO:0002074,1.00000000000456,0.862248107183999,0,3,extraocular skeletal muscle development,BP,
18575,GO:1903775,1.00000000000457,0.909450922687371,0,2,regulation of DNA double-strand break processing,BP,
6501,GO:0021859,1.00000000000459,0.77408194920026,0,5,pyramidal neuron differentiation,BP,
6502,GO:0021860,1.00000000000459,0.77408194920026,0,5,pyramidal neuron development,BP,
5417,GO:0016259,1.0000000000046,0.825907895932433,0,4,selenocysteine metabolic process,BP,
10081,GO:0042577,1.0000000000046,0.717166755481846,0,7,lipid phosphatase activity,MF,
16985,GO:0098993,1.0000000000046,0.704596200854916,0,8,anchored component of synaptic vesicle membrane,CC,
584,GO:0001735,1.00000000000461,0.903518677587821,0,2,prenylcysteine oxidase activity,MF,
6863,GO:0030328,1.00000000000461,0.903518677587821,0,2,prenylcysteine catabolic process,BP,
6864,GO:0030329,1.00000000000461,0.903518677587821,0,2,prenylcysteine metabolic process,BP,
10697,GO:0043972,1.00000000000461,0.947134147857447,0,1,histone H3-K23 acetylation,BP,
10708,GO:0043994,1.00000000000461,0.947134147857447,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
7,GO:0000014,1.00000000000462,0.704638365486476,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
8699,GO:0034331,1.00000000000462,0.697753255667212,0,7,cell junction maintenance,BP,
2354,GO:0005427,1.00000000000462,0.952625988760632,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
5087,GO:0015322,1.00000000000462,0.952625988760632,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
7152,GO:0030997,1.00000000000462,0.860726873800764,0,3,regulation of centriole-centriole cohesion,BP,
10475,GO:0043353,1.00000000000463,0.729495270198173,0,6,enucleate erythrocyte differentiation,BP,
51,GO:0000105,1.00000000000463,0.908218573355524,0,2,histidine biosynthetic process,BP,
13300,GO:0051977,1.00000000000464,0.955445254212852,0,1,lysophospholipid transport,BP,
13301,GO:0051978,1.00000000000464,0.955445254212852,0,1,lysophospholipid transporter activity,MF,
10459,GO:0043313,1.00000000000464,0.8047707851479,0,4,regulation of neutrophil degranulation,BP,
18054,GO:1902563,1.00000000000464,0.8047707851479,0,4,regulation of neutrophil activation,BP,
11925,GO:0046951,1.00000000000464,0.757859382437053,0,6,ketone body biosynthetic process,BP,
19013,GO:1904796,1.00000000000465,0.784025390390029,0,5,regulation of core promoter binding,BP,
1534,GO:0003916,1.00000000000466,0.736182275575675,0,6,DNA topoisomerase activity,MF,
7225,GO:0031115,1.00000000000466,0.645723102593861,0,9,negative regulation of microtubule polymerization,BP,
1570,GO:0003974,1.00000000000467,0.960274384628744,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1574,GO:0003978,1.00000000000467,0.960274384628744,0,1,UDP-glucose 4-epimerase activity,MF,
1250,GO:0002947,1.00000000000467,0.948439193025107,0,1,tumor necrosis factor receptor superfamily complex,CC,
19092,GO:1904954,1.00000000000468,0.915226034733691,0,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
115,GO:0000243,1.00000000000469,0.722285890427771,0,8,commitment complex,CC,
17338,GO:0150018,1.00000000000469,0.855795187330528,0,3,basal dendrite development,BP,
17339,GO:0150019,1.00000000000469,0.855795187330528,0,3,basal dendrite morphogenesis,BP,
17340,GO:0150020,1.00000000000469,0.855795187330528,0,3,basal dendrite arborization,BP,
8665,GO:0034224,1.00000000000469,0.955216176036232,0,1,cellular response to zinc ion starvation,BP,
15060,GO:0070995,1.00000000000469,0.952553410174184,0,1,NADPH oxidation,BP,
19450,GO:1990031,1.00000000000469,0.952553410174184,0,1,pinceau fiber,CC,
1592,GO:0004000,1.00000000000469,0.742698724771718,0,6,adenosine deaminase activity,MF,
18757,GO:1904207,1.0000000000047,0.909571278828956,0,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,
18758,GO:1904209,1.0000000000047,0.909571278828956,0,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,
4296,GO:0009720,1.0000000000047,0.953235049780613,0,1,detection of hormone stimulus,BP,
8576,GO:0034041,1.0000000000047,0.953235049780613,0,1,sterol-transporting ATPase activity,MF,
3131,GO:0006713,1.00000000000471,0.9581744245233,0,1,glucocorticoid catabolic process,BP,
4273,GO:0009624,1.00000000000471,0.954269862818749,0,1,response to nematode,BP,
4291,GO:0009692,1.00000000000471,0.954269862818749,0,1,ethylene metabolic process,BP,
4292,GO:0009698,1.00000000000471,0.954269862818749,0,1,phenylpropanoid metabolic process,BP,
4321,GO:0009804,1.00000000000471,0.954269862818749,0,1,coumarin metabolic process,BP,
5635,GO:0016711,1.00000000000471,0.954269862818749,0,1,flavonoid 3'-monooxygenase activity,MF,
6109,GO:0019341,1.00000000000471,0.954269862818749,0,1,dibenzo-p-dioxin catabolic process,BP,
10526,GO:0043449,1.00000000000471,0.954269862818749,0,1,cellular alkene metabolic process,BP,
10596,GO:0043559,1.00000000000471,0.764392696891387,0,5,insulin binding,MF,
12245,GO:0048499,1.00000000000472,0.87642357459878,0,3,synaptic vesicle membrane organization,BP,
14820,GO:0070541,1.00000000000472,0.869503222700844,0,3,response to platinum ion,BP,
2668,GO:0006013,1.00000000000472,0.680743956445497,0,8,mannose metabolic process,BP,
7294,GO:0031282,1.00000000000474,0.826285650148361,0,4,regulation of guanylate cyclase activity,BP,
7295,GO:0031284,1.00000000000474,0.826285650148361,0,4,positive regulation of guanylate cyclase activity,BP,
6549,GO:0021957,1.00000000000475,0.806396151955552,0,4,corticospinal tract morphogenesis,BP,
10415,GO:0043249,1.00000000000475,0.649950923179726,0,9,erythrocyte maturation,BP,
170,GO:0000354,1.00000000000475,0.901270932125742,0,2,cis assembly of pre-catalytic spliceosome,BP,
16340,GO:0090541,1.00000000000476,0.903711396196999,0,2,MIT domain binding,MF,
10148,GO:0042719,1.00000000000479,0.843765578538769,0,5,mitochondrial intermembrane space protein transporter complex,CC,
14576,GO:0070097,1.00000000000479,0.896519959631305,0,2,delta-catenin binding,MF,
760,GO:0001998,1.0000000000048,0.95701610361049,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
780,GO:0002034,1.0000000000048,0.95701610361049,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
1281,GO:0003072,1.0000000000048,0.95701610361049,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
18528,GO:1903673,1.0000000000048,0.95701610361049,0,1,mitotic cleavage furrow formation,BP,
18961,GO:1904695,1.0000000000048,0.95701610361049,0,1,positive regulation of vascular smooth muscle contraction,BP,
6469,GO:0021794,1.0000000000048,0.700944700694362,0,7,thalamus development,BP,
9552,GO:0036310,1.00000000000481,0.674056398232908,0,8,annealing helicase activity,MF,
16502,GO:0097180,1.00000000000482,0.937548196957492,0,2,serine protease inhibitor complex,CC,
7951,GO:0032541,1.00000000000482,0.797179519479768,0,5,cortical endoplasmic reticulum,CC,
18003,GO:1902415,1.00000000000484,0.662438010321474,0,9,regulation of mRNA binding,BP,
13424,GO:0052794,1.00000000000485,0.912000176784503,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13425,GO:0052795,1.00000000000485,0.912000176784503,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13426,GO:0052796,1.00000000000485,0.912000176784503,0,2,exo-alpha-(2->8)-sialidase activity,MF,
4906,GO:0014832,1.00000000000485,0.855240468627997,0,3,urinary bladder smooth muscle contraction,BP,
4915,GO:0014848,1.00000000000485,0.855240468627997,0,3,urinary tract smooth muscle contraction,BP,
12119,GO:0048149,1.00000000000485,0.813877519340632,0,4,behavioral response to ethanol,BP,
640,GO:0001827,1.00000000000485,0.896587166408608,0,2,inner cell mass cell fate commitment,BP,
641,GO:0001828,1.00000000000485,0.896587166408608,0,2,inner cell mass cellular morphogenesis,BP,
1686,GO:0004149,1.00000000000486,0.953673371050766,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
5659,GO:0016751,1.00000000000486,0.953673371050766,0,1,S-succinyltransferase activity,MF,
11599,GO:0046166,1.00000000000487,0.920050103394587,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
1789,GO:0004408,1.00000000000487,0.955079608320491,0,1,holocytochrome-c synthase activity,MF,
5785,GO:0017003,1.00000000000487,0.955079608320491,0,1,protein-heme linkage,BP,
5788,GO:0017006,1.00000000000487,0.955079608320491,0,1,protein-tetrapyrrole linkage,BP,
5896,GO:0018063,1.00000000000487,0.955079608320491,0,1,cytochrome c-heme linkage,BP,
7735,GO:0032226,1.00000000000488,0.795850932601598,0,5,positive regulation of synaptic transmission, dopaminergic,BP,
6417,GO:0021670,1.00000000000489,0.685413742762133,0,8,lateral ventricle development,BP,
20031,GO:2000618,1.0000000000049,0.78301165637638,0,5,regulation of histone H4-K16 acetylation,BP,
7148,GO:0030984,1.00000000000491,0.923235353882282,0,2,kininogen binding,MF,
9756,GO:0039502,1.00000000000491,0.946745840930703,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9757,GO:0039503,1.00000000000491,0.946745840930703,0,1,suppression by virus of host innate immune response,BP,
9761,GO:0039514,1.00000000000491,0.946745840930703,0,1,suppression by virus of host JAK-STAT cascade,BP,
9777,GO:0039562,1.00000000000491,0.946745840930703,0,1,suppression by virus of host STAT activity,BP,
9778,GO:0039563,1.00000000000491,0.946745840930703,0,1,suppression by virus of host STAT1 activity,BP,
9779,GO:0039564,1.00000000000491,0.946745840930703,0,1,suppression by virus of host STAT2 activity,BP,
10880,GO:0044414,1.00000000000491,0.946745840930703,0,1,suppression of host defenses,BP,
13218,GO:0051833,1.00000000000491,0.946745840930703,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13311,GO:0052029,1.00000000000491,0.946745840930703,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13313,GO:0052037,1.00000000000491,0.946745840930703,0,1,negative regulation by symbiont of host defense response,BP,
13328,GO:0052167,1.00000000000491,0.946745840930703,0,1,modulation by symbiont of host innate immune response,BP,
13329,GO:0052170,1.00000000000491,0.946745840930703,0,1,negative regulation by symbiont of host innate immune response,BP,
13347,GO:0052261,1.00000000000491,0.946745840930703,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13348,GO:0052306,1.00000000000491,0.946745840930703,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13349,GO:0052309,1.00000000000491,0.946745840930703,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13371,GO:0052493,1.00000000000491,0.946745840930703,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13381,GO:0052561,1.00000000000491,0.946745840930703,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13382,GO:0052562,1.00000000000491,0.946745840930703,0,1,negative regulation by symbiont of host immune response,BP,
15961,GO:0075109,1.00000000000491,0.946745840930703,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15962,GO:0075111,1.00000000000491,0.946745840930703,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15963,GO:0075112,1.00000000000491,0.946745840930703,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15964,GO:0075114,1.00000000000491,0.946745840930703,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
16970,GO:0098968,1.00000000000491,0.946745840930703,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
3153,GO:0006751,1.00000000000492,0.80804069992957,0,5,glutathione catabolic process,BP,
3207,GO:0006844,1.00000000000492,0.914168214139579,0,2,acyl carnitine transport,BP,
5047,GO:0015227,1.00000000000492,0.914168214139579,0,2,acyl carnitine transmembrane transporter activity,MF,
4211,GO:0009331,1.00000000000492,0.89858147240707,0,2,glycerol-3-phosphate dehydrogenase complex,CC,
16482,GO:0097152,1.00000000000492,0.705275229945658,0,7,mesenchymal cell apoptotic process,BP,
9224,GO:0035609,1.00000000000493,0.947617867533581,0,1,C-terminal protein deglutamylation,BP,
9225,GO:0035610,1.00000000000493,0.947617867533581,0,1,protein side chain deglutamylation,BP,
4134,GO:0009191,1.00000000000493,0.771631851745403,0,6,ribonucleoside diphosphate catabolic process,BP,
17294,GO:0140031,1.00000000000493,0.910231273075898,0,2,phosphorylation-dependent protein binding,MF,
2763,GO:0006172,1.00000000000493,0.955089550837733,0,1,ADP biosynthetic process,BP,
16529,GO:0097226,1.00000000000493,0.955089550837733,0,1,sperm mitochondrial sheath,CC,
7203,GO:0031088,1.00000000000496,0.797585727269045,0,5,platelet dense granule membrane,CC,
8395,GO:0033313,1.00000000000496,0.784705822042345,0,5,meiotic cell cycle checkpoint,BP,
4143,GO:0009202,1.00000000000496,0.818583801200571,0,5,deoxyribonucleoside triphosphate biosynthetic process,BP,
19290,GO:1905458,1.00000000000496,0.948965133529362,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
19791,GO:2000174,1.00000000000496,0.948965133529362,0,1,regulation of pro-T cell differentiation,BP,
19792,GO:2000176,1.00000000000496,0.948965133529362,0,1,positive regulation of pro-T cell differentiation,BP,
8933,GO:0034777,1.00000000000496,0.955263939764789,0,1,recycling endosome lumen,CC,
5971,GO:0018395,1.00000000000497,0.95046468408337,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6563,GO:0021998,1.00000000000497,0.95046468408337,0,1,neural plate mediolateral regionalization,BP,
8523,GO:0033746,1.00000000000497,0.95046468408337,0,1,histone demethylase activity (H3-R2 specific),MF,
8524,GO:0033749,1.00000000000497,0.95046468408337,0,1,histone demethylase activity (H4-R3 specific),MF,
12200,GO:0048338,1.00000000000497,0.95046468408337,0,1,mesoderm structural organization,BP,
12204,GO:0048352,1.00000000000497,0.95046468408337,0,1,paraxial mesoderm structural organization,BP,
14563,GO:0070077,1.00000000000497,0.95046468408337,0,1,histone arginine demethylation,BP,
14564,GO:0070078,1.00000000000497,0.95046468408337,0,1,histone H3-R2 demethylation,BP,
14565,GO:0070079,1.00000000000497,0.95046468408337,0,1,histone H4-R3 demethylation,BP,
18846,GO:1904412,1.00000000000497,0.95046468408337,0,1,regulation of cardiac ventricle development,BP,
18847,GO:1904414,1.00000000000497,0.95046468408337,0,1,positive regulation of cardiac ventricle development,BP,
19215,GO:1905285,1.00000000000497,0.95046468408337,0,1,fibrous ring of heart morphogenesis,BP,
11040,GO:0045004,1.00000000000497,0.900451362308472,0,2,DNA replication proofreading,BP,
10730,GO:0044065,1.00000000000497,0.666355001344328,0,8,regulation of respiratory system process,BP,
15738,GO:0072298,1.00000000000497,0.859862311960478,0,3,regulation of metanephric glomerulus development,BP,
18338,GO:1903265,1.00000000000498,0.703423995951786,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
14974,GO:0070859,1.00000000000498,0.869327114701033,0,3,positive regulation of bile acid biosynthetic process,BP,
18782,GO:1904253,1.00000000000498,0.869327114701033,0,3,positive regulation of bile acid metabolic process,BP,
6884,GO:0030375,1.00000000000498,0.854420807084706,0,3,thyroid hormone receptor coactivator activity,MF,
10690,GO:0043951,1.00000000000501,0.650301779053624,0,9,negative regulation of cAMP-mediated signaling,BP,
11184,GO:0045254,1.00000000000501,0.711569454425304,0,7,pyruvate dehydrogenase complex,CC,
6018,GO:0019064,1.00000000000501,0.870959065072776,0,3,fusion of virus membrane with host plasma membrane,BP,
9782,GO:0039663,1.00000000000501,0.870959065072776,0,3,membrane fusion involved in viral entry into host cell,BP,
11002,GO:0044800,1.00000000000501,0.870959065072776,0,3,multi-organism membrane fusion,BP,
5276,GO:0015920,1.00000000000501,0.954104617477691,0,1,lipopolysaccharide transport,BP,
7927,GO:0032497,1.00000000000501,0.954104617477691,0,1,detection of lipopolysaccharide,BP,
14800,GO:0070506,1.00000000000501,0.954104617477691,0,1,high-density lipoprotein particle receptor activity,MF,
1749,GO:0004346,1.00000000000501,0.959951323099458,0,1,glucose-6-phosphatase activity,MF,
12478,GO:0050309,1.00000000000501,0.959951323099458,0,1,sugar-terminal-phosphatase activity,MF,
17898,GO:1902162,1.00000000000502,0.938420535030175,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17899,GO:1902164,1.00000000000502,0.938420535030175,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
9209,GO:0035590,1.00000000000502,0.718388563867344,0,7,purinergic nucleotide receptor signaling pathway,BP,
11668,GO:0046404,1.00000000000502,0.870135278542869,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
13173,GO:0051733,1.00000000000502,0.870135278542869,0,3,polydeoxyribonucleotide kinase activity,MF,
13174,GO:0051734,1.00000000000502,0.870135278542869,0,3,ATP-dependent polynucleotide kinase activity,MF,
12668,GO:0050859,1.00000000000504,0.86744832068283,0,3,negative regulation of B cell receptor signaling pathway,BP,
2660,GO:0006001,1.00000000000504,0.828565577732442,0,4,fructose catabolic process,BP,
14391,GO:0061624,1.00000000000504,0.828565577732442,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
14537,GO:0070026,1.00000000000504,0.928391550018931,0,2,nitric oxide binding,MF,
17209,GO:0106020,1.00000000000504,0.90663986189619,0,2,regulation of vesicle docking,BP,
9347,GO:0035851,1.00000000000505,0.953286508234847,0,1,Krueppel-associated box domain binding,MF,
11523,GO:0046016,1.00000000000506,0.87217933494155,0,3,positive regulation of transcription by glucose,BP,
16524,GO:0097213,1.00000000000506,0.955250936335009,0,1,regulation of lysosomal membrane permeability,BP,
9322,GO:0035790,1.00000000000506,0.949484246282225,0,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,
20013,GO:2000583,1.00000000000506,0.949484246282225,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
20014,GO:2000584,1.00000000000506,0.949484246282225,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
2858,GO:0006348,1.00000000000506,0.72245251060847,0,8,chromatin silencing at telomere,BP,
11868,GO:0046848,1.00000000000507,0.963968949597946,0,1,hydroxyapatite binding,MF,
14745,GO:0070404,1.00000000000508,0.891001531932972,0,3,NADH binding,MF,
13272,GO:0051938,1.00000000000508,0.740894945366829,0,6,L-glutamate import,BP,
16838,GO:0098712,1.00000000000508,0.740894945366829,0,6,L-glutamate import across plasma membrane,BP,
1792,GO:0004418,1.00000000000508,0.962442212229748,0,1,hydroxymethylbilane synthase activity,MF,
5917,GO:0018160,1.00000000000508,0.962442212229748,0,1,peptidyl-pyrromethane cofactor linkage,BP,
9309,GO:0035752,1.00000000000508,0.957130335625334,0,1,lysosomal lumen pH elevation,BP,
2701,GO:0006064,1.00000000000508,0.819340872820818,0,5,glucuronate catabolic process,BP,
6194,GO:0019640,1.00000000000508,0.819340872820818,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
12862,GO:0051167,1.00000000000508,0.819340872820818,0,5,xylulose 5-phosphate metabolic process,BP,
17578,GO:1901159,1.00000000000508,0.819340872820818,0,5,xylulose 5-phosphate biosynthetic process,BP,
12475,GO:0050291,1.00000000000508,0.788304515041154,0,5,sphingosine N-acyltransferase activity,MF,
1713,GO:0004301,1.0000000000051,0.736471423458616,0,7,epoxide hydrolase activity,MF,
12987,GO:0051371,1.0000000000051,0.760417029940744,0,5,muscle alpha-actinin binding,MF,
18506,GO:1903608,1.00000000000511,0.707781190502363,0,7,protein localization to cytoplasmic stress granule,BP,
17397,GO:1900112,1.00000000000511,0.640522442115468,0,9,regulation of histone H3-K9 trimethylation,BP,
16968,GO:0098960,1.00000000000511,0.785316608590726,0,5,postsynaptic neurotransmitter receptor activity,MF,
17063,GO:0099529,1.00000000000511,0.785316608590726,0,5,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18807,GO:1904315,1.00000000000511,0.785316608590726,0,5,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
1301,GO:0003131,1.00000000000511,0.953741605690889,0,1,mesodermal-endodermal cell signaling,BP,
7173,GO:0031049,1.00000000000511,0.953741605690889,0,1,programmed DNA elimination,BP,
7175,GO:0031052,1.00000000000511,0.953741605690889,0,1,chromosome breakage,BP,
9152,GO:0035501,1.00000000000511,0.953741605690889,0,1,MH1 domain binding,MF,
9417,GO:0035978,1.00000000000511,0.953741605690889,0,1,histone H2A-S139 phosphorylation,BP,
20082,GO:2000685,1.00000000000511,0.953741605690889,0,1,positive regulation of cellular response to X-ray,BP,
12156,GO:0048251,1.00000000000511,0.668449961576721,0,8,elastic fiber assembly,BP,
1909,GO:0004594,1.00000000000512,0.830308654430238,0,4,pantothenate kinase activity,MF,
19218,GO:1905292,1.00000000000513,0.860711338628949,0,3,regulation of neural crest cell differentiation,BP,
19219,GO:1905294,1.00000000000513,0.860711338628949,0,3,positive regulation of neural crest cell differentiation,BP,
19225,GO:1905310,1.00000000000513,0.860711338628949,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19226,GO:1905312,1.00000000000513,0.860711338628949,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
16834,GO:0098703,1.00000000000514,0.73757617610322,0,6,calcium ion import across plasma membrane,BP,
18088,GO:1902656,1.00000000000514,0.73757617610322,0,6,calcium ion import into cytosol,BP,
18187,GO:1902938,1.00000000000514,0.909676204368554,0,2,regulation of intracellular calcium activated chloride channel activity,BP,
173,GO:0000379,1.00000000000514,0.873394964114959,0,3,tRNA-type intron splice site recognition and cleavage,BP,
10167,GO:0042748,1.00000000000515,0.861542360408908,0,3,circadian sleep/wake cycle, non-REM sleep,BP,
13619,GO:0060075,1.00000000000516,0.863162776542104,0,3,regulation of resting membrane potential,BP,
14544,GO:0070042,1.00000000000517,0.953049299514482,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
8502,GO:0033678,1.00000000000517,0.954149491031031,0,1,5'-3' DNA/RNA helicase activity,MF,
8506,GO:0033682,1.00000000000517,0.954149491031031,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
17553,GO:1901069,1.00000000000518,0.926367952418802,0,2,guanosine-containing compound catabolic process,BP,
17461,GO:1900226,1.00000000000518,0.821373681379275,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
2353,GO:0005416,1.00000000000518,0.634343636409992,0,9,amino acid:cation symporter activity,MF,
8335,GO:0033179,1.00000000000518,0.720663622463647,0,8,proton-transporting V-type ATPase, V0 domain,CC,
1377,GO:0003266,1.00000000000519,0.807943195652267,0,5,regulation of secondary heart field cardioblast proliferation,BP,
9043,GO:0035256,1.00000000000519,0.752813502384156,0,6,G-protein coupled glutamate receptor binding,MF,
18696,GO:1904026,1.0000000000052,0.910095569974317,0,2,regulation of collagen fibril organization,BP,
1243,GO:0002933,1.0000000000052,0.915133991187607,0,2,lipid hydroxylation,BP,
17125,GO:0101020,1.0000000000052,0.915133991187607,0,2,estrogen 16-alpha-hydroxylase activity,MF,
8495,GO:0033650,1.00000000000521,0.958552393610214,0,1,host cell mitochondrion,CC,
10761,GO:0044190,1.00000000000521,0.958552393610214,0,1,host cell mitochondrial envelope,CC,
15815,GO:0072492,1.00000000000521,0.958552393610214,0,1,host cell mitochondrial intermembrane space,CC,
9236,GO:0035623,1.00000000000521,0.952209551805313,0,1,renal glucose absorption,BP,
14901,GO:0070685,1.00000000000521,0.95580201290659,0,1,macropinocytic cup,CC,
4094,GO:0009146,1.00000000000522,0.786873486691981,0,6,purine nucleoside triphosphate catabolic process,BP,
5023,GO:0015183,1.00000000000522,0.861962529839649,0,3,L-aspartate transmembrane transporter activity,MF,
1048,GO:0002568,1.00000000000522,0.77107782655043,0,5,somatic diversification of T cell receptor genes,BP,
1095,GO:0002681,1.00000000000522,0.77107782655043,0,5,somatic recombination of T cell receptor gene segments,BP,
8321,GO:0033153,1.00000000000522,0.77107782655043,0,5,T cell receptor V(D)J recombination,BP,
15374,GO:0071599,1.00000000000523,0.729892044496217,0,6,otic vesicle development,BP,
4737,GO:0010898,1.00000000000524,0.905032636988706,0,2,positive regulation of triglyceride catabolic process,BP,
1910,GO:0004595,1.00000000000524,0.955046950285784,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
19386,GO:1905793,1.00000000000525,0.896424823696107,0,2,protein localization to pericentriolar material,BP,
16896,GO:0098826,1.00000000000525,0.829611987079389,0,4,endoplasmic reticulum tubular network membrane,CC,
19358,GO:1905666,1.00000000000526,0.629949332117564,0,9,regulation of protein localization to endosome,BP,
19359,GO:1905668,1.00000000000526,0.629949332117564,0,9,positive regulation of protein localization to endosome,BP,
13551,GO:0055120,1.00000000000526,0.970824921636638,0,1,striated muscle dense body,CC,
6954,GO:0030576,1.00000000000527,0.865197267746098,0,3,Cajal body organization,BP,
11500,GO:0045955,1.00000000000527,0.708284558282741,0,7,negative regulation of calcium ion-dependent exocytosis,BP,
10348,GO:0043141,1.00000000000527,0.79435173100608,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
2612,GO:0005915,1.00000000000528,0.735228754499589,0,6,zonula adherens,CC,
588,GO:0001740,1.00000000000529,0.865610641738651,0,3,Barr body,CC,
5520,GO:0016479,1.00000000000529,0.865610641738651,0,3,negative regulation of transcription by RNA polymerase I,BP,
84,GO:0000171,1.00000000000529,0.90411911759731,0,2,ribonuclease MRP activity,MF,
15731,GO:0072278,1.00000000000529,0.909722494994669,0,2,metanephric comma-shaped body morphogenesis,BP,
9424,GO:0035988,1.00000000000529,0.706132198654365,0,7,chondrocyte proliferation,BP,
9304,GO:0035747,1.00000000000529,0.875694554664567,0,3,natural killer cell chemotaxis,BP,
3302,GO:0007000,1.00000000000531,0.718530222408658,0,7,nucleolus organization,BP,
8388,GO:0033291,1.00000000000532,0.988681049960472,0,1,eukaryotic 80S initiation complex,CC,
8785,GO:0034463,1.00000000000532,0.988681049960472,0,1,90S preribosome assembly,BP,
3439,GO:0007231,1.00000000000532,0.914245209927757,0,2,osmosensory signaling pathway,BP,
3460,GO:0007274,1.00000000000532,0.625216015848902,0,9,neuromuscular synaptic transmission,BP,
824,GO:0002094,1.00000000000532,0.91377307481431,0,2,polyprenyltransferase activity,MF,
12517,GO:0050613,1.00000000000532,0.91228448237527,0,2,delta14-sterol reductase activity,MF,
7521,GO:0031702,1.00000000000533,0.695522681153471,0,7,type 1 angiotensin receptor binding,MF,
19051,GO:1904875,1.00000000000533,0.911372039918722,0,2,regulation of DNA ligase activity,BP,
5580,GO:0016593,1.00000000000533,0.673529230993365,0,8,Cdc73/Paf1 complex,CC,
16504,GO:0097187,1.00000000000534,0.868439485389485,0,3,dentinogenesis,BP,
19516,GO:1990269,1.00000000000534,0.904802705113577,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
10964,GO:0044715,1.00000000000536,0.930188996079891,0,2,8-oxo-dGDP phosphatase activity,MF,
17862,GO:1902035,1.00000000000536,0.82180055674218,0,4,positive regulation of hematopoietic stem cell proliferation,BP,
5843,GO:0017126,1.00000000000536,0.946707880517341,0,1,nucleologenesis,BP,
18397,GO:1903385,1.00000000000536,0.900477373910582,0,2,regulation of homophilic cell adhesion,BP,
9816,GO:0042008,1.00000000000536,0.950921554129649,0,1,interleukin-18 receptor activity,MF,
19598,GO:1990613,1.00000000000536,0.950921554129649,0,1,mitochondrial membrane fusion,BP,
7870,GO:0032427,1.00000000000536,0.905292074470754,0,2,GBD domain binding,MF,
13876,GO:0060478,1.00000000000537,0.922182784784263,0,2,acrosomal vesicle exocytosis,BP,
19906,GO:2000367,1.00000000000537,0.922182784784263,0,2,regulation of acrosomal vesicle exocytosis,BP,
19907,GO:2000368,1.00000000000537,0.922182784784263,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
5070,GO:0015288,1.00000000000537,0.773884398886747,0,6,porin activity,MF,
14332,GO:0061470,1.00000000000538,0.819066136518854,0,4,T follicular helper cell differentiation,BP,
17950,GO:1902263,1.00000000000539,0.875422582138987,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
15974,GO:0075713,1.00000000000539,0.69732984044205,0,8,establishment of integrated proviral latency,BP,
19303,GO:1905502,1.00000000000539,0.967644015844617,0,1,acetyl-CoA binding,MF,
1649,GO:0004090,1.00000000000539,0.883346686264518,0,4,carbonyl reductase (NADPH) activity,MF,
13770,GO:0060332,1.00000000000541,0.853342467048978,0,3,positive regulation of response to interferon-gamma,BP,
13773,GO:0060335,1.00000000000541,0.853342467048978,0,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,
17031,GO:0099170,1.00000000000541,0.861736498364944,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
17074,GO:0099547,1.00000000000541,0.861736498364944,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17087,GO:0099578,1.00000000000541,0.861736498364944,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
2055,GO:0004802,1.00000000000542,0.955809543411406,0,1,transketolase activity,MF,
13282,GO:0051956,1.00000000000542,0.861573551764731,0,3,negative regulation of amino acid transport,BP,
7350,GO:0031379,1.00000000000542,0.944336670833684,0,2,RNA-directed RNA polymerase complex,CC,
20128,GO:2000774,1.00000000000543,0.685081970751175,0,9,positive regulation of cellular senescence,BP,
5895,GO:0018057,1.00000000000545,0.862623605183116,0,3,peptidyl-lysine oxidation,BP,
5031,GO:0015193,1.00000000000546,0.771492600948705,0,5,L-proline transmembrane transporter activity,MF,
9172,GO:0035524,1.00000000000546,0.771492600948705,0,5,proline transmembrane transport,BP,
12828,GO:0051120,1.00000000000546,0.908850518003999,0,2,hepoxilin A3 synthase activity,MF,
17619,GO:1901291,1.00000000000547,0.957051176458032,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
12990,GO:0051379,1.00000000000547,0.913218930895876,0,2,epinephrine binding,MF,
7394,GO:0031442,1.00000000000548,0.641048819580569,0,9,positive regulation of mRNA 3'-end processing,BP,
11973,GO:0047159,1.00000000000549,0.949049113081838,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
11978,GO:0047191,1.00000000000549,0.949049113081838,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
20303,GO:2001246,1.00000000000549,0.949049113081838,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
18953,GO:1904684,1.00000000000549,0.806510162532608,0,4,negative regulation of metalloendopeptidase activity,BP,
2626,GO:0005945,1.00000000000549,0.907086245675216,0,2,6-phosphofructokinase complex,CC,
9271,GO:0035691,1.00000000000549,0.965206743172768,0,1,macrophage migration inhibitory factor signaling pathway,BP,
9273,GO:0035693,1.00000000000549,0.965206743172768,0,1,NOS2-CD74 complex,CC,
10127,GO:0042658,1.00000000000549,0.965206743172768,0,1,MHC class II protein binding, via antigen binding groove,MF,
6038,GO:0019103,1.00000000000551,0.779823008548604,0,6,pyrimidine nucleotide binding,MF,
1337,GO:0003190,1.00000000000552,0.80780912299785,0,4,atrioventricular valve formation,BP,
19717,GO:2000017,1.00000000000552,0.906964184770951,0,2,positive regulation of determination of dorsal identity,BP,
15884,GO:0072592,1.00000000000552,0.913352283384539,0,2,oxygen metabolic process,BP,
3874,GO:0008496,1.00000000000552,0.948056532887046,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
218,GO:0000454,1.00000000000552,0.913662959878915,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
4645,GO:0010764,1.00000000000553,0.752940348923707,0,6,negative regulation of fibroblast migration,BP,
7050,GO:0030819,1.00000000000554,0.669553081311358,0,9,positive regulation of cAMP biosynthetic process,BP,
7298,GO:0031291,1.00000000000554,0.882034383898984,0,3,Ran protein signal transduction,BP,
13283,GO:0051957,1.00000000000554,0.747223456532648,0,6,positive regulation of amino acid transport,BP,
9164,GO:0035516,1.00000000000555,0.947953609502153,0,1,oxidative DNA demethylase activity,MF,
14720,GO:0070343,1.00000000000555,0.947953609502153,0,1,white fat cell proliferation,BP,
14724,GO:0070350,1.00000000000555,0.947953609502153,0,1,regulation of white fat cell proliferation,BP,
19692,GO:1990931,1.00000000000555,0.947953609502153,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
4558,GO:0010636,1.00000000000556,0.90345144762343,0,2,positive regulation of mitochondrial fusion,BP,
546,GO:0001665,1.00000000000557,0.837565764019893,0,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
15770,GO:0072349,1.00000000000557,0.626201362914348,0,9,modified amino acid transmembrane transporter activity,MF,
16463,GO:0097113,1.00000000000557,0.786040168531455,0,5,AMPA glutamate receptor clustering,BP,
16720,GO:0097688,1.00000000000557,0.786040168531455,0,5,glutamate receptor clustering,BP,
14369,GO:0061577,1.00000000000559,0.667520797184968,0,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
5058,GO:0015252,1.00000000000559,0.95273624809012,0,1,proton channel activity,MF,
9132,GO:0035445,1.00000000000559,0.95273624809012,0,1,borate transmembrane transport,BP,
11829,GO:0046713,1.00000000000559,0.95273624809012,0,1,borate transport,BP,
11830,GO:0046715,1.00000000000559,0.95273624809012,0,1,active borate transmembrane transporter activity,MF,
1456,GO:0003689,1.00000000000559,0.694443186014083,0,8,DNA clamp loader activity,MF,
8330,GO:0033170,1.00000000000559,0.694443186014083,0,8,protein-DNA loading ATPase activity,MF,
13810,GO:0060383,1.00000000000559,0.948539822288479,0,1,positive regulation of DNA strand elongation,BP,
19296,GO:1905464,1.00000000000559,0.948539822288479,0,1,positive regulation of DNA duplex unwinding,BP,
19381,GO:1905774,1.00000000000559,0.948539822288479,0,1,regulation of DNA helicase activity,BP,
19382,GO:1905776,1.00000000000559,0.948539822288479,0,1,positive regulation of DNA helicase activity,BP,
19697,GO:1990955,1.00000000000559,0.948539822288479,0,1,G-rich single-stranded DNA binding,MF,
19482,GO:1990144,1.0000000000056,0.764609801344348,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
2637,GO:0005967,1.0000000000056,0.857542254775716,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
6949,GO:0030553,1.0000000000056,0.852366135610229,0,3,cGMP binding,MF,
20026,GO:2000611,1.00000000000562,0.904683738597141,0,2,positive regulation of thyroid hormone generation,BP,
6111,GO:0019344,1.00000000000562,0.873501915728703,0,3,cysteine biosynthetic process,BP,
8911,GO:0034739,1.00000000000563,0.917521150623461,0,2,histone deacetylase activity (H4-K16 specific),MF,
2891,GO:0006398,1.00000000000564,0.784161594444272,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
14676,GO:0070269,1.00000000000564,0.70901798967671,0,8,pyroptosis,BP,
2228,GO:0005128,1.00000000000565,0.952082180819538,0,1,erythropoietin receptor binding,MF,
2233,GO:0005135,1.00000000000565,0.952082180819538,0,1,interleukin-3 receptor binding,MF,
14053,GO:0060768,1.00000000000565,0.694741857872782,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
9064,GO:0035290,1.00000000000565,0.859257144794323,0,3,trunk segmentation,BP,
9622,GO:0036484,1.00000000000565,0.859257144794323,0,3,trunk neural crest cell migration,BP,
9623,GO:0036486,1.00000000000565,0.859257144794323,0,3,ventral trunk neural crest cell migration,BP,
17584,GO:1901166,1.00000000000565,0.859257144794323,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
7774,GO:0032290,1.00000000000565,0.809033576851401,0,4,peripheral nervous system myelin formation,BP,
3173,GO:0006787,1.00000000000566,0.794899386799348,0,6,porphyrin-containing compound catabolic process,BP,
8246,GO:0033015,1.00000000000566,0.794899386799348,0,6,tetrapyrrole catabolic process,BP,
9892,GO:0042167,1.00000000000566,0.794899386799348,0,6,heme catabolic process,BP,
11595,GO:0046149,1.00000000000566,0.794899386799348,0,6,pigment catabolic process,BP,
1773,GO:0004375,1.00000000000566,0.949560029253976,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
5607,GO:0016642,1.00000000000566,0.949560029253976,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
9530,GO:0036255,1.00000000000566,0.949560029253976,0,1,response to methylamine,BP,
14681,GO:0070280,1.00000000000566,0.949560029253976,0,1,pyridoxal binding,MF,
18429,GO:1903442,1.00000000000566,0.949560029253976,0,1,response to lipoic acid,BP,
2670,GO:0006015,1.00000000000567,0.869886495960247,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
11663,GO:0046391,1.00000000000567,0.869886495960247,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
1802,GO:0004439,1.00000000000567,0.664079819717082,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
512,GO:0001575,1.00000000000569,0.91493464422424,0,2,globoside metabolic process,BP,
9489,GO:0036122,1.00000000000569,0.862348291650177,0,3,BMP binding,MF,
16777,GO:0098559,1.0000000000057,0.869223694275109,0,3,cytoplasmic side of early endosome membrane,CC,
15628,GO:0072102,1.0000000000057,0.858907840672925,0,3,glomerulus morphogenesis,BP,
10995,GO:0044789,1.00000000000572,0.772559932759182,0,5,modulation by host of viral release from host cell,BP,
10996,GO:0044791,1.00000000000572,0.772559932759182,0,5,positive regulation by host of viral release from host cell,BP,
8480,GO:0033624,1.00000000000573,0.900696230264579,0,2,negative regulation of integrin activation,BP,
1661,GO:0004113,1.00000000000574,0.946742424289997,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
2302,GO:0005275,1.00000000000574,0.953101777470331,0,1,amine transmembrane transporter activity,MF,
5060,GO:0015265,1.00000000000574,0.953101777470331,0,1,urea channel activity,MF,
5715,GO:0016842,1.00000000000575,0.75019745970663,0,7,amidine-lyase activity,MF,
10586,GO:0043546,1.00000000000575,0.737813852068936,0,6,molybdopterin cofactor binding,MF,
11971,GO:0047144,1.00000000000576,0.637083589656197,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
5413,GO:0016250,1.00000000000576,0.953901502363122,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5704,GO:0016826,1.00000000000576,0.953901502363122,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
2509,GO:0005760,1.00000000000577,0.897951716730341,0,2,gamma DNA polymerase complex,CC,
16310,GO:0090402,1.00000000000578,0.912342731466618,0,2,oncogene-induced cell senescence,BP,
13840,GO:0060423,1.00000000000579,0.908786047686852,0,2,foregut regionalization,BP,
13841,GO:0060424,1.00000000000579,0.908786047686852,0,2,lung field specification,BP,
13889,GO:0060492,1.00000000000579,0.908786047686852,0,2,lung induction,BP,
1805,GO:0004446,1.0000000000058,0.953688129579984,0,1,inositol-hexakisphosphate phosphatase activity,MF,
6878,GO:0030351,1.0000000000058,0.953688129579984,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
8531,GO:0033787,1.0000000000058,0.953688129579984,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8757,GO:0034417,1.0000000000058,0.953688129579984,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
13438,GO:0052826,1.0000000000058,0.953688129579984,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
18029,GO:1902499,1.0000000000058,0.953688129579984,0,1,positive regulation of protein autoubiquitination,BP,
7568,GO:0031906,1.0000000000058,0.9162799946995,0,2,late endosome lumen,CC,
16641,GO:0097486,1.0000000000058,0.9162799946995,0,2,multivesicular body lumen,CC,
371,GO:0000992,1.0000000000058,0.903746977147662,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0001002,1.0000000000058,0.903746977147662,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
376,GO:0001003,1.0000000000058,0.903746977147662,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
5234,GO:0015846,1.00000000000581,0.759346732351597,0,6,polyamine transport,BP,
18615,GO:1903862,1.00000000000582,0.808050792146476,0,5,positive regulation of oxidative phosphorylation,BP,
14440,GO:0061738,1.00000000000582,0.869405668092811,0,3,late endosomal microautophagy,BP,
18017,GO:1902464,1.00000000000583,0.947675701138055,0,1,regulation of histone H3-K27 trimethylation,BP,
18018,GO:1902466,1.00000000000583,0.947675701138055,0,1,positive regulation of histone H3-K27 trimethylation,BP,
5961,GO:0018335,1.00000000000583,0.818707053924545,0,4,protein succinylation,BP,
17229,GO:0106077,1.00000000000583,0.818707053924545,0,4,histone succinylation,BP,
939,GO:0002337,1.00000000000583,0.915890641789747,0,2,B-1a B cell differentiation,BP,
18991,GO:1904751,1.00000000000583,0.88676862326254,0,3,positive regulation of protein localization to nucleolus,BP,
11983,GO:0047237,1.00000000000585,0.905944655933644,0,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
4800,GO:0010989,1.00000000000587,0.864438510065069,0,3,negative regulation of low-density lipoprotein particle clearance,BP,
11740,GO:0046541,1.00000000000587,0.953966259308303,0,1,saliva secretion,BP,
15331,GO:0071535,1.00000000000589,0.832257664401334,0,4,RING-like zinc finger domain binding,MF,
16642,GO:0097487,1.00000000000589,0.885691151917652,0,3,multivesicular body, internal vesicle,CC,
15728,GO:0072272,1.0000000000059,0.913602907666041,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
8941,GO:0034971,1.0000000000059,0.95326177470164,0,1,histone H3-R17 methylation,BP,
9250,GO:0035642,1.0000000000059,0.95326177470164,0,1,histone methyltransferase activity (H3-R17 specific),MF,
1934,GO:0004630,1.0000000000059,0.789332840768885,0,5,phospholipase D activity,MF,
19926,GO:2000392,1.00000000000591,0.630040781408546,0,9,regulation of lamellipodium morphogenesis,BP,
12186,GO:0048298,1.00000000000592,0.829890097437417,0,4,positive regulation of isotype switching to IgA isotypes,BP,
486,GO:0001537,1.00000000000592,0.904478691300109,0,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
19648,GO:1990784,1.00000000000592,0.948731171351294,0,1,response to dsDNA,BP,
19650,GO:1990786,1.00000000000592,0.948731171351294,0,1,cellular response to dsDNA,BP,
477,GO:0001520,1.00000000000593,0.902311803396671,0,2,outer dense fiber,CC,
19428,GO:1905937,1.00000000000593,0.973765905228794,0,1,negative regulation of germ cell proliferation,BP,
19831,GO:2000255,1.00000000000593,0.973765905228794,0,1,negative regulation of male germ cell proliferation,BP,
14250,GO:0061200,1.00000000000593,0.786757892430705,0,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
14251,GO:0061202,1.00000000000593,0.786757892430705,0,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
16996,GO:0099053,1.00000000000594,0.863441015343624,0,3,activating signal cointegrator 1 complex,CC,
14055,GO:0060770,1.00000000000595,0.771429148391912,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
16468,GO:0097119,1.00000000000596,0.815939488246946,0,4,postsynaptic density protein 95 clustering,BP,
6472,GO:0021797,1.00000000000597,0.951497211449964,0,1,forebrain anterior/posterior pattern specification,BP,
6511,GO:0021881,1.00000000000597,0.951497211449964,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
12197,GO:0048320,1.00000000000597,0.951497211449964,0,1,axial mesoderm formation,BP,
14067,GO:0060823,1.00000000000597,0.951497211449964,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
940,GO:0002339,1.00000000000597,0.93305126646383,0,2,B cell selection,BP,
944,GO:0002352,1.00000000000597,0.93305126646383,0,2,B cell negative selection,BP,
5279,GO:0015925,1.00000000000597,0.757312718424192,0,6,galactosidase activity,MF,
7485,GO:0031645,1.00000000000597,0.721107739077283,0,7,negative regulation of neurological system process,BP,
8748,GO:0034395,1.00000000000597,0.961175224232728,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
6348,GO:0021520,1.00000000000597,0.742090893554787,0,6,spinal cord motor neuron cell fate specification,BP,
14419,GO:0061689,1.00000000000597,0.864175866141758,0,3,tricellular tight junction,CC,
9023,GO:0035226,1.00000000000598,0.95289546429053,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9024,GO:0035227,1.00000000000598,0.95289546429053,0,1,regulation of glutamate-cysteine ligase activity,BP,
9025,GO:0035229,1.00000000000598,0.95289546429053,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
15057,GO:0070991,1.00000000000598,0.8657713708043,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
2191,GO:0005047,1.00000000000598,0.791940338649799,0,5,signal recognition particle binding,MF,
124,GO:0000254,1.00000000000598,0.909249293778496,0,2,C-4 methylsterol oxidase activity,MF,
1831,GO:0004483,1.00000000000598,0.909249293778496,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2888,GO:0006393,1.00000000000598,0.909249293778496,0,2,termination of mitochondrial transcription,BP,
3209,GO:0006850,1.00000000000598,0.909249293778496,0,2,mitochondrial pyruvate transmembrane transport,BP,
4012,GO:0008988,1.00000000000598,0.909249293778496,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
5541,GO:0016524,1.00000000000598,0.909249293778496,0,2,latrotoxin receptor activity,MF,
6023,GO:0019075,1.00000000000598,0.909249293778496,0,2,virus maturation,BP,
9598,GO:0036451,1.00000000000598,0.909249293778496,0,2,cap mRNA methylation,BP,
15371,GO:0071595,1.00000000000598,0.909249293778496,0,2,Nem1-Spo7 phosphatase complex,CC,
15980,GO:0080023,1.00000000000598,0.909249293778496,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
16561,GO:0097309,1.00000000000598,0.909249293778496,0,2,cap1 mRNA methylation,BP,
19471,GO:1990112,1.00000000000598,0.909249293778496,0,2,RQC complex,CC,
19472,GO:1990116,1.00000000000598,0.909249293778496,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19674,GO:1990879,1.00000000000598,0.909249293778496,0,2,CST complex,CC,
19993,GO:2000543,1.00000000000598,0.909249293778496,0,2,positive regulation of gastrulation,BP,
17137,GO:0102121,1.00000000000599,0.910156423617135,0,2,ceramidase activity,MF,
4991,GO:0015116,1.00000000000599,0.742796104312969,0,6,sulfate transmembrane transporter activity,MF,
17981,GO:1902358,1.00000000000599,0.742796104312969,0,6,sulfate transmembrane transport,BP,
4323,GO:0009812,1.000000000006,0.672694968170958,0,9,flavonoid metabolic process,BP,
16402,GO:0097003,1.000000000006,0.906950443734612,0,2,adipokinetic hormone receptor activity,MF,
5424,GO:0016269,1.000000000006,0.954524684620224,0,1,O-glycan processing, core 3,BP,
11982,GO:0047224,1.000000000006,0.954524684620224,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
10043,GO:0042492,1.00000000000601,0.773728050418689,0,5,gamma-delta T cell differentiation,BP,
12855,GO:0051152,1.00000000000602,0.692923950329091,0,8,positive regulation of smooth muscle cell differentiation,BP,
8040,GO:0032681,1.00000000000603,0.954032042478962,0,1,regulation of lymphotoxin A production,BP,
8085,GO:0032761,1.00000000000603,0.954032042478962,0,1,positive regulation of lymphotoxin A production,BP,
10277,GO:0043016,1.00000000000603,0.954032042478962,0,1,regulation of lymphotoxin A biosynthetic process,BP,
10278,GO:0043017,1.00000000000603,0.954032042478962,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11242,GO:0045404,1.00000000000603,0.954032042478962,0,1,positive regulation of interleukin-4 biosynthetic process,BP,
12753,GO:0051005,1.00000000000603,0.893980428799768,0,3,negative regulation of lipoprotein lipase activity,BP,
9126,GO:0035435,1.00000000000604,0.670133896537057,0,8,phosphate ion transmembrane transport,BP,
16532,GO:0097229,1.00000000000605,0.964885699427677,0,1,sperm end piece,CC,
3820,GO:0008410,1.00000000000606,0.868303643065103,0,3,CoA-transferase activity,MF,
7196,GO:0031081,1.00000000000606,0.904190715856519,0,2,nuclear pore distribution,BP,
13136,GO:0051664,1.00000000000606,0.904190715856519,0,2,nuclear pore localization,BP,
15580,GO:0072017,1.00000000000606,0.683364081831323,0,7,distal tubule development,BP,
13019,GO:0051431,1.00000000000608,0.96223083795358,0,1,corticotropin-releasing hormone receptor 2 binding,MF,
16444,GO:0097070,1.00000000000609,0.946671289404361,0,1,ductus arteriosus closure,BP,
16545,GO:0097272,1.00000000000609,0.946671289404361,0,1,ammonia homeostasis,BP,
16546,GO:0097273,1.00000000000609,0.946671289404361,0,1,creatinine homeostasis,BP,
16548,GO:0097275,1.00000000000609,0.946671289404361,0,1,cellular ammonia homeostasis,BP,
16549,GO:0097276,1.00000000000609,0.946671289404361,0,1,cellular creatinine homeostasis,BP,
16550,GO:0097277,1.00000000000609,0.946671289404361,0,1,cellular urea homeostasis,BP,
3751,GO:0008290,1.00000000000609,0.757538276382947,0,6,F-actin capping protein complex,CC,
14296,GO:0061357,1.0000000000061,0.860407127398661,0,3,positive regulation of Wnt protein secretion,BP,
4479,GO:0010481,1.0000000000061,0.871852743480167,0,3,epidermal cell division,BP,
4480,GO:0010482,1.0000000000061,0.871852743480167,0,3,regulation of epidermal cell division,BP,
6829,GO:0030284,1.0000000000061,0.780181953820015,0,5,estrogen receptor activity,MF,
6044,GO:0019136,1.00000000000612,0.843209733119336,0,4,deoxynucleoside kinase activity,MF,
11072,GO:0045062,1.00000000000612,0.959050753681175,0,1,extrathymic T cell selection,BP,
15074,GO:0071021,1.00000000000612,0.959050753681175,0,1,U2-type post-spliceosomal complex,CC,
3286,GO:0006975,1.00000000000612,0.715141987628428,0,7,DNA damage induced protein phosphorylation,BP,
16719,GO:0097682,1.00000000000613,0.955829755909414,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
2587,GO:0005879,1.00000000000614,0.785554758203612,0,5,axonemal microtubule,CC,
18880,GO:1904502,1.00000000000616,0.780216905419722,0,5,regulation of lipophagy,BP,
18881,GO:1904504,1.00000000000616,0.780216905419722,0,5,positive regulation of lipophagy,BP,
12556,GO:0050692,1.00000000000616,0.906464886878942,0,2,DBD domain binding,MF,
10571,GO:0043527,1.00000000000617,0.806693481820848,0,5,tRNA methyltransferase complex,CC,
4799,GO:0010988,1.00000000000617,0.765158222502141,0,6,regulation of low-density lipoprotein particle clearance,BP,
3469,GO:0007290,1.00000000000618,0.947072608738905,0,1,spermatid nucleus elongation,BP,
11619,GO:0046293,1.00000000000618,0.947072608738905,0,1,formaldehyde biosynthetic process,BP,
3112,GO:0006689,1.00000000000618,0.829795454717838,0,4,ganglioside catabolic process,BP,
12824,GO:0051106,1.00000000000618,0.787454304847449,0,5,positive regulation of DNA ligation,BP,
2037,GO:0004774,1.00000000000618,0.878253445137323,0,3,succinate-CoA ligase activity,MF,
9202,GO:0035583,1.00000000000618,0.848455686324445,0,3,sequestering of TGFbeta in extracellular matrix,BP,
2806,GO:0006265,1.00000000000619,0.642994405839412,0,9,DNA topological change,BP,
2469,GO:0005683,1.00000000000619,0.803686357108807,0,7,U7 snRNP,CC,
7189,GO:0031071,1.0000000000062,0.954806996765815,0,1,cysteine desulfurase activity,MF,
14815,GO:0070535,1.0000000000062,0.773516400008263,0,5,histone H2A K63-linked ubiquitination,BP,
2177,GO:0005010,1.0000000000062,0.848382837630123,0,3,insulin-like growth factor-activated receptor activity,MF,
13260,GO:0051920,1.00000000000621,0.769388777098984,0,8,peroxiredoxin activity,MF,
18667,GO:1903964,1.00000000000622,0.903425959519232,0,2,monounsaturated fatty acid metabolic process,BP,
18668,GO:1903966,1.00000000000622,0.903425959519232,0,2,monounsaturated fatty acid biosynthetic process,BP,
16787,GO:0098582,1.00000000000622,0.899677868046773,0,2,innate vocalization behavior,BP,
13101,GO:0051597,1.00000000000622,0.743540283453571,0,6,response to methylmercury,BP,
3982,GO:0008803,1.00000000000622,0.972176646785653,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
18322,GO:1903223,1.00000000000623,0.853742203535072,0,3,positive regulation of oxidative stress-induced neuron death,BP,
9428,GO:0035993,1.00000000000624,0.872838776243595,0,3,deltoid tuberosity development,BP,
16141,GO:0090128,1.00000000000624,0.746532381852632,0,6,regulation of synapse maturation,BP,
20124,GO:2000767,1.00000000000624,0.678180085559419,0,8,positive regulation of cytoplasmic translation,BP,
12557,GO:0050693,1.00000000000624,0.82221491754061,0,4,LBD domain binding,MF,
6689,GO:0030050,1.00000000000626,0.729136975605183,0,6,vesicle transport along actin filament,BP,
16046,GO:0086057,1.00000000000626,0.949438353114512,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
19493,GO:1990174,1.00000000000626,0.949438353114512,0,1,phosphodiesterase decapping endonuclease activity,MF,
5964,GO:0018344,1.00000000000626,0.756390958846029,0,6,protein geranylgeranylation,BP,
6126,GO:0019370,1.00000000000626,0.753850481391571,0,7,leukotriene biosynthetic process,BP,
16752,GO:0098501,1.00000000000626,0.810549522551831,0,5,polynucleotide dephosphorylation,BP,
18134,GO:1902804,1.00000000000627,0.865112176121432,0,3,negative regulation of synaptic vesicle transport,BP,
19858,GO:2000301,1.00000000000627,0.865112176121432,0,3,negative regulation of synaptic vesicle exocytosis,BP,
18346,GO:1903286,1.00000000000627,0.867958542793816,0,3,regulation of potassium ion import,BP,
4892,GO:0014809,1.00000000000627,0.892483656621718,0,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
20263,GO:2001183,1.00000000000627,0.957281287182523,0,1,negative regulation of interleukin-12 secretion,BP,
14337,GO:0061484,1.00000000000628,0.858147605760937,0,3,hematopoietic stem cell homeostasis,BP,
17579,GO:1901160,1.00000000000628,0.708551949331052,0,7,primary amino compound metabolic process,BP,
13985,GO:0060678,1.00000000000628,0.955168090334662,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15642,GO:0072127,1.00000000000628,0.955168090334662,0,1,renal capsule development,BP,
15643,GO:0072128,1.00000000000628,0.955168090334662,0,1,renal capsule morphogenesis,BP,
15644,GO:0072129,1.00000000000628,0.955168090334662,0,1,renal capsule formation,BP,
15645,GO:0072130,1.00000000000628,0.955168090334662,0,1,renal capsule specification,BP,
15699,GO:0072213,1.00000000000628,0.955168090334662,0,1,metanephric capsule development,BP,
15724,GO:0072265,1.00000000000628,0.955168090334662,0,1,metanephric capsule morphogenesis,BP,
15725,GO:0072266,1.00000000000628,0.955168090334662,0,1,metanephric capsule formation,BP,
15726,GO:0072267,1.00000000000628,0.955168090334662,0,1,metanephric capsule specification,BP,
17687,GO:1901534,1.00000000000628,0.902743175425623,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
15692,GO:0072203,1.00000000000628,0.740310898563839,0,6,cell proliferation involved in metanephros development,BP,
1744,GO:0004340,1.00000000000629,0.85405040247723,0,3,glucokinase activity,MF,
1785,GO:0004396,1.00000000000629,0.85405040247723,0,3,hexokinase activity,MF,
3992,GO:0008865,1.00000000000629,0.85405040247723,0,3,fructokinase activity,MF,
6049,GO:0019158,1.00000000000629,0.85405040247723,0,3,mannokinase activity,MF,
3214,GO:0006858,1.0000000000063,0.877385828816687,0,3,extracellular transport,BP,
1794,GO:0004420,1.0000000000063,0.947467094450758,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
9937,GO:0042282,1.0000000000063,0.947467094450758,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
6043,GO:0019135,1.0000000000063,0.957277129422,0,1,deoxyhypusine monooxygenase activity,MF,
16132,GO:0090107,1.00000000000631,0.872823150278388,0,3,regulation of high-density lipoprotein particle assembly,BP,
7216,GO:0031104,1.00000000000632,0.94855141830485,0,1,dendrite regeneration,BP,
14097,GO:0060903,1.00000000000633,0.906056932013458,0,2,positive regulation of meiosis I,BP,
10925,GO:0044531,1.00000000000635,0.765368741194314,0,6,modulation of programmed cell death in other organism,BP,
10926,GO:0044532,1.00000000000635,0.765368741194314,0,6,modulation of apoptotic process in other organism,BP,
13314,GO:0052040,1.00000000000635,0.765368741194314,0,6,modulation by symbiont of host programmed cell death,BP,
13343,GO:0052248,1.00000000000635,0.765368741194314,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
13368,GO:0052433,1.00000000000635,0.765368741194314,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
10056,GO:0042535,1.00000000000635,0.831212319695437,0,4,positive regulation of tumor necrosis factor biosynthetic process,BP,
12188,GO:0048304,1.00000000000635,0.785528543534699,0,5,positive regulation of isotype switching to IgG isotypes,BP,
11938,GO:0046974,1.00000000000636,0.775405468175378,0,5,histone methyltransferase activity (H3-K9 specific),MF,
14961,GO:0070842,1.00000000000636,0.854115372803566,0,3,aggresome assembly,BP,
109,GO:0000225,1.00000000000636,0.968448987204011,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
7066,GO:0030849,1.00000000000636,0.94677525428384,0,1,autosome,CC,
1164,GO:0002775,1.00000000000636,0.875820774223248,0,3,antimicrobial peptide production,BP,
1165,GO:0002778,1.00000000000636,0.875820774223248,0,3,antibacterial peptide production,BP,
1166,GO:0002784,1.00000000000636,0.875820774223248,0,3,regulation of antimicrobial peptide production,BP,
1168,GO:0002786,1.00000000000636,0.875820774223248,0,3,regulation of antibacterial peptide production,BP,
14975,GO:0070860,1.00000000000636,0.955018178820145,0,1,RNA polymerase I core factor complex,CC,
17364,GO:1900040,1.00000000000637,0.775553546933871,0,5,regulation of interleukin-2 secretion,BP,
8299,GO:0033128,1.00000000000637,0.913180342561162,0,2,negative regulation of histone phosphorylation,BP,
5122,GO:0015464,1.00000000000637,0.713868989570229,0,7,acetylcholine receptor activity,MF,
10060,GO:0042539,1.00000000000637,0.901762440547963,0,2,hypotonic salinity response,BP,
15303,GO:0071477,1.00000000000637,0.901762440547963,0,2,cellular hypotonic salinity response,BP,
2410,GO:0005579,1.00000000000637,0.946681000733193,0,1,membrane attack complex,CC,
293,GO:0000797,1.00000000000639,0.94700827859738,0,1,condensin core heterodimer,CC,
13383,GO:0052564,1.00000000000639,0.796607707070342,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
13385,GO:0052572,1.00000000000639,0.796607707070342,0,5,response to host immune response,BP,
10188,GO:0042776,1.0000000000064,0.886746808056022,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
12504,GO:0050501,1.0000000000064,0.868866034725722,0,3,hyaluronan synthase activity,MF,
14138,GO:0060987,1.00000000000641,0.954974548439521,0,1,lipid tube,CC,
5496,GO:0016428,1.00000000000642,0.829327286069128,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5538,GO:0016517,1.00000000000642,0.956529222487673,0,1,interleukin-12 receptor activity,MF,
9818,GO:0042019,1.00000000000642,0.956529222487673,0,1,interleukin-23 binding,MF,
9819,GO:0042020,1.00000000000642,0.956529222487673,0,1,interleukin-23 receptor activity,MF,
9820,GO:0042022,1.00000000000642,0.956529222487673,0,1,interleukin-12 receptor complex,CC,
15845,GO:0072536,1.00000000000642,0.956529222487673,0,1,interleukin-23 receptor complex,CC,
2444,GO:0005642,1.00000000000642,0.779725553109409,0,5,annulate lamellae,CC,
7843,GO:0032393,1.00000000000643,0.929782180522234,0,2,MHC class I receptor activity,MF,
11573,GO:0046110,1.00000000000643,0.861741820684567,0,3,xanthine metabolic process,BP,
13417,GO:0052739,1.00000000000643,0.956031576289968,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13418,GO:0052740,1.00000000000643,0.956031576289968,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
18896,GO:1904550,1.00000000000643,0.956031576289968,0,1,response to arachidonic acid,BP,
19877,GO:2000324,1.00000000000643,0.956031576289968,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
13088,GO:0051582,1.00000000000643,0.918113543597939,0,2,positive regulation of neurotransmitter uptake,BP,
5879,GO:0017196,1.00000000000643,0.752525743645718,0,6,N-terminal peptidyl-methionine acetylation,BP,
7356,GO:0031393,1.00000000000644,0.904579113318303,0,2,negative regulation of prostaglandin biosynthetic process,BP,
13082,GO:0051572,1.00000000000644,0.85763197382081,0,3,negative regulation of histone H3-K4 methylation,BP,
9760,GO:0039513,1.00000000000644,0.953921719598578,0,1,suppression by virus of host catalytic activity,BP,
9762,GO:0039516,1.00000000000644,0.953921719598578,0,1,modulation by virus of host catalytic activity,BP,
9780,GO:0039650,1.00000000000644,0.953921719598578,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
13318,GO:0052053,1.00000000000644,0.953921719598578,0,1,negative regulation by symbiont of host catalytic activity,BP,
13325,GO:0052148,1.00000000000644,0.953921719598578,0,1,modulation by symbiont of host catalytic activity,BP,
2578,GO:0005863,1.00000000000644,0.950050253157699,0,1,striated muscle myosin thick filament,CC,
3310,GO:0007014,1.00000000000644,0.950050253157699,0,1,actin ubiquitination,BP,
9582,GO:0036392,1.00000000000644,0.950050253157699,0,1,chemokine (C-C motif) ligand 20 production,BP,
18618,GO:1903881,1.00000000000644,0.950050253157699,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18619,GO:1903883,1.00000000000644,0.950050253157699,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18620,GO:1903884,1.00000000000644,0.950050253157699,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18621,GO:1903886,1.00000000000644,0.950050253157699,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
14051,GO:0060766,1.00000000000645,0.671093081320514,0,8,negative regulation of androgen receptor signaling pathway,BP,
5930,GO:0018201,1.00000000000645,0.854962169828464,0,3,peptidyl-glycine modification,BP,
11780,GO:0046628,1.00000000000645,0.625519876532472,0,9,positive regulation of insulin receptor signaling pathway,BP,
18458,GO:1903525,1.00000000000646,0.765447564499379,0,5,regulation of membrane tubulation,BP,
10882,GO:0044416,1.00000000000646,0.919295091851783,0,2,induction by symbiont of host defense response,BP,
11838,GO:0046730,1.00000000000646,0.919295091851783,0,2,induction of host immune response by virus,BP,
11839,GO:0046732,1.00000000000646,0.919295091851783,0,2,active induction of host immune response by virus,BP,
13345,GO:0052251,1.00000000000646,0.919295091851783,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
13373,GO:0052509,1.00000000000646,0.919295091851783,0,2,positive regulation by symbiont of host defense response,BP,
13374,GO:0052510,1.00000000000646,0.919295091851783,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
4930,GO:0014878,1.00000000000648,0.946709957932672,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
14385,GO:0061617,1.00000000000649,0.728653443807052,0,8,MICOS complex,CC,
429,GO:0001147,1.00000000000649,0.900486426625656,0,2,transcription termination site sequence-specific DNA binding,MF,
432,GO:0001160,1.00000000000649,0.900486426625656,0,2,transcription termination site DNA binding,MF,
12498,GO:0050436,1.00000000000651,0.898672744649839,0,2,microfibril binding,MF,
7851,GO:0032405,1.00000000000652,0.791422671562524,0,5,MutLalpha complex binding,MF,
1645,GO:0004085,1.00000000000654,0.95700062411734,0,1,butyryl-CoA dehydrogenase activity,MF,
6189,GO:0019605,1.00000000000654,0.95700062411734,0,1,butyrate metabolic process,BP,
11650,GO:0046359,1.00000000000654,0.95700062411734,0,1,butyrate catabolic process,BP,
13462,GO:0052890,1.00000000000654,0.95700062411734,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
18909,GO:1904576,1.00000000000655,0.915294338101583,0,2,response to tunicamycin,BP,
18910,GO:1904577,1.00000000000655,0.915294338101583,0,2,cellular response to tunicamycin,BP,
8016,GO:0032641,1.00000000000655,0.908994676988592,0,2,lymphotoxin A production,BP,
9863,GO:0042109,1.00000000000655,0.908994676988592,0,2,lymphotoxin A biosynthetic process,BP,
14425,GO:0061702,1.00000000000655,0.741558508566279,0,7,inflammasome complex,CC,
14775,GO:0070459,1.00000000000656,0.809620310432964,0,5,prolactin secretion,BP,
1468,GO:0003720,1.00000000000656,0.708947460110956,0,8,telomerase activity,MF,
1566,GO:0003964,1.00000000000656,0.708947460110956,0,8,RNA-directed DNA polymerase activity,MF,
3770,GO:0008318,1.00000000000658,0.721391652592308,0,7,protein prenyltransferase activity,MF,
16971,GO:0098969,1.00000000000658,0.645074542488982,0,9,neurotransmitter receptor transport to postsynaptic membrane,BP,
18467,GO:1903539,1.00000000000658,0.645074542488982,0,9,protein localization to postsynaptic membrane,BP,
18468,GO:1903540,1.00000000000658,0.645074542488982,0,9,establishment of protein localization to postsynaptic membrane,BP,
16651,GO:0097500,1.00000000000659,0.861499919173501,0,3,receptor localization to non-motile cilium,BP,
11550,GO:0046070,1.00000000000659,0.866458050644361,0,4,dGTP metabolic process,BP,
18889,GO:1904530,1.0000000000066,0.952802544540091,0,1,negative regulation of actin filament binding,BP,
18931,GO:1904617,1.0000000000066,0.952802544540091,0,1,negative regulation of actin binding,BP,
5528,GO:0016494,1.0000000000066,0.868052250196616,0,3,C-X-C chemokine receptor activity,MF,
11324,GO:0045634,1.00000000000661,0.780939790792776,0,5,regulation of melanocyte differentiation,BP,
20227,GO:2001070,1.00000000000661,0.903726474397496,0,2,starch binding,MF,
14966,GO:0070847,1.00000000000661,0.715276141085583,0,8,core mediator complex,CC,
9951,GO:0042308,1.00000000000661,0.716472070224858,0,7,negative regulation of protein import into nucleus,BP,
18919,GO:1904590,1.00000000000661,0.716472070224858,0,7,negative regulation of protein import,BP,
8548,GO:0033878,1.00000000000661,0.949632347536741,0,1,hormone-sensitive lipase activity,MF,
9781,GO:0039656,1.00000000000662,0.913028049347542,0,2,modulation by virus of host gene expression,BP,
11843,GO:0046778,1.00000000000662,0.913028049347542,0,2,modification by virus of host mRNA processing,BP,
6113,GO:0019348,1.00000000000663,0.805738507731932,0,5,dolichol metabolic process,BP,
13070,GO:0051548,1.00000000000663,0.89618678400892,0,2,negative regulation of keratinocyte migration,BP,
1610,GO:0004030,1.00000000000664,0.784955872763634,0,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,
5548,GO:0016533,1.00000000000664,0.919575407019616,0,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
3409,GO:0007191,1.00000000000664,0.752827577013231,0,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
12594,GO:0050747,1.00000000000664,0.801829620046313,0,5,positive regulation of lipoprotein metabolic process,BP,
2360,GO:0005457,1.00000000000666,0.901548066653525,0,2,GDP-fucose transmembrane transporter activity,MF,
5197,GO:0015783,1.00000000000666,0.901548066653525,0,2,GDP-fucose transmembrane transport,BP,
9470,GO:0036080,1.00000000000666,0.901548066653525,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
601,GO:0001766,1.00000000000666,0.768992286791918,0,6,membrane raft polarization,BP,
7450,GO:0031580,1.00000000000666,0.768992286791918,0,6,membrane raft distribution,BP,
18279,GO:1903116,1.00000000000667,0.900193056262184,0,2,positive regulation of actin filament-based movement,BP,
18578,GO:1903781,1.00000000000667,0.900193056262184,0,2,positive regulation of cardiac conduction,BP,
18659,GO:1903949,1.00000000000667,0.900193056262184,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19866,GO:2000312,1.00000000000667,0.859077057797454,0,3,regulation of kainate selective glutamate receptor activity,BP,
8309,GO:0033140,1.00000000000667,0.913296111696741,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
1745,GO:0004342,1.00000000000667,0.914001243426174,0,2,glucosamine-6-phosphate deaminase activity,MF,
2683,GO:0006043,1.00000000000667,0.914001243426174,0,2,glucosamine catabolic process,BP,
15290,GO:0071460,1.00000000000668,0.935500530858406,0,2,cellular response to cell-matrix adhesion,BP,
1908,GO:0004591,1.00000000000668,0.82314329377092,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
7656,GO:0032071,1.00000000000668,0.733705507822205,0,7,regulation of endodeoxyribonuclease activity,BP,
14864,GO:0070625,1.00000000000669,0.955960497526646,0,1,zymogen granule exocytosis,BP,
15795,GO:0072387,1.00000000000669,0.908192677520476,0,2,flavin adenine dinucleotide metabolic process,BP,
19594,GO:1990597,1.0000000000067,0.858624877216504,0,3,AIP1-IRE1 complex,CC,
7272,GO:0031247,1.00000000000672,0.912274317125024,0,2,actin rod assembly,BP,
1977,GO:0004690,1.00000000000674,0.698564996822325,0,7,cyclic nucleotide-dependent protein kinase activity,MF,
8796,GO:0034481,1.00000000000674,0.818239733406063,0,4,chondroitin sulfotransferase activity,MF,
6777,GO:0030207,1.00000000000675,0.646287983297519,0,9,chondroitin sulfate catabolic process,BP,
19715,GO:2000015,1.00000000000675,0.883478439855445,0,3,regulation of determination of dorsal identity,BP,
7829,GO:0032378,1.00000000000677,0.950373235088164,0,1,negative regulation of intracellular lipid transport,BP,
7832,GO:0032381,1.00000000000677,0.950373235088164,0,1,negative regulation of intracellular sterol transport,BP,
7835,GO:0032384,1.00000000000677,0.950373235088164,0,1,negative regulation of intracellular cholesterol transport,BP,
19336,GO:1905596,1.00000000000677,0.950373235088164,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
19338,GO:1905598,1.00000000000677,0.950373235088164,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
19341,GO:1905601,1.00000000000677,0.950373235088164,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
622,GO:0001794,1.00000000000677,0.946779152315551,0,1,type IIa hypersensitivity,BP,
623,GO:0001796,1.00000000000677,0.946779152315551,0,1,regulation of type IIa hypersensitivity,BP,
624,GO:0001798,1.00000000000677,0.946779152315551,0,1,positive regulation of type IIa hypersensitivity,BP,
742,GO:0001970,1.00000000000677,0.946779152315551,0,1,positive regulation of activation of membrane attack complex,BP,
991,GO:0002445,1.00000000000677,0.946779152315551,0,1,type II hypersensitivity,BP,
1225,GO:0002892,1.00000000000677,0.946779152315551,0,1,regulation of type II hypersensitivity,BP,
1226,GO:0002894,1.00000000000677,0.946779152315551,0,1,positive regulation of type II hypersensitivity,BP,
7526,GO:0031714,1.00000000000677,0.946779152315551,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7527,GO:0031715,1.00000000000677,0.946779152315551,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
4957,GO:0015018,1.00000000000677,0.962907679101673,0,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
9541,GO:0036290,1.00000000000677,0.948791746282244,0,1,protein trans-autophosphorylation,BP,
17957,GO:1902283,1.00000000000677,0.948791746282244,0,1,negative regulation of primary amine oxidase activity,BP,
19522,GO:1990332,1.00000000000677,0.948791746282244,0,1,Ire1 complex,CC,
19589,GO:1990579,1.00000000000677,0.948791746282244,0,1,peptidyl-serine trans-autophosphorylation,BP,
19602,GO:1990630,1.00000000000677,0.948791746282244,0,1,IRE1-RACK1-PP2A complex,CC,
5976,GO:0018423,1.00000000000677,0.920683868373057,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
388,GO:0001032,1.00000000000678,0.82151649182863,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
374,GO:0000995,1.00000000000679,0.812043494315195,0,4,transcription factor activity, core RNA polymerase III binding,MF,
13879,GO:0060481,1.00000000000679,0.915901596227019,0,2,lobar bronchus epithelium development,BP,
13677,GO:0060179,1.0000000000068,0.865322276044113,0,3,male mating behavior,BP,
15678,GO:0072185,1.0000000000068,0.954854060639748,0,1,metanephric cap development,BP,
15679,GO:0072186,1.0000000000068,0.954854060639748,0,1,metanephric cap morphogenesis,BP,
16125,GO:0090094,1.0000000000068,0.954854060639748,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
16126,GO:0090095,1.0000000000068,0.954854060639748,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
16127,GO:0090096,1.0000000000068,0.954854060639748,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
8800,GO:0034498,1.0000000000068,0.679959555514241,0,8,early endosome to Golgi transport,BP,
10952,GO:0044614,1.00000000000681,0.814696992044335,0,4,nuclear pore cytoplasmic filaments,CC,
9962,GO:0042328,1.00000000000682,0.855855581051762,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
14513,GO:0062009,1.00000000000682,0.666264568347305,0,8,secondary palate development,BP,
1791,GO:0004416,1.00000000000683,0.916003194634792,0,2,hydroxyacylglutathione hydrolase activity,MF,
6090,GO:0019243,1.00000000000683,0.916003194634792,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
13100,GO:0051596,1.00000000000683,0.916003194634792,0,2,methylglyoxal catabolic process,BP,
14433,GO:0061727,1.00000000000683,0.916003194634792,0,2,methylglyoxal catabolic process to lactate,BP,
9815,GO:0042007,1.00000000000683,0.963283048751574,0,1,interleukin-18 binding,MF,
14028,GO:0060735,1.00000000000684,0.964221453802767,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
18082,GO:1902629,1.00000000000684,0.964221453802767,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
1849,GO:0004505,1.00000000000684,0.927864207336593,0,2,phenylalanine 4-monooxygenase activity,MF,
3649,GO:0008124,1.00000000000684,0.927864207336593,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
14922,GO:0070739,1.00000000000685,0.742580051734572,0,6,protein-glutamic acid ligase activity,MF,
14923,GO:0070740,1.00000000000685,0.742580051734572,0,6,tubulin-glutamic acid ligase activity,MF,
4,GO:0000010,1.00000000000686,0.912875039443364,0,2,trans-hexaprenyltranstransferase activity,MF,
12484,GO:0050347,1.00000000000686,0.912875039443364,0,2,trans-octaprenyltranstransferase activity,MF,
15370,GO:0071593,1.00000000000686,0.86461457369368,0,3,lymphocyte aggregation,BP,
9719,GO:0038131,1.00000000000687,0.911106572393042,0,2,neuregulin receptor activity,MF,
14579,GO:0070100,1.00000000000687,0.820520483625573,0,4,negative regulation of chemokine-mediated signaling pathway,BP,
6746,GO:0030160,1.00000000000687,0.857897926140673,0,3,GKAP/Homer scaffold activity,MF,
10416,GO:0043250,1.00000000000687,0.961895811803982,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
10417,GO:0043251,1.00000000000687,0.961895811803982,0,1,sodium-dependent organic anion transport,BP,
16265,GO:0090308,1.00000000000688,0.659873529772327,0,8,regulation of methylation-dependent chromatin silencing,BP,
16679,GO:0097550,1.00000000000688,0.768090382892341,0,6,transcriptional preinitiation complex,CC,
16605,GO:0097411,1.00000000000688,0.823674504267964,0,4,hypoxia-inducible factor-1alpha signaling pathway,BP,
7167,GO:0031033,1.00000000000689,0.770445230638236,0,5,myosin filament organization,BP,
18626,GO:1903893,1.0000000000069,0.95451329687937,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
18641,GO:1903912,1.0000000000069,0.819176578673072,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
1527,GO:0003896,1.0000000000069,0.876565957357418,0,3,DNA primase activity,MF,
16454,GO:0097104,1.00000000000691,0.803667806949007,0,4,postsynaptic membrane assembly,BP,
17628,GO:1901301,1.00000000000691,0.903754400702249,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
12046,GO:0047750,1.00000000000691,0.941736206932458,0,2,cholestenol delta-isomerase activity,MF,
347,GO:0000960,1.00000000000691,0.81624494236513,0,4,regulation of mitochondrial RNA catabolic process,BP,
3021,GO:0006566,1.00000000000692,0.884784930210502,0,3,threonine metabolic process,BP,
16474,GO:0097134,1.00000000000692,0.914553380227454,0,2,cyclin E1-CDK2 complex,CC,
9942,GO:0042289,1.00000000000693,0.927348811466871,0,2,MHC class II protein binding,MF,
13847,GO:0060431,1.00000000000694,0.864151405860673,0,3,primary lung bud formation,BP,
4499,GO:0010521,1.00000000000694,0.878572961280291,0,3,telomerase inhibitor activity,MF,
19592,GO:1990590,1.00000000000694,0.915459436091181,0,2,ATF1-ATF4 transcription factor complex,CC,
11576,GO:0046113,1.00000000000695,0.772420087586384,0,5,nucleobase catabolic process,BP,
10332,GO:0043121,1.00000000000696,0.771806636611771,0,5,neurotrophin binding,MF,
384,GO:0001025,1.00000000000696,0.848380216503073,0,3,RNA polymerase III transcription factor binding,MF,
430,GO:0001156,1.00000000000696,0.848380216503073,0,3,TFIIIC-class transcription factor binding,MF,
2278,GO:0005220,1.00000000000696,0.848380216503073,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2416,GO:0005588,1.00000000000696,0.848380216503073,0,3,collagen type V trimer,CC,
2429,GO:0005606,1.00000000000696,0.848380216503073,0,3,laminin-1 complex,CC,
2781,GO:0006211,1.00000000000696,0.848380216503073,0,3,5-methylcytosine catabolic process,BP,
5204,GO:0015798,1.00000000000696,0.848380216503073,0,3,myo-inositol transport,BP,
6268,GO:0019857,1.00000000000696,0.848380216503073,0,3,5-methylcytosine metabolic process,BP,
6671,GO:0030023,1.00000000000696,0.848380216503073,0,3,extracellular matrix constituent conferring elasticity,MF,
10423,GO:0043259,1.00000000000696,0.848380216503073,0,3,laminin-10 complex,CC,
10424,GO:0043260,1.00000000000696,0.848380216503073,0,3,laminin-11 complex,CC,
14135,GO:0060979,1.00000000000696,0.848380216503073,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,
15433,GO:0071688,1.00000000000696,0.848380216503073,0,3,striated muscle myosin thick filament assembly,BP,
16660,GO:0097513,1.00000000000696,0.848380216503073,0,3,myosin II filament,CC,
3943,GO:0008627,1.00000000000697,0.711618053105355,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
15828,GO:0072513,1.00000000000697,0.976733057549926,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
4181,GO:0009256,1.00000000000697,0.817195253457744,0,4,10-formyltetrahydrofolate metabolic process,BP,
11244,GO:0045409,1.00000000000698,0.901736010735036,0,2,negative regulation of interleukin-6 biosynthetic process,BP,
15429,GO:0071680,1.00000000000698,0.770879882807221,0,5,response to indole-3-methanol,BP,
15430,GO:0071681,1.00000000000698,0.770879882807221,0,5,cellular response to indole-3-methanol,BP,
12758,GO:0051013,1.00000000000698,0.748270013739153,0,6,microtubule severing,BP,
7613,GO:0031995,1.00000000000698,0.765340544064338,0,6,insulin-like growth factor II binding,MF,
7453,GO:0031584,1.00000000000699,0.798811793759521,0,5,activation of phospholipase D activity,BP,
12276,GO:0048560,1.00000000000699,0.912785647898584,0,2,establishment of anatomical structure orientation,BP,
16938,GO:0098904,1.00000000000701,0.909266274878076,0,2,regulation of AV node cell action potential,BP,
2702,GO:0006065,1.00000000000701,0.861610864757215,0,3,UDP-glucuronate biosynthetic process,BP,
11666,GO:0046398,1.00000000000701,0.861610864757215,0,3,UDP-glucuronate metabolic process,BP,
6230,GO:0019777,1.00000000000702,0.92285522613862,0,2,Atg12 transferase activity,MF,
3604,GO:0008043,1.00000000000703,0.942823701525552,0,2,intracellular ferritin complex,CC,
10350,GO:0043144,1.00000000000703,0.750193188089903,0,8,snoRNA processing,BP,
14684,GO:0070288,1.00000000000703,0.942823701525552,0,2,ferritin complex,CC,
16792,GO:0098592,1.00000000000704,0.862486237369452,0,3,cytoplasmic side of apical plasma membrane,CC,
6092,GO:0019254,1.00000000000704,0.910127706124019,0,2,carnitine metabolic process, CoA-linked,BP,
15099,GO:0071073,1.00000000000705,0.872699545018817,0,3,positive regulation of phospholipid biosynthetic process,BP,
14658,GO:0070235,1.00000000000705,0.79252765975142,0,5,regulation of activation-induced cell death of T cells,BP,
3935,GO:0008614,1.00000000000705,0.909103471928603,0,2,pyridoxine metabolic process,BP,
3936,GO:0008615,1.00000000000705,0.909103471928603,0,2,pyridoxine biosynthetic process,BP,
4730,GO:0010889,1.00000000000705,0.715717337263831,0,7,regulation of sequestering of triglyceride,BP,
1862,GO:0004522,1.00000000000706,0.9609538976582,0,1,ribonuclease A activity,MF,
3976,GO:0008785,1.00000000000706,0.9609538976582,0,1,alkyl hydroperoxide reductase activity,MF,
10602,GO:0043568,1.00000000000706,0.774398737652807,0,5,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
7749,GO:0032258,1.00000000000707,0.911223319101248,0,2,protein localization by the Cvt pathway,BP,
1936,GO:0004632,1.00000000000707,0.966167862277533,0,1,phosphopantothenate--cysteine ligase activity,MF,
13570,GO:0060019,1.00000000000707,0.671419257094013,0,9,radial glial cell differentiation,BP,
3618,GO:0008066,1.00000000000709,0.849521094769233,0,3,glutamate receptor activity,MF,
16479,GO:0097149,1.00000000000709,0.859268797047664,0,3,centralspindlin complex,CC,
9921,GO:0042262,1.0000000000071,0.843584907570246,0,5,DNA protection,BP,
5772,GO:0016942,1.00000000000712,0.878717076717965,0,3,insulin-like growth factor binding protein complex,CC,
9600,GO:0036454,1.00000000000712,0.878717076717965,0,3,growth factor complex,CC,
10873,GO:0044393,1.00000000000713,0.862811650984522,0,3,microspike,CC,
3712,GO:0008227,1.00000000000714,0.693435691571461,0,8,G-protein coupled amine receptor activity,MF,
19804,GO:2000197,1.00000000000714,0.740494804469983,0,6,regulation of ribonucleoprotein complex localization,BP,
12058,GO:0047894,1.00000000000715,0.925966624342235,0,2,flavonol 3-sulfotransferase activity,MF,
6508,GO:0021873,1.00000000000715,0.730692262045077,0,6,forebrain neuroblast division,BP,
2193,GO:0005049,1.00000000000715,0.656549952418992,0,8,nuclear export signal receptor activity,MF,
3942,GO:0008626,1.00000000000715,0.868628142074334,0,3,granzyme-mediated apoptotic signaling pathway,BP,
8168,GO:0032898,1.00000000000716,0.856891994494267,0,3,neurotrophin production,BP,
5599,GO:0016624,1.00000000000717,0.68858350759835,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
8427,GO:0033504,1.00000000000719,0.848568763402871,0,3,floor plate development,BP,
4929,GO:0014877,1.0000000000072,0.774502874873953,0,5,response to muscle inactivity involved in regulation of muscle adaptation,BP,
4937,GO:0014894,1.0000000000072,0.774502874873953,0,5,response to denervation involved in regulation of muscle adaptation,BP,
9302,GO:0035744,1.0000000000072,0.968599548646044,0,1,T-helper 1 cell cytokine production,BP,
9911,GO:0042231,1.0000000000072,0.968599548646044,0,1,interleukin-13 biosynthetic process,BP,
10346,GO:0043139,1.00000000000721,0.719269074926566,0,7,5'-3' DNA helicase activity,MF,
5518,GO:0016476,1.00000000000722,0.861570514811226,0,3,regulation of embryonic cell shape,BP,
300,GO:0000806,1.00000000000722,0.904391623221842,0,2,Y chromosome,CC,
16411,GO:0097018,1.00000000000723,0.954492943361776,0,1,renal albumin absorption,BP,
17418,GO:1900141,1.00000000000723,0.954492943361776,0,1,regulation of oligodendrocyte apoptotic process,BP,
17419,GO:1900142,1.00000000000723,0.954492943361776,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
19986,GO:2000532,1.00000000000723,0.954492943361776,0,1,regulation of renal albumin absorption,BP,
19987,GO:2000533,1.00000000000723,0.954492943361776,0,1,negative regulation of renal albumin absorption,BP,
17794,GO:1901838,1.00000000000724,0.648995075950074,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
12032,GO:0047631,1.00000000000725,0.83828087791012,0,5,ADP-ribose diphosphatase activity,MF,
706,GO:0001923,1.00000000000725,0.867198325780122,0,3,B-1 B cell differentiation,BP,
7727,GO:0032213,1.00000000000726,0.909101854223982,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7728,GO:0032214,1.00000000000726,0.909101854223982,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
18892,GO:1904534,1.00000000000726,0.909101854223982,0,2,negative regulation of telomeric loop disassembly,BP,
19384,GO:1905778,1.00000000000726,0.909101854223982,0,2,negative regulation of exonuclease activity,BP,
19395,GO:1905838,1.00000000000726,0.909101854223982,0,2,regulation of telomeric D-loop disassembly,BP,
19396,GO:1905839,1.00000000000726,0.909101854223982,0,2,negative regulation of telomeric D-loop disassembly,BP,
7463,GO:0031595,1.00000000000726,0.722137403242583,0,8,nuclear proteasome complex,CC,
20059,GO:2000656,1.00000000000727,0.957339956365122,0,1,regulation of apolipoprotein binding,BP,
20060,GO:2000657,1.00000000000727,0.957339956365122,0,1,negative regulation of apolipoprotein binding,BP,
1433,GO:0003404,1.00000000000727,0.951944319134212,0,1,optic vesicle morphogenesis,BP,
1437,GO:0003409,1.00000000000727,0.951944319134212,0,1,optic cup structural organization,BP,
6407,GO:0021622,1.00000000000727,0.951944319134212,0,1,oculomotor nerve morphogenesis,BP,
6408,GO:0021623,1.00000000000727,0.951944319134212,0,1,oculomotor nerve formation,BP,
14620,GO:0070172,1.00000000000727,0.951944319134212,0,1,positive regulation of tooth mineralization,BP,
9099,GO:0035360,1.00000000000728,0.783735487398412,0,5,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9285,GO:0035720,1.00000000000728,0.861927647198609,0,3,intraciliary anterograde transport,BP,
7472,GO:0031626,1.00000000000729,0.946749365261695,0,1,beta-endorphin binding,MF,
15243,GO:0071387,1.00000000000729,0.946749365261695,0,1,cellular response to cortisol stimulus,BP,
7571,GO:0031915,1.00000000000729,0.783996434334776,0,5,positive regulation of synaptic plasticity,BP,
19452,GO:1990034,1.0000000000073,0.864460898764432,0,3,calcium ion export across plasma membrane,BP,
15058,GO:0070992,1.0000000000073,0.942158718181815,0,2,translation initiation complex,CC,
8497,GO:0033668,1.00000000000731,0.837446954610242,0,4,negative regulation by symbiont of host apoptotic process,BP,
13315,GO:0052041,1.00000000000731,0.837446954610242,0,4,negative regulation by symbiont of host programmed cell death,BP,
13370,GO:0052490,1.00000000000731,0.837446954610242,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
6381,GO:0021562,1.00000000000731,0.81117966209767,0,4,vestibulocochlear nerve development,BP,
8987,GO:0035092,1.00000000000731,0.84936938485757,0,3,sperm chromatin condensation,BP,
12688,GO:0050882,1.00000000000732,0.731529236635377,0,6,voluntary musculoskeletal movement,BP,
15334,GO:0071540,1.00000000000733,0.946711215901004,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
14412,GO:0061668,1.00000000000733,0.751327257593309,0,6,mitochondrial ribosome assembly,BP,
7426,GO:0031515,1.00000000000734,0.870843653337278,0,3,tRNA (m1A) methyltransferase complex,CC,
2985,GO:0006528,1.00000000000734,0.880519163516008,0,3,asparagine metabolic process,BP,
1679,GO:0004140,1.00000000000734,0.913188070652998,0,2,dephospho-CoA kinase activity,MF,
4481,GO:0010484,1.00000000000734,0.813419277240874,0,4,H3 histone acetyltransferase activity,MF,
7428,GO:0031523,1.00000000000734,0.903136004656421,0,2,Myb complex,CC,
13143,GO:0051684,1.00000000000734,0.854634729502978,0,3,maintenance of Golgi location,BP,
11979,GO:0047192,1.00000000000735,0.859849912756071,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
17568,GO:1901097,1.00000000000735,0.820835556887602,0,4,negative regulation of autophagosome maturation,BP,
3803,GO:0008379,1.00000000000736,0.863495313679588,0,5,thioredoxin peroxidase activity,MF,
12099,GO:0048050,1.00000000000736,0.788935616771026,0,6,post-embryonic eye morphogenesis,BP,
10279,GO:0043020,1.00000000000737,0.906169710461757,0,3,NADPH oxidase complex,CC,
17363,GO:1900039,1.00000000000738,0.967959254526494,0,1,positive regulation of cellular response to hypoxia,BP,
17873,GO:1902071,1.00000000000738,0.967959254526494,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17874,GO:1902073,1.00000000000738,0.967959254526494,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
1917,GO:0004607,1.00000000000738,0.964422146454901,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
6972,GO:0030622,1.00000000000739,0.86247291193311,0,3,U4atac snRNA binding,MF,
9058,GO:0035279,1.00000000000739,0.906438597572057,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
16877,GO:0098795,1.00000000000739,0.906438597572057,0,2,mRNA cleavage involved in gene silencing,BP,
8755,GO:0034414,1.00000000000739,0.907125003442238,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
10189,GO:0042779,1.00000000000739,0.907125003442238,0,2,tRNA 3'-trailer cleavage,BP,
10191,GO:0042781,1.00000000000739,0.907125003442238,0,2,3'-tRNA processing endoribonuclease activity,MF,
19205,GO:1905267,1.00000000000739,0.907125003442238,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
4620,GO:0010735,1.0000000000074,0.852445504869752,0,3,positive regulation of transcription via serum response element binding,BP,
6352,GO:0021524,1.0000000000074,0.914037852900439,0,2,visceral motor neuron differentiation,BP,
3263,GO:0006933,1.0000000000074,0.915371278429603,0,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
15134,GO:0071211,1.0000000000074,0.818916789629094,0,4,protein targeting to vacuole involved in autophagy,BP,
1559,GO:0003955,1.0000000000074,0.879580650145988,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
7567,GO:0031905,1.00000000000742,0.880216925756233,0,3,early endosome lumen,CC,
5262,GO:0015888,1.00000000000743,0.906253959897877,0,2,thiamine transport,BP,
3524,GO:0007499,1.00000000000744,0.947257763877519,0,1,ectoderm and mesoderm interaction,BP,
12397,GO:0048807,1.00000000000744,0.947257763877519,0,1,female genitalia morphogenesis,BP,
16413,GO:0097021,1.00000000000744,0.907293526793235,0,2,lymphocyte migration into lymphoid organs,BP,
9017,GO:0035189,1.00000000000744,0.863276820814955,0,3,Rb-E2F complex,CC,
18434,GO:1903461,1.00000000000745,0.952776529096672,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
18151,GO:1902856,1.00000000000745,0.89978034213145,0,2,negative regulation of non-motile cilium assembly,BP,
19624,GO:1990737,1.00000000000745,0.861383713372123,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
5474,GO:0016403,1.00000000000745,0.91550531247139,0,2,dimethylargininase activity,MF,
19004,GO:1904778,1.00000000000745,0.773236198398923,0,5,positive regulation of protein localization to cell cortex,BP,
8533,GO:0033823,1.00000000000746,0.953218904594923,0,1,procollagen glucosyltransferase activity,MF,
13169,GO:0051728,1.00000000000746,0.953218904594923,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
13170,GO:0051729,1.00000000000746,0.953218904594923,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13680,GO:0060184,1.00000000000746,0.953218904594923,0,1,cell cycle switching,BP,
2994,GO:0006538,1.00000000000747,0.743426118465741,0,6,glutamate catabolic process,BP,
6889,GO:0030389,1.00000000000747,0.979953574928741,0,1,fructosamine metabolic process,BP,
1340,GO:0003195,1.00000000000747,0.952192082456943,0,1,tricuspid valve formation,BP,
11241,GO:0045403,1.00000000000747,0.952192082456943,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
12932,GO:0051267,1.00000000000747,0.952192082456943,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13542,GO:0055103,1.00000000000747,0.952192082456943,0,1,ligase regulator activity,MF,
13803,GO:0060375,1.00000000000747,0.952192082456943,0,1,regulation of mast cell differentiation,BP,
13804,GO:0060377,1.00000000000747,0.952192082456943,0,1,negative regulation of mast cell differentiation,BP,
20040,GO:2000631,1.00000000000747,0.952192082456943,0,1,regulation of pre-miRNA processing,BP,
20041,GO:2000632,1.00000000000747,0.952192082456943,0,1,negative regulation of pre-miRNA processing,BP,
12766,GO:0051021,1.00000000000748,0.826574679000074,0,4,GDP-dissociation inhibitor binding,MF,
12767,GO:0051022,1.00000000000748,0.826574679000074,0,4,Rho GDP-dissociation inhibitor binding,MF,
3669,GO:0008160,1.00000000000748,0.954254696054083,0,1,protein tyrosine phosphatase activator activity,MF,
17065,GO:0099532,1.00000000000748,0.896506730424585,0,2,synaptic vesicle endosomal processing,BP,
9021,GO:0035197,1.00000000000749,0.633824026450061,0,9,siRNA binding,MF,
16624,GO:0097450,1.00000000000749,0.904256256701387,0,2,astrocyte end-foot,CC,
16625,GO:0097451,1.00000000000749,0.904256256701387,0,2,glial limiting end-foot,CC,
8801,GO:0034499,1.00000000000749,0.896517975178148,0,2,late endosome to Golgi transport,BP,
6218,GO:0019740,1.0000000000075,0.878812592200256,0,3,nitrogen utilization,BP,
7947,GO:0032532,1.00000000000751,0.868844897631501,0,3,regulation of microvillus length,BP,
3769,GO:0008312,1.00000000000752,0.750602138023999,0,7,7S RNA binding,MF,
12052,GO:0047801,1.00000000000752,0.955711305705109,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
410,GO:0001096,1.00000000000753,0.950223312445574,0,1,TFIIF-class transcription factor binding,MF,
14033,GO:0060742,1.00000000000753,0.665636315381973,0,8,epithelial cell differentiation involved in prostate gland development,BP,
515,GO:0001579,1.00000000000754,0.906417276027003,0,2,medium-chain fatty acid transport,BP,
15072,GO:0071014,1.00000000000754,0.665822655819528,0,9,post-mRNA release spliceosomal complex,CC,
244,GO:0000700,1.00000000000755,0.839726329717708,0,4,mismatch base pair DNA N-glycosylase activity,MF,
9253,GO:0035651,1.00000000000756,0.883883123437073,0,3,AP-3 adaptor complex binding,MF,
19974,GO:2000490,1.00000000000756,0.908935408576475,0,2,negative regulation of hepatic stellate cell activation,BP,
13740,GO:0060294,1.00000000000756,0.65869045468453,0,9,cilium movement involved in cell motility,BP,
5436,GO:0016290,1.00000000000756,0.745908176055014,0,7,palmitoyl-CoA hydrolase activity,MF,
13866,GO:0060455,1.00000000000757,0.925502168283202,0,2,negative regulation of gastric acid secretion,BP,
9775,GO:0039536,1.00000000000757,0.713532437847631,0,7,negative regulation of RIG-I signaling pathway,BP,
16093,GO:0090043,1.00000000000757,0.718284153329708,0,7,regulation of tubulin deacetylation,BP,
5859,GO:0017153,1.00000000000757,0.818947322787384,0,4,sodium:dicarboxylate symporter activity,MF,
7384,GO:0031432,1.00000000000757,0.687193927185323,0,8,titin binding,MF,
4236,GO:0009414,1.00000000000758,0.769963076704825,0,6,response to water deprivation,BP,
16293,GO:0090360,1.00000000000758,0.865826798404592,0,3,platelet-derived growth factor production,BP,
16294,GO:0090361,1.00000000000758,0.865826798404592,0,3,regulation of platelet-derived growth factor production,BP,
5243,GO:0015862,1.00000000000759,0.954944190004366,0,1,uridine transport,BP,
1813,GO:0004459,1.0000000000076,0.883446012918596,0,3,L-lactate dehydrogenase activity,MF,
5617,GO:0016661,1.00000000000761,0.796817303968584,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
19196,GO:1905232,1.00000000000761,0.817751320200708,0,4,cellular response to L-glutamate,BP,
6354,GO:0021527,1.00000000000762,0.946693957554727,0,1,spinal cord association neuron differentiation,BP,
16687,GO:0097598,1.00000000000762,0.946693957554727,0,1,sperm cytoplasmic droplet,CC,
6100,GO:0019303,1.00000000000762,0.935829892445325,0,2,D-ribose catabolic process,BP,
6007,GO:0019043,1.00000000000762,0.667041668569288,0,9,establishment of viral latency,BP,
3659,GO:0008142,1.00000000000762,0.816030267230318,0,4,oxysterol binding,MF,
877,GO:0002225,1.00000000000762,0.921667410319762,0,2,positive regulation of antimicrobial peptide production,BP,
1155,GO:0002760,1.00000000000762,0.921667410319762,0,2,positive regulation of antimicrobial humoral response,BP,
1174,GO:0002803,1.00000000000762,0.921667410319762,0,2,positive regulation of antibacterial peptide production,BP,
17506,GO:1900451,1.00000000000763,0.817885024850093,0,4,positive regulation of glutamate receptor signaling pathway,BP,
17531,GO:1900753,1.00000000000763,0.947798348384594,0,1,doxorubicin transport,BP,
5670,GO:0016775,1.00000000000764,0.775525235963023,0,6,phosphotransferase activity, nitrogenous group as acceptor,MF,
12728,GO:0050942,1.00000000000765,0.773674612388965,0,5,positive regulation of pigment cell differentiation,BP,
6945,GO:0030549,1.00000000000766,0.968524180301282,0,1,acetylcholine receptor activator activity,MF,
8090,GO:0032767,1.00000000000767,0.886100369600643,0,3,copper-dependent protein binding,MF,
13987,GO:0060683,1.00000000000767,0.953893850064163,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
19535,GO:1990401,1.00000000000767,0.953893850064163,0,1,embryonic lung development,BP,
19055,GO:1904879,1.00000000000767,0.905471536012474,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
14985,GO:0070883,1.00000000000767,0.801820068094084,0,5,pre-miRNA binding,MF,
5368,GO:0016150,1.00000000000768,0.960192565068258,0,1,translation release factor activity, codon nonspecific,MF,
4221,GO:0009386,1.00000000000768,0.955015017470241,0,1,translational attenuation,BP,
14482,GO:0061847,1.00000000000768,0.955015017470241,0,1,response to cholecystokinin,BP,
15332,GO:0071538,1.00000000000768,0.955015017470241,0,1,SH2 domain-mediated complex assembly,BP,
19665,GO:1990839,1.00000000000768,0.955015017470241,0,1,response to endothelin,BP,
19669,GO:1990859,1.00000000000768,0.955015017470241,0,1,cellular response to endothelin,BP,
5814,GO:0017065,1.00000000000768,0.960895593188612,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
15800,GO:0072396,1.00000000000769,0.742850549351903,0,6,response to cell cycle checkpoint signaling,BP,
15802,GO:0072402,1.00000000000769,0.742850549351903,0,6,response to DNA integrity checkpoint signaling,BP,
15806,GO:0072423,1.00000000000769,0.742850549351903,0,6,response to DNA damage checkpoint signaling,BP,
14094,GO:0060897,1.0000000000077,0.751748207351252,0,6,neural plate regionalization,BP,
11127,GO:0045144,1.0000000000077,0.801884530543693,0,5,meiotic sister chromatid segregation,BP,
8892,GO:0034706,1.00000000000771,0.650602132606054,0,8,sodium channel complex,CC,
13894,GO:0060510,1.00000000000771,0.915527925850521,0,2,Type II pneumocyte differentiation,BP,
20316,GO:2001271,1.00000000000772,0.858496260839693,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
17643,GO:1901340,1.00000000000773,0.948424893561138,0,1,negative regulation of store-operated calcium channel activity,BP,
4870,GO:0014719,1.00000000000773,0.88006610106318,0,3,skeletal muscle satellite cell activation,BP,
16181,GO:0090188,1.00000000000773,0.819906926498139,0,4,negative regulation of pancreatic juice secretion,BP,
2015,GO:0004739,1.00000000000774,0.914882112211525,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
15562,GO:0071963,1.00000000000775,0.958628987930522,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
1898,GO:0004578,1.00000000000775,0.949099534335149,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
6054,GO:0019187,1.00000000000775,0.949099534335149,0,1,beta-1,4-mannosyltransferase activity,MF,
12776,GO:0051032,1.00000000000775,0.949099534335149,0,1,nucleic acid transmembrane transporter activity,MF,
12777,GO:0051033,1.00000000000775,0.949099534335149,0,1,RNA transmembrane transporter activity,MF,
2101,GO:0004865,1.00000000000776,0.792202414168871,0,6,protein serine/threonine phosphatase inhibitor activity,MF,
1692,GO:0004163,1.00000000000776,0.958064141739108,0,1,diphosphomevalonate decarboxylase activity,MF,
13091,GO:0051585,1.00000000000776,0.952519953534693,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13115,GO:0051620,1.00000000000776,0.952519953534693,0,1,norepinephrine uptake,BP,
13116,GO:0051621,1.00000000000776,0.952519953534693,0,1,regulation of norepinephrine uptake,BP,
13117,GO:0051622,1.00000000000776,0.952519953534693,0,1,negative regulation of norepinephrine uptake,BP,
13276,GO:0051945,1.00000000000776,0.952519953534693,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
18202,GO:1902957,1.00000000000776,0.952519953534693,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18343,GO:1903282,1.00000000000776,0.952519953534693,0,1,regulation of glutathione peroxidase activity,BP,
18344,GO:1903284,1.00000000000776,0.952519953534693,0,1,positive regulation of glutathione peroxidase activity,BP,
18345,GO:1903285,1.00000000000776,0.952519953534693,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19284,GO:1905447,1.00000000000776,0.952519953534693,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19853,GO:2000295,1.00000000000776,0.952519953534693,0,1,regulation of hydrogen peroxide catabolic process,BP,
19964,GO:2000468,1.00000000000776,0.952519953534693,0,1,regulation of peroxidase activity,BP,
19965,GO:2000470,1.00000000000776,0.952519953534693,0,1,positive regulation of peroxidase activity,BP,
14414,GO:0061673,1.00000000000777,0.782584401602074,0,5,mitotic spindle astral microtubule,CC,
19550,GO:1990423,1.00000000000778,0.859557769457507,0,3,RZZ complex,CC,
4695,GO:0010845,1.00000000000779,0.954222089901735,0,1,positive regulation of reciprocal meiotic recombination,BP,
15559,GO:0071955,1.0000000000078,0.896442735077774,0,2,recycling endosome to Golgi transport,BP,
17132,GO:0102009,1.0000000000078,0.957207113437799,0,1,proline dipeptidase activity,MF,
17254,GO:0110095,1.0000000000078,0.898744256495582,0,3,cellular detoxification of aldehyde,BP,
1815,GO:0004462,1.0000000000078,0.956162724584969,0,1,lactoylglutathione lyase activity,MF,
73,GO:0000150,1.00000000000782,0.701121940146538,0,8,recombinase activity,MF,
19630,GO:1990745,1.00000000000782,0.82055072972634,0,4,EARP complex,CC,
18636,GO:1903903,1.00000000000782,0.861743865883371,0,3,regulation of establishment of T cell polarity,BP,
1863,GO:0004523,1.00000000000783,0.78191975027654,0,6,RNA-DNA hybrid ribonuclease activity,MF,
4893,GO:0014810,1.00000000000783,0.97730290681393,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
19355,GO:1905661,1.00000000000783,0.907953656386928,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19356,GO:1905663,1.00000000000783,0.907953656386928,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
5027,GO:0015187,1.00000000000783,0.783974477052613,0,5,glycine transmembrane transporter activity,MF,
7952,GO:0032542,1.00000000000785,0.907687642410405,0,2,sulfiredoxin activity,MF,
13649,GO:0060134,1.00000000000786,0.902573500963989,0,2,prepulse inhibition,BP,
10146,GO:0042711,1.00000000000786,0.74573148553164,0,6,maternal behavior,BP,
437,GO:0001165,1.00000000000786,0.947341564115643,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
20157,GO:2000823,1.00000000000786,0.866001969605602,0,4,regulation of androgen receptor activity,BP,
20158,GO:2000825,1.00000000000786,0.866001969605602,0,4,positive regulation of androgen receptor activity,BP,
7275,GO:0031251,1.00000000000787,0.896221068594281,0,2,PAN complex,CC,
13540,GO:0055100,1.00000000000788,0.861172986759753,0,3,adiponectin binding,MF,
14486,GO:0061857,1.00000000000789,0.905271440025893,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
9267,GO:0035674,1.00000000000789,0.914608382943263,0,2,tricarboxylic acid transmembrane transport,BP,
6353,GO:0021526,1.0000000000079,0.957408067301176,0,1,medial motor column neuron differentiation,BP,
18075,GO:1902616,1.0000000000079,0.957408067301176,0,1,acyl carnitine transmembrane transport,BP,
2568,GO:0005850,1.0000000000079,0.817132488633984,0,4,eukaryotic translation initiation factor 2 complex,CC,
20211,GO:2001033,1.0000000000079,0.799810361334716,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
5416,GO:0016256,1.00000000000791,0.914896273717529,0,2,N-glycan processing to lysosome,BP,
14932,GO:0070773,1.00000000000791,0.964532461168294,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15338,GO:0071544,1.00000000000791,0.964532461168294,0,1,diphosphoinositol polyphosphate catabolic process,BP,
15517,GO:0071877,1.00000000000791,0.964532461168294,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
15521,GO:0071881,1.00000000000791,0.964532461168294,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16067,GO:0086096,1.00000000000791,0.964532461168294,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17329,GO:0140193,1.00000000000791,0.964532461168294,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17330,GO:0140194,1.00000000000791,0.964532461168294,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
7694,GO:0032142,1.00000000000791,0.855288133718655,0,3,single guanine insertion binding,MF,
11199,GO:0045294,1.00000000000791,0.671217842675807,0,8,alpha-catenin binding,MF,
17933,GO:1902231,1.00000000000792,0.799292881890189,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
20261,GO:2001181,1.00000000000792,0.89531029952569,0,3,positive regulation of interleukin-10 secretion,BP,
6098,GO:0019287,1.00000000000793,0.884297865955947,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
15859,GO:0072559,1.00000000000793,0.783343100379251,0,6,NLRP3 inflammasome complex,CC,
199,GO:0000417,1.00000000000794,0.948752417017944,0,1,HIR complex,CC,
5868,GO:0017168,1.00000000000794,0.948752417017944,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
7016,GO:0030702,1.00000000000794,0.948752417017944,0,1,chromatin silencing at centromere,BP,
15585,GO:0072033,1.00000000000794,0.729672139139828,0,6,renal vesicle formation,BP,
16615,GO:0097433,1.00000000000794,0.789302191984425,0,5,dense body,CC,
19146,GO:1905069,1.00000000000794,0.948752417017944,0,1,allantois development,BP,
5589,GO:0016603,1.00000000000794,0.916480894169777,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5877,GO:0017186,1.00000000000794,0.916480894169777,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
19217,GO:1905288,1.00000000000794,0.731520147573507,0,6,vascular associated smooth muscle cell apoptotic process,BP,
19291,GO:1905459,1.00000000000794,0.731520147573507,0,6,regulation of vascular associated smooth muscle cell apoptotic process,BP,
1726,GO:0004315,1.00000000000794,0.91440697228621,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
9418,GO:0035981,1.00000000000795,0.910838435842717,0,2,tongue muscle cell differentiation,BP,
18140,GO:1902811,1.00000000000795,0.910838435842717,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
20213,GO:2001035,1.00000000000795,0.910838435842717,0,2,regulation of tongue muscle cell differentiation,BP,
20214,GO:2001037,1.00000000000795,0.910838435842717,0,2,positive regulation of tongue muscle cell differentiation,BP,
18735,GO:1904153,1.00000000000795,0.660161610641666,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
2571,GO:0005853,1.00000000000796,0.892781086521179,0,3,eukaryotic translation elongation factor 1 complex,CC,
13573,GO:0060022,1.00000000000797,0.773070181467437,0,5,hard palate development,BP,
814,GO:0002084,1.00000000000797,0.658636939710706,0,9,protein depalmitoylation,BP,
756,GO:0001993,1.00000000000798,0.828707357049263,0,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
2897,GO:0006404,1.00000000000798,0.880990632166187,0,3,RNA import into nucleus,BP,
9059,GO:0035280,1.00000000000798,0.713269058316836,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
14074,GO:0060838,1.00000000000798,0.905564615374478,0,2,lymphatic endothelial cell fate commitment,BP,
7643,GO:0032049,1.00000000000799,0.684724725041535,0,8,cardiolipin biosynthetic process,BP,
11119,GO:0045131,1.00000000000799,0.953243983719291,0,1,pre-mRNA branch point binding,MF,
16682,GO:0097574,1.00000000000799,0.902198588595795,0,2,lateral part of cell,CC,
16683,GO:0097575,1.00000000000799,0.902198588595795,0,2,lateral cell cortex,CC,
15487,GO:0071818,1.000000000008,0.870501577719249,0,3,BAT3 complex,CC,
15789,GO:0072379,1.000000000008,0.870501577719249,0,3,ER membrane insertion complex,CC,
5090,GO:0015333,1.000000000008,0.860194605000627,0,3,peptide:proton symporter activity,MF,
17374,GO:1900063,1.00000000000801,0.857716992136103,0,3,regulation of peroxisome organization,BP,
19136,GO:1905050,1.00000000000801,0.723838257061636,0,7,positive regulation of metallopeptidase activity,BP,
3227,GO:0006880,1.00000000000802,0.901725830426681,0,3,intracellular sequestering of iron ion,BP,
16685,GO:0097577,1.00000000000802,0.901725830426681,0,3,sequestering of iron ion,BP,
10013,GO:0042430,1.00000000000804,0.68829867019523,0,8,indole-containing compound metabolic process,BP,
11069,GO:0045059,1.00000000000804,0.754492305782485,0,6,positive thymic T cell selection,BP,
17051,GO:0099515,1.00000000000805,0.622082666709445,0,9,actin filament-based transport,BP,
16835,GO:0098705,1.00000000000805,0.947070834521359,0,1,copper ion import across plasma membrane,BP,
2166,GO:0004998,1.00000000000809,0.94676479696773,0,1,transferrin receptor activity,MF,
4978,GO:0015091,1.00000000000809,0.94676479696773,0,1,ferric iron transmembrane transporter activity,MF,
8449,GO:0033570,1.00000000000809,0.94676479696773,0,1,transferrin transmembrane transporter activity,MF,
15825,GO:0072510,1.00000000000809,0.94676479696773,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
12718,GO:0050923,1.0000000000081,0.848562224273378,0,3,regulation of negative chemotaxis,BP,
17399,GO:1900114,1.0000000000081,0.897132591766085,0,2,positive regulation of histone H3-K9 trimethylation,BP,
18474,GO:1903546,1.0000000000081,0.825114469371875,0,4,protein localization to photoreceptor outer segment,BP,
6456,GO:0021771,1.00000000000811,0.946671447577019,0,1,lateral geniculate nucleus development,BP,
6552,GO:0021966,1.00000000000811,0.946874341036915,0,1,corticospinal neuron axon guidance,BP,
6553,GO:0021972,1.00000000000811,0.946874341036915,0,1,corticospinal neuron axon guidance through spinal cord,BP,
9956,GO:0042320,1.00000000000811,0.946671447577019,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
12719,GO:0050924,1.00000000000811,0.946874341036915,0,1,positive regulation of negative chemotaxis,BP,
12724,GO:0050929,1.00000000000811,0.946874341036915,0,1,induction of negative chemotaxis,BP,
13627,GO:0060084,1.00000000000811,0.946671447577019,0,1,synaptic transmission involved in micturition,BP,
15392,GO:0071623,1.00000000000811,0.946874341036915,0,1,negative regulation of granulocyte chemotaxis,BP,
16080,GO:0090024,1.00000000000811,0.946874341036915,0,1,negative regulation of neutrophil chemotaxis,BP,
16231,GO:0090260,1.00000000000811,0.946874341036915,0,1,negative regulation of retinal ganglion cell axon guidance,BP,
18079,GO:1902623,1.00000000000811,0.946874341036915,0,1,negative regulation of neutrophil migration,BP,
17488,GO:1900370,1.00000000000811,0.946696114842331,0,1,positive regulation of RNA interference,BP,
8112,GO:0032795,1.00000000000811,0.970097953665433,0,1,heterotrimeric G-protein binding,MF,
2079,GO:0004830,1.00000000000812,0.909973520259792,0,2,tryptophan-tRNA ligase activity,MF,
2926,GO:0006436,1.00000000000812,0.909973520259792,0,2,tryptophanyl-tRNA aminoacylation,BP,
8108,GO:0032790,1.00000000000812,0.693285602355902,0,8,ribosome disassembly,BP,
19854,GO:2000297,1.00000000000813,0.946715833216479,0,1,negative regulation of synapse maturation,BP,
6499,GO:0021855,1.00000000000813,0.863204377908014,0,3,hypothalamus cell migration,BP,
3789,GO:0008352,1.00000000000813,0.95415615668049,0,1,katanin complex,CC,
17484,GO:1900364,1.00000000000813,0.667849899594091,0,8,negative regulation of mRNA polyadenylation,BP,
17182,GO:0102773,1.00000000000813,0.947590832677106,0,1,dihydroceramide kinase activity,MF,
5344,GO:0016078,1.00000000000813,0.785316705175988,0,6,tRNA catabolic process,BP,
16123,GO:0090091,1.00000000000815,0.815529465906385,0,4,positive regulation of extracellular matrix disassembly,BP,
8,GO:0000015,1.00000000000815,0.957879236252025,0,1,phosphopyruvate hydratase complex,CC,
1938,GO:0004634,1.00000000000815,0.957879236252025,0,1,phosphopyruvate hydratase activity,MF,
10930,GO:0044545,1.00000000000815,0.79162359441833,0,5,NSL complex,CC,
16285,GO:0090336,1.00000000000815,0.8665987131146,0,3,positive regulation of brown fat cell differentiation,BP,
9326,GO:0035795,1.00000000000815,0.822338754007055,0,5,negative regulation of mitochondrial membrane permeability,BP,
19367,GO:1905709,1.00000000000815,0.822338754007055,0,5,negative regulation of membrane permeability,BP,
16373,GO:0090661,1.00000000000815,0.876784815048545,0,5,box H/ACA telomerase RNP complex,CC,
11106,GO:0045110,1.00000000000816,0.74169595074905,0,6,intermediate filament bundle assembly,BP,
15753,GO:0072318,1.00000000000816,0.775011676578465,0,5,clathrin coat disassembly,BP,
3493,GO:0007386,1.00000000000817,0.784762178907852,0,5,compartment pattern specification,BP,
11817,GO:0046689,1.00000000000818,0.802927466094556,0,5,response to mercury ion,BP,
9327,GO:0035799,1.00000000000818,0.85909669514381,0,3,ureter maturation,BP,
16061,GO:0086080,1.00000000000818,0.654544290146545,0,8,protein binding involved in heterotypic cell-cell adhesion,MF,
2231,GO:0005132,1.00000000000819,0.932463944300988,0,2,type I interferon receptor binding,MF,
12509,GO:0050542,1.00000000000819,0.886273916874721,0,4,icosanoid binding,MF,
12510,GO:0050543,1.00000000000819,0.886273916874721,0,4,icosatetraenoic acid binding,MF,
12511,GO:0050544,1.00000000000819,0.886273916874721,0,4,arachidonic acid binding,MF,
19597,GO:1990604,1.00000000000819,0.857917593225266,0,3,IRE1-TRAF2-ASK1 complex,CC,
633,GO:0001820,1.00000000000819,0.868432647057681,0,3,serotonin secretion,BP,
6832,GO:0030289,1.00000000000819,0.840441255275805,0,4,protein phosphatase 4 complex,CC,
15903,GO:0072656,1.0000000000082,0.799849857623062,0,5,maintenance of protein location in mitochondrion,BP,
12159,GO:0048256,1.0000000000082,0.680394592584404,0,8,flap endonuclease activity,MF,
16628,GO:0097457,1.0000000000082,0.900168337689476,0,2,hippocampal mossy fiber,CC,
3888,GO:0008518,1.00000000000821,0.953711474236444,0,1,reduced folate carrier activity,MF,
16905,GO:0098838,1.00000000000821,0.953711474236444,0,1,reduced folate transmembrane transport,BP,
12024,GO:0047555,1.00000000000821,0.80845898801549,0,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,
10114,GO:0042628,1.00000000000821,0.955169844454405,0,1,mating plug formation,BP,
11202,GO:0045297,1.00000000000821,0.955169844454405,0,1,post-mating behavior,BP,
14213,GO:0061107,1.00000000000821,0.955169844454405,0,1,seminal vesicle development,BP,
14214,GO:0061108,1.00000000000821,0.955169844454405,0,1,seminal vesicle epithelium development,BP,
2426,GO:0005600,1.00000000000822,0.952957672271471,0,1,collagen type XIII trimer,CC,
7125,GO:0030936,1.00000000000822,0.952957672271471,0,1,transmembrane collagen trimer,CC,
2234,GO:0005136,1.00000000000822,0.952703803398059,0,1,interleukin-4 receptor binding,MF,
8290,GO:0033106,1.00000000000823,0.922069298675943,0,2,cis-Golgi network membrane,CC,
13439,GO:0052827,1.00000000000823,0.90804447042194,0,2,inositol pentakisphosphate phosphatase activity,MF,
1761,GO:0004361,1.00000000000823,0.95901550467273,0,1,glutaryl-CoA dehydrogenase activity,MF,
2267,GO:0005183,1.00000000000823,0.95901550467273,0,1,gonadotropin hormone-releasing hormone activity,MF,
7433,GO:0031530,1.00000000000823,0.95901550467273,0,1,gonadotropin-releasing hormone receptor binding,MF,
19445,GO:1990008,1.00000000000823,0.95901550467273,0,1,neurosecretory vesicle,CC,
13714,GO:0060252,1.00000000000824,0.680133666305551,0,8,positive regulation of glial cell proliferation,BP,
3020,GO:0006565,1.00000000000824,0.877808780610617,0,3,L-serine catabolic process,BP,
7615,GO:0031997,1.00000000000824,0.87425209524527,0,3,N-terminal myristoylation domain binding,MF,
12974,GO:0051343,1.00000000000824,0.87425209524527,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
11372,GO:0045723,1.00000000000824,0.655814184758495,0,9,positive regulation of fatty acid biosynthetic process,BP,
4641,GO:0010760,1.00000000000825,0.875474975851392,0,4,negative regulation of macrophage chemotaxis,BP,
19309,GO:1905522,1.00000000000825,0.875474975851392,0,4,negative regulation of macrophage migration,BP,
17467,GO:1900243,1.00000000000826,0.946732803792268,0,1,negative regulation of synaptic vesicle endocytosis,BP,
19169,GO:1905154,1.00000000000826,0.946732803792268,0,1,negative regulation of membrane invagination,BP,
19171,GO:1905161,1.00000000000826,0.946732803792268,0,1,protein localization to phagocytic vesicle,BP,
19172,GO:1905162,1.00000000000826,0.946732803792268,0,1,regulation of phagosome maturation,BP,
19177,GO:1905169,1.00000000000826,0.946732803792268,0,1,regulation of protein localization to phagocytic vesicle,BP,
19178,GO:1905171,1.00000000000826,0.946732803792268,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
19297,GO:1905468,1.00000000000826,0.946732803792268,0,1,regulation of clathrin-coated pit assembly,BP,
19298,GO:1905469,1.00000000000826,0.946732803792268,0,1,negative regulation of clathrin-coated pit assembly,BP,
1409,GO:0003340,1.00000000000827,0.904467729767631,0,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
20086,GO:2000697,1.00000000000827,0.904467729767631,0,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,
7610,GO:0031987,1.00000000000827,0.669155072894417,0,8,locomotion involved in locomotory behavior,BP,
1429,GO:0003383,1.00000000000828,0.848593150571809,0,3,apical constriction,BP,
3863,GO:0008479,1.00000000000829,0.858468167356916,0,4,queuine tRNA-ribosyltransferase activity,MF,
2883,GO:0006384,1.00000000000829,0.714523306916909,0,7,transcription initiation from RNA polymerase III promoter,BP,
16412,GO:0097020,1.0000000000083,0.9516505478479,0,1,COPII adaptor activity,MF,
20068,GO:2000666,1.0000000000083,0.909130529503212,0,2,negative regulation of interleukin-13 secretion,BP,
1967,GO:0004673,1.00000000000831,0.926476024084174,0,2,protein histidine kinase activity,MF,
16451,GO:0097100,1.00000000000831,0.807643784198463,0,5,supercoiled DNA binding,MF,
19526,GO:1990379,1.00000000000831,0.924789204656421,0,2,lipid transport across blood brain barrier,BP,
16700,GO:0097635,1.00000000000833,0.896770182981924,0,2,extrinsic component of autophagosome membrane,CC,
7984,GO:0032593,1.00000000000833,0.764542818172513,0,6,insulin-responsive compartment,CC,
11010,GO:0044821,1.00000000000833,0.817475442069257,0,4,meiotic telomere tethering at nuclear periphery,BP,
14636,GO:0070197,1.00000000000833,0.817475442069257,0,4,meiotic attachment of telomere to nuclear envelope,BP,
16538,GO:0097240,1.00000000000833,0.817475442069257,0,4,chromosome attachment to the nuclear envelope,BP,
17674,GO:1901491,1.00000000000833,0.900560862480556,0,2,negative regulation of lymphangiogenesis,BP,
16267,GO:0090310,1.00000000000834,0.902965360366012,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
18328,GO:1903236,1.00000000000835,0.876707671380932,0,3,regulation of leukocyte tethering or rolling,BP,
8534,GO:0033829,1.00000000000835,0.87487895519109,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
1230,GO:0002904,1.00000000000836,0.887564930520096,0,3,positive regulation of B cell apoptotic process,BP,
3925,GO:0008594,1.00000000000837,0.900058546734474,0,2,photoreceptor cell morphogenesis,BP,
11059,GO:0045040,1.00000000000837,0.804245458467024,0,6,protein import into mitochondrial outer membrane,BP,
8194,GO:0032929,1.00000000000838,0.918079863499041,0,2,negative regulation of superoxide anion generation,BP,
17284,GO:0120103,1.00000000000838,0.631223890403547,0,9,centriolar subdistal appendage,CC,
2448,GO:0005655,1.00000000000839,0.754773178215987,0,8,nucleolar ribonuclease P complex,CC,
16087,GO:0090034,1.00000000000839,0.910898315223792,0,2,regulation of chaperone-mediated protein complex assembly,BP,
16088,GO:0090035,1.00000000000839,0.910898315223792,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
4896,GO:0014819,1.00000000000841,0.837356161420115,0,5,regulation of skeletal muscle contraction,BP,
12470,GO:0050253,1.00000000000842,0.903145755680933,0,2,retinyl-palmitate esterase activity,MF,
11895,GO:0046900,1.00000000000843,0.918321230276104,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
5553,GO:0016554,1.00000000000843,0.767745455465662,0,6,cytidine to uridine editing,BP,
8867,GO:0034665,1.00000000000843,0.899503676726827,0,2,integrin alpha1-beta1 complex,CC,
841,GO:0002144,1.00000000000844,0.955839934067888,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
11222,GO:0045347,1.00000000000844,0.864112141321248,0,3,negative regulation of MHC class II biosynthetic process,BP,
119,GO:0000247,1.00000000000844,0.968406098584748,0,1,C-8 sterol isomerase activity,MF,
2033,GO:0004769,1.00000000000844,0.968406098584748,0,1,steroid delta-isomerase activity,MF,
10089,GO:0042586,1.00000000000844,0.968406098584748,0,1,peptide deformylase activity,MF,
6521,GO:0021894,1.00000000000844,0.970505193573008,0,1,cerebral cortex GABAergic interneuron development,BP,
14705,GO:0070318,1.00000000000845,0.830750508776024,0,4,positive regulation of G0 to G1 transition,BP,
12054,GO:0047844,1.00000000000845,0.810705540070286,0,5,deoxycytidine deaminase activity,MF,
5531,GO:0016503,1.00000000000846,0.965321166952698,0,1,pheromone receptor activity,MF,
11747,GO:0046554,1.00000000000846,0.965321166952698,0,1,malate dehydrogenase (NADP+) activity,MF,
842,GO:0002151,1.00000000000846,0.742757150600407,0,6,G-quadruplex RNA binding,MF,
17281,GO:0120092,1.00000000000846,0.951655107742486,0,1,crotonyl-CoA hydratase activity,MF,
17282,GO:0120093,1.00000000000846,0.951655107742486,0,1,regulation of peptidyl-lysine crotonylation,BP,
17283,GO:0120094,1.00000000000846,0.951655107742486,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
5780,GO:0016998,1.00000000000847,0.91539854383927,0,2,cell wall macromolecule catabolic process,BP,
2476,GO:0005690,1.00000000000847,0.911049045463805,0,2,U4atac snRNP,CC,
15064,GO:0071005,1.00000000000847,0.911049045463805,0,2,U2-type precatalytic spliceosome,CC,
1740,GO:0004335,1.00000000000849,0.918485097835114,0,2,galactokinase activity,MF,
7921,GO:0032489,1.00000000000849,0.827984601884325,0,4,regulation of Cdc42 protein signal transduction,BP,
15383,GO:0071611,1.00000000000849,0.911077624712084,0,2,granulocyte colony-stimulating factor production,BP,
15412,GO:0071655,1.00000000000849,0.911077624712084,0,2,regulation of granulocyte colony-stimulating factor production,BP,
6503,GO:0021861,1.00000000000849,0.732204883636642,0,7,forebrain radial glial cell differentiation,BP,
2625,GO:0005943,1.0000000000085,0.899344838607333,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
16712,GO:0097651,1.0000000000085,0.899344838607333,0,2,phosphatidylinositol 3-kinase complex, class I,CC,
7623,GO:0032009,1.0000000000085,0.700304233683938,0,7,early phagosome,CC,
1657,GO:0004108,1.00000000000852,0.953247550136285,0,1,citrate (Si)-synthase activity,MF,
9592,GO:0036440,1.00000000000852,0.953247550136285,0,1,citrate synthase activity,MF,
15971,GO:0075525,1.00000000000853,0.800101763702943,0,5,viral translational termination-reinitiation,BP,
10331,GO:0043120,1.00000000000853,0.877087398435872,0,3,tumor necrosis factor binding,MF,
7349,GO:0031372,1.00000000000853,0.917762243395082,0,2,UBC13-MMS2 complex,CC,
13732,GO:0060283,1.00000000000854,0.900547735373079,0,2,negative regulation of oocyte development,BP,
19407,GO:1905880,1.00000000000854,0.900547735373079,0,2,negative regulation of oogenesis,BP,
8042,GO:0032685,1.00000000000854,0.952099845550707,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
16497,GO:0097169,1.00000000000855,0.912222841405978,0,3,AIM2 inflammasome complex,CC,
1549,GO:0003941,1.00000000000856,0.919819223133686,0,2,L-serine ammonia-lyase activity,MF,
4172,GO:0009236,1.00000000000857,0.856226184929445,0,3,cobalamin biosynthetic process,BP,
4218,GO:0009378,1.00000000000857,0.768787107595022,0,5,four-way junction helicase activity,MF,
18676,GO:1903976,1.00000000000857,0.873670574898062,0,3,negative regulation of glial cell migration,BP,
17129,GO:0102005,1.00000000000857,0.961785914782428,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
8003,GO:0032618,1.00000000000859,0.919319332447737,0,2,interleukin-15 production,BP,
14773,GO:0070447,1.00000000000859,0.910296952267353,0,2,positive regulation of oligodendrocyte progenitor proliferation,BP,
10766,GO:0044208,1.00000000000859,0.917913414359473,0,2,'de novo' AMP biosynthetic process,BP,
13114,GO:0051615,1.00000000000859,0.946672942784463,0,1,histamine uptake,BP,
16217,GO:0090237,1.0000000000086,0.796418794130318,0,5,regulation of arachidonic acid secretion,BP,
14857,GO:0070602,1.0000000000086,0.880640070720384,0,3,regulation of centromeric sister chromatid cohesion,BP,
16633,GO:0097470,1.0000000000086,0.769535482494614,0,5,ribbon synapse,CC,
4354,GO:0009922,1.00000000000861,0.790043962653081,0,5,fatty acid elongase activity,MF,
6123,GO:0019367,1.00000000000861,0.790043962653081,0,5,fatty acid elongation, saturated fatty acid,BP,
6124,GO:0019368,1.00000000000861,0.790043962653081,0,5,fatty acid elongation, unsaturated fatty acid,BP,
8839,GO:0034625,1.00000000000861,0.790043962653081,0,5,fatty acid elongation, monounsaturated fatty acid,BP,
8840,GO:0034626,1.00000000000861,0.790043962653081,0,5,fatty acid elongation, polyunsaturated fatty acid,BP,
17146,GO:0102336,1.00000000000861,0.790043962653081,0,5,3-oxo-arachidoyl-CoA synthase activity,MF,
17147,GO:0102337,1.00000000000861,0.790043962653081,0,5,3-oxo-cerotoyl-CoA synthase activity,MF,
17148,GO:0102338,1.00000000000861,0.790043962653081,0,5,3-oxo-lignoceronyl-CoA synthase activity,MF,
17179,GO:0102756,1.00000000000861,0.790043962653081,0,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
18465,GO:1903537,1.00000000000861,0.910652721291884,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18466,GO:1903538,1.00000000000861,0.910652721291884,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
1829,GO:0004479,1.00000000000862,0.953951552859238,0,1,methionyl-tRNA formyltransferase activity,MF,
6327,GO:0019988,1.00000000000862,0.953951552859238,0,1,charged-tRNA amino acid modification,BP,
15557,GO:0071951,1.00000000000862,0.953951552859238,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
17826,GO:1901917,1.00000000000862,0.953951552859238,0,1,regulation of exoribonuclease activity,BP,
17827,GO:1901919,1.00000000000862,0.953951552859238,0,1,positive regulation of exoribonuclease activity,BP,
19385,GO:1905779,1.00000000000862,0.953951552859238,0,1,positive regulation of exonuclease activity,BP,
8333,GO:0033177,1.00000000000862,0.694502301311015,0,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
4498,GO:0010520,1.00000000000862,0.908961624942748,0,2,regulation of reciprocal meiotic recombination,BP,
1951,GO:0004652,1.00000000000862,0.662657316235901,0,8,polynucleotide adenylyltransferase activity,MF,
4802,GO:0010991,1.00000000000862,0.896883212482123,0,2,negative regulation of SMAD protein complex assembly,BP,
15951,GO:0072739,1.00000000000862,0.912746882304267,0,2,response to anisomycin,BP,
14998,GO:0070899,1.00000000000862,0.953164500568907,0,1,mitochondrial tRNA wobble uridine modification,BP,
10337,GO:0043126,1.00000000000863,0.961943183716695,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10338,GO:0043128,1.00000000000863,0.961943183716695,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
13948,GO:0060598,1.00000000000863,0.966718380159899,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
14876,GO:0070644,1.00000000000863,0.850011772437195,0,3,vitamin D response element binding,MF,
18893,GO:1904535,1.00000000000863,0.947354150716808,0,1,positive regulation of telomeric loop disassembly,BP,
18716,GO:1904058,1.00000000000863,0.876684603826789,0,3,positive regulation of sensory perception of pain,BP,
5081,GO:0015307,1.00000000000863,0.915088952895073,0,2,drug:proton antiporter activity,MF,
11770,GO:0046618,1.00000000000863,0.915088952895073,0,2,drug export,BP,
3791,GO:0008354,1.00000000000864,0.70924810802891,0,7,germ cell migration,BP,
12834,GO:0051126,1.00000000000865,0.752524914041524,0,6,negative regulation of actin nucleation,BP,
1670,GO:0004128,1.00000000000865,0.73018030539831,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
9283,GO:0035712,1.00000000000866,0.952068912922076,0,1,T-helper 2 cell activation,BP,
20006,GO:2000569,1.00000000000866,0.952068912922076,0,1,regulation of T-helper 2 cell activation,BP,
20007,GO:2000570,1.00000000000866,0.952068912922076,0,1,positive regulation of T-helper 2 cell activation,BP,
11056,GO:0045031,1.00000000000867,0.91147086913862,0,2,ATP-activated adenosine receptor activity,MF,
19803,GO:2000196,1.00000000000867,0.914302524475944,0,2,positive regulation of female gonad development,BP,
19921,GO:2000386,1.00000000000867,0.914302524475944,0,2,positive regulation of ovarian follicle development,BP,
1735,GO:0004329,1.00000000000868,0.904059666922464,0,2,formate-tetrahydrofolate ligase activity,MF,
4182,GO:0009257,1.00000000000868,0.904059666922464,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
19812,GO:2000211,1.00000000000868,0.946832478815467,0,1,regulation of glutamate metabolic process,BP,
19813,GO:2000212,1.00000000000868,0.946832478815467,0,1,negative regulation of glutamate metabolic process,BP,
16471,GO:0097124,1.00000000000868,0.911121960408993,0,2,cyclin A2-CDK2 complex,CC,
19506,GO:1990247,1.00000000000869,0.697139528834373,0,7,N6-methyladenosine-containing RNA binding,MF,
18143,GO:1902822,1.00000000000869,0.884339234632772,0,3,regulation of late endosome to lysosome transport,BP,
5904,GO:0018106,1.0000000000087,0.978669237113859,0,1,peptidyl-histidine phosphorylation,BP,
3744,GO:0008282,1.00000000000871,0.902537294478033,0,2,inward rectifying potassium channel,CC,
13903,GO:0060528,1.00000000000872,0.855600966753435,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
2069,GO:0004820,1.00000000000873,0.916266363789227,0,2,glycine-tRNA ligase activity,MF,
2916,GO:0006426,1.00000000000873,0.916266363789227,0,2,glycyl-tRNA aminoacylation,BP,
14606,GO:0070150,1.00000000000873,0.916266363789227,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
15281,GO:0071449,1.00000000000874,0.973937528411909,0,1,cellular response to lipid hydroperoxide,BP,
20198,GO:2001016,1.00000000000874,0.825444315443621,0,4,positive regulation of skeletal muscle cell differentiation,BP,
9148,GO:0035494,1.00000000000874,0.867141580026338,0,3,SNARE complex disassembly,BP,
14748,GO:0070408,1.00000000000875,0.946671306938403,0,1,carbamoyl phosphate metabolic process,BP,
14749,GO:0070409,1.00000000000875,0.946671306938403,0,1,carbamoyl phosphate biosynthetic process,BP,
18545,GO:1903717,1.00000000000875,0.946671306938403,0,1,response to ammonia,BP,
18546,GO:1903718,1.00000000000875,0.946671306938403,0,1,cellular response to ammonia,BP,
15256,GO:0071403,1.00000000000875,0.906266830764827,0,2,cellular response to high density lipoprotein particle stimulus,BP,
1804,GO:0004445,1.00000000000876,0.781496012701575,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
691,GO:0001907,1.00000000000876,0.886286248229581,0,3,killing by symbiont of host cells,BP,
10714,GO:0044004,1.00000000000876,0.886286248229581,0,3,disruption by symbiont of host cell,BP,
10927,GO:0044533,1.00000000000876,0.886286248229581,0,3,positive regulation of apoptotic process in other organism,BP,
13316,GO:0052042,1.00000000000876,0.886286248229581,0,3,positive regulation by symbiont of host programmed cell death,BP,
13352,GO:0052330,1.00000000000876,0.886286248229581,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13372,GO:0052501,1.00000000000876,0.886286248229581,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
8798,GO:0034485,1.00000000000878,0.815877421786349,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
5173,GO:0015722,1.00000000000879,0.858036789599728,0,3,canalicular bile acid transport,BP,
15128,GO:0071203,1.00000000000879,0.743000822111905,0,6,WASH complex,CC,
14598,GO:0070137,1.00000000000879,0.808341645474665,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
14600,GO:0070139,1.00000000000879,0.808341645474665,0,4,SUMO-specific endopeptidase activity,MF,
8311,GO:0033142,1.0000000000088,0.955439023349338,0,1,progesterone receptor binding,MF,
20081,GO:2000683,1.00000000000881,0.908843896683566,0,2,regulation of cellular response to X-ray,BP,
3307,GO:0007008,1.00000000000882,0.951572869513026,0,1,outer mitochondrial membrane organization,BP,
5318,GO:0016031,1.00000000000882,0.951572869513026,0,1,tRNA import into mitochondrion,BP,
14575,GO:0070096,1.00000000000882,0.951572869513026,0,1,mitochondrial outer membrane translocase complex assembly,BP,
19197,GO:1905242,1.00000000000882,0.951572869513026,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
4629,GO:0010746,1.00000000000883,0.8090792945361,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4630,GO:0010748,1.00000000000883,0.8090792945361,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
14249,GO:0061198,1.00000000000883,0.860874123824036,0,3,fungiform papilla formation,BP,
16379,GO:0090669,1.00000000000884,0.828450963720129,0,4,telomerase RNA stabilization,BP,
2039,GO:0004776,1.00000000000884,0.919130884181047,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
960,GO:0002378,1.00000000000885,0.9475542575317,0,1,immunoglobulin biosynthetic process,BP,
5535,GO:0016508,1.00000000000885,0.86304944238293,0,3,long-chain-enoyl-CoA hydratase activity,MF,
261,GO:0000727,1.00000000000886,0.799567886508763,0,5,double-strand break repair via break-induced replication,BP,
6413,GO:0021644,1.00000000000886,0.961370448212811,0,1,vagus nerve morphogenesis,BP,
11567,GO:0046100,1.00000000000887,0.808163706000068,0,5,hypoxanthine metabolic process,BP,
18563,GO:1903756,1.00000000000887,0.904497759086034,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
18564,GO:1903758,1.00000000000887,0.904497759086034,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
1684,GO:0004146,1.00000000000887,0.920929265683962,0,2,dihydrofolate reductase activity,MF,
4668,GO:0010813,1.00000000000887,0.911134589548978,0,2,neuropeptide catabolic process,BP,
6641,GO:0023021,1.00000000000887,0.869647425462779,0,3,termination of signal transduction,BP,
7092,GO:0030882,1.00000000000888,0.949748599170782,0,1,lipid antigen binding,MF,
7093,GO:0030883,1.00000000000888,0.949748599170782,0,1,endogenous lipid antigen binding,MF,
7094,GO:0030884,1.00000000000888,0.949748599170782,0,1,exogenous lipid antigen binding,MF,
12067,GO:0048006,1.00000000000888,0.949748599170782,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
4127,GO:0009184,1.0000000000089,0.961645934942003,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4135,GO:0009192,1.0000000000089,0.961645934942003,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
10965,GO:0044716,1.0000000000089,0.961645934942003,0,1,8-oxo-GDP phosphatase activity,MF,
10966,GO:0044717,1.0000000000089,0.961645934942003,0,1,8-hydroxy-dADP phosphatase activity,MF,
11540,GO:0046056,1.0000000000089,0.961645934942003,0,1,dADP metabolic process,BP,
11541,GO:0046057,1.0000000000089,0.961645934942003,0,1,dADP catabolic process,BP,
11547,GO:0046067,1.0000000000089,0.961645934942003,0,1,dGDP catabolic process,BP,
11828,GO:0046712,1.0000000000089,0.961645934942003,0,1,GDP catabolic process,BP,
9450,GO:0036034,1.0000000000089,0.911081545234173,0,2,mediator complex assembly,BP,
20257,GO:2001176,1.0000000000089,0.911081545234173,0,2,regulation of mediator complex assembly,BP,
20258,GO:2001178,1.0000000000089,0.911081545234173,0,2,positive regulation of mediator complex assembly,BP,
11755,GO:0046586,1.00000000000891,0.928513783644216,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
708,GO:0001928,1.00000000000892,0.955182180537419,0,1,regulation of exocyst assembly,BP,
13676,GO:0060178,1.00000000000892,0.955182180537419,0,1,regulation of exocyst localization,BP,
6871,GO:0030337,1.00000000000892,0.919927936794536,0,2,DNA polymerase processivity factor activity,MF,
18470,GO:1903542,1.00000000000893,0.909012764353513,0,2,negative regulation of exosomal secretion,BP,
14631,GO:0070191,1.00000000000893,0.912408609843251,0,2,methionine-R-sulfoxide reductase activity,MF,
9980,GO:0042365,1.00000000000894,0.883008718252545,0,3,water-soluble vitamin catabolic process,BP,
14602,GO:0070141,1.00000000000896,0.782177522738426,0,5,response to UV-A,BP,
220,GO:0000459,1.00000000000896,0.749675692878658,0,7,exonucleolytic trimming involved in rRNA processing,BP,
226,GO:0000467,1.00000000000896,0.749675692878658,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
15566,GO:0071987,1.00000000000898,0.816087146253272,0,4,WD40-repeat domain binding,MF,
1488,GO:0003810,1.00000000000898,0.866904384667477,0,3,protein-glutamine gamma-glutamyltransferase activity,MF,
2174,GO:0005007,1.00000000000898,0.772912516892438,0,5,fibroblast growth factor-activated receptor activity,MF,
11397,GO:0045764,1.00000000000899,0.929826129809362,0,2,positive regulation of cellular amino acid metabolic process,BP,
3939,GO:0008622,1.00000000000899,0.810871702480854,0,5,epsilon DNA polymerase complex,CC,
4547,GO:0010621,1.00000000000899,0.969628379273265,0,1,negative regulation of transcription by transcription factor localization,BP,
9514,GO:0036164,1.00000000000899,0.969628379273265,0,1,cell-abiotic substrate adhesion,BP,
1892,GO:0004571,1.00000000000899,0.700438370189181,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
8980,GO:0035068,1.000000000009,0.63960174906866,0,9,micro-ribonucleoprotein complex,CC,
3342,GO:0007060,1.000000000009,0.910234049501273,0,2,male meiosis chromosome segregation,BP,
1503,GO:0003846,1.000000000009,0.906916174443939,0,2,2-acylglycerol O-acyltransferase activity,MF,
1682,GO:0004144,1.000000000009,0.906916174443939,0,2,diacylglycerol O-acyltransferase activity,MF,
12469,GO:0050252,1.000000000009,0.906916174443939,0,2,retinol O-fatty-acyltransferase activity,MF,
9124,GO:0035426,1.000000000009,0.812103088857412,0,4,extracellular matrix-cell signaling,BP,
14129,GO:0060971,1.000000000009,0.860858747144013,0,3,embryonic heart tube left/right pattern formation,BP,
7010,GO:0030690,1.00000000000901,0.95378501271282,0,1,Noc1p-Noc2p complex,CC,
7011,GO:0030691,1.00000000000901,0.95378501271282,0,1,Noc2p-Noc3p complex,CC,
10,GO:0000019,1.00000000000902,0.861667116969074,0,3,regulation of mitotic recombination,BP,
14204,GO:0061091,1.00000000000902,0.946835724061364,0,1,regulation of phospholipid translocation,BP,
14205,GO:0061092,1.00000000000902,0.946835724061364,0,1,positive regulation of phospholipid translocation,BP,
4021,GO:0009041,1.00000000000903,0.880681937178452,0,3,uridylate kinase activity,MF,
10931,GO:0044546,1.00000000000905,0.636651458918967,0,9,NLRP3 inflammasome complex assembly,BP,
17460,GO:1900225,1.00000000000905,0.636651458918967,0,9,regulation of NLRP3 inflammasome complex assembly,BP,
15225,GO:0071361,1.00000000000905,0.652252495973827,0,8,cellular response to ethanol,BP,
1589,GO:0003997,1.00000000000906,0.864726843695502,0,3,acyl-CoA oxidase activity,MF,
7915,GO:0032483,1.00000000000907,0.811951019433611,0,4,regulation of Rab protein signal transduction,BP,
9495,GO:0036132,1.00000000000907,0.87313031339978,0,3,13-prostaglandin reductase activity,MF,
12021,GO:0047522,1.00000000000907,0.87313031339978,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
14102,GO:0060913,1.00000000000908,0.954040240349325,0,1,cardiac cell fate determination,BP,
15414,GO:0071657,1.00000000000908,0.954040240349325,0,1,positive regulation of granulocyte colony-stimulating factor production,BP,
17614,GO:1901258,1.00000000000908,0.954040240349325,0,1,positive regulation of macrophage colony-stimulating factor production,BP,
6129,GO:0019373,1.00000000000908,0.751288384878177,0,6,epoxygenase P450 pathway,BP,
2658,GO:0005999,1.00000000000908,0.923822607925422,0,2,xylulose biosynthetic process,BP,
5654,GO:0016744,1.00000000000908,0.923822607925422,0,2,transferase activity, transferring aldehyde or ketonic groups,MF,
15669,GO:0072173,1.00000000000909,0.712445735485487,0,7,metanephric tubule morphogenesis,BP,
866,GO:0002196,1.00000000000909,0.957178646746429,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
4982,GO:0015098,1.00000000000909,0.957178646746429,0,1,molybdate ion transmembrane transporter activity,MF,
5155,GO:0015689,1.00000000000909,0.957178646746429,0,1,molybdate ion transport,BP,
6877,GO:0030350,1.0000000000091,0.900039051714292,0,2,iron-responsive element binding,MF,
7860,GO:0032416,1.00000000000911,0.956414440885395,0,1,negative regulation of sodium:proton antiporter activity,BP,
16555,GO:0097291,1.00000000000911,0.956414440885395,0,1,renal phosphate ion absorption,BP,
3395,GO:0007174,1.00000000000912,0.955273293832721,0,1,epidermal growth factor catabolic process,BP,
7863,GO:0032419,1.00000000000912,0.955273293832721,0,1,extrinsic component of lysosome membrane,CC,
19105,GO:1904979,1.00000000000912,0.955273293832721,0,1,negative regulation of endosome organization,BP,
19250,GO:1905365,1.00000000000912,0.955273293832721,0,1,regulation of intralumenal vesicle formation,BP,
19251,GO:1905366,1.00000000000912,0.955273293832721,0,1,negative regulation of intralumenal vesicle formation,BP,
6970,GO:0030620,1.00000000000912,0.79799158265181,0,6,U2 snRNA binding,MF,
7660,GO:0032076,1.00000000000912,0.954035560321818,0,1,negative regulation of deoxyribonuclease activity,BP,
9557,GO:0036316,1.00000000000912,0.954035560321818,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
14005,GO:0060703,1.00000000000912,0.954035560321818,0,1,deoxyribonuclease inhibitor activity,MF,
14723,GO:0070346,1.00000000000912,0.954035560321818,0,1,positive regulation of fat cell proliferation,BP,
17629,GO:1901303,1.00000000000912,0.954035560321818,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18032,GO:1902511,1.00000000000912,0.954035560321818,0,1,negative regulation of apoptotic DNA fragmentation,BP,
18512,GO:1903625,1.00000000000912,0.954035560321818,0,1,negative regulation of DNA catabolic process,BP,
10156,GO:0042731,1.00000000000912,0.831462358179078,0,4,PH domain binding,MF,
18484,GO:1903566,1.00000000000913,0.855697279062697,0,3,positive regulation of protein localization to cilium,BP,
1857,GO:0004517,1.00000000000913,0.903678455170285,0,2,nitric-oxide synthase activity,MF,
1546,GO:0003938,1.00000000000913,0.915550339009256,0,2,IMP dehydrogenase activity,MF,
6902,GO:0030432,1.00000000000914,0.92796585451591,0,2,peristalsis,BP,
315,GO:0000827,1.00000000000915,0.819679037786423,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
316,GO:0000828,1.00000000000915,0.819679037786423,0,4,inositol hexakisphosphate kinase activity,MF,
317,GO:0000829,1.00000000000915,0.819679037786423,0,4,inositol heptakisphosphate kinase activity,MF,
318,GO:0000832,1.00000000000915,0.819679037786423,0,4,inositol hexakisphosphate 5-kinase activity,MF,
13412,GO:0052723,1.00000000000915,0.819679037786423,0,4,inositol hexakisphosphate 1-kinase activity,MF,
13413,GO:0052724,1.00000000000915,0.819679037786423,0,4,inositol hexakisphosphate 3-kinase activity,MF,
6300,GO:0019907,1.00000000000915,0.733626888930713,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
7975,GO:0032581,1.00000000000916,0.957632864900485,0,1,ER-dependent peroxisome organization,BP,
17235,GO:0106101,1.00000000000916,0.957632864900485,0,1,ER-dependent peroxisome localization,BP,
3997,GO:0008893,1.00000000000916,0.970916747597748,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
5685,GO:0016794,1.00000000000916,0.970916747597748,0,1,diphosphoric monoester hydrolase activity,MF,
12802,GO:0051083,1.00000000000917,0.915451254104545,0,2,'de novo' cotranslational protein folding,BP,
5044,GO:0015220,1.00000000000917,0.781991646107533,0,5,choline transmembrane transporter activity,MF,
10075,GO:0042567,1.00000000000919,0.903361311652257,0,2,insulin-like growth factor ternary complex,CC,
9928,GO:0042271,1.00000000000919,0.897461384107011,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
6564,GO:0021999,1.00000000000921,0.79094416485084,0,5,neural plate anterior/posterior regionalization,BP,
19652,GO:1990796,1.00000000000921,0.953376557211293,0,1,photoreceptor cell terminal bouton,CC,
13240,GO:0051890,1.00000000000921,0.897570552866736,0,2,regulation of cardioblast differentiation,BP,
8181,GO:0032914,1.00000000000922,0.865214282271686,0,3,positive regulation of transforming growth factor beta1 production,BP,
4327,GO:0009822,1.00000000000923,0.958992107856908,0,1,alkaloid catabolic process,BP,
10639,GO:0043633,1.00000000000923,0.709200113821241,0,8,polyadenylation-dependent RNA catabolic process,BP,
9217,GO:0035602,1.00000000000923,0.948529920951928,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9218,GO:0035603,1.00000000000923,0.948529920951928,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9219,GO:0035604,1.00000000000923,0.948529920951928,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
13793,GO:0060364,1.00000000000923,0.822988118316132,0,4,frontal suture morphogenesis,BP,
13946,GO:0060595,1.00000000000923,0.948529920951928,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
13959,GO:0060615,1.00000000000923,0.948529920951928,0,1,mammary gland bud formation,BP,
13969,GO:0060648,1.00000000000923,0.948529920951928,0,1,mammary gland bud morphogenesis,BP,
13975,GO:0060667,1.00000000000923,0.948529920951928,0,1,branch elongation involved in salivary gland morphogenesis,BP,
14104,GO:0060915,1.00000000000923,0.948529920951928,0,1,mesenchymal cell differentiation involved in lung development,BP,
356,GO:0000973,1.00000000000924,0.864888653955251,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
5731,GO:0016868,1.00000000000924,0.668093340152946,0,9,intramolecular transferase activity, phosphotransferases,MF,
6237,GO:0019784,1.00000000000924,0.747334224148443,0,7,NEDD8-specific protease activity,MF,
9571,GO:0036363,1.00000000000925,0.904153248612602,0,2,transforming growth factor beta activation,BP,
4638,GO:0010757,1.00000000000925,0.828510712375369,0,4,negative regulation of plasminogen activation,BP,
1427,GO:0003376,1.00000000000925,0.646162980575106,0,9,sphingosine-1-phosphate signaling pathway,BP,
16334,GO:0090520,1.00000000000925,0.646162980575106,0,9,sphingolipid mediated signaling pathway,BP,
8993,GO:0035101,1.00000000000925,0.861198351451028,0,3,FACT complex,CC,
12485,GO:0050353,1.00000000000926,0.953655491756011,0,1,trimethyllysine dioxygenase activity,MF,
13625,GO:0060081,1.00000000000927,0.733122724220896,0,7,membrane hyperpolarization,BP,
17425,GO:1900150,1.00000000000928,0.917921636956151,0,2,regulation of defense response to fungus,BP,
2900,GO:0006407,1.00000000000928,0.884646543095854,0,3,rRNA export from nucleus,BP,
457,GO:0001302,1.00000000000928,0.765680915877871,0,6,replicative cell aging,BP,
8212,GO:0032962,1.00000000000929,0.861081682155444,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
7454,GO:0031585,1.00000000000929,0.805485530255036,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
11947,GO:0046984,1.00000000000929,0.831304411433917,0,4,regulation of hemoglobin biosynthetic process,BP,
4565,GO:0010643,1.00000000000929,0.864953210889027,0,3,cell communication by chemical coupling,BP,
15520,GO:0071880,1.0000000000093,0.657517311199337,0,8,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
9278,GO:0035700,1.00000000000931,0.958256143321532,0,1,astrocyte chemotaxis,BP,
9501,GO:0036145,1.00000000000931,0.958256143321532,0,1,dendritic cell homeostasis,BP,
19959,GO:2000458,1.00000000000931,0.958256143321532,0,1,regulation of astrocyte chemotaxis,BP,
3873,GO:0008495,1.00000000000931,0.953182734591022,0,1,protoheme IX farnesyltransferase activity,MF,
12091,GO:0048033,1.00000000000931,0.953182734591022,0,1,heme o metabolic process,BP,
12092,GO:0048034,1.00000000000931,0.953182734591022,0,1,heme O biosynthetic process,BP,
3821,GO:0008413,1.00000000000932,0.936345486113678,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
9177,GO:0035539,1.00000000000932,0.936345486113678,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
3648,GO:0008121,1.00000000000932,0.781294719345383,0,7,ubiquinol-cytochrome-c reductase activity,MF,
5627,GO:0016681,1.00000000000932,0.781294719345383,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
2003,GO:0004723,1.00000000000932,0.699615447792122,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
6614,GO:0022824,1.00000000000932,0.704699210752017,0,7,transmitter-gated ion channel activity,MF,
6618,GO:0022835,1.00000000000932,0.704699210752017,0,7,transmitter-gated channel activity,MF,
16547,GO:0097274,1.00000000000932,0.900464517109416,0,2,urea homeostasis,BP,
14473,GO:0061825,1.00000000000933,0.949142645214026,0,1,podosome core,CC,
16557,GO:0097298,1.00000000000933,0.949142645214026,0,1,regulation of nucleus size,BP,
6275,GO:0019865,1.00000000000933,0.887368823797144,0,3,immunoglobulin binding,MF,
8882,GO:0034693,1.00000000000934,0.95459440399881,0,1,U11/U12 snRNP,CC,
16399,GO:0093001,1.00000000000935,0.952330882883938,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
328,GO:0000916,1.00000000000936,0.955480987035157,0,1,actomyosin contractile ring contraction,BP,
9520,GO:0036213,1.00000000000936,0.955480987035157,0,1,contractile ring contraction,BP,
8582,GO:0034059,1.00000000000936,0.856790129865082,0,3,response to anoxia,BP,
17793,GO:1901837,1.00000000000937,0.914381128640272,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19651,GO:1990791,1.00000000000937,0.908124780374175,0,2,dorsal root ganglion development,BP,
19507,GO:1990253,1.00000000000939,0.637255055567672,0,9,cellular response to leucine starvation,BP,
12180,GO:0048291,1.00000000000939,0.678888288627325,0,8,isotype switching to IgG isotypes,BP,
18850,GO:1904424,1.0000000000094,0.634702464341879,0,9,regulation of GTP binding,BP,
11038,GO:0045002,1.0000000000094,0.717756682853379,0,7,double-strand break repair via single-strand annealing,BP,
16488,GO:0097158,1.0000000000094,0.959872322644528,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
12383,GO:0048763,1.0000000000094,0.848511812775647,0,3,calcium-induced calcium release activity,MF,
18002,GO:1902414,1.00000000000941,0.660204838051087,0,8,protein localization to cell junction,BP,
3643,GO:0008116,1.00000000000941,0.946673747269254,0,1,prostaglandin-I synthase activity,MF,
18211,GO:1902969,1.00000000000942,0.654696825202399,0,9,mitotic DNA replication,BP,
17949,GO:1902262,1.00000000000943,0.840105933599995,0,4,apoptotic process involved in blood vessel morphogenesis,BP,
13305,GO:0051987,1.00000000000944,0.78499212744717,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
5373,GO:0016174,1.00000000000944,0.81779250584794,0,4,NAD(P)H oxidase activity,MF,
11607,GO:0046185,1.00000000000944,0.676619803134132,0,9,aldehyde catabolic process,BP,
919,GO:0002309,1.00000000000945,0.976066130879465,0,1,T cell proliferation involved in immune response,BP,
17725,GO:1901621,1.00000000000945,0.774965829835433,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
6141,GO:0019405,1.00000000000945,0.746070679373605,0,6,alditol catabolic process,BP,
4954,GO:0015014,1.00000000000946,0.811603159368295,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
1586,GO:0003994,1.00000000000947,0.906951927489243,0,2,aconitate hydratase activity,MF,
5349,GO:0016093,1.00000000000947,0.767008725984455,0,6,polyprenol metabolic process,BP,
3411,GO:0007194,1.00000000000948,0.719118253538073,0,7,negative regulation of adenylate cyclase activity,BP,
7292,GO:0031280,1.00000000000948,0.719118253538073,0,7,negative regulation of cyclase activity,BP,
397,GO:0001069,1.00000000000948,0.896809973919562,0,2,regulatory region RNA binding,MF,
786,GO:0002041,1.00000000000948,0.955069733293938,0,1,intussusceptive angiogenesis,BP,
12943,GO:0051286,1.00000000000949,0.767256926687681,0,5,cell tip,CC,
1608,GO:0004028,1.00000000000949,0.714114708873397,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
17494,GO:1900378,1.00000000000951,0.897415283868565,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
8243,GO:0033010,1.00000000000953,0.743220406826038,0,6,paranodal junction,CC,
13476,GO:0052925,1.00000000000953,0.961653672628839,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
16749,GO:0097753,1.00000000000953,0.949675210273449,0,1,membrane bending,BP,
8836,GO:0034618,1.00000000000954,0.82557642568886,0,4,arginine binding,MF,
1389,GO:0003292,1.00000000000954,0.94667142308207,0,1,cardiac septum cell differentiation,BP,
14108,GO:0060922,1.00000000000954,0.94667142308207,0,1,atrioventricular node cell differentiation,BP,
14111,GO:0060928,1.00000000000954,0.94667142308207,0,1,atrioventricular node cell development,BP,
8424,GO:0033499,1.00000000000954,0.920881665697975,0,2,galactose catabolic process via UDP-galactose,BP,
11911,GO:0046929,1.00000000000954,0.673907479814463,0,8,negative regulation of neurotransmitter secretion,BP,
5278,GO:0015924,1.00000000000955,0.627744276137449,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
17800,GO:1901857,1.00000000000955,0.823621470183969,0,5,positive regulation of cellular respiration,BP,
5892,GO:0018026,1.00000000000957,0.646136529830726,0,9,peptidyl-lysine monomethylation,BP,
8667,GO:0034235,1.00000000000957,0.75069970373338,0,6,GPI anchor binding,MF,
9539,GO:0036284,1.00000000000958,0.910595608779681,0,2,tubulobulbar complex,CC,
16144,GO:0090131,1.00000000000958,0.960715346624074,0,1,mesenchyme migration,BP,
17947,GO:1902260,1.00000000000959,0.86535117299256,0,3,negative regulation of delayed rectifier potassium channel activity,BP,
14458,GO:0061770,1.00000000000959,0.955576912359879,0,1,translation elongation factor binding,MF,
18186,GO:1902937,1.00000000000959,0.955576912359879,0,1,inward rectifier potassium channel complex,CC,
19034,GO:1904842,1.00000000000959,0.955576912359879,0,1,response to nitroglycerin,BP,
19035,GO:1904843,1.00000000000959,0.955576912359879,0,1,cellular response to nitroglycerin,BP,
3782,GO:0008336,1.00000000000959,0.957248147263721,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4992,GO:0015117,1.00000000000959,0.957248147263721,0,1,thiosulfate transmembrane transporter activity,MF,
4998,GO:0015131,1.00000000000959,0.957248147263721,0,1,oxaloacetate transmembrane transporter activity,MF,
5168,GO:0015709,1.00000000000959,0.957248147263721,0,1,thiosulfate transport,BP,
5178,GO:0015729,1.00000000000959,0.957248147263721,0,1,oxaloacetate transport,BP,
5184,GO:0015743,1.00000000000959,0.957248147263721,0,1,malate transport,BP,
15266,GO:0071423,1.00000000000959,0.957248147263721,0,1,malate transmembrane transport,BP,
17980,GO:1902356,1.00000000000959,0.957248147263721,0,1,oxaloacetate(2-) transmembrane transport,BP,
3730,GO:0008265,1.00000000000962,0.953983249041294,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
17185,GO:0102867,1.00000000000962,0.953983249041294,0,1,molybdenum cofactor sulfurtransferase activity,MF,
13817,GO:0060392,1.00000000000962,0.921518766963139,0,2,negative regulation of SMAD protein signal transduction,BP,
1404,GO:0003335,1.00000000000963,0.954413053951786,0,1,corneocyte development,BP,
1405,GO:0003336,1.00000000000963,0.954413053951786,0,1,corneocyte desquamation,BP,
19370,GO:1905715,1.00000000000963,0.954413053951786,0,1,regulation of cornification,BP,
19371,GO:1905716,1.00000000000963,0.954413053951786,0,1,negative regulation of cornification,BP,
50,GO:0000104,1.00000000000963,0.811198309656631,0,5,succinate dehydrogenase activity,MF,
2502,GO:0005749,1.00000000000963,0.811198309656631,0,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
3679,GO:0008177,1.00000000000963,0.811198309656631,0,5,succinate dehydrogenase (ubiquinone) activity,MF,
11185,GO:0045257,1.00000000000963,0.811198309656631,0,5,succinate dehydrogenase complex (ubiquinone),CC,
11190,GO:0045273,1.00000000000963,0.811198309656631,0,5,respiratory chain complex II,CC,
11194,GO:0045281,1.00000000000963,0.811198309656631,0,5,succinate dehydrogenase complex,CC,
11196,GO:0045283,1.00000000000963,0.811198309656631,0,5,fumarate reductase complex,CC,
2688,GO:0006048,1.00000000000963,0.656738370352853,0,9,UDP-N-acetylglucosamine biosynthetic process,BP,
2083,GO:0004835,1.00000000000963,0.946767285166754,0,1,tubulin-tyrosine ligase activity,MF,
5918,GO:0018166,1.00000000000963,0.946767285166754,0,1,C-terminal protein-tyrosinylation,BP,
5959,GO:0018322,1.00000000000963,0.946767285166754,0,1,protein tyrosinylation,BP,
6529,GO:0021910,1.00000000000963,0.730115719552642,0,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
16258,GO:0090299,1.00000000000964,0.959614134430712,0,1,regulation of neural crest formation,BP,
16259,GO:0090301,1.00000000000964,0.959614134430712,0,1,negative regulation of neural crest formation,BP,
19868,GO:2000314,1.00000000000964,0.959614134430712,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
17225,GO:0106072,1.00000000000964,0.906395867691453,0,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
8641,GO:0034165,1.00000000000965,0.904736389867951,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
13667,GO:0060161,1.00000000000966,0.865504579550405,0,3,positive regulation of dopamine receptor signaling pathway,BP,
13103,GO:0051599,1.00000000000966,0.812926757787751,0,4,response to hydrostatic pressure,BP,
9027,GO:0035235,1.00000000000967,0.668533635815942,0,8,ionotropic glutamate receptor signaling pathway,BP,
1364,GO:0003241,1.00000000000967,0.866030865005992,0,3,growth involved in heart morphogenesis,BP,
13633,GO:0060091,1.00000000000967,0.800685652210408,0,5,kinocilium,CC,
16740,GO:0097732,1.00000000000967,0.800685652210408,0,5,9+2 non-motile cilium,CC,
16722,GO:0097694,1.00000000000968,0.85442231373062,0,3,establishment of RNA localization to telomere,BP,
16723,GO:0097695,1.00000000000968,0.85442231373062,0,3,establishment of protein-containing complex localization to telomere,BP,
2375,GO:0005502,1.00000000000968,0.94718544157687,0,1,11-cis retinal binding,MF,
2376,GO:0005503,1.00000000000968,0.94718544157687,0,1,all-trans retinal binding,MF,
14494,GO:0061896,1.00000000000968,0.94718544157687,0,1,all-trans retinol 3,4-desaturase activity,MF,
14495,GO:0061897,1.00000000000968,0.94718544157687,0,1,all-trans retinal 3,4-desaturase activity,MF,
14496,GO:0061898,1.00000000000968,0.94718544157687,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
14497,GO:0061899,1.00000000000968,0.94718544157687,0,1,11-cis-retinal 3,4-desaturase activity,MF,
15073,GO:0071020,1.00000000000969,0.919183950316008,0,2,post-spliceosomal complex,CC,
7302,GO:0031296,1.00000000000969,0.967717275779474,0,1,B cell costimulation,BP,
17889,GO:1902109,1.00000000000969,0.886766598994892,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
5381,GO:0016191,1.0000000000097,0.810502275640886,0,4,synaptic vesicle uncoating,BP,
8684,GO:0034274,1.0000000000097,0.854676945082008,0,3,Atg12-Atg5-Atg16 complex,CC,
1812,GO:0004458,1.00000000000972,0.954308792337884,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
2007,GO:0004728,1.00000000000972,0.954308792337884,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
4013,GO:0008995,1.00000000000972,0.954308792337884,0,1,ribonuclease E activity,MF,
5754,GO:0016898,1.00000000000972,0.954308792337884,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6167,GO:0019516,1.00000000000972,0.954308792337884,0,1,lactate oxidation,BP,
16225,GO:0090247,1.00000000000972,0.954308792337884,0,1,cell motility involved in somitogenic axis elongation,BP,
16226,GO:0090249,1.00000000000972,0.954308792337884,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17604,GO:1901229,1.00000000000972,0.954308792337884,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17605,GO:1901231,1.00000000000972,0.954308792337884,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17606,GO:1901232,1.00000000000972,0.954308792337884,0,1,regulation of convergent extension involved in axis elongation,BP,
17607,GO:1901233,1.00000000000972,0.954308792337884,0,1,negative regulation of convergent extension involved in axis elongation,BP,
15231,GO:0071373,1.00000000000973,0.910069768386674,0,2,cellular response to luteinizing hormone stimulus,BP,
657,GO:0001845,1.00000000000973,0.663874373752285,0,9,phagolysosome assembly,BP,
18301,GO:1903179,1.00000000000973,0.926739131964397,0,2,regulation of dopamine biosynthetic process,BP,
18302,GO:1903181,1.00000000000973,0.926739131964397,0,2,positive regulation of dopamine biosynthetic process,BP,
5472,GO:0016401,1.00000000000974,0.906738964999555,0,2,palmitoyl-CoA oxidase activity,MF,
7145,GO:0030976,1.00000000000974,0.778962864740455,0,5,thiamine pyrophosphate binding,MF,
7916,GO:0032484,1.00000000000974,0.853244110113813,0,3,Ral protein signal transduction,BP,
7917,GO:0032485,1.00000000000974,0.853244110113813,0,3,regulation of Ral protein signal transduction,BP,
11289,GO:0045588,1.00000000000974,0.896455182035659,0,2,positive regulation of gamma-delta T cell differentiation,BP,
9512,GO:0036158,1.00000000000976,0.768035442233584,0,6,outer dynein arm assembly,BP,
5069,GO:0015280,1.00000000000976,0.859166429489305,0,3,ligand-gated sodium channel activity,MF,
1421,GO:0003360,1.00000000000977,0.860797753527437,0,3,brainstem development,BP,
16776,GO:0098556,1.00000000000977,0.901777664171391,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
13678,GO:0060180,1.00000000000977,0.861790900730854,0,3,female mating behavior,BP,
4004,GO:0008940,1.00000000000978,0.861982475744697,0,3,nitrate reductase activity,MF,
12408,GO:0048840,1.00000000000978,0.816955208575606,0,4,otolith development,BP,
2758,GO:0006166,1.00000000000979,0.816581658822078,0,5,purine ribonucleoside salvage,BP,
19147,GO:1905071,1.0000000000098,0.90165309818447,0,2,occluding junction disassembly,BP,
19148,GO:1905073,1.0000000000098,0.90165309818447,0,2,regulation of occluding junction disassembly,BP,
19149,GO:1905075,1.0000000000098,0.90165309818447,0,2,positive regulation of occluding junction disassembly,BP,
3858,GO:0008470,1.0000000000098,0.947276262836782,0,1,isovaleryl-CoA dehydrogenase activity,MF,
9361,GO:0035870,1.00000000000981,0.917884957517035,0,2,dITP diphosphatase activity,MF,
15889,GO:0072602,1.00000000000981,0.817985548836361,0,4,interleukin-4 secretion,BP,
1887,GO:0004565,1.00000000000982,0.827612178255525,0,4,beta-galactosidase activity,MF,
1906,GO:0004588,1.00000000000982,0.954165020775985,0,1,orotate phosphoribosyltransferase activity,MF,
1907,GO:0004590,1.00000000000982,0.954165020775985,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
4692,GO:0010838,1.00000000000982,0.77195850733448,0,5,positive regulation of keratinocyte proliferation,BP,
16223,GO:0090245,1.00000000000982,0.810369340678259,0,4,axis elongation involved in somitogenesis,BP,
12598,GO:0050757,1.00000000000982,0.954203524001329,0,1,thymidylate synthase biosynthetic process,BP,
12599,GO:0050758,1.00000000000982,0.954203524001329,0,1,regulation of thymidylate synthase biosynthetic process,BP,
12600,GO:0050760,1.00000000000982,0.954203524001329,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
4010,GO:0008970,1.00000000000983,0.711571681129366,0,7,phosphatidylcholine 1-acylhydrolase activity,MF,
16423,GO:0097039,1.00000000000984,0.778615011892993,0,5,protein linear polyubiquitination,BP,
14025,GO:0060732,1.00000000000984,0.737708331854115,0,6,positive regulation of inositol phosphate biosynthetic process,BP,
11951,GO:0047006,1.00000000000984,0.963933146380346,0,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
11960,GO:0047042,1.00000000000984,0.963933146380346,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12042,GO:0047718,1.00000000000984,0.963933146380346,0,1,indanol dehydrogenase activity,MF,
16229,GO:0090258,1.00000000000984,0.903265922085287,0,2,negative regulation of mitochondrial fission,BP,
9345,GO:0035845,1.00000000000984,0.708598978897042,0,7,photoreceptor cell outer segment organization,BP,
11836,GO:0046725,1.00000000000985,0.950699394861551,0,1,negative regulation by virus of viral protein levels in host cell,BP,
15677,GO:0072183,1.00000000000985,0.950699394861551,0,1,negative regulation of nephron tubule epithelial cell differentiation,BP,
15747,GO:0072308,1.00000000000985,0.950699394861551,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
10151,GO:0042723,1.00000000000985,0.874039057998055,0,3,thiamine-containing compound metabolic process,BP,
7369,GO:0031407,1.00000000000985,0.954842843749765,0,1,oxylipin metabolic process,BP,
12063,GO:0047977,1.00000000000985,0.954842843749765,0,1,hepoxilin-epoxide hydrolase activity,MF,
17782,GO:1901751,1.00000000000985,0.954842843749765,0,1,leukotriene A4 metabolic process,BP,
20329,GO:2001300,1.00000000000985,0.954842843749765,0,1,lipoxin metabolic process,BP,
20330,GO:2001301,1.00000000000985,0.954842843749765,0,1,lipoxin biosynthetic process,BP,
20331,GO:2001302,1.00000000000985,0.954842843749765,0,1,lipoxin A4 metabolic process,BP,
20332,GO:2001303,1.00000000000985,0.954842843749765,0,1,lipoxin A4 biosynthetic process,BP,
20333,GO:2001304,1.00000000000985,0.954842843749765,0,1,lipoxin B4 metabolic process,BP,
20334,GO:2001306,1.00000000000985,0.954842843749765,0,1,lipoxin B4 biosynthetic process,BP,
3767,GO:0008310,1.00000000000985,0.83763411002155,0,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
17297,GO:0140035,1.00000000000986,0.737674554142039,0,6,ubiquitination-like modification-dependent protein binding,MF,
17298,GO:0140036,1.00000000000986,0.737674554142039,0,6,ubiquitin-dependent protein binding,MF,
13199,GO:0051792,1.00000000000986,0.840503967850365,0,4,medium-chain fatty acid biosynthetic process,BP,
9112,GO:0035400,1.00000000000986,0.94671569659292,0,1,histone tyrosine kinase activity,MF,
9113,GO:0035401,1.00000000000986,0.94671569659292,0,1,histone kinase activity (H3-Y41 specific),MF,
9118,GO:0035406,1.00000000000986,0.94671569659292,0,1,histone-tyrosine phosphorylation,BP,
9121,GO:0035409,1.00000000000986,0.94671569659292,0,1,histone H3-Y41 phosphorylation,BP,
16904,GO:0098837,1.00000000000986,0.870956530196416,0,3,postsynaptic recycling endosome,CC,
2075,GO:0004826,1.00000000000988,0.79649436058515,0,5,phenylalanine-tRNA ligase activity,MF,
2922,GO:0006432,1.00000000000988,0.79649436058515,0,5,phenylalanyl-tRNA aminoacylation,BP,
1920,GO:0004610,1.00000000000988,0.956440279331144,0,1,phosphoacetylglucosamine mutase activity,MF,
7491,GO:0031651,1.00000000000988,0.948320862265472,0,1,negative regulation of heat generation,BP,
7518,GO:0031699,1.00000000000988,0.948320862265472,0,1,beta-3 adrenergic receptor binding,MF,
14466,GO:0061798,1.00000000000988,0.948320862265472,0,1,GTP 3',8'-cyclase activity,MF,
14467,GO:0061799,1.00000000000988,0.948320862265472,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
16280,GO:0090327,1.00000000000988,0.948320862265472,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
15890,GO:0072603,1.00000000000989,0.823517995840542,0,4,interleukin-5 secretion,BP,
20064,GO:2000662,1.00000000000989,0.823517995840542,0,4,regulation of interleukin-5 secretion,BP,
10847,GO:0044339,1.00000000000989,0.863588187017655,0,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
5997,GO:0018993,1.00000000000989,0.95348655514979,0,1,somatic sex determination,BP,
6037,GO:0019101,1.00000000000989,0.95348655514979,0,1,female somatic sex determination,BP,
13567,GO:0060014,1.00000000000989,0.95348655514979,0,1,granulosa cell differentiation,BP,
14665,GO:0070254,1.00000000000991,0.717794807521939,0,8,mucus secretion,BP,
14559,GO:0070070,1.00000000000992,0.664290456062316,0,8,proton-transporting V-type ATPase complex assembly,BP,
14561,GO:0070072,1.00000000000992,0.664290456062316,0,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,
13599,GO:0060052,1.00000000000993,0.71761490625567,0,7,neurofilament cytoskeleton organization,BP,
18286,GO:1903136,1.00000000000993,0.826759311989167,0,5,cuprous ion binding,MF,
18637,GO:1903905,1.00000000000994,0.903318041443542,0,2,positive regulation of establishment of T cell polarity,BP,
2359,GO:0005456,1.00000000000994,0.957927217335844,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
5196,GO:0015782,1.00000000000994,0.957927217335844,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
10742,GO:0044105,1.00000000000995,0.976040623648868,0,1,L-xylulose reductase (NAD+) activity,MF,
12449,GO:0050038,1.00000000000995,0.976040623648868,0,1,L-xylulose reductase (NADP+) activity,MF,
4468,GO:0010459,1.00000000000996,0.848812337687418,0,4,negative regulation of heart rate,BP,
4097,GO:0009149,1.00000000000996,0.927951401841008,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4153,GO:0009213,1.00000000000996,0.927951401841008,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
7962,GO:0032556,1.00000000000996,0.927951401841008,0,2,pyrimidine deoxyribonucleotide binding,MF,
3597,GO:0008024,1.00000000000998,0.668543578408785,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
6422,GO:0021681,1.00000000000998,0.718823441433472,0,7,cerebellar granular layer development,BP,
13206,GO:0051799,1.00000000000999,0.852558273427572,0,3,negative regulation of hair follicle development,BP,
5995,GO:0018963,1.00000000000999,0.913216686447486,0,2,phthalate metabolic process,BP,
7159,GO:0031014,1.00000000000999,0.950900027731917,0,2,troponin T binding,MF,
15857,GO:0072557,1.00000000001,0.936138650750411,0,2,IPAF inflammasome complex,CC,
13087,GO:0051581,1.00000000001,0.861801767874533,0,3,negative regulation of neurotransmitter uptake,BP,
11940,GO:0046976,1.00000000001,0.778300504955521,0,5,histone methyltransferase activity (H3-K27 specific),MF,
4398,GO:0010070,1.00000000001001,0.95471219652608,0,1,zygote asymmetric cell division,BP,
7268,GO:0031232,1.00000000001002,0.874616977395052,0,3,extrinsic component of external side of plasma membrane,CC,
15955,GO:0072750,1.00000000001003,0.965745643614657,0,1,cellular response to leptomycin B,BP,
17647,GO:1901344,1.00000000001003,0.965745643614657,0,1,response to leptomycin B,BP,
17769,GO:1901707,1.00000000001003,0.965745643614657,0,1,leptomycin B binding,MF,
4428,GO:0010248,1.00000000001004,0.772310340574316,0,6,establishment or maintenance of transmembrane electrochemical gradient,BP,
13013,GO:0051418,1.00000000001004,0.6621227957666,0,8,microtubule nucleation by microtubule organizing center,BP,
15916,GO:0072674,1.00000000001004,0.811075286356484,0,4,multinuclear osteoclast differentiation,BP,
15917,GO:0072675,1.00000000001004,0.811075286356484,0,4,osteoclast fusion,BP,
3824,GO:0008419,1.00000000001004,0.954176065439435,0,1,RNA lariat debranching enzyme activity,MF,
15723,GO:0072262,1.00000000001005,0.908049816218395,0,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
15741,GO:0072301,1.00000000001005,0.908049816218395,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
15766,GO:0072344,1.00000000001005,0.831454496383633,0,4,rescue of stalled ribosome,BP,
85,GO:0000172,1.00000000001006,0.783206112561556,0,6,ribonuclease MRP complex,CC,
9586,GO:0036402,1.00000000001007,0.792395972764412,0,6,proteasome-activating ATPase activity,MF,
17362,GO:1900038,1.00000000001007,0.754634101671446,0,6,negative regulation of cellular response to hypoxia,BP,
19257,GO:1905383,1.00000000001007,0.89096773436232,0,3,protein localization to presynapse,BP,
4990,GO:0015114,1.00000000001008,0.700082749170654,0,7,phosphate ion transmembrane transporter activity,MF,
8781,GO:0034457,1.00000000001008,0.895708026911847,0,3,Mpp10 complex,CC,
8195,GO:0032930,1.00000000001008,0.727957466652685,0,8,positive regulation of superoxide anion generation,BP,
2417,GO:0005589,1.00000000001008,0.912058428529056,0,2,collagen type VI trimer,CC,
16816,GO:0098647,1.00000000001008,0.912058428529056,0,2,collagen beaded filament,CC,
5692,GO:0016805,1.0000000000101,0.709474350881506,0,7,dipeptidase activity,MF,
17749,GO:1901664,1.0000000000101,0.873211894744283,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
17750,GO:1901666,1.0000000000101,0.873211894744283,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
3933,GO:0008611,1.00000000001011,0.79312278578009,0,5,ether lipid biosynthetic process,BP,
11721,GO:0046504,1.00000000001011,0.79312278578009,0,5,glycerol ether biosynthetic process,BP,
17676,GO:1901503,1.00000000001011,0.79312278578009,0,5,ether biosynthetic process,BP,
2810,GO:0006269,1.00000000001011,0.789655272048005,0,5,DNA replication, synthesis of RNA primer,BP,
16952,GO:0098920,1.00000000001012,0.903130397707182,0,2,retrograde trans-synaptic signaling by lipid,BP,
16953,GO:0098921,1.00000000001012,0.903130397707182,0,2,retrograde trans-synaptic signaling by endocannabinoid,BP,
16743,GO:0097742,1.00000000001012,0.85112732511153,0,3,de novo centriole assembly,BP,
16768,GO:0098535,1.00000000001012,0.85112732511153,0,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
15982,GO:0080058,1.00000000001013,0.964330673095527,0,1,protein deglutathionylation,BP,
16681,GO:0097573,1.00000000001013,0.964330673095527,0,1,glutathione oxidoreductase activity,MF,
1604,GO:0004020,1.00000000001013,0.906141978582439,0,2,adenylylsulfate kinase activity,MF,
2041,GO:0004779,1.00000000001013,0.906141978582439,0,2,sulfate adenylyltransferase activity,MF,
2042,GO:0004781,1.00000000001013,0.906141978582439,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2772,GO:0006193,1.00000000001013,0.969595069017949,0,1,ITP catabolic process,BP,
4144,GO:0009203,1.00000000001013,0.969595069017949,0,1,ribonucleoside triphosphate catabolic process,BP,
4148,GO:0009207,1.00000000001013,0.969595069017949,0,1,purine ribonucleoside triphosphate catabolic process,BP,
9524,GO:0036220,1.00000000001013,0.969595069017949,0,1,ITP diphosphatase activity,MF,
9525,GO:0036222,1.00000000001013,0.969595069017949,0,1,XTP diphosphatase activity,MF,
3724,GO:0008251,1.00000000001013,0.903111159918452,0,2,tRNA-specific adenosine deaminase activity,MF,
17757,GO:1901678,1.00000000001014,0.656076215445922,0,9,iron coordination entity transport,BP,
12904,GO:0051232,1.00000000001014,0.954817929503405,0,1,meiotic spindle elongation,BP,
14017,GO:0060718,1.00000000001014,0.770296242278033,0,5,chorionic trophoblast cell differentiation,BP,
17547,GO:1901029,1.00000000001014,0.744034109461399,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
2385,GO:0005519,1.00000000001014,0.948953816820086,0,1,cytoskeletal regulatory protein binding,MF,
20226,GO:2001069,1.00000000001014,0.910132379658382,0,2,glycogen binding,MF,
1161,GO:0002767,1.00000000001015,0.915507922108739,0,2,immune response-inhibiting cell surface receptor signaling pathway,BP,
12733,GO:0050957,1.00000000001015,0.948976483091558,0,1,equilibrioception,BP,
18013,GO:1902459,1.00000000001015,0.730632568265143,0,6,positive regulation of stem cell population maintenance,BP,
11308,GO:0045617,1.00000000001015,0.745684679305501,0,6,negative regulation of keratinocyte differentiation,BP,
6015,GO:0019060,1.00000000001016,0.938015648286107,0,2,intracellular transport of viral protein in host cell,BP,
6958,GO:0030581,1.00000000001016,0.938015648286107,0,2,symbiont intracellular protein transport in host,BP,
13155,GO:0051708,1.00000000001016,0.938015648286107,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
8396,GO:0033314,1.00000000001016,0.683919215059742,0,8,mitotic DNA replication checkpoint,BP,
1697,GO:0004169,1.00000000001016,0.82853935709744,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
210,GO:0000438,1.00000000001017,0.882260545375575,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
9432,GO:0035999,1.00000000001017,0.697746712642101,0,8,tetrahydrofolate interconversion,BP,
2790,GO:0006226,1.00000000001017,0.87908878736246,0,3,dUMP biosynthetic process,BP,
18035,GO:1902514,1.00000000001018,0.699688946905808,0,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
12036,GO:0047676,1.00000000001019,0.946754441951436,0,1,arachidonate-CoA ligase activity,MF,
976,GO:0002424,1.00000000001019,0.90855883463106,0,2,T cell mediated immune response to tumor cell,BP,
1196,GO:0002840,1.00000000001019,0.90855883463106,0,2,regulation of T cell mediated immune response to tumor cell,BP,
5966,GO:0018352,1.00000000001019,0.915341896828393,0,2,protein-pyridoxal-5-phosphate linkage,BP,
1496,GO:0003835,1.0000000000102,0.897430106460143,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
12461,GO:0050146,1.0000000000102,0.946710082523113,0,1,nucleoside phosphotransferase activity,MF,
15895,GO:0072611,1.0000000000102,0.787737132043412,0,5,interleukin-13 secretion,BP,
20067,GO:2000665,1.0000000000102,0.787737132043412,0,5,regulation of interleukin-13 secretion,BP,
6451,GO:0021763,1.0000000000102,0.955265806168383,0,1,subthalamic nucleus development,BP,
13646,GO:0060127,1.0000000000102,0.955265806168383,0,1,prolactin secreting cell differentiation,BP,
13869,GO:0060459,1.0000000000102,0.955265806168383,0,1,left lung development,BP,
13870,GO:0060460,1.0000000000102,0.955265806168383,0,1,left lung morphogenesis,BP,
13934,GO:0060577,1.0000000000102,0.955265806168383,0,1,pulmonary vein morphogenesis,BP,
13935,GO:0060578,1.0000000000102,0.955265806168383,0,1,superior vena cava morphogenesis,BP,
14165,GO:0061031,1.0000000000102,0.955265806168383,0,1,endodermal digestive tract morphogenesis,BP,
18971,GO:1904715,1.0000000000102,0.870688574968635,0,3,negative regulation of chaperone-mediated autophagy,BP,
6455,GO:0021769,1.00000000001022,0.858940154855147,0,3,orbitofrontal cortex development,BP,
16298,GO:0090370,1.00000000001022,0.947895374129519,0,1,negative regulation of cholesterol efflux,BP,
20304,GO:2001247,1.00000000001022,0.947895374129519,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
781,GO:0002036,1.00000000001023,0.822056995071739,0,4,regulation of L-glutamate import across plasma membrane,BP,
4776,GO:0010958,1.00000000001023,0.822056995071739,0,4,regulation of amino acid import across plasma membrane,BP,
18096,GO:1902683,1.00000000001024,0.905453389426311,0,2,regulation of receptor localization to synapse,BP,
7736,GO:0032227,1.00000000001024,0.85504650641753,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
19104,GO:1904978,1.00000000001024,0.856475998049484,0,3,regulation of endosome organization,BP,
6031,GO:0019086,1.00000000001024,0.829795867549923,0,4,late viral transcription,BP,
3296,GO:0006991,1.00000000001024,0.641261412704098,0,9,response to sterol depletion,BP,
8393,GO:0033301,1.00000000001026,0.95002126155238,0,1,cell cycle comprising mitosis without cytokinesis,BP,
12040,GO:0047708,1.00000000001026,0.956059493821333,0,1,biotinidase activity,MF,
13807,GO:0060380,1.00000000001026,0.956059493821333,0,1,regulation of single-stranded telomeric DNA binding,BP,
13808,GO:0060381,1.00000000001026,0.956059493821333,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
7574,GO:0031931,1.00000000001026,0.706723578461842,0,7,TORC1 complex,CC,
6127,GO:0019371,1.00000000001027,0.723103888354568,0,7,cyclooxygenase pathway,BP,
8561,GO:0033989,1.00000000001027,0.954088709427734,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9480,GO:0036111,1.00000000001027,0.954088709427734,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10939,GO:0044594,1.00000000001027,0.954088709427734,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
12448,GO:0050023,1.00000000001027,0.957486059549203,0,1,L-fuconate dehydratase activity,MF,
3006,GO:0006551,1.00000000001027,0.721424259941134,0,7,leucine metabolic process,BP,
9776,GO:0039552,1.00000000001027,0.94668070645974,0,1,RIG-I binding,MF,
3891,GO:0008521,1.00000000001028,0.954158375166418,0,1,acetyl-CoA transmembrane transporter activity,MF,
5253,GO:0015876,1.00000000001028,0.954158375166418,0,1,acetyl-CoA transport,BP,
5272,GO:0015916,1.00000000001028,0.954158375166418,0,1,fatty-acyl-CoA transport,BP,
5351,GO:0016095,1.00000000001028,0.954158375166418,0,1,polyprenol catabolic process,BP,
17156,GO:0102389,1.00000000001028,0.954158375166418,0,1,polyprenol reductase activity,MF,
17640,GO:1901337,1.00000000001028,0.954158375166418,0,1,thioester transport,BP,
10825,GO:0044313,1.00000000001028,0.851263871958637,0,3,protein K6-linked deubiquitination,BP,
13176,GO:0051747,1.00000000001028,0.935123573074041,0,2,cytosine C-5 DNA demethylase activity,MF,
7532,GO:0031748,1.00000000001029,0.783750265258139,0,5,D1 dopamine receptor binding,MF,
4328,GO:0009826,1.0000000000103,0.906529745998476,0,2,unidimensional cell growth,BP,
16210,GO:0090226,1.0000000000103,0.976117177565505,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
13312,GO:0052031,1.0000000000103,0.870331509442705,0,3,modulation by symbiont of host defense response,BP,
13346,GO:0052255,1.0000000000103,0.870331509442705,0,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13379,GO:0052552,1.0000000000103,0.870331509442705,0,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13380,GO:0052553,1.0000000000103,0.870331509442705,0,3,modulation by symbiont of host immune response,BP,
15972,GO:0075528,1.0000000000103,0.870331509442705,0,3,modulation by virus of host immune response,BP,
19364,GO:1905696,1.0000000000103,0.896818053384492,0,2,regulation of polysome binding,BP,
10465,GO:0043320,1.0000000000103,0.748226152497299,0,6,natural killer cell degranulation,BP,
3971,GO:0008761,1.0000000000103,0.946716520539336,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4220,GO:0009384,1.0000000000103,0.946716520539336,0,1,N-acylmannosamine kinase activity,MF,
16420,GO:0097036,1.00000000001031,0.96295836929019,0,1,regulation of plasma membrane sterol distribution,BP,
3557,GO:0007598,1.00000000001031,0.954882503491542,0,1,blood coagulation, extrinsic pathway,BP,
17593,GO:1901202,1.00000000001031,0.954882503491542,0,1,negative regulation of extracellular matrix assembly,BP,
18402,GO:1903394,1.00000000001031,0.954882503491542,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
5915,GO:0018153,1.00000000001031,0.911272958193384,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
5946,GO:0018262,1.00000000001031,0.911272958193384,0,2,isopeptide cross-linking,BP,
14839,GO:0070569,1.00000000001031,0.716055178146392,0,7,uridylyltransferase activity,MF,
7456,GO:0031588,1.00000000001032,0.638511055774422,0,9,nucleotide-activated protein kinase complex,CC,
2091,GO:0004853,1.00000000001033,0.963826141880335,0,1,uroporphyrinogen decarboxylase activity,MF,
9012,GO:0035174,1.00000000001034,0.757690696862065,0,6,histone serine kinase activity,MF,
91,GO:0000179,1.00000000001034,0.841390457333331,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
7113,GO:0030905,1.00000000001034,0.824372958279006,0,4,retromer, tubulation complex,CC,
13090,GO:0051584,1.00000000001036,0.857681838259254,0,4,regulation of dopamine uptake involved in synaptic transmission,BP,
13273,GO:0051940,1.00000000001036,0.857681838259254,0,4,regulation of catecholamine uptake involved in synaptic transmission,BP,
12337,GO:0048680,1.00000000001037,0.845113296279336,0,4,positive regulation of axon regeneration,BP,
14842,GO:0070572,1.00000000001037,0.845113296279336,0,4,positive regulation of neuron projection regeneration,BP,
11064,GO:0045053,1.00000000001037,0.766266380560676,0,5,protein retention in Golgi apparatus,BP,
3658,GO:0008140,1.00000000001038,0.68951245998177,0,8,cAMP response element binding protein binding,MF,
3039,GO:0006590,1.00000000001038,0.633495135457477,0,9,thyroid hormone generation,BP,
15044,GO:0070976,1.00000000001039,0.954042575948566,0,1,TIR domain binding,MF,
2090,GO:0004852,1.0000000000104,0.964367212641935,0,1,uroporphyrinogen-III synthase activity,MF,
15262,GO:0071418,1.0000000000104,0.964367212641935,0,1,cellular response to amine stimulus,BP,
4381,GO:0010009,1.0000000000104,0.790321838422548,0,5,cytoplasmic side of endosome membrane,CC,
11513,GO:0045989,1.0000000000104,0.735353528733588,0,7,positive regulation of striated muscle contraction,BP,
3895,GO:0008527,1.00000000001041,0.841279712356078,0,5,taste receptor activity,MF,
8974,GO:0035061,1.00000000001041,0.809015279734565,0,4,interchromatin granule,CC,
424,GO:0001129,1.00000000001042,0.858699734705563,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
425,GO:0001132,1.00000000001042,0.858699734705563,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
1677,GO:0004138,1.00000000001042,0.971635459672209,0,1,deoxyguanosine kinase activity,MF,
3938,GO:0008617,1.00000000001042,0.971635459672209,0,1,guanosine metabolic process,BP,
5289,GO:0015938,1.00000000001042,0.971635459672209,0,1,coenzyme A catabolic process,BP,
8544,GO:0033869,1.00000000001042,0.971635459672209,0,1,nucleoside bisphosphate catabolic process,BP,
8567,GO:0034031,1.00000000001042,0.971635459672209,0,1,ribonucleoside bisphosphate catabolic process,BP,
8570,GO:0034034,1.00000000001042,0.971635459672209,0,1,purine nucleoside bisphosphate catabolic process,BP,
5509,GO:0016453,1.00000000001042,0.840908580354671,0,4,C-acetyltransferase activity,MF,
5477,GO:0016406,1.00000000001043,0.74730450178362,0,6,carnitine O-acyltransferase activity,MF,
16692,GO:0097623,1.00000000001043,0.946846401069386,0,1,potassium ion export across plasma membrane,BP,
18569,GO:1903764,1.00000000001043,0.946846401069386,0,1,regulation of potassium ion export across plasma membrane,BP,
13727,GO:0060272,1.00000000001044,0.690097663688766,0,8,embryonic skeletal joint morphogenesis,BP,
2583,GO:0005873,1.00000000001045,0.854818583759671,0,3,plus-end kinesin complex,CC,
17242,GO:0110021,1.00000000001046,0.908531285502377,0,2,cardiac muscle myoblast proliferation,BP,
17243,GO:0110022,1.00000000001046,0.908531285502377,0,2,regulation of cardiac muscle myoblast proliferation,BP,
17244,GO:0110024,1.00000000001046,0.908531285502377,0,2,positive regulation of cardiac muscle myoblast proliferation,BP,
15038,GO:0070966,1.00000000001046,0.856061894556932,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
18891,GO:1904533,1.00000000001047,0.861233357509073,0,3,regulation of telomeric loop disassembly,BP,
8324,GO:0033159,1.00000000001047,0.860623548598491,0,3,negative regulation of protein import into nucleus, translocation,BP,
1239,GO:0002924,1.00000000001048,0.955185723625333,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
9860,GO:0042105,1.00000000001048,0.955185723625333,0,1,alpha-beta T cell receptor complex,CC,
2198,GO:0005068,1.00000000001048,0.693319993127884,0,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
1055,GO:0002580,1.00000000001048,0.889376661604503,0,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
16085,GO:0090031,1.00000000001049,0.906040446781422,0,2,positive regulation of steroid hormone biosynthetic process,BP,
12901,GO:0051228,1.00000000001049,0.946760818754007,0,1,mitotic spindle disassembly,BP,
12902,GO:0051230,1.00000000001049,0.946760818754007,0,1,spindle disassembly,BP,
5182,GO:0015740,1.0000000000105,0.636089937287262,0,9,C4-dicarboxylate transport,BP,
14280,GO:0061325,1.0000000000105,0.870849970620565,0,3,cell proliferation involved in outflow tract morphogenesis,BP,
17455,GO:1900220,1.0000000000105,0.896911440345882,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
8835,GO:0034617,1.00000000001051,0.864920242752809,0,3,tetrahydrobiopterin binding,MF,
9344,GO:0035844,1.00000000001052,0.859282719368158,0,3,cloaca development,BP,
3457,GO:0007270,1.00000000001052,0.740890806453427,0,6,neuron-neuron synaptic transmission,BP,
4174,GO:0009240,1.00000000001053,0.814969816844639,0,5,isopentenyl diphosphate biosynthetic process,BP,
11709,GO:0046490,1.00000000001053,0.814969816844639,0,5,isopentenyl diphosphate metabolic process,BP,
13058,GO:0051525,1.00000000001053,0.897338210514383,0,2,NFAT protein binding,MF,
15813,GO:0072487,1.00000000001054,0.781594250042748,0,5,MSL complex,CC,
13220,GO:0051835,1.00000000001054,0.870316865252634,0,3,positive regulation of synapse structural plasticity,BP,
15529,GO:0071896,1.00000000001055,0.803248054677039,0,4,protein localization to adherens junction,BP,
755,GO:0001992,1.00000000001055,0.947800709140431,0,1,regulation of systemic arterial blood pressure by vasopressin,BP,
2162,GO:0004990,1.00000000001055,0.947800709140431,0,1,oxytocin receptor activity,MF,
2311,GO:0005298,1.00000000001055,0.947800709140431,0,1,proline:sodium symporter activity,MF,
10073,GO:0042564,1.00000000001055,0.947800709140431,0,1,NLS-dependent protein nuclear import complex,CC,
11412,GO:0045794,1.00000000001055,0.80525899280648,0,4,negative regulation of cell volume,BP,
7353,GO:0031389,1.00000000001056,0.953531706411932,0,1,Rad17 RFC-like complex,CC,
12825,GO:0051107,1.00000000001056,0.953531706411932,0,1,negative regulation of DNA ligation,BP,
12983,GO:0051352,1.00000000001056,0.953531706411932,0,1,negative regulation of ligase activity,BP,
19052,GO:1904876,1.00000000001056,0.953531706411932,0,1,negative regulation of DNA ligase activity,BP,
9387,GO:0035921,1.00000000001056,0.955881130730448,0,1,desmosome disassembly,BP,
17495,GO:1900387,1.00000000001056,0.955881130730448,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
865,GO:0002193,1.00000000001057,0.855723809677126,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
11769,GO:0046607,1.00000000001057,0.646818080531955,0,9,positive regulation of centrosome cycle,BP,
19258,GO:1905384,1.00000000001058,0.91432730870395,0,2,regulation of protein localization to presynapse,BP,
19259,GO:1905386,1.00000000001058,0.91432730870395,0,2,positive regulation of protein localization to presynapse,BP,
9015,GO:0035184,1.00000000001058,0.825555140681077,0,4,histone threonine kinase activity,MF,
9117,GO:0035405,1.00000000001058,0.825555140681077,0,4,histone-threonine phosphorylation,BP,
3531,GO:0007518,1.0000000000106,0.954833102201639,0,1,myoblast fate determination,BP,
7813,GO:0032358,1.0000000000106,0.975811543976741,0,1,oxidized pyrimidine DNA binding,MF,
14336,GO:0061481,1.0000000000106,0.975811543976741,0,1,response to TNF agonist,BP,
18046,GO:1902546,1.0000000000106,0.975811543976741,0,1,positive regulation of DNA N-glycosylase activity,BP,
20317,GO:2001272,1.0000000000106,0.975811543976741,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
10722,GO:0044036,1.00000000001061,0.877246665850628,0,3,cell wall macromolecule metabolic process,BP,
15345,GO:0071554,1.00000000001061,0.877246665850628,0,3,cell wall organization or biogenesis,BP,
4999,GO:0015136,1.00000000001061,0.95186355105999,0,1,sialic acid transmembrane transporter activity,MF,
5130,GO:0015538,1.00000000001061,0.95186355105999,0,1,sialic acid:proton symporter activity,MF,
5181,GO:0015739,1.00000000001061,0.95186355105999,0,1,sialic acid transport,BP,
9620,GO:0036482,1.00000000001061,0.928864187552946,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18203,GO:1902958,1.00000000001061,0.928864187552946,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18395,GO:1903383,1.00000000001061,0.928864187552946,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18396,GO:1903384,1.00000000001061,0.928864187552946,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
17468,GO:1900244,1.00000000001062,0.905560563449144,0,2,positive regulation of synaptic vesicle endocytosis,BP,
2575,GO:0005859,1.00000000001062,0.721233513079215,0,7,muscle myosin complex,CC,
8773,GO:0034448,1.00000000001062,0.846051832274761,0,4,EGO complex,CC,
16627,GO:0097454,1.00000000001063,0.868965251405831,0,3,Schwann cell microvillus,CC,
4637,GO:0010756,1.00000000001063,0.873264975134251,0,3,positive regulation of plasminogen activation,BP,
3980,GO:0008798,1.00000000001063,0.946671366668737,0,1,beta-aspartyl-peptidase activity,MF,
15013,GO:0070931,1.00000000001063,0.946671366668737,0,1,Golgi-associated vesicle lumen,CC,
9945,GO:0042297,1.00000000001063,0.806257880445556,0,4,vocal learning,BP,
16794,GO:0098596,1.00000000001063,0.806257880445556,0,4,imitative learning,BP,
16796,GO:0098598,1.00000000001063,0.806257880445556,0,4,learned vocalization behavior or vocal learning,BP,
6964,GO:0030613,1.00000000001064,0.915795054717695,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
6965,GO:0030614,1.00000000001064,0.915795054717695,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
4559,GO:0010637,1.00000000001066,0.793799523853628,0,5,negative regulation of mitochondrial fusion,BP,
3637,GO:0008107,1.00000000001067,0.903376093593825,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
7236,GO:0031127,1.00000000001067,0.903376093593825,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
8500,GO:0033676,1.00000000001068,0.963491327128683,0,1,double-stranded DNA-dependent ATPase activity,MF,
6756,GO:0030174,1.00000000001068,0.754968815022451,0,6,regulation of DNA-dependent DNA replication initiation,BP,
15681,GO:0072190,1.00000000001068,0.909517482886831,0,2,ureter urothelium development,BP,
15682,GO:0072191,1.00000000001068,0.909517482886831,0,2,ureter smooth muscle development,BP,
15684,GO:0072193,1.00000000001068,0.909517482886831,0,2,ureter smooth muscle cell differentiation,BP,
15686,GO:0072197,1.00000000001068,0.909517482886831,0,2,ureter morphogenesis,BP,
8706,GO:0034342,1.00000000001068,0.911331032322902,0,2,response to type III interferon,BP,
19811,GO:2000210,1.00000000001068,0.776286627167248,0,6,positive regulation of anoikis,BP,
8125,GO:0032808,1.00000000001069,0.810762751329537,0,4,lacrimal gland development,BP,
10712,GO:0043998,1.00000000001069,0.951782311163026,0,1,H2A histone acetyltransferase activity,MF,
2143,GO:0004953,1.00000000001069,0.795991194042078,0,5,icosanoid receptor activity,MF,
2126,GO:0004918,1.0000000000107,0.954552270765335,0,1,interleukin-8 receptor activity,MF,
6318,GO:0019959,1.0000000000107,0.954552270765335,0,1,interleukin-8 binding,MF,
9711,GO:0038112,1.0000000000107,0.954552270765335,0,1,interleukin-8-mediated signaling pathway,BP,
11643,GO:0046340,1.0000000000107,0.857633646363024,0,3,diacylglycerol catabolic process,BP,
3825,GO:0008420,1.00000000001071,0.686186244427635,0,8,CTD phosphatase activity,MF,
718,GO:0001940,1.00000000001071,0.781997357440409,0,5,male pronucleus,CC,
886,GO:0002249,1.00000000001072,0.896181653311112,0,2,lymphocyte anergy,BP,
935,GO:0002331,1.00000000001072,0.896181653311112,0,2,pre-B cell allelic exclusion,BP,
1086,GO:0002667,1.00000000001072,0.896181653311112,0,2,regulation of T cell anergy,BP,
1210,GO:0002870,1.00000000001072,0.896181653311112,0,2,T cell anergy,BP,
1233,GO:0002911,1.00000000001072,0.896181653311112,0,2,regulation of lymphocyte anergy,BP,
1367,GO:0003249,1.00000000001072,0.896181653311112,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1368,GO:0003250,1.00000000001072,0.896181653311112,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1582,GO:0003989,1.00000000001072,0.896181653311112,0,2,acetyl-CoA carboxylase activity,MF,
1596,GO:0004008,1.00000000001072,0.896181653311112,0,2,copper-exporting ATPase activity,MF,
1975,GO:0004687,1.00000000001072,0.896181653311112,0,2,myosin light chain kinase activity,MF,
2338,GO:0005365,1.00000000001072,0.896181653311112,0,2,myo-inositol transmembrane transporter activity,MF,
2431,GO:0005608,1.00000000001072,0.896181653311112,0,2,laminin-3 complex,CC,
2603,GO:0005899,1.00000000001072,0.896181653311112,0,2,insulin receptor complex,CC,
4633,GO:0010751,1.00000000001072,0.896181653311112,0,2,negative regulation of nitric oxide mediated signal transduction,BP,
5470,GO:0016362,1.00000000001072,0.896181653311112,0,2,activin receptor activity, type II,MF,
6008,GO:0019045,1.00000000001072,0.896181653311112,0,2,latent virus replication,BP,
6009,GO:0019046,1.00000000001072,0.896181653311112,0,2,release from viral latency,BP,
6082,GO:0019230,1.00000000001072,0.896181653311112,0,2,proprioception,BP,
6452,GO:0021764,1.00000000001072,0.896181653311112,0,2,amygdala development,BP,
6562,GO:0021997,1.00000000001072,0.896181653311112,0,2,neural plate axis specification,BP,
6804,GO:0030241,1.00000000001072,0.896181653311112,0,2,skeletal muscle myosin thick filament assembly,BP,
6918,GO:0030505,1.00000000001072,0.896181653311112,0,2,inorganic diphosphate transport,BP,
7883,GO:0032444,1.00000000001072,0.896181653311112,0,2,activin responsive factor complex,CC,
8389,GO:0033292,1.00000000001072,0.896181653311112,0,2,T-tubule organization,BP,
8854,GO:0034647,1.00000000001072,0.896181653311112,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8903,GO:0034721,1.00000000001072,0.896181653311112,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9047,GO:0035261,1.00000000001072,0.896181653311112,0,2,external genitalia morphogenesis,BP,
9083,GO:0035332,1.00000000001072,0.896181653311112,0,2,positive regulation of hippo signaling,BP,
9105,GO:0035373,1.00000000001072,0.896181653311112,0,2,chondroitin sulfate proteoglycan binding,MF,
9510,GO:0036156,1.00000000001072,0.896181653311112,0,2,inner dynein arm,CC,
9551,GO:0036309,1.00000000001072,0.896181653311112,0,2,protein localization to M-band,BP,
9573,GO:0036369,1.00000000001072,0.896181653311112,0,2,transcription factor catabolic process,BP,
9683,GO:0038049,1.00000000001072,0.896181653311112,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
9824,GO:0042030,1.00000000001072,0.896181653311112,0,2,ATPase inhibitor activity,MF,
10440,GO:0043291,1.00000000001072,0.896181653311112,0,2,RAVE complex,CC,
10653,GO:0043682,1.00000000001072,0.896181653311112,0,2,copper-transporting ATPase activity,MF,
11504,GO:0045967,1.00000000001072,0.896181653311112,0,2,negative regulation of growth rate,BP,
12387,GO:0048769,1.00000000001072,0.896181653311112,0,2,sarcomerogenesis,BP,
12720,GO:0050925,1.00000000001072,0.896181653311112,0,2,negative regulation of negative chemotaxis,BP,
13557,GO:0060003,1.00000000001072,0.896181653311112,0,2,copper ion export,BP,
14306,GO:0061386,1.00000000001072,0.896181653311112,0,2,closure of optic fissure,BP,
14971,GO:0070853,1.00000000001072,0.896181653311112,0,2,myosin VI binding,MF,
15242,GO:0071386,1.00000000001072,0.896181653311112,0,2,cellular response to corticosterone stimulus,BP,
15619,GO:0072092,1.00000000001072,0.896181653311112,0,2,ureteric bud invasion,BP,
15652,GO:0072137,1.00000000001072,0.896181653311112,0,2,condensed mesenchymal cell proliferation,BP,
15659,GO:0072156,1.00000000001072,0.896181653311112,0,2,distal tubule morphogenesis,BP,
15778,GO:0072361,1.00000000001072,0.896181653311112,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
15781,GO:0072364,1.00000000001072,0.896181653311112,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16208,GO:0090222,1.00000000001072,0.896181653311112,0,2,centrosome-templated microtubule nucleation,BP,
16461,GO:0097111,1.00000000001072,0.896181653311112,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
16485,GO:0097155,1.00000000001072,0.896181653311112,0,2,fasciculation of sensory neuron axon,BP,
16718,GO:0097681,1.00000000001072,0.896181653311112,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
16828,GO:0098679,1.00000000001072,0.896181653311112,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16958,GO:0098928,1.00000000001072,0.896181653311112,0,2,presynaptic signal transduction,BP,
17042,GO:0099403,1.00000000001072,0.896181653311112,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
17043,GO:0099404,1.00000000001072,0.896181653311112,0,2,mitotic sister chromatid cohesion, telomeric,BP,
17060,GO:0099526,1.00000000001072,0.896181653311112,0,2,presynapse to nucleus signaling pathway,BP,
17328,GO:0140192,1.00000000001072,0.896181653311112,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18199,GO:1902954,1.00000000001072,0.896181653311112,0,2,regulation of early endosome to recycling endosome transport,BP,
18324,GO:1903225,1.00000000001072,0.896181653311112,0,2,negative regulation of endodermal cell differentiation,BP,
18535,GO:1903691,1.00000000001072,0.896181653311112,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
18688,GO:1904017,1.00000000001072,0.896181653311112,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
18841,GO:1904398,1.00000000001072,0.896181653311112,0,2,positive regulation of neuromuscular junction development,BP,
18872,GO:1904475,1.00000000001072,0.896181653311112,0,2,regulation of Ras GTPase binding,BP,
18899,GO:1904562,1.00000000001072,0.896181653311112,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
18984,GO:1904743,1.00000000001072,0.896181653311112,0,2,negative regulation of telomeric DNA binding,BP,
19046,GO:1904868,1.00000000001072,0.896181653311112,0,2,telomerase catalytic core complex assembly,BP,
19058,GO:1904882,1.00000000001072,0.896181653311112,0,2,regulation of telomerase catalytic core complex assembly,BP,
19059,GO:1904884,1.00000000001072,0.896181653311112,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
19072,GO:1904907,1.00000000001072,0.896181653311112,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19073,GO:1904908,1.00000000001072,0.896181653311112,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19570,GO:1990498,1.00000000001072,0.896181653311112,0,2,mitotic spindle microtubule,CC,
20033,GO:2000620,1.00000000001072,0.896181653311112,0,2,positive regulation of histone H4-K16 acetylation,BP,
20139,GO:2000793,1.00000000001072,0.896181653311112,0,2,cell proliferation involved in heart valve development,BP,
20206,GO:2001027,1.00000000001072,0.896181653311112,0,2,negative regulation of endothelial cell chemotaxis,BP,
20230,GO:2001106,1.00000000001072,0.896181653311112,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20288,GO:2001228,1.00000000001072,0.896181653311112,0,2,regulation of response to gamma radiation,BP,
20328,GO:2001295,1.00000000001072,0.896181653311112,0,2,malonyl-CoA biosynthetic process,BP,
8340,GO:0033184,1.00000000001073,0.775703670255698,0,5,positive regulation of histone ubiquitination,BP,
7658,GO:0032074,1.00000000001073,0.750078483398761,0,6,negative regulation of nuclease activity,BP,
13416,GO:0052735,1.00000000001073,0.863305183064087,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
12107,GO:0048096,1.00000000001075,0.685230740858683,0,8,chromatin-mediated maintenance of transcription,BP,
16988,GO:0099010,1.00000000001075,0.854640949101673,0,3,modification of postsynaptic structure,BP,
2998,GO:0006543,1.00000000001076,0.859091865299411,0,3,glutamine catabolic process,BP,
9144,GO:0035485,1.00000000001077,0.957650999642472,0,1,adenine/guanine mispair binding,MF,
6805,GO:0030242,1.00000000001077,0.773153553652923,0,5,autophagy of peroxisome,BP,
16178,GO:0090185,1.00000000001077,0.646636592619147,0,9,negative regulation of kidney development,BP,
1603,GO:0004019,1.00000000001077,0.953914169842581,0,1,adenylosuccinate synthase activity,MF,
2053,GO:0004799,1.00000000001078,0.960665410431906,0,1,thymidylate synthase activity,MF,
6033,GO:0019088,1.00000000001078,0.960665410431906,0,1,immortalization of host cell by virus,BP,
6333,GO:0020021,1.00000000001078,0.960665410431906,0,1,immortalization of host cell,BP,
9844,GO:0042083,1.00000000001078,0.960665410431906,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
9763,GO:0039519,1.00000000001078,0.89638359166586,0,2,modulation by virus of host autophagy,BP,
19546,GO:1990415,1.00000000001079,0.865064169626903,0,3,Pex17p-Pex14p docking complex,CC,
19554,GO:1990429,1.00000000001079,0.865064169626903,0,3,peroxisomal importomer complex,CC,
11997,GO:0047323,1.00000000001079,0.955701736144587,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
13359,GO:0052381,1.00000000001079,0.955701736144587,0,1,tRNA dimethylallyltransferase activity,MF,
10374,GO:0043186,1.0000000000108,0.730644304446385,0,7,P granule,CC,
11264,GO:0045495,1.0000000000108,0.730644304446385,0,7,pole plasm,CC,
13739,GO:0060293,1.0000000000108,0.730644304446385,0,7,germ plasm,CC,
16583,GO:0097361,1.0000000000108,0.842335852229239,0,4,CIA complex,CC,
8586,GO:0034066,1.0000000000108,0.920604853183817,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
499,GO:0001554,1.00000000001081,0.766564942069345,0,5,luteolysis,BP,
12454,GO:0050115,1.00000000001082,0.946955434219007,0,1,myosin-light-chain-phosphatase activity,MF,
511,GO:0001574,1.00000000001083,0.829761011819931,0,4,ganglioside biosynthetic process,BP,
8746,GO:0034393,1.00000000001083,0.64749119579712,0,9,positive regulation of smooth muscle cell apoptotic process,BP,
16533,GO:0097231,1.00000000001083,0.958968793163318,0,1,cell motility in response to calcium ion,BP,
19618,GO:1990716,1.00000000001083,0.958968793163318,0,1,axonemal central apparatus,CC,
7904,GO:0032468,1.00000000001084,0.951032813946281,0,1,Golgi calcium ion homeostasis,BP,
8208,GO:0032957,1.00000000001085,0.661339292073367,0,8,inositol trisphosphate metabolic process,BP,
14368,GO:0061575,1.00000000001085,0.882406834358434,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
4356,GO:0009931,1.00000000001085,0.715279835657677,0,7,calcium-dependent protein serine/threonine kinase activity,MF,
3831,GO:0008428,1.00000000001086,0.864852587013533,0,3,ribonuclease inhibitor activity,MF,
1418,GO:0003352,1.00000000001089,0.789878026034667,0,5,regulation of cilium movement,BP,
1419,GO:0003356,1.00000000001089,0.789878026034667,0,5,regulation of cilium beat frequency,BP,
13741,GO:0060295,1.00000000001089,0.789878026034667,0,5,regulation of cilium movement involved in cell motility,BP,
13742,GO:0060296,1.00000000001089,0.789878026034667,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
17857,GO:1902019,1.00000000001089,0.789878026034667,0,5,regulation of cilium-dependent cell motility,BP,
1767,GO:0004367,1.0000000000109,0.949206060666419,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
11601,GO:0046168,1.0000000000109,0.949206060666419,0,1,glycerol-3-phosphate catabolic process,BP,
13167,GO:0051725,1.00000000001091,0.919160064140166,0,2,protein de-ADP-ribosylation,BP,
13142,GO:0051683,1.00000000001091,0.725560983488784,0,7,establishment of Golgi localization,BP,
10149,GO:0042720,1.00000000001091,0.939428502202261,0,2,mitochondrial inner membrane peptidase complex,CC,
13403,GO:0052659,1.00000000001091,0.628881135068687,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
15544,GO:0071922,1.00000000001092,0.781009180001999,0,5,regulation of cohesin loading,BP,
19320,GO:1905555,1.00000000001094,0.908743487914657,0,2,positive regulation blood vessel branching,BP,
1497,GO:0003836,1.00000000001094,0.749872100862,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1529,GO:0003905,1.00000000001094,0.969918359844653,0,1,alkylbase DNA N-glycosylase activity,MF,
3963,GO:0008725,1.00000000001094,0.969918359844653,0,1,DNA-3-methyladenine glycosylase activity,MF,
10659,GO:0043733,1.00000000001094,0.969918359844653,0,1,DNA-3-methylbase glycosylase activity,MF,
10678,GO:0043916,1.00000000001094,0.969918359844653,0,1,DNA-7-methylguanine glycosylase activity,MF,
13435,GO:0052821,1.00000000001094,0.969918359844653,0,1,DNA-7-methyladenine glycosylase activity,MF,
13436,GO:0052822,1.00000000001094,0.969918359844653,0,1,DNA-3-methylguanine glycosylase activity,MF,
5784,GO:0017002,1.00000000001095,0.775012028998986,0,5,activin-activated receptor activity,MF,
3871,GO:0008493,1.00000000001095,0.957472959563005,0,1,tetracycline transmembrane transporter activity,MF,
5266,GO:0015904,1.00000000001095,0.957472959563005,0,1,tetracycline transport,BP,
2361,GO:0005459,1.00000000001095,0.927868660450168,0,2,UDP-galactose transmembrane transporter activity,MF,
15761,GO:0072334,1.00000000001095,0.927868660450168,0,2,UDP-galactose transmembrane transport,BP,
19000,GO:1904768,1.00000000001096,0.922917537918103,0,2,all-trans-retinol binding,MF,
9966,GO:0042340,1.00000000001097,0.71735919712452,0,7,keratan sulfate catabolic process,BP,
9010,GO:0035166,1.00000000001097,0.859547608155818,0,3,post-embryonic hemopoiesis,BP,
1984,GO:0004699,1.00000000001098,0.858706121356666,0,3,calcium-independent protein kinase C activity,MF,
4448,GO:0010359,1.000000000011,0.743075826939279,0,6,regulation of anion channel activity,BP,
5866,GO:0017162,1.00000000001101,0.677723456824702,0,8,aryl hydrocarbon receptor binding,MF,
5771,GO:0016941,1.00000000001101,0.951282897519467,0,1,natriuretic peptide receptor activity,MF,
13873,GO:0060465,1.00000000001101,0.951282897519467,0,1,pharynx development,BP,
17442,GO:1900194,1.00000000001101,0.951282897519467,0,1,negative regulation of oocyte maturation,BP,
9733,GO:0038180,1.00000000001101,0.679332741701308,0,8,nerve growth factor signaling pathway,BP,
12774,GO:0051030,1.00000000001102,0.852734370985386,0,4,snRNA transport,BP,
11837,GO:0046726,1.00000000001103,0.814335785934383,0,4,positive regulation by virus of viral protein levels in host cell,BP,
1648,GO:0004089,1.00000000001103,0.780416078082027,0,5,carbonate dehydratase activity,MF,
2181,GO:0005025,1.00000000001104,0.85434702483367,0,3,transforming growth factor beta receptor activity, type I,MF,
4132,GO:0009189,1.00000000001104,0.897738973552104,0,3,deoxyribonucleoside diphosphate biosynthetic process,BP,
6504,GO:0021869,1.00000000001104,0.850047936631625,0,3,forebrain ventricular zone progenitor cell division,BP,
6374,GO:0021554,1.00000000001105,0.747280668872887,0,6,optic nerve development,BP,
17470,GO:1900246,1.00000000001105,0.766371991845602,0,5,positive regulation of RIG-I signaling pathway,BP,
4636,GO:0010755,1.00000000001105,0.723475757567382,0,7,regulation of plasminogen activation,BP,
12302,GO:0048627,1.00000000001106,0.917683317630921,0,2,myoblast development,BP,
4598,GO:0010710,1.00000000001106,0.885606496669424,0,3,regulation of collagen catabolic process,BP,
2669,GO:0006014,1.00000000001106,0.896249336980168,0,3,D-ribose metabolic process,BP,
1160,GO:0002765,1.00000000001106,0.875384364111357,0,3,immune response-inhibiting signal transduction,BP,
1655,GO:0004104,1.00000000001106,0.910799990679026,0,2,cholinesterase activity,MF,
8372,GO:0033265,1.00000000001106,0.910799990679026,0,2,choline binding,MF,
4880,GO:0014739,1.00000000001107,0.953288267093525,0,1,positive regulation of muscle hyperplasia,BP,
18325,GO:1903231,1.00000000001107,0.953288267093525,0,1,mRNA binding involved in posttranscriptional gene silencing,MF,
16010,GO:0086007,1.00000000001107,0.900277077492131,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17797,GO:1901843,1.00000000001107,0.900277077492131,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
1628,GO:0004061,1.00000000001107,0.959193589464892,0,1,arylformamidase activity,MF,
7158,GO:0031013,1.00000000001107,0.959193589464892,0,1,troponin I binding,MF,
12034,GO:0047658,1.00000000001107,0.959193589464892,0,1,alpha-amino-acid esterase activity,MF,
2000,GO:0004720,1.00000000001108,0.781838412429783,0,5,protein-lysine 6-oxidase activity,MF,
461,GO:0001401,1.00000000001108,0.912349419186876,0,2,mitochondrial sorting and assembly machinery complex,CC,
7235,GO:0031126,1.00000000001109,0.776908463682688,0,7,snoRNA 3'-end processing,BP,
19612,GO:1990698,1.00000000001109,0.90936691790662,0,2,palmitoleoyltransferase activity,MF,
8285,GO:0033087,1.0000000000111,0.870351470265514,0,3,negative regulation of immature T cell proliferation,BP,
16038,GO:0086045,1.00000000001111,0.899494871224151,0,2,membrane depolarization during AV node cell action potential,BP,
9342,GO:0035838,1.00000000001111,0.897672500156843,0,2,growing cell tip,CC,
9328,GO:0035800,1.00000000001111,0.915149084366976,0,2,deubiquitinase activator activity,MF,
19785,GO:2000158,1.00000000001111,0.915149084366976,0,2,positive regulation of ubiquitin-specific protease activity,BP,
4199,GO:0009304,1.00000000001111,0.718144011301065,0,7,tRNA transcription,BP,
17946,GO:1902259,1.00000000001113,0.640381022599125,0,9,regulation of delayed rectifier potassium channel activity,BP,
8594,GO:0034092,1.00000000001113,0.873485344957627,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
8644,GO:0034183,1.00000000001113,0.873485344957627,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
471,GO:0001514,1.00000000001114,0.716361573145524,0,7,selenocysteine incorporation,BP,
2934,GO:0006451,1.00000000001114,0.716361573145524,0,7,translational readthrough,BP,
3044,GO:0006597,1.00000000001116,0.913296963648122,0,2,spermine biosynthetic process,BP,
6430,GO:0021692,1.00000000001116,0.655134734676654,0,8,cerebellar Purkinje cell layer morphogenesis,BP,
19604,GO:1990637,1.00000000001116,0.865324224114811,0,3,response to prolactin,BP,
13701,GO:0060228,1.00000000001118,0.954506125232888,0,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
2443,GO:0005641,1.00000000001118,0.709480403485033,0,7,nuclear envelope lumen,CC,
12373,GO:0048743,1.00000000001118,0.901440797977966,0,2,positive regulation of skeletal muscle fiber development,BP,
3973,GO:0008775,1.00000000001119,0.957822291503852,0,1,acetate CoA-transferase activity,MF,
4331,GO:0009850,1.00000000001119,0.957822291503852,0,1,auxin metabolic process,BP,
4332,GO:0009852,1.00000000001119,0.957822291503852,0,1,auxin catabolic process,BP,
4403,GO:0010124,1.00000000001119,0.957822291503852,0,1,phenylacetate catabolic process,BP,
14093,GO:0060896,1.00000000001121,0.673664700582494,0,8,neural plate pattern specification,BP,
19727,GO:2000042,1.00000000001121,0.630505594549358,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
2965,GO:0006500,1.00000000001121,0.955682733105192,0,1,N-terminal protein palmitoylation,BP,
5883,GO:0018009,1.00000000001121,0.955682733105192,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
15059,GO:0070993,1.00000000001122,0.898527384517166,0,2,translation preinitiation complex,CC,
13943,GO:0060591,1.00000000001125,0.860601398102434,0,3,chondroblast differentiation,BP,
9817,GO:0042015,1.00000000001125,0.866587194424606,0,3,interleukin-20 binding,MF,
9139,GO:0035469,1.00000000001125,0.946695746187034,0,1,determination of pancreatic left/right asymmetry,BP,
15537,GO:0071908,1.00000000001125,0.946695746187034,0,1,determination of intestine left/right asymmetry,BP,
15538,GO:0071909,1.00000000001125,0.946695746187034,0,1,determination of stomach left/right asymmetry,BP,
19786,GO:2000167,1.00000000001125,0.946695746187034,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
5575,GO:0016586,1.00000000001126,0.896983917662997,0,2,RSC-type complex,CC,
14937,GO:0070778,1.00000000001127,0.819127736814298,0,4,L-aspartate transmembrane transport,BP,
12106,GO:0048087,1.00000000001127,0.716171786619615,0,7,positive regulation of developmental pigmentation,BP,
9594,GO:0036444,1.00000000001127,0.676620260297381,0,8,calcium import into the mitochondrion,BP,
14118,GO:0060940,1.00000000001127,0.907437729741644,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
16604,GO:0097409,1.00000000001127,0.956722467413564,0,1,glial cytoplasmic inclusion,CC,
16607,GO:0097414,1.00000000001127,0.956722467413564,0,1,classical Lewy body,CC,
16630,GO:0097462,1.00000000001127,0.956722467413564,0,1,Lewy neurite,CC,
19455,GO:1990038,1.00000000001127,0.956722467413564,0,1,Lewy body corona,CC,
7062,GO:0030836,1.00000000001128,0.727036747745645,0,7,positive regulation of actin filament depolymerization,BP,
1843,GO:0004496,1.00000000001128,0.956001240674101,0,1,mevalonate kinase activity,MF,
13463,GO:0052894,1.00000000001128,0.956001240674101,0,1,norspermine:oxygen oxidoreductase activity,MF,
13464,GO:0052895,1.00000000001128,0.956001240674101,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
20252,GO:2001168,1.00000000001129,0.814097355347332,0,4,positive regulation of histone H2B ubiquitination,BP,
18370,GO:1903333,1.00000000001129,0.809613502231007,0,5,negative regulation of protein folding,BP,
11815,GO:0046687,1.00000000001129,0.969728495479674,0,1,response to chromate,BP,
15156,GO:0071247,1.00000000001129,0.969728495479674,0,1,cellular response to chromate,BP,
17924,GO:1902220,1.00000000001129,0.969728495479674,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
16160,GO:0090160,1.00000000001129,0.670612746026058,0,8,Golgi to lysosome transport,BP,
434,GO:0001162,1.0000000000113,0.681665312248939,0,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
19603,GO:1990635,1.0000000000113,0.821039413088774,0,4,proximal dendrite,CC,
390,GO:0001042,1.0000000000113,0.734881995583385,0,6,RNA polymerase I core binding,MF,
4993,GO:0015119,1.00000000001131,0.863557737543545,0,3,hexose phosphate transmembrane transporter activity,MF,
5082,GO:0015315,1.00000000001131,0.863557737543545,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5129,GO:0015526,1.00000000001131,0.863557737543545,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
14345,GO:0061513,1.00000000001131,0.863557737543545,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
3882,GO:0008510,1.00000000001131,0.763439338988818,0,5,sodium:bicarbonate symporter activity,MF,
6220,GO:0019747,1.00000000001132,0.974406241559749,0,1,regulation of isoprenoid metabolic process,BP,
6893,GO:0030421,1.00000000001132,0.974406241559749,0,1,defecation,BP,
2465,GO:0005677,1.00000000001133,0.634480212455152,0,9,chromatin silencing complex,CC,
4702,GO:0010857,1.00000000001133,0.682467527677338,0,8,calcium-dependent protein kinase activity,MF,
602,GO:0001767,1.00000000001133,0.731648838712018,0,6,establishment of lymphocyte polarity,BP,
4838,GO:0014041,1.00000000001133,0.71092481464712,0,7,regulation of neuron maturation,BP,
15357,GO:0071569,1.00000000001133,0.777697915214084,0,6,protein ufmylation,BP,
8876,GO:0034680,1.00000000001134,0.899246957980732,0,2,integrin alpha10-beta1 complex,CC,
20326,GO:2001293,1.00000000001134,0.856231735742302,0,3,malonyl-CoA metabolic process,BP,
11538,GO:0046051,1.00000000001134,0.720477291030041,0,9,UTP metabolic process,BP,
19537,GO:1990403,1.00000000001135,0.671654813336564,0,8,embryonic brain development,BP,
9201,GO:0035582,1.00000000001135,0.867931269584783,0,3,sequestering of BMP in extracellular matrix,BP,
5742,GO:0016885,1.00000000001135,0.673702493059201,0,8,ligase activity, forming carbon-carbon bonds,MF,
19502,GO:1990226,1.00000000001135,0.791489941755853,0,5,histone methyltransferase binding,MF,
4531,GO:0010593,1.00000000001135,0.896373897500573,0,2,negative regulation of lamellipodium assembly,BP,
6484,GO:0021823,1.00000000001135,0.896373897500573,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6488,GO:0021827,1.00000000001135,0.896373897500573,0,2,postnatal olfactory bulb interneuron migration,BP,
6491,GO:0021836,1.00000000001135,0.896373897500573,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6264,GO:0019852,1.00000000001136,0.682889016001251,0,9,L-ascorbic acid metabolic process,BP,
7084,GO:0030868,1.00000000001136,0.873272250995645,0,3,smooth endoplasmic reticulum membrane,CC,
16611,GO:0097425,1.00000000001136,0.873272250995645,0,3,smooth endoplasmic reticulum part,CC,
1852,GO:0004512,1.00000000001136,0.955164588197761,0,1,inositol-3-phosphate synthase activity,MF,
5732,GO:0016872,1.00000000001136,0.955164588197761,0,1,intramolecular lyase activity,MF,
2049,GO:0004794,1.00000000001137,0.963613963986237,0,1,L-threonine ammonia-lyase activity,MF,
6977,GO:0030628,1.00000000001137,0.790331789024754,0,6,pre-mRNA 3'-splice site binding,MF,
12243,GO:0048495,1.00000000001139,0.812909846981055,0,4,Roundabout binding,MF,
9884,GO:0042148,1.00000000001139,0.695103067613301,0,8,strand invasion,BP,
19107,GO:1904983,1.00000000001142,0.955730581899413,0,1,glycine import into mitochondrion,BP,
14226,GO:0061146,1.00000000001143,0.864144653667444,0,3,Peyer's patch morphogenesis,BP,
1730,GO:0004320,1.00000000001144,0.907378990910374,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
5437,GO:0016295,1.00000000001144,0.907378990910374,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5438,GO:0016296,1.00000000001144,0.907378990910374,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5439,GO:0016297,1.00000000001144,0.907378990910374,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
2682,GO:0006041,1.00000000001144,0.829715519490797,0,4,glucosamine metabolic process,BP,
2312,GO:0005308,1.00000000001144,0.950833527832996,0,1,creatine transmembrane transporter activity,MF,
2313,GO:0005309,1.00000000001144,0.950833527832996,0,1,creatine:sodium symporter activity,MF,
5257,GO:0015881,1.00000000001144,0.950833527832996,0,1,creatine transmembrane transport,BP,
17560,GO:1901077,1.00000000001144,0.815776632769552,0,4,regulation of relaxation of muscle,BP,
8574,GO:0034039,1.00000000001145,0.916517833839711,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9082,GO:0035331,1.00000000001145,0.658747485885645,0,8,negative regulation of hippo signaling,BP,
7902,GO:0032466,1.00000000001145,0.759740155836181,0,6,negative regulation of cytokinesis,BP,
5910,GO:0018125,1.00000000001145,0.875560682077451,0,3,peptidyl-cysteine methylation,BP,
14269,GO:0061307,1.00000000001145,0.68149644413384,0,8,cardiac neural crest cell differentiation involved in heart development,BP,
14270,GO:0061308,1.00000000001145,0.68149644413384,0,8,cardiac neural crest cell development involved in heart development,BP,
1572,GO:0003976,1.00000000001145,0.874305613779783,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
13140,GO:0051673,1.00000000001146,0.919886054173133,0,2,membrane disruption in other organism,BP,
1425,GO:0003373,1.00000000001147,0.665098088120889,0,8,dynamin family protein polymerization involved in membrane fission,BP,
1426,GO:0003374,1.00000000001147,0.665098088120889,0,8,dynamin family protein polymerization involved in mitochondrial fission,BP,
1953,GO:0004654,1.00000000001147,0.947315231959247,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
16361,GO:0090616,1.00000000001147,0.947315231959247,0,1,mitochondrial mRNA 3'-end processing,BP,
16525,GO:0097222,1.00000000001147,0.947315231959247,0,1,mitochondrial mRNA polyadenylation,BP,
19617,GO:1990715,1.00000000001147,0.948657953228444,0,1,mRNA CDS binding,MF,
19283,GO:1905446,1.00000000001147,0.810727243990425,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
9490,GO:0036123,1.00000000001148,0.798119718868779,0,5,histone H3-K9 dimethylation,BP,
2753,GO:0006154,1.0000000000115,0.917470430404545,0,2,adenosine catabolic process,BP,
11570,GO:0046103,1.0000000000115,0.917470430404545,0,2,inosine biosynthetic process,BP,
9157,GO:0035508,1.0000000000115,0.946673909423485,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
18531,GO:1903677,1.00000000001151,0.873281609362589,0,3,regulation of cap-independent translational initiation,BP,
18532,GO:1903679,1.00000000001151,0.873281609362589,0,3,positive regulation of cap-independent translational initiation,BP,
4225,GO:0009397,1.00000000001153,0.874000301389505,0,3,folic acid-containing compound catabolic process,BP,
10071,GO:0042560,1.00000000001153,0.874000301389505,0,3,pteridine-containing compound catabolic process,BP,
10859,GO:0044355,1.00000000001153,0.962857146553441,0,1,clearance of foreign intracellular DNA,BP,
10860,GO:0044356,1.00000000001153,0.962857146553441,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
16995,GO:0099046,1.00000000001153,0.962857146553441,0,1,clearance of foreign intracellular nucleic acids,BP,
18933,GO:1904627,1.00000000001153,0.962857146553441,0,1,response to phorbol 13-acetate 12-myristate,BP,
18934,GO:1904628,1.00000000001153,0.962857146553441,0,1,cellular response to phorbol 13-acetate 12-myristate,BP,
4452,GO:0010385,1.00000000001153,0.78378883238423,0,5,double-stranded methylated DNA binding,MF,
16432,GO:0097057,1.00000000001154,0.929184039264842,0,2,TRAF2-GSTP1 complex,CC,
9238,GO:0035625,1.00000000001154,0.950731738914568,0,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
8120,GO:0032803,1.00000000001155,0.797875204629396,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
1504,GO:0003847,1.00000000001155,0.854963114345308,0,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
16140,GO:0090119,1.00000000001155,0.947433903741661,0,1,vesicle-mediated cholesterol transport,BP,
18796,GO:1904290,1.00000000001155,0.947433903741661,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
19688,GO:1990926,1.00000000001155,0.947433903741661,0,1,short-term synaptic potentiation,BP,
8398,GO:0033319,1.00000000001155,0.95589678091521,0,1,UDP-D-xylose metabolic process,BP,
8399,GO:0033320,1.00000000001155,0.95589678091521,0,1,UDP-D-xylose biosynthetic process,BP,
12096,GO:0048040,1.00000000001155,0.95589678091521,0,1,UDP-glucuronate decarboxylase activity,MF,
1793,GO:0004419,1.00000000001156,0.961887932400353,0,1,hydroxymethylglutaryl-CoA lyase activity,MF,
13891,GO:0060502,1.00000000001156,0.674805407174821,0,8,epithelial cell proliferation involved in lung morphogenesis,BP,
14234,GO:0061156,1.00000000001156,0.859316930889538,0,3,pulmonary artery morphogenesis,BP,
13295,GO:0051969,1.00000000001156,0.822013929283134,0,4,regulation of transmission of nerve impulse,BP,
4804,GO:0010994,1.00000000001157,0.813197932763618,0,5,free ubiquitin chain polymerization,BP,
14026,GO:0060733,1.00000000001157,0.899187175410418,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
15163,GO:0071262,1.00000000001157,0.899187175410418,0,2,regulation of translational initiation in response to starvation,BP,
15164,GO:0071264,1.00000000001157,0.899187175410418,0,2,positive regulation of translational initiation in response to starvation,BP,
15734,GO:0072284,1.00000000001158,0.82098668221602,0,4,metanephric S-shaped body morphogenesis,BP,
14792,GO:0070488,1.00000000001159,0.970860842002627,0,2,neutrophil aggregation,BP,
16266,GO:0090309,1.00000000001159,0.810386956688652,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
661,GO:0001850,1.00000000001159,0.957794076311164,0,1,complement component C3a binding,MF,
662,GO:0001851,1.00000000001159,0.957794076311164,0,1,complement component C3b binding,MF,
9305,GO:0035748,1.0000000000116,0.734558825531711,0,6,myelin sheath abaxonal region,CC,
13693,GO:0060212,1.0000000000116,0.957860178231869,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
17427,GO:1900152,1.0000000000116,0.957860178231869,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
6030,GO:0019085,1.0000000000116,0.901836944895226,0,2,early viral transcription,BP,
14389,GO:0061622,1.0000000000116,0.9183068147043,0,2,glycolytic process through glucose-1-phosphate,BP,
17996,GO:1902396,1.0000000000116,0.949222042571244,0,1,protein localization to bicellular tight junction,BP,
8165,GO:0032891,1.0000000000116,0.659958296602386,0,8,negative regulation of organic acid transport,BP,
5766,GO:0016926,1.00000000001161,0.702667518598822,0,7,protein desumoylation,BP,
4873,GO:0014731,1.00000000001161,0.733277059179814,0,6,spectrin-associated cytoskeleton,CC,
8887,GO:0034699,1.00000000001161,0.861528841336604,0,3,response to luteinizing hormone,BP,
348,GO:0000961,1.00000000001162,0.902691868556447,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
646,GO:0001834,1.00000000001162,0.902691868556447,0,2,trophectodermal cell proliferation,BP,
6480,GO:0021816,1.00000000001162,0.902691868556447,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
7647,GO:0032053,1.00000000001162,0.902691868556447,0,2,ciliary basal body organization,BP,
7685,GO:0032116,1.00000000001162,0.902691868556447,0,2,SMC loading complex,CC,
9496,GO:0036135,1.00000000001162,0.902691868556447,0,2,Schwann cell migration,BP,
16387,GO:0090694,1.00000000001162,0.902691868556447,0,2,Scc2-Scc4 cohesin loading complex,CC,
17422,GO:1900147,1.00000000001162,0.902691868556447,0,2,regulation of Schwann cell migration,BP,
17433,GO:1900169,1.00000000001162,0.902691868556447,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
17807,GO:1901873,1.00000000001162,0.902691868556447,0,2,regulation of post-translational protein modification,BP,
17808,GO:1901874,1.00000000001162,0.902691868556447,0,2,negative regulation of post-translational protein modification,BP,
18585,GO:1903796,1.00000000001162,0.902691868556447,0,2,negative regulation of inorganic anion transmembrane transport,BP,
18812,GO:1904327,1.00000000001162,0.902691868556447,0,2,protein localization to cytosolic proteasome complex,BP,
18830,GO:1904379,1.00000000001162,0.902691868556447,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
3494,GO:0007387,1.00000000001163,0.954041408514242,0,1,anterior compartment pattern formation,BP,
3495,GO:0007388,1.00000000001163,0.954041408514242,0,1,posterior compartment specification,BP,
15680,GO:0072189,1.00000000001164,0.700209017201873,0,7,ureter development,BP,
214,GO:0000447,1.00000000001165,0.688403774760919,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
15174,GO:0071281,1.00000000001165,0.77021248574626,0,6,cellular response to iron ion,BP,
9661,GO:0038002,1.00000000001166,0.946702204315342,0,1,endocrine signaling,BP,
5899,GO:0018094,1.00000000001167,0.951453546450076,0,1,protein polyglycylation,BP,
14920,GO:0070735,1.00000000001167,0.951453546450076,0,1,protein-glycine ligase activity,MF,
14921,GO:0070736,1.00000000001167,0.951453546450076,0,1,protein-glycine ligase activity, initiating,MF,
2912,GO:0006422,1.00000000001168,0.954938196364623,0,1,aspartyl-tRNA aminoacylation,BP,
10173,GO:0042756,1.00000000001168,0.880173377381007,0,3,drinking behavior,BP,
16534,GO:0097232,1.00000000001168,0.95176419837189,0,1,lamellar body membrane,CC,
16535,GO:0097233,1.00000000001168,0.95176419837189,0,1,alveolar lamellar body membrane,CC,
14978,GO:0070863,1.0000000000117,0.6650206575872,0,8,positive regulation of protein exit from endoplasmic reticulum,BP,
14710,GO:0070327,1.00000000001173,0.855940711451921,0,3,thyroid hormone transport,BP,
5709,GO:0016833,1.00000000001173,0.800997274063772,0,5,oxo-acid-lyase activity,MF,
7314,GO:0031313,1.00000000001173,0.713492833063697,0,7,extrinsic component of endosome membrane,CC,
8639,GO:0034163,1.00000000001174,0.856479442979163,0,3,regulation of toll-like receptor 9 signaling pathway,BP,
5095,GO:0015362,1.00000000001174,0.948644207069963,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
3047,GO:0006601,1.00000000001174,0.971752539027679,0,1,creatine biosynthetic process,BP,
7023,GO:0030731,1.00000000001174,0.971752539027679,0,1,guanidinoacetate N-methyltransferase activity,MF,
1685,GO:0004148,1.00000000001175,0.950630175477832,0,1,dihydrolipoyl dehydrogenase activity,MF,
10354,GO:0043159,1.00000000001175,0.950630175477832,0,1,acrosomal matrix,CC,
10584,GO:0043544,1.00000000001175,0.950630175477832,0,1,lipoamide binding,MF,
12799,GO:0051068,1.00000000001175,0.950630175477832,0,1,dihydrolipoamide metabolic process,BP,
15358,GO:0071573,1.00000000001175,0.953412089023445,0,1,shelterin complex assembly,BP,
19010,GO:1904790,1.00000000001175,0.953412089023445,0,1,regulation of shelterin complex assembly,BP,
19011,GO:1904792,1.00000000001175,0.953412089023445,0,1,positive regulation of shelterin complex assembly,BP,
19040,GO:1904850,1.00000000001175,0.953412089023445,0,1,negative regulation of establishment of protein localization to telomere,BP,
19074,GO:1904910,1.00000000001175,0.953412089023445,0,1,regulation of establishment of RNA localization to telomere,BP,
19075,GO:1904911,1.00000000001175,0.953412089023445,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19076,GO:1904913,1.00000000001175,0.953412089023445,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19077,GO:1904914,1.00000000001175,0.953412089023445,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
11981,GO:0047223,1.00000000001175,0.868442733569641,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
2793,GO:0006231,1.00000000001176,0.876923738031823,0,3,dTMP biosynthetic process,BP,
11552,GO:0046073,1.00000000001176,0.876923738031823,0,3,dTMP metabolic process,BP,
48,GO:0000101,1.00000000001176,0.857256739863133,0,3,sulfur amino acid transport,BP,
11927,GO:0046958,1.00000000001176,0.952086599782179,0,1,nonassociative learning,BP,
14016,GO:0060717,1.00000000001176,0.699771352150746,0,7,chorion development,BP,
3676,GO:0008174,1.00000000001176,0.652533457806077,0,9,mRNA methyltransferase activity,MF,
5145,GO:0015669,1.00000000001176,0.876625498249117,0,3,gas transport,BP,
10113,GO:0042627,1.00000000001177,0.911846836800641,0,3,chylomicron,CC,
13231,GO:0051877,1.00000000001177,0.908989920478291,0,2,pigment granule aggregation in cell center,BP,
16510,GO:0097195,1.00000000001177,0.90515042297665,0,2,pilomotor reflex,BP,
19041,GO:1904851,1.00000000001178,0.663222427127772,0,9,positive regulation of establishment of protein localization to telomere,BP,
2304,GO:0005283,1.00000000001178,0.704372659400026,0,7,amino acid:sodium symporter activity,MF,
6161,GO:0019482,1.00000000001178,0.905736361827483,0,2,beta-alanine metabolic process,BP,
12823,GO:0051105,1.00000000001178,0.750847106811213,0,6,regulation of DNA ligation,BP,
3094,GO:0006667,1.00000000001178,0.906278315137401,0,2,sphinganine metabolic process,BP,
11028,GO:0044861,1.00000000001178,0.906278315137401,0,2,protein transport into plasma membrane raft,BP,
11722,GO:0046511,1.00000000001178,0.906278315137401,0,2,sphinganine biosynthetic process,BP,
12592,GO:0050733,1.00000000001179,0.786573423247348,0,5,RS domain binding,MF,
420,GO:0001112,1.00000000001179,0.953064367711871,0,1,DNA-templated transcriptional open complex formation,BP,
421,GO:0001113,1.00000000001179,0.953064367711871,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
422,GO:0001120,1.00000000001179,0.953064367711871,0,1,protein-DNA complex remodeling,BP,
8198,GO:0032937,1.0000000000118,0.863010468444149,0,3,SREBP-SCAP-Insig complex,CC,
10883,GO:0044417,1.0000000000118,0.672584684247928,0,9,translocation of molecules into host,BP,
13221,GO:0051836,1.0000000000118,0.672584684247928,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
2238,GO:0005142,1.0000000000118,0.954876768346465,0,1,interleukin-11 receptor binding,MF,
5847,GO:0017133,1.0000000000118,0.954876768346465,0,1,mitochondrial electron transfer flavoprotein complex,CC,
10663,GO:0043783,1.0000000000118,0.954876768346465,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11182,GO:0045251,1.0000000000118,0.954876768346465,0,1,electron transfer flavoprotein complex,CC,
9727,GO:0038163,1.0000000000118,0.972414018447234,0,1,thrombopoietin-mediated signaling pathway,BP,
19429,GO:1905938,1.0000000000118,0.972414018447234,0,1,positive regulation of germ cell proliferation,BP,
19832,GO:2000256,1.0000000000118,0.972414018447234,0,1,positive regulation of male germ cell proliferation,BP,
3912,GO:0008559,1.0000000000118,0.811905090560672,0,4,xenobiotic transmembrane transporting ATPase activity,MF,
815,GO:0002085,1.0000000000118,0.867521637916445,0,3,inhibition of neuroepithelial cell differentiation,BP,
11306,GO:0045608,1.0000000000118,0.867521637916445,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
14333,GO:0061474,1.00000000001181,0.954410862646396,0,1,phagolysosome membrane,CC,
6944,GO:0030548,1.00000000001181,0.779485240476411,0,6,acetylcholine receptor regulator activity,MF,
17093,GO:0099602,1.00000000001181,0.779485240476411,0,6,neurotransmitter receptor regulator activity,MF,
5555,GO:0016557,1.00000000001181,0.884580184356703,0,3,peroxisome membrane biogenesis,BP,
930,GO:0002325,1.00000000001183,0.96798038763899,0,1,natural killer cell differentiation involved in immune response,BP,
8135,GO:0032824,1.00000000001183,0.96798038763899,0,1,negative regulation of natural killer cell differentiation,BP,
8137,GO:0032826,1.00000000001183,0.96798038763899,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8138,GO:0032827,1.00000000001183,0.96798038763899,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
18518,GO:1903644,1.00000000001183,0.938484667494273,0,2,regulation of chaperone-mediated protein folding,BP,
11847,GO:0046786,1.00000000001183,0.946931665712563,0,1,viral replication complex formation and maintenance,BP,
20063,GO:2000661,1.00000000001183,0.946931665712563,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
1669,GO:0004127,1.00000000001184,0.909054656916688,0,2,cytidylate kinase activity,MF,
8904,GO:0034722,1.00000000001185,0.962070307265177,0,1,gamma-glutamyl-peptidase activity,MF,
934,GO:0002329,1.00000000001185,0.804094618116232,0,4,pre-B cell differentiation,BP,
17073,GO:0099545,1.00000000001185,0.94696350738453,0,1,trans-synaptic signaling by trans-synaptic complex,BP,
17080,GO:0099557,1.00000000001185,0.94696350738453,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
17212,GO:0106028,1.00000000001185,0.94696350738453,0,1,neuron projection retraction,BP,
17505,GO:1900450,1.00000000001185,0.94696350738453,0,1,negative regulation of glutamate receptor signaling pathway,BP,
19007,GO:1904782,1.00000000001185,0.94696350738453,0,1,negative regulation of NMDA glutamate receptor activity,BP,
7230,GO:0031120,1.00000000001186,0.884633171863412,0,4,snRNA pseudouridine synthesis,BP,
19599,GO:1990617,1.00000000001187,0.934121937094216,0,2,CHOP-ATF4 complex,CC,
9936,GO:0042281,1.00000000001188,0.912560579171762,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10003,GO:0042415,1.00000000001188,0.714862487679382,0,7,norepinephrine metabolic process,BP,
2769,GO:0006185,1.00000000001188,0.972129322275489,0,1,dGDP biosynthetic process,BP,
4117,GO:0009170,1.00000000001188,0.972129322275489,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4126,GO:0009183,1.00000000001188,0.972129322275489,0,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
11539,GO:0046054,1.00000000001188,0.972129322275489,0,1,dGMP metabolic process,BP,
11827,GO:0046711,1.00000000001188,0.972129322275489,0,1,GDP biosynthetic process,BP,
17189,GO:0102991,1.00000000001189,0.845547027713603,0,4,myristoyl-CoA hydrolase activity,MF,
13252,GO:0051902,1.0000000000119,0.800713833989343,0,5,negative regulation of mitochondrial depolarization,BP,
18745,GO:1904180,1.0000000000119,0.800713833989343,0,5,negative regulation of membrane depolarization,BP,
12275,GO:0048557,1.0000000000119,0.704565860159872,0,7,embryonic digestive tract morphogenesis,BP,
16472,GO:0097125,1.00000000001191,0.916346713280755,0,2,cyclin B1-CDK1 complex,CC,
78,GO:0000155,1.00000000001191,0.946671285816813,0,1,phosphorelay sensor kinase activity,MF,
192,GO:0000409,1.00000000001191,0.946671285816813,0,1,regulation of transcription by galactose,BP,
193,GO:0000411,1.00000000001191,0.946671285816813,0,1,positive regulation of transcription by galactose,BP,
197,GO:0000415,1.00000000001191,0.946671285816813,0,1,negative regulation of histone H3-K36 methylation,BP,
206,GO:0000431,1.00000000001191,0.946671285816813,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
208,GO:0000435,1.00000000001191,0.946671285816813,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
379,GO:0001011,1.00000000001191,0.946671285816813,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
406,GO:0001087,1.00000000001191,0.946671285816813,0,1,transcription factor activity, TFIIB-class binding,MF,
491,GO:0001543,1.00000000001191,0.946671285816813,0,1,ovarian follicle rupture,BP,
492,GO:0001544,1.00000000001191,0.946671285816813,0,1,initiation of primordial ovarian follicle growth,BP,
529,GO:0001640,1.00000000001191,0.946671285816813,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
530,GO:0001642,1.00000000001191,0.946671285816813,0,1,group III metabotropic glutamate receptor activity,MF,
604,GO:0001770,1.00000000001191,0.946671285816813,0,1,establishment of natural killer cell polarity,BP,
643,GO:0001831,1.00000000001191,0.946671285816813,0,1,trophectodermal cellular morphogenesis,BP,
743,GO:0001971,1.00000000001191,0.946671285816813,0,1,negative regulation of activation of membrane attack complex,BP,
811,GO:0002081,1.00000000001191,0.946671285816813,0,1,outer acrosomal membrane,CC,
827,GO:0002100,1.00000000001191,0.946671285816813,0,1,tRNA wobble adenosine to inosine editing,BP,
1067,GO:0002605,1.00000000001191,0.946671285816813,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1072,GO:0002635,1.00000000001191,0.946671285816813,0,1,negative regulation of germinal center formation,BP,
1087,GO:0002669,1.00000000001191,0.946671285816813,0,1,positive regulation of T cell anergy,BP,
1234,GO:0002913,1.00000000001191,0.946671285816813,0,1,positive regulation of lymphocyte anergy,BP,
1266,GO:0003017,1.00000000001191,0.946671285816813,0,1,lymph circulation,BP,
1355,GO:0003220,1.00000000001191,0.946671285816813,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1356,GO:0003221,1.00000000001191,0.946671285816813,0,1,right ventricular cardiac muscle tissue morphogenesis,BP,
1359,GO:0003226,1.00000000001191,0.946671285816813,0,1,right ventricular compact myocardium morphogenesis,BP,
1369,GO:0003251,1.00000000001191,0.946671285816813,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1370,GO:0003252,1.00000000001191,0.946671285816813,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1378,GO:0003270,1.00000000001191,0.946671285816813,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1422,GO:0003363,1.00000000001191,0.946671285816813,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1424,GO:0003366,1.00000000001191,0.946671285816813,0,1,cell-matrix adhesion involved in ameboidal cell migration,BP,
1569,GO:0003973,1.00000000001191,0.946671285816813,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
1637,GO:0004077,1.00000000001191,0.946671285816813,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1638,GO:0004078,1.00000000001191,0.946671285816813,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1639,GO:0004079,1.00000000001191,0.946671285816813,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1640,GO:0004080,1.00000000001191,0.946671285816813,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1673,GO:0004133,1.00000000001191,0.946671285816813,0,1,glycogen debranching enzyme activity,MF,
1674,GO:0004134,1.00000000001191,0.946671285816813,0,1,4-alpha-glucanotransferase activity,MF,
1675,GO:0004135,1.00000000001191,0.946671285816813,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1724,GO:0004313,1.00000000001191,0.946671285816813,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1727,GO:0004316,1.00000000001191,0.946671285816813,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1728,GO:0004317,1.00000000001191,0.946671285816813,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1729,GO:0004319,1.00000000001191,0.946671285816813,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1733,GO:0004325,1.00000000001191,0.946671285816813,0,1,ferrochelatase activity,MF,
1747,GO:0004344,1.00000000001191,0.946671285816813,0,1,glucose dehydrogenase activity,MF,
1760,GO:0004360,1.00000000001191,0.946671285816813,0,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1768,GO:0004368,1.00000000001191,0.946671285816813,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
1797,GO:0004423,1.00000000001191,0.946671285816813,0,1,iduronate-2-sulfatase activity,MF,
1830,GO:0004482,1.00000000001191,0.946671285816813,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
1837,GO:0004489,1.00000000001191,0.946671285816813,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
1970,GO:0004676,1.00000000001191,0.946671285816813,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
1974,GO:0004686,1.00000000001191,0.946671285816813,0,1,elongation factor-2 kinase activity,MF,
1983,GO:0004698,1.00000000001191,0.946671285816813,0,1,calcium-dependent protein kinase C activity,MF,
2026,GO:0004753,1.00000000001191,0.946671285816813,0,1,saccharopine dehydrogenase activity,MF,
2036,GO:0004773,1.00000000001191,0.946671285816813,0,1,steryl-sulfatase activity,MF,
2109,GO:0004883,1.00000000001191,0.946671285816813,0,1,glucocorticoid receptor activity,MF,
2152,GO:0004968,1.00000000001191,0.946671285816813,0,1,gonadotropin-releasing hormone receptor activity,MF,
2171,GO:0005004,1.00000000001191,0.946671285816813,0,1,GPI-linked ephrin receptor activity,MF,
2175,GO:0005008,1.00000000001191,0.946671285816813,0,1,hepatocyte growth factor-activated receptor activity,MF,
2176,GO:0005009,1.00000000001191,0.946671285816813,0,1,insulin-activated receptor activity,MF,
2183,GO:0005030,1.00000000001191,0.946671285816813,0,1,neurotrophin receptor activity,MF,
2309,GO:0005294,1.00000000001191,0.946671285816813,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2339,GO:0005366,1.00000000001191,0.946671285816813,0,1,myo-inositol:proton symporter activity,MF,
2340,GO:0005367,1.00000000001191,0.946671285816813,0,1,myo-inositol:sodium symporter activity,MF,
2341,GO:0005368,1.00000000001191,0.946671285816813,0,1,taurine transmembrane transporter activity,MF,
2342,GO:0005369,1.00000000001191,0.946671285816813,0,1,taurine:sodium symporter activity,MF,
2362,GO:0005461,1.00000000001191,0.946671285816813,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2364,GO:0005464,1.00000000001191,0.946671285816813,0,1,UDP-xylose transmembrane transporter activity,MF,
2418,GO:0005590,1.00000000001191,0.946671285816813,0,1,collagen type VII trimer,CC,
2420,GO:0005592,1.00000000001191,0.946671285816813,0,1,collagen type XI trimer,CC,
2639,GO:0005969,1.00000000001191,0.946671285816813,0,1,serine-pyruvate aminotransferase complex,CC,
2745,GO:0006127,1.00000000001191,0.946671285816813,0,1,glycerophosphate shuttle,BP,
3413,GO:0007196,1.00000000001191,0.946671285816813,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3486,GO:0007352,1.00000000001191,0.946671285816813,0,1,zygotic specification of dorsal/ventral axis,BP,
3528,GO:0007509,1.00000000001191,0.946671285816813,0,1,mesoderm migration involved in gastrulation,BP,
3576,GO:0007621,1.00000000001191,0.946671285816813,0,1,negative regulation of female receptivity,BP,
3613,GO:0008057,1.00000000001191,0.946671285816813,0,1,eye pigment granule organization,BP,
3622,GO:0008078,1.00000000001191,0.946671285816813,0,1,mesodermal cell migration,BP,
3727,GO:0008254,1.00000000001191,0.946671285816813,0,1,3'-nucleotidase activity,MF,
3732,GO:0008267,1.00000000001191,0.946671285816813,0,1,poly-glutamine tract binding,MF,
3754,GO:0008294,1.00000000001191,0.946671285816813,0,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
3784,GO:0008343,1.00000000001191,0.946671285816813,0,1,adult feeding behavior,BP,
3862,GO:0008478,1.00000000001191,0.946671285816813,0,1,pyridoxal kinase activity,MF,
3883,GO:0008511,1.00000000001191,0.946671285816813,0,1,sodium:potassium:chloride symporter activity,MF,
3890,GO:0008520,1.00000000001191,0.946671285816813,0,1,L-ascorbate:sodium symporter activity,MF,
3931,GO:0008609,1.00000000001191,0.946671285816813,0,1,alkylglycerone-phosphate synthase activity,MF,
3960,GO:0008705,1.00000000001191,0.946671285816813,0,1,methionine synthase activity,MF,
4183,GO:0009258,1.00000000001191,0.946671285816813,0,1,10-formyltetrahydrofolate catabolic process,BP,
4200,GO:0009305,1.00000000001191,0.946671285816813,0,1,protein biotinylation,BP,
4246,GO:0009443,1.00000000001191,0.946671285816813,0,1,pyridoxal 5'-phosphate salvage,BP,
4290,GO:0009674,1.00000000001191,0.946671285816813,0,1,potassium:sodium symporter activity,MF,
4310,GO:0009758,1.00000000001191,0.946671285816813,0,1,carbohydrate utilization,BP,
4409,GO:0010157,1.00000000001191,0.946671285816813,0,1,response to chlorate,BP,
4459,GO:0010428,1.00000000001191,0.946671285816813,0,1,methyl-CpNpG binding,MF,
4472,GO:0010465,1.00000000001191,0.946671285816813,0,1,nerve growth factor receptor activity,MF,
4572,GO:0010650,1.00000000001191,0.946671285816813,0,1,positive regulation of cell communication by electrical coupling,BP,
4610,GO:0010722,1.00000000001191,0.946671285816813,0,1,regulation of ferrochelatase activity,BP,
4635,GO:0010754,1.00000000001191,0.946671285816813,0,1,negative regulation of cGMP-mediated signaling,BP,
4664,GO:0010808,1.00000000001191,0.946671285816813,0,1,positive regulation of synaptic vesicle priming,BP,
4757,GO:0010931,1.00000000001191,0.946671285816813,0,1,macrophage tolerance induction,BP,
4758,GO:0010932,1.00000000001191,0.946671285816813,0,1,regulation of macrophage tolerance induction,BP,
4759,GO:0010933,1.00000000001191,0.946671285816813,0,1,positive regulation of macrophage tolerance induction,BP,
4876,GO:0014734,1.00000000001191,0.946671285816813,0,1,skeletal muscle hypertrophy,BP,
4912,GO:0014843,1.00000000001191,0.946671285816813,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
4946,GO:0014908,1.00000000001191,0.946671285816813,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
5049,GO:0015229,1.00000000001191,0.946671285816813,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5088,GO:0015327,1.00000000001191,0.946671285816813,0,1,cystine:glutamate antiporter activity,MF,
5089,GO:0015328,1.00000000001191,0.946671285816813,0,1,cystine secondary active transmembrane transporter activity,MF,
5103,GO:0015378,1.00000000001191,0.946671285816813,0,1,sodium:chloride symporter activity,MF,
5113,GO:0015420,1.00000000001191,0.946671285816813,0,1,cobalamin-transporting ATPase activity,MF,
5115,GO:0015431,1.00000000001191,0.946671285816813,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5180,GO:0015734,1.00000000001191,0.946671285816813,0,1,taurine transport,BP,
5199,GO:0015787,1.00000000001191,0.946671285816813,0,1,UDP-glucuronic acid transmembrane transport,BP,
5200,GO:0015790,1.00000000001191,0.946671285816813,0,1,UDP-xylose transmembrane transport,BP,
5258,GO:0015882,1.00000000001191,0.946671285816813,0,1,L-ascorbic acid transmembrane transport,BP,
5343,GO:0016077,1.00000000001191,0.946671285816813,0,1,snoRNA catabolic process,BP,
5370,GO:0016155,1.00000000001191,0.946671285816813,0,1,formyltetrahydrofolate dehydrogenase activity,MF,
5380,GO:0016189,1.00000000001191,0.946671285816813,0,1,synaptic vesicle to endosome fusion,BP,
5757,GO:0016901,1.00000000001191,0.946671285816813,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
5763,GO:0016920,1.00000000001191,0.946671285816813,0,1,pyroglutamyl-peptidase activity,MF,
5773,GO:0016964,1.00000000001191,0.946671285816813,0,1,alpha-2 macroglobulin receptor activity,MF,
5846,GO:0017130,1.00000000001191,0.946671285816813,0,1,poly(C) RNA binding,MF,
5947,GO:0018271,1.00000000001191,0.946671285816813,0,1,biotin-protein ligase activity,MF,
5972,GO:0018400,1.00000000001191,0.946671285816813,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6051,GO:0019171,1.00000000001191,0.946671285816813,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6233,GO:0019780,1.00000000001191,0.946671285816813,0,1,FAT10 activating enzyme activity,MF,
6338,GO:0021503,1.00000000001191,0.946671285816813,0,1,neural fold bending,BP,
6339,GO:0021508,1.00000000001191,0.946671285816813,0,1,floor plate formation,BP,
6373,GO:0021553,1.00000000001191,0.946671285816813,0,1,olfactory nerve development,BP,
6416,GO:0021650,1.00000000001191,0.946671285816813,0,1,vestibulocochlear nerve formation,BP,
6426,GO:0021685,1.00000000001191,0.946671285816813,0,1,cerebellar granular layer structural organization,BP,
6443,GO:0021730,1.00000000001191,0.946671285816813,0,1,trigeminal sensory nucleus development,BP,
6444,GO:0021740,1.00000000001191,0.946671285816813,0,1,principal sensory nucleus of trigeminal nerve development,BP,
6461,GO:0021778,1.00000000001191,0.946671285816813,0,1,oligodendrocyte cell fate specification,BP,
6462,GO:0021779,1.00000000001191,0.946671285816813,0,1,oligodendrocyte cell fate commitment,BP,
6463,GO:0021780,1.00000000001191,0.946671285816813,0,1,glial cell fate specification,BP,
6477,GO:0021812,1.00000000001191,0.946671285816813,0,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6505,GO:0021870,1.00000000001191,0.946671285816813,0,1,Cajal-Retzius cell differentiation,BP,
6570,GO:0022012,1.00000000001191,0.946671285816813,0,1,subpallium cell proliferation in forebrain,BP,
6571,GO:0022018,1.00000000001191,0.946671285816813,0,1,lateral ganglionic eminence cell proliferation,BP,
6803,GO:0030240,1.00000000001191,0.946671285816813,0,1,skeletal muscle thin filament assembly,BP,
6887,GO:0030379,1.00000000001191,0.946671285816813,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
6917,GO:0030504,1.00000000001191,0.946671285816813,0,1,inorganic diphosphate transmembrane transporter activity,MF,
6966,GO:0030616,1.00000000001191,0.946671285816813,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
6973,GO:0030623,1.00000000001191,0.946671285816813,0,1,U5 snRNA binding,MF,
7038,GO:0030807,1.00000000001191,0.946671285816813,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7053,GO:0030822,1.00000000001191,0.946671285816813,0,1,positive regulation of cAMP catabolic process,BP,
7065,GO:0030846,1.00000000001191,0.946671285816813,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7243,GO:0031151,1.00000000001191,0.946671285816813,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7316,GO:0031315,1.00000000001191,0.946671285816813,0,1,extrinsic component of mitochondrial outer membrane,CC,
7367,GO:0031405,1.00000000001191,0.946671285816813,0,1,lipoic acid binding,MF,
7385,GO:0031433,1.00000000001191,0.946671285816813,0,1,telethonin binding,MF,
7395,GO:0031443,1.00000000001191,0.946671285816813,0,1,fast-twitch skeletal muscle fiber contraction,BP,
7436,GO:0031533,1.00000000001191,0.946671285816813,0,1,mRNA cap methyltransferase complex,CC,
7442,GO:0031554,1.00000000001191,0.946671285816813,0,1,regulation of DNA-templated transcription, termination,BP,
7460,GO:0031592,1.00000000001191,0.946671285816813,0,1,centrosomal corona,CC,
7505,GO:0031673,1.00000000001191,0.946671285816813,0,1,H zone,CC,
7542,GO:0031775,1.00000000001191,0.946671285816813,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7543,GO:0031798,1.00000000001191,0.946671285816813,0,1,type 1 metabotropic glutamate receptor binding,MF,
7558,GO:0031870,1.00000000001191,0.946671285816813,0,1,thromboxane A2 receptor binding,MF,
7732,GO:0032222,1.00000000001191,0.946671285816813,0,1,regulation of synaptic transmission, cholinergic,BP,
7733,GO:0032224,1.00000000001191,0.946671285816813,0,1,positive regulation of synaptic transmission, cholinergic,BP,
7906,GO:0032470,1.00000000001191,0.946671285816813,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8161,GO:0032887,1.00000000001191,0.946671285816813,0,1,regulation of spindle elongation,BP,
8162,GO:0032888,1.00000000001191,0.946671285816813,0,1,regulation of mitotic spindle elongation,BP,
8255,GO:0033030,1.00000000001191,0.946671285816813,0,1,negative regulation of neutrophil apoptotic process,BP,
8297,GO:0033123,1.00000000001191,0.946671285816813,0,1,positive regulation of purine nucleotide catabolic process,BP,
8327,GO:0033167,1.00000000001191,0.946671285816813,0,1,ARC complex,CC,
8328,GO:0033168,1.00000000001191,0.946671285816813,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8365,GO:0033241,1.00000000001191,0.946671285816813,0,1,regulation of cellular amine catabolic process,BP,
8366,GO:0033242,1.00000000001191,0.946671285816813,0,1,negative regulation of cellular amine catabolic process,BP,
8378,GO:0033274,1.00000000001191,0.946671285816813,0,1,response to vitamin B2,BP,
8405,GO:0033343,1.00000000001191,0.946671285816813,0,1,positive regulation of collagen binding,BP,
8409,GO:0033364,1.00000000001191,0.946671285816813,0,1,mast cell secretory granule organization,BP,
8428,GO:0033505,1.00000000001191,0.946671285816813,0,1,floor plate morphogenesis,BP,
8458,GO:0033593,1.00000000001191,0.946671285816813,0,1,BRCA2-MAGE-D1 complex,CC,
8634,GO:0034150,1.00000000001191,0.946671285816813,0,1,toll-like receptor 6 signaling pathway,BP,
8640,GO:0034164,1.00000000001191,0.946671285816813,0,1,negative regulation of toll-like receptor 9 signaling pathway,BP,
8792,GO:0034474,1.00000000001191,0.946671285816813,0,1,U2 snRNA 3'-end processing,BP,
8844,GO:0034634,1.00000000001191,0.946671285816813,0,1,glutathione transmembrane transporter activity,MF,
8870,GO:0034669,1.00000000001191,0.946671285816813,0,1,integrin alpha4-beta7 complex,CC,
8914,GO:0034752,1.00000000001191,0.946671285816813,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
8915,GO:0034753,1.00000000001191,0.946671285816813,0,1,nuclear aryl hydrocarbon receptor complex,CC,
8919,GO:0034757,1.00000000001191,0.946671285816813,0,1,negative regulation of iron ion transport,BP,
8920,GO:0034759,1.00000000001191,0.946671285816813,0,1,regulation of iron ion transmembrane transport,BP,
8921,GO:0034760,1.00000000001191,0.946671285816813,0,1,negative regulation of iron ion transmembrane transport,BP,
8931,GO:0034775,1.00000000001191,0.946671285816813,0,1,glutathione transmembrane transport,BP,
8947,GO:0034986,1.00000000001191,0.946671285816813,0,1,iron chaperone activity,MF,
8948,GO:0034987,1.00000000001191,0.946671285816813,0,1,immunoglobulin receptor binding,MF,
8949,GO:0034988,1.00000000001191,0.946671285816813,0,1,Fc-gamma receptor I complex binding,MF,
9001,GO:0035120,1.00000000001191,0.946671285816813,0,1,post-embryonic appendage morphogenesis,BP,
9002,GO:0035127,1.00000000001191,0.946671285816813,0,1,post-embryonic limb morphogenesis,BP,
9003,GO:0035128,1.00000000001191,0.946671285816813,0,1,post-embryonic forelimb morphogenesis,BP,
9048,GO:0035262,1.00000000001191,0.946671285816813,0,1,gonad morphogenesis,BP,
9094,GO:0035355,1.00000000001191,0.946671285816813,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9115,GO:0035403,1.00000000001191,0.946671285816813,0,1,histone kinase activity (H3-T6 specific),MF,
9120,GO:0035408,1.00000000001191,0.946671285816813,0,1,histone H3-T6 phosphorylation,BP,
9129,GO:0035441,1.00000000001191,0.946671285816813,0,1,cell migration involved in vasculogenesis,BP,
9131,GO:0035443,1.00000000001191,0.946671285816813,0,1,tripeptide transmembrane transport,BP,
9334,GO:0035811,1.00000000001191,0.946671285816813,0,1,negative regulation of urine volume,BP,
9343,GO:0035841,1.00000000001191,0.946671285816813,0,1,new growing cell tip,CC,
9353,GO:0035862,1.00000000001191,0.946671285816813,0,1,dITP metabolic process,BP,
9354,GO:0035863,1.00000000001191,0.946671285816813,0,1,dITP catabolic process,BP,
9400,GO:0035936,1.00000000001191,0.946671285816813,0,1,testosterone secretion,BP,
9401,GO:0035938,1.00000000001191,0.946671285816813,0,1,estradiol secretion,BP,
9430,GO:0035995,1.00000000001191,0.946671285816813,0,1,detection of muscle stretch,BP,
9498,GO:0036138,1.00000000001191,0.946671285816813,0,1,peptidyl-histidine hydroxylation,BP,
9499,GO:0036139,1.00000000001191,0.946671285816813,0,1,peptidyl-histidine dioxygenase activity,MF,
9500,GO:0036140,1.00000000001191,0.946671285816813,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
9574,GO:0036371,1.00000000001191,0.946671285816813,0,1,protein localization to T-tubule,BP,
9588,GO:0036404,1.00000000001191,0.946671285816813,0,1,conversion of ds siRNA to ss siRNA,BP,
9624,GO:0036487,1.00000000001191,0.946671285816813,0,1,nitric-oxide synthase inhibitor activity,MF,
9684,GO:0038051,1.00000000001191,0.946671285816813,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
9845,GO:0042084,1.00000000001191,0.946671285816813,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
9923,GO:0042265,1.00000000001191,0.946671285816813,0,1,peptidyl-asparagine hydroxylation,BP,
10038,GO:0042483,1.00000000001191,0.946671285816813,0,1,negative regulation of odontogenesis,BP,
10129,GO:0042660,1.00000000001191,0.946671285816813,0,1,positive regulation of cell fate specification,BP,
10180,GO:0042766,1.00000000001191,0.946671285816813,0,1,nucleosome mobilization,BP,
10236,GO:0042937,1.00000000001191,0.946671285816813,0,1,tripeptide transmembrane transporter activity,MF,
10291,GO:0043033,1.00000000001191,0.946671285816813,0,1,isoamylase complex,CC,
10422,GO:0043257,1.00000000001191,0.946671285816813,0,1,laminin-8 complex,CC,
10573,GO:0043532,1.00000000001191,0.946671285816813,0,1,angiostatin binding,MF,
10621,GO:0043610,1.00000000001191,0.946671285816813,0,1,regulation of carbohydrate utilization,BP,
10635,GO:0043629,1.00000000001191,0.946671285816813,0,1,ncRNA polyadenylation,BP,
10636,GO:0043630,1.00000000001191,0.946671285816813,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
10662,GO:0043754,1.00000000001191,0.946671285816813,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
10695,GO:0043969,1.00000000001191,0.946671285816813,0,1,histone H2B acetylation,BP,
10815,GO:0044299,1.00000000001191,0.946671285816813,0,1,C-fiber,CC,
10820,GO:0044305,1.00000000001191,0.946671285816813,0,1,calyx of Held,CC,
10822,GO:0044307,1.00000000001191,0.946671285816813,0,1,dendritic branch,CC,
10844,GO:0044335,1.00000000001191,0.946671285816813,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
10968,GO:0044725,1.00000000001191,0.946671285816813,0,1,chromatin reprogramming in the zygote,BP,
10969,GO:0044727,1.00000000001191,0.946671285816813,0,1,DNA demethylation of male pronucleus,BP,
11134,GO:0045163,1.00000000001191,0.946671285816813,0,1,clustering of voltage-gated potassium channels,BP,
11149,GO:0045186,1.00000000001191,0.946671285816813,0,1,zonula adherens assembly,BP,
11400,GO:0045769,1.00000000001191,0.946671285816813,0,1,negative regulation of asymmetric cell division,BP,
11413,GO:0045795,1.00000000001191,0.946671285816813,0,1,positive regulation of cell volume,BP,
11453,GO:0045887,1.00000000001191,0.946671285816813,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
11771,GO:0046619,1.00000000001191,0.946671285816813,0,1,optic placode formation involved in camera-type eye formation,BP,
11775,GO:0046623,1.00000000001191,0.946671285816813,0,1,sphingolipid-translocating ATPase activity,MF,
11967,GO:0047117,1.00000000001191,0.946671285816813,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
11968,GO:0047130,1.00000000001191,0.946671285816813,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
11969,GO:0047131,1.00000000001191,0.946671285816813,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12012,GO:0047451,1.00000000001191,0.946671285816813,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12023,GO:0047545,1.00000000001191,0.946671285816813,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12060,GO:0047933,1.00000000001191,0.946671285816813,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12061,GO:0047936,1.00000000001191,0.946671285816813,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12334,GO:0048677,1.00000000001191,0.946671285816813,0,1,axon extension involved in regeneration,BP,
12419,GO:0048855,1.00000000001191,0.946671285816813,0,1,adenohypophysis morphogenesis,BP,
12464,GO:0050185,1.00000000001191,0.946671285816813,0,1,phosphatidylinositol deacylase activity,MF,
12697,GO:0050897,1.00000000001191,0.946671285816813,0,1,cobalt ion binding,MF,
13040,GO:0051463,1.00000000001191,0.946671285816813,0,1,negative regulation of cortisol secretion,BP,
13145,GO:0051686,1.00000000001191,0.946671285816813,0,1,establishment of ER localization,BP,
13268,GO:0051933,1.00000000001191,0.946671285816813,0,1,amino acid neurotransmitter reuptake,BP,
13270,GO:0051935,1.00000000001191,0.946671285816813,0,1,glutamate reuptake,BP,
13274,GO:0051941,1.00000000001191,0.946671285816813,0,1,regulation of amino acid uptake involved in synaptic transmission,BP,
13277,GO:0051946,1.00000000001191,0.946671285816813,0,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
13317,GO:0052047,1.00000000001191,0.946671285816813,0,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
13386,GO:0052590,1.00000000001191,0.946671285816813,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13387,GO:0052591,1.00000000001191,0.946671285816813,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
13410,GO:0052717,1.00000000001191,0.946671285816813,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13411,GO:0052718,1.00000000001191,0.946671285816813,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
13475,GO:0052918,1.00000000001191,0.946671285816813,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13477,GO:0052926,1.00000000001191,0.946671285816813,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13504,GO:0055028,1.00000000001191,0.946671285816813,0,1,cortical microtubule,CC,
13508,GO:0055048,1.00000000001191,0.946671285816813,0,1,anastral spindle assembly,BP,
13546,GO:0055113,1.00000000001191,0.946671285816813,0,1,epiboly involved in gastrulation with mouth forming second,BP,
13555,GO:0060001,1.00000000001191,0.946671285816813,0,1,minus-end directed microfilament motor activity,MF,
13582,GO:0060032,1.00000000001191,0.946671285816813,0,1,notochord regression,BP,
13607,GO:0060060,1.00000000001191,0.946671285816813,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
13616,GO:0060072,1.00000000001191,0.946671285816813,0,1,large conductance calcium-activated potassium channel activity,MF,
13644,GO:0060125,1.00000000001191,0.946671285816813,0,1,negative regulation of growth hormone secretion,BP,
13794,GO:0060366,1.00000000001191,0.946671285816813,0,1,lambdoid suture morphogenesis,BP,
13795,GO:0060367,1.00000000001191,0.946671285816813,0,1,sagittal suture morphogenesis,BP,
13800,GO:0060372,1.00000000001191,0.946671285816813,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,
13805,GO:0060378,1.00000000001191,0.946671285816813,0,1,regulation of brood size,BP,
13927,GO:0060566,1.00000000001191,0.946671285816813,0,1,positive regulation of DNA-templated transcription, termination,BP,
14066,GO:0060821,1.00000000001191,0.946671285816813,0,1,inactivation of X chromosome by DNA methylation,BP,
14079,GO:0060843,1.00000000001191,0.946671285816813,0,1,venous endothelial cell differentiation,BP,
14089,GO:0060873,1.00000000001191,0.946671285816813,0,1,anterior semicircular canal development,BP,
14090,GO:0060875,1.00000000001191,0.946671285816813,0,1,lateral semicircular canal development,BP,
14156,GO:0061010,1.00000000001191,0.946671285816813,0,1,gall bladder development,BP,
14172,GO:0061040,1.00000000001191,0.946671285816813,0,1,female gonad morphogenesis,BP,
14224,GO:0061141,1.00000000001191,0.946671285816813,0,1,lung ciliated cell differentiation,BP,
14265,GO:0061301,1.00000000001191,0.946671285816813,0,1,cerebellum vasculature morphogenesis,BP,
14324,GO:0061444,1.00000000001191,0.946671285816813,0,1,endocardial cushion cell development,BP,
14338,GO:0061485,1.00000000001191,0.946671285816813,0,1,memory T cell proliferation,BP,
14353,GO:0061534,1.00000000001191,0.946671285816813,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
14386,GO:0061618,1.00000000001191,0.946671285816813,0,1,sublamina densa,CC,
14410,GO:0061663,1.00000000001191,0.946671285816813,0,1,NEDD8 ligase activity,MF,
14426,GO:0061709,1.00000000001191,0.946671285816813,0,1,reticulophagy,BP,
14462,GO:0061780,1.00000000001191,0.946671285816813,0,1,mitotic cohesin loading,BP,
14464,GO:0061789,1.00000000001191,0.946671285816813,0,1,dense core granule priming,BP,
14465,GO:0061792,1.00000000001191,0.946671285816813,0,1,secretory granule maturation,BP,
14475,GO:0061828,1.00000000001191,0.946671285816813,0,1,apical tubulobulbar complex,CC,
14476,GO:0061829,1.00000000001191,0.946671285816813,0,1,basal tubulobulbar complex,CC,
14501,GO:0061920,1.00000000001191,0.946671285816813,0,1,protein propionyltransferase activity,MF,
14502,GO:0061921,1.00000000001191,0.946671285816813,0,1,peptidyl-lysine propionylation,BP,
14590,GO:0070123,1.00000000001191,0.946671285816813,0,1,transforming growth factor beta receptor activity, type III,MF,
14619,GO:0070171,1.00000000001191,0.946671285816813,0,1,negative regulation of tooth mineralization,BP,
14714,GO:0070335,1.00000000001191,0.946671285816813,0,1,aspartate binding,MF,
14804,GO:0070510,1.00000000001191,0.946671285816813,0,1,regulation of histone H4-K20 methylation,BP,
14805,GO:0070512,1.00000000001191,0.946671285816813,0,1,positive regulation of histone H4-K20 methylation,BP,
14824,GO:0070548,1.00000000001191,0.946671285816813,0,1,L-glutamine aminotransferase activity,MF,
14825,GO:0070550,1.00000000001191,0.946671285816813,0,1,rDNA condensation,BP,
14855,GO:0070593,1.00000000001191,0.946671285816813,0,1,dendrite self-avoidance,BP,
14908,GO:0070701,1.00000000001191,0.946671285816813,0,1,mucus layer,CC,
14909,GO:0070702,1.00000000001191,0.946671285816813,0,1,inner mucus layer,CC,
14910,GO:0070703,1.00000000001191,0.946671285816813,0,1,outer mucus layer,CC,
14940,GO:0070781,1.00000000001191,0.946671285816813,0,1,response to biotin,BP,
14972,GO:0070856,1.00000000001191,0.946671285816813,0,1,myosin VI light chain binding,MF,
14992,GO:0070890,1.00000000001191,0.946671285816813,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
14997,GO:0070898,1.00000000001191,0.946671285816813,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
15003,GO:0070904,1.00000000001191,0.946671285816813,0,1,transepithelial L-ascorbic acid transport,BP,
15043,GO:0070975,1.00000000001191,0.946671285816813,0,1,FHA domain binding,MF,
15109,GO:0071110,1.00000000001191,0.946671285816813,0,1,histone biotinylation,BP,
15183,GO:0071301,1.00000000001191,0.946671285816813,0,1,cellular response to vitamin B1,BP,
15285,GO:0071454,1.00000000001191,0.946671285816813,0,1,cellular response to anoxia,BP,
15384,GO:0071612,1.00000000001191,0.946671285816813,0,1,IP-10 production,BP,
15415,GO:0071658,1.00000000001191,0.946671285816813,0,1,regulation of IP-10 production,BP,
15416,GO:0071660,1.00000000001191,0.946671285816813,0,1,positive regulation of IP-10 production,BP,
15427,GO:0071678,1.00000000001191,0.946671285816813,0,1,olfactory bulb axon guidance,BP,
15434,GO:0071691,1.00000000001191,0.946671285816813,0,1,cardiac muscle thin filament assembly,BP,
15490,GO:0071821,1.00000000001191,0.946671285816813,0,1,FANCM-MHF complex,CC,
15518,GO:0071878,1.00000000001191,0.946671285816813,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15567,GO:0071988,1.00000000001191,0.946671285816813,0,1,protein localization to spindle pole body,BP,
15568,GO:0071997,1.00000000001191,0.946671285816813,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
15717,GO:0072244,1.00000000001191,0.946671285816813,0,1,metanephric glomerular epithelium development,BP,
15718,GO:0072248,1.00000000001191,0.946671285816813,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
15719,GO:0072249,1.00000000001191,0.946671285816813,0,1,metanephric glomerular visceral epithelial cell development,BP,
15730,GO:0072274,1.00000000001191,0.946671285816813,0,1,metanephric glomerular basement membrane development,BP,
15736,GO:0072287,1.00000000001191,0.946671285816813,0,1,metanephric distal tubule morphogenesis,BP,
15751,GO:0072312,1.00000000001191,0.946671285816813,0,1,metanephric glomerular epithelial cell differentiation,BP,
15752,GO:0072313,1.00000000001191,0.946671285816813,0,1,metanephric glomerular epithelial cell development,BP,
15779,GO:0072362,1.00000000001191,0.946671285816813,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15780,GO:0072363,1.00000000001191,0.946671285816813,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15782,GO:0072365,1.00000000001191,0.946671285816813,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15783,GO:0072366,1.00000000001191,0.946671285816813,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15790,GO:0072382,1.00000000001191,0.946671285816813,0,1,minus-end-directed vesicle transport along microtubule,BP,
15804,GO:0072414,1.00000000001191,0.946671285816813,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15811,GO:0072432,1.00000000001191,0.946671285816813,0,1,response to G1 DNA damage checkpoint signaling,BP,
15830,GO:0072518,1.00000000001191,0.946671285816813,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
15843,GO:0072534,1.00000000001191,0.946671285816813,0,1,perineuronal net,CC,
15882,GO:0072590,1.00000000001191,0.946671285816813,0,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
15883,GO:0072591,1.00000000001191,0.946671285816813,0,1,citrate-L-glutamate ligase activity,MF,
15905,GO:0072658,1.00000000001191,0.946671285816813,0,1,maintenance of protein location in membrane,BP,
15907,GO:0072660,1.00000000001191,0.946671285816813,0,1,maintenance of protein location in plasma membrane,BP,
15956,GO:0072752,1.00000000001191,0.946671285816813,0,1,cellular response to rapamycin,BP,
16026,GO:0086024,1.00000000001191,0.946671285816813,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
16033,GO:0086039,1.00000000001191,0.946671285816813,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
16039,GO:0086046,1.00000000001191,0.946671285816813,0,1,membrane depolarization during SA node cell action potential,BP,
16227,GO:0090251,1.00000000001191,0.946671285816813,0,1,protein localization involved in establishment of planar polarity,BP,
16247,GO:0090284,1.00000000001191,0.946671285816813,0,1,positive regulation of protein glycosylation in Golgi,BP,
16305,GO:0090389,1.00000000001191,0.946671285816813,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
16377,GO:0090667,1.00000000001191,0.946671285816813,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16378,GO:0090668,1.00000000001191,0.946671285816813,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
16383,GO:0090673,1.00000000001191,0.946671285816813,0,1,endothelial cell-matrix adhesion,BP,
16415,GO:0097026,1.00000000001191,0.946671285816813,0,1,dendritic cell dendrite assembly,BP,
16458,GO:0097108,1.00000000001191,0.946671285816813,0,1,hedgehog family protein binding,MF,
16466,GO:0097117,1.00000000001191,0.946671285816813,0,1,guanylate kinase-associated protein clustering,BP,
16467,GO:0097118,1.00000000001191,0.946671285816813,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
16486,GO:0097156,1.00000000001191,0.946671285816813,0,1,fasciculation of motor neuron axon,BP,
16490,GO:0097161,1.00000000001191,0.946671285816813,0,1,DH domain binding,MF,
16494,GO:0097166,1.00000000001191,0.946671285816813,0,1,lens epithelial cell proliferation,BP,
16580,GO:0097356,1.00000000001191,0.946671285816813,0,1,perinucleolar compartment,CC,
16594,GO:0097382,1.00000000001191,0.946671285816813,0,1,deoxynucleoside-diphosphatase activity,MF,
16595,GO:0097383,1.00000000001191,0.946671285816813,0,1,dIDP diphosphatase activity,MF,
16598,GO:0097393,1.00000000001191,0.946671285816813,0,1,telomeric repeat-containing RNA transcription,BP,
16599,GO:0097394,1.00000000001191,0.946671285816813,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
16721,GO:0097692,1.00000000001191,0.946671285816813,0,1,histone H3-K4 monomethylation,BP,
16747,GO:0097749,1.00000000001191,0.946671285816813,0,1,membrane tubulation,BP,
16785,GO:0098577,1.00000000001191,0.946671285816813,0,1,inactive sex chromosome,CC,
16817,GO:0098648,1.00000000001191,0.946671285816813,0,1,collagen anchoring fibril,CC,
16819,GO:0098652,1.00000000001191,0.946671285816813,0,1,collagen type VII anchoring fibril,CC,
16848,GO:0098736,1.00000000001191,0.946671285816813,0,1,negative regulation of the force of heart contraction,BP,
16899,GO:0098829,1.00000000001191,0.946671285816813,0,1,intestinal folate absorption,BP,
16929,GO:0098885,1.00000000001191,0.946671285816813,0,1,modification of postsynaptic actin cytoskeleton,BP,
16932,GO:0098888,1.00000000001191,0.946671285816813,0,1,extrinsic component of presynaptic membrane,CC,
16933,GO:0098890,1.00000000001191,0.946671285816813,0,1,extrinsic component of postsynaptic membrane,CC,
16941,GO:0098907,1.00000000001191,0.946671285816813,0,1,regulation of SA node cell action potential,BP,
16954,GO:0098923,1.00000000001191,0.946671285816813,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
16955,GO:0098924,1.00000000001191,0.946671285816813,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
16956,GO:0098926,1.00000000001191,0.946671285816813,0,1,postsynaptic signal transduction,BP,
16963,GO:0098939,1.00000000001191,0.946671285816813,0,1,dendritic transport of mitochondrion,BP,
16965,GO:0098948,1.00000000001191,0.946671285816813,0,1,intrinsic component of postsynaptic specialization membrane,CC,
16974,GO:0098972,1.00000000001191,0.946671285816813,0,1,anterograde dendritic transport of mitochondrion,BP,
16983,GO:0098988,1.00000000001191,0.946671285816813,0,1,G-protein coupled glutamate receptor activity,MF,
16993,GO:0099039,1.00000000001191,0.946671285816813,0,1,sphingolipid translocation,BP,
16999,GO:0099060,1.00000000001191,0.946671285816813,0,1,integral component of postsynaptic specialization membrane,CC,
17000,GO:0099061,1.00000000001191,0.946671285816813,0,1,integral component of postsynaptic density membrane,CC,
17014,GO:0099089,1.00000000001191,0.946671285816813,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
17028,GO:0099146,1.00000000001191,0.946671285816813,0,1,intrinsic component of postsynaptic density membrane,CC,
17029,GO:0099159,1.00000000001191,0.946671285816813,0,1,regulation of modification of postsynaptic structure,BP,
17030,GO:0099163,1.00000000001191,0.946671285816813,0,1,synaptic signaling by nitric oxide,BP,
17040,GO:0099243,1.00000000001191,0.946671285816813,0,1,extrinsic component of synaptic membrane,CC,
17061,GO:0099527,1.00000000001191,0.946671285816813,0,1,postsynapse to nucleus signaling pathway,BP,
17072,GO:0099543,1.00000000001191,0.946671285816813,0,1,trans-synaptic signaling by soluble gas,BP,
17075,GO:0099548,1.00000000001191,0.946671285816813,0,1,trans-synaptic signaling by nitric oxide,BP,
17088,GO:0099580,1.00000000001191,0.946671285816813,0,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
17095,GO:0099606,1.00000000001191,0.946671285816813,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17096,GO:0099607,1.00000000001191,0.946671285816813,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
17120,GO:0100057,1.00000000001191,0.946671285816813,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
17136,GO:0102113,1.00000000001191,0.946671285816813,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
17138,GO:0102131,1.00000000001191,0.946671285816813,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17139,GO:0102132,1.00000000001191,0.946671285816813,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
17168,GO:0102500,1.00000000001191,0.946671285816813,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
17203,GO:0106005,1.00000000001191,0.946671285816813,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
17232,GO:0106088,1.00000000001191,0.946671285816813,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17233,GO:0106089,1.00000000001191,0.946671285816813,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17247,GO:0110028,1.00000000001191,0.946671285816813,0,1,positive regulation of mitotic spindle organization,BP,
17279,GO:0120077,1.00000000001191,0.946671285816813,0,1,angiogenic sprout fusion,BP,
17280,GO:0120078,1.00000000001191,0.946671285816813,0,1,cell adhesion involved in sprouting angiogenesis,BP,
17305,GO:0140064,1.00000000001191,0.946671285816813,0,1,peptide crotonyltransferase activity,MF,
17306,GO:0140065,1.00000000001191,0.946671285816813,0,1,peptide butyryltransferase activity,MF,
17308,GO:0140067,1.00000000001191,0.946671285816813,0,1,peptidyl-lysine butyrylation,BP,
17309,GO:0140068,1.00000000001191,0.946671285816813,0,1,histone crotonyltransferase activity,MF,
17310,GO:0140069,1.00000000001191,0.946671285816813,0,1,histone butyryltransferase activity,MF,
17331,GO:0140196,1.00000000001191,0.946671285816813,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17332,GO:0140199,1.00000000001191,0.946671285816813,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17333,GO:0140200,1.00000000001191,0.946671285816813,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
17341,GO:0150031,1.00000000001191,0.946671285816813,0,1,regulation of protein localization to lysosome,BP,
17342,GO:0150033,1.00000000001191,0.946671285816813,0,1,negative regulation of protein localization to lysosome,BP,
17378,GO:1900081,1.00000000001191,0.946671285816813,0,1,regulation of arginine catabolic process,BP,
17379,GO:1900082,1.00000000001191,0.946671285816813,0,1,negative regulation of arginine catabolic process,BP,
17385,GO:1900095,1.00000000001191,0.946671285816813,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
17424,GO:1900149,1.00000000001191,0.946671285816813,0,1,positive regulation of Schwann cell migration,BP,
17459,GO:1900224,1.00000000001191,0.946671285816813,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17534,GO:1900827,1.00000000001191,0.946671285816813,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
17561,GO:1901078,1.00000000001191,0.946671285816813,0,1,negative regulation of relaxation of muscle,BP,
17648,GO:1901350,1.00000000001191,0.946671285816813,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
17696,GO:1901555,1.00000000001191,0.946671285816813,0,1,response to paclitaxel,BP,
17710,GO:1901580,1.00000000001191,0.946671285816813,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17711,GO:1901581,1.00000000001191,0.946671285816813,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17712,GO:1901582,1.00000000001191,0.946671285816813,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17732,GO:1901631,1.00000000001191,0.946671285816813,0,1,positive regulation of presynaptic membrane organization,BP,
17733,GO:1901639,1.00000000001191,0.946671285816813,0,1,XDP catabolic process,BP,
17734,GO:1901640,1.00000000001191,0.946671285816813,0,1,XTP binding,MF,
17735,GO:1901641,1.00000000001191,0.946671285816813,0,1,ITP binding,MF,
17755,GO:1901675,1.00000000001191,0.946671285816813,0,1,negative regulation of histone H3-K27 acetylation,BP,
17759,GO:1901680,1.00000000001191,0.946671285816813,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
17774,GO:1901726,1.00000000001191,0.946671285816813,0,1,negative regulation of histone deacetylase activity,BP,
17816,GO:1901895,1.00000000001191,0.946671285816813,0,1,negative regulation of calcium-transporting ATPase activity,BP,
17819,GO:1901898,1.00000000001191,0.946671285816813,0,1,negative regulation of relaxation of cardiac muscle,BP,
17837,GO:1901980,1.00000000001191,0.946671285816813,0,1,positive regulation of inward rectifier potassium channel activity,BP,
17921,GO:1902216,1.00000000001191,0.946671285816813,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
17984,GO:1902363,1.00000000001191,0.946671285816813,0,1,regulation of protein localization to spindle pole body,BP,
17985,GO:1902365,1.00000000001191,0.946671285816813,0,1,positive regulation of protein localization to spindle pole body,BP,
18024,GO:1902488,1.00000000001191,0.946671285816813,0,1,cholangiocyte apoptotic process,BP,
18040,GO:1902528,1.00000000001191,0.946671285816813,0,1,regulation of protein linear polyubiquitination,BP,
18041,GO:1902530,1.00000000001191,0.946671285816813,0,1,positive regulation of protein linear polyubiquitination,BP,
18077,GO:1902618,1.00000000001191,0.946671285816813,0,1,cellular response to fluoride,BP,
18083,GO:1902630,1.00000000001191,0.946671285816813,0,1,regulation of membrane hyperpolarization,BP,
18084,GO:1902631,1.00000000001191,0.946671285816813,0,1,negative regulation of membrane hyperpolarization,BP,
18128,GO:1902769,1.00000000001191,0.946671285816813,0,1,regulation of choline O-acetyltransferase activity,BP,
18129,GO:1902771,1.00000000001191,0.946671285816813,0,1,positive regulation of choline O-acetyltransferase activity,BP,
18147,GO:1902846,1.00000000001191,0.946671285816813,0,1,positive regulation of mitotic spindle elongation,BP,
18162,GO:1902889,1.00000000001191,0.946671285816813,0,1,protein localization to spindle microtubule,BP,
18193,GO:1902948,1.00000000001191,0.946671285816813,0,1,negative regulation of tau-protein kinase activity,BP,
18200,GO:1902955,1.00000000001191,0.946671285816813,0,1,positive regulation of early endosome to recycling endosome transport,BP,
18223,GO:1902997,1.00000000001191,0.946671285816813,0,1,negative regulation of neurofibrillary tangle assembly,BP,
18242,GO:1903027,1.00000000001191,0.946671285816813,0,1,regulation of opsonization,BP,
18243,GO:1903028,1.00000000001191,0.946671285816813,0,1,positive regulation of opsonization,BP,
18334,GO:1903248,1.00000000001191,0.946671285816813,0,1,regulation of citrulline biosynthetic process,BP,
18335,GO:1903249,1.00000000001191,0.946671285816813,0,1,negative regulation of citrulline biosynthetic process,BP,
18410,GO:1903420,1.00000000001191,0.946671285816813,0,1,protein localization to endoplasmic reticulum tubular network,BP,
18432,GO:1903450,1.00000000001191,0.946671285816813,0,1,regulation of G1 to G0 transition,BP,
18433,GO:1903452,1.00000000001191,0.946671285816813,0,1,positive regulation of G1 to G0 transition,BP,
18449,GO:1903515,1.00000000001191,0.946671285816813,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
18537,GO:1903699,1.00000000001191,0.946671285816813,0,1,tarsal gland development,BP,
18543,GO:1903709,1.00000000001191,0.946671285816813,0,1,uterine gland development,BP,
18644,GO:1903918,1.00000000001191,0.946671285816813,0,1,regulation of actin filament severing,BP,
18645,GO:1903919,1.00000000001191,0.946671285816813,0,1,negative regulation of actin filament severing,BP,
18686,GO:1904000,1.00000000001191,0.946671285816813,0,1,positive regulation of eating behavior,BP,
18713,GO:1904054,1.00000000001191,0.946671285816813,0,1,regulation of cholangiocyte proliferation,BP,
18714,GO:1904056,1.00000000001191,0.946671285816813,0,1,positive regulation of cholangiocyte proliferation,BP,
18717,GO:1904059,1.00000000001191,0.946671285816813,0,1,regulation of locomotor rhythm,BP,
18721,GO:1904073,1.00000000001191,0.946671285816813,0,1,regulation of trophectodermal cell proliferation,BP,
18722,GO:1904075,1.00000000001191,0.946671285816813,0,1,positive regulation of trophectodermal cell proliferation,BP,
18747,GO:1904192,1.00000000001191,0.946671285816813,0,1,regulation of cholangiocyte apoptotic process,BP,
18748,GO:1904193,1.00000000001191,0.946671285816813,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18749,GO:1904195,1.00000000001191,0.946671285816813,0,1,regulation of granulosa cell proliferation,BP,
18750,GO:1904197,1.00000000001191,0.946671285816813,0,1,positive regulation of granulosa cell proliferation,BP,
18752,GO:1904200,1.00000000001191,0.946671285816813,0,1,iodide transmembrane transport,BP,
18753,GO:1904201,1.00000000001191,0.946671285816813,0,1,regulation of iodide transport,BP,
18754,GO:1904202,1.00000000001191,0.946671285816813,0,1,negative regulation of iodide transport,BP,
18755,GO:1904204,1.00000000001191,0.946671285816813,0,1,regulation of skeletal muscle hypertrophy,BP,
18756,GO:1904206,1.00000000001191,0.946671285816813,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18761,GO:1904212,1.00000000001191,0.946671285816813,0,1,regulation of iodide transmembrane transport,BP,
18762,GO:1904213,1.00000000001191,0.946671285816813,0,1,negative regulation of iodide transmembrane transport,BP,
18769,GO:1904229,1.00000000001191,0.946671285816813,0,1,regulation of succinate dehydrogenase activity,BP,
18770,GO:1904231,1.00000000001191,0.946671285816813,0,1,positive regulation of succinate dehydrogenase activity,BP,
18771,GO:1904232,1.00000000001191,0.946671285816813,0,1,regulation of aconitate hydratase activity,BP,
18772,GO:1904234,1.00000000001191,0.946671285816813,0,1,positive regulation of aconitate hydratase activity,BP,
18773,GO:1904235,1.00000000001191,0.946671285816813,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18774,GO:1904237,1.00000000001191,0.946671285816813,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18787,GO:1904265,1.00000000001191,0.946671285816813,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
18788,GO:1904266,1.00000000001191,0.946671285816813,0,1,regulation of Schwann cell chemotaxis,BP,
18789,GO:1904268,1.00000000001191,0.946671285816813,0,1,positive regulation of Schwann cell chemotaxis,BP,
18838,GO:1904393,1.00000000001191,0.946671285816813,0,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18839,GO:1904395,1.00000000001191,0.946671285816813,0,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18842,GO:1904404,1.00000000001191,0.946671285816813,0,1,response to formaldehyde,BP,
18861,GO:1904447,1.00000000001191,0.946671285816813,0,1,folic acid import across plasma membrane,BP,
18864,GO:1904454,1.00000000001191,0.946671285816813,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
18873,GO:1904477,1.00000000001191,0.946671285816813,0,1,positive regulation of Ras GTPase binding,BP,
18921,GO:1904594,1.00000000001191,0.946671285816813,0,1,regulation of termination of RNA polymerase II transcription,BP,
18922,GO:1904595,1.00000000001191,0.946671285816813,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
18940,GO:1904647,1.00000000001191,0.946671285816813,0,1,response to rotenone,BP,
18990,GO:1904750,1.00000000001191,0.946671285816813,0,1,negative regulation of protein localization to nucleolus,BP,
18999,GO:1904766,1.00000000001191,0.946671285816813,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
19014,GO:1904797,1.00000000001191,0.946671285816813,0,1,negative regulation of core promoter binding,BP,
19027,GO:1904826,1.00000000001191,0.946671285816813,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
19028,GO:1904828,1.00000000001191,0.946671285816813,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
19054,GO:1904878,1.00000000001191,0.946671285816813,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19106,GO:1904980,1.00000000001191,0.946671285816813,0,1,positive regulation of endosome organization,BP,
19116,GO:1905000,1.00000000001191,0.946671285816813,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
19152,GO:1905089,1.00000000001191,0.946671285816813,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19153,GO:1905090,1.00000000001191,0.946671285816813,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19156,GO:1905099,1.00000000001191,0.946671285816813,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
19167,GO:1905152,1.00000000001191,0.946671285816813,0,1,positive regulation of voltage-gated sodium channel activity,BP,
19194,GO:1905223,1.00000000001191,0.946671285816813,0,1,epicardium morphogenesis,BP,
19202,GO:1905255,1.00000000001191,0.946671285816813,0,1,regulation of RNA binding transcription factor activity,BP,
19210,GO:1905274,1.00000000001191,0.946671285816813,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19222,GO:1905304,1.00000000001191,0.946671285816813,0,1,regulation of cardiac myofibril assembly,BP,
19223,GO:1905305,1.00000000001191,0.946671285816813,0,1,negative regulation of cardiac myofibril assembly,BP,
19224,GO:1905309,1.00000000001191,0.946671285816813,0,1,positive regulation of cohesin loading,BP,
19238,GO:1905335,1.00000000001191,0.946671285816813,0,1,regulation of aggrephagy,BP,
19239,GO:1905337,1.00000000001191,0.946671285816813,0,1,positive regulation of aggrephagy,BP,
19267,GO:1905405,1.00000000001191,0.946671285816813,0,1,regulation of mitotic cohesin loading,BP,
19268,GO:1905406,1.00000000001191,0.946671285816813,0,1,positive regulation of mitotic cohesin loading,BP,
19292,GO:1905460,1.00000000001191,0.946671285816813,0,1,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
19311,GO:1905524,1.00000000001191,0.946671285816813,0,1,negative regulation of protein autoubiquitination,BP,
19351,GO:1905643,1.00000000001191,0.946671285816813,0,1,positive regulation of DNA methylation,BP,
19366,GO:1905705,1.00000000001191,0.946671285816813,0,1,cellular response to paclitaxel,BP,
19373,GO:1905720,1.00000000001191,0.946671285816813,0,1,cytoplasmic microtubule bundle,CC,
19376,GO:1905767,1.00000000001191,0.946671285816813,0,1,regulation of double-stranded telomeric DNA binding,BP,
19377,GO:1905768,1.00000000001191,0.946671285816813,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
19387,GO:1905794,1.00000000001191,0.946671285816813,0,1,response to puromycin,BP,
19388,GO:1905795,1.00000000001191,0.946671285816813,0,1,cellular response to puromycin,BP,
19397,GO:1905843,1.00000000001191,0.946671285816813,0,1,regulation of cellular response to gamma radiation,BP,
19443,GO:1990003,1.00000000001191,0.946671285816813,0,1,IDP phosphatase activity,MF,
19453,GO:1990036,1.00000000001191,0.946671285816813,0,1,calcium ion import into sarcoplasmic reticulum,BP,
19491,GO:1990172,1.00000000001191,0.946671285816813,0,1,G-protein coupled receptor catabolic process,BP,
19509,GO:1990256,1.00000000001191,0.946671285816813,0,1,signal clustering,BP,
19518,GO:1990280,1.00000000001191,0.946671285816813,0,1,RNA localization to chromatin,BP,
19549,GO:1990421,1.00000000001191,0.946671285816813,0,1,subtelomeric heterochromatin,CC,
19561,GO:1990448,1.00000000001191,0.946671285816813,0,1,exon-exon junction complex binding,MF,
19571,GO:1990502,1.00000000001191,0.946671285816813,0,1,dense core granule maturation,BP,
19588,GO:1990578,1.00000000001191,0.946671285816813,0,1,perinuclear endoplasmic reticulum membrane,CC,
19614,GO:1990705,1.00000000001191,0.946671285816813,0,1,cholangiocyte proliferation,BP,
19615,GO:1990707,1.00000000001191,0.946671285816813,0,1,nuclear subtelomeric heterochromatin,CC,
19626,GO:1990739,1.00000000001191,0.946671285816813,0,1,granulosa cell proliferation,BP,
19632,GO:1990751,1.00000000001191,0.946671285816813,0,1,Schwann cell chemotaxis,BP,
19641,GO:1990771,1.00000000001191,0.946671285816813,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
19673,GO:1990876,1.00000000001191,0.946671285816813,0,1,cytoplasmic side of nuclear pore,CC,
19700,GO:1990968,1.00000000001191,0.946671285816813,0,1,modulation by host of RNA binding by virus,BP,
19701,GO:1990969,1.00000000001191,0.946671285816813,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
19737,GO:2000055,1.00000000001191,0.946671285816813,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19848,GO:2000283,1.00000000001191,0.946671285816813,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
19878,GO:2000325,1.00000000001191,0.946671285816813,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19879,GO:2000327,1.00000000001191,0.946671285816813,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19918,GO:2000382,1.00000000001191,0.946671285816813,0,1,positive regulation of mesoderm development,BP,
20094,GO:2000707,1.00000000001191,0.946671285816813,0,1,positive regulation of dense core granule biogenesis,BP,
20141,GO:2000795,1.00000000001191,0.946671285816813,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20144,GO:2000804,1.00000000001191,0.946671285816813,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20145,GO:2000806,1.00000000001191,0.946671285816813,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20154,GO:2000820,1.00000000001191,0.946671285816813,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20168,GO:2000843,1.00000000001191,0.946671285816813,0,1,regulation of testosterone secretion,BP,
20169,GO:2000845,1.00000000001191,0.946671285816813,0,1,positive regulation of testosterone secretion,BP,
20180,GO:2000864,1.00000000001191,0.946671285816813,0,1,regulation of estradiol secretion,BP,
20231,GO:2001108,1.00000000001191,0.946671285816813,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20232,GO:2001109,1.00000000001191,0.946671285816813,0,1,regulation of lens epithelial cell proliferation,BP,
20233,GO:2001111,1.00000000001191,0.946671285816813,0,1,positive regulation of lens epithelial cell proliferation,BP,
20275,GO:2001202,1.00000000001191,0.946671285816813,0,1,negative regulation of transforming growth factor-beta secretion,BP,
20289,GO:2001229,1.00000000001191,0.946671285816813,0,1,negative regulation of response to gamma radiation,BP,
4669,GO:0010814,1.00000000001191,0.946782138935608,0,1,substance P catabolic process,BP,
4671,GO:0010816,1.00000000001191,0.946782138935608,0,1,calcitonin catabolic process,BP,
7307,GO:0031302,1.00000000001191,0.946782138935608,0,1,intrinsic component of endosome membrane,CC,
8935,GO:0034959,1.00000000001191,0.946782138935608,0,1,endothelin maturation,BP,
4081,GO:0009133,1.00000000001192,0.857413313910072,0,4,nucleoside diphosphate biosynthetic process,BP,
2531,GO:0005785,1.00000000001193,0.745091760587483,0,7,signal recognition particle receptor complex,CC,
15447,GO:0071707,1.00000000001195,0.966078891993586,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
12095,GO:0048039,1.00000000001195,0.784185272217002,0,6,ubiquinone binding,MF,
2331,GO:0005344,1.00000000001196,0.956783537232659,0,1,oxygen carrier activity,MF,
12057,GO:0047888,1.00000000001196,0.956783537232659,0,1,fatty acid peroxidase activity,MF,
16197,GO:0090205,1.00000000001196,0.73843085759443,0,6,positive regulation of cholesterol metabolic process,BP,
10166,GO:0042747,1.00000000001197,0.84336172049627,0,4,circadian sleep/wake cycle, REM sleep,BP,
3772,GO:0008321,1.00000000001197,0.896288518185021,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
104,GO:0000215,1.00000000001197,0.926598796237615,0,2,tRNA 2'-phosphotransferase activity,MF,
11005,GO:0044805,1.00000000001198,0.899397654242175,0,2,late nucleophagy,BP,
5295,GO:0015959,1.00000000001198,0.722579637000221,0,7,diadenosine polyphosphate metabolic process,BP,
17007,GO:0099078,1.00000000001199,0.719763256722702,0,8,BORC complex,CC,
18911,GO:1904578,1.00000000001199,0.88408515560897,0,3,response to thapsigargin,BP,
18912,GO:1904579,1.00000000001199,0.88408515560897,0,3,cellular response to thapsigargin,BP,
5770,GO:0016939,1.00000000001199,0.854183956578863,0,3,kinesin II complex,CC,
7354,GO:0031390,1.00000000001199,0.696041964474583,0,8,Ctf18 RFC-like complex,CC,
17023,GO:0099122,1.000000000012,0.856542227196805,0,3,RNA polymerase II C-terminal domain binding,MF,
16118,GO:0090086,1.00000000001201,0.899538468413417,0,3,negative regulation of protein deubiquitination,BP,
4670,GO:0010815,1.00000000001201,0.823392240271298,0,4,bradykinin catabolic process,BP,
11850,GO:0046811,1.00000000001202,0.946671512981002,0,1,histone deacetylase inhibitor activity,MF,
8371,GO:0033263,1.00000000001202,0.811335092905689,0,4,CORVET complex,CC,
654,GO:0001842,1.00000000001202,0.791493343859104,0,5,neural fold formation,BP,
13961,GO:0060623,1.00000000001204,0.866311476977046,0,3,regulation of chromosome condensation,BP,
2018,GO:0004742,1.00000000001204,0.947810185169142,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
6934,GO:0030523,1.00000000001204,0.947810185169142,0,1,dihydrolipoamide S-acyltransferase activity,MF,
12466,GO:0050211,1.00000000001204,0.908935835425809,0,2,procollagen galactosyltransferase activity,MF,
8375,GO:0033269,1.00000000001206,0.90602349607412,0,2,internode region of axon,CC,
7768,GO:0032280,1.00000000001208,0.805158294815364,0,4,symmetric synapse,CC,
15786,GO:0072369,1.00000000001208,0.902500726258767,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
13813,GO:0060386,1.00000000001209,0.946671381765651,0,1,synapse assembly involved in innervation,BP,
17713,GO:1901585,1.00000000001209,0.95375434046753,0,1,regulation of acid-sensing ion channel activity,BP,
5696,GO:0016812,1.00000000001211,0.765865071607309,0,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
850,GO:0002169,1.00000000001211,0.906863097001067,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
1833,GO:0004485,1.00000000001211,0.906863097001067,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
19182,GO:1905202,1.00000000001211,0.906863097001067,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
15561,GO:0071962,1.00000000001211,0.887441504612738,0,3,mitotic sister chromatid cohesion, centromeric,BP,
7595,GO:0031959,1.00000000001211,0.902734219729196,0,2,mineralocorticoid receptor signaling pathway,BP,
297,GO:0000801,1.00000000001211,0.948353012524023,0,1,central element,CC,
18285,GO:1903135,1.00000000001212,0.8812032005134,0,3,cupric ion binding,MF,
4451,GO:0010370,1.00000000001213,0.908078435755988,0,2,perinucleolar chromocenter,CC,
19613,GO:1990700,1.00000000001214,0.94908395848686,0,1,nucleolar chromatin organization,BP,
952,GO:0002368,1.00000000001214,0.954989976795563,0,1,B cell cytokine production,BP,
1197,GO:0002842,1.00000000001214,0.954989976795563,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
9567,GO:0036351,1.00000000001214,0.954989976795563,0,1,histone H2A-K13 ubiquitination,BP,
9568,GO:0036352,1.00000000001214,0.954989976795563,0,1,histone H2A-K15 ubiquitination,BP,
10517,GO:0043418,1.00000000001214,0.867286771798837,0,3,homocysteine catabolic process,BP,
15382,GO:0071609,1.00000000001214,0.684197587284169,0,8,chemokine (C-C motif) ligand 5 production,BP,
16442,GO:0097068,1.00000000001215,0.859671498360755,0,3,response to thyroxine,BP,
18836,GO:1904386,1.00000000001215,0.859671498360755,0,3,response to L-phenylalanine derivative,BP,
2441,GO:0005639,1.00000000001215,0.668882358500589,0,8,integral component of nuclear inner membrane,CC,
7266,GO:0031229,1.00000000001215,0.668882358500589,0,8,intrinsic component of nuclear inner membrane,CC,
10911,GO:0044453,1.00000000001215,0.668882358500589,0,8,nuclear membrane part,CC,
18398,GO:1903387,1.00000000001216,0.94672167909374,0,1,positive regulation of homophilic cell adhesion,BP,
12959,GO:0051305,1.00000000001216,0.774535390775489,0,5,chromosome movement towards spindle pole,BP,
19702,GO:1990983,1.00000000001217,0.954319602150744,0,1,tRNA demethylation,BP,
19703,GO:1990984,1.00000000001217,0.954319602150744,0,1,tRNA demethylase activity,MF,
17741,GO:1901656,1.00000000001217,0.903766662290442,0,2,glycoside transport,BP,
2146,GO:0004957,1.00000000001217,0.951439743085511,0,1,prostaglandin E receptor activity,MF,
15924,GO:0072682,1.00000000001217,0.951439743085511,0,1,eosinophil extravasation,BP,
19944,GO:2000417,1.00000000001217,0.951439743085511,0,1,negative regulation of eosinophil migration,BP,
19946,GO:2000419,1.00000000001217,0.951439743085511,0,1,regulation of eosinophil extravasation,BP,
19947,GO:2000420,1.00000000001217,0.951439743085511,0,1,negative regulation of eosinophil extravasation,BP,
13393,GO:0052642,1.00000000001218,0.957936871360397,0,1,lysophosphatidic acid phosphatase activity,MF,
20335,GO:2001311,1.00000000001218,0.957936871360397,0,1,lysobisphosphatidic acid metabolic process,BP,
8556,GO:0033961,1.00000000001218,0.958601515201534,0,1,cis-stilbene-oxide hydrolase activity,MF,
744,GO:0001972,1.0000000000122,0.644456523334259,0,9,retinoic acid binding,MF,
71,GO:0000147,1.0000000000122,0.849816921717322,0,3,actin cortical patch assembly,BP,
10875,GO:0044396,1.0000000000122,0.849816921717322,0,3,actin cortical patch organization,BP,
13138,GO:0051666,1.0000000000122,0.849816921717322,0,3,actin cortical patch localization,BP,
8124,GO:0032807,1.0000000000122,0.828025536958,0,4,DNA ligase IV complex,CC,
13007,GO:0051410,1.0000000000122,0.80611047855171,0,5,detoxification of nitrogen compound,BP,
17625,GO:1901298,1.00000000001221,0.663944711888138,0,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,
13406,GO:0052692,1.00000000001222,0.96326580423646,0,1,raffinose alpha-galactosidase activity,MF,
16592,GO:0097376,1.00000000001222,0.96326580423646,0,1,interneuron axon guidance,BP,
1823,GO:0004471,1.00000000001222,0.861225509231167,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1824,GO:0004473,1.00000000001222,0.861225509231167,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
5926,GO:0018197,1.00000000001224,0.853705172795781,0,3,peptidyl-aspartic acid modification,BP,
2737,GO:0006114,1.00000000001224,0.871003759198514,0,3,glycerol biosynthetic process,BP,
9409,GO:0035965,1.00000000001225,0.786990897564083,0,5,cardiolipin acyl-chain remodeling,BP,
2291,GO:0005247,1.00000000001225,0.705704318869357,0,7,voltage-gated chloride channel activity,MF,
9640,GO:0036506,1.00000000001226,0.862877733307137,0,3,maintenance of unfolded protein,BP,
18829,GO:1904378,1.00000000001226,0.862877733307137,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
16256,GO:0090297,1.00000000001226,0.965882313627184,0,1,positive regulation of mitochondrial DNA replication,BP,
17803,GO:1901860,1.00000000001226,0.965882313627184,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
19456,GO:1990046,1.00000000001226,0.965882313627184,0,1,stress-induced mitochondrial fusion,BP,
1245,GO:0002940,1.00000000001226,0.911064900053493,0,2,tRNA N2-guanine methylation,BP,
1416,GO:0003350,1.00000000001227,0.904399827669859,0,2,pulmonary myocardium development,BP,
16449,GO:0097091,1.00000000001228,0.808479651595169,0,4,synaptic vesicle clustering,BP,
14078,GO:0060842,1.00000000001228,0.860438297957593,0,3,arterial endothelial cell differentiation,BP,
20271,GO:2001198,1.00000000001228,0.881725382817371,0,3,regulation of dendritic cell differentiation,BP,
7850,GO:0032404,1.00000000001229,0.689938225121979,0,8,mismatch repair complex binding,MF,
11723,GO:0046512,1.00000000001231,0.70041863697101,0,8,sphingosine biosynthetic process,BP,
16894,GO:0098821,1.00000000001231,0.851835473106866,0,3,BMP receptor activity,MF,
18962,GO:1904700,1.00000000001231,0.954291497332646,0,1,granulosa cell apoptotic process,BP,
18967,GO:1904708,1.00000000001231,0.954291497332646,0,1,regulation of granulosa cell apoptotic process,BP,
17582,GO:1901164,1.00000000001231,0.901414541006964,0,3,negative regulation of trophoblast cell migration,BP,
4299,GO:0009737,1.00000000001232,0.947805440549162,0,1,response to abscisic acid,BP,
4300,GO:0009738,1.00000000001232,0.947805440549162,0,1,abscisic acid-activated signaling pathway,BP,
4313,GO:0009787,1.00000000001232,0.947805440549162,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4314,GO:0009789,1.00000000001232,0.947805440549162,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
15136,GO:0071215,1.00000000001232,0.947805440549162,0,1,cellular response to abscisic acid stimulus,BP,
17669,GO:1901419,1.00000000001232,0.947805440549162,0,1,regulation of response to alcohol,BP,
17670,GO:1901421,1.00000000001232,0.947805440549162,0,1,positive regulation of response to alcohol,BP,
19438,GO:1905957,1.00000000001232,0.947805440549162,0,1,regulation of cellular response to alcohol,BP,
19439,GO:1905959,1.00000000001232,0.947805440549162,0,1,positive regulation of cellular response to alcohol,BP,
3587,GO:0007638,1.00000000001233,0.651070312730004,0,8,mechanosensory behavior,BP,
15372,GO:0071596,1.00000000001234,0.84841905323732,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
12178,GO:0048289,1.00000000001235,0.821726975074262,0,4,isotype switching to IgE isotypes,BP,
12181,GO:0048293,1.00000000001235,0.821726975074262,0,4,regulation of isotype switching to IgE isotypes,BP,
9097,GO:0035358,1.00000000001235,0.705917397269927,0,7,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
7791,GO:0032324,1.00000000001236,0.722617379925925,0,7,molybdopterin cofactor biosynthetic process,BP,
10585,GO:0043545,1.00000000001236,0.722617379925925,0,7,molybdopterin cofactor metabolic process,BP,
12881,GO:0051189,1.00000000001236,0.722617379925925,0,7,prosthetic group metabolic process,BP,
2591,GO:0005883,1.00000000001236,0.706473171766953,0,7,neurofilament,CC,
18763,GO:1904217,1.00000000001236,0.87182911363908,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18764,GO:1904219,1.00000000001236,0.87182911363908,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18766,GO:1904222,1.00000000001236,0.87182911363908,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
19068,GO:1904895,1.00000000001237,0.959576092810931,0,1,ESCRT complex assembly,BP,
19070,GO:1904902,1.00000000001237,0.959576092810931,0,1,ESCRT III complex assembly,BP,
15539,GO:0071910,1.00000000001237,0.896343812417704,0,2,determination of liver left/right asymmetry,BP,
11129,GO:0045153,1.00000000001239,0.967228871458042,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
5055,GO:0015247,1.00000000001241,0.849988541957562,0,3,aminophospholipid transmembrane transporter activity,MF,
19802,GO:2000195,1.00000000001241,0.912036655322841,0,2,negative regulation of female gonad development,BP,
4563,GO:0010641,1.00000000001241,0.812513043764834,0,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
18855,GO:1904430,1.00000000001241,0.859318027364629,0,3,negative regulation of t-circle formation,BP,
3902,GO:0008537,1.00000000001242,0.901522073338751,0,3,proteasome activator complex,CC,
8404,GO:0033342,1.00000000001242,0.9544527295903,0,1,negative regulation of collagen binding,BP,
5054,GO:0015245,1.00000000001242,0.788843077423905,0,5,fatty acid transmembrane transporter activity,MF,
6363,GO:0021540,1.00000000001242,0.847316474006516,0,4,corpus callosum morphogenesis,BP,
7686,GO:0032119,1.00000000001243,0.719849563414365,0,8,sequestering of zinc ion,BP,
12512,GO:0050560,1.00000000001244,0.95167789061687,0,1,aspartate-tRNA(Asn) ligase activity,MF,
14605,GO:0070145,1.00000000001244,0.95167789061687,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
8182,GO:0032915,1.00000000001246,0.955769688134304,0,1,positive regulation of transforming growth factor beta2 production,BP,
18947,GO:1904674,1.00000000001247,0.903117985803183,0,2,positive regulation of somatic stem cell population maintenance,BP,
6836,GO:0030294,1.00000000001248,0.955367953158539,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
16901,GO:0098831,1.00000000001248,0.760293605733125,0,5,presynaptic active zone cytoplasmic component,CC,
2205,GO:0005087,1.00000000001249,0.853695422338369,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
3998,GO:0008894,1.00000000001251,0.953980832705098,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
5307,GO:0016005,1.00000000001252,0.90362307977051,0,2,phospholipase A2 activator activity,MF,
8154,GO:0032877,1.00000000001252,0.899353301853988,0,2,positive regulation of DNA endoreduplication,BP,
15409,GO:0071649,1.00000000001252,0.713169079795254,0,7,regulation of chemokine (C-C motif) ligand 5 production,BP,
7127,GO:0030943,1.00000000001254,0.871149553366266,0,3,mitochondrion targeting sequence binding,MF,
3937,GO:0008616,1.00000000001254,0.889854401740605,0,3,queuosine biosynthetic process,BP,
11577,GO:0046116,1.00000000001254,0.889854401740605,0,3,queuosine metabolic process,BP,
5112,GO:0015410,1.00000000001254,0.859011963723186,0,3,manganese-transporting ATPase activity,MF,
6432,GO:0021694,1.00000000001255,0.76804540208763,0,5,cerebellar Purkinje cell layer formation,BP,
6439,GO:0021702,1.00000000001255,0.76804540208763,0,5,cerebellar Purkinje cell differentiation,BP,
18867,GO:1904464,1.00000000001255,0.958751416428582,0,1,regulation of matrix metallopeptidase secretion,BP,
18868,GO:1904465,1.00000000001255,0.958751416428582,0,1,negative regulation of matrix metallopeptidase secretion,BP,
19642,GO:1990773,1.00000000001255,0.958751416428582,0,1,matrix metallopeptidase secretion,BP,
8437,GO:0033553,1.00000000001255,0.82273884853219,0,4,rDNA heterochromatin,CC,
11003,GO:0044803,1.00000000001257,0.824727432135684,0,4,multi-organism membrane organization,BP,
19394,GO:1905832,1.00000000001257,0.810992395432475,0,4,positive regulation of spindle assembly,BP,
13430,GO:0052810,1.00000000001257,0.949954632313751,0,1,1-phosphatidylinositol-5-kinase activity,MF,
5981,GO:0018479,1.00000000001257,0.955845041211336,0,1,benzaldehyde dehydrogenase (NAD+) activity,MF,
14349,GO:0061519,1.00000000001257,0.950597920573067,0,1,macrophage homeostasis,BP,
936,GO:0002332,1.00000000001257,0.946672696990829,0,1,transitional stage B cell differentiation,BP,
937,GO:0002333,1.00000000001257,0.946672696990829,0,1,transitional one stage B cell differentiation,BP,
18890,GO:1904531,1.00000000001257,0.946672696990829,0,1,positive regulation of actin filament binding,BP,
18932,GO:1904618,1.00000000001257,0.946672696990829,0,1,positive regulation of actin binding,BP,
19460,GO:1990051,1.00000000001257,0.946672696990829,0,1,activation of protein kinase C activity,BP,
10763,GO:0044205,1.00000000001258,0.863548572750741,0,3,'de novo' UMP biosynthetic process,BP,
8815,GO:0034552,1.00000000001259,0.852259913745925,0,4,respiratory chain complex II assembly,BP,
8816,GO:0034553,1.00000000001259,0.852259913745925,0,4,mitochondrial respiratory chain complex II assembly,BP,
3331,GO:0007042,1.00000000001261,0.724713372681471,0,8,lysosomal lumen acidification,BP,
17906,GO:1902174,1.00000000001261,0.914566624953422,0,2,positive regulation of keratinocyte apoptotic process,BP,
408,GO:0001093,1.00000000001261,0.8585523478476,0,3,TFIIB-class transcription factor binding,MF,
5387,GO:0016206,1.00000000001261,0.91022464714896,0,2,catechol O-methyltransferase activity,MF,
17134,GO:0102084,1.00000000001261,0.91022464714896,0,2,L-dopa O-methyltransferase activity,MF,
17186,GO:0102938,1.00000000001261,0.91022464714896,0,2,orcinol O-methyltransferase activity,MF,
821,GO:0002091,1.00000000001262,0.704118341820342,0,7,negative regulation of receptor internalization,BP,
8758,GO:0034418,1.00000000001262,0.912308435921427,0,2,urate biosynthetic process,BP,
16405,GO:0097010,1.00000000001262,0.85729811296972,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
10948,GO:0044609,1.00000000001262,0.911285402537681,0,2,DBIRD complex,CC,
8252,GO:0033026,1.00000000001263,0.946695290522982,0,1,negative regulation of mast cell apoptotic process,BP,
10107,GO:0042613,1.00000000001263,0.899818140882607,0,3,MHC class II protein complex,CC,
9672,GO:0038028,1.00000000001263,0.817600073920594,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
6405,GO:0021615,1.00000000001264,0.952152658072569,0,1,glossopharyngeal nerve morphogenesis,BP,
8456,GO:0033591,1.00000000001265,0.837902002692429,0,4,response to L-ascorbic acid,BP,
4907,GO:0014834,1.00000000001266,0.822506207279799,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
9171,GO:0035523,1.00000000001266,0.814074070433689,0,4,protein K29-linked deubiquitination,BP,
8094,GO:0032771,1.00000000001267,0.947974290661372,0,1,regulation of monophenol monooxygenase activity,BP,
8095,GO:0032773,1.00000000001267,0.947974290661372,0,1,positive regulation of monophenol monooxygenase activity,BP,
8179,GO:0032912,1.00000000001267,0.947974290661372,0,1,negative regulation of transforming growth factor beta2 production,BP,
12084,GO:0048023,1.00000000001267,0.947974290661372,0,1,positive regulation of melanin biosynthetic process,BP,
13203,GO:0051796,1.00000000001267,0.947974290661372,0,1,negative regulation of timing of catagen,BP,
14096,GO:0060901,1.00000000001267,0.947974290661372,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
18174,GO:1902908,1.00000000001267,0.947974290661372,0,1,regulation of melanosome transport,BP,
18175,GO:1902910,1.00000000001267,0.947974290661372,0,1,positive regulation of melanosome transport,BP,
5621,GO:0016670,1.00000000001268,0.704608663812578,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
15165,GO:0071265,1.00000000001269,0.73339985402042,0,7,L-methionine biosynthetic process,BP,
1888,GO:0004566,1.00000000001269,0.915320748222365,0,2,beta-glucuronidase activity,MF,
3025,GO:0006570,1.00000000001269,0.851629267316438,0,4,tyrosine metabolic process,BP,
7439,GO:0031544,1.00000000001269,0.826317847079299,0,4,peptidyl-proline 3-dioxygenase activity,MF,
9891,GO:0042166,1.00000000001269,0.786462893781891,0,5,acetylcholine binding,MF,
4099,GO:0009151,1.0000000000127,0.704755294769223,0,9,purine deoxyribonucleotide metabolic process,BP,
6515,GO:0021886,1.0000000000127,0.87894007007199,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6516,GO:0021888,1.0000000000127,0.87894007007199,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
2157,GO:0004977,1.0000000000127,0.912287710945356,0,2,melanocortin receptor activity,MF,
2550,GO:0005816,1.00000000001271,0.704530214155265,0,7,spindle pole body,CC,
5483,GO:0016413,1.00000000001271,0.742728403400035,0,6,O-acetyltransferase activity,MF,
14477,GO:0061833,1.00000000001272,0.905479490206568,0,2,protein localization to tricellular tight junction,BP,
8913,GO:0034751,1.00000000001272,0.873486313373452,0,3,aryl hydrocarbon receptor complex,CC,
2845,GO:0006313,1.00000000001273,0.948734702184817,0,1,transposition, DNA-mediated,BP,
5361,GO:0016128,1.00000000001273,0.871572011491909,0,3,phytosteroid metabolic process,BP,
5362,GO:0016129,1.00000000001273,0.871572011491909,0,3,phytosteroid biosynthetic process,BP,
8407,GO:0033353,1.00000000001273,0.816713029202351,0,4,S-adenosylmethionine cycle,BP,
2394,GO:0005534,1.00000000001275,0.874990749947352,0,3,galactose binding,MF,
6810,GO:0030252,1.00000000001275,0.695574119022047,0,7,growth hormone secretion,BP,
1651,GO:0004095,1.00000000001275,0.822935642668472,0,4,carnitine O-palmitoyltransferase activity,MF,
5486,GO:0016416,1.00000000001275,0.822935642668472,0,4,O-palmitoyltransferase activity,MF,
7018,GO:0030718,1.00000000001275,0.949528351854994,0,1,germ-line stem cell population maintenance,BP,
8817,GO:0034584,1.00000000001275,0.949528351854994,0,1,piRNA binding,MF,
10211,GO:0042823,1.00000000001277,0.900460130188378,0,2,pyridoxal phosphate biosynthetic process,BP,
4449,GO:0010360,1.00000000001277,0.861351795449977,0,3,negative regulation of anion channel activity,BP,
16513,GO:0097198,1.00000000001277,0.902315281984705,0,2,histone H3-K36 trimethylation,BP,
8152,GO:0032875,1.00000000001278,0.691485699870189,0,7,regulation of DNA endoreduplication,BP,
12008,GO:0047408,1.00000000001278,0.911308136501732,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12009,GO:0047409,1.00000000001278,0.911308136501732,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
4942,GO:0014900,1.00000000001279,0.833911121767181,0,4,muscle hyperplasia,BP,
15273,GO:0071435,1.0000000000128,0.896715814504809,0,2,potassium ion export,BP,
17965,GO:1902302,1.0000000000128,0.896715814504809,0,2,regulation of potassium ion export,BP,
13016,GO:0051428,1.0000000000128,0.664294416382239,0,9,peptide hormone receptor binding,MF,
15106,GO:0071107,1.00000000001281,0.85378014646978,0,3,response to parathyroid hormone,BP,
14547,GO:0070051,1.00000000001281,0.903427880466359,0,2,fibrinogen binding,MF,
14271,GO:0061309,1.00000000001282,0.749308992301553,0,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
16931,GO:0098887,1.00000000001282,0.782888085361809,0,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
9462,GO:0036056,1.00000000001282,0.760674355541626,0,5,filtration diaphragm,CC,
9463,GO:0036057,1.00000000001282,0.760674355541626,0,5,slit diaphragm,CC,
11371,GO:0045722,1.00000000001283,0.636623956132829,0,9,positive regulation of gluconeogenesis,BP,
11909,GO:0046923,1.00000000001284,0.843805074873038,0,4,ER retention sequence binding,MF,
4419,GO:0010189,1.00000000001287,0.959431936539162,0,1,vitamin E biosynthetic process,BP,
9975,GO:0042360,1.00000000001287,0.959431936539162,0,1,vitamin E metabolic process,BP,
18730,GO:1904121,1.00000000001287,0.959431936539162,0,1,phosphatidylethanolamine transporter activity,MF,
9868,GO:0042118,1.00000000001287,0.670112519222579,0,8,endothelial cell activation,BP,
7964,GO:0032558,1.00000000001288,0.888379154055547,0,3,adenyl deoxyribonucleotide binding,MF,
7968,GO:0032564,1.00000000001288,0.888379154055547,0,3,dATP binding,MF,
16626,GO:0097452,1.00000000001289,0.838308940186624,0,4,GAIT complex,CC,
18834,GO:1904383,1.00000000001289,0.955581393517402,0,1,response to sodium phosphate,BP,
18915,GO:1904585,1.00000000001289,0.955581393517402,0,1,response to putrescine,BP,
18916,GO:1904586,1.00000000001289,0.955581393517402,0,1,cellular response to putrescine,BP,
19659,GO:1990828,1.00000000001289,0.955581393517402,0,1,hepatocyte dedifferentiation,BP,
8750,GO:0034398,1.00000000001289,0.773917449621698,0,5,telomere tethering at nuclear periphery,BP,
1927,GO:0004618,1.0000000000129,0.954681911237601,0,1,phosphoglycerate kinase activity,MF,
16961,GO:0098936,1.0000000000129,0.896728999804165,0,2,intrinsic component of postsynaptic membrane,CC,
16998,GO:0099055,1.0000000000129,0.896728999804165,0,2,integral component of postsynaptic membrane,CC,
17039,GO:0099240,1.0000000000129,0.896728999804165,0,2,intrinsic component of synaptic membrane,CC,
17116,GO:0099699,1.0000000000129,0.896728999804165,0,2,integral component of synaptic membrane,CC,
20148,GO:2000809,1.0000000000129,0.896728999804165,0,2,positive regulation of synaptic vesicle clustering,BP,
11108,GO:0045112,1.00000000001291,0.880944467135911,0,3,integrin biosynthetic process,BP,
16215,GO:0090234,1.00000000001292,0.860591461404901,0,3,regulation of kinetochore assembly,BP,
4003,GO:0008934,1.00000000001294,0.825352792864588,0,4,inositol monophosphate 1-phosphatase activity,MF,
13444,GO:0052832,1.00000000001294,0.825352792864588,0,4,inositol monophosphate 3-phosphatase activity,MF,
13445,GO:0052833,1.00000000001294,0.825352792864588,0,4,inositol monophosphate 4-phosphatase activity,MF,
13446,GO:0052834,1.00000000001294,0.825352792864588,0,4,inositol monophosphate phosphatase activity,MF,
14447,GO:0061750,1.00000000001294,0.954959287203367,0,1,acid sphingomyelin phosphodiesterase activity,MF,
9223,GO:0035608,1.00000000001294,0.903737443455581,0,2,protein deglutamylation,BP,
11375,GO:0045726,1.00000000001294,0.946751572749965,0,1,positive regulation of integrin biosynthetic process,BP,
13241,GO:0051891,1.00000000001294,0.946751572749965,0,1,positive regulation of cardioblast differentiation,BP,
18538,GO:1903701,1.00000000001294,0.946751572749965,0,1,substantia propria of cornea development,BP,
1550,GO:0003943,1.00000000001294,0.905602314231737,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1851,GO:0004511,1.00000000001296,0.957118353825282,0,1,tyrosine 3-monooxygenase activity,MF,
3036,GO:0006585,1.00000000001296,0.957118353825282,0,1,dopamine biosynthetic process from tyrosine,BP,
8275,GO:0033076,1.00000000001296,0.957118353825282,0,1,isoquinoline alkaloid metabolic process,BP,
9029,GO:0035240,1.00000000001296,0.957118353825282,0,1,dopamine binding,MF,
9903,GO:0042214,1.00000000001296,0.957118353825282,0,1,terpene metabolic process,BP,
10006,GO:0042418,1.00000000001296,0.957118353825282,0,1,epinephrine biosynthetic process,BP,
13351,GO:0052314,1.00000000001296,0.957118353825282,0,1,phytoalexin metabolic process,BP,
9705,GO:0038101,1.00000000001296,0.958819255527689,0,1,sequestering of nodal from receptor via nodal binding,BP,
17394,GO:1900108,1.00000000001296,0.958819255527689,0,1,negative regulation of nodal signaling pathway,BP,
17421,GO:1900146,1.00000000001296,0.958819255527689,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17436,GO:1900176,1.00000000001296,0.958819255527689,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
11224,GO:0045349,1.00000000001297,0.833617860445521,0,4,interferon-alpha biosynthetic process,BP,
11229,GO:0045354,1.00000000001297,0.833617860445521,0,4,regulation of interferon-alpha biosynthetic process,BP,
17978,GO:1902338,1.00000000001297,0.856842572870095,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,
18986,GO:1904746,1.00000000001297,0.856842572870095,0,3,negative regulation of apoptotic process involved in development,BP,
4535,GO:0010603,1.00000000001297,0.687647404273939,0,7,regulation of cytoplasmic mRNA processing body assembly,BP,
12105,GO:0048075,1.00000000001298,0.94791290687291,0,1,positive regulation of eye pigmentation,BP,
19654,GO:1990812,1.00000000001298,0.860159804416827,0,3,growth cone filopodium,CC,
830,GO:0002114,1.00000000001298,0.949634485106247,0,1,interleukin-33 receptor activity,MF,
9731,GO:0038172,1.00000000001298,0.949634485106247,0,1,interleukin-33-mediated signaling pathway,BP,
12005,GO:0047389,1.00000000001299,0.901664918060439,0,2,glycerophosphocholine phosphodiesterase activity,MF,
8764,GO:0034433,1.000000000013,0.760393844273073,0,7,steroid esterification,BP,
8765,GO:0034434,1.000000000013,0.760393844273073,0,7,sterol esterification,BP,
8766,GO:0034435,1.000000000013,0.760393844273073,0,7,cholesterol esterification,BP,
15767,GO:0072345,1.000000000013,0.778754489973747,0,5,NAADP-sensitive calcium-release channel activity,MF,
3579,GO:0007624,1.000000000013,0.948376231403879,0,1,ultradian rhythm,BP,
251,GO:0000712,1.00000000001301,0.642954848940772,0,9,resolution of meiotic recombination intermediates,BP,
16761,GO:0098519,1.00000000001301,0.789471563253015,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
18737,GO:1904155,1.00000000001302,0.951752867413356,0,1,DN2 thymocyte differentiation,BP,
18738,GO:1904156,1.00000000001302,0.951752867413356,0,1,DN3 thymocyte differentiation,BP,
20151,GO:2000812,1.00000000001302,0.949335294421624,0,1,regulation of barbed-end actin filament capping,BP,
10299,GO:0043045,1.00000000001302,0.741909527837561,0,6,DNA methylation involved in embryo development,BP,
17691,GO:1901538,1.00000000001302,0.741909527837561,0,6,changes to DNA methylation involved in embryo development,BP,
4438,GO:0010286,1.00000000001302,0.815948394017601,0,5,heat acclimation,BP,
14728,GO:0070370,1.00000000001302,0.815948394017601,0,5,cellular heat acclimation,BP,
915,GO:0002299,1.00000000001302,0.961005161909519,0,1,alpha-beta intraepithelial T cell differentiation,BP,
916,GO:0002300,1.00000000001302,0.961005161909519,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
917,GO:0002304,1.00000000001302,0.961005161909519,0,1,gamma-delta intraepithelial T cell differentiation,BP,
918,GO:0002305,1.00000000001302,0.961005161909519,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
15019,GO:0070937,1.00000000001303,0.773905641265415,0,5,CRD-mediated mRNA stability complex,CC,
10002,GO:0042414,1.00000000001303,0.906072505521422,0,2,epinephrine metabolic process,BP,
19678,GO:1990889,1.00000000001303,0.957477321707091,0,1,H4K20me3 modified histone binding,MF,
9269,GO:0035686,1.00000000001304,0.890932664972634,0,3,sperm fibrous sheath,CC,
12553,GO:0050689,1.00000000001304,0.806631044681638,0,5,negative regulation of defense response to virus by host,BP,
5495,GO:0016427,1.00000000001305,0.68492214447241,0,8,tRNA (cytosine) methyltransferase activity,MF,
10851,GO:0044343,1.00000000001305,0.947564318030788,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
10853,GO:0044345,1.00000000001305,0.947564318030788,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
16224,GO:0090246,1.00000000001305,0.947564318030788,0,1,convergent extension involved in somitogenesis,BP,
19725,GO:2000040,1.00000000001305,0.947564318030788,0,1,regulation of planar cell polarity pathway involved in axis elongation,BP,
19726,GO:2000041,1.00000000001305,0.947564318030788,0,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
19736,GO:2000054,1.00000000001305,0.947564318030788,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19748,GO:2000079,1.00000000001305,0.947564318030788,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19749,GO:2000080,1.00000000001305,0.947564318030788,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20274,GO:2001201,1.00000000001306,0.896272974233261,0,2,regulation of transforming growth factor-beta secretion,BP,
5588,GO:0016602,1.00000000001307,0.834251099173623,0,4,CCAAT-binding factor complex,CC,
9565,GO:0036343,1.00000000001307,0.983870552469302,0,1,psychomotor behavior,BP,
13122,GO:0051643,1.00000000001307,0.767783379178233,0,5,endoplasmic reticulum localization,BP,
14452,GO:0061760,1.00000000001307,0.953433838177912,0,1,antifungal innate immune response,BP,
15147,GO:0071228,1.00000000001307,0.953433838177912,0,1,cellular response to tumor cell,BP,
19124,GO:1905034,1.00000000001307,0.953433838177912,0,1,regulation of antifungal innate immune response,BP,
19125,GO:1905035,1.00000000001307,0.953433838177912,0,1,negative regulation of antifungal innate immune response,BP,
5718,GO:0016846,1.00000000001307,0.775029262939189,0,7,carbon-sulfur lyase activity,MF,
1216,GO:0002883,1.00000000001308,0.872485754542498,0,3,regulation of hypersensitivity,BP,
2094,GO:0004856,1.00000000001308,0.950128643703801,0,1,xylulokinase activity,MF,
2657,GO:0005998,1.00000000001308,0.950128643703801,0,1,xylulose catabolic process,BP,
27,GO:0000052,1.00000000001308,0.707543142211657,0,7,citrulline metabolic process,BP,
8186,GO:0032919,1.00000000001309,0.972748420057014,0,1,spermine acetylation,BP,
8187,GO:0032920,1.00000000001309,0.972748420057014,0,1,putrescine acetylation,BP,
11610,GO:0046204,1.00000000001309,0.972748420057014,0,1,nor-spermidine metabolic process,BP,
12479,GO:0050313,1.00000000001309,0.972748420057014,0,1,sulfur dioxygenase activity,MF,
1276,GO:0003065,1.0000000000131,0.958164299646775,0,1,positive regulation of heart rate by epinephrine,BP,
4931,GO:0014883,1.0000000000131,0.824859213459268,0,4,transition between fast and slow fiber,BP,
8516,GO:0033693,1.00000000001311,0.861189581350482,0,3,neurofilament bundle assembly,BP,
4353,GO:0009918,1.00000000001312,0.954168338193331,0,1,sterol delta7 reductase activity,MF,
5127,GO:0015499,1.00000000001312,0.954168338193331,0,1,formate transmembrane transporter activity,MF,
5143,GO:0015660,1.00000000001312,0.954168338193331,0,1,formate efflux transmembrane transporter activity,MF,
5175,GO:0015724,1.00000000001312,0.954168338193331,0,1,formate transport,BP,
5203,GO:0015797,1.00000000001312,0.954168338193331,0,1,mannitol transport,BP,
5363,GO:0016131,1.00000000001312,0.954168338193331,0,1,brassinosteroid metabolic process,BP,
5364,GO:0016132,1.00000000001312,0.954168338193331,0,1,brassinosteroid biosynthetic process,BP,
11835,GO:0046724,1.00000000001312,0.954168338193331,0,1,oxalic acid secretion,BP,
12027,GO:0047598,1.00000000001312,0.954168338193331,0,1,7-dehydrocholesterol reductase activity,MF,
16029,GO:0086028,1.00000000001312,0.83739912418723,0,4,bundle of His cell to Purkinje myocyte signaling,BP,
16036,GO:0086043,1.00000000001312,0.83739912418723,0,4,bundle of His cell action potential,BP,
3844,GO:0008449,1.00000000001314,0.897626892005591,0,2,N-acetylglucosamine-6-sulfatase activity,MF,
19733,GO:2000051,1.00000000001314,0.80494515735309,0,4,negative regulation of non-canonical Wnt signaling pathway,BP,
10848,GO:0044340,1.00000000001315,0.782440535550126,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
6343,GO:0021513,1.00000000001315,0.695178171926476,0,7,spinal cord dorsal/ventral patterning,BP,
1508,GO:0003860,1.00000000001316,0.956935575157132,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
14114,GO:0060935,1.00000000001317,0.859036947411543,0,3,cardiac fibroblast cell differentiation,BP,
14115,GO:0060936,1.00000000001317,0.859036947411543,0,3,cardiac fibroblast cell development,BP,
14116,GO:0060938,1.00000000001317,0.859036947411543,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
14117,GO:0060939,1.00000000001317,0.859036947411543,0,3,epicardium-derived cardiac fibroblast cell development,BP,
14648,GO:0070213,1.00000000001318,0.8133509920625,0,4,protein auto-ADP-ribosylation,BP,
1564,GO:0003962,1.00000000001318,0.958645534239017,0,1,cystathionine gamma-synthase activity,MF,
1667,GO:0004123,1.00000000001318,0.958645534239017,0,1,cystathionine gamma-lyase activity,MF,
5948,GO:0018272,1.00000000001318,0.958645534239017,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
9372,GO:0035887,1.00000000001318,0.958645534239017,0,1,aortic smooth muscle cell differentiation,BP,
10922,GO:0044524,1.00000000001318,0.958645534239017,0,1,protein sulfhydration,BP,
10929,GO:0044540,1.00000000001318,0.958645534239017,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
12064,GO:0047982,1.00000000001318,0.958645534239017,0,1,homocysteine desulfhydrase activity,MF,
15166,GO:0071266,1.00000000001318,0.958645534239017,0,1,'de novo' L-methionine biosynthetic process,BP,
15994,GO:0080146,1.00000000001318,0.958645534239017,0,1,L-cysteine desulfhydrase activity,MF,
19029,GO:1904829,1.00000000001318,0.958645534239017,0,1,regulation of aortic smooth muscle cell differentiation,BP,
19030,GO:1904831,1.00000000001318,0.958645534239017,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
1515,GO:0003873,1.00000000001318,0.85331015096026,0,3,6-phosphofructo-2-kinase activity,MF,
2768,GO:0006183,1.00000000001318,0.730246022422408,0,9,GTP biosynthetic process,BP,
2144,GO:0004954,1.00000000001318,0.870150834929419,0,3,prostanoid receptor activity,MF,
14630,GO:0070189,1.00000000001319,0.840479114437885,0,4,kynurenine metabolic process,BP,
16889,GO:0098810,1.00000000001319,0.70887215749501,0,8,neurotransmitter reuptake,BP,
11963,GO:0047066,1.0000000000132,0.973327247783463,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
16727,GO:0097707,1.0000000000132,0.973327247783463,0,1,ferroptosis,BP,
17252,GO:0110075,1.0000000000132,0.973327247783463,0,1,regulation of ferroptosis,BP,
17253,GO:0110076,1.0000000000132,0.973327247783463,0,1,negative regulation of ferroptosis,BP,
11374,GO:0045725,1.00000000001321,0.615129986925838,0,9,positive regulation of glycogen biosynthetic process,BP,
7163,GO:0031021,1.00000000001321,0.887656464063263,0,3,interphase microtubule organizing center,CC,
14747,GO:0070407,1.00000000001322,0.952707869517632,0,1,oxidation-dependent protein catabolic process,BP,
1783,GO:0004394,1.00000000001323,0.948308723353955,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
14686,GO:0070291,1.00000000001323,0.824727827832075,0,4,N-acylethanolamine metabolic process,BP,
18196,GO:1902951,1.00000000001323,0.91199892132061,0,2,negative regulation of dendritic spine maintenance,BP,
19357,GO:1905664,1.00000000001323,0.91199892132061,0,2,regulation of calcium ion import across plasma membrane,BP,
754,GO:0001991,1.00000000001324,0.681645482728592,0,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
12218,GO:0048387,1.00000000001324,0.784659221254631,0,5,negative regulation of retinoic acid receptor signaling pathway,BP,
1635,GO:0004074,1.00000000001324,0.946216528941269,0,2,biliverdin reductase activity,MF,
15938,GO:0072710,1.00000000001325,0.632490436237568,0,9,response to hydroxyurea,BP,
1962,GO:0004663,1.00000000001325,0.837560383835112,0,4,Rab geranylgeranyltransferase activity,MF,
17024,GO:0099130,1.00000000001326,0.955307429607444,0,1,estrogen binding,MF,
18648,GO:1903924,1.00000000001326,0.955307429607444,0,1,estradiol binding,MF,
1380,GO:0003273,1.00000000001327,0.816064956328539,0,4,cell migration involved in endocardial cushion formation,BP,
16105,GO:0090070,1.00000000001327,0.696461779917116,0,8,positive regulation of ribosome biogenesis,BP,
19822,GO:2000234,1.00000000001327,0.696461779917116,0,8,positive regulation of rRNA processing,BP,
6382,GO:0021563,1.00000000001327,0.901371188702881,0,2,glossopharyngeal nerve development,BP,
9597,GO:0036449,1.00000000001328,0.691249506235732,0,7,microtubule minus-end,CC,
113,GO:0000235,1.00000000001328,0.666327010757211,0,8,astral microtubule,CC,
2551,GO:0005818,1.00000000001328,0.666327010757211,0,8,aster,CC,
1506,GO:0003857,1.0000000000133,0.685228576642687,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
11203,GO:0045298,1.0000000000133,0.83458093053417,0,4,tubulin complex,CC,
13133,GO:0051657,1.0000000000133,0.658829421653456,0,8,maintenance of organelle location,BP,
703,GO:0001920,1.00000000001331,0.861653621156642,0,3,negative regulation of receptor recycling,BP,
8279,GO:0033080,1.00000000001331,0.861483764993618,0,3,immature T cell proliferation in thymus,BP,
13665,GO:0060158,1.00000000001331,0.838875415837288,0,4,phospholipase C-activating dopamine receptor signaling pathway,BP,
17365,GO:1900041,1.00000000001332,0.865421293935687,0,3,negative regulation of interleukin-2 secretion,BP,
16112,GO:0090080,1.00000000001333,0.896182876048454,0,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
16390,GO:0090722,1.00000000001333,0.896182876048454,0,2,receptor-receptor interaction,MF,
19039,GO:1904849,1.00000000001333,0.896182876048454,0,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
19995,GO:2000546,1.00000000001333,0.896182876048454,0,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
840,GO:0002143,1.00000000001333,0.837223534534373,0,4,tRNA wobble position uridine thiolation,BP,
18198,GO:1902953,1.00000000001334,0.819954249053662,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
14319,GO:0061438,1.00000000001334,0.819826463647059,0,4,renal system vasculature morphogenesis,BP,
14320,GO:0061439,1.00000000001334,0.819826463647059,0,4,kidney vasculature morphogenesis,BP,
9447,GO:0036022,1.00000000001335,0.911226933803525,0,2,limb joint morphogenesis,BP,
9448,GO:0036023,1.00000000001335,0.911226933803525,0,2,embryonic skeletal limb joint morphogenesis,BP,
15968,GO:0075519,1.00000000001335,0.979603617831379,0,1,microtubule-dependent intracellular transport of viral material,BP,
15969,GO:0075521,1.00000000001335,0.979603617831379,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15973,GO:0075606,1.00000000001335,0.979603617831379,0,1,transport of viral material towards nucleus,BP,
15081,GO:0071031,1.00000000001335,0.925458985835628,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15093,GO:0071049,1.00000000001335,0.925458985835628,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
10767,GO:0044209,1.00000000001335,0.935506052024014,0,2,AMP salvage,BP,
7389,GO:0031437,1.00000000001336,0.86212465388025,0,3,regulation of mRNA cleavage,BP,
12303,GO:0048630,1.00000000001336,0.85725413279716,0,3,skeletal muscle tissue growth,BP,
12304,GO:0048631,1.00000000001336,0.85725413279716,0,3,regulation of skeletal muscle tissue growth,BP,
12305,GO:0048633,1.00000000001336,0.85725413279716,0,3,positive regulation of skeletal muscle tissue growth,BP,
18435,GO:1903463,1.00000000001337,0.861839384004646,0,3,regulation of mitotic cell cycle DNA replication,BP,
9207,GO:0035588,1.00000000001337,0.697559247745199,0,8,G-protein coupled purinergic receptor signaling pathway,BP,
5954,GO:0018298,1.00000000001337,0.861623745651507,0,3,protein-chromophore linkage,BP,
9528,GO:0036245,1.00000000001337,0.911268537697894,0,2,cellular response to menadione,BP,
3013,GO:0006558,1.00000000001337,0.866176280790396,0,4,L-phenylalanine metabolic process,BP,
3014,GO:0006559,1.00000000001337,0.866176280790396,0,4,L-phenylalanine catabolic process,BP,
17925,GO:1902221,1.00000000001337,0.866176280790396,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
17926,GO:1902222,1.00000000001337,0.866176280790396,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
4312,GO:0009786,1.00000000001338,0.91222228604559,0,2,regulation of asymmetric cell division,BP,
5247,GO:0015867,1.00000000001339,0.656860910683214,0,9,ATP transport,BP,
17131,GO:0102008,1.00000000001339,0.946851214007763,0,1,cytosolic dipeptidase activity,MF,
17192,GO:0103046,1.00000000001339,0.946851214007763,0,1,alanylglutamate dipeptidase activity,MF,
13014,GO:0051425,1.00000000001339,0.811621185133964,0,4,PTB domain binding,MF,
15208,GO:0071340,1.0000000000134,0.747430686449978,0,6,skeletal muscle acetylcholine-gated channel clustering,BP,
18536,GO:1903697,1.0000000000134,0.951709738740732,0,1,negative regulation of microvillus assembly,BP,
3032,GO:0006578,1.00000000001341,0.754593860802485,0,6,amino-acid betaine biosynthetic process,BP,
12708,GO:0050912,1.00000000001341,0.797515642111433,0,6,detection of chemical stimulus involved in sensory perception of taste,BP,
16496,GO:0097168,1.00000000001342,0.947348257527814,0,1,mesenchymal stem cell proliferation,BP,
18014,GO:1902460,1.00000000001342,0.947348257527814,0,1,regulation of mesenchymal stem cell proliferation,BP,
18015,GO:1902462,1.00000000001342,0.947348257527814,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
6060,GO:0019203,1.00000000001342,0.781062659045375,0,5,carbohydrate phosphatase activity,MF,
12477,GO:0050308,1.00000000001342,0.781062659045375,0,5,sugar-phosphatase activity,MF,
14171,GO:0061038,1.00000000001342,0.813589653143959,0,4,uterus morphogenesis,BP,
15131,GO:0071207,1.00000000001343,0.908288039604981,0,2,histone pre-mRNA stem-loop binding,MF,
854,GO:0002177,1.00000000001344,0.884267706376207,0,3,manchette,CC,
20049,GO:2000645,1.00000000001345,0.862112162991528,0,3,negative regulation of receptor catabolic process,BP,
10959,GO:0044691,1.00000000001346,0.898287804814686,0,2,tooth eruption,BP,
9276,GO:0035697,1.00000000001346,0.916383812139971,0,2,CD8-positive, alpha-beta T cell extravasation,BP,
9277,GO:0035698,1.00000000001346,0.916383812139971,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
15925,GO:0072683,1.00000000001346,0.916383812139971,0,2,T cell extravasation,BP,
19937,GO:2000407,1.00000000001346,0.916383812139971,0,2,regulation of T cell extravasation,BP,
19955,GO:2000449,1.00000000001346,0.916383812139971,0,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19957,GO:2000452,1.00000000001346,0.916383812139971,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
19203,GO:1905258,1.00000000001346,0.935816306872808,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19204,GO:1905259,1.00000000001346,0.935816306872808,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
18724,GO:1904098,1.00000000001348,0.86532017178735,0,3,regulation of protein O-linked glycosylation,BP,
18725,GO:1904100,1.00000000001348,0.86532017178735,0,3,positive regulation of protein O-linked glycosylation,BP,
2932,GO:0006449,1.00000000001348,0.713878737142406,0,7,regulation of translational termination,BP,
5825,GO:0017089,1.00000000001348,0.913390267044964,0,2,glycolipid transporter activity,MF,
12423,GO:0048859,1.00000000001348,0.920194820911974,0,2,formation of anatomical boundary,BP,
11140,GO:0045176,1.0000000000135,0.62645644989734,0,9,apical protein localization,BP,
17469,GO:1900245,1.0000000000135,0.855158115623239,0,3,positive regulation of MDA-5 signaling pathway,BP,
9644,GO:0036510,1.0000000000135,0.864271749112734,0,3,trimming of terminal mannose on C branch,BP,
10442,GO:0043293,1.00000000001351,0.907318191989703,0,2,apoptosome,CC,
8011,GO:0032634,1.00000000001351,0.670112148043973,0,8,interleukin-5 production,BP,
8035,GO:0032674,1.00000000001351,0.670112148043973,0,8,regulation of interleukin-5 production,BP,
2984,GO:0006527,1.00000000001351,0.664097833236495,0,9,arginine catabolic process,BP,
19312,GO:1905535,1.00000000001352,0.946737675873543,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19313,GO:1905537,1.00000000001352,0.946737675873543,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19344,GO:1905610,1.00000000001352,0.946737675873543,0,1,regulation of mRNA cap binding,BP,
19345,GO:1905612,1.00000000001352,0.946737675873543,0,1,positive regulation of mRNA cap binding,BP,
14574,GO:0070095,1.00000000001352,0.952494750106153,0,1,fructose-6-phosphate binding,MF,
16782,GO:0098574,1.00000000001353,0.825227510295244,0,4,cytoplasmic side of lysosomal membrane,CC,
20056,GO:2000653,1.00000000001353,0.858407280780921,0,3,regulation of genetic imprinting,BP,
2158,GO:0004979,1.00000000001354,0.957459900201269,0,1,beta-endorphin receptor activity,MF,
7477,GO:0031635,1.00000000001354,0.957459900201269,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7672,GO:0032097,1.00000000001354,0.957459900201269,0,1,positive regulation of response to food,BP,
7675,GO:0032100,1.00000000001354,0.957459900201269,0,1,positive regulation of appetite,BP,
9682,GO:0038047,1.00000000001354,0.957459900201269,0,1,morphine receptor activity,MF,
11728,GO:0046521,1.00000000001354,0.957459900201269,0,1,sphingoid catabolic process,BP,
14297,GO:0061358,1.00000000001354,0.957459900201269,0,1,negative regulation of Wnt protein secretion,BP,
9516,GO:0036179,1.00000000001355,0.953934220099256,0,1,osteoclast maturation,BP,
19747,GO:2000078,1.00000000001355,0.923849644435726,0,2,positive regulation of type B pancreatic cell development,BP,
20315,GO:2001270,1.00000000001355,0.837724751791267,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
13021,GO:0051434,1.00000000001356,0.840318966547503,0,4,BH3 domain binding,MF,
3629,GO:0008090,1.00000000001356,0.729420299180643,0,7,retrograde axonal transport,BP,
13092,GO:0051586,1.00000000001356,0.961219996065317,0,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13275,GO:0051944,1.00000000001356,0.961219996065317,0,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
4701,GO:0010856,1.00000000001356,0.95201567995072,0,1,adenylate cyclase activator activity,MF,
15125,GO:0071169,1.00000000001358,0.716372334418104,0,8,establishment of protein localization to chromatin,BP,
5310,GO:0016012,1.00000000001358,0.909113688464723,0,2,sarcoglycan complex,CC,
7390,GO:0031438,1.00000000001358,0.952903288031863,0,1,negative regulation of mRNA cleavage,BP,
12770,GO:0051025,1.00000000001358,0.952903288031863,0,1,negative regulation of immunoglobulin secretion,BP,
18976,GO:1904721,1.00000000001358,0.952903288031863,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
15028,GO:0070948,1.00000000001359,0.87473059715954,0,3,regulation of neutrophil mediated cytotoxicity,BP,
11187,GO:0045263,1.0000000000136,0.963719746957254,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
7376,GO:0031419,1.0000000000136,0.754309260209528,0,6,cobalamin binding,MF,
3849,GO:0008456,1.00000000001361,0.949985677247515,0,1,alpha-N-acetylgalactosaminidase activity,MF,
9639,GO:0036505,1.00000000001361,0.953349159747009,0,1,prosaposin receptor activity,MF,
8350,GO:0033204,1.00000000001361,0.95454649248599,0,1,ribonuclease P RNA binding,MF,
17758,GO:1901679,1.00000000001361,0.689813403028088,0,8,nucleotide transmembrane transport,BP,
14472,GO:0061821,1.00000000001362,0.807779487421775,0,4,telomeric D-loop binding,MF,
4016,GO:0009008,1.00000000001362,0.781869095733242,0,5,DNA-methyltransferase activity,MF,
6371,GO:0021548,1.00000000001363,0.776692892368774,0,5,pons development,BP,
2813,GO:0006272,1.00000000001364,0.86459281567866,0,3,leading strand elongation,BP,
11460,GO:0045903,1.00000000001364,0.905217797689921,0,3,positive regulation of translational fidelity,BP,
5921,GO:0018192,1.00000000001364,0.954615848795196,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
7885,GO:0032447,1.00000000001364,0.954615848795196,0,1,protein urmylation,BP,
9943,GO:0042292,1.00000000001364,0.954615848795196,0,1,URM1 activating enzyme activity,MF,
14379,GO:0061604,1.00000000001364,0.954615848795196,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14380,GO:0061605,1.00000000001364,0.954615848795196,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
16895,GO:0098822,1.00000000001364,0.954615848795196,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
11641,GO:0046338,1.00000000001365,0.90713368102848,0,2,phosphatidylethanolamine catabolic process,BP,
4956,GO:0015016,1.00000000001365,0.898244195275916,0,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
12455,GO:0050119,1.00000000001365,0.898244195275916,0,2,N-acetylglucosamine deacetylase activity,MF,
3929,GO:0008607,1.00000000001365,0.87164545428144,0,3,phosphorylase kinase regulator activity,MF,
5062,GO:0015269,1.00000000001366,0.723381522687409,0,7,calcium-activated potassium channel activity,MF,
9060,GO:0035281,1.00000000001366,0.918534610739936,0,2,pre-miRNA export from nucleus,BP,
10074,GO:0042565,1.00000000001366,0.918534610739936,0,2,RNA nuclear export complex,CC,
5678,GO:0016784,1.00000000001366,0.962352415638693,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6265,GO:0019853,1.00000000001366,0.962352415638693,0,1,L-ascorbic acid biosynthetic process,BP,
6709,GO:0030108,1.00000000001366,0.962352415638693,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7845,GO:0032397,1.00000000001366,0.962352415638693,0,1,activating MHC class I receptor activity,MF,
10219,GO:0042839,1.00000000001366,0.962352415638693,0,1,D-glucuronate metabolic process,BP,
10220,GO:0042840,1.00000000001366,0.962352415638693,0,1,D-glucuronate catabolic process,BP,
12062,GO:0047939,1.00000000001366,0.962352415638693,0,1,L-glucuronate reductase activity,MF,
4631,GO:0010749,1.00000000001366,0.855282368458958,0,3,regulation of nitric oxide mediated signal transduction,BP,
13621,GO:0060077,1.00000000001367,0.635355550022341,0,9,inhibitory synapse,CC,
9406,GO:0035962,1.00000000001367,0.949505213147705,0,1,response to interleukin-13,BP,
9407,GO:0035963,1.00000000001367,0.949505213147705,0,1,cellular response to interleukin-13,BP,
12473,GO:0050277,1.00000000001367,0.949505213147705,0,1,sedoheptulokinase activity,MF,
15540,GO:0071914,1.00000000001367,0.949505213147705,0,1,prominosome,CC,
19855,GO:2000298,1.00000000001367,0.908615386765418,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
7373,GO:0031416,1.00000000001368,0.918639115468301,0,2,NatB complex,CC,
5461,GO:0016333,1.00000000001368,0.953391844974856,0,1,morphogenesis of follicular epithelium,BP,
5462,GO:0016334,1.00000000001368,0.953391844974856,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
9915,GO:0042247,1.00000000001368,0.953391844974856,0,1,establishment of planar polarity of follicular epithelium,BP,
10125,GO:0042643,1.00000000001368,0.953391844974856,0,1,actomyosin, actin portion,CC,
4599,GO:0010711,1.00000000001369,0.977537457206765,0,1,negative regulation of collagen catabolic process,BP,
13751,GO:0060309,1.00000000001369,0.977537457206765,0,1,elastin catabolic process,BP,
13752,GO:0060310,1.00000000001369,0.977537457206765,0,1,regulation of elastin catabolic process,BP,
13753,GO:0060311,1.00000000001369,0.977537457206765,0,1,negative regulation of elastin catabolic process,BP,
3978,GO:0008794,1.00000000001369,0.974060467618327,0,1,arsenate reductase (glutaredoxin) activity,MF,
6963,GO:0030611,1.00000000001369,0.974060467618327,0,1,arsenate reductase activity,MF,
3991,GO:0008859,1.0000000000137,0.972964662044835,0,1,exoribonuclease II activity,MF,
14002,GO:0060700,1.0000000000137,0.658189390025698,0,9,regulation of ribonuclease activity,BP,
19464,GO:1990074,1.0000000000137,0.950954001010184,0,1,polyuridylation-dependent mRNA catabolic process,BP,
58,GO:0000121,1.0000000000137,0.952667074898837,0,1,glycerol-1-phosphatase activity,MF,
10343,GO:0043136,1.0000000000137,0.952667074898837,0,1,glycerol-3-phosphatase activity,MF,
12581,GO:0050720,1.0000000000137,0.952667074898837,0,1,interleukin-1 beta biosynthetic process,BP,
12583,GO:0050722,1.0000000000137,0.952667074898837,0,1,regulation of interleukin-1 beta biosynthetic process,BP,
12584,GO:0050725,1.0000000000137,0.952667074898837,0,1,positive regulation of interleukin-1 beta biosynthetic process,BP,
15743,GO:0072303,1.0000000000137,0.952667074898837,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
18169,GO:1902897,1.00000000001371,0.906633540212084,0,2,regulation of postsynaptic density protein 95 clustering,BP,
19404,GO:1905874,1.00000000001371,0.906633540212084,0,2,regulation of postsynaptic density organization,BP,
3146,GO:0006741,1.00000000001371,0.82844169229107,0,4,NADP biosynthetic process,BP,
3205,GO:0006842,1.00000000001372,0.822823520914525,0,4,tricarboxylic acid transport,BP,
5000,GO:0015137,1.00000000001372,0.822823520914525,0,4,citrate transmembrane transporter activity,MF,
5003,GO:0015142,1.00000000001372,0.822823520914525,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5186,GO:0015746,1.00000000001372,0.822823520914525,0,4,citrate transport,BP,
17180,GO:0102758,1.00000000001372,0.968086271793617,0,1,very-long-chain enoyl-CoA reductase activity,MF,
1921,GO:0004611,1.00000000001373,0.956659039222198,0,1,phosphoenolpyruvate carboxykinase activity,MF,
1922,GO:0004613,1.00000000001373,0.956659039222198,0,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
6180,GO:0019543,1.00000000001373,0.956659039222198,0,1,propionate catabolic process,BP,
11633,GO:0046327,1.00000000001373,0.956659039222198,0,1,glycerol biosynthetic process from pyruvate,BP,
19563,GO:1990452,1.00000000001373,0.904600954456173,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
2381,GO:0005513,1.00000000001374,0.72364459777389,0,7,detection of calcium ion,BP,
7078,GO:0030862,1.00000000001375,0.946676538889556,0,1,positive regulation of polarized epithelial cell differentiation,BP,
9749,GO:0039007,1.00000000001375,0.946676538889556,0,1,pronephric nephron morphogenesis,BP,
9750,GO:0039008,1.00000000001375,0.946676538889556,0,1,pronephric nephron tubule morphogenesis,BP,
9753,GO:0039020,1.00000000001375,0.946676538889556,0,1,pronephric nephron tubule development,BP,
9754,GO:0039022,1.00000000001375,0.946676538889556,0,1,pronephric duct development,BP,
9755,GO:0039023,1.00000000001375,0.946676538889556,0,1,pronephric duct morphogenesis,BP,
14588,GO:0070121,1.00000000001375,0.946676538889556,0,1,Kupffer's vesicle development,BP,
15638,GO:0072114,1.00000000001375,0.946676538889556,0,1,pronephros morphogenesis,BP,
3129,GO:0006710,1.00000000001375,0.957373869703834,0,1,androgen catabolic process,BP,
6243,GO:0019798,1.00000000001375,0.75370722414009,0,6,procollagen-proline dioxygenase activity,MF,
10983,GO:0044771,1.00000000001375,0.908476957120661,0,2,meiotic cell cycle phase transition,BP,
17848,GO:1901993,1.00000000001375,0.908476957120661,0,2,regulation of meiotic cell cycle phase transition,BP,
17849,GO:1901994,1.00000000001375,0.908476957120661,0,2,negative regulation of meiotic cell cycle phase transition,BP,
9384,GO:0035912,1.00000000001375,0.819520180099614,0,4,dorsal aorta morphogenesis,BP,
625,GO:0001806,1.00000000001375,0.878153506934702,0,3,type IV hypersensitivity,BP,
19649,GO:1990785,1.00000000001375,0.853253994700364,0,3,response to water-immersion restraint stress,BP,
10769,GO:0044211,1.00000000001376,0.884622326425525,0,3,CTP salvage,BP,
8738,GO:0034384,1.00000000001376,0.7918392932047,0,5,high-density lipoprotein particle clearance,BP,
7907,GO:0032471,1.00000000001377,0.752799402724809,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
11151,GO:0045188,1.00000000001377,0.910084047772858,0,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
3011,GO:0006556,1.00000000001378,0.911732997275749,0,2,S-adenosylmethionine biosynthetic process,BP,
12170,GO:0048269,1.00000000001378,0.911732997275749,0,2,methionine adenosyltransferase complex,CC,
14614,GO:0070166,1.00000000001378,0.633629248222552,0,9,enamel mineralization,BP,
8827,GO:0034602,1.00000000001379,0.947923000440565,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9275,GO:0035695,1.00000000001379,0.947923000440565,0,1,mitophagy by induced vacuole formation,BP,
14167,GO:0061034,1.00000000001379,0.947923000440565,0,1,olfactory bulb mitral cell layer development,BP,
8635,GO:0034154,1.00000000001381,0.821161657270793,0,4,toll-like receptor 7 signaling pathway,BP,
16783,GO:0098575,1.00000000001381,0.913402726122915,0,2,lumenal side of lysosomal membrane,CC,
16074,GO:0089717,1.00000000001381,0.768673657044361,0,5,spanning component of membrane,CC,
16255,GO:0090296,1.00000000001382,0.830217839615907,0,4,regulation of mitochondrial DNA replication,BP,
17801,GO:1901858,1.00000000001382,0.830217839615907,0,4,regulation of mitochondrial DNA metabolic process,BP,
9074,GO:0035312,1.00000000001382,0.742818547493578,0,6,5'-3' exodeoxyribonuclease activity,MF,
12041,GO:0047710,1.00000000001382,0.969884782756686,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
1185,GO:0002829,1.00000000001383,0.686526923517861,0,8,negative regulation of type 2 immune response,BP,
15012,GO:0070926,1.00000000001383,0.94939279005528,0,1,regulation of ATP:ADP antiporter activity,BP,
9794,GO:0040009,1.00000000001384,0.81025114415158,0,4,regulation of growth rate,BP,
1505,GO:0003854,1.00000000001384,0.875351576844586,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
8487,GO:0033632,1.00000000001385,0.794610011675563,0,5,regulation of cell-cell adhesion mediated by integrin,BP,
1734,GO:0004326,1.00000000001385,0.954529256681368,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
3988,GO:0008841,1.00000000001385,0.954529256681368,0,1,dihydrofolate synthase activity,MF,
11896,GO:0046901,1.00000000001385,0.954529256681368,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
4031,GO:0009061,1.00000000001385,0.954758817173297,0,1,anaerobic respiration,BP,
11191,GO:0045274,1.00000000001385,0.954758817173297,0,1,plasma membrane respiratory chain complex II,CC,
11195,GO:0045282,1.00000000001385,0.954758817173297,0,1,plasma membrane succinate dehydrogenase complex,CC,
5812,GO:0017062,1.00000000001386,0.667876768871765,0,9,respiratory chain complex III assembly,BP,
8814,GO:0034551,1.00000000001386,0.667876768871765,0,9,mitochondrial respiratory chain complex III assembly,BP,
7840,GO:0032389,1.00000000001387,0.710881603659185,0,7,MutLalpha complex,CC,
12681,GO:0050872,1.00000000001387,0.642425979733005,0,9,white fat cell differentiation,BP,
1458,GO:0003691,1.0000000000139,0.653149361013677,0,9,double-stranded telomeric DNA binding,MF,
2034,GO:0004771,1.00000000001391,0.777139766070186,0,5,sterol esterase activity,MF,
6402,GO:0021604,1.00000000001391,0.781276513212227,0,5,cranial nerve structural organization,BP,
6404,GO:0021612,1.00000000001391,0.781276513212227,0,5,facial nerve structural organization,BP,
12981,GO:0051350,1.00000000001392,0.661990012259196,0,9,negative regulation of lyase activity,BP,
10244,GO:0042954,1.00000000001392,0.77754151238196,0,5,lipoprotein transporter activity,MF,
1140,GO:0002729,1.00000000001392,0.925056462261846,0,2,positive regulation of natural killer cell cytokine production,BP,
18510,GO:1903621,1.00000000001392,0.956816332007016,0,1,protein localization to photoreceptor connecting cilium,BP,
5908,GO:0018117,1.00000000001393,0.959794032940688,0,1,protein adenylylation,BP,
5920,GO:0018175,1.00000000001393,0.959794032940688,0,1,protein nucleotidylation,BP,
10945,GO:0044601,1.00000000001393,0.959794032940688,0,1,protein denucleotidylation,BP,
10946,GO:0044602,1.00000000001393,0.959794032940688,0,1,protein deadenylylation,BP,
10947,GO:0044603,1.00000000001393,0.959794032940688,0,1,protein adenylylhydrolase activity,MF,
14918,GO:0070733,1.00000000001393,0.959794032940688,0,1,protein adenylyltransferase activity,MF,
14823,GO:0070545,1.00000000001394,0.825053164091093,0,4,PeBoW complex,CC,
6483,GO:0021822,1.00000000001395,0.955661569906938,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
17537,GO:1901004,1.00000000001395,0.965980406964992,0,1,ubiquinone-6 metabolic process,BP,
17538,GO:1901006,1.00000000001395,0.965980406964992,0,1,ubiquinone-6 biosynthetic process,BP,
6079,GO:0019227,1.00000000001396,0.87162651729974,0,3,neuronal action potential propagation,BP,
16920,GO:0098870,1.00000000001396,0.87162651729974,0,3,action potential propagation,BP,
2576,GO:0005861,1.00000000001396,0.900185153603283,0,3,troponin complex,CC,
14454,GO:0061763,1.000000000014,0.909898729899856,0,2,multivesicular body-lysosome fusion,BP,
15397,GO:0071633,1.00000000001401,0.953670403936507,0,1,dihydroceramidase activity,MF,
9629,GO:0036493,1.00000000001401,0.86528590633143,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
4616,GO:0010730,1.00000000001403,0.857444391922884,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
249,GO:0000707,1.00000000001403,0.700154865335319,0,8,meiotic DNA recombinase assembly,BP,
9187,GO:0035562,1.00000000001404,0.663552603845072,0,8,negative regulation of chromatin binding,BP,
9917,GO:0042253,1.00000000001404,0.91710330923708,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
1937,GO:0004633,1.00000000001404,0.955326710559792,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
1956,GO:0004657,1.00000000001404,0.955326710559792,0,1,proline dehydrogenase activity,MF,
19578,GO:1990535,1.00000000001404,0.81316431780792,0,4,neuron projection maintenance,BP,
17099,GO:0099617,1.00000000001405,0.951517869254338,0,1,matrix side of mitochondrial inner membrane,CC,
2185,GO:0005034,1.00000000001407,0.952565912092683,0,1,osmosensor activity,MF,
6707,GO:0030103,1.00000000001407,0.952565912092683,0,1,vasopressin secretion,BP,
16648,GO:0097497,1.00000000001407,0.952565912092683,0,1,blood vessel endothelial cell delamination,BP,
18430,GO:1903444,1.00000000001407,0.952565912092683,0,1,negative regulation of brown fat cell differentiation,BP,
18565,GO:1903759,1.00000000001407,0.952565912092683,0,1,signal transduction involved in regulation of aerobic respiration,BP,
9730,GO:0038171,1.00000000001407,0.817157668493513,0,4,cannabinoid signaling pathway,BP,
15545,GO:0071926,1.00000000001407,0.817157668493513,0,4,endocannabinoid signaling pathway,BP,
15846,GO:0072537,1.00000000001408,0.784865983334501,0,5,fibroblast activation,BP,
5398,GO:0016231,1.00000000001408,0.946780638827369,0,1,beta-N-acetylglucosaminidase activity,MF,
17142,GO:0102166,1.00000000001408,0.946780638827369,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17143,GO:0102167,1.00000000001408,0.946780638827369,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17174,GO:0102571,1.00000000001408,0.946780638827369,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
15177,GO:0071285,1.00000000001408,0.711682282376031,0,7,cellular response to lithium ion,BP,
271,GO:0000773,1.00000000001408,0.972058429566737,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
1918,GO:0004608,1.00000000001408,0.972058429566737,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
11959,GO:0047035,1.00000000001408,0.972058429566737,0,1,testosterone dehydrogenase (NAD+) activity,MF,
15985,GO:0080101,1.00000000001408,0.972058429566737,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
3005,GO:0006550,1.00000000001409,0.917603346779505,0,2,isoleucine catabolic process,BP,
4919,GO:0014854,1.00000000001409,0.677083935771897,0,8,response to inactivity,BP,
2771,GO:0006189,1.00000000001409,0.748829904091423,0,6,'de novo' IMP biosynthetic process,BP,
12350,GO:0048702,1.0000000000141,0.703008214874803,0,7,embryonic neurocranium morphogenesis,BP,
11705,GO:0046485,1.0000000000141,0.722750890387849,0,7,ether lipid metabolic process,BP,
527,GO:0001635,1.00000000001411,0.880037191344992,0,3,calcitonin gene-related peptide receptor activity,MF,
16706,GO:0097642,1.00000000001411,0.880037191344992,0,3,calcitonin family receptor activity,MF,
3393,GO:0007172,1.00000000001411,0.704132231861511,0,7,signal complex assembly,BP,
5900,GO:0018095,1.00000000001412,0.675155612978589,0,8,protein polyglutamylation,BP,
19517,GO:1990275,1.00000000001412,0.953571231736863,0,1,preribosome binding,MF,
14616,GO:0070168,1.00000000001413,0.699944708821056,0,7,negative regulation of biomineral tissue development,BP,
1653,GO:0004098,1.00000000001413,0.957134338067222,0,1,cerebroside-sulfatase activity,MF,
3476,GO:0007320,1.00000000001413,0.811996981843306,0,4,insemination,BP,
1244,GO:0002934,1.00000000001413,0.628450967399684,0,9,desmosome organization,BP,
18059,GO:1902570,1.00000000001414,0.681939493517022,0,9,protein localization to nucleolus,BP,
191,GO:0000408,1.00000000001416,0.818373090387428,0,5,EKC/KEOPS complex,CC,
18959,GO:1904693,1.00000000001417,0.853476631282723,0,3,midbrain morphogenesis,BP,
4538,GO:0010606,1.00000000001417,0.76455486317354,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
823,GO:0002093,1.00000000001419,0.714526183570857,0,7,auditory receptor cell morphogenesis,BP,
782,GO:0002037,1.00000000001419,0.955740288929774,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
14856,GO:0070601,1.00000000001421,0.691463807995732,0,8,centromeric sister chromatid cohesion,BP,
2725,GO:0006102,1.00000000001421,0.806530575108951,0,5,isocitrate metabolic process,BP,
20065,GO:2000663,1.00000000001421,0.950414337725985,0,1,negative regulation of interleukin-5 secretion,BP,
12619,GO:0050785,1.00000000001422,0.964680471255032,0,1,advanced glycation end-product receptor activity,MF,
18923,GO:1904596,1.00000000001422,0.964680471255032,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18924,GO:1904597,1.00000000001422,0.964680471255032,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18925,GO:1904599,1.00000000001422,0.964680471255032,0,1,advanced glycation end-product binding,MF,
18926,GO:1904603,1.00000000001422,0.964680471255032,0,1,regulation of advanced glycation end-product receptor activity,BP,
18927,GO:1904604,1.00000000001422,0.964680471255032,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
19184,GO:1905204,1.00000000001422,0.964680471255032,0,1,negative regulation of connective tissue replacement,BP,
12225,GO:0048406,1.00000000001422,0.813037198842242,0,4,nerve growth factor binding,MF,
15793,GO:0072385,1.00000000001422,0.811163272749314,0,4,minus-end-directed organelle transport along microtubule,BP,
10312,GO:0043084,1.00000000001422,0.821892950149585,0,4,penile erection,BP,
7333,GO:0031339,1.00000000001423,0.861217249073203,0,3,negative regulation of vesicle fusion,BP,
1620,GO:0004046,1.00000000001424,0.87841065381834,0,3,aminoacylase activity,MF,
2413,GO:0005584,1.00000000001425,0.896195137459297,0,2,collagen type I trimer,CC,
3574,GO:0007619,1.00000000001425,0.86500424061199,0,3,courtship behavior,BP,
19137,GO:1905051,1.00000000001425,0.935187293525074,0,2,regulation of base-excision repair,BP,
19138,GO:1905053,1.00000000001425,0.935187293525074,0,2,positive regulation of base-excision repair,BP,
8719,GO:0034363,1.00000000001425,0.967917032108117,0,1,intermediate-density lipoprotein particle,CC,
8721,GO:0034365,1.00000000001425,0.967917032108117,0,1,discoidal high-density lipoprotein particle,CC,
8727,GO:0034371,1.00000000001425,0.967917032108117,0,1,chylomicron remodeling,BP,
11901,GO:0046911,1.00000000001425,0.967917032108117,0,1,metal chelating activity,MF,
16394,GO:0090731,1.00000000001425,0.967917032108117,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17731,GO:1901630,1.00000000001425,0.967917032108117,0,1,negative regulation of presynaptic membrane organization,BP,
18225,GO:1903000,1.00000000001425,0.967917032108117,0,1,regulation of lipid transport across blood brain barrier,BP,
18226,GO:1903002,1.00000000001425,0.967917032108117,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19398,GO:1905853,1.00000000001425,0.967917032108117,0,1,regulation of heparan sulfate binding,BP,
19399,GO:1905855,1.00000000001425,0.967917032108117,0,1,positive regulation of heparan sulfate binding,BP,
19400,GO:1905858,1.00000000001425,0.967917032108117,0,1,regulation of heparan sulfate proteoglycan binding,BP,
19401,GO:1905860,1.00000000001425,0.967917032108117,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
19409,GO:1905890,1.00000000001425,0.967917032108117,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
4363,GO:0009956,1.00000000001425,0.949212047963557,0,1,radial pattern formation,BP,
14083,GO:0060849,1.00000000001425,0.949212047963557,0,1,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
1259,GO:0003010,1.00000000001426,0.919883190191098,0,2,voluntary skeletal muscle contraction,BP,
4871,GO:0014721,1.00000000001426,0.919883190191098,0,2,twitch skeletal muscle contraction,BP,
8636,GO:0034155,1.00000000001426,0.950972544270407,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
8637,GO:0034157,1.00000000001426,0.950972544270407,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
5232,GO:0015842,1.00000000001426,0.916079969747319,0,2,aminergic neurotransmitter loading into synaptic vesicle,BP,
16833,GO:0098700,1.00000000001426,0.916079969747319,0,2,neurotransmitter loading into synaptic vesicle,BP,
6272,GO:0019862,1.00000000001427,0.960910140945522,0,1,IgA binding,MF,
5874,GO:0017182,1.00000000001428,0.653235736424063,0,9,peptidyl-diphthamide metabolic process,BP,
5875,GO:0017183,1.00000000001428,0.653235736424063,0,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
296,GO:0000800,1.00000000001429,0.696640113337032,0,7,lateral element,CC,
16430,GO:0097055,1.00000000001429,0.911025545501548,0,2,agmatine biosynthetic process,BP,
17580,GO:1901162,1.00000000001429,0.911025545501548,0,2,primary amino compound biosynthetic process,BP,
18139,GO:1902809,1.0000000000143,0.868549425546126,0,3,regulation of skeletal muscle fiber differentiation,BP,
8460,GO:0033596,1.00000000001431,0.851935399767009,0,3,TSC1-TSC2 complex,CC,
145,GO:0000296,1.00000000001431,0.955073017511612,0,1,spermine transport,BP,
19783,GO:2000156,1.00000000001431,0.905345615995108,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
233,GO:0000481,1.00000000001431,0.950501369955332,0,1,maturation of 5S rRNA,BP,
10845,GO:0044336,1.00000000001432,0.85953085094987,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
106,GO:0000220,1.00000000001433,0.807556659083664,0,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
8422,GO:0033489,1.00000000001433,0.835234361887745,0,4,cholesterol biosynthetic process via desmosterol,BP,
8423,GO:0033490,1.00000000001433,0.835234361887745,0,4,cholesterol biosynthetic process via lathosterol,BP,
1539,GO:0003921,1.00000000001434,0.954589674170941,0,1,GMP synthase activity,MF,
1540,GO:0003922,1.00000000001434,0.954589674170941,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
9306,GO:0035749,1.00000000001435,0.784962307767502,0,5,myelin sheath adaxonal region,CC,
4384,GO:0010032,1.00000000001436,0.761258230026355,0,5,meiotic chromosome condensation,BP,
4634,GO:0010752,1.00000000001436,0.897266677137826,0,2,regulation of cGMP-mediated signaling,BP,
1614,GO:0004034,1.00000000001437,0.954545338853811,0,1,aldose 1-epimerase activity,MF,
9402,GO:0035945,1.00000000001437,0.954545338853811,0,1,mitochondrial ncRNA surveillance,BP,
9403,GO:0035946,1.00000000001437,0.954545338853811,0,1,mitochondrial mRNA surveillance,BP,
15076,GO:0071026,1.00000000001437,0.954545338853811,0,1,cytoplasmic RNA surveillance,BP,
20160,GO:2000827,1.00000000001437,0.954545338853811,0,1,mitochondrial RNA surveillance,BP,
2038,GO:0004775,1.00000000001437,0.919767791221478,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
12783,GO:0051045,1.00000000001438,0.71518928166931,0,7,negative regulation of membrane protein ectodomain proteolysis,BP,
5385,GO:0016199,1.00000000001439,0.807504131792697,0,4,axon midline choice point recognition,BP,
11801,GO:0046657,1.00000000001439,0.923242615326305,0,2,folic acid catabolic process,BP,
7886,GO:0032449,1.00000000001439,0.785384767906104,0,5,CBM complex,CC,
19198,GO:1905244,1.0000000000144,0.666410438661053,0,8,regulation of modification of synaptic structure,BP,
8521,GO:0033743,1.0000000000144,0.835445287187315,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
57,GO:0000120,1.00000000001441,0.799064429728576,0,5,RNA polymerase I transcription factor complex,CC,
17481,GO:1900275,1.00000000001442,0.900573141154277,0,2,negative regulation of phospholipase C activity,BP,
15860,GO:0072560,1.00000000001442,0.952691587155195,0,1,type B pancreatic cell maturation,BP,
1551,GO:0003944,1.00000000001444,0.955373929456054,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
6660,GO:0030007,1.00000000001444,0.703467588938984,0,7,cellular potassium ion homeostasis,BP,
7963,GO:0032557,1.00000000001444,0.863426724842927,0,3,pyrimidine ribonucleotide binding,MF,
10581,GO:0043541,1.00000000001445,0.9053761301297,0,2,UDP-N-acetylglucosamine transferase complex,CC,
4989,GO:0015112,1.00000000001446,0.954173859527331,0,1,nitrate transmembrane transporter activity,MF,
5167,GO:0015706,1.00000000001446,0.954173859527331,0,1,nitrate transport,BP,
2855,GO:0006343,1.00000000001446,0.949490529448457,0,1,establishment of chromatin silencing,BP,
10097,GO:0042595,1.00000000001446,0.949490529448457,0,1,behavioral response to starvation,BP,
15278,GO:0071441,1.00000000001446,0.949490529448457,0,1,negative regulation of histone H3-K14 acetylation,BP,
20057,GO:2000654,1.00000000001446,0.949490529448457,0,1,regulation of cellular response to testosterone stimulus,BP,
20058,GO:2000655,1.00000000001446,0.949490529448457,0,1,negative regulation of cellular response to testosterone stimulus,BP,
3403,GO:0007185,1.00000000001446,0.80312614995254,0,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
5419,GO:0016262,1.00000000001446,0.864247662354965,0,3,protein N-acetylglucosaminyltransferase activity,MF,
18326,GO:1903232,1.00000000001447,0.823603901746686,0,5,melanosome assembly,BP,
1297,GO:0003127,1.00000000001447,0.946818099934684,0,1,detection of nodal flow,BP,
15293,GO:0071464,1.00000000001447,0.946818099934684,0,1,cellular response to hydrostatic pressure,BP,
15598,GO:0072055,1.00000000001447,0.946818099934684,0,1,renal cortex development,BP,
15599,GO:0072059,1.00000000001447,0.946818099934684,0,1,cortical collecting duct development,BP,
15685,GO:0072194,1.00000000001447,0.946818099934684,0,1,kidney smooth muscle tissue development,BP,
15696,GO:0072208,1.00000000001447,0.946818099934684,0,1,metanephric smooth muscle tissue development,BP,
15700,GO:0072214,1.00000000001447,0.946818099934684,0,1,metanephric cortex development,BP,
15705,GO:0072219,1.00000000001447,0.946818099934684,0,1,metanephric cortical collecting duct development,BP,
15990,GO:0080129,1.00000000001447,0.969784235512692,0,1,proteasome core complex assembly,BP,
1912,GO:0004597,1.00000000001448,0.950421196220466,0,1,peptide-aspartate beta-dioxygenase activity,MF,
5594,GO:0016615,1.00000000001449,0.767973498195735,0,6,malate dehydrogenase activity,MF,
4005,GO:0008941,1.0000000000145,0.913235401646268,0,2,nitric oxide dioxygenase activity,MF,
5633,GO:0016708,1.0000000000145,0.913235401646268,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
13215,GO:0051823,1.00000000001451,0.829947524878382,0,4,regulation of synapse structural plasticity,BP,
15536,GO:0071907,1.00000000001452,0.866065490052399,0,3,determination of digestive tract left/right asymmetry,BP,
1516,GO:0003874,1.00000000001453,0.973497379168999,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
5960,GO:0018323,1.00000000001453,0.973497379168999,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
8690,GO:0034309,1.00000000001453,0.973497379168999,0,1,primary alcohol biosynthetic process,BP,
9610,GO:0036470,1.00000000001453,0.973497379168999,0,1,tyrosine 3-monooxygenase activator activity,MF,
9611,GO:0036471,1.00000000001453,0.973497379168999,0,1,cellular response to glyoxal,BP,
9617,GO:0036478,1.00000000001453,0.973497379168999,0,1,L-dopa decarboxylase activator activity,MF,
9652,GO:0036524,1.00000000001453,0.973497379168999,0,1,protein deglycase activity,MF,
9653,GO:0036525,1.00000000001453,0.973497379168999,0,1,protein deglycation,BP,
9654,GO:0036526,1.00000000001453,0.973497379168999,0,1,peptidyl-cysteine deglycation,BP,
9655,GO:0036527,1.00000000001453,0.973497379168999,0,1,peptidyl-arginine deglycation,BP,
9656,GO:0036528,1.00000000001453,0.973497379168999,0,1,peptidyl-lysine deglycation,BP,
9657,GO:0036529,1.00000000001453,0.973497379168999,0,1,protein deglycation, glyoxal removal,BP,
9658,GO:0036530,1.00000000001453,0.973497379168999,0,1,protein deglycation, methylglyoxal removal,BP,
9659,GO:0036531,1.00000000001453,0.973497379168999,0,1,glutathione deglycation,BP,
11216,GO:0045340,1.00000000001453,0.973497379168999,0,1,mercury ion binding,MF,
11621,GO:0046295,1.00000000001453,0.973497379168999,0,1,glycolate biosynthetic process,BP,
17214,GO:0106044,1.00000000001453,0.973497379168999,0,1,guanine deglycation,BP,
17215,GO:0106045,1.00000000001453,0.973497379168999,0,1,guanine deglycation, methylglyoxal removal,BP,
17216,GO:0106046,1.00000000001453,0.973497379168999,0,1,guanine deglycation, glyoxal removal,BP,
17299,GO:0140041,1.00000000001453,0.973497379168999,0,1,cellular detoxification of methylglyoxal,BP,
18267,GO:1903072,1.00000000001453,0.973497379168999,0,1,regulation of death-inducing signaling complex assembly,BP,
18268,GO:1903073,1.00000000001453,0.973497379168999,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18282,GO:1903122,1.00000000001453,0.973497379168999,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18294,GO:1903167,1.00000000001453,0.973497379168999,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18295,GO:1903168,1.00000000001453,0.973497379168999,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18299,GO:1903176,1.00000000001453,0.973497379168999,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18300,GO:1903178,1.00000000001453,0.973497379168999,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18304,GO:1903184,1.00000000001453,0.973497379168999,0,1,L-dopa metabolic process,BP,
18305,GO:1903185,1.00000000001453,0.973497379168999,0,1,L-dopa biosynthetic process,BP,
18306,GO:1903189,1.00000000001453,0.973497379168999,0,1,glyoxal metabolic process,BP,
18307,GO:1903195,1.00000000001453,0.973497379168999,0,1,regulation of L-dopa biosynthetic process,BP,
18308,GO:1903197,1.00000000001453,0.973497379168999,0,1,positive regulation of L-dopa biosynthetic process,BP,
18309,GO:1903198,1.00000000001453,0.973497379168999,0,1,regulation of L-dopa decarboxylase activity,BP,
18310,GO:1903200,1.00000000001453,0.973497379168999,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19843,GO:2000277,1.00000000001453,0.973497379168999,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19849,GO:2000284,1.00000000001453,0.973497379168999,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
5492,GO:0016422,1.00000000001454,0.871942086231581,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
3529,GO:0007512,1.00000000001454,0.786454032230031,0,5,adult heart development,BP,
2009,GO:0004730,1.00000000001455,0.959563452251854,0,1,pseudouridylate synthase activity,MF,
15001,GO:0070902,1.00000000001455,0.959563452251854,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
10408,GO:0043237,1.00000000001456,0.806532049363294,0,4,laminin-1 binding,MF,
3995,GO:0008890,1.00000000001456,0.960679654058598,0,1,glycine C-acetyltransferase activity,MF,
6168,GO:0019518,1.00000000001456,0.960679654058598,0,1,L-threonine catabolic process to glycine,BP,
12208,GO:0048369,1.00000000001456,0.899774312418114,0,2,lateral mesoderm morphogenesis,BP,
12209,GO:0048370,1.00000000001456,0.899774312418114,0,2,lateral mesoderm formation,BP,
12210,GO:0048371,1.00000000001456,0.899774312418114,0,2,lateral mesodermal cell differentiation,BP,
12211,GO:0048372,1.00000000001456,0.899774312418114,0,2,lateral mesodermal cell fate commitment,BP,
12212,GO:0048377,1.00000000001456,0.899774312418114,0,2,lateral mesodermal cell fate specification,BP,
12213,GO:0048378,1.00000000001456,0.899774312418114,0,2,regulation of lateral mesodermal cell fate specification,BP,
8749,GO:0034397,1.00000000001457,0.636187983206009,0,9,telomere localization,BP,
18832,GO:1904381,1.00000000001457,0.897868912531847,0,2,Golgi apparatus mannose trimming,BP,
19864,GO:2000310,1.00000000001457,0.635875293665194,0,9,regulation of NMDA receptor activity,BP,
15504,GO:0071863,1.00000000001457,0.814768140166639,0,4,regulation of cell proliferation in bone marrow,BP,
15505,GO:0071864,1.00000000001457,0.814768140166639,0,4,positive regulation of cell proliferation in bone marrow,BP,
4881,GO:0014740,1.00000000001458,0.910124863499745,0,2,negative regulation of muscle hyperplasia,BP,
8402,GO:0033328,1.00000000001458,0.950494487063891,0,1,peroxisome membrane targeting sequence binding,MF,
9478,GO:0036105,1.00000000001458,0.950494487063891,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
17411,GO:1900130,1.00000000001458,0.950494487063891,0,1,regulation of lipid binding,BP,
17412,GO:1900131,1.00000000001458,0.950494487063891,0,1,negative regulation of lipid binding,BP,
15335,GO:0071541,1.00000000001458,0.74950717450271,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
6976,GO:0030627,1.0000000000146,0.922666768313194,0,2,pre-mRNA 5'-splice site binding,MF,
13293,GO:0051967,1.0000000000146,0.878884995791759,0,3,negative regulation of synaptic transmission, glutamatergic,BP,
19262,GO:1905395,1.0000000000146,0.92702029341535,0,2,response to flavonoid,BP,
13617,GO:0060073,1.0000000000146,0.812077916726175,0,4,micturition,BP,
12165,GO:0048263,1.00000000001461,0.844784985495421,0,4,determination of dorsal identity,BP,
476,GO:0001519,1.00000000001462,0.949983456889504,0,1,peptide amidation,BP,
1848,GO:0004504,1.00000000001462,0.949983456889504,0,1,peptidylglycine monooxygenase activity,MF,
1913,GO:0004598,1.00000000001462,0.949983456889504,0,1,peptidylamidoglycolate lyase activity,MF,
5894,GO:0018032,1.00000000001462,0.949983456889504,0,1,protein amidation,BP,
7250,GO:0031179,1.00000000001462,0.949983456889504,0,1,peptide modification,BP,
15039,GO:0070970,1.00000000001462,0.664243601589248,0,8,interleukin-2 secretion,BP,
8605,GO:0034112,1.00000000001463,0.81891644072164,0,5,positive regulation of homotypic cell-cell adhesion,BP,
16221,GO:0090241,1.00000000001463,0.834220812121613,0,4,negative regulation of histone H4 acetylation,BP,
9297,GO:0035733,1.00000000001464,0.824966854060344,0,4,hepatic stellate cell activation,BP,
7552,GO:0031849,1.00000000001464,0.949857648050096,0,1,olfactory receptor binding,MF,
10617,GO:0043602,1.00000000001464,0.954488444129879,0,1,nitrate catabolic process,BP,
11613,GO:0046210,1.00000000001464,0.954488444129879,0,1,nitric oxide catabolic process,BP,
12043,GO:0047726,1.00000000001464,0.954488444129879,0,1,iron-cytochrome-c reductase activity,MF,
16291,GO:0090345,1.00000000001464,0.954488444129879,0,1,cellular organohalogen metabolic process,BP,
16292,GO:0090346,1.00000000001464,0.954488444129879,0,1,cellular organofluorine metabolic process,BP,
4879,GO:0014738,1.00000000001465,0.867604238462467,0,3,regulation of muscle hyperplasia,BP,
1636,GO:0004075,1.00000000001466,0.855311675772115,0,3,biotin carboxylase activity,MF,
18728,GO:1904116,1.00000000001467,0.859786801025272,0,3,response to vasopressin,BP,
18729,GO:1904117,1.00000000001467,0.859786801025272,0,3,cellular response to vasopressin,BP,
9227,GO:0035612,1.0000000000147,0.665067682507115,0,8,AP-2 adaptor complex binding,MF,
13802,GO:0060374,1.00000000001471,0.858986756422859,0,3,mast cell differentiation,BP,
4905,GO:0014831,1.00000000001471,0.83873211485004,0,4,gastro-intestinal system smooth muscle contraction,BP,
12128,GO:0048172,1.00000000001472,0.699916410133396,0,7,regulation of short-term neuronal synaptic plasticity,BP,
17910,GO:1902178,1.00000000001472,0.947940795720498,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
2440,GO:0005638,1.00000000001472,0.825374796614176,0,4,lamin filament,CC,
17486,GO:1900368,1.00000000001473,0.889008720339927,0,3,regulation of RNA interference,BP,
11065,GO:0045054,1.00000000001473,0.86943084866278,0,3,constitutive secretory pathway,BP,
14941,GO:0070782,1.00000000001473,0.955590387994529,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
8767,GO:0034436,1.00000000001473,0.880822451681373,0,3,glycoprotein transport,BP,
16596,GO:0097384,1.00000000001473,0.72444504053875,0,7,cellular lipid biosynthetic process,BP,
1766,GO:0004366,1.00000000001474,0.783196263191287,0,5,glycerol-3-phosphate O-acyltransferase activity,MF,
13642,GO:0060123,1.00000000001475,0.808107098253655,0,4,regulation of growth hormone secretion,BP,
6535,GO:0021934,1.00000000001475,0.896183055219779,0,2,hindbrain tangential cell migration,BP,
6536,GO:0021935,1.00000000001475,0.896183055219779,0,2,cerebellar granule cell precursor tangential migration,BP,
294,GO:0000798,1.00000000001476,0.860361734303633,0,3,nuclear cohesin complex,CC,
18234,GO:1903012,1.00000000001476,0.823510066241133,0,4,positive regulation of bone development,BP,
1825,GO:0004475,1.00000000001476,0.96038456399379,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
4002,GO:0008905,1.00000000001476,0.96038456399379,0,1,mannose-phosphate guanylyltransferase activity,MF,
10265,GO:0043000,1.00000000001476,0.912116921104549,0,2,Golgi to plasma membrane CFTR protein transport,BP,
14896,GO:0070676,1.00000000001478,0.881761439710014,0,3,intralumenal vesicle formation,BP,
10396,GO:0043224,1.00000000001478,0.945634178064739,0,2,nuclear SCF ubiquitin ligase complex,CC,
11047,GO:0045016,1.00000000001479,0.951736990822469,0,1,mitochondrial magnesium ion transmembrane transport,BP,
6101,GO:0019317,1.00000000001479,0.737613207171045,0,6,fucose catabolic process,BP,
9970,GO:0042354,1.00000000001479,0.737613207171045,0,6,L-fucose metabolic process,BP,
9971,GO:0042355,1.00000000001479,0.737613207171045,0,6,L-fucose catabolic process,BP,
8273,GO:0033063,1.00000000001479,0.734282820358062,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
19521,GO:1990316,1.0000000000148,0.663401987703907,0,8,Atg1/ULK1 kinase complex,CC,
11729,GO:0046523,1.0000000000148,0.952774522408439,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
17255,GO:0110096,1.0000000000148,0.827319435431461,0,5,cellular response to aldehyde,BP,
18385,GO:1903365,1.0000000000148,0.872944729244708,0,3,regulation of fear response,BP,
20156,GO:2000822,1.0000000000148,0.872944729244708,0,3,regulation of behavioral fear response,BP,
8401,GO:0033327,1.00000000001481,0.74923803904646,0,6,Leydig cell differentiation,BP,
16424,GO:0097045,1.00000000001481,0.947060298963903,0,1,phosphatidylserine exposure on blood platelet,BP,
17966,GO:1902304,1.00000000001481,0.947060298963903,0,1,positive regulation of potassium ion export,BP,
9243,GO:0035634,1.00000000001481,0.976836293750951,0,1,response to stilbenoid,BP,
2693,GO:0006055,1.00000000001483,0.966637582167713,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
11659,GO:0046381,1.00000000001483,0.966637582167713,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12011,GO:0047444,1.00000000001483,0.966637582167713,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12500,GO:0050462,1.00000000001483,0.966637582167713,0,1,N-acetylneuraminate synthase activity,MF,
14360,GO:0061549,1.00000000001483,0.734550864622834,0,6,sympathetic ganglion development,BP,
3184,GO:0006808,1.00000000001484,0.927237669997494,0,2,regulation of nitrogen utilization,BP,
11805,GO:0046666,1.00000000001484,0.927237669997494,0,2,retinal cell programmed cell death,BP,
2062,GO:0004813,1.00000000001484,0.862676696547979,0,3,alanine-tRNA ligase activity,MF,
2909,GO:0006419,1.00000000001484,0.862676696547979,0,3,alanyl-tRNA aminoacylation,BP,
6800,GO:0030237,1.00000000001484,0.905089323848033,0,2,female sex determination,BP,
4988,GO:0015111,1.00000000001485,0.8534877727623,0,3,iodide transmembrane transporter activity,MF,
8866,GO:0034663,1.00000000001486,0.669985596912576,0,9,endoplasmic reticulum chaperone complex,CC,
15959,GO:0075044,1.00000000001486,0.808040009411429,0,4,autophagy of host cells involved in interaction with symbiont,BP,
15960,GO:0075071,1.00000000001486,0.808040009411429,0,4,autophagy involved in symbiotic interaction,BP,
1525,GO:0003886,1.00000000001486,0.851693722580552,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
8098,GO:0032776,1.00000000001486,0.851693722580552,0,3,DNA methylation on cytosine,BP,
16138,GO:0090116,1.00000000001486,0.851693722580552,0,3,C-5 methylation of cytosine,BP,
7515,GO:0031694,1.00000000001487,0.969011728508361,0,1,alpha-2A adrenergic receptor binding,MF,
17590,GO:1901193,1.00000000001487,0.969011728508361,0,1,regulation of formation of translation preinitiation complex,BP,
17591,GO:1901194,1.00000000001487,0.969011728508361,0,1,negative regulation of formation of translation preinitiation complex,BP,
18956,GO:1904689,1.00000000001487,0.969011728508361,0,1,negative regulation of cytoplasmic translational initiation,BP,
14685,GO:0070290,1.00000000001487,0.776235206432843,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
1035,GO:0002541,1.00000000001488,0.912948000883867,0,2,activation of plasma proteins involved in acute inflammatory response,BP,
1373,GO:0003256,1.00000000001488,0.856828121080429,0,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1796,GO:0004422,1.00000000001489,0.921826438741334,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
2766,GO:0006178,1.00000000001489,0.921826438741334,0,2,guanine salvage,BP,
7753,GO:0032263,1.00000000001489,0.921826438741334,0,2,GMP salvage,BP,
11566,GO:0046099,1.00000000001489,0.921826438741334,0,2,guanine biosynthetic process,BP,
1867,GO:0004528,1.00000000001489,0.830754792110638,0,4,phosphodiesterase I activity,MF,
2451,GO:0005658,1.00000000001489,0.753073535883387,0,6,alpha DNA polymerase:primase complex,CC,
4696,GO:0010847,1.00000000001491,0.818043890485245,0,4,regulation of chromatin assembly,BP,
5576,GO:0016589,1.00000000001491,0.714785908118455,0,7,NURF complex,CC,
13798,GO:0060370,1.00000000001492,0.946671303047434,0,1,susceptibility to T cell mediated cytotoxicity,BP,
1971,GO:0004677,1.00000000001492,0.854717675146466,0,3,DNA-dependent protein kinase activity,MF,
11061,GO:0045046,1.00000000001492,0.747244544449375,0,6,protein import into peroxisome membrane,BP,
19963,GO:2000467,1.00000000001493,0.856358304619985,0,3,positive regulation of glycogen (starch) synthase activity,BP,
11649,GO:0046356,1.00000000001493,0.928559258412004,0,2,acetyl-CoA catabolic process,BP,
8543,GO:0033867,1.00000000001493,0.959846146986164,0,1,Fas-activated serine/threonine kinase activity,MF,
11750,GO:0046577,1.00000000001495,0.94981605803734,0,1,long-chain-alcohol oxidase activity,MF,
4854,GO:0014063,1.00000000001495,0.968107492265707,0,1,negative regulation of serotonin secretion,BP,
17699,GO:1901563,1.00000000001496,0.776269833613393,0,5,response to camptothecin,BP,
1205,GO:0002862,1.00000000001497,0.867869491236769,0,4,negative regulation of inflammatory response to antigenic stimulus,BP,
9381,GO:0035907,1.00000000001497,0.780211301348734,0,5,dorsal aorta development,BP,
1755,GO:0004352,1.00000000001498,0.95110698065911,0,1,glutamate dehydrogenase (NAD+) activity,MF,
1756,GO:0004353,1.00000000001498,0.95110698065911,0,1,glutamate dehydrogenase [NAD(P)+] activity,MF,
5605,GO:0016639,1.00000000001498,0.95110698065911,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
19805,GO:2000199,1.00000000001498,0.95280454019337,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19806,GO:2000200,1.00000000001498,0.95280454019337,0,1,regulation of ribosomal subunit export from nucleus,BP,
19807,GO:2000202,1.00000000001498,0.95280454019337,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19808,GO:2000206,1.00000000001498,0.95280454019337,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19809,GO:2000208,1.00000000001498,0.95280454019337,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
1037,GO:0002543,1.00000000001498,0.904327184628668,0,2,activation of blood coagulation via clotting cascade,BP,
80,GO:0000160,1.000000000015,0.899399759583701,0,2,phosphorelay signal transduction system,BP,
16216,GO:0090235,1.00000000001501,0.695296875550345,0,7,regulation of metaphase plate congression,BP,
8622,GO:0034137,1.00000000001501,0.895283830130314,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
9854,GO:0042097,1.00000000001502,0.908417947006399,0,2,interleukin-4 biosynthetic process,BP,
11240,GO:0045402,1.00000000001502,0.908417947006399,0,2,regulation of interleukin-4 biosynthetic process,BP,
5831,GO:0017102,1.00000000001502,0.909180402808547,0,2,methionyl glutamyl tRNA synthetase complex,CC,
5432,GO:0016282,1.00000000001502,0.947507018751139,0,1,eukaryotic 43S preinitiation complex,CC,
13326,GO:0052150,1.00000000001503,0.792985928974776,0,5,modulation by symbiont of host apoptotic process,BP,
2263,GO:0005175,1.00000000001503,0.980250890396388,0,1,CD27 receptor binding,MF,
14943,GO:0070814,1.00000000001504,0.833411895530463,0,4,hydrogen sulfide biosynthetic process,BP,
16659,GO:0097512,1.00000000001504,0.979764944475214,0,1,cardiac myofibril,CC,
19979,GO:2000508,1.00000000001505,0.841768758992925,0,4,regulation of dendritic cell chemotaxis,BP,
19980,GO:2000510,1.00000000001505,0.841768758992925,0,4,positive regulation of dendritic cell chemotaxis,BP,
4644,GO:0010763,1.00000000001505,0.634073131575966,0,9,positive regulation of fibroblast migration,BP,
9944,GO:0042296,1.00000000001506,0.847994440045721,0,4,ISG15 transferase activity,MF,
301,GO:0000808,1.00000000001506,0.65095191214514,0,9,origin recognition complex,CC,
2454,GO:0005664,1.00000000001506,0.65095191214514,0,9,nuclear origin of replication recognition complex,CC,
15065,GO:0071006,1.00000000001506,0.868009210428646,0,3,U2-type catalytic step 1 spliceosome,CC,
19324,GO:1905572,1.00000000001506,0.953720142437046,0,1,ganglioside GM1 transport to membrane,BP,
19326,GO:1905574,1.00000000001506,0.953720142437046,0,1,ganglioside GM2 binding,MF,
19327,GO:1905575,1.00000000001506,0.953720142437046,0,1,ganglioside GM3 binding,MF,
19329,GO:1905577,1.00000000001506,0.953720142437046,0,1,ganglioside GP1c binding,MF,
15411,GO:0071651,1.00000000001508,0.81353941942352,0,4,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
10849,GO:0044341,1.00000000001509,0.857984022962542,0,3,sodium-dependent phosphate transport,BP,
926,GO:0002318,1.00000000001511,0.865322363865678,0,3,myeloid progenitor cell differentiation,BP,
18692,GO:1904021,1.00000000001512,0.951435140496586,0,1,negative regulation of G-protein coupled receptor internalization,BP,
10811,GO:0044294,1.00000000001513,0.697231445652738,0,7,dendritic growth cone,CC,
14367,GO:0061574,1.00000000001513,0.865160563424715,0,3,ASAP complex,CC,
9416,GO:0035977,1.00000000001513,0.818169383176915,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
12778,GO:0051036,1.00000000001513,0.799622679395897,0,5,regulation of endosome size,BP,
16631,GO:0097466,1.00000000001513,0.818169383176915,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
18833,GO:1904382,1.00000000001513,0.818169383176915,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
18917,GO:1904587,1.00000000001513,0.818169383176915,0,4,response to glycoprotein,BP,
2742,GO:0006121,1.00000000001514,0.849614597424207,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
5208,GO:0015803,1.00000000001514,0.863532466677527,0,3,branched-chain amino acid transport,BP,
13179,GO:0051754,1.00000000001514,0.862435237631447,0,3,meiotic sister chromatid cohesion, centromeric,BP,
15381,GO:0071608,1.00000000001514,0.825798144411601,0,4,macrophage inflammatory protein-1 alpha production,BP,
15404,GO:0071640,1.00000000001514,0.825798144411601,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
4995,GO:0015127,1.00000000001514,0.946810364546125,0,1,bilirubin transmembrane transporter activity,MF,
5159,GO:0015694,1.00000000001514,0.946810364546125,0,1,mercury ion transport,BP,
5174,GO:0015723,1.00000000001514,0.946810364546125,0,1,bilirubin transport,BP,
6984,GO:0030653,1.00000000001514,0.946810364546125,0,1,beta-lactam antibiotic metabolic process,BP,
9955,GO:0042316,1.00000000001514,0.946810364546125,0,1,penicillin metabolic process,BP,
17562,GO:1901086,1.00000000001514,0.946810364546125,0,1,benzylpenicillin metabolic process,BP,
7408,GO:0031467,1.00000000001514,0.809561535443008,0,5,Cul7-RING ubiquitin ligase complex,CC,
8143,GO:0032847,1.00000000001515,0.911068819524025,0,2,regulation of cellular pH reduction,BP,
1810,GO:0004454,1.00000000001515,0.954704567895528,0,1,ketohexokinase activity,MF,
7861,GO:0032417,1.00000000001515,0.90512433116233,0,2,positive regulation of sodium:proton antiporter activity,BP,
2631,GO:0005955,1.00000000001517,0.814141957226057,0,4,calcineurin complex,CC,
14014,GO:0060715,1.00000000001517,0.86358508902252,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
10470,GO:0043328,1.00000000001518,0.863500436721036,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
14268,GO:0061304,1.00000000001518,0.803298553396587,0,4,retinal blood vessel morphogenesis,BP,
19465,GO:1990075,1.00000000001519,0.859570705802754,0,3,periciliary membrane compartment,CC,
3843,GO:0008448,1.0000000000152,0.957724282978327,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4213,GO:0009353,1.0000000000152,0.964960817468845,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
7434,GO:0031531,1.0000000000152,0.964960817468845,0,1,thyrotropin-releasing hormone receptor binding,MF,
7746,GO:0032241,1.00000000001521,0.701086063531487,0,7,positive regulation of nucleobase-containing compound transport,BP,
11861,GO:0046833,1.00000000001521,0.701086063531487,0,7,positive regulation of RNA export from nucleus,BP,
18640,GO:1903911,1.00000000001521,0.86340650372739,0,3,positive regulation of receptor clustering,BP,
13900,GO:0060525,1.00000000001523,0.652741705411621,0,8,prostate glandular acinus development,BP,
13006,GO:0051409,1.00000000001524,0.677259771550207,0,9,response to nitrosative stress,BP,
10530,GO:0043461,1.00000000001525,0.835797974275347,0,4,proton-transporting ATP synthase complex assembly,BP,
7946,GO:0032530,1.00000000001526,0.636782159875115,0,9,regulation of microvillus organization,BP,
7021,GO:0030729,1.00000000001527,0.95179135969804,0,1,acetoacetate-CoA ligase activity,MF,
12050,GO:0047760,1.00000000001527,0.95179135969804,0,1,butyrate-CoA ligase activity,MF,
3606,GO:0008046,1.00000000001527,0.804608753213813,0,4,axon guidance receptor activity,MF,
5091,GO:0015347,1.00000000001527,0.636875761118893,0,9,sodium-independent organic anion transmembrane transporter activity,MF,
3899,GO:0008534,1.00000000001528,0.867798821240508,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
19682,GO:1990910,1.0000000000153,0.88583359944951,0,3,response to hypobaric hypoxia,BP,
13074,GO:0051561,1.00000000001531,0.677363055782521,0,9,positive regulation of mitochondrial calcium ion concentration,BP,
3089,GO:0006662,1.00000000001531,0.686666111517689,0,9,glycerol ether metabolic process,BP,
12462,GO:0050152,1.00000000001532,0.965941122549866,0,1,omega-amidase activity,MF,
9456,GO:0036046,1.00000000001532,0.952592915234241,0,1,protein demalonylation,BP,
9457,GO:0036047,1.00000000001532,0.952592915234241,0,1,peptidyl-lysine demalonylation,BP,
9458,GO:0036048,1.00000000001532,0.952592915234241,0,1,protein desuccinylation,BP,
9459,GO:0036049,1.00000000001532,0.952592915234241,0,1,peptidyl-lysine desuccinylation,BP,
9460,GO:0036054,1.00000000001532,0.952592915234241,0,1,protein-malonyllysine demalonylase activity,MF,
9461,GO:0036055,1.00000000001532,0.952592915234241,0,1,protein-succinyllysine desuccinylase activity,MF,
14421,GO:0061697,1.00000000001532,0.952592915234241,0,1,protein-glutaryllysine deglutarylase activity,MF,
14422,GO:0061698,1.00000000001532,0.952592915234241,0,1,protein deglutarylation,BP,
14423,GO:0061699,1.00000000001532,0.952592915234241,0,1,peptidyl-lysine deglutarylation,BP,
11544,GO:0046061,1.00000000001532,0.896459810327183,0,3,dATP catabolic process,BP,
14072,GO:0060836,1.00000000001533,0.811534393867674,0,4,lymphatic endothelial cell differentiation,BP,
336,GO:0000931,1.00000000001533,0.665980700376425,0,8,gamma-tubulin large complex,CC,
3738,GO:0008274,1.00000000001533,0.665980700376425,0,8,gamma-tubulin ring complex,CC,
2324,GO:0005330,1.00000000001534,0.947419453771728,0,1,dopamine:sodium symporter activity,MF,
2326,GO:0005335,1.00000000001534,0.947419453771728,0,1,serotonin:sodium symporter activity,MF,
4855,GO:0014064,1.00000000001534,0.947419453771728,0,1,positive regulation of serotonin secretion,BP,
6249,GO:0019811,1.00000000001534,0.947419453771728,0,1,cocaine binding,MF,
6541,GO:0021941,1.00000000001534,0.947419453771728,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
16102,GO:0090067,1.00000000001534,0.947419453771728,0,1,regulation of thalamus size,BP,
14027,GO:0060734,1.00000000001534,0.947228514399778,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19705,GO:2000002,1.00000000001534,0.788881866446822,0,5,negative regulation of DNA damage checkpoint,BP,
13202,GO:0051795,1.00000000001537,0.884069739503498,0,3,positive regulation of timing of catagen,BP,
11006,GO:0044806,1.00000000001537,0.69267782976261,0,7,G-quadruplex DNA unwinding,BP,
1629,GO:0004062,1.00000000001539,0.856996634705352,0,4,aryl sulfotransferase activity,MF,
3766,GO:0008309,1.00000000001539,0.837248097161637,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
3778,GO:0008331,1.0000000000154,0.866356895910386,0,3,high voltage-gated calcium channel activity,MF,
6678,GO:0030035,1.00000000001541,0.855007467625888,0,3,microspike assembly,BP,
5239,GO:0015853,1.00000000001541,0.846987551617558,0,4,adenine transport,BP,
14987,GO:0070885,1.00000000001542,0.861156232862657,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
17220,GO:0106057,1.00000000001542,0.861156232862657,0,3,negative regulation of calcineurin-mediated signaling,BP,
4680,GO:0010825,1.00000000001543,0.736783557966729,0,6,positive regulation of centrosome duplication,BP,
7344,GO:0031362,1.00000000001544,0.664095707171324,0,9,anchored component of external side of plasma membrane,CC,
13198,GO:0051791,1.00000000001545,0.728759958348313,0,7,medium-chain fatty acid metabolic process,BP,
13460,GO:0052858,1.00000000001545,0.950680923823713,0,1,peptidyl-lysine acetyltransferase activity,MF,
20010,GO:2000576,1.00000000001546,0.823876567482895,0,5,positive regulation of microtubule motor activity,BP,
14446,GO:0061749,1.00000000001546,0.896886596349124,0,2,forked DNA-dependent helicase activity,MF,
14483,GO:0061849,1.00000000001546,0.896886596349124,0,2,telomeric G-quadruplex DNA binding,MF,
3383,GO:0007161,1.00000000001548,0.811487871157739,0,4,calcium-independent cell-matrix adhesion,BP,
979,GO:0002430,1.00000000001549,0.955074662412499,0,1,complement receptor mediated signaling pathway,BP,
1930,GO:0004621,1.00000000001549,0.955074662412499,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2969,GO:0006507,1.00000000001549,0.955074662412499,0,1,GPI anchor release,BP,
4736,GO:0010897,1.00000000001549,0.955074662412499,0,1,negative regulation of triglyceride catabolic process,BP,
8564,GO:0034014,1.00000000001549,0.955074662412499,0,1,response to triglyceride,BP,
15254,GO:0071401,1.00000000001549,0.955074662412499,0,1,cellular response to triglyceride,BP,
17745,GO:1901660,1.00000000001549,0.7386990330345,0,6,calcium ion export,BP,
11745,GO:0046548,1.00000000001549,0.863463071474778,0,3,retinal rod cell development,BP,
11446,GO:0045869,1.0000000000155,0.728969992539006,0,7,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
8709,GO:0034346,1.0000000000155,0.95303795972415,0,1,positive regulation of type III interferon production,BP,
8589,GO:0034085,1.00000000001551,0.707965750249644,0,7,establishment of sister chromatid cohesion,BP,
13055,GO:0051499,1.00000000001551,0.91942813933135,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13056,GO:0051500,1.00000000001551,0.91942813933135,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
14756,GO:0070419,1.00000000001551,0.711355667410027,0,7,nonhomologous end joining complex,CC,
4632,GO:0010750,1.00000000001553,0.954371599421752,0,1,positive regulation of nitric oxide mediated signal transduction,BP,
8459,GO:0033594,1.00000000001553,0.954371599421752,0,1,response to hydroxyisoflavone,BP,
10270,GO:0043006,1.00000000001553,0.954371599421752,0,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
16643,GO:0097489,1.00000000001553,0.954371599421752,0,1,multivesicular body, internal vesicle lumen,CC,
16263,GO:0090306,1.00000000001554,0.819136941891705,0,4,spindle assembly involved in meiosis,BP,
2110,GO:0004886,1.00000000001554,0.902740196792762,0,2,9-cis retinoic acid receptor activity,MF,
8153,GO:0032876,1.00000000001556,0.807379205502961,0,4,negative regulation of DNA endoreduplication,BP,
10386,GO:0043203,1.00000000001556,0.771700015475264,0,6,axon hillock,CC,
6306,GO:0019919,1.00000000001559,0.727161091935229,0,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
9031,GO:0035242,1.00000000001559,0.727161091935229,0,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,
6905,GO:0030473,1.00000000001559,0.76718737369051,0,5,nuclear migration along microtubule,BP,
3609,GO:0008049,1.0000000000156,0.957102437534958,0,1,male courtship behavior,BP,
3853,GO:0008460,1.0000000000156,0.957102437534958,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
10721,GO:0044035,1.00000000001561,0.959944712639791,0,1,multi-organism catabolic process,BP,
10748,GO:0044115,1.00000000001561,0.959944712639791,0,1,development of symbiont involved in interaction with host,BP,
10755,GO:0044145,1.00000000001561,0.959944712639791,0,1,modulation of development of symbiont involved in interaction with host,BP,
10757,GO:0044147,1.00000000001561,0.959944712639791,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
10972,GO:0044730,1.00000000001561,0.959944712639791,0,1,bone sialoprotein binding,MF,
13339,GO:0052214,1.00000000001561,0.959944712639791,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
13340,GO:0052227,1.00000000001561,0.959944712639791,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
13341,GO:0052229,1.00000000001561,0.959944712639791,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
13353,GO:0052360,1.00000000001561,0.959944712639791,0,1,catabolism by host of symbiont macromolecule,BP,
13354,GO:0052361,1.00000000001561,0.959944712639791,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
13355,GO:0052362,1.00000000001561,0.959944712639791,0,1,catabolism by host of symbiont protein,BP,
13356,GO:0052363,1.00000000001561,0.959944712639791,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13357,GO:0052364,1.00000000001561,0.959944712639791,0,1,catabolism by host of substance in symbiont,BP,
13362,GO:0052416,1.00000000001561,0.959944712639791,0,1,metabolism by host of symbiont macromolecule,BP,
13363,GO:0052417,1.00000000001561,0.959944712639791,0,1,metabolism by host of symbiont protein,BP,
13364,GO:0052418,1.00000000001561,0.959944712639791,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13365,GO:0052419,1.00000000001561,0.959944712639791,0,1,metabolism by host of substance in symbiont,BP,
19332,GO:1905581,1.00000000001561,0.959944712639791,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
19337,GO:1905597,1.00000000001561,0.959944712639791,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
19339,GO:1905599,1.00000000001561,0.959944712639791,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20279,GO:2001206,1.00000000001561,0.869313915706128,0,3,positive regulation of osteoclast development,BP,
15547,GO:0071930,1.00000000001562,0.855353432921569,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
1642,GO:0004082,1.00000000001562,0.880373921137205,0,3,bisphosphoglycerate mutase activity,MF,
1928,GO:0004619,1.00000000001562,0.880373921137205,0,3,phosphoglycerate mutase activity,MF,
11737,GO:0046538,1.00000000001562,0.880373921137205,0,3,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
13757,GO:0060315,1.00000000001563,0.725861933582111,0,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14931,GO:0070772,1.00000000001563,0.952768497662491,0,1,PAS complex,CC,
20212,GO:2001034,1.00000000001564,0.777343677800051,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
15380,GO:0071606,1.00000000001565,0.956566237524451,0,1,chemokine (C-C motif) ligand 4 production,BP,
15407,GO:0071643,1.00000000001565,0.956566237524451,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
15408,GO:0071644,1.00000000001565,0.956566237524451,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
15896,GO:0072615,1.00000000001565,0.956566237524451,0,1,interleukin-17 secretion,BP,
19150,GO:1905076,1.00000000001565,0.956566237524451,0,1,regulation of interleukin-17 secretion,BP,
19151,GO:1905077,1.00000000001565,0.956566237524451,0,1,negative regulation of interleukin-17 secretion,BP,
19265,GO:1905403,1.00000000001565,0.956566237524451,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
2133,GO:0004935,1.00000000001565,0.913630996605902,0,2,adrenergic receptor activity,MF,
2108,GO:0004882,1.00000000001566,0.95205119699575,0,1,androgen receptor activity,MF,
9399,GO:0035935,1.00000000001566,0.95205119699575,0,1,androgen secretion,BP,
16491,GO:0097162,1.00000000001566,0.95205119699575,0,1,MADS box domain binding,MF,
20166,GO:2000834,1.00000000001566,0.95205119699575,0,1,regulation of androgen secretion,BP,
20167,GO:2000836,1.00000000001566,0.95205119699575,0,1,positive regulation of androgen secretion,BP,
8918,GO:0034756,1.00000000001566,0.880641029006704,0,3,regulation of iron ion transport,BP,
136,GO:0000285,1.00000000001567,0.866817299500671,0,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
5962,GO:0018342,1.00000000001567,0.651359427896251,0,9,protein prenylation,BP,
16579,GO:0097354,1.00000000001567,0.651359427896251,0,9,prenylation,BP,
16348,GO:0090560,1.00000000001567,0.955588135347181,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
5139,GO:0015643,1.00000000001567,0.716337195894376,0,7,toxic substance binding,MF,
5012,GO:0015166,1.00000000001567,0.818140572579523,0,4,polyol transmembrane transporter activity,MF,
7709,GO:0032184,1.00000000001568,0.814690093418357,0,4,SUMO polymer binding,MF,
5755,GO:0016899,1.00000000001568,0.899158992566233,0,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
1806,GO:0004448,1.00000000001569,0.80669501754724,0,5,isocitrate dehydrogenase activity,MF,
19627,GO:1990742,1.00000000001569,0.933991663772999,0,2,microvesicle,CC,
12118,GO:0048148,1.00000000001569,0.718738675649705,0,7,behavioral response to cocaine,BP,
13099,GO:0051595,1.00000000001569,0.887993404776406,0,3,response to methylglyoxal,BP,
7381,GO:0031429,1.0000000000157,0.857011645847957,0,5,box H/ACA snoRNP complex,CC,
8810,GO:0034513,1.0000000000157,0.857011645847957,0,5,box H/ACA snoRNA binding,MF,
1999,GO:0004719,1.0000000000157,0.863093344107773,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
311,GO:0000822,1.00000000001571,0.854768886362331,0,3,inositol hexakisphosphate binding,MF,
4446,GO:0010340,1.00000000001572,0.717536698464892,0,7,carboxyl-O-methyltransferase activity,MF,
13309,GO:0051998,1.00000000001572,0.717536698464892,0,7,protein carboxyl O-methyltransferase activity,MF,
12000,GO:0047341,1.00000000001573,0.951379855449452,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
16446,GO:0097086,1.00000000001574,0.950291296328883,0,1,amniotic stem cell differentiation,BP,
20093,GO:2000706,1.00000000001574,0.950291296328883,0,1,negative regulation of dense core granule biogenesis,BP,
20109,GO:2000740,1.00000000001574,0.950291296328883,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20142,GO:2000797,1.00000000001574,0.950291296328883,0,1,regulation of amniotic stem cell differentiation,BP,
20143,GO:2000798,1.00000000001574,0.950291296328883,0,1,negative regulation of amniotic stem cell differentiation,BP,
187,GO:0000404,1.00000000001576,0.857643254090917,0,3,heteroduplex DNA loop binding,MF,
13020,GO:0051433,1.00000000001577,0.947406960891505,0,1,BH2 domain binding,MF,
11426,GO:0045829,1.00000000001578,0.86382225249241,0,3,negative regulation of isotype switching,BP,
3739,GO:0008275,1.00000000001578,0.816079088492498,0,4,gamma-tubulin small complex,CC,
16717,GO:0097680,1.00000000001578,0.858331169004705,0,3,double-strand break repair via classical nonhomologous end joining,BP,
5581,GO:0016594,1.00000000001579,0.827212235058851,0,4,glycine binding,MF,
11924,GO:0046950,1.00000000001579,0.720488589787584,0,7,cellular ketone body metabolic process,BP,
17927,GO:1902224,1.00000000001579,0.720488589787584,0,7,ketone body metabolic process,BP,
13731,GO:0060282,1.00000000001579,0.865246499714055,0,3,positive regulation of oocyte development,BP,
19408,GO:1905881,1.00000000001579,0.865246499714055,0,3,positive regulation of oogenesis,BP,
8043,GO:0032687,1.0000000000158,0.790584083372606,0,5,negative regulation of interferon-alpha production,BP,
8226,GO:0032982,1.0000000000158,0.683743372648617,0,7,myosin filament,CC,
1106,GO:0002692,1.0000000000158,0.832660718342227,0,4,negative regulation of cellular extravasation,BP,
1720,GO:0004309,1.0000000000158,0.817061737227406,0,4,exopolyphosphatase activity,MF,
3180,GO:0006798,1.0000000000158,0.817061737227406,0,4,polyphosphate catabolic process,BP,
517,GO:0001582,1.00000000001581,0.954378122523329,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
8263,GO:0033041,1.00000000001581,0.954378122523329,0,1,sweet taste receptor activity,MF,
10667,GO:0043843,1.00000000001581,0.954378122523329,0,1,ADP-specific glucokinase activity,MF,
18570,GO:1903767,1.00000000001581,0.954378122523329,0,1,sweet taste receptor complex,CC,
18571,GO:1903768,1.00000000001581,0.954378122523329,0,1,taste receptor complex,CC,
8210,GO:0032959,1.00000000001581,0.73375316703549,0,6,inositol trisphosphate biosynthetic process,BP,
520,GO:0001605,1.00000000001585,0.946858241451464,0,1,adrenomedullin receptor activity,MF,
2140,GO:0004948,1.00000000001585,0.946858241451464,0,1,calcitonin receptor activity,MF,
15198,GO:0071324,1.00000000001585,0.946858241451464,0,1,cellular response to disaccharide stimulus,BP,
15200,GO:0071329,1.00000000001585,0.946858241451464,0,1,cellular response to sucrose stimulus,BP,
18290,GO:1903143,1.00000000001585,0.946858241451464,0,1,adrenomedullin receptor complex,CC,
19543,GO:1990409,1.00000000001585,0.946858241451464,0,1,adrenomedullin binding,MF,
14424,GO:0061700,1.00000000001587,0.654541241405547,0,9,GATOR2 complex,CC,
1537,GO:0003919,1.00000000001588,0.956624343209953,0,1,FMN adenylyltransferase activity,MF,
3150,GO:0006747,1.00000000001588,0.956624343209953,0,1,FAD biosynthetic process,BP,
11678,GO:0046443,1.00000000001588,0.956624343209953,0,1,FAD metabolic process,BP,
15796,GO:0072388,1.00000000001588,0.956624343209953,0,1,flavin adenine dinucleotide biosynthetic process,BP,
16658,GO:0097510,1.00000000001588,0.956124949205659,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
4903,GO:0014827,1.00000000001589,0.955288375645484,0,1,intestine smooth muscle contraction,BP,
7722,GO:0032207,1.00000000001589,0.953528512028655,0,1,regulation of telomere maintenance via recombination,BP,
7723,GO:0032208,1.00000000001589,0.953528512028655,0,1,negative regulation of telomere maintenance via recombination,BP,
18451,GO:1903517,1.00000000001589,0.953528512028655,0,1,negative regulation of single strand break repair,BP,
18572,GO:1903770,1.00000000001589,0.953528512028655,0,1,negative regulation of beta-galactosidase activity,BP,
18594,GO:1903823,1.00000000001589,0.953528512028655,0,1,telomere single strand break repair,BP,
18595,GO:1903824,1.00000000001589,0.953528512028655,0,1,negative regulation of telomere single strand break repair,BP,
2727,GO:0006104,1.00000000001589,0.793926340581873,0,5,succinyl-CoA metabolic process,BP,
3674,GO:0008172,1.0000000000159,0.794940363242621,0,5,S-methyltransferase activity,MF,
17610,GO:1901254,1.00000000001592,0.947758717912316,0,1,positive regulation of intracellular transport of viral material,BP,
18115,GO:1902737,1.00000000001592,0.947758717912316,0,1,dendritic filopodium,CC,
3946,GO:0008635,1.00000000001592,0.665416391660249,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
5501,GO:0016435,1.00000000001593,0.847253555423492,0,4,rRNA (guanine) methyltransferase activity,MF,
12187,GO:0048302,1.00000000001593,0.71090559377807,0,7,regulation of isotype switching to IgG isotypes,BP,
16001,GO:0085020,1.00000000001594,0.744276359404498,0,7,protein K6-linked ubiquitination,BP,
14155,GO:0061009,1.00000000001594,0.872409999219749,0,3,common bile duct development,BP,
4794,GO:0010982,1.00000000001594,0.905772046741372,0,2,regulation of high-density lipoprotein particle clearance,BP,
4795,GO:0010983,1.00000000001594,0.905772046741372,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
235,GO:0000492,1.00000000001595,0.739933077960896,0,7,box C/D snoRNP assembly,BP,
17627,GO:1901300,1.00000000001596,0.832140319746513,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
7101,GO:0030893,1.00000000001596,0.857475085395161,0,3,meiotic cohesin complex,CC,
2799,GO:0006253,1.00000000001597,0.969252683261094,0,1,dCTP catabolic process,BP,
11545,GO:0046065,1.00000000001597,0.969252683261094,0,1,dCTP metabolic process,BP,
12053,GO:0047840,1.00000000001597,0.969252683261094,0,1,dCTP diphosphatase activity,MF,
3093,GO:0006666,1.00000000001599,0.946749763574171,0,1,3-keto-sphinganine metabolic process,BP,
12025,GO:0047560,1.00000000001599,0.946749763574171,0,1,3-dehydrosphinganine reductase activity,MF,
146,GO:0000298,1.000000000016,0.834193194838875,0,4,endopolyphosphatase activity,MF,
3868,GO:0008486,1.000000000016,0.834193194838875,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
5297,GO:0015961,1.000000000016,0.834193194838875,0,4,diadenosine polyphosphate catabolic process,BP,
8762,GO:0034431,1.000000000016,0.834193194838875,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
8763,GO:0034432,1.000000000016,0.834193194838875,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
13450,GO:0052840,1.000000000016,0.834193194838875,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
13451,GO:0052841,1.000000000016,0.834193194838875,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
13452,GO:0052842,1.000000000016,0.834193194838875,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
13453,GO:0052843,1.000000000016,0.834193194838875,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
13454,GO:0052844,1.000000000016,0.834193194838875,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
13455,GO:0052845,1.000000000016,0.834193194838875,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
13456,GO:0052846,1.000000000016,0.834193194838875,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
13457,GO:0052847,1.000000000016,0.834193194838875,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13458,GO:0052848,1.000000000016,0.834193194838875,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
15337,GO:0071543,1.000000000016,0.834193194838875,0,4,diphosphoinositol polyphosphate metabolic process,BP,
17820,GO:1901906,1.000000000016,0.834193194838875,0,4,diadenosine pentaphosphate metabolic process,BP,
17821,GO:1901907,1.000000000016,0.834193194838875,0,4,diadenosine pentaphosphate catabolic process,BP,
17822,GO:1901908,1.000000000016,0.834193194838875,0,4,diadenosine hexaphosphate metabolic process,BP,
17823,GO:1901909,1.000000000016,0.834193194838875,0,4,diadenosine hexaphosphate catabolic process,BP,
17824,GO:1901910,1.000000000016,0.834193194838875,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
17825,GO:1901911,1.000000000016,0.834193194838875,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
1939,GO:0004637,1.000000000016,0.951280586222774,0,1,phosphoribosylamine-glycine ligase activity,MF,
1942,GO:0004641,1.000000000016,0.951280586222774,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1945,GO:0004644,1.000000000016,0.951280586222774,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
1954,GO:0004655,1.00000000001601,0.952433460290483,0,1,porphobilinogen synthase activity,MF,
19042,GO:1904854,1.00000000001601,0.952433460290483,0,1,proteasome core complex binding,MF,
17905,GO:1902173,1.00000000001601,0.952463114935504,0,1,negative regulation of keratinocyte apoptotic process,BP,
4018,GO:0009019,1.00000000001601,0.820802155556022,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
12472,GO:0050265,1.00000000001601,0.854714523952766,0,3,RNA uridylyltransferase activity,MF,
8990,GO:0035095,1.00000000001602,0.816745849754778,0,4,behavioral response to nicotine,BP,
2149,GO:0004962,1.00000000001602,0.949572739822595,0,1,endothelin receptor activity,MF,
16069,GO:0086100,1.00000000001602,0.949572739822595,0,1,endothelin receptor signaling pathway,BP,
10122,GO:0042637,1.00000000001605,0.838065329875322,0,4,catagen,BP,
13201,GO:0051794,1.00000000001605,0.838065329875322,0,4,regulation of timing of catagen,BP,
16439,GO:0097065,1.00000000001606,0.818040843991128,0,4,anterior head development,BP,
981,GO:0002432,1.00000000001606,0.947666988442528,0,1,granuloma formation,BP,
19340,GO:1905600,1.00000000001606,0.8697854240138,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
4006,GO:0008948,1.00000000001607,0.826251236648015,0,4,oxaloacetate decarboxylase activity,MF,
16908,GO:0098842,1.00000000001607,0.912238686909078,0,2,postsynaptic early endosome,CC,
17368,GO:1900045,1.00000000001611,0.770395829065587,0,5,negative regulation of protein K63-linked ubiquitination,BP,
18097,GO:1902685,1.00000000001611,0.948005728050398,0,1,positive regulation of receptor localization to synapse,BP,
2686,GO:0006046,1.00000000001612,0.875354974135641,0,3,N-acetylglucosamine catabolic process,BP,
17856,GO:1902018,1.00000000001612,0.650626819751667,0,9,negative regulation of cilium assembly,BP,
8468,GO:0033604,1.00000000001612,0.902220083757483,0,2,negative regulation of catecholamine secretion,BP,
7200,GO:0031085,1.00000000001614,0.904422126225293,0,2,BLOC-3 complex,CC,
14863,GO:0070618,1.00000000001615,0.954095541187229,0,1,Grb2-Sos complex,CC,
17311,GO:0140074,1.00000000001616,0.946756322065531,0,1,cardiac endothelial to mesenchymal transition,BP,
15016,GO:0070934,1.00000000001616,0.816005005132584,0,4,CRD-mediated mRNA stabilization,BP,
13148,GO:0051697,1.00000000001616,0.835576564082191,0,4,protein delipidation,BP,
10528,GO:0043456,1.00000000001617,0.839469159525732,0,4,regulation of pentose-phosphate shunt,BP,
8163,GO:0032889,1.00000000001618,0.954450512594657,0,1,regulation of vacuole fusion, non-autophagic,BP,
20235,GO:2001136,1.00000000001618,0.951723370242505,0,1,negative regulation of endocytic recycling,BP,
16936,GO:0098902,1.00000000001619,0.789591992326437,0,5,regulation of membrane depolarization during action potential,BP,
15472,GO:0071797,1.00000000001619,0.828468189184615,0,4,LUBAC complex,CC,
15015,GO:0070933,1.00000000001619,0.634599783290867,0,9,histone H4 deacetylation,BP,
6937,GO:0030538,1.00000000001619,0.904623691554723,0,2,embryonic genitalia morphogenesis,BP,
1622,GO:0004052,1.0000000000162,0.911376455730069,0,2,arachidonate 12-lipoxygenase activity,MF,
5326,GO:0016048,1.00000000001621,0.718408917757022,0,7,detection of temperature stimulus,BP,
12735,GO:0050961,1.00000000001621,0.718408917757022,0,7,detection of temperature stimulus involved in sensory perception,BP,
12737,GO:0050965,1.00000000001621,0.718408917757022,0,7,detection of temperature stimulus involved in sensory perception of pain,BP,
2765,GO:0006177,1.00000000001621,0.805630978074765,0,5,GMP biosynthetic process,BP,
2190,GO:0005046,1.00000000001622,0.916852148191612,0,2,KDEL sequence binding,MF,
3729,GO:0008263,1.00000000001622,0.908918536614681,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
18001,GO:1902412,1.00000000001623,0.853036302889027,0,3,regulation of mitotic cytokinesis,BP,
14438,GO:0061736,1.00000000001624,0.94667148578318,0,1,engulfment of target by autophagosome,BP,
14449,GO:0061753,1.00000000001624,0.94667148578318,0,1,substrate localization to autophagosome,BP,
12001,GO:0047349,1.00000000001624,0.946686111544727,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
8779,GO:0034455,1.00000000001625,0.86168862304789,0,3,t-UTP complex,CC,
4082,GO:0009134,1.00000000001626,0.735985905011855,0,7,nucleoside diphosphate catabolic process,BP,
3318,GO:0007023,1.00000000001627,0.85286103193596,0,4,post-chaperonin tubulin folding pathway,BP,
5452,GO:0016320,1.00000000001628,0.914509313950822,0,2,endoplasmic reticulum membrane fusion,BP,
8400,GO:0033326,1.00000000001629,0.946923323491707,0,1,cerebrospinal fluid secretion,BP,
10932,GO:0044547,1.00000000001629,0.781093439832888,0,5,DNA topoisomerase binding,MF,
543,GO:0001661,1.00000000001629,0.904630317629295,0,2,conditioned taste aversion,BP,
18958,GO:1904691,1.0000000000163,0.955716107582353,0,1,negative regulation of type B pancreatic cell proliferation,BP,
16725,GO:0097698,1.0000000000163,0.962086279170015,0,1,telomere maintenance via base-excision repair,BP,
16799,GO:0098619,1.0000000000163,0.957158442278398,0,1,selenocysteine-tRNA ligase activity,MF,
7657,GO:0032072,1.0000000000163,0.951384466171006,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7867,GO:0032423,1.0000000000163,0.951384466171006,0,1,regulation of mismatch repair,BP,
7868,GO:0032425,1.0000000000163,0.951384466171006,0,1,positive regulation of mismatch repair,BP,
9282,GO:0035711,1.0000000000163,0.951384466171006,0,1,T-helper 1 cell activation,BP,
19951,GO:2000426,1.0000000000163,0.951384466171006,0,1,negative regulation of apoptotic cell clearance,BP,
14394,GO:0061628,1.0000000000163,0.904136064805528,0,2,H3K27me3 modified histone binding,MF,
10971,GO:0044729,1.00000000001631,0.861640181516274,0,3,hemi-methylated DNA-binding,MF,
5902,GO:0018103,1.00000000001631,0.753446571738613,0,6,protein C-linked glycosylation,BP,
5937,GO:0018211,1.00000000001631,0.753446571738613,0,6,peptidyl-tryptophan modification,BP,
5958,GO:0018317,1.00000000001631,0.753446571738613,0,6,protein C-linked glycosylation via tryptophan,BP,
5974,GO:0018406,1.00000000001631,0.753446571738613,0,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
12003,GO:0047372,1.00000000001632,0.645839362094162,0,9,acylglycerol lipase activity,MF,
15417,GO:0071664,1.00000000001632,0.813288185354802,0,4,catenin-TCF7L2 complex,CC,
11396,GO:0045763,1.00000000001634,0.89633426409986,0,2,negative regulation of cellular amino acid metabolic process,BP,
12732,GO:0050955,1.00000000001634,0.948402803829349,0,1,thermoception,BP,
12734,GO:0050960,1.00000000001634,0.948402803829349,0,1,detection of temperature stimulus involved in thermoception,BP,
12739,GO:0050968,1.00000000001634,0.948402803829349,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,
13865,GO:0060454,1.00000000001634,0.948402803829349,0,1,positive regulation of gastric acid secretion,BP,
16203,GO:0090212,1.00000000001634,0.948402803829349,0,1,negative regulation of establishment of blood-brain barrier,BP,
16689,GO:0097603,1.00000000001634,0.948402803829349,0,1,temperature-gated ion channel activity,MF,
17714,GO:1901594,1.00000000001634,0.948402803829349,0,1,response to capsazepine,BP,
3984,GO:0008817,1.00000000001635,0.948394959909134,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
11578,GO:0046121,1.00000000001635,0.878174326105449,0,3,deoxyribonucleoside catabolic process,BP,
16313,GO:0090409,1.00000000001636,0.955076309178885,0,1,malonyl-CoA synthetase activity,MF,
16314,GO:0090410,1.00000000001636,0.955076309178885,0,1,malonate catabolic process,BP,
14862,GO:0070615,1.00000000001638,0.948571408854273,0,1,nucleosome-dependent ATPase activity,MF,
16339,GO:0090537,1.00000000001638,0.948571408854273,0,1,CERF complex,CC,
14726,GO:0070365,1.00000000001638,0.693141997285011,0,8,hepatocyte differentiation,BP,
14301,GO:0061370,1.00000000001638,0.905704905781864,0,2,testosterone biosynthetic process,BP,
5876,GO:0017185,1.00000000001639,0.677661867311885,0,8,peptidyl-lysine hydroxylation,BP,
8850,GO:0034642,1.00000000001639,0.949598227708724,0,1,mitochondrion migration along actin filament,BP,
18283,GO:1903126,1.00000000001641,0.955696968411762,0,1,negative regulation of centriole-centriole cohesion,BP,
20256,GO:2001173,1.00000000001641,0.955696968411762,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
8336,GO:0033180,1.00000000001642,0.712652195311923,0,8,proton-transporting V-type ATPase, V1 domain,CC,
248,GO:0000706,1.00000000001643,0.903343870287078,0,2,meiotic DNA double-strand break processing,BP,
19686,GO:1990918,1.00000000001643,0.903343870287078,0,2,double-strand break repair involved in meiotic recombination,BP,
4614,GO:0010728,1.00000000001645,0.81994361309125,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
9806,GO:0040030,1.00000000001646,0.94970535112547,0,1,regulation of molecular function, epigenetic,BP,
10293,GO:0043035,1.00000000001646,0.94970535112547,0,1,chromatin insulator sequence binding,MF,
2627,GO:0005947,1.00000000001649,0.798300979003797,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
1807,GO:0004449,1.00000000001649,0.881126983443823,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
14715,GO:0070336,1.00000000001649,0.902691870377458,0,2,flap-structured DNA binding,MF,
3488,GO:0007356,1.00000000001649,0.913328752156168,0,2,thorax and anterior abdomen determination,BP,
20228,GO:2001074,1.00000000001649,0.913328752156168,0,2,regulation of metanephric ureteric bud development,BP,
20229,GO:2001076,1.00000000001649,0.913328752156168,0,2,positive regulation of metanephric ureteric bud development,BP,
7814,GO:0032361,1.0000000000165,0.956427330932667,0,1,pyridoxal phosphate catabolic process,BP,
8550,GO:0033883,1.0000000000165,0.956427330932667,0,1,pyridoxal phosphatase activity,MF,
10209,GO:0042820,1.0000000000165,0.956427330932667,0,1,vitamin B6 catabolic process,BP,
13083,GO:0051573,1.0000000000165,0.636116594376477,0,9,negative regulation of histone H3-K9 methylation,BP,
3108,GO:0006685,1.00000000001651,0.783019901941494,0,5,sphingomyelin catabolic process,BP,
9232,GO:0035617,1.00000000001651,0.863207567326788,0,3,stress granule disassembly,BP,
14201,GO:0061086,1.00000000001651,0.820953385016223,0,4,negative regulation of histone H3-K27 methylation,BP,
9829,GO:0042043,1.00000000001652,0.631548789673327,0,9,neurexin family protein binding,MF,
6591,GO:0022417,1.00000000001653,0.703521904324871,0,9,protein maturation by protein folding,BP,
159,GO:0000322,1.00000000001654,0.871822536209572,0,3,storage vacuole,CC,
4545,GO:0010615,1.00000000001656,0.947234433055187,0,1,positive regulation of cardiac muscle adaptation,BP,
18333,GO:1903244,1.00000000001656,0.947234433055187,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19185,GO:1905205,1.00000000001656,0.947234433055187,0,1,positive regulation of connective tissue replacement,BP,
5637,GO:0016714,1.00000000001656,0.888070515625271,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
16644,GO:0097490,1.00000000001656,0.813444949579006,0,4,sympathetic neuron projection extension,BP,
16645,GO:0097491,1.00000000001656,0.813444949579006,0,4,sympathetic neuron projection guidance,BP,
3084,GO:0006657,1.00000000001656,0.724321195938269,0,7,CDP-choline pathway,BP,
10226,GO:0042891,1.00000000001658,0.712437115565722,0,7,antibiotic transport,BP,
16196,GO:0090204,1.00000000001659,0.888313820117159,0,3,protein localization to nuclear pore,BP,
6391,GO:0021578,1.0000000000166,0.853261269966212,0,3,hindbrain maturation,BP,
6409,GO:0021626,1.0000000000166,0.853261269966212,0,3,central nervous system maturation,BP,
8966,GO:0035033,1.00000000001661,0.911901042395123,0,2,histone deacetylase regulator activity,MF,
6537,GO:0021936,1.00000000001661,0.851972364554753,0,3,regulation of cerebellar granule cell precursor proliferation,BP,
5011,GO:0015165,1.00000000001661,0.664684214908057,0,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
16977,GO:0098976,1.00000000001661,0.8173447814381,0,4,excitatory chemical synaptic transmission,BP,
4014,GO:0009000,1.00000000001662,0.95458731397509,0,1,selenocysteine lyase activity,MF,
14029,GO:0060736,1.00000000001662,0.690121025819202,0,7,prostate gland growth,BP,
8959,GO:0035021,1.00000000001662,0.81628534935572,0,4,negative regulation of Rac protein signal transduction,BP,
19498,GO:1990188,1.00000000001664,0.954234065796397,0,1,euchromatin binding,MF,
3646,GO:0008119,1.00000000001664,0.952170200016794,0,1,thiopurine S-methyltransferase activity,MF,
8109,GO:0032792,1.00000000001665,0.834447432237278,0,4,negative regulation of CREB transcription factor activity,BP,
19289,GO:1905457,1.00000000001666,0.879837894011211,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20186,GO:2000974,1.00000000001666,0.879837894011211,0,3,negative regulation of pro-B cell differentiation,BP,
4436,GO:0010269,1.00000000001666,0.890370512996224,0,3,response to selenium ion,BP,
1588,GO:0003996,1.00000000001666,0.955210758023902,0,1,acyl-CoA ligase activity,MF,
8784,GO:0034462,1.00000000001666,0.955210758023902,0,1,small-subunit processome assembly,BP,
16772,GO:0098547,1.00000000001666,0.955210758023902,0,1,lumenal side of Golgi membrane,CC,
11133,GO:0045162,1.00000000001666,0.808429211050058,0,4,clustering of voltage-gated sodium channels,BP,
13566,GO:0060013,1.00000000001667,0.772107524090563,0,5,righting reflex,BP,
2343,GO:0005372,1.00000000001667,0.838772900780893,0,4,water transmembrane transporter activity,MF,
5057,GO:0015250,1.00000000001667,0.838772900780893,0,4,water channel activity,MF,
11568,GO:0046101,1.00000000001667,0.844547868111459,0,4,hypoxanthine biosynthetic process,BP,
1580,GO:0003987,1.00000000001668,0.903194730281142,0,2,acetate-CoA ligase activity,MF,
6145,GO:0019413,1.00000000001668,0.903194730281142,0,2,acetate biosynthetic process,BP,
6148,GO:0019427,1.00000000001668,0.903194730281142,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6179,GO:0019542,1.00000000001668,0.903194730281142,0,2,propionate biosynthetic process,BP,
4318,GO:0009794,1.00000000001669,0.829663981523415,0,4,regulation of mitotic cell cycle, embryonic,BP,
11256,GO:0045448,1.00000000001669,0.829663981523415,0,4,mitotic cell cycle, embryonic,BP,
5800,GO:0017040,1.00000000001669,0.846464539843932,0,4,N-acylsphingosine amidohydrolase activity,MF,
16475,GO:0097135,1.00000000001669,0.911291286554551,0,2,cyclin E2-CDK2 complex,CC,
1044,GO:0002560,1.00000000001673,0.94824597170932,0,1,basophil mediated immunity,BP,
1045,GO:0002561,1.00000000001673,0.94824597170932,0,1,basophil degranulation,BP,
8491,GO:0033644,1.00000000001673,0.94824597170932,0,1,host cell membrane,CC,
10776,GO:0044218,1.00000000001673,0.94824597170932,0,1,other organism cell membrane,CC,
10778,GO:0044221,1.00000000001673,0.94824597170932,0,1,host cell synapse,CC,
10781,GO:0044231,1.00000000001673,0.94824597170932,0,1,host cell presynaptic membrane,CC,
10804,GO:0044279,1.00000000001673,0.94824597170932,0,1,other organism membrane,CC,
15856,GO:0072556,1.00000000001673,0.94824597170932,0,1,other organism presynaptic membrane,CC,
1765,GO:0004365,1.00000000001673,0.965187728855919,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
6255,GO:0019828,1.00000000001673,0.965187728855919,0,1,aspartic-type endopeptidase inhibitor activity,MF,
9220,GO:0035605,1.00000000001673,0.965187728855919,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
10672,GO:0043891,1.00000000001673,0.965187728855919,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
6423,GO:0021682,1.00000000001674,0.94667158417005,0,1,nerve maturation,BP,
1832,GO:0004484,1.00000000001675,0.947546263803732,0,1,mRNA guanylyltransferase activity,MF,
12487,GO:0050355,1.00000000001675,0.947546263803732,0,1,triphosphatase activity,MF,
522,GO:0001609,1.00000000001675,0.872558028507545,0,3,G-protein coupled adenosine receptor activity,MF,
18145,GO:1902824,1.00000000001675,0.928962108106494,0,2,positive regulation of late endosome to lysosome transport,BP,
18373,GO:1903337,1.00000000001675,0.928962108106494,0,2,positive regulation of vacuolar transport,BP,
15024,GO:0070943,1.00000000001676,0.88079480053789,0,3,neutrophil mediated killing of symbiont cell,BP,
1899,GO:0004579,1.00000000001676,0.687111772807777,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
725,GO:0001951,1.00000000001676,0.856943498488946,0,3,intestinal D-glucose absorption,BP,
17200,GO:0106001,1.00000000001676,0.856943498488946,0,3,intestinal hexose absorption,BP,
7476,GO:0031630,1.00000000001676,0.949184168466034,0,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
17210,GO:0106022,1.00000000001676,0.949184168466034,0,1,positive regulation of vesicle docking,BP,
10950,GO:0044611,1.00000000001677,0.849501142926698,0,3,nuclear pore inner ring,CC,
509,GO:0001572,1.00000000001677,0.94702543016851,0,1,lactosylceramide biosynthetic process,BP,
11702,GO:0046478,1.00000000001677,0.94702543016851,0,1,lactosylceramide metabolic process,BP,
2113,GO:0004890,1.00000000001678,0.952576311648035,0,1,GABA-A receptor activity,MF,
2285,GO:0005237,1.00000000001678,0.952576311648035,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
6628,GO:0022851,1.00000000001678,0.952576311648035,0,1,GABA-gated chloride ion channel activity,MF,
17017,GO:0099095,1.00000000001678,0.952576311648035,0,1,ligand-gated anion channel activity,MF,
18102,GO:1902710,1.00000000001678,0.952576311648035,0,1,GABA receptor complex,CC,
18103,GO:1902711,1.00000000001678,0.952576311648035,0,1,GABA-A receptor complex,CC,
18513,GO:1903626,1.00000000001679,0.855752053048164,0,4,positive regulation of DNA catabolic process,BP,
17256,GO:0120009,1.0000000000168,0.786201224702294,0,5,intermembrane lipid transfer,BP,
17258,GO:0120013,1.0000000000168,0.786201224702294,0,5,intermembrane lipid transfer activity,MF,
18687,GO:1904016,1.0000000000168,0.812797050955212,0,4,response to Thyroglobulin triiodothyronine,BP,
12951,GO:0051295,1.0000000000168,0.853312333522885,0,3,establishment of meiotic spindle localization,BP,
6317,GO:0019958,1.00000000001681,0.86594976384655,0,3,C-X-C chemokine binding,MF,
11514,GO:0045990,1.00000000001681,0.825655890171829,0,4,carbon catabolite regulation of transcription,BP,
11515,GO:0045991,1.00000000001681,0.825655890171829,0,4,carbon catabolite activation of transcription,BP,
14646,GO:0070209,1.00000000001681,0.95175513424115,0,1,ASTRA complex,CC,
18655,GO:1903939,1.00000000001681,0.95175513424115,0,1,regulation of TORC2 signaling,BP,
18884,GO:1904515,1.00000000001681,0.95175513424115,0,1,positive regulation of TORC2 signaling,BP,
3952,GO:0008650,1.00000000001682,0.950694776301985,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
2414,GO:0005586,1.00000000001682,0.946677700599849,0,1,collagen type III trimer,CC,
4490,GO:0010509,1.00000000001682,0.946677700599849,0,1,polyamine homeostasis,BP,
5854,GO:0017146,1.00000000001684,0.851192270825918,0,3,NMDA selective glutamate receptor complex,CC,
12026,GO:0047578,1.00000000001684,0.954620651161249,0,1,4-hydroxyglutamate transaminase activity,MF,
8553,GO:0033906,1.00000000001684,0.914139941090211,0,2,hyaluronoglucuronidase activity,MF,
2463,GO:0005674,1.00000000001685,0.918767141437246,0,2,transcription factor TFIIF complex,CC,
4885,GO:0014744,1.00000000001685,0.854819623936226,0,3,positive regulation of muscle adaptation,BP,
386,GO:0001030,1.00000000001685,0.776108999818408,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
387,GO:0001031,1.00000000001685,0.776108999818408,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
15983,GO:0080084,1.00000000001685,0.776108999818408,0,5,5S rDNA binding,MF,
10092,GO:0042589,1.00000000001687,0.721922147340824,0,7,zymogen granule membrane,CC,
12620,GO:0050786,1.00000000001687,0.845994441645217,0,7,RAGE receptor binding,MF,
6050,GO:0019166,1.00000000001687,0.878122415652958,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
10808,GO:0044284,1.00000000001687,0.974331956560237,0,1,mitochondrial crista junction,CC,
10397,GO:0043225,1.00000000001688,0.650655197771164,0,8,ATPase-coupled anion transmembrane transporter activity,MF,
17027,GO:0099133,1.00000000001688,0.650655197771164,0,8,ATP hydrolysis coupled anion transmembrane transport,BP,
15169,GO:0071275,1.0000000000169,0.955617630506601,0,1,cellular response to aluminum ion,BP,
19361,GO:1905672,1.0000000000169,0.955617630506601,0,1,negative regulation of lysosome organization,BP,
10246,GO:0042975,1.0000000000169,0.637237828790056,0,9,peroxisome proliferator activated receptor binding,MF,
8448,GO:0033567,1.00000000001692,0.80193023373364,0,5,DNA replication, Okazaki fragment processing,BP,
595,GO:0001757,1.00000000001693,0.901157750415469,0,2,somite specification,BP,
1260,GO:0003011,1.00000000001694,0.900007625355399,0,2,involuntary skeletal muscle contraction,BP,
2253,GO:0005165,1.00000000001694,0.707570754900045,0,7,neurotrophin receptor binding,MF,
2255,GO:0005167,1.00000000001694,0.707570754900045,0,7,neurotrophin TRK receptor binding,MF,
3651,GO:0008127,1.00000000001694,0.965474629922989,0,1,quercetin 2,3-dioxygenase activity,MF,
16939,GO:0098905,1.00000000001696,0.929789487571824,0,2,regulation of bundle of His cell action potential,BP,
8845,GO:0034635,1.00000000001697,0.905406069512364,0,2,glutathione transport,BP,
10238,GO:0042939,1.00000000001697,0.905406069512364,0,2,tripeptide transport,BP,
7437,GO:0031536,1.00000000001697,0.858141637441324,0,4,positive regulation of exit from mitosis,BP,
2317,GO:0005315,1.00000000001697,0.856425804503036,0,3,inorganic phosphate transmembrane transporter activity,MF,
9040,GO:0035253,1.00000000001698,0.636137786181618,0,9,ciliary rootlet,CC,
533,GO:0001651,1.00000000001699,0.923154214681137,0,2,dense fibrillar component,CC,
16157,GO:0090155,1.00000000001699,0.834464786481869,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17372,GO:1900060,1.00000000001699,0.834464786481869,0,4,negative regulation of ceramide biosynthetic process,BP,
9175,GO:0035529,1.000000000017,0.809265058040845,0,5,NADH pyrophosphatase activity,MF,
17533,GO:1900825,1.000000000017,0.834087046300696,0,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
4875,GO:0014733,1.00000000001701,0.669196815088202,0,8,regulation of skeletal muscle adaptation,BP,
18886,GO:1904527,1.00000000001701,0.860635738328945,0,3,negative regulation of microtubule binding,BP,
10086,GO:0042583,1.00000000001701,0.781306522046698,0,5,chromaffin granule,CC,
1705,GO:0004185,1.00000000001701,0.679315336059058,0,8,serine-type carboxypeptidase activity,MF,
11323,GO:0045632,1.00000000001703,0.837495764258083,0,4,negative regulation of mechanoreceptor differentiation,BP,
20190,GO:2000981,1.00000000001703,0.837495764258083,0,4,negative regulation of inner ear receptor cell differentiation,BP,
11230,GO:0045355,1.00000000001705,0.923794518640116,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
9628,GO:0036492,1.00000000001705,0.734538638975034,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
14340,GO:0061502,1.00000000001705,0.814598201391005,0,4,early endosome to recycling endosome transport,BP,
16807,GO:0098634,1.00000000001705,0.806171345851682,0,4,cell-matrix adhesion mediator activity,MF,
16809,GO:0098639,1.00000000001705,0.806171345851682,0,4,collagen binding involved in cell-matrix adhesion,MF,
9376,GO:0035898,1.00000000001705,0.863514683106543,0,3,parathyroid hormone secretion,BP,
15486,GO:0071817,1.00000000001706,0.812188338207407,0,5,MMXD complex,CC,
14770,GO:0070444,1.00000000001706,0.824511344448198,0,4,oligodendrocyte progenitor proliferation,BP,
14771,GO:0070445,1.00000000001706,0.824511344448198,0,4,regulation of oligodendrocyte progenitor proliferation,BP,
14722,GO:0070345,1.00000000001706,0.816190279636321,0,4,negative regulation of fat cell proliferation,BP,
12110,GO:0048104,1.00000000001708,0.806267998060104,0,4,establishment of body hair or bristle planar orientation,BP,
12111,GO:0048105,1.00000000001708,0.806267998060104,0,4,establishment of body hair planar orientation,BP,
1680,GO:0004142,1.00000000001709,0.869613112546607,0,3,diacylglycerol cholinephosphotransferase activity,MF,
10347,GO:0043140,1.0000000000171,0.689382067770428,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
7828,GO:0032377,1.0000000000171,0.723260212451599,0,7,regulation of intracellular lipid transport,BP,
7831,GO:0032380,1.0000000000171,0.723260212451599,0,7,regulation of intracellular sterol transport,BP,
7834,GO:0032383,1.0000000000171,0.723260212451599,0,7,regulation of intracellular cholesterol transport,BP,
86,GO:0000173,1.0000000000171,0.959774571849741,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
2195,GO:0005053,1.00000000001713,0.962166409461026,0,1,peroxisome matrix targeting signal-2 binding,MF,
5473,GO:0016402,1.00000000001713,0.953674852686311,0,1,pristanoyl-CoA oxidase activity,MF,
7391,GO:0031439,1.00000000001714,0.904742624382032,0,2,positive regulation of mRNA cleavage,BP,
19735,GO:2000053,1.00000000001715,0.897027138889668,0,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
13988,GO:0060684,1.00000000001715,0.829660253073651,0,4,epithelial-mesenchymal cell signaling,BP,
10671,GO:0043890,1.00000000001715,0.954828947898191,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
13801,GO:0060373,1.00000000001717,0.820759488625428,0,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
15419,GO:0071670,1.00000000001717,0.800204515212794,0,5,smooth muscle cell chemotaxis,BP,
5388,GO:0016208,1.0000000000172,0.68455467949061,0,9,AMP binding,MF,
493,GO:0001545,1.0000000000172,0.948673493968239,0,1,primary ovarian follicle growth,BP,
15247,GO:0071393,1.0000000000172,0.948673493968239,0,1,cellular response to progesterone stimulus,BP,
17496,GO:1900390,1.0000000000172,0.930256805732291,0,2,regulation of iron ion import,BP,
18857,GO:1904432,1.0000000000172,0.930256805732291,0,2,regulation of ferrous iron binding,BP,
18858,GO:1904434,1.0000000000172,0.930256805732291,0,2,positive regulation of ferrous iron binding,BP,
18859,GO:1904435,1.0000000000172,0.930256805732291,0,2,regulation of transferrin receptor binding,BP,
18860,GO:1904437,1.0000000000172,0.930256805732291,0,2,positive regulation of transferrin receptor binding,BP,
18975,GO:1904720,1.0000000000172,0.909725382914919,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
844,GO:0002154,1.00000000001721,0.773875192394274,0,5,thyroid hormone mediated signaling pathway,BP,
15155,GO:0071245,1.00000000001721,0.950375516339332,0,1,cellular response to carbon monoxide,BP,
18406,GO:1903406,1.00000000001721,0.950375516339332,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
18407,GO:1903408,1.00000000001721,0.950375516339332,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
10311,GO:0043083,1.00000000001722,0.807384360811874,0,4,synaptic cleft,CC,
16206,GO:0090219,1.00000000001722,0.821694382549596,0,4,negative regulation of lipid kinase activity,BP,
5574,GO:0016584,1.00000000001723,0.762832736837649,0,7,nucleosome positioning,BP,
13543,GO:0055105,1.00000000001725,0.838047277574614,0,6,ubiquitin-protein transferase inhibitor activity,MF,
4177,GO:0009249,1.00000000001729,0.798193844115227,0,7,protein lipoylation,BP,
9211,GO:0035594,1.0000000000173,0.868653968835242,0,3,ganglioside binding,MF,
14942,GO:0070813,1.00000000001731,0.810692545643617,0,5,hydrogen sulfide metabolic process,BP,
9857,GO:0042101,1.00000000001731,0.710522453512078,0,7,T cell receptor complex,CC,
14666,GO:0070255,1.00000000001731,0.733627607299841,0,7,regulation of mucus secretion,BP,
18874,GO:1904481,1.00000000001731,0.954603902088579,0,1,response to tetrahydrofolate,BP,
18875,GO:1904482,1.00000000001731,0.954603902088579,0,1,cellular response to tetrahydrofolate,BP,
162,GO:0000333,1.00000000001732,0.933908065720097,0,2,telomerase catalytic core complex,CC,
17124,GO:0101006,1.00000000001732,0.88528476351423,0,3,protein histidine phosphatase activity,MF,
255,GO:0000720,1.00000000001733,0.872592782134519,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
5851,GO:0017143,1.00000000001735,0.910498624947252,0,2,insecticide metabolic process,BP,
17528,GO:1900747,1.00000000001735,0.822828334000274,0,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18048,GO:1902548,1.00000000001735,0.822828334000274,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
8960,GO:0035022,1.00000000001735,0.831322600769194,0,4,positive regulation of Rac protein signal transduction,BP,
15940,GO:0072714,1.00000000001735,0.958695454758276,0,1,response to selenite ion,BP,
15941,GO:0072715,1.00000000001735,0.958695454758276,0,1,cellular response to selenite ion,BP,
18904,GO:1904569,1.00000000001735,0.958695454758276,0,1,regulation of selenocysteine incorporation,BP,
18905,GO:1904570,1.00000000001735,0.958695454758276,0,1,negative regulation of selenocysteine incorporation,BP,
18906,GO:1904572,1.00000000001735,0.958695454758276,0,1,negative regulation of mRNA binding,BP,
18907,GO:1904573,1.00000000001735,0.958695454758276,0,1,regulation of selenocysteine insertion sequence binding,BP,
18908,GO:1904574,1.00000000001735,0.958695454758276,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
19191,GO:1905215,1.00000000001735,0.958695454758276,0,1,negative regulation of RNA binding,BP,
14179,GO:0061047,1.00000000001736,0.870824653575961,0,3,positive regulation of branching involved in lung morphogenesis,BP,
2638,GO:0005968,1.00000000001737,0.825574160665768,0,4,Rab-protein geranylgeranyltransferase complex,CC,
16950,GO:0098917,1.00000000001737,0.831043072605281,0,4,retrograde trans-synaptic signaling,BP,
19620,GO:1990726,1.00000000001738,0.874916686761949,0,5,Lsm1-7-Pat1 complex,CC,
10091,GO:0042588,1.00000000001738,0.6545458006887,0,9,zymogen granule,CC,
10318,GO:0043095,1.00000000001739,0.979175042123106,0,1,regulation of GTP cyclohydrolase I activity,BP,
10324,GO:0043105,1.00000000001739,0.979175042123106,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10934,GO:0044549,1.00000000001739,0.979175042123106,0,1,GTP cyclohydrolase binding,MF,
17541,GO:1901018,1.00000000001739,0.648896489427429,0,9,positive regulation of potassium ion transmembrane transporter activity,BP,
12980,GO:0051349,1.0000000000174,0.685018717920467,0,8,positive regulation of lyase activity,BP,
19193,GO:1905222,1.0000000000174,0.95265272750875,0,1,atrioventricular canal morphogenesis,BP,
2050,GO:0004795,1.00000000001741,0.955784545402768,0,1,threonine synthase activity,MF,
4052,GO:0009088,1.00000000001741,0.955784545402768,0,1,threonine biosynthetic process,BP,
11651,GO:0046360,1.00000000001741,0.955784545402768,0,1,2-oxobutyrate biosynthetic process,BP,
11652,GO:0046361,1.00000000001741,0.955784545402768,0,1,2-oxobutyrate metabolic process,BP,
13890,GO:0060501,1.00000000001742,0.821333480333023,0,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
16495,GO:0097167,1.00000000001742,0.8223952390018,0,4,circadian regulation of translation,BP,
108,GO:0000224,1.00000000001743,0.954424029243574,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
583,GO:0001733,1.00000000001743,0.954424029243574,0,1,galactosylceramide sulfotransferase activity,MF,
12558,GO:0050694,1.00000000001743,0.954424029243574,0,1,galactose 3-O-sulfotransferase activity,MF,
12559,GO:0050698,1.00000000001743,0.954424029243574,0,1,proteoglycan sulfotransferase activity,MF,
16465,GO:0097116,1.00000000001743,0.947249412837258,0,1,gephyrin clustering involved in postsynaptic density assembly,BP,
579,GO:0001729,1.00000000001745,0.903435561412039,0,2,ceramide kinase activity,MF,
1905,GO:0004587,1.00000000001747,0.956556097354176,0,1,ornithine-oxo-acid transaminase activity,MF,
4402,GO:0010121,1.00000000001747,0.956556097354176,0,1,arginine catabolic process to proline via ornithine,BP,
6163,GO:0019493,1.00000000001747,0.956556097354176,0,1,arginine catabolic process to proline,BP,
6181,GO:0019544,1.00000000001747,0.956556097354176,0,1,arginine catabolic process to glutamate,BP,
12157,GO:0048254,1.00000000001747,0.847300570705775,0,4,snoRNA localization,BP,
11669,GO:0046415,1.00000000001749,0.785403799858899,0,5,urate metabolic process,BP,
6684,GO:0030043,1.00000000001749,0.842109302748855,0,4,actin filament fragmentation,BP,
15592,GO:0072047,1.00000000001751,0.842302864982679,0,4,proximal/distal pattern formation involved in nephron development,BP,
15613,GO:0072081,1.00000000001751,0.842302864982679,0,4,specification of nephron tubule identity,BP,
15614,GO:0072086,1.00000000001751,0.842302864982679,0,4,specification of loop of Henle identity,BP,
5250,GO:0015871,1.00000000001751,0.700779280664234,0,7,choline transport,BP,
9100,GO:0035363,1.00000000001751,0.828428872985473,0,4,histone locus body,CC,
15086,GO:0071042,1.00000000001752,0.848714804455638,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15091,GO:0071047,1.00000000001752,0.848714804455638,0,4,polyadenylation-dependent mRNA catabolic process,BP,
4752,GO:0010919,1.00000000001752,0.699192066635514,0,7,regulation of inositol phosphate biosynthetic process,BP,
8703,GO:0034338,1.00000000001752,0.863132505113607,0,3,short-chain carboxylesterase activity,MF,
2179,GO:0005021,1.00000000001753,0.903659998958139,0,2,vascular endothelial growth factor-activated receptor activity,MF,
2016,GO:0004740,1.00000000001754,0.856511639224913,0,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
16011,GO:0086008,1.00000000001754,0.953541260949346,0,1,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
16064,GO:0086089,1.00000000001754,0.953541260949346,0,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17956,GO:1902282,1.00000000001754,0.953541260949346,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
7355,GO:0031392,1.00000000001754,0.825781854868433,0,4,regulation of prostaglandin biosynthetic process,BP,
20321,GO:2001279,1.00000000001754,0.825781854868433,0,4,regulation of unsaturated fatty acid biosynthetic process,BP,
13875,GO:0060474,1.00000000001754,0.938565507823191,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
118,GO:0000246,1.00000000001756,0.947966509335599,0,1,delta24(24-1) sterol reductase activity,MF,
12518,GO:0050614,1.00000000001756,0.947966509335599,0,1,delta24-sterol reductase activity,MF,
16320,GO:0090461,1.00000000001756,0.947966509335599,0,1,glutamate homeostasis,BP,
5051,GO:0015232,1.00000000001757,0.703393598774801,0,7,heme transporter activity,MF,
5260,GO:0015886,1.00000000001757,0.703393598774801,0,7,heme transport,BP,
8304,GO:0033133,1.00000000001757,0.839927355023244,0,4,positive regulation of glucokinase activity,BP,
689,GO:0001905,1.00000000001757,0.896283776800033,0,2,activation of membrane attack complex,BP,
741,GO:0001969,1.00000000001757,0.896283776800033,0,2,regulation of activation of membrane attack complex,BP,
8928,GO:0034770,1.00000000001758,0.631071156123646,0,9,histone H4-K20 methylation,BP,
7009,GO:0030689,1.00000000001758,0.872872933836549,0,3,Noc complex,CC,
10816,GO:0044300,1.00000000001758,0.851474029875293,0,3,cerebellar mossy fiber,CC,
342,GO:0000942,1.00000000001759,0.829874632367998,0,4,condensed nuclear chromosome outer kinetochore,CC,
20032,GO:2000619,1.00000000001759,0.873743293262218,0,3,negative regulation of histone H4-K16 acetylation,BP,
6341,GO:0021511,1.00000000001759,0.659043154284236,0,8,spinal cord patterning,BP,
250,GO:0000710,1.0000000000176,0.814125439341603,0,4,meiotic mismatch repair,BP,
13574,GO:0060023,1.0000000000176,0.819760696585909,0,4,soft palate development,BP,
18012,GO:1902455,1.00000000001762,0.815926680932916,0,4,negative regulation of stem cell population maintenance,BP,
18854,GO:1904429,1.00000000001762,0.709140206898848,0,7,regulation of t-circle formation,BP,
7393,GO:0031441,1.00000000001763,0.637300138795037,0,9,negative regulation of mRNA 3'-end processing,BP,
12100,GO:0048058,1.00000000001763,0.951870300383843,0,1,compound eye corneal lens development,BP,
12376,GO:0048749,1.00000000001763,0.951870300383843,0,1,compound eye development,BP,
8545,GO:0033871,1.00000000001763,0.956805364531139,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
11936,GO:0046970,1.00000000001763,0.956805364531139,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
14316,GO:0061433,1.00000000001763,0.956805364531139,0,1,cellular response to caloric restriction,BP,
14772,GO:0070446,1.00000000001763,0.956805364531139,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
2282,GO:0005230,1.00000000001765,0.639045686070795,0,9,extracellular ligand-gated ion channel activity,MF,
1480,GO:0003747,1.00000000001766,0.747349039854812,0,6,translation release factor activity,MF,
3623,GO:0008079,1.00000000001766,0.747349039854812,0,6,translation termination factor activity,MF,
13863,GO:0060452,1.00000000001766,0.792175144524128,0,5,positive regulation of cardiac muscle contraction,BP,
12482,GO:0050337,1.00000000001766,0.982667085287719,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
17507,GO:1900452,1.00000000001768,0.819347325192131,0,4,regulation of long term synaptic depression,BP,
1487,GO:0003796,1.0000000000177,0.961707964940198,0,1,lysozyme activity,MF,
10249,GO:0042979,1.00000000001771,0.837953812010733,0,4,ornithine decarboxylase regulator activity,MF,
17951,GO:1902267,1.00000000001771,0.837953812010733,0,4,regulation of polyamine transmembrane transport,BP,
4242,GO:0009438,1.00000000001772,0.815032343586815,0,5,methylglyoxal metabolic process,BP,
11499,GO:0045954,1.00000000001772,0.676026879311329,0,8,positive regulation of natural killer cell mediated cytotoxicity,BP,
18549,GO:1903722,1.00000000001772,0.927032494882998,0,2,regulation of centriole elongation,BP,
1498,GO:0003839,1.00000000001773,0.858041199660123,0,4,gamma-glutamylcyclotransferase activity,MF,
1759,GO:0004359,1.00000000001773,0.863382034465023,0,3,glutaminase activity,MF,
3585,GO:0007634,1.00000000001773,0.954647316643813,0,1,optokinetic behavior,BP,
14091,GO:0060876,1.00000000001773,0.954647316643813,0,1,semicircular canal formation,BP,
15023,GO:0070942,1.00000000001773,0.839208850756457,0,4,neutrophil mediated cytotoxicity,BP,
2373,GO:0005499,1.00000000001774,0.905550003930778,0,2,vitamin D binding,MF,
2449,GO:0005656,1.00000000001774,0.877011722040129,0,3,nuclear pre-replicative complex,CC,
2808,GO:0006267,1.00000000001774,0.877011722040129,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
9580,GO:0036387,1.00000000001774,0.877011722040129,0,3,pre-replicative complex,CC,
9581,GO:0036388,1.00000000001774,0.877011722040129,0,3,pre-replicative complex assembly,BP,
17964,GO:1902299,1.00000000001774,0.877011722040129,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
381,GO:0001013,1.00000000001774,0.677949271809387,0,8,RNA polymerase I regulatory region DNA binding,MF,
435,GO:0001163,1.00000000001774,0.677949271809387,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
436,GO:0001164,1.00000000001774,0.677949271809387,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
441,GO:0001188,1.00000000001774,0.677949271809387,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
10432,GO:0043273,1.00000000001775,0.946693267260282,0,1,CTPase activity,MF,
16376,GO:0090666,1.00000000001775,0.835104650152153,0,4,scaRNA localization to Cajal body,BP,
3016,GO:0006561,1.00000000001776,0.835415988328165,0,4,proline biosynthetic process,BP,
13553,GO:0055129,1.00000000001776,0.835415988328165,0,4,L-proline biosynthetic process,BP,
16428,GO:0097051,1.00000000001778,0.851339566208111,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
14897,GO:0070678,1.00000000001778,0.95411140101349,0,1,preprotein binding,MF,
11763,GO:0046600,1.00000000001778,0.674896510905243,0,8,negative regulation of centriole replication,BP,
9526,GO:0036228,1.00000000001779,0.90512820443681,0,2,protein localization to nuclear inner membrane,BP,
20022,GO:2000601,1.00000000001781,0.732825865329385,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
16621,GO:0097444,1.00000000001782,0.946778905881056,0,1,spine apparatus,CC,
19247,GO:1905355,1.00000000001782,0.946778905881056,0,1,spine apparatus assembly,BP,
1295,GO:0003105,1.00000000001783,0.886292624755288,0,3,negative regulation of glomerular filtration,BP,
5431,GO:0016281,1.00000000001784,0.655117145643874,0,9,eukaryotic translation initiation factor 4F complex,CC,
5775,GO:0016972,1.00000000001785,0.816703112880989,0,4,thiol oxidase activity,MF,
2279,GO:0005225,1.00000000001786,0.65568797974041,0,8,volume-sensitive anion channel activity,MF,
18574,GO:1903774,1.00000000001788,0.876274392468204,0,3,positive regulation of viral budding via host ESCRT complex,BP,
15021,GO:0070939,1.00000000001789,0.860468246023253,0,3,Dsl1/NZR complex,CC,
18260,GO:1903054,1.0000000000179,0.811833617365907,0,5,negative regulation of extracellular matrix organization,BP,
1757,GO:0004356,1.0000000000179,0.947781915248183,0,1,glutamate-ammonia ligase activity,MF,
2997,GO:0006542,1.0000000000179,0.947781915248183,0,1,glutamine biosynthetic process,BP,
5390,GO:0016211,1.0000000000179,0.947781915248183,0,1,ammonia ligase activity,MF,
6202,GO:0019676,1.0000000000179,0.947781915248183,0,1,ammonia assimilation cycle,BP,
1641,GO:0004081,1.00000000001794,0.927383009710686,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
3979,GO:0008796,1.00000000001794,0.927383009710686,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
6139,GO:0019401,1.00000000001795,0.839257629288232,0,4,alditol biosynthetic process,BP,
16543,GO:0097264,1.00000000001795,0.745673428518884,0,6,self proteolysis,BP,
4020,GO:0009032,1.00000000001796,0.959639595351897,0,1,thymidine phosphorylase activity,MF,
5369,GO:0016154,1.00000000001796,0.959639595351897,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
8898,GO:0034714,1.00000000001797,0.86150328063608,0,3,type III transforming growth factor beta receptor binding,MF,
9165,GO:0035517,1.00000000001797,0.853700388552049,0,3,PR-DUB complex,CC,
13538,GO:0055095,1.00000000001798,0.949534675913218,0,1,lipoprotein particle mediated signaling,BP,
13539,GO:0055096,1.00000000001798,0.949534675913218,0,1,low-density lipoprotein particle mediated signaling,BP,
6096,GO:0019276,1.00000000001798,0.95362223944461,0,1,UDP-N-acetylgalactosamine metabolic process,BP,
9035,GO:0035248,1.00000000001798,0.95362223944461,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
1514,GO:0003872,1.00000000001799,0.865552556853677,0,3,6-phosphofructokinase activity,MF,
19875,GO:2000322,1.000000000018,0.707040465045035,0,7,regulation of glucocorticoid receptor signaling pathway,BP,
14900,GO:0070682,1.00000000001801,0.873956299000366,0,3,proteasome regulatory particle assembly,BP,
1012,GO:0002488,1.00000000001801,0.94877023317477,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1013,GO:0002489,1.00000000001801,0.94877023317477,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
8806,GO:0034506,1.00000000001801,0.94877023317477,0,1,chromosome, centromeric core domain,CC,
11934,GO:0046968,1.00000000001801,0.94877023317477,0,1,peptide antigen transport,BP,
11944,GO:0046980,1.00000000001801,0.94877023317477,0,1,tapasin binding,MF,
15774,GO:0072356,1.00000000001801,0.94877023317477,0,1,chromosome passenger complex localization to kinetochore,BP,
12075,GO:0048014,1.00000000001801,0.946726897931484,0,1,Tie signaling pathway,BP,
12723,GO:0050928,1.00000000001801,0.946726897931484,0,1,negative regulation of positive chemotaxis,BP,
14218,GO:0061133,1.00000000001802,0.832908420663692,0,5,endopeptidase activator activity,MF,
254,GO:0000718,1.00000000001802,0.958842034258424,0,1,nucleotide-excision repair, DNA damage removal,BP,
1678,GO:0004139,1.00000000001802,0.958842034258424,0,1,deoxyribose-phosphate aldolase activity,MF,
10855,GO:0044349,1.00000000001802,0.958842034258424,0,1,DNA excision,BP,
11667,GO:0046403,1.00000000001802,0.958842034258424,0,1,polynucleotide 3'-phosphatase activity,MF,
16754,GO:0098503,1.00000000001802,0.958842034258424,0,1,DNA 3' dephosphorylation,BP,
16755,GO:0098504,1.00000000001802,0.958842034258424,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16757,GO:0098506,1.00000000001802,0.958842034258424,0,1,polynucleotide 3' dephosphorylation,BP,
20097,GO:2000721,1.00000000001803,0.947334915000395,0,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
4697,GO:0010848,1.00000000001803,0.952046763531293,0,1,regulation of chromatin disassembly,BP,
867,GO:0002199,1.00000000001803,0.727021235285019,0,7,zona pellucida receptor complex,CC,
9920,GO:0042256,1.00000000001806,0.809062385229631,0,5,mature ribosome assembly,BP,
19973,GO:2000489,1.00000000001806,0.865758442790332,0,3,regulation of hepatic stellate cell activation,BP,
3414,GO:0007197,1.00000000001807,0.904150048840414,0,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
5759,GO:0016907,1.00000000001807,0.904150048840414,0,2,G-protein coupled acetylcholine receptor activity,MF,
9783,GO:0039689,1.00000000001807,0.865809753789924,0,3,negative stranded viral RNA replication,BP,
20009,GO:2000574,1.00000000001808,0.707890477672022,0,8,regulation of microtubule motor activity,BP,
17217,GO:0106049,1.00000000001808,0.787732924716665,0,5,regulation of cellular response to osmotic stress,BP,
17922,GO:1902218,1.00000000001808,0.787732924716665,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
15880,GO:0072588,1.00000000001809,0.836839151286933,0,8,box H/ACA RNP complex,CC,
8573,GO:0034038,1.00000000001809,0.967727756220948,0,1,deoxyhypusine synthase activity,MF,
18624,GO:1903891,1.00000000001809,0.821469196803974,0,4,regulation of ATF6-mediated unfolded protein response,BP,
16612,GO:0097427,1.0000000000181,0.771988834383265,0,5,microtubule bundle,CC,
2487,GO:0005726,1.0000000000181,0.809362515507043,0,4,perichromatin fibrils,CC,
112,GO:0000229,1.00000000001811,0.960524026593744,0,1,cytoplasmic chromosome,CC,
127,GO:0000262,1.00000000001811,0.960524026593744,0,1,mitochondrial chromosome,CC,
18511,GO:1903624,1.00000000001813,0.738335792224871,0,7,regulation of DNA catabolic process,BP,
7960,GO:0032554,1.00000000001817,0.846071487431413,0,4,purine deoxyribonucleotide binding,MF,
8413,GO:0033385,1.00000000001817,0.953790519259933,0,1,geranylgeranyl diphosphate metabolic process,BP,
8414,GO:0033386,1.00000000001817,0.953790519259933,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
6812,GO:0030259,1.00000000001818,0.827684129276796,0,4,lipid glycosylation,BP,
1579,GO:0003986,1.00000000001822,0.902188058641086,0,3,acetyl-CoA hydrolase activity,MF,
16211,GO:0090230,1.00000000001822,0.815013982167757,0,4,regulation of centromere complex assembly,BP,
17409,GO:1900126,1.00000000001823,0.860221226938237,0,3,negative regulation of hyaluronan biosynthetic process,BP,
1623,GO:0004053,1.00000000001823,0.920937570139683,0,2,arginase activity,MF,
6182,GO:0019547,1.00000000001823,0.920937570139683,0,2,arginine catabolic process to ornithine,BP,
17159,GO:0102420,1.00000000001824,0.82089600397226,0,4,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
1725,GO:0004314,1.00000000001826,0.905765830483324,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
5489,GO:0016419,1.00000000001826,0.905765830483324,0,2,S-malonyltransferase activity,MF,
5490,GO:0016420,1.00000000001826,0.905765830483324,0,2,malonyltransferase activity,MF,
1959,GO:0004660,1.00000000001826,0.91599149090871,0,2,protein farnesyltransferase activity,MF,
2636,GO:0005965,1.00000000001826,0.91599149090871,0,2,protein farnesyltransferase complex,CC,
2258,GO:0005170,1.00000000001827,0.946708000607208,0,1,neurotrophin TRKC receptor binding,MF,
6134,GO:0019388,1.00000000001827,0.700247132411708,0,8,galactose catabolic process,BP,
9747,GO:0038203,1.00000000001827,0.715431138338879,0,7,TORC2 signaling,BP,
19420,GO:1905908,1.00000000001828,0.831153617024077,0,4,positive regulation of amyloid fibril formation,BP,
5428,GO:0016277,1.00000000001828,0.954740509579638,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
17788,GO:1901804,1.00000000001828,0.954740509579638,0,1,beta-glucoside metabolic process,BP,
17789,GO:1901805,1.00000000001828,0.954740509579638,0,1,beta-glucoside catabolic process,BP,
18866,GO:1904457,1.00000000001828,0.954740509579638,0,1,positive regulation of neuronal action potential,BP,
10752,GO:0044128,1.00000000001828,0.946802343356717,0,1,positive regulation of growth of symbiont in host,BP,
10758,GO:0044148,1.00000000001828,0.946802343356717,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
2165,GO:0004996,1.00000000001828,0.94937630553152,0,1,thyroid-stimulating hormone receptor activity,MF,
9743,GO:0038194,1.00000000001828,0.94937630553152,0,1,thyroid-stimulating hormone signaling pathway,BP,
9748,GO:0039003,1.00000000001828,0.94937630553152,0,1,pronephric field specification,BP,
9751,GO:0039017,1.00000000001828,0.94937630553152,0,1,pattern specification involved in pronephros development,BP,
10154,GO:0042728,1.00000000001828,0.94937630553152,0,1,flavin-containing compound catabolic process,BP,
14776,GO:0070460,1.00000000001828,0.94937630553152,0,1,thyroid-stimulating hormone secretion,BP,
15570,GO:0072003,1.00000000001828,0.94937630553152,0,1,kidney rudiment formation,BP,
15571,GO:0072004,1.00000000001828,0.94937630553152,0,1,kidney field specification,BP,
15583,GO:0072025,1.00000000001828,0.94937630553152,0,1,distal convoluted tubule development,BP,
15602,GO:0072069,1.00000000001828,0.94937630553152,0,1,DCT cell differentiation,BP,
15706,GO:0072221,1.00000000001828,0.94937630553152,0,1,metanephric distal convoluted tubule development,BP,
15715,GO:0072240,1.00000000001828,0.94937630553152,0,1,metanephric DCT cell differentiation,BP,
15744,GO:0072304,1.00000000001828,0.94937630553152,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15745,GO:0072305,1.00000000001828,0.94937630553152,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15748,GO:0072309,1.00000000001828,0.94937630553152,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15797,GO:0072389,1.00000000001828,0.94937630553152,0,1,flavin adenine dinucleotide catabolic process,BP,
17444,GO:1900200,1.00000000001828,0.94937630553152,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17445,GO:1900204,1.00000000001828,0.94937630553152,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17446,GO:1900205,1.00000000001828,0.94937630553152,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17449,GO:1900211,1.00000000001828,0.94937630553152,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17450,GO:1900212,1.00000000001828,0.94937630553152,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17451,GO:1900214,1.00000000001828,0.94937630553152,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17452,GO:1900215,1.00000000001828,0.94937630553152,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17453,GO:1900217,1.00000000001828,0.94937630553152,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17454,GO:1900218,1.00000000001828,0.94937630553152,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17577,GO:1901147,1.00000000001828,0.94937630553152,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18228,GO:1903004,1.00000000001828,0.94937630553152,0,1,regulation of protein K63-linked deubiquitination,BP,
18229,GO:1903006,1.00000000001828,0.94937630553152,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18230,GO:1903007,1.00000000001828,0.94937630553152,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
20020,GO:2000592,1.00000000001828,0.94937630553152,0,1,regulation of metanephric DCT cell differentiation,BP,
20021,GO:2000594,1.00000000001828,0.94937630553152,0,1,positive regulation of metanephric DCT cell differentiation,BP,
20027,GO:2000612,1.00000000001828,0.94937630553152,0,1,regulation of thyroid-stimulating hormone secretion,BP,
8144,GO:0032848,1.00000000001829,0.949477969062331,0,1,negative regulation of cellular pH reduction,BP,
10486,GO:0043375,1.00000000001829,0.949477969062331,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11806,GO:0046668,1.00000000001829,0.949477969062331,0,1,regulation of retinal cell programmed cell death,BP,
11807,GO:0046671,1.00000000001829,0.949477969062331,0,1,negative regulation of retinal cell programmed cell death,BP,
9266,GO:0035673,1.00000000001829,0.811768117200529,0,4,oligopeptide transmembrane transporter activity,MF,
1053,GO:0002578,1.00000000001829,0.836487910461311,0,4,negative regulation of antigen processing and presentation,BP,
2011,GO:0004733,1.0000000000183,0.951190365818015,0,1,pyridoxamine-phosphate oxidase activity,MF,
17144,GO:0102200,1.0000000000183,0.946745456016543,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
8464,GO:0033600,1.00000000001831,0.822426596994881,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
7388,GO:0031436,1.00000000001832,0.903394106383518,0,2,BRCA1-BARD1 complex,CC,
15279,GO:0071442,1.00000000001832,0.865744546163335,0,3,positive regulation of histone H3-K14 acetylation,BP,
9713,GO:0038114,1.00000000001833,0.806859228087384,0,4,interleukin-21-mediated signaling pathway,BP,
16858,GO:0098756,1.00000000001833,0.806859228087384,0,4,response to interleukin-21,BP,
16859,GO:0098757,1.00000000001833,0.806859228087384,0,4,cellular response to interleukin-21,BP,
7168,GO:0031034,1.00000000001833,0.806071410297414,0,4,myosin filament assembly,BP,
18356,GO:1903301,1.00000000001833,0.800898596998128,0,5,positive regulation of hexokinase activity,BP,
9602,GO:0036457,1.00000000001835,0.80656200918312,0,4,keratohyalin granule,CC,
2147,GO:0004960,1.00000000001836,0.955142021034895,0,1,thromboxane receptor activity,MF,
2148,GO:0004961,1.00000000001836,0.955142021034895,0,1,thromboxane A2 receptor activity,MF,
5322,GO:0016036,1.00000000001836,0.955142021034895,0,1,cellular response to phosphate starvation,BP,
7330,GO:0031335,1.00000000001836,0.955142021034895,0,1,regulation of sulfur amino acid metabolic process,BP,
7331,GO:0031337,1.00000000001836,0.955142021034895,0,1,positive regulation of sulfur amino acid metabolic process,BP,
9337,GO:0035814,1.00000000001836,0.955142021034895,0,1,negative regulation of renal sodium excretion,BP,
9742,GO:0038193,1.00000000001836,0.955142021034895,0,1,thromboxane A2 signaling pathway,BP,
12536,GO:0050666,1.00000000001836,0.955142021034895,0,1,regulation of homocysteine metabolic process,BP,
12538,GO:0050668,1.00000000001836,0.955142021034895,0,1,positive regulation of homocysteine metabolic process,BP,
18076,GO:1902617,1.00000000001836,0.830302880099049,0,4,response to fluoride,BP,
16487,GO:0097157,1.00000000001836,0.674325943782031,0,8,pre-mRNA intronic binding,MF,
9205,GO:0035586,1.00000000001836,0.726170849858531,0,7,purinergic receptor activity,MF,
341,GO:0000941,1.00000000001838,0.955196402573596,0,1,condensed nuclear chromosome inner kinetochore,CC,
13034,GO:0051456,1.00000000001838,0.955196402573596,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
6012,GO:0019050,1.00000000001838,0.883040125766914,0,3,suppression by virus of host apoptotic process,BP,
9766,GO:0039526,1.00000000001838,0.883040125766914,0,3,modulation by virus of host apoptotic process,BP,
1501,GO:0003844,1.00000000001839,0.9527604537818,0,1,1,4-alpha-glucan branching enzyme activity,MF,
17178,GO:0102752,1.00000000001839,0.9527604537818,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
7570,GO:0031914,1.0000000000184,0.875341578591465,0,3,negative regulation of synaptic plasticity,BP,
3521,GO:0007495,1.0000000000184,0.952450420827511,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
14789,GO:0070483,1.0000000000184,0.952450420827511,0,1,detection of hypoxia,BP,
7554,GO:0031859,1.0000000000184,0.95712633743979,0,1,platelet activating factor receptor binding,MF,
9879,GO:0042137,1.0000000000184,0.95712633743979,0,1,sequestering of neurotransmitter,BP,
17304,GO:0140059,1.00000000001841,0.77928998911704,0,5,dendrite arborization,BP,
5767,GO:0016929,1.00000000001843,0.732381682330516,0,6,SUMO-specific protease activity,MF,
1618,GO:0004044,1.00000000001843,0.949897213023247,0,1,amidophosphoribosyltransferase activity,MF,
10827,GO:0044316,1.00000000001843,0.950025717232532,0,1,cone cell pedicle,CC,
14713,GO:0070330,1.00000000001844,0.650744766518105,0,9,aromatase activity,MF,
7892,GO:0032455,1.00000000001846,0.859008000503533,0,3,nerve growth factor processing,BP,
309,GO:0000820,1.00000000001846,0.856120255103065,0,3,regulation of glutamine family amino acid metabolic process,BP,
14659,GO:0070236,1.00000000001847,0.828176181261209,0,4,negative regulation of activation-induced cell death of T cells,BP,
19622,GO:1990730,1.00000000001847,0.902654974868388,0,2,VCP-NSFL1C complex,CC,
9967,GO:0042350,1.00000000001848,0.878100901483552,0,3,GDP-L-fucose biosynthetic process,BP,
19616,GO:1990712,1.00000000001848,0.792440064996859,0,5,HFE-transferrin receptor complex,CC,
2030,GO:0004766,1.00000000001849,0.965921503871303,0,1,spermidine synthase activity,MF,
560,GO:0001692,1.0000000000185,0.974208378789926,0,1,histamine metabolic process,BP,
561,GO:0001695,1.0000000000185,0.974208378789926,0,1,histamine catabolic process,BP,
11738,GO:0046539,1.0000000000185,0.974208378789926,0,1,histamine N-methyltransferase activity,MF,
18550,GO:1903723,1.0000000000185,0.974208378789926,0,1,negative regulation of centriole elongation,BP,
1644,GO:0004084,1.00000000001851,0.90896378144742,0,2,branched-chain-amino-acid transaminase activity,MF,
4047,GO:0009082,1.00000000001851,0.90896378144742,0,2,branched-chain amino acid biosynthetic process,BP,
4055,GO:0009098,1.00000000001851,0.90896378144742,0,2,leucine biosynthetic process,BP,
4056,GO:0009099,1.00000000001851,0.90896378144742,0,2,valine biosynthetic process,BP,
13398,GO:0052654,1.00000000001851,0.90896378144742,0,2,L-leucine transaminase activity,MF,
13399,GO:0052655,1.00000000001851,0.90896378144742,0,2,L-valine transaminase activity,MF,
13400,GO:0052656,1.00000000001851,0.90896378144742,0,2,L-isoleucine transaminase activity,MF,
8088,GO:0032764,1.00000000001852,0.913954368351696,0,2,negative regulation of mast cell cytokine production,BP,
17902,GO:1902167,1.00000000001852,0.982722742378831,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19018,GO:1904803,1.00000000001852,0.982722742378831,0,1,regulation of translation involved in cellular response to UV,BP,
3128,GO:0006707,1.00000000001853,0.835862041409718,0,4,cholesterol catabolic process,BP,
5360,GO:0016127,1.00000000001853,0.835862041409718,0,4,sterol catabolic process,BP,
13796,GO:0060368,1.00000000001854,0.751570815319299,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
5919,GO:0018171,1.00000000001854,0.852035547859478,0,4,peptidyl-cysteine oxidation,BP,
3742,GO:0008278,1.00000000001854,0.664216040815748,0,8,cohesin complex,CC,
783,GO:0002038,1.00000000001855,0.95515760824766,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
4720,GO:0010879,1.00000000001855,0.95515760824766,0,1,cholesterol transport involved in cholesterol storage,BP,
9092,GO:0035352,1.00000000001855,0.95515760824766,0,1,NAD transmembrane transport,BP,
10342,GO:0043132,1.00000000001855,0.95515760824766,0,1,NAD transport,BP,
10949,GO:0044610,1.00000000001855,0.95515760824766,0,1,FMN transmembrane transporter activity,MF,
13166,GO:0051724,1.00000000001855,0.95515760824766,0,1,NAD transmembrane transporter activity,MF,
914,GO:0002296,1.00000000001855,0.898293075953193,0,2,T-helper 1 cell lineage commitment,BP,
8211,GO:0032960,1.00000000001855,0.816136271946658,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
1507,GO:0003858,1.00000000001856,0.907218070870285,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
13669,GO:0060166,1.00000000001856,0.916089773632126,0,2,olfactory pit development,BP,
895,GO:0002265,1.00000000001857,0.8523893634027,0,3,astrocyte activation involved in immune response,BP,
6743,GO:0030157,1.00000000001858,0.742012339189388,0,6,pancreatic juice secretion,BP,
7986,GO:0032595,1.00000000001859,0.955502347697,0,1,B cell receptor transport within lipid bilayer,BP,
7988,GO:0032597,1.00000000001859,0.955502347697,0,1,B cell receptor transport into membrane raft,BP,
7989,GO:0032599,1.00000000001859,0.955502347697,0,1,protein transport out of membrane raft,BP,
7990,GO:0032600,1.00000000001859,0.955502347697,0,1,chemokine receptor transport out of membrane raft,BP,
8180,GO:0032913,1.00000000001859,0.955502347697,0,1,negative regulation of transforming growth factor beta3 production,BP,
8470,GO:0033606,1.00000000001859,0.955502347697,0,1,chemokine receptor transport within lipid bilayer,BP,
15654,GO:0072139,1.00000000001859,0.955502347697,0,1,glomerular parietal epithelial cell differentiation,BP,
20125,GO:2000768,1.00000000001859,0.955502347697,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
302,GO:0000811,1.0000000000186,0.874881956341565,0,3,GINS complex,CC,
4654,GO:0010793,1.0000000000186,0.777191097396223,0,5,regulation of mRNA export from nucleus,BP,
12805,GO:0051086,1.00000000001861,0.956676531865055,0,1,chaperone mediated protein folding independent of cofactor,BP,
13797,GO:0060369,1.00000000001861,0.824198434741521,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
8651,GO:0034191,1.00000000001861,0.864780532941574,0,3,apolipoprotein A-I receptor binding,MF,
3855,GO:0008466,1.00000000001862,0.957995202283165,0,1,glycogenin glucosyltransferase activity,MF,
17177,GO:0102751,1.00000000001862,0.957995202283165,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
3869,GO:0008488,1.00000000001862,0.952509463543074,0,1,gamma-glutamyl carboxylase activity,MF,
6200,GO:0019673,1.00000000001862,0.763324511613406,0,7,GDP-mannose metabolic process,BP,
13118,GO:0051639,1.00000000001862,0.662243973589889,0,8,actin filament network formation,BP,
1304,GO:0003139,1.00000000001865,0.837366790498251,0,4,secondary heart field specification,BP,
9679,GO:0038039,1.00000000001866,0.947777249617954,0,1,G-protein coupled receptor heterodimeric complex,CC,
7971,GO:0032571,1.00000000001867,0.90893163832749,0,2,response to vitamin K,BP,
15186,GO:0071307,1.00000000001867,0.90893163832749,0,2,cellular response to vitamin K,BP,
18205,GO:1902960,1.00000000001869,0.904042838328059,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19200,GO:1905246,1.00000000001869,0.904042838328059,0,2,negative regulation of aspartic-type peptidase activity,BP,
16618,GO:0097441,1.00000000001871,0.869861300817391,0,3,basal dendrite,CC,
19559,GO:1990442,1.00000000001871,0.911584796596449,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
14780,GO:0070470,1.00000000001872,0.864045165652155,0,4,plasma membrane respiratory chain,CC,
12885,GO:0051195,1.00000000001872,0.639397168248048,0,9,negative regulation of cofactor metabolic process,BP,
6969,GO:0030619,1.00000000001873,0.738448716952235,0,7,U1 snRNA binding,MF,
862,GO:0002190,1.00000000001873,0.817608607522521,0,5,cap-independent translational initiation,BP,
8103,GO:0032783,1.00000000001873,0.824868836240343,0,4,ELL-EAF complex,CC,
2689,GO:0006049,1.00000000001874,0.953457046365369,0,1,UDP-N-acetylglucosamine catabolic process,BP,
16272,GO:0090315,1.00000000001874,0.830035476634263,0,4,negative regulation of protein targeting to membrane,BP,
1838,GO:0004490,1.00000000001874,0.96058035019883,0,1,methylglutaconyl-CoA hydratase activity,MF,
12447,GO:0050011,1.00000000001874,0.96058035019883,0,1,itaconyl-CoA hydratase activity,MF,
2084,GO:0004839,1.00000000001875,0.774213708234405,0,5,ubiquitin activating enzyme activity,MF,
1842,GO:0004494,1.00000000001876,0.953314523636602,0,1,methylmalonyl-CoA mutase activity,MF,
16584,GO:0097362,1.00000000001876,0.906925462986798,0,2,MCM8-MCM9 complex,CC,
13563,GO:0060010,1.00000000001877,0.951861300555999,0,1,Sertoli cell fate commitment,BP,
12127,GO:0048170,1.0000000000188,0.816431527190019,0,4,positive regulation of long-term neuronal synaptic plasticity,BP,
12394,GO:0048793,1.0000000000188,0.808578474558663,0,4,pronephros development,BP,
558,GO:0001681,1.0000000000188,0.953699843480281,0,1,sialate O-acetylesterase activity,MF,
3650,GO:0008126,1.0000000000188,0.953699843480281,0,1,acetylesterase activity,MF,
17811,GO:1901881,1.00000000001881,0.660761836431033,0,9,positive regulation of protein depolymerization,BP,
761,GO:0001999,1.00000000001882,0.820871719266036,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
762,GO:0002001,1.00000000001882,0.820871719266036,0,4,renin secretion into blood stream,BP,
17934,GO:1902232,1.00000000001884,0.915057285814061,0,2,regulation of positive thymic T cell selection,BP,
11976,GO:0047184,1.00000000001884,0.786232321743922,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
11233,GO:0045358,1.00000000001884,0.923963525267496,0,2,negative regulation of interferon-beta biosynthetic process,BP,
8053,GO:0032701,1.00000000001885,0.914067504480874,0,2,negative regulation of interleukin-18 production,BP,
19423,GO:1905918,1.00000000001886,0.955572441890158,0,1,regulation of CoA-transferase activity,BP,
19424,GO:1905920,1.00000000001886,0.955572441890158,0,1,positive regulation of CoA-transferase activity,BP,
8126,GO:0032809,1.00000000001886,0.696957419944047,0,7,neuronal cell body membrane,CC,
10814,GO:0044298,1.00000000001886,0.696957419944047,0,7,cell body membrane,CC,
17718,GO:1901611,1.00000000001887,0.668525050879011,0,9,phosphatidylglycerol binding,MF,
10264,GO:0042999,1.00000000001887,0.947330781732259,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10267,GO:0043002,1.00000000001887,0.947330781732259,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10268,GO:0043004,1.00000000001887,0.947330781732259,0,1,cytoplasmic sequestering of CFTR protein,BP,
1634,GO:0004070,1.00000000001887,0.896181673308104,0,2,aspartate carbamoyltransferase activity,MF,
1646,GO:0004087,1.00000000001887,0.896181673308104,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1647,GO:0004088,1.00000000001887,0.896181673308104,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1687,GO:0004151,1.00000000001887,0.896181673308104,0,2,dihydroorotase activity,MF,
5653,GO:0016743,1.00000000001887,0.896181673308104,0,2,carboxyl- or carbamoyltransferase activity,MF,
1776,GO:0004378,1.00000000001888,0.953506018629089,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
17175,GO:0102704,1.00000000001888,0.953506018629089,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
9630,GO:0036494,1.00000000001889,0.946674580771948,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
3872,GO:0008494,1.00000000001889,0.743278581522985,0,7,translation activator activity,MF,
6946,GO:0030550,1.0000000000189,0.872204589722578,0,3,acetylcholine receptor inhibitor activity,MF,
10243,GO:0042953,1.00000000001891,0.74010395639354,0,6,lipoprotein transport,BP,
11035,GO:0044872,1.00000000001891,0.74010395639354,0,6,lipoprotein localization,BP,
3518,GO:0007468,1.00000000001891,0.956127834884172,0,1,regulation of rhodopsin gene expression,BP,
11448,GO:0045872,1.00000000001891,0.956127834884172,0,1,positive regulation of rhodopsin gene expression,BP,
12145,GO:0048227,1.00000000001892,0.69563014258213,0,8,plasma membrane to endosome transport,BP,
805,GO:0002071,1.00000000001893,0.908432972688152,0,2,glandular epithelial cell maturation,BP,
2958,GO:0006489,1.00000000001895,0.719130558309692,0,7,dolichyl diphosphate biosynthetic process,BP,
11691,GO:0046465,1.00000000001895,0.719130558309692,0,7,dolichyl diphosphate metabolic process,BP,
17694,GO:1901551,1.00000000001895,0.948207942010993,0,1,negative regulation of endothelial cell development,BP,
18288,GO:1903141,1.00000000001895,0.948207942010993,0,1,negative regulation of establishment of endothelial barrier,BP,
8717,GO:0034361,1.00000000001896,0.759460989563678,0,7,very-low-density lipoprotein particle,CC,
8739,GO:0034385,1.00000000001896,0.759460989563678,0,7,triglyceride-rich plasma lipoprotein particle,CC,
18853,GO:1904428,1.00000000001896,0.866687188892187,0,3,negative regulation of tubulin deacetylation,BP,
4059,GO:0009106,1.00000000001896,0.912085115980605,0,2,lipoate metabolic process,BP,
15894,GO:0072610,1.00000000001897,0.823652526763487,0,4,interleukin-12 secretion,BP,
20262,GO:2001182,1.00000000001897,0.823652526763487,0,4,regulation of interleukin-12 secretion,BP,
4161,GO:0009221,1.00000000001897,0.718443623579582,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
8326,GO:0033162,1.00000000001898,0.782693650664826,0,6,melanosome membrane,CC,
11045,GO:0045009,1.00000000001898,0.782693650664826,0,6,chitosome,CC,
16398,GO:0090741,1.00000000001898,0.782693650664826,0,6,pigment granule membrane,CC,
4145,GO:0009204,1.000000000019,0.75306499820925,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
11124,GO:0045141,1.00000000001903,0.672007298366438,0,8,meiotic telomere clustering,BP,
16207,GO:0090220,1.00000000001903,0.672007298366438,0,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
18371,GO:1903335,1.00000000001903,0.843916192080909,0,4,regulation of vacuolar transport,BP,
10116,GO:0042631,1.00000000001904,0.95067861555428,0,1,cellular response to water deprivation,BP,
15662,GO:0072162,1.00000000001904,0.902443390381206,0,2,metanephric mesenchymal cell differentiation,BP,
18882,GO:1904505,1.00000000001904,0.815918121054323,0,4,regulation of telomere maintenance in response to DNA damage,BP,
18883,GO:1904506,1.00000000001904,0.815918121054323,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
1207,GO:0002864,1.00000000001904,0.849356825979823,0,4,regulation of acute inflammatory response to antigenic stimulus,BP,
15784,GO:0072367,1.00000000001904,0.809834205438628,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
851,GO:0002174,1.00000000001905,0.95340704305205,0,1,mammary stem cell proliferation,BP,
12007,GO:0047395,1.00000000001905,0.95340704305205,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12029,GO:0047620,1.00000000001905,0.95340704305205,0,1,acylglycerol kinase activity,MF,
18948,GO:1904675,1.00000000001905,0.95340704305205,0,1,regulation of somatic stem cell division,BP,
18949,GO:1904677,1.00000000001905,0.95340704305205,0,1,positive regulation of somatic stem cell division,BP,
19754,GO:2000101,1.00000000001905,0.95340704305205,0,1,regulation of mammary stem cell proliferation,BP,
19755,GO:2000103,1.00000000001905,0.95340704305205,0,1,positive regulation of mammary stem cell proliferation,BP,
9563,GO:0036337,1.00000000001906,0.817219970275488,0,4,Fas signaling pathway,BP,
9560,GO:0036333,1.00000000001906,0.954216637107357,0,1,hepatocyte homeostasis,BP,
19001,GO:1904772,1.00000000001906,0.954216637107357,0,1,response to tetrachloromethane,BP,
19086,GO:1904947,1.00000000001907,0.953090593955902,0,1,folic acid import into mitochondrion,BP,
4001,GO:0008903,1.00000000001908,0.969406896972966,0,1,hydroxypyruvate isomerase activity,MF,
4913,GO:0014846,1.0000000000191,0.948089276225,0,1,esophagus smooth muscle contraction,BP,
5036,GO:0015204,1.00000000001911,0.865736420927192,0,3,urea transmembrane transporter activity,MF,
5231,GO:0015840,1.00000000001911,0.865736420927192,0,3,urea transport,BP,
12467,GO:0050220,1.00000000001912,0.857967794854874,0,4,prostaglandin-E synthase activity,MF,
7465,GO:0031616,1.00000000001913,0.677063564135585,0,9,spindle pole centrosome,CC,
9529,GO:0036250,1.00000000001916,0.956946967852089,0,1,peroxisome transport along microtubule,BP,
10967,GO:0044721,1.00000000001916,0.956946967852089,0,1,protein import into peroxisome matrix, substrate release,BP,
9712,GO:0038113,1.00000000001916,0.896330464464082,0,2,interleukin-9-mediated signaling pathway,BP,
15103,GO:0071104,1.00000000001916,0.896330464464082,0,2,response to interleukin-9,BP,
15220,GO:0071355,1.00000000001916,0.896330464464082,0,2,cellular response to interleukin-9,BP,
246,GO:0000702,1.00000000001917,0.833855373899255,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
4526,GO:0010585,1.00000000001918,0.95695458352263,0,1,glutamine secretion,BP,
18591,GO:1903803,1.00000000001918,0.95695458352263,0,1,L-glutamine import across plasma membrane,BP,
1972,GO:0004679,1.00000000001919,0.706359620504476,0,7,AMP-activated protein kinase activity,MF,
1069,GO:0002625,1.00000000001919,0.956812672186255,0,1,regulation of T cell antigen processing and presentation,BP,
1070,GO:0002626,1.00000000001919,0.956812672186255,0,1,negative regulation of T cell antigen processing and presentation,BP,
4400,GO:0010106,1.00000000001919,0.956812672186255,0,1,cellular response to iron ion starvation,BP,
18792,GO:1904282,1.00000000001919,0.956812672186255,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18793,GO:1904283,1.00000000001919,0.956812672186255,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20266,GO:2001186,1.00000000001919,0.956812672186255,0,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
4306,GO:0009753,1.0000000000192,0.927338290950696,0,2,response to jasmonic acid,BP,
5983,GO:0018636,1.0000000000192,0.927338290950696,0,2,phenanthrene 9,10-monooxygenase activity,MF,
11957,GO:0047023,1.0000000000192,0.927338290950696,0,2,androsterone dehydrogenase activity,MF,
11964,GO:0047086,1.0000000000192,0.927338290950696,0,2,ketosteroid monooxygenase activity,MF,
11966,GO:0047115,1.0000000000192,0.927338290950696,0,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
15249,GO:0071395,1.0000000000192,0.927338290950696,0,2,cellular response to jasmonic acid stimulus,BP,
8985,GO:0035090,1.0000000000192,0.786651243303564,0,5,maintenance of apical/basal cell polarity,BP,
11157,GO:0045199,1.0000000000192,0.786651243303564,0,5,maintenance of epithelial cell apical/basal polarity,BP,
19586,GO:1990573,1.00000000001923,0.867079550804406,0,3,potassium ion import across plasma membrane,BP,
13645,GO:0060126,1.00000000001924,0.906778419691231,0,2,somatotropin secreting cell differentiation,BP,
17398,GO:1900113,1.00000000001925,0.79067203589948,0,5,negative regulation of histone H3-K9 trimethylation,BP,
4390,GO:0010040,1.00000000001927,0.842175351080533,0,4,response to iron(II) ion,BP,
6106,GO:0019322,1.00000000001929,0.844072994905518,0,4,pentose biosynthetic process,BP,
6401,GO:0021603,1.0000000000193,0.818736837114407,0,4,cranial nerve formation,BP,
11189,GO:0045272,1.00000000001931,0.90499558005221,0,3,plasma membrane respiratory chain complex I,CC,
6302,GO:0019911,1.00000000001933,0.70006916892912,0,8,structural constituent of myelin sheath,MF,
18354,GO:1903299,1.00000000001934,0.737237215598375,0,7,regulation of hexokinase activity,BP,
8909,GO:0034729,1.00000000001935,0.868217148950984,0,3,histone H3-K79 methylation,BP,
14274,GO:0061314,1.00000000001935,0.772799118355338,0,5,Notch signaling involved in heart development,BP,
8848,GO:0034640,1.00000000001935,0.952270430722708,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
17018,GO:0099098,1.00000000001935,0.952270430722708,0,1,microtubule polymerization based movement,BP,
19577,GO:1990523,1.00000000001935,0.952270430722708,0,1,bone regeneration,BP,
8191,GO:0032926,1.00000000001936,0.715802990803927,0,7,negative regulation of activin receptor signaling pathway,BP,
10150,GO:0042721,1.00000000001936,0.829482440186151,0,5,mitochondrial inner membrane protein insertion complex,CC,
7014,GO:0030696,1.00000000001937,0.952545062052579,0,1,tRNA (m5U54) methyltransferase activity,MF,
7015,GO:0030697,1.00000000001937,0.952545062052579,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
19938,GO:2000409,1.00000000001938,0.957592332109484,0,1,positive regulation of T cell extravasation,BP,
19956,GO:2000451,1.00000000001938,0.957592332109484,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19958,GO:2000454,1.00000000001938,0.957592332109484,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9678,GO:0038037,1.00000000001942,0.8742336625121,0,3,G-protein coupled receptor dimeric complex,CC,
16711,GO:0097648,1.00000000001942,0.8742336625121,0,3,G-protein coupled receptor complex,CC,
15288,GO:0071458,1.00000000001942,0.784071428149873,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16099,GO:0090063,1.00000000001942,0.817674228659202,0,4,positive regulation of microtubule nucleation,BP,
2738,GO:0006116,1.00000000001944,0.905637645217752,0,2,NADH oxidation,BP,
902,GO:0002278,1.00000000001944,0.838082209320826,0,4,eosinophil activation involved in immune response,BP,
993,GO:0002447,1.00000000001944,0.838082209320826,0,4,eosinophil mediated immunity,BP,
10454,GO:0043307,1.00000000001944,0.838082209320826,0,4,eosinophil activation,BP,
10455,GO:0043308,1.00000000001944,0.838082209320826,0,4,eosinophil degranulation,BP,
12324,GO:0048665,1.00000000001946,0.706367076960039,0,7,neuron fate specification,BP,
19968,GO:2000480,1.00000000001947,0.726009895518165,0,7,negative regulation of cAMP-dependent protein kinase activity,BP,
6739,GO:0030151,1.00000000001947,0.828302351275547,0,4,molybdenum ion binding,MF,
3009,GO:0006554,1.00000000001947,0.67561746584679,0,8,lysine catabolic process,BP,
969,GO:0002408,1.00000000001947,0.946681100169202,0,1,myeloid dendritic cell chemotaxis,BP,
3420,GO:0007206,1.00000000001947,0.948164829515462,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
15462,GO:0071765,1.00000000001947,0.948164829515462,0,1,nuclear inner membrane organization,BP,
19730,GO:2000048,1.00000000001948,0.928964964120625,0,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,
6572,GO:0022027,1.00000000001949,0.803563981627004,0,4,interkinetic nuclear migration,BP,
16947,GO:0098914,1.00000000001949,0.902685860643422,0,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,
17102,GO:0099624,1.00000000001949,0.902685860643422,0,2,atrial cardiac muscle cell membrane repolarization,BP,
7315,GO:0031314,1.0000000000195,0.782617894316042,0,5,extrinsic component of mitochondrial inner membrane,CC,
8337,GO:0033181,1.00000000001951,0.959488029472646,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
10190,GO:0042780,1.00000000001951,0.735250812189186,0,7,tRNA 3'-end processing,BP,
19539,GO:1990405,1.00000000001951,0.814943856349238,0,4,protein antigen binding,MF,
2696,GO:0006059,1.00000000001952,0.886803270776442,0,3,hexitol metabolic process,BP,
10640,GO:0043634,1.00000000001952,0.748663520099637,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
13171,GO:0051731,1.00000000001952,0.823720679113762,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
5740,GO:0016882,1.00000000001955,0.927262615437947,0,2,cyclo-ligase activity,MF,
3644,GO:0008117,1.00000000001956,0.946671287131652,0,1,sphinganine-1-phosphate aldolase activity,MF,
1547,GO:0003939,1.00000000001956,0.954443871327138,0,1,L-iditol 2-dehydrogenase activity,MF,
2699,GO:0006062,1.00000000001956,0.954443871327138,0,1,sorbitol catabolic process,BP,
6143,GO:0019407,1.00000000001956,0.954443871327138,0,1,hexitol catabolic process,BP,
6169,GO:0019519,1.00000000001956,0.954443871327138,0,1,pentitol metabolic process,BP,
6172,GO:0019527,1.00000000001956,0.954443871327138,0,1,pentitol catabolic process,BP,
7317,GO:0031320,1.00000000001956,0.954443871327138,0,1,hexitol dehydrogenase activity,MF,
11731,GO:0046526,1.00000000001956,0.954443871327138,0,1,D-xylulose reductase activity,MF,
12860,GO:0051160,1.00000000001956,0.954443871327138,0,1,L-xylitol catabolic process,BP,
12861,GO:0051164,1.00000000001956,0.954443871327138,0,1,L-xylitol metabolic process,BP,
5346,GO:0016080,1.00000000001957,0.85222382351374,0,3,synaptic vesicle targeting,BP,
14505,GO:0061944,1.00000000001957,0.947848619964123,0,1,negative regulation of protein K48-linked ubiquitination,BP,
5094,GO:0015355,1.00000000001958,0.837370819658627,0,4,secondary active monocarboxylate transmembrane transporter activity,MF,
3162,GO:0006772,1.00000000001959,0.958113973403275,0,1,thiamine metabolic process,BP,
9973,GO:0042357,1.00000000001959,0.958113973403275,0,1,thiamine diphosphate metabolic process,BP,
12481,GO:0050333,1.00000000001959,0.958113973403275,0,1,thiamin-triphosphatase activity,MF,
13530,GO:0055087,1.00000000001959,0.868630853111603,0,3,Ski complex,CC,
15912,GO:0072669,1.0000000000196,0.77183775938695,0,7,tRNA-splicing ligase complex,CC,
19274,GO:1905424,1.00000000001961,0.912362232232788,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19275,GO:1905426,1.00000000001961,0.912362232232788,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
1006,GO:0002477,1.00000000001961,0.972247727384744,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1010,GO:0002481,1.00000000001961,0.972247727384744,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
16401,GO:0097001,1.00000000001964,0.68738280442434,0,8,ceramide binding,MF,
1696,GO:0004168,1.00000000001965,0.955406166074686,0,1,dolichol kinase activity,MF,
10302,GO:0043048,1.00000000001965,0.955406166074686,0,1,dolichyl monophosphate biosynthetic process,BP,
16520,GO:0097209,1.00000000001965,0.829103425081995,0,4,epidermal lamellar body,CC,
18628,GO:1903895,1.00000000001965,0.822868477978515,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
1531,GO:0003908,1.00000000001966,0.966138170449867,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
7650,GO:0032057,1.00000000001966,0.81544004143675,0,4,negative regulation of translational initiation in response to stress,BP,
16499,GO:0097177,1.00000000001967,0.88555337724645,0,3,mitochondrial ribosome binding,MF,
16542,GO:0097255,1.00000000001967,0.809209360344083,0,5,R2TP complex,CC,
3436,GO:0007227,1.00000000001968,0.853659374112386,0,3,signal transduction downstream of smoothened,BP,
16106,GO:0090071,1.00000000001969,0.814949279402012,0,4,negative regulation of ribosome biogenesis,BP,
1073,GO:0002636,1.00000000001969,0.961355319239957,0,1,positive regulation of germinal center formation,BP,
2754,GO:0006157,1.00000000001969,0.961355319239957,0,1,deoxyadenosine catabolic process,BP,
9957,GO:0042321,1.00000000001969,0.961355319239957,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
9958,GO:0042323,1.00000000001969,0.961355319239957,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11563,GO:0046090,1.00000000001969,0.961355319239957,0,1,deoxyadenosine metabolic process,BP,
11574,GO:0046111,1.00000000001969,0.961355319239957,0,1,xanthine biosynthetic process,BP,
11580,GO:0046124,1.00000000001969,0.961355319239957,0,1,purine deoxyribonucleoside catabolic process,BP,
13670,GO:0060167,1.00000000001969,0.961355319239957,0,1,regulation of adenosine receptor signaling pathway,BP,
13671,GO:0060169,1.00000000001969,0.961355319239957,0,1,negative regulation of adenosine receptor signaling pathway,BP,
13830,GO:0060407,1.00000000001969,0.961355319239957,0,1,negative regulation of penile erection,BP,
14667,GO:0070256,1.00000000001969,0.961355319239957,0,1,negative regulation of mucus secretion,BP,
6085,GO:0019237,1.0000000000197,0.745620834549459,0,6,centromeric DNA binding,MF,
1827,GO:0004477,1.00000000001971,0.824608212982784,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1836,GO:0004488,1.00000000001971,0.824608212982784,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
12771,GO:0051026,1.00000000001972,0.829003488441547,0,4,chiasma assembly,BP,
7670,GO:0032095,1.00000000001972,0.703602742036623,0,8,regulation of response to food,BP,
14807,GO:0070522,1.00000000001973,0.821253716841236,0,4,ERCC4-ERCC1 complex,CC,
6534,GO:0021932,1.00000000001973,0.701953675129494,0,7,hindbrain radial glia guided cell migration,BP,
11977,GO:0047186,1.00000000001975,0.949298634034312,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
763,GO:0002002,1.00000000001975,0.830447643798449,0,4,regulation of angiotensin levels in blood,BP,
764,GO:0002003,1.00000000001975,0.830447643798449,0,4,angiotensin maturation,BP,
312,GO:0000823,1.00000000001976,0.958123998984442,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
313,GO:0000824,1.00000000001976,0.958123998984442,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
314,GO:0000825,1.00000000001976,0.958123998984442,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
11999,GO:0047326,1.00000000001976,0.958123998984442,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12729,GO:0050951,1.00000000001977,0.680074715449115,0,8,sensory perception of temperature stimulus,BP,
20034,GO:2000622,1.00000000001977,0.813748026066886,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
20035,GO:2000623,1.00000000001977,0.813748026066886,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
5738,GO:0016880,1.00000000001977,0.90375099125901,0,2,acid-ammonia (or amide) ligase activity,MF,
14570,GO:0070087,1.00000000001977,0.731471665736562,0,6,chromo shadow domain binding,MF,
6187,GO:0019563,1.00000000001977,0.781697378291916,0,5,glycerol catabolic process,BP,
612,GO:0001778,1.00000000001977,0.803823509819077,0,4,plasma membrane repair,BP,
14903,GO:0070695,1.00000000001978,0.777040618642508,0,5,FHF complex,CC,
11736,GO:0046534,1.00000000001978,0.947568363550918,0,1,positive regulation of photoreceptor cell differentiation,BP,
11339,GO:0045654,1.00000000001981,0.918540130581252,0,2,positive regulation of megakaryocyte differentiation,BP,
5878,GO:0017187,1.00000000001984,0.853703267442997,0,4,peptidyl-glutamic acid carboxylation,BP,
5939,GO:0018214,1.00000000001984,0.853703267442997,0,4,protein carboxylation,BP,
142,GO:0000293,1.00000000001985,0.862225349529257,0,3,ferric-chelate reductase activity,MF,
1668,GO:0004126,1.00000000001986,0.750470349877618,0,7,cytidine deaminase activity,MF,
16519,GO:0097208,1.00000000001986,0.795070152779967,0,5,alveolar lamellar body,CC,
3169,GO:0006781,1.0000000000199,0.955532684523278,0,1,succinyl-CoA pathway,BP,
1772,GO:0004373,1.0000000000199,0.951287519764744,0,1,glycogen (starch) synthase activity,MF,
14358,GO:0061547,1.0000000000199,0.951287519764744,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
14309,GO:0061395,1.00000000001991,0.958951361089315,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
9214,GO:0035598,1.00000000001992,0.952037891277984,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
14428,GO:0061712,1.00000000001992,0.952037891277984,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
10448,GO:0043301,1.00000000001994,0.780085005499141,0,5,negative regulation of leukocyte degranulation,BP,
838,GO:0002135,1.00000000001994,0.954408672534489,0,1,CTP binding,MF,
5828,GO:0017098,1.00000000001994,0.954408672534489,0,1,sulfonylurea receptor binding,MF,
17665,GO:1901388,1.00000000001994,0.954408672534489,0,1,regulation of transforming growth factor beta activation,BP,
17666,GO:1901389,1.00000000001994,0.954408672534489,0,1,negative regulation of transforming growth factor beta activation,BP,
18523,GO:1903659,1.00000000001994,0.954408672534489,0,1,regulation of complement-dependent cytotoxicity,BP,
18524,GO:1903660,1.00000000001994,0.954408672534489,0,1,negative regulation of complement-dependent cytotoxicity,BP,
19684,GO:1990913,1.00000000001994,0.954408672534489,0,1,sperm head plasma membrane,CC,
19685,GO:1990917,1.00000000001994,0.954408672534489,0,1,ooplasm,CC,
16530,GO:0097227,1.00000000001995,0.819250782007508,0,4,sperm annulus,CC,
4657,GO:0010797,1.00000000001995,0.967167114614299,0,1,regulation of multivesicular body size involved in endosome transport,BP,
18593,GO:1903818,1.00000000001996,0.850432914059982,0,3,positive regulation of voltage-gated potassium channel activity,BP,
5116,GO:0015432,1.00000000001997,0.950845105322179,0,1,bile acid-exporting ATPase activity,MF,
8384,GO:0033283,1.00000000001997,0.950845105322179,0,1,organic acid-transporting ATPase activity,MF,
8385,GO:0033284,1.00000000001997,0.950845105322179,0,1,carboxylic acid-transporting ATPase activity,MF,
8386,GO:0033285,1.00000000001997,0.950845105322179,0,1,monocarboxylic acid-transporting ATPase activity,MF,
15578,GO:0072014,1.00000000001997,0.829212387986572,0,4,proximal tubule development,BP,
11620,GO:0046294,1.00000000001998,0.923215472945918,0,2,formaldehyde catabolic process,BP,
1565,GO:0003963,1.00000000002002,0.911125721914633,0,2,RNA-3'-phosphate cyclase activity,MF,
3934,GO:0008612,1.00000000002002,0.846490978491212,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
18684,GO:1903998,1.00000000002004,0.875163941684341,0,3,regulation of eating behavior,BP,
13009,GO:0051413,1.00000000002004,0.954483953116049,0,1,response to cortisone,BP,
7418,GO:0031501,1.00000000002005,0.878985054040653,0,4,mannosyltransferase complex,CC,
11655,GO:0046368,1.00000000002005,0.835936539249355,0,4,GDP-L-fucose metabolic process,BP,
16457,GO:0097107,1.00000000002005,0.803619302889002,0,4,postsynaptic density assembly,BP,
16832,GO:0098698,1.00000000002005,0.803619302889002,0,4,postsynaptic specialization assembly,BP,
11441,GO:0045852,1.00000000002005,0.867112866213409,0,3,pH elevation,BP,
13032,GO:0051454,1.00000000002005,0.867112866213409,0,3,intracellular pH elevation,BP,
4624,GO:0010739,1.00000000002007,0.81132349886413,0,5,positive regulation of protein kinase A signaling,BP,
16610,GO:0097422,1.00000000002007,0.784035201301518,0,5,tubular endosome,CC,
12013,GO:0047464,1.00000000002008,0.946831834934006,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12488,GO:0050379,1.00000000002008,0.946831834934006,0,1,UDP-glucuronate 5'-epimerase activity,MF,
19281,GO:1905443,1.00000000002009,0.947495478597628,0,1,regulation of clathrin coat assembly,BP,
19282,GO:1905445,1.00000000002009,0.947495478597628,0,1,positive regulation of clathrin coat assembly,BP,
7283,GO:0031262,1.00000000002009,0.864938978378915,0,4,Ndc80 complex,CC,
11998,GO:0047325,1.00000000002011,0.95214387527564,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
13414,GO:0052725,1.00000000002011,0.95214387527564,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
13415,GO:0052726,1.00000000002011,0.95214387527564,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
13437,GO:0052825,1.00000000002011,0.95214387527564,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
13442,GO:0052830,1.00000000002011,0.95214387527564,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
13443,GO:0052831,1.00000000002011,0.95214387527564,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
13447,GO:0052835,1.00000000002011,0.95214387527564,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14480,GO:0061845,1.00000000002011,0.95214387527564,0,1,neuron projection branch point,CC,
14481,GO:0061846,1.00000000002011,0.95214387527564,0,1,dendritic spine cytoplasm,CC,
16054,GO:0086072,1.00000000002014,0.954573217302958,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16062,GO:0086082,1.00000000002014,0.954573217302958,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
10076,GO:0042568,1.00000000002015,0.972724454257513,0,1,insulin-like growth factor binary complex,CC,
4207,GO:0009313,1.00000000002015,0.646716509425438,0,9,oligosaccharide catabolic process,BP,
6717,GO:0030123,1.00000000002015,0.636626711515033,0,9,AP-3 adaptor complex,CC,
8007,GO:0032625,1.00000000002017,0.950734050109267,0,1,interleukin-21 production,BP,
15898,GO:0072619,1.00000000002017,0.950734050109267,0,1,interleukin-21 secretion,BP,
12184,GO:0048296,1.0000000000202,0.793107283011393,0,5,regulation of isotype switching to IgA isotypes,BP,
9472,GO:0036089,1.0000000000202,0.712769308235053,0,7,cleavage furrow formation,BP,
16350,GO:0090571,1.0000000000202,0.87381271141977,0,3,RNA polymerase II transcription repressor complex,CC,
3923,GO:0008592,1.00000000002021,0.952218274105685,0,1,regulation of Toll signaling pathway,BP,
9912,GO:0042241,1.00000000002021,0.952218274105685,0,1,interleukin-18 biosynthetic process,BP,
11237,GO:0045381,1.00000000002021,0.952218274105685,0,1,regulation of interleukin-18 biosynthetic process,BP,
11391,GO:0045751,1.00000000002021,0.952218274105685,0,1,negative regulation of Toll signaling pathway,BP,
14625,GO:0070181,1.00000000002021,0.759351778898947,0,8,small ribosomal subunit rRNA binding,MF,
4462,GO:0010452,1.00000000002023,0.636899437442433,0,9,histone H3-K36 methylation,BP,
2993,GO:0006537,1.00000000002023,0.817439509828976,0,4,glutamate biosynthetic process,BP,
1578,GO:0003985,1.00000000002025,0.875335290243909,0,3,acetyl-CoA C-acetyltransferase activity,MF,
3854,GO:0008465,1.00000000002026,0.966657758736929,0,1,glycerate dehydrogenase activity,MF,
9234,GO:0035621,1.00000000002026,0.905564245754155,0,2,ER to Golgi ceramide transport,BP,
4209,GO:0009328,1.00000000002028,0.831724891670426,0,4,phenylalanine-tRNA ligase complex,CC,
2031,GO:0004767,1.00000000002028,0.787541309896811,0,5,sphingomyelin phosphodiesterase activity,MF,
6208,GO:0019695,1.00000000002028,0.820368584242244,0,4,choline metabolic process,BP,
6894,GO:0030422,1.00000000002028,0.685190788928468,0,9,production of siRNA involved in RNA interference,BP,
14184,GO:0061052,1.00000000002029,0.824642777521426,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
882,GO:0002238,1.00000000002029,0.946837362894434,0,1,response to molecule of fungal origin,BP,
943,GO:0002351,1.00000000002029,0.946837362894434,0,1,serotonin production involved in inflammatory response,BP,
988,GO:0002442,1.00000000002029,0.946837362894434,0,1,serotonin secretion involved in inflammatory response,BP,
1043,GO:0002554,1.00000000002029,0.946837362894434,0,1,serotonin secretion by platelet,BP,
6250,GO:0019814,1.00000000002029,0.946837362894434,0,1,immunoglobulin complex,CC,
6251,GO:0019815,1.00000000002029,0.946837362894434,0,1,B cell receptor complex,CC,
8078,GO:0032752,1.00000000002029,0.946837362894434,0,1,positive regulation of interleukin-3 production,BP,
9908,GO:0042223,1.00000000002029,0.946837362894434,0,1,interleukin-3 biosynthetic process,BP,
11238,GO:0045399,1.00000000002029,0.946837362894434,0,1,regulation of interleukin-3 biosynthetic process,BP,
11239,GO:0045401,1.00000000002029,0.946837362894434,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
11249,GO:0045423,1.00000000002029,0.946837362894434,0,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11250,GO:0045425,1.00000000002029,0.946837362894434,0,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
15146,GO:0071226,1.00000000002029,0.946837362894434,0,1,cellular response to molecule of fungal origin,BP,
9405,GO:0035948,1.00000000002031,0.85954407069817,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
2654,GO:0005991,1.00000000002032,0.953335356829125,0,1,trehalose metabolic process,BP,
14753,GO:0070413,1.00000000002032,0.953335356829125,0,1,trehalose metabolism in response to stress,BP,
4329,GO:0009838,1.00000000002032,0.805535939353642,0,5,abscission,BP,
11305,GO:0045607,1.00000000002033,0.798579798560467,0,5,regulation of inner ear auditory receptor cell differentiation,BP,
11322,GO:0045631,1.00000000002033,0.798579798560467,0,5,regulation of mechanoreceptor differentiation,BP,
20189,GO:2000980,1.00000000002033,0.798579798560467,0,5,regulation of inner ear receptor cell differentiation,BP,
19689,GO:1990927,1.00000000002034,0.896961957573871,0,2,calcium ion regulated lysosome exocytosis,BP,
10857,GO:0044352,1.00000000002034,0.818174367188398,0,4,pinosome,CC,
10858,GO:0044354,1.00000000002034,0.818174367188398,0,4,macropinosome,CC,
12051,GO:0047800,1.00000000002035,0.950030174584993,0,1,cysteamine dioxygenase activity,MF,
351,GO:0000964,1.00000000002035,0.838769411184337,0,4,mitochondrial RNA 5'-end processing,BP,
5827,GO:0017095,1.00000000002037,0.899220809354568,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
13164,GO:0051722,1.00000000002038,0.954599146572345,0,1,protein C-terminal methylesterase activity,MF,
13165,GO:0051723,1.00000000002038,0.954599146572345,0,1,protein methylesterase activity,MF,
1089,GO:0002674,1.00000000002039,0.843208558161723,0,4,negative regulation of acute inflammatory response,BP,
7379,GO:0031427,1.00000000002039,0.858203679510126,0,3,response to methotrexate,BP,
3015,GO:0006560,1.0000000000204,0.759892279555597,0,6,proline metabolic process,BP,
1872,GO:0004534,1.00000000002042,0.852455774620645,0,3,5'-3' exoribonuclease activity,MF,
9249,GO:0035641,1.00000000002043,0.720222457914531,0,7,locomotory exploration behavior,BP,
10257,GO:0042988,1.00000000002043,0.946754857334336,0,1,X11-like protein binding,MF,
14122,GO:0060957,1.00000000002044,0.953323222832995,0,1,endocardial cell fate commitment,BP,
14325,GO:0061445,1.00000000002044,0.953323222832995,0,1,endocardial cushion cell fate commitment,BP,
9707,GO:0038108,1.00000000002044,0.868735656435046,0,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,
15791,GO:0072383,1.00000000002045,0.689220709971119,0,7,plus-end-directed vesicle transport along microtubule,BP,
15944,GO:0072718,1.00000000002046,0.639961781799658,0,9,response to cisplatin,BP,
17224,GO:0106071,1.00000000002046,0.856261611979567,0,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
4053,GO:0009092,1.00000000002047,0.837362674827181,0,4,homoserine metabolic process,BP,
6112,GO:0019346,1.00000000002047,0.837362674827181,0,4,transsulfuration,BP,
1847,GO:0004500,1.00000000002048,0.953015181697567,0,1,dopamine beta-monooxygenase activity,MF,
3038,GO:0006589,1.00000000002048,0.953015181697567,0,1,octopamine biosynthetic process,BP,
11639,GO:0046333,1.00000000002048,0.953015181697567,0,1,octopamine metabolic process,BP,
18794,GO:1904288,1.0000000000205,0.815822733331913,0,4,BAT3 complex binding,MF,
11682,GO:0046452,1.00000000002052,0.880283370699236,0,3,dihydrofolate metabolic process,BP,
18339,GO:1903276,1.00000000002053,0.916691495002801,0,2,regulation of sodium ion export across plasma membrane,BP,
18340,GO:1903278,1.00000000002053,0.916691495002801,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18347,GO:1903288,1.00000000002053,0.916691495002801,0,2,positive regulation of potassium ion import,BP,
15711,GO:0072235,1.00000000002055,0.850936822920347,0,3,metanephric distal tubule development,BP,
13098,GO:0051593,1.00000000002057,0.696132074133263,0,8,response to folic acid,BP,
20164,GO:2000832,1.00000000002058,0.901325364637091,0,2,negative regulation of steroid hormone secretion,BP,
20171,GO:2000847,1.00000000002058,0.901325364637091,0,2,negative regulation of corticosteroid hormone secretion,BP,
20174,GO:2000850,1.00000000002058,0.901325364637091,0,2,negative regulation of glucocorticoid secretion,BP,
13513,GO:0055064,1.00000000002058,0.629386237823618,0,9,chloride ion homeostasis,BP,
4309,GO:0009757,1.00000000002058,0.806092930917537,0,5,hexose mediated signaling,BP,
4418,GO:0010182,1.00000000002058,0.806092930917537,0,5,sugar mediated signaling pathway,BP,
4429,GO:0010255,1.00000000002058,0.806092930917537,0,5,glucose mediated signaling pathway,BP,
18983,GO:1904742,1.00000000002059,0.831732322009051,0,4,regulation of telomeric DNA binding,BP,
14334,GO:0061476,1.00000000002061,0.811278211568076,0,4,response to anticoagulant,BP,
15323,GO:0071503,1.00000000002061,0.811278211568076,0,4,response to heparin,BP,
15324,GO:0071504,1.00000000002061,0.811278211568076,0,4,cellular response to heparin,BP,
14569,GO:0070086,1.00000000002061,0.842467477157603,0,4,ubiquitin-dependent endocytosis,BP,
3985,GO:0008821,1.00000000002063,0.670518727359423,0,9,crossover junction endodeoxyribonuclease activity,MF,
14586,GO:0070119,1.00000000002064,0.948415403629779,0,1,ciliary neurotrophic factor binding,MF,
5046,GO:0015226,1.00000000002065,0.826237462737447,0,4,carnitine transmembrane transporter activity,MF,
4781,GO:0010963,1.00000000002065,0.962756555565975,0,1,regulation of L-arginine import,BP,
15027,GO:0070947,1.00000000002065,0.962756555565975,0,1,neutrophil mediated killing of fungus,BP,
15032,GO:0070953,1.00000000002065,0.962756555565975,0,1,regulation of neutrophil mediated killing of fungus,BP,
15037,GO:0070965,1.00000000002065,0.962756555565975,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
19997,GO:2000552,1.00000000002065,0.962756555565975,0,1,negative regulation of T-helper 2 cell cytokine production,BP,
5769,GO:0016938,1.00000000002066,0.953350880250189,0,1,kinesin I complex,CC,
16498,GO:0097176,1.00000000002068,0.837839494855952,0,4,epoxide metabolic process,BP,
1271,GO:0003050,1.00000000002069,0.952420713867565,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
16735,GO:0097724,1.0000000000207,0.957780032712128,0,1,sperm flagellum movement,BP,
19271,GO:1905419,1.0000000000207,0.957780032712128,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
12183,GO:0048295,1.00000000002071,0.909128316116882,0,2,positive regulation of isotype switching to IgE isotypes,BP,
4382,GO:0010015,1.00000000002071,0.977407049886909,0,1,root morphogenesis,BP,
4396,GO:0010053,1.00000000002071,0.977407049886909,0,1,root epidermal cell differentiation,BP,
4397,GO:0010054,1.00000000002071,0.977407049886909,0,1,trichoblast differentiation,BP,
6606,GO:0022622,1.00000000002071,0.977407049886909,0,1,root system development,BP,
7538,GO:0031763,1.00000000002071,0.977407049886909,0,1,galanin receptor binding,MF,
7539,GO:0031764,1.00000000002071,0.977407049886909,0,1,type 1 galanin receptor binding,MF,
7540,GO:0031765,1.00000000002071,0.977407049886909,0,1,type 2 galanin receptor binding,MF,
7541,GO:0031766,1.00000000002071,0.977407049886909,0,1,type 3 galanin receptor binding,MF,
12205,GO:0048364,1.00000000002071,0.977407049886909,0,1,root development,BP,
12384,GO:0048764,1.00000000002071,0.977407049886909,0,1,trichoblast maturation,BP,
12385,GO:0048765,1.00000000002071,0.977407049886909,0,1,root hair cell differentiation,BP,
12386,GO:0048767,1.00000000002071,0.977407049886909,0,1,root hair elongation,BP,
13041,GO:0051464,1.00000000002071,0.977407049886909,0,1,positive regulation of cortisol secretion,BP,
15995,GO:0080147,1.00000000002071,0.977407049886909,0,1,root hair cell development,BP,
16346,GO:0090558,1.00000000002071,0.977407049886909,0,1,plant epidermis development,BP,
16364,GO:0090627,1.00000000002071,0.977407049886909,0,1,plant epidermal cell differentiation,BP,
17041,GO:0099402,1.00000000002071,0.977407049886909,0,1,plant organ development,BP,
18071,GO:1902606,1.00000000002071,0.977407049886909,0,1,regulation of large conductance calcium-activated potassium channel activity,BP,
18072,GO:1902608,1.00000000002071,0.977407049886909,0,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,
18163,GO:1902890,1.00000000002071,0.977407049886909,0,1,regulation of root hair elongation,BP,
18164,GO:1902891,1.00000000002071,0.977407049886909,0,1,negative regulation of root hair elongation,BP,
18622,GO:1903888,1.00000000002071,0.977407049886909,0,1,regulation of plant epidermal cell differentiation,BP,
18623,GO:1903889,1.00000000002071,0.977407049886909,0,1,negative regulation of plant epidermal cell differentiation,BP,
19260,GO:1905392,1.00000000002071,0.977407049886909,0,1,plant organ morphogenesis,BP,
19272,GO:1905421,1.00000000002071,0.977407049886909,0,1,regulation of plant organ morphogenesis,BP,
19273,GO:1905422,1.00000000002071,0.977407049886909,0,1,negative regulation of plant organ morphogenesis,BP,
19744,GO:2000067,1.00000000002071,0.977407049886909,0,1,regulation of root morphogenesis,BP,
19846,GO:2000280,1.00000000002071,0.977407049886909,0,1,regulation of root development,BP,
20175,GO:2000851,1.00000000002071,0.977407049886909,0,1,positive regulation of glucocorticoid secretion,BP,
6830,GO:0030285,1.00000000002072,0.701503780482739,0,7,integral component of synaptic vesicle membrane,CC,
6772,GO:0030202,1.00000000002074,0.808536130187211,0,4,heparin metabolic process,BP,
6780,GO:0030210,1.00000000002074,0.808536130187211,0,4,heparin biosynthetic process,BP,
11497,GO:0045950,1.00000000002075,0.910215820652646,0,2,negative regulation of mitotic recombination,BP,
6445,GO:0021747,1.00000000002077,0.851528914776459,0,3,cochlear nucleus development,BP,
8560,GO:0033981,1.00000000002077,0.981012540347557,0,1,D-dopachrome decarboxylase activity,MF,
8975,GO:0035063,1.0000000000208,0.950148876869767,0,1,nuclear speck organization,BP,
5660,GO:0016755,1.00000000002084,0.659880088707248,0,9,transferase activity, transferring amino-acyl groups,MF,
1571,GO:0003975,1.00000000002085,0.955640632415119,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
4008,GO:0008963,1.00000000002085,0.955640632415119,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
20110,GO:2000741,1.00000000002086,0.851221489215995,0,3,positive regulation of mesenchymal stem cell differentiation,BP,
5880,GO:0017198,1.00000000002086,0.974679502089419,0,1,N-terminal peptidyl-serine acetylation,BP,
5881,GO:0018002,1.00000000002086,0.974679502089419,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
7122,GO:0030920,1.00000000002086,0.974679502089419,0,1,peptidyl-serine acetylation,BP,
14484,GO:0061850,1.00000000002086,0.974679502089419,0,1,growth cone leading edge,CC,
15560,GO:0071960,1.00000000002086,0.974679502089419,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
19500,GO:1990190,1.00000000002086,0.974679502089419,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
20095,GO:2000718,1.00000000002086,0.974679502089419,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20096,GO:2000719,1.00000000002086,0.974679502089419,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
11984,GO:0047238,1.00000000002087,0.815953589788238,0,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
16201,GO:0090209,1.00000000002087,0.831725896961405,0,4,negative regulation of triglyceride metabolic process,BP,
9393,GO:0035928,1.00000000002089,0.892735850500146,0,3,rRNA import into mitochondrion,BP,
12010,GO:0047429,1.00000000002089,0.683583758171593,0,9,nucleoside-triphosphate diphosphatase activity,MF,
4846,GO:0014049,1.00000000002091,0.826183196211576,0,4,positive regulation of glutamate secretion,BP,
7692,GO:0032138,1.00000000002092,0.815678424424319,0,4,single base insertion or deletion binding,MF,
9392,GO:0035927,1.00000000002094,0.849494463015292,0,4,RNA import into mitochondrion,BP,
12020,GO:0047499,1.00000000002095,0.794351000637025,0,5,calcium-independent phospholipase A2 activity,MF,
1736,GO:0004331,1.00000000002096,0.813660701352988,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
2662,GO:0006003,1.00000000002096,0.813660701352988,0,4,fructose 2,6-bisphosphate metabolic process,BP,
9123,GO:0035425,1.00000000002096,0.866089429594785,0,3,autocrine signaling,BP,
15362,GO:0071579,1.00000000002097,0.956344579740968,0,1,regulation of zinc ion transport,BP,
15363,GO:0071580,1.00000000002097,0.956344579740968,0,1,regulation of zinc ion transmembrane transport,BP,
15364,GO:0071581,1.00000000002097,0.956344579740968,0,1,regulation of zinc ion transmembrane import,BP,
15365,GO:0071582,1.00000000002097,0.956344579740968,0,1,negative regulation of zinc ion transport,BP,
15366,GO:0071583,1.00000000002097,0.956344579740968,0,1,negative regulation of zinc ion transmembrane transport,BP,
15367,GO:0071584,1.00000000002097,0.956344579740968,0,1,negative regulation of zinc ion transmembrane import,BP,
15368,GO:0071585,1.00000000002097,0.956344579740968,0,1,detoxification of cadmium ion,BP,
19490,GO:1990170,1.00000000002097,0.956344579740968,0,1,stress response to cadmium ion,BP,
7141,GO:0030969,1.00000000002097,0.86313213655538,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
14550,GO:0070054,1.00000000002097,0.86313213655538,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
14551,GO:0070055,1.00000000002097,0.86313213655538,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
329,GO:0000917,1.00000000002097,0.957601307124227,0,1,division septum assembly,BP,
16337,GO:0090529,1.00000000002097,0.957601307124227,0,1,cell septum assembly,BP,
13606,GO:0060059,1.00000000002097,0.803124094621931,0,4,embryonic retina morphogenesis in camera-type eye,BP,
16025,GO:0086023,1.00000000002097,0.803124094621931,0,4,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
1557,GO:0003953,1.00000000002098,0.962038417697039,0,1,NAD+ nucleosidase activity,MF,
12457,GO:0050135,1.00000000002098,0.962038417697039,0,1,NAD(P)+ nucleosidase activity,MF,
14468,GO:0061809,1.00000000002098,0.962038417697039,0,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
355,GO:0000972,1.00000000002099,0.711312186135082,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
13769,GO:0060331,1.00000000002099,0.768974777195849,0,6,negative regulation of response to interferon-gamma,BP,
13774,GO:0060336,1.00000000002099,0.768974777195849,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
13200,GO:0051793,1.00000000002099,0.863638680450572,0,3,medium-chain fatty acid catabolic process,BP,
14546,GO:0070050,1.00000000002101,0.824067064088611,0,4,neuron cellular homeostasis,BP,
18551,GO:1903724,1.00000000002103,0.95157744684482,0,1,positive regulation of centriole elongation,BP,
8682,GO:0034271,1.00000000002104,0.86213933929644,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
8683,GO:0034272,1.00000000002104,0.86213933929644,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
6909,GO:0030485,1.00000000002106,0.910245122534775,0,2,smooth muscle contractile fiber,CC,
2911,GO:0006421,1.00000000002107,0.866781285097935,0,3,asparaginyl-tRNA aminoacylation,BP,
3876,GO:0008503,1.00000000002111,0.931551247693546,0,2,benzodiazepine receptor activity,MF,
13395,GO:0052650,1.00000000002111,0.73806050188175,0,7,NADP-retinol dehydrogenase activity,MF,
15755,GO:0072320,1.00000000002111,0.855122907687061,0,3,volume-sensitive chloride channel activity,MF,
19009,GO:1904784,1.00000000002111,0.946681711065502,0,1,NLRP1 inflammasome complex assembly,BP,
1520,GO:0003878,1.00000000002113,0.947794813429805,0,1,ATP citrate synthase activity,MF,
4212,GO:0009346,1.00000000002113,0.947794813429805,0,1,citrate lyase complex,CC,
3975,GO:0008783,1.00000000002113,0.955410239032184,0,1,agmatinase activity,MF,
8416,GO:0033388,1.00000000002113,0.955410239032184,0,1,putrescine biosynthetic process from arginine,BP,
15067,GO:0071008,1.00000000002115,0.838391137914638,0,4,U2-type post-mRNA release spliceosomal complex,CC,
19024,GO:1904815,1.00000000002116,0.912405119662313,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
10021,GO:0042447,1.00000000002117,0.754652598843266,0,6,hormone catabolic process,BP,
2294,GO:0005250,1.00000000002119,0.947140692524822,0,1,A-type (transient outward) potassium channel activity,MF,
11183,GO:0045252,1.00000000002121,0.710909908380508,0,7,oxoglutarate dehydrogenase complex,CC,
2750,GO:0006147,1.00000000002127,0.946688242208216,0,1,guanine catabolic process,BP,
3996,GO:0008892,1.00000000002127,0.946688242208216,0,1,guanine deaminase activity,MF,
4302,GO:0009744,1.00000000002128,0.860464576863979,0,3,response to sucrose,BP,
8688,GO:0034285,1.00000000002128,0.860464576863979,0,3,response to disaccharide,BP,
16170,GO:0090176,1.00000000002129,0.946673266629564,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
2424,GO:0005597,1.00000000002129,0.94667238162424,0,1,collagen type XVI trimer,CC,
5679,GO:0016785,1.00000000002129,0.94667238162424,0,1,transferase activity, transferring selenium-containing groups,MF,
16800,GO:0098621,1.00000000002129,0.94667238162424,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
18589,GO:1903800,1.0000000000213,0.72400608383703,0,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
1964,GO:0004668,1.0000000000213,0.95239942089525,0,1,protein-arginine deiminase activity,MF,
5901,GO:0018101,1.0000000000213,0.95239942089525,0,1,protein citrullination,BP,
9589,GO:0036414,1.0000000000213,0.95239942089525,0,1,histone citrullination,BP,
4833,GO:0014034,1.0000000000213,0.899387817913697,0,2,neural crest cell fate commitment,BP,
9637,GO:0036502,1.00000000002131,0.952662979273795,0,1,Derlin-1-VIMP complex,CC,
5120,GO:0015450,1.00000000002133,0.793912837775301,0,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
1900,GO:0004581,1.00000000002133,0.968075667006531,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
1676,GO:0004137,1.00000000002134,0.903531331671873,0,2,deoxycytidine kinase activity,MF,
3575,GO:0007620,1.00000000002135,0.692661263035208,0,8,copulation,BP,
5076,GO:0015296,1.00000000002138,0.69149635230561,0,7,anion:cation symporter activity,MF,
19718,GO:2000018,1.00000000002138,0.77895825416988,0,5,regulation of male gonad development,BP,
9870,GO:0042126,1.00000000002144,0.828741100598981,0,4,nitrate metabolic process,BP,
1948,GO:0004648,1.00000000002149,0.95575738756906,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
16232,GO:0090261,1.0000000000215,0.846713876116962,0,4,positive regulation of inclusion body assembly,BP,
1103,GO:0002689,1.0000000000215,0.761722170433629,0,7,negative regulation of leukocyte chemotaxis,BP,
9252,GO:0035650,1.00000000002151,0.843661909623212,0,4,AP-1 adaptor complex binding,MF,
3428,GO:0007217,1.00000000002153,0.954358572830311,0,1,tachykinin receptor signaling pathway,BP,
3062,GO:0006624,1.00000000002153,0.933915116747729,0,2,vacuolar protein processing,BP,
16148,GO:0090138,1.00000000002154,0.950255002609484,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
11101,GO:0045098,1.00000000002155,0.959588753367804,0,1,type III intermediate filament,CC,
12151,GO:0048244,1.00000000002155,0.959588753367804,0,1,phytanoyl-CoA dioxygenase activity,MF,
16447,GO:0097089,1.00000000002155,0.959588753367804,0,1,methyl-branched fatty acid metabolic process,BP,
15050,GO:0070984,1.00000000002155,0.948302676332804,0,1,SET domain binding,MF,
2964,GO:0006499,1.00000000002155,0.809944831517777,0,4,N-terminal protein myristoylation,BP,
5968,GO:0018377,1.00000000002155,0.809944831517777,0,4,protein myristoylation,BP,
17170,GO:0102522,1.00000000002156,0.955350151680229,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
13666,GO:0060159,1.00000000002157,0.833378079755476,0,4,regulation of dopamine receptor signaling pathway,BP,
12704,GO:0050908,1.00000000002157,0.818080487088286,0,4,detection of light stimulus involved in visual perception,BP,
12736,GO:0050962,1.00000000002157,0.818080487088286,0,4,detection of light stimulus involved in sensory perception,BP,
1741,GO:0004336,1.00000000002159,0.953493061673328,0,1,galactosylceramidase activity,MF,
3106,GO:0006683,1.00000000002159,0.953493061673328,0,1,galactosylceramide catabolic process,BP,
6132,GO:0019376,1.00000000002159,0.953493061673328,0,1,galactolipid catabolic process,BP,
295,GO:0000799,1.00000000002159,0.849408984281655,0,3,nuclear condensin complex,CC,
19720,GO:2000020,1.0000000000216,0.820622605221526,0,4,positive regulation of male gonad development,BP,
4276,GO:0009631,1.0000000000216,0.946791959353725,0,1,cold acclimation,BP,
11624,GO:0046317,1.0000000000216,0.946791959353725,0,1,regulation of glucosylceramide biosynthetic process,BP,
11625,GO:0046318,1.0000000000216,0.946791959353725,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
18276,GO:1903108,1.0000000000216,0.946791959353725,0,1,regulation of mitochondrial transcription,BP,
18277,GO:1903109,1.0000000000216,0.946791959353725,0,1,positive regulation of mitochondrial transcription,BP,
453,GO:0001226,1.00000000002162,0.951993425558522,0,1,RNA polymerase II transcription corepressor binding,MF,
3827,GO:0008424,1.00000000002162,0.951993425558522,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
9467,GO:0036071,1.00000000002162,0.951993425558522,0,1,N-glycan fucosylation,BP,
11907,GO:0046921,1.00000000002162,0.951993425558522,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
6005,GO:0019035,1.00000000002163,0.946671401193877,0,1,viral integration complex,CC,
11447,GO:0045870,1.00000000002163,0.946671401193877,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
19295,GO:1905463,1.00000000002163,0.946671401193877,0,1,negative regulation of DNA duplex unwinding,BP,
7812,GO:0032357,1.00000000002165,0.652230483744329,0,9,oxidized purine DNA binding,MF,
9663,GO:0038007,1.00000000002167,0.855499774044388,0,3,netrin-activated signaling pathway,BP,
9310,GO:0035754,1.00000000002168,0.781252067961259,0,5,B cell chemotaxis,BP,
9421,GO:0035985,1.00000000002171,0.846161722917128,0,4,senescence-associated heterochromatin focus,CC,
12808,GO:0051089,1.00000000002171,0.949107342565688,0,1,constitutive protein ectodomain proteolysis,BP,
1820,GO:0004467,1.00000000002171,0.640034097254681,0,9,long-chain fatty acid-CoA ligase activity,MF,
3688,GO:0008192,1.00000000002173,0.867583657346639,0,3,RNA guanylyltransferase activity,MF,
2628,GO:0005952,1.00000000002174,0.783122965564593,0,5,cAMP-dependent protein kinase complex,CC,
10199,GO:0042799,1.00000000002174,0.820757415604742,0,4,histone methyltransferase activity (H4-K20 specific),MF,
9968,GO:0042351,1.00000000002177,0.925143148683174,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
15785,GO:0072368,1.00000000002179,0.897340568988068,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
4926,GO:0014870,1.0000000000218,0.738509046265104,0,6,response to muscle inactivity,BP,
2078,GO:0004829,1.00000000002181,0.866741063225507,0,3,threonine-tRNA ligase activity,MF,
2925,GO:0006435,1.00000000002181,0.866741063225507,0,3,threonyl-tRNA aminoacylation,BP,
15329,GO:0071528,1.00000000002181,0.949318971360001,0,1,tRNA re-export from nucleus,BP,
19556,GO:1990439,1.00000000002181,0.953368025519967,0,1,MAP kinase serine/threonine phosphatase activity,MF,
8552,GO:0033897,1.00000000002182,0.966436660025631,0,1,ribonuclease T2 activity,MF,
974,GO:0002420,1.00000000002183,0.820491708904184,0,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
975,GO:0002423,1.00000000002183,0.820491708904184,0,4,natural killer cell mediated immune response to tumor cell,BP,
1198,GO:0002855,1.00000000002183,0.820491708904184,0,4,regulation of natural killer cell mediated immune response to tumor cell,BP,
1201,GO:0002858,1.00000000002183,0.820491708904184,0,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
3096,GO:0006669,1.00000000002184,0.953311036510342,0,1,sphinganine-1-phosphate biosynthetic process,BP,
2749,GO:0006145,1.00000000002186,0.808438231172786,0,4,purine nucleobase catabolic process,BP,
3619,GO:0008073,1.00000000002187,0.927006223864782,0,2,ornithine decarboxylase inhibitor activity,MF,
17952,GO:1902268,1.00000000002187,0.927006223864782,0,2,negative regulation of polyamine transmembrane transport,BP,
10210,GO:0042822,1.00000000002187,0.861217360340399,0,3,pyridoxal phosphate metabolic process,BP,
2776,GO:0006203,1.00000000002188,0.891757651235895,0,3,dGTP catabolic process,BP,
269,GO:0000741,1.0000000000219,0.958617983164176,0,1,karyogamy,BP,
3482,GO:0007344,1.0000000000219,0.958617983164176,0,1,pronuclear fusion,BP,
13172,GO:0051732,1.0000000000219,0.958617983164176,0,1,polyribonucleotide kinase activity,MF,
13175,GO:0051736,1.0000000000219,0.958617983164176,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
16527,GO:0097224,1.0000000000219,0.958617983164176,0,1,sperm connecting piece,CC,
11793,GO:0046642,1.00000000002191,0.860147347218989,0,3,negative regulation of alpha-beta T cell proliferation,BP,
4394,GO:0010044,1.00000000002191,0.832213696295948,0,4,response to aluminum ion,BP,
19293,GO:1905461,1.00000000002192,0.772748561769515,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
7689,GO:0032133,1.00000000002193,0.841491124773071,0,4,chromosome passenger complex,CC,
188,GO:0000405,1.00000000002193,0.697312102939127,0,7,bubble DNA binding,MF,
835,GO:0002127,1.00000000002194,0.96299225018048,0,1,tRNA wobble base cytosine methylation,BP,
1249,GO:0002946,1.00000000002194,0.96299225018048,0,1,tRNA C5-cytosine methylation,BP,
4827,GO:0014022,1.00000000002195,0.860248720276152,0,3,neural plate elongation,BP,
6565,GO:0022007,1.00000000002195,0.860248720276152,0,3,convergent extension involved in neural plate elongation,BP,
4968,GO:0015057,1.00000000002195,0.86437684307291,0,3,thrombin-activated receptor activity,MF,
4839,GO:0014042,1.00000000002196,0.805736304666965,0,4,positive regulation of neuron maturation,BP,
16623,GO:0097449,1.00000000002196,0.746522031547285,0,6,astrocyte projection,CC,
15878,GO:0072586,1.00000000002198,0.947480257801433,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15879,GO:0072587,1.00000000002198,0.947480257801433,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
7191,GO:0031074,1.00000000002199,0.87058053502476,0,3,nucleocytoplasmic transport complex,CC,
15083,GO:0071034,1.000000000022,0.835661548421707,0,4,CUT catabolic process,BP,
15087,GO:0071043,1.000000000022,0.835661548421707,0,4,CUT metabolic process,BP,
1834,GO:0004486,1.00000000002201,0.951157947553513,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
10463,GO:0043317,1.00000000002201,0.951157947553513,0,1,regulation of cytotoxic T cell degranulation,BP,
10464,GO:0043318,1.00000000002201,0.951157947553513,0,1,negative regulation of cytotoxic T cell degranulation,BP,
3909,GO:0008553,1.00000000002206,0.656707613614483,0,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,
2698,GO:0006061,1.00000000002208,0.963561302725163,0,1,sorbitol biosynthetic process,BP,
5993,GO:0018931,1.00000000002208,0.963561302725163,0,1,naphthalene metabolic process,BP,
6142,GO:0019406,1.00000000002208,0.963561302725163,0,1,hexitol biosynthetic process,BP,
10664,GO:0043795,1.00000000002208,0.963561302725163,0,1,glyceraldehyde oxidoreductase activity,MF,
16316,GO:0090420,1.00000000002208,0.963561302725163,0,1,naphthalene-containing compound metabolic process,BP,
18216,GO:1902990,1.00000000002208,0.866085508274651,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
12522,GO:0050652,1.0000000000221,0.950007904623636,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12523,GO:0050653,1.0000000000221,0.950007904623636,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
3090,GO:0006663,1.00000000002211,0.867276092358383,0,3,platelet activating factor biosynthetic process,BP,
15926,GO:0072684,1.00000000002211,0.949593973598917,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
19769,GO:2000118,1.00000000002213,0.948393393978379,0,1,regulation of sodium-dependent phosphate transport,BP,
1774,GO:0004376,1.00000000002213,0.830183179209347,0,4,glycolipid mannosyltransferase activity,MF,
6032,GO:0019087,1.00000000002217,0.868834098082169,0,3,transformation of host cell by virus,BP,
1957,GO:0004658,1.00000000002217,0.914320543548536,0,2,propionyl-CoA carboxylase activity,MF,
3450,GO:0007263,1.00000000002218,0.684830326437714,0,8,nitric oxide mediated signal transduction,BP,
440,GO:0001181,1.00000000002219,0.912085767820814,0,2,transcription factor activity, core RNA polymerase I binding,MF,
5928,GO:0018199,1.00000000002223,0.83515190441572,0,4,peptidyl-glutamine modification,BP,
18804,GO:1904304,1.00000000002225,0.92607787881072,0,2,regulation of gastro-intestinal system smooth muscle contraction,BP,
18805,GO:1904306,1.00000000002225,0.92607787881072,0,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
1315,GO:0003160,1.00000000002225,0.868782853997523,0,3,endocardium morphogenesis,BP,
1563,GO:0003960,1.00000000002226,0.882189506322682,0,3,NADPH:quinone reductase activity,MF,
20076,GO:2000675,1.00000000002227,0.815004244165698,0,4,negative regulation of type B pancreatic cell apoptotic process,BP,
17817,GO:1901896,1.00000000002228,0.91837060123266,0,2,positive regulation of calcium-transporting ATPase activity,BP,
13197,GO:0051790,1.00000000002229,0.833826191685442,0,4,short-chain fatty acid biosynthetic process,BP,
18387,GO:1903371,1.0000000000223,0.810527461166051,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
16009,GO:0086006,1.00000000002233,0.897323084777268,0,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
2088,GO:0004849,1.00000000002233,0.8051542565618,0,5,uridine kinase activity,MF,
9034,GO:0035247,1.00000000002234,0.661899703029325,0,9,peptidyl-arginine omega-N-methylation,BP,
5391,GO:0016212,1.00000000002235,0.911950841913645,0,2,kynurenine-oxoglutarate transaminase activity,MF,
9497,GO:0036137,1.00000000002235,0.911950841913645,0,2,kynurenine aminotransferase activity,MF,
16429,GO:0097052,1.00000000002235,0.911950841913645,0,2,L-kynurenine metabolic process,BP,
16257,GO:0090298,1.00000000002235,0.859551752726427,0,3,negative regulation of mitochondrial DNA replication,BP,
17802,GO:1901859,1.00000000002235,0.859551752726427,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
7662,GO:0032079,1.00000000002235,0.842407186685981,0,4,positive regulation of endodeoxyribonuclease activity,BP,
6176,GO:0019534,1.00000000002236,0.811740456978258,0,4,toxin transmembrane transporter activity,MF,
7199,GO:0031084,1.00000000002237,0.856339577282502,0,3,BLOC-2 complex,CC,
847,GO:0002159,1.00000000002237,0.814325021535473,0,4,desmosome assembly,BP,
2672,GO:0006021,1.00000000002237,0.827563549727482,0,4,inositol biosynthetic process,BP,
6337,GO:0021502,1.00000000002243,0.900222525595499,0,2,neural fold elevation formation,BP,
18576,GO:1903778,1.00000000002244,0.903404341147589,0,2,protein localization to vacuolar membrane,BP,
54,GO:0000111,1.00000000002245,0.950487606123416,0,1,nucleotide-excision repair factor 2 complex,CC,
1694,GO:0004165,1.00000000002248,0.863062609285956,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
14813,GO:0070531,1.00000000002248,0.78383984844498,0,5,BRCA1-A complex,CC,
1891,GO:0004569,1.00000000002249,0.947361777833569,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2216,GO:0005105,1.00000000002249,0.955118093645331,0,1,type 1 fibroblast growth factor receptor binding,MF,
7228,GO:0031118,1.00000000002249,0.752043280582309,0,8,rRNA pseudouridine synthesis,BP,
9576,GO:0036374,1.0000000000225,0.869481065268306,0,3,glutathione hydrolase activity,MF,
17187,GO:0102953,1.0000000000225,0.869481065268306,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
17196,GO:0103068,1.0000000000225,0.869481065268306,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
17780,GO:1901748,1.0000000000225,0.869481065268306,0,3,leukotriene D4 metabolic process,BP,
17781,GO:1901750,1.0000000000225,0.869481065268306,0,3,leukotriene D4 biosynthetic process,BP,
12392,GO:0048788,1.00000000002251,0.803140590771116,0,4,cytoskeleton of presynaptic active zone,CC,
17084,GO:0099569,1.00000000002251,0.803140590771116,0,4,presynaptic cytoskeleton,CC,
1577,GO:0003983,1.00000000002253,0.955645265801233,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
13177,GO:0051748,1.00000000002253,0.955645265801233,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
6322,GO:0019964,1.00000000002253,0.951176473959287,0,1,interferon-gamma binding,MF,
19531,GO:1990390,1.00000000002253,0.951176473959287,0,1,protein K33-linked ubiquitination,BP,
9365,GO:0035877,1.00000000002255,0.833561791534602,0,4,death effector domain binding,MF,
7790,GO:0032311,1.00000000002256,0.930806450379212,0,2,angiogenin-PRI complex,CC,
2099,GO:0004862,1.00000000002256,0.72839587987867,0,7,cAMP-dependent protein kinase inhibitor activity,MF,
13239,GO:0051886,1.00000000002258,0.946767742256425,0,1,negative regulation of timing of anagen,BP,
20276,GO:2001203,1.00000000002258,0.946767742256425,0,1,positive regulation of transforming growth factor-beta secretion,BP,
15111,GO:0071139,1.00000000002258,0.903381818684479,0,2,resolution of recombination intermediates,BP,
15112,GO:0071140,1.00000000002258,0.903381818684479,0,2,resolution of mitotic recombination intermediates,BP,
8475,GO:0033615,1.00000000002259,0.86963437392788,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
5406,GO:0016240,1.0000000000226,0.837323228421687,0,4,autophagosome membrane docking,BP,
151,GO:0000306,1.00000000002261,0.816180747884377,0,4,extrinsic component of vacuolar membrane,CC,
18508,GO:1903613,1.00000000002261,0.946704174500751,0,1,regulation of protein tyrosine phosphatase activity,BP,
18509,GO:1903615,1.00000000002261,0.946704174500751,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
17871,GO:1902047,1.00000000002264,0.795081961042364,0,5,polyamine transmembrane transport,BP,
6364,GO:0021541,1.00000000002266,0.948140761494062,0,1,ammon gyrus development,BP,
5982,GO:0018585,1.00000000002266,0.955561312311973,0,1,fluorene oxygenase activity,MF,
5992,GO:0018917,1.00000000002266,0.955561312311973,0,1,fluorene metabolic process,BP,
12754,GO:0051006,1.00000000002266,0.829990831510988,0,4,positive regulation of lipoprotein lipase activity,BP,
14299,GO:0061365,1.00000000002266,0.829990831510988,0,4,positive regulation of triglyceride lipase activity,BP,
18428,GO:1903441,1.00000000002267,0.711748532639571,0,7,protein localization to ciliary membrane,BP,
3904,GO:0008541,1.00000000002267,0.748802028902031,0,7,proteasome regulatory particle, lid subcomplex,CC,
19562,GO:1990450,1.00000000002268,0.955912542016876,0,1,linear polyubiquitin binding,MF,
15939,GO:0072711,1.00000000002268,0.663325964244484,0,8,cellular response to hydroxyurea,BP,
9307,GO:0035750,1.0000000000227,0.946700831438888,0,1,protein localization to myelin sheath abaxonal region,BP,
20251,GO:2001166,1.0000000000227,0.778017181483679,0,5,regulation of histone H2B ubiquitination,BP,
7548,GO:0031826,1.00000000002271,0.878430279524045,0,3,type 2A serotonin receptor binding,MF,
13629,GO:0060087,1.00000000002272,0.852922228486936,0,4,relaxation of vascular smooth muscle,BP,
497,GO:0001552,1.00000000002272,0.956849450754164,0,1,ovarian follicle atresia,BP,
19901,GO:2000355,1.00000000002272,0.956849450754164,0,1,negative regulation of ovarian follicle development,BP,
2121,GO:0004909,1.00000000002274,0.905870284143792,0,2,interleukin-1, Type I, activating receptor activity,MF,
7407,GO:0031466,1.00000000002276,0.849195515133201,0,4,Cul5-RING ubiquitin ligase complex,CC,
4932,GO:0014886,1.00000000002276,0.902127154972615,0,2,transition between slow and fast fiber,BP,
3878,GO:0008506,1.00000000002276,0.905508647208957,0,2,sucrose:proton symporter activity,MF,
3886,GO:0008515,1.00000000002276,0.905508647208957,0,2,sucrose transmembrane transporter activity,MF,
4289,GO:0009669,1.00000000002276,0.905508647208957,0,2,sucrose:cation symporter activity,MF,
5009,GO:0015154,1.00000000002276,0.905508647208957,0,2,disaccharide transmembrane transporter activity,MF,
5010,GO:0015157,1.00000000002276,0.905508647208957,0,2,oligosaccharide transmembrane transporter activity,MF,
5192,GO:0015766,1.00000000002276,0.905508647208957,0,2,disaccharide transport,BP,
5193,GO:0015770,1.00000000002276,0.905508647208957,0,2,sucrose transport,BP,
5194,GO:0015772,1.00000000002276,0.905508647208957,0,2,oligosaccharide transport,BP,
11063,GO:0045048,1.00000000002278,0.79247570567679,0,5,protein insertion into ER membrane,BP,
19478,GO:1990131,1.00000000002279,0.883255040257008,0,3,Gtr1-Gtr2 GTPase complex,CC,
18557,GO:1903748,1.00000000002279,0.826203070141089,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
2045,GO:0004790,1.00000000002281,0.954382475340243,0,1,thioether S-methyltransferase activity,MF,
7026,GO:0030748,1.00000000002281,0.954382475340243,0,1,amine N-methyltransferase activity,MF,
17176,GO:0102707,1.00000000002281,0.954382475340243,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
3515,GO:0007439,1.00000000002284,0.953307545140083,0,1,ectodermal digestive tract development,BP,
9521,GO:0036215,1.00000000002284,0.953307545140083,0,1,response to stem cell factor,BP,
9522,GO:0036216,1.00000000002284,0.953307545140083,0,1,cellular response to stem cell factor stimulus,BP,
9708,GO:0038109,1.00000000002284,0.953307545140083,0,1,Kit signaling pathway,BP,
12298,GO:0048611,1.00000000002284,0.953307545140083,0,1,embryonic ectodermal digestive tract development,BP,
3839,GO:0008442,1.00000000002284,0.956579810656857,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
14999,GO:0070900,1.00000000002288,0.672616319525888,0,9,mitochondrial tRNA modification,BP,
17535,GO:1900864,1.00000000002288,0.672616319525888,0,9,mitochondrial RNA modification,BP,
5355,GO:0016103,1.00000000002288,0.947441198034781,0,1,diterpenoid catabolic process,BP,
5357,GO:0016115,1.00000000002288,0.947441198034781,0,1,terpenoid catabolic process,BP,
8859,GO:0034653,1.00000000002288,0.947441198034781,0,1,retinoic acid catabolic process,BP,
18584,GO:1903795,1.00000000002289,0.816700451230282,0,4,regulation of inorganic anion transmembrane transport,BP,
1886,GO:0004563,1.00000000002292,0.785580153597227,0,5,beta-N-acetylhexosaminidase activity,MF,
5004,GO:0015143,1.00000000002296,0.957433903011639,0,1,urate transmembrane transporter activity,MF,
15808,GO:0072428,1.00000000002296,0.957433903011639,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
17768,GO:1901702,1.00000000002296,0.957433903011639,0,1,salt transmembrane transporter activity,MF,
18649,GO:1903925,1.00000000002296,0.957433903011639,0,1,response to bisphenol A,BP,
18650,GO:1903926,1.00000000002296,0.957433903011639,0,1,cellular response to bisphenol A,BP,
16501,GO:0097179,1.00000000002298,0.890371939590035,0,4,protease inhibitor complex,CC,
18723,GO:1904090,1.00000000002298,0.890371939590035,0,4,peptidase inhibitor complex,CC,
17634,GO:1901317,1.000000000023,0.858686820495028,0,4,regulation of flagellated sperm motility,BP,
14105,GO:0060916,1.000000000023,0.811104697006882,0,4,mesenchymal cell proliferation involved in lung development,BP,
8418,GO:0033477,1.00000000002301,0.956479476628321,0,1,S-methylmethionine metabolic process,BP,
11972,GO:0047150,1.00000000002301,0.956479476628321,0,1,betaine-homocysteine S-methyltransferase activity,MF,
14393,GO:0061627,1.00000000002301,0.956479476628321,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
8261,GO:0033037,1.00000000002301,0.946671315341199,0,1,polysaccharide localization,BP,
3028,GO:0006574,1.00000000002302,0.835575524509652,0,4,valine catabolic process,BP,
16600,GO:0097396,1.00000000002303,0.823197079938809,0,4,response to interleukin-17,BP,
16601,GO:0097398,1.00000000002303,0.823197079938809,0,4,cellular response to interleukin-17,BP,
16602,GO:0097400,1.00000000002303,0.823197079938809,0,4,interleukin-17-mediated signaling pathway,BP,
15132,GO:0071208,1.00000000002304,0.874640564779932,0,4,histone pre-mRNA DCP binding,MF,
13102,GO:0051598,1.00000000002306,0.947314420396497,0,1,meiotic recombination checkpoint,BP,
1902,GO:0004583,1.00000000002308,0.823021360126401,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
14294,GO:0061355,1.00000000002309,0.823795511390097,0,4,Wnt protein secretion,BP,
14295,GO:0061356,1.00000000002309,0.823795511390097,0,4,regulation of Wnt protein secretion,BP,
10705,GO:0043987,1.0000000000231,0.832114380320855,0,4,histone H3-S10 phosphorylation,BP,
5568,GO:0016576,1.00000000002312,0.865384733027349,0,3,histone dephosphorylation,BP,
17395,GO:1900109,1.00000000002312,0.927049919594253,0,2,regulation of histone H3-K9 dimethylation,BP,
17396,GO:1900110,1.00000000002312,0.927049919594253,0,2,negative regulation of histone H3-K9 dimethylation,BP,
3262,GO:0006931,1.00000000002312,0.870381394165629,0,3,substrate-dependent cell migration, cell attachment to substrate,BP,
5273,GO:0015917,1.00000000002315,0.80464677349205,0,4,aminophospholipid transport,BP,
19969,GO:2000481,1.00000000002316,0.813635314570035,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
519,GO:0001595,1.00000000002316,0.967832762807126,0,1,angiotensin receptor activity,MF,
2138,GO:0004945,1.00000000002316,0.967832762807126,0,1,angiotensin type II receptor activity,MF,
1681,GO:0004143,1.00000000002322,0.658748727180635,0,8,diacylglycerol kinase activity,MF,
5098,GO:0015369,1.00000000002322,0.94668416729176,0,1,calcium:proton antiporter activity,MF,
12845,GO:0051139,1.00000000002322,0.94668416729176,0,1,metal ion:proton antiporter activity,MF,
13484,GO:0055005,1.00000000002322,0.94668416729176,0,1,ventricular cardiac myofibril assembly,BP,
18709,GO:1904046,1.00000000002325,0.932920766532119,0,2,negative regulation of vascular endothelial growth factor production,BP,
7718,GO:0032203,1.00000000002325,0.957525604103637,0,1,telomere formation via telomerase,BP,
13997,GO:0060694,1.00000000002325,0.957525604103637,0,1,regulation of cholesterol transporter activity,BP,
15765,GO:0072343,1.00000000002325,0.957525604103637,0,1,pancreatic stellate cell proliferation,BP,
17697,GO:1901558,1.00000000002325,0.957525604103637,0,1,response to metformin,BP,
19322,GO:1905563,1.00000000002325,0.957525604103637,0,1,negative regulation of vascular endothelial cell proliferation,BP,
19818,GO:2000229,1.00000000002325,0.957525604103637,0,1,regulation of pancreatic stellate cell proliferation,BP,
19819,GO:2000230,1.00000000002325,0.957525604103637,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
16456,GO:0097106,1.00000000002326,0.692188919885294,0,7,postsynaptic density organization,BP,
17012,GO:0099084,1.00000000002326,0.692188919885294,0,7,postsynaptic specialization organization,BP,
13111,GO:0051610,1.00000000002326,0.854297404757962,0,3,serotonin uptake,BP,
15727,GO:0072268,1.00000000002332,0.872637747845371,0,3,pattern specification involved in metanephros development,BP,
8772,GO:0034447,1.00000000002332,0.871750415062322,0,4,very-low-density lipoprotein particle clearance,BP,
3640,GO:0008111,1.00000000002334,0.956610572246878,0,1,alpha-methylacyl-CoA racemase activity,MF,
8782,GO:0034458,1.00000000002335,0.904214747236109,0,2,3'-5' RNA helicase activity,MF,
6573,GO:0022028,1.00000000002336,0.805397115692463,0,4,tangential migration from the subventricular zone to the olfactory bulb,BP,
2623,GO:0005940,1.00000000002337,0.634002908000807,0,9,septin ring,CC,
7217,GO:0031105,1.00000000002337,0.634002908000807,0,9,septin complex,CC,
7704,GO:0032160,1.00000000002337,0.634002908000807,0,9,septin filament array,CC,
8121,GO:0032804,1.00000000002338,0.910254447127018,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
11754,GO:0046581,1.00000000002338,0.857327359073262,0,3,intercellular canaliculus,CC,
16279,GO:0090326,1.00000000002339,0.951971129080981,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
18144,GO:1902823,1.00000000002339,0.951971129080981,0,1,negative regulation of late endosome to lysosome transport,BP,
18372,GO:1903336,1.00000000002339,0.951971129080981,0,1,negative regulation of vacuolar transport,BP,
19883,GO:2000331,1.00000000002339,0.951971129080981,0,1,regulation of terminal button organization,BP,
8770,GO:0034441,1.00000000002339,0.958069102739526,0,1,plasma lipoprotein particle oxidation,BP,
4251,GO:0009448,1.00000000002341,0.813474992515925,0,4,gamma-aminobutyric acid metabolic process,BP,
11987,GO:0047273,1.00000000002344,0.951877046404661,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
13194,GO:0051786,1.00000000002344,0.951877046404661,0,1,all-trans-retinol 13,14-reductase activity,MF,
17357,GO:1900028,1.00000000002344,0.829331721152272,0,4,negative regulation of ruffle assembly,BP,
13760,GO:0060318,1.00000000002345,0.814063105029808,0,4,definitive erythrocyte differentiation,BP,
5166,GO:0015705,1.00000000002346,0.807959664142153,0,4,iodide transport,BP,
9101,GO:0035368,1.00000000002348,0.824639814919017,0,4,selenocysteine insertion sequence binding,MF,
5787,GO:0017005,1.00000000002349,0.950364112776519,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6447,GO:0021757,1.00000000002349,0.950364112776519,0,1,caudate nucleus development,BP,
6448,GO:0021758,1.00000000002349,0.950364112776519,0,1,putamen development,BP,
9167,GO:0035519,1.0000000000235,0.859839746511383,0,4,protein K29-linked ubiquitination,BP,
5309,GO:0016011,1.0000000000235,0.860623939751448,0,3,dystroglycan complex,CC,
14697,GO:0070305,1.00000000002351,0.850421503308026,0,3,response to cGMP,BP,
15196,GO:0071321,1.00000000002351,0.850421503308026,0,3,cellular response to cGMP,BP,
12639,GO:0050811,1.00000000002354,0.667543518514419,0,9,GABA receptor binding,MF,
8652,GO:0034196,1.00000000002354,0.954300145318208,0,1,acylglycerol transport,BP,
8653,GO:0034197,1.00000000002354,0.954300145318208,0,1,triglyceride transport,BP,
10874,GO:0044395,1.00000000002354,0.954300145318208,0,1,protein targeting to vacuolar membrane,BP,
17510,GO:1900483,1.00000000002354,0.954300145318208,0,1,regulation of protein targeting to vacuolar membrane,BP,
5425,GO:0016272,1.00000000002355,0.815235251297256,0,7,prefoldin complex,CC,
551,GO:0001672,1.00000000002356,0.697962286438418,0,7,regulation of chromatin assembly or disassembly,BP,
816,GO:0002086,1.00000000002358,0.950547303817297,0,1,diaphragm contraction,BP,
1895,GO:0004574,1.00000000002358,0.950547303817297,0,1,oligo-1,6-glucosidase activity,MF,
2651,GO:0005985,1.00000000002358,0.950547303817297,0,1,sucrose metabolic process,BP,
10370,GO:0043181,1.00000000002358,0.950547303817297,0,1,vacuolar sequestering,BP,
4217,GO:0009374,1.00000000002359,0.774628831055814,0,5,biotin binding,MF,
9435,GO:0036004,1.00000000002359,0.966779138924193,0,1,GAF domain binding,MF,
6088,GO:0019240,1.0000000000236,0.806935489257755,0,4,citrulline biosynthetic process,BP,
7372,GO:0031415,1.0000000000236,0.840133589274859,0,4,NatA complex,CC,
2356,GO:0005436,1.00000000002361,0.904679734726397,0,2,sodium:phosphate symporter activity,MF,
5085,GO:0015319,1.00000000002361,0.904679734726397,0,2,sodium:inorganic phosphate symporter activity,MF,
5086,GO:0015321,1.00000000002361,0.904679734726397,0,2,sodium-dependent phosphate transmembrane transporter activity,MF,
14944,GO:0070815,1.00000000002362,0.819224529397634,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
14470,GO:0061819,1.00000000002363,0.861272494796245,0,3,telomeric DNA-containing double minutes formation,BP,
19374,GO:1905764,1.00000000002363,0.861272494796245,0,3,regulation of protection from non-homologous end joining at telomere,BP,
19375,GO:1905765,1.00000000002363,0.861272494796245,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
19595,GO:1990599,1.00000000002363,0.861272494796245,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
5052,GO:0015234,1.00000000002364,0.912256114437572,0,2,thiamine transmembrane transporter activity,MF,
15550,GO:0071934,1.00000000002364,0.912256114437572,0,2,thiamine transmembrane transport,BP,
12246,GO:0048500,1.00000000002364,0.691002838331314,0,9,signal recognition particle,CC,
5832,GO:0017108,1.00000000002365,0.74833083008095,0,6,5'-flap endonuclease activity,MF,
1784,GO:0004395,1.00000000002366,0.966118395370147,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
3828,GO:0008425,1.00000000002366,0.966118395370147,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3958,GO:0008689,1.00000000002366,0.966118395370147,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4457,GO:0010420,1.00000000002366,0.966118395370147,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4655,GO:0010795,1.00000000002366,0.966118395370147,0,1,regulation of ubiquinone biosynthetic process,BP,
6957,GO:0030580,1.00000000002366,0.966118395370147,0,1,quinone cofactor methyltransferase activity,MF,
10940,GO:0044595,1.00000000002366,0.966118395370147,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10941,GO:0044596,1.00000000002366,0.966118395370147,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
13178,GO:0051750,1.00000000002366,0.966118395370147,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14357,GO:0061542,1.00000000002366,0.966118395370147,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
17485,GO:1900365,1.00000000002366,0.857279436957655,0,3,positive regulation of mRNA polyadenylation,BP,
14848,GO:0070579,1.00000000002373,0.809614569286682,0,4,methylcytosine dioxygenase activity,MF,
16179,GO:0090186,1.00000000002374,0.783830555477391,0,5,regulation of pancreatic juice secretion,BP,
1548,GO:0003940,1.00000000002374,0.955426628334336,0,1,L-iduronidase activity,MF,
3841,GO:0008444,1.00000000002374,0.955426628334336,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
6779,GO:0030209,1.00000000002374,0.955426628334336,0,1,dermatan sulfate catabolic process,BP,
9603,GO:0036458,1.00000000002374,0.955426628334336,0,1,hepatocyte growth factor binding,MF,
19015,GO:1904798,1.00000000002375,0.828207325118496,0,4,positive regulation of core promoter binding,BP,
1901,GO:0004582,1.00000000002376,0.920553100939964,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
8341,GO:0033185,1.00000000002376,0.920553100939964,0,3,dolichol-phosphate-mannose synthase complex,CC,
4927,GO:0014874,1.00000000002377,0.706764763229472,0,7,response to stimulus involved in regulation of muscle adaptation,BP,
2283,GO:0005231,1.00000000002377,0.70784373369958,0,7,excitatory extracellular ligand-gated ion channel activity,MF,
7499,GO:0031666,1.00000000002379,0.841088405569231,0,4,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
4901,GO:0014825,1.00000000002379,0.976475700283099,0,1,stomach fundus smooth muscle contraction,BP,
4914,GO:0014847,1.00000000002379,0.976475700283099,0,1,proximal stomach smooth muscle contraction,BP,
7549,GO:0031839,1.00000000002379,0.976475700283099,0,1,type 1 neuromedin U receptor binding,MF,
7550,GO:0031840,1.00000000002379,0.976475700283099,0,1,type 2 neuromedin U receptor binding,MF,
9143,GO:0035483,1.00000000002379,0.976475700283099,0,1,gastric emptying,BP,
10234,GO:0042922,1.00000000002379,0.976475700283099,0,1,neuromedin U receptor binding,MF,
10919,GO:0044495,1.00000000002379,0.976475700283099,0,1,modulation of blood pressure in other organism,BP,
10920,GO:0044497,1.00000000002379,0.976475700283099,0,1,positive regulation of blood pressure in other organism,BP,
17274,GO:0120060,1.00000000002379,0.976475700283099,0,1,regulation of gastric emptying,BP,
17275,GO:0120061,1.00000000002379,0.976475700283099,0,1,negative regulation of gastric emptying,BP,
17276,GO:0120063,1.00000000002379,0.976475700283099,0,1,stomach smooth muscle contraction,BP,
17277,GO:0120068,1.00000000002379,0.976475700283099,0,1,regulation of stomach fundus smooth muscle contraction,BP,
17278,GO:0120069,1.00000000002379,0.976475700283099,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
6701,GO:0030091,1.0000000000238,0.765798582521877,0,7,protein repair,BP,
794,GO:0002055,1.00000000002381,0.978457300411814,0,1,adenine binding,MF,
1591,GO:0003999,1.00000000002381,0.978457300411814,0,1,adenine phosphoribosyltransferase activity,MF,
7680,GO:0032105,1.00000000002381,0.702542170770905,0,8,negative regulation of response to extracellular stimulus,BP,
7683,GO:0032108,1.00000000002381,0.702542170770905,0,8,negative regulation of response to nutrient levels,BP,
7293,GO:0031281,1.00000000002381,0.649722655396807,0,9,positive regulation of cyclase activity,BP,
4656,GO:0010796,1.00000000002382,0.884765340592487,0,3,regulation of multivesicular body size,BP,
3908,GO:0008545,1.00000000002384,0.903922499002395,0,2,JUN kinase kinase activity,MF,
11954,GO:0047016,1.00000000002386,0.9554556886904,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
16421,GO:0097037,1.00000000002388,0.95132909785696,0,1,heme export,BP,
16052,GO:0086069,1.00000000002388,0.640716096072201,0,9,bundle of His cell to Purkinje myocyte communication,BP,
3834,GO:0008431,1.00000000002389,0.952990359028066,0,1,vitamin E binding,MF,
1545,GO:0003937,1.00000000002391,0.955870758563443,0,1,IMP cyclohydrolase activity,MF,
1944,GO:0004643,1.00000000002391,0.955870758563443,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
13427,GO:0052798,1.00000000002391,0.955870758563443,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
439,GO:0001179,1.00000000002393,0.957494815484425,0,1,RNA polymerase I transcription factor binding,MF,
16235,GO:0090267,1.00000000002394,0.720257464040641,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
4751,GO:0010918,1.00000000002396,0.727148213382363,0,7,positive regulation of mitochondrial membrane potential,BP,
15947,GO:0072733,1.000000000024,0.875571935789577,0,3,response to staurosporine,BP,
15948,GO:0072734,1.000000000024,0.875571935789577,0,3,cellular response to staurosporine,BP,
4808,GO:0010999,1.00000000002401,0.947551254198187,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
11517,GO:0045993,1.00000000002401,0.947551254198187,0,1,negative regulation of translational initiation by iron,BP,
11949,GO:0046986,1.00000000002401,0.947551254198187,0,1,negative regulation of hemoglobin biosynthetic process,BP,
1305,GO:0003140,1.00000000002401,0.826153019900024,0,4,determination of left/right asymmetry in lateral mesoderm,BP,
19114,GO:1904998,1.00000000002401,0.953423823744326,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
813,GO:0002083,1.00000000002403,0.959898577275266,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
11994,GO:0047293,1.00000000002403,0.959898577275266,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
14674,GO:0070267,1.00000000002404,0.950625565659938,0,1,oncosis,BP,
7585,GO:0031945,1.00000000002404,0.949246109444911,0,1,positive regulation of glucocorticoid metabolic process,BP,
7588,GO:0031948,1.00000000002404,0.949246109444911,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
7801,GO:0032346,1.00000000002404,0.949246109444911,0,1,positive regulation of aldosterone metabolic process,BP,
7804,GO:0032349,1.00000000002404,0.949246109444911,0,1,positive regulation of aldosterone biosynthetic process,BP,
14038,GO:0060748,1.00000000002404,0.949246109444911,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
14186,GO:0061054,1.00000000002404,0.949246109444911,0,1,dermatome development,BP,
14242,GO:0061183,1.00000000002404,0.949246109444911,0,1,regulation of dermatome development,BP,
14243,GO:0061184,1.00000000002404,0.949246109444911,0,1,positive regulation of dermatome development,BP,
14252,GO:0061205,1.00000000002404,0.949246109444911,0,1,paramesonephric duct development,BP,
14300,GO:0061369,1.00000000002404,0.949246109444911,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
18422,GO:1903434,1.00000000002404,0.949425893653286,0,1,negative regulation of constitutive secretory pathway,BP,
19719,GO:2000019,1.00000000002404,0.949246109444911,0,1,negative regulation of male gonad development,BP,
19743,GO:2000066,1.00000000002404,0.949246109444911,0,1,positive regulation of cortisol biosynthetic process,BP,
19814,GO:2000224,1.00000000002404,0.949246109444911,0,1,regulation of testosterone biosynthetic process,BP,
19815,GO:2000225,1.00000000002404,0.949246109444911,0,1,negative regulation of testosterone biosynthetic process,BP,
18499,GO:1903588,1.00000000002405,0.869801252276674,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
16769,GO:0098536,1.00000000002406,0.853391236174771,0,3,deuterosome,CC,
14443,GO:0061741,1.00000000002406,0.911942531216924,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
11037,GO:0044878,1.00000000002407,0.844790267870604,0,4,mitotic cytokinesis checkpoint,BP,
4085,GO:0009137,1.00000000002407,0.836722349351642,0,4,purine nucleoside diphosphate catabolic process,BP,
4124,GO:0009181,1.00000000002407,0.836722349351642,0,4,purine ribonucleoside diphosphate catabolic process,BP,
14437,GO:0061734,1.00000000002412,0.765473824238523,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
9517,GO:0036194,1.00000000002418,0.888300881850682,0,3,muscle cell projection,CC,
9518,GO:0036195,1.00000000002418,0.888300881850682,0,3,muscle cell projection membrane,CC,
13137,GO:0051665,1.00000000002418,0.733480367455076,0,7,membrane raft localization,BP,
8221,GO:0032977,1.00000000002421,0.947450381172061,0,1,membrane insertase activity,MF,
8222,GO:0032978,1.00000000002421,0.947450381172061,0,1,protein insertion into membrane from inner side,BP,
8223,GO:0032979,1.00000000002421,0.947450381172061,0,1,protein insertion into mitochondrial membrane from inner side,BP,
1716,GO:0004305,1.00000000002421,0.829285723866373,0,4,ethanolamine kinase activity,MF,
4549,GO:0010624,1.00000000002421,0.811317738404317,0,4,regulation of Schwann cell proliferation,BP,
4550,GO:0010626,1.00000000002421,0.811317738404317,0,4,negative regulation of Schwann cell proliferation,BP,
484,GO:0001534,1.00000000002422,0.949809507863573,0,1,radial spoke,CC,
485,GO:0001536,1.00000000002422,0.949809507863573,0,1,radial spoke stalk,CC,
16887,GO:0098808,1.00000000002426,0.912280314460509,0,2,mRNA cap binding,MF,
5953,GO:0018293,1.00000000002427,0.967332099076728,0,1,protein-FAD linkage,BP,
9789,GO:0039713,1.00000000002427,0.951308313931771,0,1,viral factory,CC,
9790,GO:0039714,1.00000000002427,0.951308313931771,0,1,cytoplasmic viral factory,CC,
15829,GO:0072517,1.00000000002427,0.951308313931771,0,1,host cell viral assembly compartment,CC,
17482,GO:1900276,1.00000000002427,0.951308313931771,0,1,regulation of proteinase activated receptor activity,BP,
17521,GO:1900736,1.00000000002427,0.951308313931771,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17522,GO:1900737,1.00000000002427,0.951308313931771,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18603,GO:1903837,1.00000000002428,0.954568542394027,0,1,regulation of mRNA 3'-UTR binding,BP,
18604,GO:1903839,1.00000000002428,0.954568542394027,0,1,positive regulation of mRNA 3'-UTR binding,BP,
8982,GO:0035087,1.0000000000243,0.833108073561671,0,4,siRNA loading onto RISC involved in RNA interference,BP,
4129,GO:0009186,1.00000000002433,0.863300323945603,0,4,deoxyribonucleoside diphosphate metabolic process,BP,
16647,GO:0097494,1.00000000002434,0.826846755868398,0,4,regulation of vesicle size,BP,
338,GO:0000938,1.00000000002439,0.816548335964484,0,4,GARP complex,CC,
14734,GO:0070376,1.0000000000244,0.953538080880118,0,1,regulation of ERK5 cascade,BP,
14735,GO:0070377,1.0000000000244,0.953538080880118,0,1,negative regulation of ERK5 cascade,BP,
6084,GO:0019236,1.00000000002442,0.916243440839984,0,2,response to pheromone,BP,
2599,GO:0005892,1.00000000002444,0.780446759920934,0,5,acetylcholine-gated channel complex,CC,
19480,GO:1990136,1.00000000002445,0.954481710629371,0,1,linoleate 9S-lipoxygenase activity,MF,
4735,GO:0010896,1.00000000002446,0.864366525535957,0,3,regulation of triglyceride catabolic process,BP,
6107,GO:0019323,1.00000000002446,0.849171831314898,0,4,pentose catabolic process,BP,
14198,GO:0061083,1.0000000000245,0.823337758829145,0,4,regulation of protein refolding,BP,
14199,GO:0061084,1.0000000000245,0.823337758829145,0,4,negative regulation of protein refolding,BP,
2032,GO:0004768,1.00000000002451,0.860570696535818,0,3,stearoyl-CoA 9-desaturase activity,MF,
5393,GO:0016215,1.00000000002451,0.860570696535818,0,3,acyl-CoA desaturase activity,MF,
2059,GO:0004809,1.00000000002453,0.871639451649974,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
12998,GO:0051388,1.00000000002456,0.816827381360366,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
7473,GO:0031627,1.00000000002457,0.863957724463658,0,3,telomeric loop formation,BP,
4797,GO:0010985,1.00000000002458,0.819064841002796,0,5,negative regulation of lipoprotein particle clearance,BP,
13707,GO:0060242,1.00000000002461,0.723524167776587,0,7,contact inhibition,BP,
10394,GO:0043220,1.00000000002462,0.64417298695283,0,9,Schmidt-Lanterman incisure,CC,
13207,GO:0051800,1.00000000002463,0.946676705044278,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
20147,GO:2000808,1.00000000002463,0.946676705044278,0,1,negative regulation of synaptic vesicle clustering,BP,
16202,GO:0090210,1.00000000002467,0.904343085457338,0,2,regulation of establishment of blood-brain barrier,BP,
6242,GO:0019797,1.00000000002467,0.867005346301098,0,3,procollagen-proline 3-dioxygenase activity,MF,
8440,GO:0033557,1.00000000002467,0.867005346301098,0,3,Slx1-Slx4 complex,CC,
13470,GO:0052905,1.00000000002467,0.867005346301098,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
18522,GO:1903651,1.0000000000247,0.625750031337536,0,9,positive regulation of cytoplasmic transport,BP,
9938,GO:0042284,1.00000000002472,0.957565517335145,0,1,sphingolipid delta-4 desaturase activity,MF,
2461,GO:0005672,1.00000000002473,0.853761124584033,0,4,transcription factor TFIIA complex,CC,
4335,GO:0009881,1.00000000002474,0.821100153823874,0,4,photoreceptor activity,MF,
18482,GO:1903564,1.00000000002476,0.814168362144575,0,4,regulation of protein localization to cilium,BP,
534,GO:0001652,1.00000000002479,0.835805213150861,0,4,granular component,CC,
19081,GO:1904928,1.00000000002481,0.896281000448269,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
2395,GO:0005536,1.00000000002486,0.641378451033593,0,9,glucose binding,MF,
3779,GO:0008332,1.00000000002487,0.956894116981405,0,1,low voltage-gated calcium channel activity,MF,
8855,GO:0034648,1.00000000002489,0.810623747933833,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
4460,GO:0010430,1.00000000002489,0.947156650926228,0,1,fatty acid omega-oxidation,BP,
10218,GO:0042835,1.00000000002489,0.947156650926228,0,1,BRE binding,MF,
15451,GO:0071713,1.00000000002489,0.947156650926228,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
13534,GO:0055091,1.0000000000249,0.810156380515622,0,4,phospholipid homeostasis,BP,
3098,GO:0006671,1.0000000000249,0.947717781781152,0,1,phytosphingosine metabolic process,BP,
14933,GO:0070774,1.0000000000249,0.947717781781152,0,1,phytoceramidase activity,MF,
15376,GO:0071602,1.0000000000249,0.947717781781152,0,1,phytosphingosine biosynthetic process,BP,
2938,GO:0006463,1.00000000002491,0.949919260344712,0,1,steroid hormone receptor complex assembly,BP,
10344,GO:0043137,1.00000000002492,0.841689949512439,0,4,DNA replication, removal of RNA primer,BP,
19454,GO:1990037,1.00000000002493,0.876616675293888,0,3,Lewy body core,CC,
1241,GO:0002930,1.00000000002494,0.946771921533481,0,1,trabecular meshwork development,BP,
1819,GO:0004466,1.00000000002496,0.838912920015162,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
5829,GO:0017099,1.00000000002496,0.838912920015162,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
18989,GO:1904749,1.00000000002496,0.839468316340397,0,4,regulation of protein localization to nucleolus,BP,
13432,GO:0052812,1.00000000002497,0.899432565190407,0,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
2367,GO:0005477,1.00000000002497,0.950847421030121,0,1,pyruvate secondary active transmembrane transporter activity,MF,
10684,GO:0043932,1.00000000002497,0.909965590761878,0,2,ossification involved in bone remodeling,BP,
9535,GO:0036265,1.00000000002498,0.861888371933789,0,4,RNA (guanine-N7)-methylation,BP,
13704,GO:0060232,1.00000000002498,0.829537723634032,0,4,delamination,BP,
9257,GO:0035662,1.00000000002498,0.930301219250535,0,3,Toll-like receptor 4 binding,MF,
4195,GO:0009298,1.00000000002499,0.848773694359238,0,4,GDP-mannose biosynthetic process,BP,
5497,GO:0016429,1.000000000025,0.869530980238854,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
14508,GO:0061953,1.000000000025,0.869530980238854,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
13490,GO:0055011,1.000000000025,0.959169579565671,0,1,atrial cardiac muscle cell differentiation,BP,
13493,GO:0055014,1.000000000025,0.959169579565671,0,1,atrial cardiac muscle cell development,BP,
11742,GO:0046544,1.00000000002502,0.946794098096546,0,1,development of secondary male sexual characteristics,BP,
11564,GO:0046092,1.00000000002505,0.946825803382375,0,1,deoxycytidine metabolic process,BP,
8579,GO:0034056,1.00000000002508,0.857600326177439,0,3,estrogen response element binding,MF,
17250,GO:0110057,1.0000000000251,0.946682132098471,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17251,GO:0110059,1.0000000000251,0.946682132098471,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
13076,GO:0051563,1.00000000002514,0.90041628036215,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
3810,GO:0008395,1.00000000002514,0.692225798226443,0,8,steroid hydroxylase activity,MF,
5475,GO:0016404,1.00000000002514,0.947547260367858,0,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
16537,GO:0097238,1.00000000002515,0.938022660140535,0,2,cellular response to methylglyoxal,BP,
16793,GO:0098594,1.00000000002518,0.978430851877551,0,1,mucin granule,CC,
5988,GO:0018879,1.00000000002519,0.870576118462499,0,3,biphenyl metabolic process,BP,
15190,GO:0071314,1.00000000002519,0.953820426986739,0,1,cellular response to cocaine,BP,
17983,GO:1902362,1.00000000002519,0.953820426986739,0,1,melanocyte apoptotic process,BP,
12142,GO:0048210,1.00000000002521,0.876203836645225,0,3,Golgi vesicle fusion to target membrane,BP,
628,GO:0001809,1.00000000002525,0.963772868073271,0,1,positive regulation of type IV hypersensitivity,BP,
13874,GO:0060467,1.00000000002525,0.963772868073271,0,1,negative regulation of fertilization,BP,
19902,GO:2000359,1.00000000002525,0.963772868073271,0,1,regulation of binding of sperm to zona pellucida,BP,
19903,GO:2000360,1.00000000002525,0.963772868073271,0,1,negative regulation of binding of sperm to zona pellucida,BP,
19922,GO:2000387,1.00000000002525,0.963772868073271,0,1,regulation of antral ovarian follicle growth,BP,
19923,GO:2000388,1.00000000002525,0.963772868073271,0,1,positive regulation of antral ovarian follicle growth,BP,
12526,GO:0050656,1.00000000002525,0.818184483706227,0,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
17923,GO:1902219,1.00000000002527,0.81233271599468,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
8461,GO:0033597,1.0000000000253,0.95560169165039,0,1,mitotic checkpoint complex,CC,
19519,GO:1990298,1.0000000000253,0.95560169165039,0,1,bub1-bub3 complex,CC,
11137,GO:0045168,1.00000000002537,0.916399598282205,0,2,cell-cell signaling involved in cell fate commitment,BP,
11637,GO:0046331,1.00000000002537,0.916399598282205,0,2,lateral inhibition,BP,
12332,GO:0048674,1.00000000002544,0.95464243578253,0,1,collateral sprouting of injured axon,BP,
12340,GO:0048686,1.00000000002544,0.95464243578253,0,1,regulation of sprouting of injured axon,BP,
12341,GO:0048687,1.00000000002544,0.95464243578253,0,1,positive regulation of sprouting of injured axon,BP,
12342,GO:0048688,1.00000000002544,0.95464243578253,0,1,negative regulation of sprouting of injured axon,BP,
12343,GO:0048689,1.00000000002544,0.95464243578253,0,1,formation of growth cone in injured axon,BP,
12344,GO:0048693,1.00000000002544,0.95464243578253,0,1,regulation of collateral sprouting of injured axon,BP,
12345,GO:0048694,1.00000000002544,0.95464243578253,0,1,positive regulation of collateral sprouting of injured axon,BP,
19330,GO:1905578,1.00000000002544,0.95464243578253,0,1,regulation of ERBB3 signaling pathway,BP,
19331,GO:1905580,1.00000000002544,0.95464243578253,0,1,positive regulation of ERBB3 signaling pathway,BP,
19433,GO:1905942,1.00000000002544,0.95464243578253,0,1,regulation of formation of growth cone in injured axon,BP,
19434,GO:1905943,1.00000000002544,0.95464243578253,0,1,negative regulation of formation of growth cone in injured axon,BP,
1167,GO:0002785,1.00000000002548,0.950264068540498,0,1,negative regulation of antimicrobial peptide production,BP,
1169,GO:0002787,1.00000000002548,0.950264068540498,0,1,negative regulation of antibacterial peptide production,BP,
3787,GO:0008348,1.00000000002548,0.950264068540498,0,1,negative regulation of antimicrobial humoral response,BP,
3601,GO:0008035,1.00000000002549,0.824369443119251,0,4,high-density lipoprotein particle binding,MF,
2349,GO:0005391,1.00000000002549,0.783925811145359,0,5,sodium:potassium-exchanging ATPase activity,MF,
3911,GO:0008556,1.00000000002549,0.783925811145359,0,5,potassium-transporting ATPase activity,MF,
18945,GO:1904672,1.00000000002553,0.813439447583615,0,4,regulation of somatic stem cell population maintenance,BP,
2154,GO:0004970,1.00000000002553,0.897386696398755,0,2,ionotropic glutamate receptor activity,MF,
2155,GO:0004972,1.00000000002553,0.897386696398755,0,2,NMDA glutamate receptor activity,MF,
10323,GO:0043103,1.00000000002553,0.883810180743562,0,3,hypoxanthine salvage,BP,
16855,GO:0098749,1.00000000002556,0.947281730752215,0,1,cerebellar neuron development,BP,
10593,GO:0043553,1.0000000000256,0.862538641505546,0,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11043,GO:0045007,1.00000000002561,0.888943102734794,0,3,depurination,BP,
13825,GO:0060400,1.00000000002562,0.94725395804523,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
3807,GO:0008385,1.00000000002565,0.657730448023984,0,9,IkappaB kinase complex,CC,
12055,GO:0047860,1.00000000002566,0.96600007267948,0,1,diiodophenylpyruvate reductase activity,MF,
13777,GO:0060339,1.00000000002566,0.707388624544332,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
7954,GO:0032545,1.00000000002566,0.874701971622709,0,3,CURI complex,CC,
8780,GO:0034456,1.00000000002566,0.874701971622709,0,3,UTP-C complex,CC,
2999,GO:0006544,1.00000000002567,0.693437379678094,0,8,glycine metabolic process,BP,
18974,GO:1904719,1.00000000002572,0.954635142019638,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
1320,GO:0003165,1.00000000002574,0.946672126793297,0,1,Purkinje myocyte development,BP,
212,GO:0000444,1.00000000002575,0.83726143393419,0,4,MIS12/MIND type complex,CC,
5441,GO:0016300,1.00000000002581,0.861611303132787,0,3,tRNA (uracil) methyltransferase activity,MF,
1127,GO:0002713,1.00000000002581,0.825100599457448,0,4,negative regulation of B cell mediated immunity,BP,
1223,GO:0002890,1.00000000002581,0.825100599457448,0,4,negative regulation of immunoglobulin mediated immune response,BP,
15640,GO:0072125,1.00000000002582,0.866543090511148,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16187,GO:0090194,1.00000000002582,0.866543090511148,0,3,negative regulation of glomerulus development,BP,
13560,GO:0060007,1.00000000002583,0.94827863737751,0,1,linear vestibuloocular reflex,BP,
2481,GO:0005713,1.00000000002583,0.954580251964617,0,1,recombination nodule,CC,
2482,GO:0005715,1.00000000002583,0.954580251964617,0,1,late recombination nodule,CC,
5016,GO:0015173,1.00000000002583,0.954580251964617,0,1,aromatic amino acid transmembrane transporter activity,MF,
5034,GO:0015196,1.00000000002583,0.954580251964617,0,1,L-tryptophan transmembrane transporter activity,MF,
10303,GO:0043060,1.00000000002583,0.954580251964617,0,1,meiotic metaphase I plate congression,BP,
12924,GO:0051257,1.00000000002583,0.954580251964617,0,1,meiotic spindle midzone assembly,BP,
12964,GO:0051311,1.00000000002583,0.954580251964617,0,1,meiotic metaphase plate congression,BP,
18790,GO:1904271,1.00000000002583,0.954580251964617,0,1,L-proline import across plasma membrane,BP,
18897,GO:1904555,1.00000000002583,0.954580251964617,0,1,L-proline transmembrane transport,BP,
18898,GO:1904556,1.00000000002583,0.954580251964617,0,1,L-tryptophan transmembrane transport,BP,
19352,GO:1905647,1.00000000002583,0.954580251964617,0,1,proline import across plasma membrane,BP,
11132,GO:0045161,1.00000000002583,0.700166726893719,0,7,neuronal ion channel clustering,BP,
6718,GO:0030124,1.00000000002585,0.832200271342074,0,4,AP-4 adaptor complex,CC,
8503,GO:0033679,1.00000000002589,0.947277041958917,0,1,3'-5' DNA/RNA helicase activity,MF,
8505,GO:0033681,1.00000000002589,0.947277041958917,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8783,GO:0034459,1.00000000002589,0.947277041958917,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9786,GO:0039695,1.00000000002589,0.947277041958917,0,1,DNA-templated viral transcription,BP,
19099,GO:1904971,1.00000000002589,0.947277041958917,0,1,regulation of viral translation,BP,
19100,GO:1904973,1.00000000002589,0.947277041958917,0,1,positive regulation of viral translation,BP,
19179,GO:1905172,1.00000000002589,0.947277041958917,0,1,RISC complex binding,MF,
19365,GO:1905698,1.00000000002589,0.947277041958917,0,1,positive regulation of polysome binding,BP,
19575,GO:1990518,1.00000000002589,0.947277041958917,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
16165,GO:0090168,1.00000000002589,0.832650676127471,0,4,Golgi reassembly,BP,
5813,GO:0017064,1.00000000002591,0.955834838975511,0,1,fatty acid amide hydrolase activity,MF,
17133,GO:0102077,1.00000000002591,0.955834838975511,0,1,oleamide hydrolase activity,MF,
17197,GO:0103073,1.00000000002591,0.955834838975511,0,1,anandamide amidohydrolase activity,MF,
7146,GO:0030981,1.00000000002591,0.855162014172392,0,3,cortical microtubule cytoskeleton,CC,
8130,GO:0032815,1.00000000002592,0.814003467276977,0,5,negative regulation of natural killer cell activation,BP,
9169,GO:0035521,1.00000000002592,0.820313415645549,0,4,monoubiquitinated histone deubiquitination,BP,
9170,GO:0035522,1.00000000002592,0.820313415645549,0,4,monoubiquitinated histone H2A deubiquitination,BP,
49,GO:0000103,1.00000000002596,0.876144310311874,0,3,sulfate assimilation,BP,
14781,GO:0070471,1.00000000002598,0.855794062663008,0,3,uterine smooth muscle contraction,BP,
14782,GO:0070472,1.00000000002598,0.855794062663008,0,3,regulation of uterine smooth muscle contraction,BP,
14783,GO:0070474,1.00000000002598,0.855794062663008,0,3,positive regulation of uterine smooth muscle contraction,BP,
15477,GO:0071802,1.00000000002603,0.948225417044586,0,1,negative regulation of podosome assembly,BP,
16045,GO:0086056,1.00000000002603,0.948225417044586,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16946,GO:0098912,1.00000000002603,0.948225417044586,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
103,GO:0000214,1.00000000002607,0.837243364422606,0,4,tRNA-intron endonuclease complex,CC,
14034,GO:0060743,1.00000000002609,0.954386831652781,0,1,epithelial cell maturation involved in prostate gland development,BP,
3870,GO:0008489,1.00000000002611,0.953517294288309,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
11986,GO:0047263,1.00000000002611,0.953517294288309,0,1,N-acylsphingosine galactosyltransferase activity,MF,
1275,GO:0003064,1.00000000002611,0.9576555449194,0,1,regulation of heart rate by hormone,BP,
19421,GO:1905912,1.00000000002611,0.9576555449194,0,1,regulation of calcium ion export across plasma membrane,BP,
19422,GO:1905913,1.00000000002611,0.9576555449194,0,1,negative regulation of calcium ion export across plasma membrane,BP,
16455,GO:0097105,1.00000000002611,0.803672408888407,0,4,presynaptic membrane assembly,BP,
2040,GO:0004777,1.00000000002612,0.946770049482325,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
4017,GO:0009013,1.00000000002612,0.946770049482325,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
10341,GO:0043131,1.00000000002612,0.946770049482325,0,1,erythrocyte enucleation,BP,
10476,GO:0043354,1.00000000002612,0.946770049482325,0,1,enucleate erythrocyte maturation,BP,
14503,GO:0061930,1.00000000002612,0.946770049482325,0,1,regulation of erythrocyte enucleation,BP,
14504,GO:0061931,1.00000000002612,0.946770049482325,0,1,positive regulation of erythrocyte enucleation,BP,
16358,GO:0090601,1.00000000002612,0.946770049482325,0,1,enucleation,BP,
18146,GO:1902838,1.00000000002612,0.946770049482325,0,1,regulation of nuclear migration along microtubule,BP,
234,GO:0000491,1.00000000002612,0.676227712440505,0,9,small nucleolar ribonucleoprotein complex assembly,BP,
7415,GO:0031493,1.00000000002613,0.867747993843902,0,3,nucleosomal histone binding,MF,
1519,GO:0003877,1.00000000002616,0.955807030271701,0,1,ATP adenylyltransferase activity,MF,
2073,GO:0004824,1.00000000002616,0.955807030271701,0,1,lysine-tRNA ligase activity,MF,
2920,GO:0006430,1.00000000002616,0.955807030271701,0,1,lysyl-tRNA aminoacylation,BP,
17861,GO:1902033,1.00000000002618,0.784025293197445,0,5,regulation of hematopoietic stem cell proliferation,BP,
7252,GO:0031204,1.00000000002619,0.881884088782097,0,3,posttranslational protein targeting to membrane, translocation,BP,
3172,GO:0006784,1.00000000002619,0.90234642265454,0,2,heme a biosynthetic process,BP,
11596,GO:0046160,1.00000000002619,0.90234642265454,0,2,heme a metabolic process,BP,
11628,GO:0046322,1.00000000002619,0.823127263225511,0,4,negative regulation of fatty acid oxidation,BP,
5521,GO:0016480,1.00000000002621,0.89422893984626,0,3,negative regulation of transcription by RNA polymerase III,BP,
14795,GO:0070492,1.00000000002622,0.849911686041884,0,4,oligosaccharide binding,MF,
14001,GO:0060699,1.00000000002622,0.831723785046335,0,4,regulation of endoribonuclease activity,BP,
12104,GO:0048073,1.00000000002625,0.898427859213494,0,2,regulation of eye pigmentation,BP,
8869,GO:0034667,1.00000000002626,0.899366902710644,0,2,integrin alpha3-beta1 complex,CC,
10837,GO:0044327,1.00000000002629,0.675118531477919,0,8,dendritic spine head,CC,
9446,GO:0036021,1.00000000002631,0.829959386383094,0,4,endolysosome lumen,CC,
15312,GO:0071486,1.00000000002632,0.946725327312987,0,1,cellular response to high light intensity,BP,
16635,GO:0097473,1.00000000002632,0.946725327312987,0,1,retinal rod cell apoptotic process,BP,
19446,GO:1990009,1.00000000002632,0.946725327312987,0,1,retinal cell apoptotic process,BP,
7508,GO:0031682,1.00000000002635,0.953039851978687,0,1,G-protein gamma-subunit binding,MF,
18130,GO:1902773,1.00000000002635,0.953039851978687,0,1,GTPase activator complex,CC,
7592,GO:0031956,1.00000000002637,0.812058574181596,0,4,medium-chain fatty acid-CoA ligase activity,MF,
17158,GO:0102391,1.00000000002637,0.812058574181596,0,4,decanoate-CoA ligase activity,MF,
13256,GO:0051908,1.00000000002639,0.952382343041742,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
13017,GO:0051429,1.00000000002641,0.872315697539961,0,3,corticotropin-releasing hormone receptor binding,MF,
7869,GO:0032426,1.00000000002643,0.710940937506145,0,7,stereocilium tip,CC,
3743,GO:0008281,1.00000000002646,0.947164764068443,0,1,sulfonylurea receptor activity,MF,
1811,GO:0004457,1.00000000002653,0.843071369270374,0,4,lactate dehydrogenase activity,MF,
10631,GO:0043625,1.00000000002656,0.844616911246596,0,4,delta DNA polymerase complex,CC,
2310,GO:0005295,1.00000000002657,0.952300711493175,0,1,neutral amino acid:sodium symporter activity,MF,
5101,GO:0015375,1.00000000002657,0.952300711493175,0,1,glycine:sodium symporter activity,MF,
7522,GO:0031704,1.00000000002657,0.952300711493175,0,1,apelin receptor binding,MF,
10499,GO:0043396,1.00000000002657,0.952300711493175,0,1,corticotropin-releasing hormone secretion,BP,
10500,GO:0043397,1.00000000002657,0.952300711493175,0,1,regulation of corticotropin-releasing hormone secretion,BP,
13042,GO:0051466,1.00000000002657,0.952300711493175,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13565,GO:0060012,1.00000000002657,0.952300711493175,0,1,synaptic transmission, glycinergic,BP,
13634,GO:0060092,1.00000000002657,0.952300711493175,0,1,regulation of synaptic transmission, glycinergic,BP,
13679,GO:0060183,1.00000000002657,0.952300711493175,0,1,apelin receptor signaling pathway,BP,
14355,GO:0061536,1.00000000002657,0.952300711493175,0,1,glycine secretion,BP,
14356,GO:0061537,1.00000000002657,0.952300711493175,0,1,glycine secretion, neurotransmission,BP,
18693,GO:1904022,1.00000000002657,0.952300711493175,0,1,positive regulation of G-protein coupled receptor internalization,BP,
20245,GO:2001151,1.00000000002657,0.952300711493175,0,1,regulation of renal water transport,BP,
20246,GO:2001153,1.00000000002657,0.952300711493175,0,1,positive regulation of renal water transport,BP,
14707,GO:0070324,1.00000000002657,0.788710231166986,0,5,thyroid hormone binding,MF,
6981,GO:0030643,1.00000000002658,0.811402921778567,0,4,cellular phosphate ion homeostasis,BP,
15818,GO:0072501,1.00000000002658,0.811402921778567,0,4,cellular divalent inorganic anion homeostasis,BP,
15819,GO:0072502,1.00000000002658,0.811402921778567,0,4,cellular trivalent inorganic anion homeostasis,BP,
956,GO:0002373,1.00000000002659,0.97337579702136,0,1,plasmacytoid dendritic cell cytokine production,BP,
1144,GO:0002736,1.00000000002659,0.97337579702136,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1145,GO:0002737,1.00000000002659,0.97337579702136,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
17609,GO:1901253,1.00000000002659,0.97337579702136,0,1,negative regulation of intracellular transport of viral material,BP,
1430,GO:0003400,1.0000000000266,0.955537059917934,0,1,regulation of COPII vesicle coating,BP,
2208,GO:0005090,1.0000000000266,0.955537059917934,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
13970,GO:0060661,1.0000000000266,0.955537059917934,0,1,submandibular salivary gland formation,BP,
15204,GO:0071335,1.0000000000266,0.955537059917934,0,1,hair follicle cell proliferation,BP,
15205,GO:0071336,1.0000000000266,0.955537059917934,0,1,regulation of hair follicle cell proliferation,BP,
15206,GO:0071338,1.0000000000266,0.955537059917934,0,1,positive regulation of hair follicle cell proliferation,BP,
16136,GO:0090113,1.0000000000266,0.955537059917934,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
1690,GO:0004157,1.0000000000266,0.947405187637882,0,1,dihydropyrimidinase activity,MF,
18711,GO:1904048,1.0000000000266,0.947405187637882,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18712,GO:1904050,1.0000000000266,0.947405187637882,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
19220,GO:1905301,1.0000000000266,0.947405187637882,0,1,regulation of macropinocytosis,BP,
19221,GO:1905302,1.0000000000266,0.947405187637882,0,1,negative regulation of macropinocytosis,BP,
10647,GO:0043653,1.00000000002661,0.730196319258766,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
7274,GO:0031249,1.00000000002665,0.954691939069382,0,1,denatured protein binding,MF,
17992,GO:1902380,1.00000000002665,0.954691939069382,0,1,positive regulation of endoribonuclease activity,BP,
18977,GO:1904722,1.00000000002665,0.954691939069382,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18062,GO:1902576,1.00000000002666,0.827629695356992,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
1511,GO:0003867,1.00000000002667,0.946926375876584,0,1,4-aminobutyrate transaminase activity,MF,
4849,GO:0014053,1.00000000002667,0.946926375876584,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
7696,GO:0032144,1.00000000002667,0.946926375876584,0,1,4-aminobutyrate transaminase complex,CC,
7697,GO:0032145,1.00000000002667,0.946926375876584,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8466,GO:0033602,1.00000000002667,0.946926375876584,0,1,negative regulation of dopamine secretion,BP,
8740,GO:0034386,1.00000000002667,0.946926375876584,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
11995,GO:0047298,1.00000000002667,0.946926375876584,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
14352,GO:0061528,1.00000000002667,0.946926375876584,0,1,aspartate secretion,BP,
18862,GO:1904448,1.00000000002667,0.946926375876584,0,1,regulation of aspartate secretion,BP,
18863,GO:1904450,1.00000000002667,0.946926375876584,0,1,positive regulation of aspartate secretion,BP,
19208,GO:1905271,1.00000000002668,0.981478284503604,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19209,GO:1905273,1.00000000002668,0.981478284503604,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
3354,GO:0007089,1.00000000002674,0.824114755781377,0,4,traversing start control point of mitotic cell cycle,BP,
15121,GO:0071163,1.00000000002679,0.883068906680114,0,3,DNA replication preinitiation complex assembly,BP,
16868,GO:0098779,1.0000000000268,0.685903438485585,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
17683,GO:1901526,1.0000000000268,0.685903438485585,0,8,positive regulation of mitophagy,BP,
11555,GO:0046078,1.00000000002683,0.844502188277086,0,4,dUMP metabolic process,BP,
16707,GO:0097643,1.0000000000269,0.974183697921037,0,1,amylin receptor activity,MF,
18427,GO:1903440,1.0000000000269,0.974183697921037,0,1,amylin receptor complex,CC,
19541,GO:1990407,1.0000000000269,0.974183697921037,0,1,calcitonin gene-related peptide binding,MF,
833,GO:0002118,1.00000000002692,0.951352178229119,0,1,aggressive behavior,BP,
834,GO:0002121,1.00000000002692,0.951352178229119,0,1,inter-male aggressive behavior,BP,
14621,GO:0070176,1.00000000002692,0.95807406865737,0,1,DRM complex,CC,
3811,GO:0008396,1.00000000002694,0.954761451593002,0,1,oxysterol 7-alpha-hydroxylase activity,MF,
1575,GO:0003979,1.00000000002697,0.952403684346492,0,1,UDP-glucose 6-dehydrogenase activity,MF,
6643,GO:0023024,1.00000000002697,0.952403684346492,0,1,MHC class I protein complex binding,MF,
15172,GO:0071279,1.00000000002697,0.834217794742266,0,4,cellular response to cobalt ion,BP,
494,GO:0001546,1.00000000002698,0.95976809473069,0,1,preantral ovarian follicle growth,BP,
1689,GO:0004155,1.00000000002698,0.95976809473069,0,1,6,7-dihydropteridine reductase activity,MF,
12122,GO:0048162,1.00000000002698,0.95976809473069,0,1,multi-layer follicle stage,BP,
4326,GO:0009820,1.00000000002698,0.83475539249427,0,4,alkaloid metabolic process,BP,
15594,GO:0072049,1.00000000002699,0.845493089321512,0,4,comma-shaped body morphogenesis,BP,
17948,GO:1902261,1.000000000027,0.89834979775428,0,2,positive regulation of delayed rectifier potassium channel activity,BP,
10976,GO:0044752,1.00000000002702,0.864458756863135,0,3,response to human chorionic gonadotropin,BP,
15185,GO:0071306,1.00000000002702,0.906458073466051,0,2,cellular response to vitamin E,BP,
8224,GO:0032980,1.00000000002703,0.954707106445235,0,1,keratinocyte activation,BP,
8696,GO:0034316,1.00000000002707,0.822000509658355,0,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
13494,GO:0055015,1.0000000000271,0.720942429168211,0,7,ventricular cardiac muscle cell development,BP,
15485,GO:0071816,1.00000000002712,0.83713296584859,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
3208,GO:0006848,1.00000000002712,0.864549809608042,0,3,pyruvate transport,BP,
12653,GO:0050833,1.00000000002712,0.864549809608042,0,3,pyruvate transmembrane transporter activity,MF,
17672,GO:1901475,1.00000000002712,0.864549809608042,0,3,pyruvate transmembrane transport,BP,
19245,GO:1905349,1.00000000002716,0.967466852765254,0,1,ciliary transition zone assembly,BP,
19266,GO:1905404,1.00000000002716,0.96132511705587,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
18122,GO:1902746,1.00000000002718,0.954722429303112,0,1,regulation of lens fiber cell differentiation,BP,
6694,GO:0030060,1.0000000000272,0.891749639661044,0,3,L-malate dehydrogenase activity,MF,
1880,GO:0004556,1.00000000002722,0.955468292552975,0,1,alpha-amylase activity,MF,
17190,GO:0103025,1.00000000002722,0.955468292552975,0,1,alpha-amylase activity (releasing maltohexaose),MF,
2577,GO:0005862,1.00000000002724,0.838251658440388,0,4,muscle thin filament tropomyosin,CC,
5045,GO:0015222,1.00000000002726,0.906796208169863,0,2,serotonin transmembrane transporter activity,MF,
14755,GO:0070418,1.00000000002727,0.946761036747394,0,1,DNA-dependent protein kinase complex,CC,
7976,GO:0032584,1.00000000002732,0.861112938942203,0,3,growth cone membrane,CC,
10012,GO:0042428,1.00000000002733,0.815233675133828,0,4,serotonin metabolic process,BP,
10716,GO:0044020,1.00000000002734,0.837659833592456,0,4,histone methyltransferase activity (H4-R3 specific),MF,
10501,GO:0043398,1.00000000002738,0.869709596996944,0,3,HLH domain binding,MF,
2656,GO:0005997,1.00000000002739,0.856708582121939,0,4,xylulose metabolic process,BP,
15010,GO:0070922,1.00000000002739,0.647661989742947,0,9,small RNA loading onto RISC,BP,
9449,GO:0036033,1.0000000000274,0.804602838144904,0,4,mediator complex binding,MF,
17729,GO:1901628,1.00000000002741,0.874722130857828,0,3,positive regulation of postsynaptic membrane organization,BP,
19637,GO:1990761,1.00000000002744,0.907581128492275,0,2,growth cone lamellipodium,CC,
16167,GO:0090170,1.00000000002746,0.832216992915213,0,4,regulation of Golgi inheritance,BP,
11526,GO:0046032,1.00000000002748,0.961408351875465,0,1,ADP catabolic process,BP,
16236,GO:0090269,1.00000000002748,0.849125297233183,0,3,fibroblast growth factor production,BP,
16237,GO:0090270,1.00000000002748,0.849125297233183,0,3,regulation of fibroblast growth factor production,BP,
10660,GO:0043734,1.00000000002749,0.845945928679005,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
3500,GO:0007403,1.00000000002753,0.95137524410103,0,1,glial cell fate determination,BP,
14054,GO:0060769,1.00000000002753,0.95137524410103,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14279,GO:0061324,1.00000000002753,0.95137524410103,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
18878,GO:1904499,1.00000000002753,0.95137524410103,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18879,GO:1904501,1.00000000002753,0.95137524410103,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
19012,GO:1904793,1.00000000002753,0.95137524410103,0,1,regulation of euchromatin binding,BP,
16511,GO:0097196,1.00000000002755,0.912401541565727,0,2,Shu complex,CC,
18069,GO:1902603,1.00000000002755,0.870842715658165,0,3,carnitine transmembrane transport,BP,
1512,GO:0003868,1.00000000002756,0.958103967605331,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
15837,GO:0072526,1.00000000002756,0.834739124576671,0,4,pyridine-containing compound catabolic process,BP,
19900,GO:2000354,1.00000000002757,0.838979948619502,0,4,regulation of ovarian follicle development,BP,
8970,GO:0035037,1.00000000002759,0.947455925976435,0,1,sperm entry,BP,
836,GO:0002133,1.00000000002764,0.896320650776862,0,2,polycystin complex,CC,
15582,GO:0072021,1.00000000002764,0.896320650776862,0,2,ascending thin limb development,BP,
15673,GO:0072177,1.00000000002764,0.896320650776862,0,2,mesonephric duct development,BP,
15704,GO:0072218,1.00000000002764,0.896320650776862,0,2,metanephric ascending thin limb development,BP,
268,GO:0000738,1.00000000002767,0.836827568804142,0,4,DNA catabolic process, exonucleolytic,BP,
15867,GO:0072572,1.00000000002769,0.955663910186107,0,1,poly-ADP-D-ribose binding,MF,
14343,GO:0061511,1.0000000000277,0.830852676356997,0,4,centriole elongation,BP,
14589,GO:0070122,1.0000000000277,0.81752319281983,0,4,isopeptidase activity,MF,
17962,GO:1902296,1.00000000002771,0.951988969598467,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17975,GO:1902319,1.00000000002771,0.951988969598467,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
18214,GO:1902983,1.00000000002771,0.951988969598467,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
10826,GO:0044314,1.00000000002771,0.86420500278898,0,4,protein K27-linked ubiquitination,BP,
2800,GO:0006256,1.00000000002771,0.95342047658184,0,1,UDP catabolic process,BP,
4088,GO:0009140,1.00000000002771,0.95342047658184,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4136,GO:0009193,1.00000000002771,0.95342047658184,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4137,GO:0009195,1.00000000002771,0.95342047658184,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4162,GO:0009222,1.00000000002771,0.95342047658184,0,1,pyrimidine ribonucleotide catabolic process,BP,
11536,GO:0046048,1.00000000002771,0.95342047658184,0,1,UDP metabolic process,BP,
5335,GO:0016062,1.00000000002775,0.954362912351544,0,1,adaptation of rhodopsin mediated signaling,BP,
9572,GO:0036367,1.00000000002775,0.954362912351544,0,1,light adaption,BP,
1979,GO:0004692,1.00000000002778,0.949585472710662,0,1,cGMP-dependent protein kinase activity,MF,
6895,GO:0030423,1.00000000002782,0.827628210176884,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
13792,GO:0060363,1.00000000002785,0.717961700853603,0,7,cranial suture morphogenesis,BP,
6751,GO:0030167,1.00000000002791,0.86866959082456,0,3,proteoglycan catabolic process,BP,
6770,GO:0030200,1.00000000002791,0.86866959082456,0,3,heparan sulfate proteoglycan catabolic process,BP,
1058,GO:0002583,1.00000000002791,0.861044098485349,0,4,regulation of antigen processing and presentation of peptide antigen,BP,
6191,GO:0019626,1.00000000002795,0.736587669893732,0,7,short-chain fatty acid catabolic process,BP,
2023,GO:0004749,1.00000000002796,0.833555877461857,0,4,ribose phosphate diphosphokinase activity,MF,
5672,GO:0016778,1.00000000002796,0.833555877461857,0,4,diphosphotransferase activity,MF,
18544,GO:1903715,1.00000000002796,0.824947122911182,0,4,regulation of aerobic respiration,BP,
238,GO:0000495,1.00000000002799,0.954335825371312,0,1,box H/ACA snoRNA 3'-end processing,BP,
8559,GO:0033979,1.00000000002799,0.954335825371312,0,1,box H/ACA snoRNA metabolic process,BP,
8937,GO:0034964,1.00000000002799,0.954335825371312,0,1,box H/ACA snoRNA processing,BP,
8549,GO:0033882,1.00000000002799,0.968341873433508,0,1,choloyl-CoA hydrolase activity,MF,
11172,GO:0045222,1.00000000002799,0.968341873433508,0,1,CD4 biosynthetic process,BP,
11173,GO:0045223,1.00000000002799,0.968341873433508,0,1,regulation of CD4 biosynthetic process,BP,
11174,GO:0045225,1.00000000002799,0.968341873433508,0,1,negative regulation of CD4 biosynthetic process,BP,
13434,GO:0052815,1.00000000002799,0.968341873433508,0,1,medium-chain acyl-CoA hydrolase activity,MF,
4917,GO:0014852,1.000000000028,0.953626809651092,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
4918,GO:0014853,1.000000000028,0.953626809651092,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5794,GO:0017020,1.000000000028,0.953626809651092,0,1,myosin phosphatase regulator activity,MF,
3892,GO:0008523,1.00000000002809,0.951928653336064,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
5254,GO:0015878,1.00000000002809,0.951928653336064,0,1,biotin transport,BP,
5261,GO:0015887,1.00000000002809,0.951928653336064,0,1,pantothenate transmembrane transport,BP,
9536,GO:0036266,1.00000000002811,0.954396647155679,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
15913,GO:0072671,1.00000000002811,0.954396647155679,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
17462,GO:1900227,1.00000000002811,0.812525994512653,0,4,positive regulation of NLRP3 inflammasome complex assembly,BP,
4375,GO:0009992,1.00000000002816,0.955487368467354,0,1,cellular water homeostasis,BP,
9111,GO:0035385,1.00000000002817,0.689421974929872,0,7,Roundabout signaling pathway,BP,
8051,GO:0032696,1.00000000002818,0.864592800654411,0,3,negative regulation of interleukin-13 production,BP,
8863,GO:0034657,1.00000000002819,0.825311981821686,0,4,GID complex,CC,
17206,GO:0106017,1.0000000000282,0.85006587361972,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
3447,GO:0007258,1.00000000002825,0.82570327693574,0,4,JUN phosphorylation,BP,
1841,GO:0004493,1.00000000002825,0.975104513028833,0,1,methylmalonyl-CoA epimerase activity,MF,
11710,GO:0046491,1.00000000002825,0.975104513028833,0,1,L-methylmalonyl-CoA metabolic process,BP,
3641,GO:0008112,1.00000000002826,0.960794289418407,0,1,nicotinamide N-methyltransferase activity,MF,
7027,GO:0030760,1.00000000002826,0.960794289418407,0,1,pyridine N-methyltransferase activity,MF,
8351,GO:0033206,1.00000000002827,0.816195001653803,0,4,meiotic cytokinesis,BP,
5987,GO:0018872,1.00000000002832,0.954577904071441,0,1,arsonoacetate metabolic process,BP,
7028,GO:0030791,1.00000000002832,0.954577904071441,0,1,arsenite methyltransferase activity,MF,
7029,GO:0030792,1.00000000002832,0.954577904071441,0,1,methylarsonite methyltransferase activity,MF,
8900,GO:0034718,1.00000000002833,0.946689872056151,0,1,SMN-Gemin2 complex,CC,
15646,GO:0072131,1.00000000002836,0.857596334892113,0,3,kidney mesenchyme morphogenesis,BP,
15648,GO:0072133,1.00000000002836,0.857596334892113,0,3,metanephric mesenchyme morphogenesis,BP,
19155,GO:1905098,1.00000000002848,0.823330088402461,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
4540,GO:0010609,1.00000000002849,0.910934722860326,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
8791,GO:0034473,1.00000000002849,0.895925666535515,0,3,U1 snRNA 3'-end processing,BP,
8794,GO:0034476,1.00000000002849,0.895925666535515,0,3,U5 snRNA 3'-end processing,BP,
4406,GO:0010139,1.00000000002851,0.960233387348595,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4412,GO:0010164,1.00000000002851,0.960233387348595,0,1,response to cesium ion,BP,
6873,GO:0030343,1.00000000002851,0.960233387348595,0,1,vitamin D3 25-hydroxylase activity,MF,
14875,GO:0070643,1.00000000002851,0.960233387348595,0,1,vitamin D 25-hydroxylase activity,MF,
9116,GO:0035404,1.00000000002851,0.65676621246605,0,9,histone-serine phosphorylation,BP,
3877,GO:0008504,1.00000000002852,0.818542744615606,0,4,monoamine transmembrane transporter activity,MF,
9030,GO:0035241,1.00000000002857,0.868692379879845,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
13735,GO:0060287,1.00000000002857,0.828210994595094,0,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,
19142,GO:1905065,1.00000000002858,0.870823238604445,0,3,positive regulation of vascular smooth muscle cell differentiation,BP,
4023,GO:0009051,1.0000000000286,0.887319571125587,0,3,pentose-phosphate shunt, oxidative branch,BP,
2597,GO:0005890,1.00000000002862,0.824632668712034,0,4,sodium:potassium-exchanging ATPase complex,CC,
1523,GO:0003882,1.00000000002863,0.954623057517765,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
19975,GO:2000491,1.00000000002866,0.952505262960216,0,1,positive regulation of hepatic stellate cell activation,BP,
1383,GO:0003278,1.00000000002868,0.860163850697261,0,3,apoptotic process involved in heart morphogenesis,BP,
5557,GO:0016559,1.00000000002868,0.758796388478806,0,7,peroxisome fission,BP,
1923,GO:0004614,1.00000000002869,0.822946144150466,0,4,phosphoglucomutase activity,MF,
2760,GO:0006168,1.0000000000287,0.901964809370446,0,3,adenine salvage,BP,
11558,GO:0046083,1.0000000000287,0.901964809370446,0,3,adenine metabolic process,BP,
11559,GO:0046084,1.0000000000287,0.901964809370446,0,3,adenine biosynthetic process,BP,
12829,GO:0051121,1.00000000002871,0.827760526559132,0,4,hepoxilin metabolic process,BP,
12830,GO:0051122,1.00000000002871,0.827760526559132,0,4,hepoxilin biosynthetic process,BP,
621,GO:0001792,1.00000000002872,0.947995193302453,0,1,polymeric immunoglobulin receptor activity,MF,
965,GO:0002386,1.00000000002872,0.947995193302453,0,1,immune response in mucosal-associated lymphoid tissue,BP,
971,GO:0002415,1.00000000002872,0.947995193302453,0,1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
3961,GO:0008709,1.00000000002874,0.973073152509978,0,1,cholate 7-alpha-dehydrogenase activity,MF,
6828,GO:0030283,1.00000000002874,0.973073152509978,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
11953,GO:0047015,1.00000000002874,0.973073152509978,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
1864,GO:0004525,1.00000000002875,0.8199930315094,0,4,ribonuclease III activity,MF,
7777,GO:0032296,1.00000000002875,0.8199930315094,0,4,double-stranded RNA-specific ribonuclease activity,MF,
3534,GO:0007525,1.00000000002876,0.903412527790403,0,2,somatic muscle development,BP,
7560,GO:0031883,1.00000000002877,0.955855291750839,0,1,taste receptor binding,MF,
11054,GO:0045027,1.00000000002877,0.955855291750839,0,1,DNA end binding,MF,
15248,GO:0071394,1.00000000002879,0.715685547004208,0,7,cellular response to testosterone stimulus,BP,
10629,GO:0043622,1.00000000002882,0.813375507643382,0,4,cortical microtubule organization,BP,
8342,GO:0033186,1.00000000002884,0.860480330984879,0,3,CAF-1 complex,CC,
8873,GO:0034676,1.00000000002885,0.946671293004656,0,1,integrin alpha6-beta4 complex,CC,
15030,GO:0070950,1.00000000002887,0.953591485655773,0,1,regulation of neutrophil mediated killing of bacterium,BP,
15031,GO:0070951,1.00000000002887,0.953591485655773,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
15035,GO:0070962,1.00000000002887,0.953591485655773,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
15036,GO:0070963,1.00000000002887,0.953591485655773,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16191,GO:0090198,1.00000000002887,0.953591485655773,0,1,negative regulation of chemokine secretion,BP,
16418,GO:0097029,1.00000000002887,0.953591485655773,0,1,mature conventional dendritic cell differentiation,BP,
17415,GO:1900135,1.00000000002887,0.953591485655773,0,1,positive regulation of renin secretion into blood stream,BP,
19103,GO:1904977,1.00000000002887,0.953591485655773,0,1,lymphatic endothelial cell migration,BP,
5039,GO:0015211,1.00000000002888,0.954563879147962,0,1,purine nucleoside transmembrane transporter activity,MF,
1464,GO:0003708,1.00000000002892,0.819502665959235,0,4,retinoic acid receptor activity,MF,
1946,GO:0004645,1.00000000002895,0.821958032872411,0,4,phosphorylase activity,MF,
18213,GO:1902977,1.00000000002895,0.956985211071873,0,1,mitotic DNA replication preinitiation complex assembly,BP,
10604,GO:0043570,1.00000000002907,0.811597609032168,0,4,maintenance of DNA repeat elements,BP,
15420,GO:0071671,1.00000000002911,0.839907217523654,0,4,regulation of smooth muscle cell chemotaxis,BP,
2751,GO:0006148,1.00000000002919,0.954714748106443,0,1,inosine catabolic process,BP,
3143,GO:0006738,1.00000000002919,0.954714748106443,0,1,nicotinamide riboside catabolic process,BP,
11712,GO:0046495,1.00000000002919,0.954714748106443,0,1,nicotinamide riboside metabolic process,BP,
14872,GO:0070637,1.00000000002919,0.954714748106443,0,1,pyridine nucleoside metabolic process,BP,
14873,GO:0070638,1.00000000002919,0.954714748106443,0,1,pyridine nucleoside catabolic process,BP,
8127,GO:0032810,1.0000000000292,0.909978320874949,0,2,sterol response element binding,MF,
9098,GO:0035359,1.00000000002921,0.948671763222922,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
11143,GO:0045179,1.00000000002925,0.781327804186829,0,5,apical cortex,CC,
4322,GO:0009810,1.00000000002928,0.955369942887888,0,1,stilbene metabolic process,BP,
8551,GO:0033885,1.00000000002928,0.955369942887888,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
11617,GO:0046272,1.00000000002928,0.955369942887888,0,1,stilbene catabolic process,BP,
47,GO:0000099,1.00000000002929,0.811527928633788,0,4,sulfur amino acid transmembrane transporter activity,MF,
6397,GO:0021592,1.0000000000293,0.946722275356178,0,1,fourth ventricle development,BP,
6561,GO:0021993,1.0000000000293,0.946722275356178,0,1,initiation of neural tube closure,BP,
5985,GO:0018773,1.00000000002931,0.959400949830181,0,1,acetylpyruvate hydrolase activity,MF,
8813,GO:0034545,1.00000000002931,0.959400949830181,0,1,fumarylpyruvate hydrolase activity,MF,
12030,GO:0047621,1.00000000002931,0.959400949830181,0,1,acylpyruvate hydrolase activity,MF,
13378,GO:0052550,1.00000000002931,0.959400949830181,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13384,GO:0052567,1.00000000002931,0.959400949830181,0,1,response to defense-related host reactive oxygen species production,BP,
5008,GO:0015152,1.00000000002935,0.9558246848448,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
843,GO:0002153,1.00000000002936,0.954698240255055,0,1,steroid receptor RNA activator RNA binding,MF,
11479,GO:0045925,1.00000000002936,0.954698240255055,0,1,positive regulation of female receptivity,BP,
9509,GO:0036155,1.00000000002939,0.783659404018911,0,5,acylglycerol acyl-chain remodeling,BP,
10519,GO:0043423,1.0000000000294,0.947817326911091,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
19990,GO:2000537,1.0000000000294,0.947817326911091,0,1,regulation of B cell chemotaxis,BP,
19991,GO:2000538,1.0000000000294,0.947817326911091,0,1,positive regulation of B cell chemotaxis,BP,
3815,GO:0008404,1.00000000002944,0.957503589537831,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3816,GO:0008405,1.00000000002944,0.957503589537831,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
15385,GO:0071614,1.00000000002944,0.957503589537831,0,1,linoleic acid epoxygenase activity,MF,
1894,GO:0004573,1.00000000002946,0.953996476555333,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
14793,GO:0070489,1.00000000002949,0.94895758539324,0,1,T cell aggregation,BP,
10632,GO:0043626,1.00000000002954,0.964745556368285,0,1,PCNA complex,CC,
11000,GO:0044796,1.00000000002954,0.964745556368285,0,1,DNA polymerase processivity factor complex,CC,
10395,GO:0043221,1.00000000002956,0.949396918239313,0,1,SMC family protein binding,MF,
5838,GO:0017116,1.00000000002961,0.860098740389303,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
2058,GO:0004807,1.00000000002963,0.96259031426179,0,1,triose-phosphate isomerase activity,MF,
5665,GO:0016768,1.00000000002963,0.959241853275018,0,1,spermine synthase activity,MF,
12227,GO:0048408,1.00000000002963,0.851715519094863,0,4,epidermal growth factor binding,MF,
1693,GO:0004164,1.00000000002964,0.958144109597436,0,1,diphthine synthase activity,MF,
1738,GO:0004333,1.00000000002964,0.958144109597436,0,1,fumarate hydratase activity,MF,
5133,GO:0015578,1.00000000002971,0.954613452736457,0,1,mannose transmembrane transporter activity,MF,
5191,GO:0015761,1.00000000002971,0.954613452736457,0,1,mannose transmembrane transport,BP,
17865,GO:1902038,1.00000000002971,0.951296762835574,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17945,GO:1902257,1.00000000002971,0.951296762835574,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
9413,GO:0035971,1.00000000002973,0.967044006702382,0,1,peptidyl-histidine dephosphorylation,BP,
17595,GO:1901207,1.00000000002975,0.948961357632266,0,1,regulation of heart looping,BP,
18567,GO:1903762,1.00000000002975,0.948961357632266,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18658,GO:1903947,1.00000000002975,0.948961357632266,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18660,GO:1903952,1.00000000002975,0.948961357632266,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18661,GO:1903954,1.00000000002975,0.948961357632266,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19121,GO:1905026,1.00000000002975,0.948961357632266,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19123,GO:1905033,1.00000000002975,0.948961357632266,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
12709,GO:0050913,1.00000000002977,0.756137082251523,0,7,sensory perception of bitter taste,BP,
17006,GO:0099077,1.00000000002978,0.946671291502155,0,1,histone-dependent DNA binding,MF,
19362,GO:1905687,1.00000000002978,0.946671291502155,0,1,regulation of diacylglycerol kinase activity,BP,
19363,GO:1905689,1.00000000002978,0.946671291502155,0,1,positive regulation of diacylglycerol kinase activity,BP,
6028,GO:0019082,1.00000000002979,0.948240080539811,0,1,viral protein processing,BP,
16321,GO:0090472,1.00000000002979,0.948240080539811,0,1,dibasic protein processing,BP,
13901,GO:0060526,1.00000000002983,0.805460683895801,0,4,prostate glandular acinus morphogenesis,BP,
13902,GO:0060527,1.00000000002983,0.805460683895801,0,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
5824,GO:0017087,1.00000000002983,0.949154472334824,0,1,mitochondrial processing peptidase complex,CC,
10677,GO:0043914,1.00000000002983,0.949154472334824,0,1,NADPH:sulfur oxidoreductase activity,MF,
3836,GO:0008434,1.00000000002986,0.947145310328277,0,1,calcitriol receptor activity,MF,
9734,GO:0038181,1.00000000002986,0.947145310328277,0,1,bile acid receptor activity,MF,
9735,GO:0038183,1.00000000002986,0.947145310328277,0,1,bile acid signaling pathway,BP,
9736,GO:0038186,1.00000000002986,0.947145310328277,0,1,lithocholic acid receptor activity,MF,
17879,GO:1902098,1.00000000002986,0.947145310328277,0,1,calcitriol binding,MF,
17894,GO:1902121,1.00000000002986,0.947145310328277,0,1,lithocholic acid binding,MF,
17954,GO:1902271,1.00000000002986,0.947145310328277,0,1,D3 vitamins binding,MF,
7545,GO:0031811,1.00000000002995,0.949268268588506,0,1,G-protein coupled nucleotide receptor binding,MF,
7546,GO:0031812,1.00000000002995,0.949268268588506,0,1,P2Y1 nucleotide receptor binding,MF,
1775,GO:0004377,1.00000000003001,0.954430630315669,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
19653,GO:1990809,1.00000000003001,0.829608958591172,0,4,endoplasmic reticulum tubular network membrane organization,BP,
1251,GO:0002949,1.00000000003002,0.879055574547947,0,3,tRNA threonylcarbamoyladenosine modification,BP,
9706,GO:0038107,1.00000000003003,0.869711926702915,0,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,
17384,GO:1900094,1.00000000003003,0.869711926702915,0,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
17431,GO:1900164,1.00000000003003,0.869711926702915,0,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
6411,GO:0021636,1.00000000003005,0.813421809908486,0,4,trigeminal nerve morphogenesis,BP,
6412,GO:0021637,1.00000000003005,0.813421809908486,0,4,trigeminal nerve structural organization,BP,
2634,GO:0005960,1.00000000003008,0.913337091645377,0,2,glycine cleavage complex,CC,
14009,GO:0060709,1.00000000003009,0.953634401630558,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
17118,GO:0100002,1.00000000003009,0.953634401630558,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
5146,GO:0015670,1.00000000003011,0.959550831701724,0,1,carbon dioxide transport,BP,
8145,GO:0032849,1.00000000003011,0.959550831701724,0,1,positive regulation of cellular pH reduction,BP,
3671,GO:0008169,1.00000000003013,0.873441472133992,0,3,C-methyltransferase activity,MF,
12279,GO:0048563,1.00000000003017,0.747045640774479,0,7,post-embryonic animal organ morphogenesis,BP,
14827,GO:0070552,1.00000000003021,0.868579114969109,0,3,BRISC complex,CC,
18514,GO:1903630,1.00000000003021,0.967105492929847,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18515,GO:1903632,1.00000000003021,0.967105492929847,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
13964,GO:0060631,1.00000000003027,0.863077082085028,0,3,regulation of meiosis I,BP,
19448,GO:1990026,1.0000000000303,0.950882164231209,0,1,hippocampal mossy fiber expansion,CC,
19560,GO:1990446,1.00000000003033,0.850829284044445,0,4,U1 snRNP binding,MF,
19891,GO:2000344,1.00000000003035,0.840743971493326,0,4,positive regulation of acrosome reaction,BP,
5494,GO:0016426,1.00000000003035,0.829129143858248,0,4,tRNA (adenine) methyltransferase activity,MF,
1192,GO:0002836,1.00000000003054,0.862652343021147,0,3,positive regulation of response to tumor cell,BP,
1195,GO:0002839,1.00000000003054,0.862652343021147,0,3,positive regulation of immune response to tumor cell,BP,
13782,GO:0060346,1.00000000003055,0.695838870564523,0,7,bone trabecula formation,BP,
2782,GO:0006212,1.00000000003055,0.952695662208934,0,1,uracil catabolic process,BP,
2784,GO:0006214,1.00000000003055,0.952695662208934,0,1,thymidine catabolic process,BP,
4426,GO:0010232,1.00000000003055,0.952695662208934,0,1,vascular transport,BP,
5837,GO:0017113,1.00000000003055,0.952695662208934,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6162,GO:0019483,1.00000000003055,0.952695662208934,0,1,beta-alanine biosynthetic process,BP,
11582,GO:0046127,1.00000000003055,0.952695662208934,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
13663,GO:0060156,1.00000000003055,0.952695662208934,0,1,milk ejection reflex,BP,
18386,GO:1903367,1.00000000003055,0.952695662208934,0,1,positive regulation of fear response,BP,
20193,GO:2000987,1.00000000003055,0.952695662208934,0,1,positive regulation of behavioral fear response,BP,
9814,GO:0042000,1.0000000000306,0.954710922375417,0,1,translocation of peptides or proteins into host,BP,
10725,GO:0044053,1.0000000000306,0.954710922375417,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
13211,GO:0051808,1.0000000000306,0.954710922375417,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
16784,GO:0098576,1.00000000003062,0.830175303624731,0,4,lumenal side of membrane,CC,
15002,GO:0070903,1.00000000003063,0.956648590007624,0,1,mitochondrial tRNA thio-modification,BP,
17034,GO:0099174,1.00000000003063,0.858462661096479,0,3,regulation of presynapse organization,BP,
19343,GO:1905606,1.00000000003063,0.858462661096479,0,3,regulation of presynapse assembly,BP,
3548,GO:0007576,1.00000000003065,0.954406483591667,0,1,nucleolar fragmentation,BP,
19545,GO:1990414,1.00000000003065,0.821193152276153,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
19431,GO:1905940,1.00000000003074,0.865739698008508,0,3,negative regulation of gonad development,BP,
3969,GO:0008753,1.00000000003077,0.951250529282068,0,1,NADPH dehydrogenase (quinone) activity,MF,
20011,GO:2000580,1.0000000000308,0.864023001287107,0,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
20012,GO:2000582,1.0000000000308,0.864023001287107,0,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
2116,GO:0004900,1.00000000003086,0.957583375489883,0,1,erythropoietin receptor activity,MF,
9726,GO:0038162,1.00000000003086,0.957583375489883,0,1,erythropoietin-mediated signaling pathway,BP,
16431,GO:0097056,1.00000000003087,0.830796850283689,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
1611,GO:0004031,1.00000000003087,0.946890547033332,0,1,aldehyde oxidase activity,MF,
5598,GO:0016623,1.00000000003087,0.946890547033332,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
17183,GO:0102797,1.00000000003087,0.946890547033332,0,1,geranial:oxygen oxidoreductase activity,MF,
17184,GO:0102798,1.00000000003087,0.946890547033332,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
6419,GO:0021678,1.00000000003099,0.909895975105287,0,3,third ventricle development,BP,
1026,GO:0002524,1.00000000003102,0.831406686029503,0,4,hypersensitivity,BP,
2235,GO:0005137,1.00000000003102,0.955541445777519,0,1,interleukin-5 receptor binding,MF,
2600,GO:0005895,1.00000000003102,0.955541445777519,0,1,interleukin-5 receptor complex,CC,
299,GO:0000805,1.00000000003108,0.701524594317927,0,7,X chromosome,CC,
4704,GO:0010859,1.00000000003111,0.947751822318202,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
9662,GO:0038003,1.00000000003119,0.832781787103394,0,4,opioid receptor signaling pathway,BP,
9279,GO:0035701,1.00000000003124,0.862985612924893,0,3,hematopoietic stem cell migration,BP,
19504,GO:1990239,1.00000000003126,0.829036833534755,0,4,steroid hormone binding,MF,
6602,GO:0022615,1.00000000003128,0.841174900625387,0,4,protein to membrane docking,BP,
1981,GO:0004694,1.00000000003128,0.810619846910091,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
13511,GO:0055059,1.00000000003129,0.812613291143678,0,4,asymmetric neuroblast division,BP,
1870,GO:0004531,1.00000000003134,0.956382469744702,0,1,deoxyribonuclease II activity,MF,
2028,GO:0004757,1.00000000003136,0.962640001045125,0,1,sepiapterin reductase activity,MF,
5033,GO:0015195,1.00000000003139,0.947929336651394,0,1,L-threonine transmembrane transporter activity,MF,
5226,GO:0015826,1.00000000003139,0.947929336651394,0,1,threonine transport,BP,
8819,GO:0034589,1.00000000003139,0.947929336651394,0,1,hydroxyproline transport,BP,
8820,GO:0034590,1.00000000003139,0.947929336651394,0,1,L-hydroxyproline transmembrane transporter activity,MF,
1227,GO:0002901,1.0000000000314,0.869362998670478,0,4,mature B cell apoptotic process,BP,
1231,GO:0002905,1.0000000000314,0.869362998670478,0,4,regulation of mature B cell apoptotic process,BP,
1232,GO:0002906,1.0000000000314,0.869362998670478,0,4,negative regulation of mature B cell apoptotic process,BP,
2843,GO:0006311,1.00000000003141,0.95257215387582,0,1,meiotic gene conversion,BP,
5392,GO:0016213,1.00000000003141,0.95257215387582,0,1,linoleoyl-CoA desaturase activity,MF,
11118,GO:0045128,1.00000000003141,0.95257215387582,0,1,negative regulation of reciprocal meiotic recombination,BP,
17248,GO:0110029,1.00000000003141,0.95257215387582,0,1,negative regulation of meiosis I,BP,
5596,GO:0016618,1.00000000003144,0.87797088458767,0,3,hydroxypyruvate reductase activity,MF,
6818,GO:0030267,1.00000000003144,0.87797088458767,0,3,glyoxylate reductase (NADP) activity,MF,
758,GO:0001996,1.00000000003148,0.866668445719317,0,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,
1400,GO:0003321,1.00000000003148,0.866668445719317,0,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
12670,GO:0050861,1.00000000003149,0.820320684561482,0,4,positive regulation of B cell receptor signaling pathway,BP,
8657,GO:0034203,1.0000000000315,0.946795718634473,0,1,glycolipid translocation,BP,
5986,GO:0018812,1.00000000003151,0.826720657284074,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
7628,GO:0032021,1.00000000003151,0.826720657284074,0,4,NELF complex,CC,
17141,GO:0102158,1.00000000003151,0.826720657284074,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
17153,GO:0102343,1.00000000003151,0.826720657284074,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
17154,GO:0102344,1.00000000003151,0.826720657284074,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
17155,GO:0102345,1.00000000003151,0.826720657284074,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
19505,GO:1990246,1.00000000003151,0.826720657284074,0,4,uniplex complex,CC,
789,GO:0002046,1.00000000003156,0.972485472320334,0,1,opsin binding,MF,
9575,GO:0036372,1.00000000003156,0.972485472320334,0,1,opsin transport,BP,
15881,GO:0072589,1.00000000003158,0.888768866228013,0,4,box H/ACA scaRNP complex,CC,
12152,GO:0048245,1.0000000000316,0.842564897328863,0,4,eosinophil chemotaxis,BP,
4872,GO:0014722,1.00000000003162,0.851087926111452,0,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,
767,GO:0002016,1.00000000003176,0.979791864331773,0,1,regulation of blood volume by renin-angiotensin,BP,
769,GO:0002019,1.00000000003176,0.979791864331773,0,1,regulation of renal output by angiotensin,BP,
1284,GO:0003083,1.00000000003176,0.979791864331773,0,1,negative regulation of renal output by angiotensin,BP,
1296,GO:0003106,1.00000000003176,0.979791864331773,0,1,negative regulation of glomerular filtration by angiotensin,BP,
4938,GO:0014895,1.00000000003176,0.979791864331773,0,1,smooth muscle hypertrophy,BP,
10110,GO:0042624,1.00000000003176,0.979791864331773,0,1,ATPase activity, uncoupled,MF,
3832,GO:0008429,1.00000000003178,0.714753197534785,0,8,phosphatidylethanolamine binding,MF,
8647,GO:0034186,1.00000000003178,0.83186182803883,0,4,apolipoprotein A-I binding,MF,
4173,GO:0009237,1.0000000000318,0.953447127336575,0,1,siderophore metabolic process,BP,
6099,GO:0019290,1.0000000000318,0.953447127336575,0,1,siderophore biosynthetic process,BP,
1139,GO:0002728,1.00000000003185,0.947563308556524,0,1,negative regulation of natural killer cell cytokine production,BP,
13471,GO:0052906,1.00000000003188,0.94672287630383,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
5433,GO:0016286,1.00000000003189,0.954489568159781,0,1,small conductance calcium-activated potassium channel activity,MF,
5321,GO:0016035,1.00000000003197,0.917095900140299,0,2,zeta DNA polymerase complex,CC,
2211,GO:0005094,1.00000000003204,0.925987549847571,0,2,Rho GDP-dissociation inhibitor activity,MF,
15315,GO:0071494,1.00000000003205,0.833171054316784,0,4,cellular response to UV-C,BP,
1374,GO:0003257,1.00000000003207,0.947892883025133,0,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
4621,GO:0010736,1.00000000003207,0.947892883025133,0,1,serum response element binding,MF,
4908,GO:0014835,1.00000000003207,0.947892883025133,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
17603,GO:1901228,1.00000000003207,0.947892883025133,0,1,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
7121,GO:0030917,1.00000000003209,0.824783742348579,0,4,midbrain-hindbrain boundary development,BP,
14441,GO:0061739,1.00000000003215,0.858581214394872,0,3,protein lipidation involved in autophagosome assembly,BP,
123,GO:0000253,1.00000000003219,0.864785882355064,0,4,3-keto sterol reductase activity,MF,
13134,GO:0051660,1.00000000003221,0.810658243889034,0,4,establishment of centrosome localization,BP,
18391,GO:1903377,1.00000000003222,0.83981103153092,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
16433,GO:0097058,1.00000000003228,0.958088995946419,0,1,CRLF-CLCF1 complex,CC,
16434,GO:0097059,1.00000000003228,0.958088995946419,0,1,CNTFR-CLCF1 complex,CC,
15042,GO:0070973,1.00000000003229,0.815675398171593,0,4,protein localization to endoplasmic reticulum exit site,BP,
15189,GO:0071313,1.0000000000323,0.818391231224649,0,4,cellular response to caffeine,BP,
15260,GO:0071415,1.0000000000323,0.818391231224649,0,4,cellular response to purine-containing compound,BP,
5350,GO:0016094,1.00000000003232,0.8601948452118,0,3,polyprenol biosynthetic process,BP,
1893,GO:0004572,1.00000000003232,0.896279631346495,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
3346,GO:0007066,1.00000000003276,0.973424394087535,0,1,female meiosis sister chromatid cohesion,BP,
16146,GO:0090135,1.00000000003278,0.865729945086774,0,3,actin filament branching,BP,
10834,GO:0044324,1.00000000003282,0.974109724886288,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
19716,GO:2000016,1.00000000003282,0.974109724886288,0,1,negative regulation of determination of dorsal identity,BP,
580,GO:0001730,1.00000000003285,0.829633963632347,0,4,2'-5'-oligoadenylate synthetase activity,MF,
13850,GO:0060435,1.00000000003291,0.964904454523194,0,1,bronchiole development,BP,
13878,GO:0060480,1.00000000003291,0.964904454523194,0,1,lung goblet cell differentiation,BP,
6390,GO:0021577,1.00000000003295,0.948991666584329,0,1,hindbrain structural organization,BP,
6394,GO:0021589,1.00000000003295,0.948991666584329,0,1,cerebellum structural organization,BP,
14098,GO:0060904,1.00000000003295,0.948991666584329,0,1,regulation of protein folding in endoplasmic reticulum,BP,
18806,GO:1904313,1.00000000003295,0.948991666584329,0,1,response to methamphetamine hydrochloride,BP,
9455,GO:0036042,1.00000000003299,0.864324117545253,0,4,long-chain fatty acyl-CoA binding,MF,
9013,GO:0035175,1.000000000033,0.959038983521843,0,1,histone kinase activity (H3-S10 specific),MF,
15772,GO:0072354,1.000000000033,0.959038983521843,0,1,histone kinase activity (H3-T3 specific),MF,
15773,GO:0072355,1.000000000033,0.959038983521843,0,1,histone H3-T3 phosphorylation,BP,
4613,GO:0010727,1.00000000003305,0.81323007460768,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
10668,GO:0043849,1.00000000003308,0.953465280727443,0,1,Ras palmitoyltransferase activity,MF,
10999,GO:0044795,1.00000000003324,0.968384675819557,0,1,trans-Golgi network to recycling endosome transport,BP,
1960,GO:0004661,1.00000000003334,0.799018492452316,0,5,protein geranylgeranyltransferase activity,MF,
8099,GO:0032777,1.0000000000334,0.830118475165028,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
2163,GO:0004992,1.00000000003346,0.948390264967823,0,1,platelet activating factor receptor activity,MF,
10461,GO:0043315,1.00000000003346,0.948390264967823,0,1,positive regulation of neutrophil degranulation,BP,
15161,GO:0071258,1.00000000003346,0.948390264967823,0,1,cellular response to gravity,BP,
18056,GO:1902565,1.00000000003346,0.948390264967823,0,1,positive regulation of neutrophil activation,BP,
18189,GO:1902941,1.00000000003346,0.948390264967823,0,1,regulation of voltage-gated chloride channel activity,BP,
18190,GO:1902943,1.00000000003346,0.948390264967823,0,1,positive regulation of voltage-gated chloride channel activity,BP,
18586,GO:1903797,1.00000000003346,0.948390264967823,0,1,positive regulation of inorganic anion transmembrane transport,BP,
18800,GO:1904298,1.00000000003346,0.948390264967823,0,1,regulation of transcytosis,BP,
18801,GO:1904300,1.00000000003346,0.948390264967823,0,1,positive regulation of transcytosis,BP,
18802,GO:1904301,1.00000000003346,0.948390264967823,0,1,regulation of maternal process involved in parturition,BP,
18803,GO:1904303,1.00000000003346,0.948390264967823,0,1,positive regulation of maternal process involved in parturition,BP,
18808,GO:1904316,1.00000000003346,0.948390264967823,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18809,GO:1904317,1.00000000003346,0.948390264967823,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
13867,GO:0060456,1.00000000003347,0.863185333978471,0,3,positive regulation of digestive system process,BP,
1840,GO:0004492,1.00000000003356,0.955779581234867,0,1,methylmalonyl-CoA decarboxylase activity,MF,
731,GO:0001957,1.00000000003368,0.81758470057094,0,4,intramembranous ossification,BP,
9468,GO:0036072,1.00000000003368,0.81758470057094,0,4,direct ossification,BP,
1371,GO:0003253,1.00000000003381,0.822197838522162,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
10452,GO:0043305,1.00000000003386,0.915131532426723,0,2,negative regulation of mast cell degranulation,BP,
3884,GO:0008513,1.00000000003394,0.955422516338442,0,1,secondary active organic cation transmembrane transporter activity,MF,
9601,GO:0036455,1.00000000003398,0.96908821213018,0,1,iron-sulfur transferase activity,MF,
18559,GO:1903750,1.00000000003402,0.842900695836549,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18560,GO:1903751,1.00000000003402,0.842900695836549,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10087,GO:0042584,1.00000000003404,0.81925896327888,0,4,chromaffin granule membrane,CC,
19782,GO:2000152,1.0000000000341,0.860264163299133,0,4,regulation of ubiquitin-specific protease activity,BP,
3728,GO:0008260,1.00000000003415,0.950713253631804,0,1,3-oxoacid CoA-transferase activity,MF,
10296,GO:0043041,1.00000000003415,0.950713253631804,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
237,GO:0000494,1.00000000003419,0.968128727258991,0,1,box C/D snoRNA 3'-end processing,BP,
8558,GO:0033967,1.00000000003419,0.968128727258991,0,1,box C/D snoRNA metabolic process,BP,
8936,GO:0034963,1.00000000003419,0.968128727258991,0,1,box C/D snoRNA processing,BP,
9438,GO:0036009,1.00000000003419,0.968128727258991,0,1,protein-glutamine N-methyltransferase activity,MF,
19510,GO:1990258,1.00000000003419,0.968128727258991,0,1,histone glutamine methylation,BP,
19511,GO:1990259,1.00000000003419,0.968128727258991,0,1,histone-glutamine methyltransferase activity,MF,
4015,GO:0009007,1.00000000003431,0.950218790537906,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
8097,GO:0032775,1.00000000003431,0.950218790537906,0,1,DNA methylation on adenine,BP,
2795,GO:0006235,1.00000000003436,0.856176245453731,0,4,dTTP biosynthetic process,BP,
4152,GO:0009212,1.00000000003436,0.856176245453731,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
11553,GO:0046075,1.00000000003436,0.856176245453731,0,4,dTTP metabolic process,BP,
9089,GO:0035339,1.00000000003436,0.843759758773943,0,4,SPOTS complex,CC,
12185,GO:0048297,1.00000000003441,0.955692212010753,0,1,negative regulation of isotype switching to IgA isotypes,BP,
3910,GO:0008555,1.00000000003442,0.946698601761529,0,1,chloride-transporting ATPase activity,MF,
6140,GO:0019402,1.00000000003443,0.964275988489166,0,1,galactitol metabolic process,BP,
14390,GO:0061623,1.00000000003443,0.964275988489166,0,1,glycolytic process from galactose,BP,
2076,GO:0004827,1.00000000003444,0.876055203280592,0,3,proline-tRNA ligase activity,MF,
2923,GO:0006433,1.00000000003444,0.876055203280592,0,3,prolyl-tRNA aminoacylation,BP,
2588,GO:0005880,1.00000000003446,0.962615137731869,0,1,nuclear microtubule,CC,
9425,GO:0035989,1.00000000003448,0.818844269516851,0,4,tendon development,BP,
6840,GO:0030298,1.00000000003457,0.966941831480598,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
7528,GO:0031726,1.00000000003457,0.966941831480598,0,1,CCR1 chemokine receptor binding,MF,
7529,GO:0031729,1.00000000003457,0.966941831480598,0,1,CCR4 chemokine receptor binding,MF,
11852,GO:0046817,1.00000000003457,0.966941831480598,0,1,chemokine receptor antagonist activity,MF,
8353,GO:0033210,1.00000000003475,0.707599613745429,0,7,leptin-mediated signaling pathway,BP,
3962,GO:0008721,1.00000000003482,0.954554586856623,0,1,D-serine ammonia-lyase activity,MF,
5722,GO:0016855,1.00000000003482,0.954554586856623,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
5907,GO:0018114,1.00000000003482,0.954554586856623,0,1,threonine racemase activity,MF,
6886,GO:0030378,1.00000000003482,0.954554586856623,0,1,serine racemase activity,MF,
9570,GO:0036361,1.00000000003482,0.954554586856623,0,1,racemase activity, acting on amino acids and derivatives,MF,
11670,GO:0046416,1.00000000003482,0.954554586856623,0,1,D-amino acid metabolic process,BP,
11675,GO:0046437,1.00000000003482,0.954554586856623,0,1,D-amino acid biosynthetic process,BP,
12035,GO:0047661,1.00000000003482,0.954554586856623,0,1,amino-acid racemase activity,MF,
14622,GO:0070178,1.00000000003482,0.954554586856623,0,1,D-serine metabolic process,BP,
14623,GO:0070179,1.00000000003482,0.954554586856623,0,1,D-serine biosynthetic process,BP,
8387,GO:0033290,1.00000000003484,0.948311752469718,0,1,eukaryotic 48S preinitiation complex,CC,
10765,GO:0044207,1.00000000003484,0.948311752469718,0,1,translation initiation ternary complex,CC,
3086,GO:0006659,1.00000000003494,0.827623341652978,0,4,phosphatidylserine biosynthetic process,BP,
6415,GO:0021649,1.00000000003499,0.954543033588645,0,1,vestibulocochlear nerve structural organization,BP,
9694,GO:0038085,1.00000000003499,0.954543033588645,0,1,vascular endothelial growth factor binding,MF,
13746,GO:0060301,1.00000000003499,0.954543033588645,0,1,positive regulation of cytokine activity,BP,
14363,GO:0061552,1.00000000003499,0.954543033588645,0,1,ganglion morphogenesis,BP,
16591,GO:0097374,1.00000000003499,0.954543033588645,0,1,sensory neuron axon guidance,BP,
17990,GO:1902378,1.00000000003499,0.954543033588645,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19032,GO:1904835,1.00000000003499,0.954543033588645,0,1,dorsal root ganglion morphogenesis,BP,
19129,GO:1905040,1.00000000003499,0.954543033588645,0,1,otic placode development,BP,
20108,GO:2000739,1.00000000003504,0.808896328045389,0,4,regulation of mesenchymal stem cell differentiation,BP,
6046,GO:0019145,1.00000000003514,0.954495196120927,0,1,aminobutyraldehyde dehydrogenase activity,MF,
8520,GO:0033737,1.00000000003514,0.954495196120927,0,1,1-pyrroline dehydrogenase activity,MF,
11965,GO:0047105,1.00000000003514,0.954495196120927,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
18413,GO:1903423,1.00000000003517,0.772879435193214,0,5,positive regulation of synaptic vesicle recycling,BP,
11766,GO:0046604,1.00000000003517,0.877957889717744,0,3,positive regulation of mitotic centrosome separation,BP,
5978,GO:0018455,1.0000000000352,0.965862742083627,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
10938,GO:0044571,1.0000000000353,0.871228107702253,0,4,[2Fe-2S] cluster assembly,BP,
15354,GO:0071566,1.00000000003541,0.953366315897352,0,1,UFM1 activating enzyme activity,MF,
3481,GO:0007342,1.00000000003548,0.866696516553798,0,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
7239,GO:0031134,1.00000000003551,0.864884483210806,0,3,sister chromatid biorientation,BP,
15934,GO:0072706,1.00000000003564,0.954355319784118,0,1,response to sodium dodecyl sulfate,BP,
15935,GO:0072707,1.00000000003564,0.954355319784118,0,1,cellular response to sodium dodecyl sulfate,BP,
16544,GO:0097267,1.00000000003587,0.815174050207636,0,4,omega-hydroxylase P450 pathway,BP,
102,GO:0000213,1.00000000003588,0.835609296196391,0,4,tRNA-intron endonuclease activity,MF,
1220,GO:0002887,1.00000000003589,0.820157238298537,0,4,negative regulation of myeloid leukocyte mediated immunity,BP,
3823,GO:0008418,1.00000000003593,0.969296674809816,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
14787,GO:0070481,1.000000000036,0.953473486326196,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14881,GO:0070651,1.000000000036,0.953473486326196,0,1,nonfunctional rRNA decay,BP,
19212,GO:1905277,1.00000000003613,0.952928621525564,0,1,negative regulation of epithelial tube formation,BP,
20023,GO:2000606,1.00000000003613,0.952928621525564,0,1,regulation of cell proliferation involved in mesonephros development,BP,
20024,GO:2000607,1.00000000003613,0.952928621525564,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
20088,GO:2000699,1.00000000003613,0.952928621525564,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20089,GO:2000701,1.00000000003613,0.952928621525564,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20090,GO:2000702,1.00000000003613,0.952928621525564,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20091,GO:2000703,1.00000000003613,0.952928621525564,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20103,GO:2000733,1.00000000003613,0.952928621525564,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20104,GO:2000734,1.00000000003613,0.952928621525564,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
19285,GO:1905448,1.00000000003613,0.851151571894623,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
18262,GO:1903059,1.00000000003628,0.824886322668314,0,4,regulation of protein lipidation,BP,
18263,GO:1903061,1.00000000003628,0.824886322668314,0,4,positive regulation of protein lipidation,BP,
6257,GO:0019834,1.00000000003639,0.888022821773265,0,3,phospholipase A2 inhibitor activity,MF,
15322,GO:0071502,1.00000000003641,0.877094598522231,0,3,cellular response to temperature stimulus,BP,
12256,GO:0048521,1.00000000003642,0.842801749596723,0,4,negative regulation of behavior,BP,
196,GO:0000414,1.00000000003649,0.811461345421582,0,4,regulation of histone H3-K36 methylation,BP,
19108,GO:1904990,1.00000000003653,0.954650987065015,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19109,GO:1904992,1.00000000003653,0.954650987065015,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
18023,GO:1902480,1.00000000003657,0.954684412024962,0,1,protein localization to mitotic spindle,BP,
8702,GO:0034334,1.00000000003668,0.813472657002937,0,4,adherens junction maintenance,BP,
1721,GO:0004310,1.00000000003679,0.955819625756793,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
7169,GO:0031038,1.00000000003679,0.955819625756793,0,1,myosin II filament organization,BP,
10566,GO:0043519,1.00000000003679,0.955819625756793,0,1,regulation of myosin II filament organization,BP,
13308,GO:0051996,1.00000000003679,0.955819625756793,0,1,squalene synthase activity,MF,
7474,GO:0031628,1.00000000003682,0.819314449735795,0,4,opioid receptor binding,MF,
7553,GO:0031852,1.00000000003682,0.819314449735795,0,4,mu-type opioid receptor binding,MF,
194,GO:0000412,1.00000000003685,0.953563386953655,0,1,histone peptidyl-prolyl isomerization,BP,
11918,GO:0046940,1.00000000003691,0.840043037540829,0,4,nucleoside monophosphate phosphorylation,BP,
12460,GO:0050145,1.00000000003691,0.840043037540829,0,4,nucleoside phosphate kinase activity,MF,
9398,GO:0035933,1.00000000003693,0.880957872875593,0,3,glucocorticoid secretion,BP,
20173,GO:2000849,1.00000000003693,0.880957872875593,0,3,regulation of glucocorticoid secretion,BP,
3472,GO:0007308,1.00000000003726,0.954349900832133,0,1,oocyte construction,BP,
3473,GO:0007309,1.00000000003726,0.954349900832133,0,1,oocyte axis specification,BP,
3474,GO:0007314,1.00000000003726,0.954349900832133,0,1,oocyte anterior/posterior axis specification,BP,
3475,GO:0007315,1.00000000003726,0.954349900832133,0,1,pole plasm assembly,BP,
3794,GO:0008358,1.00000000003726,0.954349900832133,0,1,maternal determination of anterior/posterior axis, embryo,BP,
7019,GO:0030719,1.00000000003726,0.954349900832133,0,1,P granule organization,BP,
9311,GO:0035755,1.00000000003726,0.954349900832133,0,1,cardiolipin hydrolase activity,MF,
8363,GO:0033239,1.00000000003732,0.815458962186865,0,4,negative regulation of cellular amine metabolic process,BP,
12451,GO:0050072,1.00000000003733,0.719348406681878,0,7,m7G(5')pppN diphosphatase activity,MF,
10698,GO:0043973,1.00000000003776,0.955383937492531,0,1,histone H3-K4 acetylation,BP,
19909,GO:2000370,1.0000000000378,0.809554930637751,0,4,positive regulation of clathrin-dependent endocytosis,BP,
9976,GO:0042361,1.0000000000383,0.952422839809589,0,1,menaquinone catabolic process,BP,
9987,GO:0042377,1.0000000000383,0.952422839809589,0,1,vitamin K catabolic process,BP,
3972,GO:0008768,1.00000000003838,0.975204986906431,0,1,UDP-sugar diphosphatase activity,MF,
14635,GO:0070195,1.00000000003849,0.947784252981612,0,1,growth hormone receptor complex,CC,
14152,GO:0061004,1.00000000003868,0.731870877515643,0,7,pattern specification involved in kidney development,BP,
15593,GO:0072048,1.00000000003868,0.731870877515643,0,7,renal system pattern specification,BP,
1619,GO:0004045,1.0000000000389,0.873469151451,0,4,aminoacyl-tRNA hydrolase activity,MF,
18876,GO:1904491,1.0000000000393,0.841637673179436,0,4,protein localization to ciliary transition zone,BP,
1517,GO:0003875,1.00000000003932,0.951319861866828,0,1,ADP-ribosylarginine hydrolase activity,MF,
3638,GO:0008108,1.00000000003933,0.964736246200977,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
5320,GO:0016034,1.00000000003933,0.964736246200977,0,1,maleylacetoacetate isomerase activity,MF,
17127,GO:0101030,1.00000000003933,0.964736246200977,0,1,tRNA-guanine transglycosylation,BP,
1626,GO:0004057,1.00000000003934,0.955342300830964,0,1,arginyltransferase activity,MF,
18856,GO:1904431,1.00000000003936,0.825279718838153,0,4,positive regulation of t-circle formation,BP,
1822,GO:0004470,1.00000000003938,0.831936019731796,0,4,malic enzyme activity,MF,
3987,GO:0008832,1.00000000003938,0.95238661609668,0,1,dGTPase activity,MF,
5684,GO:0016793,1.00000000003938,0.95238661609668,0,1,triphosphoric monoester hydrolase activity,MF,
7966,GO:0032560,1.00000000003938,0.95238661609668,0,1,guanyl deoxyribonucleotide binding,MF,
7969,GO:0032567,1.00000000003938,0.95238661609668,0,1,dGTP binding,MF,
12452,GO:0050080,1.00000000003958,0.955430750151556,0,1,malonyl-CoA decarboxylase activity,MF,
16478,GO:0097145,1.00000000003958,0.955430750151556,0,1,BAK complex,CC,
20327,GO:2001294,1.00000000003958,0.955430750151556,0,1,malonyl-CoA catabolic process,BP,
16218,GO:0090238,1.00000000004067,0.841150251206799,0,4,positive regulation of arachidonic acid secretion,BP,
12871,GO:0051177,1.00000000004089,0.839509306351393,0,4,meiotic sister chromatid cohesion,BP,
5131,GO:0015556,1.00000000004094,0.714248083731741,0,7,C4-dicarboxylate transmembrane transporter activity,MF,
15936,GO:0072708,1.00000000004101,0.827220174600138,0,4,response to sorbitol,BP,
9471,GO:0036085,1.00000000004133,0.952339482814567,0,1,GDP-fucose import into Golgi lumen,BP,
1659,GO:0004111,1.00000000004165,0.83709078815723,0,4,creatine kinase activity,MF,
1309,GO:0003150,1.00000000004191,0.812554311313132,0,4,muscular septum morphogenesis,BP,
1535,GO:0003917,1.00000000004224,0.821435406718036,0,4,DNA topoisomerase type I activity,MF,
13223,GO:0051852,1.0000000000426,0.85012529987103,0,4,disruption by host of symbiont cells,BP,
13229,GO:0051873,1.0000000000426,0.85012529987103,0,4,killing by host of symbiont cells,BP,
19053,GO:1904877,1.00000000004325,0.955789521348933,0,1,positive regulation of DNA ligase activity,BP,
17149,GO:0102339,1.00000000004421,0.954415246475414,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
17150,GO:0102340,1.00000000004421,0.954415246475414,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
17151,GO:0102341,1.00000000004421,0.954415246475414,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
17152,GO:0102342,1.00000000004421,0.954415246475414,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18241,GO:1903026,1.00000000004448,0.860867902582479,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
10923,GO:0044528,1.00000000004479,0.826365471600813,0,4,regulation of mitochondrial mRNA stability,BP,
16736,GO:0097726,1.00000000004829,0.96915390621885,0,1,LEM domain binding,MF,
